<SEC-DOCUMENT>0001193125-23-266296.txt : 20231030
<SEC-HEADER>0001193125-23-266296.hdr.sgml : 20231030
<ACCEPTANCE-DATETIME>20231030172139
ACCESSION NUMBER:		0001193125-23-266296
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		114
FILED AS OF DATE:		20231030
DATE AS OF CHANGE:		20231030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Abacus Life, Inc.
		CENTRAL INDEX KEY:			0001814287
		STANDARD INDUSTRIAL CLASSIFICATION:	INVESTMENT ADVICE [6282]
		IRS NUMBER:				851210472
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-274553
		FILM NUMBER:		231361538

	BUSINESS ADDRESS:	
		STREET 1:		2101 PARK CENTER DRIVE, SUITE 170
		CITY:			ORLANDO
		STATE:			FL
		ZIP:			32835
		BUSINESS PHONE:		(800) 561-4148

	MAIL ADDRESS:	
		STREET 1:		2101 PARK CENTER DRIVE, SUITE 170
		CITY:			ORLANDO
		STATE:			FL
		ZIP:			32835

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	East Resources Acquisition Co
		DATE OF NAME CHANGE:	20200605
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>d423260ds1a.htm
<DESCRIPTION>S-1/A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:abl="http://www.emslp.com/20230630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>S-1/A</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="">
<h5><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="hidden91072615" contextRef="P01_01_2023To06_30_2023">S-1/A</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2023To06_30_2023">0001814287</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2023To06_30_2023">false</ix:nonNumeric><ix:footnote id="FN_315464" xml:lang="en-US">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of Business Combination.</ix:footnote><ix:footnote id="FN_315465" xml:lang="en-US">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of the successful Business Combination.</ix:footnote></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="abl-20230630.xsd"/></ix:references><ix:resources><xbrli:context id="P01_01_2023To06_30_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_01_2022To10_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-10-01</xbrli:startDate> <xbrli:endDate>2022-10-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To01_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-01-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P11_01_2021To11_30_2021"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-11-01</xbrli:startDate> <xbrli:endDate>2021-11-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn10_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-10-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn11_30_2021"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-11-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_01_2021"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-01</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn10_04_2021"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-10-04</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_07_2022To01_07_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-07</xbrli:startDate> <xbrli:endDate>2022-01-07</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abl:OwnersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ExpenseReimbursementsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:MarketPlaceTechnologyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:APATechnologyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipsFinancialRelationshipsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipAgentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipsFinancialRelationshipsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:MarketPlaceTechnologyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipAgentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:APATechnologyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abl:OwnersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdThreeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ExpenseReimbursementsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LongevityMarketAdvisorsLLCMemberdeiLegalEntityAxis_RegionalInvestmentServicesIncMembersrtOwnershipAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:LongevityMarketAdvisorsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:RegionalInvestmentServicesIncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-04-01</xbrli:startDate> <xbrli:endDate>2022-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_InvestmentMethodRevenueBenchmarkMemberusgaapConcentrationRiskByBenchmarkAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:InvestmentMethodRevenueBenchmarkMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFaceValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:AmericanGeneralLifeInsuranceCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:AmericanGeneralLifeInsuranceCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:ReliaStarLifeInsuranceCompanyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFaceValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:ReliaStarLifeInsuranceCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFaceValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:LincolnNationalLifeInsuranceCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:LincolnNationalLifeInsuranceCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_PrivatePlacementWarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">abl:LifeSettlementContractMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdThreeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ScenarioPreviouslyReportedMembersrtRestatementAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ServiceFeeAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ServiceFeeAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-01</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_04_2021To10_04_2021_LMXSeriesLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LMXSeriesLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-10-04</xbrli:startDate> <xbrli:endDate>2021-10-04</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P10_04_2021To10_04_2021_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-10-04</xbrli:startDate> <xbrli:endDate>2021-10-04</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P03_03_2022To03_03_2022_LongevityMarketAdvisorsLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LongevityMarketAdvisorsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-03-03</xbrli:startDate> <xbrli:endDate>2022-03-03</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P03_03_2022To03_03_2022_RegionalInvestmentServicesIncMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:RegionalInvestmentServicesIncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-03-03</xbrli:startDate> <xbrli:endDate>2022-03-03</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipAgentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:MarketPlaceTechnologyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:APATechnologyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P06_30_2023To06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipsFinancialRelationshipsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-30</xbrli:startDate> <xbrli:endDate>2023-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-22</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_01_2022To12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-12-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_21_2020To12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesB1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-12-21</xbrli:startDate> <xbrli:endDate>2020-12-21</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesB1PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-21</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-01</xbrli:startDate> <xbrli:endDate>2023-08-14</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_25_2020_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-08-25</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_16_2022_LMATTSeries22024IncMembersrtOwnershipAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-16</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMembersrtOwnershipAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-16</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-16</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-16</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_PolicyAPAMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:PolicyAPAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_LineOfCreditMemberusgaapCreditFacilityAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_05_2023_BaseRateMemberusgaapVariableRateAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-07-05</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn08_30_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-08-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-05</xbrli:startDate> <xbrli:endDate>2023-07-05</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-05</xbrli:startDate> <xbrli:endDate>2023-07-05</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:VariableRateComponentAxis">abl:VariableRateComponentOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-05</xbrli:startDate> <xbrli:endDate>2023-07-05</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:VariableRateComponentAxis">abl:VariableRateComponentTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-05</xbrli:startDate> <xbrli:endDate>2023-07-05</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="abl:VariableRateComponentAxis">abl:VariableRateComponentThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-05</xbrli:startDate> <xbrli:endDate>2023-07-05</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_16_2022To09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-09-16</xbrli:startDate> <xbrli:endDate>2022-09-16</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P03_31_2022To03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-03-31</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P03_31_2022To03_31_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-03-31</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">abl:LifeSettlementContractMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">abl:LifeSettlementContractMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AbacusSettlementsLLCMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001814287</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Year"> <xbrli:measure>utr:Year</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Day"> <xbrli:measure>utr:Day</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Month"> <xbrli:measure>utr:Month</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD_per_Share"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><xbrli:unit id="Unit_insurance_contract"> <xbrli:measure>abl:insurance_contract</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_entity"> <xbrli:measure>abl:entity</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_segment"> <xbrli:measure>abl:segment</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_provider"> <xbrli:measure>abl:provider</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_option"> <xbrli:measure>abl:option</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_extension"> <xbrli:measure>abl:extension</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_payment"> <xbrli:measure>abl:payment</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_investor"> <xbrli:measure>abl:investor</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_vote"> <xbrli:measure>abl:vote</xbrli:measure> </xbrli:unit><ix:relationship fromRefs="Fact_91071780" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91071827" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91071834" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91071835" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91071836" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91071837" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91071838" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91071839" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072917" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072918" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072950" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91072951" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91072952" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91072953" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91072956" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91072957" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91072958" toRefs="FN_315464"></ix:relationship><ix:relationship fromRefs="Fact_91072974" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072975" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072976" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072977" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072978" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072979" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072980" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072981" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072982" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072983" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072984" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072985" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072986" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072987" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072988" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072989" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072990" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072991" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072992" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072993" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072994" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072995" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072996" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072997" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072998" toRefs="FN_315465"></ix:relationship><ix:relationship fromRefs="Fact_91072999" toRefs="FN_315465"></ix:relationship></ix:resources></ix:header></div><div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="-sec-ix-redline:true;;display:inline;;font-weight:bold;display:inline;">As filed with the Securities and Exchange Commission on <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">October 30</div>, 2023. </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: right;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Registration <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;333-274553</div> </div></div> <div style="font-size: 4pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 4pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="line-height: 1pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 14pt; margin-top: 4pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; letter-spacing: 0px; top: 0px;;display:inline;">U<div style="letter-spacing: 0px; top: 0px;;display:inline;">N</div>ITED STATES </div></div></div></div> <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 14pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; letter-spacing: 0px; top: 0px;;display:inline;">SECURITIES AND EXCHANGE COMMISSION </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Washington, D.C. </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">20549 </div></div></div></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center;;text-indent: 0px;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 14pt; font-family: &quot;Times New Roman&quot;; text-align: center;"></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 14pt; margin-top: 2pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="-sec-ix-redline:true;;display:inline;">AMENDMENT No.&#160;2 </div></div></div></div></div> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 14pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="-sec-ix-redline:true;;display:inline;;font-weight:bold;display:inline;"> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 14pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; letter-spacing: 0px; top: 0px;;display:inline;">TO</div></div></div></div> </div> <div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0pt; margin-bottom: 0pt; font-size: 14pt; text-align: center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">FORM<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden91072615">S-1</span></div></div></div></div> <div style="letter-spacing: 0px; font-size: 14pt;;font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="letter-spacing: 0px; top: 0px; text-indent: 0px; background: none; text-decoration: none;;display:inline;"> </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 14pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; letter-spacing: 0px; top: 0px;;display:inline;">REGISTRATION STATEMENT </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">UNDER </div></div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">THE SECURITIES ACT OF 1933 </div></div></div></div></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center;;text-indent: 0px;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 20pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 20pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2023To06_30_2023">Abacus Life, Inc.</ix:nonNumeric> </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(<div style="letter-spacing: 0px; top: 0px;;display:inline;">Exact </div>Name of Registrant as Specified in Its Charter) </div></div></div></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center;;text-indent: 0px;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 7pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 34%;"/>
<td style="vertical-align: bottom;"/>
<td style="width: 32%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td style="width: 32%;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="P01_01_2023To06_30_2023" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityPrimarySicNumber" contextRef="P01_01_2023To06_30_2023">6282</ix:nonNumeric></div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="P01_01_2023To06_30_2023">85-1210472</ix:nonNumeric></div></div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 7pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">(State or Other Jurisdiction of</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">Incorporation or Organization)</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">(Primary Standard Industrial</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">Classification Code Number)</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">(I.R.S. Employer</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">Identification No.)</div></div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_01_2023To06_30_2023">2101 Park Center Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="P01_01_2023To06_30_2023">Suite 170</ix:nonNumeric> </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_01_2023To06_30_2023">Orlando</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_01_2023To06_30_2023" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_01_2023To06_30_2023">32835</ix:nonNumeric> </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_01_2023To06_30_2023">800</ix:nonNumeric>) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_01_2023To06_30_2023">561-4148</ix:nonNumeric></div> </div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices) </div></div></div></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center;;text-indent: 0px;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Jay J. Jackson</ix:nonNumeric> </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Chief Executive Officer </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Abacus Life, Inc. </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">2101 Park Center Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Suite 170</ix:nonNumeric> </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Orlando</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">32835</ix:nonNumeric> </div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">800</ix:nonNumeric>) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">561-4148</ix:nonNumeric></div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">Service) </div></div></div></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center;;text-indent: 0px;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Copies to: </div></div></div></div></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 51%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td style="width: 47%;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Brian T. Casey, Esq.</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Locke Lord LLP</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Terminus 200, Suite 2000</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">3333 Piedmont Road, NE</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Atlanta, GA 30305</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(404) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">870-4600</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: top;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Michael J. Kessler, Esq.</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">David E. Brown, Esq.</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Alston &amp; Bird LLP</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">90 Park Avenue</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">New York, NY 10016</div></div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">(202) 239-3300</div></div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center;;text-indent: 0px;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> <div style="font-family: Times New Roman; font-size: 7pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Approximate date of commencement of proposed sale to the public:</div></div> As soon as practicable after the effective date of this Registration Statement </div></div> <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"> </div> <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 7pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, please check the following box.&#8194;&#9744; </div></div></div> <div style="font-family: Times New Roman; font-size: 7pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </div></div></div> <div style="font-family: Times New Roman; font-size: 7pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </div></div></div> <div style="font-family: Times New Roman; font-size: 7pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </div></div></div> <div style="font-family: Times New Roman; font-size: 7pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accelerated</div> filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12b-2</div> under the Securities Exchange Act of 1934: </div></div> <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"> </div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 7pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 14%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td style="width: 64%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td style="width: 17%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td style="width: 2%;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 7pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Large&#160;accelerated&#160;filer</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9744;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Accelerated filer</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9744;</div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 7pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityFilerCategory" contextRef="P01_01_2023To06_30_2023" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#9746;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Smaller&#160;reporting&#160;company</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="P01_01_2023To06_30_2023" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div></td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td colspan="2" style="height: 6pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 7pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Emerging&#160;growth&#160;company</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P01_01_2023To06_30_2023" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></div></td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 7pt; margin-top: 2pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="P01_01_2023To06_30_2023" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric> </div></div></div> <div style="letter-spacing: 0px; top: 0px; background: none;;text-indent: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;display:inline;"> </div></div> <div style="font-size: 2pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 2pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center;;text-indent: 0px;"> <div style="margin: 0pt auto 2pt; width: 21%; text-align: center; line-height: 6pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; margin-top: 4pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 7pt; letter-spacing: 0px; top: 0px;;display:inline;">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section&#160;8(a), may determine. </div></div></div></div> <div style="font-size: 4pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 4pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="line-height: 1pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </div> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><span style="color:#ff4338"><span style="font-weight:bold">This preliminary prospectus relates to a registration statement under the Securities Act of 1933 but is not complete and may be changed. This preliminary prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </span></span></p> <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="color:#ff4338"><span style="font-weight:bold">Subject to Completion, Dated October 30, 2023. </span></span></p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">PRELIMINARY PROSPECTUS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g10a01.jpg" alt="LOGO"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Up to $60,000,000 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman;font-weight:bold;text-align:center">% Fixed Rate Senior Notes due 2028 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc., a Delaware corporation (&#8220;Abacus&#8221; or the &#8220;Company&#8221;), is offering up to $60,000,000 aggregate principal amount of Fixed Rate Senior Notes (the &#8220;notes&#8221;). The notes will bear interest at the rate of&#8195;&#8195;% per annum, payable quarterly in arrears on March&#160;30, June&#160;30, September&#160;30 and December&#160;30 of each year, beginning on December&#160;30, 2023 and ending on the maturity date. The notes will mature on September&#160;30, 2028 (the &#8220;maturity date&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may, at its option, redeem the notes in whole or in part at any time or from time to time on or after September&#160;30, 2025 at a redemption price of 100% of the outstanding principal amount of the notes to be redeemed plus accrued and unpaid interest payments otherwise payable thereon for the then-current quarterly interest period accrued to, but excluding, the date fixed for redemption as further described under &#8220;<span style="font-style:italic">Description of the Notes&#8212;Optional Redemption</span>.&#8221; In addition, each holder of the notes may require the Company to repurchase all or a portion of such holder&#8217;s notes at a purchase price equal to 100% of their principal amount, plus accrued and unpaid interest thereon, if any, to, but excluding, the date of repurchase as further described under <span style="font-style:italic">&#8220;Description of the Notes-Offer to Repurchase Upon a Change of Control Repurchase Event.&#8221;</span> The notes will not be entitled to any sinking fund. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes will be senior unsecured obligations of the Company and will rank equal in right of payment to all of the Company&#8217;s other senior unsecured indebtedness from time to time outstanding (including the Company&#8217;s $10.5&#160;million Amended and Restated Unsecured Senior Promissory Note, dated as of July&#160;5, 2023). Because the notes will not be secured by any of the Company&#8217;s assets, they will be effectively subordinated to any future secured indebtedness of the Company to the extent of the value of the assets securing such indebtedness. The notes will be structurally subordinated to all existing and future indebtedness and other obligations of any of the Company&#8217;s subsidiaries because the notes will be obligations exclusively of the Company and will not be guaranteed by any of the Company&#8217;s subsidiaries. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes will be issued only in registered book-entry form, in minimum denominations of $25 and integral multiples of $25 in excess thereof. The Company intends to list the notes on the Nasdaq Global Market<sup style="font-size:75%; vertical-align:top">&#174;</sup> (&#8220;NASDAQ&#8221;) within 30 days of the original issue date under the trading symbol &#8220;&#8195;&#8195;&#8195;&#8195; .&#8221; Currently, there is no public market for the notes and there can be no assurance that one will develop. </p> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Investing in the notes involves risks. See &#8220;</span><span style="font-weight:bold"><span style="font-style:italic"><a href="#stoc423260_17a">Risk Factors</a></span></span><span style="font-weight:bold">&#8221; beginning on page 10 of this prospectus for a discussion of risks that you should consider in connection with an investment in the notes. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes nor have any of the foregoing authorities determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:74%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Per<br/>Note</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total<sup style="font-size:75%; vertical-align:top">(2)</sup></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Price to Public<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">60,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discount</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to the Company</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">60,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><sup style="font-size:75%; vertical-align:top">(1)</sup>&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Plus accrued interest, if any, from &#8195;, 2023. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><sup style="font-size:75%; vertical-align:top">(2)</sup>&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">We have granted the underwriters an option to purchase up to an additional $&#8195;&#8195;&#8195; aggregate principal amount of the notes, solely to cover overallotments, if any, within 30 days from the date of this prospectus. If the underwriters exercise this option in full, the total public offering price will be $&#8195;&#8195;&#8195;, the total underwriting discounts and commissions paid by us will be $&#8195;&#8195;&#8195;, and total proceeds, before expenses, to us will be $&#8195;&#8195;&#8195;. </p></td></tr></table> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters expect to deliver the notes in book-entry only form through the facilities of The Depository Trust Company on or about November&#8195;&#8195;, 2023, which is the fifth business day following the pricing of the Notes. </p></div> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt;width:100%;border:0">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<td style="vertical-align:top;white-space:nowrap" align="center"><span style="font-weight:bold">Piper Sandler</span></td></tr>
</table> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">[*] </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">The date of this prospectus is&#8195;&#8195;&#8195;&#8195;, 2023 </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Neither we nor the underwriters have authorized any other person to provide you with any information other than that contained or incorporated by reference in this prospectus. Neither we nor the underwriters take any responsibility for, or provide any assurance as to the reliability of, any other information that others may give you. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">We are not, and the underwriters are not, making an offer to sell the notes in any jurisdiction where the offer or sale is not permitted. This prospectus does not constitute an offer of, or an invitation on our behalf or on behalf of the underwriters to subscribe for and purchase, any securities, and may not be used for or in connection with an offer or solicitation by anyone, in any jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an offer or solicitation. You should assume that the information contained in this prospectus is accurate only as of the date on the front of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc">TABLE OF CONTENTS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Prospectus </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:96%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_1">INFORMATION ABOUT THIS PROSPECTUS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_3">FORWARD-LOOKING STATEMENTS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_4">SUMMARY</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_4a">RISK FACTORS SUMMARY</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_5">THE OFFERING</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_17a">RISK FACTORS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_7">USE OF PROCEEDS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_8">CAPITALIZATION OF ABACUS LIFE AND ITS CONSOLIDATED SUBSIDIARIES</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc423260_8a">UNAUDITED PRO FORMA FINANCIAL INFORMATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc423260_8b">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc423260_8c">BUSINESS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc423260_8d">MANAGEMENT</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">94</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc423260_8e">EXECUTIVE AND DIRECTOR COMPENSATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc423260_8f">PRINCIPAL SECURITYHOLDERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">107</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#toc423260_8g">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_9">DESCRIPTION OF THE NOTES</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">110</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_10">BOOK-ENTRY ISSUANCE</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">118</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_11">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_12">UNDERWRITING</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">126</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_13">LEGAL MATTERS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">130</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_14">EXPERTS</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#stoc423260_15">WHERE YOU CAN FIND ADDITIONAL INFORMATION</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">132</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">i </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_1">INFORMATION ABOUT THIS PROSPECTUS </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement on Form <span style="white-space:nowrap">S-1</span> (File <span style="white-space:nowrap">No.&#160;333-</span><span style="text-decoration:underline">274553</span>). As permitted by SEC rules, this prospectus does not contain all of the information included in the registration statement. For further information, we refer you to the registration statement, including its exhibits. Statements contained in this prospectus about the provisions or contents of any agreement or other document are not necessarily complete. If the SEC&#8217;s rules and regulations require that an agreement or document be filed as an exhibit to the registration statement, please see that agreement or document for a complete description of these matters. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus together with any additional information you may need to make your investment decision. You should also read and carefully consider the information in the documents we have referred you to in &#8220;<span style="font-style:italic">Where You Can Find Additional Information</span>&#8221; below. Neither we nor the underwriters have authorized any other person to provide you with any information other than that contained in this prospectus. Neither we nor the underwriters take any responsibility for, or provide any assurance as to the reliability of, any other information that others may give you. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References in this prospectus to &#8220;Abacus,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Abacus Life, Inc. (formerly known as East Resources Acquisition Company), and not to any of its consolidated subsidiaries, unless otherwise specified or as the context otherwise requires. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_3">FORWARD-LOOKING STATEMENTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus includes forward-looking statements regarding, among other things, the plans, strategies and prospects, both business and financial, of the Company. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements are based on the beliefs and assumptions of the management of the Company. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These statements may be preceded by, followed by or include the words &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;forecasts,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;seeks,&#8221; &#8220;plans,&#8221; &#8220;scheduled,&#8221; &#8220;possible,&#8221; &#8220;continue,&#8221; &#8220;potential,&#8221; &#8220;anticipates&#8221; or &#8220;intends&#8221; or similar expressions; provided that the absence of these does not means that a statement is not forward-looking. Forward-looking statements contained in this prospectus include, but are not limited to, statements about the ability of the Company to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">realize the benefits expected from the previously disclosed business combination (the &#8220;Business Combination&#8221;) and related transactions consummated by the Company on June&#160;30, 2023; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">maintain the listing of the Company on a securities exchange; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">achieve projections and anticipate uncertainties relating to the business, operations and financial performance of the Company, including: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expectations with respect to financial and business performance, including financial projections and business metrics and any underlying assumptions thereunder; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expectations regarding product development and pipeline; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expectations regarding market size; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expectations regarding the competitive landscape; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">expectations regarding future acquisitions, partnerships or other relationships with third parties; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">future capital requirements and sources and uses of cash, including the ability to obtain additional capital in the future. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">develop, design and sell services that are differentiated from those of competitors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">retain and hire necessary employees; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">attract, train and retain effective officers, key employees or directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">enhance future operating and financial results; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">comply with laws and regulations applicable to its business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">stay abreast of modified or new laws and regulations applying to its business, including privacy regulation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">anticipate the impact of, and response to, new accounting standards; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">anticipate the significance and timing of contractual obligations; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">maintain key strategic relationships with partners and customers. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_4">SUMMARY </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">This summary highlights selected information included in this prospectus and does not contain all of the information that may be important to you. You should read the entire prospectus and the other documents to which we refer before you decide to invest. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overview of the Company </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. is composed of two principal operating subsidiaries, Abacus Settlements, LLC (&#8220;Abacus Settlements&#8221;) and Longevity Market Assets, LLC (&#8220;LMA&#8221;). These principal operating subsidiaries comprise a leading vertically integrated alternative asset manager specializing in investing in inforce life insurance products throughout the lifecycle of a life insurance policy. As an alternative asset manager, the Company focuses on originating, holding and servicing life insurance policies. The Company purchases life insurance policies from consumers seeking liquidity and actively manages those policies over time (via trading, holding and/or servicing). To date, the Company has purchased over $2.9&#160;billion in policy value and has helped thousands of clients maximize the value of their life insurance policies. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The mailing address of the Company&#8217;s principal executive office is 2101 Park Center Drive, Suite 170, Orlando, Florida 32835 and the telephone number of the Company&#8217;s principal executive office is <span style="white-space:nowrap"><span style="white-space:nowrap">800-561-4148.</span></span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary of Historical Financial Data for LMA </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The summary of historical statements of income data of LMA for the years ended December&#160;31, 2022 and 2021 and the historical balance sheet data as of December 31, 2022 and December 31, 2021 are derived from LMA&#8217;s audited financial statements included elsewhere in this prospectus. The summary historical statements of income data of LMA for the six months ended June 30, 2023 and 2022 and the balance sheet data as of June&#160;30, 2023 and 2022 are derived from LMA&#8217;s unaudited interim condensed financial statements included elsewhere in this prospectus. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LMA&#8217;s historical results are not necessarily indicative of the results that may be expected in the future. The information below is only a summary and should be read in conjunction with the section entitled &#8220;<span style="font-style:italic">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span>&#8221; and the financial statements, and the notes and schedules related thereto, which are included elsewhere in this prospectus. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:53%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the six<br/>months&#160;ended<br/>June 30, 2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the six<br/>months&#160;ended<br/>June 30, 2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the&#160;year&#160;ended<br/>December 31,<br/>2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/><span style="white-space:nowrap">the&#160;year-ended</span><br/>December 31,<br/>2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Statement of Income Data:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,584,974</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,276,299</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44,713,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,199,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,462,950</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,086,075</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,245,131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">735,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,122,024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,190,224</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,468,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">464,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales, general, administrative, and depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,689,417</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,298,344</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,666,826</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">597,702</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,398,662</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">375,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss on investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(798,156</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,054,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Income (loss) from operations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,832,101</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,461,392</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,665,255</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other (expense) income Other (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(21,651</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(242,247</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347,013</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(941,458</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(42,798</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,457</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,474</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Total other (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(955,652</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(242,247</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(388,337</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Income (loss) before income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,876,449</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,219,145</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,276,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for Income taxes (benefit)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(528,104</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(296,806</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the six<br/>months&#160;ended<br/>June 30, 2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the six<br/>months&#160;ended<br/>June 30, 2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the&#160;year&#160;ended<br/>December&#160;31,<br/>2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/><span style="white-space:nowrap">the&#160;year-ended</span><br/>December&#160;31,<br/>2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net Income (Loss) attributable to Noncontrolling Interest</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(487,303</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">406,641</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net and Comprehensive Income (loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 14,835,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,515,698</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,386,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Balance Sheet Data:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">277,334,437</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,933,083</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,094,847</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,840,218</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">116,835,522</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,626,292</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,945,150</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,073,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total members&#8217; equity</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160,498,915</td>
<td style="white-space:nowrap;vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,306,791</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,149,697</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">766,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary of Historical Financial Data for Abacus Settlements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The summary historical statements of income data of Abacus Settlements for the years ended December 31, 2022 and 2021 and the historical balance sheet data as of December 31, 2022 and December 31, 2021 are derived from Abacus Settlement&#8217;s audited financial statements included elsewhere in this prospectus. The summary historical statements of income data of Abacus Settlements for the three months ended June 30, 2023 and 2022 and the balance sheet data as of June 30, 2023 and 2022 are derived from our unaudited interim financial statements included elsewhere in this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Settlement&#8217;s historical results are not necessarily indicative of the results that may be expected in the future. The information below is only a summary and should be read in conjunction with the section entitled &#8220;<span style="font-style:italic">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span>&#8221; and the financial statements, and the notes and schedules related thereto, which are included elsewhere in this prospectus. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the six</span><br/><span style="font-weight:bold">months&#160;ended<br/>June&#160;30, 2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As&#160;of&#160;and&#160;for<br/>the six<br/>months&#160;ended<br/>June&#160;30, 2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/>the&#160;year&#160;ended<br/>December 31,<br/>2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of and for<br/><span style="white-space:nowrap">the&#160;year-ended</span><br/>December 31,<br/>2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Statement of Income Data:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,184,676</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,014,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,203,463</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,592,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,293,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,787,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,561,005</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,205,341</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,891,373</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,227,039</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,642,458</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,386,803</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating Expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,854,177</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,954,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,686,590</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,449,688</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Income (loss) from operations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(962,804</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,693</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(44,132</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">937,115</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other (expense) income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,147</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,199</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,870</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,725</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,817</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting income . . . . . . . . . . . . . . .</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income . . . . . . . . . . . . . . . . . . .</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">630</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Total other (expense) income </span>. . . . .</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,808</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,345</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">61,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Income (loss) before income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(972,612</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">274,113</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">(50,477)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">998,615</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for Income taxes.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">1,200</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net income (loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(52,495</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">997,415</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Balance Sheet Data:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,666,138</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,215,812</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">$5,291,997</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1.330.224</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,204,675</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">2,569,002</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total members&#8217; equity</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2.335.914</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,011,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">2,722,995</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_4a">RISK FACTORS SUMMARY </p> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The notes will be unsecured and therefore are effectively subordinated to any secured indebtedness we have incurred or may incur in the future. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The indenture under which the notes are issued contains limited protection for holders of the notes. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">There is no existing trading market for the notes, and, even if NASDAQ approves the listing of the notes, an active trading market for the notes may not develop, which could limit your ability to sell the notes or the market price of the notes. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We may choose to redeem the notes when prevailing interest rates are relatively low. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">An increase in interest rates could result in a decrease in the fair value of the notes. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">A downgrade, suspension or withdrawal of any credit rating assigned by a rating agency to us or the notes or change in the debt markets could cause the liquidity or market value of the notes to decline significantly. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the notes. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We may not be able to repurchase the notes upon a Change of Control Repurchase Event. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company has entered into certain credit agreements. Each of these agreements limit the Company&#8217;s ability to enter into further credit facilities or take on additional debt which could result in additional financial strain on the Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company&#8217;s valuation of certain life insurance policies is tied to their actual maturity date and any erroneous valuations could have a material adverse impact on the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company could fail to accurately forecast life expectancies. There may also be changes to life expectancies generally, which could result in a lower return on the Company&#8217;s life settlement policies. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company&#8217;s policy acquisitions are limited by the market availability of life insurance policies that meet the Company&#8217;s eligibility criteria and purchase parameters; failure to secure a sufficient number of quality life insurance policies could have a material adverse effect on the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company may experience increased competition from originating life insurance companies, life insurance brokers, and investment funds which could adversely affect the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Historically, there has been a negative public perception of the life settlement industry that could affect the value and/or liquidity of the Company&#8217;s investments and the life settlement industry faces political opposition from life insurance companies which could adversely affect the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company or third parties the Company relies upon could fail to accurately evaluate, acquire, maintain, track, or collect on life settlement policies, which could adversely affect the Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">There is a risk of fraud in the origination of the original life insurance policy or in subsequent sales of the life insurance policy that could adversely affect the Company&#8217;s returns. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company may become subject to claims by life insurance companies, individuals and their families, or regulatory authorities. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If the life settlements in which the Company invests were to become regulated as securities, further compliance with federal and state securities laws would be required, which could result in significant additional regulatory burdens on the Company and limit the Company&#8217;s investments. </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company faces privacy and cyber security risks related to its maintenance of proprietary information, including information regarding life settlement policies and the related insureds, and any adverse impact related to such risks could have a material adverse impact on the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company is subject to U.S. privacy laws and regulations. Failure to comply with such obligations could lead to regulatory investigations or actions; litigation; fines and penalties; disruptions of operations; reputational harm; loss of revenue or profits; and other adverse business consequences. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company&#8217;s business may be subject to additional or different government regulation in the future, which could have a material adverse impact on the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">There is currently no direct legal authority regarding the proper federal tax treatment of life settlements and potential future rulings from the Internal Revenue Service (&#8220;IRS&#8221;) may have significant tax consequences on the Company. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">There have been lawsuits in various states questioning whether a purchaser of a life insurance policy has the requisite &#8220;insurable interest&#8221; in the policy which would permit the purchaser to collect the insurance benefits and an adverse finding in any of these lawsuits could have a material adverse effect on the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The failure of the Company to accurately and timely track and pay premium payments on the life insurance policies it holds could result in the lapse of such policies which would have a material adverse impact on the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The originating life insurance company may increase the cost of insurance premiums, which would adversely affect the Company&#8217;s returns. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company may not be able to liquidate its life insurance policies which could have a material adverse effect on the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company assumes the credit risk associated with life insurance companies and may not be able to realize the full value of insurance company payouts. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company&#8217;s success is dependent upon the services of its management and employees. If the Company is unable to such individuals, its ability to compete could be harmed. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company&#8217;s intellectual property rights may not adequately protect the Company&#8217;s business. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The Company may become subject to costly intellectual property disputes. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The ongoing COVID-19 pandemic, along with rising interest rates and inflation, may disrupt the ability of the Company and its providers to originate life settlement policies which could have a material adverse impact on the Company&#8217;s financial position. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">We have identified material weaknesses in our internal control over financial reporting. If our remediation of these issues is not effective, or if we experience additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to accurately or timely report our financial condition or results of operations. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">If we do not develop and implement all required accounting practices and policies, we may be unable to provide the financial information required of a public company in a timely and reliable manner. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our ability to raise capital in the future may be limited, or may be unavailable on acceptable terms, if at all. Debt issued to raise additional capital could affect our ability to execute our investment strategy or impact the value of our investments. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our management has limited experience in operating a public company. </p></td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_5">THE OFFERING </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The following is a brief summary of certain terms of this offering. For a more complete description of the terms of the notes, see &#8220;Description of the Notes</span>&#8221;<span style="font-style:italic"> in this prospectus.</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:37%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:61%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Issuer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Abacus Life, Inc., a Delaware corporation.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title of the securities</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">% Fixed Rate Senior Notes due 2028 (the &#8220;notes&#8221;).</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Initial aggregate principal amount being&#160;offered</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">$60,000,000</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Overallotment option</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The underwriters may also purchase from us up to an additional $ aggregate principal amount of notes solely to cover overallotments, if any, within 30 days of the date of this prospectus.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Principal payable at maturity</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">100% of the aggregate principal amount. The outstanding principal amount of the notes will be payable on the stated maturity date at the office of the trustee, paying agent and security registrar for the notes or at such other office as we may designate.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Maturity date</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The notes will mature on September&#160;30, 2028.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Interest rate</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">&#8195;% per annum.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Interest periods</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The initial interest period will be the period from and including the issue date, to, but excluding, the initial interest payment date, and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Interest payment dates</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Each March&#160;30, June&#160;30, September&#160;30 and December&#160;30, beginning on December&#160;30, 2023 and ending on the maturity date. If an interest payment date falls on a <span style="white-space:nowrap">non-business</span> day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Interest day count convention</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Interest will be computed on the basis of a <span style="white-space:nowrap">360-day</span> year consisting of twelve <span style="white-space:nowrap">30-day</span> months.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Record dates</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Interest will be paid to the person in whose name a note is registered at the close of business on the 15th calendar day (whether or not a Business Day) preceding the related date an interest payment is due with respect to such note; <span style="font-style:italic">provided</span> that if the notes are global notes held by DTC, the record date for such notes will be the close of business on the Business Day preceding the applicable interest payment date.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">No guarantees</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The notes are not guaranteed by any of the Company&#8217;s subsidiaries. As a result, the notes will be structurally subordinated to the liabilities of the Company&#8217;s subsidiaries as discussed below under &#8220;<span style="font-style:italic">Ranking</span>.&#8221;</td></tr></table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:37%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:61%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Ranking</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be the Company&#8217;s senior unsecured obligations and will rank: (i)&#160;equal in right of payment to the Company&#8217;s other outstanding and future senior unsecured indebtedness (including the Company&#8217;s $10.5&#160;million Amended and Restated Unsecured Senior Promissory Note, dated as of July&#160;5, 2023); (ii) senior to any of the Company&#8217;s existing and future indebtedness that expressly provides it is subordinated to the notes (including the Company&#8217;s indebtedness under its SPV Investment Facility, dated as of July&#160;5, 2023); (iii) effectively subordinated to all of the Company&#8217;s existing and future secured indebtedness (including indebtedness that is initially unsecured to which the Company subsequently grants security), to the extent of the value of the assets securing such indebtedness; and (iv)&#160;structurally subordinated to all existing and future indebtedness and other obligations of any of the Company&#8217;s subsidiaries.</p> <p style="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">As of July&#160;5, 2023, the Company had approximately $25&#160;million in principal amount of other senior unsecured long-term debt outstanding, all of which will be repaid with the proceeds of this offering, and approximately $35.5&#160;million in principal amount of subordinated long-term debt outstanding.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Optional redemption</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes may be redeemed in whole or in part at any time or from time to time at the Company&#8217;s option on or after September&#160;30, 2025, upon not less than 15 days nor more than 60 days written notice to holders prior to the date fixed for redemption thereof, at a redemption price of 100% of the outstanding principal amount of the notes to be redeemed plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to, but not including, the date fixed for redemption.</p> <p style="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may be prevented from exchanging or transferring the notes when they are subject to redemption. Any exercise of our option to redeem the notes will be done in compliance with the Indenture.</p> <p style="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">If the Company redeems only some of the notes by partial redemption, the global notes shall be selected in accordance with applicable rules and procedures of the Depository Trust Company (&#8220;DTC&#8221;), or in the case of certificated notes, any other method in accordance with the policies and procedures of the trustee. Unless we default in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the notes called for redemption.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Change of control offer to repurchase</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">If the Company is subject to a Change of Control Repurchase Event, each holder of the Notes may require the Company to purchase all or a portion of such holder&#8217;s notes at a price equal to 100% of their principal amount, plus accrued and unpaid interest thereon, if any, to, but excluding, the date of purchase.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Repayment at holder&#8217;s option</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The notes will not be subject to repayment at the option of the holder at any time prior to the maturity date, except as set forth under <span style="font-style:italic">&#8220;Description of the Notes-Offer to Repurchase Upon a Change of Control Repurchase Event&#8221;</span> and will not be entitled to any sinking fund.</td></tr>
</table> </div>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<div style="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:37%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:61%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Use of proceeds</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The net proceeds from the offering will be approximately $ million, after deducting the discounts and commissions payable to the underwriters and estimated offering expenses payable by us. The Company intends to use these proceeds for to refinance outstanding debt, which will include the Owl Rock Credit Facility, with the remained used for general corporate purposes. For further information, see &#8220;<span style="font-style:italic">Use of Proceeds</span>&#8221; in this prospectus.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Form and denomination</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The notes will be issued as fully registered global notes which will be deposited with, or on behalf of, the DTC and registered, at the request of DTC, in the name of Cede&#160;&amp; Co. Beneficial interests in the global notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as participants in DTC. Beneficial interests in the global notes must be held in minimum denominations of $25 or any amount in excess thereof which is an integral multiple of $25.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Further issuances</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The amount of debt securities the Company can issue under the Indenture is unlimited. The Company will issue notes in the initial aggregate principal amount of $&#8195;&#8195;&#8195; ($&#8195;&#8195;&#8195; if the underwriters&#8217; overallotment option is exercised in full). However, the Company may, without your consent and without notifying you, create and issue further notes, which notes may be consolidated and form a single series with the series of notes offered by this prospectus and may have the same terms as to interest rate, maturity, covenants or otherwise; <span style="font-style:italic">provided</span> that if any such additional notes are not fungible with the notes for U.S. federal income tax purposes, such additional notes will have a separate CUSIP or other identifying number.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Events of default</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">For a discussion of events that will permit acceleration of the payment of the principal of the notes, see &#8220;<span style="font-style:italic">Description of the Notes&#8212;Events of Default; Waivers</span>&#8221; in this prospectus.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Indenture and trustee</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The notes will be issued under an indenture, to be entered into with U.S. Bank Trust Company, National Association, as trustee, as supplemented by a supplemental indenture relating to the issuance of the notes.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Governing law</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The notes will be governed by and construed in accordance with the laws of the State of New York.</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Listing</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">We intend to list the notes on NASDAQ within 30 days of the issue date under the trading symbol &#8220; &#8195;&#8195;&#8195;.&#8221;</td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Risk factors</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">An investment in the notes involves risks. You should carefully consider the information set forth in the section entitled &#8220;&#8212;<span style="font-style:italic">Risk Factors&#8221; </span>below, as well as other information included in this prospectus before deciding whether to invest in the notes.<span style="font-style:italic"></span></td></tr>
</table>
</div></div>

 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_17a">RISK FACTORS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">You should carefully consider the risks and uncertainties described below and the other information in this prospectus before making an investment in our notes. Our business, financial condition, results of operations, or prospects could be materially and adversely affected if any of these risks occurs, and as a result, the market price of our notes could decline and you could lose all or part of your investment. This prospectus also contains forward-looking statements that involve risks and uncertainties. See the section titled &#8220;Forward-Looking Statements.&#8221; Our actual results could differ materially and adversely from those anticipated in these forward-looking statements as a result of certain factors, including those set forth below. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to our Notes </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The notes will be unsecured and therefore are effectively subordinated to any secured indebtedness we have incurred or may incur in the future. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes will not be secured by any of our assets or any of the assets of our subsidiaries, including our wholly owned subsidiaries. As a result, the notes will be effectively subordinated to all of our existing and future secured indebtedness (including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness. As of June&#160;30, 2023, the Company and its subsidiaries had long-term debt with a fair market value of $66,165,396. Because the notes will not be secured by any of our assets, they will be effectively subordinated to any secured indebtedness we may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our future secured indebtedness may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The notes will be structurally subordinated to the indebtedness and other liabilities of our subsidiaries. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes will be obligations exclusively of the Company, and will not be of any of our subsidiaries. None of our subsidiaries will be a guarantor of the notes and the notes are not required to be guaranteed by any subsidiary we may acquire or create in the future. Any assets of our subsidiaries will not be directly available to satisfy the claims of our creditors, including holders of the notes. Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors of our subsidiaries will have priority over our equity interests in such entities (and therefore the claims of our creditors, including holders of the notes) with respect to the assets of such entities. Even if we are recognized as a creditor of one or more of these entities, our claims would still be effectively subordinated to any security interests in the assets of any such entity and to any indebtedness or other liabilities of any such entity senior to our claims. Consequently, the notes will be structurally subordinated to all indebtedness and other liabilities of any of our subsidiaries and portfolio companies with respect to which we hold equity investments. As of June&#160;30, 2023, the Company and its subsidiaries had long-term debt with a fair market value of $66,165,396. In addition, the Company and its subsidiaries may incur substantial indebtedness in the future, all of which would be structurally senior to the notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The indenture under which the notes are issued contains limited protection for holders of the notes. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indenture under which the notes are issued offers limited protection to holders of the notes. The terms of the indenture and the notes do not restrict our or any of our subsidiaries&#8217; ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have a material adverse impact on your investment in the notes. In particular, the terms of the indenture and the notes do not place any restrictions on our or our subsidiaries&#8217; ability to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">issue securities or otherwise incur additional indebtedness or other obligations, including (1)&#160;any indebtedness or other obligations that would be equal in right of payment to the notes, (2)&#160;any </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the notes to the extent of the values of the assets securing such debt and (3)&#160;indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore is structurally senior to the notes; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">enter into transactions with affiliates; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">make investments; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">create restrictions on the payment of dividends or other amounts to us from our subsidiaries. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the terms of the indenture and the notes do not protect holders of the notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, if any, as they do not require that we adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow, or liquidity. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the notes may have important consequences for you as a holder of the notes, including making it more difficult for us to satisfy our obligations with respect to the notes or negatively affecting the trading value of the notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other debt we issue or incur in the future could contain more protections for its holders than the indenture and the notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">There is no existing trading market for the notes, and, even if NASDAQ approves the listing of the notes, an active trading market for the notes may not develop, which could limit your ability to sell the notes or the market price of the notes. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes will be a new issue of debt securities for which there initially will not be a trading market. We intend to list the notes on NASDAQ within 30 days of the original issue date under the symbol &#8220;&#8195;.&#8221; However, there is no assurance that the notes will be approved for listing on NASDAQ. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, even if the listing of the notes is approved, we cannot provide any assurances that an active trading market will develop or be maintained for the notes or that you will be able to sell your notes. If the notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, if any, general economic conditions, our financial condition, performance and prospects and other factors. The underwriters have advised us that they intend to make a market in the notes, but they are not obligated to do so. The underwriters may discontinue any market-making in the notes at any time at their sole discretion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, we cannot assure you that the notes will be approved for listing on NASDAQ, that a liquid trading market will develop for the notes, that you will be able to sell your notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the notes for an indefinite period of time. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may choose to redeem the notes when prevailing interest rates are relatively low. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or after &#8195;&#8195;&#8195;&#8195;, 2025, we may choose to redeem the notes from time to time, especially when prevailing interest rates are lower than the rate borne by the notes. If prevailing rates are lower at the time of redemption, you would not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the interest rate on the notes being redeemed. Our redemption right also may adversely impact your ability to sell the notes as the optional redemption date or period approaches. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">An increase in interest rates could result in a decrease in the fair value of the notes. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, as market interest rates rise, notes bearing interest at a fixed rate generally decrease in value. Consequently, if you purchase these notes and market interest rates increase, the fair value of your notes will likely decrease. We cannot predict the future level of market interest rates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">A downgrade, suspension or withdrawal of any credit rating assigned by a rating agency to us or the notes or change in the debt markets could cause the liquidity or market value of the notes to decline significantly. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any credit rating is an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in any credit ratings will generally affect the market value of the notes. These credit ratings may not reflect the potential impact of risks relating to the structure or marketing of the notes. Credit ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization in its sole discretion. Neither we nor any underwriter undertakes any obligation to obtain or maintain any credit ratings or to advise holders of notes of any changes in any credit ratings. There can be no assurance that any credit ratings will remain for any given period of time or that such credit ratings will not be lowered or withdrawn entirely by the rating agencies if in their judgment future circumstances relating to the basis of the credit ratings, such as adverse changes in our company, so warrant. The conditions of the financial markets and prevailing interest rates have fluctuated in the past and are likely to fluctuate in the future, which could have an adverse effect on the market price of the notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the notes. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any default under the agreements governing our indebtedness that is not waived by the required lenders and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the notes and substantially decrease the market value of the notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness, including the notes. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the other debt we may incur in the future could elect to terminate its commitment, cease making further loans and institute foreclosure proceedings against our assets and we could be forced into bankruptcy or liquidation. In addition, any such default may constitute a default under the notes, which could further limit our ability to repay our debt, including the notes. If our operating performance declines, we may in the future need to seek to obtain waivers from the lender under the other debt that we may incur in the future to avoid being in default. If we breach our covenants under the other debt and seek a waiver, we may not be able to obtain a waiver from the required lenders. If this occurs, we would be in default under the other debt, the lender could exercise its rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We may not be able to repurchase the notes upon a Change of Control Repurchase Event. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of a Change of Control Repurchase Event, unless we have exercised our right to redeem the notes, each holder of the notes will have the right to require us to repurchase all or any part of such holder&#8217;s notes at a price equal to 100% of their principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the date of repurchase. If we experience a Change of Control Repurchase Event, there can be no assurance that we would have sufficient financial resources available to satisfy our obligations to repurchase the notes and any other indebtedness that may be required to be repaid or repurchased as a result of such event. A failure to repurchase the notes as required under the indenture would result in a default under the indenture, which could have material adverse consequences for us and the holders of the notes. See &#8220;<span style="font-style:italic">Description of the Notes&#8212;Offer to Repurchase Upon a Change of Control Repurchase Event</span>&#8221; herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">On or about June&#160;30, 2023, the Company entered into each of the Owl Rock Credit Facility, the SPV Purchase and Sale, including the Policy APA, and the SPV Investment Facility. Each of these agreements limits the Company&#8217;s ability to enter into further credit facilities or take on additional debt which could result in additional financial strain on the Company. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Owl Rock Credit Facility </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;5, 2023, the Company entered into a Credit Agreement (the &#8220;Owl Rock Credit Facility&#8221;), among the Company, as borrower, the several banks and other persons from time to time party thereto (the &#8220;Owl Rock Lenders&#8221;), and Owl Rock Capital Corporation, as administrative and collateral agent for the Owl Rock Lenders thereunder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Owl Rock Credit Facility, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">requires Abacus Settlements and LMA and certain subsidiaries of Abacus Settlements and LMA to guarantee the loans to be provided under the Owl Rock Credit Facility pursuant to separate loan documentation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides credit extensions for (i)&#160;an initial term loan in an aggregate principal amount of $25.0&#160;million upon the closing of the Owl Rock Credit Facility, and (ii)&#160;a delayed draw term loan in an aggregate principal amount of $25.0&#160;million, with the delayed draw term loan drawn in a period between 90 and 120 days after the closing of the Owl Rock Credit Facility upon satisfaction of certain conditions precedent; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides proceeds from the Owl Rock Credit Facility for working capital and the business requirements of the enterprise, and to fund acquisitions, investments and other transactions not prohibited by the loan documentation (with expected prohibitions related to, among other potential items, the use of such proceeds to pay transaction costs incurred in connection with the Business Combination); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">contains a maturity date that shall be the date that is five years after the closing of the Owl Rock Credit Facility; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">is secured by a first-priority security interest in substantially all of the assets of the Company and the subsidiary guarantors. No pledge of any equity interests in the Company shall be required by any holder of such equity interests; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides for interest to accrue on such loans, at the election of the Company, by reference to either (i)&#160;an alternative base rate (such loans, &#8220;ABR Loans&#8221;) or (ii)&#160;an adjusted term SOFR rate (such loans, &#8220;SOFR Loans&#8221;) plus an applicable margin. The adjusted term SOFR rate is expected to be determined by the applicable term SOFR for a relevant interest period plus a credit spread adjustment of 0.10%, 0.15% and 0.25% per annum for interest periods of 1, 3 and 6 months, respectively. The applicable margin for each type of loan is expected to be (i)&#160;6.25% per annum for any ABR Loans and (ii) 7.25% per annum for any SOFR Loans, with an expected interest period for SOFR Loans of one, three or six months (or other periods if agreed by all lenders); </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides a default rate that will accrue at 2.00% per annum over the rate otherwise applicable; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides for amortization payments based on the initial principal amount of the loans outstanding of 1.0% per year (0.25% due per quarter), with adjustments expected to be made to the overall amortization amount upon the incurrence of the delayed draw loans; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">contains provisions requiring mandatory prepayment of the initial term loans and delayed draw term loans with 100% of the proceeds of (i)&#160;indebtedness not permitted by the Owl Rock Credit Facility and <span style="white-space:nowrap">(ii)&#160;non-ordinary</span> course asset dispositions and settlements or payments in respect of any property, casualty insurance claims or condemnation proceedings, with the proceeds received under clause (ii)&#160;subject to certain specified reinvestment rights and procedures to be set forth in the Owl Rock Credit Facility. The Owl Rock Credit Facility permits voluntary prepayments of outstanding loans at any time; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides for a prepayment premium equal to (i) 4.00% of the principal amount of such loans prepaid on or prior to the first anniversary of the closing of the Owl Rock Credit Facility, (ii) 3.00% of the principal amount of such loans prepaid after the first anniversary of the closing of the Owl Rock Credit Facility but on or prior to the second anniversary of the closing of the Owl Rock Credit Facility and (iii) 2.00% of the principal amount of such loans prepaid after the second anniversary of the closing of the Owl Rock Credit Facility but on or prior to the third anniversary of the closing of the Owl Rock Credit Facility. No prepayment premium will be applicable for any such prepayment made after the third anniversary of the closing of the Owl Rock Credit Facility. The prepayment premium is expected to be applicable to voluntary prepayments and certain specified mandatory prepayment during such applicable periods; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">contains certain closing conditions that the Owl Rock Credit Facility is subject to, including (i)&#160;the consummation of the Business Combination pursuant to the terms of the Merger Agreement and (ii)&#160;satisfaction of the conditions precedent to funding of the initial term loans, which is expected to include, among others, (A)&#160;customary deliverables for financings of this type, (B)&#160;a notice of borrowing request and (C)&#160;payment of certain other specified fees. It is also expected that the funding of delayed draw term loans will be subject to certain specified conditions, including, among others, the making of representations, the absence of events of defaults and a notice of borrowing request; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides for financial covenants such that (i)&#160;a consolidated net leverage ratio cannot exceed 2.50 to 1.00 and (ii)&#160;a liquid asset coverage ratio cannot be less than 1.80 to 1.00; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">contains affirmative covenants related to, among other things, delivery of certain financial reports and compliance certificates, maintenance of existence, compliance with laws, payment of taxes, property and insurance matters, inspection of property, books and records, notices, collateral matters and future subsidiaries, in each case, subject to specified limitations and exceptions; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">contains negative covenants related to, among other things, incurrence of debt, creation of liens, mergers, acquisitions and certain other fundamental changes, conditions concerning the creation of new subsidiaries, conditions concerning opening of new accounts, disposition of assets, dividends and other restricted payments, transactions with affiliates, burdensome agreements, investments and limitations on lines of business, in each case, subject to specified limitations and exceptions; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provides for certain specified events of default upon the occurrence and continuation of certain events or conditions (subject to specified exceptions, grace periods or cure rights, as applicable) each as set forth in the Owl Rock Credit Facility, which includes, among other things, with respect to <span style="white-space:nowrap">non-payment,</span> representations and warranties, compliance with covenants, cross-default to other material indebtedness, bankruptcy and insolvency matters, ERISA matters, material judgments, collateral and perfection matters, and the occurrence of a change of control. The occurrence and continuance of an event of default that is not cured or waived will enable the agent and/or the lenders, as applicable, to accelerate the loans or take other remedial steps as provided in the Owl Rock Credit Facility and the other loan documents. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SPV Purchase and Sale </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or about June&#160;30, 2023 the Company entered into the Abacus Investment SPV, LLC (&#8220;SPV&#8221;) Purchase and Sale, including the Asset Purchase Agreement (&#8220;Policy APA&#8221;). The Company and the SPV are parties to the Policy APA. The payable obligation owing by the Company to the SPV in connection with the SPV Purchase and Sale is evidenced by a note issued by the Company under the SPV Investment Facility in an original principal amount equal to the aggregate fair market value of the acquired insurance policies. The aforementioned note has the same material terms and conditions as the other credit extensions under the SPV Investment Facility (as defined below). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Relationships </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor, members of the Company&#8217;s founding team, directors or officers of Abacus Settlements and LMA or its or their affiliates are members of the SPV and thereby indirectly receive economic or other benefits from the Policy APA. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">SPV Investment Facility </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or about July&#160;5, 2023, the Company entered into a SPV Investment Facility (the &#8220;SPV Investment Facility&#8221;), between the Company, as borrower, and the SPV, as lender. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SPV Investment Facility, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">was unsecured without collateral security expected to be provided in favor of the SPV; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">evidenced or provided for certain credit extensions to include: (i)&#160;an initial credit extension in an original principal amount of $15.0&#160;million that is expected to be funded upon the closing of the SPV Investment Facility, (ii)&#160;a note in favor of the SPV in an original principal amount of $10.0&#160;million to finance the purchase of the insurance policies under the Policy APA and (iii)&#160;a delayed draw credit extension in an original principal amount of $25.0&#160;million, with the delayed draw credit extension drawn in a period between 90 and 120 days after the closing of the SPV Investment Facility upon satisfaction of certain conditions precedent (such $25.0&#160;million delayed drawing expected to be made substantially concurrently with the delayed drawing in the same amount expected under the Owl Rock Credit Facility); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provided proceeds from the SPV Investment Facility for payment of certain transaction expenses, general corporate purposes and any other purposes not prohibited by law (it being expected that a significant portion of the proceeds from the SPV Investment Facility will be used by the Company for purchasing insurance policies, among other purposes); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">was subordinated in right of payment to the Company&#8217;s obligations under the Owl Rock Credit Facility, subject to limited specified exceptions and circumstances for permitting early payment; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">required Abacus Settlements and LMA and certain subsidiaries of Abacus Settlements and LMA to guarantee the credit extensions to be provided under the SPV Investment Facility pursuant to separate documentation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">contained a maturity date that is at least three years after the closing of the SPV Investment Facility, subject to two automatic extensions of one year each without any amendment of the relevant documentation; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provided for interest to accrue on the SPV Investment Facility at a rate of 12.00% per annum, payable quarterly, all of which is expected be paid <span style="white-space:nowrap">in-kind</span> by the Company by increasing the principal amount of the SPV Investment Facility owing to the SPV on each interest payment date; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provided a default rate that will accrue at 2.00% per annum (subject to applicable subordination restrictions) over the rate otherwise applicable. If cash payment is not permitted due to applicable subordination restrictions or otherwise, such default interest shall be paid <span style="white-space:nowrap">in-kind;</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provided that no amortization payments shall be required prior to maturity; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provided for financial and other covenants no worse than those contained in the Owl Rock Credit Facility from the perspective of the Company; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">provided for certain specified events of default (including certain events of default which are expected to be subject to grace or cure periods), with the occurrence and continuance of such events of default enabling the lender under the SPV Investment Facility to accelerate the obligations under the SPV Investment Facility, among other potential rights or remedies; and contain certain specified closing conditions. The SPV&#8217;s investment resulting from credit extensions under the SPV Investment Facility is expected to be treated by the Company as debt for U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) accounting purposes. To the extent that multiple notes are issued under the SPV Investment Facility, it is expected that the documentation will provide flexibility for the SPV to request such notes be reissued as a single note under such facility. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Relationships </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Directors and officers of the Company and significant shareholders of the Company are members of the SPV and thereby indirectly receive economic or other benefits from the SPV Investment Facility. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to the Business of the Company </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company&#8217;s valuation of life insurance policies is uncertain as many life insurance policies&#8217; values are tied to their actual maturity date and any erroneous valuations could have a material adverse impact on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The valuation of life insurance policies involves inherent uncertainty (including, without limitation, the life expectancies of insureds and future increases in premium costs to keep the policies in force). There is no guarantee that the value determined with respect to a particular life settlement policy by the Company will represent the value that will be realized by the Company on the eventual disposition of the related investment or that would, in fact, be realized upon an immediate disposition of the investment. In addition, there can be no guarantee that such valuation accurately reflects the current present value of such life insurance policy at its actual maturity. Uncertainties as to the valuation of life insurance policies held by the Company could require adjustments to reported net asset values and could have a material adverse impact on the Company&#8217;s business. Uncertainties as to the valuation may also result in the Company being less competitive in the market for originating new life settlement policies and could adversely affect the profits the Company realizes on life settlements purchased and sold. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company could fail to accurately forecast life expectancies. There may also be changes to life expectancies generally, resulting in people living longer in the future, which could result in a lower return on the Company&#8217;s life settlement policies. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prices for life insurance policies and annuities that may be obtained by the Company depend, in large measure, upon the life expectancy of the underlying insureds. The returns of the Company&#8217;s hold portfolio is almost entirely dependent upon how accurate the actual longevity of an insured is as compared to the Company&#8217;s expectation for that insured. Life expectancies are estimates of the expected longevity or mortality of an insured. In determining the life expectancy of an insured, the Company relies on medical underwriting conducted by various medical underwriting firms. The medical underwriting process underlying life expectancy estimates is highly subjective, and mortality and longevity estimates are inherently uncertain. In addition, there can be no assurance that the applicable medical underwriting firm received accurate or complete information regarding the health of an insured under a life insurance policy, or that such insured&#8217;s health has not changed since the information was received. Different medical underwriting firms use different methods and may arrive at materially different mortality estimates for the same individual based on the same information, thus causing a life </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
insurance policy&#8217;s value to vary. Moreover, as methods of calculating mortality estimates change over time, a mortality estimate prepared by any medical underwriting firm in connection with the acquisition of a life insurance policy may be different from a mortality estimate prepared by the same person at a later time. The valuation of the life insurance policies will vary depending on the dates of the related mortality estimates and the medical underwriting firms that provide the supporting information. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other factors, including, but not limited to, better access to health care, better adherence to treatment plans, improved nutritional habits, improved lifestyle, an improved economic environment and a higher standard of living could also lead to increases in the longevity of the insureds under the life insurance policies. In addition to other factors affecting the accuracy of life expectancy estimates, improvements in medicine, disease treatment, pharmaceuticals and other medical and health services may enable insureds to live longer. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The actual longevity of an insured may be materially different than the predicted mortality estimate. If the actual maturity date of life insurance policies are longer than projected, it would delay when the Company could expect to receive a return on its investment and the Company may be unable to meet its investment objectives and goals. For example, a term life insurance policy in which the Company may invest have a stated expiration date on the date at which the underlying insured reaches a certain attained age and, beyond such date, the issuing insurance company may not be obligated to pay the face value, but rather only the cash surrender value which is usually maintained at a low value by investors, if any, in accordance with the terms of such life insurance policy. Therefore, if the underlying insured survives to the stated maturity date set forth in the terms of the life insurance policy, the issuing insurance company may only be obligated to pay an amount substantially less than the face value, which could have an adverse effect on the performance of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The medical underwriting and other firms that provide information for the Company&#8217;s forecasts of life expectancies are generally not regulated by the U.S. federal or state governments, with the exception of the states of Florida and Texas, which require life expectancy providers to register with their respective offices of insurance regulation. There can be no assurance that this business will not become more broadly regulated and, if so, that any such regulation would not have a material adverse effect on the ability of the Company to establish appropriate life expectancies in connection with the purchase or sale of policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company&#8217;s policy acquisitions are limited by the market availability of life insurance policies that meet the Company&#8217;s eligibility criteria and purchase parameters, and failure to secure a sufficient number of quality life insurance policies could have a material adverse effect on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The life insurance policy secondary market has grown substantially in the past several years, however, as to whether and how it will continue to develop is uncertain. There are only a limited number of life insurance policies available in the market from time to time. There can be no assurance that the Company will be able to source life insurance policies on terms acceptable to the Company. As more investment funds flow into the market for life insurance policies, margins may be squeezed and the value of the collateral may become comparatively more expensive to purchase or subject to greater competition on the purchase side. There can be no assurance that secondary market life insurance policies will be available to the Company on satisfactory or competitive terms. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The supply of life insurance policies available in the market may be reduced by, among other things: (i)&#160;improvement in the economy, resulting in higher investment returns to insureds and other owners of life insurance policies from their investment portfolios; (ii)&#160;improvements in health insurance coverage, limiting the need of insureds to obtain funds to pay the cost of their medical treatment by selling their life insurance policies; (iii)&#160;the entry into the market of less reputable third-party brokers who submit inaccurate or false life insurance policy information to the Company; (iv)&#160;the establishment of new licensing requirements for market participants and a delay in complying or an inability to comply with such new requirements; or (v)&#160;refusal of the carrier that issued a life insurance policy to consent to its transfer. A change in the availability of life insurance policies could adversely affect the Company&#8217;s ability to execute its strategy and meet its objectives. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company may experience increased competition from originating life insurance companies, life insurance brokers, and investment funds which could have a material adverse effect on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Life insurance companies have begun offering to repurchase their own <span style="white-space:nowrap">in-force</span> life insurance policies from their current policyholders by offering &#8220;enhanced cash surrender value payments&#8221; above the amount of the net cash surrender value provided under the life insurance contracts&#8217; terms and thus compete directly with the Company and other life settlement providers. The life settlements industry has challenged the legal validity of the life insurance companies&#8217; actions, and some state insurance regulators have declared that these repurchase offers are unlawful while other state insurance regulators have approved them. To the extent that life insurance companies can seek to repurchase their own <span style="white-space:nowrap">in-force</span> life insurance policies, they present competition to the Company in acquiring policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Company is subject to significant competition from other life settlement brokers and investment funds for the purchase of life settlement policies. Increased competition for life settlement policies may result in the Company being unable to access the number of life settlement policies that it desires for its business at prices that it deems acceptable. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Historically, there has been a negative public perception of the life settlement industry that could affect the value and/or liquidity of the Company&#8217;s investments and the life settlement industry faces political opposition from life insurance companies which could have a material adverse effect on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many regulators, lawmakers and other governmental authorities, as well as many insurance companies and insurance industry organizations, are hostile to or otherwise concerned about certain aspects of the longevity-contingent asset markets. The life settlement industry and some of its participants have also been, and may continue to be, portrayed negatively in a number of widely read publications and other forms of media. These opponents regularly contend that life settlement transactions are contrary to public policy by promoting financial speculation on human life and often involve elements of fraud and other wrongdoing. Continued public opposition to the life settlement industry, as well as actual or alleged wrongdoing by participants in the industry, could have a material adverse effect on the Company and its investors, including on the value and/or liquidity of the Company&#8217;s investments. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2010, the American Council of Life Insurers, an insurance carrier trade association, issued a press release calling for a complete ban on life settlement securitization. While that effort was not successful, any such federal or state legislation, if passed, could have the effect of severely limiting or potentially prohibiting the continued operation of the Company&#8217;s life settlement purchasing operations. All of the foregoing could adversely affect the Company&#8217;s ability to execute its investment strategy and meet its investment objective. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company or third parties the Company relies upon could fail to accurately evaluate, acquire, maintain, track, or collect on life settlement policies, which could have a material adverse impact on the Company&#8217;s revenues. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company relies on third party data for tracking and servicing its life settlement policies. This includes the origination and servicing of life settlement policies by the servicing and tracking agent, market counterparties and other service providers, and the Company may not be in a position to verify the risks or reliability of such third-party data and systems. Failures in the systems employed by the Company and other service providers, counterparties, and other parties could result in mistakes made in the evaluation, acquisition, maintenance, tracking and collection of life settlement policies and other longevity-linked investments. This could result in the Company overpaying for life settlement policies it acquires or underpricing life settlement policies it sells. In addition, disruptions in the Company&#8217;s operations as a result of a failure in a third party system may cause the Company to suffer, among other things, financial loss, the disruption of its business, liability to third-parties, regulatory intervention or reputational damage. Any of the foregoing failures or disruptions could have a material adverse effect on the Company. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">There is a risk of fraud in the origination of the original life insurance policy or in subsequent sales of the life insurance policy that could adversely affect the Company&#8217;s returns which could have a material adverse impact on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company faces the risk that an original owner of a life insurance policy, the related insured, the insurance agent involved in the issuance of such life insurance policy, or other party may have committed fraud, or misstated or failed to provide material information in connection with the origination or subsequent sale of that life insurance policy. While most life insurance policies may not be challenged for fraud after the end of the <span style="white-space:nowrap">two-year</span> contestability period, there may be situations where such fraud in connection with the issuance of a life insurance policy may survive the contestability period. If an issuing insurance company successfully challenges a life insurance policy acquired by the Company on the grounds of fraud, the Company may lose its entire investment in that life insurance policy. Furthermore, if the age of an insured was misstated, the Company may receive lower death benefits than expected. In addition, there may be information directly relevant to the value of a life insurance policy, including, but not limited to, information relating to the insured&#8217;s medical or financial condition, to which the Company will not have access. It is not possible to verify the accuracy or completeness of each piece of information or the completeness of the overall information supplied by such parties. Any such misstatement or omission could cause the Company to rely on assumptions which turn out to be inaccurate. Additionally, there can be no assurance that the seller of a life insurance policy in the tertiary market properly acquired that policy from the former owner, or that a former beneficiary or other interested party will not attempt to challenge the validity of the transfer. The occurrence of any one or more of these factors could adversely affect the Company&#8217;s performance and returns. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company may become subject to claims by life insurance companies, individuals and their families, or regulatory authorities which could have a material adverse impact on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The secondary market for life insurance policies has been subjected to allegations of fraud and misconduct as reflected in certain litigated cases. Some of these cases, some of which have been brought by regulatory authorities, involve allegations of fraud, breaches of fiduciary duty, bid rigging, <span style="white-space:nowrap">non-disclosure</span> of material facts and associated misconduct in life settlement transactions. Cases have also been brought by the life insurance companies that challenge the legality of the original issuance of the life insurance policies based on lack of insurable interest, fraud and misrepresentation grounds. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, both federal and U.S. state statutes safeguard an insured&#8217;s private health information. In addition, insureds frequently have an expectation of confidentiality even if they are not legally entitled to it. Even if the Company properly obtains and uses otherwise private health information, but fails to maintain the confidentiality of such information, the Company may be the subject of complaints from the affected individuals, their families and relatives and, potentially, interested regulatory authorities. Because of the uncertainty of applicable laws, it is not possible to predict the outcome of those disputes. It is also possible that, due to a misunderstanding regarding the scope of consents that a transaction party possesses, the Company may request and receive from health care providers, information that it in fact did not have a right to request or receive. If the Company finds itself to be the recipient of complaints for these acts, it is not possible to predict what the results will be. This uncertainty also increases the likelihood that a transaction party may sell, or cause to be sold, life insurance policies in violation of applicable law, which could potentially result in additional costs related to defending claims or enduring regulatory inquiries, rescinding such transactions, possible legal damages and penalties and probable reduced market value of the affected life insurance policies. Each of the foregoing factors may delay or reduce the return on the policies and adversely affect the Company&#8217;s business and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Life settlements in which we invest are not currently regulated under the federal securities laws, but if deemed to be securities would require further compliance with federal and state securities laws, which could result in significant additional regulatory burdens on the Company, and limit the Company&#8217;s investments, which could have an adverse impact on the Company&#8217;s business and results of operations. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The origination and trading in whole, <span style="white-space:nowrap">non-variable</span> life insurance policies has historically been understood to not involve transactions in securities. However, on February&#160;22, 2019, the United States Court of Appeals for </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Fifth Circuit in a case captioned In the Matter of Living Benefits Asset Management, LLC, vs. Kestrel Aircraft Company, Incorporated, case <span style="white-space:nowrap">No.&#160;18-10510,</span> concluded that whole, <span style="white-space:nowrap">non-variable</span> life insurance policies, when offered for sale to an investor, were securities for purposes of the Investment Company Act. If this same conclusion were to be reached in other circuits or at the Supreme Court and extended to the Securities Act, there would be significant changes to our industry and it would materially impact the Company&#8217;s ability to conduct its business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2002, the Eleventh Circuit Court of Appeals reached a similar conclusion with respect to fractionalized death benefits payable under <span style="white-space:nowrap">non-variable</span> policies in SEC v. Mutual Benefits Corp., but, the District of Columbia Circuit Court of Appeals reached a contrary result with respect to fractionalized death benefits in SEC v. Life Partners which was decided in 1996. The Company does not presently transact in fractionalized death benefits, i.e. buying or selling a part of, but not all of, a life settlement policy, nor does it currently plan to transact in fractionalized death benefits. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;22, 2010, the SEC released a staff report that recommended that Congress clearly define life settlements to be securities, so that the investors in life settlements transactions would be protected under the U.S. federal securities laws. To date, the SEC has not made another such recommendation to Congress nor has Congress acted on the SEC staff&#8217;s report. If the statutory definitions of &#8220;security&#8221; were to be amended to encompass life settlements involving <span style="white-space:nowrap">non-variable</span> life insurance policies, or if the Supreme Court or other Circuit Courts were to conclude that <span style="white-space:nowrap">non-variable</span> life insurance policies are securities for purposes of the Securities Act, the Company could become subject to additional extensive regulatory requirements under the federal securities laws. Those regulatory requirements would include the obligation to register the Company&#8217;s sales and offerings of life settlements with the SEC as public offerings under the Securities Act. Also, if the resale of <span style="white-space:nowrap">non-variable</span> life insurance policies were to be considered securities, the Company&#8217;s ownership of those policies as a percentage of its assets or source of income could be limited as it would likely manage its business to avoid being required to register as an &#8220;investment company&#8221; pursuant to the Investment Company Act. Those limitations could have an adverse effect on the Company&#8217;s business and results of operations. Any legislation or court or regulatory interpretations leading to that regulatory change or a change in the transactions that are characterized as life settlement transactions could lead to significantly increased compliance costs and increased liability risk to the Company, and could adversely affect the Company&#8217;s ability to acquire or sell life insurance policies in the future. This could materially and adversely affect the Company&#8217;s business, financial condition and results of operations, which in turn could materially and adversely affect the performance of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company cannot assure you as to the ultimate content, timing, or effect of changes, nor is it possible at this time to estimate the impact of any such potential change in administration or new legislation on the Company&#8217;s business, financial condition, or results of operations and consequently, any potential material and adverse effect on the performance of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">The Company may be subject to certain U.S. state securities laws, and failure to comply with applicable requirements may result in fines, sanctions and rescission of purchase or sale transactions. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain U.S. state laws specifically characterize life settlements as securities transactions. Thus, in some U.S. states, purchases and sales of life insurance policies by the Company may be subject to applicable U.S. state blue sky laws or other U.S. state securities laws. The Company intends to comply with all applicable federal and state securities laws. However, this will not necessarily exempt the Company from compliance with U.S. federal or state broker-dealer laws. The failure to comply with applicable securities laws in connection with the purchase or sale of life settlement policies could result in the Company being subject to fines, administrative and civil sanctions and rescission of life settlement policy purchase or sales transactions. Each of the foregoing factors could materially and adversely affect the performance of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">The Company could in the future be required to register as an investment company under the Investment Company Act or could have to substantively change its business model in order to fit within an applicable exemption from such registration requirement. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s sales of life insurance policies and investment and financing programs of which the purchase or sale of a life insurance policy is a part are subject to an evolving regulatory landscape. Depending on the facts and circumstances attending such sales or programs, U.S. state and federal securities laws, including the Investment Company Act could be implicated, and it is possible that the Company could in the future be required to register as an investment company under the Investment Company Act. The Company would not be able to continue to operate its business as it does today if required to register as an investment company. In such event, the Company would have to substantively change its business model to avoid registration as an investment company under the Investment Company Act. If the Company were re quired to change its business model in order to fit within an exemption from registration, it would have a material adverse effect on the performance of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company faces privacy and cyber security risks related to its maintenance of proprietary information, including information regarding life settlement policies and the related insureds, and any adverse impact related to such risks could have a material adverse impact on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company relies on data processing systems to price and close transactions, to evaluate investments, to monitor its portfolio and capital, and to generate risk management and other reports that are critical to oversight of the Company&#8217;s activities. Further, the Company relies on information systems to store sensitive information about the Company, its affiliates, and its investments, including life settlement policies and information about the related insured individuals and others. While the Company is not aware of security breaches or proceedings related to the processing of information, the loss or improper access, use or disclosure of the Company&#8217;s proprietary information can adversely impact the Company. For example, the Company could suffer, among other things, financial loss, the disruption of its business, liability to third parties, regulatory intervention or reputational damage. Any of the foregoing events could have a material adverse effect on the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the Company collects information related to life insurance, including nonpublic personal information (&#8220;NPI&#8221;) and protected health information (&#8220;PHI&#8221;), and information from its website, such as contact information and high-level policy information. The Company also collects information from its employees, such as standard HR information, and business contact information from third party employees. The Company shares information with its service providers, and has entered into <span style="white-space:nowrap">non-disclosure</span> and business association agreements, where appropriate. Although the Company has, and believes that each service provider has, procedures and systems in place that it believes are reasonably designed to protect such information and prevent data loss and security breaches, such measures cannot guarantee absolute security. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the techniques used to obtain unauthorized access to data, disable or degrade service, or sabotage systems change frequently with increasing sophistication and may be difficult to detect for long periods of time. For example, hardware or software acquired from third parties may contain defects in design or other problems that could unexpectedly compromise information security. Network connected services provided by third parties to the Company may be susceptible to compromise, leading to a breach of the Company&#8217;s network and/or business interruptions. The Company&#8217;s systems or facilities may be susceptible to employee error or malfeasance, government surveillance, or other security threats. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company is subject to U.S. privacy laws and regulations. Failure to comply with such obligations could lead to regulatory investigations or actions; litigation; fines and penalties; disruptions of operations; reputational harm; loss of revenue or profits; and other adverse business consequences. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the type of information the Company collects, including personal, medical, and financial information on the underlying insureds, and the nature of its services, the Company is subject to privacy laws. In the United States, federal, state and local governments have enacted numerous data privacy and security laws to address privacy, data protection and collection, and the processing and disclosure of certain types of information. Obligations related to these laws are quickly changing, becoming increasingly stringent and creating regulatory uncertainty. In addition, these obligations may be subject to differing applications and interpretations, which can </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
result in inconsistency or conflict among jurisdictions. Among these laws, the Company is likely subject to the Telephone Consumer Protection Act (&#8220;TCPA&#8221;), Controlling Assault of <span style="white-space:nowrap">Non-Solicited</span> Pornography and Marketing Act of 2003, the Gramm-Leach Bliley Act (&#8220;GLBA&#8221;) and the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may be considered a financial institution under the GLBA, and is subject to the GLBA through the NPI it collects. The GLBA regulates, among other things, the use of certain information about individuals (NPI) in the context of the provision of financial services. The GLBA includes both a &#8220;Privacy Rule,&#8221; which imposes obligations on financial institutions relating to the use or disclosure of NPI, and a &#8220;Safeguards Rule,&#8221; which imposes obligations on financial institutions, and indirectly, their service providers, to implement and maintain physical, administrative and technological measures to protect the security of NPI. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has certain business components that are subject to HIPAA. HIPAA imposes privacy, security and breach notification obligations on &#8220;covered entities&#8221; and &#8220;business associates.&#8221; Furthermore, HIPAA requires &#8220;covered entities&#8221; and &#8220;business associates&#8221; to develop and maintain policies with respect to the protection of PHI. If in violation of HIPAA, the Company may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations. HIPAA also authorizes state Attorneys Generals to file suit on behalf of their residents. Courts may award damages, costs and attorneys&#8217; fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to sue the Company in civil court for violations of HIPAA, its standards have been used as the basis for duty of care in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the complexity of the various data privacy laws the Company may be subject to, compliance can be costly. The Company has taken general steps to comply with data privacy and security laws. For example, the Company has implemented a number of policies, including policies regarding access controls, customer data privacy, secure data disposal, and incident response and risk assessments. Despite these efforts, the Company may at times fail in its efforts due to the complexity and evolving nature of these laws. Failure to comply with relevant data privacy laws could negatively impact the Company&#8217;s operations, including subject the Company to possible government enforcement actions which could result in investigations, fines, penalties, audits, inspection, litigation, additional reporting requirements and/or oversight. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">The Company&#8217;s business may be subject to additional or different government regulation in the future, which could have a material adverse impact on the Company&#8217;s business.</span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is currently licensed and operating in 49 states. Increased regulation (whether promulgated under insurance laws or any other applicable law) and regulatory oversight of and changes in law applicable to life settlements may restrict the ability of the Company to carry on its business as currently conducted. This could also impose additional administrative burdens on the Company, including responding to examinations and other regulatory inquiries and implementing policies and procedures. Regulatory inquiries often are confidential in nature, may involve a review of an individual&#8217;s or a firm&#8217;s activities or may involve studies of the industry or industry practices, as well as the practices of a particular institution. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">There is currently no direct legal authority regarding the proper federal tax treatment of life settlements and potential future rulings from the IRS may have significant tax consequences on the Company.</span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no direct legal authority regarding the proper U.S. federal income tax treatment of life settlements, and the Company does not plan to request a ruling from the IRS. Consequently, significant aspects of the tax treatment of the Company&#8217;s assets are uncertain, and the IRS or a court might not agree with the Company&#8217;s treatment of life settlements as prepaid financial contracts that are not debt. If the IRS were successful in asserting an alternative treatment, the tax consequences of ownership and disposition of life settlements could be materially and adversely affected. In addition, in 2007, the U.S. Treasury Department and the IRS released a notice requesting public comments on various issues regarding the U.S. federal income tax treatment of &#8220;prepaid </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forward contracts&#8221; and similar instruments. Any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in life settlements, possibly with retroactive effect. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">There have been lawsuits in various states questioning whether a purchaser of a life insurance policy has the requisite &#8220;insurable interest&#8221; in the policy which would permit the purchaser to collect the insurance benefits and an adverse finding in any of these lawsuits could have a material adverse effect on the Company&#8217;s business.</span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All states require that the initial purchaser of a new life insurance policy insuring the life of another individual have an insurable interest in that individual&#8217;s life at the time of the original issuance of the policy. An &#8220;insurable interest&#8221; is an economic stake in an event for which a person or entity purchases an insurance policy. An insurance policy may only be initially purchased by a person or entity who has an insurable interest in the insured. For example, if a spouse purchases an insurance policy on his or her spouse or a company purchases an insurance policy on an employee. In addition, some states may require that the Company have an insurable interest in the insured. Whether an insurable interest exists in the context of the purchase of a life insurance policy is critical because in the absence of a valid insurable interest, life insurance policies are unenforceable under the laws of most states. Where a life insurance policy has been issued to a policy holder without an insurable interest in the life of the insured, the life insurance company may not be required to pay the face value under the policy and may also be entitled to retain the premiums paid. Generally, there are two forms of insurable interest in the life of an individual, familial and financial. Additionally, an individual is deemed to have an insurable interest in his or her own life. Insurable interest is determined at the inception of the policy. The definition of exactly what constitutes &#8220;insurable interest&#8221; tends to vary by state. Some cases have also been initiated by life insurance companies, challenging the legality of the original issuance of policies on insurable interest grounds and asserting that such policies constitute &#8220;Stranger-Originated Life Insurance&#8221; or &#8220;STOLI,&#8221; which is defined as a practice or plan to initiate a life insurance policy for a third-party investor who, at the time of policy origination, has no insurable interest in the insured. Some states (such as Utah and New York) permit the heirs and beneficiaries of an insured to recover the face value under such STOLI policies rather than the policy owner which lacked insurable interest. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the Company does not believe it has invested in any STOLI polices, and has policies and procedures in place to identify potential STOLI policies, there can be no guarantee that the Company will identify all STOLI policies. As such, the Company may acquire certain life insurance policies that may be deemed by an issuing insurance company to be STOLI policies, whether purposefully, if the Company deems such life insurance policy to be an attractive investment even after taking into account the insurable interest risk, or inadvertently, where the true nature of such life insurance policy is not discovered prior to its acquisition by the Company. Should an issuing insurance company successfully challenge the validity of a life insurance policy acquired by the Company, the Company will lose its investment in such life insurance policy. Furthermore, the Company will also suffer losses if a family member of an insured is successful in asserting a claim that he or she, and not the Company, is entitled to the face value payable under a life insurance policy. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The failure of the Company to accurately and timely track and pay premium payments on the life insurance policies it holds could result in the lapse of such policies which would have a material adverse impact on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to realize on its investment in life insurance policies, the Company must ensure that the life insurance policies remain in force until they mature or are sold by the Company. Failure by the Company to pay premiums on the life insurance policies when due will result in termination or &#8220;lapse&#8221; of the life insurance policies and will result in the loss of the Company&#8217;s investment in such life insurance policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The originating life insurance company may increase the cost of insurance premiums, which would adversely affect the Company&#8217;s returns. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For any life insurance policies that may be obtained by the Company, the Company will be responsible for maintaining the policies, including paying insurance premiums. If a life insurance company increases the cost of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
insurance charged for any of the life insurance policies held by the Company, the amounts required to be paid for insurance premiums due for these life insurance policies may increase, requiring the Company to incur additional costs for the life insurance policies which may reduce the value of such life insurance policies and consequently affect the returns available on such policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Life insurance companies have in the past materially increased the cost of insurance charges. There can be no assurance that life insurance policies acquired by the Company will not be subject to cost of insurance increases. If any such life insurance policies are affected by a cost of insurance increase, the value of such life insurance policy may be materially reduced and the Company may decide or may be forced to allow such life insurance policy to lapse, resulting in a loss to the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event an insurance company experiences significantly higher than anticipated expenses associated with operation and/or policy administration, or, in some instances, lower investment returns, the insurance company may have the right to increase the charges to each of its policy owners, but not beyond guaranteed maximums. While the insurance companies did not specify the reason for the increases, it is generally believed that the low interest rate environment was a significant contributing factor in the decision to raise the cost of insurance. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company may not be able to liquidate its life insurance policies which could have a material adverse effect on the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of its business, the Company engages in the purchase and sale of life insurance policies. The liquidation value of these life insurance policies is important where, for example, it becomes necessary to sell life insurance policies from the Company&#8217;s hold portfolio in order to meet the Company&#8217;s cash flow needs, including the payment of future premiums. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In many cases liquidations may not be a viable option to meet the Company&#8217;s liquidity because of, among other things: (1)&#160;the lack of a market for such life insurance policies at the time; (2)&#160;the uncertainties surrounding the liquidation value of an individual life insurance policy; (3)&#160;the extensive amount of time and effort it might take to sell a life insurance policy; (4)&#160;the effect excessive sales of life insurance policies may have on transactions and future cash flows; and (5)&#160;the tax consequences. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company assumes the credit risk associated with life insurance companies and may not be able to realize the full value of insurance company payouts which could have a material adverse effect on the Company&#8217;s profits. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will assume the credit risk associated with life insurance policies issued by various life insurance companies. The failure or bankruptcy of any such life insurance company could have a material adverse impact on the Company&#8217;s ability to achieve its investment objectives. A life insurance company&#8217;s business tends to track general economic and market conditions that are beyond its control, including extended economic recessions, interest rate changes, the subprime lending market crisis or changes in investor perceptions regarding the strength of insurers generally and the life insurance policies or annuities they offer. Adverse economic factors and volatility in the financial markets may have a material adverse effect on a life insurance company&#8217;s business obligation to pay the face value of policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The insolvency of any insurance company or a downgrade in the ratings of an insurance company could have a material adverse impact on the value of the related life insurance policies, the collectability of the related face value, cash surrender value or other amounts agreed to be paid by such insurance company. In the event that a life insurance carrier becomes insolvent or is placed into receivership, most state guaranty associations place a $300,000 or lower cap on face value for policies per insured. In addition to the limitations on the amount of coverage, which vary by state, there are limitations on who may make claims under such coverage and the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company may not be eligible to make claims under U.S. state guarantee funds as most U.S. state guarantee fund laws were enacted with the stated goal of assisting policyholders residing in such states. Even if available to the Company, guarantee fund coverage limits are typically smaller than the face values of some of the life insurance policies that the Company will acquire. There can be no assurance that as more life settlement transactions are undertaken, legislators will not adopt additional restrictions on the availability of U.S. state guaranty funds. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company&#8217;s success is dependent upon the services of its experienced management and talented employees. If the Company is unable to retain management and/or key employees, its ability to compete could be harmed. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The success of the Company is dependent upon the talents and efforts of highly skilled individuals employed by the Company and the Company&#8217;s ability to identify and willingness to provide acceptable compensation to attract, retain and motivate experienced management, talented investment professionals and other employees. Most of the shares registered for sale by the Registration Statement of which this Prospectus is a part are owned by our founders who are also key members of management of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that the Company&#8217;s management and professionals will continue to be associated with the Company, and the failure to attract or retain such professionals could have a material adverse effect on the Company&#8217;s ability to execute on its business plan. Competition in the financial services industry for qualified management and employees is intense and there is no guarantee that, if lost, the talents of the Company&#8217;s professionals could be replaced. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company&#8217;s intellectual property rights may not adequately protect the Company&#8217;s business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be successful, the Company must protect its technology, <span style="white-space:nowrap">know-how</span> and brand through means, such as<span style="font-weight:bold"><span style="font-style:italic"></span></span> trademarks, trade secrets, patents, copyrights, service marks, contractual restrictions, and other intellectual property rights and confidentiality procedures. Despite the Company&#8217;s efforts to implement these protections, they may not adequately protect its business for a variety of reasons, including: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">inability to successfully register or obtain patents and other intellectual property rights for important innovations that sufficiently protect the full scope of such innovations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">inability to maintain appropriate confidentiality and other protective measures to establish and maintain the Company&#8217;s trade secrets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">uncertainty in, and evolution of, legal standards relating to the validity, enforceability and scope of protection of intellectual property rights; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">potential invalidation of the Company&#8217;s intellectual property rights through administrative processes or litigation; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">other practical, resource, or business limitations on the Company&#8217;s ability to detect and prevent infringement or misappropriation of our rights and to enforce our rights. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Litigation may be necessary to enforce the Company&#8217;s intellectual property or proprietary rights, protect the Company&#8217;s trade secrets, or determine the validity and scope of proprietary rights claimed by others. Any litigation, whether or not resolved in the Company&#8217;s favor, could result in significant expense to the Company, and divert the time and efforts of the Company&#8217;s technical and management personnel. If the Company is unable to prevent third parties from infringing upon, violating or misappropriating the Company&#8217;s intellectual property or is required to incur substantial expenses defending the Company&#8217;s intellectual property rights, the Company&#8217;s business, financial condition and results of operations may be materially adversely affected. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The Company may become subject to intellectual property disputes, which are costly and may subject the Company to significant liability and increased costs of doing business. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may in the future become subject to intellectual property disputes. The Company&#8217;s success depends, in part, on the Company&#8217;s ability to operate without infringing, misappropriating or otherwise violating </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the intellectual property rights of third parties. However, the Company may not be aware that its practices are infringing, misappropriating or otherwise violating third-party intellectual property rights, and such third parties may bring claims against the Company or its business partners alleging such infringement, misappropriation or violation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any claims of intellectual property infringement, even those without merit, may be time-consuming and expensive to resolve, divert management&#8217;s time and attention, cause the Company to cease using or incorporating the asserted challenged intellectual property rights expose it to other legal liabilities, or require it to enter into licensing agreements to obtain the right to use a third party&#8217;s intellectual property. Although the Company carries general liability insurance, it may not cover potential claims of this type or may not be adequate to indemnify the Company for all liability that may be imposed. The Company cannot predict the outcome of lawsuits and cannot ensure that the results of any such actions will not have an adverse effect on the Company&#8217;s business, financial condition, or results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if the claims do not result in litigation or are resolved in the Company&#8217;s favor, these claims, and the time and resources necessary to resolve them, could divert the resources of the Company&#8217;s management and harm the Company&#8217;s business and results of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The ongoing <span style="white-space:nowrap">COVID-19</span> pandemic, along with rising interest rates and inflation, may disrupt the ability of the Company and its providers to originate life settlement policies which could have a material adverse impact on the Company&#8217;s financial position. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <span style="white-space:nowrap">COVID-19</span> pandemic disrupted the global economy in several ways, some of which are still unfolding. <span style="white-space:nowrap">COVID-19,</span> or any outbreak of contagious diseases and other adverse public health developments, particularly in the United States, could have a material and adverse effect on our business operations. These could include disruptions or restrictions on our ability to source life settlement policies, as well as temporary closures of our facilities and the facilities of our third-party service providers. Any disruption or delay of our third-party service providers would likely impact our operating results. In addition, a significant outbreak of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of the United States and throughout the world, resulting in an economic downturn that could affect demand for the life insurance policies and significantly impact the Company&#8217;s operating results. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We have identified material weaknesses in our internal control over financial reporting. And, prior to the Business Combination, we were not timely in filing our Form 10-K for the year ended December 31, 2022 and our Form 10-Q for the quarter ended March 31, 2023. If our remediation of the material weaknesses are not effective, or if we experience additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls in the future, we may not be able to accurately or timely report our financial condition or results of operations. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the audit of our financial statements for Abacus and LMA for the years ended December&#160;31, 2022 and 2021, we identified the same material weakness in our internal control over financial reporting for both Abacus and LMA. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses for both entities related to members of executive management having access to post to the general ledger; members of finance having inappropriate information technology access to the general ledger; and journal entry users having the ability to post to the general ledger without formal review or approval. The material weaknesses did not result in a misstatement to our financial statements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are taking steps to remediate the material weaknesses and, as it related to executive management and information technology access to the general ledger, LMA and Abacus revoked the inappropriate privileges before 2022 <span style="white-space:nowrap">year-end.</span> We have also hired a new qualified accounting resource and are in the process of enhancing and formalizing our accounting, business operations and information technology policies, procedures </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and controls. We have engaged outside resources to enhance our business documentation process, provide company-wide training and to help with management&#8217;s self-assessment and testing of internal controls. We are implementing a new accounting system in 2023 that will require the appropriate approval of journal entries in our accounting system and are currently working with outside advisors to ensure proper segregation of duties and put mitigating controls in place. However, we are still in the process of implementing these steps and cannot assure investors that these measures will significantly improve or remediate the material weaknesses described above. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, prior to the Business Combination, the Company (then known as East Resources Acquisition Company), was not timely in filing its Form 10-K for the year ended December 31, 2022 and its Form 10-Q for the quarter ended March 31, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may in the future discover additional material weaknesses in our system of internal financial and accounting controls and procedures that could result in a material misstatement of our financial statements. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risks Related to Being a Public Company </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">The market price of our notes may be volatile or may decline regardless of our operating performance. You may lose some or all of your investment. </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading price of our notes may be volatile. The securities markets have recently experienced extreme volatility. This volatility often has been unrelated or disproportionate to the operating performance of particular companies. You may not be able to resell your notes at an attractive price due to a number of factors such as the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the impact of the <span style="white-space:nowrap">COVID-19</span> pandemic on our financial condition and the results of operations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our operating and financial performance and prospects; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">our quarterly or annual earnings or those of other companies in our industry compared to market expectations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">conditions that impact demand for our products and/or services; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">future announcements concerning our business, our clients&#8217; businesses or our competitors&#8217; businesses; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the public&#8217;s reaction to our press releases, other public announcements and filings with the SEC; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the market&#8217;s reaction to our reduced disclosure and other requirements as a result of being an &#8220;emerging growth company&#8221; under the Jumpstart Our Business Startups Act (the &#8220;JOBS Act&#8221;); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the size of our public float; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">coverage by or changes in financial estimates by securities analysts or failure to meet their expectations; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">market and industry perception of our success, or lack thereof, in pursuing our growth strategy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">strategic actions by us or our competitors, such as acquisitions or restructurings; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in laws or regulations which adversely affect our industry or us; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">privacy and data protection laws, privacy or data breaches, or the loss of data; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in accounting standards, policies, guidance, interpretations or principles; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in senior management or key personnel; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">issuances, exchanges or sales, or expected issuances, exchanges or sales of our capital stock; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in our dividend policy; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">adverse resolution of new or pending litigation against us; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">changes in general market, economic and political conditions in the United States and global economies or financial markets, including those resulting from inflation, natural disasters, terrorist attacks, acts of war and responses to such events. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These broad market and industry factors may materially reduce the market price of the notes, regardless of our operating performance. In addition, price volatility may be greater if the public float and trading volume of our notes is low. As a result, you may suffer a loss on your investment. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the past, following periods of market volatility, stockholders have instituted securities class action litigation. If we were involved in securities litigation, it could have a substantial cost and divert resources and the attention of management from our business regardless of the outcome of such litigation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">If we do not develop and implement all required accounting practices and policies, we may be unable to provide the financial information required of a U.S. publicly traded company in a timely and reliable manner. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The implementation of all required accounting practices and policies and the hiring of additional financial staff has increased and may continue to increase our operating costs and requires our management to devote significant time and resources to such implementation. If we fail to develop and maintain effective internal controls and procedures and disclosure procedures and controls, we may be unable to provide financial information and required SEC reports that are timely and reliable. Any such delays or deficiencies could harm us, including by limiting our ability to obtain financing, either in the public capital markets or from private sources and damaging our reputation, which in either cause could impede our ability to implement our growth strategy. In addition, any such delays or deficiencies could result in our failure to meet the requirements for continued listing of our notes on NASDAQ. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our ability to timely raise capital in the future may be limited, or may be unavailable on acceptable terms, if at all. Our failure to raise capital when needed could harm our business, operating results and financial condition. Debt issued to raise additional capital may reduce the cash flow available to make required payments with respect to the notes and affect our ability to execute our investment strategy or impact the value of our investments. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have funded our operations since inception primarily through our origination, active management and holding of life settlement policies. We cannot be certain when or if our operations will generate sufficient cash to fund our ongoing operations or the growth of our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to continue to make investments to support our business and may require additional funds. Additional financing may not be available on favorable terms, if at all. If adequate funds are not available on acceptable terms, we may be unable to invest in future growth opportunities, which could harm our business, operating results and financial condition. If we incur debt, the debt holders could have rights senior to holders of the notes to make claims on our assets. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has a series of warrants outstanding (collectively the &#8220;Warrants&#8221;), which include: (i) warrants (the &#8220;Private Placement Warrants&#8221;) originally issued in connection the Company&#8217;s initial public offering (the &#8220;Company IPO&#8221;) to purchase up to 7,120,000 shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;), issuable upon the exercise, at an exercise price of $11.50 per share; (ii) warrants issued in connection with the Closing of the Business Combination to purchase up to 1,780,000 shares of our Common Stock issuable upon the exercise, at an exercise price of $11.50 per share; (iii) warrants (the &#8220;Public Warrants&#8221;) issued in connection with the Company IPO to purchase up to 17,250,000 shares of Common Stock, at an exercise price of $11.50 per share, of the public warrants. We receive no capital until the Warrants are exercised, which do not expire until 2028. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity and Capital Resources.&#8221; </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">We are an &#8220;emerging growth company.&#8221; The reduced public company reporting requirements applicable to emerging growth companies may make our notes less attractive to investors. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We qualify as an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. While we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These provisions include: (1)&#160;an exemption from compliance with the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to Section&#160;404 of the Sarbanes-Oxley Act, (2)&#160;not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements, (3)&#160;reduced disclosure obligations regarding executive compensation arrangements in our periodic reports, registration statements and proxy statements and (4)&#160;exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, the information we provide will be different than the information that is available with respect to other public companies that are not emerging growth companies. In addition, Section&#160;107 of the JOBS Act provides that an emerging growth company can take advantage of the exemption from complying with new or revised accounting standards provided in Section&#160;7(a)(2)(B) of the Securities Act as long as we are an emerging growth company. An emerging growth company can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <span style="white-space:nowrap">non-emerging</span> growth companies, but any such election to opt out is irrevocable. We have elected to irrevocably opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we will adopt the new or revised standard at the time public companies adopt the new or revised standard. This may make comparison of our financial statements with another emerging growth company that has not opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot predict whether investors will find our notes less attractive if we rely on these exemptions. If some investors find our notes less attractive as a result, there may be a less active trading market for our notes. The market price of our notes may be more volatile. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company until the earliest of: (1)&#160;the last day of the fiscal year following the fifth anniversary of the date of the completion of the Company IPO, (2)&#160;in which we have total annual gross revenue of at least $1.235&#160;billion, (3)&#160;the date on which we have, during the immediately preceding three-year period, issued more than $1.0&#160;billion in <span style="white-space:nowrap">non-convertible</span> debt securities, or (4)&#160;the end of any fiscal year in which the market value of our Common Stock held by <span style="white-space:nowrap">non-affiliates</span> is at least $700&#160;million as of the end of the second quarter of that fiscal year. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Our management has limited experience in operating a public company. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive officers have limited experience in the management of a publicly traded company. Our management team may not successfully or effectively manage its transition to a public company that will be subject to significant regulatory oversight and reporting obligations under federal securities laws. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which will result in less time being devoted to the management and growth of the Company. We may not have adequate personnel with the appropriate level of knowledge, experience and training in the accounting policies, practices or internal controls over financial reporting required of public companies in the United States. The development and implementation of the standards and controls necessary for the Company to achieve the level of accounting standards required of a public company in the United States may require costs greater than expected. It is possible that the Company will be required to expand its employee base and hire additional employees to support its operations as a public company which will increase its operating costs in future periods. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, prior to the Business Combination, the Company (then known as East Resources Acquisition Company), was not timely in filing its <span style="white-space:nowrap">Form&#160;10-K</span> for the year ended December&#160;31, 2022 and its <span style="white-space:nowrap">Form&#160;10-Q</span> for the quarter ended March&#160;31, 2023. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_7">USE OF PROCEEDS </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The net proceeds received from the sale of the notes are estimated to be approximately $&#8195;&#8195;&#8195;&#8195;, after deducting the discounts and commissions payable to the underwriters and $&#8195;&#8195;of estimated offering expenses payable by us. The net proceeds received will be used to repay approximately $&#8195;&#8195;&#8195;&#8195;in principal amount of indebtedness with an interest rate of &#8195;% under the Owl Rock Credit Facility, dated as of July&#160;5, 2023 and to retire such credit facility. The Company affirms that it is currently in compliance with the net leverage ratio, liquid asset coverage ratio, and all other requirements under the Owl Rock Credit Facility. Any remainder will be used primarily to refinance other outstanding indebtedness and for general corporate purposes. </p> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_8">CAPITALIZATION OF ABACUS AND ITS CONSOLIDATED SUBSIDIARIES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the unaudited capitalization of Abacus and its consolidated subsidiaries as of June&#160;30, 2023 on an actual basis and on an as adjusted basis to give effect to the sale of the notes. This table should be read in conjunction with the financial statements of Abacus and its subsidiaries in the prospectus. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:74%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As of June&#160;30, 2023</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Actual</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">As&#160;Adjusted</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;(Dollars&#160;in&#160;thousands&#160;&#8212;&#160;unaudited)&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LONG-TERM DEBT<sup style="font-size:75%; vertical-align:top">(1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">% Fixed Rate Senior Notes due 2028 offered hereby</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">69,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Long-Term Debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL LONG-TERM DEBT</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">135,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">STOCKHOLDERS&#8217; EQUITY</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, par value $0.0001 per share; 200,000,000 authorized shares; 62,961,688 and 50,369,350 issued and outstanding, respectively</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <span style="white-space:nowrap">paid-in</span> capital</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">188,642</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">188,642</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">877</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">877</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income (loss), net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(29,382</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(29,382</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-Controlling interest</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL SHAREHOLDERS&#8217; EQUITY</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL CAPITALIZATION</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">226,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">295,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><sup style="font-size:75%; vertical-align:top">(1)</sup>&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Long-term debt consists of debt with a maturity of one year or more at the time it is incurred. These amounts are presented at the gross principal amounts outstanding and exclude unamortized debt issuance costs and purchase accounting adjustments. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_8a">UNAUDITED PRO FORMA FINANCIAL INFORMATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Introduction </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and its subsidiaries are providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the financial aspects of the Company. The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of <span style="white-space:nowrap">Regulation&#160;S-X</span> and should be read in conjunction with the accompanying notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined statement of operations for the six months ended June&#160;30, 2023 combines the unaudited condensed statement of operations of East Resources Acquisition Company for the six months ended June&#160;30, 2023, the unaudited condensed statement of operations of LMA for the six months ended June&#160;30, 2023, and the unaudited condensed statement of operations of Abacus Settlements for the six months ended June&#160;30, 2023. The unaudited pro forma condensed combined statement of operations for the year ended December&#160;31, 2022 combines the audited statement of operations of East Resources Acquisition Company for the year ended December&#160;31, 2022, the audited statement of operations of LMA for the year ended December&#160;31, 2022, and the audited statement of operations of Abacus Settlements for the year ended December&#160;31, 2022, giving effect to the Business Combination as if it had been consummated on January&#160;1, 2022, the beginning of the earliest period presented. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial information was derived from, and should be read in conjunction with, the following historical financial statements and the accompanying notes, which are included elsewhere in this prospectus and incorporated by reference into the prospectus to which this Unaudited Pro Forma Condensed Combined Financial Information is attached: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The historical unaudited condensed financial statements of East Resources Acquisition Company as of and for the six months ended June&#160;30, 2023, and the historical audited financial statements of East Resources Acquisition Company as of and for year ended December&#160;31, 2022; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The historical unaudited condensed financial statements of LMA as of and for the six months ended June&#160;30, 2023, and the historical audited financial statements of LMA as of and for the year ended December&#160;31, 2022; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">The historical unaudited condensed financial statements of Abacus Settlements as of and for the six months ended June&#160;30, 2023, and the historical audited financial statements of Abacus Settlements as of and for the year ended December&#160;31, 2022. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing historical financial statements have been prepared in accordance with GAAP. The pro forma adjustments reflect transaction accounting adjustments related to the Business Combination, which is discussed in further detail below. The unaudited pro forma condensed combined financial statements are presented for illustrative purposes only and do not purport to represent the Company&#8217;s consolidated results of operations or consolidated financial position that would actually have occurred had the Business Combination been consummated on the dates assumed or to project the Company&#8217;s consolidated results of operations or consolidated financial position for any future date or period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial information should also be read together with &#8220;<span style="font-style:italic">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span>,&#8221; and other financial information included elsewhere in this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Description of the Business Combination </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;30, 2022, East Resource Acquisition Company entered into an Agreement and Plan of Merger, as amended on October&#160;14, 2022 (the &#8220;Merger Agreement&#8221;), with Abacus Settlements, LMA, Abacus Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (&#8220;Abacus Merger Sub&#8221;) and LMA Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">32 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Company (&#8220;LMA Merger Sub&#8221; and, together with Abacus Settlements, LMA and Abacus Merger Sub, the &#8220;Merger Subs&#8221;), pursuant to which, among other things and subject to the terms and conditions contained in the Merger Agreement, Abacus Merger Sub merged with and into Abacus Settlements, with Abacus Settlements surviving the merger as a wholly owned subsidiary of East Resource Acquisition Company (the &#8220;Abacus Merger&#8221;), and LMA Merger Sub merged with and into LMA, with LMA surviving the merger as a wholly owned subsidiary of East Resource Acquisition Company (the &#8220;LMA Merger&#8221; and, together with the Abacus Merger, the &#8220;Merger&#8221; and, along with the other transactions contemplated by the Merger Agreement, the &#8220;Business Combination&#8221;). In connection with the closing of the Merger (the &#8220;Closing&#8221;), East Resource Acquisition Company was renamed Abacus Life, Inc. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&#160;14, 2022, East Resource Acquisition Company entered into the First Amendment to the Merger Agreement with Abacus Settlements, LMA and the Merger Subs, which modified certain terms and conditions contained within the Merger Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&#160;20, 2023, East Resource Acquisition Company entered into the Second Amendment to the Merger Agreement with Abacus Settlements, LMA and the Merger Subs, which modified certain terms and conditions contained within the Merger Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, on June&#160;30, 2023, the Business Combination was consummated. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Accounting for the Business Combination </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination has been accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, East Resource Acquisition Company has been treated as the &#8220;acquired&#8221; company for financial reporting purposes. This determination was primarily based on the LMA shareholders having a relative majority of the voting power of the Post-Combination Company, the LMA shareholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the Post-Combination Company. LMA was then determined to be the &#8220;acquirer&#8221; for financial reporting purposes based on the relative size of LMA as compared to Abacus Settlements, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of East Resource Acquisition Company, accompanied by a recapitalization. The net assets of East Resource Acquisition Company have been stated at historical cost, with no goodwill or other intangible assets recorded. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Abacus Settlements Merger has been accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus Settlements have been recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, has been recognized as goodwill. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Basis of Pro Forma Presentation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The historical financial information has been adjusted to give pro forma effect to the transaction accounting required for the Business Combination. The adjustments in the unaudited pro forma condensed combined financial information have been identified and presented to provide relevant information necessary for an accurate understanding of the Company upon Closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial information is for illustrative purposes only. The financial results may have been different had East Resource Acquisition Company always been combined with LMA and Abacus Settlements (together, the &#8220;Companies&#8221;). You should not rely on the unaudited pro forma condensed combined financial information as being indicative of the historical results that would have been achieved had East Resource Acquisition Company and the Companies always been combined or the future results that the Company will experience. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Settlements and LMA were related parties, although they were determined not to be under common control. As such, an adjustment was applied to the statement of operations for the year ended December&#160;31, 2022 to remove activity that would be considered intercompany activity and eliminated upon consolidation. This activity represented revenue for Abacus Settlements and cost of sales for LMA in the amount of $2.3&#160;million for the year ended December&#160;31, 2022, respectively. Abacus Settlements and LMA have not had any historical relationship with East Resource Acquisition Company prior to the Business Combination. Accordingly, no pro forma adjustments were required to eliminate activities between East Resource Acquisition Company and either the Company or Abacus Settlements and LMA. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">34 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unaudited Pro Forma Condensed Combined Statement of Operations </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Six Months Ended June&#160;30, 2023 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(In thousands) </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:46%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7pt"><span style="font-weight:bold">(1)</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">ERES<br/>Historical</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7pt"><span style="font-weight:bold">(2)</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Abacus<br/>Life, Inc.</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Historical</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7pt"><span style="font-weight:bold">(3)</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Transaction</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Adjustments</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7pt"><span style="font-weight:bold">(4)</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Pro&#160;Forma</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Combined</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">ERES and<br/>LMA</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">(1)&#160;+&#160;(2)&#160;+&#160;(3)</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7pt"><span style="font-weight:bold">(5)</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Transaction</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Adjustments&#160;-</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Abacus<br/>Acquisition</span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-size:7pt"><span style="font-weight:bold">Pro Forma</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">Combined</span></span><br/><span style="font-size:7pt"><span style="font-weight:bold">(4) + (5)</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,585</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,585</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,585</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cost of sales</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,463</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,463</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,463</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,122</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,122</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,122</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Formation and operating costs</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,109</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,413</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,413</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,413</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">General and administrative expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,274</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(BB)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized gain on life settlement policies</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized loss on investments</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(798</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(798</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(798</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Loss on change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Amortization expense</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(HH)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,253</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,290</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29,627</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,237</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,864</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Loss from Operations</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(15,253</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,832</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,084</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,505</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,237</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(12,742</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Other income (expense):</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Change in fair value of warrant liability</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,828</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,408</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(CC)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Interest expense</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(941</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,500</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(EE)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,534</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,534</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,465</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(FF)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(628</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(GG)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Interest earned on marketable securities held in Trust Account</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">745</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(745</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(AA)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,702</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(22</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,724</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,724</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Total other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,886</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(956</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,746</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,184</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,184</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Net income before provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,633</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,876</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(20,830</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,321</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,237</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,558</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">(Provision for)/Benefit from income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(52</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(528</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,723</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(DD)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,143</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">820</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(DD)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,963</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Net income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,348</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(18,107</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,178</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,417</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,595</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net income attributable to noncontrolling interest</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(487</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(487</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(487</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman;font-weight:bold">Net income / (loss) attributable to members / shareholders</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,835</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(18,107</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,691</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,417</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,108</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, Class&#160;A common stock subject to possible redemption</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Basic and diluted net income per share, Class&#160;A common stock subject to possible redemption</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, Non-redeemable common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Basic and diluted net income per share, <span style="white-space:nowrap">Non-redeemable</span> common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, Class&#160;A common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,438,921</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,438,921</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Basic and diluted net loss per share, Class&#160;A common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.29</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.09</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">35 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Unaudited Pro Forma Condensed Combined Statement of Operations </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Year Ended December&#160;31, 2022 </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(in thousands) </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:43%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">(1)</span><br/><span style="font-weight:bold">ERES<br/>Historical</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">(2)</span><br/><span style="font-weight:bold">LMA</span><br/><span style="font-weight:bold">Historical</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">(3)</span><br/><span style="font-weight:bold">Transaction</span><br/><span style="font-weight:bold">Adjustments</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">(4)</span><br/><span style="font-weight:bold">Pro Forma</span><br/><span style="font-weight:bold">Combined</span><br/><span style="font-weight:bold">ERES and<br/>LMA</span><br/><span style="font-weight:bold">(1)&#160;+&#160;(2)&#160;+&#160;(3)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">(5)</span><br/><span style="font-weight:bold">Abacus</span><br/><span style="font-weight:bold">Settlements</span><br/><span style="font-weight:bold">Acquisition</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">(6)</span><br/><span style="font-weight:bold">Transaction</span><br/><span style="font-weight:bold">Adjustments<br/>&#8211; Abacus</span><br/><span style="font-weight:bold">Settlements<br/>Acquisition</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Pro Forma</span><br/><span style="font-weight:bold">Combined</span><br/><span style="font-weight:bold">(4)&#160;+&#160;(5)&#160;+&#160;(6)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44,713</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,268</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(II)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42,445</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,203</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Cost of Sales</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,245</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,268</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(II)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,977</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,561</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,538</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,468</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,468</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,642</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">47,110</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Formation and operating costs</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,722</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,722</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,722</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">General and administrative expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,066</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,168</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(LL)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,234</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,674</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29,908</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Loss (gain) on change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">91</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">91</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">91</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Unrealized loss (gain) on investments</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,046</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,046</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,046</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization expense</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,474</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(SS)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,474</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,722</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,803</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,168</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">36,693</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,686</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,474</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">51,853</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Loss from operations</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,722</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,665</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(20,168</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,775</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(44</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,474</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,743</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Other income (expense):</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Change in fair value of warrant liability</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,336</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,794</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(KK)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,542</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,542</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Change in fair value of forward purchase agreement liability</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">600</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">600</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">600</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(43</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(OO)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,404</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,413</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,104</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(PP)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,257</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(QQ)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Interest earned on marketable securities held in Trust Account</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(672</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(JJ)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Consulting income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other income/(expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">166</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">166</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Total other income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(388</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(13,827</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,084</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,090</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Net income before provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(591</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,277</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(33,995</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,309</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(50</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,474</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,833</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">(Provision for)/Benefit from income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(53</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(890</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,671</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(MM)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,295</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">(MM)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,758</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,023</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">(NN)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="2"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Net income / (loss)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(644</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,387</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(40,347</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,604</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(52</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,935</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(13,591</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net income / (loss) attributable to noncontrolling interest</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman;font-weight:bold">Net income / (loss) attributable to members / share</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(644</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31,682</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(40,347</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,309</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(52</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,935</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14,296</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, Class&#160;A common stock subject to possible redemption</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,637,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Basic and diluted net income per share, Class&#160;A common stock subject to possible redemption</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.02</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, <span style="white-space:nowrap">Non-redeemable</span> common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Basic and diluted net income per share, <span style="white-space:nowrap">Non-redeemable</span> common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.02</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, Class&#160;A common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,369,350</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,438,921</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Basic and diluted net loss per share, Class&#160;A common stock</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.63</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.27</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">36 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">1. Basis of Presentation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma adjustments have been prepared as if the Business Combination had been consummated on January&#160;1, 2022, the beginning of the earliest period presented in the unaudited pro forma condensed combined statement of operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The LMA Merger is expected to be accounted for using the reverse recapitalization method of accounting, with no goodwill or other intangible assets recorded in accordance with GAAP. Accordingly, for accounting purposes, the financial statements of the Company represent a continuation of the financial statements of LMA with the acquisition being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of East Resource Acquisition Company have been stated at historical cost, with no goodwill or other intangible assets recorded. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Abacus Settlements Merger is expected to be accounted for using the acquisition method of accounting in accordance with GAAP. Accordingly, for accounting purposes, the identified assets and liabilities of Abacus Settlements have been recorded at their estimated fair values as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, has been recognized as goodwill. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma adjustments represent management&#8217;s estimates based on information available as of the date of this prospectus and incorporated by reference into the prospectus to which this Unaudited Pro Forma Condensed Combined Financial Information is attached and are subject to change as additional information becomes available and additional analyses are performed. Management considers this basis of presentation to be reasonable under the circumstances. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">2. Adjustments and Assumptions to the Unaudited Pro Forma Condensed Combined Statement of Operations for the six months ended June&#160;30, 2023 </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustments included in the unaudited pro forma condensed combined statement of operations for the six months ended June&#160;30, 2023 are as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(AA)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the elimination of interest earned on marketable securities held in the Trust Account. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(BB)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects recurring compensation expense due to <span style="white-space:nowrap"><span style="white-space:nowrap">a&#160;non-pro-rata&#160;distribution</span></span> to one of the existing owners of the Companies, which vests in two equal tranches over the period of 25 months and 30&#160;months, respectively, following Closing and which is subject to forfeiture prior to vesting. The negotiations related to the draft Restriction Agreement governing these shares, attached to this prospectus as Annex I, were considered to be concluded as of January&#160;12, 2023, and this was determined to be the grant date of these incentive shares. The compensation expense amount was calculated using East Resource Acquisition Company&#8217;s closing stock price on the grant date. This adjustment is expected to result in a permanent difference between book and taxable income, and as such, no income tax benefit has been reflected herein related to this adjustment. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(CC)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents the elimination of the change in fair value of the ERES&#8217;s public warrants for the six months ended June&#160;30, 2023 as a result of the reclassification of these warrants and the forfeiture of 20% of ERES&#8217;s Private Placement Warrants. This adjustment is expected to result in a permanent difference between book and taxable income, and as such, no income tax benefit has been reflected herein related to this adjustment. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(DD)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents the pro forma adjustment to taxes as a result of adjustments to the income statement for the six months ended June&#160;30, 2023, which was calculated using the statutory income tax rate of 26.5%. Adjustments that were expected to result in permanent differences between book and taxable income, as noted herein, were not included in the calculation of the tax impact of pro forma adjustments. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">37 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(EE)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the interest expense related to the issuance of new debt, calculated based on an interest rate of 12%. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(FF)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the interest expense related to the issuance of debt by Blue Owl, calculated based on an interest rate of 725 basis points over SOFR. A change in SOFR of 1/8 of a percent would not result in a significant increase or decrease in interest expense for the six months ended June&#160;30, 2023. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(GG)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the interest expense related to the incremental issuance under the promissory note with the Sponsor, which is subject to a fixed interest rate of 12%, for the six months ended June&#160;30, 2023. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(HH)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the incremental amortization expense related to intangibles. These intangibles include customer relationships, internally developed and used technology, <span style="white-space:nowrap">and&#160;non-compete&#160;agreements,</span> which were previously not present within Abacus Settlements&#8217; historical financial statements and were adjusted to fair value based on the purchase price allocation. The amortization expense for intangibles was calculated on a straight-line basis using the estimated remaining useful lives of the assets, which varied among the different intangibles. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">3. Adjustments and Assumptions to the Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December&#160;31, 2022 </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustments included in the unaudited pro forma condensed combined statement of operations for the year ended December&#160;31, 2022 are as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(II)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the elimination of activity between LMA and Abacus Settlements for the year ended December&#160;31, 2022 that, following the Business Combination, would be considered intercompany activity and eliminated upon consolidation. This activity was historically recorded as revenue for Abacus Settlements and as cost of sales for LMA. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(JJ)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the elimination of interest earned on marketable securities held in the Trust Account. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(KK)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents the elimination of the change in fair value of the ERES&#8217;s public warrants for the year ended December&#160;31, 2022 as a result of the reclassification of these warrants and the forfeiture of 20% of ERES&#8217;s Private Placement Warrants. This adjustment is expected to result in a permanent difference between book and taxable income, and as such, no income tax benefit has been reflected herein related to this adjustment. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(LL)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects recurring compensation expense due to <span style="white-space:nowrap"><span style="white-space:nowrap">a&#160;non-pro-rata&#160;distribution</span></span> to one of the existing owners of the Companies, which vests in two equal tranches over the period of 25 months and 30&#160;months, respectively, following Closing and which is subject to forfeiture prior to vesting. The negotiations related to the draft Restriction Agreement governing these shares, attached to this prospectus as Annex I, were considered to be concluded as of January&#160;12, 2023, and this was determined to be the grant date of these incentive shares. The compensation expense amount was calculated using East Resource Acquisition Company&#8217;s closing stock price on the grant date. This adjustment is expected to result in a permanent difference between book and taxable income, and as such, no income tax benefit has been reflected herein related to this adjustment. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(MM)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Represents the pro forma adjustment to taxes as a result of adjustments to the income statement for the year ended December&#160;31, 2022, which was calculated using the statutory income tax rate of 26.5%. Adjustments that were expected to result in permanent differences between book and taxable income, as noted herein, were not included in the calculation of the tax impact of pro forma adjustments. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(NN)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the tax impact of transitioning the Companies from pass-through entities for tax purposes to taxable entities for the year ended December&#160;31, 2022. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(OO)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the interest expense related to the debt issued as part of a capital contribution, calculated based on an interest rate of 12%. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">38 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(PP)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the interest expense related to the issuance of debt by Blue Owl, calculated based on an interest rate of 725 basis points over SOFR. A change in SOFR of 1/8 of a percent would not result in a significant increase or decrease in interest expense for the year ended December&#160;31, 2022. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(QQ)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the interest expense related to the incremental issuance under the promissory note with the Sponsor, which is subject to a fixed interest rate of 12%, for the year ended December&#160;31, 2022. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:6%;vertical-align:top" align="left">(RR)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Reflects the incremental amortization expense related to intangibles. These intangibles include customer relationships, internally developed and used technology, <span style="white-space:nowrap">and&#160;non-compete&#160;agreements,</span> which were previously not present within Abacus Settlements&#8217; historical financial statements and were adjusted to fair value based on the purchase price allocation. The amortization expense for intangibles was calculated on a straight-line basis using the estimated remaining useful lives of the assets, which varied among the different intangibles. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">4. Earnings per Share Information </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma weighted average shares calculations have been performed for the six months ended June&#160;30, 2023 and the year ended December&#160;31, 2022 using the historical weighted average shares outstanding, and the issuance of additional shares in connection with the Business Combination, assuming the transaction occurred on January&#160;1, 2022. As the Business Combination is being reflected as if it had occurred at the beginning of the periods presented, the calculation of weighted average share outstanding for both basic and diluted earnings per share assumes that the shares issued relating to the Business Combination have been outstanding for the entire periods presented. As such, historical weighted average common shares outstanding&#8212;basic and diluted for the six months ended June&#160;30, 2023 were determined to appropriately approximate the pro forma weighted average common shares outstanding &#8212; basic and diluted for the pro forma periods presented. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:67%"/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">(In thousands, except share and per share data)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three</span><br/><span style="font-weight:bold">Months&#160;Ended</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended</span><br/><span style="font-weight:bold">December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,595</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(13,591</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average Class&#160;A Common Stock outstanding&#8212;basic and&#160;diluted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,438,921</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,438,921</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma Class&#160;A Common Stock income per share</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.09</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.27</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The above calculation excludes the effects of potentially dilutive shares from the computation of diluted net income per share as the effect would have an antidilutive impact under the treasury stock method. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net profit per share attributable to common shareholders of the Company is the same. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">39 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_8b">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is composed of two principal operating subsidiaries, LMA and Abacus Settlements. The following sets forth management&#8217;s discussion and analysis of financial condition and results of operations of the Company and its operating subsidiaries. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Business Combination </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company was formed under the laws of the State of Delaware on May&#160;22, 2020 as a blank check company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. The Business Combination was effectuated using cash from the proceeds of the Company IPO and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt. On August&#160;30, 2022, the Company entered into the Merger Agreement, and the Business Combination was consummated on June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Business Combination, the Company neither engaged in any operations (other than searching for a business combination after the Company IPO) nor generated any revenues to date. Our only activities from May&#160;22, 2020 (inception) through June 30, 2023 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination and completing such Business Combination. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Longevity Market Assets </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Overview </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LMA directly acquires life insurance policies in a mutually beneficial transaction for both us and the underlying insured. With meaningful support from our proprietary risk rating heat map, we consistently evaluate policies (at origination and throughout the lifecycle) to generate essentially uncorrelated risk adjusted returns. Additionally, we provide a range of services for owners of life settlement assets. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon acquiring a policy, we have the option to either (i)&#160;trade that policy to a third-party institutional investor (i.e., generating a spread on each trade) or (ii)&#160;hold that policy on our balance sheet until maturity (i.e., paying the premiums over time and receiving the final claim / payout). This process is predicated on driving the best economics for LMA and we categorize this revenue as &#8220;Trading&#8221; or &#8220;Active management revenue.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, LMA provides a wide range of services to owners and purchasers of life settlements assets (i.e., acquired policies). More specifically, LMA provides consulting, valuation, actuarial services, and performs administrative work involved in keeping a policy in force and at the premium level most advantageous to the owner. We have experience servicing a large number of policies for highly sophisticated institutions, including policies for large institutional life settlement funds. We generate revenue on these services by charging a base servicing fee of approximately 0.5% of total asset value of the portfolio. We categorize this revenue as &#8220;Servicing&#8221; or &#8220;Portfolio servicing revenue.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2021, we shifted our focus from a service based only business model and began directly acquiring life insurance policies. Our first purchase under the expanded model was in June 2021, and the revenue related to that purchase is included in the Active management revenue line item in the accompanying financial statements for the period ended December&#160;31, 2022. We have seen rapid growth in this segment as we have continued to dedicate capital and resources towards our marketing and diversified origination channels. Such items are appropriately reflected in the operating expenses section of the accompanying financial statements for the period ended June 30, 2023. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">40 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">LMA was formed as Abacus Life Services, LLC in the state of Florida in February 2017. Subsequently, in February 2022, we changed our name to Longevity Market Assets, LLC. We are headquartered in Orlando, Florida. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Our Business Model </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As mentioned in the above Overview section, LMA generates revenue in two main ways. The first is through our active portfolio management strategy (&#8220;Active management revenue&#8221;), whereby we can (i)&#160;generate a spread on traded policies, (ii)&#160;hold policies on our balance sheet (paying premiums over time and receiving the payout/claim), or (iii)&#160;generate unrealized gains or losses on policies purchased by our structured note offerings: LMATT Series 2024, Inc., LMATT Growth Series 2.2024, Inc., LMATT Growth and Income Series 1.2026, Inc., and LMA Income Series, LP using the proceeds from the debt offerings with the intention to hold to maturity. The second is through our portfolio and policy servicing activities, whereby we provide a range of services to life settlement asset owners. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Active management revenue derives from buying and selling policies; and the receipt of death benefits proceeds on policies we hold where the insured dies. Of the purchased policies, some are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. We elect to account for each investment in life settlement contracts using either the investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. LMA accounts for life settlement policies purchased through the structured note and fund offerings on a fair value basis, and life settlement policies that we intend to trade in the near term at cost plus premiums paid. At the time that this election was made, this was the result of a cost-benefit analysis: because of our intention to hold the instruments for a relatively short period, we believed that the investment method provided a more cost-effective method of accounting for the instruments and did not believe that, in the course of the short period, the fair value would differ materially from the accumulated cost. For the life settlement policies accounted for under the fair value method, these policies are part of the collateral consideration for the market linked structured notes issued under LMX Series, LLC and LMA Series, LLC subsidiaries where quarterly valuations are a condition of the private placement memorandum. Given that there is a valuation requirement stipulated in the notes, management has elected to use the fair value method for these policies as the information is readily available and also captures the change in fair value within the income statement when those changes occur as opposed to when the policies mature given management&#8217;s intention to hold them to maturity. For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. Under the investment method, investments in contracts are recorded at investment price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and direct external costs, if any) to keep the policy in force are capitalized. Gains/losses on sales of such are recorded at the time of sale or maturity. Under the fair value method, we record the initial investment of the transaction price and remeasure the investment at fair value at each subsequent reporting period. Changes in fair value are reported in revenue when they occur including those related to life insurance proceeds (policy maturities) and premium payments. Upon sale of a life settlement contract, we record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generating Portfolio servicing revenue involves the provision of services to one affiliate by common ownership, and third parties, which own life insurance policies. Portfolio servicing revenue is derived from services related to maintaining these settled policies pursuant to agreement with investors in settled policies (&#8220;Service Agreement(s)&#8221;). Additionally, also included in servicing revenue are fees for limited consulting services related to the evaluation of policies that we perform for third parties. Portfolio servicing revenue is recognized ratably over the life of the Service Agreements, which range from one month to ten years. The duties performed by the Company under these arrangements are considered a single performance obligation that is satisfied ratably as the customer simultaneously receives and consumes the benefit provided by us. As such, revenue is recognized for services provided for the corresponding month. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Portfolio servicing revenue also consists of revenue related to consulting engagements. We provide services for the owners of life settlement contracts who are often customers of the servicing business line, or customers of </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">41 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Abacus Settlements. These consulting engagements are comprised of valuation, actuarial services, and overall policy assessments related to life settlement contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be provided in tandem, as agreed to in the engagement letter or contract. Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is transferred to the customer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Key Factors Affecting Our Performance </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The markets for our consulting and portfolio servicing are affected by economic, regulatory, and legislative changes, technological developments, and increased competition from established and new competitors. We believe that the primary factors in selecting LMA include reputation, the ability to provide measurable increases to shareholder value and return on investment, global scale, quality of service and the ability to tailor services to each client&#8217;s specific needs. In that regard, with our ability to leverage the technology we develop, we are focused on developing and implementing data and analytic solutions for both internal operations and for maintaining industry standards and meeting client needs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Results of Operations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables set forth our results of operations for the periods presented. The <span style="white-space:nowrap"><span style="white-space:nowrap">period-to-period</span></span> comparison of financial results is not indicative of future results: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:38%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended </span><br/><span style="font-weight:bold">June 30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Portfolio Servicing Revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Related party servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">329,629</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">419,253</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">543,076</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">620,159</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">818,300</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">699,884</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Portfolio servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,737</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">169</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46,981</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">370,169</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">652,672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">380,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total Portfolio servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">354,366</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">419,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">590,057</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">990,328</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,470,972</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,079,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Active management revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Investment income from life insurance policies held using investment method</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,263,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,965,466</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,655,833</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,980,466</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,828,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of life insurance policies (policies held&#160;using fair value method)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,760,900</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,014,013</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,339,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,305,505</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,413,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total active management revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,024,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,979,479</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,994,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,285,971</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,242,580</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total Revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,378,765</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,398,901</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,584,974</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,276,299</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44,713,552</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,199,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cost of revenues (excluding depreciation stated below)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">973,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">666,119</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,462,950</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,086,075</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,245,131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">735,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gross Profit</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,405,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,732,782</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,122,024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,190,224</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,468,421</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">464,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">683,841</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,019,498</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,412,845</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,649,498</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,596,140</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">General, administrative and other</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">577,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,274,431</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">646,705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,066,403</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">101,406</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Unrealized loss (gain) on investments</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(672,936</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,039,022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(798,156</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,054,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss on change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,445,229</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">333,879</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,398,662</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">375,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">493,849</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,098</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,098</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,447</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,034,771</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,398,996</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,289,923</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,728,832</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,803,167</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">597,702</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">42 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:39%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended </span><br/><span style="font-weight:bold">June 30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,370,594</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,333,786</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,832,101</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,461,392</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,665,254</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other (expense) income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">121,601</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(127,455</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(21,651</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(242,247</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347,013</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(584,075</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(941,458</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(41,324</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,457</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net income before provision for income&#160;taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,908,120</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,206,331</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,876,449</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,219,145</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,276,918</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,184,571</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(120,132</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(528,104</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(296,806</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,723,549</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,086,199</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,348,345</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,922,339</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,386,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Less: Net income (loss) attributable to noncontrolling interest</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(26,596</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">406,641</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(487,303</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">406,641</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">704,699</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(148,155</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net income attributable to Abacus Life,&#160;Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,750,145</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,679,558</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,835,648</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,515,698</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31,682,275</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,546</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Revenue </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Related Party Services </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have a related-party relationship with Nova Trading (US), LLC (&#8220;Nova Trading&#8221;), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (&#8220;Nova Holding&#8221; and collectively with Nova Trading, the &#8220;Nova Funds&#8221;) as some of the owners of Abacus Life, Inc. and certain members of management jointly own 11% of the Nova Funds. We enter into service agreements with the owners of life settlement contracts and are responsible for maintaining the policies, managing processing of claims in the event of death of the insured and ensuring timely payment of optimized premiums computed to derive maximum return on maturity of the policy. We neither assume the ownership of the contracts nor undertake the responsibility to make the associated premium payments. The duties that we perform under these arrangements are considered a single performance obligation that is satisfied over time and revenue is recognized for services provided for the corresponding time period. We earn servicing revenue related to policy and administrative services on behalf of Nova Funds portfolio (the &#8220;Nova Portfolio&#8221;). The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided by 12. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:50%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">329,629</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">419,253</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(89,624</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(21.4</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party servicing revenue decreased by $89,624, or 21%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The decrease in related party servicing revenue is primarily due to the joint venture (&#8220;JV&#8221;) owning less policies at June&#160;30, 2023. Total policy count for the Nova Portfolio was 353 and 413 for the periods ended June&#160;30, 2023 and June&#160;30, 2022, respectively. This translated to total invested dollars of $151,738,261 and $162,162,124 as of June&#160;30, 2023 and June&#160;30, 2022, respectively. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">543,076</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">620,159</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(77,083)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(12.4</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="8"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portfolio servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,737</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">169</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,568</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,537.3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">43 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Portfolio servicing revenue increased by $24,568, or 14,537%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase in portfolio servicing revenue is primarily attributable to servicing more external funds during the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. There were zero <span style="white-space:nowrap">non-recurring</span> consulting projects in Q2, 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:50%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portfolio servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46,981</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">370,169</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(323,188)</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(87.3</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Portfolio servicing revenue decreased by $323,188, or 87%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The decrease in portfolio servicing revenue is primarily attributable to a reduction in the <span style="white-space:nowrap">non-recurring</span> consulting projects in 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">818,300</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">699,884</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">118,416</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party servicing revenue increased by $118,416, or 17%, for the year ended December&#160;31, 2022 compared to the year ended December&#160;31, 2021. The increase in related party servicing revenue is primarily attributable to the increase in size of the Nova Portfolio, both in policy count and invested dollars. Total policy count for the Nova Portfolio was 392 and 231 for the periods ended December&#160;31, 2022 and December&#160;31, 2021, respectively. This translated to total invested dollars of $155,451,161 and $76,016,669 as of December&#160;31, 2022 and December&#160;31, 2021, respectively. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Active management revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Active management revenue is generated by buying, selling, and trading policies and maintaining policies through to receipt of maturity or death benefits. Policies are accounted for under both the investment method and fair value method. We have elected on an <span style="white-space:nowrap"><span style="white-space:nowrap">instrument-by-instrument</span></span> basis to account for these policies under the investment method, pursuant to ASC <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">323-30-25-2.</span></span></span> Abacus Life, Inc. engages in direct buying and selling of life settlement policies whereby each potential policy is independently researched to determine if it would be a profitable investment. Policies purchased under Abacus Life, Inc. are typically purchased with the intention to sell within twelve months and are measured for under the investment method given that the purchase dates are recent, and policies turn fairly quickly. Policies purchased under LMATT Series 2024, Inc. or LMATT Growth Series 2.2024, Inc. (the &#8220;LMATT subsidiaries&#8221;) are measured under the fair value method and will either be sold or held until the policies mature. Upon sale of a life settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies accounted for under the investment method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,263,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,965,466</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,298,033</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38.5</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies accounted for under the fair value method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,760,900</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,014,013</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">746,887</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,024,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,979,479</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,044,920</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38.2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total active management revenue increased by $3,044,920, or 38%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase in active management revenue was primarily attributable to maturities of policies accounted for under the investment method. As of June&#160;30, 2023, Abacus Life, Inc. holds 167 policies, of which 122 are accounted for under the fair value method and 45 are accounted for using the investment method (cost, plus premiums paid). Policies recorded under the investment </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">44 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
method represent those policies purchased by Abacus Life, Inc. with the intent to sell within the next 12 months. Policies recorded under the investment method resulted in a revenue increase in of $2,298,033, or 39%. Aggregate face value of policies accounted for using the investment method is $39,520,877 as of June&#160;30, 2023, with a corresponding carrying value of approximately $9,889,610. Additional information regarding policies accounted for under the investment method is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:13%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment method:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies bought</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">79</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">88</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies matured</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average realized gain (loss) on policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16.7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of external counter parties that purchased policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Policies accounted for under the fair value method, resulted in a revenue increase of $746,887, which was driven primarily by a realized gain on the sale of 22 policies of $1,297,702 for the three months ended June&#160;30, 2023. In the three months period ended June&#160;30, 2023, an unrealized gain of $2,126,723 was recorded on 54 policies purchased. For the policies held at fair value, the unrealized gain on policies of $2,126,723 represents a change in fair value of the aforementioned policies. Abacus Life, Inc. realized a gain of $1,297,702 for the three months ended June&#160;30, 2023 for 9 policies that sold that were included in the change in fair value of life insurance policies held using the fair value method and made premium payments of $663,424, which were also included in the same line item. Additional information regarding policies accounted for under the fair value method is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:13%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value method:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies bought</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">54</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies matured</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average realized gain (loss) on policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14.7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of external counter parties that purchased policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies accounted for under the investment method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,655,833</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,980,466</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,675,367</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies accounted for under the fair value method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,339,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,305,505</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,033,579</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,994,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,285,971</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,708,946</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total active management revenue increased by $3,708,946, or 21%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The increase in active management revenue was primarily attributable to an increase in policy sales and maturities. As of June&#160;30, 2023, Abacus Life, Inc. holds 167 policies, of which 122 are accounted for under the fair value method and 45 are accounted for using the investment method (cost, plus premiums paid). Policies recorded under the investment method represent those policies purchased by Abacus Life, Inc. with the intent to sell within the next 12 months. Policies recorded under the investment method resulted in an increase of $2,675,367, or 19%. Aggregate face value of policies accounted </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for using the investment method is $39,520,877 as of June&#160;30, 2023, with a corresponding carrying value of approximately $9,889,610. Additional information regarding policies accounted for under the investment method is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:13%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment method:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies bought</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies matured</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average realized gain (loss) on policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16.3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13.5</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of external counter parties that purchased policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Policies accounted for under the fair value method, with the intention to hold to maturity, resulted in an increase in revenue of $1,033,579 driven primarily by a realized gain on life settlement policies of $1,898,958 for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. Aggregate face value of policies held at fair value is $195,205,585 as of June&#160;30, 2023, with a corresponding fair value of $56,685,617. For the policies held at fair value, the unrealized gain recorded on 69 purchased policies as of $3,319,588 represents a change in fair value of the aforementioned policies. Abacus Life, Inc. realized a gain of $ 1,898,958 for the six months ended June&#160;30, 2023 for 11 sold policies that were included in the change in fair value of life insurance policies held using the fair value method and made premium payments of $879,461, which were also included in the same line item. Additional information regarding policies accounted for under the fair value method is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:13%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value method:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies bought</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">69</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies matured</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average realized gain (loss) on policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10.4</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of external counter parties that purchased policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies accounted for under the investment method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,828,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,708,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31,424</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies accounted for under the fair value method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,413,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,413,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,242,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,122,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">35,935</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Active management revenue increased by $43,122,581, or 35,935%, for the year ended December&#160;31, 2022 compared to the year ended December&#160;31, 2021. The increase in Active management revenue was primarily attributable to LMA making a strategic shift and re-organizing the business to include an active management segment. This shift in business model occurred in 2021. As of December&#160;31, 2022, LMA holds 53 policies, of which 35 are accounted for under the fair value method and 18 are accounted for using the investment method (cost, plus premiums paid). Policies recorded under the investment method represent those policies purchased by LMA with the intent to sell within the next 12&#160;months. Policies recorded under the investment method resulted in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">46 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an increase of $37,708,829. Aggregate face value of policies accounted for using the investment method is $42,330,000 as of December&#160;31, 2022, with a corresponding carrying value of approximately $8,716,111. Additional information regarding policies accounted for under the investment method is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:15%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies bought</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">145</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies matured</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average realized gain (loss) on policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of external counter parties that purchased policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life insurance proceeds received</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Policies accounted for under the fair value method, with the intention to hold to maturity, resulted in an increase in revenue of $5,413,751 driven primarily by an unrealized gain on policies of $5,742,377 for the year ended December&#160;31, 2022 compared to the year ended December&#160;31, 2021. Aggregate face value of policies held at fair value is $40,092,154 as of December&#160;31, 2022, with a corresponding fair value of $13,809,352. For the policies held at fair value, the unrealized gain on policies of $5,742,377 represents a change in fair value of the aforementioned policies. LMA realized a gain of $105,000 for the year-ended December&#160;31, 2022 for two policies that had matured that were included in the change in fair value of life insurance policies held using the fair value method and made premium payments of $433,626, which were also included in the same line item. Additional information regarding policies accounted for under the fair value method is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:66%"/>

<td style="vertical-align:bottom;width:13%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:13%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies bought</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies matured</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average realized gain (loss) on policies sold</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of external counter parties that purchased policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life insurance proceeds received</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cost of Revenues (Excluding Depreciation) and Gross Profit </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues (excluding depreciation) primarily consists of payroll costs for employees who service policies and consulting expenses for discretionary commissions directly related to active management trading revenue. Cost of revenues excludes depreciation expense as Abacus Life, Inc. does not hold any material property and equipment that is directly used to support the servicing or trading of life settlement policies. The payroll costs related to policy servicing are for recurring and <span style="white-space:nowrap">non-recurring</span> projects where the time incurred for servicing policies is measurable and directly correlates to revenue earned. Similarly, consulting expenses are for discretionary commissions earned directly related to revenue generated as part of the Active management revenue stream. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue (excluding depreciation)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">973,400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">666,119</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">307,281</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">46</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">47 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues (excluding depreciation) increased by $307,281, or 46%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase in cost of revenues is primarily due to an increase of payroll expenses related to increased headcount and changes to various benefit packages in 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue (excluding depreciation)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,462,950</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,086,075</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(623,125</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(30</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues (excluding depreciation) decreased by $623,125, or 30%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The decrease in cost of revenues is primarily due to a $1,057,735 decrease in consulting expenses primarily represents discretionary commissions for individuals directly related to active management trading revenue and bonuses paid out during the first quarter of 2022. The bonuses and commissions did not recur during 2023. The decrease in consulting expenses offset by a $427,380 increase in wages related to policy servicing activity as a result of increased headcount of 4 people and changes to various benefit packages in 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:47%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue (excluding depreciation)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,245,131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">735,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,509,238</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">749</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues (excluding depreciation) increased by $5,509,238, or 749%, for the year ended December&#160;31, 2022 compared to the year ended December&#160;31, 2021. The increase in cost of revenues is primarily due to a $5,012,394 increase in consulting expenses which represent primarily discretionary commissions for individuals directly related to active management trading revenue along with various due diligence and consulting fees. There was also a $708,727 increase in wages related to policy servicing activity as a result of increased headcount and changes to various benefit packages in 2022, offset by a $211,883 decrease in policy serving. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:50%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,405,366</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,732,782</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,672,584</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">35</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit increased by $2,672,584, or 35%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase in gross profit is due to the decrease in the cost of revenue by $307,281, or 46% which was attributable to reductions in consulting expenses. The expansion of the active management business resulted in increased revenues of $3,044,920, or 38%, of the total increase in revenues of $2,979,864 or 35%. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,122,024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,190,224</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,931,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit increased by $3,931,800, or 24%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The increase in gross profit is primarily due to decrease of cost of revenue by $623,125, or 30% and the expansion of the active management business which resulted in increased revenues of $ 3,708,946 , or 21%, of the total increase in revenues of $3,308,675, or 18%, offset by a decrease of portfolio servicing revenue of $323,188, or 87%. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:46%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,468,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">464,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,004,329</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,189</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">48 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit increased by $38,004,329, or 8,189%, for the year ended December&#160;31, 2022 compared to the year ended December 31, 2021. The increase in gross profit is primarily due to the expansion of the active service management services which resulted in increased revenues of $43,049,541, or 99%, of the total increase in revenues of $43,122,581, offset by an increase in cost of revenues of 5,509,238. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Sales and Marketing Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses primarily consist of advertising and marketing related expenses<span style="font-weight:bold"><span style="font-style:italic">.</span></span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">683,841</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,019,498</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(335,657</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(33</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses decreased by $335,657 or 333% for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The decrease in sales and marketing expense was attributable to reduction in advertising costs. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,412,845</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,649,498</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(236,653</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses decreased by $236,653, or 14% for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The decrease is attributable to reduction in advertising costs. The increase in 2022 was attributable to marketing of the new active management segment. Sales and marketing expense relates to sponsoring a sports organization and are not directly attributable to revenue generating activity, therefore these expenses do not represent cost of revenue. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,596,140</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,596,140</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales and marketing expenses increased by $2,596,140, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in 2022 is attributable to marketing of the new active management segment. Sales and marketing expense relates to sponsoring a sports organization and are not directly attributable to revenue generating activity, therefore these expenses do not represent cost of revenue. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">General, Administrative, and Other </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General, administrative, and other primarily consists of compensation and benefits related costs associated with our finance, legal, human resources, information technology, and administrative functions. General, administrative and other costs also consist of third-party professional service fees for external legal, accounting and other consulting services, rent and lease charges, insurance costs, and software expense. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General, administrative and other</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">577,539</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">572,040</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,403</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General, administrative, and other increased by $572,040, or 10,403%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase of $284,588 and $40,060 in general, administrative and other of is related to launching the new income funds: LMA Income Series, LP and LMA Income Series II GP LLC, respectively, which did not exist during the three months ended June&#160;30, 2022. The </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">49 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
remaining difference is attributable to other various consolidated entities pertaining to policy servicing and administrator expenses, accounting, legal, and bank fees as we finalized the SPAC. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General, administrative and other</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,274,431</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">646,705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">627,726</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">97</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General, administrative, and other increased by $627,726, or 97%, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in general, administrative and other is related to various expenses, including but not limited to increases in payroll related expense (excluding payroll expenses wages) of $245,842, an increase in Errors and Omissions insurance of $55,250, an increase in medical record consulting expense of $132,688 and an increase of $31,000 in software expenses. Additionally, $341,064 in general, administrative and other expenses were recorded in LMA Income Series, LP and LMA Income Series II GP LL pertaining to policy servicing and administrator expenses, accounting, legal, and bank fees. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General, administrative and other</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,066,403</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">101,406</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">964,997</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">952</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General, administrative, and other increased by $964,997, or 952%, for the year ended December&#160;31, 2022 compared to the year ended December 31, 2021. The increase in general, administrative and other is related to various expenses, including but not limited to increases in payroll expense and payroll related expense of $242,628, an increase in legal expense of $83,644, and an increase in rent expense of $31,561. Additionally, $384,374 in general, administrative and other expenses were recorded in various consolidated entities pertaining to consulting charges, administrator expenses, accounting, legal, and bank fees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Depreciation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense consists primarily of depreciation on property and equipment purchased and leasehold improvements made. The property at Abacus Life, Inc. currently consists of furniture, fixtures and leasehold improvements for the office and are not directly used to support the servicing or trading of life settlement policies. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,098</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,098</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation is consistent for the three months ended June&#160;30, 2023 and June&#160;30, 2022 as no purchases of property and equipment were made in 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:56%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation is consistent for the six months ended June&#160;30, 2023 and June&#160;30, 2022 as no purchases of property and equipment were made in 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,447</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,835</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">75</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation increased by $1,835, or 75%, for the year ended December&#160;31, 2022 compared to the year ended December 31, 2021. The $1,835 increase in depreciation is primarily due to the acquisition of furniture and fixtures in 2022 and the incremental depreciation expense that accompanies its acquisition. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">50 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Unrealized Loss (Gain) on Investments </span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss (gain) on investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(672,936</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,039,022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,711,958</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(165</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unrealized loss on investments increased by $1,711,958 for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The primary cause of this increase driven by changes in fair value of put and call options. During the three months ended June&#160;30, 2023, the unrealized loss was $467,701, $186,470, $15,289, and $3,475 for LMATT Series 2024 Inc., LMATT Growth Series Inc., and LMATT Growth, Income Series Inc. and Longevity Market Assets, LLC, respectively. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss (gain) on investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(798,156</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,054,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,853,131</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(176</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unrealized loss (gain) on investments increased by $1,853,131 for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. During the first and third quarters of 2022, Abacus Life, Inc., through three subsidiaries, LMATT Series 2024 Inc., LMATT Growth Series Inc., LMATT Growth and Income Series Inc., and purchased S&amp;P 500 call options and sold S&amp;P 500 put options through a broker as an economic hedge related to the market-indexed instruments described below. The primary cause of this decrease pertains to $540,818, $230,231, $23,632, and $3,475 respectively, which represents a change in fair value of those options and is classified as an unrealized loss on investments within the results of operations. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss on investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unrealized loss on investments increased by $1,045,623 for the year ended December 31, 2022 compared to the year ended December 31, 2021. During the first and third quarters of 2022, LMA, through three subsidiaries, LMATT Series 2024 Inc., LMATT Growth Series Inc., and LMATT Growth and Income Series Inc., purchased S&amp;P 500 put and call options through a broker as an economic hedge related to the market-indexed instruments described below. The primary cause of this increase pertains to $971,281, $68,965, and $5,377, respectively, which represents a change in fair value of those options and is classified as an unrealized loss on investments within the results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Loss on Change in Fair Value of Debt </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:47%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,445,229</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">333,879</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,111,350</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">333</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Loss on change in fair value of debt increased by $1,111,350 for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase is primarily attributable to changes in the risk-free fair value of LMATT debt. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,398,662</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">375,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,023,149</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">539</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Loss on change in fair value of debt increased by $2,023,149 for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase is primarily attributable to changes in the risk-free fair value of LMATT debt. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">51 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;31, 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, issued $10,166,900 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Series (LMATTS) 2024, are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes haves a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-to-one</span></span> basis. As of June&#160;30, 2023, $9,866,900 of the principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2024, Inc. notes was $9,621,141. The notes are secured by the assets of the issuing entities, which includes cash, S&amp;P 500 options, and life settlement policies totaling $11,195,701 as of June&#160;30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $2,333,391 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (&#8220;LMATTSTM Series 2.2024, Inc.&#8221;) are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to provide upside performance participation that is capped at 120% of the performance of the S&amp;P 500. A separate layer of the notes has a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investments will experience all subsequent losses on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-to-one</span></span> basis. As of June&#160;30, 2023, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2.2024, Inc. notes was $3,446,527. The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $3,331,872 as of June&#160;30, 2023. The notes agreement do not restrict the trading of life settlement contracts prior to maturity of the notes, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, on September&#160;16, 2022, LMATT Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $400,000 in market-indexed private placement notes. LMATTSTM Growth and Income Series 1.2026, Inc. are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to provide upside performance participation that is capped at 140% of the performance of the S&amp;P 500. A separate layer of the notes has a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investments will experience all subsequent losses on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-to-one</span></span> basis. These notes also include a 4% dividend feature that will be paid annually. As of June&#160;30, 2023, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes was $459,533. The notes are secured by the assets of the issuing entity, LMATT Growth and Income Series 1.2026, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $517,218 as of June&#160;30, 2023. The notes agreement does not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply. See additional fair value considerations within the Fair Value footnote. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">52 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:50%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Loss on change in fair value of debt increased by $90,719 for the year ended December 31, 2022 compared to the year ended December 31, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 31, 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, issued $10,166,900 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Series (LMATTS) 2024, are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes haves a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes on a one-to-one basis. As of December 31, 2022, $9,886,900 of the principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2022, the fair value of the LMATT Series 2024, Inc. notes was $8,067,291. The notes are secured by the assets of the issuing entities, which includes cash, S&amp;P 500 options, and life settlement policies totaling $12,200,797 as of December 31, 2022. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $2,333,391 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (&#8220;LMATTSTM Series 2.2024, Inc.&#8221;) are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to provide upside performance participation that is capped at 120% of the performance of the S&amp;P 500. A separate layer of the notes has a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investments will experience all subsequent losses on a one-to-one basis. As of December 31, 2022, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2022, the fair value of the LMATT Series 2.2024, Inc. notes was $2,354,013. The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $3,246,756, as of December 31, 2022. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the notes, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, on September 16, 2022, LMATT Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $400,000 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (&#8220;LMATTSTM Growth and Income Series 1.2026, Inc.&#8221;) are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to provide upside performance participation that is capped at 140% of the performance of the S&amp;P 500. A separate layer of the notes has a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investments will experience all subsequent losses on a one-to-one basis. These notes also include a 4% dividend feature that will be paid annually. As of December 31, 2022, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December 31, 2022, the fair value of the LMATT Growth and Income Series </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">53 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
1.2026, Inc., notes were $400,000. The notes are secured by the assets of the issuing entity, LMATT Growth and Income Series 1.2026, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $752,236, as of December 31, 2022. The note agreement does not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply. See additional fair value considerations within the Fair Value footnote. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other Operating Expenses </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other operating expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">493,849</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(493,849</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other operating expense decreased by $493,849, for the year ended December 31, 2022 compared to the year ended December 31, 2021. This decrease in other operating expense consisted primarily of legal, bank, and consulting expenses related to the start-up for LMATT Series 2024 Inc. which occurred in 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other Income (Expense) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income (expense) consists of working capital support that Abacus Life, Inc. provides to two life settlement Providers through a contractual agreement (the &#8220;Strategic Services and Expenses Support Agreement&#8221; or &#8220;SSES&#8221;). Abacus Life, Inc. entered into the SSES with the Providers and simultaneously acquired an option to purchase the outstanding equity ownership of the Providers, upon the achievement by the Providers of certain financial targets. For the years ended December&#160;31, 2022 and December&#160;31, 2021, the Providers were considered to be VIEs, but were not consolidated in our interim condensed consolidated financial statements as we do not hold a controlling financial interest in the Providers. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">121,601</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(127,455</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">249,056</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(195.4</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(584,075</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(584,075</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income (expense) decreased by $249,056, for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The increase in other income is driven by reduction of excess return expense of $184,795 at LMA Income Series, LP for the three months ended June&#160;30, 2023. As noted above, LMA Income Series, LP did not exist during the three months ended June&#160;30, 2022. The remaining difference is attributable to dividend income of $4,063 at LMA Income Series GP and other income at Regional Investment Services for the three months ended June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest (expense) increased by $584,075, for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The increase in interest expense is driven by the dividend of 6.5% required to be paid out by the LMA Income Series to its limited partner investors. The remaining increase is attributable to interest expense at LMATT Growth&#160;&amp; Income Series Inc. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(21,651</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(242,247</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">220,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(91.1</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(941,458</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(941,458</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,457</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,457</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">54 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income (expense) decreased by $220,596, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in other income is driven by reduction of excess return expense of $212,526. $29,721 was paid to the Providers during the six months ended June&#160;30, 2023, compared to $242,247 paid during the six months ended June&#160;30, 2022. The remaining difference is attributable to dividend income of $8,125 at LMA Income Series GP and other income at Regional Investment Services for the six months ended June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest (expense) increased by $941,458, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in interest expense is driven primarily by $713,149 and $220,309 accrued interest payments relating to LMA Income Series LP LLC and LMA Income Series II LP, respectively, along with $8,000 in interest expense for LMATT Growth&#160;&amp; Income Series, Inc. for the six months ended June&#160;30, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income increased by $7,457, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in interest income is driven by interest on proceeds from policies that matured in the first three months of 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense)/income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347,013</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347,013</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(42,798</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(42,798</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,474</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,474</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other (expense)/income increased by $347,013, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in other (expense) is driven by an increase in SSES paid to the Providers described above of $347,013. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest (expense) increased by $42,798, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in interest expense is driven primarily by a $26,587 accrued interest payment relating to LMA Income Series LP along with $11,111 and $5,100 in interest expense for LMA and LMATT Growth &amp; Income Series, Inc. for the year ended December 31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income increased by $1,474, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The decrease in interest income is driven by increases in bank interest. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Provision for income taxes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As the Company elected to file as an S corporation for federal and Florida state income tax purposes, the Company incurred no federal or Florida state income taxes, except for income taxes recorded related to LMATT Series 2024, Inc. (&#8220;LMATT&#8221;), a Delaware C corporation and wholly owned subsidiary of LMX Series, LLC (&#8220;LMX&#8221;), which Abacus Life, Inc. consolidates. Accordingly, tax expense has historically been attributable to tax expense for LMATT Series 2024, Inc. However, the Business Combination resulted in changes to the tax status of certain entities which impacted the provision for income taxes by $1,383,692. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,184,571</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(120,132</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,064,439</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">886</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provision for income taxes increased by $1,064,439, or 886% for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. Our effective income tax rate for the three months ended June&#160;30, 2023 and three months June&#160;30, 2022, was 15% and 12%, respectively. The Company&#8217;s effective tax rate as of June&#160;30, 2022 differed from the statutory rate of 21% due to state taxes and the release of the valuation </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">55 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
allowance. The higher provision for income taxes for the three months ended June&#160;30, 2023 is mainly related to Longevity Market Assets LLC taxable income of $7,081,252 resulting in $1,203,190 of provision for income taxes from the change in tax status upon the Business Combination. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(528,104</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(296,806</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(231,298</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">78</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provision for income taxes increased by $231,298, or 78% for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. Our effective income tax rate for the six months ended June&#160;30, 2023, and six months ended June&#160;30, 2022, was 3.6% and 18%, respectively. The Company&#8217;s effective tax rate as of June&#160;30, 2022 differed from the statutory rate of 21% due to the impact of state income taxes and valuation allowance released, as there was sufficient evidence of the Company&#8217;s ability to generate future taxable income at June&#160;30, 2022. The existence of <span style="white-space:nowrap">non-taxable</span> flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to be significantly lower than the statutory rate. The higher provision for income taxes for the six months ended June&#160;30, 2023 is related to Longevity Market Assets LLC (LMA) taxable income of $13,876,206 resulting in $1,203,190 of provision for income taxes, offset by LMATT Series 2024, Inc. net taxable loss of $2,118,344 resulting in $536,894 of income tax benefit and LMATT Growth&#160;&amp; Income Series, Inc. net taxable loss of $303,328 resulting in $76,878 of income tax benefit and LMATT Growth Series, Inc. net taxable loss of $954,095 resulting in $241,815 of income tax benefit. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2021&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Income tax expense decreased by $889,943 for the year ended December 31, 2022 compared to the year ended December 31, 2021. Our effective income tax rate for the year ended December 31, 2022 and year ended December 31, 2021 was 22.22% and 0.0%, respectively. The difference in the effective tax rate for the year ended December 31, 2021 and year ended December 31, 2021 is related to LMX&#8217;s taxable income of $3,088,732 resulting in $657,673 of income tax expense, LMATT Growth Series, Inc. taxable income of $562,263 resulting in $142,505 of income tax expense, and LMATT Growth &amp; Income Series, Inc. taxable income of $358,658 resulting in $90,902 of income tax expense. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Results of Operations&#8212;Segment Results </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. organizes its business into two reportable segments (i)&#160;portfolio servicing and (ii)&#160;active management, which generate revenue in different manners. During 2021, we primarily focused on the Portfolio Servicing business. At the end of June 2021, we underwent a change in our business to focus on active management services in addition to portfolio servicing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This segment structure reflects the financial information and reports used by Abacus Life, Inc.&#8217;s management, specifically its chief operating decision maker (CODM), to make decisions regarding Abacus Life, Inc.&#8217;s business, including resource allocations and performance assessments as well as the current operating focus in accordance with ASC 280, Segment Reporting. Abacus Life, Inc.&#8217;s CODM is the Chief Executive Officer of Abacus Life, Inc. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The portfolio servicing segment generates revenues by providing policy services to customers on a contract basis. The active management segment generates revenues by buying, selling and trading policies and maintaining policies through to death benefit. Abacus Life, Inc.&#8217;s reportable segments are not aggregated. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">56 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables provide supplemental information on revenue and profitability by operating segment: </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Portfolio Servicing </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">354,366</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">419,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(65,056</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(16</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(76,705</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">280,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(357,008</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(127</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total revenue for the portfolio servicing segment decreased by $65,056, or 16% for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The decrease in portfolio servicing revenue is primarily attributable to a decrease in the <span style="white-space:nowrap">non-recurring</span> consulting projects in Portfolio servicing revenue. Gross profit from our portfolio servicing segment decreased by $357,008 or 127%, for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The decrease in gross margin is primarily due to increases in total cost of revenue of $359,132, or 258% and the reduction of revenue by $65,056, or 16%. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">590,057</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">990,327</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(400,270</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(40</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(166,128</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">668,752</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(834,880</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(125</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total revenue for the portfolio servicing segment decreased by $400,270 or 40% for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The decrease in portfolio servicing revenue is primarily attributable to decrease in the <span style="white-space:nowrap">non-recurring</span> consulting projects in Portfolio servicing revenue. Gross profit from our portfolio servicing segment decreased by $834,880, or 125%, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The decrease in gross margin is primarily due to increases in total cost of revenue of $434,610, or 135% and the reduction of revenue by $400,270, or 40%. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total revenue for the portfolio servicing segment increased by $390,987, or 36%, for the year ended December&#160;31, 2022 compared to the year ended December 31, 2021. The increase in Portfolio servicing revenue is primarily attributable to $118,416 in increased related party servicing revenue and $272,570 in Portfolio servicing revenue. Gross profit from our portfolio servicing segment decreased $105,858, or 26%, for the year ended December&#160;31, 2022 compared to the year ended December 31, 2021. The decrease in gross margin is primarily due to an increase in total cost of revenue of $496,844 partially offset by increases in revenue of $390,987. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Active Management </span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,024,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,979,479</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,044,920</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38.2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,482,070</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,452,479</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,029,591</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40.7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total revenue for the active management segment increased by $3,044,920, or 38% for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. Gross profit from our active management segment increased $3,029,591, or 41% for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The increase in active management revenue and gross profit was primarily attributable to the increase in revenue of $3,044,920 and decrease in cost of revenue from 7% of revenue to 5% of revenue. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,994,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,285,971</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,708,946</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21.5</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,288,152</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,521,471</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,766,681</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30.7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">57 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total revenue for the active management segment increased by $3,708,946, or 22% for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. Gross profit from our active management segment increased $4,766,681, or 31% for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in Active management revenue and gross profit was primarily attributable to the increase in revenue of $3,708,946 and decrease in cost of revenue from 10% of revenue to 3% of revenue. The decrease in cost of revenue of approximately $1,073,064 was related to the decrease in consulting bonus expenses. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,242,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,122,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">35.934</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Total revenue for the active management segment increased by $43,122,581 for the year ended December&#160;31, 2022 compared to the year ended December&#160;31, 2021. The increase in Active management revenue was primarily attributable to LMA making a strategic shift and <span style="white-space:nowrap">re-organizing</span> the business to focus on active management services in addition to portfolio servicing at the end of September 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Key Business Metrics and <span style="white-space:nowrap">Non-GAAP</span> Financial Measures </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Abacus Life, Inc. have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. We monitor key business metrics and <span style="white-space:nowrap">non-GAAP</span> financial measures that assist us in evaluating our business, measuring our performance, identifying trends and making strategic decisions. We have presented the following <span style="white-space:nowrap">non-GAAP</span> measures, their most directly comparable GAAP measure, and key business metrics: </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Adjusted EBITDA </span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:35%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:63%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><span style="font-weight:bold"><span style="white-space:nowrap">Non-GAAP</span> Measure</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Comparable GAAP Measure</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Adjusted EBITDA</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Net Income</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA is net income adjusted for depreciation expense, income tax and other <span style="white-space:nowrap">non-cash</span> and <span style="white-space:nowrap">non-recurring</span> items that in our judgement significantly impact the period-over-period assessment of performance and operating results that do not directly relate to business performance within Abacus Life, Inc.&#8217;s control. These unusual items may include proceeds from the PPP loan, payments made as part of Abacus Life, Inc.&#8217;s expense support commitment, loss on the change in fair value of debt, S&amp;P 500 put and call options that were entered into as an economic hedge related to the debt (described as the unrealized loss on investments), and other <span style="white-space:nowrap">non-recurring</span> items. Management plans to terminate the agreement for the expense support commitment within the next twelve months. As such, management has deemed this to be <span style="white-space:nowrap">non-recurring</span> item. Adjusted EBITDA should not be determined as substitution for net income (loss), cash flows provided (used in) operating, investing, and financing activities, operating income (loss), or other metrics prepared in accordance with U.S. GAAP. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management believes the use of Adjusted EBITDA assists investors in understanding the ongoing operating performance by presenting comparable financial results between periods. We believe that by removing the impact of depreciation and amortization and excluding certain <span style="white-space:nowrap">non-cash</span> charges, amounts spent on interest and taxes and certain other <span style="white-space:nowrap">non-recurring</span> charges that are highly variable from year to year, Adjusted EBITDA provides our investors with performance measures that reflect the impact to operations from trends in changes in revenue, policy values and operating expenses, providing a perspective not immediately apparent from net income and operating income. The adjustments we make to derive the <span style="white-space:nowrap">non-GAAP</span> measure of Adjusted EBITDA exclude items which may cause short-term fluctuations in net income and operating income and which we do not consider to be the fundamental attributes or primary drivers of our business. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">58 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents a reconciliation of Adjusted EBITDA to the most comparable GAAP financial measure, net income (loss), on a historical basis for the periods indicated below: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:35%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,723,549</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,086,199</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,348,345</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,922,339</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,386,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,098</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,098</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,284</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,447</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest Income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">584,075</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">934,001</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,474</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,184,571</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,132</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">528,104</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">296,806</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(121,601</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">127,455</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21,651</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">242,247</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">389,811</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">485,405</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,445,229</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">333,879</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,398,662</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">375,513</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,718</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss (gain) on investments</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(672,936</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,039,022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(798,156</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,054,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,143,985</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,707,785</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,434,748</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,894,021</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34,805,879</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">354,243</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA Margin</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80.4</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">79.9</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80.8</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">76.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77.8</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29.5</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Income Margin</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">60.6</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66.5</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">65.2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">72.4</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">-11.1</span></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA for the three months ended June&#160;30, 2023 was $9,143,985 compared to $6,707,785 for the three months ended June&#160;30, 2022. The increase of $2,436,200, or 36% in adjusted EBITDA is primarily due to the increase of $1,637,350, or 32% in net and comprehensive income and the increase of $1,111,350, or 333% in gain on change in fair value of debt. There is an offset in unrealized loss on investments of $672,936. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA for the six months ended June&#160;30, 2023 was $17,434,748 compared to $13,894,021 for the six months ended June&#160;30, 2022. The increase of $3,540,727, or 25% in adjusted EBITDA is primarily due to the expansion of the active management services which resulted in increased revenues of $3,708,946, or 21% and the increase of $2,023,149, or 539% in gain on change in fair value of debt. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA for the year ended December 31, 2022 was $34,805,879 compared to $354,243 for the year ended December&#160;31, 2021. The increase in adjusted EBITDA is primarily due to the expansion of the active management services which resulted in increased revenues of $43,122,581, offset by an increase in cost of revenues of $38,110,187 for active management sales. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We monitor the following key business metrics: (i)&#160;number of policies serviced, (ii)&#160;value of policies serviced, and (iii)&#160;total invested dollars. Servicing revenue involves the provision of services to one affiliate by common ownership and third parties which own life insurance policies. The number of policies and the value of policies serviced represents the volume and dollar value of policies over which the above services are performed. Total invested dollars represent the acquisition cost plus premiums paid by the policy. We use the aforementioned metrics to assess business operations and provide concrete benchmarks that provide a clear snapshot of growth between the periods under consideration. Please refer to the following Key Business Metrics below: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Key business metric</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of policies serviced</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">819</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">441</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">378</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">85.7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value of policies serviced ($)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,823,437,795</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">650,461,869</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,172,975,926</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">180.3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total invested dollars ($)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">678,400,432</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">167,374,107</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">511,026,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">305.3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">59 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years&#160;Ended&#160;December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Key business metric</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of policies serviced</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">421</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">379</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value of policies serviced ($)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">649,842,091</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">600,651,852</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">49,190,239</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total invested dollars ($)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">163,939,204</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">153,378,077</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,561,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Liquidity and Capital Resources </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. has financed operations since our inception primarily through customer payments, debt issuances, and net proceeds from equity financings in the form of capital contributions from our limited liability company members. Our principal uses of cash and cash equivalents in recent periods have been funding our operations as Abacus Life, Inc. must actively manage its working capital and the associated cash requirements when servicing policies while also effectively utilizing cash and other sources of liquidity to purchase additional policies. As of June&#160;30, 2023, our principal sources of liquidity was cash totaling $20,611,122. During the six months ended June&#160;30, 2023, Abacus Life, Inc. had a net income attributable to Abacus Life, Inc. of $14,348,345 and during the six months ended June&#160;30, 2022, Abacus Life, Inc. had a net income attributable to Abacus Life, Inc. of $11,515,698. During the six months ended June&#160;30, 2023, and 2022, Abacus Life, Inc. had a net cash used in operations of $38,364,171 and $4,751,170, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described above, Abacus Life, Inc. has entered into an SSES with the Providers. Since inception of the SSES on January&#160;1, 2021 through December&#160;31, 2021, Abacus Life, Inc. had incurred $120,000 related to initial funding of operations, and $0 related to expenses. As of June&#160;30, 2023, Abacus Life, Inc. did not incurred related expenses to fund the deficits. Additionally, the Providers reimbursed Abacus Life, Inc. for the initial funding of $120,000 but have not reimbursed other expenses paid by Abacus Life, Inc. on behalf of the Providers in 2022. For the three months and six months ended June&#160;30, 2023, the Providers were considered to be VIEs, but were not consolidated in our consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future capital requirements will depend on many factors, including our revenue growth rate and, the expansion of our active management and portfolio activities. Abacus Life, Inc. may, in the future, enter into arrangements to acquire or invest in complementary businesses, products and technologies. Abacus Life, Inc. may be required to seek additional equity or debt financing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cash Flows from our operations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows for the periods presented: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:50%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended </span><br/><span style="font-weight:bold">June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(38,364,171</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,751,170</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,693,252</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(139,168</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,060,627</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,704,654</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(275,346</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">35,983,097</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,744,154</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,961,795</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">381,663</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Operating Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the six months ended June&#160;30, 2023, our operating activities used $38,364,171 of net cash as compared to $4,751,170 of net cash used from operating activities during the six months ended June&#160;30, 2022. The increase in net cash used from operating activities during the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022, was primarily due to purchases of $39,556,677 life settlement policies at fair value and $11,374,605 life settlement policies at cost during the six months ended June&#160;30, 2023 compared to purchases of $7,211,509 life settlement polices at fair value and $7,204,753 life settlement polices at cost during the six months ended in June&#160;30, 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">60 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2022, our operating activities generated $10,693,252 of net cash as compared to net cash used from operating activities of $139,168 during the year ended December 31, 2021. The increase in net cash from operating activities during 2022 compared to 2021 was primarily due to the increased net income, which was primarily attributable to increases in Active management revenue. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Investing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the six months ended June&#160;30, 2023, investing activities used $7,060,627 of net cash as compared to $250,000 net cash used during the six months ended June&#160;30, 2022. $7,060,627 of net cash used in investing activities during the six months ended June&#160;30, 2023 was related to payments of $6,760,627 due from affiliates and $300,000 of net cash was used for the purchase of other investments. $250,000 of net cash used in investing activities during the six months ended June&#160;30, 2022 was related to the purchase of other investments. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2022, investing activities used $3,704,645 of net cash as compared to $275,346 during the year ended December 31, 2021. Net cash used in investing activities during the year ended December 31, 2022 was related to purchase of available-for-sale investments, other investments and the increase in the amounts due from affiliates during the year. Net cash used in investing activities during the year ended December 31, 2021 was related to purchase of available-for-sale investments and the purchase of property and equipment during the year, along with amounts due from affiliates of $2,904,646. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Financing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the six months ended June&#160;30, 2023, financing activities generated $35,983,097 of net cash as compared to $7,744,154 of net cash generated during the six months ended June&#160;30, 2022. The increase of $28,238,943 in net cash generated in financing activities during the six months ended June&#160;30, 2023 compared to June&#160;30, 2022, was related to the proceeds of $25,000,000 received from the SPV Purchase and Sale Note as well as $35,206,351 from the issuance of debt certificates, offset by $23,533,072 of capital distributions to members during June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2022, financing activities generated $22,961,795 of net cash as compared to net cash generated of $381,663 during the year ended December 31, 2021. Net cash generated in financing activities during the year ended December 31, 2022 was related to the increase in amount for issuance of debt securities of $ 30,028,640, partially offset by amount due to affiliates of $666,845 and distributions to members of $6,400,000. Net cash generated in financing activities during the year ended December 31, 2021 was related to the increase in the amounts due to members of $781,663, partially offset by distributions to members of $400,000. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Contractual Obligations and Commitments </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our significant contractual obligations as of June&#160;30, 2023, include three notes, LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 2024, LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 2.2024, and LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 1.2026. The $10,166,900 LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 2024 notes are a market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes. The notes do not pay interest to the holders. As of June&#160;30, 2023, $9,866,900 of the principal amount remained outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The $2,333,391 LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 2.2024 notes are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 20%. Any subsequent losses below the 20% threshold will reduce the notes. The notes do not pay interest to the holders. As of June&#160;30, 2023, the entire principal amount remained outstanding. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">61 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The $400,000 LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 1.2026 notes are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 10%. Any subsequent losses below the 10% threshold will reduce the notes. The notes pay annual interest of 4% on invested capital to the holders. As of June&#160;30, 2023, the entire principal amount remained outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional <span style="white-space:nowrap">one-year</span> periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December&#160;31, 2022, and interim condensed consolidated financial statements for the three and six months ended June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the six months ended June 30, 2023, LMA Income Series II, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional <span style="white-space:nowrap">one-year</span> periods at the discretion of the general partner, LMA Income Series II, GP, LLC. The limited partners will receive annual dividends equal to the Preferred Return Amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the three and six months ended June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The private placement offerings proceeds for both LMA Income Series, LP and LMA Income Series II, LP will be used to acquire an actively managed large and diversified portfolio of financial assets. Abacus Life, Inc. elected to account for the secured borrowings at fair value under the collateralized financing entity guidance within ASC <span style="white-space:nowrap"><span style="white-space:nowrap">810-10-30.</span></span> As of June&#160;30, 2023, the fair value of the LMA Income Series, LP secured borrowing was $22,124,676. As of June&#160;30, 2023, the fair value of the LMA Income Series II, LP secured borrowing was $20,041,851. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, Abacus Life, Inc. has operating lease obligations, which are included as liabilities on our balance sheet, for our office space. As of June&#160;30, 2023, operating lease obligations were $244,425 with $227,561 due in less than one year and $16,864 due within one to three years, which are comprised of the minimum commitments for our office space. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Critical Accounting Policies and Estimates </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. has prepared our consolidated financial statements in accordance with GAAP. Our preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities and related disclosures at the date of the financial statements, as well as revenue and expense recorded during the reporting periods. Abacus Life, Inc. evaluates our estimates and judgments on an ongoing basis. Abacus Life, Inc. bases our estimates on historical experience and or other relevant assumptions that Abacus Life, Inc. believes to be reasonable under the circumstances. Actual results may differ materially from management&#8217;s estimates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements contained herein, Abacus Life, Inc. believes the following accounting policies to be critical to the judgments and estimates used in the preparation of our financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">62 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Longevity Market Assets Target-Term Series (LMATTSTM) Note </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;31, 2022, LMATT Series 2024, Inc., which Abacus Life, Inc. consolidates for financial reporting, issued approximately $10,166,900 in market-indexed private placement notes. The notes, LMATTSTM 2024, are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes. The notes do not pay interest to the holders. As of June&#160;30, 2023, $9,866,900 of the principal amount remained outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;16, 2022, LMATT Growth Series, Inc., which Abacus Life, Inc. consolidates for financial reporting, issued approximately $2,333,391 in market-indexed private placement notes. The notes, LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 2.2024, are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 20%. Any subsequent losses below the 20% threshold will reduce the notes. The notes do not pay interest to the holders. As of June&#160;30, 2023, the entire principal amount remained outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;16, 2022, LMATT Growth and Income Series, Inc., which Abacus Life, Inc. consolidates for financial reporting, issued approximately $400,000 in market-indexed private placement notes. The notes, LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 1.2026, are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 10%. Any subsequent losses below the 10% threshold will reduce the notes. The notes pay an annual 4% interest rate on invested capital to the holders. As of June&#160;30, 2023, the entire principal amount remained outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. has elected the fair value option in accounting for the instruments. Fair value is determined using Level&#160;3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i)&#160;the S&amp;P 500 Index price, (ii)&#160;S&amp;P 500 Index volatility, (iii)&#160;a risk-free rate based on data published by the US Treasury, and (iv)&#160;a term assumption based on the contractual term of the LMATT<sup style="font-size:75%; vertical-align:top">TM</sup> note. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate assumption developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three months ended June&#160;30, 2023, Abacus Life, Inc. has recognized a loss of $620,085 and a loss of $765,591 for the LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 2024, Inc. notes and LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> Growth Series, Inc. notes respectively on the change in fair value fair value of the debt resulting from risk-free valuation scenarios, which is included within loss on change in fair value of debt within the interim Condensed Consolidated Statement of Operations. For the six months ended June&#160;30, 2023, Abacus Life, Inc. has recognized a loss of $1,305,293 and a loss of $1,033,816 for the LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> 2024, Inc. notes and LMATTS<sup style="font-size:75%; vertical-align:top">TM</sup> Growth Series, Inc. notes, respectively on the change in fair value fair value of the debt resulting from risk-free valuation scenarios, which is included within loss on change in fair value of debt within the interim Condensed Consolidated Statement of Operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Longevity Market Assets Income Series, LP </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&#160;30, 2022, LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, which Abacus Life, Inc. consolidates, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December&#160;31, 2022. The limited partners will receive an </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">63 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at 9% which would require a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. The general partner committed $250,000, with the limited partners contributing $17,428,349. Additional limited partner contributions of $4,461,095 were raised in the first quarter of 2023 bringing the total deposit amount to $22,139,444. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The private placement offerings proceeds were used to acquire an actively managed large and diversified portfolio of financial assets. Abacus Life, Inc., through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, Abacus Life, Inc. has the unilateral ability to acquire and dispose of any of the above investments. Abacus Life, Inc. elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC <span style="white-space:nowrap"><span style="white-space:nowrap">810-10-30.</span></span> As of June&#160;30, 2023, the fair value of the secured borrowing, not including the $250,000 committed from the general partner, was $22,124,676 and there was no gain or loss recognized. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Longevity Market Assets Income Series II, LP </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the three months ended June&#160;30, 2023. The limited partners will receive annual dividends equal to the preferred return amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The private placement offerings proceeds were used to acquire an actively managed large and diversified portfolio of financial assets. Abacus Life, Inc., through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, Abacus Life, Inc. has the unilateral ability to acquire and dispose of any of the above investments. Abacus Life, Inc. elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC <span style="white-space:nowrap"><span style="white-space:nowrap">810-10-30.</span></span> As of June&#160;30, 2023, the fair value of the secured borrowing, not including the commitment from the general partner, was $20,041,851 and there was no gain or loss recognized. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Valuation of Life Insurance Policies </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. accounts for its holdings of life insurance settlement policies at fair value in accordance with ASC <span style="white-space:nowrap">325-30,</span> Investments in Insurance Contracts. Any resulting changes in estimates are reflected in operations in the period the change becomes apparent. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies, which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level&#160;1 relates to quoted prices in active markets for identical assets or liabilities. Level&#160;2 relates to observable inputs other than quoted prices included in Level&#160;1. Level&#160;3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Abacus Life, Inc.&#8217;s valuation of life settlements is considered to be Level&#160;3, as there is currently no active market where Abacus Life, Inc. is able to observe quoted prices for identical assets. Abacus Life, Inc.&#8217;s valuation model incorporates significant inputs that are not observable. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">64 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate face value of policies held at fair value is approximately $195,205,585 as of June&#160;30, 2023, with a corresponding fair value of approximately $56,685,617. Aggregate face value of policies accounted for using the investment method is $39,520,877 as of June&#160;30, 2023, with a corresponding carrying value of approximately $9,889,610. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Credit Exposure to Insurance Companies </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company&#8217;s life insurance policies as of June&#160;30, 2023: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Carrier</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Percentage of Face Value</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Percentage of Fair Value</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Carrier Rating</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">American General Life Insurance Company</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">14.0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">11.0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">A</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">ReliaStar Life Insurance Company</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">6.0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">12.0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">A</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Lincoln National Life Insurance Company</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">14.0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">12.0%</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">A</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company reviews the composition of its portfolio with respect to the concentration of life insurance carriers on an ongoing basis. In addition, as a general policy, the Company typically invests in life insurance policies issued by &#8220;A-&#8221; rated or better life insurance carriers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Equity Investments in Privately-Held Companies </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Equity investments without readily determinable fair values include our investments in privately-held companies in which Abacus Life, Inc. holds less than a 20% ownership interest and does not have the ability to exercise significant influence. Abacus Life, Inc. determines fair value using level 3 inputs under the measurement alternative. These investments are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, Abacus Life, Inc. monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term prospects of these companies. As of June&#160;30, 2023, Abacus Life, Inc. did not identify any impairment indicators and determined that the carrying value of $1,600,000 is the fair value for these equity investments in privately held companies, given that there have been no observable price changes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic"><span style="white-space:nowrap"><span style="white-space:nowrap">Available-For-Sale</span></span> Securities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. has investments in securities that are classified as <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities, and which are reflected on the Consolidated Balance Sheets at fair value. These securities solely consist of a convertible promissory note in a private company that was entered into an arms-length. Abacus Life, Inc. determines the fair value using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. Unrealized gains and losses on these investments are included as a separate component of accumulated other comprehensive loss, net of tax, on the Consolidated Balance Sheets. Abacus Life, Inc. classifies its <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. Abacus Life, Inc. monitors its <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities for possible other-than-temporary impairment when business events or changes in circumstances indicate that the carrying value of the investment may not be recoverable. As of June&#160;30, 2023, Abacus Life, Inc. evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000, and no unrealized gains and losses were recorded. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">65 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Quantitative and Qualitative Disclosures About Market Risk </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not required for smaller reporting companies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">JOBS Act Election </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <span style="white-space:nowrap">non-emerging</span> growth companies but any such election to opt out is irrevocable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Life, Inc. has irrevocably elected to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, Abacus Life, Inc., as an emerging growth company, will adopt the new or revised standard at the time public companies adopt the new or revised standard. As a result, following the consummation of the Business Combination, Abacus Life, Inc. will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for <span style="white-space:nowrap">non-emerging</span> growth companies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Abacus Settlements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Overview </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Settlements originates life insurance policy settlement contracts as a licensed life settlement provider on behalf of third-party institutional investors (&#8220;Financing Entities&#8221;) interested in investing in the life settlement asset class. Specifically, Abacus Settlements originates policies through three primary origination channels (Agents/Financial Advisors, <span style="white-space:nowrap"><span style="white-space:nowrap">Direct-to-Consumers,</span></span> Life Settlement Brokers and Third-Party Intermediaries), screens them for eligibility by verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates. This process is characterized as our origination services, which averages a fee of approximately 2% of face value (&#8220;Origination Revenue&#8221;). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Our Business Model </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a life settlement provider, Abacus Settlements serves as a purchaser of outstanding life insurance policies. When serving as a purchaser, Abacus Settlements&#8217; primary purpose in the transaction is to connect buyers and sellers through an origination process. The origination process is core to Abacus Settlements&#8217; business and drives its economics. Abacus Settlements averages approximately 2% of face value in origination fees on policies and has developed three high quality origination channels which include agents and financial advisors, direct to consumer, life settlements brokers and third-party intermediaries. Generally, diversification across multiple origination channels lowers average policy acquisition cost and increases estimated returns. Abacus Settlements finds sellers through its origination channels using strategic marketing practices in its core markets, with the purpose of finding policy owners who want to capitalize on their investments prior to death by extracting value from their policies through the sale of such policies to Financing Entities. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Key Factors Affecting Our Performance </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operations and financial performance are impacted by economic factors affecting the industry, including: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Opportunities in the Life Settlements Industry </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within the life settlements industry, there is significant policy value that lapses on an annual basis. Currently, the life settlements industry only captures a narrow portion of the potential market leaving significant </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">66 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
runway for future growth for industry participants. With the anticipation of growth in total face value of life insurance policies, we believe we are well positioned to capitalize on the overall market growth. Abacus is currently conducting business in 49 states and the District of Columbia. The company holds viatical settlement and or life settlement provider licenses in forty-three (43)&#160;of those jurisdictions. Abacus also conducts business in seven (7)&#160;jurisdictions which do not currently have life and or viatical settlement provider licensing requirements. Abacus conducts business where is it legally allowed to across the United States. The only state Abacus is not currently conducting business in is Alaska and there are no current plans to procure a license. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to originate policies is essential to scale our business over time. In order to support this expected growth, we continue to invest in our technology and marketing infrastructure. In general, we expect our efforts will continue to focus on driving education and awareness of life settlements. In order to meet this growing demand, we have increased our total headcount by 18% since December, 2022, and anticipate a total of 36% growth of our total headcount from December&#160;31, 2022 to December&#160;31, 2024, of which 18% has already been captured. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Macroeconomic Changes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Global macroeconomic factors, including regulatory policies, unemployment, changes in retirement savings, the cost of healthcare, inflation, and tax rate changes impact demand for our origination services. These factors evolve over time and while these changes have not currently made any significant impact on performance, these trends may shift the timing and volume of transactions, or the number of customers using our origination services. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Components of Results of Operations </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Results of Operations </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables set forth our results of operations for each of the periods indicated, and we presented and expressed the relationship of certain line items as a percentage of revenue for those periods. The <span style="white-space:nowrap"><span style="white-space:nowrap">period-to-period</span></span> comparison of financial results is not necessarily indicative of future results. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables set forth our historical results for the periods indicated, and the changes between periods: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:35%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Origination Revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,689,088</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 743,388</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 3,252,738</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 3,185,068</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 7,050,007</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 4,906,374</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related-party revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,195,602</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,948,528</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,931,938</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,829,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,153,456</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,685,770</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,884,690</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,691,916</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,184,676</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,014,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,203,463</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,592,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,505,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">956,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,734,949</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,265,313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,538,470</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,678,029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,392,647</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,615,307</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,558,354</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,522,312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,022,535</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,527,312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Profit</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,986,710</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,119,984</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,891,373</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,227,039</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,642,458</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,386,803</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General, administrative and other</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,297,577</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,208,051</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,848,580</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,948,358</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,674,425</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,439,549</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,561</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,048</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,597</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,988</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,139</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,300,138</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,211,099</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,854,177</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,954,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,686,590</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,449,688</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">67 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:36%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December&#160;31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income (loss) from operations</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(313,428</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(91,115</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(962,804</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,693</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(44,132</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">937,115</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,193</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">599</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,147</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,199</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,863</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,725</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,817</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,670</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">872</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,808</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,345</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">61,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income (loss) before income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(318,098</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(90,243</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(972,612</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">274,113</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(50,477</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">998,615</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,200</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to Abacus Life, Inc.</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(318,098</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(90,243</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 272,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(52,495</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 997,415</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Origination Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements by representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:52%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Origination revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,689,088</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">743,388</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">945,700</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">127</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue increased by $945,700, or 127%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. This increase was primarily attributable to higher pricing on the sale of broker policies arising from various factors such as policy death benefits, cash surrender values, life expectancy and policyholder age pertaining to the policies sold. These factors resulted in an increase of the commission fee paid to Abacus. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Origination revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,252,738</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,185,068</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,670</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue increased by $67,670, or 2%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The increase in revenue is primarily attributable to an increase in agent and client direct sales during 2023, which is driven by higher face values on the policies originated and higher commission flows, partially offset by a decrease in broker sales. The agent, broker, and client direct sales are all in line with normal, recurring business. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Origination revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,050,007</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,906,374</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,143,633</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue increased by $2,143,633, or 44%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in revenue is primarily attributable to an increase in agent and broker </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">68 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sales during 2022 of $489,687 and $1,681,175, which is driven by higher face values on the policies originated, partially offset by a decrease in client direct sales of $63,297. The agent, broker, and client direct sales are all in line with normal, recurring business. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Related Party Revenue </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus has a related party relationship with the Nova Funds as the owners of Abacus jointly own 11% of the Nova Funds. Pricing for origination fees are governed by origination contracts that have been negotiated by both parties and are considered to be arms-length and consistent with origination fees charged to third party customers. For its origination services to the Nova Funds, Abacus earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:53%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related Party Revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,195,602</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,948,529</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">247,073</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three months ended June&#160;30, 2023 and June&#160;30, 2022, Abacus has originated 38 and 92 policies, respectively, for the Nova Funds with a total value of approximately $56,688,680 and $102,307,954 respectively. This decrease in the origination of Nova Fund policies was partially offset by increases in origination services to LMA. For the three months ended June&#160;30, 2023 and June&#160;30, 2022, Abacus has originated 69 and 8 policies, respectively, for LMA with a total value of approximately $114,999,768 and $31,200,000, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party revenue decreased by $247,073, or 5%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The decrease in related party revenue is primarily attributable to decrease in Nova origination sales and transaction fee reimbursement of $2,176,724 and $1,196,167, partially offset by increased LMA originations services of $3,438,539. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:53%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related Party Revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,931,938</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,829,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">102,342</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the six months ended June&#160;30, 2023 and June&#160;30, 2022, Abacus has originated 72 and 183 policies, respectively, for the Nova Funds with a total value of approximately $96,674,080 and $282,804,838, respectively. This decrease in the origination of Nova Fund policies was partially offset by increases in origination services to LMA. For the six months ended June&#160;30, 2023 and June&#160;30, 2022, Abacus has originated 103 and 8 policies, respectively, for LMA with a total value of approximately $192,685,578 and $31,200,000, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party revenue decreased by $102,342 or 1%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The decrease in related party revenue is primarily attributable to a decrease in Nova origination sales and transaction fee reimbursement of $4,770,057 and $1,284,679, partially offset by increased LMA originations services of $6,324,441. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$ Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related Party Revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,153,456</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,685,770</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">467,686</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the years ended December 31, 2022 and December 31, 2021, Abacus Settlements originated 333 and 313 policies, respectively, for the Nova Funds with a total value of approximately $87,143,005 and $106,633,792, respectively. Related party revenue increased by $467,686, or 3%, for the year ended December&#160;31, 2022 compared to the year ended December 31, 2021. The increase in related party revenue is primarily attributable to increased agent and direct client sales of $3,627,939, partially offset by decreased broker </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">69 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sales during 2022 of $3,160,223. There was an increase in origination policies of 16% in 2022, with origination fees increasing 13%. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Cost of Revenue, Related Party Cost of Revenue, and Gross Margin </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenue is primarily comprised of third-party commissions, which includes third-party sales and marketing commission fees, as well as transaction costs that are reimbursed as part of the origination activity and depreciation and amortization expense. Abacus receives an origination fee plus any commission to be paid from the purchaser for its part in arranging the life settlement transactions. Out of that fee income, Abacus pays commissions to the licensed representative of the seller, if one is required. Commission expense is recorded at the same time revenue is recognized and is included within cost of revenue. Depreciation expense consists of depreciation of property and equipment assets, which are computer equipment. Amortization expense consists primarily of amortization of capitalized costs incurred for the development of internal use software. The costs incurred exclusively consist of fees incurred from an external consulting firm during the development stage of the project and is amortized on the straight-line basis over an estimated useful life of three years. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:50%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,505,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">956,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">548,708</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,392,647</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,615,307</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">777,340</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,986,710</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,119,984</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,274</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Margin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenue increased by $548,708 or 57%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase in cost of revenue is primarily due to increases in sales-agents commission expenses of $838,577, partially offset by a decrease in marketing origination payout and consulting fees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party cost of revenue increased by $777,340 or 30%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase in related party cost of revenue is primarily attributable to an increase in LMA agent commission expenses of $2,245,314 partially offset by a decrease in the originations of policies sold to Nova Fund of $1,478,661. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit decreased by $133,274 or 6%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. Gross margin decreased to 29% for the three months ended June&#160;30, 2023 compared to 37% for the three months ended June&#160;30, 2022. The decrease in gross profit and gross margin is primarily due to the increased commission expense per related party policy and correspondingly the decrease in gross margin due to a greater portion of the profit margin allocated to the licensed agent or broker. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,734,949</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,265,313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(530,364</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(16</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,558,354</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,522,312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,036,042</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,891,373</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,227,039</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(335,666</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Margin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenue decreased by $530,364, or 16%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The decrease in cost of revenue is primarily due to decreases in sales-agents commission expenses and marketing origination payout. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party cost of revenue increased by $1,036,042, or 19%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. The increase in related party cost of revenue is primarily </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">70 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
attributable to increase in LMA agent commission expenses of $4,634,216 partially offset by a decrease in the originations of policies sold to Nova Fund of $3,368,361. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit decreased by $335,666, or 8%, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. Gross margin decreased to 30% for the six months ended June&#160;30, 2023, compared to 32% for the six months ended June&#160;30, 2022. The decrease in gross profit and gross margin is primarily due to the increased commission expense per related party policy and correspondingly the decrease in gross margin due to a greater part of the profit margin allocated to the licensed agent or broker. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:49%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31, </span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,538,470</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,678,029</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,860,441</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">107</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,022,535</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,527,312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(504,777</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-4</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,642,458</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,386,803</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">255,656</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Margin</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-8</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of revenue increased by $2,860,441, or 107%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in cost of revenue is primarily due to increases in agent commission expenses of $1,570,908 due to increases in agent and broker origination revenue, which is driven by increased origination activity and an increase in the face value of policies sold to third parties. There was also an increase in life expectancy report fees of $470,883 which is driven off of increases in agent and broker activity during 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party cost of revenue decreased by $504,777, or 4%, for the year ended December 31, 2022 compared to the year ended December 30, 2021. The decrease in related party cost of revenue is primarily attributable to decreases in agent commission expenses of $569,229 as a result of decrease in the total face value of policies sold to the Nova funds, which agent commission expense is primarily based off of. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit increased by $255,656, or 3%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. Gross margin decreased to 34% for the year ended December 31, 2022 compared to 37% for the year ended December 31, 2021. The increase in gross profit and decrease in gross margin is primarily due to a decrease in client direct sales of 12%, as no agent commission needs to be paid for client direct sales, so the margins are much higher than agent and broker origination sales which increased by 16% in 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Expenses </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Operating expenses is comprised of general and administrative expenses as well as depreciation expense. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses include compensation, payroll, advertising, marketing, rent, insurance, recruitment, trade shows, telephone&#160;&amp; internet, licenses, and other professional fees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense consists of depreciation of property and equipment assets, which are computer equipment, office furniture and lease improvement. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,297,577</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,208,444</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">89,133</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,561</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,048</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(487</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(16</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $89,133, or 4%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The increase in general and administrative expenses are primarily due to increases in payroll expenses of $180,520 for administration support as a result of higher </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">71 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employee headcounts, and compensation raises, partially offset by a decrease in payroll expenses of $11,963 for the sales department. There was an increase in marketing expenses of $80,723 due to increased spending in internet advertising. There was also an increase of $57,000 in sponsorships. Rent and office expense also increased by $15,508 and $34,812 respectively. Salaries and payroll expense, as a percentage of total revenue, represented 23% and 25% for the three months ended June&#160;30, 2023 and 2022, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense decreased by $487, or 16%, for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. The decrease in depreciation expense is primarily due to the declining book value of obsolescent furniture in normal course of business operations. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:53%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,848,580</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,948,358</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">900,222</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,597</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,988</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(391</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $900,222, or 23%, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in general and administrative expenses are primarily due to increases in payroll expenses of $138,944 for the sales department and $479,068 for administration support as a result of higher employee headcounts, and compensation raises. There was an increase in marketing expenses of $186,987 due to increased spending in internet advertising. There was also an increase of $125,500 in sponsorships. Rent and office expense also increased by $41,271 and $71,688 respectively. Salaries and payroll expense, as a percentage of total revenue, represented 24% and 19% for the six months ended June&#160;30, 2023 and 2022, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense decreased by $391, or 7%, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The decrease in the expense is primarily due to the declining book value of obsolescent furniture in normal course of business operations. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,674,425</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,439,549</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,234,876</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,139</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,026</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $1,234,876, or 17%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in general and administrative expenses are primarily due to increases in payroll expenses as a result of higher employee headcounts as there was an increase of 40% during 2022, and compensation raises. There was an increase in marketing expenses due to increased television ads and radio commercials, as well as increased spending in internet advertising. Salaries and payroll expense, as a percentage of total revenue, represented 21% and 18% for the years ended December 31, 2022 and 2021, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense increased by $2,026, or 20%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in the expense is primarily due to an increase in the purchase of depreciable assets. The majority of the purchases are computer equipment. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">72 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Other income (expense) </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income (expense) includes interest income, consulting income, and other income. Interest income represents the interest earned on Abacus&#8217; certificates of deposits. Consulting income represents income earned on various origination consulting services performed. Other income comprises of income from credit card cash rewards. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:53%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2023&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8195;2022&#8195;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,193</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">599</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">594</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">99</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,863</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,863</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(100</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(273</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(100</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income increased by $594, or 99%, for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The increase in interest income is primarily due to favorable changes in interest rate terms for the Abacus certificate of deposit. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense increased by $5,863, or 100% for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The increase in interest expense is primarily due to the amortization of the deferred financing fees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income decreased by $273, or 100% for the three months ended June&#160;30, 2023, compared to the three months ended June&#160;30, 2022. The decrease in other income is primarily due to none collected credit card cash rewards during 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8194;&#8195;2023&#8194;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8194;&#8195;2022&#8194;&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,147</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">770</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,725</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,725</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(100</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(273</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(100</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income increased by $770, or 67%, for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in interest income is primarily due to favorable changes in interest rate terms for the Abacus certificate of deposit. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense increased by $11,725, or 100% for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The increase in interest expense is primarily due to the amortization of the deferred financing fees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income decreased by $273 or 100% for the six months ended June&#160;30, 2023, compared to the six months ended June&#160;30, 2022. The decrease in other income is primarily due to none collected credit card cash rewards during 2023. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:56%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8194;2022&#8195;&#8194;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8194;2021&#8195;&#8194;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,199</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,301</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-81</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,817</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,817</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">100</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(49,727</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">-99</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income decreased by $9,301, or 81%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The decrease in interest income is primarily due to an unfavorable change in interest rate terms for Abacus Settlements certificate of deposit. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">73 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense increased by $8,817 or 100% for the year ended December 31, 2022 compared to the year ended December 31, 2021. The increase in interest expense is primarily due to a fee for the certificate of deposit of $1,000 as well as amortized deferred financing fees of $7,817 for the year ended December 31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income decreased by $49,727, or 99%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. The decrease in other income is primarily due to a decrease in consulting income as the Company serviced a policy during 2021 for $50,000 that did not occur for the year ended December 31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Provision for Income Taxes </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provision for income taxes reflected no change for the three months ended June&#160;30, 2023 compared to the three months ended June&#160;30, 2022. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended&#160;June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2023&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;2022&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">964</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">73</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provision for income taxes increased by $964, or 73%, for the six months ended June&#160;30, 2023 compared to the six months ended June&#160;30, 2022. These amounts are primarily LLC annual report filing fees within the various states. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8194;&#8195;2022&#8195;&#8194;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8194;&#8195;2021&#8195;&#8194;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">$&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,018</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,200</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(818</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">68</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provision for income taxes decreased by $818 or 68%, for the year ended December 31, 2022 compared to the year ended December 31, 2021. These amounts are primarily LLC annual report filing fees within the various states. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Business Segments </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Operating as a centrally led life insurance policy intermediary, Abacus&#8217; Chief Executive Officer is the Chief Operating Decision Maker (CODM) who allocates resources and assesses financial performance. As a result of this management approach, Abacus is organized as a single operating segment. The CODM reviews performance and allocates resources based on the total originations, total corresponding revenue generated for the period, gross profit, and adjusted EBITDA. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Key Business Metrics and <span style="white-space:nowrap">Non-GAAP</span> Financial Measures </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management uses <span style="white-space:nowrap">non-GAAP</span> financial measures, in conjunction with GAAP financial measures, as an integral part of managing our business and to, among other things: (i)&#160;monitor and evaluate the performance of our business operations and financial performance; (ii)&#160;facilitate internal comparisons of the historical operating performance of our business operations; (iii)&#160;review and assess the operating performance of our management team; (iv)&#160;analyze and evaluate financial and strategic planning decisions regarding future operating investments; and (v)&#160;plan for and prepare future annual operating budgets and determine appropriate levels of operating investments. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">74 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We monitor the following key business metrics and <span style="white-space:nowrap">non-GAAP</span> financial measures that assist us in evaluating our business, measuring our performance, identifying trends and making strategic decisions. As such, we have presented the following <span style="white-space:nowrap">non-GAAP</span> measure, their most directly comparable U.S. GAAP measure, and key business metrics: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:47%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Non-GAAP</span> Measure</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Comparable U.S. GAAP Measure</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Adjusted EBITDA</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Net Income</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA is net income adjusted for depreciation expense, provision for income taxes, interest income, and <span style="white-space:nowrap">non-recurring</span> items that in our judgement significantly impact the period-over-period assessment of performance and operating results. Adjusted EBITDA should not be construed as an indicator of our operating performance, liquidity, or cash flows provided by or used in operating, investing, and financing activities, as there may be significant factors or trends that it fails to address. We caution investors that <span style="white-space:nowrap">non-GAAP</span> financial information departs from traditional accounting conventions. Therefore, its use can make it difficult to compare current results with results from other reporting periods and with the results of other companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management believes the use of Adjusted EBITDA measures assists investors in understanding the ongoing operating performance by presenting comparable financial results between periods. We believe that by removing the impact of depreciation and amortization, amounts spent on interest and taxes and certain other <span style="white-space:nowrap">non-recurring</span> income and charges that are highly variable from year to year, Adjusted EBITDA provides our investors with performance measures that reflect the impact to operations from trends in changes in revenue and operating expenses, providing a perspective not immediately apparent from net income and operating income. The adjustments we make to derive the <span style="white-space:nowrap">non-GAAP</span> measure of Adjusted EBITDA exclude items which may cause short-term fluctuations in net income and operating income and which we do not consider to be the fundamental attributes or primary drivers of our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table illustrates the reconciliations from net income to adjusted EBITDA for the three months ended June&#160;30, 2023, and 2022 and for the six months ended June&#160;30, 2023, and 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three Months Ended<br/>June 30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended<br/>June 30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Twelve Months Ended<br/>December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(318,098</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(90,243</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(52,495</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">997,415</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,561</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,048</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,597</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,988</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,165</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,139</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest Income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,193</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(599</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,917</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,147</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,199</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,500</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,018</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,200</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,863</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,725</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,818</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(310,867</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(87,794</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(957,207</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">278,954</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(31,694</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">997,254</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA for the three months ended June&#160;30, 2023 was $(310,867) compared to $(87,794) for the three months ended June&#160;30, 2022. This decrease was attributable to lower revenues and gross profit during second quarter of 2023 as well as increased general and administrative costs including payroll, legal and marketing expenses for three months ended June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA for the six months ended June&#160;30, 2023, was $(957,207), compared to $278,594 for the six months ended June&#160;30, 2022. This decrease was attributable to higher costs of revenue primarily driven by higher commission expense during 2023 as well as increased general and administrative costs and interest expense for the six months ended June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA for the year ended December 31, 2022 was ($31,694), compared to $997,254 for the year ended December 31, 2021. This decrease was attributable to higher costs of revenue primarily driven by higher </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">75 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commission expense during 2022 as well as increased general and administrative costs including payroll and marketing for the year ended December 31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We monitor the following key business metrics such as the number of policies originated year-over-year in measuring our performance. Origination revenues represent fees negotiated for each purchase and sale of a policy to an investor. The number of policy originations represents the volume of policies over which the above origination services are performed. The number of policy originations directly correlates with origination revenues allowing management to evaluate fees earned upon each transaction. There are no estimates, assumptions, or limitations specific to the number of policy originations. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:56%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Three&#160;Months&#160;Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six&#160;Months&#160;Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Policy Originations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">141</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">135</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">253</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">259</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:61%"/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8194;2022&#8195;&#8194;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">&#8195;&#8194;2021&#8195;&#8194;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">%&#160;Change</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Policy Originations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">487</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">445</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Liquidity and Capital Resources </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have financed operations since our inception primarily through customer payments and net proceeds from equity financings in the form of capital contributions from our members. Our principal (uses) of cash and cash equivalents in recent periods have been funding our operations. As of June&#160;30, 2023 and June&#160;30, 2022, our principal sources of liquidity were cash, cash equivalents, and restricted cash totaling $808,226 and $1,439,522, respectively, and we had retained earnings of $509,953 and $2,251,914, respectively. During the three months ended June&#160;30, 2023, we had a net (loss) of $(318.098), and net cash provided by operations of $20,655. During the six months ended June&#160;30, 2023, we had a net (loss) of $(974,901), and net cash (used) by operations of $24,292. We believe our existing cash, cash equivalents, restricted cash, proceeds from equity financings will be sufficient to fund anticipated cash requirements for the next twelve months. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future capital requirements will depend on many factors, including our revenue growth rate, the expansion of our sales and marketing activities, the timing and extent of spending to support product development efforts. We may, in the future, enter into arrangements to acquire or invest in complementary businesses, products and technologies. We may be required to seek additional equity or debt financing. The additional debt financing would result in debt service obligations, and any future instruments governing such debt could provide for operating and financing covenants that could restrict our operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cash Flows </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cash Flows for the Six Months Ended June&#160;30, 2023 and 2022: </span></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows for the six months ended June&#160;30, 2023 and 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:72%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used) in operating activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(24,292</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(452,367</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used) in investing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(182,528</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(35,687</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used) in financing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(443,694</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(671,726</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">76 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-style:italic">Cash Flows for the Years Ended December 31, 2022 and 2021</span><span style="font-weight:bold"><span style="font-style:italic"> </span></span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows for the years ended December 31, 2022 and 2021: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:69%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Years Ended December 31,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by (used in) operating activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(383,291</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,342,763</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used) in investing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(64,011</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(241,528</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used) in financing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(693,259</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(354,577</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Operating Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the six months ended June&#160;30, 2023, our operating activities (used) $(24,292) of net cash as compared to net cash (used) in operating activities of $(452,367) during the six months ended June&#160;30, 2022. The decrease in net cash from operating activities during six months ended June&#160;30, 2023, compared to six months ended June&#160;30, 2022, was primarily due to decreases in contract liabilities. The timing of revenue recognition, customer billing, and cash collection can result in billed accounts receivable, unbilled revenue (contract assets), and deferred revenues (contract liabilities). This decrease in contract liabilities was partially offset by decreases in net income and certificate of deposit. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2022, our operating activities (used) $(383,291) of net cash as compared to net cash provided from operating activities of $1,342,763 during the year ended December 31, 2021. The decrease in net cash from operating activities during 2022 compared to 2021 was primarily due to decreases in contract liabilities. The timing of revenue recognition, customer billing, and cash collection can result in billed accounts receivable, unbilled revenue (contract assets), and deferred revenues (contract liabilities). This decrease in contract liabilities was partially offset by increases in related party receivables. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Investing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the six months ended June&#160;30, 2023, investing activities (used) $(182,528) of net cash as compared to net cash (used) in investing activities of $(35,687) during the six months ended June&#160;30, 2022. The change in cash (used) in investing activities was primarily attributable to the purchases of property, plant, and equipment for $108,394. Net cash (used) in investing activities also increased due to an increase in accounts receivable for expenses related to the Merger and payments to members / affiliates as a result of payroll true up with the LMA entity for shared employees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2022, investing activities (used) $(64,011) of net cash as compared to net cash (used) in investing activities of $(241,528) during the year ended December 31, 2021. The change in cash (used) in investing activities was primarily attributable to the amortization of the marketplace development software acquired during December 31, 2021, partially offset by purchases of property, plant, and equipment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Financing Activities </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the six months ended June&#160;30, 2023, financing activities (used) $(443,694) of net cash as compared to $(671,726) during the six months ended June&#160;30, 2022. Net cash (used) in financing activities during the six months ended June&#160;30, 2023, was primarily related to the distribution to members of $442,283. Net cash (used) in financing activities for the six months ended June&#160;30, 2022, was primarily related to a distribution to members of $659,869, offset by a $11,857 change in due from members and affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2022, financing activities (used) $(693,259) of net cash as compared to $(354,577) during the year ended December 31, 2021. The change in cash (used) in financing activities was primarily attributable to the distributions to members of $(659,363) partially offset by an inflow of $980 for amounts due to members and affiliates of $10,877. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">77 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Contractual Obligations and Commitments </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our contractual obligations as of June&#160;30, 2023, which are included as liabilities on our balance sheet, include operating lease obligations of $190,521 with $177,873 due in less than one year and $12,648 due within one to three years, which are comprised of the minimum commitments for our office space. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Critical Accounting Policies and Estimates </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have prepared our financial statements in accordance with GAAP. Our significant accounting policies are described in more detail in Note 2 to our financial statements contained herein. While our preparation of these financial statements requires us to make estimates, assumptions and judgments from time to time that may affect the reported amounts of assets, liabilities and related disclosures, as of the date of these financial statements, we have not identified any estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty which have had or are reasonably likely to have a material impact on the financial condition or results of operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Related Party Receivables </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Related party receivables include fees to be reimbursed to Abacus from life expectancy reports, assisted physician services and escrow services incurred on policies that related party financing entities purchase as part of the origination agreement with Abacus. Related party receivables are stated at their net realizable value. All of the outstanding receivables of $5,710 as of June&#160;30, 2023 were collected in July, 2023 and 55% of these fees as of June&#160;30, 2022 were collected in July, 2022. Abacus provides an allowance for doubtful accounts equal to the estimated collection losses that will be incurred in collection of all receivables. The estimated losses are based upon historical collection experience coupled with a review of the current status of all existing receivables. Account balances are charged off against the allowance for doubtful accounts after all means of collection have been exhausted and the potential for recovery is remote. There is no allowance for doubtful accounts as of, June&#160;30, 2023, or June&#160;30, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Intangible Assets </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are stated at cost, less accumulated amortization, and consist of capitalized costs incurred for the development of internal use software. The costs incurred exclusively consist of fees incurred from an external consulting firm during the development stage of the project and are subject to capitalization under ASC <span style="white-space:nowrap">350-40,</span> <span style="white-space:nowrap">Internal-Use</span> Software. The software is amortized on the straight-line basis over an estimated useful life of 3 years. Abacus reviews definite-lived intangible assets and other long-lived assets for impairment at least annually or whenever an event occurs that indicates the carrying amount of an asset may not be recoverable. No impairment was recorded for the three months ending June&#160;30, 2023, and 2022 or for the six months ending June&#160;30, 2023, and 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Revenue Recognition </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus&#8217; revenue-generating arrangements are within the scope of Accounting Standards Codification (&#8220;ASC&#8221;) 606, Revenue from Contracts with Customers. Abacus originates life settlements policies with third parties that include settlement brokers, life insurance agents, and direct consumers or policyholders. Abacus then provides the administration services needed to initiate the transfer of the life settlement policies to investors in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">78 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and Abacus has a single performance obligation to originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by Abacus and is dependent upon the policy death benefits held by each life settlement policy. The revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. Abacus recognizes revenue from life settlement transactions when the closing has occurred and any right of rescission under applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the right to rescind the contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs simultaneously, and only the fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For agent and broker commissions received and transaction costs reimbursed, Abacus has determined that they are acting as the principal in the relationship as they maintain control of the services being performed as part of performance obligation prior to facilitating the transfer of the life settlement policy to the investor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the origination fees are fixed amounts based on the face value of the policy death benefit, there is variable consideration present due to the owner&#8217;s rescission right. When variable consideration is present in a contract, Abacus estimates the amount of variable consideration to which it expects to be entitled at contract inception and again at each reporting period until the amount is known. Abacus applies the variable consideration constraint so that variable consideration is included in the transaction price only to the extent it is probable that a subsequent change in estimate will not result in a significant revenue reversal. While origination fees are variable due to the rescission periods, given the that the rescission periods are relatively short in nature, Abacus has concluded that such fees are fully constrained until the rescission period lapses and thus records revenue at a fixed amount based on the face value of the policy death benefit after the rescission period is over. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">79 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_8c">BUSINESS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Mission </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus&#8217; Mission: to educate every life insurance policy owner that their life insurance is personal property and, like any other asset they own, has a market value that can be monetized by selling into the secondary market. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Abacus Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus is a leading vertically integrated alternative asset manager specializing in investing in inforce life insurance products throughout the lifecycle of a life insurance policy. Traditionally, life insurance policies are owned by individuals to insure their lives. Consistent with our mission, we educate policyholders regarding the potential to sell their policies to investors, often at a significant premium to the current cash surrender value. As an alternative asset manager, we purchase life insurance policies from consumers seeking liquidity and actively manage these policies over time via trading, holding and/or servicing. To date, we have purchased over $2.9&#160;billion in policy value and have helped thousands of clients maximize the value of their life insurance. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As one of the leading buyers of life insurance policies in the U.S. for the last 18 years, we sit at the heart of the life settlements industry. We leverage our strong market position, highly efficient origination platform and proprietary technology to drive our revenue and profitability. Abacus and its executive team have deep experience in the life settlement industry. Using this experience, the Company has established policies and guidelines with respect to its purchase of universal life, whole life and convertible term life insurance policies. Currently, the Company principally invests in <span style="white-space:nowrap">non-variable</span> universal life insurance policies, with approximately 89% of the insurance policies, measured by face value, acquired by the Company in fiscal year 2021 being <span style="white-space:nowrap">non-variable</span> universal life policies, but the Company retains the discretion to invest in whole life or convertible term life insurance policies. These guidelines focus on the age of the insured, whether the insured is a man or a woman, the duration of the underlying life insurance policy, the expected mortality risk of the underlying life insurance policy, the projected internal rate of return of the investment in the underlying life insurance policy and the amount of the death benefit of the underlying life insurance policy. The Company excludes making investments in life insurance policies based on certain types of the primary health impairment associated with the underlying insured to ensure that all policies are purchased in accordance with established industry standards and state law requirements. The Company&#8217;s guidelines are designed to allow the Company to target the life insurance policies that it believes have the most upside potential to generate attractive risk-adjusted returns to the Company through either its hold or trade portfolio. Our proven policy origination process first locates policies and screens them for eligibility for a life settlement. This process includes verifying that the policy is in force, obtaining consents and disclosures and submitting cases for life expectancy estimates, which is a process known as origination services. We generate fees on the policies we originate, which are sourced from three channels: (i)&#160;a large and growing network of financial advisors and agents, (ii)&#160;an <span style="white-space:nowrap">on-going</span> <span style="white-space:nowrap"><span style="white-space:nowrap">direct-to-consumer</span></span> marketing campaign and (iii)&#160;a number of traditional life settlements intermediaries that submit policies to us on behalf of an advisor or client. Once identified, we utilize our proprietary <span style="white-space:nowrap">&#8220;heat-map&#8221;</span> technology platform to determine the initial risk and viability of policies. Thereafter, a purchased policy is &#8220;actively managed,&#8221; whereby we consistently monitor the policy risk to optimize revenue by choosing to either (x)&#160;trade the policy to a third-party institutional investor (i.e., receive a trade spread) or (y)&#160;hold the policy over time (i.e., pay premiums and receive payout). Additionally, we service policies on behalf of third parties for which we receive fees as a percentage of the values of the policies. Our multi-faceted and dynamic revenue model is made possible by the fact that we sit at the heart of the entire life settlements industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our revenue generation platform and economic model is best summarized below: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Origination Fees</span> (on average, 2% of face value of acquired policies) </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Active Management</span> (spreads for traded policies and realized returns for held policies) </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold">Third Party Portfolio Servicing</span> (on average, 0.5% of total asset value) </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">80 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently a leader in the life settlements industry. The Company has approximately 20% market share based on our 2021 capital invested/total industry capital invested and data compiled in a 2021 report by The Deal and Life Settlements Report, a U.S. life settlements industry news source. Data for the report was aggregated from each state based on 2021 annual reporting. We have a proven track record of growth and strong asset returns. We are currently operational in 49 states, which is a key differentiator in an industry with high barriers to entry given the significant regulatory requirements. Our business is supported by a total of approximately 82 employees and an innovative leadership team members, each of whom has an average of over 20 years of experience in the U.S. life settlements industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our outstanding operations and execution team are led by a seasoned management team. Jay Jackson (CEO) has worked in the investment industry for over 25 years (including at a family office, major investment firms and alternative asset managers) and pioneered the origination process and trading platform for our firm. William McCauley (CFO) has over <span style="white-space:nowrap">20-years</span> of experience and has held Senior Finance positions for some of the largest insurance carriers (including Transamerica, MassMutual and John Hancock). In addition, we have three Managing Partners (Todd &#8220;Sean&#8221; McNealy, Kevin &#8220;Scott&#8221; Kirby and Matthew Ganovsky) who <span style="white-space:nowrap">co-founded</span> Abacus in 2004 and helped build the institutional and broker market for the entire industry. In summary, our leaders are innovators and have directly contributed to the development of the broader life settlements industry. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have grown our origination business by nearly four times since 2016 and have serviced approximately $950&#160;million in policies since October 2021. With a previous $150&#160;million capital base from a top alternative asset manager, we have acquired nearly 1,600 policies over the past three years via our active portfolio management strategy. Within our traded portfolio, we acquired 1,245 policies and generated a 22% realized return. Within our hold portfolio, we acquired 238 policies with a 12% projected annual return and held an additional 71 policies to maturity yielding a 102% realized return. These returns demonstrate our ability to originate policies and drive meaningful economics with a scaled capital base. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus Settlements was formed as a New York limited liability company in 2004 and LMA was formed in 2017 as a Florida limited liability company. In 2016, Abacus Settlements was licensed in Florida as a life settlement broker and became a Florida limited liability company. We are not an insurance company, are not licensed or regulated as an insurance company and therefore do not underwrite insurable risks for our own account. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">81 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Industry / Opportunity </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Large Addressable Market with Meaningful Growth Potential </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We operate within a large, growing and currently underpenetrated market. The U.S. life insurance industry is an approximately $13 trillion market, which is almost three times the size of the entire real estate industry in the Americas. Notably, given the scale of the overall life insurance industry, more than 90% of life insurance policies will never end up paying a claim. Approximately 75% of policyholders over the age of 65 will either cancel or allow their coverage to lapse, forfeiting the right to ever receive a payout. The life settlements industry helps solve this problem by allowing policyholders the opportunity to monetize their otherwise underutilized asset. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g22g59.jpg" alt="LOGO"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The combination of the large U.S. life insurance market and the high percentage of policies that never pay a claim creates a considerable opportunity for Abacus and the broader life settlements industry. Specifically, the scale of the life settlements market opportunity is $233&#160;billion each year. However, in 2021, the life settlements industry only captured $4&#160;billion, or approximately 2% of the annual market of lapsed life insurance policies. We believe there is a significant opportunity to increase this market penetration, primarily by driving awareness and education regarding the ability to monetize life insurance policies by utilizing our services. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g10a02.jpg" alt="LOGO"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Life insurance is often a senior citizen&#8217;s largest asset and one that can be used to alleviate retirement challenges, but it is rarely treated in this way. This can be partially attributed to the fact that almost half of all financial advisors are not aware that selling a life insurance policy is an option for their clients. We help financial advisors and their clients understand that a life insurance policy is personal property and selling it for a fair market value is a legitimate, safe and viable choice to create more options for the future. While less than 1% of financial advisors and agents currently transact in the life settlements market, based on research conducted by the Life Insurance Settlement Association, the primary industry trade association for the U.S. life settlements industry, of which the Company is a long-standing member, we believe approximately 90% of senior citizens </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">82 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
who let their life insurance policies lapse, or surrendered their policies, would have considered this alternative if they had been made aware of it before lapsing or surrendering their policies. The reference to this study can be found at the Life Insurance Settlement <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">Association&#8212;https://www.lisa.org/life-settlements-industry-will-grow-as-more-seniors-are-informed-of-their-options-say-experts-at-lisa-conference/.</span></span></span></span></span></span></span></span></span></span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling a life insurance policy is a valuable transaction and for those consumers who transact, the benefits can be substantial. On average, life settlements companies pay sellers nearly eight times more than the current cash value of a policy. Selling a life insurance policy not only alleviates the requirement for a policyholder to pay premiums but creates a meaningful and immediate monetization event. Sellers use these proceeds in a variety of ways, including to support their retirement, transfer wealth and pay medical bills. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Generally Uncorrelated Alternative Asset Class&#160;with Institutional Investment Grade Counterparts </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While selling life insurance policies at a fair market value can have significantly positive impacts on a person&#8217;s life, it is a mutually beneficial transaction. The underlying life insurance policy is a highly attractive asset that has minimal payout risk and generally uncorrelated returns. The counterparties to these transactions are generally high-quality investment grade insurance companies. In fact, 95% of our carriers have an &#8220;A Rating&#8221; or better. Additionally, these life insurance policies are cash backed by the carriers, which means they are required to pay policy claims ahead of any other contractual obligation, including senior debt. We do not believe that there has ever been a life insurance policy issued that did not ultimately pay a claim at mortality due to the illiquidity of a carrier. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to counterparty quality, this is a largely <span style="white-space:nowrap">a-cyclical</span> asset class. A life insurance policy is sometimes described as a &#8220;mortality-driven <span style="white-space:nowrap">zero-coupon</span> bond&#8221; because its underlying value will appreciate over time as it approaches maturity (i.e., as the policyholder ages). This is best demonstrated when comparing our historical risk-adjusted returns relative to other benchmark asset classes. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g10a03.jpg" alt="LOGO"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our stockholders will have the opportunity to gain access to this unique asset class, which has historically been reserved for firms that can either directly originate policies or large institutional investors that can deploy meaningful amounts of capital. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">83 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">We are at the Heart of the Life Settlements Industry </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g10a04.jpg" alt="LOGO"/>
 </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Abacus&#8217; Origination Model </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our &#8220;Origination Process&#8221; is core to our entire business and drives our economics. We average approximately 2% of face value in origination fees on policies and have spent the last 20 years developing three high quality origination channels (financial advisors or agents, direct to consumer and life settlements brokers). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An example of our target market includes policyholders averaging 75 years old whose insurance needs have changed, rendering their life insurance policy no longer necessary. We then focus our origination process on these targeted individuals, developing processes and procedures for identifying and screening policies that have the most potential return for the least projected cost. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g10a05.jpg" alt="LOGO"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have three distinct origination channels to reach this target market. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Financial Advisor or Agent&#8212;</span></span>Our largest origination channel involves working directly with financial advisors to facilitate the sale of client policies. Since our founding, we have been at the forefront of developing this market and are now ingrained in a network of over 30,000 financial advisors. We are currently on multiple national platforms, we present at conferences, and we develop marketing tools specifically to help advisors efficiently present the benefits of this product to their clients. As we highlighted earlier, 49% of financial advisors are unaware this financial option exists and less than 1% have completed a life settlement transaction. This origination channel has driven our four times growth over the last six years, and we believe it will continue to be a priority for our future growth. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">84 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Direct to Consumer</span></span>&#8212;We have been building this channel for several years and have focused heavily on increasing broad consumer awareness and education regarding the ability to monetize life insurance policies by utilizing our services. We have been active in a variety of common <span style="white-space:nowrap"><span style="white-space:nowrap">direct-to-consumer</span></span> advertisement channels, including radio and television advertisements in particular. In addition, we have created a unique &#8220;Policy Value Calculator&#8221; whereby individuals can receive an instant valuation on their life insurance policies. The <span style="white-space:nowrap"><span style="white-space:nowrap">direct-to-consumer</span></span> channel has historically driven origination on smaller face value policies through our financial advisor or agent channel, thereby expanding the scope of policies we are able to value and acquire. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Traditional Life Settlements Intermediaries</span></span>&#8212;Within this channel, we engage with life settlements intermediaries or brokers who submit policies to us on behalf of an advisor or client, for which the life settlement intermediary earns a commission. We intend to slowly reduce our reliance on these intermediaries over time and focus our efforts on building out the technology required to gain access to and educate both the financial advisor and <span style="white-space:nowrap"><span style="white-space:nowrap">direct-to-consumer</span></span> channels. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus currently has a dedicated <span style="white-space:nowrap">45-person</span> origination team with 16 sales members assigned by channel. We intend to continue to fuel origination growth by expanding our team and outreach. In order to drive awareness across all origination channels, we plan to expand our marketing and launch national television advertising campaigns. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Abacus&#8217; Policy Acquisition Process </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A life settlement transaction is the process by which a third-party intermediary acquires an existing life insurance policy for an amount greater than its current cash surrender value. Upon closing of the life settlement transaction, the insured receives an immediate cash payment, and the third-party intermediary receives ownership of the policy. Thus, the third-party intermediary becomes the beneficiary of the insured&#8217;s claim payout but is now solely responsible for all future premium payments. Our company functions as this third-party intermediary. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The process of acquiring a policy is highly regulated and policyholder friendly. Unique licenses are mandatory to operate and significant disclosures are required to be made available to consumers. We originate these policies through three distinct channels (i.e., financial advisors / agents, <span style="white-space:nowrap"><span style="white-space:nowrap">direct-to-consumer</span></span> and traditional life settlements intermediaries). We first screen each policy to ensure it is eligible for a life settlement, including verifying the policy is in force, obtaining appropriate consents and disclosures, and submitting cases for medical underwriting and life expectancy estimates. In connection with this process, we use our proprietary analytics and risk-rating systems to determine an estimated market value for each individual policy. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has established policies and guidelines with respect to its purchase of life insurance policies. These guidelines focus on the age of the insured, the sex of the insured, the duration of the underlying life insurance policy, the expected mortality risk of the underlying life insurance policy, the projected internal rate of return of the investment in the underlying life insurance policy and the amount of the death benefit of the underlying life insurance policy. The Company excludes making investments in life insurance policies based on certain types of the primary health impairment associated with the underlying insured to ensure that all policies are purchased in accordance with established industry standards and state law requirements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the origination, underwriting and valuation processes, we formally present our proposed purchase price to the policyholder or advisor. If agreed upon, the settlement closing process begins. Appropriate closing documents are reviewed by our <span style="white-space:nowrap">in-house</span> counsel, and we send funds to an independent escrow agent. Simultaneously, change of ownership and beneficiary documentation is sent to the underlying insurance carrier. Once the changes are confirmed by the carrier, the escrow agent sends the proceeds to the appropriate party, and we become responsible for the underlying insurance policy (i.e., paying premiums and receiving claim). The proceeds from the escrow agent will also include the commission(s) we owe to the broker and / or agent as well as our fee for completing the origination services. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">85 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the transaction is deemed closed, it is important to note that the policy owner may generally rescind the life settlement contract within 30 days from execution of the agreement or 15 days from the receipt of cash proceeds by the owner. As such, revenue is not recorded until this rescission process is over. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once the transaction is closed, the policy enters our active portfolio management whereby we determine whether a policy should be sold to a third-party institutional investor or held on our balance sheet. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Proprietary Technology Platforms Support Our Business </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have and continue to develop a comprehensive suite of technology products that helps drive origination, underwriting and trading. Specifically, we have created: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Risk Rating Heat Map</span></span>&#8212;Using the large amount of data we have gathered over time, we have developed a proprietary risk-rating platform that measures the risk of life insurance contracts on a range from 1&#8211;5 (low&#8211;high risk, respectively). This risk score is calculated on a wide range of factors, including (i)&#160;duration and extension risk, (ii)&#160;policy face value and purchase type, (iii)&#160;policy type, (iv)&#160;carrier rating, (v)&#160;life expectancy (&#8220;LE&#8221;) and LE extension ratios, (vi)&#160;age and age on LE date and (vii)&#160;survival probability. We believe this platform is a key differentiating factor relative to our competitors as it gives us a meaningful advantage when valuing and purchasing life insurance policies. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g22g63.jpg" alt="LOGO"/>
 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">86 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Policy Value Creator</span></span>&#8212;Our &#8220;Policy Value Calculator&#8221; drives origination by using proprietary data to instantly value policies for both individuals and financial advisors. This <span style="white-space:nowrap"><span style="white-space:nowrap">easy-to-use</span></span> online tool only requires four pieces of information: (i)&#160;gender, (ii) age, (iii)&#160;face value and (iv)&#160;policy type. These data points then generate a valuation range that advisors and individuals can use to quickly assess the current value of their policy. This product helps educate consumers and bridges the gap between our specific offering and the $233&#160;billion annual market of lapsed policies. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g21g64.jpg" alt="LOGO"/>
 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Innovations in &#8220;InsurTech&#8221;</span></span>&#8212;More recently, we have begun developing &#8220;Abacusmarketplace.com&#8221;, which is a blockchain tertiary trading, servicing and valuation platform. Given we will be able to see a large suite of data gathered by this website, we believe it will help us maintain our leading market position and keep us at the heart of the life settlements industry. We added the ability for investors to directly purchase policies in the third quarter of 2023. Abacusmarketplace.com is still in the early stages of development and we do not currently expect that Abacusmarketplace.com will have a material impact on the Company&#8217;s future financial results. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Active Portfolio Management Strategy </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With meaningful support from our proprietary risk rating heat map, we consistently evaluate policies (at origination and throughout the lifecycle) to generate essentially uncorrelated risk adjusted returns. Upon acquiring a policy, we have the option to either (i)&#160;trade that policy to a third-party institutional investor (i.e., generating a spread on each trade) or (ii)&#160;hold that policy on our balance sheet until maturity (i.e., paying the premiums over time and receiving the final claim / payout). This process is predicated on driving the best economics for Abacus. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Traded Portfolio</span></span>&#8212;Our traded portfolio returns are driven by (i)&#160;the spread we generate by selling policies to third-party institutional investors and (ii)&#160;our ability to quickly recycle capital. Our trade spreads average 20% and we have historically recycled capital 3.6 times per year. These two metrics are driven by our ability to effectively originate new policies (supply) and the underlying market interest for the policies (demand). </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g22g64.jpg" alt="LOGO"/>
 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">87 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Hold Portfolio</span></span>&#8212;Relative to our traded portfolio, our hold portfolio has the potential to generate a higher estimated annual return than our traded portfolio but requires approximately a 3 to 4 times greater capital investment, which is driven by the need to hold policies, rather than recycle the policies in trading, and to fund premium payments during the holding period for a policy. To the extent that we are not able to commit the required capital, we then focus efforts more on our traded portfolio. Our origination platform and proprietary risk rating heat map has allowed us to hold only what we determine to be the highest quality policies which have our lowest risk ratings. Of the 71 policies we have held to maturity ($37&#160;million in face value), we have achieved a 102% realized return. We currently have an additional 238 policies with a projected 12% annual return ($317&#160;million in face value). We anticipate growing the size of our hold portfolio over time as we scale our capital base. We believe there is a unique opportunity to securitize a basket of high-quality policies to sell to a third-party investor for a realized profit much sooner than contracts may actually expire. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">


<img src="g423260g10a06.jpg" alt="LOGO"/>
 </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Policy Servicing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to generating economics on the polices we directly originate and actively manage, we have a dynamic platform to service bundles of policies for a variety of third-party institutions. We generate revenue by charging a base servicing fee of approximately 0.5% of total asset value of the portfolio. We have experience servicing a large number of policies for highly sophisticated institutions, including policies for KKR and Apollo. Beyond our fees, servicing policies at scale supports our data analytics and keeps us at the heart of the life settlements industry. We have a sophisticated team of professionals solely focused on servicing these policies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Prospects for Future Growth </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Continued Maturation of the Life Settlements Industry </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described above, there is $233&#160;billion in policy value that lapses on an annual basis. However, the life settlements industry captured only approximately 2% of the potential market in 2021, which leaves significant runway for future growth for industry participants. The total face value of life insurance policies is expected to grow from approximately $6&#160;billion in 2022 to approximately $8&#160;billion in 2028, which is a 5% compounded annual growth rate. Given our position at the heart of the life settlements industry, we believe that we are well positioned to capitalize on this anticipated market growth. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Focus on Growing our Origination Process </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to originate policies is essential to scale our business over time. In order to support this expected growth, we continue to invest in our technology and marketing infrastructure. In general, we expect our efforts will continue to focus on driving education and awareness of life settlements. In order to meet this growing demand, we have increased our total employee headcount by 23% over the last twelve months and we anticipate a 50% increase in our headcount by 2024. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">88 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Continued Innovation in Technology </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Using technology to improve our analytics, market liquidity and velocity of capital use is a key priority. Certain key technology elements are: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Analytics (Abacus Analytics)</span></span>&#8212;the standard pricing and valuation platform for policy valuation and portfolio assessment that we believe will allow us to obtain visibility into every transaction in the industry. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Liquidity (Abacusmarketplace.com)</span></span>&#8212;tertiary trading, servicing and valuation platform (added direct purchase in 2023). Abacusmarketplace.com is a proprietary technology platform that has been designed in order to facilitate tertiary trading, servicing and valuation for the life settlement industry. This platform is intended to increase the trading volume for the entire industry by removing intermediaries and improving the efficiency and security of the transactions. The Company expects to realize future revenue through licensing agreements with Abacusmarketplace.com. However, Abacusmarketplace.com is still in the early stages of development, and we do not currently expect that Abacusmarketplace.com will have a material impact on the Company&#8217;s future financial results. With blockchain technology, we expect that there will be increased comfort that the documents are secure on a private blockchain, which we believe will facilitate faster closing times. The blockchain technology to be used is still in the early stages of development and is currently not a material part of the Company&#8217;s business. We believe that Abacusmarketplace.com could be a leader in the industry and will allow an investor to fully understand how it may impact future business strategies and financial results. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">Velocity (Lapetus Life Event Solutions, AgingIQ and BlockCerts)</span></span>&#8212;key partnerships and tools that complement and enhance our core analytics platforms. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">a.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Lapetus Life Event Solutions&#8212;partnership between Abacus and Lapetus Solutions, Inc. to build and develop current life expectancy tables based on our 18 years of data. This information includes tens of thousands of unique datapoints, aiding more accurate predictions of mortality experience related to several demographics including age, income and location. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">b.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">AgingIQ&#8212;lifespan prediction tool utilizing our mortality database. This tool explores how people can extend their lifespans and healthspans by adjusting current lifestyle related decisions (financial, healthy living and education). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">c.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">BlockCerts&#8212;partnership utilizing BlockCerts Web 4.0 technology to lead the next generation of life insurance and annuity purchases using blockchain capabilities. The resulting benefit includes cost reductions, enhanced data security and a competitive edge in the origination marketplace. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Access to Capital Markets Provides More Attractive Financing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that as a publicly traded company, we will have access to a lower cost of capital, which will optimize our per policy revenue and allow us to fund additional investment in infrastructure. Additionally, as discussed in more detail below, we plan to begin increasing our balance sheet hold portfolio, which we believe will drive higher long-term returns. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Transitioning Our Business Model as Our Capital Base Scales </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As our capital base scales, we aim to increase the proportion of policies that we hold on our balance sheet so that the policies we hold and the policies we trade each comprise 50% of our business model. One of the most obvious benefits to a larger hold portfolio is that it increases the predictability of returns (i.e., held policies will likely increase in value over time, largely independent of trading market conditions). Additionally, with a larger hold portfolio, there is a unique opportunity to begin securitizing policies. In the long-term, we believe securitized portfolios can drive an even lower cost of capital and can be sold in scale to third parties at a significant multiple. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">89 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Proven Ability to Deploy Capital and Scale </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past few years, we managed a $150&#160;million capital base via a joint venture with a large alternative asset manager. This joint venture was terminated on the Closing Date. Under GAAP the financial results of the entire joint venture are not included in our financial statements as the joint venture is not under common control and neither Abacus nor LMA have a direct ownership interest or investment in the joint venture. The financial impacts of the joint venture recognized in the financial statements solely relate to the services provided by Abacus and LMA to the joint venture and are discussed in the respective related party transaction notes in the financial statements. However, our track record shows our ability to operate and generate highly attractive returns. The joint venture produced $21.6&#160;million and $27.4&#160;million in revenue and $16.2&#160;million and $22.5&#160;million in net income for fiscal year ended December&#160;31, 2021 and December&#160;31, 2020, respectively. We believe that becoming a publicly traded company will allow us to more effectively deploy capital to scale our business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past six years, we have grown our total originations by approximately four times. Within our traded portfolio we have acquired 1,245 policies for a total face value of $1.9&#160;billion, generating a 22% realized return per policy. Within our hold portfolio, we have acquired 309 policies, with 238 policies currently on our balance sheet with a projected annual return of 12% and 71 policies that have matured and generated a realized return of 102%. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beyond our traded and held portfolios, we have serviced approximately $950&#160;million in policies over the last twelve months (including assets for KKR and Apollo). Additionally, we have underwritten and valued approximately $520&#160;million of policies on behalf of third parties. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is currently expected that the Company will require approximately thirty-five million dollars ($35,000,000) to fund its operations over the next 12 months. The Company believes that its funds from operations will provide sufficient funds to continue its operations for the foreseeable future. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Business Combination </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;30, 2022, East Resource Acquisition Company entered into the Merger Agreement with the Merger Subs, pursuant to which, among other things and subject to the terms and conditions contained in the Merger Agreement, Abacus Merger Sub merged with and into Abacus Settlements, with Abacus Settlements surviving the Abacus Merger as a wholly owned subsidiary of East Resource Acquisition Company, and LMA Merger Sub merged with and into LMA, with LMA surviving the LMA Merger as a wholly owned subsidiary of East Resource Acquisition Company. In connection with the Closing of the Merger, East Resource Acquisition Company was renamed Abacus Life, Inc. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, on June&#160;30, 2023, the Business Combination was consummated. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Our Employees </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of July 25, 2023, we had <span style="white-space:nowrap">eighty-four</span> (84)&#160;employees, none of whom are subject to any collective bargaining agreement or represented by a labor union. All of our employees are based in the United States. To date, we have not experienced any work stoppages and we consider our employee relations to be good. We believe that our employees are critical to our long-term success, and in 2019, we were ranked a top 3 place to work in Orlando based on employee reviews. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The core of our business is driven by our ability to successfully originate new policies. We have built a highly experienced forty-five (45)&#160;person team dedicated solely on the origination and policy acquisition process. Specifically, we have a (i)&#160;sixteen (16) person sales team, (ii)&#160;ten (10) person team of acquisition managers and case processors, (iii)&#160;fifteen (15) person team focused on policy evaluation and closing processes (i.e., contracts, </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">90 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
legal and accounting) and (iv)&#160;four (4) person team supporting our broad marketing and information technology efforts. In addition, we have a fourteen (14)&#160;person team that supports our active portfolio management and portfolio servicing efforts. Specifically, we have (a)&#160;three (3) actuarial review and financial analysts, (b)&#160;three (3) contract and accounting professionals, (c)&#160;six (6) servicing specialists and (d)&#160;two (2) institutional traders. While our employees have a wide range of roles and responsibilities, we have spent the last 19 years building a highly efficient model. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Customers </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2021, we have served over 3,000 customers with operations in forty-nine (49)&#160;states. Abacus maintains a broad customer base with a balance of policy origination across three distinct channels described above. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our customers include institutional investors seeking to invest in life settlement assets as well as life settlement policy sellers. During the years ended December&#160;31, 2021 and 2020, our largest origination customer based on revenue accounted for 33% and 35% of our revenue, respectively, and our ten largest customers together accounted for 80% and 81% of our revenue, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May of 2019, Abacus owners and certain executives of Abacus formed a joint venture with KKR called Nova Trading and Nova Holding (funds that KKR invested money in and Abacus provided investment and trading services). These related party funds, Nova Trading and Nova Holding, are collectively called the &#8220;Nova Funds.&#8221; Following the Business Combination, Abacus does not intend to continue its relationship with the Nova Funds or provide management services to the Nova Funds. While the Company does not intend to continue its joint venture relationship with the Nova Funds after the expiration of this joint venture following the Business Combination, the Company expects to retain KKR as a client. For the fiscal years ended December&#160;31, 2021 and December&#160;31, 2020, the Nova Funds generated $21.6&#160;million and $27.4&#160;million in revenue and $16.2&#160;million and $22.5&#160;million in net income, respectively. For the percent of revenue that the Nova Funds contributed to Abacus, please refer to the footnote disclosures on page <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">F-115-F-116</span></span></span> of the Abacus Audited Financials for fiscal years ended December&#160;31, 2021 and December&#160;31, 2020. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Intellectual Property </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business depends, in part, on our ability to develop and maintain the proprietary aspects of its core technology. We rely on patents and trademarks to protect our intellectual property. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of October&#160;14, 2022, we own one pending United States patent application relating to market-linked investment vehicles secured by <span style="white-space:nowrap">non-correlated</span> or <span style="white-space:nowrap">low-correlated</span> assets, and we have been issued a federal registration for our &#8220;Abacus Settlements&#8221; trademark. We also hold various domain names for websites that we use in our business.<span style="font-weight:bold"></span>&#160;Additionally, we have developed and maintain proprietary software for our internal use to aid in pricing, valuation and risk analysis of life settlement policies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Regulatory Overview </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to various laws, regulations and licensing requirements in the United States which may expose us to liability, increase costs or have other adverse effects that could harm our business. These laws and regulations include, but are not limited to, data privacy and data localization, healthcare, insurance, copyright or similar laws, anti-spam, consumer protection, employment and taxation. Compliance with such laws can require changes to our business practices and significant management time and effort. Additionally, as we continue to develop and improve consumer-facing products and services, and as those offerings grow in popularity, the risk that additional laws and regulations will impact our business will continue to increase. We believe that we are in material compliance with all such laws, regulations and licensing requirements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">91 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Data Privacy Laws and Regulations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we receive, use, transmit, disclose and store personal data, we are subject to numerous state and federal laws and regulations that address privacy, data protection and the collection, storing, sharing, use, transfer, disclosure and protection of certain types of data. We are subject to the TCPA which restricts the making of telemarketing calls and the use of automatic telephone dialing systems. Violators of the TCPA face regulatory enforcement action, substantial civil penalties, injunctions, and in some states, private lawsuits for damages. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Privacy and data security regulation in the U.S. is rapidly evolving. For example, California enacted the California Consumer Privacy Act (&#8220;CCPA&#8221;), which came into force in 2020. The CCPA and related regulations give California residents expanded rights to access and request deletion of their personal information, opt out of certain personal information sharing and receive detailed information about how their personal information is used and shared. The CCPA allows for the California Attorney General to impose civil penalties for violations, as well as providing a private right of action for certain data breaches. California voters also recently passed the California Privacy Rights Act (&#8220;CPRA&#8221;), which will take effect on January&#160;1, 2023. The CPRA significantly modifies the CCPA, including by imposing additional obligations on covered companies and expanding California consumers&#8217; rights with respect to certain personal information. The CCPA&#8217;s restrictions on &#8220;sales&#8221; of personal information may restrict our use of cookies and similar technologies for advertising purposes, as well as increasing our compliance costs and potential liability. The CCPA excludes information covered by the Gramm-Leach-Bliley Act, the Driver&#8217;s Privacy Protection Act, the Fair Credit Reporting Act and the California Financial Information Privacy Act from the CCPA&#8217;s scope, but the CCPA&#8217;s definition of &#8220;personal information&#8221; is broad and may encompass other information that we maintain. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The passage of the CCPA likely marked the beginning of a trend toward more stringent privacy legislation in the U.S., and multiple states have enacted or proposed similar laws. For example, in 2020, Nevada enacted SB 220 which restricts the &#8220;selling&#8221; of personal information and, in 2021, Virginia passed the Consumer Data Protection Act which is set to take effect on January&#160;1, 2023 and creates new privacy rights for Virginia residents. There is also discussion in Congress of new comprehensive federal data protection and privacy law to which we likely would be subject if it is enacted. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Various regulators are interpreting existing state consumer protection laws to impose evolving standards for the online collection, use, dissemination and security of other personal data. Courts may also adopt the standards for fair information practices which concern consumer notice, choice, security and access. Consumer protection laws require us to publish statements that describe how we handle personal information and choices individuals may have about the way we handle their personal data. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure to comply with these privacy laws or regulations could expose us to significant fines and penalties imposed by regulators and has in the past and could in the future expose us to legal claims by buyers, or other relevant stakeholders. Some of these laws, such as the CCPA, permit individual or class action claims for certain alleged violations, increasing the likelihood of such legal claims. Similarly, many of these laws require us to maintain an online privacy policy, terms of service and other informational pages that disclose our practices regarding the collection, processing and disclosure of personal information. If these disclosures contain any information that a court or regulator finds to be inaccurate, we could also be exposed to legal or regulatory liability. Any such proceedings or violations could force us to spend money in defense or settlement of these proceedings, result in the imposition of monetary liability or demanding injunctive relief, divert management&#8217;s time and attention, increase our costs of doing business and materially adversely affect our reputation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Insurance Laws and Regulations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We operate as a life settlement producer in forty-nine (49)&#160;states. We have a strong track record with each state in which we are licensed and have not had any reportable incidents. Our <span style="white-space:nowrap">in-house</span> counsel and compliance staff reviews every life insurance policy we consider acquiring for compliance with applicable state regulations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">92 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
We file an annual report with each state in which it operates and each state has the ability to request an audit at its discretion. Currently, 42 states have regulations that support the sale of life insurance policies to a third party, like our Company. Each state also has its own policyholder-facing disclosure requirements that we comply with in the ordinary course of its business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We focus on acquiring and trading <span style="white-space:nowrap">non-variable,</span> <span style="white-space:nowrap">non-fractionalized</span> life insurance policies. These life insurance policies are deemed to be personal property of the owner based upon the Supreme Court decision <span style="font-style:italic">Grigsby v. Russell</span> in 1911. Furthermore, <span style="white-space:nowrap">non-variable,</span> <span style="white-space:nowrap">non-fractionalized</span> life insurance policies are not deemed to be securities under the federal securities laws, and so the Company is not required to register as an investment adviser or an investment company under the Investment Advisers Act of 1940, as amended or the Investment Company Act, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may, in the future, purchase some amount of variable life insurance policies or interests in the death benefit of underlying life insurance policies. The Company has recently acquired a limited purpose broker dealer, which the Company intends to license to engage in transactions for variable and fractionalized life insurance policies. Abacus expects that any transactions in variable or fractionalized life insurance policies will represent less than 20% of the life insurance policies acquired by the Company at any time. The Company does not, and does not in the future intend to, engage in any life insurance securitization. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Facilities </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate headquarters is located at 2101 Park Center Drive, Suite 170, Orlando, Florida 32835 and our telephone number is <span style="white-space:nowrap"><span style="white-space:nowrap">800-561-4148.</span></span> The headquarters consists of 6,812 square feet of &#8220;Class&#160;A&#8221; office space pursuant to a lease that expires in June 2024. We also sublease additional office space in Orlando, Florida, which consists of approximately 3,000 square feet of space pursuant to a sublease that expires in October 2023. We believe our facilities are adequate and suitable for our current needs and that, should it be needed, suitable additional or alternative space will be available to accommodate our operations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Legal Proceedings </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not currently a party to any material legal proceedings. However, in the ordinary course of business we may be subject from time to time to various claims, lawsuits and other legal and administrative proceedings. Some of these claims, lawsuits and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines, penalties, <span style="white-space:nowrap">non-monetary</span> sanctions or relief. We intend to recognize provisions for claims or pending litigation when we determine that an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Due to the inherent uncertain nature of litigation, the ultimate outcome or actual cost of settlement may materially vary from estimates. Additionally, any such claims, lawsuits and proceedings, whether or not successful, could damage our reputation and business. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">93 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_8d">MANAGEMENT </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Management and Board of Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following sets forth certain information, as of July&#160;25, 2023, concerning the executive officers and members of the board of directors of the Company. Each of the Company&#8217;s officers is appointed for a term of one year, or until earlier removed or replaced. Messrs. Gusky and McNealy were appointed to serve as Class I directors, with terms expiring at the Company&#8217;s annual meeting of stockholders to be held in 2024; Mr. Katwijk and Mmes. Schulte and Radka were appointed to serve as Class II directors, with terms expiring at the Company&#8217;s annual meeting of stockholders to be held in 2025; and Messrs. Jackson and Corbett were appointed to serve as Class III directors, with terms expiring at the Company&#8217;s annual meeting of stockholders to be held in 2026. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:48%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:46%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Name</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Age</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay Jackson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">51</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Executive Officer and Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Ganovsky</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="white-space:nowrap">Co-Founder</span> and President</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Scott Kirby</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="white-space:nowrap">Co-Founder</span> and President</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sean McNealy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="white-space:nowrap">Co-Founder,</span> President and Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William McCauley</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">51</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Financial Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adam Gusky</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karla Radka</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">54</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cornelis Michiel van Katwijk</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas W. Corbett, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">73</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Beth Schulte</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Director</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Executive Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Jay Jackson&#8212;Chief Executive Officer and Director </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Jackson is the President and Chief Executive Officer of Abacus. He joined Abacus Settlements in 2016 as President&#160;&amp; Chief Executive Officer and has also served as Chief Executive Officer of LMA since June 2019. His strategic business development and creation of innovative new processes and efficiencies has propelled Abacus forward. Mr.&#160;Jackson is an industry thought leader relating to longevity and senior finances; he <span style="white-space:nowrap">co-authored</span> the book &#8220;Pursuing Wealthspan.&#8221; Mr.&#160;Jackson also serves as a current member of the Orlando Mayor&#8217;s Committee on Livability and Healthy Aging and serves as an Executive Board Member for the Senior Resource Alliance, an agency of the Florida Department of Elder Affairs. Mr.&#160;Jackson began his career at Franklin Templeton Investments, where he served as vice president for more than a decade. Prior to joining Abacus, Mr.&#160;Jackson <span style="white-space:nowrap">co-founded</span> and managed the Fayerweather Street Life Fund, as well as the Cambridge Life Management origination platform for FDO Partners, a $3&#160;billion quantitative investment firm founded by Harvard Business School Professor Ken Froot. We believe that Mr.&#160;Jackson is qualified to serve on the board of directors of the Company due to his current role as Chief Executive Officer of Abacus and his 20 years of experience in the financial services and life settlement industry. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Sean <span style="white-space:nowrap">McNealy&#8212;Co-Founder,</span> President and Director </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;McNealy is the <span style="white-space:nowrap">Co-Founder</span> and President of Abacus. Mr.&#160;McNealy has been a leader in the life settlements industry for over 16 years with extensive industry experience in marketing and capital markets. Along with the other two Managing Partners, he <span style="white-space:nowrap">co-founded</span> Abacus Settlements in 2004, and has served as <span style="white-space:nowrap">Co-Founder</span> and President of Abacus since that date. Mr.&#160;McNealy has written numerous articles about the life settlement industry that have been published in various trade magazines, and has presented to many large insurance broker consortiums, producer groups and key national accounts. In 1991, he graduated from the University of Central Florida with a Bachelor of Science in Marketing. We believe that Mr.&#160;McNealy is qualified to serve on the board of directors of the Company due to his current role as President of Abacus and experience in the life settlement industry. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">94 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">William McCauley&#8212;Chief Financial Officer </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;McCauley currently serves as the Chief Financial Officer of LMA. Upon the closing of the Business Combination, Mr.&#160;McCauley began serving as the Chief Financial Officer of the Company. From January 2020 through May 2022, Mr.&#160;McCauley served as the Chief Financial Officer of Abacus Settlements, where he managed financial activities and developed financing models. Prior to joining Abacus, he served as the Chief Financial Officer at IFP Advisors, LLC, a registered investment adviser and broker, where he was responsible for all financial activities of the company and was involved in both debt and equity financing. Mr.&#160;McCauley also served as a Director of Finance at McKinsey&#160;&amp; Company from January 2017 until May 2018, where he was responsible for the financial statements of more than 30 <span style="white-space:nowrap">start-up</span> businesses. Mr.&#160;McCauley received his Bachelor of Science in Accounting from Bentley University and his MBA from Babson College. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Matthew <span style="white-space:nowrap">Ganovsky&#8212;Co-</span> Founder and President </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Ganovsky has been a leader in the life settlements industry for over 25 years with extensive industry experience. He <span style="white-space:nowrap">co-founded</span> Abacus Settlements, in 2004, and has served as <span style="white-space:nowrap">Co-Founder</span> and Managing Partner of Abacus since that date. Mr.&#160;Ganovsky manages our broker division, with involvement in more than 3,000 transactions. Upon the closing of the Business Combination, Mr.&#160;Ganovsky began serving as the President of the Company. Mr.&#160;Ganovsky received his degree in Hospitality and Real Estate from Valencia College. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Kevin Scott <span style="white-space:nowrap">Kirby&#8212;Co-</span> Founder and President </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Kirby <span style="white-space:nowrap">co-founded</span> Abacus Settlements, in 2004, and has served as <span style="white-space:nowrap">Co-Founder</span> and Managing Partner of Abacus since that date. Upon the closing of the Business Combination, Mr.&#160;Kirby began serving as the President of the Company. Mr.&#160;Kirby has held a Life and Annuity license in the state of Florida since 2006. He received his Bachelor of Science in Business Administration in Business Management from the University of Central Florida<span style="font-weight:bold">.</span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Independent Board Members </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Karla Radka&#8212;Director </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&#160;Radka has been the President and Chief Executive Officer of Senior Resource Alliance, a <span style="white-space:nowrap">non-profit</span> agency for the Florida Department of Elder Affairs, since 2019. Ms.&#160;Radka previously held leadership roles at Goodwill Industries of Central Florida, where she served as Chief Operating Officer from 2015 through 2019, Florida Family Care, and Community Based Care of Central Florida, a child welfare <span style="white-space:nowrap">non-profit.</span> She also founded Public Allies Central Florida, a nationally recognized program, and served as its executive director until 2014. Ms.&#160;Radka received her Bachelor of Science and Master of Science in Counseling from Central Christian University. She also later received a <span style="white-space:nowrap">mini-MBA</span> at Rollins College Crummer Graduate School of Business. We believe that Ms.&#160;Radka is qualified to serve on the board of directors of the Company due to her relevant experience as the Chief Executive Officer of Senior Resource Alliance, a <span style="white-space:nowrap">non-profit</span> that assists seniors in everyday living and a division of the Department of the Elder Affairs in Florida. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Thomas W. Corbett, Jr.&#8212;Director </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Corbett has been the principal member of Corbett Consulting, LLC since 2015 and, from 2011 to 2015, served as the Governor of Pennsylvania. He has also served as Pennsylvania&#8217;s Attorney General and as the US Attorney for the Western District of Pennsylvania. Mr.&#160;Corbett received a Bachelor of Arts in political science from Lebanon Valley College and a Juris Doctor from St. Mary&#8217;s University Law School. He was a member of the board of directors for Composites Consolidation Company LLC from 2015 to 2016 and was a member of the board for Animal Friends of Pittsburgh until 2019. Mr.&#160;Corbett has served as a member of the Company Board since July 2020. In addition, he currently serves on the board of the Variety Club, The Children&#8217;s Charity Pittsburgh. We believe that Mr.&#160;Corbett is qualified to serve on the board of directors of the Company due to his extensive leadership and risk management experience as former Governor of Pennsylvania and former Pennsylvania State Attorney General, as well as his service on other public company boards of directors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">95 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cornelis Michiel van Katwijk&#8212;Director </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cornelis Michiel van Katwijk is the former Chief Financial Officer, Treasurer, Director&#160;&amp; Executive Vice President at Transamerica Life Insurance Co. (Iowa) and the former Treasurer&#160;&amp; Senior Vice President at Transamerica Advisors Life Insurance Company of New York where he was employed from September 2012 through September 2021. He also served on the board of Transamerica Advisors Life Insurance Co. He previously held the position of Group Treasurer at Aegon NV and Chief Financial Officer at AEGON USA LLC (a subsidiary of Aegon NV). Mr.&#160;van Katwijk received an MBA from the University of Rochester and an undergraduate degree from Nyenrode Business Universiteit. We believe that Mr.&#160;van Katwijk is qualified to serve on the board of directors of the Company due to former roles as the Chief Financial Officer of Transamerica and financial leadership positions at Aegon NV and AEGON USA LLC. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Adam Gusky&#8212;Director </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Gusky has served as the Chief Investment Officer of East Management Services, LP, an affiliate of East Sponsor, LLC, since the inception of East Management Services in 2010. At East Management Services, Mr.&#160;Gusky was responsible for all financial due diligence for acquisitions, and he was in charge of the reserve-based lending facility. He also developed and implemented the corporate hedging strategy. Mr.&#160;Gusky currently serves on the Board of Directors of Rand Capital Corporation, a publicly traded business development company, where East Asset Management made a control investment. Mr.&#160;Gusky received his Bachelor of Arts in History and his MBA from Duke University. We believe that Mr.&#160;Gusky is qualified to serve on the board of directors of the Company due to his role as the Chief Investment Officer of East Management Services and his history as an investor in both public and private companies. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Mary Beth Schulte&#8212;Director </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&#160;Schulte has been a Certified Public Accountant for over 30 years and is currently the Chief Financial Officer of Attivo Partners. In this role, Ms.&#160;Schulte is responsible for providing CFO strategy and accounting services to promote business development to primarily early stage companies. Ms.&#160;Schulte formerly served as a Director at Anders CPAs&#160;&amp; Advisors until 2022, as well as a Principal at UHY Advisors MO, Inc. from 2015 to 2020. Ms.&#160;Schulte also currently serves on the Board of Directors of Richard A. Chaifetz School of Business &#8211; St. Louis University, Capital Innovators, Cultivation Capital and Arch Grants. Ms.&#160;Schulte received her MBA and Bachelor of Science in Business Administration for Accounting from the Richard A. Chaifetz School of Business &#8211; St. Louis University. We believe that Ms.&#160;Schulte is qualified to serve on the board of directors of the Company due to her prior experience as a Chief Financial Officer of a public company and a Certified Public Accountant. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Corporate Governance </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate governance is structured in a manner the Company believes closely aligns our interests with those of our stockholders. Notable features of this corporate governance include: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">we have independent director representation on our audit, compensation and nominating committees, and our independent directors will meet regularly in executive sessions without the presence of our corporate officers or <span style="white-space:nowrap">non-independent</span> directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at least one of our directors will qualify as an &#8220;audit committee financial expert&#8221; as defined by the SEC; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">we have implemented a range of other corporate governance best practices, including implementing a robust director education program. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Composition of the Board of Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business and affairs are managed under the direction of our board of directors. Our board of directors is staggered in three classes, with two (2)&#160;directors in Class&#160;I (Adam Gusky and Sean McNealy), three (3)&#160;directors </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">96 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in Class&#160;II (Cornelis Michiel van Katwijk, Mary Beth Schulte and Karla Radka) and two (2)&#160;directors in Class&#160;III (Thomas W. Corbett, Jr. and Jay Jackson). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Board Committees </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors directs the management of our business and affairs, as provided by Delaware law, and conducts its business through meetings of the board of directors and standing committees. We have a standing audit committee, nominating committee and compensation committee. In addition, from time to time, special committees may be established under the direction of the board of directors when necessary to address specific issues. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Audit Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee is responsible for, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">discussing with our independent registered public accounting firm their independence from management; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing, with our independent registered public accounting firm, the scope and results of their audit; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">approving all audit and permissible <span style="white-space:nowrap">non-audit</span> services to be performed by our independent registered public accounting firm; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the quarterly and annual financial statements that we file with the SEC; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing our financial and accounting controls and compliance with legal and regulatory requirements; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing our policies on risk assessment and risk management; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing related person transactions; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee consists of Mary Beth Schulte, Karla Radka and Cornelis Michiel van Katwijk, with Ms.&#160;Schulte serving as chair. Rule <span style="white-space:nowrap">10A-3</span> of the Exchange Act and NASDAQ rules require that our audit committee be composed entirely of independent members. Our board of directors has affirmatively determined that Ms.&#160;Schulte, Ms.&#160;Radka and Mr.&#160;van Katwijk each meets the definition of &#8220;independent director&#8221; for purposes of serving on the audit committee under Rule <span style="white-space:nowrap">10A-3</span> of the Exchange Act and NASDAQ rules. Each member of our audit committee also meets the financial literacy requirements of NASDAQ listing standards. In addition, our board of directors has determined that Ms.&#160;Schulte and Mr.&#160;van Katwijk will each qualify as an &#8220;audit committee financial expert,&#8221; as such term is defined in Item 407(d)(5) of Regulation <span style="white-space:nowrap">S-K.</span> Our board of directors has adopted a written charter for the audit committee, which is available on our corporate website at https://abacuslife.com/. The information on any of our websites is deemed not to be incorporated in this prospectus or to be part of this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Compensation Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee is responsible for, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing and approving (either alone or, if directed by the board of directors, in conjunction with a </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">97 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
majority of the independent members of the board of directors) the compensation of our Chief Executive Officer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing an evaluation of the performance of and reviewing and setting or making recommendations to our board of directors regarding the compensation of our other executive officers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and approving or making recommendations to our board of directors regarding our incentive compensation and equity-based plans, policies and programs; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reviewing and approving all employment agreement and severance arrangements for our executive officers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">making recommendations to our board of directors regarding the compensation of our directors; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">retaining and overseeing any compensation consultants. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee consists of Mary Beth Schulte, Karla Radka and Cornelis Michiel van Katwijk, with Ms.&#160;Schulte serving as chair. Our board of directors has affirmatively determined that Ms.&#160;Schulte, Ms.&#160;Radka and Mr.&#160;van Katwijk each meets the definition of &#8220;independent director&#8221; for purposes of serving on the compensation committee under NASDAQ rules, and are <span style="white-space:nowrap">&#8220;non-employee</span> directors&#8221; as defined in Rule <span style="white-space:nowrap">16b-3</span> of the Exchange Act. Our board of directors has adopted a written charter for the compensation committee, which is available on our corporate website at https://abacuslife.com/. The information on any of our websites is deemed not to be incorporated in this prospectus or to be part of this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Nominating Committee </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our nominating committee is responsible for, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">identifying individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing succession planning for our Chief Executive Officer and other executive officers; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">periodically reviewing our board of directors&#8217; leadership structure and recommending any proposed changes to our board of directors; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">overseeing an annual evaluation of the effectiveness of our board of directors and its committees; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">developing and recommending to our board of directors a set of corporate governance guidelines. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our nominating committee consists of Karla Radka, Mary Beth Schulte and Thomas W. Corbett, Jr. with Ms.&#160;Radka serving as chair. Our board of directors has affirmatively determined that Ms.&#160;Radka, Ms.&#160;Schulte and Mr.&#160;Corbett, Jr. each meets the definition of &#8220;independent director&#8221; under NASDAQ rules. Our board of directors has adopted a written charter for the nominating committee, which is available on our corporate website at https://abacuslife.com/. The information on any of our websites is deemed not to be incorporated in this prospectus or to be part of this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Risk Oversight </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors is responsible for overseeing our risk management process. Our board of directors focuses on our general risk management strategy, the most significant risks facing us and oversees the implementation of risk mitigation strategies by management. Our audit committee is also responsible for discussing our policies with respect to risk assessment and risk management. Our board of directors believes its administration of its risk oversight function has not negatively affected our board of directors&#8217; leadership structure. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">98 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Committee Interlocks and Insider Participation </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of our executive officers serves as a member of the board of directors or compensation committee (or other committee performing equivalent functions) of any entity that has one or more executive officers serving on our board of directors or compensation committee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Code of Business Conduct and Ethics </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon completion of the Business Combination, we adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is posted on our corporate website at https://abacuslifesettlements.com/. In addition, we have posted on our website all disclosures that are required by law or NASDAQ listing standards concerning any amendments to, or waivers from, any provision of the code. The information on any of our websites is deemed not to be incorporated in this prospectus or to be part of this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation of Directors and Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s executive compensation program is consistent with Abacus Settlements&#8217; and LMA&#8217;s compensation policies and philosophies in effect prior to the Business Combination, which are designed to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">attract, retain and motivate senior management leaders who are capable of advancing our mission and strategy and ultimately, creating and maintaining our long-term equity value. Such leaders must engage in a collaborative approach and possess the ability to execute our business strategy in an industry characterized by competitiveness and growth; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reward senior management in a manner aligned with our financial performance; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">align senior management&#8217;s interests with our equity owners&#8217; long-term interests through equity participation and ownership. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Decisions with respect to the compensation of our executive officers, will be made by the compensation committee of our board of directors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">99 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_8e">EXECUTIVE AND DIRECTOR COMPENSATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section discusses the material components of the executive compensation program for our executive officers who are named in the &#8220;2022 Summary Compensation Table&#8221; below. As an emerging growth company, Abacus complies with the executive compensation disclosure rules applicable to &#8220;smaller reporting companies,&#8221; as such term is defined in the rules promulgated under the Securities Act, which require compensation disclosure for our principal executive officer and our two most highly compensated executive officers other than our principal executive officer. In 2022, our &#8220;named executive officers&#8221; and their positions were as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Jay Jackson, Founder, President and Chief Executive Officer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Sean McNealy, Founder and President; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Matthew Ganovsky, Founder and President. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Kevin Scott Kirby, Founder and President. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">2022 Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation of our named executive officers for the year ended December&#160;31, 2022. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:39%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Name</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Principal Position</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Year</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Salary</span><br/><span style="font-weight:bold">($)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">All&#160;other</span><br/><span style="font-weight:bold">compensation&#160;($)(1)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Total ($)</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay Jackson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief&#160;Executive&#160;Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">210,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,846&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">238,846</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sean McNealy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">President</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">210,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">210,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Ganovsky</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">President</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">210,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">210,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">K. Scott Kirby</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">President</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2022</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">210,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">210,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Other compensation reflects medical insurance paid on behalf of the named executive officers. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Narrative to the Summary Compensation Table </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">2022 Annual Base Salary </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus pays the named executive officers a base salary to compensate them for services rendered to Abacus. The base salary payable to the named executive officers is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role and responsibilities. For fiscal year 2022, the named executive officers&#8217; annual base salaries were as follows: Mr.&#160;Jackson: ($210,000); Mr.&#160;McNealy: ($210,000); Mr.&#160;Ganovsky: ($210,000); and Mr.&#160;Kirby: ($210,000). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Annual Bonus </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, Abacus did not pay any annual bonuses to its named executive officers. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Equity Compensation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, Abacus had no equity compensation plans or outstanding equity awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination, the Company has adopted, the Incentive Plan in order to facilitate the grant of cash and equity incentives to directors, employees, including named executive officers, and consultants to help attract and retain the services of these individuals. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">The Incentive Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the Incentive Plan is to provide a means through which Abacus and its affiliates may attract, retain and motivate persons who make (or are expected to make) important contributions by providing these </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">100 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
individuals with equity ownership opportunities and/or equity-linked compensatory opportunities. Equity awards and equity-linked compensatory opportunities are intended to motivate high levels of performance and align the interests of directors, employees and consultants with those of stockholders by giving directors, employees and consultants the perspective of an owner with an equity or equity-linked stake in Abacus and provide a means of recognizing their contributions to our success. The board of directors believes that equity awards are necessary for Abacus to remain competitive in its industry and are essential to recruiting and retaining highly qualified employees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Summary of the Incentive Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section summarizes certain principal features of the Incentive Plan. The summary is qualified in its entirety by reference to the complete text of the Incentive Plan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Eligibility and Administration </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our employees, consultants and directors may be eligible to receive awards under the Incentive Plan. As of June&#160;30, 2023, Abacus has 82 employees, four <span style="white-space:nowrap">(4)&#160;non-employee</span> directors and no other individual service providers who may be eligible to receive awards under the Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Incentive Plan provides that it will be administered by a committee of, and appointed by, the board of directors of Abacus that shall be composed of two or more independent directors, and which shall be subject to the limitations imposed under the Incentive Plan, Section&#160;16 of the Exchange Act, stock exchange rules and other applicable laws. The compensation committee of the board of directors was appointed to administer the Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee will have the authority to take all actions and make all determinations under the Incentive Plan, to construe the Incentive Plan and award agreements and to prescribe rules and regulations relating to the administration of the Incentive Plan as it deems necessary or advisable. The committee will also have the authority to determine which eligible directors, employees and consultants receive awards, grant awards and set the terms and conditions of all awards under the Incentive Plan, including any vesting and vesting acceleration provisions, subject to the conditions and limitations in the Incentive Plan. The compensation committee will make determinations as to awards grants under the Incentive Plan at the time of hiring of a participant and, annually, following the release of material non-public information. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Shares Available for Awards </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate number of shares that may be issued under the Plan shall be equal to 5% of the issued and outstanding common stock of the Company. The aggregate number of shares with respect to which incentive stock options may be granted under the Incentive Plan shall be equal to 5% of the issued and outstanding common stock of the Company. The aggregate fair market value compensation on the date of grant of an award made to a <span style="white-space:nowrap">non-employee</span> director during a calendar year shall be determined by the committee and shall not exceed $75,000 per calendar year. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an award under the Incentive Plan is forfeited, expires unexercised or is settled for cash, any shares subject to such award may, to the extent of such forfeiture, expiration or cash settlement, immediately be used again for new grants under the Incentive Plan. Any shares that are the subject of awards under the Incentive Plan which are exchanged for awards that do not involve shares shall also again immediately become available to be issued pursuant to awards granted under the Incentive Plan. If shares are withheld to satisfy tax obligations with respect to an option or a stock appreciation right, such shares shall not again be available for issuance under the Incentive Plan. If shares are tendered in payment of an option price of an option or the exercise price of a stock appreciation right, such shares shall not be available for issuance under the Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards granted under the Incentive Plan upon the assumption of, or in substitution for, awards authorized or outstanding under a qualifying equity plan maintained by an entity with which we enter into a merger or </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">101 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
similar corporate transaction will not reduce the shares available for grant under the Incentive Plan, nor shall such shares subject to substitute awards again be available for grant under the Incentive Plan to the extent of any forfeiture, expiration, or cash settlement under an award. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Awards </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Incentive Plan provides for the grant of stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards, performance awards, phantom stock awards, restricted stock unit awards (&#8220;RSUs&#8221;) and stock awards. Certain awards under the Incentive Plan may constitute or provide for payment of &#8220;nonqualified deferred compensation&#8221; under Section&#160;409A of the Code, which may impose additional requirements on the terms and conditions of such awards. All awards under the Incentive Plan will be evidenced by award agreements, which will detail the terms and conditions of awards, including any applicable vesting and payment terms and post-termination exercise limitations. Awards other than cash awards generally will be settled in shares of Abacus common stock, but the applicable award agreement may provide for cash settlement of any award. A brief description of each award type follows. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Stock Options and SARs</span>. Stock options provide for the purchase of shares of our Common Stock in the future at an exercise price set on the grant date. Incentive stock options, in contrast to <span style="white-space:nowrap">non-qualified</span> stock options, may provide tax deferral beyond exercise and favorable capital gains tax treatment to their holders if certain holding period and other requirements of the Code are satisfied. SARs entitle their holder, upon exercise, to receive from us an amount equal to the appreciation of the shares subject to the award between the grant date and the exercise date. Unless otherwise determined by the compensation committee, the exercise price of a stock option or SAR may not be less than 100% of the fair market value of the underlying share on the grant date (or 110% in the case of incentive stock options granted to certain significant stockholders), except with respect to certain substitute awards granted in connection with a corporate transaction. Unless otherwise determined by the compensation committee, the term of a stock option or SAR may not be longer than ten years (or five years in the case of incentive stock options granted to certain significant stockholders). </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Restricted Stock</span>. Restricted stock is an award of <span style="white-space:nowrap">non-transferable</span> shares of our Common Stock that are subject to certain vesting conditions and other restrictions. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Performance Awards</span>. A Performance Award under the Incentive Plan is an award of rights subject to vesting and transferability restrictions generally based upon the attainment of performance goals as the committee may determine, payment of which may be made in cash or shares of our Common Stock, as specified in the holder&#8217;s Performance Award agreement. The Incentive Plan provides that a performance goal may be based on one or more business criteria that apply to the holder, one or more of our business units, or us as a whole. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Phantom Stock</span>.<span style="font-style:italic"> </span>Phantom Stock Awards under the Incentive Plan are awards of rights to receive the value of shares of our Common Stock that are subject to certain vesting conditions. Following the end of the vesting period for a Phantom Stock Award (or at such other time as may be provided in a Phantom Stock Award agreement), the holder of a Phantom Stock Award will be entitled to receive payment of cash, our Common Stock, or a combination thereof as determined by the committee, in an amount not exceeding the maximum value of the Phantom Stock Award, based on the then vested value of the award. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Restricted Stock Units</span>. RSUs are contractual promises to deliver shares of our Common Stock in the future or an equivalent in cash and other consideration determined by the committee, which may also remain forfeitable unless and until specified conditions are met and may be accompanied by the right to receive the equivalent value of dividends paid on shares of our Common Stock prior to the delivery of the underlying shares (i.e., dividend equivalent rights). The terms and conditions applicable to RSUs will be determined by the committee, subject to the conditions and limitations contained in the Incentive Plan. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">102 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Stock Awards</span>. Stock awards are awards of fully vested shares of our Common Stock. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Dividend Equivalents</span>. Dividend equivalents represent the right to receive the equivalent value of dividends paid on shares of our Common Stock and may be granted alone or in tandem with awards other than stock options or SARs. Dividend equivalents are credited as of the dividend record dates during the period between the date an award is granted and the date such award vests, is exercised, is distributed or expires, as determined by the committee. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Transactions </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation committee has broad discretion to take action under the Incentive Plan, as well as make adjustments to the terms and conditions of existing and future awards, to prevent the dilution or enlargement of intended benefits and facilitate necessary or desirable changes in the event of certain transactions and events affecting our Common Stock, such as stock dividends (other than ordinary cash dividends), stock splits, spinoffs, recapitalizations, mergers, acquisitions, combinations, exchange of shares, consolidations and other corporate transactions. In addition, in the event of certain <span style="white-space:nowrap">non-reciprocal</span> transactions with our stockholders known as &#8220;equity restructurings,&#8221; the committee will make equitable adjustments to the Incentive Plan and outstanding awards. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Repricing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except in connection with certain changes in our capital structure, stockholder approval will be required for any amendment that reduces the exercise price of any stock option or SAR, or cancels any stock option or SAR that has an exercise price that is greater than the then-current fair market value of Common Stock in exchange for cash, other awards or stock options or SARs with an exercise price per share that is less than the exercise price per share of the original stock options or SARs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Transferability </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Incentive Stock Option is not transferable other than by will or the laws of descent and distribution, and may be exercised during the employee&#8217;s lifetime only by the employee or such employee&#8217;s guardian or legal representative. All other awards under the Incentive Plan are not transferable other than by will or the laws of descent and distribution, pursuant to a qualified domestic relations order, or with the consent of the committee (as to certain family transfers, or otherwise). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Plan Amendment and Termination</p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors may amend or terminate the Incentive Plan at any time; however, no amendment may impair the rights of a participant with respect to an award outstanding under the Incentive Plan without the consent of the affected participant. Further, the board of directors may not, without the consent of the stockholders, amend the Incentive Plan to increase the maximum aggregate number of shares that may be issued under the Incentive Plan or change the class of individuals eligible to receive awards under the Incentive Plan or amend or eliminate the restrictions on repricing of awards. No awards may be granted under the Incentive Plan after its termination. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Material U.S. Federal Income Tax Consequences</p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a general summary under current law of the Internal Revenue Code (the &#8220;Code&#8221;) principal U.S. federal income tax consequences related to awards under the Incentive Plan. Deductions described below may be limited by Section&#160;162(m) of the Code. This summary deals with the general federal income tax principles that apply and is provided only for general information. Phantom Stock, and certain other awards that may be granted pursuant to the Incentive Plan, could be subject to additional taxes unless they are designed to comply with certain restrictions set forth in Section&#160;409A of the Code and guidance promulgated thereunder. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">103 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Some kinds of taxes, such as state, local and foreign income taxes and federal employment taxes, are not discussed. This summary is not intended as tax advice to participants, who should consult their own tax advisors. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Restricted Stock</span>. The recipient of a Restricted Stock award generally will not realize taxable income at the time of grant, and we generally will not be entitled to a deduction at that time, assuming that the restrictions constitute a substantial risk of forfeiture for federal income tax purposes. When the risk of forfeiture with respect to the stock subject to the award lapses, the holder generally will realize ordinary income in an amount equal to the fair market value of the shares of our Common stock at such time less the amount paid for the stock (if any), and, subject to Section&#160;162(m), we will be entitled to a corresponding deduction. All dividends and distributions (or the cash equivalent thereof) with respect to a Restricted Stock award paid to the holder before the risk of forfeiture lapses generally will also be compensation income to the holder when paid and, subject to Section&#160;162(m) as discussed below, deductible as such by us. Notwithstanding the foregoing, the holder of a Restricted Stock award may elect under Section&#160;83(b) of the Code to be taxed at the time of grant of the Restricted Stock award based on the fair market value of the shares of our Common Stock on the date of the award less the amount paid for the stock (if any), in which case (a)&#160;subject to Section&#160;162(m), we will be entitled to a deduction at the same time and in the same amount, (b)&#160;dividends paid to the recipient during the period the forfeiture restrictions apply will be taxable as dividends and will not be deductible by us and (c)&#160;there will be no further federal income tax consequences when the risk of forfeiture lapses. Such election must be made not later than 30 days after the grant of the Restricted Stock award, and is irrevocable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Restricted Stock Unit Awards</span>. The grant of a Restricted Stock Unit Award (&#8220;RSU Award&#8221;) under the Incentive Plan generally will not result in the recognition of any U.S. federal taxable income by the recipient or a deduction for us at the time of grant. At the time an RSU Award is settled the recipient will generally recognize ordinary income and, subject to Section&#160;162(m) of the Code, we will be entitled to a corresponding deduction. Generally, the measure of the income and the deduction will be based on the number of shares of common stock issued in settlement of the RSU Award multiplied by the value of our Common Stock at the time the RSU Award is settled. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Stock Awards</span>. The recipient of a Stock Award generally will realize taxable ordinary income at the time of grant in an amount equal to the fair market value of the shares of our Common Stock on the date of the award, and, subject to Section&#160;162(m) of the Code, we will be entitled to a corresponding deduction. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Incentive Stock Options</span>. Incentive Stock Options are subject to special federal income tax treatment. No federal income tax is imposed on the optionee upon the grant or the exercise of an Incentive Stock Option if the optionee does not dispose of the shares acquired pursuant to the exercise within the <span style="white-space:nowrap">two-year</span> period beginning on the date the option was granted or within the <span style="white-space:nowrap">one-year</span> period beginning on the date the option was exercised (collectively, the &#8220;holding period&#8221;). In such event, we would not be entitled to any deduction for federal income tax purposes in connection with the grant or exercise of the option or the disposition of the shares so acquired. With respect to an Incentive Stock Option, the difference between the fair market value of the stock on the date of exercise and the exercise price must generally be included as an item of adjustment for purposes of the optionee&#8217;s alternative minimum taxable income for the year in which such exercise occurs. However, if the optionee exercises an Incentive Stock Option and disposes of the shares received in the same year and the amount realized is less than the fair market value of the shares on the date of exercise, then the amount included in alternative minimum taxable income will not exceed the amount realized over the adjusted basis of the shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Upon disposition of the shares received upon exercise of an Incentive Stock Option after the holding period, any appreciation of the shares above the exercise price should constitute long-term capital gain. If an optionee disposes of shares acquired pursuant to his or her exercise of an Incentive Stock Option prior to the end of the holding period, the optionee will be treated as having received, at the time of </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">104 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
disposition, compensation taxable as ordinary income. In such event, and subject to Section&#160;162(m) of the Code, we may claim a deduction for compensation paid at the same time and in the same amount as compensation is treated as received by the optionee. The amount treated as compensation is the excess of the fair market value of the shares at the time of exercise (or in the case of a sale in which a loss would be recognized, the amount realized on the sale if less) over the exercise price; any amount realized in excess of the fair market value of the shares at the time of exercise would be treated as short-term or long-term capital gain, depending on the holding period of the shares. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic"><span style="white-space:nowrap">Non-statutory</span> Stock Options and Stock Appreciation Rights</span>. Generally, no federal income tax is imposed on the optionee upon the grant of a <span style="white-space:nowrap">Non-statutory</span> Stock Option or a SAR, and we are not entitled to a tax deduction by reason of such grant. Generally, upon the exercise of a <span style="white-space:nowrap">Non-statutory</span> Stock Option, the optionee generally will be treated as receiving compensation taxable as ordinary income in the year of exercise in an amount equal to the excess of the fair market value of the shares of stock at the time of exercise over the option price paid for such shares. In the case of the exercise of a SAR, the holder generally will be treated as receiving compensation taxable as ordinary income in the year of exercise in an amount equal to the cash received or the fair market value of the shares distributed to the optionee. Upon the exercise of a <span style="white-space:nowrap">Non-statutory</span> Stock Option or a SAR, and subject to Section&#160;162(m) of the Code, we may claim a deduction for compensation paid at the same time and in the same amount as compensation income is recognized by the optionee assuming any federal income tax reporting requirements are satisfied. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Performance Awards, Phantom Stock Awards and Stock Awards</span>. An individual who has been granted a Performance Award, a Phantom Stock Award or a Stock Award generally will not realize taxable income at the time of grant, and we will not be entitled to a deduction at that time. Whether such an award is paid in cash or shares of Common Stock, the individual generally will have taxable compensation and, subject to Section&#160;162(m) of the Code, we generally will have a corresponding deduction. The measure of such income and deduction will be based on the amount of any cash paid and the fair market value of any shares of our Common Stock either at the time the award is paid or at the time any restrictions on the shares subsequently lapse, depending on the nature, if any, of the restrictions imposed and whether the individual elects to be taxed without regard to any such restrictions. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left"><span style="font-style:italic">Section</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;162(m)</span>. Generally, Section&#160;162(m) of the Code precludes a public corporation from taking a deduction for annual compensation in excess of $1,000,000 paid to its covered employees (as defined in Section&#160;162(m) of the Code). </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;409A of the Code </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain types of awards under the Incentive Plan may constitute, or provide for, a deferral of compensation subject to Section&#160;409A of the Code. Unless certain requirements set forth in Section&#160;409A of the Code are complied with, holders of such awards may be taxed earlier than would otherwise be the case (e.g., at the time of vesting instead of the time of payment) and may be subject to an additional 20% penalty tax (and, potentially, certain interest, penalties and additional state taxes). To the extent applicable, the Incentive Plan and awards granted under the Incentive Plan are intended to be structured and interpreted in a manner intended to either comply with or be exempt from Section&#160;409A of the Code and the Department of Treasury regulations and other interpretive guidance that may be issued under Section&#160;409A of the Code. To the extent determined necessary or appropriate by the committee, the Incentive Plan and applicable award agreements may be amended to further comply with Section&#160;409A of the Code or to exempt the applicable awards from Section&#160;409A of the Code. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Retirement Plans </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus currently maintains a 401(k) retirement savings plan for its employees, including its named executive officers, who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the 401(k) plan on the same terms as other full-time employees. The Code allows eligible </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">105 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employees to defer a portion of their compensation, within prescribed limits, through contributions to the 401(k) plan. Abacus believes that providing a vehicle for <span style="white-space:nowrap">tax-deferred</span> retirement savings though its 401(k) plan adds to the overall desirability of its executive compensation package and further incentivizes its employees, including its named executive officers, in accordance with our compensation policies. Abacus did not make any matching contributions under the 401(k) plan with respect to 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Employee Benefits and Perquisites </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our named executive officers are eligible to participate in our employee benefit plans and programs, including medical and dental benefits and life insurance, to the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans. Abacus provides perquisites on a <span style="white-space:nowrap"><span style="white-space:nowrap">case-by-case</span></span> basis when it believes it is necessary to attract or retain a named executive officer. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">No Tax <span style="white-space:nowrap">Gross-Ups</span> </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abacus has no obligations to make <span style="white-space:nowrap">gross-up</span> payments to cover named executive officers&#8217; personal income taxes that may pertain to any of the compensation or perquisites paid or provided by Abacus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Executive Compensation Arrangements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The named executive officers were not party to or covered by any employment or severance arrangements for 2021 or 2022. In connection with the Business Combination, Abacus entered into employment agreements with its named executive officers. These agreements provide for <span style="white-space:nowrap">at-will</span> employment and generally include the named executive officer&#8217;s initial base salary, standard benefit plan eligibility and other terms and conditions of employment with Abacus. The terms of each of these employment agreements provide for a term of 36 months with 12-month renewals if not terminated at least 90 days before the expiration date. The agreements also provide for payments in the event of certain terminations of employment, including a higher severance payment if a termination occurs in connection with a change in control event. The terms of each of these employment agreements include a cell-phone reimbursement to the named executive officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of each of these employment agreements, if the executive is terminated without cause or resigns for good reason, and timely executes a release of claims against Abacus, he or she will receive the greater of one year of continued base salary or continued salary for the balance of the then-current employment term. The employment agreements also include <span style="white-space:nowrap">non-competition</span> and <span style="white-space:nowrap">non-solicitation</span> covenants in favor of Abacus for a period of one year after the executive&#8217;s termination of employment. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Managers </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our named executive officers did not receive any compensation in their role as managers of the Company in 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">106 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_8f">PRINCIPAL SECURITYHOLDERS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table and accompanying footnotes set forth information with respect to the beneficial ownership of Common Stock, as of June&#160;30, 2023, after the completion of the Business Combination, for (1)&#160;each person known by us to be the beneficial owner of more than 5% of the outstanding shares of Common Stock, (2)&#160;each member of the Board, and (3)&#160;each of our named executive officers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Shares of Common Stock issuable pursuant to options or warrants are deemed to be outstanding for purposes of computing the beneficial ownership percentage of the person or group holding such options or warrants but are not deemed to be outstanding for purposes of computing the beneficial ownership percentage of any other person. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June&#160;30, 2023 after the completion of the Business Combination, there were outstanding 62,961,688 shares of Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise noted in the footnotes to the following table, and subject to applicable community property laws, the persons and entities named in the table have sole voting and investment power with respect to their beneficially owned shares of Common Stock. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:67%"/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name of Beneficial Owners</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of</span><br/><span style="font-weight:bold">Shares&#160;of</span><br/><span style="font-weight:bold">Common</span><br/><span style="font-weight:bold">Stock</span><br/><span style="font-weight:bold">Beneficially</span><br/><span style="font-weight:bold">Owned</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Percentage&#160;of</span><br/><span style="font-weight:bold">Outstanding</span><br/><span style="font-weight:bold">Common</span><br/><span style="font-weight:bold">Stock</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">5% Stockholders:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">East Sponsor, LLC<sup style="font-size:75%; vertical-align:top"> (1)</sup></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,735,000</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(2)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24.8</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Terry Pegula</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,735,000</td>
<td style="white-space:nowrap;vertical-align:bottom"><sup style="font-size:75%; vertical-align:top">(2)</sup>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24.8</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay Jackson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">K. Scott Kirby</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Ganovsky</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sean McNealy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Directors and Named Executive Officers:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jay Jackson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Scott Kirby</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Ganovsky</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sean McNealy</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,293,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adam Gusky</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,452</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"/>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karla Radka</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cornelis Michiel van Katwijk</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas M. Corbett, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"/>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Beth Schulte</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Less than 1% </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">East Sponsor, LLC is the record holder of the shares of Common Stock and the Private Placement Warrants reported herein. East Asset Management, LLC is the managing member of East Sponsor, LLC. Trusts controlled by Terrence M. Pegula are the sole members of East Asset Management, LLC. As such, Mr.&#160;Pegula may be deemed to have or share beneficial ownership of the shares of Common Stock and the Private Placement Warrants held directly by East Sponsor, LLC. Mr.&#160;Pegula disclaims any beneficial ownership of the reported shares of Common Stock and the Private Placement Warrants other than to the extent of any pecuniary interest he may have therein, directly or indirectly. The business address of East Sponsor, LLC is c/o East Asset Management, LLC, 7777 NW Beacon Square Boulevard, Boca Raton, Florida 33487. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">107 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Consists of (i) 8,615,000 shares of Common Stock and (ii) 7,180,000 Private Placement Warrants to purchase the same number of shares of Common Stock that are exercisable within 60 days of the date hereof. </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Warrant Forfeiture Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date of the Business Combination, the Company and Sponsor entered into the Warrant Forfeiture Agreement (the &#8220;Warrant Forfeiture Agreement&#8221;), pursuant to which Sponsor forfeited 1,780,000 of the Private Placement Warrants held by Sponsor. The above description of the Warrant Forfeiture Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Warrant Forfeiture Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Registration Rights Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Closing Date of the Business Combination, certain stockholders of the Company and certain holders of limited liability company interests in Abacus Settlements and LMA entered into that certain Amended and Restated Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;). Pursuant to the Registration Rights Agreement, the Company has agreed to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of Common Stock and other equity securities of the Company that are held by the parties thereto from time to time. Pursuant to the Registration Rights Agreement, the Company agreed to file a shelf registration statement registering the resale of the Common Stock (including those held as of the effective time or issuable upon future exercise of the Private Placement Warrants) and the Private Placement Warrants (the &#8220;Registrable Securities&#8221;) under the Registration Rights Agreement within 30 days of the closing of the Business Combination. The Holders may request to sell all or any portion of their Registrable Securities in an underwritten offering (the &#8220;Underwritten Shelf Takedown&#8221;) so long as the total offering price is reasonably expected to exceed $20,000,000. The Sponsor may not demand more than two Underwritten Shelf Takedowns, the Holders (other than the Sponsor) may not demand more than two Underwritten Shelf Takedowns and the Company shall not be obligated to participate in more than four Underwritten Shelf Takedowns, in the aggregate, in any <span style="white-space:nowrap">12-month</span> period. The Company also agreed to provide customary &#8220;piggyback&#8221; registration rights, subject to certain requirements and customary conditions. The Registration Rights Agreement also provides that the Company will pay certain expenses relating to such registrations and indemnify the stockholders against certain liabilities. The above description of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Registration Rights Agreement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">108 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_8g">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Registration Rights Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the closing of the Business Combination, the Company, and certain stockholders of the Company entered into an Amended and Restated Registration Rights Agreement, pursuant to which the Company will agree to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of Company Class&#160;A Common Stock and other equity securities of the Company that are held by the parties thereto from time to time. Pursuant to the Registration Rights Agreement, the Company agreed to file a shelf registration statement registering the resale of the Class&#160;A Common Stock (including those held as of the effective time or issuable upon future exercise of the Private Placement Warrants) and the Private Placement Warrants (the &#8220;Registrable Securities&#8221;) under the Registration Rights Agreement within 30 days of the closing of the Business Combination. The holders may request to sell all or any portion of their Registrable Securities in an underwritten offering (an&#160;&#8220;Underwritten Shelf Takedown&#8221;) so long as the total offering price is reasonably expected to exceed $20,000,000. The sponsor may not demand more than two Underwritten Shelf Takedowns, the holders (other than the sponsor) may not demand more than two Underwritten Shelf Takedowns and the Company shall not be obligated to participate in more than four Underwritten Shelf Takedowns, in the aggregate, in any <span style="white-space:nowrap">12-month</span> period. The Company also agreed to provide customary &#8220;piggyback&#8221; registration rights, subject to certain requirements and customary conditions. The Registration Rights Agreement also provides that the Company will pay certain expenses relating to such registrations and indemnify the stockholders against certain liabilities. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Procedures with Respect to Review and Approval of Related Person Transactions </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors of the Company recognizes the fact that transactions with related persons present a heightened risk of conflicts of interests (or the perception thereof). The board of directors has adopted a written policy on transactions with related persons that is in conformity with the requirements for issuers having publicly held common stock that is listed on Nasdaq. Under the policy, the&#160;Company&#8217;s legal team will be primarily responsible for developing and implementing processes and procedures to obtain information regarding related persons with respect to potential related person transactions and then determining, based on the facts and circumstances, whether such potential related person transactions do, in fact, constitute related person transactions requiring compliance with the policy. If the legal team determines that a transaction or relationship is a related person transaction requiring compliance with the policy, the&#160;Company&#8217;s general counsel will be required to present to the audit committee all relevant facts and circumstances relating to the related person transaction. The audit committee will be required to review the relevant facts and circumstances of each related person transaction, including if the transaction is on terms comparable to those that could be obtained in arm&#8217;s length dealings with an unrelated third party and the extent of the related person&#8217;s interest in the transaction, take into account the conflicts of interest and corporate opportunity provisions of the&#160;Company&#8217;s code of business conduct and ethics, and either approve or disapprove the related person transaction. If advance audit committee approval of a related person transaction requiring the audit committee&#8217;s approval is not feasible, then the transaction may be preliminarily entered into by management upon prior approval of the transaction by the chair of the audit committee, subject to ratification of the transaction by the audit committee at the audit committee&#8217;s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. If a transaction was not initially recognized as a related person transaction, then, upon such recognition, the transaction will be presented to the audit committee for ratification at the audit committee&#8217;s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. The&#160;Company&#8217;s management will update the audit committee as to any material changes to any approved or ratified related person transaction and will provide a status report at least annually of all then current related person transactions. No director will be permitted to participate in approval of a related person transaction for which he or she is a related person. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">109 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_9">DESCRIPTION OF THE NOTES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The following summary description sets forth certain terms and provisions of the notes, and to the extent inconsistent therewith replaces the description of the general terms and provisions of the notes set forth in the prospectus, to which we refer you. Because this description is a summary, it does not describe every aspect of the notes. The following summary does not purport to be complete and is subject to and is qualified in its entirety by reference to all of the provisions of the notes and the indenture, including the definitions therein. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The indenture will be qualified under the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;), and you should refer to the Trust Indenture Act for provisions that apply to the notes. </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">General </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be issued under an indenture, to be entered into prior to the issuance of the notes, which we refer to as the base indenture, between us and U.S. Bank Trust Company, National Association, as trustee, which we refer to as the trustee, as supplemented by a supplemental indenture, which we refer to as the first supplemental indenture, to be dated as of the date of initial issuance of the notes. We refer to the base indenture and the first supplemental indenture, collectively, as the indenture. This description of the notes is subject to and qualified in its entirety by reference to the indenture and the forms of notes. The notes will be represented by one or more global notes registered in the name of Cede&#160;&amp; Co., as nominee of DTC, as depositary, in minimum denominations of $25 or any amount in excess thereof that is an integral multiple of $25. See &#8220;<span style="font-style:italic">Book-Entry Issuance&#8212;Book-Entry System</span>.&#8221; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be our senior unsecured obligations. No recourse will be had for the payment of principal of or interest on any note, for any claim based thereon, or otherwise in respect thereof, against any shareholder, employee, agent, officer or director as such, past, present or future, of us or of any successor person. The notes will not contain any provision that would provide protection to the holders of the notes against a sudden and dramatic decline in credit quality resulting from a merger, takeover, recapitalization, or similar restructuring of us or our subsidiaries or significant sales of our capital stock by holders of such stock or any other event involving us or our subsidiaries that may adversely affect our credit quality, except as set forth under<span style="font-style:italic"> &#8220;- Offer to Repurchase Upon a Change of Control Repurchase Event.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Principal Amount; Maturity and Interest </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will issue the notes offered by this prospectus in an initial aggregate principal amount of $60,000,000 (or up to $69,000,000 aggregate principal amount if the underwriters&#8217; overallotment option to purchase additional notes is exercised in full). The notes will mature on September&#160;30, 2028. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be denominated in U.S. dollars and all payments of principal and interest thereon will be paid in U.S. dollars. The notes do not have the benefit of a sinking fund. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest will be paid to the person in whose name a note is registered at the close of business on the 15th calendar day (whether or not a Business Day) preceding the related date an interest payment is due with respect to such note; <span style="font-style:italic">provided</span> that if the notes are global notes held by DTC, the record date for such notes will be the close of business on the Business Day preceding the applicable interest payment date; <span style="font-style:italic">provided</span> further that interest payable on the maturity of the principal of the notes or (subject to the exceptions described under the heading &#8220;&#8212; <span style="font-style:italic">Optional Redemption of the Notes</span>&#8221;) any redemption date will be paid to the person to whom principal is paid. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest on the notes will accrue from and including the date the notes are issued (the &#8220;issue date&#8221;) or from and including the most recent interest payment date (whether or not such interest payment date was a Business Day) for which interest has been paid or provided for with respect to the notes to, but excluding, the next interest </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">110 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payment date, redemption date or the maturity date, as the case may be. Each of these periods is referred to as an &#8220;interest period&#8221; for the notes. Interest not punctually paid or duly made available for payment with respect to an interest period, if any, will be paid instead to the person in whose name the note is registered on a special record date rather than on the regular record date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any interest payment, any redemption date or the maturity date falls on a day that is not a Business Day, then payment of any interest, principal or premium payable on such date will be postponed to the next succeeding Business Day, with the same force and effect as if made on the date such payment was due, and no interest or other payment will accrue as a result of such delay. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this description of the notes, the term &#8220;Business Day&#8221; means any day that is not a Saturday or Sunday and that is not a day on which banking institutions are generally authorized or obligated by law or executive order to close in The City of New York or on which the corporate trust office of the trustee is closed for business. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Interest Rate Periods </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the period from, and including, the issue date, the notes will bear interest at the rate of &#8195;% per annum. Interest will be payable quarterly, in arrears, on March&#160;30, June&#160;30, September&#160;30 and December&#160;30 of each year, beginning on December&#160;30, 2023 and ending on the maturity date. The notes will mature on September&#160;30, 2028. Interest will be computed on the basis of a <span style="white-space:nowrap">360-day</span> year consisting of twelve <span style="white-space:nowrap">30-day</span> months. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Additional Amounts </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that any payment on the notes is subject to withholding of any U.S. federal income tax or other tax or assessment (as a result of a change in law or otherwise), we will not pay additional amounts with respect to such tax. For a discussion relating to certain U.S. federal income tax consequences of the ownership and disposition of the notes for <span style="white-space:nowrap">non-U.S.</span> holders, see &#8220;<span style="font-style:italic">Material U.S. Federal Income Tax Consequences&#8212;Tax Consequences to <span style="white-space:nowrap">Non-U.S.</span> Holders</span>.&#8221; </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Optional Redemption of the Notes </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be redeemable at our option, in whole or in part, at any time and from time to time, on or after September&#160;30, 2025, upon not less than 15 days nor more than 60 days written notice to holders prior to the date fixed for redemption thereof, at a redemption price of 100% of the outstanding principal amount of the notes to be redeemed plus accrued and unpaid interest otherwise payable thereon for the then-current quarterly interest period accrued to, but excluding, the date fixed for redemption. We must provide notice to the trustee of any redemption no later than 5 days prior to when notice is sent to holders, unless some shorter period is reasonably agreed to by us and the trustee. A notice of redemption may be made subject to the satisfaction of certain conditions set forth therein, and may be revoked if such conditions are not satisfied. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the notes are held in book-entry form through DTC, we may provide notice in any manner permitted or required by DTC. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to any redemption date, we will deposit with the trustee or a paying agent an amount of money sufficient to pay the redemption price of, and (except if the redemption date is an interest payment date) accrued interest on, the notes which are to be redeemed on such date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the notes called for redemption. If fewer than all of the notes of any series are to be redeemed, the particular notes to be redeemed will be selected by us, not more than 60 days prior to the redemption date, from the outstanding notes not previously called for redemption, in compliance with the policies and procedures of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">111 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
trustee and the requirements of DTC, as applicable, <span style="font-style:italic">provided</span> that the unredeemed portion of the principal amount of any note will be in an authorized denomination (which will not be less than the minimum authorized denomination) for such note. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we may at any time purchase notes by tender, in the open market or by private agreement, subject to applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will not be subject to repayment at the option of the holder at any time prior to the maturity date, except as set forth under <span style="font-style:italic">&#8220;- Offer to Repurchase Upon a Change of Control Repurchase Event.&#8221;</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Offer to Repurchase Upon a Change of Control Repurchase Event </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Change of Control Repurchase Event (as defined below) occurs, unless we have exercised our option to redeem the notes as described under &#8220;&#8212; <span style="font-style:italic">Optional Redemption of the Notes</span>,&#8221; each holder of notes will have the right, at such holder&#8217;s option, to require that we repurchase for cash all of such holder&#8217;s notes, or any portion thereof, on a date specified by us that is not less than 20 calendar days nor more than 35 calendar days following the date on which we deliver notice of such Change of Control Repurchase Event, at a purchase price equal to 100% of the principal amount of notes to be repurchased, plus accrued and unpaid interest thereon, if any, to, but excluding, the date of repurchase, pursuant to the offer described below. On or before the 20th calendar day after the occurrence of a Change of Control Repurchase Event, we shall provide to all holders of the notes and the trustee notice of the occurrence of such Change of Control Repurchase Event and of the purchase right at the option of the holders arising as a result thereof. Simultaneously with providing such notice, we shall publish this information in a newspaper of general circulation in The City of New York or publish the information on our website or through such other public medium as we may use at that time. The notice shall, if given prior to the date of consummation of the Change of Control Repurchase Event, state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, interest due on an interest payment date falling on or prior to a repurchase date will be payable to holders at the close of business on the record date for such interest payment date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will comply with the requirements of Rule <span style="white-space:nowrap">14e-1</span> under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the indenture by virtue of such conflict. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the Change of Control Repurchase Event payment date, we will, to the extent lawful: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">accept for payment all notes or portions of notes properly tendered pursuant to our offer; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">deposit with the paying agent an amount equal to the aggregate repurchase price in respect of all notes or portions of notes properly tendered; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">deliver or cause to be delivered to the trustee the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us and requesting that such notes be cancelled. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The paying agent will promptly send to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and send (or cause to be transferred by book entry) to each holder a new note equal in principal amount to any unrepurchased portion of any notes surrendered; <span style="font-style:italic">provided </span>that each new note will be in a minimum principal amount of $25 and integral multiples of $25 in excess thereof. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">112 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in the foregoing, we will not be required to purchase, or to make an offer to purchase, the notes upon a Change of Control Repurchase Event if a third party makes the offer in the manner, at the times, and otherwise in compliance with the requirements set forth in the indenture applicable to an offer by us to purchase the notes upon a Change of Control Repurchase Event, and such third party purchases all notes validly tendered and not withdrawn upon such offer in the manner and otherwise in compliance with such requirements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that sufficient funds will be available at the time of any Change of Control Repurchase Event to make required repurchases of notes tendered. Our failure to repurchase the notes upon a Change of Control Repurchase Event would result in an Event of Default under the indenture. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of any of the following: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">any &#8220;person&#8221; or &#8220;group&#8221; (within the meaning of Section&#160;13(d) of the Exchange Act), files a Schedule TO or any schedule, form or report under the Exchange Act disclosing that such person or group has become the direct or indirect ultimate &#8220;beneficial owner,&#8221; as defined in Rule <span style="white-space:nowrap">13d-3</span> under the Exchange Act, of our common stock representing more than 50% of the voting power of our common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the consummation of (x)&#160;any consolidation, merger, amalgamation, scheme of arrangement or other binding share exchange or reclassification or similar transaction between us and another person, in each case pursuant to which our common stock shall be converted into cash, securities or other property, other than a transaction (i)&#160;that results in the holders of all classes of our common stock immediately prior to such transaction owning, directly or indirectly, as a result of such transaction, more than 50% of the surviving corporation or transferee or the parent thereof immediately after such event, or (ii)&#160;effected solely to change our jurisdiction of formation or to form a holding company for us and that results in a share exchange or reclassification or similar exchange of the outstanding common stock solely into common shares of the surviving entity or (y)&#160;any sale or other disposition in one transaction or a series of transactions of all or substantially all of our assets to another person; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">our shareholders approve any plan or proposal for the liquidation or dissolution of us (other than in a transaction described in clause (2)&#160;above); or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">our common stock ceases to be listed on the Nasdaq Capital Market, the Nasdaq Global Select Market, the Nasdaq Global Market or the New York Stock Exchange (or any of their respective successors). </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Ranking of the Notes </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be our senior unsecured obligations and will rank equal in right of payment to our other existing or future senior unsecured obligations. </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of July 5, 2023, we had approximately $25 million in principal amount of other senior unsecured long-term debt outstanding, all of which will be repaid with the proceeds of this offering, and approximately $35.5 million in principal amount of subordinated long-term debt outstanding. The notes will be effectively subordinated to all of our future secured indebtedness to the extent of the value of our assets securing such indebtedness. Our subsidiaries are separate and distinct legal entities and have no obligation to pay any amounts due on the notes or to provide us with funds to pay our obligations, whether by dividends, distributions, loans or other payments. </p> </div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our right to participate in any distribution of assets of any of our subsidiaries upon the subsidiary&#8217;s liquidation or otherwise will generally be subject to the prior claims of creditors of that subsidiary. The notes are our obligations and not those of our subsidiaries and, as such, will be structurally subordinated to all of the existing and future indebtedness and other liabilities of our subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be senior in right of payment to any unsecured and subordinated indebtedness of ours that is subordinated in right of payment to the notes. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">113 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Events of Default; Waivers </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following events will be &#8220;Events of Default&#8221; under the indenture with respect to the notes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Default for 30 days in any interest payment in respect of the notes; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Default in any principal or premium payment at maturity of the notes, including a redemption or repurchase date; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Default in the performance or breach of any covenant or warranty of ours in the indenture for 90 days after the receipt of a notice of default; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Default by us under any bond, debenture, note or other evidence of indebtedness for money borrowed by us having an aggregate principal amount outstanding of at least $10,000,000, whether such indebtedness now exists or is created or incurred in the future, which default (i)&#160;constitutes a failure to pay an aggregate principal amount of such indebtedness, individually or in the aggregate for all such indebtedness, in excess of $10,000,000, when due and payable after the expiration of any applicable grace period or (ii)&#160;results in such indebtedness becoming due or being declared due and payable prior to the date on which it otherwise would have become due and payable without, in the case of clause (i), such indebtedness having been discharged or, in the case of clause (ii), such indebtedness having been discharged or such acceleration having been rescinded or annulled; <span style="font-style:italic">provided</span>, that for purposes of the indenture, the term &#8220;indebtedness&#8221; shall not include any indebtedness or obligations of subsidiaries of us that is guaranteed by us; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Our bankruptcy, insolvency or reorganization. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an Event of Default relating to the notes has occurred and is continuing, either the trustee or the holders of at least 25% in aggregate principal amount of the outstanding notes of such series may declare the principal amount of the notes to be due and payable immediately. No such declaration is required, however, with respect to an Event of Default triggered by bankruptcy, insolvency or reorganization. Subject to certain conditions, this declaration may be annulled by the holders of a majority in principal amount of the notes. In addition, the holders of a majority in principal amount of notes of all affected series (voting as one class except in the case of Events of Default regarding a default in any principal, premium or interest payment or deposit of any sinking fund, as to which each series so affected will vote as a separate class) may waive any past default with respect to the notes of such series. The trustee shall not be deemed to have knowledge or notice of the occurrence of any default or event of default, unless a responsible trust officer of the trustee shall have received written notice from us or a holder describing such default or event of default and stating that such notice is a notice of default or event of default. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Modification and Waiver </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Without the consent of any holders of any notes, we, when authorized by a board resolution, and the trustee, at any time and from time to time, may enter into one or more supplemental indentures, in form satisfactory to the trustee, for any of the following purposes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to evidence the succession of another person to us and the assumption by any such successor of the covenants of us in the indenture and in the notes; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to add to the covenants of us for the benefit of the holders of all or any series of debt securities, including the notes (and if such covenants are to be for the benefit of less than all series of debt securities, stating that such covenants are expressly being included solely for the benefit of such series), or to surrender any right or power conferred upon us pursuant to the indenture; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to add any additional Events of Default for the benefit of the holders of all or any series of debt securities (and if such additional Events of Default are to be for the benefit of less than all series of debt securities, stating that such additional Events of Default are expressly being included solely for the benefit of such series); or </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">114 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to add to or change any of the provisions of the indenture to such extent as will be necessary to permit or facilitate the issuance of debt securities, including the notes, registrable or not registrable as to principal, and with or without interest coupons, or to permit or facilitate the issuance of notes in uncertificated form; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to add to, change or eliminate any of the provisions of the indenture in respect of one or more series of debt securities under the indenture, provided that any such addition, change or elimination (i)&#160;will neither (A)&#160;apply to any such securities of any series created prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor (B)&#160;modify the rights of the holder of any such securities with respect to such provision or (ii)&#160;will become effective only when there is no such securities outstanding; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to secure the notes or provide for guarantees of the notes; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to establish the form or terms of debt securities of any series under the indenture as permitted pursuant thereto; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to evidence and provide for the acceptance of appointment under the indenture by a successor trustee with respect to the debt securities of one or more series, including the notes, and to add to or change any of the provisions of the indenture as will be necessary to provide for or facilitate the administration of the trusts thereunder by more than one trustee; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to comply with any requirements of the SEC in connection with qualifying the indenture under the Trust Indenture Act; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to cure any ambiguity, to correct or supplement any provision in the indenture which may be defective or inconsistent with any other provision therein; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to supplement any of the provisions of the indenture to the extent necessary to permit or facilitate the defeasance and discharge of any series of debt securities pursuant to the indenture; <span style="font-style:italic">provided</span> that any such action will not adversely affect the interests of the holders of securities of any series in any material respect; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to make provisions with respect to conversion or exchange rights of holders of securities of any series; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to add, delete from or revise the conditions, limitations or restrictions on issue, authentication and delivery of securities; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to conform the terms of the notes or the indenture with the description set forth in this prospectus or with the requirements of the Trust Indenture Act; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">to make any other provisions with respect to matters or questions arising under the indenture, provided that such action pursuant to this clause will not adversely affect the interests of the holders of debt securities of any series, including the notes, in any material respect. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With the consent of the holders of not less than a majority in principal amount of the outstanding notes of each series affected by such supplemental indenture, by act of such holders delivered to us and the trustee, we, when authorized by a board resolution, and the trustee may enter into one or more supplemental indentures for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the indenture or of modifying in any manner the rights of the holders of notes of such series under the indenture; <span style="font-style:italic">provided</span>, <span style="font-style:italic">however</span>, that no such supplemental indenture will, without the consent of the holder of each outstanding note affected thereby: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">change the stated maturity of the principal of, or any installment of principal of or interest on, any note, or reduce the principal amount thereof or the rate of interest thereon or any premium payable upon the redemption thereof, or reduce the amount of the principal of any note which would be due and payable upon a declaration of acceleration of the maturity thereof pursuant to the terms of the indenture, adversely </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">115 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
affect any right of repayment at the option of the holder of any security, or change any place of payment where any note or any premium or interest thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the stated maturity thereof (or, in the case of redemption, on or after the redemption date), or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reduce the percentage in principal amount of the outstanding notes of any series, the consent of whose holders is required for any such supplemental indenture, or the consent of whose holders is required for any waiver (of compliance with certain provisions of the indenture or certain defaults thereunder and their consequences) provided for in the indenture, or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">modify any of the provisions of this paragraph or certain provisions of the indenture relating to waivers of past defaults and waivers of certain covenants, except to increase any such percentage or to provide that certain other provisions of the indenture cannot be modified or waived without the consent of the holder of each outstanding note affected thereby; <span style="font-style:italic">provided</span>, <span style="font-style:italic">however</span>, that this clause will not be deemed to require the consent of any holder with respect to changes in the references to &#8220;the trustee&#8221; and concomitant changes in this paragraph, or the deletion of this proviso, in certain circumstances. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A supplemental indenture which changes or eliminates any covenant or other provision of the indenture which has expressly been included solely for the benefit of one or more particular series of debt securities, or which modifies the rights of the holders of debt securities of such series with respect to such covenant or other provision, will be deemed not to affect the rights under the indenture of the holders of debt securities of any other series. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with any modification, amendment, supplement or waiver in respect of the indenture or the notes, we must deliver to the trustee an officers&#8217; certificate and an opinion of counsel, each stating (i)&#160;that such modification, amendment, supplement or waiver is authorized or permitted pursuant to the terms of the indenture and the notes, (ii)&#160;that all related conditions precedent to such modification, amendment, supplement or waiver have been complied with; and (iii)&#160;that such supplemental indenture will be valid and binding upon us in accordance with its terms. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Consolidation, Merger and Sale of Assets </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture will provide that we may not consolidate with or merge into another person or convey, transfer or lease our properties and assets substantially as an entirety to another person or permit any person to consolidate with or merge into us or convey, transfer or lease its properties and assets substantially as an entirety to us unless: (i)&#160;in case we will consolidate with or merge into another person or convey, transfer or lease our properties and assets substantially as an entirety to another person, the person formed by the consolidation or into which we are merged or the person which acquires by conveyance or transfer, or which leases the properties and assets of us substantially as an entirety, (a)&#160;is a corporation organized and validly existing under the laws of the United States of America, any State thereof or the District of Columbia and (b)&#160;expressly assumes by supplemental indenture, executed and delivered to the trustee, the due and punctual payment of the principal of and any premium and interest on all the notes and the performance or observance of every covenant of the indenture on the part of us to be performed or observed; and (ii)&#160;immediately after giving effect to the transaction, no Event of Default and no event which, after notice or lapse of time or both, would become an Event of Default will have occurred and be continuing under the indenture, and we have delivered to the trustee an officers&#8217; certificate and an opinion of counsel as required by the indenture. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Trustee </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be issued under the base indenture as supplemented by the first supplemental indenture by and between us and U.S. Bank Trust Company, National Association, as trustee. U.S. Bank Trust Company, National Association, in each of its capacities, including without limitation as trustee, security registrar, and paying agent, assumes no responsibility for the accuracy or completeness of the information contained in this document or the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">116 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
related documents or for any failure by us or any other party to disclose events that may have occurred and may affect the significance or accuracy of such information. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Defeasance and Discharge </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The defeasance provisions of the indenture will apply to the notes. The &#8220;defeasance&#8221; provisions of the indenture provide that we may terminate some of our obligations with respect to any series of notes by depositing with the trustee as trust funds a combination of money and U.S. government obligations sufficient to pay the principal of or premium, if any, and interest on, the securities of such series as they come due. Defeasance is permitted only if, among other things, we deliver to the trustee an officers&#8217; certificate and opinion of counsel on the terms described in the indenture. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture also provides that we are entitled to cause the indenture to cease to be of further effect (a &#8220;satisfaction and discharge&#8221;), with certain limited exceptions, if (i)&#160;either (a) all securities under the indenture, with certain exceptions, have been delivered to the trustee for cancellation or (b)&#160;all such securities not delivered to the trustee for cancellation (x)&#160;have become due and payable or (y)&#160;will become due and payable at their stated maturity within one year or (z)&#160;are to be called for redemption within one year under arrangements satisfactory to the trustee and us (in the case of (x), (y), or (z)&#160;above) has deposited or caused to be deposited with the trustee as trust funds money sufficient to pay the principal of or premium, if any, and interest on, such securities as they come due or are to be redeemed, (ii)&#160;we have paid or caused to be paid all other sums payable under the indenture by us and (iii)&#160;we have delivered the trustee an officers&#8217; certificate and opinion of counsel stating that all conditions precedent provided for in the indenture relating to the satisfaction and discharge of the indenture have been complied with. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Further Issuances </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amount of notes we can issue under the indenture is unlimited. We will issue notes in the initial aggregate principal amount of $60,000,000 (or up to $69,000,000 aggregate principal amount if the underwriters&#8217; overallotment option to purchase additional notes is exercised in full). However, we may, without your consent and without notifying you, create and issue further notes, which notes may be consolidated and form a single series with either series of notes offered by this prospectus and may have the same terms as to interest rate, maturity, covenants or otherwise; <span style="font-style:italic">provided</span> that if any such additional notes are not fungible with the notes for U.S. federal income tax purposes, such additional notes will have a separate CUSIP or other identifying number. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Notices </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notices to holders of notes will be given by first-class mail to the addresses of such holders as they appear in the note register. Where notices are to be provided to a holder of a global security, the notice will be deemed sufficiently given if provided to the depositary for such security pursuant to its applicable procedures. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Governing Law </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes and the indenture will be governed by and construed in accordance with the laws of the State of New York. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Miscellaneous </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We or our affiliates may from time to time purchase any of the notes that are then outstanding by tender, in the open market or by private agreement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">117 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_10">BOOK-ENTRY ISSUANCE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Book-Entry System </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes will be represented by global securities that will be deposited and registered in the name of DTC or its nominee. This means that, except in limited circumstances, you will not receive certificates for the notes. Beneficial interests in the notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC. Investors may elect to hold interests in the notes through either DTC, if they are a participant, or indirectly through organizations that are participants in DTC. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes will be issued as fully registered securities registered in the name of Cede&#160;&amp; Co. (DTC&#8217;s partnership nominee) or such other name as may be requested by an authorized representative of DTC. One fully registered certificate will be issued for each issuance of the notes, in the aggregate principal amount thereof, and will be deposited with DTC. Interests in the notes will trade in DTC&#8217;s Same Day Funds Settlement System, and any permitted secondary market trading activity in such notes will, therefore, be required by DTC to be settled in immediately available funds. None of the Company, the trustee or the paying agent will have any responsibility for the performance by DTC or its participants or indirect participants of their respective obligations under the rules and procedures governing their operations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DTC is a limited-purpose trust company organized under the New York Banking Law, a &#8220;banking organization&#8221; within the meaning of the New York Banking Law, a member of the Federal Reserve System, a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code, and a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section&#160;17A of the Exchange Act. DTC holds and provides asset servicing for over 3.5&#160;million issues of U.S. and&#160;non-U.S.&#160;equity, corporate and municipal debt issues, and money market instruments from over 100 countries that DTC&#8217;s participants (&#8220;Direct Participants&#8221;) deposit with DTC. DTC also facilitates the post-trade settlement among Direct Participants of sales and other securities transactions in deposited securities through electronic computerized book-entry transfers and pledges between Direct Participants&#8217; accounts. This eliminates the need for physical movement of securities certificates. Direct Participants include both U.S. and&#160;non-U.S.&#160;securities brokers and dealers, banks, trust companies, clearing corporations, and certain other organizations. DTC is a wholly owned subsidiary of The Depository Trust&#160;&amp; Clearing Corporation (&#8220;DTCC&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also available to others such as both U.S. and&#160;non-U.S.&#160;securities brokers and dealers, banks, trust companies and clearing corporations that clear through or maintain a custodial relationship with a Direct Participant, either directly or indirectly (&#8220;Indirect Participants&#8221;). DTC has a Standard&#160;&amp; Poor&#8217;s Ratings Services&#8217; rating of AA+. The DTC rules applicable to its participants are on file with the SEC. More information about DTC can be found at<span style="font-style:italic">&#160;www.dtcc.com.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchases of the notes under the DTC system must be made by or through Direct Participants, which will receive a credit for the notes on DTC&#8217;s records. The ownership interest of each actual purchaser of each security, or the &#8220;Beneficial Owner,&#8221; is in turn to be recorded on the Direct and Indirect Participants&#8217; records. Beneficial Owners will not receive written confirmation from DTC of their purchase. Beneficial Owners are, however, expected to receive written confirmations providing details of the transaction, as well as periodic statements of their holdings, from the Direct or Indirect Participant through which the Beneficial Owner entered into the transaction. Transfers of ownership interests in the notes are to be accomplished by entries made on the books of&#160;Direct and Indirect Participants acting on behalf of Beneficial Owners. Beneficial Owners will not receive certificates representing their ownership interests in the notes, except in the event that use of the book-entry system for the notes is discontinued. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">118 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To facilitate subsequent transfers, all notes deposited by Direct Participants with DTC are registered in the name of DTC&#8217;s partnership nominee, Cede&#160;&amp; Co. or such other name as may be requested by an authorized representative of DTC. The deposit of the notes with DTC and their registration in the name of Cede&#160;&amp; Co. or such other DTC nominee do not effect any change in beneficial ownership. DTC has no knowledge of the actual Beneficial Owners of the notes; DTC&#8217;s records reflect only the identity of the Direct Participants to whose accounts the notes are credited, which may or may not be the Beneficial Owners. The Direct and Indirect Participants will remain responsible for keeping account of their holdings on behalf of their customers. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Conveyance of notices and other communications by DTC to Direct Participants, by Direct Participants to Indirect Participants, and by Direct Participants and Indirect Participants to Beneficial Owners will be governed by arrangements among them, subject to any statutory or regulatory requirements as may be in effect from time to time. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Redemption notices shall be sent to DTC. If less than all of the notes within an issue are being redeemed, DTC&#8217;s practice is to determine by lot the amount of the interest of each Direct Participant in such issue to be redeemed. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Redemption proceeds, distributions, and interest payments on the notes will be made to Cede&#160;&amp; Co., or such other nominee as may be requested by an authorized representative of DTC. DTC&#8217;s practice is to credit Direct Participants&#8217; accounts upon DTC&#8217;s receipt of funds and corresponding detail information from us or the trustee on the payment date in accordance with their respective holdings shown on DTC&#8217;s records. Payments by participants to Beneficial Owners will be governed by standing instructions and customary practices, as is the case with securities held for the accounts of customers in bearer form or registered in &#8220;street name,&#8221; and will be the responsibility of such participant and not of DTC nor its nominee, the trustee, or us, subject to any statutory or regulatory requirements as may be in effect from time to time. Payment of redemption proceeds, distributions, and interest payments to Cede&#160;&amp; Co. (or such other nominee as may be requested by an authorized representative of DTC) is the responsibility of us or the trustee, but disbursement of such payments to Direct Participants will be the responsibility of DTC, and disbursement of such payments to the Beneficial Owners will be the responsibility of Direct and Indirect Participants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DTC may discontinue providing its services as securities depository with respect to the notes at any time by giving reasonable notice to us or to the trustee. Under such circumstances, in the event that a successor securities depository is not obtained, certificates are required to be printed and delivered. We may decide to discontinue use of the system of book-entry-only transfers through DTC (or a successor securities depository). In that event, certificates will be printed and delivered to DTC. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this section concerning DTC and DTC&#8217;s book-entry system has been obtained from sources that we believe to be reliable, but we take no responsibility for its accuracy. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">119 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_11">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>The following discussion summarizes the material U.S. federal income tax consequences of the purchase, beneficial ownership and disposition of the notes by a U.S. Holder or a Non-U.S. Holder (each as defined below). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary is based on the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), Treasury Regulations promulgated under the Code, judicial authority and administrative rulings and practice, all of which are subject to change and differing interpretation. Any such change or interpretation may be applied retroactively and may affect the accuracy of the statements and conclusions set forth in this prospectus. This summary addresses only tax consequences to investors that purchase the notes pursuant to this prospectus at their offering price and hold them as &#8220;capital assets&#8221; within the meaning of Section 1221 of the Code. This summary does not discuss all of the tax consequences that may be relevant to particular investors or to investors subject to special treatment under the U.S. federal income tax laws (such as insurance companies, financial institutions, tax-exempt persons, partnerships or other pass-through entities (and persons holding the notes through a partnership or other pass-through entity), retirement plans, regulated investment companies, dealers in securities or currencies, traders in securities who elect to apply a mark-to-market method of accounting, persons holding the notes as part of a &#8220;straddle,&#8221; &#8220;constructive sale,&#8221; or a &#8220;conversion transaction&#8221; for U.S. federal income tax purposes, or as part of some other integrated investment or risk reduction transaction, &#8220;passive foreign investment companies,&#8221; &#8220;controlled foreign corporations,&#8221; expatriates or U.S. Holders (as defined below) whose functional currency for tax purposes is not the U.S. dollar). This summary also does not discuss any tax consequences arising under the laws of any state, local, foreign or other tax jurisdiction or any tax consequences arising under U.S. federal tax laws other than U.S. federal income tax laws. Furthermore, this summary does not discuss any tax consequences arising under the Foreign Account Tax Compliance Act (including the Treasury Regulations promulgated thereunder and any intergovernmental agreements entered into in connection therewith) nor any tax consequences arising under the unearned income Medicare contribution tax pursuant to the Health Care and Education Reconciliation Act of 2010. The term &#8220;holder&#8221; as used in this section refers to a beneficial holder of the notes and not the record holder. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Persons considering the purchase of the notes should consult their own tax advisors concerning the application of U.S. federal tax laws to their particular situations as well as any consequences of the purchase, beneficial ownership and disposition of the notes arising under the laws of any other taxing jurisdiction.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#8220;U.S. Holder&#8221; means: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a citizen or resident of the United States; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a corporation or other entity or arrangement taxable as a corporation created or organized in or under the laws of the United States or any State thereof or the District of Columbia; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an estate whose income is subject to U.S. federal income taxation regardless of its source; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a trust if a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons (within the meaning of Section 7701(a)(30) of the Code) have the authority to control all substantial decisions of the trust, or the trust has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>If a partnership or other entity or arrangement treated as a partnership for U.S. federal income tax purposes holds notes, the tax treatment of such partnership and a partner thereof will generally depend on the status of the partner and upon the activities of the partner and the partnership. Persons who are partners in a partnership, or other entity or arrangement treated as a partnership for U.S. federal income tax purposes, holding notes should consult their tax advisors. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">120 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Additional Payments </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In certain circumstances under &#8220;Description of the Notes&#8221; such as a Change of Control or Optional Redemption, we may be obligated to make payments in excess of stated interest and the principal amount of the notes. Although not free from doubt, we intend to take the position that the notes should not be treated as contingent payment debt instruments despite the possibility of these additional payments. This position is based in part on assumptions regarding the likelihood, as of the date of issuance of the notes, that such additional payments will have to be paid. Our position that the contingencies described above are remote is binding on a holder unless such holder discloses its contrary position in the manner required by applicable Treasury Regulations. If the IRS successfully challenged our position, then the notes could be treated as contingent payment debt instruments, in which case holders could be required to accrue interest income at a rate higher than the stated interest rate on the notes and to treat as ordinary income, rather than capital gain, any gain recognized on a sale, exchange, redemption, or other taxable disposition of a note. Holders are urged to consult their tax advisors regarding the potential application of the contingent payment debt instrument rules to the notes and the consequences thereof. The remainder of this discussion assumes that the notes are not treated as contingent payment debt instruments. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">U.S. Federal Tax Consequences to U.S. Holders </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is anticipated, and this discussion assumes, that the issue price of the notes will be equal to the stated principal amount or, if the issue price is less than the stated principal amount, the difference will be a <span style="font-style:italic">de minimis</span> amount (as set forth in the applicable Treasury Regulations). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Taxation of Interest </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest on the notes will be taxable to a U.S. Holder as ordinary interest income. A U.S. Holder must report this income either when it accrues or is received, depending on the holder&#8217;s method of accounting for U.S. federal income tax purposes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Original Issue Discount </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes may be issued with original issue discount (&#8220;OID&#8221;) for U.S. federal income tax purposes. The stated redemption price at maturity of the notes may exceed their issue price by an amount that equals or exceeds the statutory de minimis amount for U.S. federal income tax purposes (as described below). In such event, the notes will be treated for U.S. federal income tax purposes as issued with OID in an amount equal to such excess, and beneficial owners of notes that are subject to U.S. federal income taxation generally will be required to include the OID in gross income (as ordinary income) as it accrues (on a constant yield-to-maturity basis) for U.S. federal income tax purposes in advance of the receipt of cash payment thereof and regardless of such beneficial owner&#8217;s regular method of accounting for U.S. federal income tax purposes. Under this method, U.S. Holders generally will be required to include in income increasingly greater amounts of OID in successive accrual periods. If the difference between a note&#8217;s stated redemption price at maturity and its issue price is less than the de minimis threshold of one quarter of 1 percent (i.e., 0.25%) of the stated principal amount multiplied by the number of complete years to maturity, then the note will be under the de minimis threshold and will not be treated as having OID. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Treatment of Dispositions of Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the sale, exchange, retirement or other taxable disposition of a note, a U.S. Holder generally will recognize gain or loss equal to the difference between the amount received on such disposition (other than amounts received in respect of accrued and unpaid interest, which will be taxable as ordinary income to the extent not previously included in income) and the U.S. Holder&#8217;s tax basis in the note. A U.S. Holder&#8217;s tax basis in a note generally will be the cost of the note. Gain or loss realized on the sale, exchange, retirement or other taxable disposition of a note&#160;generally will be capital gain or loss, and will be long-term capital gain or loss if, at the time of such sale, exchange, retirement or other taxable disposition, the U.S. Holder has held the note for more than one year. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">121 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<span style="white-space:nowrap">Long-term</span> capital gains generally are taxed at reduced rates for individuals and certain other non-corporate U.S. Holders. The ability to deduct capital losses is subject to limitation under U.S. federal income tax laws. Net <span style="white-space:nowrap">long-term</span> capital gain recognized by a non-corporate U.S. Holder is generally taxed at preferential rates. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Medicare Tax </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. Holder that is an individual, estate, or a trust that does not fall into a special category of trusts that is exempt from such tax will be subject to an additional 3.8% Medicare tax on the lesser of (1)&#160;the U.S. Holder&#8217;s &#8220;net investment income&#8221; for the relevant taxable year and (2)&#160;the excess of the U.S. Holder&#8217;s modified gross income for the taxable year over a certain threshold (which in the case of individuals will be between $125,000 and $250,000 depending on the individual&#8217;s circumstances). Net investment income generally includes interest income and net gains from the disposition of the notes, unless such interest income or net gains are derived in the&#160;ordinary course of the conduct of a trade or business (other than a trade or business that consists of certain passive or trading activities). A U.S. Holder that is an individual, estate, or trust should consult its tax advisor regarding the applicability of this tax to its income and gains in respect of its investment in the notes. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">U.S. Federal Tax Consequences to Non-U.S. Holders </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a general discussion of U.S. federal income consequences of the purchase, beneficial ownership and disposition of the notes by a holder that is a beneficial owner of notes (other than a partnership or other pass-through entity) that is not a U.S. Holder (a &#8220;Non-U.S. Holder&#8221;). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Taxation of Interest </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#8220;<span style="font-style:italic">&#8212;U.S. Information Reporting Requirements and Backup Withholding Tax Applicable to U.S. Holders and Non-U.S. Holders</span>,&#8221; a Non-U.S. Holder will not be subject to U.S. federal income or withholding tax in respect of interest income on the notes (including OID) if each of the following requirements is satisfied: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the interest is not effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (or, in the case of an income tax treaty resident, is not attributable to a permanent establishment of the Non-U.S. Holder in the United States); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Non-U.S. Holder provides to the applicable withholding agent a properly completed and executed Internal Revenue Service (&#8220;IRS&#8221;) Form W-8BEN or IRS Form W-8BEN-E, as applicable, together with all appropriate attachments, signed under penalties of perjury, identifying the Non-U.S. Holder and stating, among other things, that the Non-U.S. Holder is not a U.S. person, and the payor does not have actual knowledge or reason to know that such holder is a U.S. person. If a note is held through a securities clearing organization, bank or another financial institution that holds customers&#8217; securities in the ordinary course of its trade or business, this requirement is satisfied if (i) the Non-U.S. Holder provides such a form to the organization or institution, and (ii) the organization or institution, under penalties of perjury, certifies to the applicable withholding agent that it has received such a form from the beneficial owner or another intermediary and furnishes the applicable withholding agent with a copy thereof; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Non-U.S. Holder is not a bank whose receipt of interest on the notes is in connection with an extension of credit made pursuant to a loan agreement entered into in the ordinary course of such non-U.S. holder&#8217;s trade or business; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Non-U.S. Holder does not actually or constructively own 10% or more of the total combined voting power of all classes of the Company&#8217;s stock within the meaning of the Code and applicable Treasury Regulations; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Non-U.S. Holder is not a &#8220;controlled foreign corporation&#8221; that is actually or constructively related to the Company. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">122 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If these conditions are not met, a 30% withholding tax will apply to interest income on the notes, unless one of the following two exceptions is satisfied. The first exception is that an applicable income tax treaty reduces or eliminates such tax, and a Non-U.S. Holder claiming the benefit of that treaty provides to the applicable withholding agent a properly executed IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable (or other applicable IRS Form) and the payor does not have actual knowledge or reason to know that such holder is a U.S. person. The second exception is that the interest is effectively connected with such Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment of the Non-U.S. Holder in the United States) and the Non-U.S. Holder provides an appropriate statement to that effect on an IRS Form W-8ECI (or other applicable IRS Form). In the case of the second exception, such Non-U.S. Holder generally will be subject to U.S. federal income tax with respect to all income from the notes in the same manner as U.S. Holders, as described above. Additionally, in such event, Non-U.S. Holders that are corporations could be subject to an additional &#8220;branch profits&#8221; tax on such income. Non-U.S. Holders eligible for an exemption from or reduced rate of U.S. federal withholding tax under an applicable income tax treaty may obtain a refund of any excess amounts withheld by timely filing an appropriate claim with the IRS. Non-U.S. Holders should consult their own tax advisors regarding their entitlement to benefits under an applicable income tax treaty and the requirements for claiming any such benefits. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Treatment of Dispositions of Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#8220;<span style="font-style:italic">&#8212;U.S. Information Reporting Requirements and Backup Withholding Tax Applicable to U.S. Holders and Non-U.S. Holders</span>,&#8221; and except with respect to accrued and unpaid interest (which will be treated as described above under &#8220;<span style="font-style:italic">U.S. Federal Tax Consequences to Non-U.S. Holders&#8212;Taxation of Interest</span>,&#8221; generally, a Non-U.S. Holder will not be subject to U.S. federal income tax on gain realized upon the sale, exchange, retirement or other disposition of a note unless: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the gain is effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment of the non-U.S. holder in the United States); or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">such holder is an individual present in the United States for 183 days or more in the taxable year of the sale, exchange, retirement or other disposition and certain other conditions are met. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular graduated U.S. federal income tax rates in the same manner as if such Non-U.S. Holder were a U.S. person. A Non-U.S. Holder that is a corporation also may be subject to an additional &#8220;branch profits tax&#8221; at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) of its &#8220;effectively connected earnings and profits&#8221; for the taxable year, subject to certain adjustments. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain described in the second bullet point above generally will be subject to U.S. federal income tax at a 30% rate (or such lower rate as may be specified by an applicable income tax treaty), but may be offset by U.S. source capital losses, if any, of the Non-U.S. Holder. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">FATCA </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Sections 1471 through 1474 of the Code, Treasury regulations promulgated thereunder and applicable administrative guidance (collectively, &#8220;FATCA&#8221;), a 30% U.S. federal withholding tax will generally apply to payments of interest on the notes made to (i)&#160;a foreign financial institution (whether such foreign financial institution is a beneficial owner or an intermediary), unless such institution undertakes either under an agreement with the U.S. Department of Treasury or an intergovernmental agreement between the jurisdiction in which it is a&#160;resident and the U.S. Department of Treasury to generally identify accounts held by certain U.S. persons and non-U.S. entities with substantial U.S. owners, annually report certain information about such accounts and withhold 30% on payments made to non-compliant foreign financial institutions and certain other account holders or such institution qualifies for an exemption from these rules or (ii)&#160;a non-financial foreign entity </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">123 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(whether such non-financial foreign entity is a beneficial owner or an intermediary), unless such entity provides the paying agent with a certification that it does not have any substantial United States owners or a certification identifying the direct and indirect substantial United States owners of the entity and meets certain other specified requirements or such entity qualifies for an exemption under these rules. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While withholding under FATCA would also have applied to payments of gross proceeds from the sale or other disposition of the notes (including retirement or redemption) on or after January 1, 2019, proposed Treasury Regulations have been issued that, if finalized, will eliminate FATCA withholding on payments of gross proceeds entirely. Although these Treasury regulations are not final, the preamble to these Treasury regulations indicates that taxpayers may rely on them pending their finalization. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prospective investors are urged to consult their own tax advisors regarding the application of FATCA to the notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">U.S. Information Reporting Requirements and Backup Withholding Tax Applicable to U.S. Holders and Non-U.S. Holders</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information reporting generally will apply to payments of interest on the notes and to the proceeds of a sale or other taxable disposition of a note paid to a U.S. Holder unless the U.S. Holder is an exempt recipient. U.S. federal backup withholding (currently, at a rate of 24% for payments made before January 1, 2026) generally will apply to such payments if the U.S. Holder fails to provide the applicable withholding agent with a properly completed and executed IRS Form W-9 providing such U.S. Holder&#8217;s correct taxpayer identification number and certifying that such U.S. Holder is not subject to backup withholding, or to otherwise establish an exemption. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, we must report annually to the IRS and to each Non-U.S. Holder the amount of interest paid to such Non-U.S. Holder and the amount of tax, if any, withheld with respect to such payments. These reporting requirements apply regardless of whether withholding was reduced or eliminated by an applicable income tax treaty. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. backup withholding tax (currently, at a rate of 24% for payments made before January 1, 2026) is imposed on certain payments to persons that fail to furnish the information required under the U.S. information reporting rules. Interest paid to a non-U.S. Holder generally will be exempt from backup withholding if the non-U.S. holder provides the applicable withholding agent with a properly executed IRS Form W-8BEN or IRS Form <span style="white-space:nowrap">W-8BEN-E,</span> as applicable, or otherwise establishes an exemption (and the applicable withholding agent does not have actual knowledge or reason to know that such holder is a U.S. person or that the conditions of any exemption are not in fact satisfied). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Treasury Regulations, the payment of proceeds from the disposition of a note by a Non-U.S. Holder effected at a U.S. office of a broker generally will be subject to information reporting and backup withholding, unless the Non-U.S. Holder provides a properly executed IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable (or other applicable IRS Form W-8), certifying such Non-U.S. Holder&#8217;s non-U.S. status and such broker does not have actual knowledge or reason to know that such Non-U.S. Holder is a U.S. person, or otherwise establishes an exemption. The payment of proceeds from the disposition of notes by a Non-U.S. Holder effected at a non-U.S. office of a U.S. broker or a non-U.S. broker with certain specified U.S. connections generally will be subject to information reporting (but not backup withholding) unless such Non-U.S. Holder provides a properly executed IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable (or other applicable IRS Form W-8), certifying such Non-U.S. Holder&#8217;s non-U.S. status and such broker does not have actual knowledge or reason to know that such evidence is false, or otherwise establishes an exemption. Backup withholding will apply if the disposition is subject to information reporting and the broker has actual knowledge that the Non-U.S. Holder is a U.S. person. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax and may be refunded or credited against the holder&#8217;s U.S. federal income tax liability, provided that certain required information is timely furnished to the IRS. The information </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">124 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reporting requirements may apply regardless of whether withholding is required. Copies of the information returns reporting such interest and withholding may be made available to the tax authorities in foreign countries under the provisions of a tax treaty or agreement. Holders should consult their own tax advisors regarding the effect, if any, of these rules with respect to their particular situation. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preceding discussion of material U.S. federal income tax considerations is for general information only and is not tax advice. We urge you to consult your own tax advisor with respect to the particular tax consequences to you of an investment in the notes, including the possible effect of any pending legislation or proposed regulations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">125 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_12">UNDERWRITING </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are offering the notes described in this prospectus through a number of underwriters. We have entered into an underwriting agreement dated the date of this prospectus with the underwriters listed below. Piper Sandler&#160;&amp; Co. is acting as representative of the underwriters named below. Subject to the terms and conditions set forth in an underwriting agreement between the Company and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the principal amount of notes set forth opposite its name below. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:68%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:30%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Name of Underwriter</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Principal</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Amount of Notes</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piper Sandler&#160;&amp; Co.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[*]</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td></tr>
</table> </div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of a <span style="white-space:nowrap">non-defaulting</span> underwriter may also be increased or the offering may be terminated. The offering of the notes by the underwriters is subject to receipt and acceptance and subject to the underwriters&#8217; right to reject any order in whole or in part. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in respect of those liabilities. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement provides that the obligations of the underwriters to purchase the notes are subject to approval of legal matters by counsel to the underwriters and certain other conditions, including the receipt by the underwriters of officers&#8217; certificates and legal opinions. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. Investors must pay for the notes purchased in this offering on or about&#8195;&#8195;&#8195;&#8195;, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Commissions and Discounts </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An underwriting discount of&#8195;&#8195;% per note will be paid by us. This underwriting discount will also apply to any notes purchased pursuant to the overallotment option. The underwriters have advised us that they propose initially to offer the notes to the public at the public offering price on the cover of this prospectus and to certain other Financial Industry Regulatory Authority, Inc. members at that price less a concession not in excess of $&#8195;&#8195;&#8195;&#8195;per note. The underwriters may allow, and the dealers may reallow, a discount not in excess of $&#8195;&#8195;&#8195;&#8195;per note. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the total underwriting discounts and commissions that we are to pay to the underwriters in connection with this offering. The information assumes either no exercise or full exercise by the underwriters of their overallotment option. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:64%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Per&#160;Note</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Without<br/>Option</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">With&#160;Option</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The expenses of the offering, not including the underwriting discounts and commissions, are estimated at $&#8195;&#8195;&#8195;&#8195;and are payable by us. We have agreed to reimburse the underwriters for their reasonable and documented <span style="white-space:nowrap"><span style="white-space:nowrap">out-of-pocket</span></span> expenses incurred in connection with the transactions, including their legal fees and expenses, marketing, syndication and travel expenses; <span style="font-style:italic">provided</span>, that such fees and expenses, including legal fees </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">126 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and legal expenses, will not exceed $155,000 without the prior written consent of the Company and will be reimbursed through Piper Sandler&#160;&amp; Co. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Overallotment Option </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted an option to the underwriters to purchase up to an additional $&#8195;&#8195;&#8195;&#8195;aggregate principal amount of the notes offered hereby at the public offering price, less the underwriting discounts and commissions, within 30 days from the date of this prospectus solely to cover any overallotments. If the underwriters exercise this option, each will be obligated, subject to conditions contained in the underwriting agreement, to purchase a principal amount of additional notes proportionate to that underwriter&#8217;s initial principal amount reflected in the table above. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Sales of Similar Securities </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed not to directly or indirectly offer, sell, short sell or otherwise dispose of, or enter into any agreement to offer, sell, short sell or otherwise dispose of, any debt securities issued or guaranteed by us or other securities convertible into or exchangeable or exercisable for debt securities issued or guaranteed by us or derivative of debt securities issued or guaranteed by us for a period of 30 days after the date of this prospectus without first obtaining the written consent of Piper Sandler&#160;&amp; Co. This consent may be given at any time without public notice. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Listing </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The notes are a new issue of securities with no established trading market. We intend to list the notes on NASDAQ and will use our reasonable best efforts to maintain such listing. We expect trading in the notes on NASDAQ to begin within 30 days after the issue date under the trading symbol &#8220;&#8195;&#8195;&#8195;&#8195;.&#8221; Currently there is no public market for the notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been advised by certain of the underwriters that they presently intend to make a market in the notes after completion of the offering as permitted by applicable laws and regulations. The underwriters are not obligated, however, to make a market in the notes and any such market-making may be discontinued at any time in the sole discretion of the underwriters without any notice. Accordingly, no assurance can be given as to the liquidity of, or development of a public trading market for, the notes. If an active public trading market for the notes does not develop, the market price and liquidity of the notes may be adversely affected. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Price Stabilization and Short Positions </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters may purchase and sell notes in the open market. These transactions may include overallotment, covering transactions and stabilizing transactions, which may have the effect of stabilizing or maintaining the market price of the notes at a level above that which might otherwise prevail in the open market. Overallotment involves sales of securities in excess of the aggregate principal amount of securities to be purchased by the underwriters in the offering, which creates a short position for the underwriters. Covering transactions involve purchases of the notes in the open market after the distribution has been completed in order to cover short positions. Stabilizing transactions consist of certain bids or purchases of securities made for the purpose of preventing or retarding a decline in the market price of the notes while the offering is in progress. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representative has repurchased notes sold by or for the account of such underwriter in stabilizing or short covering transactions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters are not obligated to engage in these activities and, if commenced, any of the activities may be discontinued at any time. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">127 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of these activities may cause the price of the notes to be higher than the price that otherwise would exist in the open market in the absence of such transactions. These transactions may be affected in the <span style="white-space:nowrap"><span style="white-space:nowrap">over-the-counter</span></span> market or otherwise and, if commenced, may be discontinued at any time without any notice relating thereto. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Relationships </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of the underwriters and their affiliates have provided in the past and may provide from time to time in the future in the ordinary course of their business certain commercial banking, financial advisory, investment banking and other services to us or our affiliates for which they have received or will be entitled to receive separate fees. In particular, the underwriters or their affiliates may execute transactions with us, on behalf of us or our affiliates. In addition, after the offering period for the sale of the notes, the underwriters or their affiliates may act as arrangers, underwriters or placement agents for companies whose securities are sold to or whose loans are syndicated to us or our affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters or their affiliates may also trade in our securities or other financial instruments related thereto for their own accounts or for the account of others and may extend loans or financing directly or through derivative transactions to us or our affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the date of this prospectus, the underwriters and their affiliates may from time to time obtain information regarding our subsidiaries or us that may not be available to the general public. Any such information is obtained by the underwriters and their affiliates in the ordinary course of its business and not in connection with the offering of the notes. In addition, the underwriters or their affiliates may develop analyses or opinions related to us and may engage in competitive activities. There is no obligation on behalf of these parties to disclose their respective analyses, opinions or purchase and sale activities regarding us to our noteholders or any other persons. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal business address of the representative for the underwriters is Piper Sandler&#160;&amp; Co., Piper Sandler&#160;&amp; Co., 1251 Avenue of the Americas, 6th Floor, New York, NY 10020. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Alternative Settlement Cycle </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is expected that delivery of the notes will be made against payment therefor on or about&#8195;, 2023, which is the fifth business day following the date hereof (such settlement cycle being referred to as &#8220;T+5&#8221;). Under <span style="white-space:nowrap">Rule&#160;15c6-1</span> under the Exchange Act, trades in the secondary market generally are required to settle in two business days unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes on any date prior to the second business day before delivery thereof will be required, by virtue of the fact that the notes initially will settle in T+5, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement. Purchasers of the notes who wish to trade the notes prior to their date of delivery hereunder should consult their own advisors. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Jurisdictions </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the notes offered by this prospectus in any jurisdiction where action for that purpose is </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">128 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required. The notes offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such notes be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restriction relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy the notes offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">129 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_13">LEGAL MATTERS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain legal matters in connection with the notes offered by this prospectus will be passed upon for the Company by Locke Lord LLP, New York, New York. Legal matters in connection with the notes offered hereby will be passed upon for the underwriters by Alston&#160;&amp; Bird LLP, New York, New York. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">130 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="stoc423260_14">EXPERTS </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements included in this prospectus and the related consolidated financial statement schedules included elsewhere in the Registration Statement as of December&#160;31, 2022 and 2021 have been audited by Marcum LLP, an independent registered public accounting firm with respect to the Company prior to the Business Combination (then known as East Resources Acquisition Company) upon the authority of said firm as experts in accounting and auditing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements for Abacus Settlements included in this prospectus and elsewhere in the Registration Statement have been so included in reliance upon the report of Grant Thornton LLP, an independent registered public accounting firm, upon the authority of said firm as experts in accounting and auditing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements for LMA included in this prospectus and elsewhere in the Registration </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Statement have been so included in reliance upon the report of Grant Thornton LLP, an independent registered public accounting firm, upon the authority of said firm as experts in accounting and auditing. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">131 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_23"><span id="stoc423260_15"></span>WHERE YOU CAN FIND ADDITIONAL INFORMATION </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <span style="white-space:nowrap">S-1</span> under the Securities Act of 1933 with respect to the notes offered in this document. As permitted by the rules and regulations of the SEC, this prospectus does not contain all the information set forth in the registration statement. Such information is available through the SEC&#8217;s web site on the internet at http://www.sec.gov. The statements contained in this prospectus as to the contents of any contract or other document filed as an exhibit to the registration statement are, of necessity, brief descriptions thereof and are not necessarily complete. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and in accordance with the Exchange Act we file reports and other information with the SEC. The Company&#8217;s SEC filings are available through the SEC&#8217;s web site on the internet at http://www.sec.gov. We also maintains a website at https://abacuslife.com where information about Abacus can be obtained. The information contained on the Abacus web site is not part of nor is it incorporated by reference into this prospectus. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">132 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_26">INDEX TO FINANCIAL STATEMENTS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:96%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_101">Report of Independent Registered Public Accounting Firm</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-2</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_102">Consolidated Balance Sheets as of December&#160;31, 2022 and December&#160;31, 2021</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-3</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_103">Consolidated Statements of Operations for the years ended December&#160;31, 2022 and December&#160;31, 2021</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-4</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_104">Consolidated Statements of Stockholders&#8217; Deficit for the years ended December&#160;31, 2022 and December&#160;31, 2021</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-5</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_105">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2022 and December&#160;31, 2021</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-6</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_106">Notes to Financial Statements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-7</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="fin423260_101">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders and Board of Directors of </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">East Resources Acquisition Company </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Opinion on the Financial Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the accompanying consolidated balance sheets of&#160;East Resources Acquisition Company&#160;(the &#8220;Company&#8221;) as of&#160;December&#160;31, 2022 and 2021,<span style="font-weight:bold"></span>&#160;the related<span style="font-weight:bold"></span>&#160;consolidated statements of operations, changes in stockholders&#8217; deficit and cash flows for each of the two years in the period ended December&#160;31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).&#160;In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December&#160;31, 2022, in conformity with accounting principles generally accepted in the United States of America. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Explanatory Paragraph&#8212;Going Concern </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. Additionally, if the Company is unable to complete a Business Combination by the close of business on July&#160;27, 2023, the Company will cease all operations except for the purpose of liquidating.&#160;These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Basis for Opinion </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Marcum&#160;<small>LLP</small> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marcum&#160;<small>LLP</small> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#8217;s auditor since 2020<span style="font-weight:bold">.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Houston, TX </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&#160;17, 2023 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="fin423260_102">CONSOLIDATED BALANCE SHEETS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:75%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,<br/>2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,<br/>2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">ASSETS</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">86,572</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">853,130</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">64,914</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">91,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Current Assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">151,486</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">944,755</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and securities held in Trust Account</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">99,222,704</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">345,048,888</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Total Assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">99,374,190</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">345,993,643</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities&#8212;Accrued expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,227,518</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">144,254</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities&#8212;Note payable to related party</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,924,356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52,485</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred underwriting fee payable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,075,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forward purchase agreement liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,576,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,911,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Total Liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">18,780,609</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">29,231,054</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Commitments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&#160;A common stock subject to possible redemption, $0.0001&#160;par value;&#160;9,718,972&#160;and&#160;34,500,000&#160;shares at $10.18&#160;and&#160;10.00&#160;per share at December&#160;31, 2022 and December&#160;31, 2021, respectively</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">98,983,437</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">345,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Stockholders&#8217; Deficit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.0001&#160;par value;&#160;1,000,000&#160;shares authorized; none&#160;issued and outstanding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&#160;A common stock, $0.0001&#160;par value;&#160;200,000,000&#160;shares authorized; 0&#160;issued and outstanding (excluding 34,500,000 shares subject to possible redemption)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&#160;B common stock, $0.0001&#160;par value;&#160;20,000,000&#160;shares authorized; 8,625,000&#160;shares issued and outstanding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">863</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">863</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <span style="white-space:nowrap">paid-in</span> capital</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(18,414,856</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(28,262,411</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Total Stockholders&#8217; Deficit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(18,389,856</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(28,237,411</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">99,374,190</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">345,993,643</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">The accompanying notes are an integral part of the consolidated financial statements. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="fin423260_103">CONSOLIDATED STATEMENTS OF OPERATIONS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:68%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For&#160;the&#160;Year&#160;Ended<br/>December&#160;31,<br/>2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For&#160;the&#160;Year&#160;Ended<br/>December&#160;31,<br/>2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Formation and operating costs</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,722,287</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,382,681</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Loss from operations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(11,722,287</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(1,382,681</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrant liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,335,550</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,899,200</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of forward purchase agreement liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deferred underwriting fees waiver</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">513,188</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest earned&#8212;bank</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,031</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest earned on marketable securities held in Trust Account</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">672,439</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,784</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other income (expense), net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">11,131,208</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">17,222,046</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income before provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(591,079</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,839,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52,485</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net Income (Loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(643,564</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">15,839,365</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, Class&#160;A common stock subject to possible redemption</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,637,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share, Class&#160;A common stock subject to possible redemption</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(0.02</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">0.37</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding, <span style="white-space:nowrap">Non-redeemable</span> common&#160;stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Basic and diluted net income per share, <span style="white-space:nowrap">Non-redeemable</span> common stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(0.02</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">0.37</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">The accompanying notes are an integral part of the consolidated financial statements. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="fin423260_104">CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:40%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="26" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For the year ended December&#160;31, 2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Class&#160;A</span><br/><span style="font-weight:bold">Common Stock</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Class&#160;B</span><br/><span style="font-weight:bold">Common Stock</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Additional</span><br/><span style="font-weight:bold"><span style="white-space:nowrap">Paid-in</span></span><br/><span style="font-weight:bold">Capital</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Accumulated</span><br/><span style="font-weight:bold">Deficit</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total</span><br/><span style="font-weight:bold">Stockholders&#8217;</span><br/><span style="font-weight:bold">Deficit</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Balance&#8212;January&#160;1, 2022</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">863</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(28,262,411</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(28,237,411</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(643,564</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(643,564</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred underwriting fees waiver</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,561,812</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,561,812</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination of forward purchase agreement</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remeasurement of Class&#160;A common stock to redemption value</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">(2,070,693</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">(2,070,693</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Balance&#8212;December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">8,625,000</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">863</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">24,137</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(18,414,856</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(18,389,856</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="28"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="26" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For the year ended December&#160;31, 2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Class&#160;A</span><br/><span style="font-weight:bold">Common Stock</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Class&#160;B</span><br/><span style="font-weight:bold">Common Stock</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Additional</span><br/><span style="font-weight:bold"><span style="white-space:nowrap">Paid-in</span></span><br/><span style="font-weight:bold">Capital</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Accumulated</span><br/><span style="font-weight:bold">Deficit</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total</span><br/><span style="font-weight:bold">Stockholders&#8217;</span><br/><span style="font-weight:bold">Equity&#160;(Deficit)</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Shares</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Balance&#8212;January&#160;1, 2021</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">863</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">24,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">(44,101,776</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">(44,076,776</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">15,839,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="right">15,839,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Balance&#8212;December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">8,625,000</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">863</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">24,137</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(28,262,411</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(28,237,411</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">The accompanying notes are an integral part of the consolidated financial statements. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="fin423260_105">CONSOLIDATED STATEMENTS OF CASH FLOWS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:69%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For&#160;the&#160;Year&#160;Ended<br/>December&#160;31,<br/>2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For&#160;the&#160;Year&#160;Ended<br/>December&#160;31,<br/>2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cash Flows from Operating Activities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(643,564</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,839,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net income (loss) to net cash used in operating activities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of prepaid insurance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">425,144</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">236,417</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrant liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,335,550</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(15,899,200</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of forward purchase agreement liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on deferred underwriting fees waiver</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(513,188</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest earned on marketable securities held in Trust Account</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(672,439</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(22,784</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid insurance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(398,433</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(93,292</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes payable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52,485</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,083,264</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,939</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net cash used in operating activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">(2,602,281</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">(1,236,555</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cash Flows from Investing Activities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trust Account withdrawal for redemption of Class&#160;A shares</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">248,087,256</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment into Trust Account</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,924,356</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trust Account withdrawal for payment of taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">335,723</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net cash provided by investing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">246,498,623</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cash Flows from Financing Activities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redemption of Class&#160;A Common Stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(248,087,256</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from note payable&#8212;Related Party</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,424,356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net cash provided by (used in) financing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">(244,662,900</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">1,500,000</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Net Change in Cash</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(766,558</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">263,445</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash&#8212;Beginning</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">853,130</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">589,685</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cash&#8212;Ending</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">86,572</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">853,130</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Non-cash</span> investing and financing activities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remeasurement of Class&#160;A common stock subject to</p> <p style="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">possible redemption to redemption value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">2,070,693</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination of forward purchase agreement</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">1,000,000</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred underwriting fee payable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(12,075,000</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="font-weight:bold">&#8212;&#8194;</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="font-style:italic">The accompanying notes are an integral part of the consolidated financial statements. </span></p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="fin423260_106">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">East Resources Acquisition Company (the &#8220;Company&#8221;) is a newly organized blank check company incorporated in Delaware on May&#160;22, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus its search for a target business in the energy industry in North America. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company had not commenced any operations. All activity for the year ended December&#160;31, 2022 relates to the Company&#8217;s formation, its initial public offering (&#8220;Initial Public Offering&#8221;), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generated <span style="white-space:nowrap">non-operating</span> income in the form of interest income from the proceeds derived from the Initial Public Offering until June 2022, when the investments in the trust account (the &#8220;Trust Account&#8221;) holding the proceeds were liquidated to thereafter be held in cash. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on July&#160;22, 2020. On&#160;July&#160;27, 2020, the Company consummated the Initial Public Offering of&#160;30,000,000&#160;units (the &#8220;Units&#8221; and, with respect to the shares of Class&#160;A common stock included in the Units sold, the &#8220;Public Shares&#8221;), at $10.00&#160;per Unit, generating gross proceeds of $300,000,000, which is described in Note 3. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of&#160;8,000,000 Private Placement Warrants at a price of $1.00&#160;per Private Placement Warrant in a private placement to East Sponsor, LLC (the &#8220;Sponsor&#8221;), generating gross proceeds of $8,000,000, which is described in Note 4. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;25, 2020, the underwriters exercised their over-allotment option in full, resulting in an additional&#160;4,500,000&#160;Units issued for total gross proceeds of $45,000,000. In connection with the underwriters&#8217; exercise of their over-allotment option in full, the Company also consummated the sale of an additional&#160;900,000&#160;Private Placement Warrants at $1.00&#160;per Private Placement Warrant, generating total proceeds of $900,000. A total of $45,000,000&#160;was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $345,000,000. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transaction costs amounted to $19,840,171, consisting of $6,900,000&#160;of underwriting fees, $12,075,000&#160;of deferred underwriting fees and $865,171&#160;of other offering costs. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the closing of the Initial Public Offering on July&#160;27, 2020 and the exercise of the over-allotment option on August&#160;25, 2020, an amount of $345,000,000&#160;($10.00&#160;per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the &#8220;Trust Account&#8221;) located in the United States and invested only in U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of&#160;185&#160;days or less or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of <span style="white-space:nowrap">Rule&#160;2a-7</span> of the Investment Company Act, as determined by the Company, until the earlier of: (i)&#160;the completion of a Business Combination and (ii)&#160;the distribution of the funds in the Trust Account to the Company&#8217;s stockholders, as described below. The investments in the Trust Account were liquidated&#160;in June 2022 to thereafter be held in cash. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least&#160;80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting commissions held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires&#160;50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company. There is no assurance that the Company will be able to successfully effect a Business Combination. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection with a stockholder meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company&#8217;s warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001&#160;upon consummation of such Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (&#8220;SEC&#8221;), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive their redemption rights with respect to any such shares in connection with a stockholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination. Additionally, each public stockholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company&#8217;s Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares without the Company&#8217;s prior written consent. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed (a)&#160;to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b)&#160;not to propose an amendment to the Certificate of Incorporation (i)&#160;to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii)&#160;with respect to any other provision relating to stockholders&#8217; rights or <span style="white-space:nowrap">pre-initial</span> Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii)&#160;to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination.&#160;The Company will have until July&#160;27, 2023&#160;(or such earlier time that the Company elects not to deposit additional funds into the Trust Account, as described below) to complete a Business Combination (the &#8220;Combination Period&#8221;). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i)&#160;cease all operations except for the purpose of winding up, (ii)&#160;as promptly as reasonably possible but no more than 10 business days thereafter, redeem&#160;100% of the outstanding Public Shares, at a <span style="white-space:nowrap">per-share</span> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000&#160;of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidation distributions, if any), and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company&#8217;s board of directors, dissolve and liquidate, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Proposed Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note&#160;5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1)&#160;$10.00 per Public Share or (2)&#160;such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of&#160;any and all&#160;rights to seek access to the Trust Account nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).&#160;Moreover,&#160;in the event that&#160;an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company&#8217;s independent public accountants), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-9 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;25, 2022, the Company convened a special meeting of stockholders at which a proposal to extend the date by which the Company has to complete a Business Combination from July&#160;27, 2022 to January&#160;27, 2023 (the &#8220;First Extension Amendment Proposal&#8221;) was approved. In connection with the special meeting, the Company provided the stockholders the opportunity to redeem all or a portion of their Class&#160;A common stock, and stockholders holding&#160;24,781,028&#160;shares of Class&#160;A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Consequently, approximately $248,087,256 (approximately $10.01&#160;per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the First Extension Amendment Proposal, the Company issued a promissory note (the &#8220;First Extension Note&#8221;) in the principal amount of up to $1,924,356&#160;to the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $1,924,356. The First Extension Note bears no interest and is repayable in full upon the earlier of (a)&#160;the date of consummation of the Company&#8217;s Business Combination or (b)&#160;the date of liquidation of the Company.&#160;In order to further extend the period the Company has to complete a Business Combination beyond the 27<sup style="font-size:75%; vertical-align:top">th</sup>&#160;of a given month, an additional $320,726&#160;was to be deposited into the Trust Account commencing on July&#160;27, 2022 and on the 27th of each subsequent month, or portion thereof, for each additional month that the Company requires to complete a Business Combination from July&#160;27, 2022 until January&#160;27, 2023. As of December&#160;31, 2022, $1,924,356&#160;has been deposited into Trust Account by our Sponsor. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;30, 2022, the Company, LMA Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (&#8220;LMA Merger Sub&#8221;), Abacus Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (&#8220;Abacus Merger Sub&#8221;), Longevity Market Assets, LLC, a Florida limited liability company (&#8220;LMA&#8221;) and Abacus Settlements, LLC, a Florida limited liability company (&#8220;Abacus&#8221;) entered into an Agreement and Plan of Merger, as amended on October&#160;14, 2022 (as it may be further amended, supplemented or otherwise modified from time to time in accordance with its terms, the &#8220;Merger Agreement&#8221;), pursuant to which, subject to the satisfaction or waiver of certain conditions precedent in the Merger Agreement, (i)&#160;LMA Merger Sub will merge with and into LMA, with LMA surviving such merger as a direct wholly owned subsidiary of the Company (the &#8220;LMA Merger&#8221;) and (ii)&#160;Abacus Merger Sub will merge with and into Abacus, with Abacus surviving such merger as a direct wholly owned subsidiary of the Company (the &#8220;Abacus Merger&#8221; and, together with the LMA Merger and the other transactions contemplated by the Merger Agreement, the &#8220;Proposed Business Combination&#8221;). The Proposed Business Combination is expected to be consummated in the first half of 2023, subject to the fulfillment of certain conditions. Subject to the terms of the Merger Agreement, the aggregate merger consideration with respect to the holders of issued and outstanding limited liability company interests in LMA and Abacus will consist of approximately $531.8&#160;million, payable in a number of newly issued shares of Class&#160;A common stock at a deemed value of $10.00&#160;per share, with a portion of the aggregate merger consideration payable in cash upon the satisfaction of certain conditions. For additional information regarding the Merger Agreement, see the Company&#8217;s Current Reports on Form <span style="white-space:nowrap">8-K</span> filed on August&#160;30, 2022 and October&#160;14, 2022, and the Company&#8217;s preliminary proxy statement (as amended, the &#8220;Proxy Statement&#8221;), initially filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on October&#160;14, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;20, 2023, the Company convened a special meeting of stockholders at which a proposal to extend the date by which the Company has to complete a Business Combination from January&#160;27, 2023 to July&#160;27, 2023 (the &#8220;Second Extension Amendment Proposal&#8221;) was approved. In connection with the special meeting, stockholders were provided an opportunity to redeem all or a portion of their Class&#160;A common stock, and stockholders holding&#160;6,862,925&#160;shares of Class&#160;A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Consequently, approximately $70,070,464 (approximately $10.21&#160;per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the Second Extension Amendment Proposal, the Company </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-10 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issued a promissory note (the &#8220;Second Extension Note&#8221;) in the principal amount of up to $565,497&#160;to the Sponsor, pursuant to which the Sponsor agreed to loan us up to $565,497. The Second Extension Note bears no interest and is repayable in full upon the earlier of (a)&#160;the date of consummation of Company&#8217;s Business Combination or (b)&#160;the date of liquidation of the Company. In order to further extend the period the Company has to complete a Business Combination beyond the 27th of a given month until July&#160;27, 2023, the Sponsor will deposit an additional $94,250&#160;into the Trust Account commencing on January&#160;27, 2023 and on the 27th of each subsequent month until July&#160;27, 2023. As of April&#160;17, 2023, $282,750&#160;has been deposited into Trust Account by the Sponsor for the second extension. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Risks and Uncertainties </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management continues to evaluate the impact of the <span style="white-space:nowrap">COVID-19</span> pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Going Concern Considerations </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company had $86,572&#160;in cash and a working capital deficiency of $14,052,873. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company&#8217;s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company&#8217;s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. In addition, the Company may have to liquidate if the Business Combination is not completed by July&#160;27, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all or that it will complete a Business Combination prior to the expiration of the Combination Period. The Company is in the process of preparing and finalizing the Proxy Statement with the SEC for the purpose of soliciting stockholder approval of the Proposed Business Combination at a special meeting of the Company&#8217;s stockholders as promptly as possible. If the Proposed Business Combination is approved at a special meeting for such purpose, the Company would consummate the Proposed Business Combination shortly thereafter. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern through one year from the issuance of these financial statements. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-11 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Basis of Presentation </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for financial information and in accordance with the instructions to Article 8 of Regulation <span style="white-space:nowrap">S-X</span> promulgated under the Securities Act. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Emerging Growth Company </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to <span style="white-space:nowrap">non-emerging</span> growth companies but any such election to opt out is irrevocable. The Company has elected to&#160;irrevocably&#160;opt out of such extended transition period,&#160;which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,&#160;will&#160;adopt the new or revised standard at the time&#160;public&#160;companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another&#160;emerging growth company&#160;that has not&#160;opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Use&#160;of Estimates </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-12 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Cash and Cash Equivalents </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. In June 2022, the Company liquidated all investments held in the Trust Account to thereafter be held in the form of cash in the Trust Account. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Marketable Securities Held in Trust Account </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior&#160;to the liquidation of investments in the Trust Account, the Company&#8217;s portfolio of investments was comprised of U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act, with a maturity of&#160;185&#160;days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities and are recognized at fair value. When the Company&#8217;s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Gains and losses resulting from the change in fair value of these securities are included in gain on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At December&#160;31, 2022, substantially all of the assets held in the Trust Account were held in cash, as further explained in Note 1 above. At December&#160;31, 2021, substantially all of the assets held in the Trust Account were held in money market funds, which primarily invest in U.S. Treasury Bills. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Class&#160;A Common Stock Subject to Possible Redemption </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its shares of Class&#160;A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares of Class&#160;A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&#8217; equity. The Company&#8217;s Class&#160;A common stock features certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, Class&#160;A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&#8217; equity section of the Company&#8217;s balance sheet. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-13 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At December&#160;31, 2022 and December&#160;31, 2021, the Class&#160;A common stock reflected in the condensed balance sheets is reconciled in the following table: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:76%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Gross Proceeds</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">345,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds allocated to Public Warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(14,662,500</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds allocated to FPA liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&#160;A common stock issuance costs</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(18,978,817</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Plus:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remeasurement of carrying value to redemption value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34,641,317</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Class&#160;A common stock subject to possible redemption at December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">345,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redemption of Class&#160;A common stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(248,087,256</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remeasurement of carrying value to redemption value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">146,337</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution to trust account for extension</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,924,356</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Class&#160;A common stock subject to possible redemption at December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">98,983,437</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Derivative Financial Instruments </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, &#8220;Derivatives and Hedging&#8221;. The Company&#8217;s derivative instruments are recorded at fair value and <span style="white-space:nowrap">re-valued</span> at each reporting date, with changes in the fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or <span style="white-space:nowrap">non-current</span> based on whether or not <span style="white-space:nowrap">net-cash</span> settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the warrants and the forward contract for additional warrants are derivatives. As the financial instruments meet the definition of a derivative the warrants and the forward contract for additional warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the Statement of Operations in the period of change. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Income Taxes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company follows the asset and liability method of accounting for income taxes under ASC&#160;740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-14 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were&#160;no&#160;unrecognized tax benefits and&#160;no&#160;amounts accrued for interest and penalties as of December&#160;31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Inflation Reduction Act of 2022 </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal&#160;1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January&#160;1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally&#160;1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market&#160;value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the &#8220;Treasury&#8221;) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i)&#160;the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii)&#160;the structure of a Business Combination, (iii)&#160;the nature and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv)&#160;the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and inhibit the Company&#8217;s ability to complete a Business Combination. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Net Income (Loss) per Common Share </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company complies with accounting and disclosure of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; Net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period, excluding common stock shares subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of&#160;26,150,000&#160;shares in the calculation of diluted loss per share, since the inclusion of such warrants would be anti-dilutive. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s statements of operations include a presentation of income per share for common shares subject to possible redemption in a manner similar to the <span style="white-space:nowrap">two-class</span> method of income per share. Net income per common share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income on earnings, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to possible redemption outstanding over the period. Net loss is allocated evenly on a pro rata basis between Class&#160;A and Class&#160;B based on weighted average number of shares of common stock outstanding over the period. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-15 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with ASC Topic <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">480-10-S99-3A,</span></span></span> accretion associated with the redeemable shares of Class&#160;A common stock is excluded from earnings per share as the redemption value approximates its fair value. The calculation of diluted income per common share does not consider the effect of the warrants issued since the exercise of the warrants are contingent upon the occurrence of future events. However, the diluted earnings per share calculation includes the shares subject to forfeiture from the first day of the interim period in which the contingency on such shares was resolved. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:63%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For the</span><br/><span style="font-weight:bold">Year Ended</span><br/><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For the</span><br/><span style="font-weight:bold">Year Ended</span><br/><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net earnings (loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(643,564</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,839,365</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net earnings attributable to shareholders</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(643,564</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,956,991</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Redeemable Class&#160;A Common Stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator: Earnings (loss) allocable to Redeemable Class A Common Stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(471,513</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,671,492</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator: Weighted Average Share Outstanding, Redeemable Class&#160;A Common Stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23,637,084</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">34,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net earnings per share, Redeemable Class&#160;A</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(0.02</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">0.37</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="white-space:nowrap">Non-Redeemable</span> Class&#160;A and Class&#160;B Common Stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator: Earnings (loss) allocable to <span style="white-space:nowrap">Non-Redeemable</span> Class&#160;A and Class&#160;B Common Stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(172,051</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,167,873</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator: Weighted Average <span style="white-space:nowrap">Non-Redeemable</span> Class&#160;A and Class&#160;B Common Stock</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,625,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share, <span style="white-space:nowrap">Non-Redeemable</span> Class&#160;A and Class&#160;B</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">(0.02</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">)&#160;</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">0.37</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Concentration of Credit Risk </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Fair Value of Financial Instruments </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value Measurement,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-16 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Fair Value Measurements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The&#160;Company follows the guidance in ASC 820 for its financial assets and liabilities that are <span style="white-space:nowrap">re-measured</span> and reported at fair value at each reporting period, and <span style="white-space:nowrap">non-financial</span> assets and liabilities that are <span style="white-space:nowrap">re-measured</span> and reported at fair value at least annually.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%;vertical-align:top" align="left">Level&#8201;1:</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%;vertical-align:top" align="left">Level&#8201;2:</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Observable inputs other than Level&#160;1 inputs. Examples of Level&#160;2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%;vertical-align:top" align="left">Level&#8201;3:</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In&#160;some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Reclassification </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain prior period amounts have been reclassified to conform to current presentation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Recent Accounting Standards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) <span style="white-space:nowrap">2020-06,</span> Debt&#8212;Debt with Conversion and Other Options (Subtopic <span style="white-space:nowrap">470-20)</span> and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic <span style="white-space:nowrap">815-40)</span> (&#8220;ASU <span style="white-space:nowrap">2020-06&#8221;)</span> to simplify accounting for certain financial instruments. ASU <span style="white-space:nowrap">2020-06</span> eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU <span style="white-space:nowrap">2020-06</span> amends the diluted earnings per share guidance, including the requirement to use the <span style="white-space:nowrap">if-converted</span> method for all convertible instruments. ASU <span style="white-space:nowrap">2020-06</span> is effective January&#160;1, 2022 for public business entities that meet the definition of a Securities SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January&#160;1, 2021. The Company has adopted the standard on January&#160;1, 2022 and has assessed that it had no impact on the accounting of the Company. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-17 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s&#160;financial statements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 3. PUBLIC OFFERING </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Initial Public Offering, the Company sold&#160;34,500,000&#160;Units, which includes the full exercise by the underwriters of their over-allotment option on&#160;August 25, 2020, in the amount of&#160;4,500,000&#160;Units, at a purchase price of $10.00&#160;per Unit. Each Unit consists of one share of Class&#160;A common stock and <span style="white-space:nowrap">one-half</span> of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant entitles the holder to purchase&#160;one&#160;share of Class&#160;A common stock at a price of $11.50&#160;per share, subject to adjustment (see Note 8). </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 4. PRIVATE PLACEMENT </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of&#160;8,900,000&#160;Private Placement Warrants at a price of $1.00&#160;per Private Placement Warrant, for an aggregate purchase price of $8,900,000. Each Private Placement Warrant is exercisable for&#160;one&#160;share of Class&#160;A common stock at a price of $11.50&#160;per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 5. RELATED PARTY TRANSACTIONS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Founder Shares </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;1, 2020, the Sponsor purchased&#160;8,625,000&#160;shares (the &#8220;Founder Shares&#8221;) of the Company&#8217;s Class&#160;B common stock, par value $0.0001&#160;per share (the &#8220;Class&#160;B common stock&#8221;), for an aggregate price of $25,000. The Founder Shares will automatically convert into Class&#160;A common stock on <span style="white-space:nowrap"><span style="white-space:nowrap">a&#160;one-for-one</span></span> basis at the time of the Company&#8217;s initial Business Combination and are subject to certain transfer restrictions. The Founder Shares included up to an aggregate of&#160;1,125,000&#160;shares subject to forfeiture to the extent that the over-allotment option was not exercised in full or in part by the underwriters so that the Founder Shares would represent&#160;20% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. In July 2020, Sponsor transferred&#160;10,000&#160;founder shares to Thomas W. Corbett, Jr., one of our independent director nominees. As a result of the underwriters&#8217; election to fully exercise their over-allotment option on August&#160;25, 2020,&#160;1,125,000&#160;Founder Shares are no longer subject to forfeiture. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s Founder Shares are subject to transfer restrictions pursuant to <span style="white-space:nowrap">lock-up</span> provisions in a letter agreement with the Company entered into by the initial stockholders, and officers and directors. Those <span style="white-space:nowrap">lock-up</span> provisions provide that such securities are not transferable or salable until the earlier to occur of: (1)&#160;one year&#160;after the completion of the initial Business Combination, or (2)&#160;subsequent to the initial Business Combination if the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all of the public stockholders having the right to exchange their Public Shares for cash, securities or other property. Notwithstanding the foregoing, the Sponsor has the right to transfer its ownership in the Founder Shares at any time, and to any transferee, to the extent that the Sponsor determines, in good faith, that such transfer is necessary to ensure that it and/or any of its parents, subsidiaries or affiliates are in compliance with the Investment Company Act of 1940. Further, and notwithstanding the foregoing, if subsequent to the initial </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-18 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Business Combination the reported last sale price of the common stock equals or exceeds&#160;$12.00&#160;per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any&#160;20&#160;trading days within <span style="white-space:nowrap">any&#160;30-trading</span> day period commencing at least&#160;150&#160;days&#160;after our initial Business Combination, all of the Founder Shares will be released from the <span style="white-space:nowrap">lock-up.</span> Any permitted transferees will be subject to the same restrictions and other agreements of the initial stockholders with respect to any Founder Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As noted above, prior to the closing of the IPO, our Sponsor transferred&#160;10,000&#160;Founder Shares to our independent directors in recognition of and as compensation for their future services to the Company. The transfer of Founder Shares to these directors is within the scope of FASB ASC Topic 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the&#160;10,000&#160;shares granted to our independent directors was&#160;$61,173&#160;or&#160;$6.12&#160;per share. Compensation expense related to the Founder Shares is recognized only when the performance condition (i.e. the remediation of the <span style="white-space:nowrap">lock-up</span> provision) is probable of achievement under the applicable accounting literature. Stock-based compensation would be recognized at the date the <span style="white-space:nowrap">lock-up</span> provisions have been remediated, or are probable to be remediated, in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the transfer of the Founder Shares. As of December&#160;31, 2021, the Company has not yet entered into any definitive agreements in connection with any Business Combination and as such, the <span style="white-space:nowrap">lock-up</span> provisions have not been remediated and are not probable to be remediated. Any such agreements may be subject to certain conditions to closing, such as, for example, approval by the Company&#8217;s shareholders. As a result, the Company determined that, taking into account that there is a possibility that a Business Combination might not happen,&#160;no&#160;stock-based compensation expense should be recognized&#160;until the Business Combination occurs. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Administrative Support Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company entered into an agreement, commencing on July&#160;24, 2020 through the earlier of the Company&#8217;s consummation of a Business Combination and its liquidation, to pay&#160;two&#160;affiliates of the Sponsor $10,000&#160;each, per month, for office space and administrative support services. For the years ended December&#160;31, 2022 and 2021, the Company incurred and paid $240,000. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Related Party Loans </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company&#8217;s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221; or &#8220;Note&#8221;). In August 2021, the Sponsor committed to provide the Company up to an aggregate of $1,500,000&#160;in loans for working capital purposes. The Note does not bear interest and is repayable in full upon consummation of a Business Combination. If the Company does not complete a Business Combination, the Note shall not be repaid and all amounts owed under it will be forgiven. As of December&#160;31, 2022 and December&#160;31, 2021, there was a balance of $1,500,000&#160;under this loan. Subsequent to the reporting period, on January&#160;31, 2023, the Sponsor agreed to loan us up to an additional $1,500,000&#160;under this loan.&#160;Upon the consummation of a Business Combination, the holder of the Note (or a permitted assignee) shall have the option, but not the obligation, to convert all or a portion of the unpaid principal balance of the Note into that number of Working Capital Warrants equal to the principal amount of the Note so converted divided by $1.50. The conversion option should be bifurcated and accounted for as a derivative in accordance with ASC 815. However, the exercise price of the underlying warrants was greater than the warrant fair value as of December&#160;31, 2022, and when the Note was drawn on.&#160;The Company believes that the likelihood of the Sponsor&#8217;s exercise of the option to convert the Note to warrants is de minimis. As a result, the Company recorded zero liability related to the conversion option. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-19 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Working Capital Warrants will be identical to the terms of the warrants issued by the Company to the Sponsor in a private placement that took place simultaneously with the Company&#8217;s Initial Public Offering. The Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid principal balance of the Note and all other sums payable with regard to the Note becoming immediately due and payable. As of December&#160;31, 2022 and 2021, there was a balance of $1,500,000&#160;under this loan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Sponsor Loans </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;15, 2021, the Sponsor committed to provide the Company up to an aggregate of $500,000&#160;in loans for working capital purposes. These loans will be <span style="white-space:nowrap">non-interest</span> bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company in connection with these loans will be forgiven except to the extent that the Company has funds available to it outside of its Trust Account. As of December&#160;31, 2022 and 2021, the outstanding balance of the loan is $0. On June&#160;24, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000&#160;to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Note&#8221;). The Note was <span style="white-space:nowrap">non-interest</span> bearing and payable on the earlier of August&#160;31, 2020 or the completion of the Initial Public Offering. The outstanding balance under the Note of $97,126&#160;was repaid at the closing of the Initial Public Offering on July&#160;27, 2020. Affiliates of the Company and of the Sponsor advanced the Company an aggregate of $265,763&#160;to cover expenses related to the Initial Public Offering. The advances were <span style="white-space:nowrap">non-interest</span> bearing and due on demand. The outstanding advances of $265,763&#160;were repaid at the closing of the Initial Public Offering on July&#160;27, 2020. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;25, 2022, in connection with the approval of the First Extension Amendment Proposal, the Company issued the Extension Note in the principal amount of up to $1,924,356&#160;to the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $1,924,356. The First Extension Note bears no interest and is repayable in full upon the earlier of (a)&#160;the date of the consummation of the Company&#8217;s Business Combination, or (b)&#160;the date of the liquidation of the&#160;Company. The maturity date of the First Extension Note may be accelerated upon the occurrence of an Event of Default (as defined therein). Any outstanding principal under the First Extension Note may be prepaid at any time by the Company, at its election and without penalty, provided, however, that the Sponsor shall have a right to first convert such principal balance as described in Section&#160;17 of the First Extension Note upon notice of such prepayment. If a Business Combination is not completed and the Company winds up, there will not be sufficient assets to repay the First Extension Note and it will be worthless. As of December&#160;31, 2022, $1,924,356&#160;had been deposited into Trust Account by the Sponsor to extend the period the Company has to complete a Business Combination from July&#160;27,&#160;2022&#160;to January&#160;27, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the consummation of a Business Combination, the holder of the Note (or a permitted assignee) shall have the option, but not the obligation, to convert up to $1,500,000 or a portion of the unpaid principal balance of the Note into that number of Working Capital Warrants equal to the principal amount of the Note so converted divided by $1.50.&#160;The conversion option should be bifurcated and accounted for as a derivative in accordance with ASC 815. However, the exercise price of the underlying warrants was greater than the warrant fair value as of December&#160;31, 2022, and when the Note was drawn on.&#160;The Company believes that the likelihood of the Sponsor&#8217;s exercise of the option to convert the Note to warrants is de minimis. As a result, the Company recorded zero liability related to the conversion option. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;29, 2022, the Sponsor agreed to loan the Company an aggregate of $1,500,000&#160;to cover expenses related to the Business Combination and other operating activities until the consummation of the initial business combination, this is a separate $1,500,000&#160;than the convertible note discussed above. This note bears no interest and is repayable in full upon the earlier of (a)&#160;the date of the consummation of the Company&#8217;s initial </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-20 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business combination, or (b)&#160;if the initial business combination does not occur this note will not be repaid. As of December&#160;31, 2022 $1,500,000&#160;was outstanding on this loan. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 6. COMMITMENTS </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Registration Rights </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a registration rights agreement entered into on July&#160;23, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any shares of Class&#160;A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Underwriting Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters were paid a cash underwriting discount of $6,900,000&#160;in the aggregate. In addition, the underwriters were entitled to a deferred fee of $0.35&#160;per Unit, or $12,075,000. The deferred fee was to become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&#160;25, 2022, the Company received a letter providing notice from Wells Fargo Securities, LLC. (&#8220;Wells Fargo&#8221;), waiving any entitlement to their portion of the $12,075,000&#160;deferred underwriting fee that accrued from Wells Fargo&#8217;s participation as the underwriters of the Initial Public Offering and their right of first refusal to act <span style="white-space:nowrap">as&#160;co-placement&#160;agents</span> in connection with any equity or debt financing transaction (including any investment banking and financial advisory services) related to the Business Combination. Such waiver reduces the estimated expenses of the Business Combination by $12,075,000. A&#160;portion of deferred underwriting discount previously recorded in the additional <span style="white-space:nowrap">paid-in</span> capital is recorded as a recovery in the additional <span style="white-space:nowrap">paid-in</span> capital and a portion previously expensed is recorded as a recovery in the statement of operations in year ended December&#160;31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forward Purchase Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;2, 2020, the Company entered into a forward purchase agreement pursuant to which East Asset Management, LLC (&#8220;East Asset Management&#8221;), an affiliate of the Sponsor, agreed to purchase an aggregate of up to&#160;5,000,000&#160;units (the &#8220;forward purchase units&#8221;), consisting of&#160;one&#160;share of Class&#160;A common stock (the &#8220;forward purchase shares&#8221;) <span style="white-space:nowrap">and&#160;one-half</span> of one&#160;warrant to purchase&#160;one&#160;share of Class&#160;A common stock (the &#8220;forward purchase warrants&#8221;), for $10.00&#160;per unit, or an aggregate maximum amount of $50,000,000, in a private placement that will close simultaneously with the closing of a Business Combination.&#160;East Asset Management was too purchase a number of forward purchase units that would result in gross proceeds to the Company necessary to enable the Company to consummate a Business Combination and pay related fees and expenses, after first applying amounts available to the Company from the Trust Account (after paying the deferred underwriting discount and giving effect to any redemptions of Public Shares) and any other financing source </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-21 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obtained by the Company for such purpose at or prior to the consummation of a Business Combination, plus any additional amounts mutually agreed by the Company and East Asset Management to be retained by the post-business combination company for working capital or other purposes. East Asset Management&#8217;s obligation to purchase forward purchase units was, among other things, be conditioned on the Business Combination (including the target assets or business, and the terms of the Business Combination) being reasonably acceptable to East Asset Management and on a requirement that such initial Business Combination is approved by a unanimous vote of the Company&#8217;s board of directors. In determining whether a target is reasonably acceptable to East Asset Management, the Company expected that East Asset Management would consider many of the same criteria as the Company will consider but would also consider whether the investment is an appropriate investment for East Asset Management. The Forward Purchase Agreement is treated as a level 3 financial instrument under ASC 820.&#160;This agreement was terminated on December&#160;2, 2022.&#160;Please refer to Note 10 for additional information. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Trust Extension </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;25, 2022, the Company convened a special meeting of stockholders at which the First Extension Amendment Proposal was approved, extending the date by which the Company has to complete a Business Combination from July&#160;27, 2022 to January&#160;27, 2023. In connection with the special meeting, the Company provided the stockholders the opportunity to redeem all or a portion of their Class&#160;A common stock, and stockholders holding&#160;24,781,028&#160;shares of Class&#160;A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Consequently, approximately $248,087,256&#160;(approximately $10.01&#160;per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the First Extension Amendment Proposal, the Company issued the First Extension Note in the principal amount of up to $1,924,356&#160;to the Sponsor, pursuant to which the Sponsor agreed to loan the Company up to $1,924,356. The First Extension Note bears no interest and is repayable in full upon the earlier of (a)&#160;the date of the consummation of the Company&#8217;s Business Combination or (b)&#160;the date of the liquidation of the Company. In order to further extend the period the Company has to complete a Business Combination beyond July&#160;27, 2022, an additional $320,726&#160;was deposited into the Trust Account commencing on July&#160;27, 2022 and on the 27th of each subsequent month, or portion thereof, for each additional month that the Company requires to complete a Business Combination from July&#160;27, 2022 until January&#160;27, 2023. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Business Combination </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&#160;30, 2022, the Company, LMA Merger Sub, Abacus Merger Sub, LMA and Abacus, entered into (the Merger Agreement), pursuant to which, subject to the satisfaction or waiver of certain conditions precedent in the Merger Agreement, (i)&#160;LMA Merger Sub will merge with and into LMA, with LMA surviving such merger as a direct wholly owned subsidiary of the Company and (ii)&#160;Abacus Merger Sub will merge with and into Abacus, with Abacus surviving such merger as a direct wholly owned subsidiary of the Company. The Proposed Business Combination is expected to be consummated in the first half of 2023, subject to the fulfillment of certain conditions. Subject to the terms of the Merger Agreement, the aggregate merger consideration with respect to the holders of issued and outstanding limited liability company interests in LMA and Abacus will consist of approximately $531.8&#160;million, payable in a number of newly issued Company Class&#160;A common stock at a deemed value of $10.00&#160;per share, with a portion of the aggregate merger consideration payable in cash upon the satisfaction of certain conditions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In conjunction with the Business Combination certain legal and advisory fees have been incurred and will become due at closing of the Business Combination. The Company has accrued approximately $3.1&#160;million in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-22 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such legal fees and $4.8&#160;million in advisory fees, these amounts are reflected in the&#160;consolidated&#160;financial statements as of December&#160;31, 2022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 7. STOCKHOLDERS&#8217; EQUITY </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Preferred Stock</span></span>&#8212;The Company is authorized to issue&#160;1,000,000&#160;shares of preferred stock with a par value of $0.0001&#160;per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. As of December&#160;31, 2022 and December&#160;31, 2021, there were&#160;no&#160;shares of preferred stock issued or outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Class</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;A Common Stock</span></span>&#8212;The Company is authorized to issue&#160;200,000,000&#160;shares of Class&#160;A common stock with a par value of $0.0001&#160;per share. At December&#160;31, 2022 and December&#160;31, 2021, there was&#160;0&#160;shares of Class&#160;A common stock issued and outstanding, excluding the&#160;9,718,972&#160;and&#160;34,500,000&#160;shares of Class&#160;A common stock subject to possible redemption at December&#160;31, 2022 and December&#160;31, 2021, respectively. In connection with the special meeting convened on July&#160;25, 2022 related to the First Extension Amendment Proposal, stockholders totaling&#160;24,781,028&#160;shares of Class&#160;A common stock exercised their right to redeem such shares for a pro rata portion of the funds held in the Trust Account. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Class</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;B Common Stock</span></span>&#8212;The Company is authorized to issue&#160;20,000,000&#160;shares of Class&#160;B common stock with a par value of $0.0001&#160;per share. As of December&#160;31, 2022 and December&#160;31, 2021, there was&#160;8,625,000&#160;shares of Class&#160;B common stock issued and outstanding. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Common stockholders of record are entitled to&#160;one vote&#160;for each share held on all matters to be voted on by stockholders. Holders of the Class&#160;A common stock and holders of the Class&#160;B common stock will vote together as a single class on all matters submitted to a vote of the Company&#8217;s stockholders, except as required by law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Class&#160;B common stock are identical to the shares of Class&#160;A common stock included in the Units sold in the Initial Public Offering, and holders of Class&#160;B common stock have the same stockholder rights as public stockholders, except that (i)&#160;the Class&#160;B common stock are subject to certain transfer restrictions, as described in more detail below, (ii)&#160;the Sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed (A)&#160;to waive their redemption rights with respect to any Class&#160;B common stock and any Public Shares held by them in connection with the completion of a Business Combination and (B)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to any Class&#160;B common stock held by them if the Company fails to complete a Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete a Business Combination within the Combination Period, (iii)&#160;the Class&#160;B common stock will automatically convert into shares of Class&#160;A common stock at the time of a Business Combination, on <span style="white-space:nowrap"><span style="white-space:nowrap">a&#160;one-for-one&#160;basis,</span></span> subject to adjustment pursuant to certain anti-dilution rights and (iv)&#160;are subject to registration rights. If the Company submits a Business Combination to the public stockholders for a vote, the Sponsor has agreed to vote any Class&#160;B common stock held by it and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With certain limited exceptions, the shares of Class&#160;B common stock are not transferable, assignable or salable (except to the Company&#8217;s officers and directors and other persons or entities affiliated with the Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A)&#160;one year&#160;after the completion of a Business Combination or (B)&#160;subsequent to a Business Combination, (x)&#160;if the last sale price of the Class&#160;A common stock equals or exceeds $12.00&#160;per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any <span style="white-space:nowrap">30-trading</span> day period </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-23 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commencing at least&#160;150&#160;days after a Business Combination, or (y)&#160;the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the stockholders having the right to exchange their shares of common stock for cash, securities or other property. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 8. WARRANT LIABILITY </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Public Warrants may only be exercised for a whole number of shares.&#160;No&#160;fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a)&#160;30&#160;days after the completion of a Business Combination and (b)&#160;12&#160;months from the closing of the Proposed Offering. The Public Warrants will expire&#160;five years&#160;from the completion of a Business Combination, at 5:00&#160;p.m., New York City time, or earlier upon redemption or liquidation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will not be obligated to deliver any shares of Class&#160;A common stock pursuant to the exercise of a Public Warrant and will have&#160;no&#160;obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class&#160;A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available.&#160;No&#160;warrant will be exercisable and the Company will not be obligated to issue a share of Class&#160;A common stock upon exercise of a warrant unless the share of Class&#160;A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class&#160;A common stock issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the issuance of the shares of Class&#160;A common stock issuable upon exercise of the warrants is not effective by the 60th&#160;business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9) of the Securities Act or another exemption. In addition, if the shares of Class&#160;A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1) of the Securities Act, the Company may, at its option, require holders of the Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9) of the Securities Act and, in the event the Company elects to do so, the Company will not be required to file or maintain in effect a registration statement, but it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Redemption of Warrants for Cash</span>&#8212;Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in whole and not in part; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at a price of $0.01&#160;per warrant; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon not less than&#160;30&#160;days&#8217; prior written notice of redemption to each warrant holder; and </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-24 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $18.00&#160;per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a <span style="white-space:nowrap">30-trading</span> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class&#160;A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class&#160;A common stock is available throughout the <span style="white-space:nowrap">30-day</span> redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Redemption of Warrants for Shares of Class</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;A Common Stock</span>&#8212;Once the warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class&#160;A common stock: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">in whole and not in part; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at a price equal to a number of shares of Class&#160;A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the &#8220;fair market value&#8221; of the Class&#160;A common stock; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">upon not less than&#160;30&#160;days&#8217; prior written notice of redemption to each warrant holder; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $10.00&#160;per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price and number of shares of Class&#160;A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of Class&#160;A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if (x)&#160;the Company issues additional shares of Class&#160;A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20&#160;per share of Class&#160;A common stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y)&#160;the aggregate gross proceeds from such issuances represent more than&#160;60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of the Company&#8217;s shares of Class&#160;A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-25 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described above adjacent to &#8220;Redemption of Warrants For Cash&#8221; and &#8220;Redemption of Warrants For Shares of Class&#160;A Common Stock&#8221; will be adjusted (to the nearest cent) to be equal to&#160;100% and&#160;180% of the higher of the Market Value and the Newly Issued Price, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30&#160;days after the completion of a Business Combination, subject to certain limited exceptions, (y)&#160;the Private Placement Warrants will be exercisable on a cashless basis and be <span style="white-space:nowrap">non-redeemable</span> so long as they are held by the initial purchasers or their permitted transferees and (z)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 9. INCOME TAX </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s net deferred tax assets are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:66%"/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating loss carryforward</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57,440</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Startup and organizational expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">753,230</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">322,752</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">753,230</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">380,192</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation Allowance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(753,230</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(380,192</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets, net of allowance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The income tax provision consists of the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:66%"/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">41,592</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(243,908</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(380,192</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State and Local</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(129,130</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation allowance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">373,038</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">380,192</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax provision</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52,485</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022 and December&#160;31, 2021, the Company had $0, and $273,522&#160;of U.S. federal net operating loss carryovers, which do not expire, available to offset future taxable income, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-26 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.&#160;After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the years ended December&#160;31, 2022 and 2021, the change in the valuation allowance was $373,038&#160;and $380,192, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:66%"/>

<td style="vertical-align:bottom;width:12%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,</span><br/><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Statutory federal income tax rate</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State taxes, net of federal tax benefit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20.39</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger costs</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(358.38</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">331.68</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(21.1</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of forward purchase agreement liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21.32</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1.7</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred underwriting fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18.23</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(63.11</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1.8</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax provision</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8.87</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(0.0</td>
<td style="white-space:nowrap;vertical-align:bottom">)%&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company&#8217;s tax returns since inception remain open to examination by the taxing authorities. The Company considers Florida&#160;to be a significant state tax jurisdiction. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 10. FAIR VALUE MEASUREMENTS </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>The following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis at December&#160;31, 2022 and December&#160;31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:59%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Level</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,<br/>2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Level</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,<br/>2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marketable securities held in Trust Account</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">99,222,704</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">345,048,888</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant Liability&#8212;Public Warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,018,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,177,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant Liability&#8212;Private Placement Warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,557,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,734,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forward Purchase Agreement Liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Public Warrants and Private Placement Warrants (collectively, the &#8220;Warrants&#8221;) and forward purchase agreement were accounted for as liabilities in accordance with ASC <span style="white-space:nowrap">815-40</span> and are presented separately in the condensed balance sheets. The warrant liabilities and forward purchase agreement liability are measured at fair value at inception and on a recurring basis, with changes in fair value presented separately in the condensed statements of operations. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-27 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the roll forward for the Level&#160;3 Derivative liabilities as of December&#160;31, 2022 and 2021: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:79%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&#160;3 Derivative liabilities as of December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of forward purchase agreement</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelation of forward purchase agreement</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&#160;3 Derivative liabilities as of December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&#160;3 Derivative liabilities as of December&#160;31, 2020</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,046,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of Private Placement Warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,411,200</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of forward purchase agreement</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer from Level&#160;3 to Level&#160;2 derivative&#8212;Private Placement Warrants</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,734,800</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&#160;3 Derivative liabilities as of December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units on September&#160;14, 2020 were classified as Level&#160;1 due to the use of an observable market quote in an active market. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price will be used as the fair value as of each relevant date. The Private Placement Warrants are considered to be a Level&#160;2 fair value measurement and are valued the same as Public Warrant even though they are not traded on the market. The Private Placement Warrants were considered a Level&#160;3 fair value measurement prior to Quarterly period ended September&#160;30, 2021 using a binomial lattice model. The binomial lattice model&#8217;s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable &#8216;blank-check&#8217; companies without an identified target. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the changes in the fair value of warrant liabilities: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Private</span><br/><span style="font-weight:bold">Placement</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Public</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Warrant</span><br/><span style="font-weight:bold">Liabilities</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment liabilities as of December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,734,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,177,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,911,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation inputs or other assumptions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,177,300</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,158,250</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,335,550</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investment liabilities as of December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,557,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,018,750</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,576,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Derivative liabilities as of December&#160;31, 2020</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,146,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,665,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29,811,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation inputs or other assumptions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,411,200</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,488,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(15,899,200</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value as of December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,734,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,177,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,911,800</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward purchase agreement was valued using the publicly traded price of the Company&#8217;s Units, based upon the fact that the Forward Purchase Units are equivalent to the Company&#8217;s publicly traded Units, and the publicly traded price of the Units considered (i)&#160;the market&#8217;s expectation of an initial Business Combination and (ii)&#160;the Company&#8217;s redemption of the common stock within the Units at $10.00&#160;per shares if an initial Business Combination does not occur.&#160;The forward purchase agreement was terminated on December&#160;2, 2022. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-28 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EAST RESOURCES ACQUISITION COMPANY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">DECEMBER&#160;31, 2022 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the quantitative information regarding Level&#160;3 fair value measurements of the forward purchase agreement: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:74%"/>

<td style="vertical-align:bottom;width:21%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unit price</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10.31</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term to initial business combination (in years)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free rate</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.19</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0.0</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the changes in the fair value of the forward purchase agreement liability: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:80%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value as of December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelation of forward purchase agreement</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value as of December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value as of December&#160;31, 2020</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,900,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value as of December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTE 11. SUBSEQUENT EVENTS </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company evaluates subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&#160;20, 2023, the Company convened a special meeting of stockholders at which the Second Extension Amendment Proposal to extend the date by which the Company has to complete a Business Combination from January&#160;27, 2023 to July&#160;27, 2023 was approved. In connection with the special meeting, stockholders were provided an opportunity to redeem all or a portion of their Class&#160;A common stock, and stockholders holding&#160;6,862,925&#160;shares of Class&#160;A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. Consequently, approximately $70,070,464&#160;(approximately $10.21&#160;per share) was removed from the Trust Account to pay such redeeming holders. Additionally, in connection with the approval of the Second Extension Amendment Proposal, the Company issued the Second Extension Note in the principal amount of up to $565,497&#160;to the Sponsor, pursuant to which the Sponsor agreed to loan us up to $565,497. The Second Extension Note bears no interest and is repayable in full upon the earlier of (a)&#160;the date of consummation of Company&#8217;s Business Combination or (b)&#160;the date of liquidation of the Company. In order to further extend the period the Company has to complete a Business Combination beyond the 27th of a given month until July&#160;27, 2023, the Sponsor will deposit an additional $94,250&#160;into the Trust Account commencing on January&#160;27, 2023 and on the 27th of each subsequent month until July&#160;27, 2023. As of&#160;April 17, 2023, $282,750&#160;has been deposited into Trust Account by the Sponsor. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-29 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman">Abacus Settlements, LLC d/b/a Abacus Life </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial Statements as of and for the Years Ended December&#160;31, 2022, and 2021, and </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Report of Independent Registered Public Accounting Firm </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-30 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">TABLE OF CONTENTS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:90%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Page</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_1">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AUDITED FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_2">Balance Sheets</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_3">Statements of Operations and Comprehensive (Loss) Income</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-34</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_4">Statements of Cash Flows</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-35</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_5">Statements of Changes in Members&#8217; Equity</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-36</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_6">Notes to Financial Statements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-37-F-47</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-31 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman;font-weight:bold" id="fin423260_1">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Abacus Settlements, LLC d/b/a Abacus Life </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Opinion on the financial statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the accompanying balance sheets of Abacus Settlements, LLC d/b/a Abacus Life (a Florida limited liability company) (the &#8220;Company&#8221;) as of December&#160;31, 2022 and 2021, the related statements of operations and comprehensive (loss) income, changes in members&#8217; equity, and cash flows for each of the two years in the period ended December&#160;31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December&#160;31, 2022, in conformity with accounting principles generally accepted in the United States of America. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Basis for opinion </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt">


<img src="g423260g01y03.jpg" alt="LOGO"/>
 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#8217;s auditor since 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philadelphia, Pennsylvania </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&#160;17, 2023 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-32 </p>

</div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>
<div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="abl:DebtInstrumentBasisSpreadOnVariableRateTerm" id="hidden91072234" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis">P1M</ix:nonNumeric><ix:nonNumeric name="abl:DebtInstrumentBasisSpreadOnVariableRateTerm" id="hidden91072235" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis">P3M</ix:nonNumeric><ix:nonNumeric name="abl:DebtInstrumentBasisSpreadOnVariableRateTerm" id="hidden91071984" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis">P3M</ix:nonNumeric><ix:nonNumeric name="abl:DebtInstrumentBasisSpreadOnVariableRateTerm" id="hidden91071985" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis">P1M</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="abl-20230630.xsd"/></ix:references></ix:header></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div id="fin423260_2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE SHEETS </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">AS OF DECEMBER&#160;31, 2022 AND 2021 </div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASSETS</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CURRENT ASSETS:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,458,740</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,599,302</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party receivables</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">402,749</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">590,371</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other receivables</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">122,455</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">40,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">216,150</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">305,516</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other current assets</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,633</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total current assets</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,215,727</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,535,189</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PROPERTY AND EQUIPMENT&#8212;Net</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">72,218</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,303</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INTANGIBLE ASSETS&#8212;Net</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,933</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">214,071</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">OTHER ASSETS:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="5" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">300,866</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">367,508</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Due from members and affiliates</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,448</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,536</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State security deposits</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">206,873</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">206,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certificate of deposit</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">262,500</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">918,750</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,246</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total other assets</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">778,933</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,509,434</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">TOTAL ASSETS</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,215,812</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,291,997</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LIABILITIES AND MEMBERS&#8217; EQUITY</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="5" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CURRENT LIABILITIES:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="5" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts Payable</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,750</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued payroll and other expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">541,866</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">510,846</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities- current portion</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">214,691</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">135,321</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract liability&#8212;deposits on pending settlements</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">322,150</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,678,791</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Due to members</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,411</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,857</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total current liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,116,869</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,336,815</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities- noncurrent portion</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">87,806</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">232,187</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,204,675</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,569,002</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">COMMITMENTS AND CONTINGENCIES (NOTE 7) </div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="5" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">MEMBERS&#8217; EQUITY:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common units; $10 par value; 400 common units issued and outstanding at December&#160;31, 2022 and 2021</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Retained earnings</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,927,137</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,638,995</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total members&#8217; equity</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,011,137</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,722,995</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">TOTAL LIABILITIES AND MEMBERS&#8217; EQUITY</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,215,812</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,291,997</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 75pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">See accompanying notes to financial statements. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-33 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div id="fin423260_3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021 </div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 76%;"/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ORIGINATION REVENUE</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,050,007</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,906,374</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RELATED PARTY REVENUE</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,153,456</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,685,770</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,203,463</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,592,144</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">COST OF REVENUE</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,538,470</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,678,029</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RELATED PARTY COST OF REVENUE</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,022,535</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,527,312</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cost of revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,561,005</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,205,341</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">GROSS PROFIT</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,642,458</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,386,803</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">OPERATING EXPENSES:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,674,425</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,439,549</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,165</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,139</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,686,590</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,449,688</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(LOSS) INCOME FROM OPERATIONS</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(44,132</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">937,115</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">OTHER (EXPENSE) INCOME:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,199</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,500</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest (expense)</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,817</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Consulting income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">273</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total other (expense)/ income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,345</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">61,500</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(LOSS) INCOME BEFORE INCOME TAXES</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(50,477</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">998,615</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INCOME TAX EXPENSE</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,018</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,200</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income and comprehensive (loss) income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(52,495</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">997,415</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">WEIGHTED-AVERAGE UNITS USED IN COMPUTING</div></div><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NET INCOME (LOSS) PER UNIT:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NET INCOME (LOSS) PER UNIT:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic earnings per unit</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(131.24</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,493.54</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Diluted earnings per unit</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(131.24</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,493.54</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 120pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 120pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-indent: -2%; font-family: Times New Roman; font-size: 10pt; margin-top: 60pt; margin-bottom: 0pt; margin-left: 2%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">See accompanying notes to financial statements. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-34 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div id="fin423260_4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">STATEMENTS OF CASH FLOWS </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021 </div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH FLOWS FROM OPERATING ACTIVITIES:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss) income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(52,495</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">997,415</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Adjustments to reconcile net income to net cash provided by operating activities:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,184</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,651</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,138</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,593</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization of deferred financing fees</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,817</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-cash</div> lease expense</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,631</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in operating assets and liabilities:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party receivables</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">187,622</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(456,240</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other receivables</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(82,455</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(40,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">89,366</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(58,316</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,246</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts payable</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">36,750</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued payroll and other expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">31,020</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4,349</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract liability&#8212;deposits on pending settlements</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,356,641</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">610,541</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State security deposit</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(233</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(32</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certificate of deposit</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">656,250</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">262,500</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net cash (used in)/ from operating activities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(383,291</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,342,763</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH FLOWS FROM INVESTING ACTIVITIES:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of property and equipment</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(64,099</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of intangible asset</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(15,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(226,664</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in due from members and affiliates</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,088</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(14,864</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net cash (used in) investing activities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(64,011</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(241,528</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH FLOWS FROM FINANCING ACTIVITIES:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financing fees</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(23,450</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in due to members</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(10,446</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,639</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions to members</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(659,363</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(358,216</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net cash (used in) financing activities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(693,259</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(354,577</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NET (DECREASE)/ INCREASE IN CASH AND CASH EQUIVALENTS</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,140,562</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">746,658</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH AND CASH EQUIVALENTS&#8212;Beginning of year</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,599,302</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,852,644</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH AND CASH EQUIVALENTS&#8212;End of year</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,458,740</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,599,302</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: -2%; font-family: Times New Roman; font-size: 10pt; margin-top: 120pt; margin-bottom: 0pt; margin-left: 2%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">See accompanying notes to financial statements. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-35 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div id="fin423260_5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">STATEMENTS OF CHANGES IN MEMBERS&#8217; EQUITY&#8195; </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021 </div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 53%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td rowspan="3" style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" rowspan="3" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Additional</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-in&#160;Capital</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom;">&#160;</td>
<td rowspan="3" style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" rowspan="3" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Retained</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Earnings</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom;">&#160;</td>
<td rowspan="3" style="vertical-align: bottom;">&#160;</td>
<td colspan="2" rowspan="3" style="vertical-align: bottom;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Members&#8217;&#160;Equity</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common units</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Units</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE&#8212;January 1, 2021</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,999,796</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,083,796</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">997,415</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">997,415</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(358,216</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(358,216</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE&#8212;December 31, 2021</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,638,995</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,722,995</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net (loss)</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(52,495</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(52,495</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(659,363</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(659,363</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE&#8212;December 31, 2022</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400</td>
<td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">80,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,927,137</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,011,137</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 120pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 120pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-size: 120pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 120pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 120pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">See accompanying notes to financial statements. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-36 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div id="fin423260_6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTES TO FINANCIAL STATEMENTS </div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">DESCRIPTION OF THE BUSINESS </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Abacus Settlements, LLC d/b/a Abacus Life (the &#8220;Company&#8221;) was formed in 2004 in the state of New York. In 2016, the Company obtained its licensure in Florida and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-domesticated</div> to that state. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company acts as a purchaser of outstanding life insurance policies on behalf of investors (&#8220;financing entities&#8221;) by locating policies and screening them for eligibility for a life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known as origination services. When the sale of a policy is completed, this is deemed &#8220;settled&#8221; and the policy is then referred to as either a &#8220;life settlements,&#8221; in which the insured&#8217;s life expectancy is greater than two years or &#8220;viatical settlements,&#8221; in which the insured&#8217;s life expectancy is less than two years. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is not an insurance company, and therefore does not underwrite insurable risks for its own account. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On August&#160;30, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with East Resources Acquisition Company (&#8220;ERES&#8221;), which was subsequently amended on October&#160;14, 2022 and April&#160;20, 2023. As part of the Merger Agreement, the total transaction value is $618,000,000, where the holders of the Company&#8217;s common units together with the holders of Longevity Markets Assets, LLC (&#8220;LMA&#8221;), a commonly owned affiliate, will receive aggregate consideration of approximately $531,800,000, payable in a number of newly issued shares of ERES Class&#160;A common stock, par value $0.0001 per share (&#8220;ERES Class&#160;A common stock&#8221;), with a value ascribed to each share of ERES Class&#160;A common stock of $10.00 and, to the extent the aggregate transaction proceeds exceed $200.0&#160;million, at the election of the Company&#8217;s and LMA&#8217;s members, up to $20.0&#160;million of the aggregate consideration will be payable in cash to the Company&#8217;s and LMA&#8217;s members. The transaction is expected to close in Q2 2023, subject to shareholder approval and customary closing conditions. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation</div></div>&#8212;The accompanying financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div>&#8212;The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the reports amounts of revenue and expenses during the reporting periods. Company&#8217;s estimates, judgments and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, impairment testing, valuation of other receivables, income taxes and legal reserves. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Going Concern</div></div>&#8212;Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. Management&#8217;s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about Company&#8217;s ability to continue as a going concern within one year after the date these financial statements were issued. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cash and Cash Equivalents</div></div>&#8212;Cash and cash equivalents include short-term and all <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">highly-liquid</div> debt instruments purchased with an original maturity of three months or less. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-37 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Related party receivables</div></div>&#8212;Related party receivables include fees to be reimbursed to the Company from life expectancy reports, assisted physician services and escrow services incurred on policies that related party financing entities purchase as part of the origination agreement with the Company. Related party receivables are stated at their net realizable value. Approximately, three-quarters of the outstanding receivables as of December&#160;31, 2022 were collected in January 2023 and half of these fees as of December&#160;31, 2021 were collected in January 2022. The Company recognizes allowances for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses when deemed uncollectible (after all means of collection have been exhausted and the potential for recovery is deemed remote). The Company does not have any material allowance for credit losses as of December&#160;31, 2022 or December&#160;31, 2021. Refer to Note 12&#8212;Related Party Transactions for additional information. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other receivables</div></div>&#8212;Other receivables include origination fees for policies in which the recission period has ended, but the funds have not been received yet from financing entities. These fees were collected in the subsequent month. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provides an allowance for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses after all means of collection have been exhausted and the potential for recovery is deemed remote. The Company does not have any material allowance for credit losses as of December&#160;31, 2022 or December&#160;31, 2021. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the financial condition of the Company&#8217;s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company did not record material allowance for credit losses as of December&#160;31, 2022 and December&#160;31, 2021, respectively. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations</div></div>&#8212;All of the Company&#8217;s revenues are derived from life settlement transactions in which the Company represents financing entities that purchased existing life insurance policies. One financing entity, a company in which the Company&#8217;s members&#8217; own interests, represented 60% and 76% of the Company&#8217;s revenues in 2022 and 2021, respectively. The Company works with licensed life settlement brokers and agents who represent the sellers. No single broker or agent represented the sellers for over 10% of the Company&#8217;s life settlement commission expense in 2022 and 2021. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company maintains cash deposits with a major bank which from time to time may exceed federally insured limits. The Company periodically assesses the financial condition of the institution and believes that the risk of loss is minimal. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying Balance Sheet. The Company extends different levels of credit to its customers and maintains allowance for credit loss accounts based upon the expected collectability of accounts receivable. The Company&#8217;s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer&#8217;s financial condition, monitoring credit history and current economic conditions, using historical experience applied to an aging of accounts, and reasonable and supportable forecasts. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Property and Equipment&#8212;Net</div></div>&#8212;Property and equipment, net is stated at cost less accumulated depreciation. Depreciation expense is recognized over the useful lives of the assets using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">straight-line</div> method. The estimated useful life of each asset category is as follows: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 89%;"/>
<td style="width: 9%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Office furniture</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-38 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expenditures for repairs and maintenance are charged to expense in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts. The difference between the net book value of the assets and proceeds from disposal is recognized as a gain or loss on disposal, which is included in other income), in the statements of operations and comprehensive (loss) income. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment are tested for recoverability whenever events or changes in circumstance indicate that their carrying amounts may not be recoverable. An impairment loss is recognized if the carrying amount of property and equipment is not recoverable and exceeds its fair value. Recoverability is determined based on the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. There were no impairments recognized during the years ended December&#160;31, 2022 and 2021, respectively. Property and equipment to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Intangible Assets&#8212;Net</div></div>&#8212;Intangible assets are stated at cost, less accumulated amortization, and consist of capitalized costs incurred for the development of internal use software. The costs incurred exclusively consist of fees incurred from an external consulting firm during the development stage of the project and are subject to capitalization under Accounting Standards Codification (&#8220;ASC&#8221;) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">350-40,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software</div></div>. The software is amortized on the straight-line basis over an estimated useful life of 3 years. Company reviews definite-lived intangible assets and other long-lived assets for impairment whenever an event occurs that indicates the carrying amount of an asset may not be recoverable. No impairment was recorded for the years ended December&#160;31, 2022 and 2021. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">State security deposit and Certificate of Deposit</div></div>&#8212;As a requirement of the licensing process, the Company is required to maintain a security deposit with a depository bank for the New Jersey Department of Banking and Insurance. The Company maintains a money market account in TD Wealth (NJ) to comply with these requirements. Additionally, a deposit was made with the Florida Department of Financial Services to meet a similar requirement in the state of Florida. Further, Bank of America required the Company to purchase a certificate of deposit as collateral for an irrevocable letter of credit, which supports the bonds that are required by certain states for licensing. As these deposits cannot be withdrawn due to regulatory requirements, they are not short term in nature and are classified as noncurrent assets on the balance sheets. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Measurements</div></div>&#8212;The following fair value hierarchy is used in selecting inputs for those assets and liabilities measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company&#8217;s assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels, if any, at the end of each reporting period. The hierarchy consists of three levels: </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Level 1</div></div></div></div>&#8212;Valuation based on quoted market prices in active markets for identical assets or liabilities; </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Level 2</div></div></div></div>&#8212;Valuation based on inputs other than Level&#160;1 inputs that are observable for the assets or liabilities either directly or indirectly; </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Level 3</div></div></div></div>&#8212;Valuation based on prices or valuation techniques that require inputs that are both significant to the fair value measurement and supported by little or no observable market activity. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The carrying values of the Company&#8217;s financial assets and liabilities, including cash and cash equivalents, premiums, commissions and fees receivable, premiums payable and accrued expenses and other current liabilities, approximate their fair values because of the short period of time to maturity and liquidity of those instruments. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Revenue Recognition</div></div>&#8212;The Company recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-39 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">commissions received and the reimbursement of transaction costs. For revenue disaggregation based upon the source of the policy, see disclosure in Note 8&#8212;Revenue. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Company&#8217;s revenue-generating arrangements are within the scope of ASC 606, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenue from Contracts with Customers</div></div>. The Company originates life settlements policies with third parties that include settlement brokers, life insurance agents, and direct consumers or policyholders. The Company then provides the administration services needed to initiate the transfer of the life settlement policies to investors in exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and the Company has a single performance obligation to originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by the Company and is dependent upon the policy death benefits held by each life settlement policy. The revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. The Company recognizes revenue from life settlement transactions when the closing has occurred and any right of rescission under applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the right to rescind the contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs simultaneously, and only the fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For agent and broker commissions received and transaction costs reimbursed, the Company has determined that it is acting as the principal in the relationship as it maintains control of the services being performed as part of performance obligation prior to facilitating the transfer of the life settlement policy to the investor. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">While the origination fees are fixed amounts based on the face value of the policy death benefit, there is variable consideration present due to the owners recission right. When variable consideration is present in a contract, the Company estimates the amount of variable consideration to which it expects to be entitled at contract inception and again at each reporting period until the amount is known. The entity applies the variable consideration constraint so that variable consideration is included in the transaction price only to the extent it is probable that a subsequent change in estimate will not result in a significant revenue reversal. While origination fees are variable due to the recission periods, given that the recission periods are relatively short in nature, the Company has concluded that such fees are fully constrained until the rescission period lapses and thus records revenue at a fixed amount based on the face value of the policy death benefit after the recission period is over. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost to Obtain or Fulfill Contracts</div></div>&#8212;Costs to obtain or fulfill contracts include commissions for brokers or agents under specific agreements that would not be incurred without a contract being signed and executed. The Company has elected to apply the ASC 606 &#8216;practical expedient&#8217; which allows us to expense these costs as incurred if the amortization period related to the resulting asset would be one year or less. The Company has no instances of contracts that would be amortized for a period greater than a year, and therefore has no contract costs capitalized for these arrangements. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Contract Balances</div></div>&#8212;The timing of revenue recognition, customer billing and cash collection can result in billed accounts receivable, unbilled receivables (contract assets), and deferred revenues (contract liabilities). Contract liabilities consist of deposits on pending settlements, where origination fees and commissions were received from policies that had closed in December, but the right of rescission period had not expired as of December 31. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Commissions</div></div>&#8212;The Company receives a fee from the purchaser for their part in arranging the life settlement transactions. Out of that fee income, the Company pays commissions to the licensed representative of the seller, if one is required. Commission expense is recorded at the same time revenue is recognized and is included in the accompanying statements of operations and comprehensive (loss) income as cost of sales. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-40 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segment</div></div>&#8212;Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;) in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#8217;s CODM is its President and Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented for purposes of making operating decisions, allocating resources, and evaluating financial performance. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes</div></div>&#8212;The Company is taxed as an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-corporation</div> for U.S. federal income tax purposes as provided in Section&#160;1362(a) of the Internal Revenue Code. As such, the Company&#8217;s income or loss and credits are passed through to the members and reported on their individual Federal income tax return. The Company is required to file tax returns in most of the states in which it does business. Not all of the states recognize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-corporations</div> as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pass-through</div> entities, and the Company is taxed at the corporate level. Accordingly, the Company pays income taxes to those states that do not treat S corporations as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pass-through</div> entities for tax purposes. The income tax expense or benefit is based on taxable income allocated to the states that do not recognize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-corporations</div> as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pass-through</div> entities. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Company records uncertain tax positions in accordance with ASC 740, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div>, on the basis of a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-step</div> process whereby: (i)&#160;management determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii)&#160;for those tax positions that meet the more likely than not recognition threshold, management recognizes the largest amount of tax benefit that is greater than 50&#160;percent likely to be realized upon ultimate settlement with the related tax authority. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes interest and penalties as a component of income tax expense. The Company is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Advertising</div></div>&#8212;All advertising expenditures incurred by the Company are charged to expense in the period to which they relate and are included in general and administrative expenses on the accompanying statements of operations and comprehensive (loss) income. Advertising expense totaled $1,414,828 and $1,803,000 for the years ended December&#160;31, 2022 and 2021, respectively. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Leases</div></div>&#8212;The Company accounts for its leases in accordance with ASC 842, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Leases</div></div>. A contract is or contains a lease if there is identified property, plant and equipment that is either explicitly or implicitly specified in the contract and the lessee has the right to control the use of the property, plant and equipment throughout the contract term, which is based on an evaluation of whether the lessee has the right to direct the use of the property, plant and equipment. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In April 2022, the Company entered into an agreement to lease additional office space in Orlando, Florida from a vendor. The lease commenced on May&#160;1, 2022 and goes through October&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Historically, the Company&#8217;s lease portfolio consisted of a single lease of office space in Orlando, Florida, which is accounted for as an operating lease. In April 2021, the lease was modified to expand the office space leased by the Company and also extend the term of the lease through July&#160;31, 2024. The Company is responsible for utilities, maintenance, taxes and insurance, which are variable payments based on a reimbursement to the lessor of the lessor&#8217;s costs incurred. The Company excludes variable lease payments from the measurement of lease liabilities and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (&#8220;ROU&#8221;) assets recognized on the Company&#8217;s balance sheets. Variable lease payments are recognized as a lease expense on the Company&#8217;s statements of operations and comprehensive (loss) income in the period incurred. The Company has elected the practical expedient to account for lease components and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components together as a single lease component for its real estate leases noted above. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has elected the short-term lease exemption, which permits the Company to not recognize a lease liability and ROU asset for leases with an original term of one year or less. Currently, the Company does not have any short-term leases. The Company&#8217;s current lease includes a renewal option. The Company has determined that the renewal option is not reasonably certain of exercise based on an evaluation of </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-41 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contract, market and asset-based factors, and therefore does not include periods covered by renewal options in its lease term. The Company&#8217;s leases generally do not include purchase options, residual value guarantees, or material restrictive covenants. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determines its lease liability and ROU by calculating the present value of future lease payments. The present value of future lease payments is discounted using the Company&#8217;s incremental borrowing rate. As the Company&#8217;s leases generally do not have a readily determinable implicit rate, the Company uses its incremental borrowing rate based on market yields and comparable credit ratings, adjusted for lease term, to determine the present value of fixed lease payments based on information available at the lease commencement date. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company does not have any finance leases, nor is the Company a lessor (or sublessor). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">See Note 14 for additional disclosures related to leases. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Earnings Per Unit</div></div>&#8212;The Company has only one class of equity. Basic net (loss) income per unit is calculated by dividing net (loss) income by the weighted average number of units outstanding during the applicable period. If the number of units outstanding increases as a result of a unit dividend or unit split or decreases as a result of a reverse unit split, the computations of basic net (loss) income per unit are adjusted retroactively for all periods presented to reflect that change in capital structure. If such changes occur after the close of the reporting period but before issuance of the financial statements, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-units</div> computations for that period and any prior-period financial statements presented are based on the new number of units. </div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SEGMENT REPORTING </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Operating as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">centrally-led</div> life insurance policy intermediary, the Company&#8217;s President and Chief Executive Officer is the CODM who allocates resources and assesses financial performance based on financial information presented for the Company as a whole. As a result of this management approach, the Company is organized as a single operating segment. </div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PROPERTY AND EQUIPMENT&#8212;NET </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net consists of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 72%;"/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">91,993</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45,172</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Office furniture</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">68,778</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,069</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvement</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,569</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total property and equipment</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">163,340</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">99,241</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(91,122</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(65,938</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;net</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">72,218</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,303</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense recorded for property and equipment was $25,184 and $18,651, of which $13,019 and $8,512 has been included in cost of sales, for the years ended December&#160;31, 2022 and 2021, respectively. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INTANGIBLE ASSETS&#8212;NET </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets&#8212;net, consist of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 72%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Software</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">241,664</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">226,664</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated amortization</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">92,731</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,593</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets&#8212;net</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">148,933</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">214,071</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-42 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense for the year ended December&#160;31, 2022 and 2021 amounted to $80,138 and $12,593, respectively, and has been included in cost of sales. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ACCRUED PAYROLL AND OTHER EXPENSES </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s accrued payroll and other expenses were as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 72%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued payroll</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">224,168</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">188,529</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued credit card fees</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">235,680</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">172,189</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">82,018</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,128</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total accrued payroll and other expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">541,866</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">510,846</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">COMMITMENTS AND CONTINGENCIES </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Legal Proceedings</div></div>&#8212;The Company is a defendant in a lawsuit brought by a third party. The third party seeks to rescind a viatical settlement contract regarding a $4&#160;million life insurance policy as the third party contends that the subject transaction documents were inconsistent with Delaware law and therefore the rescission provisions of the transaction documents were not enforceable. The trial is expected to begin in April 2023. The Company believes it has acted properly and in accordance with applicable state law and regulations. Legal counsel feels that a favorable outcome is likely for the Company; therefore, no liability has been accrued on the accompanying balance sheets. Although the Company believes there is no merit to this case, there is a five (5)&#160;million-dollar errors and omissions insurance policy in place with a $50,000 deductible per occurrence, which would limit any exposure to the Company. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Letter of credit</div></div>&#8212;The Company entered into a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-year</div> letter of credit agreement in August 2022 to support bonding requirements associated with state insurance licenses and provide the Company the ability to borrow up to $1,012,500 related to state penal bonds. The letter of credit has variable interest based on Wall Street Journal Prime rates, beginning at 6.5%. Interest is only due on the outstanding principal amount. The Company did not draw on the letter of credit during 2022, as such $0 was outstanding as of December&#160;31, 2022. The Company incurred $23,450 of financing fees associated with establishing the letter of credit, which have been capitalized in other current assets and amortized over the stated term. </div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">REVENUE </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Remaining performance obligation</div></div>&#8212;The Company is recognizing revenue at a point in time when the closing has occurred and any right of rescission under applicable state law has expired. As of December&#160;31, 2022 and 2021, there are $322,150 and $1,678,791 in revenues allocated to performance obligations to be satisfied, of which all are expected to be recognized as revenue in the following year when the right of rescission has expired. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Disaggregated Revenue</div></div>&#8212;The following table presents a disaggregation of the Company&#8217;s revenue by major sources for the years ended December&#160;31, 2022 and 2021: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 64%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Agent</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,156,552</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,668,256</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Broker</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,938,808</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,378,713</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Client direct</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,108,103</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,545,175</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,203,463</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,592,144</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-43 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Contract Balances</div></div>&#8212;The balances of contract liabilities arising from contracts with customers for the years ended December&#160;31, 2022 and 2021 were as follows: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 69%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract liabilities&#8212;beginning of year</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,678,791</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,068,250</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions to Contract Liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">322,150</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,678,791</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recognition of revenue deferred in the prior year</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,678,791</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,068,250</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract liabilities&#8212;end of year</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">322,150</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,678,791</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INCOME TAXES </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Since the Company elected to file as an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-corporation</div> for Federal and State income tax purposes, the Company incurred no Federal or State income taxes. Accordingly, tax expense is attributable to minimum state tax payments that are due regardless of their <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-corporation</div> status and income position. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The components of expense for income taxes for the years ended December&#160;31, 2022 and 2021 are as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State income taxes:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,018</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,200</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expense for income taxes</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,018</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,200</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This expense solely relates to state minimum tax for state taxes that have been paid and settled during the respective years shown above. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">For the years ended December&#160;31, 2022 and 2021, the income tax expense differs from the provision that would result from applying state statutory tax rates to the income before income taxes due to the Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-corporation</div> election. A reconciliation of the statutory federal income tax rate to the Company&#8217;s effective tax rate is as follows: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax at federal statutory rate</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State taxes, net of federal benefit</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.12</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">U.S. income attributable to pass-through entity</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Effective income tax rate</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(4.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">)%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.12</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not have any unrecognized tax benefits relating to uncertain tax positions at December&#160;31, 2022 and 2021 and did not recognize any interest or penalties related to uncertain tax position at December&#160;31, 2022 and 2021. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Given the company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-Corporation</div> status, temporary book and tax differences do not create a deferred tax asset or liability on the balance sheets. Accordingly, an assessment of realizability of any deferred tax asset balances is not relevant. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March&#160;27, 2020, the CARES Act was enacted. The CARES Act includes provisions, among others, addressing the carryback of net operating losses for specific periods, refunds of alternative minimum tax credits, temporary modifications to the limitations placed on the tax deductibility of net interest expenses, and technical amendments for qualified improvement property. Additionally, the CARES Act provides for various payroll incentives, including PPP loans, refundable employee retention tax credits, and the deferral of the employer-paid portion of social security payroll taxes. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-44 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RETIREMENT PLAN </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company had a 401(k)&#160;Safe Harbor and Discretionary Profit-Sharing Plan (the Plan) with a service provider until May&#160;30, 2021, at which time the Company switched to Paychex&#8217;s Retirement Services 401(k)&#160;Profit Sharing Plan. All eligible employees are able to participate in voluntary salary reduction contributions to the Profit-Sharing Plan. All employees who have completed one year of service with the Company are eligible to receive employer matching contributions. The Company may match contributions to the Profit-Sharing Plan, up to 4% of compensation. For the years ended December&#160;31, 2022 and 2021, the Company made a discretionary contribution of $0 and $100,000 to the Profit Sharing Plan, respectively. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">MEMBERS&#8217; EQUITY </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is authorized to issue up to 400 units of par value common units. Holders of the Company&#8217;s common units are entitled to one vote for each share. At December&#160;31, 2022 and 2021, there were 400 shares of common units issued and outstanding. Holders of the common units were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets available for distribution to the unit holders after payment of all liabilities. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RELATED PARTY TRANSACTIONS </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Due from members and affiliates includes $1,448 and $16,536 of short-term advances to affiliates with no stated terms at December&#160;31, 2022 and 2021, respectively. Due to members and affiliates includes $1,411 and $11,857 of distributions owed to members at December&#160;31, 2022 and 2021, respectively. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has a related party relationship with Nova Trading (US), LLC (&#8220;Nova Trading&#8221;), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (&#8220;Nova Holding&#8221; and collectively with Nova Trading, the &#8220;Nova Funds&#8221;) as the owners of the Company jointly own 11% of the Nova Funds. For the years ended December&#160;31, 2022 and December&#160;31, 2021, the Company has originated 333 and 313 policies, respectively, for the Nova Funds with a total value of $87,143,005 and $106,633,792. For its origination services to the Nova Funds, the Company earns origination fees equal to the lesser of (i)&#160;2% of the net death benefit for the policy or (ii)&#160;$20,000 in addition to agent and broker commissions and reimbursements for transaction expenses, where the Company has determined that it is acting as the principal. For the years ended December&#160;31, 2022 and December&#160;31, 2021, revenue earned and contracts originated are as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Origination fee revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,586,922</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,158,458</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Commissions and transaction reimbursement revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,656,885</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,093,512</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,243,806</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,251,970</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">87,143,005</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">106,633,792</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Face value</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">481,648,010</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">459,217,638</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total policies</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">333</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">313</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Average Age</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">78</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company also has two other affiliated investors that it provides origination services for. Total revenue earned related to the other affiliated investors was $2,909,650 and $433,800, respectively of which $2,268,150 and $0 related to LMA, for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively. Total cost of sales were $2,365,650 and $433,800 for the other affiliated investors for the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, at December&#160;31, 2022 and 2021, there were $175,194 and $590,371, respectively, in expense reimbursements due from the Nova funds, which are included as related party receivables in the accompanying balance sheets. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-45 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">13.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">For the years ended December&#160;31, 2022 and December&#160;31, 2021, respectively, supplemental cash flow information and supplemental disclosure of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> investing and financing activity consists of the following: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 75%;"/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 8%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Supplemental cash flow information:</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash paid for income taxes</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,200</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Supplemental disclosure of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> investing and financing activity:</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions owed to the members</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,411</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,857</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LEASES </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s ROU assets and lease liabilities for its operating leases consisted of the following amounts as of December&#160;31, 2022 and 2021: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 72%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">300,866</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">367,508</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liability, current</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">214,691</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">135,321</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liability, noncurrent</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">87,806</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">232,187</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">302,497</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">367,508</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes lease expense for its operating leases within general and administrative expenses on the Company&#8217;s statements of operations and comprehensive (loss) income. The Company&#8217;s lease expense for the periods presented consisted of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 72%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended December&#160;31,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">190,183</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">126,178</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Variable lease cost</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,403</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,756</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">199,586</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">136,935</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows supplemental cash flow information related to lease activities for the periods presented: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 74%;"/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year&#160;Ended&#160;December&#160;31,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash paid for amounts included in the measurement of the lease liability</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">201,478</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">126,178</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ROU assets obtained in exchange for new lease liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">123,541</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">417,076</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below shows a weighted-average analysis for lease term and discount rate for all operating leases as of December&#160;31, 2022 and 2021: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 79%;"/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 6%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;December&#160;31,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average remaining lease term (in years)</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.41</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.58</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average discount rate</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.71</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.36</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-46 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future minimum noncancelable lease payments under the Company&#8217;s operating leases on an undiscounted basis reconciled to the respective lease liability at December&#160;31, 2022 are as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 76%;"/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Operating&#160;Leases</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">221,182</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">88,543</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#8194;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease payments (undiscounted)</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">309,726</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Imputed interest</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,229</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liability as of December&#160;31, 2022</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">302,497</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">15.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SUBSEQUENT EVENTS </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has evaluated its subsequent events through February&#160;17, 2023, the date that the financial statements were available to be issued. </div></div><div id="fin423260_100" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">*&#8201;*&#8201;*&#8201;*&#8201;*&#8201;* </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-47 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 30pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 30pt; letter-spacing: 0px; top: 0px;;display:inline;">Abacus Settlements, LLC d/b/a Abacus Life </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Condensed Financial Statements as of June 30, 2023 and December&#160;31, 2022 and for the Six Months Ended June 30, 2023, and 2022 </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-48 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ABACUS SETTLEMENTS, LLC D/B/A ABACUS LIFE </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">TABLE OF CONTENTS </div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 90%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Page</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_31">Condensed Consolidated Balance Sheets</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-50</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_32">Condensed Consolidated Statements of Operations and Comprehensive Income</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-51</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_33">Condensed Consolidated Statements of Shareholders&#8217; Equity</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-52</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_34">Condensed Consolidated Statements of Cash Flows</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-54</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_35">Notes to Unaudited Condensed Consolidated Financial Statements</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-55-F-82</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial Statements of Abacus Settlements LLC (as predecessor) (Unaudited)</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_36">Condensed Consolidated Balance Sheets</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_37">Condensed Consolidated Statements of Operations and Comprehensive Income</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-83</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_38">Condensed Consolidated Statements of Shareholders&#8217; Equity</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-84</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_39">Condensed Consolidated Statements of Cash Flows</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-86</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin423260_40">Notes to Unaudited Condensed Consolidated Financial Statements</a></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">F-87</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-49 </div></div></div></div><div style="margin-bottom: 0px; margin-top: 0px;"></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="-sec-ix-redline:true;;display:inline;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></div> <div id="fin423260_7" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">ABACUS LIFE, INC. </div></div> <div id="fin423260_31" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CONDENSED CONSOLIDATED BALANCE SHEETS </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">AS OF JUNE 30, 2023 AND DECEMBER 31, 2022 </div></div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(unaudited)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(unaudited)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">ASSETS</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">CURRENT ASSETS:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and cash equivalents</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,611,122</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">30,052,823</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">192,595</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,448</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party receivable</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">78,310</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn12_31_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">198,364</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Due from affiliates</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,473,748</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,904,646</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Other receivables</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">21,252</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses and other current assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">829,595</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">116,646</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total current assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">32,206,622</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">33,282,927</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment, net</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">177,931</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">18,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets, net</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">32,900,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">140,287,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">240,816</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">77,011</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies, at cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,889,610</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,716,111</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies, at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,685,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,809,352</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Available for sale securities, at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Other investments<div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,600,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,300,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Due from members and affiliates</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">75,582</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">State security deposit</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:StateSecurityDepositsNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">206,873</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="abl:StateSecurityDepositsNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Certificate of deposit</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:CertificatesOfDepositNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">262,500</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="abl:CertificatesOfDepositNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets, at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,801,886</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">890,829</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">TOTAL ASSETS</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">277,334,437</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">59,094,847</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">CURRENT LIABILITIES:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued expenses</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">524,400</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts payable</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">401,500</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">40,014</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities&#8212;current portion</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">227,561</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">48,127</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Due to members and affiliates</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,415,154</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">263,785</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Due to owners</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn06_30_2023_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">717,429</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn12_31_2022_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Contract liabilities&#8212;deposits on pending settlements</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">981,217</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued transaction costs</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:AccruedTransactionCostsCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">182,571</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:AccruedTransactionCostsCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">908,256</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Other current liabilities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">258,759</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">42,227</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Income taxes payable</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">185,831</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total current liabilities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,894,422</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,302,409</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV purchase and sale note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:SecuredLongTermDebt" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:SecuredLongTermDebt" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt, at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLongTermDebtNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">66,165,396</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherLongTermDebtNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,249,653</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liabilities&#8212;noncurrent portion</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">16,864</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">29,268</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax liability</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,320,240</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,363,820</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liability</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:WarrantLiabilitiesNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,438,600</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="abl:WarrantLiabilitiesNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">TOTAL LIABILITIES</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">116,835,522</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">30,945,150</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">COMMITMENTS AND CONTINGENCIES (11)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">SHAREHOLDERS&#8217; EQUITY (DEFICIT)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Class&#160;A common stock, $</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction> p<div style="letter-spacing: 0px; top: 0px;;display:inline;">a</div>r value; </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">200,000,000</ix:nonFraction></ix:nonFraction> authorized shares; </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">62,961,688</ix:nonFraction></ix:nonFraction> and </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">50,369,350</ix:nonFraction></ix:nonFraction></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"> shares issued and outstanding at June&#160;30, 2023 and December&#160;31, 2022, respectively</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,296</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,037</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">188,641,886</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">704,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Retained earnings/(accumulated deficit)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">29,382,362</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,487,323</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Accumulated other comprehensive income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">877,306</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,052,836</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-controlling</div> interest</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">355,789</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">899,538</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total shareholders&#8217; equity (deficit)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">160,498,915</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,149,697</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">277,334,437</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">59,094,847</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying notes are an integral part of these interim condensed consolidated financial statements. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">50</div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="-sec-ix-redline:true;;display:inline;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div></div> <div id="fin423260_8" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">ABACUS LIFE, INC. </div></div> <div id="fin423260_32" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FOR THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022 </div></div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; background: none; text-decoration: none;;-sec-ix-redline:true;;display:inline;"> </div></div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 58%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">REVENUES:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio servicing revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party servicing revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">329,629</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">419,253</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">543,076</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">620,159</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio Servicing revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">24,737</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">169</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">46,981</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">370,169</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total portfolio servicing revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">354,366</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">419,422</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">590,057</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">990,328</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Active management revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment Income from life insurance policies held using investment method</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceInvestmentIncome" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,263,499</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceInvestmentIncome" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,965,466</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceInvestmentIncome" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">16,655,833</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceInvestmentIncome" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,980,466</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of life insurance policies (policies held using fair value method)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodGainLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,760,900</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodGainLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,014,013</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodGainLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,339,084</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodGainLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,305,505</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total active management revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceServicesRevenue" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,024,399</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceServicesRevenue" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,979,479</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceServicesRevenue" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,994,917</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InsuranceServicesRevenue" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">17,285,971</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenues</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,378,765</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,398,901</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">21,584,974</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">18,276,299</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">COST OF REVENUES (excluding depreciation stated below)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Cost of revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">973,400</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">666,119</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,462,950</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,086,075</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total cost of revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">973,400</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">666,119</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,462,950</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,086,075</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Gross Profit</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,405,365</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,732,782</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,122,024</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">16,190,224</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">OPERATING EXPENSES:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">683,841</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,019,498</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,412,845</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,649,498</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">General and administrative expenses</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">577,539</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,499</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,274,431</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">646,705</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss on change in fair value of debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,445,229</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">333,879</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,398,662</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">375,513</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized loss (gain) on investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">672,936</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,039,022</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">798,156</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,054,975</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,098</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,098</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating expenses</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,034,771</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,398,996</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,289,923</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,728,832</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,370,594</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,333,786</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">15,832,101</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,461,392</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">OTHER INCOME (EXPENSE)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest (expense)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">584,075</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">941,458</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,457</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 7%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Other income (expense)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">121,601</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">127,455</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">21,651</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">242,247</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total other income (expense)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">462,474</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">127,455</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">955,652</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">242,247</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income before provision for income taxes</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,908,120</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,206,331</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,876,449</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,219,145</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Provision for income taxes</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,184,571</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">120,132</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">528,104</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">296,806</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">NET INCOME</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,723,549</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,086,199</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,348,345</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,922,339</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">26,596</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">406,641</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">487,303</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">406,641</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">NET INCOME ATTRIBUTABLE TO SHAREHOLDERS</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,750,145</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,679,558</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,835,648</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,515,698</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">EARNINGS PER SHARE:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:7.5px">(1)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91071780"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072953">50,507,728</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072958"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072952">50,369,350</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072957"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072951">50,438,921</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072956"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072950">50,369,350</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per share</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.13</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.09</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.29</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.23</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">NET INCOME</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,723,549</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,086,199</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,348,345</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,922,339</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive income, net of tax:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">119,663</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,017,559</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">231,976</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,017,559</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,603,886</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,103,758</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,116,369</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,939,898</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Comprehensive income (loss) attributable to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">56,111</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,011,909</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">543,749</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,011,909</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive income attributable to Abacus Life Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,659,997</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,091,849</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,660,118</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,927,989</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of Business Combination. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying notes are an integral part of these interim condensed consolidated financial statements. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">51</div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div id="fin423260_9" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">ABACUS LIFE, INC. </div></div> <div id="fin423260_33" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FOR THE THREE MONTHS ENDED JUNE 30, 2023 AND 2022 </div></div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 28%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A&#160;Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-In</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Retained<br/>Earnings</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Non-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Controlling</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shareholders&#8217;</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF MARCH&#160;31,&#160;2022<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_91072998">50,369,350</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072982">5,037</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072983">704,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072984">4,951,188</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="Fact_91072917">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="Fact_91072985">148,155</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072986">5,513,033</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">310,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">310,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Comprehensive Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,412,291</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P04_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">605,268</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,017,559</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,679,558</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">406,641</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,086,199</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF JUNE&#160;30, 2022<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">50,369,350</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,037</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">704,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,320,746</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,412,291</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">863,754</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,306,791</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td colspan="8" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-In</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Deficit</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Non-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Controlling</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shareholders&#8217;</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF MARCH&#160;31,&#160;2023<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_91072996">50,369,350</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072975">5,037</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072974">704,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072995">33,572,826</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072994">967,454</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072993">411,900</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn03_31_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072992">35,662,180</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">34,451,607</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">34,451,607</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred transaction costs</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockholdersEquityDeferredTransactionCosts" contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,841,551</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockholdersEquityDeferredTransactionCosts" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,841,551</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public warrants</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,726,500</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">3,765,600</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">960,900</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger with East Resources Acquisition Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:StockIssuedDuringPeriodSharesReverseRecapitalization" contextRef="P04_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">12,592,338</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P04_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,259</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">17,849,091</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">20,646,575</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,796,225</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Acquisition of Abacus Settlements, LLC</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">165,361,332</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">165,361,332</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Comprehensive Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">90,148</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P04_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">29,515</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">119,663</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,750,145</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">26,596</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,723,549</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF JUNE&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">62,961,688</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,296</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">188,641,886</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">29,382,362</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">877,306</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">355,789</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">160,498,915</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of the successful Business Combination. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 120pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying notes are an integral part of these interim condensed consolidated financial statements. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">52</div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ABACUS LIFE, INC. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FOR THE <div style="letter-spacing: 0px; top: 0px;;display:inline;">SIX</div> MONTHS ENDED JUNE 30, 2023 AND 2022 </div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 28%;"/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 1%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-In</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Retained<br/>Earnings</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Non-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Controlling</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shareholders&#8217;</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF DECEMBER&#160;31, 2021<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_91072999">50,369,350</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072991">5,037</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072990">704,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072989">205,048</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero" id="Fact_91072918">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2021_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal" id="Fact_91072988">148,155</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072987">766,893</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P01_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,400,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,400,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other comprehensive income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P01_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,412,291</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P01_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">605,268</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,017,559</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,515,698</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">406,641</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,922,339</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF JUNE&#160;30, 2022<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_91071827">50,369,350</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91071834">5,037</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91071835">704,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91071836">9,320,746</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91071837">1,412,291</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91071838">863,754</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91071839">12,306,791</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="8" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td colspan="4" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A Common<br/>Stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-In</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Deficit</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Comprehensive</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Loss</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Non-</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Controlling</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shareholders&#8217;</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF DECEMBER&#160;31, 2022&#160;<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_91072997">50,369,350</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072981">5,037</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072980">704,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072979">25,487,323</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072978">1,052,836</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072977">899,538</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="Fact_91072976">28,149,697</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">34,451,607</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Dividends" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">34,451,607</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred transaction costs</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockholdersEquityDeferredTransactionCosts" contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,841,551</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockholdersEquityDeferredTransactionCosts" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,841,551</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public warrants</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,726,500</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">3,765,600</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">960,900</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger with East Resources Acquisition Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:StockIssuedDuringPeriodSharesReverseRecapitalization" contextRef="P01_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">12,592,338</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P01_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,259</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">17,849,091</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">20,646,575</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:StockIssuedDuringPeriodValueReverseRecapitalization" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,796,225</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Acquisition of Abacus Settlements, LLC</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">165,361,332</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">165,361,332</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Comprehensive Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P01_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">175,530</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P01_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">56,446</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">231,976</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,835,648</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">487,303</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,348,345</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BALANCE AS OF JUNE&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">62,961,688</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,296</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">188,641,886</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">29,382,362</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">877,306</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">355,789</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">160,498,915</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of the successful Business Combination. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 72pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying notes are an integral part of these interim condensed consolidated financial statements. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">53</div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div id="fin423260_10" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">ABACUS LIFE, INC. </div></div> <div id="fin423260_34" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND 2022 </div></div></div></div> <div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 76%;"/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 2%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH FLOWS FROM OPERATING ACTIVITIES:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,348,345</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,922,339</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized (gain) loss on investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">798,156</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,054,975</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain on policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodUnrealizedGainLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,319,588</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodUnrealizedGainLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,305,505</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss on change in fair value of debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,398,662</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">375,513</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred income taxes</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">252,659</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">999,927</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-cash</div> lease expense</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">384</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in operating assets and liabilities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P01_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">182,147</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P01_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Related party receivable</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P01_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">125,764</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="P01_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">77,657</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prepaid expenses and other current assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">193,462</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,379,579</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other noncurrent assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">105,655</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accounts payable</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">361,486</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued transaction costs</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">725,685</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other current liabilities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">402,363</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">72,938</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life Settlement Policies purchased, at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:LifeSettlementContractPurchasedFairValueMethod" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">39,556,677</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:LifeSettlementContractPurchasedFairValueMethod" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,211,509</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life Settlement Policies purchased, at cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:LifeSettlementContractPurchasedInvestmentMethod" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,374,605</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:LifeSettlementContractPurchasedInvestmentMethod" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,204,753</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net cash used in operating activities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">38,364,171</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">4,751,170</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH FLOWS FROM INVESTING ACTIVITIES:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">300,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Due from affiliates</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:ProceedsDueFromPaymentsDueToAffiliates" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">6,760,627</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="abl:ProceedsDueFromPaymentsDueToAffiliates" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net cash used in investing activities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">7,060,627</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">250,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH FLOWS FROM FINANCING ACTIVITIES:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of debt certificates</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">35,206,351</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,463,779</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transaction costs</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,841,551</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Capital distribution to members</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsOfDistributionsToAffiliates" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">23,533,072</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsOfDistributionsToAffiliates" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,400,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds from receipt of SPV purchase and sale note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Due to members and affiliates</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,151,369</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">680,375</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net cash provided by financing activities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">35,983,097</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,744,154</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">9,441,701</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,742,984</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">30,052,823</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">102,421</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,611,122</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,845,405</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 48pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying notes are an integral part of these interim condensed consolidated financial statements. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">54</div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div id="fin423260_11" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">ABACUS LIFE, INC. </div></div><div id="fin423260_35" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </div></div></div></div><div style="line-height: 3pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><ix:nonNumeric name="us-gaap:NatureOfOperations" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">DESCRIPTION OF BUSINESS </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Organization and Merger </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Abacus Life, Inc. (&#8220;the Company&#8221;) was formerly known as East Resources Acquisition Company (&#8220;ERES&#8221;), a blank check company incorporated in Delaware on May&#160;22, 2020. Abacus Life, Inc. conducts its business through its wholly-owned, consolidated subsidiaries, primarily Abacus Settlements LLC (&#8220;Abacus&#8221;) and Longevity Market Assets,&#160;LLC (&#8220;LMA&#8221;), which are incorporated in the state of Delaware (collectively, the &#8220;Companies&#8221;). On June&#160;30, 2023, (the &#8220;Closing Date&#8221;), ERES, Longevity Market Assets, LLC and Abacus Settlements, LLC consummated the combining of the Companies as contemplated by the Merger Agreement dated as of August&#160;30, 2022 (as amended on October&#160;14, 2022 and April&#160;20, 2023) with LMA Merger Sub, LLC, a wholly owned subsidiary of ERES (&#8220;LMA Merger Sub&#8221;), Abacus Merger Sub, LLC, a wholly owned subsidiary of ERES (&#8220;Abacus Merger Sub&#8221;), LMA&#160;and Abacus Settlements, LLC (&#8220;Legacy Abacus&#8221; and, together with LMA, the &#8220;Legacy Companies&#8221;). Pursuant to the Merger Agreement, on June&#160;30, 2023, (i) LMA Merger Sub merged with and into LMA, with LMA surviving such merger (the &#8220;LMA Merger&#8221;) and (ii)&#160;Abacus Merger Sub merged with and into Legacy Abacus, with Legacy Abacus surviving such merger (the &#8220;Abacus Merger&#8221; and, together with the LMA Merger, the &#8220;Mergers&#8221; and, along with the other transactions contemplated by the Merger Agreement, the &#8220;Business Combination&#8221;) and the Legacy Companies became direct wholly owned subsidiaries of Abacus and ERES changed its name to Abacus Life, Inc. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The condensed consolidated assets, liabilities and statements of operations and comprehensive income prior to the Business Combination are those of legacy LMA. The stocks and corresponding capital amounts and income per stock, prior to the Business Combination, have been retroactively restated based on stocks reflecting the exchange ratio established in the Business Combination. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company&#8217;s common stock, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn06_30_2023" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> par value per share, issued to legacy LMA&#8217;s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of <ix:nonFraction name="abl:BusinessAcquisitionExchangeRatio" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.8</ix:nonFraction> established in the Business Combination. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Business Activity </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company, through its LMA subsidiary, is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life settlement assets, as well as consulting, valuation, and actuarial services. The Company is also engaged in buying and selling of life settlement policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout or to sell to another purchaser of life settlement contracts for a gain on the sale. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company, through its Abacus subsidiary, also is an originator of outstanding life insurance policies as a licensed life settlement provider on behalf of investors (&#8220;Financing Entities&#8221;). Abacus locates and screens policies for eligibility as a commercially desirable life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known, collectively, as origination services. When the sale of a policy is completed, this is deemed &#8220;settled&#8221; and the policy is then referred to as either a &#8220;life settlement&#8221; in which the insured&#8217;s life expectancy is greater than two years or &#8220;viatical settlement,&#8221; in which the insured&#8217;s life expectancy is less than two years. The Company is not an insurance company, and therefore the Company does not underwrite insurable risks for its own account. </div></div></ix:nonNumeric> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">55</div></div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072705">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation</div></div>&#8212;In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). Under U.S. GAAP, ERES has been treated as the &#8220;acquired&#8221; company for financial reporting purposes. This determination was primarily based on the LMA shareholders having a relative majority of the voting power of the Company, the LMA shareholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the &#8220;acquirer&#8221; for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Abacus Merger will be accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will be recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, will be recognized as goodwill. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In considering the foregoing principles of predecessor determination and in light of the Company&#8217;s specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. </div></div></ix:nonNumeric><ix:nonNumeric name="us-gaap:ConsolidationPolicyTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unaudited Condensed Consolidated Financial Statements</div></div>&#8212;The condensed consolidated financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2023, and the condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023 and 2022, respectively, and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022, respectively. The condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for Abacus for the year ended December&#160;31, 2022, and the financial statements and notes for LMA for the year ended December&#160;31, 2022. All references to financial information as of and for the periods ended June&#160;30, 2023, and 2022 in the notes to condensed consolidated financial statements are unaudited. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Refer to this note in the LMA annual financial statements for the full list of the Company&#8217;s significant accounting policies. The details in those notes have not changed, except as discussed below and as a result of normal adjustments in the interim periods. </div></div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:ConsolidationVariableInterestEntityPolicy" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072706"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Consolidation of Variable Interest Entities</div></div>&#8212;For entities in which the Company has variable interests, the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Company </div>first evaluates whether the entity meets the definition of a variable interest entity (&#8220;VIE&#8221;) or a </div><ix:exclude> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">56</div></div></div></ix:exclude></ix:nonNumeric></ix:nonNumeric></div></div><ix:continuation id="TextSelection_91072706" continuedAt="TextSelectionAppend_91072706_1"><ix:continuation id="TextSelection_91072705" continuedAt="TextSelectionAppend_91072705_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_1" continuedAt="TextSelectionAppend_91072705_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_2" continuedAt="TextSelectionAppend_91072705_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072706_1" continuedAt="TextSelectionAppend_91072706_2"><ix:continuation id="TextSelectionAppend_91072705_3" continuedAt="TextSelectionAppend_91072705_4"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">voting interest entity (&#8220;VOE&#8221;). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company&#8217;s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;810, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidations</div></div>, requires the Company to separately disclose on its condensed consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of June&#160;30, 2023, total assets and liabilities of consolidated VIEs were $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">57,577,034</ix:nonFraction> and $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">52,474,820</ix:nonFraction>, respectively. As of December&#160;31, 2022, total assets and liabilities of consolidated VIEs were $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">30,073,972</ix:nonFraction> and $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">27,116,762</ix:nonFraction>, respectively. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January&#160;1, 2021, the Company entered into an option agreement with <ix:nonFraction name="abl:NumberOfProvidersInvolvedInOptionAgreement" contextRef="PAsOn01_01_2021" unitRef="Unit_provider" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> commonly owned full-service origination, servicing, and investment providers (the &#8220;Providers&#8221;), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the &#8220;Option Agreement&#8221;). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321. In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815 and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the share price has no readily determinable fair value. The Company&#8217;s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provided $<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P04_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction> and $<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P04_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">127,455</ix:nonFraction> of funding for the three months ended June&#160;30, 2023 and June&#160;30, 2022, respectively and provided $<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P01_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">29,721</ix:nonFraction> and $<ix:nonFraction name="us-gaap:InterestExpense" contextRef="P01_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">242,247</ix:nonFraction> of funding for the six months ended June&#160;30, 2023 and June&#160;30, 2022, respectively which is included in other (expense) income on the condensed consolidated statements of operations and comprehensive income. See Note 11, Commitments and Contingencies. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the period ended June&#160;30, 2023, and for the year ended December&#160;31, 2022, the Providers were considered to be VIEs, but were not consolidated in the Company&#8217;s condensed consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of June&#160;30, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">318,178</ix:nonFraction> and liabilities of $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn06_30_2023_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">450</ix:nonFraction> and held assets of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">483,167</ix:nonFraction> and liabilities of $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn06_30_2023_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">184,621</ix:nonFraction>, respectively. As of December&#160;31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">126,040</ix:nonFraction> and liabilities of $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction> and held assets of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">861,924</ix:nonFraction> and liabilities of $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">358,586</ix:nonFraction>, respectively. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October&#160;4, 2021, the Company entered into an operating agreement with LMX Series,&#160;LLC (&#8220;LMX&#8221;) and <ix:nonFraction name="abl:NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" contextRef="PAsOn10_04_2021" unitRef="Unit_investor" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction> other unaffiliated investors to obtain a <ix:nonFraction name="us-gaap:VariableInterestEntityOwnershipPercentage" contextRef="P10_04_2021To10_04_2021_LMXSeriesLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">70</ix:nonFraction>% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series&#160;2024,&#160;Inc., a Delaware C corporation. While the Company and <ix:nonFraction name="abl:NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" contextRef="PAsOn10_04_2021" unitRef="Unit_investor" decimals="INF" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction> other investors each contributed $<ix:nonFraction name="us-gaap:VariableInterestEntityFinancialOrOtherSupportAmount" contextRef="P10_04_2021To10_04_2021_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">100</ix:nonFraction> to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a <ix:nonFraction name="us-gaap:VariableInterestEntityOwnershipPercentage" contextRef="P10_04_2021To10_04_2021_LMXSeriesLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">70</ix:nonFraction>% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its condensed consolidated financial statements for the period ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March&#160;3, 2022, the Company obtained an <ix:nonFraction name="us-gaap:VariableInterestEntityOwnershipPercentage" contextRef="P03_03_2022To03_03_2022_LongevityMarketAdvisorsLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">80</ix:nonFraction>% ownership interest in Longevity Market Advisors,&#160;LLC (&#8220;Longevity Market Advisors&#8221;). The Longevity Market Advisors legal entity was established primarily for </div></div><ix:exclude> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">57</div></div></div></ix:exclude></ix:continuation></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_91072706_2" continuedAt="TextSelectionAppend_91072706_3"><ix:continuation id="TextSelectionAppend_91072705_4" continuedAt="TextSelectionAppend_91072705_5"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_5" continuedAt="TextSelectionAppend_91072705_6"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_6" continuedAt="TextSelectionAppend_91072705_7"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072705_7" continuedAt="TextSelectionAppend_91072705_8"><ix:continuation id="TextSelectionAppend_91072706_3"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the purpose of acquiring the assets of a broker/dealer, Regional Investment Services,&#160;Inc. (&#8220;RIS&#8221;), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price payable in exchange for RIS was $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="P03_03_2022To03_03_2022_RegionalInvestmentServicesIncMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">60,000</ix:nonFraction>. The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of the RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being registered by the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;). As there are no tangible or intangible assets of value from the RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="PAsOn06_30_2023_LongevityMarketAdvisorsLLCMemberdeiLegalEntityAxis_RegionalInvestmentServicesIncMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of Longevity Market Advisors in its condensed consolidated financial statements for the period ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November&#160;30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January&#160;31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. </div></div></ix:continuation><ix:nonNumeric name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Noncontrolling Interest</div></div>&#8212;Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the condensed consolidated balance sheets at an amount equal to the noncontrolling interest&#8217;s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholder&#8217;s additional contributions, distributions, and the shareholder&#8217;s share of the net earnings or losses of each respective consolidated entity. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholder&#8217;s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the condensed consolidated statements of operations and comprehensive income. </div></div></ix:nonNumeric><ix:nonNumeric name="us-gaap:UseOfEstimates" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div>&#8212;The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reports amounts of revenue and expenses during the reporting periods. Company&#8217;s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:LifeSettlementContractsPolicy" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072703"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life Insurance Settlement Policies</div></div>&#8212;The Company accounts for its holdings of life insurance settlement policies in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;325-30,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments in Insurance Contracts</div></div>. The Company accounts for life settlement policies purchased that we intend to hold to maturity at fair value and life settlement policies that we intend to trade in the near term at cost plus premiums paid. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">58</div></ix:exclude></div></div></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_91072703" continuedAt="TextSelectionAppend_91072703_1"><ix:continuation id="TextSelectionAppend_91072705_8" continuedAt="TextSelectionAppend_91072705_9"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_9" continuedAt="TextSelectionAppend_91072705_10"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_10" continuedAt="TextSelectionAppend_91072705_11"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072705_11" continuedAt="TextSelectionAppend_91072705_12"><ix:continuation id="TextSelectionAppend_91072703_1"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">The Company follows ASC&#160;820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements and Disclosures</div></div>, in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level&#160;1 relates to quoted prices in active markets for identical assets or liabilities. Level&#160;2 relates to observable inputs other than quoted prices included in Level&#160;1.&#160;Level&#160;3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company&#8217;s valuation of life settlements is considered to be Level&#160;3, as there is currently no active market where we are able to observe quoted prices for identical assets. The Company&#8217;s valuation model incorporates significant inputs that are not observable. See Note&#160;10, &#8220;Fair Value Measurements.&#8221; For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that include medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the condensed consolidated statements of cash flows. </div></div></ix:continuation><ix:nonNumeric name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost of Revenues</div></div>&#8212;Cost of revenue represents the direct costs associated with fulfilling the Company&#8217;s obligations to its customers, primarily policy servicing and consulting expense. </div></ix:nonNumeric><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071794"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes</div></div>&#8212;The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, the provision for income taxes represents income taxes paid or payable (or received or receivable) for the current year plus the change in deferred taxes during the year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid, and result from differences between the financial and tax bases of the Company&#8217;s assets and liabilities and are adjusted for changes in tax rates and tax laws when enacted. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not (greater than 50%) that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company&#8217;s experience with similar operations. Existing favorable contracts are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow for the utilization of a deferred tax asset based on existing projections of income. Deferred tax assets for which no valuation allowance is recorded may not be realized upon changes in facts and circumstances, resulting in a future charge to establish a valuation allowance. Existing valuation allowances are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-examined</div> under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">59</div></ix:exclude></div></div></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_91071794" continuedAt="TextSelectionAppend_91071794_1"><ix:continuation id="TextSelectionAppend_91072705_12" continuedAt="TextSelectionAppend_91072705_13"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_13" continuedAt="TextSelectionAppend_91072705_14"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_14" continuedAt="TextSelectionAppend_91072705_15"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072705_15" continuedAt="TextSelectionAppend_91072705_16"><ix:continuation id="TextSelectionAppend_91071794_1"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets and liabilities are also remeasured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the statute of limitations has expired or the appropriate taxing authority has completed their examination even though the statute of limitations remains open. Interest and penalties related to uncertain tax positions are recognized as part of the provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized. </div></div></ix:continuation><ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations</div></div>&#8212;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying condensed consolidated balance sheets. The Company extends different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company&#8217;s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer&#8217;s financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of accounts. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Two related party customers accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">12</ix:nonFraction>% and <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">13</ix:nonFraction>% of the total balance of accounts receivable and related party receivables as of June&#160;30, 2023, and two related party customers accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">75</ix:nonFraction>% and <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">16</ix:nonFraction>% of the total accounts receivable as of December&#160;31, 2022, respectively. The largest receivables balances are from related parties where exposed credit risk is low. As such, there is <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> allowance for doubtful accounts as of June&#160;30, 2023, and December&#160;31, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">27</ix:nonFraction>% of active management revenue for the three months ended June&#160;30, 2023. Two related party customers each accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P04_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% and <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P04_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% of the portfolio servicing revenue for the three months ended June&#160;30, 2023. One customer accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P04_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">26</ix:nonFraction>% of the total revenues for the three months ended June&#160;30, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">29</ix:nonFraction>% of active management revenue, while <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_InvestmentMethodRevenueBenchmarkMemberusgaapConcentrationRiskByBenchmarkAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">16</ix:nonFraction>% of revenue related to 2 policies that matured that were accounted for under the investment method and 1 policy that matured that was accounted for under the fair-value method for the six months ended June&#160;30, 2023. Two related party customers each accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">25</ix:nonFraction>% and <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">27</ix:nonFraction>% of the portfolio servicing revenue for the six months ended June&#160;30, 2023. One customer accounted for <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">71</ix:nonFraction>% of the total revenues for the six months ended June&#160;30, 2022. </div></div></ix:nonNumeric><ix:nonNumeric name="abl:WarrantsPolicyTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071792"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div>&#8212;The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 480 <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div> (&#8220;ASC&#160;480&#8221;) and ASC 815, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging</div></div> (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock and whether the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants </div></div><ix:exclude> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">60</div></div></div></ix:exclude></ix:nonNumeric></ix:continuation></div></div><ix:continuation id="TextSelection_91071792" continuedAt="TextSelectionAppend_91071792_1"><ix:continuation id="TextSelectionAppend_91072705_16" continuedAt="TextSelectionAppend_91072705_17"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_17" continuedAt="TextSelectionAppend_91072705_18"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072705_18" continuedAt="TextSelectionAppend_91072705_19"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91071792_1"><ix:continuation id="TextSelectionAppend_91072705_19"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the condensed consolidated statements of operations and comprehensive income. </div></ix:continuation><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"></div></ix:continuation> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></div><ix:nonNumeric name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071799">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BUSINESS COMBINATION </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger consideration conveyed of $<ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">531.8</ix:nonFraction>&#160;million was allocated <div style="letter-spacing: 0px; top: 0px;;display:inline;">between </div>the Companies based on relative values derived through both the discounted cash flow method within the income approach and the guideline public company method within the market approach. Within the discounted cash flow method, the present values of cash flows reasonably expected to be produced by the Companies from their operations were summed to produce an estimate of the Companies&#8217; business enterprise values on a controlling, marketable basis. The cash flows used in the discounted cash flow analysis were discounted at the weighted average cost of capital of <ix:nonFraction name="abl:BusinessCombinationMeasurementInput" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">14.5</ix:nonFraction>% for LMA and <ix:nonFraction name="abl:BusinessCombinationMeasurementInput" contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">16.5</ix:nonFraction>% for Abacus. The discounted cash flow method resulted in a business enterprise value range of $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">380.0</ix:nonFraction>&#160;million to $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">460.0</ix:nonFraction>&#160;million for LMA and $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">180.0</ix:nonFraction>&#160;million to $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">195.0</ix:nonFraction>&#160;million for Abacus. Within the market approach, Company applied the guideline public company method, which employs market multiples derived from market prices of stocks of Companies that are engaged in the same or similar lines of business as the Companies and that are actively traded on a free and open market. The guideline public company method resulted in a business enterprise value range of $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">400.0</ix:nonFraction>&#160;million to $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">440.0</ix:nonFraction>&#160;million for LMA and $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">180.0</ix:nonFraction>&#160;million to $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">190.0</ix:nonFraction>&#160;million for Abacus. Management concluded on a business enterprise value of $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">165.4</ix:nonFraction>&#160;million for Abacus and $<ix:nonFraction name="abl:BusinessCombinationEnterpriseValue" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">366.4</ix:nonFraction>&#160;million for LMA based upon the relative fair value of the Companies allocated to the consideration transferred. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The preliminary purchase price was allocated among the identified assets to be acquired. The primary area of the acquisition accounting that is not yet finalized is our estimate of the impact of acquisition accounting on deferred income taxes. An estimate of deferred income taxes has been recorded in the Company&#8217;s books based on information available as of June&#160;30, 2023. As the initial acquisition accounting is based on our preliminary assessments, actual values may differ when final information becomes available. We believe that the information gathered to date provides a reasonable basis for estimating the preliminary values of deferred taxes recorded. We will continue to evaluate this item until it is satisfactorily resolved and adjust our acquisition accounting accordingly, within the allowable measurement period, as defined by ASC 805, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combinations</div></div>. Transaction costs incurred as a result of the Business Combination were recognized within retained earnings/(accumulated deficit) on the condensed consolidated balance sheet ending June&#160;30, 2023. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All valuation procedures related to existing assets as no new assets were identified as a result of procedures performed. Goodwill was recognized as a result of the acquisition, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Assets Identified</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangibles</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">32,900,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">140,287,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current Assets</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,280,100</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Current</div> Assets</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">901,337</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Tax Liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,310,966</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued Expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">524,400</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,171,739</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Fair Value</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">165,361,332</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table></ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div><ix:exclude> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">61</div></div></div></ix:exclude></ix:nonNumeric></div></div><ix:continuation id="TextSelection_91071799" continuedAt="TextSelectionAppend_91071799_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91071799_1" continuedAt="TextSelectionAppend_91071799_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91071799_2" continuedAt="TextSelectionAppend_91071799_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91071799_3"><ix:nonNumeric name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Value Conveyed</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Abacus Purchase Consideration</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="P06_30_2023To06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">165,361,332</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMA Business Enterprise Value</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">366,388,668</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Consideration</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">531,750,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table></ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div><ix:nonNumeric name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets were comprised of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 35%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Type</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Life</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Methodology</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships-Agents</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,600,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P06_30_2023To06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" format="ixt-sec:durwordsen">5 years</ix:nonNumeric></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Multi-period&#160;excess&#160;earnings&#160;method</div></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships-Financing Entities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P06_30_2023To06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" format="ixt-sec:durwordsen">8 years</ix:nonNumeric></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Multi-period excess earnings method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Internally Developed and Used <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Technology-APA</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,600,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P06_30_2023To06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" format="ixt-sec:durwordsen">2 years</ix:nonNumeric></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from royalty method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology-Marketplace</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">100,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:durwordsen">3 years</ix:nonNumeric></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement cost method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trade Name</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">900,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from royalty method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Compete</div> Agreements</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:durwordsen">2 years</ix:nonNumeric></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">With and without method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State Insurance Licenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,700,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement cost method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Fair Value</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">32,900,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr></table></ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Useful lives for customer relationships were developed using attrition data for agents and financing entities which resulted in a useful life of <ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P06_30_2023To06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" format="ixt-sec:durwordsen">5 years</ix:nonNumeric> and <ix:nonNumeric name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextRef="P06_30_2023To06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" format="ixt-sec:durwordsen">8 years</ix:nonNumeric>, respectively. Estimates over the useful lives of internally developed and used technology contemplates the period in which the Company expects to utilize the technology and the length of time the technology is expected to maintain recognition and value in the market without significant <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">investment.Non-compete</div> agreements have a useful life commensurate with the executed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-compete</div> agreements in place as a result of the Business Combination. </div><ix:nonNumeric name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071788"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined as of January&#160;1, 2022. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proforma revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">18,263,455</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="P04_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,090,817</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="P01_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">34,769,650</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="P01_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">31,290,963</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proforma net income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,432,047</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="P04_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,589,315</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="P01_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,373,444</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="P01_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,788,486</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table></ix:nonNumeric></ix:continuation><ix:continuation id="TextSelection_91071788"> </ix:continuation> <div style="clear: both; max-height: 0px;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:LifeSettlementContractsDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071978">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LIFE INSURANCE SETTLEMENT POLICIES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, the Company holds <ix:nonFraction name="abl:LifeSettlementContractsNumberOfContracts" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">167</ix:nonFraction> life settlement policies, of which <ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">122</ix:nonFraction> are accounted for under the fair value method and <ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">45</ix:nonFraction> are accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value is $<ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValue" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">195,205,585</ix:nonFraction> as of June&#160;30, 2023, with a corresponding fair value of $<ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,685,617</ix:nonFraction>. Aggregate face value of policies accounted for using the investment method is $<ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValue" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">39,520,877</ix:nonFraction> as of June&#160;30, 2023, with a corresponding carrying value of $<ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,889,610</ix:nonFraction>. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2022, the Company held <ix:nonFraction name="abl:LifeSettlementContractsNumberOfContracts" contextRef="PAsOn12_31_2022" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">53</ix:nonFraction> life settlement policies, of which <ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts" contextRef="PAsOn12_31_2022" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">35</ix:nonFraction> were accounted for under the fair value method and <ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts" contextRef="PAsOn12_31_2022" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">18</ix:nonFraction> were accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value was $<ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">40,092,154</ix:nonFraction> as of December&#160;31, 2022, with a corresponding fair value of $<ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,809,352</ix:nonFraction>. Aggregate face value of policies accounted for using the investment method was $<ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">42,330,000</ix:nonFraction> as of December&#160;31, 2022, with a corresponding carrying value of $<ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,716,111</ix:nonFraction>. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">62</div></ix:exclude></div></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_91071978" continuedAt="TextSelectionAppend_91071978_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91071978_1" continuedAt="TextSelectionAppend_91071978_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91071978_2" continuedAt="TextSelectionAppend_91071978_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91071978_3"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">At June&#160;30, 2023, the Company did not have any contractual restrictions on its ability to sell policies, including those held as collateral for the issuance of long-term debt. See Note 13, &#8220;Long-Term Debt.&#8221; </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. The following tables summarize the Company&#8217;s life insurance policies grouped by remaining life expectancy as of June&#160;30, 2023: </div></div> <ix:nonNumeric name="us-gaap:ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies Carried at Fair Value</div></div>&#8212; </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 56%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Life Expectancy (Years)</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0-1</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1-2</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">10</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,314,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMaturingInNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,855,769</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2-3</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">11</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">16,886,778</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMaturingInYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,530,949</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3-4</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">10</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">33,631,467</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMaturingInYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,174,200</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4-5</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">13</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">18,755,193</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMaturingInYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,564,469</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">78</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">113,618,147</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:LifeSettlementContractFairValueMaturityAfterYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">22,560,230</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">122</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodFaceValue" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">195,205,585</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,685,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <ix:nonNumeric name="us-gaap:ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies accounted for using the investment method</div></div>&#8212; </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 57%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Life Expectancy (Years)</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/> Life</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Insurance</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying<br/> Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0-1</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1-2</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2-3</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">2</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,400,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,131,679</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3-4</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">4</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,100,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,281,524</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4-5</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">4</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,362,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">518,736</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">35</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">29,658,877</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,957,671</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts" contextRef="PAsOn06_30_2023" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">45</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFaceValue" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">39,520,877</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,889,610</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of June&#160;30, 2023, are as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 81%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023 remaining</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,024,151</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,243,423</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,310,936</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,044,640</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,288,619</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,911,769</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is required to pay premiums to keep its portion of life insurance policies in force. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differ from the estimated life expectancies. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For policies accounted for under the investment method, the Company has not been made aware of information causing a material change to assumptions relating to the timing of realization of life insurance settlement proceeds. We have also not been made aware of information indicating impairment to the carrying value of policies. </div></div> </ix:continuation> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">6<div style="letter-spacing: 0px; top: 0px;;display:inline;">3</div></div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PROPERTY AND EQUIPMENT&#8212;NET </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;net composed of the following: </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 69%;"/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2023</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn06_30_2023_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">144,202</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn06_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">34,300</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">19,444</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn06_30_2023_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,299</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,902</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;gross</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">186,801</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,346</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,870</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,729</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;net</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">177,931</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">18,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense for the three months ended June&#160;30, 2023 and 2022, was $<ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,098</ix:nonFraction> and $<ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,098</ix:nonFraction>, respectively and depreciation expense for the six months ended June&#160;30, 2023, and 2022, was $<ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction> and $<ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction>, respectively. </div></div> </ix:nonNumeric> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">GOODWILL AND OTHER INTANGIBLE ASSETS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill of $<ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">140,287,000</ix:nonFraction> was recognized as a result of the Business Combination, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. The estimates of fair value are based upon preliminary valuation assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. Refer to footnote 3 for further details. </div></div> <ix:nonNumeric name="us-gaap:ScheduleOfGoodwillTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The changes in goodwill by reportable segments were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%;"/>
<td style="width: 7%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Abacus<br/> Settlements,<br/> LLC</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at January&#160;1, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2021_AbacusSettlementsLLCMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="P01_01_2022To06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at June&#160;30, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at January&#160;1, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn12_31_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="P01_01_2023To06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">140,287,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Goodwill" contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">140,287,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <ix:nonNumeric name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"><ix:nonNumeric name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible Assets Acquired comprised of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 41%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 36%; font-family: &quot;Times New Roman&quot;;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Type</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Life</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Methodology</div></div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Agents</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,600,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:duryear">5</ix:nonNumeric> years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Multi-period&#160;excess-earnings&#160;method</div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Financial Relationships</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:duryear">8</ix:nonNumeric> years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Multi-period excess-earnings method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;APA</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,600,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:duryear">2</ix:nonNumeric> years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;Market Place</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">100,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="PAsOn06_30_2023_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:duryear">3</ix:nonNumeric> years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trade Name</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">900,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Compete</div> Agreements</div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextRef="PAsOn06_30_2023_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis" format="ixt-sec:duryear">2</ix:nonNumeric> years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">With or Without Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State Insurance Licenses</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,700,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">32,900,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr> </table> </ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">64</div></div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:nonNumeric name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">AVAILABLE-FOR-SALE</div></div> SECURITIES, AT FAIR VALUE </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible Promissory Note</div></div>&#8212;The Company holds a convertible promissory note in a separate unrelated insurance technology company. In November 2021, the Company purchased a $<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P11_01_2021To11_30_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction> note and then purchased an additional note in January 2022 for $<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P01_01_2022To01_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction> as part of the Tranche 5 offering (&#8220;Tranche 5 Promissory Note&#8221;). The Tranche 5 Promissory Note pays <ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleWeightedAverageYield" contextRef="PAsOn11_30_2021" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">6</ix:nonFraction>% interest per annum. The Tranche 5 Promissory Note matures on November&#160;12, 2023 (&#8220;Maturity Date&#8221;) and will be paid in full as to outstanding principal and accrued interest on the Maturity Date unless the Tranche 5 Promissory Note converts prior to the 2023 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $<ix:nonFraction name="abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" contextRef="PAsOn11_30_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction> (&#8220;Next Equity Financing&#8221;). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">In October 2022, the Company purchased an additional convertible promissory note in the same unrelated insurance technology company for $<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P10_01_2022To10_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> as part of the Tranche 6<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>offering<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>(&#8220;Tranche 6 Promissory Note&#8221; and collectively, the &#8220;Convertible Promissory Notes&#8221;). The Tranche 6 Promissory Note pays eight percent (<ix:nonFraction name="us-gaap:DebtSecuritiesAvailableForSaleWeightedAverageYield" contextRef="PAsOn10_31_2022" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">8</ix:nonFraction>)% interest per annum and matures September&#160;30, 2024 (&#8220;2024 Maturity Date&#8221;) and will be paid in full as to outstanding principal and accrued interest on the 2024 Maturity Date unless the Tranche 6 Promissory Note converts prior to the 2024 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $<ix:nonFraction name="abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" contextRef="PAsOn10_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction> (&#8220;Next Round Securities&#8221;). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Company applies the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> method of accounting for its investment in the Convertible Promissory Note, which is a debt investment. The Convertible Promissory Note does not qualify for either the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> method due to the Convertible Promissory Note&#8217;s conversion rights or the trading securities method because the Company holds the Convertible Promissory Note as a long-term investment. The Convertible Promissory Notes are measured at fair value at each reporting <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">period-end.</div> Unrealized gains and losses are reported in other comprehensive income until realized. As of December&#160;31, 2022 and June&#160;30, 2023, the Company evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $<ix:nonFraction name="abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction> and there was no unrealized gain or loss recorded. </div></ix:nonNumeric> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:OtherAssetsDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071974">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Investments: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible Preferred Stock Ownership</div></div>&#8212;The Company owns convertible preferred stock in <ix:nonFraction name="abl:NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" contextRef="PAsOn06_30_2023" unitRef="Unit_entity" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> entities, further described below. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;22, 2020, the Company purchased <ix:nonFraction name="abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" contextRef="P07_22_2020To07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">224,551</ix:nonFraction>&#160;units of an unrelated insurance technology company&#8217;s Series Seed Preferred units for $<ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">750,000</ix:nonFraction> (&#8220;Seed Units&#8221;). During December 2022, the Company agreed to purchase <ix:nonFraction name="abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" contextRef="P12_01_2022To12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">119,760</ix:nonFraction> Series Seed Preferred Units for $<ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">400,000</ix:nonFraction> in cash consideration by way of <ix:nonFraction name="abl:NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" contextRef="PAsOn12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_payment" decimals="0" scale="0" format="ixt-sec:numwordsen">eight</ix:nonFraction> monthly payments of $<ix:nonFraction name="abl:MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" contextRef="P12_01_2022To12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">50,000</ix:nonFraction> starting December&#160;15, 2022, resulting in a total of $<ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn03_31_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">950,000</ix:nonFraction> investment as of March&#160;31, 2023 and $<ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn06_30_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,100,000</ix:nonFraction> investment as of June&#160;30, 2023. Upon conversion, the Seed Units held by the Company would represent <ix:nonFraction name="us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" contextRef="PAsOn06_30_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">8.6</ix:nonFraction>% control in the technology company. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">On December&#160;21, 2020, the Company purchased <ix:nonFraction name="abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" contextRef="P12_21_2020To12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">207,476</ix:nonFraction>&#160;shares of a separate unrelated insurance technology company&#8217;s Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-1</div> preferred stock for $<ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> (&#8220;Preferred Shares&#8221;). The Preferred Shares are convertible into voting common stock of insured consent at the option of the Company. Upon conversion, the Preferred Shares would represent less than <ix:nonFraction name="us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" contextRef="PAsOn12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">1</ix:nonFraction>% control in the technology company. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company applies the measurement alternative for its investments in the Seed Units and Preferred Shares because these investments are of an equity nature, and the Company does not have the ability to exercise significant influence over operating and financial policies of entities even in the event of conversion of the Seed Units or Preferred Shares. Under the measurement alternative, the Company records the investment based on original cost, less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the investee. The Company&#8217;s share of income or loss of such companies is not included in the Company&#8217;s condensed </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>&#160;</ix:exclude></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">65</div></ix:exclude></div></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_91071974" continuedAt="TextSelectionAppend_91071974_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91071974_1" continuedAt="TextSelectionAppend_91071974_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91071974_2" continuedAt="TextSelectionAppend_91071974_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91071974_3"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">consolidated statements of operations and comprehensive income. The Company tests its investments for impairment whenever circumstances indicate that the carrying value of the investment may not be recoverable. <ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt-sec:numwordsen">No</ix:nonFraction> impairment of investments occurred for the three and six months ended June&#160;30, 2023 and 2022. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Noncurrent Assets- at fair value: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">S&amp;P Options</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div>The Company is long S&amp;P 500 call options and short S&amp;P 500 put options which were purchased and sold through a broker as an economic hedge related to the market-indexed debt instruments included in the long-term debt note. The value is based on shares owned and quoted market prices in active markets. Changes in fair value are recorded in the Unrealized Loss on Investments line item on the condensed consolidated statements of operations and comprehensive income. </div></ix:continuation> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:VariableInterestEntityDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CONSOLIDATION OF VARIABLE INTEREST ENTITIES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company consolidates VIEs for which it is the primary beneficiary or VOEs for which it controls through a majority voting interest or other arrangement. See Note&#160;2 for more information on how the Company evaluates an entity for consolidation. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated any entity in which it had a variable interest upon formation to determine whether the entity should be consolidated. The Company also evaluated the consolidation conclusion during each reconsideration event, such as changes in the governing documents or additional equity contributions to the entity. During the six months ended June&#160;30, 2023, the Company&#8217;s consolidated VIEs, LMA Income Series&#160;II LP, LMX Series LLC (LMATT Series 2024, Inc.), Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">57,577,034</ix:nonFraction> and liabilities of $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">52,474,820</ix:nonFraction>. For the year ended December&#160;31, 2022, the Company&#8217;s consolidated VIEs, LMATT Series 2024, Inc., Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets and liabilities of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">30,073,972</ix:nonFraction> and $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">27,116,762</ix:nonFraction>, respectively. The Company did not deconsolidate any entities during the period ended June&#160;30, 2023, or during the year ended December&#160;31, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, the Company held total assets of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">801,345</ix:nonFraction> and liabilities of $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn06_30_2023_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">185,071</ix:nonFraction>, in unconsolidated VIEs. As of December&#160;31, 2022, the Company held total assets of $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2022_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">987,964</ix:nonFraction> and liabilities of $<ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2022_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">358,586</ix:nonFraction> in unconsolidated VIEs. </div></div></ix:nonNumeric> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:SegmentReportingDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072959">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SEGMENT REPORTING </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segment Information</div></div>&#8212;The Company organizes its business into <ix:nonFraction name="us-gaap:NumberOfReportableSegments" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_segment" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> reportable segments (1)&#160;Portfolio Servicing and (2)&#160;Active Management, which generate revenue in different manners. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">This segment structure reflects the financial information and reports used by the Company&#8217;s management, specifically its chief operating decision maker (CODM), to make decisions regarding the Company&#8217;s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC&#160;280, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment Reporting</div></div>. The Company&#8217;s CODM is the President and Chief Executive Officer. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Portfolio Servicing segment generates revenues by providing policy services to customers on a contract basis. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Active Management segment generates revenues by buying, selling, and trading policies and maintaining policies until receipt of death benefits. The Company&#8217;s reportable segments are not aggregated. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review asset information related to investments nor expenditures incurred for long-lived assets given the Company&#8217;s investments are recognized using the measurement alternative, and the Company&#8217;s long-lived assets are immaterial to the condensed consolidated financial statements. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">66</div></ix:exclude></div></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_91072959" continuedAt="TextSelectionAppend_91072959_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072959_1" continuedAt="TextSelectionAppend_91072959_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072959_2" continuedAt="TextSelectionAppend_91072959_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072959_3" continuedAt="TextSelectionAppend_91072959_4"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"></div></ix:continuation></div></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072959_4"><ix:nonNumeric name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">Revenue related to the Company&#8217;s reporting segments for the three-month and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> periods ended June&#160;30, 2023, and June&#160;30, 2022, is as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 46%;"/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio servicing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">354,366</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">419,422</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">590,057</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">990,328</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Active management</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetInvestmentIncome" contextRef="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,024,399</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetInvestmentIncome" contextRef="P04_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,979,479</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetInvestmentIncome" contextRef="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,994,917</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetInvestmentIncome" contextRef="P01_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">17,285,971</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,378,765</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,398,901</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">21,584,974</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:Revenues" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">18,276,299</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <ix:nonNumeric name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Information related to the Company&#8217;s reporting segments for the three-month and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> periods ended June&#160;30, 2023 and June&#160;30, 2022 is as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 42%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio servicing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">76,705</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">280,303</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">166,128</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">668,752</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Active management</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,482,070</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,452,479</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,288,152</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">15,521,472</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gross profit</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,405,365</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,732,782</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,122,024</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">16,190,224</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">683,841</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,019,498</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,412,845</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,649,498</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General, administrative and other</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">577,539</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">5,499</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,274,431</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">646,705</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Depreciation" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,098</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Depreciation" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,098</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:Depreciation" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,141</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other (expense) income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">121,601</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">127,455</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">21,651</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">242,247</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest expense</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">584,075</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">934,001</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:InterestRevenueExpenseNet" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss on change in fair value of debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,445,229</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">333,879</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,398,662</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">375,513</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain (loss) on investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">672,936</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,039,022</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">798,156</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,054,975</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Provision for income taxes</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,184,571</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">120,132</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">528,104</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">296,806</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Less: Net loss attributable to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">26,596</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">406,641</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">487,303</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">406,641</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Abacus Life, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,750,145</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,679,558</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,835,648</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,515,698</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric></ix:continuation> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072688">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">COMMITMENTS AND CONTINGENCIES </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Legal Proceedings</div></div>&#8212;Occasionally, the Company may be subject to various proceedings such as lawsuits, disputes, or claims. The Company assesses these proceedings as they arise and accrues a liability when losses are probable and reasonably estimable. Although legal proceedings are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company&#8217;s business, financial position, results of operations, or cash flows. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Commitment</div></div>&#8212;The Company has entered into a Strategic Services and Expenses Support Agreement (&#8220;Expense Support Agreement&#8221;) with <ix:nonFraction name="abl:NumberOfProvidersInvolvedInOptionAgreement" contextRef="PAsOn06_30_2023" unitRef="Unit_provider" decimals="INF" scale="0" format="ixt-sec:numwordsen">two </ix:nonFraction>commonly owned full-service origination, servicing, and investment Providers in exchange for an option to purchase the outstanding equity ownership of the Providers. Pursuant to the Expense Support Agreement, Abacus Life, Inc. provides financial support and advice for the expenses of the Providers incurred in connection with their life settlement transactions businesses and the Providers are required to hire a life settlement transactions operations employee of an affiliate of Abacus Life, Inc. No later than December&#160;1 of each calendar year, Abacus Life, Inc. provides a budget for the Providers, in which Abacus Life, Inc. commits to extend financial support for all operating expenses up to the budgeted amount. &#8220;Operating Expenses&#8221; for purposes of the Expense Support Agreement means all annual operating expenses of the Providers incurred in the ordinary course of business, excluding the premiums paid for the Providers insurance coverages that are allocable to the insurance coverage </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>&#160;</ix:exclude></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">67</div></ix:exclude></div></div> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_91072688" continuedAt="TextSelectionAppend_91072688_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072688_1" continuedAt="TextSelectionAppend_91072688_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072688_2" continuedAt="TextSelectionAppend_91072688_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072688_3"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provided to Institutional Life Holdings,&#160;LLC, which owns all the outstanding membership interests of the Providers if unrelated to the Providers settlement business. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June&#160;30, 2023, Abacus Life, Inc. did <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P04_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></div>t</div> incur expenses related to the Expense Support Agreement. For the six months ended June&#160;30, 2023, Abacus Life, Inc. incurred $<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="P01_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">29,721</ix:nonFraction> of expenses, related to the Expense Support Agreement, which is included in the Other (expense) line of the condensed consolidated statements of operations and comprehensive income and have not been reimbursed by the Providers. </div></div> </ix:continuation> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072689">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FAIR VALUE MEASUREMENTS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determines fair value based on assumptions that market participants would use in pricing an asset or a liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;2 inputs: Other than quoted prices in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recurring Fair Value Measurements</div></div>&#8212;<ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072582">The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. </ix:nonNumeric></div> <ix:continuation id="TextSelection_91072582" continuedAt="TextSelectionAppend_91072582_1"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 46%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Hierarchy</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,685,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,685,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> securities, at fair value</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,600,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,600,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">S&amp;P 500 options</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,794,640</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,794,640</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,246</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OtherAssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,246</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets held at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,801,886</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">59,285,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">61,087,503</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">66,165,396</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">66,165,396</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrants</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="abl:WarrantLiabilitiesNoncurrent" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="abl:WarrantLiabilitiesNoncurrent" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:WarrantLiabilitiesNoncurrent" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,438,600</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:WarrantLiabilitiesNoncurrent" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,438,600</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities held at fair value:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">68,603,996</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">68,603,996</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">68</div></ix:exclude></div></div></ix:continuation> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelectionAppend_91072582_1" continuedAt="TextSelectionAppend_91072582_2"><ix:continuation id="TextSelection_91072689" continuedAt="TextSelectionAppend_91072689_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072689_1" continuedAt="TextSelectionAppend_91072689_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072689_2" continuedAt="TextSelectionAppend_91072689_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> </ix:continuation><div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072582_2" continuedAt="TextSelectionAppend_91072582_3"><ix:continuation id="TextSelectionAppend_91072689_3" continuedAt="TextSelectionAppend_91072689_4"> </ix:continuation></ix:continuation></div> </div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072689_4" continuedAt="TextSelectionAppend_91072689_5"><ix:continuation id="TextSelectionAppend_91072582_3">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 51%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Hierarchy</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,809,352</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,809,352</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> securities, at fair value</div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other investments</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,300,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,300,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">S&amp;P 500 options</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">890,829</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeAssets" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">890,829</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets held at fair value</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">890,829</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">16,109,352</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">17,000,181</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,249,653</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,249,653</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities held at fair value:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,249,653</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,249,653</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:continuation> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life Settlement Policies</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></div></div>The Company separately accounts for each owned life settlement policy using either the fair value method, or investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For policies carried at fair value, the Company utilizes valuation services of a third-party actuarial firm, who values the contracts using Level&#160;3 unobservable inputs, including actuarial assumptions, such as life expectancies and cash flow discount rates. The valuation model is based on a discounted cash flow analysis and is sensitive to changes in the discount rate used. The Company utilized a discount rate of <ix:nonFraction name="abl:LifeSettlementContractsMeasurementInput" contextRef="PAsOn06_30_2023_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">16</ix:nonFraction>% at June&#160;30, 2023 and <ix:nonFraction name="abl:LifeSettlementContractsMeasurementInput" contextRef="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">12</ix:nonFraction>% at December&#160;31, 2022, respectively, for policy valuation, which is based on economic and company-specific factors. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Subsequent to the reporting date, the Company sold <ix:nonFraction name="abl:LifeSettlementContractsNumberOfContractsSold" contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">3</ix:nonFraction> policies carried at fair value. As of June&#160;30, 2023, the Company valued these <ix:nonFraction name="abl:LifeSettlementContractsNumberOfContractsSold" contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">3</ix:nonFraction> policies using the price at the time of sale. Valuing these <ix:nonFraction name="abl:LifeSettlementContractsNumberOfContractsSold" contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_insurance_contract" decimals="INF" scale="0" format="ixt:num-dot-decimal">3</ix:nonFraction> policies using the takeout price resulted in a decrease in valuation of $<ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodGainLoss" contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">231,775</ix:nonFraction> compared to the third-party valuation. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For life settlement policies carried using the investment method, the Company measures these at the cost of the policy plus premiums paid. The policies accounted for using the investment method totaled $<ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,889,610</ix:nonFraction> at June&#160;30, 2023 and $<ix:nonFraction name="us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,716,111</ix:nonFraction> at December&#160;31, 2022, respectively. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Discount Rate Sensitivity</div></div>&#8212;Changes in the <ix:nonFraction name="abl:LifeSettlementContractsMeasurementInput" contextRef="PAsOn06_30_2023_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">16</ix:nonFraction>% discount rate on the death benefit and premiums used to estimate the policies issued under LMATT Series&#160;2024 Inc.,&#160;LMATT Growth Series 2.2024 Inc., LMATT Growth and Income Series 1.2026, Inc., LMA Income Series, LP and LMA Income Series II, LP (&#8220;LMATT Policies&#8221;) fair value has been analyzed. <ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072584">If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of June&#160;30, 2023, would be as follows:</ix:nonNumeric> </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:continuation id="TextSelection_91072584" continuedAt="TextSelectionAppend_91072584_1">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Rate Adjustment</div></div></div> </td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">+2%</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">53,987,508</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,698,109</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No change</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,685,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">-2%</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">59,857,879</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,172,262</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> </ix:continuation> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Credit Exposure to Insurance Companies</div></div>&#8212;<ix:nonNumeric name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072585">The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company&#8217;s life insurance policies as of June&#160;30, 2023: </ix:nonNumeric></div> <ix:continuation id="TextSelection_91072585"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"/>
<td style="width: 11%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 10%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrier</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrier</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rating</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">American General Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">14.0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">11.0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ReliaStar Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">6.0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lincoln National Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">14.0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> </ix:continuation> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">69</div></ix:exclude></div></div> </ix:continuation></div> </div> <ix:continuation id="TextSelectionAppend_91072689_5" continuedAt="TextSelectionAppend_91072689_6"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072689_6" continuedAt="TextSelectionAppend_91072689_7"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072689_7" continuedAt="TextSelectionAppend_91072689_8"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072689_8" continuedAt="TextSelectionAppend_91072689_9"><ix:nonNumeric name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a roll forward of the fair value of life insurance policies for the six months-ended June&#160;30, 2023: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%; font-family: &quot;Times New Roman&quot;;"/>
<td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/>
<td style="font-family: &quot;Times New Roman&quot;;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at December&#160;31, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="PAsOn12_31_2022_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,809,352</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Policies purchased</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">58,543,580</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Realized gain (loss) on matured/sold policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,898,958</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Premiums paid</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">879,462</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain(loss) on held policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,319,588</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in estimated fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,339,084</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Matured/sold policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,885,861</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Premiums paid</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">879,462</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" contextRef="PAsOn06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,685,617</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Long-Term Debt</div></div>&#8212;See Note&#160;13<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div>&#160;&#8220;Long-Term Debt&#8221; for background information on the market-indexed debt. The Company has elected the fair value option in accounting for the instruments. Fair value is determined using Level&#160;3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i)&#160;the S&amp;P 500 Index price, (ii)&#160;S&amp;P 500 Index volatility, (iii)&#160;a risk-free rate based on data published by the US Treasury, and (iv)&#160;a term assumption based on the contractual term of the LMATT Notes. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total change in fair value of the debt resulted in a gain of $<ix:nonFraction name="abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,602,042</ix:nonFraction>. This gain is comprised of $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">90,148</ix:nonFraction>, net of tax, which is included within accumulated other comprehensive income and $<ix:nonFraction name="abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">29,515</ix:nonFraction> net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $<ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">1,445,229</ix:nonFraction> on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the three months ended June&#160;30, 2023. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total change in fair value of the debt resulted in a gain of $<ix:nonFraction name="abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,705,918</ix:nonFraction>. This gain is comprised of $<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">175,530</ix:nonFraction>, net of tax, which is included within accumulated other comprehensive income and $<ix:nonFraction name="abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">56,446</ix:nonFraction> net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $<ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,398,662</ix:nonFraction> on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the six months ended June&#160;30, 2023. </div></div> <ix:nonNumeric name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a roll forward of the fair value of the issued notes for the six months ended June&#160;30, 2023: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at December&#160;31, 2022</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,249,653</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Debt issued to third parties</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">35,209,825</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized loss on change in fair value (risk-free)</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,398,662</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain on change in fair value (credit-adjusted)</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueOptionCreditRiskGainsLossesOnAssets" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">307,256</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in estimated fair value</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:num-dot-decimal">2,705,918</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">66,165,396</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement Warrants</div></div>&#8212;Simultaneously with the closing of the Initial Public Offering, ERES consummated the sale of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">8,900,000</ix:nonFraction> warrants (the &#8220;Private Placement Warrants&#8221;) to East Sponsor, LLC (the </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>&#160;</ix:exclude></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">70</div></ix:exclude></div></div> </ix:continuation></div> </div> <ix:continuation id="TextSelectionAppend_91072689_9" continuedAt="TextSelectionAppend_91072689_10"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072689_10" continuedAt="TextSelectionAppend_91072689_11"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072689_11" continuedAt="TextSelectionAppend_91072689_12"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072689_12" continuedAt="TextSelectionAppend_91072689_13"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Sponsor&#8221;), which included the sale of an additional <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn08_25_2020_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">900,000</ix:nonFraction> Private Placement Warrants in connection with the full exercise by the underwriters of their over-allotment option on August&#160;25, 2020, at a price of $<ix:nonFraction name="abl:ClassOfWarrantOrRightPricePerWarrant" contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">1.00</ix:nonFraction> per Private Placement Warrant, for an aggregate purchase price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,900,000</ix:nonFraction>. Each Private Placement Warrant is exercisable for <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of Class&#160;A common stock at a price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction> per share, subject to adjustment. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric> days after the completion of a Business Combination, subject to certain limited exceptions, (y)&#160;the Private Placement Warrants will be exercisable on a cashless basis and be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> so long as they are held by the initial purchasers or their permitted transferees and (z)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Private Placement Warrants were accounted for as liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented separately in the condensed consolidated statements of operations. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants were considered a Level&#160;3 fair value measurement using a binomial lattice model in a risk-neutral framework. The binomial lattice model&#8217;s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The implied volatility as of the reporting date was derived from observable public warrant traded price provided by Bloomberg LP. </div></div> <ix:continuation id="TextSelectionAppend_91072584_1"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the key assumptions in the analysis: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 79%;"/>
<td style="width: 16%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/> Placement<br/> Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected implied volatility</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">de&#160;minimis</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.09</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term to expiration</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">5.0</ix:nonFraction> years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Price</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">10.03</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend Yield</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 10%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:continuation> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other Noncurrent Assets: S&amp;P 500 Options</div></div>&#8212;In February 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, purchased and sold S&amp;P 500 call and put options through a broker. The Company purchased and sold additional S&amp;P 500 call options through a broker in June 2022 through their 100% owned and fully consolidated subsidiaries LMATT Growth Series 2.2024, Inc. and LMATT Growth and Income Series 1.2026, Inc. The options are exchange traded, and fair value is determined using Level&#160;1 inputs of quoted market prices as of the condensed consolidated balance sheets dates. Changes in fair value are classified as unrealized (gain)/loss on investments within the condensed consolidated statements of operations and comprehensive income. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial Instruments Measured at Fair Value on a Nonrecurring Basis</div></div>&#8212;The following financial assets, composed of equity securities without readily determinable fair values, are adjusted to fair value when observable price changes are identified, or an impairment charge is recognized. Such fair value measurements are based predominantly on Level&#160;3 inputs. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-Sale</div></div> Investment</div></div>&#8212;The Convertible Promissory Note is classified as an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> security. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> investments are subsequently measured at fair value. Unrealized holding gains </div> <ix:exclude> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">71</div></div></div> </ix:exclude></ix:continuation></div> </div> <ix:continuation id="TextSelectionAppend_91072689_13" continuedAt="TextSelectionAppend_91072689_14"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072689_14" continuedAt="TextSelectionAppend_91072689_15"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072689_15" continuedAt="TextSelectionAppend_91072689_16"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072689_16"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> investments using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. The Company initially purchased a $<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction> convertible promissory note from the issuer in 2021 and then on January&#160;7, 2022, the Company purchased an additional $<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P01_07_2022To01_07_2022" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction> convertible promissory note from the same issuer and then an additional $<ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="P10_01_2022To10_31_2022" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> in October 2022. As of June&#160;30, 2023 and December&#160;31, 2022, the Company evaluated the fair value of its Promissory Note and determined that the fair value approximates the carrying value of $<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction> and $<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction>, respectively. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other Investments</div></div>&#8212;The Company determines fair value using Level&#160;3 inputs under the measurement alternative. These investments are recorded at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively. As of June&#160;30, 2023, and December&#160;31, 2022, the Company did not identify any impairment indicators and determined that the carrying value of $<ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,600,000</ix:nonFraction> and $<ix:nonFraction name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,300,000</ix:nonFraction> is the fair value for these equity investments in privately held companies, given that there have been no observable price changes. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial Instruments Where Carrying Value Approximates Fair Value</div></div>&#8212;The carrying value of cash, cash equivalents, accounts receivables, and due to affiliates approximates fair value due to the short-term nature of their maturities. </div> </ix:continuation> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:LongTermDebtTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072690">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">13.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LONG-TERM DEBT </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <ix:nonNumeric name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt comprises of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 3%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market-indexed notes:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2024, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,866,900</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,621,141</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,866,900</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,067,291</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2.2024, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,333,391</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,446,527</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,333,391</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,354,013</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Growth&#160;&amp; Income Series 1.2026, Inc</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">400,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">459,553</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">400,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">400,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Secured borrowing:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Income Series, LP</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">21,889,444</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">22,124,676</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">17,428,349</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">17,428,349</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Income Series II, LP</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,041,851</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,041,851</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unsecured borrowing:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sponsor PIK Note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,471,648</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,471,648</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total long-term debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">65,003,234</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">66,165,396</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">30,028,640</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">28,249,653</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV purchase and sale note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,000,000</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sponsor PIK Note </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On the June&#160;30, 2023, in connection with the consummation of the Business Combination and as contemplated by the Merger Agreement, East Sponsor, LLC, a Delaware limited liability company (&#8220;Sponsor&#8221;), made an unsecured loan to the Company in the aggregate amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn06_30_2023_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">10,471,648</ix:nonFraction> (the &#8220;Sponsor PIK Note&#8221;). The Sponsor PIK Note matures on June&#160;30, 2028 (the &#8220;Maturity Date&#8221;) and may be prepaid at any time in accordance with its terms without any premium or penalty. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2024, Inc. Market-Indexed Notes: </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March&#160;31, 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, issued $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">10,166,900</ix:nonFraction>&#160;in market-indexed private placement notes. The note, titled the Longevity Market Assets </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>&#160;</ix:exclude></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">72</div></ix:exclude></div></div> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_91072690" continuedAt="TextSelectionAppend_91072690_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072690_1" continuedAt="TextSelectionAppend_91072690_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072690_2" continuedAt="TextSelectionAppend_91072690_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072690_3" continuedAt="TextSelectionAppend_91072690_4"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">Target-Term Series (LMATTS) 2024, is a market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The note has a feature to protect debt holders from market downturns, up to <ix:nonFraction name="abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage" contextRef="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">40</ix:nonFraction>%. Any subsequent losses below the <ix:nonFraction name="abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage" contextRef="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">40</ix:nonFraction>% threshold will reduce the note on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold" contextRef="P03_31_2022To03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt-sec:numwordsen">one</ix:nonFraction>-to-one</div></div> basis. As of June&#160;30, 2023, $<ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,866,900</ix:nonFraction> of the principal amount remained outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2024, Inc. notes were $<ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">9,621,141</ix:nonFraction>. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are secured by the assets of the issuing entities, which includes cash, S&amp;P 500 options, and life settlement policies totaling $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,195,701</ix:nonFraction> as of June&#160;30, 2023. The notes&#8217; agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2.2024, Inc. Market-Indexed Notes: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">On September&#160;16, 2022, LMATTS Series 2.2024, Inc., a <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="PAsOn09_16_2022_LMATTSeries22024IncMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% owned subsidiary which the Company consolidates for financial reporting issued $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">2,333,391</ix:nonFraction> in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (&#8220;LMATTSTM Series 2.2024, Inc.&#8221;) is a market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at <ix:nonFraction name="abl:DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">120</ix:nonFraction>% of the performance of the S&amp;P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to <ix:nonFraction name="abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage" contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than <ix:nonFraction name="abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage" contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">20</ix:nonFraction>%, the investment will experience all subsequent losses on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold" contextRef="P03_31_2022To03_31_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt-sec:numwordsen">one</ix:nonFraction>-to-one</div></div> basis. . As of June&#160;30, 2023, the entire principal amount remained outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2.2024, Inc. notes were $<ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,446,527</ix:nonFraction>. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,331,872</ix:nonFraction> as of June&#160;30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Additionally, on September&#160;16, 2022, LMATTS Growth and Income Series 1.2026, Inc., a <ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMembersrtOwnershipAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% owned subsidiary which the Company consolidates for financial reporting issued $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="INF" scale="0" format="ixt:num-dot-decimal">400,000</ix:nonFraction> in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (&#8220;LMATTSTM Growth and Income Series 1.2026, Inc.&#8221;) is a market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2026, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at <ix:nonFraction name="abl:DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">140</ix:nonFraction>% of the performance of the S&amp;P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to <ix:nonFraction name="abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage" contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction>% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than <ix:nonFraction name="abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage" contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">10</ix:nonFraction>%, the investment will experience all subsequent losses on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold" contextRef="P09_16_2022To09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt-sec:numwordsen">one</ix:nonFraction>-to-one</div></div> basis. This note also includes <ix:nonFraction name="abl:DebtInstrumentDividendFeaturePercentage" contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">4</ix:nonFraction>% dividend feature that will be paid annually. As of June&#160;30, 2023, the entire principal amount remained outstanding. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">73</div></ix:exclude></div></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_91072690_4" continuedAt="TextSelectionAppend_91072690_5"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072690_5" continuedAt="TextSelectionAppend_91072690_6"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072690_6" continuedAt="TextSelectionAppend_91072690_7"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072690_7" continuedAt="TextSelectionAppend_91072690_8"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes were $<ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">459,553</ix:nonFraction>. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are secured by the assets of the issuing entity, LMATTS Growth and Income Series 1.2026, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $<ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">517,218</ix:nonFraction> as of June&#160;30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">See additional fair value considerations within Note 12. &#8220;Fair Value Measurements.&#8221; </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" format="ixt-sec:durwordsen">three years</ix:nonNumeric> with the ability to extend for <ix:nonFraction name="abl:DebtInstrumentExtensionOptions" contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_option" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="abl:DebtInstrumentExtensionTerm" contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" format="ixt-sec:durwordsen">one-year</ix:nonNumeric></div> periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of <ix:nonFraction name="abl:DebtInstrumentDividendFeaturePercentage" contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">6.5</ix:nonFraction>% paid quarterly and <ix:nonFraction name="abl:DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">25</ix:nonFraction>% of returns in excess of a <ix:nonFraction name="abl:DebtInstrumentMinimumInternalRateOfReturn" contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">6.5</ix:nonFraction>% internal rate of return capped at <ix:nonFraction name="abl:DebtInstrumentInternalRateOfReturnCap" contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">9</ix:nonFraction>% which would require a <ix:nonFraction name="abl:DebtInstrumentNetInternalRateOfReturnAtCap" contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">15</ix:nonFraction>% net internal rate of return. The General Partner will receive <ix:nonFraction name="abl:DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" contextRef="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">75</ix:nonFraction>% of returns in excess of a <ix:nonFraction name="abl:DebtInstrumentMinimumInternalRateOfReturn" contextRef="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">6.5</ix:nonFraction>% internal rate of return to limited partners then <ix:nonFraction name="abl:DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" contextRef="PAsOn06_30_2023_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% in excess of a <ix:nonFraction name="abl:DebtInstrumentInternalRateOfReturnCap" contextRef="PAsOn06_30_2023_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">15</ix:nonFraction>% net internal rate of return. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the six months ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10.</div> As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10-50-6A(d)).</div></div></div> In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-30-25-2,</div></div></div> as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">810-10-30.</div></div> As of June&#160;30, 2023, the fair value of the secured borrowing was $<ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">22,124,676</ix:nonFraction>. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA Income Series II, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" format="ixt-sec:durwordsen">three years</ix:nonNumeric> with the ability to extend for <ix:nonFraction name="abl:DebtInstrumentExtensionOptions" contextRef="PAsOn06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_option" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="abl:DebtInstrumentExtensionTerm" contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" format="ixt-sec:durwordsen">one-year</ix:nonNumeric></div> periods at the discretion of the general partner, LMA Income Series II, GP, LLC. The limited partners will receive annual dividends equal to the Preferred Return Amounts as follows: Capital commitment less than $<ix:nonFraction name="abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction>, <ix:nonFraction name="abl:DebtInstrumentDividendFeaturePercentage" contextRef="PAsOn06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">7.5</ix:nonFraction>%; between $<ix:nonFraction name="abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">500,000</ix:nonFraction> and $<ix:nonFraction name="abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction>, <ix:nonFraction name="abl:DebtInstrumentDividendFeaturePercentage" contextRef="PAsOn06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">7.75</ix:nonFraction>%; over $<ix:nonFraction name="abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction>, <ix:nonFraction name="abl:DebtInstrumentDividendFeaturePercentage" contextRef="PAsOn06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">8</ix:nonFraction>%. Thereafter, <ix:nonFraction name="abl:DebtInstrumentDividendFeaturePercentage" contextRef="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of the excess to be paid to the General Partner. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">74</div></ix:exclude></div></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_91072690_8" continuedAt="TextSelectionAppend_91072690_9"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072690_9" continuedAt="TextSelectionAppend_91072690_10"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072690_10" continuedAt="TextSelectionAppend_91072690_11"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072690_11" continuedAt="TextSelectionAppend_91072690_12"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the three and six months ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10.</div> As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10-50-6A(d)).</div></div></div> In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-30-25-2,</div></div></div> as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">810-10-30.</div></div> As of June&#160;30, 2023, the fair value of the secured borrowing was $<ix:nonFraction name="us-gaap:LongTermDebtFairValue" contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,041,851</ix:nonFraction>. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Purchase and Sale </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;5, 2023, the Company entered into an Asset Purchase Agreement (the &#8220;Policy APA&#8221;) to acquire certain insurance policies with an aggregate fair market value of $<ix:nonFraction name="abl:LifeSettlementContractsSpecialPurchaseVehicleFairValue" contextRef="PAsOn07_05_2023_PolicyAPAMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million from Abacus Investment SPV, LLC, a Delaware limited liability company (&#8220;SPV&#8221;), in exchange for a payable obligation owing by the Company to the SPV (such acquisition transaction under the Policy APA, the &#8220;SPV Purchase and Sale&#8221;). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The payable obligation owing by the Company to the SPV in connection with the SPV Purchase and Sale is evidenced by a note issued by the Company under the SPV Investment Facility (the &#8220;SPV Purchase and Sale Note&#8221;) in an original principal amount equal to the aggregate fair market value of the acquired insurance policies. The SPV Purchase and Sale Note has the same material terms and conditions as the other credit extensions under the SPV Investment Facility (as defined below). </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Investment Facility </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;5, 2023, the Company entered into that certain SPV Investment Facility (the &#8220;SPV Investment Facility&#8221;), between the Company, as borrower, and the SPV, as lender. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The SPV Investment Facility, among other things: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">requires certain subsidiaries of the Company to guarantee the credit extensions provided under the SPV Investment Facility pursuant to separate documentation </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">is unsecured without collateral security provided in favor of the SPV and subordinated in right of payment to the Company&#8217;s obligations under the Owl Rock Credit Facility, subject to limited specified exceptions and circumstances for permitting early payment; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for certain credit extensions in an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">25.0</ix:nonFraction>&#160;million, including: (i)&#160;an initial credit extension in an original principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">15.0</ix:nonFraction>&#160;million that was funded upon the closing of the SPV Investment Facility, and (ii)&#160;the SPV Purchase and Sale Note in favor of the SPV in an original principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapCreditFacilityAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">10.0</ix:nonFraction>&#160;million to finance the purchase of the insurance policies under the Policy APA; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides proceeds from the SPV Investment Facility for payment of certain transaction expenses, general corporate purposes and any other purposes not prohibited by the agreement or applicable law; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F<div style="letter-spacing: 0px; top: 0px;;display:inline;">-<div style="letter-spacing: 0px; top: 0px;;display:inline;">75</div></div></ix:exclude></div></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_91072690_12" continuedAt="TextSelectionAppend_91072690_13"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072690_13" continuedAt="TextSelectionAppend_91072690_14"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072690_14" continuedAt="TextSelectionAppend_91072690_15"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072690_15">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">matures on July&#160;5, 2026, <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" format="ixt-sec:durwordsen">three years</ix:nonNumeric> after the closing of the SPV Investment Facility, subject to <ix:nonFraction name="abl:DebtInstrumentNumberOfExtensions" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_extension" decimals="INF" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> automatic extensions of <ix:nonNumeric name="abl:DebtInstrumentExtensionTerm" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" format="ixt-sec:durwordsen">one year</ix:nonNumeric> each without any amendment of the relevant documentation, but also subject to applicable subordination restrictions in relation to the Owl Rock Credit Facility; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">provides for interest to accrue on the SPV Investment Facility at a rate of <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">12.00</ix:nonFraction>% per annum, payable quarterly, all of which is to be paid <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-kind</div> by the Company by increasing the principal amount of the SPV Investment Facility owing to the SPV on each interest payment date; </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">provides a default rate that will accrue at <ix:nonFraction name="abl:DebtInstrumentDefaultRate" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">2.00</ix:nonFraction>% per annum (subject to applicable subordination restrictions) over the rate otherwise applicable. If cash payment is not permitted due to applicable subordination restrictions or otherwise, such default interest shall be paid <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-kind;</div> </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides that no amortization payments shall be required prior to maturity; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains financial and other covenants substantially similar and not materially worse than those contained in the Owl Rock Credit Facility from the perspective of the Company; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for certain specified events of default (including certain events of default subject to grace or cure periods), with the occurrence and during the continuance of such events of default enabling the lender under the SPV Investment Facility to accelerate the obligations under the SPV Investment Facility, among other rights or remedies, subject to applicable subordination restrictions. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The SPV&#8217;s investment resulting from credit extensions under the SPV Investment Facility is treated by the Company as debt for U.S. GAAP accounting purposes. While the timing of the Policy APA and SPV Investment Facility occurred on July&#160;5, 2023, such amounts are included within the condensed consolidated balance sheet as cash was received prior to June&#160;30, 2023. </div></div></ix:continuation> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072691">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SHAREHOLDERS&#8217; EQUITY </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is authorized to issue up to <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">200,000,000</ix:nonFraction>&#160;shares of common stock, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn06_30_2023" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share, and <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">1,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn06_30_2023" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> per share. <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction> shares of preferred stock are issued or outstanding. Holders of the Company&#8217;s common stock are entitled to <ix:nonFraction name="abl:NumberOfVotesPerCommonShare" contextRef="PAsOn06_30_2023" unitRef="Unit_vote" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> vote for each share. As of June&#160;30, 2023, there were <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">62,961,688</ix:nonFraction></ix:nonFraction>&#160;shares of common stock issued and outstanding. Holders of shares were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets available for distribution to the shareholders after payment of all liabilities. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company&#8217;s common stock, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn06_30_2023" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> par value per share, issued to legacy LMA&#8217;s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of <ix:nonFraction name="abl:BusinessAcquisitionExchangeRatio" contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal">0.8</ix:nonFraction> established in the Business Combination. As of December&#160;31, 2022, this resulted in <ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">50,369,350</ix:nonFraction> shares of common stock issued and outstanding. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, the Company has <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">17,250,000</ix:nonFraction> Public Warrants outstanding. Each redeemable whole Public Warrant entitles the holder thereof to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock at a price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction> per full share, subject to adjustment as described. The Public Warrants represent a freestanding financial instrument as it is traded on the </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">NASDAQ </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> under the symbol &#8220;ABLLW&#8221; and legally detachable and separately exercisable from the related underlying shares of the Company&#8217;s common stock. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) <ix:nonNumeric name="abl:WarrantsAndRightsOutstandingExercisableTermBusinessCombination" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric> days after the completion of a Business Combination and (b) <ix:nonNumeric name="abl:WarrantsAndRightsOutstandingExercisableTermProposedOffering" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durmonth">12</ix:nonNumeric> months from the closing of the Proposed Offering. The Public Warrants will expire <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durwordsen">five years</ix:nonNumeric> from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">76</div></ix:exclude></div></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_91072691" continuedAt="TextSelectionAppend_91072691_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072691_1" continuedAt="TextSelectionAppend_91072691_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072691_2" continuedAt="TextSelectionAppend_91072691_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072691_3" continuedAt="TextSelectionAppend_91072691_4"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will not be obligated to deliver any shares of Class&#160;A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class&#160;A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class&#160;A common stock upon exercise of a warrant unless the share of Class&#160;A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of Warrants for Cash&#8212;Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $<ix:nonFraction name="abl:ClassOfWarrantOrRightRedemptionPricePerWarrant" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.01</ix:nonFraction> per Public Warrant; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than <ix:nonNumeric name="abl:ClassOfWarrantOrRightRedemptionNoticePeriod" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric> days&#8217; prior written notice of redemption to each warrant holder; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $<ix:nonFraction name="abl:ClassOfWarrantOrRightRedemptionPricePerShareThreshold" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">18.00</ix:nonFraction> per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any <ix:nonNumeric name="abl:ClassOfWarrantOrRightRedemptionNumberOfTradingDays" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">20</ix:nonNumeric>&#160;trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="abl:ClassOfWarrantOrRightRedemptionTradingDayPeriod" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric>-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">If and when the Public warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class&#160;A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class&#160;A common stock is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="abl:ClassOfWarrantOrRightRedemptionTradingDayPeriod" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric>-day</div> redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of Warrants for Shares of Class&#160;A Common Stock&#8212;Once the Public warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class&#160;A common stock: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price equal to a number of shares of Class&#160;A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the &#8220;fair market value&#8221; of the Class&#160;A common stock; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than <ix:nonNumeric name="abl:ClassOfWarrantOrRightRedemptionNoticePeriod" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">30</ix:nonNumeric> days&#8217; prior written notice of redemption to each warrant holder; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $<ix:nonFraction name="abl:ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">10.00</ix:nonFraction> per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if (x)&#160;the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company&#8217;s initial Business Combination at an issue price or effective issue price of less than $<ix:nonFraction name="abl:ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">9.20</ix:nonFraction> per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (y) the volume weighted average trading price of the Company&#8217;s common stock during the <ix:nonNumeric name="abl:ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:durday">20</ix:nonNumeric> trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Price&#8221;) is below $<ix:nonFraction name="abl:ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">9.20</ix:nonFraction> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <ix:nonFraction name="abl:ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">115</ix:nonFraction>% of the higher of Market Price and the newly issued price. Further, the $<ix:nonFraction name="abl:ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">10.00</ix:nonFraction> and $<ix:nonFraction name="abl:ClassOfWarrantOrRightRedemptionPricePerShareThreshold" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal">18.00</ix:nonFraction> per share redemption trigger prices will be adjusted to be equal to <ix:nonFraction name="abl:ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% and <ix:nonFraction name="abl:ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">180</ix:nonFraction>%, respectively, of the higher of the market value and the newly issued price. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">77</div></ix:exclude></div></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_91072691_4" continuedAt="TextSelectionAppend_91072691_5"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072691_5" continuedAt="TextSelectionAppend_91072691_6"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072691_6" continuedAt="TextSelectionAppend_91072691_7"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072691_7"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company elects to redeem all of the Public Warrants or the common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange, management has the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. However, in no instance can the warrant holder unilaterally decide to exercise its Public Warrant on a cashless basis. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the Business Combination, the Company accounted for the Public Warrants issued with the IPO as equity instruments. The Company accounted for the warrant as an expense of the IPO resulting in a charge directly to stockholders&#8217; equity. The Company estimates that the fair value of the warrants upon the Business Combination is approximately $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="PAsOn08_30_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-4" scale="6" format="ixt:num-dot-decimal">4.73</ix:nonFraction>&#160;million, or $<ix:nonFraction name="abl:WarrantsAndRightsOutstandingFairValuePerShare" contextRef="PAsOn08_30_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="3" scale="0" format="ixt:num-dot-decimal">0.274</ix:nonFraction> per Public Warrant, using the binomial lattice model. The fair value of the warrants is estimated as of the date of grant using the following assumptions: (1)&#160;risk-free interest rate of <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">4.09</ix:nonFraction>%, (2) term to expiration of <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" format="ixt-sec:duryear">5.0</ix:nonNumeric> years, (3)&#160;exercise price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction> and (4)&#160;stock price of $<ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:num-dot-decimal">10.03</ix:nonFraction>. </div></div></ix:continuation> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:DefinedContributionPlanTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">15.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">EMPLOYEE BENEFIT PLAN </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has a defined contribution plan in the U.S. intended to qualify under Section&#160;401(k)&#160;of the Internal Revenue Code (the &#8220;401(k)&#160;Plan&#8221;). The 401(k)&#160;Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer up to <ix:nonFraction name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction>% of their annual compensation on a pretax basis. For the year ended December&#160;31, 2022, the Company elected to match <ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction>% of employee contributions up to a maximum of <ix:nonFraction name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" contextRef="P01_01_2022To12_31_2022" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">4</ix:nonFraction>% of eligible employee compensation. For the three months ended June&#160;30, 2023 and 2022, the Company recognized expenses related to the 401(k)&#160;Plan amounting to $<ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">13,075</ix:nonFraction> and $<ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,577</ix:nonFraction>, respectively and for the six months ended June&#160;30, 2023 and 2022, the Company recognized expenses related to the 401(k)&#160;Plan amounting to $<ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,315</ix:nonFraction> and $<ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,048</ix:nonFraction>, respectively. </div></div></ix:nonNumeric> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072693">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INCOME TAXES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Before June&#160;30, 2023, the Company elected to file as an S corporation for Federal and state income tax purposes, the Company incurred no Federal or state income taxes, except for income taxes recorded related to some of their consolidated variable interest entities and subsidiaries which are taxable C corporations. These VIE&#8217;s and subsidiaries include LMATT Series&#160;2024,&#160;Inc., the wholly owned subsidiary of LMX, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATTS Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, the provision for income taxes was attributable to amounts for LMATT Series&#160;2024,&#160;Inc, LMATT Growth Series, Inc. and LMATT Growth and Income Series, Inc. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June&#160;30, 2023 and 2022, the Company recorded provision for income taxes of $<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,184,571</ix:nonFraction> and $<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">120,132</ix:nonFraction>, respectively. The effective tax rate is <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">15.0</ix:nonFraction>% for the three months ended June&#160;30, 2023. The effective rate for the three months ended June&#160;30, 2022 was <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">12.0</ix:nonFraction>% due to the impact of state income taxes and the release of the Company&#8217;s valuation allowance, as there was sufficient evidence of the Company&#8217;s ability to generate future taxable income at June&#160;30, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">For the six months ended June&#160;30, 2023 and 2022, the Company recorded provision for income taxes of $<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">528,104</ix:nonFraction> and $<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">296,806</ix:nonFraction>, respectively. The effective tax rate is <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal">3.6</ix:nonFraction>% for the six months ended June&#160;30, 2023. The existence of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-taxable</div> flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to be significantly lower than </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>&#160;</ix:exclude></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">78</div></ix:exclude></div></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_91072693" continuedAt="TextSelectionAppend_91072693_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072693_1" continuedAt="TextSelectionAppend_91072693_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072693_2" continuedAt="TextSelectionAppend_91072693_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div></ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072693_3"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the statutory rate. The effective rate for the six months ended June&#160;30, 2022 was <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal">18</ix:nonFraction>% due to the impact of state income taxes and the release of the Company&#8217;s valuation allowance, as there was sufficient evidence of the Company&#8217;s ability to generate future taxable income at June&#160;30, 2022. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not have any unrecognized tax benefits relating to uncertain tax positions as of June&#160;30, 2023, and December&#160;31, 2022, and did not recognize any interest or penalties related to uncertain tax positions as of June&#160;30, 2023, and December&#160;31, 2022. </div></div> </ix:continuation> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">17.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RELATED-PARTY TRANSACTIONS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023 and December&#160;31, 2022, $<ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,415,154</ix:nonFraction> and $<ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">263,785</ix:nonFraction>, respectively, were due to members and affiliates primarily for reimbursable transaction costs as well as distributions to owners of $<ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="PAsOn06_30_2023_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">717,429</ix:nonFraction> as a part of the Business Combination as of June&#160;30, 2023. As of June&#160;30, 2023 and December&#160;31, 2022, $<ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">10,473,748</ix:nonFraction> and $<ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">2,904,646</ix:nonFraction> was due from affiliates, respectively. The amount to be received as of June&#160;30, 2023 is due from the Sponsor as part of the Sponsor PIK Note. Additionally, the SPV purchase and sale note for $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn06_30_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,000,000</ix:nonFraction> as of June&#160;30, 2023 was also recorded as a related party transaction given the transfer of cash and policies between the Company and the SPV. Refer to footnote 13 for more information. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has a related-party relationship with Nova Trading (US),&#160;LLC (&#8220;Nova Trading&#8221;), a Delaware limited liability company and Nova Holding (US)&#160;LP, a Delaware limited partnership (&#8220;Nova Holding&#8221; and collectively with Nova Trading, the &#8220;Nova Funds&#8221;). The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The servicing fee is equal to <ix:nonFraction name="us-gaap:RelatedPartyTransactionRate" contextRef="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">50</ix:nonFraction> basis points (<ix:nonFraction name="us-gaap:RelatedPartyTransactionRate" contextRef="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ScenarioPreviouslyReportedMembersrtRestatementAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">0.50</ix:nonFraction>%) times the monthly invested amount in policies held by Nova Funds divided by 12.&#160;The Company earned $<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">197,629</ix:nonFraction> and $<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P04_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">205,224</ix:nonFraction>, respectively, in service revenue related to Nova Funds for the three months ended June&#160;30, 2023 and 2022 and earned $<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">411,076</ix:nonFraction> and $<ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="P01_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">406,129</ix:nonFraction>, respectively, in service revenue related to Nova Funds for the six months ended June&#160;30, 2023 and 2022. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the Merger, LMA used Abacus to originate life settlement policies that it accounts for under the investment method. For the three and six months ended June&#160;30, 2023, the Company incurred $<ix:nonFraction name="abl:LifeSettlementContractsOriginationExpense" contextRef="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">837,975</ix:nonFraction> and $<ix:nonFraction name="abl:LifeSettlementContractsOriginationExpense" contextRef="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,627,975</ix:nonFraction>, respectively in origination costs for life settlement policies that were originated by Abacus. These costs are capitalized on the condensed consolidated balance sheets as life settlement policies, at cost. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, and December&#160;31, 2022, there were $<ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">72,600</ix:nonFraction> and $<ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">196,289</ix:nonFraction>, respectively owed from the Nova Funds, which are included as related-party receivables in the accompanying condensed consolidated balance sheets. </div></div> </ix:nonNumeric> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072696">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">18.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LEASES </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <ix:nonNumeric name="abl:AssetsAndLiabilitiesLesseeTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071796"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities for its operating lease consisted of the following amounts as of June&#160;30, 2023 and December&#160;31, 2022: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 14%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/>
<td style="vertical-align: bottom; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">240,816</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">77,011</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liability, current</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">227,561</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">48,127</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease liability, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">16,864</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">29,268</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease liability</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">244,425</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn12_31_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">77,395</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">79</div></ix:exclude></div></div> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_91072696" continuedAt="TextSelectionAppend_91072696_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072696_1" continuedAt="TextSelectionAppend_91072696_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072696_2" continuedAt="TextSelectionAppend_91072696_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072696_3"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes lease expense for its operating leases within general, administrative, and other expenses on the Company&#8217;s condensed consolidated statements of operations and comprehensive income.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><ix:nonNumeric name="us-gaap:LeaseCostTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071798">The Company&#8217;s lease expense for the periods presented consisted of the following:</ix:nonNumeric></div> <ix:continuation id="TextSelection_91071798"><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 60%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,471</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,921</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">24,942</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">23,842</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Variable lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">7,704</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">612</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">8,925</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">1,223</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">20,175</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">12,533</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">33,867</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">25,065</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows supplemental cash flow information related to lease activities for the periods presented: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 74%;"/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 5%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash paid for amounts included in the measurement of the lease liability</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">24,557</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">23,842</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ROU assets obtained in exchange for new lease liabilities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> </ix:continuation> <div style="clear: both; max-height: 0px;"></div> <ix:continuation id="TextSelection_91071796"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"/>
<td style="width: 19%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 18%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average remaining lease term (in years)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="PAsOn06_30_2023" format="ixt-sec:duryear">1.00</ix:nonNumeric></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="PAsOn12_31_2022" format="ixt-sec:duryear">1.58</ix:nonNumeric></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average discount rate</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="PAsOn06_30_2023" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.54</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="PAsOn12_31_2022" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal">3.36</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr> </table> </ix:continuation> <div style="clear: both; max-height: 0px;"></div> <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072614"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future minimum noncancellable lease payments under the Company&#8217;s operating leases on an undiscounted basis reconciled to the respective lease liability at June&#160;30, 2023 are as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 88%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Operating<br/> leases</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining of 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">130,176</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">118,057</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"><ix:nonFraction name="abl:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease payments (undiscounted)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">248,233</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Imputed interest</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">3,808</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liability as of June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="PAsOn06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">244,425</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"/>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric></ix:continuation><ix:continuation id="TextSelection_91072614"> </ix:continuation> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91072697">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">19.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">EARNINGS PER SHARE </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic earnings per share represents income available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding during the reported period. Net income per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the Public and Private Placement Warrants to purchase an aggregate of <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2023To06_30_2023_PrivatePlacementWarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:num-dot-decimal">26,150,000</ix:nonFraction></ix:nonFraction> shares in the calculation of diluted income per ordinary share, since the </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>&#160;</ix:exclude></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">80</div></ix:exclude></div></div> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_91072697" continuedAt="TextSelectionAppend_91072697_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91072697_1" continuedAt="TextSelectionAppend_91072697_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91072697_2" continuedAt="TextSelectionAppend_91072697_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="null;text-indent: 0px;">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91072697_3"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">average market price of the Company&#8217;s Class&#160;A common shares for the three and six months ended June&#160;30, 2023 was below the warrants&#8217; $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">11.50</ix:nonFraction> exercise price. As a result, diluted income per share is the same as basic net income per share for the period presented. </div></div> <ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding and earnings per share were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 11pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 40%;"/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/>
<td style="width: 4%; vertical-align: bottom;"/>
<td/>
<td/>
<td/> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Longevity Market Assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">6,750,145</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">4,679,558</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">14,835,648</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal">11,515,698</ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares used in computing net income per share, basic and diluted</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">50,507,728</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">50,369,350</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">50,438,921</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal">50,369,350</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted earnings per share:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P04_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.13</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P04_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.09</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2023To06_30_2023" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.29</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2022To06_30_2022" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal">0.23</ix:nonFraction></ix:nonFraction></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> </ix:nonNumeric></ix:continuation> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" contextRef="P01_01_2023To06_30_2023" escape="true" continuedAt="TextSelection_91071971">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">20.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SUBSEQUENT EVENTS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated&#160;subsequent events&#160;and transactions from the condensed consolidated balance sheet date through the date at which the condensed consolidated financial statements were issued. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owl Rock Credit Facility </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;5, 2023 (the &#8220;Owl Rock Closing Date&#8221;), the Company entered into that certain Credit Agreement (the &#8220;Owl Rock Credit Facility&#8221;), among the Company, as borrower, the several banks and other persons from time to time party thereto (the &#8220;Owl Rock Lenders&#8221;), and Owl Rock Capital Corporation, as administrative and collateral agent for the Owl Rock Lenders thereunder. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Owl Rock Credit Facility, among other things: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">requires the Company and certain subsidiaries of the Company to guarantee the loans provided under the Owl Rock Credit Facility pursuant to separate loan documentation; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides credit extensions for (i)&#160;an initial term loan in an aggregate principal amount of $<ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">25.0</ix:nonFraction>&#160;million upon the closing of the Owl Rock Credit Facility and (ii)&#160;optional delayed draw term loans (which can be drawn on multiple drawing dates) in an aggregate principal amount of up to $<ix:nonFraction name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:num-dot-decimal">25.0</ix:nonFraction>&#160;million available for one hundred eighty (<ix:nonNumeric name="abl:LineOfCreditFacilityRemainingBorrowingCapacityTerm" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" format="ixt-sec:durday">180</ix:nonNumeric>)&#160;days after the Owl Rock Closing Date (the &#8220;Delayed Draw Term Loan Availability Period&#8221;), subject to the requirement that on each delayed draw date, the liquid asset coverage ratio shall not be less than <ix:nonFraction name="abl:DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal">1.80</ix:nonFraction> to 1.00, together with other specified conditions to drawings, the proceeds of which may be used for working capital and the business requirements of the enterprise, and to fund acquisitions, investments and other transactions permitted by the loan documentation; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides a delayed draw commitment fee rate of <ix:nonFraction name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">0.50</ix:nonFraction>% per annum applicable to undrawn commitments during the Delayed Draw Term Loan Availability Period </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">matures on July&#160;5, 2028, the date that is <ix:nonNumeric name="us-gaap:DebtInstrumentTerm" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" format="ixt-sec:durwordsen">five years</ix:nonNumeric> after the closing of the Owl Rock Credit Facility; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">is secured by a first-priority security interest in substantially all of the assets of the Company and the subsidiary guarantors. No pledge of any equity interests in the Company is required by any holder of such equity interests; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for interest to accrue on the loans drawn under the Owl Rock Credit Facility at the election of the Company, by reference to either (i)&#160;an alternative base rate (such loans, &#8220;ABR Loans&#8221;) or (ii)&#160;an adjusted term SOFR rate (such loans, &#8220;SOFR Loans&#8221;) plus an applicable margin. The adjusted term SOFR rate is determined by the applicable term SOFR for a relevant interest period plus a credit spread adjustment of <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">0.10</ix:nonFraction>%, <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">0.15</ix:nonFraction>% and <ix:nonFraction name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">0.25</ix:nonFraction>% per annum for interest periods of <span style="-sec-ix-hidden:hidden91072234">one</span>, <span style="-sec-ix-hidden:hidden91072235">three</span> and <ix:nonNumeric name="abl:DebtInstrumentBasisSpreadOnVariableRateTerm" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis" format="ixt-sec:durwordsen">six months</ix:nonNumeric>, </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>&#160;</ix:exclude></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:exclude>F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">81</div></ix:exclude></div></div> </ix:nonNumeric></div> </div> <ix:continuation id="TextSelection_91071971" continuedAt="TextSelectionAppend_91071971_1"><ix:exclude><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></ix:exclude></ix:continuation> <ix:continuation id="TextSelectionAppend_91071971_1" continuedAt="TextSelectionAppend_91071971_2"><ix:exclude><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_91071971_2" continuedAt="TextSelectionAppend_91071971_3"><ix:exclude> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </ix:exclude></ix:continuation> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><ix:continuation id="TextSelectionAppend_91071971_3">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="vertical-align: top; width: 9%;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div> </td>
<td style="vertical-align: top;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">respectively. The applicable margin for each type of loan is (i) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn07_05_2023_BaseRateMemberusgaapVariableRateAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">6.25</ix:nonFraction>% per annum for any ABR Loans and (ii) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">7.25</ix:nonFraction>% per annum for any SOFR Loans, with interest periods for SOFR Loans of </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden91071985">one</span>, </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden91071984">three</span> or </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="abl:DebtInstrumentBasisSpreadOnVariableRateTerm" contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis" format="ixt-sec:durwordsen">six months</ix:nonNumeric></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> (or other periods if agreed by all lenders); </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides a default rate that will accrue at </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentDefaultRate" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">2.00</ix:nonFraction></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% per annum over the rate otherwise applicable; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for amortization payments based on the initial principal amount of the loans outstanding of </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentAmortizationPaymentPercentage" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">1.0</ix:nonFraction>% per year (</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentAmortizationPaymentPercentagePerQuarter" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">0.25</ix:nonFraction></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% due per quarter), with adjustments made to the overall amortization amount upon the incurrence of any delayed draw loans; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains provisions requiring mandatory prepayment of the initial term loans and delayed draw term loans with </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentCovenantMandatoryPrepaymentPercentage" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">100</ix:nonFraction></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the proceeds of (a)&#160;indebtedness not permitted by the Owl Rock Credit Facility and (b)&#160;certain specified asset dispositions and payments (including in respect of settlements) in respect of property, casualty insurance claims or condemnation proceedings, with the proceeds received under this clause (b)&#160;subject to certain specified reinvestment rights and procedures set forth in the Owl Rock Credit Facility. The Owl Rock Credit Facility permits voluntary prepayments of outstanding loans at any time; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for a prepayment premium equal to (a) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">4.00</ix:nonFraction>% of the principal amount of such loans prepaid on or prior to the first anniversary of the closing of the Owl Rock Credit Facility, (b) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">3.00</ix:nonFraction>% of the principal amount of such loans prepaid after the first anniversary of the closing of the Owl Rock Credit Facility but on or prior to the second anniversary of the closing of the Owl Rock Credit Facility and (c) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">2.00</ix:nonFraction></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the principal amount of such loans prepaid after the second anniversary of the closing of the Owl Rock Credit Facility but on or prior to the third anniversary of the closing of the Owl Rock Credit Facility. No prepayment premium will be applicable for any such prepayment made after the third anniversary of the closing of the Owl Rock Credit Facility. The prepayment premium is applicable to voluntary prepayments and certain specified mandatory prepayment during such applicable periods; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for financial covenants such that (i)&#160;a consolidated net leverage ratio cannot exceed </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentCovenantLeverageRatioMaximum" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal">2.50</ix:nonFraction> to 1.00 as of the last day of any fiscal quarter and (ii)&#160;a liquid asset coverage ratio cannot be less than </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal">1.80</ix:nonFraction></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;to 1.00; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains affirmative covenants related to, among other things, delivery of certain financial reports and compliance certificates, maintenance of existence, compliance with laws, material contracts, payment of taxes, property and insurance matters, inspection of property, books and records, notices, collateral matters and future subsidiaries, in each case, subject to specified limitations and exceptions; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains an affirmative representation and corresponding covenant that the Company and certain subsidiaries of the Company do not, and will not during the term of the Owl Rock Facility (or if the term of the Owl Rock Credit Facility continues for longer than a year, during the Company&#8217;s and certain subsidiaries of the Company&#8217;s most recent fiscal year), derive more than fifteen percent (</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="abl:DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal">15</ix:nonFraction></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%) of their aggregate gross revenues from securities related activities; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains negative covenants related to, among other things, incurrence of debt, creation of liens, mergers, acquisitions and certain other fundamental changes, conditions concerning the creation of new subsidiaries, conditions concerning opening of new accounts, disposition of assets, dividends and other restricted payments, prepayment of certain indebtedness, transactions with affiliates, investments and limitations on lines of business, in each case, subject to specified limitations and exceptions; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td id="fin527481_35a" style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for certain specified events of default upon the occurrence and during the continuation of certain events or conditions (subject to specified exceptions, grace periods or cure rights, as applicable) each as set forth in the Owl Rock Credit Facility, which includes among other things, defaults with respect to nonpayment, breaches of representations and warranties, failure to comply with covenants, cross-default to other material indebtedness, bankruptcy and insolvency matters, ERISA matters, material judgments, collateral and perfection matters, the occurrence of a change of control and subordination matters with respect to certain specified indebtedness. The occurrence and continuance of an event of default that is not cured or waived will enable the agent and/or the lenders, as applicable, to accelerate the loans or take other remedial steps as provided in the Owl Rock Credit Facility and the other loan documents. </div></div> </td> </tr> </table> </ix:continuation> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-<div style="letter-spacing: 0px; top: 0px;;display:inline;">82</div></div></div> </div> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ABACUS SETTLEMENTS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_37">UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FOR THE THREE AND SIX MONTHS ENDED JUNE&#160;30, 2023 AND 2022 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">Six Months Ended<br/>June&#160;30</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Origination revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,689,088</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">743,388</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,252,738</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,185,068</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,195,602</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,948,528</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,931,938</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,829,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,884,690</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,691,916</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,184,676</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,014,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,505,333</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">956,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,734,949</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,265,313</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,392,647</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,615,307</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,558,354</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,522,312</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cost of revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,897,980</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,571,932</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,293,303</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,787,625</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross Profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,986,710</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,119,984</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,891,373</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,227,039</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OPERATING EXPENSES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,297,577</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,208,051</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,848,580</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,948,358</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,561</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,048</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,597</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,988</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,300,138</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,211,099</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,854,177</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,954,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income (Loss) from operations</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(313,428</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(91,115</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(962,804</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,693</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OTHER INCOME (EXPENSE)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,193</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">599</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,147</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,863</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,725</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">273</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,670</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">872</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(9,808</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income (Loss) before provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(318,098</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(90,243</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(972,612</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">274,113</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,289</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NET INCOME (LOSS) AND COMPREHENSIVE</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(318,098</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(90,243</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WEIGHTED-AVERAGE UNITS USED IN COMPUTING NET INCOME (LOSS) PER UNIT:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NET INCOME/(LOSS) PER UNIT:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic earnings per unit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(795.25</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(225.61</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,437.25</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">681.97</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted earnings per unit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(795.25</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(225.61</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,437.25</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">681.97</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:140pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">See accompanying notes to interim condensed consolidated financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-83 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ABACUS SETTLEMENTS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_38">UNAUDITED CONDENSED STATEMENTS OF CHANGES IN MEMBERS&#8217; EQUITY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FOR THREE MONTHS ENDED JUNE&#160;30, 2023 AND 2022 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:53%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Common units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Additional</span><br/><span style="font-weight:bold"><span style="white-space:nowrap">Paid-In&#160;Capital</span></span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Retained</span><br/><span style="font-weight:bold">Earnings</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;March 31, 2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,270,334</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,354,334</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(318,098</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(318,098</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(442,283</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(442,283</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;June 30, 2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">509,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">593,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="8"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Common units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Additional</span><br/><span style="font-weight:bold"><span style="white-space:nowrap">Paid-In</span> Capital</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Retained</span><br/><span style="font-weight:bold">Earnings</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;December 31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,927,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,011,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(442,283</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(442,283</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;June 30, 2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">509,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">593,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:200pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See accompanying notes to interim condensed financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-84 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ABACUS SETTLEMENTS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">UNAUDITED CONDENSED STATEMENTS OF CHANGES IN MEMBERS&#8217; EQUITY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FOR SIX MONTHS ENDED JUNE&#160;30, 2023 AND 2022 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:53%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Common units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Additional</span><br/><span style="font-weight:bold"><span style="white-space:nowrap">Paid-In&#160;Capital</span></span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Retained</span><br/><span style="font-weight:bold">Earnings</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;December 31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,638,995</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,722,995</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(659,869</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(659,869</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;June 30, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,251,914</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,335,914</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="8"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Common units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Additional</span><br/><span style="font-weight:bold"><span style="white-space:nowrap">Paid-In</span> Capital</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Retained</span><br/><span style="font-weight:bold">Earnings</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td colspan="2" rowspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Total</span></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;December 31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,927,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,011,137</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(442,283</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(442,283</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#8212;June 30, 2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">80,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">509,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">593,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:200pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See accompanying notes to interim condensed financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-85 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ABACUS SETTLEMENTS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_39">UNAUDITED INTERIM CONDENSED STATEMENTS OF CASH FLOWS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FOR SIX MONTHS ENDED JUNE&#160;30, 2023 AND 2022 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:77%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Six Months<br/>Ended June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH FLOWS FROM OPERATING ACTIVITIES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(974,901</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">272,788</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net income to net cash used in operating activities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,157</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40,278</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,952</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of deferred financing fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,725</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Non-cash</span> lease expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,210</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party receivables</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">397,039</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other receivables</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">101,203</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(202,491</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(198,643</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">71,038</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(26,211</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(20,111</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of deposit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">656,250</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued payroll and other expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(17,466</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">155,994</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contract liability&#8212;deposits on pending settlements</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">659,067</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,427,291</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(36,750</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(7,247</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(24,292</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(452,367</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH FLOWS FROM INVESTING ACTIVITIES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital expenditures</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(108,394</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(32,212</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of intangible asset</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(15,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to/from members and affiliates</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(74,134</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,525</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(182,528</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(35,687</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH FLOWS FROM FINANCING ACTIVITIES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to members</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,411</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,857</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions to members</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(442,283</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(659,869</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in financing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(443,694</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(671,726</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NET DECREASE IN CASH AND CASH EQUIVALENTS</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(650,514</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,159,780</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH AND CASH EQUIVALENTS:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Beginning of period</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,458,740</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,599,302</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">End of period</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">808,226</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,439,522</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:120pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">See accompanying notes to interim condensed financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-86 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">ABACUS SETTLEMENTS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_40">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">1.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">DESCRIPTION OF THE BUSINESS </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Abacus Settlements, LLC d/b/a Abacus Life (the &#8220;Company&#8221;) was formed in 2004 in the state of New York. In 2016, the Company obtained its licensure in Florida and <span style="white-space:nowrap">re-domesticated</span> to that state. On June&#160;13, 2023, the Company <span style="white-space:nowrap">re-domesticated</span> to Delaware. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company acts as a purchaser of outstanding life insurance policies (&#8220;Provider&#8221;) on behalf of investors (&#8220;Financing Entities&#8221;) by locating policies and screening them for eligibility for a life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known as origination services. When the sale of a policy is completed, this is deemed &#8220;settled&#8221; and the policy is then referred to as either a &#8220;life settlement&#8221; in which the insured&#8217;s life expectancy is greater than two years or &#8220;viatical settlement,&#8221; in which the insured&#8217;s life expectancy is less than two years. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is not an insurance company, and therefore the Company does not underwrite insurable risks for its own account. On August&#160;30, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with East Resources Acquisition Company (&#8220;ERES&#8221;), which was subsequently amended on October&#160;14, 2022. As part of the Merger Agreement, the holders of the Company&#8217;s common units together with the holders of Longevity Markets Assets, LLC (&#8220;LMA&#8221;), a commonly owned affiliate, will receive aggregate consideration of approximately $531,750,000, payable in a number of newly issued shares of ERES Class&#160;A common stock, par value $0.0001 per share (&#8220;ERES Class&#160;A common stock&#8221;), with a value ascribed to each share of ERES Class&#160;A common stock of $10.00 and, to the extent the aggregate transaction proceeds exceed $200.0&#160;million, at the election of the Company&#8217;s and LMA&#8217;s members, up to $20.0&#160;million of the aggregate consideration will be payable in cash to the Company&#8217;s and LMA&#8217;s members. The transaction closed on June&#160;30, 2023 upon shareholder approval and customary closing conditions. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">2.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The condensed balance sheet as of June&#160;30, 2023, was derived from amounts included in the Company&#8217;s annual financial statements for the year ended December&#160;31, 2022. Such amounts are included within the condensed consolidated financial statements of Abacus Life, Inc. Capitalized terms used herein without definition have the meanings ascribed to them in the Company&#8217;s financial statements for the year ended December&#160;31, 2022. Refer to this note in the annual financial statements for the full list of the Company&#8217;s significant accounting policies. The details in those notes have not changed except as discussed below and as a result of normal adjustments in the interim periods. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Basis of Presentation</span>&#8212;The accompanying condensed financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and are prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Unaudited Condensed Financial Statements</span>&#8212;The condensed financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2023, and the condensed results of its operations and comprehensive income/(loss) and cash flows for the three and six months ended June&#160;30, 2023 and 2022. The condensed results of operations and comprehensive income/(loss) and cash flows for the period January&#160;1, 2023 to June&#160;30, 2023, are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2023, or any other period. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-87 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Use of Estimates</span>&#8212;The preparation of US&#160;GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the reports amounts of revenue and expenses during the reporting periods. Company&#8217;s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, impairment testing, valuation of other receivables from clients, income taxes, and legal reserves. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Going Concern</span>&#8212;Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. Management&#8217;s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date these financial statements were issued. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Other receivables</span>&#8212;Other receivables include origination fees for policies in which the recission period has ended, but the funds have not been received yet from financing entities. These fees were collected in the subsequent month. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company provides an allowance for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses after all means of collection have been exhausted and the potential for recovery is deemed remote. The Company does not have any material allowance for credit losses as of June&#160;30, 2023 or December&#160;31, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If the financial condition of the Company&#8217;s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company did not record material allowance for credit losses as of June&#160;30, 2023, and December&#160;31, 2022, respectively. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Concentrations</span>&#8212;All of the Company&#8217;s revenues are derived from life settlement transactions in which the Company represents Financing Entities that purchased existing life insurance policies. One financing entity, a company in which the Company&#8217;s members own interests, represented 23% and 66% of the Company&#8217;s revenues in six months ended June&#160;30, 2023 and 2022, respectively. The Company originates policies through three different channels: Direct to Consumer, Agent, and Broker. Two brokers represented the sellers for over 10% of the Company&#8217;s life settlement commission expense during the period six months ended June&#160;30, 2023. No brokers represented the sellers for over 10% of the Company&#8217;s life settlement commission expense during the period six months ended June&#160;30, 2022. The Company maintains cash deposits with a major financial institution, which from time to time may exceed federally insured limits. The Company periodically assesses the financial condition of the institution and believes that the risk of loss is minimal. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Advertising</span>&#8212;All advertising expenditures incurred by the Company are charged to expense in the period to which they relate and are included in general and administrative expenses on the accompanying condensed statements of operations and comprehensive income/(loss). Advertising expense totaled $367,418 and $286,695 for three months ended June&#160;30, 2023 and 2022, respectively. Advertising expense totaled $741,789 and $554,802 for six months ended June&#160;30, 2023 and 2022, respectively. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">3.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">SEGMENT REPORTING </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Operating as a centrally led life insurance policy intermediary, the Company&#8217;s president and chief executive officer is the chief operating decision maker who allocates resources and assesses financial performance </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-88 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
based on financial information presented for the Company as a whole. As a result of this management approach, the Company is organized as a single operating segment. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">4.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">REVENUE </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Disaggregated Revenue&#8212;</span>The following table presents a disaggregation of the Company&#8217;s revenue by major sources for three months ended June&#160;30, 2023 and 2022, and for six months ended June&#160;30, 2023 and 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">Six Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agent</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,334,402</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,717,512</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,143,016</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,690,701</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Broker</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,809,499</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,247,953</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,675,973</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,727,970</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Client direct</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">740,789</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">726,451</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,365,687</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,595,993</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,884,690</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,691,916</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,184,676</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,014,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">5.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">INCOME TAXES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Since the Company elected to file as an S corporation for federal and State income tax purposes, the Company incurred no federal or state income taxes. Accordingly, provision for income taxes is attributable to minimum state tax payments that are due regardless of their S corporation status and income position. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the three months ended June&#160;30, 2023 and 2022, the company did not record provision for income taxes. For the six months ended June&#160;30, 2023 and 2022, the company recorded provision for income taxes of $2,289 and $1,325, respectively, which consist of state minimum taxes for state taxes that have been paid and settled during the period. The effective tax rate was approximately (0.24%) for the six months ended June&#160;30, 2023, compared to 0.48% for the six months ended June&#160;30, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Given the company&#8217;s S Corporation status, temporary book and tax differences do not create a deferred tax asset or liability on the balance sheets. Accordingly, an assessment of realizability of any deferred tax asset balances is not relevant. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">6.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">RETIREMENT PLAN </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company provides a defined contribution plan to its employees, Abacus Settlements LLC 401(k) Profit Sharing Plan&#160;&amp; Trust (the &#8220;Plan&#8221;). All eligible employees are able to participate in voluntary salary reduction contributions to the Profit-Sharing Plan. All employees who have completed one year of service with the Company are eligible to receive employer-matching contributions. The Company may match contributions to the Plan, up to 4% of compensation. For the three months ended June&#160;30, 2023 and 2022, and for six months ended June&#160;30, 2023 and 2022, the Company made no discretionary contribution to the Plan. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">7.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">RELATED-PARTY TRANSACTIONS </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has a related-party relationship with Nova Trading (US), LLC (&#8220;Nova Trading&#8221;), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (&#8220;Nova Holding&#8221; and collectively with Nova Trading, the &#8220;Nova Funds&#8221;) as the owners of Abacus jointly own 11% of the Nova Funds. For the three months ended June&#160;30, 2023 and 2022, the Company originated 38 and 92 policies, respectively, for the Nova Funds with a total value of $56,688,680 and $102,307,954, respectively. For six months ended June&#160;30, 2023 and 2022, the Company originated 72 and 183 policies, respectively, for the Nova Funds with a total value of $96,674,080 and $282,804,838, respectively. For its origination services to the Nova Funds, the Company earns origination fees equal to the lesser of (i) 2% of the net death benefit for </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-89 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the policy or (ii) $20,000. For three months ended June&#160;30, 2023 and 2022, and for six months ended June&#160;30, 2023 and 2022, revenue earned, and contracts originated are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:42%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">Three Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">Six Months Ended<br/>June&#160;30,</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2023</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Origination fee revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,504,532</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,164,107</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,952,837</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,569,034</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transaction reimbursement revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">75,332</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">152,221</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">140,960</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">306,361</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,579,864</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,316,328</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,093,797</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,875,395</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,290,504</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,201,256</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11,656,637</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,738,202</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Face value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,688,680</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">102,307,954</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">96,674,080</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">282,804,838</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">72</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">183</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Average Age</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">0</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">75</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition to the Nova Funds, the Company also has another affiliated investor that they provide origination services for. Total revenue earned related to the other affiliated investor was $3,615,738 and $589,700, of which $3,615,739 and $470,200 related to LMA for the three months ended June&#160;30, 2023 and 2022, respectively. Total cost of sales related to the other affiliated investor was $2,623,201 and $363,700, of which $2,623,201 and $326,200 related to LMA for three months ended June&#160;30, 2023 and 2022, respectively. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Total revenue earned related to the other affiliated investor was $6,838,141 and $911,700, of which $6,794,641 and $470,200 related to LMA, for the six months ended June&#160;30, 2023 and 2022, respectively. Total cost of sales related to the other affiliated investor was $5,020,603 and $612,700, of which $5,012,103 and $326,200 related to LMA for the six months ended June&#160;30, 2023 and 2022, respectively. In addition, there is a related party receivable due from LMA related to transaction expenses of $19,246 and $0 as of June&#160;30, 2023 and 2022, respectively, which is included as due from members and affiliates in the accompanying condensed balance sheets. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">8.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">SUBSEQUENT EVENT </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2023, the Company consummated the merger with LMA. The Company has evaluated its subsequent events through August&#160;14, 2023, the date that the financial statements were issued and determined that there were no events that occurred that required disclosure. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-90 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman">Longevity Market </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman">Assets,&#160;LLC </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consolidated Financial Statements as of and </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">for the Years Ended December&#160;31, 2022 and </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2021, and Report of Independent Registered </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Public Accounting Firm </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-91 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">LONGEVITY MARKET ASSETS,&#160;LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">TABLE OF CONTENTS </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:89%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Page</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_12">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-93</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_13">Consolidated Balance Sheets</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-94</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_14">Consolidated Statements of Operations and Comprehensive Income (Loss)</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-95</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_15">Consolidated Statements of Changes in Members&#8217; Equity</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-96</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_16">Consolidated Statements of Cash Flows</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-97</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_17">Notes to Consolidated Financial Statements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-98-F-120</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-92 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_12">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#8195; </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Longevity Market Assets, LLC </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Opinion on the financial statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the accompanying consolidated balance sheets of Longevity Market Assets, LLC (a Florida limited liability company) and subsidiaries (the &#8220;Company&#8221;) as of December&#160;31, 2022 and 2021, the related consolidated statements of operations and comprehensive income (loss), changes in members&#8217; equity, and cash flows for each of the two years in the period ended December&#160;31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December&#160;31, 2022, in conformity with accounting principles generally accepted in the United States of America. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Basis for opinion </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:100%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt;margin-bottom:1pt">


<img src="g423260g37n37.jpg" alt="LOGO"/>
</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">We&#160;have&#160;served&#160;as&#160;the&#160;Company&#8217;s&#160;auditor&#160;since&#160;2022.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Philadelphia, Pennsylvania</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">March&#160;24, 2023</td></tr>
</table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-93 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_13">LONGEVITY MARKET ASSETS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">CONSOLIDATED BALANCE SHEETS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">AS OF DECEMBER&#160;31, 2022 AND 2021</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:77%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">ASSETS</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CURRENT ASSETS:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,052,823</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 102,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,448</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party receivable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">198,364</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">67,491</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due from affiliates</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,904,646</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">116,646</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">24,905</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,282,927</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">194,816</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PROPERTY AND EQUIPMENT&#8212;Net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,617</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,899</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OTHER ASSETS</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating <span style="white-space:nowrap"><span style="white-space:nowrap">right-of-use</span></span> asset</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77,011</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">122,503</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life settlement policies, at cost</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,716,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life settlement policies, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,809,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Available for sale securities, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <span style="white-space:nowrap">non-current</span> assets, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">890,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL ASSETS</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,094,847</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,840,218</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">LIABILITIES AND MEMBERS&#8217; EQUITY</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CURRENT LIABILITIES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 40,014</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to affiliates</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">263,785</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">930,630</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities- current portion</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">45,107</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued transaction costs</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">908,256</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42,227</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,192</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,302,409</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">995,929</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,249,653</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities- noncurrent portion</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29,268</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77,396</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,363,820</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL LIABILITIES</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,945,150</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,073,325</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COMMITMENTS AND CONTINGENCIES (Note 9)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MEMBERS&#8217; EQUITY:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common units, $10.00 par value; 5,000 common units issued and outstanding at December&#160;31, 2022 and 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <span style="white-space:nowrap">paid-in</span> capital</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">660,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">660,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,487,323</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">205,048</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,052,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Non-controlling</span> interest</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">899,538</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(148,155</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total members&#8217; equity</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,149,697</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">766,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL LIABILITIES AND EQUITY</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">59,094,847</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,840,218</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:20pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying notes are an integral part of these consolidated financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-94 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_14">LONGEVITY MARKET ASSETS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:78%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">REVENUES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Portfolio servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Related party servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 818,300</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 699,884</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Portfolio Servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">652,672</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">380,102</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total portfolio servicing revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,470,973</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,079,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Investment Income from life insurance policies held using investment method</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">37,828,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of life insurance policies (policies held using fair value method)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,413,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total active management revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,242,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total revenues</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44,713,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,199,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">COST OF REVENUES (Excluding depreciation stated below)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,245,131</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">735,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,468,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">464,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">OPERATING EXPENSES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Sales and marketing</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,596,140</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">General, administrative and other</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,066,403</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">101,406</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Unrealized loss on investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other operating expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">493,849</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,447</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total operating expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,803,168</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">597,702</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating income (loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,665,255</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">OTHER (EXPENSE) INCOME</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest (expense), net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(41,324</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347,013</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total other (expense) income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(388,337</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net income (loss) before tax</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,276,917</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Income tax expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">NET INCOME (LOSS)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,386,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">704,699</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(148,155</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">NET INCOME ATTRIBUTABLE TO LONGEVITY MARKET ASSETS, LLC</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31,682,275</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 14,546</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">EARNINGS PER UNIT:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Basic earnings per unit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 6,477.39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 2.91</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Diluted earnings per unit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 6,477.39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 2.91</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Weighted average shares outstanding&#8212;basic</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Weighted average shares outstanding&#8212;diluted</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">NET INCOME</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,386,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other comprehensive income, net of tax:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,395,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Comprehensive income before <span style="white-space:nowrap">non-controlling</span> interests</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,782,804</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Less: Net income attributable to <span style="white-space:nowrap">non-controlling</span> interests</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">704,699</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Less: Comprehensive income attributable to <span style="white-space:nowrap">non-controlling</span> interests</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">342,994</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Comprehensive income attributable to Longevity Market Assets, LLC</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,735,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying notes are an integral part of these consolidated financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-95 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_15">LONGEVITY MARKET ASSETS, LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">CONSOLIDATED STATEMENTS OF CHANGES IN MEMBERS&#8217; EQUITY </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:39%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="6" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Common&#160;Units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" colspan="2" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Additional</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Paid-In</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Capital</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" colspan="2" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Retained</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Earnings</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" colspan="2" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Non-</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Controlling</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Interests</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" colspan="2" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Accumulated</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Other</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Comprehensive</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Income</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td>
<td style="vertical-align:bottom" colspan="2" rowspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Total</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Members&#8217;</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Equity</p></td>
<td style="vertical-align:bottom" rowspan="2">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Units</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Amount</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE AS OF DECEMBER&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">660,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">590,502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,300,502</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,546</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(148,155</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE AS OF DECEMBER&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">660,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">205,048</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(148,155</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">766,893</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Distributions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Comprehensive Income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">342,994</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,052,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,395,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31,682,275</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">704,699</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,386,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE AS OF DECEMBER&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">660,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,487,323</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">899,538</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,052,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,149,697</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-96 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_16">LONGEVITY MARKET ASSETS, LLC&#8195; </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">CONSOLIDATED STATEMENTS OF CASH FLOWS&#8195; </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:78%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH FLOWS FROM OPERATING ACTIVITIES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,386,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(133,609</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,282</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,447</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss on investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized (gain) on policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(5,742,377</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Non-cash</span> lease expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">383</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(10,448</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party receivable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(130,873</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(11,047</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other receivable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,315</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(91,741</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(23,738</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other noncurrent assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,936,452</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40,014</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued transaction costs</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">908,256</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,035</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,463</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life Settlement Policies purchased, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,066,975</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life Settlement Policies purchased, at cost</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(8,716,111</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by/(used in) operating activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,693,254</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(139,169</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH FLOWS FROM INVESTING ACTIVITIES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(25,346</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of available for sale securities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(750,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of other investments, at cost</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due from affiliates</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,904,646</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) investing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(3,704,646</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(275,346</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH FLOWS FROM FINANCING ACTIVITIES:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of long term debt, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,028,640</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to affiliates</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(666,845</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">781,663</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Member capital distribution</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by/(used in) financing activities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">22,961,795</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">381,663</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NET INCREASE (DECREASE) IN CASH</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29,950,403</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(32,852</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH AT THE BEGINNING OF THE YEAR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">102,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">135,272</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CASH AT THE END OF THE YEAR</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,052,823</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">102,420</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying notes are an integral part of these consolidated financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-97 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold" id="fin423260_17">LONGEVITY MARKET ASSETS,&#160;LLC </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">AS OF AND FOR THE YEARS ENDED DECEMBER&#160;31, 2022 AND 2021 </p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">1.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">DESCRIPTION OF BUSINESS </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Longevity Market Assets,&#160;LLC (together with its subsidiaries, the &#8220;Company&#8221; or &#8220;LMA&#8221;) was formed in February 2017 as Abacus Life Services,&#160;LLC in the state of Florida and subsequently changed its name in February 2022. The Company is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life settlement assets, as well as consulting, valuation, and actuarial services. The Company offers value to the owners of life settlements by monitoring and maintaining the policy, and performing all administrative work involved to keep the policy in force and at the premium level most advantageous to the owner. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is also engaged in buying and selling of life settlement policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout, or to sell to another purchaser of life settlement contracts for a gain on the sale. The Company is headquartered in Orlando, Florida. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August&#160;30, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with East Resources Acquisition Company (&#8220;ERES&#8221;), which was subsequently amended on October&#160;14, 2022 and April&#160;20, 2023. As part of the Merger Agreement, the total transaction value is $618,000,000, where the holders of the Company&#8217;s common units together with the holders of Abacus Settlements, LLC (&#8220;Abacus&#8221;), a commonly owned affiliate, will receive aggregate consideration of approximately $531,800,000, payable in a number of newly issued shares of ERES Class&#160;A common stock, par value $0.0001 per share (&#8220;ERES Class&#160;A common stock&#8221;), with a value ascribed to each share of ERES Class&#160;A common stock of $10.00 and, to the extent the aggregate transaction proceeds exceed $200.0&#160;million, at the election of the Company&#8217;s and Abacus&#8217;s members, up to $20.0&#160;million will be payable in cash to the Company&#8217;s and Abacus&#8217;s members. The transaction is expected to close in Q2 2023, subject to shareholder approval and customary closing conditions. The Company has accrued $908,226 of legal, advisory and audit fees related to the pending merger transaction, which have been included in Accrued Transaction Costs on the Consolidated Balance Sheets. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">2.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Basis of Presentation</span>&#8212;The accompanying consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and are prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). These statements include the financial statements of Longevity Market Assets,&#160;LLC and its wholly owned and controlled subsidiaries and subsidiaries in which the Company holds a controlling financial interest or is the primary beneficiary. Intercompany transactions and accounts have been eliminated in consolidation. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Consolidation of Variable Interest Entities</span>&#8212;For entities in which the Company has variable interests, the Company first evaluates whether the entity meets the definition of a variable interest entity (&#8220;VIE&#8221;) or a voting interest entity (&#8220;VOE&#8221;). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the variable interest entity will be included in the Company&#8217;s consolidated financial statements. The proportionate share not owned by the Company is recognized as Noncontrolling interest and Net income (loss) attributable to noncontrolling interest on the Consolidated Balance Sheets and Consolidated Statements of Operations and Comprehensive (Loss) Income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-98 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, <span style="font-style:italic">Consolidations</span>, requires the Company to separately disclose on its Consolidated Balance Sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of December&#160;31, 2022, total assets and liabilities of consolidated VIEs is $30,073,972 and $27,116,762, respectively. As of December&#160;31, 2021, total assets and liabilities of consolidated VIEs is $400 and $0, respectively. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On October&#160;4, 2021, the Company entered into an Operating Agreement with LMX Series,&#160;LLC (&#8220;LMX&#8220;) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the Operating Agreement being signed. LMX has a wholly owned subsidiary, LMATT Series&#160;2024,&#160;Inc., a Delaware <span style="white-space:nowrap">C-Corporation.</span> While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its consolidated financial statements for the year ended December&#160;31, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&#160;3, 2022, the Company formed Longevity Market Advisors, LLC (&#8220;Longevity Market Advisors&#8221;), which the Company has an 80% ownership interest in. The Longevity Market Advisors legal entity was established primarily for the purpose of acquiring the assets of a broker/dealer, Regional Investment Services, Inc. (&#8220;RIS&#8221;), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price in exchange for RIS was $60,000. The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being registered by the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;). As there are no tangible or intangible assets of value from RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise 100% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of Longevity Market Advisors and its subsidiaries in its consolidated financial statements for the year ended December&#160;31, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November&#160;30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December&#160;31, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="white-space:nowrap">Non-Consolidated</span> Variable Interest Entities</span>&#8212;On January&#160;1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing and investment providers (&#8220;the Providers&#8221;) in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for its investment in the call options as an equity security, pursuant to ASC 321. In arriving at this accounting conclusion, the Company first considered whether the call option met the definition of a derivative pursuant to ASC 815 and concluded that it did not as the instrument does not provide for net settlement and accordingly is not a derivative. The Company also concluded that the call option does not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call option includes material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call option is in a legal entity for which the share price has no readily determinable fair value. The Company&#8217;s basis in the call option, pursuant to ASC 321, is zero and accordingly the call option is not reflected in the statement of financial position. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-99 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company provided $347,013 of funding for the year ended December&#160;31, 2022 which is included in Other (Expense) Income on the Consolidated Statements of Operations and Comprehensive Income (Loss) and $120,000 of funding for the year ended December&#160;31, 2021 which was repaid in full by the Providers during that same year. See Note 9, &#8220;Commitments and Contingencies.&#8221; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&#160;31, 2022 and 2021, the Providers were considered to be VIEs, but were not consolidated in the Company&#8217;s consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. For the year ended December&#160;31, 2022, the unaudited financial information for the unconsolidated VIE&#8217;s are as follows: held assets of $126,040 and liabilities of $0 and held assets of $861,924 and liabilities of $358,586, respectively. As of December&#160;31, 2021, unaudited financial information for the <span style="white-space:nowrap">non-consolidated</span> VIEs were as follows: held assets of $122,279 and liabilities of $0 and held assets of $474,288 and liabilities of $2,218, respectively. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Noncontrolling Interest</span>&#8212;Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the Consolidated Balance Sheets at an amount equal to the noncontrolling interest&#8217;s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholder&#8217;s additional contributions, distributions, and the shareholder&#8217;s share of the net earnings or losses of each respective consolidated entity. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholder&#8217;s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in Net income (loss) attributable to noncontrolling interests in the Consolidated Statement of Operations and Comprehensive Income (Loss). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Use of Estimates</span>&#8212; The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the report&#8217;s amounts of revenue and expenses during the reporting periods. The Company&#8217;s estimates, judgments and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, valuation of other receivables, valuation of other investments, valuation of life settlement policies, valuation of available for sale securities, impairment testing, income taxes and legal reserves. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Life Insurance Settlement Policies</span>&#8212;The Company accounts for its holdings of life insurance settlement policies in accordance with <span style="white-space:nowrap">ASC&#160;325-30,</span> <span style="font-style:italic">Investments in Insurance Contracts</span>. The Company accounts for life settlement policies purchased that it intends to hold to maturity at fair value and life settlement policies that it intends to trade in the near term at cost plus premiums paid. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company follows ASC&#160;820, <span style="font-style:italic">Fair Value Measurements and Disclosures</span>, in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level&#160;1 relates to quoted prices in active markets for identical assets or liabilities. Level&#160;2 relates to observable inputs other than quoted prices included in Level&#160;1.&#160;Level&#160;3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company&#8217;s valuation of life settlements is considered to be Level&#160;3, as there is currently no active market where it is able to observe quoted prices for identical assets. The Company&#8217;s valuation model incorporates significant inputs that are not observable. See Note&#160;10, &#8220;Fair Value Measurements.&#8221; For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-100 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For policies held under the investment method, the Company tests the impairment if it becomes aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that includes medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the Consolidated Statements of Cash Flows. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Going Concern</span>&#8212;Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Company&#8217;s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. Management&#8217;s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the consolidated financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about Company&#8217;s ability to continue as a going concern within one year after the date these consolidated financial statements were issued. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Cash and Cash Equivalents</span>&#8212;Cash and cash equivalents include short-term and all <span style="white-space:nowrap">highly-liquid</span> debt instruments purchased with an original maturity of three months or less. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Fair Value Measurements</span>&#8212;The following fair value hierarchy is used in selecting inputs for those assets and liabilities measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company&#8217;s assumptions (unobservable inputs). The Company evaluates these inputs and recognizes transfers between levels, if any, at the end of each reporting period. The hierarchy consists of three levels: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Level</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;1</span></span>&#8212;Valuation based on quoted market prices in active markets for identical assets or liabilities. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Level</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;2</span></span>&#8212;Valuation based on inputs other than Level&#160;1 inputs that are observable for the assets or liabilities either directly or indirectly. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Level</span></span><span style="font-weight:bold"><span style="font-style:italic"></span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;3</span></span>&#8212;Valuation based on prices or valuation techniques that require inputs that are both significant to the fair value measurement and supported by little or no observable market activity. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s financial instruments consist of cash, cash equivalents, accounts receivables, due to affiliates, equity investments in privately held companies, S&amp;P options, life settlement policies, available for sale securities, market-indexed debt and secured borrowings. Cash, cash equivalents, accounts receivables, and due to affiliates are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Equity investments in privately held companies without readily determinable fair values are recognized at fair value on a nonrecurring basis when observable price changes from orderly transactions for identical or similar investments become available. <span style="white-space:nowrap"><span style="white-space:nowrap">Available-for-sale</span></span> securities are measured at fair value using inputs that are not readily determinable. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">S&amp;P options are recognized at fair value using quoted market prices in active markets, with changes in fair value included in net income. Market-indexed debt is measured on a quarterly basis, with qualifying changes in fair value recognized in net income, except for the portion of the total change in the fair value of the liability that results from a change in the instrument-specific credit risk, which is separately included in </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-101 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
other comprehensive income in accordance with ASC <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">825-10-45-5.</span></span></span> The measurement approach for life settlement policies is included above within the Life Settlement Policies disclosure. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Related party receivables</span>&#8212;Related party receivable are amounts owed to the Company by related party customers for services delivered. Management regularly reviews customer accounts for collectability and will record an allowance for these accounts when deemed necessary. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Related party receivables are charged off against the allowance for credit losses when deemed uncollectible (after all means of collection have been exhausted and the potential for recovery is deemed remote). Recoveries of related party receivables previously written off are recorded when received. Due to the nature of operations, related party receivables are due primarily from parties which the Company serves. As a result, management deems all amounts due to be collectable. If the financial condition of the Company&#8217;s customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company did not record material allowance for credit losses as of December&#160;31, 2022 and December&#160;31, 2021, respectively. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Other Investments</span>&#8212;Equity investments without readily determinable fair values include the Company&#8217;s investments in privately-held companies in which the Company holds less than a 20% ownership interest and does not have the ability to exercise significant influence. The Company measures these investments at cost, and these investments are adjusted through net earnings when they are deemed to be impaired or when there is an adjustment from observable price changes (referred to as the &#8220;measurement alternative&#8221;). These investments are included in other investments on the financial statements, at cost on the Consolidated Balance Sheets. In addition, the Company monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term prospects of these companies. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="white-space:nowrap"><span style="white-space:nowrap">Available-For-Sale</span></span> Securities</span>&#8212;The Company has investments in securities that are classified as <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities, and which are reflected on the Consolidated Balance Sheets at fair value. These securities solely consist of a convertible promissory note in a private company that was entered into at arms-length. The Company determines the fair value using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. If any unrealized gains and losses on these investments are incurred, these would be included as a separate component of accumulated other comprehensive loss, net of tax, on the Consolidated Balance Sheets. The Company classifies its <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. The Company monitors the fair value of the securities fall below amortized cost basis. Credit losses identified are reflected in the allowance for credit losses and any credit losses reversed are recognized in earnings. As of December&#160;31, 2022 and 2021, the fair value of the securities were determined to materially approximate amortized cost basis, thus no unrealized gains or losses were recorded, and the Company did not record any allowance for credit losses. The Company writes off uncollectible accrued interest receivable balances in a timely manner. The Company did not have material accrued interest on its <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities as of December&#160;31, 2022 and December&#160;31, 2021. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Other Noncurrent Assets, at fair value</span>&#8212;<span style="font-weight:bold"> </span>The other noncurrent assets balance consists of S&amp;P 500 put and call options that were purchased through a broker as an economic hedge related to the market-indexed instruments that are included in Long-Term Debt. The Company records these options at fair value and recognizes changes in fair value as part of net income. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Concentrations</span>&#8212;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable and <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying Consolidated Balance Sheets. The Company extends </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-102 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company&#8217;s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer&#8217;s financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of accounts. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Two related party customers accounted for 75% and 16% of the total accounts receivable as of December&#160;31, 2022 and two related party customers accounted for 51% and 49% as of December&#160;31, 2021. The largest receivables balances are from related parties where exposed credit risk is low. As such, there is no allowance for doubtful accounts as of December&#160;31, 2022 and December&#160;31, 2021. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">One customer accounted for 51% of active management revenue, while 22% of revenue related to two policies that matured that were accounted for under the investment method for the year ended December&#160;31, 2022. Two related party customers each accounted for 28% of the portfolio servicing revenue for the year ended December&#160;31, 2022. Three customers accounted for 29%, 29% and 20% of the total revenues for the year ended December&#160;31, 2021, respectively. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Property and Equipment, Net</span>&#8212;Property and equipment are stated at cost less accumulated depreciation and are depreciated on a straight-line basis over the following estimated useful lives: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:55%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Estimated Useful Life</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">5 years</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Shorter of remaining lease term or estimated useful life</td></tr>
</table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Expenditures for maintenance and repairs that do not extend the useful lives of property and equipment are expensed as incurred. Upon retirement or sale of assets, the cost and related accumulated depreciation are written off and any resulting gain or loss is reflected in the accompanying Consolidated Statements of Operations and Comprehensive Income (Loss). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are tested for recoverability whenever events or changes in circumstance indicate that their carrying amounts may not be recoverable. An impairment loss is recognized if the carrying amount of property and equipment is not recoverable and exceeds its fair value. Recoverability is determined based on the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. There were no impairments recognized during the years ended December&#160;31, 2022 and 2021, respectively. Property and equipment to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Revenue Recognition</span>&#8212;The Company generally derives its revenue from life settlement servicing and consulting activities (Portfolio Servicing Revenue) and life settlement trading activities (Active Management Revenue). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Portfolio Servicing Revenue</span></span><span style="font-style:italic">&#8212;</span>Portfolio servicing is comprised of servicing activities and consulting activities. The Company enters into service agreements with the owners of life settlement contracts and is responsible for maintaining the policy, manages processing of claims in the event of death of the insured and ensuring timely payment of optimized premiums computed to derive maximum return on maturity of the policy. The company neither assumes the ownership of the contracts nor undertakes the responsibility to make the premium payments, which remains with the owner of the policy. These service arrangements have contractual terms typically ranging from <span style="white-space:nowrap">one-month</span> to ten years and include fixed charges within its contracts as part of the total transaction price which are recognized on gross basis. To the extent that variable consideration is not constrained, the Company includes an estimate of the variable amount, as appropriate, within the total transaction price and updates its assumptions over the duration of the contract. Variable consideration has not been material. The duties performed by the company under these arrangements are considered as a single performance obligation that is satisfied on a monthly basis as the customer simultaneously receives and consumes the benefit provided by the Company as the Company performs the service. As such, revenue is recognized for services provided for the corresponding month. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-103 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under consulting engagements, the Company provides services typically for the owners of life settlement contracts who are often customers of the servicing business line, or customers of Abacus. These consulting engagements are comprised of valuation, actuarial services, and overall policy assessments related to life settlement contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be provided in tandem, as agreed to in the engagement letter or contract. Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is transferred to the customer. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Active Management Revenue</span></span><span style="font-style:italic">&#8212;</span>The Company also engages in buying and selling life settlement policies whereby each potential policy is independently researched to determine if it would be a profitable investment. Some of the policies are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. The Company elects to account for each investment in life settlement contracts using either the investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. Under the investment method, investments in contracts are based on the initial investment at the purchase price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and direct external costs, if any) to keep the policy in force are capitalized. Under the fair value method, the company will record the initial investment of the transaction price and remeasures the investment at fair value at each subsequent reporting period. Changes in fair value are reported on earnings when they occur. Upon sale of a life settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Other Consideration</span></span><span style="font-style:italic">&#8212;</span> Payment terms and conditions vary by contract type, although terms generally require payment within 30&#160;days of the invoice date. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied; however, the Company&#8217;s contracts do not contain a significant financing component. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Cost to Obtain and Fulfill Contracts</span></span><span style="font-style:italic">&#8212;</span> Costs to obtain contracts solely relate to commissions for brokers agents and employees who are directly involved in buying and selling policies as part of the active management revenue stream. The Company has elected to apply the ASC&#160;606, <span style="font-style:italic">Revenue from Contracts with Customers</span>, &#8216;practical expedient&#8217; which allows us to expense these costs as incurred if the amortization period related to the resulting asset would be one year or less. The Company has no significant instances of contracts that would be amortized for a period greater than a year, and therefore has no contract costs capitalized for these arrangements. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Segments</span>&#8212; Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the chief operating decision maker (&#8220;CODM&#8221;) in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#8217;s CODM is the President and Chief Executive Officer (&#8220;CEO&#8221;). The Company has determined that it operates in two operating segments and two reportable segments, portfolio servicing and active management as the CODM reviews financial information presented for purposes of making operating decisions, allocating resources, and evaluating financial performance. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Income Taxes</span>&#8212; The Company is taxed as an <span style="white-space:nowrap">S-corporation</span> for U.S. federal income tax purposes as provided in Section&#160;1362(a) of the Internal Revenue Code with the exception of three consolidated entities that are Delaware <span style="white-space:nowrap">C-corporations.</span> These VIEs and subsidiaries include LMATT Series&#160;2024,&#160;Inc., the wholly owned subsidiary of LMX Series, LLC., which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATT Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., which are all included in the consolidated financial statements. As such, the Company&#8217;s income or loss and credits are passed through to the members and reported on their individual federal income tax return. The three <span style="white-space:nowrap">C-corporations</span> file federal returns and in the state of Florida, where the businesses operates. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For LMATT Series&#160;2024,&#160;Inc., taxes on earnings are based on pretax financial accounting income (losses). </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-104 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company records uncertain tax positions in accordance with ASC&#160;740, <span style="font-style:italic">Income Taxes</span>, on the basis of a <span style="white-space:nowrap">two-step</span> process whereby: (i)&#160;management determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii)&#160;for those tax positions that meet the more likely than not recognition threshold, management recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. There are currently no uncertain tax positions. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes interest and penalties as a component of income tax expense. The Company is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Leases</span>&#8212; The Company accounts for its leases in accordance with ASC 842, <span style="font-style:italic">Leases</span>. A contract is or contains a lease if there is identified property, plant and equipment that is either explicitly or implicitly specified in the contract and the lessee has the right to control the use of the property, plant and equipment throughout the contract term, which is based on an evaluation of whether the lessee has the right to direct the use of the property, plant and equipment. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has one lease for office space in Orlando, Florida that is accounted for as an operating lease and goes through July&#160;31, 2024. The Company is responsible for utilities, maintenance, taxes and insurance, which are variable payments based on a reimbursement to the lessor of the lessor&#8217;s costs incurred. The Company excludes variable lease payments from the measurement of lease liabilities and <span style="white-space:nowrap"><span style="white-space:nowrap">right-of-use</span></span> (&#8220;ROU&#8221;) assets recognized on the Company&#8217;s Consolidated Balance Sheets. Variable lease payments are recognized as a lease expense on the Company&#8217;s Consolidated Statements of Operations and Comprehensive Income in the period incurred. The Company has elected the practical expedient to account for lease components and <span style="white-space:nowrap">non-lease</span> components together as a single lease component for its real estate lease noted above. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected the short-term lease exemption, which permits the Company to not recognize a lease liability and ROU asset for leases with an original term of one year or less. Currently the Company does not have any short-term leases. The Company&#8217;s current lease includes a renewal option. The Company has determined that the renewal option is not reasonably certain of exercise based on an evaluation of contract, market and asset-based factors, and therefore does not include periods covered by renewal options in its lease term. The Company&#8217;s leases generally do not include purchase options, residual value guarantees, or material restrictive covenants. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company determines its lease liability and ROU by calculating the present value of future lease payments. The present value of future lease payments is discounted using the Company&#8217;s incremental borrowing rate. As the Company&#8217;s leases generally do not have a readily determinable implicit rate, the Company uses its incremental borrowing rate based on market yields and comparable credit ratings, adjusted for lease term, to determine the present value of fixed lease payments based on information available at the lease commencement date. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company does not have any finance leases, nor is the Company a lessor (or sublessor). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">See Note 16 for additional disclosures related to leases. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Earnings Per Unit</span>&#8212;The Company has only one class of equity for net income (loss)per unit. Basic net income per unit is calculated by dividing net income by the weighted average number of units outstanding during the applicable period. If the number of units outstanding increases as a result of a stock dividend or stock split or decreases as a result of a reverse stock split, the computations of basic net income per unit are adjusted retroactively for all periods presented to reflect that change in capital structure. If such changes occur after the close of the reporting period but before issuance of the financial statements, the <span style="white-space:nowrap">per-unit</span> computations for that period and any prior-period financial statements presented are based on the new number of units. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-105 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">3.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">LIFE INSURANCE SETTLEMENT POLICIES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company holds 53 life settlement policies, of which 35 are accounted for under the fair value method and 18 are accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value is approximately $40,092,154 as of December&#160;31, 2022, with a corresponding fair value of approximately $13,809,352. Aggregate face value of policies accounted for using the investment method is $42,330,000 as of December&#160;31, 2022, with a corresponding carrying value of approximately $8,716,111.<span style="font-weight:bold"> </span> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2021, the Company did not own life settlement policies. As such, information herein has been presented only for the Consolidated Balance Sheets, dated as of December&#160;31, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022, the Company did not have any contractual restrictions on its ability to sell policies, including those held as collateral for the issuance of long-term debt. See Note 11, &#8220;Long-Term Debt.&#8221; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. The following tables summarize the Company&#8217;s life insurance policies grouped by remaining life expectancy as of December&#160;31, 2022: </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Policies Carried at Fair Value&#8212; </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Remaining Life Expectancy (Years)</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Number&#160;of&#160;Life<br/>Insurance<br/>Policies</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Face Value</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">&#8195;Fair&#160;Value&#8195;</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">0-1</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">1-2</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">200,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">160,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">2-3</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,085,549</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,274,406</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">3-4</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,200,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,406,451</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">4-5</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">526,416</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">21</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">33,606,605</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,442,079</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">35</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">40,092,154</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,809,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Policies accounted for using the investment method&#8212; </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Remaining Life Expectancy (Years)</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number&#160;of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Life&#160;Insurance<br/>Policies</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Face Value</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Carrying<br/>Value</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">0-1</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 3,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,220,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">1-2</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">327,683</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">2-3</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,039,088</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">3-4</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">260,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">4-5</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,850,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">845,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">32,480,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,024,340</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">42,330,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,716,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-106 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of December&#160;31, 2022, are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:80%"/>

<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 799,201</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">896,961</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">895,559</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">981,749</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,096,323</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,197,118</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;8,866,912</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is required to pay premiums to keep its portion of life insurance policies in force. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differ from the estimated life expectancies. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For policies accounted for under the investment method, the Company has not been made aware of information causing a material change to assumptions relating to the timing of realization of life insurance settlement proceeds. The Company has also not been made aware of information indicating impairment to the carrying value of policies. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">4.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">PROPERTY AND EQUIPMENT, NET </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net comprised of the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:56%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">As of</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">As of</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;19,444</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;19,444</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,902</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,902</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment&#8212;gross</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">25,346</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: accumulated depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,729</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,447</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment&#8212;net</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 18,617</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 22,899</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense for the years ended December&#160;31, 2022 and 2021 was $4,282 and $2,447, respectively. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">5.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="white-space:nowrap"><span style="white-space:nowrap">AVAILABLE-FOR-SALE</span></span> SECURITIES, AT FAIR VALUE </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Convertible Promissory Notes</span>&#8212;The Company holds convertible promissory notes in a separate unrelated insurance technology company. In November 2021, the Company purchased a $250,000 note and then purchased an additional note in January 2022 for $250,000 as part of the Tranche 5 offering (&#8220;Tranche 5 Promissory Note&#8221;). The Tranche 5 Promissory Note pays six percent (6%) interest per annum. The Tranche 5 Promissory Note matures November&#160;12, 2023 (&#8220;2023 Maturity Date&#8221;) and will be paid in full as to outstanding principal and accrued interest on the 2023 Maturity Date unless the Tranche 5 Promissory Note converts prior to the 2023 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $1,000,000 (&#8220;Next Equity Financing&#8221;). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2022, the Company purchased an additional convertible promissory note in the same unrelated insurance technology company for $500,000 as part of the Tranche 6<span style="font-weight:bold"> </span>offering<span style="font-weight:bold"> </span>(&#8220;Tranche 6 Promissory Note&#8221; and collectively with the Tranche 5 Promissory Note, the &#8220;Convertible Promissory Notes&#8221;). The Tranche 6 Promissory Note pays eight percent (8%) interest per annum and matures September&#160;30, 2024 (&#8220;2024 Maturity Date&#8221;) and will be paid in full as to outstanding principal and accrued interest on the 2024 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-107 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Maturity Date unless the Tranche 6 Promissory Note converts prior to the 2024 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $5,000,000 (&#8220;Next Round Securities&#8221;). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company applies the <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> method of accounting for its investment in the Convertible Promissory Notes which are debt investments. The Convertible Promissory Notes do not qualify for either the <span style="white-space:nowrap"><span style="white-space:nowrap">held-to-maturity</span></span> method due to the Convertible Promissory Notes&#8217; conversion rights or the trading-securities method because the Company holds the Convertible Promissory Notes as a long-term investment. The Convertible Promissory Notes are measured at fair value at each reporting-period end. Unrealized gains and losses are reported in other comprehensive income until realized. As of December&#160;31, 2022, the Company evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000 and there was no unrealized gain or loss recorded. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">6.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Investments: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Convertible Preferred Stock Ownership</span><span style="font-style:italic">&#8212;</span>The Company owns convertible preferred stock in two entities, further described below: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On July&#160;22, 2020, the Company purchased 224,551&#160;units of an unrelated insurance technology company&#8217;s Series Seed Preferred units for $750,000 (&#8220;Seed Units&#8221;). Upon conversion, the Seed Units held by the Company would represent 8.1% control in the technology company. During December 2022, the Company purchased an incremental 14,970 of Series Seed Preferred units for $50,000 and had a total of $800,000 investment as of December&#160;31, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December&#160;21, 2020, the Company purchased 207,476&#160;shares of a separate unrelated insurance technology company&#8217;s Series <span style="white-space:nowrap">B-1</span> preferred stock for $500,000 (&#8220;Preferred Shares&#8221;). The Preferred Shares are convertible into voting common stock of the technology company at the option of the Company. Upon conversion, the Preferred Shares would represent less than 1% control in the technology company. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company applies the measurement alternative for its investments in the Seed Units and Preferred Shares because these investments are of an equity nature, and the Company does not have the ability to exercise significant influence over operating and financial policies of entities even in the event of conversion of the Seed Units or Preferred Shares. Under the measurement alternative, the Company records the investment based on original cost less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the investee. The Company&#8217;s share of income or loss of such companies is not included in the Company&#8217;s Consolidated Statements of Operations and Comprehensive Income (Loss). The Company tests its investments for impairment whenever circumstances indicate that the carrying value of the investment may not be recoverable. No impairment of investments occurred for the years ended December&#160;31, 2022 and 2021. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">Other Noncurrent Assets- at fair value: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">S&amp;P Options</span><span style="font-style:italic">&#8212;</span>The Company owns S&amp;P 500 put and call options that were purchased through a broker as an economic hedge related to the market-indexed debt instruments included in the long-term debt note. The value is based on shares owned and quoted market prices in active markets. Changes in fair value are recorded in the Unrealized Loss on Investments line item on the income statement. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">7.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">CONSOLIDATION OF VARIABLE INTEREST ENTITIES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company consolidates VIEs for which it is the primary beneficiary or VOEs for which it controls through a majority voting interest or other arrangement. See Note&#160;2, &#8220;Summary of Significant Accounting Policies&#8221; for more information on how the Company evaluates an entity for consolidation. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-108 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company evaluated any entity in which it had a variable interest upon formation to determine whether the entity should be consolidated. The Company also evaluated the consolidation conclusion during each reconsideration event, such as changes in the governing documents or additional equity contributions to the entity. During the year ended December&#160;31, 2022, the Company consolidated LMX, Longevity Market Advisors and LMA Income Series, LP, which had total assets and liabilities of $30,073,972 and $27,116,762, respectively. For the year ended December&#160;31, 2021, the Company consolidated LMX, which had total assets and liabilities of $400 and $0, respectively. The Company did not deconsolidate any entities during the years ended December&#160;31, 2022 or December&#160;31, 2021. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended December&#160;31, 2022, the Company held total assets of $987,964 and liabilities of $358,586, in unconsolidated VIEs. As of December&#160;31, 2021, the Company held total assets of $596,567 and liabilities of $2,218 in unconsolidated VIEs. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">8.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">SEGMENT REPORTING </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Segment Information</span>&#8212;The Company organizes its business into two reportable segments (1)&#160;Portfolio Servicing and (2)&#160;Active Management, which generate revenue in different manners. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This segment structure reflects the financial information and reports used by the Company&#8217;s management, specifically its CODM, to make decisions regarding the Company&#8217;s business, including resource allocations and performance assessments as well as the current operating focus in compliance with <span style="font-style:italic">ASC</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;280, Segment Reporting</span>. The Company&#8217;s CODM is the President and CEO of the Company. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Portfolio Servicing segment generates revenues by providing policy services to customers on a contract basis. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Active Management segment generates revenues by buying, selling and trading policies and maintaining policies through to death benefit. The Company&#8217;s reportable segments are not aggregated. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review asset information related to investments nor expenditures incurred for long-lived assets given the Company&#8217;s investments are recognized on a cost basis and the Company&#8217;s long-lived assets are immaterial to the consolidated financial statements. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-109 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Information related to the Company&#8217;s reporting segments for the years ended December&#160;31, 2022 and December&#160;31, 2021 is as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:16%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:16%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">As&#160;of&#160;December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">As&#160;of&#160;December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portfolio Servicing</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,470,973</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,079,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Active Management</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">43,242,581</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">120,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Revenue</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">44,713,553</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,199,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Portfolio Servicing</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">300,235</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">406,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Active Management</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,168,187</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">58,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">38,468,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">464,093</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales and Marketing</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,596,140</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General, administrative and other</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,066,403</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(101,406</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other operating expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(493,849</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(4,282</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(2,447</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(347,013</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest (expense)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(42,798</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,474</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change on fair value of debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain(loss) on investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,045,623</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax expense</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to <span style="white-space:nowrap">non-controlling</span> interest</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(704,699</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">148,155</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to Longevity Market Assets, LLC</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31,682,275</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">14,546</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">9.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">COMMITMENTS AND CONTINGENCIES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Legal Proceedings</span><span style="font-style:italic">&#8212;</span>Occasionally, the Company may be subject to various proceedings, lawsuits, disputes, or claims. The Company investigates these claims as they arise and accrues a liability when losses are probable and reasonably estimated. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together, have a material adverse effect on the Company&#8217;s business, financial position, results of operations, or cash flows. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Commitment</span><span style="font-style:italic">&#8212;</span> The Company has entered into a Strategic Services and Expenses Support Agreement (&#8220;Expense Support Agreement&#8221;) with two commonly owned full-service origination, servicing, and investment providers (the &#8220;Providers&#8221;) in exchange for an option to purchase the outstanding equity ownership of the Providers. Pursuant to the Expense Support Agreement, LMA provides financial support and advice for the expenses of the Providers incurred in connection with their life settlement transactions businesses and the Providers are required to hire a life settlement transactions operations employee of an affiliate of LMA. No later than December&#160;1 of each calendar year, LMA provides a budget for the Providers, in which LMA commits to extend financial support for all operating expenses up to the budgeted amount. &#8220;Operating Expenses&#8221; for purposes of the Expense Support Agreement means all annual operating expenses of the Providers incurred in the ordinary course of business, excluding the premiums paid for the Providers insurance coverages that are allocable to the insurance coverage provided to Institutional Life Holdings,&#160;LLC, which owns all the outstanding membership interests of the Providers if unrelated to the Providers&#8217; settlement businesses. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Since inception of the Expense Support Agreement on January&#160;1, 2021 through December&#160;31, 2021, LMA had incurred $120,000 related to initial funding of operations, which were subsequently reimbursed and $0 </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-110 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
related to expenses. For the year ended December&#160;31, 2022, LMA incurred $347,013 of expenses related to the Expense Support Agreement, which is included in the Other Expense line of the Consolidated Statements of Operations and Comprehensive Income (Loss) and have not been reimbursed by the Providers. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">10.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">FAIR VALUE MEASUREMENTS </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company determines fair value based on assumptions that market participants would use in pricing an asset or a liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Level&#160;1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Level&#160;2 inputs: Other than quoted prices in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">Level&#160;3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Recurring Fair Value Measurements</span>&#8212;The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">As of December&#160;31, 2022</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="14" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fair Value Hierarchy</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Level&#160;1</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Level&#160;2</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Level&#160;3</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Total</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life settlement policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,809,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,809,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap"><span style="white-space:nowrap">Available-for-sale</span></span> securities, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,300,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S&amp;P 500 options</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">890,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">890,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tot assets held at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">890,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,109,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,000,181</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,249,653</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,249,653</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:58%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="14" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Fair Value Hierarchy</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">As of December&#160;31, 2021</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Level&#160;1</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Level&#160;2</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Level&#160;3</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Total</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Life settlement policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap"><span style="white-space:nowrap">Available-for-sale</span></span> securities, at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other investments</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,250,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <span style="white-space:nowrap">non-current</span> assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tot assets held at fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,500,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Life Settlement Policies</span><span style="font-weight:bold"><span style="font-style:italic">&#8212;</span></span>The Company separately accounts for each owned life settlement policy using either the fair value method, or the investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-111 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For policies carried at fair value, the Company utilizes valuation services of third-party actuarial firm, who value the contracts using Level&#160;3 unobservable inputs, including actuarial assumptions, such as life expectancies and cash flow discount rates. The valuation model is based on a discounted cash flow analysis and is sensitive to changes in the discount rate used. The Company utilizes a discount rate of 12% for policy valuation, which is based on economic and company-specific factors. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For life settlement policies carried using the investment method, the Company measures these at the cost of the policy plus premiums paid. The policies accounted for using the investment method totaled $8,716,111 at December&#160;31, 2022 and $0 at December&#160;31, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Discount Rate Sensitivity</span>&#8212;Changes in the 12% discount rate on the death benefit and premiums used to estimate the policies issued under LMATT Series&#160;2024,&#160;Inc (&#8220;LMATT Policies&#8221;) fair value has been analyzed. If the discount rate increased or decreased by 2&#160;percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of December&#160;31, 2022, would be as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">As of December&#160;31, 2022</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Change in</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Rate Adjustment</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Fair Value</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Fair Value</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">+2%</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,376,891</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,432,461</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No change</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,809,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">-2%</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,571,704</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,762,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Credit Exposure to Insurance Companies</span>&#8212;The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit or 10% of total fair value of the Company&#8217;s life insurance policies as of December&#160;31, 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:66%"/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">Carrier</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Face&#160;Value</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Fair&#160;Value</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Rating</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">American General Life Insurance Company</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">A</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Hancock Life Insurance Company</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">31</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">A+</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ReliaStar Life Insurance Company</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">NR</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Principal Life</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">A+</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securian Life Insurance Company</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">A+</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table provides a roll forward of the fair value of life insurance as of December&#160;31, 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:79%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value at December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Policies purchased</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,161,975</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Realized gain on matured/sold policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">105,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Premius Paid</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(433,626</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain on held policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,742,377</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in estimated fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,413,751</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matured/sold policies</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(200,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Premiums paid</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">433,626</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value at December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">13,809,352</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Long-Term Debt</span>&#8212;See Note&#160;11,&#160;&#8220;Long-Term Debt&#8221; for background information on the market-indexed debt. The Company has elected the fair value option in accounting for the instruments. Fair value is determined using Level&#160;3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i)&#160;the S&amp;P 500 Index price, (ii)&#160;S&amp;P 500 Index volatility, (iii)&#160;a risk-free rate based on data published by the US Treasury, and (iv)&#160;a term assumption based on the contractual term of the LMATT Notes. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate developed </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-112 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The total change in fair value of the debt resulted in a gain of $1,778,987. This comprises of a gain of $1,052,836, net of tax, which is included within accumulated other comprehensive income and $342,994, net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios and a recognized a loss of $90,719 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within <span style="font-style:italic">Change in fair value of debt</span> within the Consolidated Statements of Operations and Comprehensive Income (Loss) for the year ended December&#160;31, 2022. </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table provides a roll forward of the fair value of the issued as of December&#160;31, 2022: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:79%"/>

<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value at December&#160;31, 2021</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt issued to third parties</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,028,640</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss on change in fair value (risk-free)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,719</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized (gain) on change in fair value (credit-adjusted)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,869,706</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in estimated fair value</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,778,987</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value at December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,249,653</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Other Noncurrent Assets: S&amp;P 500 Options</span>&#8212; In February 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, purchased and sold S&amp;P 500 call and put options through a broker. The Company purchased and sold additional S&amp;P 500 call options through a broker in September 2022 through their 100% owned and fully consolidated subsidiaries, LMATT Growth Series 2.2024, Inc. and LMATT Growth&#160;&amp; Income Series 1.2026, Inc. The options are exchange traded, and fair value is determined using Level&#160;1 inputs of quoted market prices as of the Consolidated Balance Sheets date. Changes in fair value are classified as Unrealized gain/loss on investments within the Consolidated Statements of Operations and Comprehensive Income (Loss). </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Financial Instruments Measured at Fair Value on a Nonrecurring Basis</span>&#8212;The following financial assets, composed of equity securities without readily determinable fair values, are adjusted to fair value when observable price changes are identified, or an impairment charge is recognized. Such fair value measurements are based predominantly on Level&#160;3 inputs. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="white-space:nowrap"><span style="white-space:nowrap">Available-for-Sale</span></span> Investment</span>&#8212;The Convertible Promissory Notes are classified as an <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> securities. <span style="white-space:nowrap"><span style="white-space:nowrap">Available-for-sale</span></span> investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its <span style="white-space:nowrap"><span style="white-space:nowrap">available-for-sale</span></span> investments using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. The Company initially purchased a $250,000 convertible promissory note from the issuer in 2021 and then on January&#160;7, 2022, the Company purchased an additional $250,000 convertible promissory note from the same issuer and then an additional $500,000 in October 2022. As of December&#160;31, 2022 and 2021, the Company evaluated the fair value of its Convertible Promissory Notes and determined that the fair value approximates the carrying value of $1,000,000 and $250,000, respectively. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Other Investments</span>&#8212;The Company determines fair value using Level&#160;3 inputs under the measurement alternative. These investments are recorded at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively. As of December&#160;31, 2022 and 2021, the Company did not identify any impairment indictors and determined that the carrying value of $1,300,000 and $1,250,000, respectively, is the fair value for these equity investments in privately held companies, given that there have been no observable price changes. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-113 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Long-Term Debt &#8211; LMATT 1.2026 Issuance</span>&#8212;The Company has issued $400,000 in market-indexed notes, which include participation in S&amp;P 500 index returns and offer downside market protection. See additional information in the Long-Term Debt footnote. The company evaluates the fair value of the note using Level&#160;3 unobservable inputs. As of December&#160;31, 2022, the Company evaluated the fair value of the note and determined that the fair value approximates the carrying value of $400,000. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Financial Instruments Where Carrying Value Approximates Fair Value</span>&#8212;The carrying value of cash, cash equivalents, accounts receivables, and due to affiliates approximates fair value due to the short-term nature of their maturities. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">11.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">LONG-TERM DEBT </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Long-term debt comprises of the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:54%"/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">December&#160;31, 2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="6" align="center"><span style="font-weight:bold">December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Cost</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Fair value</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Cost</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Fair&#160;value</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Market-indexed notes:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LMATT Series 2024, Inc.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 9,866,900</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 8,067,291</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#160;&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LMATT Series 2.2024, Inc.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,333,391</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,354,013</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LMATT Growth&#160;&amp; Income Series 1.2026, Inc</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">400,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Secured borrowing:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LMATT Income Series, LP</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,428,349</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">17,428,349</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total long-term debt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">30,028,640</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,249,653</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">LMATT Series 2024, Inc. Market-Indexed Notes: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March&#160;31, 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, issued $10,166,900&#160;in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Series (LMATTS) 2024, are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-to-one</span></span> basis. As of December&#160;31, 2022, $9,886,900 of the principal amount remained outstanding. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December&#160;31, 2022, the fair value of the LMATT Series 2024, Inc. notes was $8,067,291. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The notes are secured by the assets of the issuing entities, which includes cash, S&amp;P 500 options, and life settlement policies totaling $12,200,797 as of December&#160;31, 2022. The notes agreements do not restrict the trading of life settlement contracts prior to maturity of the notes, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">LMATT Series 2.2024, Inc. Market-Indexed Notes: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On September&#160;16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $2,333,391 in market-indexed private placement notes. The LMATTSTM Series 2.2024, Inc. are market-indexed instruments designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to provide upside performance </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-114 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
participation that is capped at 120% of the performance of the S&amp;P 500. A separate layer of the notes have a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investments will experience all subsequent losses on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-to-one</span></span> basis. As of December&#160;31, 2022, the entire principal amount remained outstanding. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December&#160;31, 2022, the fair value of the LMATT Series 2.2024, Inc. notes was $2,354,013. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which include cash, S&amp;P 500 options, and life settlement policies totaling $3,246,756 as of December&#160;31, 2022. The notes agreement does not restrict the trading of life settlement contracts prior to maturity of the notes, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Additionally, on September&#160;16, 2022, LMATT Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $400,000 in market-indexed private placement notes. The notes, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (&#8220;LMATTSTM Growth and Income Series 1.2026, Inc.&#8221;) are market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The notes have a feature to provide upside performance participation that is capped at 140% of the performance of the S&amp;P 500. A separate layer of the notes have a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investment will experience all subsequent losses on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-to-one</span></span> basis. These notes also include a 4% dividend feature that will be paid annually. As of December&#160;31, 2022, the entire principal amount remained outstanding. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of December&#160;31, 2022, the fair value of the LMATT Growth and Income Series 1.2026, Inc. notes was $400,000. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The notes are secured by the assets of the issuing entity, LMATT Growth and Income Series 1.2026, Inc., which include cash, S&amp;P 500 options, and life settlement policies totaling $752,236 as of December&#160;31, 2022. The notes agreement does not restrict the trading of life settlement contracts prior to maturity of the notes, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notes with which the entity must comply. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">See additional fair value considerations within the Fair Value footnote. </p> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">LMA Income Series, LP and LMA Income Series, GP, LLC Secured Borrowing </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional <span style="white-space:nowrap">one-year</span> periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-115 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December&#160;31, 2022. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC <span style="white-space:nowrap">860-10.</span> As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">860-10-50-6A(d)).</span></span></span> In accordance with ASC <span style="white-space:nowrap"><span style="white-space:nowrap"><span style="white-space:nowrap">860-30-25-2,</span></span></span> as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC <span style="white-space:nowrap"><span style="white-space:nowrap">810-10-30.</span></span> As of December&#160;31, 2022, the fair value of the secured borrowing was $17,428,349. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">12.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">MEMBERS&#8217; EQUITY </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is authorized to issue up to 5,000&#160;units of par value common units. Holders of the Company&#8217;s common units are entitled to one vote for each share. At December&#160;31, 2022 and 2021, there were 5,000&#160;units issued and outstanding. Holders of the common units were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets available for distribution to the stockholders after payment of all liabilities. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">13.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">EMPLOYEE BENEFIT PLAN </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has a defined contribution plan in the U.S. intended to qualify under Section&#160;401 (k) of the Internal Revenue Code (the &#8220;401(k)&#160;Plan&#8221;). The 401(k)&#160;Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer up to 100% of their annual compensation on a <span style="white-space:nowrap">pre-tax</span> basis. For the years ended December&#160;31, 2022 and 2021, the Company elected to match 50% of employee contributions up to a maximum of 4% of eligible employee compensation. For the years ended December&#160;31, 2022 and 2021, the Company recognized expenses related to the 401(k)&#160;Plan amounting to $22,559 and $8,368, respectively. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">14.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">INCOME TAXES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company elected to file as an <span style="white-space:nowrap">S-corporation</span> for federal and state income tax purposes, the Company incurred no federal or state income taxes, except for income taxes recorded related to some of their consolidated variable interest entities and subsidiaries which are taxable C corporations. These VIEs and subsidiaries include LMATT Series 2024, Inc., the wholly owned subsidiary of LMX Series, LLC, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATT Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, tax expense (benefit) is attributable to amounts for LMATT Series 2024, Inc, LMATT Growth Series, Inc. and LMATT Growth and Income Series, Inc. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-116 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The components of provision for income taxes are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:16%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:16%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current provision:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current tax</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred provision (benefit):</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">737,376</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">152,567</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&#160;31, 2022 and 2021, the income tax expense differs from the provision that would result from applying federal and state statutory tax rates to income before income taxes due to the Company&#8217;s <span style="white-space:nowrap">S-corporation</span> election recognized for federal and state purposes. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For LMATT Series&#160;2024,&#160;Inc., LMATT Growth Series, Inc. and LMATT Growth and Income Series, Inc., the Company recognized $889,943 of provision related to income taxes for the year ended December&#160;31, 2022. For the year ended December&#160;31, 2021, the Company recognized no provision related to income taxes for LMATT Series 2024, Inc. because the Company incurred operating losses and maintained a full valuation allowance against its net deferred tax assets. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The effective income tax rate differs from the federal statutory income tax rate applied to the profit loss before provision for income taxes due to the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:12%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:12%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended<br/>December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended<br/>December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax benefit computed at federal statutory rate</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,988,153</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(28,058</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of pass through entities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(6,147,068</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(75,650</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State taxes, net of federal benefit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">174,024</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(21,458</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(125,166</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">125,166</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax benefit at effective tax rate</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 889,943</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-117 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The effects of temporary differences that give rise to significant portions of the deferred tax assets are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:56%"/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:11%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended<br/>December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended<br/>December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating loss carryforwards</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 167,554</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 125,166</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basis Difference in Life Insurance Contracts</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 109,903</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross deferred tax assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">277,457</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">125,166</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: valuation allowance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(125,166</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">277,457</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized Gain</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,641,277</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross deferred tax liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,641,277</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities&#8212;net of allowance</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,363,820</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> &#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The components of the Company&#8217;s net deferred tax assets are subject to realizability analysis in accordance with ASC 740. The establishment of a valuation allowance is based on consideration of all available evidence, both positive and negative, concerning the expectation of future realization, including, among other items: historical operating results; forecasts of future operations; the duration of statutory carryforward periods; experience with tax attributes expiring unused; and future reversals of existing taxable temporary differences and tax planning alternatives. In making such judgments, greater weight is given to evidence that can be objectively verified. Based on this analysis, the Company determined that sufficient positive evidence existed as of December&#160;31, 2022 to support releasing the valuation allowance recorded against net operating loss tax attributes at December&#160;31, 2021. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has $661,092 of Federal Net Operating Losses and $661,092 State Net Operating Losses that can be carried forward indefinitely. The Federal Net Operating Losses may be used to offset 80% of taxable income in a given year. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company did not have any unrecognized tax benefits relating to uncertain tax positions at December&#160;31, 2022 and 2021 and did not recognize any interest or penalties related to uncertain tax position at December&#160;31, 2022 and 2021. The Company does not anticipate that changes in its unrecognized tax benefits will have a material impact on the Consolidated Statements of Operations and Comprehensive Income during 2023. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">15.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">RELATED PARTY TRANSACTIONS </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2022 and 2021, $263,785 and $930,630 of due to affiliates, respectively, were payable to the companies in which Company&#8217;s members own interest. As of December&#160;31, 2022 and 2021, $2,904,646 and $0 of due from affiliates, respectively, were receivable from the companies in which the Company&#8217;s members own interest or are currently in negotiations with. The majority of the due from affiliate amount represents transaction costs incurred by the Company related to the planned business combination in which ERES has committed to reimburse the Company upon consummation of the merger. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has a related party relationship with Nova Trading (US), LLC (&#8220;Nova Trading&#8221;), a Delaware limited liability company, and Nova Holding (US) LP, a Delaware limited partnership (&#8220;Nova Holding&#8221; and collectively with Nova Trading, &#8220;Nova Funds&#8221;), as the owners of the Company jointly own 11% of the </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-118 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Nova Funds. The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The annual servicing fee is equal to 50 basis points (0.50%) times the invested amount in policies held by Nova Funds. The servicing fee is billed monthly. The Company earned $818,300 and $699,884, respectively, in service revenue related to Nova Funds for the years ended December&#160;31, 2022 and December&#160;31, 2021. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company also uses Abacus to originate life settlement policies that it accounts for under the investment method. For the year ended December&#160;31, 2022, the Company incurred $2,268,150 in origination expenses for life settlement policies that are included as part of active management revenue, given that revenue is presented on a net basis. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At December&#160;31, 2022 and 2021, there were $196,289 and $67,491, respectively, in expense reimbursements owed from the Nova funds, which are included as related party receivables in the accompanying balance sheets. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">16.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">LEASES </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In April 2021, the Company entered into an agreement to lease office space in Orlando, Florida from a related party. The lease is classified as an operating lease and goes through July&#160;31, 2024. The Company does not have any other leasing activities. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#8217;s ROU assets and lease liabilities for its operating leases consisted of the following amounts as of December&#160;31, 2022 and 2021: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease <span style="white-space:nowrap"><span style="white-space:nowrap">right-of-use</span></span> assets</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77,011</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">122,503</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liabilities:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liability, current</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48,127</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">45,107</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liability, <span style="white-space:nowrap">non-current</span></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29,268</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77,396</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total lease liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77,395</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">122,503</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes lease expense for its operating leases within general, administrative, and other expenses on the Company&#8217;s Consolidated Statements of Operations and Comprehensive Income (Loss). The Company&#8217;s lease expense for the periods presented consisted of the following: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:56%"/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:14%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease cost</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48,784</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,868</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Variable lease cost</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,664</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,019</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52,449</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,887</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table shows supplemental cash flow information related to lease activities for the periods presented: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:73%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Cash paid for amounts included in the measurement of the lease liability</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating cash flows from operating leases</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">48,399</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"> 19,868</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="4"/>
<td style="height:6pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROU assets obtained in exchange for new lease liabilities</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">139,025</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-119 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:55%"/>

<td style="vertical-align:bottom;width:19%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:18%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Year Ended</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2022</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">December&#160;31,&#160;2021</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average remaining lease term (in years)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1.58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2.58</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average discount rate</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3.36</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3.36</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Future minimum noncancelable lease payments under the Company&#8217;s operating leases on an undiscounted basis reconciled to the respective lease liability at December&#160;31, 2022 are as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:77%"/>

<td style="vertical-align:bottom;width:15%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Operating&#160;leases</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">49,855</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">29,514</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8212;&#8194;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating lease payments (undiscounted)</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">79,369</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Imputed interest</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">(1,974</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability as of December&#160;31, 2022</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">77,395</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left"><span style="font-weight:bold">17.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">SUBSEQUENT EVENTS </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company evaluated&#160;subsequent events&#160;and transactions from the balance sheet date through March&#160;24, 2023, the date at which the financial statements were issued. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center" id="fin423260_17a">*&#8194;*&#8194;*&#8194;*&#8194;*&#8194;* </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-120 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in this prospectus. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities to any person in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. Information contained on our web site is not part of this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table of contents is located on the inside of the front cover of this prospectus. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">&#8195;% Fixed Rate Senior Notes due 2028 </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center">ABACUS LIFE, INC. </p> <p style="font-size:150pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PROSPECTUS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">&#8195;&#8195;&#8195;&#8195;, 2023 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Piper Sandler </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">[*] </p> </div> <p style="font-size:150pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_24">PART II </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INFORMATION NOT REQUIRED IN PROSPECTUS </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;13. Other Expenses of Issuance and Distribution. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth the costs and expenses payable by us in connection with the issuance and distribution of the securities being registered. All amounts are estimated, except for the SEC registration fee. All costs and expenses are payable by us. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:82%"/>

<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC Registration Fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,603.80</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA Filing Fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Fees and Expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous Expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">&#8195;&#8195;&#8195;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">*&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be defined at this time. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will bear all costs, expenses and fees in connection with the registration of the securities, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws. All amounts are estimates except the SEC registration fee. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;14. Indemnification of Directors and Officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&#160;145 of the DGCL authorizes a court to award, or a corporation&#8217;s board of directors to grant, indemnity to officers, directors and other corporate agents in terms sufficiently broad to permit such indemnification under certain circumstances and subject to certain limitations. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our charter and bylaws, as they will be in effect upon the completion of this offering, provide that we will indemnify our directors and officers, and may indemnify our employees and agents, to the fullest extent permitted by Delaware law, including in circumstances in which indemnification is otherwise discretionary under Delaware law. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have entered into separate indemnification agreements with our directors and executive officers which requires us, among other things, to indemnify them against certain liabilities which may arise by reason of their status as directors or officers. We will also maintain director and officer liability insurance. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These indemnification provisions may be sufficiently broad to permit indemnification of our officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the employment agreements that we have entered into require the Company to indemnify any executive who is made a party or is threatened to be made a party to any action, suit or proceeding because he or she is or was a director or officer of the Company, subject to certain conditions. In such case, the Company will provide for the advancement of expenses. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-1 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;15. Recent Sales of Unregistered Securities. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2023, at the Closing of the Business Combination pursuant to the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), as described in the Company&#8217;s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on June&#160;5, 2023, as supplemented, Jay Jackson, Sean McNealy, Matthew Ganovsky, and Kevin Scott Kirby received Common Stock of the Company as consideration for the common units of LMA and Abacus Settlements. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;16. Exhibits and Financial Statement Schedules. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <span style="font-style:italic">List of Exhibits. </span>See the Exhibit Index filed as part of this Registration Statement. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;1.1**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523247536/d423260dex11.htm">Form of Underwriting Agreement. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;2.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000156459022030357/eresu-ex21_7.htm">Agreement and Plan of Merger, dated as of August&#160;30, 2022, by and among East Resources Acquisition Company, LMA Merger Sub, LLC, Abacus Merger Sub, LLC, Longevity Market Assets, LLC and Abacus Settlements, LLC, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed August&#160;30, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;2.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312522262995/d326265dex21.htm">First Amendment to Agreement and Plan of Merger, dated as of October&#160;14, 2022, by and among East Resources Acquisition Company, LMA Merger Sub, LLC, Abacus Merger Sub, LLC, Longevity Market Assets, LLC and Abacus Settlements, LLC, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed October&#160;14, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;2.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523108364/d479667dex21.htm">Second Amendment to Agreement and Plan of Merger, dated as of April&#160;20, 2023, by and among East Resources Acquisition Company, LMA Merger Sub, LLC, Abacus Merger Sub, LLC, Longevity Market Assets, LLC and Abacus Settlements, LLC (incorporated by reference to Exhibit&#160;2.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap">8-K</span> (File <span style="white-space:nowrap">No.&#160;001-39403)</span> filed with the SEC on&#160;April&#160;20, 2023), incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed April&#160;20, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex31.htm">Second Amended and Restated Certificate of Incorporation of Abacus Life, Inc., incorporated by reference from the Company&#8217;s <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex32.htm">Amended and Restated Bylaws of Abacus Life, Inc., incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.3**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523247536/d423260dex33.htm">Form of Base Indenture. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;3.4**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523247536/d423260dex34.htm">Form of Supplemental Indenture. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000156459020031714/cik0001814287-ex42_20.htm">Specimen Common Stock Certificate, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">S-1</span> filed July&#160;2, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000156459020031714/cik0001814287-ex43_19.htm">Specimen Warrant Certificate, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">S-1</span> filed July&#160;2, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000156459020033609/eres-ex41_23.htm">Warrant Agreement, dated July&#160;23, 2020 between East Resources Acquisition Company and Continental Stock Transfer&#160;&amp; Trust Company, as warrant agent, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;27, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex44.htm">Unsecured Promissory Note, dated as of June&#160;30, 2023, issued to Sponsor, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex45.htm">Amended and Restated Unsecured Promissory Note, dated as of July&#160;5, 2023, issued to East Asset Management, LLC, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex46.htm">Credit Agreement, dated as of July&#160;5, 2023, among Abacus Life, Inc., as borrower, the several lenders from time to time party thereto, Owl Rock Capital Corporation, as administrative agent and collateral agent, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex47.htm">Asset Purchase Agreement, dated as of July&#160;5, 2023, between Abacus Investment SPV, LLC, as seller, and Abacus Life, Inc., as purchaser, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.8**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523247536/d423260dex34.htm">Form of Fixed Rate Senior Notes (included in Exhibit&#160;3.4) </a></td></tr></table> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:6%"/>
<td style="width:90%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex48.htm">SPV Investment Facility, dated July&#160;5, 2023, between Abacus Life, Inc., as borrower, and Abacus Investment SPV, LLC, as lender, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.10</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex49.htm">Unsecured Promissory Note for funds drawn under the SPV Investment Facility, dated as of July&#160;5, 2023, issued to Abacus Investment SPV, LLC, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;4.11</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex410.htm">Unsecured Promissory Note for value of polices received under the SPV Investment Facility, dated as of July&#160;5, 2023, issued to Abacus Investment SPV, LLC, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;5.1**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523247536/d423260dex51.htm">Opinion of Locke Lord LLP Regarding the Legality of the Securities Being Registered. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex101.htm">Warrant Forfeiture Agreement, dated as of June&#160;30, 2023, by and among East Resources Acquisition Company and Sponsor incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex102.htm">Amended and Restated Registration Rights Agreement, dated as of June&#160;30, 2023, by and among the Company, Sponsor, certain equityholders of East Resources Acquisition Company named therein and certain equityholders of the LMA and Legacy Abacus named therein, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000156459020033609/eres-ex101_20.htm">Letter Agreement, dated as of July&#160;23, 2020, among the Company, its officers and directors and the Sponsor, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;27, 2020. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000156459022030357/eresu-ex101_9.htm">Sponsor Support Agreement, dated as of August&#160;30, 2022, by and among the East Resources Acquisition Company, Sponsor, LMA and Legacy Abacus, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed August&#160;30, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.5</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000156459022030357/eresu-ex102_8.htm">Company Support Agreement, dated as of August&#160;30, 2022, by and among East Resources Acquisition Company, LMA, Legacy Abacus and the other parties signatory thereto, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed August&#160;30, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.6</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex106.htm">Form of Indemnification Agreement, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.7</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex107.htm">Abacus Life, Inc. 2023 Long-Term Equity Incentive Plan, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.8</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex108.htm">Form of Restricted Stock Unit Award granted under the Abacus Life, Inc. 2023 Long-Term Equity Incentive Plan, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.9</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex109.htm">Form of Option Award granted under the Abacus Life, Inc. 2023 Long-Term Equity Incentive Plan, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.10</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523193281/d527481dex1010.htm">Form of Employment Agreement incorporated by reference from the Company&#8217;s Form S-1 filed July 26, 2023 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">14.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex141.htm">Code of Business Conduct and Ethics of Abacus Life, Inc., incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">21.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523182812/d525613dex211.htm">Subsidiaries of the Company, incorporated by reference from the Company&#8217;s Form <span style="white-space:nowrap">8-K</span> filed July&#160;6, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d423260dex231.htm">Consent of Grant Thornton LLP, Independent Registered Public Accounting Firm re: Abacus Settlements, LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d423260dex232.htm">Consent of Grant Thornton LLP, Independent Registered Public Accounting Firm re: Longevity Market Assets, LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><a href="d423260dex233.htm">Consent of Marcum LLP, Independent Registered Public Accounting Firm. </a></p></td></tr></table> </div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.4**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523247536/d423260dex51.htm">Consent of Locke Lord LLP (included in Exhibit 5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">24.1**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523236341/d423260ds1.htm#ii423260_1">Power of Attorney (included in the signature page)</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">25.1**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523247536/d423260dex251.htm">Form T-1 Statement of Eligibility under Trust Indenture Act of 1939, as amended, of the trustee under the Indenture</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">107**</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1814287/000119312523236341/d423260dexfilingfees.htm">Filing Fee Table</a></td></tr>
</table> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Schedules and exhibits have been omitted pursuant to Item&#160;601(b)(2) of Regulation&#160;S-K. Abacus Life, Inc. agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">**</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Previously Filed </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <span style="font-style:italic">Financial Statement Schedules. </span>The following financial statement schedules are filed as a part of this registration statement beginning on page <span style="white-space:nowrap">F-1</span> of the prospectus: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents are filed as part of this prospectus: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(1)&#8195;Financial Statements: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:95%"/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">Page</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">East Resources Acquisition Company</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_101">Report of Independent Registered Public Accounting Firm (PCAOB ID #688)</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-2</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_102">Consolidated Balance Sheets</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-3</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_103">Consolidated Statements of Operation</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-4</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_104">Consolidated Statements of Changes in Stockholders&#8217; Deficit</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-5</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_105">Consolidated Statements of Cash Flows</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-6</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_106">Notes to Consolidated Financial Statements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right"><span style="white-space:nowrap">F-7</span></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Abacus Settlements, LLC d/b/a Abacus Life</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_1">Report of Independent Registered Public Accounting Firm (PCAOB ID #248) </a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-32</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-style:italic">Audited Financial Statements as of and for the years ended December&#160;31, 2022 and 2021:</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_2">Balance Sheets</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-33</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_3">Statements of Operations and Comprehensive (Loss) Income</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-34</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_4">Statements of Cash Flows</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-35</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_5">Statements of Changes in Members&#8217; Equity</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-36</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_6">Notes to Financial Statements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-37</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-style:italic">Unaudited Condensed Financial Statements as of June&#160;30, 2023 and December&#160;31, 2022 and for the Six Months Ended June&#160;30, 2023 and 2022:</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_7">Balance Sheets</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="center">F-50</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_8">Statements of Operations and Comprehensive (Loss) Income</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-51</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_9">Statements of Changes in Members&#8217; Equity</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-52</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_10">Statements of Cash Flows</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-54</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_11">Notes to Financial Statements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-55</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Longevity Market Assets, LLC</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_12">Report of Independent Registered Public Accounting Firm (PCAOB ID #248) </a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-93</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><span style="font-style:italic">Audited Financial Statements as of and for the years ended December&#160;31, 2022 and 2021:</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_13">Balance Sheets</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-94</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_14">Statements of Operations and Comprehensive (Loss) Income</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-95</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_15">Statements of Changes in Members&#8217; Equity</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-96</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_16">Statements of Cash Flows</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-97</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin423260_17">Notes to Financial Statements</a></p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">F-98</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(2)&#8195;Financial Statement Schedules: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">None. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(3)&#8195;Exhibits </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The exhibits listed in the following index are filed, furnished, or incorporated by reference as part of this prospectus. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span><span style="font-style:italic"></span><span style="font-weight:bold">Item 17. Undertakings. </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">A.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">That, for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">B.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">That, for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">E.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(i)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(ii)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(iii)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(iv)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"></span>(b) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">II-5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
<h5><a href="#toc">Table of Contents</a></h5>


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="toc423260_25"><span id="ii423260_1"></span>SIGNATURES </p> <div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Orlando, State of Florida, on October 30, 2023. </p> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">ABACUS LIFE, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jay J. Jackson</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Jay J. Jackson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chairman of the Board,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer</p></td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:39%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:39%"/>

<td style="vertical-align:bottom;width:2%"/>
<td style="width:18%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signature</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jay J. Jackson</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Jay J. Jackson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director, President and Chief Executive Officer (Principal Executive Officer)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William H. McCauley</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">William H. McCauley</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Financial Officer (Principal Financial Officer)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Adam Gusky</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Karla Radka</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Cornelis Michiel van Katwijk</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Thomas W. Corbett, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Mary Beth Schulte</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">*</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">October 30, 2023</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Todd Sean McNealy</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
</table> </div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0">


<tr>

<td style="width:8%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:91%"/></tr>


<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">*By</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">/s/ Jay Jackson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#8195;Jay Jackson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#8195;As Attorney-in-Fact</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>d423260dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have issued our report dated February&nbsp;17, 2023, with respect to the financial statements of Abacus Settlements, LLC contained in the Registration
Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption &#147;Experts.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ GRANT THORNTON LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philadelphia, Pennsylvania </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;30, 2023 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d423260dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;23.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have issued our report dated March&nbsp;24, 2023, with respect to the consolidated financial statements of Longevity Market Assets, LLC contained in the
Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption &#147;Experts.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ GRANT THORNTON LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philadelphia, Pennsylvania </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;30, 2023 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>d423260dex233.htm
<DESCRIPTION>EX-23.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;23.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#146;S CONSENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the inclusion in this Registration Statement of Abacus Life, Inc. (formerly known as East Resources Acquisition Company)<B> </B>on Amendment
No.&nbsp;2 to Form <FONT STYLE="white-space:nowrap">S-1</FONT><B> </B>(File <FONT STYLE="white-space:nowrap">No.&nbsp;333-274553)</FONT> of our report dated April&nbsp;17, 2023, which includes an explanatory paragraph as to East Resources
Acquisition Company&#146;s ability to continue as a going concern,<B> </B>with respect to our audits of the consolidated financial statements of East Resources Acquisition Company as of December&nbsp;31, 2022 and 2021<B> </B>and for the years then
ended, which report appears in the Prospectus, which is part of this Registration Statement. We were dismissed as auditors on July&nbsp;17, 2023 and, accordingly, we have not performed any audit or review procedures with respect to any financial
statements appearing in such Prospectus for the periods after the date of our dismissal. We also consent to the reference to our Firm under the heading &#147;Experts&#148; in such Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Marcum <SMALL>LLP</SMALL> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marcum <SMALL>LLP</SMALL> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Houston, Texas<B> </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;30, 2023 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>abl-20230630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-October-2023 [07:31:27] {AM}-->
<schema targetNamespace="http://www.emslp.com/20230630" elementFormDefault="qualified" xmlns:abl="http://www.emslp.com/20230630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.emslp.com/role/Cover" id="Cover">
<link:definition>1001 - Document - COVER</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
<link:definition>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical" id="CondensedConsolidateBalanceSheetsParenthetical">
<link:definition>1003 - Statement - CONDENSED CONSOLIDATE BALANCE SHEETS (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome" id="UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome">
<link:definition>1004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity" id="UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity">
<link:definition>1005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" id="UnauditedCondensedConsolidatedStatementsOfCashFlows">
<link:definition>1006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
<link:definition>1007 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/BusinessCombination" id="BusinessCombination">
<link:definition>1009 - Disclosure - BUSINESS COMBINATION</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPolicies" id="LifeInsuranceSettlementPolicies">
<link:definition>1010 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
<link:definition>1011 - Disclosure - PROPERTY AND EQUIPMENT---NET</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets" id="GoodwillAndOtherIntangibleAssets">
<link:definition>1012 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue" id="AvailableForSaleSecuritiesAtFairValue">
<link:definition>1013 - Disclosure -  AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets" id="OtherInvestmentsAndOtherNoncurrentAssets">
<link:definition>1014 - Disclosure -  OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/ConsolidationOfVariableInterestEntities" id="ConsolidationOfVariableInterestEntities">
<link:definition>1015 - Disclosure - CONSOLIDATION OF VARIABLE INTEREST ENTITIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SegmentReporting" id="SegmentReporting">
<link:definition>1016 - Disclosure - SEGMENT REPORTING</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>1017 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurements" id="FairValueMeasurements">
<link:definition>1018 - Disclosure -  FAIR VALUE MEASUREMENTS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebt" id="LongTermDebt">
<link:definition>1019 - Disclosure - LONG-TERM DEBT</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/ShareholdersEquity" id="ShareholdersEquity">
<link:definition>1020 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/EmployeeBenefitPlan" id="EmployeeBenefitPlan">
<link:definition>1021 - Disclosure - EMPLOYEE BENEFIT PLAN</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition>1022 - Disclosure - INCOME TAXES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition>1023 - Disclosure - RELATED-PARTY TRANSACTIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/Leases" id="Leases">
<link:definition>1024 - Disclosure - LEASES</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/EarningsPerShare" id="EarningsPerShare">
<link:definition>1025 - Disclosure - EARNINGS PER SHARE</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1026 - Disclosure - SUBSEQUENT EVENTS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1027 - Disclosure -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/BusinessCombinationTables" id="BusinessCombinationTables">
<link:definition>1028 - Disclosure - BUSINESS COMBINATION (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables" id="LifeInsuranceSettlementPoliciesTables">
<link:definition>1029 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
<link:definition>1030 - Disclosure - PROPERTY AND EQUIPMENT---NET (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables" id="GoodwillAndOtherIntangibleAssetsTables">
<link:definition>1031 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SegmentReportingTables" id="SegmentReportingTables">
<link:definition>1032 - Disclosure - SEGMENT REPORTING (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
<link:definition>1033 - Disclosure -  FAIR VALUE MEASUREMENTS (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtTables" id="LongTermDebtTables">
<link:definition>1034 - Disclosure - LONG-TERM DEBT (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LeasesTables" id="LeasesTables">
<link:definition>1035 - Disclosure - LEASES (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/EarningsPerShareTables" id="EarningsPerShareTables">
<link:definition>1036 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/DescriptionOfBusinessDetails" id="DescriptionOfBusinessDetails">
<link:definition>1037 - Disclosure - DESCRIPTION OF BUSINESS (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails" id="SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails">
<link:definition>1038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation of Variable Interest Entities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails" id="SummaryOfSignificantAccountingPoliciesConcentrationsDetails">
<link:definition>1039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/BusinessCombinationNarrativeDetails" id="BusinessCombinationNarrativeDetails">
<link:definition>1040 - Disclosure - BUSINESS COMBINATION - Narrative (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails" id="BusinessCombinationPurchasePriceAllocationDetails">
<link:definition>1041 - Disclosure - BUSINESS COMBINATION - Purchase Price Allocation (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/BusinessCombinationValueConveyedDetails" id="BusinessCombinationValueConveyedDetails">
<link:definition>1042 - Disclosure - BUSINESS COMBINATION - Value Conveyed (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails" id="BusinessCombinationIntangibleAssetsAcquiredDetails">
<link:definition>1043 - Disclosure - BUSINESS COMBINATION - Intangible Assets Acquired (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails" id="BusinessCombinationProFormaFinancialInformationDetails">
<link:definition>1044 - Disclosure - BUSINESS COMBINATION - Pro Forma Financial Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails" id="LifeInsuranceSettlementPoliciesNarrativeDetails">
<link:definition>1045 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Narrative (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails" id="LifeInsuranceSettlementPoliciesFairValueDetails">
<link:definition>1046 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Fair Value (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails" id="LifeInsuranceSettlementPoliciesInvestmentMethodDetails">
<link:definition>1047 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Investment Method (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails" id="LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails">
<link:definition>1048 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Estimated Premiums (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
<link:definition>1049 - Disclosure - PROPERTY AND EQUIPMENT---NET (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails" id="GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails">
<link:definition>1050 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill by Reportable Segments (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails" id="GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails">
<link:definition>1051 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Acquired (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails" id="AvailableForSaleSecuritiesAtFairValueDetails">
<link:definition>1052 - Disclosure -  AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails" id="OtherInvestmentsAndOtherNoncurrentAssetsDetails">
<link:definition>1053 - Disclosure -  OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails" id="ConsolidationOfVariableInterestEntitiesDetails">
<link:definition>1054 - Disclosure - CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SegmentReportingNarrativeDetails" id="SegmentReportingNarrativeDetails">
<link:definition>1055 - Disclosure - SEGMENT REPORTING - Narrative (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails" id="SegmentReportingRevenueBySegmentDetails">
<link:definition>1056 - Disclosure - SEGMENT REPORTING - Revenue by Segment (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails" id="SegmentReportingReconciliationOfNetIncomeDetails">
<link:definition>1057 - Disclosure - SEGMENT REPORTING - Reconciliation of Net Income (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
<link:definition>1058 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails" id="FairValueMeasurementsRecurringFairValueMeasurementsDetails">
<link:definition>1059 - Disclosure -  FAIR VALUE MEASUREMENTS - Recurring Fair Value Measurements (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails" id="FairValueMeasurementsNarrativeDetails">
<link:definition>1060 - Disclosure -  FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails" id="FairValueMeasurementsDiscountRateSensitivityDetails">
<link:definition>1061 - Disclosure -  FAIR VALUE MEASUREMENTS - Discount Rate Sensitivity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails" id="FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails">
<link:definition>1062 - Disclosure -  FAIR VALUE MEASUREMENTS - Credit Exposure to Insurance Companies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails" id="FairValueMeasurementsLifeInsurancePoliciesDetails">
<link:definition>1063 - Disclosure -  FAIR VALUE MEASUREMENTS - Life Insurance Policies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails" id="FairValueMeasurementsIssuedNotesDetails">
<link:definition>1064 - Disclosure -  FAIR VALUE MEASUREMENTS - Issued Notes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails" id="FairValueMeasurementsAssumptionsDetails">
<link:definition>1065 - Disclosure -  FAIR VALUE MEASUREMENTS - Assumptions (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtLongTermDebtDetails" id="LongTermDebtLongTermDebtDetails">
<link:definition>1066 - Disclosure - LONG-TERM DEBT - Long-Term Debt (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails" id="LongTermDebtSponsorPikNoteDetails">
<link:definition>1067 - Disclosure - LONG-TERM DEBT - Sponsor PIK Note (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails" id="LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails">
<link:definition>1068 - Disclosure - LONG-TERM DEBT - LMATT Series 2024, Inc. Market-Indexed Notes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails" id="LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails">
<link:definition>1069 - Disclosure - LONG-TERM DEBT - LMATT Series 2.2024, Inc. Market-Indexed Notes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails" id="LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails">
<link:definition>1070 - Disclosure - LONG-TERM DEBT - LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails" id="LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails">
<link:definition>1071 - Disclosure - LONG-TERM DEBT - LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails" id="LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails">
<link:definition>1072 - Disclosure - LONG-TERM DEBT - LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails" id="LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails">
<link:definition>1073 - Disclosure - LONG-TERM DEBT - SPV Purchase and Sale and SPV Investment Facility (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/ShareholdersEquityDetails" id="ShareholdersEquityDetails">
<link:definition>1074 - Disclosure - SHAREHOLDERS' EQUITY (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/EmployeeBenefitPlanDetails" id="EmployeeBenefitPlanDetails">
<link:definition>1075 - Disclosure - EMPLOYEE BENEFIT PLAN (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
<link:definition>1076 - Disclosure - INCOME TAXES (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
<link:definition>1077 - Disclosure - RELATED-PARTY TRANSACTIONS (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails" id="LeasesRouAssetsAndLeaseLiabilitiesDetails">
<link:definition>1078 - Disclosure - LEASES - ROU Assets and Lease Liabilities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LeasesLeaseExpenseDetails" id="LeasesLeaseExpenseDetails">
<link:definition>1079 - Disclosure - LEASES - Lease Expense (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails" id="LeasesSupplementalCashFlowInformationDetails">
<link:definition>1080 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails" id="LeasesLeaseTermsAndDiscountRatesDetails">
<link:definition>1081 - Disclosure - LEASES - Lease Terms and Discount Rates (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails" id="LeasesFutureMinimumNoncancellableLeasePaymentsDetails">
<link:definition>1082 - Disclosure - LEASES - Future Minimum Noncancellable Lease Payments (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/EarningsPerShareNarrativeDetails" id="EarningsPerShareNarrativeDetails">
<link:definition>1083 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails" id="EarningsPerShareBasicAndDilutedDetails">
<link:definition>1084 - Disclosure - EARNINGS PER SHARE - Basic and Diluted (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.emslp.com/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
<link:definition>1085 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="abl-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="abl-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="abl-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="abl-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
<import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
<import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<element name="AccruedTransactionCostsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_AccruedTransactionCostsCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="WarrantLiabilitiesNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_WarrantLiabilitiesNoncurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="CertificatesOfDepositNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_CertificatesOfDepositNoncurrent" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="StateSecurityDepositsNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_StateSecurityDepositsNoncurrent" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OwnersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_OwnersMember" substitutionGroup="xbrli:item" />
<element name="StockIssuedDuringPeriodValueReverseRecapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_StockIssuedDuringPeriodValueReverseRecapitalization" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="StockholdersEquityDeferredTransactionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_StockholdersEquityDeferredTransactionCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="StockIssuedDuringPeriodSharesReverseRecapitalization" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_StockIssuedDuringPeriodSharesReverseRecapitalization" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractPurchasedFairValueMethod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_LifeSettlementContractPurchasedFairValueMethod" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="LifeSettlementContractPurchasedInvestmentMethod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_LifeSettlementContractPurchasedInvestmentMethod" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ProceedsDueFromPaymentsDueToAffiliates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_ProceedsDueFromPaymentsDueToAffiliates" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="WarrantsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_WarrantsPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="AssetsAndLiabilitiesLesseeTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_AssetsAndLiabilitiesLesseeTableTextBlock" substitutionGroup="xbrli:item" />
<element name="LongevityMarketAssetsLLCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LongevityMarketAssetsLLCMember" substitutionGroup="xbrli:item" />
<element name="BusinessAcquisitionExchangeRatio" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_BusinessAcquisitionExchangeRatio" substitutionGroup="xbrli:item" />
<element name="NumberOfProvidersInvolvedInOptionAgreement" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_NumberOfProvidersInvolvedInOptionAgreement" substitutionGroup="xbrli:item" />
<element name="NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" substitutionGroup="xbrli:item" />
<element name="ExpenseSupportAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_ExpenseSupportAgreementMember" substitutionGroup="xbrli:item" />
<element name="ProviderOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_ProviderOneMember" substitutionGroup="xbrli:item" />
<element name="ProviderTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_ProviderTwoMember" substitutionGroup="xbrli:item" />
<element name="LongevityMarketAdvisorsLLCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LongevityMarketAdvisorsLLCMember" substitutionGroup="xbrli:item" />
<element name="RegionalInvestmentServicesIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_RegionalInvestmentServicesIncMember" substitutionGroup="xbrli:item" />
<element name="LMXSeriesLLCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LMXSeriesLLCMember" substitutionGroup="xbrli:item" />
<element name="Customer1Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_Customer1Member" substitutionGroup="xbrli:item" />
<element name="Customer2Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_Customer2Member" substitutionGroup="xbrli:item" />
<element name="InvestmentMethodRevenueBenchmarkMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_InvestmentMethodRevenueBenchmarkMember" substitutionGroup="xbrli:item" />
<element name="ActiveManagementSegmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_ActiveManagementSegmentMember" substitutionGroup="xbrli:item" />
<element name="PortfolioServicingSegmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_PortfolioServicingSegmentMember" substitutionGroup="xbrli:item" />
<element name="CustomerRelationshipAgentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_CustomerRelationshipAgentsMember" substitutionGroup="xbrli:item" />
<element name="CustomerRelationshipsFinancialRelationshipsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_CustomerRelationshipsFinancialRelationshipsMember" substitutionGroup="xbrli:item" />
<element name="LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" substitutionGroup="xbrli:item" />
<element name="AbacusSettlementsLLCMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_AbacusSettlementsLLCMember" substitutionGroup="xbrli:item" />
<element name="BusinessCombinationMeasurementInput" type="xbrli:decimalItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_BusinessCombinationMeasurementInput" substitutionGroup="xbrli:item" />
<element name="BusinessCombinationEnterpriseValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_BusinessCombinationEnterpriseValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="APATechnologyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_APATechnologyMember" substitutionGroup="xbrli:item" />
<element name="MarketPlaceTechnologyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_MarketPlaceTechnologyMember" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractsNumberOfContracts" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractsNumberOfContracts" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractFairValueMaturityAfterYearFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractFairValueMaturityAfterYearFour" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SeriesSeedPreferredUnitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_SeriesSeedPreferredUnitsMember" substitutionGroup="xbrli:item" />
<element name="SeriesB1PreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_SeriesB1PreferredStockMember" substitutionGroup="xbrli:item" />
<element name="MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" substitutionGroup="xbrli:item" />
<element name="NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" substitutionGroup="xbrli:item" />
<element name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" substitutionGroup="xbrli:item" />
<element name="FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="LifeSettlementContractsMeasurementInput" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractsMeasurementInput" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractsNumberOfContractsSold" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_LifeSettlementContractsNumberOfContractsSold" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightPricePerWarrant" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightPricePerWarrant" substitutionGroup="xbrli:item" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PrivatePlacementWarrantMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_PrivatePlacementWarrantMember" substitutionGroup="xbrli:item" />
<element name="SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LifeInsuranceCarrierConcentrationRiskMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LifeInsuranceCarrierConcentrationRiskMember" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractsFaceValueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LifeSettlementContractsFaceValueMember" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractsFairValueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LifeSettlementContractsFairValueMember" substitutionGroup="xbrli:item" />
<element name="LifeInsuranceCarrierAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LifeInsuranceCarrierAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="LifeInsuranceCarrierDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LifeInsuranceCarrierDomain" substitutionGroup="xbrli:item" />
<element name="AmericanGeneralLifeInsuranceCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_AmericanGeneralLifeInsuranceCompanyMember" substitutionGroup="xbrli:item" />
<element name="ReliaStarLifeInsuranceCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_ReliaStarLifeInsuranceCompanyMember" substitutionGroup="xbrli:item" />
<element name="LincolnNationalLifeInsuranceCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LincolnNationalLifeInsuranceCompanyMember" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LifeSettlementContractMember" substitutionGroup="xbrli:item" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="LMATTSeries22024IncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LMATTSeries22024IncMember" substitutionGroup="xbrli:item" />
<element name="LMATTGrowthIncomeSeries12026IncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LMATTGrowthIncomeSeries12026IncMember" substitutionGroup="xbrli:item" />
<element name="LMATTIncomeSeriesLPMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LMATTIncomeSeriesLPMember" substitutionGroup="xbrli:item" />
<element name="LMATTIncomeSeriesIILPMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LMATTIncomeSeriesIILPMember" substitutionGroup="xbrli:item" />
<element name="SponsorPIKNoteMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_SponsorPIKNoteMember" substitutionGroup="xbrli:item" />
<element name="SPVInvestmentFacilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_SPVInvestmentFacilityMember" substitutionGroup="xbrli:item" />
<element name="LMATTSeries2024IncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_LMATTSeries2024IncMember" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentMaximumMarketDownturnProtectionPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentNoteReductionRatioForLossesBelowThreshold" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentDividendFeaturePercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentDividendFeaturePercentage" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentInternalRateOfReturnCap" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentInternalRateOfReturnCap" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentMinimumInternalRateOfReturn" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentMinimumInternalRateOfReturn" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentExtensionOptions" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentExtensionOptions" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentExtensionTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_DebtInstrumentExtensionTerm" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentNetInternalRateOfReturnAtCap" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentNetInternalRateOfReturnAtCap" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" substitutionGroup="xbrli:item" />
<element name="CapitalCommitmentThresholdOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_CapitalCommitmentThresholdOneMember" substitutionGroup="xbrli:item" />
<element name="CapitalCommitmentThresholdTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_CapitalCommitmentThresholdTwoMember" substitutionGroup="xbrli:item" />
<element name="CapitalCommitmentThresholdThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_CapitalCommitmentThresholdThreeMember" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="DebtInstrumentDefaultRate" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentDefaultRate" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractsSpecialPurchaseVehicleFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DebtInstrumentNumberOfExtensions" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentNumberOfExtensions" substitutionGroup="xbrli:item" />
<element name="PolicyAPAMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_PolicyAPAMember" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionTradingDayPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" substitutionGroup="xbrli:item" />
<element name="WarrantsAndRightsOutstandingExercisableTermProposedOffering" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" substitutionGroup="xbrli:item" />
<element name="WarrantsAndRightsOutstandingExercisableTermBusinessCombination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" substitutionGroup="xbrli:item" />
<element name="NumberOfVotesPerCommonShare" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_NumberOfVotesPerCommonShare" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" substitutionGroup="xbrli:item" />
<element name="WarrantsAndRightsOutstandingFairValuePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_WarrantsAndRightsOutstandingFairValuePerShare" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionPricePerWarrant" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionNoticePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_ClassOfWarrantOrRightRedemptionNoticePeriod" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionPricePerShareThreshold" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionNumberOfTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" substitutionGroup="xbrli:item" />
<element name="PublicWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_PublicWarrantsMember" substitutionGroup="xbrli:item" />
<element name="BinomialLatticeModelMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_BinomialLatticeModelMember" substitutionGroup="xbrli:item" />
<element name="LifeSettlementContractsOriginationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_LifeSettlementContractsOriginationExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="NovaTradingUSLLCAndNovaHoldingUSLPMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" substitutionGroup="xbrli:item" />
<element name="ServiceFeeAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_ServiceFeeAgreementMember" substitutionGroup="xbrli:item" />
<element name="ExpenseReimbursementsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_ExpenseReimbursementsMember" substitutionGroup="xbrli:item" />
<element name="OperatingLeaseAssetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_OperatingLeaseAssetAbstract" substitutionGroup="xbrli:item" />
<element name="LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="OwlRockCreditFacilityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_OwlRockCreditFacilityMember" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentAmortizationPaymentPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentAmortizationPaymentPercentage" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentAmortizationPaymentPercentagePerQuarter" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCovenantMandatoryPrepaymentPercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentBasisSpreadOnVariableRateTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_DebtInstrumentBasisSpreadOnVariableRateTerm" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCovenantLeverageRatioMaximum" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentCovenantLeverageRatioMaximum" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" substitutionGroup="xbrli:item" />
<element name="LineOfCreditFacilityRemainingBorrowingCapacityTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" substitutionGroup="xbrli:item" />
<element name="DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" substitutionGroup="xbrli:item" />
<element name="VariableRateComponentAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_VariableRateComponentAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="VariableRateComponentDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_VariableRateComponentDomain" substitutionGroup="xbrli:item" />
<element name="VariableRateComponentThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_VariableRateComponentThreeMember" substitutionGroup="xbrli:item" />
<element name="VariableRateComponentOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_VariableRateComponentOneMember" substitutionGroup="xbrli:item" />
<element name="VariableRateComponentTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="abl_VariableRateComponentTwoMember" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>abl-20230630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-October-2023 [07:31:27] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationPurchasePriceAllocationDetails" roleURI="http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesFairValueDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesInvestmentMethodDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.emslp.com/role/PropertyAndEquipmentNetDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingRevenueBySegmentDetails" roleURI="http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingReconciliationOfNetIncomeDetails" roleURI="http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsRecurringFairValueMeasurementsDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesRouAssetsAndLeaseLiabilitiesDetails" roleURI="http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesLeaseExpenseDetails" roleURI="http://www.emslp.com/role/LeasesLeaseExpenseDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesFutureMinimumNoncancellableLeasePaymentsDetails" roleURI="http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails" />
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xlink:label="loc_ABL_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_ABL_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="loc_ABL_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_ABL_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" use="optional" order="3" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaap_Goodwill" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" use="optional" order="7" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" use="optional" order="1" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="4" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" use="optional" order="7" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_NonoperatingIncomeExpense" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InvestmentIncomeInterest" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestExpense" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_OperatingIncomeLoss" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_OperatingExpenses" use="optional" order="14" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_DepreciationAndAmortization" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments" use="optional" order="16" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" use="optional" order="17" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="loc_us-gaap_SellingAndMarketingExpense" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_GrossProfit" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_CostOfRevenue" use="optional" order="21" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit" xlink:to="loc_us-gaap_Revenues" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceInvestmentIncome" xlink:label="loc_us-gaap_InsuranceInvestmentIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_us-gaap_InsuranceInvestmentIncome" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" use="optional" order="25" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceServicesRevenue" xlink:label="loc_us-gaap_InsuranceServicesRevenue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InsuranceServicesRevenue" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" use="optional" order="26" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceInvestmentIncome" xlink:label="loc_us-gaap_InsuranceInvestmentIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InsuranceServicesRevenue" xlink:to="loc_us-gaap_InsuranceInvestmentIncome" use="optional" order="27" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProceedsDueFromPaymentsDueToAffiliates" xlink:label="loc_ABL_ProceedsDueFromPaymentsDueToAffiliates" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ABL_ProceedsDueFromPaymentsDueToAffiliates" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" use="optional" order="9" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedInvestmentMethod" xlink:label="loc_ABL_LifeSettlementContractPurchasedInvestmentMethod" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ABL_LifeSettlementContractPurchasedInvestmentMethod" use="optional" order="11" weight="-1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedFairValueMethod" xlink:label="loc_ABL_LifeSettlementContractPurchasedFairValueMethod" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ABL_LifeSettlementContractPurchasedFairValueMethod" use="optional" order="12" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" use="optional" order="16" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" use="optional" order="17" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" order="18" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" use="optional" order="21" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" use="optional" order="22" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments" use="optional" order="23" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_DepreciationAndAmortization" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="25" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome" xlink:label="loc_us-gaap_NetInvestmentIncome" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_us-gaap_NetInvestmentIncome" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" use="optional" order="1" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRevenueExpenseNet" xlink:label="loc_us-gaap_InterestRevenueExpenseNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_InterestRevenueExpenseNet" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_Depreciation" use="optional" order="7" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" use="optional" order="8" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_SellingAndMarketingExpense" use="optional" order="9" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_GrossProfit" use="optional" order="10" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/PropertyAndEquipmentNetDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" order="1" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" xlink:label="loc_ABL_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:to="loc_ABL_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" xlink:label="loc_ABL_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:to="loc_ABL_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" use="optional" order="12" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" xlink:label="loc_ABL_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:to="loc_ABL_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" use="optional" order="18" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMaturityAfterYearFour" xlink:label="loc_ABL_LifeSettlementContractFairValueMaturityAfterYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:to="loc_ABL_LifeSettlementContractFairValueMaturityAfterYearFour" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" xlink:label="loc_ABL_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:to="loc_ABL_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" use="optional" order="12" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" xlink:label="loc_ABL_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:to="loc_ABL_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" use="optional" order="18" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" xlink:label="loc_ABL_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:to="loc_ABL_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" use="optional" order="5" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesLeaseExpenseDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost" xlink:to="loc_us-gaap_VariableLeaseCost" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost" xlink:to="loc_us-gaap_OperatingLeaseCost" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:label="loc_ABL_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_ABL_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" use="optional" order="6" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantLiabilitiesNoncurrent" xlink:label="loc_ABL_WarrantLiabilitiesNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="loc_ABL_WarrantLiabilitiesNoncurrent" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="loc_us-gaap_LongTermDebtFairValue" use="optional" order="2" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_DerivativeAssets" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" use="optional" order="7" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_MinorityInterest" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_AdditionalPaidInCapital" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantLiabilitiesNoncurrent" xlink:label="loc_ABL_WarrantLiabilitiesNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_ABL_WarrantLiabilitiesNoncurrent" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredLongTermDebt" xlink:label="loc_us-gaap_SecuredLongTermDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_SecuredLongTermDebt" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AccruedTransactionCostsCurrent" xlink:label="loc_ABL_AccruedTransactionCostsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_ABL_AccruedTransactionCostsCurrent" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" use="optional" order="20" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CertificatesOfDepositNoncurrent" xlink:label="loc_ABL_CertificatesOfDepositNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_ABL_CertificatesOfDepositNoncurrent" use="optional" order="22" weight="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StateSecurityDepositsNoncurrent" xlink:label="loc_ABL_StateSecurityDepositsNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_ABL_StateSecurityDepositsNoncurrent" use="optional" order="23" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" use="optional" order="24" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" use="optional" order="25" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" use="optional" order="26" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" use="optional" order="27" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" use="optional" order="28" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset" use="optional" order="29" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_Goodwill" use="optional" order="30" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" use="optional" order="31" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="32" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="33" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" use="optional" order="34" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent" use="optional" order="35" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" use="optional" order="36" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="37" weight="1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>abl-20230630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-October-2023 [07:31:27] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#Cover" roleURI="http://www.emslp.com/role/Cover" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CondensedConsolidateBalanceSheetsParenthetical" roleURI="http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#DescriptionOfBusinessDetails" roleURI="http://www.emslp.com/role/DescriptionOfBusinessDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPoliciesConcentrationsDetails" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationNarrativeDetails" roleURI="http://www.emslp.com/role/BusinessCombinationNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationPurchasePriceAllocationDetails" roleURI="http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationValueConveyedDetails" roleURI="http://www.emslp.com/role/BusinessCombinationValueConveyedDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationIntangibleAssetsAcquiredDetails" roleURI="http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationProFormaFinancialInformationDetails" roleURI="http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.emslp.com/role/PropertyAndEquipmentNetDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#OtherInvestmentsAndOtherNoncurrentAssetsDetails" roleURI="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ConsolidationOfVariableInterestEntitiesDetails" roleURI="http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingRevenueBySegmentDetails" roleURI="http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingReconciliationOfNetIncomeDetails" roleURI="http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CommitmentsAndContingenciesDetails" roleURI="http://www.emslp.com/role/CommitmentsAndContingenciesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsRecurringFairValueMeasurementsDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsNarrativeDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsLifeInsurancePoliciesDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsAssumptionsDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLongTermDebtDetails" roleURI="http://www.emslp.com/role/LongTermDebtLongTermDebtDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtSponsorPikNoteDetails" roleURI="http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails" roleURI="http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ShareholdersEquityDetails" roleURI="http://www.emslp.com/role/ShareholdersEquityDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#RelatedPartyTransactionsDetails" roleURI="http://www.emslp.com/role/RelatedPartyTransactionsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShareNarrativeDetails" roleURI="http://www.emslp.com/role/EarningsPerShareNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SubsequentEventsDetails" roleURI="http://www.emslp.com/role/SubsequentEventsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#DescriptionOfBusiness" roleURI="http://www.emslp.com/role/DescriptionOfBusiness" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombination" roleURI="http://www.emslp.com/role/BusinessCombination" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPolicies" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPolicies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#PropertyAndEquipmentNet" roleURI="http://www.emslp.com/role/PropertyAndEquipmentNet" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssets" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#AvailableForSaleSecuritiesAtFairValue" roleURI="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#OtherInvestmentsAndOtherNoncurrentAssets" roleURI="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ConsolidationOfVariableInterestEntities" roleURI="http://www.emslp.com/role/ConsolidationOfVariableInterestEntities" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReporting" roleURI="http://www.emslp.com/role/SegmentReporting" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CommitmentsAndContingencies" roleURI="http://www.emslp.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurements" roleURI="http://www.emslp.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebt" roleURI="http://www.emslp.com/role/LongTermDebt" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ShareholdersEquity" roleURI="http://www.emslp.com/role/ShareholdersEquity" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EmployeeBenefitPlan" roleURI="http://www.emslp.com/role/EmployeeBenefitPlan" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#IncomeTaxes" roleURI="http://www.emslp.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#RelatedPartyTransactions" roleURI="http://www.emslp.com/role/RelatedPartyTransactions" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#Leases" roleURI="http://www.emslp.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShare" roleURI="http://www.emslp.com/role/EarningsPerShare" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SubsequentEvents" roleURI="http://www.emslp.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationTables" roleURI="http://www.emslp.com/role/BusinessCombinationTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesTables" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#PropertyAndEquipmentNetTables" roleURI="http://www.emslp.com/role/PropertyAndEquipmentNetTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssetsTables" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsTables" roleURI="http://www.emslp.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtTables" roleURI="http://www.emslp.com/role/LongTermDebtTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesTables" roleURI="http://www.emslp.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesNarrativeDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingTables" roleURI="http://www.emslp.com/role/SegmentReportingTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShareTables" roleURI="http://www.emslp.com/role/EarningsPerShareTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesFairValueDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesInvestmentMethodDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#AvailableForSaleSecuritiesAtFairValueDetails" roleURI="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingNarrativeDetails" roleURI="http://www.emslp.com/role/SegmentReportingNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsDiscountRateSensitivityDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsIssuedNotesDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EmployeeBenefitPlanDetails" roleURI="http://www.emslp.com/role/EmployeeBenefitPlanDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#IncomeTaxesDetails" roleURI="http://www.emslp.com/role/IncomeTaxesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesRouAssetsAndLeaseLiabilitiesDetails" roleURI="http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesLeaseExpenseDetails" roleURI="http://www.emslp.com/role/LeasesLeaseExpenseDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesLeaseTermsAndDiscountRatesDetails" roleURI="http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesFutureMinimumNoncancellableLeasePaymentsDetails" roleURI="http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShareBasicAndDilutedDetails" roleURI="http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/Cover">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_107" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityExTransitionPeriod_130" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_119" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressPostalZipCode_119" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_102" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_DocumentInformationTable_102" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_102" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1584" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1585" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1584" xlink:to="loc_dei_AddressTypeDomain_1585" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1585_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1584" xlink:to="loc_dei_AddressTypeDomain_1585_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_1585" xlink:to="loc_dei_BusinessContactMember_1586" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_103" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_102" xlink:to="loc_us-gaap_StatementClassOfStockAxis_103" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_104" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_103" xlink:to="loc_us-gaap_ClassOfStockDomain_104" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_104_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_103" xlink:to="loc_us-gaap_ClassOfStockDomain_104_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_108" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_DocumentType_108" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityRegistrantName_113" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_CityAreaCode_120" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_LocalPhoneNumber_121" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityTaxIdentificationNumber_115" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityFilerCategory_127" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntitySmallBusiness_128" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityEmergingGrowthCompany_129" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_AmendmentFlag_137" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityCentralIndexKey_133" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressAddressLine1_116" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber_1581" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityPrimarySicNumber_1581" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_1582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressAddressLine2_1582" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_1583" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_ContactPersonnelName_1583" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_118" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressStateOrProvince_118" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityIncorporationStateCountryCode_114" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_117" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressCityOrTown_117" use="optional" order="27" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_150" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_195" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredLongTermDebt" xlink:label="loc_us-gaap_SecuredLongTermDebt_181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_SecuredLongTermDebt_181" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_172" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_172" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_173" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_173" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_175" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_AccountsPayableCurrent_174" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_176" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AccruedTransactionCostsCurrent" xlink:label="loc_abl_AccruedTransactionCostsCurrent_177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_abl_AccruedTransactionCostsCurrent_177" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_178" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_178" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_179" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_LiabilitiesCurrent_180" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_182" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_183" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_AdditionalPaidInCapital_190" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_191" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_191" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_193" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_MinorityInterest_193" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_189" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_CommonStockValue_189" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_192" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_184" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantLiabilitiesNoncurrent" xlink:label="loc_abl_WarrantLiabilitiesNoncurrent_185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_abl_WarrantLiabilitiesNoncurrent_185" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_186" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_Liabilities_186" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_187" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_CommitmentsAndContingencies_187" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_151" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_AssetsAbstract_151" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_164" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_165" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_166" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_158" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_163" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_170" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_Assets_170" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_152" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_AssetsCurrentAbstract_152" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_156" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_156" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_153" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_154" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_155" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_157" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_AssetsCurrent_157" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_162" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CertificatesOfDepositNoncurrent" xlink:label="loc_abl_CertificatesOfDepositNoncurrent_168" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_abl_CertificatesOfDepositNoncurrent_168" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_169" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_159" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_159" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_Goodwill_160" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_161" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StateSecurityDepositsNoncurrent" xlink:label="loc_abl_StateSecurityDepositsNoncurrent_167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_abl_StateSecurityDepositsNoncurrent_167" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_StatementTable_140" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_147" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_140" xlink:to="loc_us-gaap_StatementClassOfStockAxis_147" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_147" xlink:to="loc_us-gaap_ClassOfStockDomain_148" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_148_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_147" xlink:to="loc_us-gaap_ClassOfStockDomain_148_default" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_149" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_148" xlink:to="loc_us-gaap_CommonClassAMember_149" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_140" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_141" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_141" xlink:to="loc_us-gaap_RelatedPartyDomain_142" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_142_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_141" xlink:to="loc_us-gaap_RelatedPartyDomain_142_default" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_us-gaap_NonrelatedPartyMember_143" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_srt_AffiliatedEntityMember_144" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwnersMember" xlink:label="loc_abl_OwnersMember_146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_abl_OwnersMember_146" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_us-gaap_RelatedPartyMember_145" use="optional" order="57" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_202" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_203" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_203" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_205" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockSharesIssued_205" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_206" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_206" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_StatementTable_198" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_199" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_198" xlink:to="loc_us-gaap_StatementClassOfStockAxis_199" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_200" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_199" xlink:to="loc_us-gaap_ClassOfStockDomain_200" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_200_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_199" xlink:to="loc_us-gaap_ClassOfStockDomain_200_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_201" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_200" xlink:to="loc_us-gaap_CommonClassAMember_201" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_204" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_204" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_214" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaap_CostOfRevenueAbstract_221" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_CostOfRevenueAbstract_221" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_222" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_221" xlink:to="loc_us-gaap_CostOfRevenue_222" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_224" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_OperatingExpensesAbstract_224" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_227" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_227" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_228" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_228" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_DepreciationAndAmortization_229" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_OperatingExpenses_230" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_225" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_SellingAndMarketingExpense_225" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_226" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_251" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_252" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_239" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ProfitLoss_239" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_248" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent_249" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_248" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent_249" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_231" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_OperatingIncomeLoss_231" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_237" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_237" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_238" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_240" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_240" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_NetIncomeLoss_241" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_EarningsPerShareAbstract_242" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_EarningsPerShareBasic_245" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_243" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_244" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_244" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_EarningsPerShareDiluted_246" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_223" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_GrossProfit_223" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_250" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_209" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_StatementTable_209" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_210" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_209" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_210" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_211" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_210" xlink:to="loc_us-gaap_RelatedPartyDomain_211" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_211_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_210" xlink:to="loc_us-gaap_RelatedPartyDomain_211_default" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_211" xlink:to="loc_us-gaap_NonrelatedPartyMember_213" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_211" xlink:to="loc_us-gaap_RelatedPartyMember_212" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_215" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_RevenuesAbstract_215" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_220" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_Revenues_220" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceServicesRevenue" xlink:label="loc_us-gaap_InsuranceServicesRevenue_219" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_InsuranceServicesRevenue_219" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_216" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_216" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_218" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceInvestmentIncome" xlink:label="loc_us-gaap_InsuranceInvestmentIncome_217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_InsuranceInvestmentIncome_217" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_235" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_235" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_236" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_233" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_InterestExpense_233" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_InvestmentIncomeInterest_234" use="optional" order="43" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_266" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_255" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_266" xlink:to="loc_us-gaap_StatementTable_255" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_256" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_255" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_256" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_257" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_256" xlink:to="loc_us-gaap_EquityComponentDomain_257" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_257_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_256" xlink:to="loc_us-gaap_EquityComponentDomain_257_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_NoncontrollingInterestMember_262" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_258" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_CommonStockMember_258" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_259" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_259" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_RetainedEarningsMember_260" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_255" xlink:to="loc_us-gaap_StatementClassOfStockAxis_263" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_264" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_263" xlink:to="loc_us-gaap_ClassOfStockDomain_264" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_264_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_263" xlink:to="loc_us-gaap_ClassOfStockDomain_264_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_265" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_264" xlink:to="loc_us-gaap_CommonClassAMember_265" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_266" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:label="loc_abl_StockIssuedDuringPeriodValueReverseRecapitalization_274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_abl_StockIssuedDuringPeriodValueReverseRecapitalization_274" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_269" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_270" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_Dividends_270" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockholdersEquityDeferredTransactionCosts" xlink:label="loc_abl_StockholdersEquityDeferredTransactionCosts_271" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_abl_StockholdersEquityDeferredTransactionCosts_271" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_275" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_276" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_ProfitLoss_277" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_268" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_268" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_272" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:label="loc_abl_StockIssuedDuringPeriodSharesReverseRecapitalization_273" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_abl_StockIssuedDuringPeriodSharesReverseRecapitalization_273" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_287" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_318" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_318" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_312" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_312" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_317" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_317" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_316" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_316" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_315" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_315" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_314" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_314" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_313" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_313" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_StatementTable_282" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_282" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_283" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_283" xlink:to="loc_us-gaap_RelatedPartyDomain_284" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_284_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_283" xlink:to="loc_us-gaap_RelatedPartyDomain_284_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_286" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_284" xlink:to="loc_us-gaap_RelatedPartyMember_286" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_284" xlink:to="loc_us-gaap_NonrelatedPartyMember_285" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_295" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_295" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_294" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_294" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss_293" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss_293" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_292" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_292" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_291" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_DepreciationAndAmortization_291" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_296" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_298" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_299" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_299" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_301" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_302" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_303" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_300" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedFairValueMethod" xlink:label="loc_abl_LifeSettlementContractPurchasedFairValueMethod_304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_abl_LifeSettlementContractPurchasedFairValueMethod_304" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedInvestmentMethod" xlink:label="loc_abl_LifeSettlementContractPurchasedInvestmentMethod_305" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_abl_LifeSettlementContractPurchasedInvestmentMethod_305" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_289" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" xlink:to="loc_us-gaap_ProfitLoss_289" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_306" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProceedsDueFromPaymentsDueToAffiliates" xlink:label="loc_abl_ProceedsDueFromPaymentsDueToAffiliates_309" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" xlink:to="loc_abl_ProceedsDueFromPaymentsDueToAffiliates_309" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_310" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_310" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_308" use="optional" order="38" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_546" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_546" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_547" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_548" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsPolicy" xlink:label="loc_us-gaap_LifeSettlementContractsPolicy_551" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_LifeSettlementContractsPolicy_551" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_552" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_552" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_549" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_UseOfEstimates_549" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_540" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_540" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_541" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_540" xlink:to="loc_srt_ConsolidatedEntitiesAxis_541" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_541" xlink:to="loc_srt_ConsolidatedEntitiesDomain_542" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_542_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_541" xlink:to="loc_srt_ConsolidatedEntitiesDomain_542_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_553" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_553" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_554" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_554" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsPolicyTextBlock" xlink:label="loc_abl_WarrantsPolicyTextBlock_555" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_abl_WarrantsPolicyTextBlock_555" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_545" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_545" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/DescriptionOfBusinessDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_619" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessAcquisitionExchangeRatio" xlink:label="loc_abl_BusinessAcquisitionExchangeRatio_621" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_619" xlink:to="loc_abl_BusinessAcquisitionExchangeRatio_621" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_615" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_619" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_615" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_616" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_615" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_616" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_616" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_616" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_618" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_618" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_620" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_619" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_620" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" xlink:label="loc_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount_652" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount_652" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_653" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_653" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_654" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_654" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_646" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_Assets_646" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_647" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_Liabilities_647" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfProvidersInvolvedInOptionAgreement" xlink:label="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_648" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_648" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_649" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_InterestExpense_649" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" xlink:label="loc_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership_650" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership_650" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_651" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_651" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_629" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_us-gaap_OtherCommitmentsAxis_629" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_630" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_629" xlink:to="loc_us-gaap_OtherCommitmentsDomain_630" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_630_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_629" xlink:to="loc_us-gaap_OtherCommitmentsDomain_630_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseSupportAgreementMember" xlink:label="loc_abl_ExpenseSupportAgreementMember_631" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_630" xlink:to="loc_abl_ExpenseSupportAgreementMember_631" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_632" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_dei_LegalEntityAxis_632" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_633" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_632" xlink:to="loc_dei_EntityDomain_633" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_633_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_632" xlink:to="loc_dei_EntityDomain_633_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProviderOneMember" xlink:label="loc_abl_ProviderOneMember_634" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_633" xlink:to="loc_abl_ProviderOneMember_634" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProviderTwoMember" xlink:label="loc_abl_ProviderTwoMember_635" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_633" xlink:to="loc_abl_ProviderTwoMember_635" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAdvisorsLLCMember" xlink:label="loc_abl_LongevityMarketAdvisorsLLCMember_636" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_633" xlink:to="loc_abl_LongevityMarketAdvisorsLLCMember_636" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAdvisorsLLCMember" xlink:label="loc_abl_LongevityMarketAdvisorsLLCMember_640" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_638" xlink:to="loc_abl_LongevityMarketAdvisorsLLCMember_640" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_642" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_642" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_642" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_642" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_RegionalInvestmentServicesIncMember" xlink:label="loc_abl_RegionalInvestmentServicesIncMember_641" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_638" xlink:to="loc_abl_RegionalInvestmentServicesIncMember_641" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_RegionalInvestmentServicesIncMember" xlink:label="loc_abl_RegionalInvestmentServicesIncMember_644" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643" xlink:to="loc_abl_RegionalInvestmentServicesIncMember_644" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_625" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_srt_ConsolidatedEntitiesAxis_625" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_626" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_625" xlink:to="loc_srt_ConsolidatedEntitiesDomain_626" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_626_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_625" xlink:to="loc_srt_ConsolidatedEntitiesDomain_626_default" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_627" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_626" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_627" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_628" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_626" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_628" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_637" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_srt_OwnershipAxis_637" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_638" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_637" xlink:to="loc_srt_OwnershipDomain_638" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_638_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_637" xlink:to="loc_srt_OwnershipDomain_638_default" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMXSeriesLLCMember" xlink:label="loc_abl_LMXSeriesLLCMember_639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_638" xlink:to="loc_abl_LMXSeriesLLCMember_639" use="optional" order="35" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_678" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_657" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_678" xlink:to="loc_us-gaap_ConcentrationRiskTable_657" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_666" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_srt_MajorCustomersAxis_666" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_667" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_666" xlink:to="loc_srt_NameOfMajorCustomerDomain_667" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_667_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_666" xlink:to="loc_srt_NameOfMajorCustomerDomain_667_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_Customer1Member" xlink:label="loc_abl_Customer1Member_668" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_667" xlink:to="loc_abl_Customer1Member_668" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_Customer2Member" xlink:label="loc_abl_Customer2Member_669" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_667" xlink:to="loc_abl_Customer2Member_669" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_661" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_661" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_661" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_661" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_664" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" xlink:to="loc_us-gaap_SalesRevenueNetMember_664" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_InvestmentMethodRevenueBenchmarkMember" xlink:label="loc_abl_InvestmentMethodRevenueBenchmarkMember_665" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" xlink:to="loc_abl_InvestmentMethodRevenueBenchmarkMember_665" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_663" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" xlink:to="loc_us-gaap_AccountsReceivableMember_663" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_658" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_658" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_659" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_658" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_659" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_659_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_658" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_659_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_660" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_659" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_660" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_670" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_670" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_671" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_670" xlink:to="loc_us-gaap_RelatedPartyDomain_671" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_671_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_670" xlink:to="loc_us-gaap_RelatedPartyDomain_671_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_673" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_671" xlink:to="loc_us-gaap_NonrelatedPartyMember_673" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_672" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_671" xlink:to="loc_us-gaap_RelatedPartyMember_672" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_674" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_674" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_675" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_674" xlink:to="loc_us-gaap_SegmentDomain_675" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_675_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_674" xlink:to="loc_us-gaap_SegmentDomain_675_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ActiveManagementSegmentMember" xlink:label="loc_abl_ActiveManagementSegmentMember_676" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_675" xlink:to="loc_abl_ActiveManagementSegmentMember_676" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PortfolioServicingSegmentMember" xlink:label="loc_abl_PortfolioServicingSegmentMember_677" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_675" xlink:to="loc_abl_PortfolioServicingSegmentMember_677" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_678" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_679" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_680" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_678" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_680" use="optional" order="28" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_704" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_692" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_srt_RangeAxis_692" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_693" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_692" xlink:to="loc_srt_RangeMember_693" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_693_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_692" xlink:to="loc_srt_RangeMember_693_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_694" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_693" xlink:to="loc_srt_MinimumMember_694" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_695" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_693" xlink:to="loc_srt_MaximumMember_695" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_700" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_700" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_700" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_700" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipAgentsMember" xlink:label="loc_abl_CustomerRelationshipAgentsMember_702" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" xlink:to="loc_abl_CustomerRelationshipAgentsMember_702" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:label="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_703" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" xlink:to="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_703" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_684" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_684" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_684" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_684" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AbacusSettlementsLLCMember" xlink:label="loc_abl_AbacusSettlementsLLCMember_688" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" xlink:to="loc_abl_AbacusSettlementsLLCMember_688" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_687" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_687" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_696" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_ValuationTechniqueAxis_696" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_697" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_696" xlink:to="loc_us-gaap_ValuationTechniqueDomain_697" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_697_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_696" xlink:to="loc_us-gaap_ValuationTechniqueDomain_697_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember_699" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_697" xlink:to="loc_us-gaap_MarketApproachValuationTechniqueMember_699" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_697" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_698" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_689" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_689" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_690" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_689" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_690" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_690_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_689" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_690_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_691" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_690" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_691" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationMeasurementInput" xlink:label="loc_abl_BusinessCombinationMeasurementInput_706" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_abl_BusinessCombinationMeasurementInput_706" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationEnterpriseValue" xlink:label="loc_abl_BusinessCombinationEnterpriseValue_707" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_abl_BusinessCombinationEnterpriseValue_707" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_708" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_708" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_705" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_705" use="optional" order="30" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_715" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_717" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_Goodwill_717" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_718" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_718" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_720" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_720" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_721" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_721" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_716" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_716" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_723" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_723" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_711" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_711" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_712" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_711" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_712" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_712" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_712" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_714" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_714" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_719" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_719" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xlink:label="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther_722" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther_722" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationValueConveyedDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_732" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_726" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_732" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_726" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_727" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_726" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_727" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_727" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_727" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AbacusSettlementsLLCMember" xlink:label="loc_abl_AbacusSettlementsLLCMember_729" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" xlink:to="loc_abl_AbacusSettlementsLLCMember_729" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_730" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_730" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_731" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_731" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_733" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_732" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_733" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_751" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_753" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_751" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_753" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_751" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_740" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_740" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_APATechnologyMember" xlink:label="loc_abl_APATechnologyMember_744" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_APATechnologyMember_744" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipAgentsMember" xlink:label="loc_abl_CustomerRelationshipAgentsMember_742" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_CustomerRelationshipAgentsMember_742" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:label="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_743" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_743" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MarketPlaceTechnologyMember" xlink:label="loc_abl_MarketPlaceTechnologyMember_745" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_MarketPlaceTechnologyMember_745" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_746" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_746" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_747" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_747" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_747" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_747" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_750" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" xlink:to="loc_us-gaap_LicensingAgreementsMember_750" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_749" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" xlink:to="loc_us-gaap_TradeNamesMember_749" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_737" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_737" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_737" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_737" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_739" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_739" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_752" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_751" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_752" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_760" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_756" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_760" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_756" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_757" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_756" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_757" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_757" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_757" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_759" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_759" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_761" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_760" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_761" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_762" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_760" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_762" use="optional" order="7" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/PropertyAndEquipmentNetDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_834" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_834" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_835" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_834" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_835" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_835" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_835" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_839" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_839" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_837" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" xlink:to="loc_us-gaap_ComputerEquipmentMember_837" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_838" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_838" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_844" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_844" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_843" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_843" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_842" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_842" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_841" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_841" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_854" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_847" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_854" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_847" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_851" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_847" xlink:to="loc_dei_LegalEntityAxis_851" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_852" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_851" xlink:to="loc_dei_EntityDomain_852" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_852_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_851" xlink:to="loc_dei_EntityDomain_852_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AbacusSettlementsLLCMember" xlink:label="loc_abl_AbacusSettlementsLLCMember_853" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_852" xlink:to="loc_abl_AbacusSettlementsLLCMember_853" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_848" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_847" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_848" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_848" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_848" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_850" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_850" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_855" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_854" xlink:to="loc_us-gaap_GoodwillRollForward_855" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_856" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_855" xlink:to="loc_us-gaap_Goodwill_856" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_857" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_855" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_857" use="optional" order="12" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_874" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_874" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_869" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_869" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_869" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_869" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_871" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" xlink:to="loc_us-gaap_TradeNamesMember_871" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_872" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" xlink:to="loc_us-gaap_LicensingAgreementsMember_872" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_862" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_862" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_862" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_862" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipAgentsMember" xlink:label="loc_abl_CustomerRelationshipAgentsMember_864" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_CustomerRelationshipAgentsMember_864" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:label="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_865" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_865" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_APATechnologyMember" xlink:label="loc_abl_APATechnologyMember_866" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_APATechnologyMember_866" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_868" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_868" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MarketPlaceTechnologyMember" xlink:label="loc_abl_MarketPlaceTechnologyMember_867" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_MarketPlaceTechnologyMember_867" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_875" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_875" use="optional" order="16" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems_892" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_897" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" xlink:label="loc_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld_893" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld_893" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_895" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_895" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_896" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_896" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" xlink:label="loc_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased_894" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased_894" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable_887" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_us-gaap_ConversionOfStockTable_887" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConversionOfStockTable_887" xlink:to="loc_us-gaap_FinancialInstrumentAxis_888" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_888" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_888" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SeriesSeedPreferredUnitsMember" xlink:label="loc_abl_SeriesSeedPreferredUnitsMember_890" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" xlink:to="loc_abl_SeriesSeedPreferredUnitsMember_890" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SeriesB1PreferredStockMember" xlink:label="loc_abl_SeriesB1PreferredStockMember_891" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" xlink:to="loc_abl_SeriesB1PreferredStockMember_891" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_899" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="loc_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_898" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_898" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_909" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_909" xlink:to="loc_us-gaap_Assets_910" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_909" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_907" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" xlink:to="loc_dei_LegalEntityAxis_907" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_908" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_907" xlink:to="loc_dei_EntityDomain_908" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_908_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_907" xlink:to="loc_dei_EntityDomain_908_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_903" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" xlink:to="loc_srt_ConsolidatedEntitiesAxis_903" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_904" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_903" xlink:to="loc_srt_ConsolidatedEntitiesDomain_904" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_904_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_903" xlink:to="loc_srt_ConsolidatedEntitiesDomain_904_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_906" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_904" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_906" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_905" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_904" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_905" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_911" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_909" xlink:to="loc_us-gaap_Liabilities_911" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_922" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome" xlink:label="loc_us-gaap_NetInvestmentIncome_924" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_922" xlink:to="loc_us-gaap_NetInvestmentIncome_924" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_925" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_922" xlink:to="loc_us-gaap_Revenues_925" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_923" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_922" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_923" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_917" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_922" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_917" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_918" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_917" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_918" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_919" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_918" xlink:to="loc_us-gaap_SegmentDomain_919" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_919_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_918" xlink:to="loc_us-gaap_SegmentDomain_919_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PortfolioServicingSegmentMember" xlink:label="loc_abl_PortfolioServicingSegmentMember_920" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_919" xlink:to="loc_abl_PortfolioServicingSegmentMember_920" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ActiveManagementSegmentMember" xlink:label="loc_abl_ActiveManagementSegmentMember_921" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_919" xlink:to="loc_abl_ActiveManagementSegmentMember_921" use="optional" order="9" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_933" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_935" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_SellingAndMarketingExpense_935" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_934" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_GrossProfit_934" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_937" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_Depreciation_937" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_942" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_942" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_940" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_940" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_941" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_941" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_944" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_NetIncomeLoss_944" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_928" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_928" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_929" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_928" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_929" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_930" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_929" xlink:to="loc_us-gaap_SegmentDomain_930" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_930_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_929" xlink:to="loc_us-gaap_SegmentDomain_930_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PortfolioServicingSegmentMember" xlink:label="loc_abl_PortfolioServicingSegmentMember_931" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_930" xlink:to="loc_abl_PortfolioServicingSegmentMember_931" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ActiveManagementSegmentMember" xlink:label="loc_abl_ActiveManagementSegmentMember_932" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_930" xlink:to="loc_abl_ActiveManagementSegmentMember_932" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_943" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_943" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRevenueExpenseNet" xlink:label="loc_us-gaap_InterestRevenueExpenseNet_939" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_InterestRevenueExpenseNet_939" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_938" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_938" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_936" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_936" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CommitmentsAndContingenciesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_954" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_947" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_954" xlink:to="loc_us-gaap_OtherCommitmentsTable_947" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_948" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_947" xlink:to="loc_us-gaap_OtherCommitmentsAxis_948" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_949" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_948" xlink:to="loc_us-gaap_OtherCommitmentsDomain_949" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_949_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_948" xlink:to="loc_us-gaap_OtherCommitmentsDomain_949_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseSupportAgreementMember" xlink:label="loc_abl_ExpenseSupportAgreementMember_950" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_949" xlink:to="loc_abl_ExpenseSupportAgreementMember_950" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_951" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_947" xlink:to="loc_srt_ConsolidatedEntitiesAxis_951" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_952" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_951" xlink:to="loc_srt_ConsolidatedEntitiesDomain_952" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_952_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_951" xlink:to="loc_srt_ConsolidatedEntitiesDomain_952_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_953" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_952" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_953" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfProvidersInvolvedInOptionAgreement" xlink:label="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_955" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_954" xlink:to="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_955" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_954" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_956" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_977" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" xlink:to="loc_us-gaap_LongTermDebtFairValue_977" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantLiabilitiesNoncurrent" xlink:label="loc_abl_WarrantLiabilitiesNoncurrent_978" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" xlink:to="loc_abl_WarrantLiabilitiesNoncurrent_978" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_979" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_979" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_960" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_960" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_961" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_960" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_961" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_961_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_960" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_961_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_962" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_961" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_962" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_963" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_963" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_963" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_963" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_965" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_965" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_966" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_966" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_967" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_967" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets_973" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_DerivativeAssets_973" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_972" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_972" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_970" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_970" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_971" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_971" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_974" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_974" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_975" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_975" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xlink:label="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets_997" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets_997" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_996" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_996" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1009" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1009" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsMeasurementInput" xlink:label="loc_abl_LifeSettlementContractsMeasurementInput_993" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_LifeSettlementContractsMeasurementInput_993" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsNumberOfContractsSold" xlink:label="loc_abl_LifeSettlementContractsNumberOfContractsSold_994" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_LifeSettlementContractsNumberOfContractsSold_994" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_995" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_995" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightPricePerWarrant" xlink:label="loc_abl_ClassOfWarrantOrRightPricePerWarrant_1002" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_ClassOfWarrantOrRightPricePerWarrant_1002" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1006" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1006" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1003" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1003" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1004" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1004" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1005" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1005" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1008" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1008" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest_999" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest_999" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_998" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_998" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_1000" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_1000" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1001" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1001" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_989" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_989" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_990" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_989" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_990" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_990_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_989" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_990_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_991" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_990" xlink:to="loc_abl_PrivatePlacementWarrantMember_991" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_983" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_983" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_984" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_983" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_984" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_984_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_983" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_984_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_985" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_984" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_985" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_986" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_986" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_987" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_986" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_987" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_987_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_986" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_987_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_988" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_987" xlink:to="loc_us-gaap_SubsequentEventMember_988" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1007" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1007" use="optional" order="30" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_1032" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskTable" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_1032" xlink:to="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1020" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1020" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1021" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1020" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1021" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1021_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1020" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1021_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierConcentrationRiskMember" xlink:label="loc_abl_LifeInsuranceCarrierConcentrationRiskMember_1022" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1021" xlink:to="loc_abl_LifeInsuranceCarrierConcentrationRiskMember_1022" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1023" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1023" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1023" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1023" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsFaceValueMember" xlink:label="loc_abl_LifeSettlementContractsFaceValueMember_1025" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" xlink:to="loc_abl_LifeSettlementContractsFaceValueMember_1025" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsFairValueMember" xlink:label="loc_abl_LifeSettlementContractsFairValueMember_1026" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" xlink:to="loc_abl_LifeSettlementContractsFairValueMember_1026" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierAxis" xlink:label="loc_abl_LifeInsuranceCarrierAxis_1027" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xlink:to="loc_abl_LifeInsuranceCarrierAxis_1027" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierDomain" xlink:label="loc_abl_LifeInsuranceCarrierDomain_1028" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abl_LifeInsuranceCarrierAxis_1027" xlink:to="loc_abl_LifeInsuranceCarrierDomain_1028" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierDomain" xlink:label="loc_abl_LifeInsuranceCarrierDomain_1028_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abl_LifeInsuranceCarrierAxis_1027" xlink:to="loc_abl_LifeInsuranceCarrierDomain_1028_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AmericanGeneralLifeInsuranceCompanyMember" xlink:label="loc_abl_AmericanGeneralLifeInsuranceCompanyMember_1029" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_LifeInsuranceCarrierDomain_1028" xlink:to="loc_abl_AmericanGeneralLifeInsuranceCompanyMember_1029" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ReliaStarLifeInsuranceCompanyMember" xlink:label="loc_abl_ReliaStarLifeInsuranceCompanyMember_1030" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_LifeInsuranceCarrierDomain_1028" xlink:to="loc_abl_ReliaStarLifeInsuranceCompanyMember_1030" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LincolnNationalLifeInsuranceCompanyMember" xlink:label="loc_abl_LincolnNationalLifeInsuranceCompanyMember_1031" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_LifeInsuranceCarrierDomain_1028" xlink:to="loc_abl_LincolnNationalLifeInsuranceCompanyMember_1031" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1033" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_1032" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1033" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1040" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1036" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1040" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1036" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1037" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1036" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1037" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1037" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1037" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractMember" xlink:label="loc_abl_LifeSettlementContractMember_1039" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038" xlink:to="loc_abl_LifeSettlementContractMember_1039" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1040" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid_1045" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid_1045" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings_1044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings_1044" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_1043" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_1043" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_1047" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_1047" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings_1046" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings_1046" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1048" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1048" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1042" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1042" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1072" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1073" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1072" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1073" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1072" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1065" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1065" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1066" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1065" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1066" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1066_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1065" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1066_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1069" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1069" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1070" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1070" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1071" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1071" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1067" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1067" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1068" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1068" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1062" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1062" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1063" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1062" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1063" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1063_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1062" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1063_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_1064" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1063" xlink:to="loc_abl_PrivatePlacementWarrantMember_1064" use="optional" order="14" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLongTermDebtDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1097" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1098" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1097" xlink:to="loc_us-gaap_LongTermDebtFairValue_1098" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1076" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1097" xlink:to="loc_us-gaap_DebtInstrumentTable_1076" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1082" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1076" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1082" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1083" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1082" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1083" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1083_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1082" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1083_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1084" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1084" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1085" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_SecuredDebtMember_1085" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaap_UnsecuredDebtMember_1086" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_UnsecuredDebtMember_1086" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1087" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_LineOfCreditMember_1087" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1088" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1076" xlink:to="loc_us-gaap_DebtInstrumentAxis_1088" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1089" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1089" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1089_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1089_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries22024IncMember" xlink:label="loc_abl_LMATTSeries22024IncMember_1091" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTSeries22024IncMember_1091" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTGrowthIncomeSeries12026IncMember" xlink:label="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1092" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1092" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesLPMember" xlink:label="loc_abl_LMATTIncomeSeriesLPMember_1093" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTIncomeSeriesLPMember_1093" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesIILPMember" xlink:label="loc_abl_LMATTIncomeSeriesIILPMember_1094" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTIncomeSeriesIILPMember_1094" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SponsorPIKNoteMember" xlink:label="loc_abl_SponsorPIKNoteMember_1095" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_SponsorPIKNoteMember_1095" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SPVInvestmentFacilityMember" xlink:label="loc_abl_SPVInvestmentFacilityMember_1096" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_SPVInvestmentFacilityMember_1096" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries2024IncMember" xlink:label="loc_abl_LMATTSeries2024IncMember_1090" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTSeries2024IncMember_1090" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1077" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1076" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1077" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1077" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1077" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1080" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1080" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1081" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1081" use="optional" order="24" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1108" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1109" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1108" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1109" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1101" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1108" xlink:to="loc_us-gaap_DebtInstrumentTable_1101" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1102" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1101" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1102" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1103" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1102" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1103" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1103_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1102" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1103_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaap_UnsecuredDebtMember_1104" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1103" xlink:to="loc_us-gaap_UnsecuredDebtMember_1104" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1105" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1101" xlink:to="loc_us-gaap_DebtInstrumentAxis_1105" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1106" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1105" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1106" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1106_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1105" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1106_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SponsorPIKNoteMember" xlink:label="loc_abl_SponsorPIKNoteMember_1107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1106" xlink:to="loc_abl_SponsorPIKNoteMember_1107" use="optional" order="10" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1126" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1127" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:label="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1128" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:label="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1129" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1129" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_us-gaap_Assets_1131" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1112" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_us-gaap_DebtInstrumentTable_1112" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1113" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_DebtInstrumentAxis_1113" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1114" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1113" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1114" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1114_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1113" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1114_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries2024IncMember" xlink:label="loc_abl_LMATTSeries2024IncMember_1115" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1114" xlink:to="loc_abl_LMATTSeries2024IncMember_1115" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1116" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1116" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1117" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1116" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1117" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1117_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1116" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1117_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1118" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1117" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1118" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis" xlink:label="loc_us-gaap_PledgedStatusAxis_1119" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_PledgedStatusAxis_1119" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1120" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PledgedStatusAxis_1119" xlink:to="loc_us-gaap_PledgedStatusDomain_1120" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1120_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PledgedStatusAxis_1119" xlink:to="loc_us-gaap_PledgedStatusDomain_1120_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_1121" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PledgedStatusDomain_1120" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_1121" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1122" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1122" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1123" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1122" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1123" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1123_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1122" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1123_default" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1151" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_DebtInstrumentTable_1134" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_1135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_srt_OwnershipAxis_1135" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_1135" xlink:to="loc_srt_OwnershipDomain_1136" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1136_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_1135" xlink:to="loc_srt_OwnershipDomain_1136_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries22024IncMember" xlink:label="loc_abl_LMATTSeries22024IncMember_1137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1136" xlink:to="loc_abl_LMATTSeries22024IncMember_1137" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries22024IncMember" xlink:label="loc_abl_LMATTSeries22024IncMember_1140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1139" xlink:to="loc_abl_LMATTSeries22024IncMember_1140" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_DebtInstrumentAxis_1138" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1138" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1139" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1139_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1138" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1139_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1141" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1141" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1142" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1142_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1141" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1142_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1142" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1143" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis" xlink:label="loc_us-gaap_PledgedStatusAxis_1148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_PledgedStatusAxis_1148" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1149" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PledgedStatusAxis_1148" xlink:to="loc_us-gaap_PledgedStatusDomain_1149" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1149_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PledgedStatusAxis_1148" xlink:to="loc_us-gaap_PledgedStatusDomain_1149_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_1150" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PledgedStatusDomain_1149" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_1150" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1144" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1144" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1144" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1147" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1147" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1152" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1152" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1153" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xlink:label="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1154" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:label="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1155" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:label="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1156" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1156" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1157" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_LongTermDebtFairValue_1157" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_Assets_1158" use="optional" order="28" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1178" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:label="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1182" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1179" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1179" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1161" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_DebtInstrumentTable_1161" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1171" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1171" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1171" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1171" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1174" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_1162" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_srt_OwnershipAxis_1162" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1163" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_1162" xlink:to="loc_srt_OwnershipDomain_1163" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1163_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_1162" xlink:to="loc_srt_OwnershipDomain_1163_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTGrowthIncomeSeries12026IncMember" xlink:label="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1164" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_1163" xlink:to="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1164" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTGrowthIncomeSeries12026IncMember" xlink:label="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1167" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1166" xlink:to="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1167" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1165" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_DebtInstrumentAxis_1165" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1166" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1165" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1166" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1166_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1165" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1166_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis" xlink:label="loc_us-gaap_PledgedStatusAxis_1175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_PledgedStatusAxis_1175" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PledgedStatusAxis_1175" xlink:to="loc_us-gaap_PledgedStatusDomain_1176" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1176_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PledgedStatusAxis_1175" xlink:to="loc_us-gaap_PledgedStatusDomain_1176_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_1177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PledgedStatusDomain_1176" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_1177" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1168" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1168" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1169" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1168" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1169" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1169_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1168" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1169_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1170" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1169" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1170" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1186" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_Assets_1186" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_LongTermDebtFairValue_1185" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDividendFeaturePercentage" xlink:label="loc_abl_DebtInstrumentDividendFeaturePercentage_1184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentDividendFeaturePercentage_1184" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:label="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1183" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xlink:label="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1181" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1180" use="optional" order="29" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1204" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentInternalRateOfReturnCap" xlink:label="loc_abl_DebtInstrumentInternalRateOfReturnCap_1211" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentInternalRateOfReturnCap_1211" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMinimumInternalRateOfReturn" xlink:label="loc_abl_DebtInstrumentMinimumInternalRateOfReturn_1210" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentMinimumInternalRateOfReturn_1210" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1189" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_us-gaap_DebtInstrumentTable_1189" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1196" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1196" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1196" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1196" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnerMember" xlink:label="loc_us-gaap_GeneralPartnerMember_1198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" xlink:to="loc_us-gaap_GeneralPartnerMember_1198" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnerMember" xlink:label="loc_us-gaap_LimitedPartnerMember_1199" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" xlink:to="loc_us-gaap_LimitedPartnerMember_1199" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1200" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1200" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1200" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1200" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1203" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1203" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_DebtInstrumentAxis_1190" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1191" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1190" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1191" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1191_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1190" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1191_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesLPMember" xlink:label="loc_abl_LMATTIncomeSeriesLPMember_1192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1191" xlink:to="loc_abl_LMATTIncomeSeriesLPMember_1192" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1193" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1193" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1193" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1194" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1194_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1193" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1194_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1194" xlink:to="loc_us-gaap_SecuredDebtMember_1195" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1214" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_us-gaap_LongTermDebtFairValue_1214" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" xlink:label="loc_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold_1213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold_1213" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1205" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_us-gaap_DebtInstrumentTerm_1205" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionOptions" xlink:label="loc_abl_DebtInstrumentExtensionOptions_1206" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentExtensionOptions_1206" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionTerm" xlink:label="loc_abl_DebtInstrumentExtensionTerm_1207" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentExtensionTerm_1207" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDividendFeaturePercentage" xlink:label="loc_abl_DebtInstrumentDividendFeaturePercentage_1208" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentDividendFeaturePercentage_1208" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" xlink:label="loc_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold_1209" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold_1209" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNetInternalRateOfReturnAtCap" xlink:label="loc_abl_DebtInstrumentNetInternalRateOfReturnAtCap_1212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentNetInternalRateOfReturnAtCap_1212" use="optional" order="28" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1241" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_us-gaap_DebtInstrumentTable_1217" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1233" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1233" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1233" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1233" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnerMember" xlink:label="loc_us-gaap_LimitedPartnerMember_1235" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" xlink:to="loc_us-gaap_LimitedPartnerMember_1235" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnerMember" xlink:label="loc_us-gaap_GeneralPartnerMember_1236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" xlink:to="loc_us-gaap_GeneralPartnerMember_1236" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_DebtInstrumentAxis_1218" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1219" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1218" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1219" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1219_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1218" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1219_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesIILPMember" xlink:label="loc_abl_LMATTIncomeSeriesIILPMember_1220" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1219" xlink:to="loc_abl_LMATTIncomeSeriesIILPMember_1220" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1221" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1221" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1222" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1221" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1222" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1222_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1221" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1222_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1223" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1222" xlink:to="loc_us-gaap_SecuredDebtMember_1223" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" xlink:label="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_1224" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_1224" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xlink:label="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_1224" xlink:to="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xlink:label="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_1224" xlink:to="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdOneMember" xlink:label="loc_abl_CapitalCommitmentThresholdOneMember_1226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" xlink:to="loc_abl_CapitalCommitmentThresholdOneMember_1226" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdTwoMember" xlink:label="loc_abl_CapitalCommitmentThresholdTwoMember_1227" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" xlink:to="loc_abl_CapitalCommitmentThresholdTwoMember_1227" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdThreeMember" xlink:label="loc_abl_CapitalCommitmentThresholdThreeMember_1228" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" xlink:to="loc_abl_CapitalCommitmentThresholdThreeMember_1228" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1237" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1237" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1237" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1237" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1240" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1240" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_srt_RangeAxis_1229" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1229" xlink:to="loc_srt_RangeMember_1230" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1230_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1229" xlink:to="loc_srt_RangeMember_1230_default" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1230" xlink:to="loc_srt_MinimumMember_1232" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1231" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1230" xlink:to="loc_srt_MaximumMember_1231" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionOptions" xlink:label="loc_abl_DebtInstrumentExtensionOptions_1243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentExtensionOptions_1243" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionTerm" xlink:label="loc_abl_DebtInstrumentExtensionTerm_1244" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentExtensionTerm_1244" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" xlink:label="loc_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends_1245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends_1245" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDividendFeaturePercentage" xlink:label="loc_abl_DebtInstrumentDividendFeaturePercentage_1246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentDividendFeaturePercentage_1246" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_us-gaap_LongTermDebtFairValue_1247" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_us-gaap_DebtInstrumentTerm_1242" use="optional" order="35" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1265" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1271" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1271" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDefaultRate" xlink:label="loc_abl_DebtInstrumentDefaultRate_1272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_DebtInstrumentDefaultRate_1272" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" xlink:label="loc_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue_1266" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue_1266" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1267" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1267" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1268" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_us-gaap_DebtInstrumentTerm_1268" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNumberOfExtensions" xlink:label="loc_abl_DebtInstrumentNumberOfExtensions_1269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_DebtInstrumentNumberOfExtensions_1269" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionTerm" xlink:label="loc_abl_DebtInstrumentExtensionTerm_1270" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_DebtInstrumentExtensionTerm_1270" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_us-gaap_DebtInstrumentTable_1250" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1255" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1255" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1256" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1255" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1256" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1256_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1255" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1256_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1257" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1256" xlink:to="loc_us-gaap_SubsequentEventMember_1257" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1258" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1258" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1259" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1258" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1259" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1259_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1258" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1259_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1260" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1259" xlink:to="loc_us-gaap_LineOfCreditMember_1260" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1263" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1262" xlink:to="loc_us-gaap_LineOfCreditMember_1263" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1261" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_CreditFacilityAxis_1261" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1262" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1261" xlink:to="loc_us-gaap_CreditFacilityDomain_1262" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1262_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1261" xlink:to="loc_us-gaap_CreditFacilityDomain_1262_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1264" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1262" xlink:to="loc_us-gaap_SecuredDebtMember_1264" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1251" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_DebtInstrumentAxis_1251" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1252" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1251" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1252" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1252_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1251" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1252_default" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SPVInvestmentFacilityMember" xlink:label="loc_abl_SPVInvestmentFacilityMember_1254" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1252" xlink:to="loc_abl_SPVInvestmentFacilityMember_1254" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PolicyAPAMember" xlink:label="loc_abl_PolicyAPAMember_1253" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1252" xlink:to="loc_abl_PolicyAPAMember_1253" use="optional" order="26" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/ShareholdersEquityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1291" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1291" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1292" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1292" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1293" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1293" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1301" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1296" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod_1311" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod_1311" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1306" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" xlink:label="loc_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering_1305" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering_1305" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" xlink:label="loc_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination_1304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination_1304" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1320" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1320" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1294" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1294" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessAcquisitionExchangeRatio" xlink:label="loc_abl_BusinessAcquisitionExchangeRatio_1299" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_BusinessAcquisitionExchangeRatio_1299" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1300" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1295" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1295" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfVotesPerCommonShare" xlink:label="loc_abl_NumberOfVotesPerCommonShare_1297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_NumberOfVotesPerCommonShare_1297" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold_1312" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold_1312" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent_1317" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent_1317" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1318" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1318" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingFairValuePerShare" xlink:label="loc_abl_WarrantsAndRightsOutstandingFairValuePerShare_1319" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_WarrantsAndRightsOutstandingFairValuePerShare_1319" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage_1315" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage_1315" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockSharesIssued_1298" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1279" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1279" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1280" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1280_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1279" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1280_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PublicWarrantsMember" xlink:label="loc_abl_PublicWarrantsMember_1281" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1280" xlink:to="loc_abl_PublicWarrantsMember_1281" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_1287" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_ValuationTechniqueAxis_1287" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_1288" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_1287" xlink:to="loc_us-gaap_ValuationTechniqueDomain_1288" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_1288_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_1287" xlink:to="loc_us-gaap_ValuationTechniqueDomain_1288_default" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BinomialLatticeModelMember" xlink:label="loc_abl_BinomialLatticeModelMember_1289" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_1288" xlink:to="loc_abl_BinomialLatticeModelMember_1289" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1282" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1282" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1283" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1283_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1282" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1283_default" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1283" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1284" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1283" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1285" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1286" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1283" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1286" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1276" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1276" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1276" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277_default" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_1278" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_1278" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent_1316" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent_1316" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" xlink:label="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare_1313" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare_1313" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant_1307" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant_1307" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionNoticePeriod" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionNoticePeriod_1308" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionNoticePeriod_1308" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold_1309" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold_1309" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1303" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1302" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" xlink:label="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod_1314" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod_1314" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays_1310" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays_1310" use="optional" order="49" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/RelatedPartyTransactionsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1352" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1355" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1355" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_1356" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_1356" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1357" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1357" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1334" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1334" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1335" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1334" xlink:to="loc_us-gaap_RelatedPartyDomain_1335" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1335_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1334" xlink:to="loc_us-gaap_RelatedPartyDomain_1335_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_1336" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1335" xlink:to="loc_srt_AffiliatedEntityMember_1336" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwnersMember" xlink:label="loc_abl_OwnersMember_1337" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1335" xlink:to="loc_abl_OwnersMember_1337" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_1338" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1335" xlink:to="loc_us-gaap_RelatedPartyMember_1338" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1339" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_DebtInstrumentAxis_1339" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1340" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1339" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1340" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1340_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1339" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1340_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SPVInvestmentFacilityMember" xlink:label="loc_abl_SPVInvestmentFacilityMember_1341" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1340" xlink:to="loc_abl_SPVInvestmentFacilityMember_1341" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_1349" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_srt_CounterpartyNameAxis_1349" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1349" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1349" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" xlink:label="loc_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember_1351" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350" xlink:to="loc_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember_1351" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1345" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1345" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1346" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1345" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1346" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1346_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1345" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1346_default" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ServiceFeeAgreementMember" xlink:label="loc_abl_ServiceFeeAgreementMember_1347" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_1346" xlink:to="loc_abl_ServiceFeeAgreementMember_1347" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseReimbursementsMember" xlink:label="loc_abl_ExpenseReimbursementsMember_1348" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_1346" xlink:to="loc_abl_ExpenseReimbursementsMember_1348" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1342" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1342" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1343" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1342" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1343" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1343_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1342" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1343_default" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1344" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1343" xlink:to="loc_us-gaap_LineOfCreditMember_1344" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1595" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_srt_RestatementAxis_1595" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1596" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1595" xlink:to="loc_srt_RestatementDomain_1596" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1596_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1595" xlink:to="loc_srt_RestatementDomain_1596_default" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_1596" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1597" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1353" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1353" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_1354" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_1354" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsOriginationExpense" xlink:label="loc_abl_LifeSettlementContractsOriginationExpense_1358" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_abl_LifeSettlementContractsOriginationExpense_1358" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1359" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1359" use="optional" order="35" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/EarningsPerShareNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1402" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1402" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1395" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1395" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1395" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1395" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_1400" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396" xlink:to="loc_abl_PrivatePlacementWarrantMember_1400" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_1589" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1588" xlink:to="loc_abl_PrivatePlacementWarrantMember_1589" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1587" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1587" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1588" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1588_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1587" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1588_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1403" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1403" use="optional" order="11" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SubsequentEventsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1435" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentAmortizationPaymentPercentage" xlink:label="loc_abl_DebtInstrumentAmortizationPaymentPercentage_1446" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentAmortizationPaymentPercentage_1446" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" xlink:label="loc_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter_1447" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter_1447" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1436" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1436" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1413" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_SubsequentEventTable_1413" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1414" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1414" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1415" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1414" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1415" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1415_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1414" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1415_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1416" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1415" xlink:to="loc_us-gaap_SubsequentEventMember_1416" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1417" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1417" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1418" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1417" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1418" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1418_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1417" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1418_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1419" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1418" xlink:to="loc_us-gaap_LineOfCreditMember_1419" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1420" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_DebtInstrumentAxis_1420" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1421" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1420" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1421" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1421_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1420" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1421_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwlRockCreditFacilityMember" xlink:label="loc_abl_OwlRockCreditFacilityMember_1422" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1421" xlink:to="loc_abl_OwlRockCreditFacilityMember_1422" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1423" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_CreditFacilityAxis_1423" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1424" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1423" xlink:to="loc_us-gaap_CreditFacilityDomain_1424" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1424_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1423" xlink:to="loc_us-gaap_CreditFacilityDomain_1424_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1425" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1424" xlink:to="loc_us-gaap_SecuredDebtMember_1425" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentAxis" xlink:label="loc_abl_VariableRateComponentAxis_1430" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_abl_VariableRateComponentAxis_1430" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentDomain" xlink:label="loc_abl_VariableRateComponentDomain_1431" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_abl_VariableRateComponentAxis_1430" xlink:to="loc_abl_VariableRateComponentDomain_1431" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentDomain" xlink:label="loc_abl_VariableRateComponentDomain_1431_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_abl_VariableRateComponentAxis_1430" xlink:to="loc_abl_VariableRateComponentDomain_1431_default" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentThreeMember" xlink:label="loc_abl_VariableRateComponentThreeMember_1434" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_VariableRateComponentDomain_1431" xlink:to="loc_abl_VariableRateComponentThreeMember_1434" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentOneMember" xlink:label="loc_abl_VariableRateComponentOneMember_1432" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_VariableRateComponentDomain_1431" xlink:to="loc_abl_VariableRateComponentOneMember_1432" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentTwoMember" xlink:label="loc_abl_VariableRateComponentTwoMember_1433" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_abl_VariableRateComponentDomain_1431" xlink:to="loc_abl_VariableRateComponentTwoMember_1433" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_1426" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_VariableRateAxis_1426" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_1427" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1426" xlink:to="loc_us-gaap_VariableRateDomain_1427" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_1427_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1426" xlink:to="loc_us-gaap_VariableRateDomain_1427_default" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1428" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1427" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1428" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_1429" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1427" xlink:to="loc_us-gaap_BaseRateMember_1429" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" xlink:label="loc_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage_1448" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage_1448" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentBasisSpreadOnVariableRateTerm" xlink:label="loc_abl_DebtInstrumentBasisSpreadOnVariableRateTerm_1443" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentBasisSpreadOnVariableRateTerm_1443" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1444" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1444" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary_1449" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary_1449" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary_1450" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary_1450" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary_1451" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary_1451" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantLeverageRatioMaximum" xlink:label="loc_abl_DebtInstrumentCovenantLeverageRatioMaximum_1452" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantLeverageRatioMaximum_1452" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" xlink:label="loc_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum_1453" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum_1453" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1437" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1437" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" xlink:label="loc_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm_1438" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm_1438" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" xlink:label="loc_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum_1439" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum_1439" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_1440" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_1440" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1441" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentTerm_1441" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1442" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1442" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDefaultRate" xlink:label="loc_abl_DebtInstrumentDefaultRate_1445" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentDefaultRate_1445" use="optional" order="46" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>abl-20230630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-October-2023 [07:31:27] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract" xml:lang="en-US">Cover [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AddressTypeDomain" xml:lang="en-US">Address Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_BusinessContactMember" xml:lang="en-US">Business Contact [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_BusinessContactMember" xml:lang="en-US">Business Contact</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod" xml:lang="en-US">Entity Ex Transition Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityExTransitionPeriod" xml:lang="en-US">Entity Ex Transition Period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness" xml:lang="en-US">Entity Small Business</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntitySmallBusiness" xml:lang="en-US">Entity Small Business</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany" xml:lang="en-US">Entity Emerging Growth Company</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityEmergingGrowthCompany" xml:lang="en-US">Entity Emerging Growth Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityPrimarySicNumber" xml:lang="en-US">Entity Primary SIC Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPrimarySicNumber" xlink:to="lab_dei_EntityPrimarySicNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2" xml:lang="en-US">Entity Address, Address Line Two</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_ContactPersonnelName" xml:lang="en-US">Contact Personnel Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressStateOrProvince" xml:lang="en-US">Entity Address, State or Province</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressStateOrProvince" xml:lang="en-US">Entity Address, State or Province</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Common Class A [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Class A Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredLongTermDebt" xlink:label="loc_us-gaap_SecuredLongTermDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SecuredLongTermDebt" xml:lang="en-US">Secured Long-Term Debt, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SecuredLongTermDebt" xml:lang="en-US">SPV purchase and sale note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredLongTermDebt" xlink:to="lab_us-gaap_SecuredLongTermDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">CURRENT LIABILITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating Lease, Liability, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating lease liabilities&#8212;current portion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xml:lang="en-US">Operating lease liability, current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US">Other Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xml:lang="en-US">Other current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AccruedTransactionCostsCurrent" xlink:label="loc_abl_AccruedTransactionCostsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_AccruedTransactionCostsCurrent" xml:lang="en-US">Accrued Transaction Costs, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_AccruedTransactionCostsCurrent" xml:lang="en-US">Accrued transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_AccruedTransactionCostsCurrent" xlink:to="lab_abl_AccruedTransactionCostsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_AccruedTransactionCostsCurrent" xml:lang="en-US">Accrued Transaction Costs, Current</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xml:lang="en-US">Contract with Customer, Liability, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xml:lang="en-US">Contract liabilities&#8212;deposits on pending settlements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xml:lang="en-US">Accrued Income Taxes, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xml:lang="en-US">Income taxes payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xml:lang="en-US">Other Long-Term Debt, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xml:lang="en-US">Long-term debt, at fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:to="lab_us-gaap_OtherLongTermDebtNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating lease liabilities&#8212;noncurrent portion</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xml:lang="en-US">Operating lease liability, non-current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xml:lang="en-US">SHAREHOLDERS' EQUITY (DEFICIT)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional Paid in Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained earnings/(accumulated deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Total shareholders' equity (deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Ending balance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinorityInterest" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MinorityInterest" xml:lang="en-US">Non-controlling interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Class A common stock, $0.0001 par value; 200,000,000 authorized shares; 62,961,688 and 50,369,350 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Accumulated other comprehensive income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xml:lang="en-US">Deferred Income Tax Liabilities, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xml:lang="en-US">Deferred tax liability</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantLiabilitiesNoncurrent" xlink:label="loc_abl_WarrantLiabilitiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_WarrantLiabilitiesNoncurrent" xml:lang="en-US">Warrant Liabilities, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_WarrantLiabilitiesNoncurrent" xml:lang="en-US">Warrant liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_abl_WarrantLiabilitiesNoncurrent" xml:lang="en-US">Private placement warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_WarrantLiabilitiesNoncurrent" xlink:to="lab_abl_WarrantLiabilitiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_WarrantLiabilitiesNoncurrent" xml:lang="en-US">Warrant Liabilities, Noncurrent</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">TOTAL LIABILITIES</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES (11)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xml:lang="en-US">Available for sale securities, at fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xml:lang="en-US">Other investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xml:lang="en-US">Equity securities without readily determinable fair value, amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xml:lang="en-US">Other Receivable, after Allowance for Credit Loss, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xml:lang="en-US">Due from members and affiliates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:to="lab_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment&#8212;net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xml:lang="en-US">Life Settlement Contracts, Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xml:lang="en-US">Life settlement policies, at fair value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xml:lang="en-US">Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xml:lang="en-US">Life settlement policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">TOTAL ASSETS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">CURRENT ASSETS:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xml:lang="en-US">Other Receivables, Net, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xml:lang="en-US">Other receivables</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xml:lang="en-US">Life Settlement Contracts, Investment Method, Carrying Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xml:lang="en-US">Life settlement policies, at cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xml:lang="en-US">Carrying Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CertificatesOfDepositNoncurrent" xlink:label="loc_abl_CertificatesOfDepositNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_CertificatesOfDepositNoncurrent" xml:lang="en-US">Certificates Of Deposit, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_CertificatesOfDepositNoncurrent" xml:lang="en-US">Certificate of deposit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_CertificatesOfDepositNoncurrent" xlink:to="lab_abl_CertificatesOfDepositNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_CertificatesOfDepositNoncurrent" xml:lang="en-US">Certificates Of Deposit, Noncurrent</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xml:lang="en-US">Other Assets, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xml:lang="en-US">Other assets, at fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xml:lang="en-US">Intangible assets, net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Goodwill</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Goodwill</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Goodwill at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_Goodwill" xml:lang="en-US">Goodwill at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating right-of-use assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xml:lang="en-US">Operating lease right-of-use assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StateSecurityDepositsNoncurrent" xlink:label="loc_abl_StateSecurityDepositsNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_StateSecurityDepositsNoncurrent" xml:lang="en-US">State Security Deposits, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_StateSecurityDepositsNoncurrent" xml:lang="en-US">State security deposit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_StateSecurityDepositsNoncurrent" xlink:to="lab_abl_StateSecurityDepositsNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_StateSecurityDepositsNoncurrent" xml:lang="en-US">State Security Deposits, Noncurrent</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party, Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party, Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonrelatedPartyMember" xml:lang="en-US">Nonrelated Party [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NonrelatedPartyMember" xml:lang="en-US">Nonrelated Party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrelatedPartyMember" xlink:to="lab_us-gaap_NonrelatedPartyMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_AffiliatedEntityMember" xml:lang="en-US">Affiliated Entity [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_AffiliatedEntityMember" xml:lang="en-US">Affiliated Entity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwnersMember" xlink:label="loc_abl_OwnersMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_OwnersMember" xml:lang="en-US">Owners [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_OwnersMember" xml:lang="en-US">Owners</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_OwnersMember" xlink:to="lab_abl_OwnersMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_OwnersMember" xml:lang="en-US">Owners</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyMember" xml:lang="en-US">Related Party [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyMember" xml:lang="en-US">Related Party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common stock, par value (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, shares issued (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, shares outstanding (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Ending balance (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Beginning balance (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaap_CostOfRevenueAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xml:lang="en-US">Cost of Revenue [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xml:lang="en-US">COST OF REVENUES (excluding depreciation stated below)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfRevenue" xml:lang="en-US">Cost of Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CostOfRevenue" xml:lang="en-US">Total cost of revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">OPERATING EXPENSES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xml:lang="en-US">Loss on change in fair value of debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xml:lang="en-US">Loss on change in fair value of debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xml:lang="en-US">Unrealized loss on change in fair value (risk-free)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xml:lang="en-US">Unrealized Gain (Loss) on Investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xml:lang="en-US">Unrealized loss (gain) on investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xml:lang="en-US">Unrealized (gain) loss on investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xml:lang="en-US">Unrealized gain (loss) on investments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepreciationAndAmortization" xml:lang="en-US">Depreciation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses" xml:lang="en-US">Total operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xml:lang="en-US">Selling and Marketing Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xml:lang="en-US">Sales and marketing</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xml:lang="en-US">Sales and marketing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General, administrative and other</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xml:lang="en-US">Comprehensive income (loss) attributable to non-controlling interests</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US">Comprehensive income attributable to Abacus Life Inc.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">NET INCOME</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">NET INCOME</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net Income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xml:lang="en-US">Other comprehensive income, net of tax:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" xml:lang="en-US">Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Tax and Reclassification Adjustment, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" xml:lang="en-US">Change in fair value of debt</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Net income before provision for income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Provision for income taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Provision for income taxes</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Provision for income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xml:lang="en-US">LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xml:lang="en-US">Less: Net loss attributable to non-controlling interests</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">NET INCOME ATTRIBUTABLE TO SHAREHOLDERS</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net income attributable to Longevity Market Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">EARNINGS PER SHARE:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Earnings Per Share, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Basic net income per share (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted-average shares used in computing net income per share, basic (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted-average shares used in computing net income per share, diluted (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Earnings Per Share, Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Diluted net income per share (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Gross Profit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Gross Profit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GrossProfit" xml:lang="en-US">Total gross profit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Comprehensive income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">Revenues [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenuesAbstract" xml:lang="en-US">REVENUES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Revenues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Revenues" xml:lang="en-US">Total revenues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceServicesRevenue" xlink:label="loc_us-gaap_InsuranceServicesRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InsuranceServicesRevenue" xml:lang="en-US">Insurance Services Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_InsuranceServicesRevenue" xml:lang="en-US">Total active management revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceServicesRevenue" xlink:to="lab_us-gaap_InsuranceServicesRevenue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xml:lang="en-US">Total portfolio servicing revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xml:lang="en-US">Portfolio servicing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xml:lang="en-US">Life Settlement Contracts, Fair Value Method, Gain (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xml:lang="en-US">Change in fair value of life insurance policies (policies held using fair value method)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xml:lang="en-US">Decrease in valuation compared to third-party valuation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodGainLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceInvestmentIncome" xlink:label="loc_us-gaap_InsuranceInvestmentIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InsuranceInvestmentIncome" xml:lang="en-US">Insurance Investment Income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InsuranceInvestmentIncome" xml:lang="en-US">Investment Income from life insurance policies held using investment method</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceInvestmentIncome" xlink:to="lab_us-gaap_InsuranceInvestmentIncome" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">OTHER INCOME (EXPENSE)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other income (expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xml:lang="en-US">Other (expense) income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Nonoperating Income (Expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Total other income (expense)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest (expense)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest (expense)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Investment Income, Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Interest income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">Accumulated Other Comprehensive Income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xml:lang="en-US">Noncontrolling Interest [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xml:lang="en-US">Non- Controlling Interests</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-In Capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:label="loc_abl_StockIssuedDuringPeriodValueReverseRecapitalization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_StockIssuedDuringPeriodValueReverseRecapitalization" xml:lang="en-US">Stock Issued During Period, Value, Reverse Recapitalization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_StockIssuedDuringPeriodValueReverseRecapitalization" xml:lang="en-US">Merger with East Resources Acquisition Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:to="lab_abl_StockIssuedDuringPeriodValueReverseRecapitalization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_StockIssuedDuringPeriodValueReverseRecapitalization" xml:lang="en-US">Stock Issued During Period, Value, Reverse Recapitalization</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Dividends" xml:lang="en-US">Dividends</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_Dividends" xml:lang="en-US">Distributions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockholdersEquityDeferredTransactionCosts" xlink:label="loc_abl_StockholdersEquityDeferredTransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_StockholdersEquityDeferredTransactionCosts" xml:lang="en-US">Stockholders Equity, Deferred Transaction Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_abl_StockholdersEquityDeferredTransactionCosts" xml:lang="en-US">Deferred transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_StockholdersEquityDeferredTransactionCosts" xlink:to="lab_abl_StockholdersEquityDeferredTransactionCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_StockholdersEquityDeferredTransactionCosts" xml:lang="en-US">Stockholders Equity, Deferred Transaction Costs</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xml:lang="en-US">Acquisition of Abacus Settlements, LLC</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US">Other Comprehensive Income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Public warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:label="loc_abl_StockIssuedDuringPeriodSharesReverseRecapitalization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_StockIssuedDuringPeriodSharesReverseRecapitalization" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Recapitalization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_StockIssuedDuringPeriodSharesReverseRecapitalization" xml:lang="en-US">Merger with East Resources Acquisition Company (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:to="lab_abl_StockIssuedDuringPeriodSharesReverseRecapitalization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_StockIssuedDuringPeriodSharesReverseRecapitalization" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Recapitalization</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xml:lang="en-US">Proceeds from Issuance of Other Long-Term Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xml:lang="en-US">Issuance of debt certificates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xml:lang="en-US">Proceeds from Contributions from Affiliates</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xml:lang="en-US">Due to members and affiliates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xml:lang="en-US">Proceeds from Issuance of Secured Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xml:lang="en-US">Proceeds from receipt of SPV purchase and sale note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xml:lang="en-US">Payments of Distributions to Affiliates</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xml:lang="en-US">Capital distribution to members</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:to="lab_us-gaap_PaymentsOfDistributionsToAffiliates" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xml:lang="en-US">Payments of Merger Related Costs, Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xml:lang="en-US">Transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:to="lab_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xml:lang="en-US">Deferred income taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" xml:lang="en-US">Life Settlement Contracts, Fair Value Method, Unrealized Gain (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" xml:lang="en-US">Unrealized gain on policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xml:lang="en-US">Non-cash lease expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Changes in operating assets and liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Accounts receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US">Prepaid expenses and other current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Accrued transaction costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xml:lang="en-US">Other current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xml:lang="en-US">Other noncurrent assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedFairValueMethod" xlink:label="loc_abl_LifeSettlementContractPurchasedFairValueMethod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractPurchasedFairValueMethod" xml:lang="en-US">Life Settlement Contract Purchased, Fair Value Method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_abl_LifeSettlementContractPurchasedFairValueMethod" xml:lang="en-US">Life Settlement Policies purchased, at fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractPurchasedFairValueMethod" xlink:to="lab_abl_LifeSettlementContractPurchasedFairValueMethod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractPurchasedFairValueMethod" xml:lang="en-US">Life Settlement Contract Purchased, Fair Value Method</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedInvestmentMethod" xlink:label="loc_abl_LifeSettlementContractPurchasedInvestmentMethod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractPurchasedInvestmentMethod" xml:lang="en-US">Life Settlement Contract Purchased, Investment Method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_abl_LifeSettlementContractPurchasedInvestmentMethod" xml:lang="en-US">Life Settlement Policies purchased, at cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractPurchasedInvestmentMethod" xlink:to="lab_abl_LifeSettlementContractPurchasedInvestmentMethod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractPurchasedInvestmentMethod" xml:lang="en-US">Life Settlement Contract Purchased, Investment Method</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProceedsDueFromPaymentsDueToAffiliates" xlink:label="loc_abl_ProceedsDueFromPaymentsDueToAffiliates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ProceedsDueFromPaymentsDueToAffiliates" xml:lang="en-US">Proceeds Due From (Payments) Due To Affiliates</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ProceedsDueFromPaymentsDueToAffiliates" xml:lang="en-US">Due from affiliates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ProceedsDueFromPaymentsDueToAffiliates" xlink:to="lab_abl_ProceedsDueFromPaymentsDueToAffiliates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ProceedsDueFromPaymentsDueToAffiliates" xml:lang="en-US">Proceeds Due From (Payments) Due To Affiliates</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash used in investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xml:lang="en-US">Purchase of investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xml:lang="en-US">Purchase of convertible promissory note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations" xml:lang="en-US">Nature of Operations [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NatureOfOperations" xml:lang="en-US">DESCRIPTION OF BUSINESS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xml:lang="en-US">BUSINESS COMBINATION</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xml:lang="en-US">Investments, All Other Investments [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsDisclosureTextBlock" xlink:label="loc_us-gaap_LifeSettlementContractsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsDisclosureTextBlock" xml:lang="en-US">Life Settlement Contracts, Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsDisclosureTextBlock" xml:lang="en-US">LIFE INSURANCE SETTLEMENT POLICIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsDisclosureTextBlock" xlink:to="lab_us-gaap_LifeSettlementContractsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">PROPERTY AND EQUIPMENT&#8212;NET</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US">AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xml:lang="en-US">Other Assets Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xml:lang="en-US">OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xml:lang="en-US">CONSOLIDATION OF VARIABLE INTEREST ENTITIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingAbstract" xml:lang="en-US">Segment Reporting [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xml:lang="en-US">SEGMENT REPORTING</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">FAIR VALUE MEASUREMENTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xml:lang="en-US">Debt Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaap_LongTermDebtTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xml:lang="en-US">Long-Term Debt [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xml:lang="en-US">LONG-TERM DEBT</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityAbstract" xml:lang="en-US">Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Equity [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">SHAREHOLDERS' EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsAbstract" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xml:lang="en-US">Postemployment Benefits [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTextBlock" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xml:lang="en-US">Defined Contribution Plan [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xml:lang="en-US">EMPLOYEE BENEFIT PLAN</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">INCOME TAXES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">RELATED-PARTY TRANSACTIONS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesAbstract" xml:lang="en-US">Leases [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xml:lang="en-US">LEASES</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Earnings Per Share [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">EARNINGS PER SHARE</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">SUBSEQUENT EVENTS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xml:lang="en-US">Schedule of Subsidiary of Limited Liability Company or Limited Partnership [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xml:lang="en-US">Schedule of Subsidiary of Limited Liability Company or Limited Partnership [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xml:lang="en-US">Consolidated Entities [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xml:lang="en-US">Consolidated Entities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xml:lang="en-US">Consolidated Entities [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xml:lang="en-US">Consolidated Entities [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xml:lang="en-US">Subsidiary of Limited Liability Company or Limited Partnership [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xml:lang="en-US">Subsidiary of Limited Liability Company or Limited Partnership [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:to="lab_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Unaudited Condensed Consolidated Financial Statements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xml:lang="en-US">Consolidation of Variable Interest Entities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xml:lang="en-US">Noncontrolling Interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsPolicy" xlink:label="loc_us-gaap_LifeSettlementContractsPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsPolicy" xml:lang="en-US">Life Settlement Contracts, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsPolicy" xml:lang="en-US">Life Insurance Settlement Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsPolicy" xlink:to="lab_us-gaap_LifeSettlementContractsPolicy" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xml:lang="en-US">Cost of Revenues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentrations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsPolicyTextBlock" xlink:label="loc_abl_WarrantsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_WarrantsPolicyTextBlock" xml:lang="en-US">Warrants [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_WarrantsPolicyTextBlock" xml:lang="en-US">Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_WarrantsPolicyTextBlock" xlink:to="lab_abl_WarrantsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_WarrantsPolicyTextBlock" xml:lang="en-US">Warrants</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Presentation and Unaudited Condensed Consolidated Financial Statements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xml:lang="en-US">Value conveyed</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xml:lang="en-US">Intangible assets acquired</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xml:lang="en-US">Purchase price allocation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xml:lang="en-US">Pro forma financial information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" xlink:label="loc_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" xml:lang="en-US">Schedule of Life Settlement Contracts, Investment Method [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" xml:lang="en-US">Schedule of Life Settlement Contracts, Investment Method</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" xlink:to="lab_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" xlink:label="loc_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" xml:lang="en-US">Schedule of Life Settlement Contracts, Fair Value Method [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" xml:lang="en-US">Schedule of Life Settlement Contracts, Fair Value Method</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" xlink:to="lab_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Summary of Property and Equipment, Net</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xml:lang="en-US">Schedule of Goodwill</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xml:lang="en-US">Summary of Revenue by Segment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xml:lang="en-US">Summary of Segment Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xml:lang="en-US">Lease Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xml:lang="en-US">Future Minimum Noncancellable Lease Payments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:label="loc_abl_AssetsAndLiabilitiesLesseeTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_AssetsAndLiabilitiesLesseeTableTextBlock" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_AssetsAndLiabilitiesLesseeTableTextBlock" xml:lang="en-US">ROU Assets and Lease Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_abl_AssetsAndLiabilitiesLesseeTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_AssetsAndLiabilitiesLesseeTableTextBlock" xml:lang="en-US">Assets And Liabilities, Lessee</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US">Business Acquisition [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US">Business Acquisition [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LongevityMarketAssetsLLCMember" xml:lang="en-US">Longevity Market Assets, LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LongevityMarketAssetsLLCMember" xml:lang="en-US">LMA</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LongevityMarketAssetsLLCMember" xlink:to="lab_abl_LongevityMarketAssetsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LongevityMarketAssetsLLCMember" xml:lang="en-US">Longevity Market Assets, LLC</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xml:lang="en-US">Business Acquisition [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xml:lang="en-US">Business Acquisition [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessAcquisitionExchangeRatio" xlink:label="loc_abl_BusinessAcquisitionExchangeRatio" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_BusinessAcquisitionExchangeRatio" xml:lang="en-US">Business Acquisition, Exchange Ratio</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_BusinessAcquisitionExchangeRatio" xml:lang="en-US">Exchange ratio</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_BusinessAcquisitionExchangeRatio" xlink:to="lab_abl_BusinessAcquisitionExchangeRatio" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_BusinessAcquisitionExchangeRatio" xml:lang="en-US">Business Acquisition, Exchange Ratio</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" xlink:label="loc_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" xml:lang="en-US">Variable Interest Entity, Financial or Other Support, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" xml:lang="en-US">Contribution amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" xlink:to="lab_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xml:lang="en-US">Business Combination, Consideration Transferred</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xml:lang="en-US">Consideration paid to acquire business</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xml:lang="en-US">Consideration</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xml:lang="en-US">Subsidiary, Ownership Percentage, Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xml:lang="en-US">Ownership percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfProvidersInvolvedInOptionAgreement" xlink:label="loc_abl_NumberOfProvidersInvolvedInOptionAgreement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_NumberOfProvidersInvolvedInOptionAgreement" xml:lang="en-US">Number Of Providers Involved In Option Agreement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_NumberOfProvidersInvolvedInOptionAgreement" xml:lang="en-US">Option agreement, number of providers</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_NumberOfProvidersInvolvedInOptionAgreement" xlink:to="lab_abl_NumberOfProvidersInvolvedInOptionAgreement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_NumberOfProvidersInvolvedInOptionAgreement" xml:lang="en-US">Number Of Providers Involved In Option Agreement</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" xlink:label="loc_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" xml:lang="en-US">Number Of Unaffiliated Investors Involved In Variable Interest Entity Ownership</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" xml:lang="en-US">Number of unaffiliated investors</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" xlink:to="lab_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" xml:lang="en-US">Number of Unaffiliated Investors</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xml:lang="en-US">Ownership percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xml:lang="en-US">Other Commitments [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xml:lang="en-US">Other Commitments [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xml:lang="en-US">Other Commitments [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xml:lang="en-US">Other Commitments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseSupportAgreementMember" xlink:label="loc_abl_ExpenseSupportAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ExpenseSupportAgreementMember" xml:lang="en-US">Expense Support Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ExpenseSupportAgreementMember" xml:lang="en-US">Expense Support Agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ExpenseSupportAgreementMember" xlink:to="lab_abl_ExpenseSupportAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ExpenseSupportAgreementMember" xml:lang="en-US">Expense Support Agreement</label>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProviderOneMember" xlink:label="loc_abl_ProviderOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ProviderOneMember" xml:lang="en-US">Provider One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ProviderOneMember" xml:lang="en-US">Provider One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ProviderOneMember" xlink:to="lab_abl_ProviderOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ProviderOneMember" xml:lang="en-US">Provider One</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProviderTwoMember" xlink:label="loc_abl_ProviderTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ProviderTwoMember" xml:lang="en-US">Provider Two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ProviderTwoMember" xml:lang="en-US">Provider Two</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ProviderTwoMember" xlink:to="lab_abl_ProviderTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ProviderTwoMember" xml:lang="en-US">Provider Two</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAdvisorsLLCMember" xlink:label="loc_abl_LongevityMarketAdvisorsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LongevityMarketAdvisorsLLCMember" xml:lang="en-US">Longevity Market Advisors, LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LongevityMarketAdvisorsLLCMember" xml:lang="en-US">Longevity Market Advisors</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LongevityMarketAdvisorsLLCMember" xlink:to="lab_abl_LongevityMarketAdvisorsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LongevityMarketAdvisorsLLCMember" xml:lang="en-US">Longevity Market Advisors, LLC</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_RegionalInvestmentServicesIncMember" xlink:label="loc_abl_RegionalInvestmentServicesIncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_RegionalInvestmentServicesIncMember" xml:lang="en-US">Regional Investment Services,&#160;Inc [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_RegionalInvestmentServicesIncMember" xml:lang="en-US">RIS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_RegionalInvestmentServicesIncMember" xlink:to="lab_abl_RegionalInvestmentServicesIncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_RegionalInvestmentServicesIncMember" xml:lang="en-US">Regional Investment Services,&#160;Inc</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_OwnershipAxis" xml:lang="en-US">Ownership [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_OwnershipAxis" xml:lang="en-US">Ownership [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_OwnershipDomain" xml:lang="en-US">Ownership [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_OwnershipDomain" xml:lang="en-US">Ownership [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMXSeriesLLCMember" xlink:label="loc_abl_LMXSeriesLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LMXSeriesLLCMember" xml:lang="en-US">LMX Series, LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LMXSeriesLLCMember" xml:lang="en-US">LMX</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LMXSeriesLLCMember" xlink:to="lab_abl_LMXSeriesLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LMXSeriesLLCMember" xml:lang="en-US">LMX Series, LLC</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTable" xml:lang="en-US">Concentration Risk [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskTable" xml:lang="en-US">Concentration Risk [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MajorCustomersAxis" xml:lang="en-US">Customer [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MajorCustomersAxis" xml:lang="en-US">Customer [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_NameOfMajorCustomerDomain" xml:lang="en-US">Customer [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_NameOfMajorCustomerDomain" xml:lang="en-US">Customer [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_Customer1Member" xlink:label="loc_abl_Customer1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_Customer1Member" xml:lang="en-US">Customer 1 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_Customer1Member" xml:lang="en-US">Customer 1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_Customer1Member" xlink:to="lab_abl_Customer1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_Customer1Member" xml:lang="en-US">Customer 1</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_Customer2Member" xlink:label="loc_abl_Customer2Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_Customer2Member" xml:lang="en-US">Customer 2 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_Customer2Member" xml:lang="en-US">Customer 2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_Customer2Member" xlink:to="lab_abl_Customer2Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_Customer2Member" xml:lang="en-US">Customer 2</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueNetMember" xml:lang="en-US">Revenue Benchmark [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SalesRevenueNetMember" xml:lang="en-US">Revenue Benchmark</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_InvestmentMethodRevenueBenchmarkMember" xlink:label="loc_abl_InvestmentMethodRevenueBenchmarkMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_InvestmentMethodRevenueBenchmarkMember" xml:lang="en-US">Investment Method Revenue Benchmark [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_InvestmentMethodRevenueBenchmarkMember" xml:lang="en-US">Investment Method Revenue Benchmark</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_InvestmentMethodRevenueBenchmarkMember" xlink:to="lab_abl_InvestmentMethodRevenueBenchmarkMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_InvestmentMethodRevenueBenchmarkMember" xml:lang="en-US">Investment Method Revenue Benchmark</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableMember" xml:lang="en-US">Accounts Receivable [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableMember" xml:lang="en-US">Accounts Receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xml:lang="en-US">Concentration Risk Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xml:lang="en-US">Concentration Risk Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xml:lang="en-US">Concentration Risk Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xml:lang="en-US">Concentration Risk Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US">Customer Concentration Risk [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xml:lang="en-US">Customer Concentration Risk</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xml:lang="en-US">Segments [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xml:lang="en-US">Segments [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentDomain" xml:lang="en-US">Segments [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SegmentDomain" xml:lang="en-US">Segments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ActiveManagementSegmentMember" xlink:label="loc_abl_ActiveManagementSegmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ActiveManagementSegmentMember" xml:lang="en-US">Active Management Segment [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ActiveManagementSegmentMember" xml:lang="en-US">Active management</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ActiveManagementSegmentMember" xlink:to="lab_abl_ActiveManagementSegmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ActiveManagementSegmentMember" xml:lang="en-US">Active Management Segment</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PortfolioServicingSegmentMember" xlink:label="loc_abl_PortfolioServicingSegmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_PortfolioServicingSegmentMember" xml:lang="en-US">Portfolio Servicing Segment [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_PortfolioServicingSegmentMember" xml:lang="en-US">Portfolio servicing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_PortfolioServicingSegmentMember" xlink:to="lab_abl_PortfolioServicingSegmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_PortfolioServicingSegmentMember" xml:lang="en-US">Portfolio Servicing Segment</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xml:lang="en-US">Concentration Risk [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xml:lang="en-US">Concentration Risk [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Concentration Risk, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Concentration risk percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xml:lang="en-US">Allowance for doubtful accounts</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipAgentsMember" xlink:label="loc_abl_CustomerRelationshipAgentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_CustomerRelationshipAgentsMember" xml:lang="en-US">Customer Relationship, Agents [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_CustomerRelationshipAgentsMember" xml:lang="en-US">Customer Relationships - Agents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_CustomerRelationshipAgentsMember" xlink:to="lab_abl_CustomerRelationshipAgentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_CustomerRelationshipAgentsMember" xml:lang="en-US">Customer Relationship, Agents</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:label="loc_abl_CustomerRelationshipsFinancialRelationshipsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_CustomerRelationshipsFinancialRelationshipsMember" xml:lang="en-US">Customer Relationships, Financial Relationships [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_CustomerRelationshipsFinancialRelationshipsMember" xml:lang="en-US">Customer Relationships - Financial Relationships</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:to="lab_abl_CustomerRelationshipsFinancialRelationshipsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_CustomerRelationshipsFinancialRelationshipsMember" xml:lang="en-US">Customer Relationships, Financial Relationships</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xml:lang="en-US">Longevity Market Assets,&#160;LLC And Abacus Settlements LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xml:lang="en-US">LMA and Abacus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:to="lab_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xml:lang="en-US">Longevity Market Assets,&#160;LLC And Abacus Settlements LLC</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AbacusSettlementsLLCMember" xlink:label="loc_abl_AbacusSettlementsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_AbacusSettlementsLLCMember" xml:lang="en-US">Abacus Settlements LLC [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_AbacusSettlementsLLCMember" xml:lang="en-US">Abacus</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_abl_AbacusSettlementsLLCMember" xml:lang="en-US">Abacus Settlements, LLC</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_AbacusSettlementsLLCMember" xlink:to="lab_abl_AbacusSettlementsLLCMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_AbacusSettlementsLLCMember" xml:lang="en-US">Abacus Settlements LLC</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationMeasurementInput" xlink:label="loc_abl_BusinessCombinationMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_BusinessCombinationMeasurementInput" xml:lang="en-US">Business Combination, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_BusinessCombinationMeasurementInput" xml:lang="en-US">Measurement input</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_BusinessCombinationMeasurementInput" xlink:to="lab_abl_BusinessCombinationMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_BusinessCombinationMeasurementInput" xml:lang="en-US">Business Combination, Measurement Input</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationEnterpriseValue" xlink:label="loc_abl_BusinessCombinationEnterpriseValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_BusinessCombinationEnterpriseValue" xml:lang="en-US">Business Combination, Enterprise Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_BusinessCombinationEnterpriseValue" xml:lang="en-US">Enterprise value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_BusinessCombinationEnterpriseValue" xlink:to="lab_abl_BusinessCombinationEnterpriseValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_BusinessCombinationEnterpriseValue" xml:lang="en-US">Business Combination, Enterprise Value</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xml:lang="en-US">Useful Life</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xml:lang="en-US">Valuation Approach and Technique [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xml:lang="en-US">Valuation Approach and Technique [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xml:lang="en-US">Valuation Approach and Technique [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xml:lang="en-US">Valuation Approach and Technique [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketApproachValuationTechniqueMember" xml:lang="en-US">Valuation, Market Approach [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MarketApproachValuationTechniqueMember" xml:lang="en-US">Market approach</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketApproachValuationTechniqueMember" xlink:to="lab_us-gaap_MarketApproachValuationTechniqueMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xml:lang="en-US">Discounted cash flow method</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xml:lang="en-US">Measurement Input Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xml:lang="en-US">Measurement Input Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xml:lang="en-US">Measurement Input Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xml:lang="en-US">Measurement Input Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xml:lang="en-US">Measurement Input, Discount Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xml:lang="en-US">Discount rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xml:lang="en-US">Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xml:lang="en-US">Deferred Tax Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xml:lang="en-US">Accrued Expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:to="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Intangibles</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xml:lang="en-US">Total Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xml:lang="en-US">Non-Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xlink:label="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Other</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xml:lang="en-US">Other Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xlink:to="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Other</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_APATechnologyMember" xlink:label="loc_abl_APATechnologyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_APATechnologyMember" xml:lang="en-US">APA Technology [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_APATechnologyMember" xml:lang="en-US">Internally Developed and Used Technology&#8212;APA</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_APATechnologyMember" xlink:to="lab_abl_APATechnologyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_APATechnologyMember" xml:lang="en-US">APA Technology</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MarketPlaceTechnologyMember" xlink:label="loc_abl_MarketPlaceTechnologyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_MarketPlaceTechnologyMember" xml:lang="en-US">Market Place Technology [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_MarketPlaceTechnologyMember" xml:lang="en-US">Internally Developed and Used Technology&#8212;Market Place</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_MarketPlaceTechnologyMember" xlink:to="lab_abl_MarketPlaceTechnologyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_MarketPlaceTechnologyMember" xml:lang="en-US">Market Place Technology</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xml:lang="en-US">Noncompete Agreements [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xml:lang="en-US">Non-Compete Agreements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LicensingAgreementsMember" xml:lang="en-US">Licensing Agreements [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LicensingAgreementsMember" xml:lang="en-US">State Insurance Licenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TradeNamesMember" xml:lang="en-US">Trade Names [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TradeNamesMember" xml:lang="en-US">Trade Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xml:lang="en-US">Proforma revenue</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xml:lang="en-US">Proforma net income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xml:lang="en-US">Life Settlement Contracts, Investment Method, Face Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xml:lang="en-US">Face value of policies accounted for using investment method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xml:lang="en-US">Face Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsNumberOfContracts" xlink:label="loc_abl_LifeSettlementContractsNumberOfContracts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractsNumberOfContracts" xml:lang="en-US">Life Settlement Contracts, Number Of Contracts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractsNumberOfContracts" xml:lang="en-US">Number of life settlement policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractsNumberOfContracts" xlink:to="lab_abl_LifeSettlementContractsNumberOfContracts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractsNumberOfContracts" xml:lang="en-US">Life Settlement Contracts, Number Of Contracts</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xml:lang="en-US">Life Settlement Contracts, Fair Value Method, Number of Contracts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xml:lang="en-US">Number of life settlement policies accounted for under fair value method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xml:lang="en-US">Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xml:lang="en-US">Life Settlement Contracts, Investment Method, Number of Contracts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xml:lang="en-US">Number of life settlement policies accounted for under investment method</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xml:lang="en-US">Number of Life Insurance Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xml:lang="en-US">Life Settlement Contracts, Fair Value Method, Face Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xml:lang="en-US">Face value of policies held at fair value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xml:lang="en-US">Face Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract" xml:lang="en-US">Life Settlement Contracts, Fair Value, Fiscal Year Maturity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract" xml:lang="en-US">Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" xml:lang="en-US">Life Settlement Contract, Fair Value, Maturity, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" xml:lang="en-US">2-3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" xml:lang="en-US">Life Settlement Contract, Fair Value, Maturity, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" xml:lang="en-US">3-4</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value, Maturity, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" xml:lang="en-US">4-5</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractFairValueMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractFairValueMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value, Maturity, After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractFairValueMaturityAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractFairValueMaturityAfterYearFour" xlink:to="lab_abl_LifeSettlementContractFairValueMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractFairValueMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value, Maturity, After Year Four</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" xml:lang="en-US">Life Settlement Contract, Fair Value, Maturity, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" xml:lang="en-US">0-1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" xml:lang="en-US">Life Settlement Contract, Fair Value, Maturity, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" xml:lang="en-US">1-2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract" xml:lang="en-US">Life Settlement Contracts, Fair Value Method, Number of Contracts, Fiscal Year Maturity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract" xml:lang="en-US">Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" xml:lang="en-US">4-5</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" xml:lang="en-US">1-2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" xlink:to="lab_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, After Year Four</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xml:lang="en-US">0-1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" xml:lang="en-US">2-3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" xml:lang="en-US">3-4</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract" xml:lang="en-US">Life Settlement Contracts, Fair Value Method, Face Value, Fiscal Year Maturity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract" xml:lang="en-US">Face Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Face Value, Maturity, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" xml:lang="en-US">0-1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" xml:lang="en-US">1-2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" xml:lang="en-US">4-5</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Face Value, Maturity, After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" xlink:to="lab_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Face Value, Maturity, After Year Four</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" xml:lang="en-US">3-4</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" xml:lang="en-US">Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" xml:lang="en-US">2-3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" xlink:to="lab_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract" xml:lang="en-US">Life Settlement Contracts, Investment Method, Face Value, Fiscal Year Maturity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract" xml:lang="en-US">Face Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" xml:lang="en-US">Life Settlement Contract, Investment Method, Face Value, Maturity, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" xml:lang="en-US">3-4</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Face Value, Maturity, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" xml:lang="en-US">4-5</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Face Value, Maturity, After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" xlink:to="lab_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Face Value, Maturity, After Year Four</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" xml:lang="en-US">Life Settlement Contract, Investment Method, Face Value, Maturity, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" xml:lang="en-US">0-1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" xml:lang="en-US">Life Settlement Contract, Investment Method, Face Value, Maturity, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" xml:lang="en-US">1-2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" xml:lang="en-US">Life Settlement Contract, Investment Method, Face Value, Maturity, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" xml:lang="en-US">2-3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract" xml:lang="en-US">Life Settlement Contracts, Investment Method, Number of Contracts, Fiscal Year Maturity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract" xml:lang="en-US">Number of Life Insurance Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xml:lang="en-US">Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xml:lang="en-US">0-1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" xml:lang="en-US">Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" xml:lang="en-US">1-2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" xml:lang="en-US">Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" xml:lang="en-US">2-3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" xml:lang="en-US">Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" xml:lang="en-US">3-4</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Number Of Contracts, Maturity, After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" xlink:to="lab_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Number Of Contracts, Maturity, After Year Four</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" xml:lang="en-US">4-5</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract" xml:lang="en-US">Life Settlement Contracts, Investment Method, Carrying Amount, Fiscal Year Maturity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract" xml:lang="en-US">Carrying Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" xml:lang="en-US">Life Settlement Contract, Investment Method, Amount, Maturity, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" xml:lang="en-US">3-4</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" xml:lang="en-US">Life Settlement Contract, Investment Method, Amount, Maturity, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" xml:lang="en-US">0-1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" xml:lang="en-US">Life Settlement Contract, Investment Method, Amount, Maturity, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" xml:lang="en-US">1-2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" xml:lang="en-US">Life Settlement Contract, Investment Method, Amount, Maturity, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" xml:lang="en-US">2-3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Amount, Maturity, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" xml:lang="en-US">4-5</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Amount, Maturity, After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" xlink:to="lab_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" xml:lang="en-US">Life Settlement Contract, Investment Method, Amount, Maturity, After Year Four</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" xml:lang="en-US">Life Settlement Contract, Investment Method, Premium To Be Paid, After Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" xlink:to="lab_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" xml:lang="en-US">Life Settlement Contract, Investment Method, Premium To Be Paid, After Year Three</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" xml:lang="en-US">Life Settlement Contract, Investment Method, Premium to be Paid, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" xml:lang="en-US">2023 remaining</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" xml:lang="en-US">Life Settlement Contract, Investment Method, Premium to be Paid, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" xml:lang="en-US">2024</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xml:lang="en-US">Life Settlement Contracts, Investment Method, Premiums to be Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xml:lang="en-US">Total</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" xml:lang="en-US">Life Settlement Contract, Investment Method, Premium to be Paid, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" xml:lang="en-US">2026</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" xml:lang="en-US">Life Settlement Contract, Investment Method, Premium to be Paid, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" xml:lang="en-US">2025</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" xlink:to="lab_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US">Leasehold Improvements [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US">Leasehold improvements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ComputerEquipmentMember" xml:lang="en-US">Computer Equipment [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ComputerEquipmentMember" xml:lang="en-US">Computer equipment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and Fixtures [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and fixtures</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US">Depreciation expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Less: accumulated depreciation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property and equipment&#8212;gross</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xml:lang="en-US">Schedule of Goodwill [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xml:lang="en-US">Schedule of Goodwill [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillLineItems" xml:lang="en-US">Goodwill [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillLineItems" xml:lang="en-US">Goodwill [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillRollForward" xml:lang="en-US">Goodwill [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillRollForward" xml:lang="en-US">Goodwill [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xml:lang="en-US">Goodwill, Acquired During Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xml:lang="en-US">Additions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xml:lang="en-US">Useful Life</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" xlink:label="loc_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" xml:lang="en-US">Debt Securities, Available-For-Sale, Equity Financing Threshold In Which Shares Convert</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" xml:lang="en-US">Equity financing threshold</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" xlink:to="lab_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" xml:lang="en-US">Debt Securities, Available-For-Sale, Equity Financing Threshold In Which Shares Convert</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield" xml:lang="en-US">Debt Securities, Available-for-Sale, Weighted Average Yield</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield" xml:lang="en-US">Interest rate per annum</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockTable" xml:lang="en-US">Conversion of Stock [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConversionOfStockTable" xml:lang="en-US">Conversion of Stock [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockTable" xlink:to="lab_us-gaap_ConversionOfStockTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xml:lang="en-US">Financial Instrument [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Financial Instruments [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xml:lang="en-US">Financial Instruments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SeriesSeedPreferredUnitsMember" xlink:label="loc_abl_SeriesSeedPreferredUnitsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SeriesSeedPreferredUnitsMember" xml:lang="en-US">Series Seed Preferred Units [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SeriesSeedPreferredUnitsMember" xml:lang="en-US">Series Seed Preferred Units</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SeriesSeedPreferredUnitsMember" xlink:to="lab_abl_SeriesSeedPreferredUnitsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SeriesSeedPreferredUnitsMember" xml:lang="en-US">Series Seed Preferred Units</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SeriesB1PreferredStockMember" xlink:label="loc_abl_SeriesB1PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SeriesB1PreferredStockMember" xml:lang="en-US">Series B-1 Preferred Stock [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SeriesB1PreferredStockMember" xml:lang="en-US">Series B-1 Preferred Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SeriesB1PreferredStockMember" xlink:to="lab_abl_SeriesB1PreferredStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SeriesB1PreferredStockMember" xml:lang="en-US">Series B-1 Preferred Stock</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConversionOfStockLineItems" xml:lang="en-US">Conversion of Stock [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConversionOfStockLineItems" xml:lang="en-US">Conversion of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockLineItems" xlink:to="lab_us-gaap_ConversionOfStockLineItems" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xml:lang="en-US">Monthly Payments To Acquire, Equity Securities Without Readily Determinable Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xml:lang="en-US">Monthly payment amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:to="lab_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xml:lang="en-US">Monthly Payments To Acquire, Equity Securities Without Readily Determinable Fair Value</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" xlink:label="loc_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" xml:lang="en-US">Number Of Entities In Which Equity Securities Without Readily Determinable Fair Value Are Held</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" xml:lang="en-US">Number of entities, convertible preferred stock ownership</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" xlink:to="lab_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" xml:lang="en-US">Number Of Entities In Which Equity Securities Without Readily Determinable Fair Value Are Held</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xml:lang="en-US">Number Of Monthly Payments To Acquire Equity Securities Without Readily Determinable Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xml:lang="en-US">Number of monthly payments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:to="lab_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xml:lang="en-US">Number Of Monthly Payments To Acquire Equity Securities Without Readily Determinable Fair Value</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" xlink:label="loc_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Securities Purchased</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" xml:lang="en-US">Units purchased (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" xlink:to="lab_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Number Of Securities Purchased</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xml:lang="en-US">Impairment of investments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="loc_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xml:lang="en-US">Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xml:lang="en-US">Equity ownership percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:to="lab_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xml:lang="en-US">Variable Interest Entity [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xml:lang="en-US">Variable Interest Entity [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NumberOfReportableSegments" xml:lang="en-US">Number of Reportable Segments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NumberOfReportableSegments" xml:lang="en-US">Number of reportable segments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xml:lang="en-US">Segment Reporting Information [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xml:lang="en-US">Segment Reporting Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome" xlink:label="loc_us-gaap_NetInvestmentIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetInvestmentIncome" xml:lang="en-US">Net Investment Income</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetInvestmentIncome" xml:lang="en-US">Active management</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_Depreciation" xml:lang="en-US">Depreciation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRevenueExpenseNet" xlink:label="loc_us-gaap_InterestRevenueExpenseNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestRevenueExpenseNet" xml:lang="en-US">Interest Revenue (Expense), Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestRevenueExpenseNet" xml:lang="en-US">Interest expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRevenueExpenseNet" xlink:to="lab_us-gaap_InterestRevenueExpenseNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsTable" xml:lang="en-US">Other Commitments [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentsTable" xml:lang="en-US">Other Commitments [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xml:lang="en-US">Other Commitments [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xml:lang="en-US">Other Commitments [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xml:lang="en-US">Liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongTermDebtFairValue" xml:lang="en-US">Long-Term Debt, Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LongTermDebtFairValue" xml:lang="en-US">Long-term debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongTermDebtFairValue" xml:lang="en-US">Long-term debt, fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Liabilities, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Total liabilities held at fair value:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xml:lang="en-US">Assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeAssets" xml:lang="en-US">Derivative Asset</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeAssets" xml:lang="en-US">S&amp;P 500 options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xml:lang="en-US">Debt Securities, Available-for-Sale</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xml:lang="en-US">Available-for-sale securities, at fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xml:lang="en-US">Other Assets, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xml:lang="en-US">Other assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US">Assets, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US">Total assets held at fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xml:lang="en-US">Measurement Frequency [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xml:lang="en-US">Measurement Frequency [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xml:lang="en-US">Measurement Frequency [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xml:lang="en-US">Measurement Frequency [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xml:lang="en-US">Fair Value, Recurring [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xml:lang="en-US">Fair Value, Recurring</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Level 1</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Level 2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Level 3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xlink:label="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xml:lang="en-US">Fair Value, Option, Change In Fair Value Gain (Loss) And Credit Risk, Gains (Losses) On Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xml:lang="en-US">Total change in fair value of debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xml:lang="en-US">Change in estimated fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xlink:to="lab_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xml:lang="en-US">Fair Value, Option, Change In Fair Value Gain (Loss) And Credit Risk, Gains (Losses) On Assets</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsMeasurementInput" xlink:label="loc_abl_LifeSettlementContractsMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractsMeasurementInput" xml:lang="en-US">Life Settlement Contracts, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractsMeasurementInput" xml:lang="en-US">Life settlement policies, measurement input</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractsMeasurementInput" xlink:to="lab_abl_LifeSettlementContractsMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractsMeasurementInput" xml:lang="en-US">Life Settlement Contracts, Measurement Input</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsNumberOfContractsSold" xlink:label="loc_abl_LifeSettlementContractsNumberOfContractsSold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractsNumberOfContractsSold" xml:lang="en-US">Life Settlement Contracts, Number Of Contracts Sold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractsNumberOfContractsSold" xml:lang="en-US">Life settlement policies sold</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractsNumberOfContractsSold" xlink:to="lab_abl_LifeSettlementContractsNumberOfContractsSold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractsNumberOfContractsSold" xml:lang="en-US">Life Settlement Contracts, Number Of Contracts Sold</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightPricePerWarrant" xlink:label="loc_abl_ClassOfWarrantOrRightPricePerWarrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightPricePerWarrant" xml:lang="en-US">Class Of Warrant Or Right, Price Per Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightPricePerWarrant" xml:lang="en-US">Price per warrant (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightPricePerWarrant" xlink:to="lab_abl_ClassOfWarrantOrRightPricePerWarrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightPricePerWarrant" xml:lang="en-US">Class Of Warrant Or Right, Price Per Warrant</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Warrants and Rights Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US">Warrants outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US">Number of securities called by each warrant (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price of warrants (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included In Equity, Attributable To Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" xml:lang="en-US">Gain on change in fair value of debt, included within equity of noncontrolling interests</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" xlink:to="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included In Equity, Attributable To Noncontrolling Interest</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xml:lang="en-US">Gain on change in fair value of debt, included within other comprehensive income</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Warrants outstanding (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_PrivatePlacementWarrantMember" xml:lang="en-US">Private Placement Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_PrivatePlacementWarrantMember" xml:lang="en-US">Private Placement Warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_PrivatePlacementWarrantMember" xlink:to="lab_abl_PrivatePlacementWarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_PrivatePlacementWarrantMember" xml:lang="en-US">Private Placement Warrant</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventMember" xml:lang="en-US">Subsequent Event</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xml:lang="en-US">Life settlement policies, change in fair value, impact of +2% discount rate adjustment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xlink:to="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xml:lang="en-US">Life settlement policies, fair value, impact of -2% discount rate adjustment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xlink:to="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xml:lang="en-US">Life settlement policies, change in fair value, impact of -2% discount rate adjustment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xlink:to="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xml:lang="en-US">Life settlement policies, fair value, impact of +2% discount rate adjustment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xlink:to="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xml:lang="en-US">Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskTable" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskTable" xml:lang="en-US">Fair Value, Concentration of Risk [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskTable" xml:lang="en-US">Fair Value, Concentration of Risk [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable" xlink:to="lab_us-gaap_FairValueConcentrationOfRiskTable" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierConcentrationRiskMember" xlink:label="loc_abl_LifeInsuranceCarrierConcentrationRiskMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeInsuranceCarrierConcentrationRiskMember" xml:lang="en-US">Life Insurance Carrier Concentration Risk [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeInsuranceCarrierConcentrationRiskMember" xml:lang="en-US">Life Insurance Carrier Concentration Risk</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeInsuranceCarrierConcentrationRiskMember" xlink:to="lab_abl_LifeInsuranceCarrierConcentrationRiskMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeInsuranceCarrierConcentrationRiskMember" xml:lang="en-US">Life Insurance Carrier Concentration Risk</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsFaceValueMember" xlink:label="loc_abl_LifeSettlementContractsFaceValueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractsFaceValueMember" xml:lang="en-US">Life Settlement Contracts, Face Value [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractsFaceValueMember" xml:lang="en-US">Life Insurance Contract, Face Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractsFaceValueMember" xlink:to="lab_abl_LifeSettlementContractsFaceValueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractsFaceValueMember" xml:lang="en-US">Life Settlement Contracts, Face Value</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsFairValueMember" xlink:label="loc_abl_LifeSettlementContractsFairValueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractsFairValueMember" xml:lang="en-US">Life Settlement Contracts, Fair Value [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractsFairValueMember" xml:lang="en-US">Life Insurance Contract, Fair Value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractsFairValueMember" xlink:to="lab_abl_LifeSettlementContractsFairValueMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractsFairValueMember" xml:lang="en-US">Life Settlement Contracts, Fair Value</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xml:lang="en-US">Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xml:lang="en-US">Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierAxis" xlink:label="loc_abl_LifeInsuranceCarrierAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeInsuranceCarrierAxis" xml:lang="en-US">Life Insurance Carrier [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeInsuranceCarrierAxis" xml:lang="en-US">Life Insurance Carrier [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeInsuranceCarrierAxis" xlink:to="lab_abl_LifeInsuranceCarrierAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeInsuranceCarrierAxis" xml:lang="en-US">Life Insurance Carrier</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierDomain" xlink:label="loc_abl_LifeInsuranceCarrierDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeInsuranceCarrierDomain" xml:lang="en-US">Life Insurance Carrier [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeInsuranceCarrierDomain" xml:lang="en-US">Life Insurance Carrier [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeInsuranceCarrierDomain" xlink:to="lab_abl_LifeInsuranceCarrierDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeInsuranceCarrierDomain" xml:lang="en-US">Life Insurance Carrier [Domain]</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AmericanGeneralLifeInsuranceCompanyMember" xlink:label="loc_abl_AmericanGeneralLifeInsuranceCompanyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_AmericanGeneralLifeInsuranceCompanyMember" xml:lang="en-US">American General Life Insurance Company [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_AmericanGeneralLifeInsuranceCompanyMember" xml:lang="en-US">American General Life Insurance Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_AmericanGeneralLifeInsuranceCompanyMember" xlink:to="lab_abl_AmericanGeneralLifeInsuranceCompanyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_AmericanGeneralLifeInsuranceCompanyMember" xml:lang="en-US">American General Life Insurance Company</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ReliaStarLifeInsuranceCompanyMember" xlink:label="loc_abl_ReliaStarLifeInsuranceCompanyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ReliaStarLifeInsuranceCompanyMember" xml:lang="en-US">ReliaStar Life Insurance Company [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ReliaStarLifeInsuranceCompanyMember" xml:lang="en-US">ReliaStar Life Insurance Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ReliaStarLifeInsuranceCompanyMember" xlink:to="lab_abl_ReliaStarLifeInsuranceCompanyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ReliaStarLifeInsuranceCompanyMember" xml:lang="en-US">ReliaStar Life Insurance Company</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LincolnNationalLifeInsuranceCompanyMember" xlink:label="loc_abl_LincolnNationalLifeInsuranceCompanyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LincolnNationalLifeInsuranceCompanyMember" xml:lang="en-US">Lincoln National Life Insurance Company [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LincolnNationalLifeInsuranceCompanyMember" xml:lang="en-US">Lincoln National Life Insurance Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LincolnNationalLifeInsuranceCompanyMember" xlink:to="lab_abl_LincolnNationalLifeInsuranceCompanyMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LincolnNationalLifeInsuranceCompanyMember" xml:lang="en-US">Lincoln National Life Insurance Company</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xml:lang="en-US">Asset Class [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xml:lang="en-US">Asset Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xml:lang="en-US">Asset Class [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xml:lang="en-US">Asset Class [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractMember" xlink:label="loc_abl_LifeSettlementContractMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractMember" xml:lang="en-US">Life Settlement Contract [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractMember" xml:lang="en-US">Life Insurance Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractMember" xlink:to="lab_abl_LifeSettlementContractMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractMember" xml:lang="en-US">Life Settlement Contract</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Premiums Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" xml:lang="en-US">Premiums paid</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" xlink:to="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Premiums Paid</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Realized Gain (Loss) Included in Earnings</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" xml:lang="en-US">Realized gain (loss) on matured/sold policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" xlink:to="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Realized Gain (Loss) Included In Earnings</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xml:lang="en-US">Policies purchased</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xml:lang="en-US">Change in estimated fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Earnings</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" xml:lang="en-US">Unrealized gain(loss) on held policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" xlink:to="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Earnings</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xml:lang="en-US">Matured/sold policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xml:lang="en-US">Fair value at end of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xml:lang="en-US">Fair value at beginning of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US">Debt issued to third parties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair value at beginning of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair value at end of period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets" xlink:label="loc_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets" xml:lang="en-US">Fair Value, Option, Credit Risk, Gains (Losses) on Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets" xml:lang="en-US">Unrealized gain on change in fair value (credit-adjusted)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets" xlink:to="lab_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xml:lang="en-US">Warrants and rights outstanding, measurement input</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember" xml:lang="en-US">Measurement Input, Exercise Price [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputExercisePriceMember" xml:lang="en-US">Exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExercisePriceMember" xlink:to="lab_us-gaap_MeasurementInputExercisePriceMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Measurement Input, Share Price [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Common Stock Price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xml:lang="en-US">Dividend Yield</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Risk-free interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US">Measurement Input, Expected Term [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US">Term to expiration</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentTable" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentTable" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xml:lang="en-US">Debt Instrument [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xml:lang="en-US">Debt Instrument [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US">Long-Term Debt, Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US">Long-Term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US">Long-Term Debt, Type [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US">Long-Term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xml:lang="en-US">Notes Payable, Other Payables [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xml:lang="en-US">Market-indexed notes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SecuredDebtMember" xml:lang="en-US">Secured Debt [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SecuredDebtMember" xml:lang="en-US">Secured borrowing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaap_UnsecuredDebtMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnsecuredDebtMember" xml:lang="en-US">Unsecured Debt [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnsecuredDebtMember" xml:lang="en-US">Unsecured borrowing</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditMember" xml:lang="en-US">Line of Credit [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LineOfCreditMember" xml:lang="en-US">Line of Credit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentAxis" xml:lang="en-US">Debt Instrument [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentAxis" xml:lang="en-US">Debt Instrument [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries22024IncMember" xlink:label="loc_abl_LMATTSeries22024IncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LMATTSeries22024IncMember" xml:lang="en-US">LMATT Series 2.2024, Inc. [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LMATTSeries22024IncMember" xml:lang="en-US">LMATT Series 2.2024, Inc.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LMATTSeries22024IncMember" xlink:to="lab_abl_LMATTSeries22024IncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LMATTSeries22024IncMember" xml:lang="en-US">LMATT Series 2.2024, Inc.</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTGrowthIncomeSeries12026IncMember" xlink:label="loc_abl_LMATTGrowthIncomeSeries12026IncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LMATTGrowthIncomeSeries12026IncMember" xml:lang="en-US">LMATT Growth &amp; Income Series 1.2026, Inc [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LMATTGrowthIncomeSeries12026IncMember" xml:lang="en-US">LMATT Growth &amp; Income Series 1.2026, Inc</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LMATTGrowthIncomeSeries12026IncMember" xlink:to="lab_abl_LMATTGrowthIncomeSeries12026IncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LMATTGrowthIncomeSeries12026IncMember" xml:lang="en-US">LMATT Growth &amp; Income Series 1.2026, Inc</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesLPMember" xlink:label="loc_abl_LMATTIncomeSeriesLPMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LMATTIncomeSeriesLPMember" xml:lang="en-US">LMATT Income Series, LP [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LMATTIncomeSeriesLPMember" xml:lang="en-US">LMATT Income Series, LP</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LMATTIncomeSeriesLPMember" xlink:to="lab_abl_LMATTIncomeSeriesLPMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LMATTIncomeSeriesLPMember" xml:lang="en-US">LMATT Income Series, LP</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesIILPMember" xlink:label="loc_abl_LMATTIncomeSeriesIILPMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LMATTIncomeSeriesIILPMember" xml:lang="en-US">LMATT Income Series II, LP [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LMATTIncomeSeriesIILPMember" xml:lang="en-US">LMATT Income Series II, LP</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LMATTIncomeSeriesIILPMember" xlink:to="lab_abl_LMATTIncomeSeriesIILPMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LMATTIncomeSeriesIILPMember" xml:lang="en-US">LMATT Income Series II, LP</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SponsorPIKNoteMember" xlink:label="loc_abl_SponsorPIKNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SponsorPIKNoteMember" xml:lang="en-US">Sponsor PIK Note [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SponsorPIKNoteMember" xml:lang="en-US">Sponsor PIK Note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SponsorPIKNoteMember" xlink:to="lab_abl_SponsorPIKNoteMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SponsorPIKNoteMember" xml:lang="en-US">Sponsor PIK Note</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SPVInvestmentFacilityMember" xlink:label="loc_abl_SPVInvestmentFacilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_SPVInvestmentFacilityMember" xml:lang="en-US">SPV Investment Facility [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_SPVInvestmentFacilityMember" xml:lang="en-US">SPV Investment Facility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_SPVInvestmentFacilityMember" xlink:to="lab_abl_SPVInvestmentFacilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_SPVInvestmentFacilityMember" xml:lang="en-US">SPV Investment Facility</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries2024IncMember" xlink:label="loc_abl_LMATTSeries2024IncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LMATTSeries2024IncMember" xml:lang="en-US">LMATT Series 2024, Inc. [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LMATTSeries2024IncMember" xml:lang="en-US">LMATT Series 2024, Inc.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LMATTSeries2024IncMember" xlink:to="lab_abl_LMATTSeries2024IncMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LMATTSeries2024IncMember" xml:lang="en-US">LMATT Series 2024, Inc.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xml:lang="en-US">Measurement Basis [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xml:lang="en-US">Measurement Basis [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xml:lang="en-US">Portion at Fair Value Measurement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xml:lang="en-US">Reported Value Measurement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xml:lang="en-US">Cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xml:lang="en-US">Fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Debt Instrument, Face Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US">Face amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:label="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xml:lang="en-US">Debt Instrument, Maximum Market Downturn Protection Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xml:lang="en-US">Market downturn protection percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:to="lab_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xml:lang="en-US">Debt Instrument, Maximum Market Downturn Protection Percentage</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:label="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xml:lang="en-US">Debt Instrument, Note Reduction Ratio For Losses Below Threshold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xml:lang="en-US">Note reduction ratio for losses below threshold</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:to="lab_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xml:lang="en-US">Debt Instrument, Note Reduction Ratio For Losses Below Threshold</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis" xlink:label="loc_us-gaap_PledgedStatusAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PledgedStatusAxis" xml:lang="en-US">Pledged Status [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PledgedStatusAxis" xml:lang="en-US">Pledged Status [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusAxis" xlink:to="lab_us-gaap_PledgedStatusAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PledgedStatusDomain" xml:lang="en-US">Pledged Status [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PledgedStatusDomain" xml:lang="en-US">Pledged Status [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PledgedStatusDomain" xlink:to="lab_us-gaap_PledgedStatusDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetPledgedAsCollateralMember" xml:lang="en-US">Asset Pledged as Collateral [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetPledgedAsCollateralMember" xml:lang="en-US">Asset Pledged as Collateral</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetPledgedAsCollateralMember" xlink:to="lab_us-gaap_AssetPledgedAsCollateralMember" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xlink:label="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xml:lang="en-US">Debt Instrument, Maximum Upside Performance Participation Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xml:lang="en-US">Upside performance participation cap</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xlink:to="lab_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xml:lang="en-US">Debt Instrument, Maximum Upside Performance Participation Percentage</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDividendFeaturePercentage" xlink:label="loc_abl_DebtInstrumentDividendFeaturePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentDividendFeaturePercentage" xml:lang="en-US">Debt Instrument, Dividend Feature Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentDividendFeaturePercentage" xml:lang="en-US">Dividend percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentDividendFeaturePercentage" xlink:to="lab_abl_DebtInstrumentDividendFeaturePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentDividendFeaturePercentage" xml:lang="en-US">Debt Instrument, Dividend Feature Percentage</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xml:lang="en-US">Partner Type [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xml:lang="en-US">Partner Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xml:lang="en-US">Partner Type of Partners' Capital Account, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:to="lab_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnerMember" xlink:label="loc_us-gaap_GeneralPartnerMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralPartnerMember" xml:lang="en-US">General Partner [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralPartnerMember" xml:lang="en-US">General Partner</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralPartnerMember" xlink:to="lab_us-gaap_GeneralPartnerMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnerMember" xlink:label="loc_us-gaap_LimitedPartnerMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LimitedPartnerMember" xml:lang="en-US">Limited Partner [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LimitedPartnerMember" xml:lang="en-US">Limited Partner</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedPartnerMember" xlink:to="lab_us-gaap_LimitedPartnerMember" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentInternalRateOfReturnCap" xlink:label="loc_abl_DebtInstrumentInternalRateOfReturnCap" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentInternalRateOfReturnCap" xml:lang="en-US">Debt Instrument, Internal Rate Of Return Cap</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentInternalRateOfReturnCap" xml:lang="en-US">Internal rate of return cap</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentInternalRateOfReturnCap" xlink:to="lab_abl_DebtInstrumentInternalRateOfReturnCap" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentInternalRateOfReturnCap" xml:lang="en-US">Debt Instrument, Internal Rate Of Return Threshold Cap</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMinimumInternalRateOfReturn" xlink:label="loc_abl_DebtInstrumentMinimumInternalRateOfReturn" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentMinimumInternalRateOfReturn" xml:lang="en-US">Debt Instrument, Minimum Internal Rate Of Return</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentMinimumInternalRateOfReturn" xml:lang="en-US">Minimum internal rate of return threshold</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentMinimumInternalRateOfReturn" xlink:to="lab_abl_DebtInstrumentMinimumInternalRateOfReturn" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentMinimumInternalRateOfReturn" xml:lang="en-US">Debt Instrument, Minimum Internal Rate Of Return Threshold</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" xlink:label="loc_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" xml:lang="en-US">Debt Instrument, Return Rate In Excess Of Capped Internal Rate Of Return Threshold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" xml:lang="en-US">Return Rate in excess of capped internal rate of return threshold</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" xlink:to="lab_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" xml:lang="en-US">Debt Instrument, Return Rate In Excess Of Capped Internal Rate Of Return Threshold</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Debt Instrument, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentTerm" xml:lang="en-US">Debt instrument term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionOptions" xlink:label="loc_abl_DebtInstrumentExtensionOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentExtensionOptions" xml:lang="en-US">Debt Instrument, Extension Options</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentExtensionOptions" xml:lang="en-US">Debt Instrument extension options</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentExtensionOptions" xlink:to="lab_abl_DebtInstrumentExtensionOptions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentExtensionOptions" xml:lang="en-US">Debt Instrument, Extension Options</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionTerm" xlink:label="loc_abl_DebtInstrumentExtensionTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentExtensionTerm" xml:lang="en-US">Debt Instrument, Extension Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentExtensionTerm" xml:lang="en-US">Debt instrument extension term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentExtensionTerm" xlink:to="lab_abl_DebtInstrumentExtensionTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentExtensionTerm" xml:lang="en-US">Debt Instrument, Extension Term</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" xlink:label="loc_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" xml:lang="en-US">Debt Instrument, Return Rate In Excess Of Minimum Internal Rate Of Return Threshold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" xml:lang="en-US">Return rate in excess of minimum internal rate of return</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" xlink:to="lab_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" xml:lang="en-US">Debt Instrument, Return Rate In Excess Of Minimum Internal Rate Of Return Threshold</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNetInternalRateOfReturnAtCap" xlink:label="loc_abl_DebtInstrumentNetInternalRateOfReturnAtCap" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentNetInternalRateOfReturnAtCap" xml:lang="en-US">Debt Instrument, Net Internal Rate Of Return At Cap</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentNetInternalRateOfReturnAtCap" xml:lang="en-US">Net internal rate of return at cap</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentNetInternalRateOfReturnAtCap" xlink:to="lab_abl_DebtInstrumentNetInternalRateOfReturnAtCap" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentNetInternalRateOfReturnAtCap" xml:lang="en-US">Debt Instrument, Net Internal Rate Of Return At Cap</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" xlink:label="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" xml:lang="en-US">Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" xml:lang="en-US">Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" xlink:to="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" xml:lang="en-US">Debt Instrument, Private Placement Offering, Capital Commitment Thresholds</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xlink:label="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xml:lang="en-US">Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xml:lang="en-US">Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xlink:to="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xml:lang="en-US">Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Domain]</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdOneMember" xlink:label="loc_abl_CapitalCommitmentThresholdOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_CapitalCommitmentThresholdOneMember" xml:lang="en-US">Capital Commitment Threshold One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_CapitalCommitmentThresholdOneMember" xml:lang="en-US">Capital Commitment Threshold One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_CapitalCommitmentThresholdOneMember" xlink:to="lab_abl_CapitalCommitmentThresholdOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_CapitalCommitmentThresholdOneMember" xml:lang="en-US">Capital Commitment Threshold One</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdTwoMember" xlink:label="loc_abl_CapitalCommitmentThresholdTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_CapitalCommitmentThresholdTwoMember" xml:lang="en-US">Capital Commitment Threshold Two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_CapitalCommitmentThresholdTwoMember" xml:lang="en-US">Capital Commitment Threshold Two</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_CapitalCommitmentThresholdTwoMember" xlink:to="lab_abl_CapitalCommitmentThresholdTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_CapitalCommitmentThresholdTwoMember" xml:lang="en-US">Capital Commitment Threshold Two</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdThreeMember" xlink:label="loc_abl_CapitalCommitmentThresholdThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_CapitalCommitmentThresholdThreeMember" xml:lang="en-US">Capital Commitment Threshold Three [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_CapitalCommitmentThresholdThreeMember" xml:lang="en-US">Capital Commitment Threshold Three</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_CapitalCommitmentThresholdThreeMember" xlink:to="lab_abl_CapitalCommitmentThresholdThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_CapitalCommitmentThresholdThreeMember" xml:lang="en-US">Capital Commitment Threshold Three</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" xlink:label="loc_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" xml:lang="en-US">Debt Instrument, Capital Commitment Thresholds To Determine Dividends</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" xml:lang="en-US">Capital commitment threshold to determine dividend rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" xlink:to="lab_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" xml:lang="en-US">Debt Instrument, Capital Commitment Thresholds To Determine Dividends</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US">Interest rate (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDefaultRate" xlink:label="loc_abl_DebtInstrumentDefaultRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentDefaultRate" xml:lang="en-US">Debt Instrument, Default Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentDefaultRate" xml:lang="en-US">Default rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentDefaultRate" xlink:to="lab_abl_DebtInstrumentDefaultRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentDefaultRate" xml:lang="en-US">Debt Instrument, Default Rate</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" xlink:label="loc_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" xml:lang="en-US">Life Settlement Contracts, Special Purchase Vehicle, Fair Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" xml:lang="en-US">Insurance policies fair value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" xlink:to="lab_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" xml:lang="en-US">Life Settlement Contracts, Special Purchase Vehicle, Fair Value</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNumberOfExtensions" xlink:label="loc_abl_DebtInstrumentNumberOfExtensions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentNumberOfExtensions" xml:lang="en-US">Debt Instrument, Number Of Extensions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentNumberOfExtensions" xml:lang="en-US">Number of extensions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentNumberOfExtensions" xlink:to="lab_abl_DebtInstrumentNumberOfExtensions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentNumberOfExtensions" xml:lang="en-US">Debt Instrument, Number Of Extensions</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityAxis" xml:lang="en-US">Credit Facility [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CreditFacilityAxis" xml:lang="en-US">Credit Facility [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityDomain" xml:lang="en-US">Credit Facility [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CreditFacilityDomain" xml:lang="en-US">Credit Facility [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PolicyAPAMember" xlink:label="loc_abl_PolicyAPAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_PolicyAPAMember" xml:lang="en-US">Policy APA [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_PolicyAPAMember" xml:lang="en-US">Policy APA</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_PolicyAPAMember" xlink:to="lab_abl_PolicyAPAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_PolicyAPAMember" xml:lang="en-US">Policy APA</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" xml:lang="en-US">Class Of Warrant Or Right, Redemption, Trading Day Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" xml:lang="en-US">Trading day period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" xlink:to="lab_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" xml:lang="en-US">Class Of Warrant Or Right, Redemption, Trading Day Period</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" xlink:label="loc_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" xml:lang="en-US">Warrants and Rights Outstanding, Exercisable Term, Proposed Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" xml:lang="en-US">Warrants, proposed offering exercisable term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" xlink:to="lab_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" xml:lang="en-US">Warrants and Rights Outstanding, Exercisable Term, Proposed Offering</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" xlink:label="loc_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" xml:lang="en-US">Warrants and Rights Outstanding, Exercisable Term, Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" xml:lang="en-US">Warrants, business combination exercisable term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" xlink:to="lab_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" xml:lang="en-US">Warrants and Rights Outstanding, Exercisable Term, Business Combination</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfVotesPerCommonShare" xlink:label="loc_abl_NumberOfVotesPerCommonShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_NumberOfVotesPerCommonShare" xml:lang="en-US">Number Of Votes Per Common Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_NumberOfVotesPerCommonShare" xml:lang="en-US">Number of votes per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_NumberOfVotesPerCommonShare" xlink:to="lab_abl_NumberOfVotesPerCommonShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_NumberOfVotesPerCommonShare" xml:lang="en-US">Number Of Votes Per Common Share</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" xml:lang="en-US">Class Of Warrant Or Right, Redemption For Common Stock, Price Per Share Threshold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" xml:lang="en-US">Common stock price threshold for redemption for common stock (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" xlink:to="lab_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" xml:lang="en-US">Class Of Warrant Or Right, Redemption For Common Stock, Price Per Share Threshold</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" xml:lang="en-US">Class Of Warrant Or Right, Issuance Of Common Stock, Redemption For Common Stock, Trigger Price Adjustment Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" xml:lang="en-US">Redemption for common stock trigger price adjustment percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" xlink:to="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" xml:lang="en-US">Class Of Warrant Or Right, Issuance Of Common Stock, Redemption For Common Stock, Trigger Price Adjustment Percent</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingFairValuePerShare" xlink:label="loc_abl_WarrantsAndRightsOutstandingFairValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_WarrantsAndRightsOutstandingFairValuePerShare" xml:lang="en-US">Warrants and Rights Outstanding, Fair Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_WarrantsAndRightsOutstandingFairValuePerShare" xml:lang="en-US">Warrant outstanding fair value per share (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_WarrantsAndRightsOutstandingFairValuePerShare" xlink:to="lab_abl_WarrantsAndRightsOutstandingFairValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_WarrantsAndRightsOutstandingFairValuePerShare" xml:lang="en-US">Warrants and Rights Outstanding, Fair Value Per Share</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" xml:lang="en-US">Class Of Warrant Or Right, Issuance Of Common Stock, Warrant Price Adjustment Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" xml:lang="en-US">Warrant price adjustment percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" xlink:to="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" xml:lang="en-US">Class Of Warrant Or Right, Issuance Of Common Stock, Warrant Price Adjustment Percentage</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" xml:lang="en-US">Class Of Warrant Or Right, Issuance Of Common Stock, Redemption, Trigger Price Adjustment Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" xml:lang="en-US">Redemption trigger price adjustment percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" xlink:to="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" xml:lang="en-US">Class Of Warrant Or Right, Issuance Of Common Stock, Redemption, Trigger Price Adjustment Percent</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" xlink:label="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" xml:lang="en-US">Class Of Warrant Or Right, Common Stock Issuance Threshold Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" xml:lang="en-US">Warrants, common stock issuance threshold price (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" xlink:to="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" xml:lang="en-US">Class Of Warrant Or Right, Common Stock Issuance Threshold Price Per Share</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" xml:lang="en-US">Class Of Warrant Or Right, Redemption Price Per Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" xml:lang="en-US">Redemption price per warrant (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" xlink:to="lab_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" xml:lang="en-US">Class Of Warrant Or Right, Redemption Price Per Warrant</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionNoticePeriod" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionNoticePeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionNoticePeriod" xml:lang="en-US">Class Of Warrant Or Right, Redemption Notice Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionNoticePeriod" xml:lang="en-US">Warrant redemption notice period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightRedemptionNoticePeriod" xlink:to="lab_abl_ClassOfWarrantOrRightRedemptionNoticePeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionNoticePeriod" xml:lang="en-US">Class Of Warrant Or Right, Redemption Notice Period</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" xml:lang="en-US">Class Of Warrant Or Right, Redemption, Price Per Share Threshold</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" xml:lang="en-US">Common stock price threshold (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" xlink:to="lab_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" xml:lang="en-US">Class Of Warrant Or Right, Redemption, Price Per Share Threshold</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" xlink:label="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" xml:lang="en-US">Class Of Warrant Or Right, Common Stock Issuance Trading Day Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" xml:lang="en-US">Warrants, common stock issuance trading day period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" xlink:to="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" xml:lang="en-US">Class Of Warrant Or Right, Common Stock Issuance Trading Day Period</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" xml:lang="en-US">Class Of Warrant Or Right, Redemption, Number Of Trading Days</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" xml:lang="en-US">Trading days</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" xlink:to="lab_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" xml:lang="en-US">Class Of Warrant Or Right, Redemption, Number Of Trading Days</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PublicWarrantsMember" xlink:label="loc_abl_PublicWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_PublicWarrantsMember" xml:lang="en-US">Public Warrants [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_PublicWarrantsMember" xml:lang="en-US">Public Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_PublicWarrantsMember" xlink:to="lab_abl_PublicWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_PublicWarrantsMember" xml:lang="en-US">Public Warrants</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BinomialLatticeModelMember" xlink:label="loc_abl_BinomialLatticeModelMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_BinomialLatticeModelMember" xml:lang="en-US">Binomial Lattice Model [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_BinomialLatticeModelMember" xml:lang="en-US">Binomial Lattice Model</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_BinomialLatticeModelMember" xlink:to="lab_abl_BinomialLatticeModelMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_BinomialLatticeModelMember" xml:lang="en-US">Binomial Lattice Model</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xml:lang="en-US">Maximum annual contributions (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xml:lang="en-US">Employer match (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xml:lang="en-US">Percent of employees gross pay (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xml:lang="en-US">Defined Contribution Plan, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xml:lang="en-US">Benefit plan expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xml:lang="en-US">Effective tax rate percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xml:lang="en-US">Related Party Transaction, Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xml:lang="en-US">Related party transaction rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsOriginationExpense" xlink:label="loc_abl_LifeSettlementContractsOriginationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LifeSettlementContractsOriginationExpense" xml:lang="en-US">Life Settlement Contracts, Origination Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LifeSettlementContractsOriginationExpense" xml:lang="en-US">Origination expenses for life settlement policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LifeSettlementContractsOriginationExpense" xlink:to="lab_abl_LifeSettlementContractsOriginationExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LifeSettlementContractsOriginationExpense" xml:lang="en-US">Life Settlement Contracts, Origination Expense</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CounterpartyNameAxis" xml:lang="en-US">Counterparty Name [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_CounterpartyNameAxis" xml:lang="en-US">Counterparty Name [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xml:lang="en-US">Counterparty Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xml:lang="en-US">Counterparty Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" xlink:label="loc_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" xml:lang="en-US">Nova Trading (US), LLC And Nova Holding (US) LP [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" xml:lang="en-US">Nova Funds</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" xlink:to="lab_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" xml:lang="en-US">Nova Trading (US), LLC And Nova Holding (US) LP</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xml:lang="en-US">Related Party Transaction [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xml:lang="en-US">Related Party Transaction [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xml:lang="en-US">Related Party Transaction [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xml:lang="en-US">Related Party Transaction [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ServiceFeeAgreementMember" xlink:label="loc_abl_ServiceFeeAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ServiceFeeAgreementMember" xml:lang="en-US">Service Fee Agreement [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ServiceFeeAgreementMember" xml:lang="en-US">Service Fee Agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ServiceFeeAgreementMember" xlink:to="lab_abl_ServiceFeeAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ServiceFeeAgreementMember" xml:lang="en-US">Service Fee Agreement</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseReimbursementsMember" xlink:label="loc_abl_ExpenseReimbursementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_ExpenseReimbursementsMember" xml:lang="en-US">Expense Reimbursements [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_ExpenseReimbursementsMember" xml:lang="en-US">Expense Reimbursements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_ExpenseReimbursementsMember" xlink:to="lab_abl_ExpenseReimbursementsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_ExpenseReimbursementsMember" xml:lang="en-US">Expense Reimbursements</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementAxis" xml:lang="en-US">Revision of Prior Period [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementDomain" xml:lang="en-US">Revision of Prior Period [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xml:lang="en-US">Previously Reported [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xml:lang="en-US">Previously Reported</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OperatingLeaseAssetAbstract" xlink:label="loc_abl_OperatingLeaseAssetAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_OperatingLeaseAssetAbstract" xml:lang="en-US">Operating Lease, Asset [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_OperatingLeaseAssetAbstract" xml:lang="en-US">Assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_OperatingLeaseAssetAbstract" xlink:to="lab_abl_OperatingLeaseAssetAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_OperatingLeaseAssetAbstract" xml:lang="en-US">Operating Lease, Asset</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xml:lang="en-US">Operating Lease, Liability [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xml:lang="en-US">Liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Operating Lease, Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Total lease liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseLiability" xml:lang="en-US">Lease liability as of June 30, 2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseCost" xml:lang="en-US">Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LeaseCost" xml:lang="en-US">Total lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseCost" xml:lang="en-US">Operating Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseCost" xml:lang="en-US">Operating lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableLeaseCost" xml:lang="en-US">Variable Lease, Cost</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableLeaseCost" xml:lang="en-US">Variable lease cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasePayments" xml:lang="en-US">Operating Lease, Payments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeasePayments" xml:lang="en-US">Operating cash flows from operating leases</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xml:lang="en-US">ROU assets obtained in exchange for new lease liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xml:lang="en-US">Weighted-average remaining lease term (in years)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xml:lang="en-US">Weighted-average discount rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xml:lang="en-US">2024</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xml:lang="en-US">2025</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xml:lang="en-US">2026</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xml:lang="en-US">2027</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:label="loc_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xml:lang="en-US">Thereafter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:to="lab_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xml:lang="en-US">Total operating lease payments (undiscounted)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xml:lang="en-US">Less: Imputed interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xml:lang="en-US">Remaining of 2023</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive securities (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US">Antidilutive Securities [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US">Antidilutive Securities [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventTable" xml:lang="en-US">Subsequent Event [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwlRockCreditFacilityMember" xlink:label="loc_abl_OwlRockCreditFacilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_OwlRockCreditFacilityMember" xml:lang="en-US">Owl Rock Credit Facility [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_OwlRockCreditFacilityMember" xml:lang="en-US">Owl Rock Credit Facility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_OwlRockCreditFacilityMember" xlink:to="lab_abl_OwlRockCreditFacilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_OwlRockCreditFacilityMember" xml:lang="en-US">Owl Rock Credit Facility</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventLineItems" xml:lang="en-US">Subsequent Event [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentAmortizationPaymentPercentage" xlink:label="loc_abl_DebtInstrumentAmortizationPaymentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentAmortizationPaymentPercentage" xml:lang="en-US">Debt Instrument, Amortization Payment, Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentAmortizationPaymentPercentage" xml:lang="en-US">Amortization payment percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentAmortizationPaymentPercentage" xlink:to="lab_abl_DebtInstrumentAmortizationPaymentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentAmortizationPaymentPercentage" xml:lang="en-US">Debt Instrument, Amortization Payment, Percentage</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" xlink:label="loc_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" xml:lang="en-US">Debt Instrument, Amortization Payment, Percentage Per Quarter</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" xml:lang="en-US">Amortization payment per quarter</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" xlink:to="lab_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" xml:lang="en-US">Debt Instrument, Amortization Payment, Percentage Per Quarter</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" xlink:label="loc_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" xml:lang="en-US">Debt Instrument, Covenant, Mandatory Prepayment Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" xml:lang="en-US">Mandatory prepayment percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" xlink:to="lab_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" xml:lang="en-US">Debt Instrument, Covenant, Mandatory Prepayment Percentage</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentBasisSpreadOnVariableRateTerm" xlink:label="loc_abl_DebtInstrumentBasisSpreadOnVariableRateTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentBasisSpreadOnVariableRateTerm" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentBasisSpreadOnVariableRateTerm" xml:lang="en-US">Basis spread on variable rate, term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentBasisSpreadOnVariableRateTerm" xlink:to="lab_abl_DebtInstrumentBasisSpreadOnVariableRateTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentBasisSpreadOnVariableRateTerm" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate, Term</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" xml:lang="en-US">Debt Instrument, Covenant, Prepayment Premium Prior To First Anniversary</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" xml:lang="en-US">Prepayment premium prior to first anniversary</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" xlink:to="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" xml:lang="en-US">Debt Instrument, Covenant, Prepayment Premium Prior To First Anniversary</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" xml:lang="en-US">Debt Instrument, Covenant, Prepayment Premium Prior To Second Anniversary</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" xml:lang="en-US">Prepayment premium prior to second anniversary</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" xlink:to="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" xml:lang="en-US">Debt Instrument, Covenant, Prepayment Premium Prior To Second Anniversary</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" xml:lang="en-US">Debt Instrument, Covenant, Prepayment Premium After Second Anniversary</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" xml:lang="en-US">Prepayment premium after second anniversary</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" xlink:to="lab_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" xml:lang="en-US">Debt Instrument, Covenant, Prepayment Premium After Second Anniversary</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantLeverageRatioMaximum" xlink:label="loc_abl_DebtInstrumentCovenantLeverageRatioMaximum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCovenantLeverageRatioMaximum" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCovenantLeverageRatioMaximum" xml:lang="en-US">Maximum leverage ratio</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_abl_DebtInstrumentCovenantLeverageRatioMaximum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCovenantLeverageRatioMaximum" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" xlink:label="loc_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" xml:lang="en-US">Debt Instrument, Covenant, Securities Percentage Of Gross Revenue, Maximum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" xml:lang="en-US">Maximum securities related activities percentage of aggregate gross revenues</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" xlink:to="lab_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" xml:lang="en-US">Debt Instrument, Covenant, Securities Percentage Of Gross Revenue, Maximum</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xml:lang="en-US">Additional borrowing capacity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" xlink:label="loc_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" xml:lang="en-US">Additional borrowing capacity availability period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" xlink:to="lab_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity, Term</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" xlink:label="loc_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" xml:lang="en-US">Debt Instrument, Covenant, Liquid Asset Coverage Ratio, Minimum</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" xml:lang="en-US">Liquid asset minimum coverage ratio</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" xlink:to="lab_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" xml:lang="en-US">Debt Instrument, Covenant, Liquid Asset Coverage Ratio, Minimum</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xml:lang="en-US">Commitment fee</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xml:lang="en-US">Basis spread on variable rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentAxis" xlink:label="loc_abl_VariableRateComponentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_VariableRateComponentAxis" xml:lang="en-US">Variable Rate Component [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_VariableRateComponentAxis" xml:lang="en-US">Variable Rate Component [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_VariableRateComponentAxis" xlink:to="lab_abl_VariableRateComponentAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_VariableRateComponentAxis" xml:lang="en-US">Variable Rate Component</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentDomain" xlink:label="loc_abl_VariableRateComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_VariableRateComponentDomain" xml:lang="en-US">Variable Rate Component [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_VariableRateComponentDomain" xml:lang="en-US">Variable Rate Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_VariableRateComponentDomain" xlink:to="lab_abl_VariableRateComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_VariableRateComponentDomain" xml:lang="en-US">Variable Rate Component [Domain]</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentThreeMember" xlink:label="loc_abl_VariableRateComponentThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_VariableRateComponentThreeMember" xml:lang="en-US">Variable Rate Component Three [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_VariableRateComponentThreeMember" xml:lang="en-US">Variable Rate Component Three</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_VariableRateComponentThreeMember" xlink:to="lab_abl_VariableRateComponentThreeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_VariableRateComponentThreeMember" xml:lang="en-US">Variable Rate Component Three</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentOneMember" xlink:label="loc_abl_VariableRateComponentOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_VariableRateComponentOneMember" xml:lang="en-US">Variable Rate Component One [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_VariableRateComponentOneMember" xml:lang="en-US">Variable Rate Component One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_VariableRateComponentOneMember" xlink:to="lab_abl_VariableRateComponentOneMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_VariableRateComponentOneMember" xml:lang="en-US">Variable Rate Component One</label>
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentTwoMember" xlink:label="loc_abl_VariableRateComponentTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_abl_VariableRateComponentTwoMember" xml:lang="en-US">Variable Rate Component Two [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_abl_VariableRateComponentTwoMember" xml:lang="en-US">Variable Rate Component Two</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_abl_VariableRateComponentTwoMember" xlink:to="lab_abl_VariableRateComponentTwoMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_abl_VariableRateComponentTwoMember" xml:lang="en-US">Variable Rate Component Two</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableRateAxis" xml:lang="en-US">Variable Rate [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableRateAxis" xml:lang="en-US">Variable Rate [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VariableRateDomain" xml:lang="en-US">Variable Rate [Domain]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_VariableRateDomain" xml:lang="en-US">Variable Rate [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BaseRateMember" xml:lang="en-US">Base Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BaseRateMember" xml:lang="en-US">Base Rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" />
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>abl-20230630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 30-October-2023 [07:31:27] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#Cover" roleURI="http://www.emslp.com/role/Cover" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CondensedConsolidateBalanceSheetsParenthetical" roleURI="http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#DescriptionOfBusiness" roleURI="http://www.emslp.com/role/DescriptionOfBusiness" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombination" roleURI="http://www.emslp.com/role/BusinessCombination" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPolicies" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPolicies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#PropertyAndEquipmentNet" roleURI="http://www.emslp.com/role/PropertyAndEquipmentNet" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssets" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#AvailableForSaleSecuritiesAtFairValue" roleURI="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#OtherInvestmentsAndOtherNoncurrentAssets" roleURI="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ConsolidationOfVariableInterestEntities" roleURI="http://www.emslp.com/role/ConsolidationOfVariableInterestEntities" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReporting" roleURI="http://www.emslp.com/role/SegmentReporting" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CommitmentsAndContingencies" roleURI="http://www.emslp.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurements" roleURI="http://www.emslp.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebt" roleURI="http://www.emslp.com/role/LongTermDebt" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ShareholdersEquity" roleURI="http://www.emslp.com/role/ShareholdersEquity" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EmployeeBenefitPlan" roleURI="http://www.emslp.com/role/EmployeeBenefitPlan" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#IncomeTaxes" roleURI="http://www.emslp.com/role/IncomeTaxes" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#RelatedPartyTransactions" roleURI="http://www.emslp.com/role/RelatedPartyTransactions" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#Leases" roleURI="http://www.emslp.com/role/Leases" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShare" roleURI="http://www.emslp.com/role/EarningsPerShare" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SubsequentEvents" roleURI="http://www.emslp.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationTables" roleURI="http://www.emslp.com/role/BusinessCombinationTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesTables" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#PropertyAndEquipmentNetTables" roleURI="http://www.emslp.com/role/PropertyAndEquipmentNetTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssetsTables" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingTables" roleURI="http://www.emslp.com/role/SegmentReportingTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsTables" roleURI="http://www.emslp.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtTables" roleURI="http://www.emslp.com/role/LongTermDebtTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesTables" roleURI="http://www.emslp.com/role/LeasesTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShareTables" roleURI="http://www.emslp.com/role/EarningsPerShareTables" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#DescriptionOfBusinessDetails" roleURI="http://www.emslp.com/role/DescriptionOfBusinessDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SummaryOfSignificantAccountingPoliciesConcentrationsDetails" roleURI="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationNarrativeDetails" roleURI="http://www.emslp.com/role/BusinessCombinationNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationPurchasePriceAllocationDetails" roleURI="http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationValueConveyedDetails" roleURI="http://www.emslp.com/role/BusinessCombinationValueConveyedDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationIntangibleAssetsAcquiredDetails" roleURI="http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#BusinessCombinationProFormaFinancialInformationDetails" roleURI="http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesNarrativeDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesFairValueDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesInvestmentMethodDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails" roleURI="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#PropertyAndEquipmentNetDetails" roleURI="http://www.emslp.com/role/PropertyAndEquipmentNetDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails" roleURI="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#AvailableForSaleSecuritiesAtFairValueDetails" roleURI="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#OtherInvestmentsAndOtherNoncurrentAssetsDetails" roleURI="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ConsolidationOfVariableInterestEntitiesDetails" roleURI="http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingNarrativeDetails" roleURI="http://www.emslp.com/role/SegmentReportingNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingRevenueBySegmentDetails" roleURI="http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SegmentReportingReconciliationOfNetIncomeDetails" roleURI="http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#CommitmentsAndContingenciesDetails" roleURI="http://www.emslp.com/role/CommitmentsAndContingenciesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsRecurringFairValueMeasurementsDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsNarrativeDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsDiscountRateSensitivityDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsLifeInsurancePoliciesDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsIssuedNotesDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#FairValueMeasurementsAssumptionsDetails" roleURI="http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLongTermDebtDetails" roleURI="http://www.emslp.com/role/LongTermDebtLongTermDebtDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtSponsorPikNoteDetails" roleURI="http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails" roleURI="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails" roleURI="http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#ShareholdersEquityDetails" roleURI="http://www.emslp.com/role/ShareholdersEquityDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EmployeeBenefitPlanDetails" roleURI="http://www.emslp.com/role/EmployeeBenefitPlanDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#IncomeTaxesDetails" roleURI="http://www.emslp.com/role/IncomeTaxesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#RelatedPartyTransactionsDetails" roleURI="http://www.emslp.com/role/RelatedPartyTransactionsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesRouAssetsAndLeaseLiabilitiesDetails" roleURI="http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesLeaseExpenseDetails" roleURI="http://www.emslp.com/role/LeasesLeaseExpenseDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesLeaseTermsAndDiscountRatesDetails" roleURI="http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#LeasesFutureMinimumNoncancellableLeasePaymentsDetails" roleURI="http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShareNarrativeDetails" roleURI="http://www.emslp.com/role/EarningsPerShareNarrativeDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#EarningsPerShareBasicAndDilutedDetails" roleURI="http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails" />
<roleRef xlink:type="simple" xlink:href="abl-20230630.xsd#SubsequentEventsDetails" roleURI="http://www.emslp.com/role/SubsequentEventsDetails" />
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/Cover">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_101" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_101" xlink:to="loc_dei_DocumentInformationTable_102" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_103" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_102" xlink:to="loc_us-gaap_StatementClassOfStockAxis_103" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_104" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_103" xlink:to="loc_us-gaap_ClassOfStockDomain_104" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_1584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_102" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_1584" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:label="loc_dei_AddressTypeDomain_1585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_1584" xlink:to="loc_dei_AddressTypeDomain_1585" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember" xlink:label="loc_dei_BusinessContactMember_1586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_1585" xlink:to="loc_dei_BusinessContactMember_1586" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_102" xlink:to="loc_dei_DocumentInformationLineItems_107" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_DocumentType_108" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityRegistrantName_113" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityIncorporationStateCountryCode_114" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityTaxIdentificationNumber_115" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName" xlink:label="loc_dei_ContactPersonnelName_1583" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_ContactPersonnelName_1583" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressAddressLine1_116" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_1582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressAddressLine2_1582" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_117" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressCityOrTown_117" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_118" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressStateOrProvince_118" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityAddressPostalZipCode_119" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_CityAreaCode_120" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_LocalPhoneNumber_121" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityFilerCategory_127" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntitySmallBusiness_128" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityEmergingGrowthCompany_129" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityExTransitionPeriod_130" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityCentralIndexKey_133" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_AmendmentFlag_137" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_dei_EntityPrimarySicNumber_1581" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_107" xlink:to="loc_dei_EntityPrimarySicNumber_1581" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_139" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_139" xlink:to="loc_us-gaap_StatementTable_140" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_140" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_141" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_141" xlink:to="loc_us-gaap_RelatedPartyDomain_142" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_us-gaap_NonrelatedPartyMember_143" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_srt_AffiliatedEntityMember_144" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_us-gaap_RelatedPartyMember_145" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwnersMember" xlink:label="loc_abl_OwnersMember_146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_142" xlink:to="loc_abl_OwnersMember_146" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_140" xlink:to="loc_us-gaap_StatementClassOfStockAxis_147" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_147" xlink:to="loc_us-gaap_ClassOfStockDomain_148" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_149" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_148" xlink:to="loc_us-gaap_CommonClassAMember_149" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_140" xlink:to="loc_us-gaap_StatementLineItems_150" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_AssetsAbstract_151" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_AssetsCurrentAbstract_152" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_153" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_154" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_155" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_156" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_152" xlink:to="loc_us-gaap_AssetsCurrent_157" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_158" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_159" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_Goodwill_160" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_161" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_162" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_163" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_164" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_165" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent" xlink:label="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent_166" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StateSecurityDepositsNoncurrent" xlink:label="loc_abl_StateSecurityDepositsNoncurrent_167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_abl_StateSecurityDepositsNoncurrent_167" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CertificatesOfDepositNoncurrent" xlink:label="loc_abl_CertificatesOfDepositNoncurrent_168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_abl_CertificatesOfDepositNoncurrent_168" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_169" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_151" xlink:to="loc_us-gaap_Assets_170" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_150" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_172" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_172" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_173" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_173" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_AccountsPayableCurrent_174" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_175" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_176" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AccruedTransactionCostsCurrent" xlink:label="loc_abl_AccruedTransactionCostsCurrent_177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_abl_AccruedTransactionCostsCurrent_177" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_178" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_179" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_172" xlink:to="loc_us-gaap_LiabilitiesCurrent_180" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredLongTermDebt" xlink:label="loc_us-gaap_SecuredLongTermDebt_181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_SecuredLongTermDebt_181" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermDebtNoncurrent" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_182" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_183" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_184" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantLiabilitiesNoncurrent" xlink:label="loc_abl_WarrantLiabilitiesNoncurrent_185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_abl_WarrantLiabilitiesNoncurrent_185" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_Liabilities_186" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_187" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_CommitmentsAndContingencies_187" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_189" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_CommonStockValue_189" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_AdditionalPaidInCapital_190" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_191" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_192" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_MinorityInterest_193" use="optional" order="54" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_188" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_194" use="optional" order="55" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_171" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_195" use="optional" order="56" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_197" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_197" xlink:to="loc_us-gaap_StatementTable_198" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_198" xlink:to="loc_us-gaap_StatementClassOfStockAxis_199" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_199" xlink:to="loc_us-gaap_ClassOfStockDomain_200" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_200" xlink:to="loc_us-gaap_CommonClassAMember_201" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_198" xlink:to="loc_us-gaap_StatementLineItems_202" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_203" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_203" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_204" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_204" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockSharesIssued_205" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_206" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_202" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_206" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_208" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_209" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_208" xlink:to="loc_us-gaap_StatementTable_209" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_210" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_209" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_210" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_210" xlink:to="loc_us-gaap_RelatedPartyDomain_211" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_211" xlink:to="loc_us-gaap_RelatedPartyMember_212" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_211" xlink:to="loc_us-gaap_NonrelatedPartyMember_213" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_209" xlink:to="loc_us-gaap_StatementLineItems_214" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_RevenuesAbstract_215" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_216" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceInvestmentIncome" xlink:label="loc_us-gaap_InsuranceInvestmentIncome_217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_InsuranceInvestmentIncome_217" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_218" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceServicesRevenue" xlink:label="loc_us-gaap_InsuranceServicesRevenue_219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_InsuranceServicesRevenue_219" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_215" xlink:to="loc_us-gaap_Revenues_220" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaap_CostOfRevenueAbstract_221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_CostOfRevenueAbstract_221" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaap_CostOfRevenue_222" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_221" xlink:to="loc_us-gaap_CostOfRevenue_222" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_GrossProfit_223" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_224" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_OperatingExpensesAbstract_224" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_SellingAndMarketingExpense_225" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_226" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_227" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_228" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_228" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_DepreciationAndAmortization_229" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_224" xlink:to="loc_us-gaap_OperatingExpenses_230" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_OperatingIncomeLoss_231" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_InterestExpense_233" use="optional" order="25" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_InvestmentIncomeInterest_234" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_235" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_235" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_236" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_237" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_238" use="optional" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ProfitLoss_239" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_240" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_NetIncomeLoss_241" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_EarningsPerShareAbstract_242" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_243" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_244" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_EarningsPerShareBasic_245" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_242" xlink:to="loc_us-gaap_EarningsPerShareDiluted_246" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ProfitLoss_247" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_248" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent_249" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_248" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent_249" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_250" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_251" use="optional" order="43" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_214" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_252" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_254" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_254" xlink:to="loc_us-gaap_StatementTable_255" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_256" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_255" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_256" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_257" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_256" xlink:to="loc_us-gaap_EquityComponentDomain_257" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_258" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_CommonStockMember_258" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_259" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_259" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_RetainedEarningsMember_260" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_257" xlink:to="loc_us-gaap_NoncontrollingInterestMember_262" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_255" xlink:to="loc_us-gaap_StatementClassOfStockAxis_263" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_264" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_263" xlink:to="loc_us-gaap_ClassOfStockDomain_264" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_264" xlink:to="loc_us-gaap_CommonClassAMember_265" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_255" xlink:to="loc_us-gaap_StatementLineItems_266" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_266" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_268" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_269" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_Dividends_270" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockholdersEquityDeferredTransactionCosts" xlink:label="loc_abl_StockholdersEquityDeferredTransactionCosts_271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_abl_StockholdersEquityDeferredTransactionCosts_271" use="optional" order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_272" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:label="loc_abl_StockIssuedDuringPeriodSharesReverseRecapitalization_273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_abl_StockIssuedDuringPeriodSharesReverseRecapitalization_273" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:label="loc_abl_StockIssuedDuringPeriodValueReverseRecapitalization_274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_abl_StockIssuedDuringPeriodValueReverseRecapitalization_274" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_275" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_276" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_ProfitLoss_277" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_278" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_267" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_279" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_281" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_281" xlink:to="loc_us-gaap_StatementTable_282" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_282" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_283" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_283" xlink:to="loc_us-gaap_RelatedPartyDomain_284" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_284" xlink:to="loc_us-gaap_NonrelatedPartyMember_285" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_286" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_284" xlink:to="loc_us-gaap_RelatedPartyMember_286" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_282" xlink:to="loc_us-gaap_StatementLineItems_287" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" xlink:to="loc_us-gaap_ProfitLoss_289" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_DepreciationAndAmortization_291" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_292" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss_293" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss_293" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_294" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_294" use="optional" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_295" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_296" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_290" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_298" use="optional" order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_299" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_299" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_300" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_301" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_302" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_303" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedFairValueMethod" xlink:label="loc_abl_LifeSettlementContractPurchasedFairValueMethod_304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_abl_LifeSettlementContractPurchasedFairValueMethod_304" use="optional" order="23" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractPurchasedInvestmentMethod" xlink:label="loc_abl_LifeSettlementContractPurchasedInvestmentMethod_305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_297" xlink:to="loc_abl_LifeSettlementContractPurchasedInvestmentMethod_305" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_288" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_306" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_308" use="optional" order="27" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProceedsDueFromPaymentsDueToAffiliates" xlink:label="loc_abl_ProceedsDueFromPaymentsDueToAffiliates_309" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" xlink:to="loc_abl_ProceedsDueFromPaymentsDueToAffiliates_309" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_310" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_312" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities" xlink:label="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities_313" use="optional" order="32" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_314" use="optional" order="33" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_315" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_315" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_316" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_316" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_317" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_311" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_317" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_318" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_318" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_319" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_320" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_287" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_320" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/DescriptionOfBusiness">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_415" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_416" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_415" xlink:to="loc_us-gaap_NatureOfOperations_416" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_418" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_419" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_418" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_419" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombination">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_421" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_421" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_422" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_424" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsDisclosureTextBlock" xlink:label="loc_us-gaap_LifeSettlementContractsDisclosureTextBlock_425" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_424" xlink:to="loc_us-gaap_LifeSettlementContractsDisclosureTextBlock_425" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/PropertyAndEquipmentNet">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_427" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_428" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_427" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_428" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_430" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_431" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_430" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_431" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_433" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_434" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_433" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_434" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_436" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_436" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_437" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/ConsolidationOfVariableInterestEntities">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_439" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_440" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_439" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_440" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReporting">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_442" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_443" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_442" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_443" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_445" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_446" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_445" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_446" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurements">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_448" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_449" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_448" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_449" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebt">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_451" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaap_LongTermDebtTextBlock_452" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_451" xlink:to="loc_us-gaap_LongTermDebtTextBlock_452" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/ShareholdersEquity">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_454" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_455" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_454" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_455" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/EmployeeBenefitPlan">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsAbstract" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_457" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTextBlock" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock_458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_457" xlink:to="loc_us-gaap_DefinedContributionPlanTextBlock_458" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/IncomeTaxes">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_460" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_460" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_461" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/RelatedPartyTransactions">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_463" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_464" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_463" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_464" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/Leases">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_466" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_467" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_466" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_467" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/EarningsPerShare">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_469" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_470" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_469" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_470" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_472" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_473" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_472" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_473" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_539" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_539" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_540" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_540" xlink:to="loc_srt_ConsolidatedEntitiesAxis_541" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_541" xlink:to="loc_srt_ConsolidatedEntitiesDomain_542" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems" xlink:label="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable_540" xlink:to="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_545" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_545" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_546" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_546" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_547" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_548" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_549" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_UseOfEstimates_549" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsPolicy" xlink:label="loc_us-gaap_LifeSettlementContractsPolicy_551" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_LifeSettlementContractsPolicy_551" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_552" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_552" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_553" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_553" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_554" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_554" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsPolicyTextBlock" xlink:label="loc_abl_WarrantsPolicyTextBlock_555" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems_544" xlink:to="loc_abl_WarrantsPolicyTextBlock_555" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_558" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_558" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_559" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_560" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_558" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_560" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_561" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_558" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_561" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_562" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_558" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_562" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_564" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock" xlink:label="loc_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock_565" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_564" xlink:to="loc_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock_565" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock" xlink:label="loc_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock_566" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_564" xlink:to="loc_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock_566" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/PropertyAndEquipmentNetTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_568" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_569" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_568" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_569" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_571" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_572" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_571" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_572" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_573" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_571" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_573" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_574" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_571" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_574" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_576" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_577" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_576" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_577" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_578" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_576" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_578" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_580" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_581" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_580" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_581" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_580" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_582" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_583" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_580" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_583" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_580" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_584" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_580" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_585" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_587" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_587" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_588" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_590" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:label="loc_abl_AssetsAndLiabilitiesLesseeTableTextBlock_591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_590" xlink:to="loc_abl_AssetsAndLiabilitiesLesseeTableTextBlock_591" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_590" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_592" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_593" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_590" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_593" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/EarningsPerShareTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_595" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_595" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_596" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/DescriptionOfBusinessDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_614" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_615" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_614" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_615" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_616" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_615" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_616" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_616" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_618" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_617" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_618" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_619" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_615" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_619" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_620" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_619" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_620" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessAcquisitionExchangeRatio" xlink:label="loc_abl_BusinessAcquisitionExchangeRatio_621" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_619" xlink:to="loc_abl_BusinessAcquisitionExchangeRatio_621" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_623" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_623" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_625" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_srt_ConsolidatedEntitiesAxis_625" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_626" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_625" xlink:to="loc_srt_ConsolidatedEntitiesDomain_626" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_627" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_626" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_627" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_628" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_626" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_628" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_629" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_us-gaap_OtherCommitmentsAxis_629" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_630" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_629" xlink:to="loc_us-gaap_OtherCommitmentsDomain_630" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseSupportAgreementMember" xlink:label="loc_abl_ExpenseSupportAgreementMember_631" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_630" xlink:to="loc_abl_ExpenseSupportAgreementMember_631" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_632" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_dei_LegalEntityAxis_632" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_633" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_632" xlink:to="loc_dei_EntityDomain_633" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProviderOneMember" xlink:label="loc_abl_ProviderOneMember_634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_633" xlink:to="loc_abl_ProviderOneMember_634" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ProviderTwoMember" xlink:label="loc_abl_ProviderTwoMember_635" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_633" xlink:to="loc_abl_ProviderTwoMember_635" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAdvisorsLLCMember" xlink:label="loc_abl_LongevityMarketAdvisorsLLCMember_636" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_633" xlink:to="loc_abl_LongevityMarketAdvisorsLLCMember_636" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_637" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_srt_OwnershipAxis_637" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_637" xlink:to="loc_srt_OwnershipDomain_638" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMXSeriesLLCMember" xlink:label="loc_abl_LMXSeriesLLCMember_639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_638" xlink:to="loc_abl_LMXSeriesLLCMember_639" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAdvisorsLLCMember" xlink:label="loc_abl_LongevityMarketAdvisorsLLCMember_640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_638" xlink:to="loc_abl_LongevityMarketAdvisorsLLCMember_640" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_RegionalInvestmentServicesIncMember" xlink:label="loc_abl_RegionalInvestmentServicesIncMember_641" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_638" xlink:to="loc_abl_RegionalInvestmentServicesIncMember_641" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_642" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_642" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_642" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_RegionalInvestmentServicesIncMember" xlink:label="loc_abl_RegionalInvestmentServicesIncMember_644" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_643" xlink:to="loc_abl_RegionalInvestmentServicesIncMember_644" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_624" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_646" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_Assets_646" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_647" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_Liabilities_647" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfProvidersInvolvedInOptionAgreement" xlink:label="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_648" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_648" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_649" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_InterestExpense_649" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership" xlink:label="loc_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership_650" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership_650" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_651" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_651" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount" xlink:label="loc_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount_652" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount_652" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_653" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_653" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_654" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_645" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_654" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_656" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaap_ConcentrationRiskTable_657" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_656" xlink:to="loc_us-gaap_ConcentrationRiskTable_657" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_658" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_658" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_659" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_658" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_659" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_660" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_659" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_660" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_661" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_661" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_661" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_663" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" xlink:to="loc_us-gaap_AccountsReceivableMember_663" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaap_SalesRevenueNetMember_664" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" xlink:to="loc_us-gaap_SalesRevenueNetMember_664" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_InvestmentMethodRevenueBenchmarkMember" xlink:label="loc_abl_InvestmentMethodRevenueBenchmarkMember_665" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_662" xlink:to="loc_abl_InvestmentMethodRevenueBenchmarkMember_665" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srt_MajorCustomersAxis_666" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_srt_MajorCustomersAxis_666" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srt_NameOfMajorCustomerDomain_667" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_666" xlink:to="loc_srt_NameOfMajorCustomerDomain_667" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_Customer1Member" xlink:label="loc_abl_Customer1Member_668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_667" xlink:to="loc_abl_Customer1Member_668" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_Customer2Member" xlink:label="loc_abl_Customer2Member_669" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_667" xlink:to="loc_abl_Customer2Member_669" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_670" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_670" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_670" xlink:to="loc_us-gaap_RelatedPartyDomain_671" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_672" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_671" xlink:to="loc_us-gaap_RelatedPartyMember_672" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaap_NonrelatedPartyMember_673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_671" xlink:to="loc_us-gaap_NonrelatedPartyMember_673" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_674" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_674" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_674" xlink:to="loc_us-gaap_SegmentDomain_675" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ActiveManagementSegmentMember" xlink:label="loc_abl_ActiveManagementSegmentMember_676" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_675" xlink:to="loc_abl_ActiveManagementSegmentMember_676" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PortfolioServicingSegmentMember" xlink:label="loc_abl_PortfolioServicingSegmentMember_677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_675" xlink:to="loc_abl_PortfolioServicingSegmentMember_677" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_657" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_678" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_678" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_679" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_678" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_680" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_682" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_682" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_684" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_684" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_684" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_685" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_687" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_687" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AbacusSettlementsLLCMember" xlink:label="loc_abl_AbacusSettlementsLLCMember_688" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_686" xlink:to="loc_abl_AbacusSettlementsLLCMember_688" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_689" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_689" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_690" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_689" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_690" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_690" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_691" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_srt_RangeAxis_692" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_692" xlink:to="loc_srt_RangeMember_693" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_694" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_693" xlink:to="loc_srt_MinimumMember_694" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_695" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_693" xlink:to="loc_srt_MaximumMember_695" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_ValuationTechniqueAxis_696" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_697" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_696" xlink:to="loc_us-gaap_ValuationTechniqueDomain_697" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_697" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_698" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketApproachValuationTechniqueMember" xlink:label="loc_us-gaap_MarketApproachValuationTechniqueMember_699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_697" xlink:to="loc_us-gaap_MarketApproachValuationTechniqueMember_699" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_700" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_700" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipAgentsMember" xlink:label="loc_abl_CustomerRelationshipAgentsMember_702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" xlink:to="loc_abl_CustomerRelationshipAgentsMember_702" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:label="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_701" xlink:to="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_703" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_683" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_704" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_705" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationMeasurementInput" xlink:label="loc_abl_BusinessCombinationMeasurementInput_706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_abl_BusinessCombinationMeasurementInput_706" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationEnterpriseValue" xlink:label="loc_abl_BusinessCombinationEnterpriseValue_707" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_abl_BusinessCombinationEnterpriseValue_707" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_704" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_708" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_710" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_711" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_710" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_711" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_712" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_711" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_712" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_712" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_713" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_714" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_715" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_711" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_715" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_716" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_716" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_717" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_Goodwill_717" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_718" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_718" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_719" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_719" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_720" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_720" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses" xlink:label="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_721" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses_721" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther" xlink:label="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther_722" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther_722" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_723" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_715" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_723" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationValueConveyedDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_725" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_726" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_725" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_726" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_727" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_726" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_727" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_727" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AbacusSettlementsLLCMember" xlink:label="loc_abl_AbacusSettlementsLLCMember_729" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" xlink:to="loc_abl_AbacusSettlementsLLCMember_729" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_730" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_730" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_731" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_728" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_731" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_732" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_726" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_732" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_733" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_732" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_733" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_735" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_735" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_737" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_737" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_739" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_738" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_739" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_740" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_740" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_740" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipAgentsMember" xlink:label="loc_abl_CustomerRelationshipAgentsMember_742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_CustomerRelationshipAgentsMember_742" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:label="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_743" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_743" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_APATechnologyMember" xlink:label="loc_abl_APATechnologyMember_744" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_APATechnologyMember_744" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MarketPlaceTechnologyMember" xlink:label="loc_abl_MarketPlaceTechnologyMember_745" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_abl_MarketPlaceTechnologyMember_745" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_746" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_741" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_746" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_747" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_747" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_747" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_749" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" xlink:to="loc_us-gaap_TradeNamesMember_749" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_750" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_748" xlink:to="loc_us-gaap_LicensingAgreementsMember_750" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_751" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_736" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_751" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_752" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_751" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_752" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_753" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_751" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_753" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_755" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_756" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_755" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_756" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_757" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_756" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_757" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_757" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_759" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_758" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_759" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_760" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_756" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_760" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_761" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_760" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_761" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_762" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_760" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_762" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsNumberOfContracts" xlink:label="loc_abl_LifeSettlementContractsNumberOfContracts_765" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" xlink:to="loc_abl_LifeSettlementContractsNumberOfContracts_765" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts_766" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts_766" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts_767" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts_767" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue_768" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue_768" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_769" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_769" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue_770" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue_770" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_771" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_764" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_771" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_773" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_773" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear_775" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear_775" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths_776" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths_776" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo_777" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo_777" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree_778" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree_778" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour_779" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour_779" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour_780" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" xlink:to="loc_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour_780" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts_781" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract_774" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts_781" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_773" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear_783" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear_783" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths_784" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths_784" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo_785" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo_785" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree_786" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree_786" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour_787" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour_787" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour_788" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" xlink:to="loc_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour_788" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue_789" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract_782" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodFaceValue_789" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_773" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear_791" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear_791" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths_792" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths_792" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo_793" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo_793" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree_794" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree_794" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour_795" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour_795" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractFairValueMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractFairValueMaturityAfterYearFour_796" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" xlink:to="loc_abl_LifeSettlementContractFairValueMaturityAfterYearFour_796" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_797" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract_790" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_797" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_799" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_799" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear_801" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear_801" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths_802" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths_802" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo_803" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo_803" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree_804" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree_804" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour_805" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour_805" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour_806" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" xlink:to="loc_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour_806" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts_807" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract_800" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts_807" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_799" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear_809" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear_809" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths_810" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths_810" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo_811" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo_811" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree_812" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree_812" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour_813" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour_813" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour_814" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" xlink:to="loc_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour_814" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFaceValue" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue_815" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract_808" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue_815" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_799" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear_817" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear_817" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths_818" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths_818" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo_819" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo_819" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree_820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree_820" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour_821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour_821" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour_822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" xlink:to="loc_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour_822" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract_816" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_823" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_825" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear_826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_825" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear_826" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths_827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_825" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths_827" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo_828" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_825" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo_828" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree_829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_825" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree_829" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree" xlink:label="loc_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree_830" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_825" xlink:to="loc_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree_830" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid_831" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_825" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid_831" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/PropertyAndEquipmentNetDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_833" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_834" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_833" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_834" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_835" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_834" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_835" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_835" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_837" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" xlink:to="loc_us-gaap_ComputerEquipmentMember_837" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_838" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_838" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_839" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_836" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_839" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_834" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_841" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_841" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_842" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_842" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_843" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_843" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_844" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_840" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_844" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_846" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_847" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_846" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_847" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_848" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_847" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_848" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_848" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_850" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_849" xlink:to="loc_abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember_850" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_851" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_847" xlink:to="loc_dei_LegalEntityAxis_851" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_852" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_851" xlink:to="loc_dei_EntityDomain_852" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AbacusSettlementsLLCMember" xlink:label="loc_abl_AbacusSettlementsLLCMember_853" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_852" xlink:to="loc_abl_AbacusSettlementsLLCMember_853" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems" xlink:label="loc_us-gaap_GoodwillLineItems_854" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_847" xlink:to="loc_us-gaap_GoodwillLineItems_854" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_855" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_854" xlink:to="loc_us-gaap_GoodwillRollForward_855" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_856" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_855" xlink:to="loc_us-gaap_Goodwill_856" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_857" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_855" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_857" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_855" xlink:to="loc_us-gaap_Goodwill_858" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_862" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_862" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipAgentsMember" xlink:label="loc_abl_CustomerRelationshipAgentsMember_864" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_CustomerRelationshipAgentsMember_864" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CustomerRelationshipsFinancialRelationshipsMember" xlink:label="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_865" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_CustomerRelationshipsFinancialRelationshipsMember_865" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_APATechnologyMember" xlink:label="loc_abl_APATechnologyMember_866" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_APATechnologyMember_866" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MarketPlaceTechnologyMember" xlink:label="loc_abl_MarketPlaceTechnologyMember_867" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_abl_MarketPlaceTechnologyMember_867" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_868" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_863" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_868" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_869" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_869" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_869" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_871" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" xlink:to="loc_us-gaap_TradeNamesMember_871" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaap_LicensingAgreementsMember_872" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_870" xlink:to="loc_us-gaap_LicensingAgreementsMember_872" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_861" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_874" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_874" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_875" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_873" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_875" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_881" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_882" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_881" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_882" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield_883" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_881" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield_883" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert" xlink:label="loc_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert_884" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_881" xlink:to="loc_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert_884" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_886" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockTable" xlink:label="loc_us-gaap_ConversionOfStockTable_887" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_886" xlink:to="loc_us-gaap_ConversionOfStockTable_887" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_887" xlink:to="loc_us-gaap_FinancialInstrumentAxis_888" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_888" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SeriesSeedPreferredUnitsMember" xlink:label="loc_abl_SeriesSeedPreferredUnitsMember_890" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" xlink:to="loc_abl_SeriesSeedPreferredUnitsMember_890" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SeriesB1PreferredStockMember" xlink:label="loc_abl_SeriesB1PreferredStockMember_891" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_889" xlink:to="loc_abl_SeriesB1PreferredStockMember_891" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockLineItems" xlink:label="loc_us-gaap_ConversionOfStockLineItems_892" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockTable_887" xlink:to="loc_us-gaap_ConversionOfStockLineItems_892" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld" xlink:label="loc_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld_893" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld_893" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased" xlink:label="loc_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased_894" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased_894" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_895" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_896" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_896" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:label="loc_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_897" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="loc_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_898" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_898" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockLineItems_892" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_899" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_901" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_901" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_903" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" xlink:to="loc_srt_ConsolidatedEntitiesAxis_903" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_904" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_903" xlink:to="loc_srt_ConsolidatedEntitiesDomain_904" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_905" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_904" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_905" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_906" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_904" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_906" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_907" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" xlink:to="loc_dei_LegalEntityAxis_907" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_908" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_907" xlink:to="loc_dei_EntityDomain_908" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_902" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_909" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_909" xlink:to="loc_us-gaap_Assets_910" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_911" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_909" xlink:to="loc_us-gaap_Liabilities_911" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_913" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_914" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_913" xlink:to="loc_us-gaap_NumberOfReportableSegments_914" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_916" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_917" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_916" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_917" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_918" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_917" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_918" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_919" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_918" xlink:to="loc_us-gaap_SegmentDomain_919" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PortfolioServicingSegmentMember" xlink:label="loc_abl_PortfolioServicingSegmentMember_920" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_919" xlink:to="loc_abl_PortfolioServicingSegmentMember_920" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ActiveManagementSegmentMember" xlink:label="loc_abl_ActiveManagementSegmentMember_921" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_919" xlink:to="loc_abl_ActiveManagementSegmentMember_921" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_922" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_917" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_922" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_923" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_922" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_923" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetInvestmentIncome" xlink:label="loc_us-gaap_NetInvestmentIncome_924" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_922" xlink:to="loc_us-gaap_NetInvestmentIncome_924" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_925" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_922" xlink:to="loc_us-gaap_Revenues_925" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_927" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_928" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_927" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_928" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_929" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_928" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_929" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_930" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_929" xlink:to="loc_us-gaap_SegmentDomain_930" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PortfolioServicingSegmentMember" xlink:label="loc_abl_PortfolioServicingSegmentMember_931" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_930" xlink:to="loc_abl_PortfolioServicingSegmentMember_931" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ActiveManagementSegmentMember" xlink:label="loc_abl_ActiveManagementSegmentMember_932" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_930" xlink:to="loc_abl_ActiveManagementSegmentMember_932" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_933" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_928" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_933" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_934" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_GrossProfit_934" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_935" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_SellingAndMarketingExpense_935" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_936" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_936" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_937" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_Depreciation_937" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_938" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_938" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRevenueExpenseNet" xlink:label="loc_us-gaap_InterestRevenueExpenseNet_939" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_InterestRevenueExpenseNet_939" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_940" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_940" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_941" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_941" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_942" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_942" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_943" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_943" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_944" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_933" xlink:to="loc_us-gaap_NetIncomeLoss_944" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/CommitmentsAndContingenciesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_946" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable" xlink:label="loc_us-gaap_OtherCommitmentsTable_947" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_946" xlink:to="loc_us-gaap_OtherCommitmentsTable_947" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaap_OtherCommitmentsAxis_948" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_947" xlink:to="loc_us-gaap_OtherCommitmentsAxis_948" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaap_OtherCommitmentsDomain_949" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_948" xlink:to="loc_us-gaap_OtherCommitmentsDomain_949" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseSupportAgreementMember" xlink:label="loc_abl_ExpenseSupportAgreementMember_950" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_949" xlink:to="loc_abl_ExpenseSupportAgreementMember_950" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srt_ConsolidatedEntitiesAxis_951" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_947" xlink:to="loc_srt_ConsolidatedEntitiesAxis_951" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srt_ConsolidatedEntitiesDomain_952" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_951" xlink:to="loc_srt_ConsolidatedEntitiesDomain_952" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_953" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_952" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_953" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_954" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_947" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_954" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfProvidersInvolvedInOptionAgreement" xlink:label="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_955" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_954" xlink:to="loc_abl_NumberOfProvidersInvolvedInOptionAgreement_955" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_954" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_956" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_958" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_958" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_960" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_960" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_961" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_960" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_961" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_962" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_961" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_962" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_963" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_963" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_963" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_965" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_965" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_966" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_966" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_967" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_964" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_967" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_959" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_970" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_970" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_971" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_971" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_972" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_972" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets_973" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_DerivativeAssets_973" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsFairValueDisclosure" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_974" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_974" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_975" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_969" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_975" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_968" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_977" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" xlink:to="loc_us-gaap_LongTermDebtFairValue_977" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantLiabilitiesNoncurrent" xlink:label="loc_abl_WarrantLiabilitiesNoncurrent_978" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" xlink:to="loc_abl_WarrantLiabilitiesNoncurrent_978" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_979" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_976" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_979" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_981" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_981" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_983" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_983" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_984" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_983" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_984" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_985" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_984" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_985" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_986" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_986" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_987" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_986" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_987" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_988" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_987" xlink:to="loc_us-gaap_SubsequentEventMember_988" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_989" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_989" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_990" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_989" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_990" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_991" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_990" xlink:to="loc_abl_PrivatePlacementWarrantMember_991" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_982" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsMeasurementInput" xlink:label="loc_abl_LifeSettlementContractsMeasurementInput_993" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_LifeSettlementContractsMeasurementInput_993" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsNumberOfContractsSold" xlink:label="loc_abl_LifeSettlementContractsNumberOfContractsSold_994" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_LifeSettlementContractsNumberOfContractsSold_994" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodGainLoss" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_995" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodGainLoss_995" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_996" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount_996" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xlink:label="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets_997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets_997" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_998" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome_998" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest_999" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest_999" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_1000" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_1000" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1001" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1001" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightPricePerWarrant" xlink:label="loc_abl_ClassOfWarrantOrRightPricePerWarrant_1002" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_abl_ClassOfWarrantOrRightPricePerWarrant_1002" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1003" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1003" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1004" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1004" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1005" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1005" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1006" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1006" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1007" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1007" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1008" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1008" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1009" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_992" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1009" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1011" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate_1012" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1011" xlink:to="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate_1012" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate_1013" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1011" xlink:to="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate_1013" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount" xlink:label="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_1014" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1011" xlink:to="loc_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount_1014" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate_1015" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1011" xlink:to="loc_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate_1015" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate" xlink:label="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate_1016" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1011" xlink:to="loc_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate_1016" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1018" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskTable" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1018" xlink:to="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1020" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1020" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1021" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1020" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1021" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierConcentrationRiskMember" xlink:label="loc_abl_LifeInsuranceCarrierConcentrationRiskMember_1022" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_1021" xlink:to="loc_abl_LifeInsuranceCarrierConcentrationRiskMember_1022" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1023" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1023" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_1023" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsFaceValueMember" xlink:label="loc_abl_LifeSettlementContractsFaceValueMember_1025" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" xlink:to="loc_abl_LifeSettlementContractsFaceValueMember_1025" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsFairValueMember" xlink:label="loc_abl_LifeSettlementContractsFairValueMember_1026" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1024" xlink:to="loc_abl_LifeSettlementContractsFairValueMember_1026" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierAxis" xlink:label="loc_abl_LifeInsuranceCarrierAxis_1027" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xlink:to="loc_abl_LifeInsuranceCarrierAxis_1027" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeInsuranceCarrierDomain" xlink:label="loc_abl_LifeInsuranceCarrierDomain_1028" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_LifeInsuranceCarrierAxis_1027" xlink:to="loc_abl_LifeInsuranceCarrierDomain_1028" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_AmericanGeneralLifeInsuranceCompanyMember" xlink:label="loc_abl_AmericanGeneralLifeInsuranceCompanyMember_1029" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_LifeInsuranceCarrierDomain_1028" xlink:to="loc_abl_AmericanGeneralLifeInsuranceCompanyMember_1029" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ReliaStarLifeInsuranceCompanyMember" xlink:label="loc_abl_ReliaStarLifeInsuranceCompanyMember_1030" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_LifeInsuranceCarrierDomain_1028" xlink:to="loc_abl_ReliaStarLifeInsuranceCompanyMember_1030" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LincolnNationalLifeInsuranceCompanyMember" xlink:label="loc_abl_LincolnNationalLifeInsuranceCompanyMember_1031" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_LifeInsuranceCarrierDomain_1028" xlink:to="loc_abl_LincolnNationalLifeInsuranceCompanyMember_1031" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_1032" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskTable_1019" xlink:to="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_1032" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1033" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems_1032" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1033" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1035" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1036" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1035" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1036" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_1037" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1036" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_1037" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_1037" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractMember" xlink:label="loc_abl_LifeSettlementContractMember_1039" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1038" xlink:to="loc_abl_LifeSettlementContractMember_1039" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1040" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1036" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1040" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1040" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1042" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1042" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_1043" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_1043" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings_1044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings_1044" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid_1045" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid_1045" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings" xlink:label="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings_1046" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings_1046" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_1047" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_1047" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1048" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1048" use="optional" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1049" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1041" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_1049" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1051" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1051" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1053" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1053" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1054" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1054" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_1055" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_1055" use="optional" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets" xlink:label="loc_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets_1056" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" xlink:to="loc_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets_1056" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets" xlink:label="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets_1057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" xlink:to="loc_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets_1057" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1058" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1052" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1058" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1060" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1060" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1062" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1062" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1063" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1062" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1063" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_1064" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1063" xlink:to="loc_abl_PrivatePlacementWarrantMember_1064" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1065" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1065" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1066" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1065" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1066" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1067" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1067" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1068" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1068" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1069" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1069" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1070" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1070" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1071" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1066" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1071" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1072" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1061" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1072" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1073" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_1072" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1073" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLongTermDebtDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1075" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1075" xlink:to="loc_us-gaap_DebtInstrumentTable_1076" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1077" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1076" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1077" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1077" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1080" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_1080" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1081" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1078" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1081" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1082" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1076" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1082" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1083" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1082" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1083" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1084" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1084" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1085" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_SecuredDebtMember_1085" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaap_UnsecuredDebtMember_1086" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_UnsecuredDebtMember_1086" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1087" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1083" xlink:to="loc_us-gaap_LineOfCreditMember_1087" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1088" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1076" xlink:to="loc_us-gaap_DebtInstrumentAxis_1088" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1089" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1089" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries2024IncMember" xlink:label="loc_abl_LMATTSeries2024IncMember_1090" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTSeries2024IncMember_1090" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries22024IncMember" xlink:label="loc_abl_LMATTSeries22024IncMember_1091" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTSeries22024IncMember_1091" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTGrowthIncomeSeries12026IncMember" xlink:label="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1092" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1092" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesLPMember" xlink:label="loc_abl_LMATTIncomeSeriesLPMember_1093" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTIncomeSeriesLPMember_1093" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesIILPMember" xlink:label="loc_abl_LMATTIncomeSeriesIILPMember_1094" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_LMATTIncomeSeriesIILPMember_1094" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SponsorPIKNoteMember" xlink:label="loc_abl_SponsorPIKNoteMember_1095" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_SponsorPIKNoteMember_1095" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SPVInvestmentFacilityMember" xlink:label="loc_abl_SPVInvestmentFacilityMember_1096" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1089" xlink:to="loc_abl_SPVInvestmentFacilityMember_1096" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1097" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1076" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1097" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1098" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1097" xlink:to="loc_us-gaap_LongTermDebtFairValue_1098" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1100" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1101" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1100" xlink:to="loc_us-gaap_DebtInstrumentTable_1101" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1101" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1102" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1103" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1102" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1103" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaap_UnsecuredDebtMember_1104" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1103" xlink:to="loc_us-gaap_UnsecuredDebtMember_1104" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1105" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1101" xlink:to="loc_us-gaap_DebtInstrumentAxis_1105" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1106" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1105" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1106" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SponsorPIKNoteMember" xlink:label="loc_abl_SponsorPIKNoteMember_1107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1106" xlink:to="loc_abl_SponsorPIKNoteMember_1107" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1101" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1108" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1108" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1109" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1111" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1112" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1111" xlink:to="loc_us-gaap_DebtInstrumentTable_1112" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1113" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_DebtInstrumentAxis_1113" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1114" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1113" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1114" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries2024IncMember" xlink:label="loc_abl_LMATTSeries2024IncMember_1115" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1114" xlink:to="loc_abl_LMATTSeries2024IncMember_1115" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1116" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1116" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1117" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1116" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1117" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1118" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1117" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1118" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis" xlink:label="loc_us-gaap_PledgedStatusAxis_1119" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_PledgedStatusAxis_1119" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1120" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusAxis_1119" xlink:to="loc_us-gaap_PledgedStatusDomain_1120" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_1121" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusDomain_1120" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_1121" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1122" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1122" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1123" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1122" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1123" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1126" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1112" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1126" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1127" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:label="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1128" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:label="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1129" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1126" xlink:to="loc_us-gaap_Assets_1131" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1133" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1133" xlink:to="loc_us-gaap_DebtInstrumentTable_1134" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_1135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_srt_OwnershipAxis_1135" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_1135" xlink:to="loc_srt_OwnershipDomain_1136" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries22024IncMember" xlink:label="loc_abl_LMATTSeries22024IncMember_1137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1136" xlink:to="loc_abl_LMATTSeries22024IncMember_1137" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_DebtInstrumentAxis_1138" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1138" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1139" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTSeries22024IncMember" xlink:label="loc_abl_LMATTSeries22024IncMember_1140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1139" xlink:to="loc_abl_LMATTSeries22024IncMember_1140" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1141" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1141" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1142" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1142" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1143" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1144" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1144" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1145" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1147" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis" xlink:label="loc_us-gaap_PledgedStatusAxis_1148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_PledgedStatusAxis_1148" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1149" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusAxis_1148" xlink:to="loc_us-gaap_PledgedStatusDomain_1149" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_1150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusDomain_1149" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_1150" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1134" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1151" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1152" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1153" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xlink:label="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1154" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:label="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1155" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:label="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1156" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_LongTermDebtFairValue_1157" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1151" xlink:to="loc_us-gaap_Assets_1158" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1160" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1161" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1160" xlink:to="loc_us-gaap_DebtInstrumentTable_1161" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis" xlink:label="loc_srt_OwnershipAxis_1162" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_srt_OwnershipAxis_1162" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain" xlink:label="loc_srt_OwnershipDomain_1163" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_1162" xlink:to="loc_srt_OwnershipDomain_1163" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTGrowthIncomeSeries12026IncMember" xlink:label="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1164" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_1163" xlink:to="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1164" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1165" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_DebtInstrumentAxis_1165" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1166" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1165" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1166" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTGrowthIncomeSeries12026IncMember" xlink:label="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1167" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1166" xlink:to="loc_abl_LMATTGrowthIncomeSeries12026IncMember_1167" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1168" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1168" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1169" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1168" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1169" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_1170" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1169" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_1170" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1171" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1171" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1171" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1172" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1174" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusAxis" xlink:label="loc_us-gaap_PledgedStatusAxis_1175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_PledgedStatusAxis_1175" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PledgedStatusDomain" xlink:label="loc_us-gaap_PledgedStatusDomain_1176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusAxis_1175" xlink:to="loc_us-gaap_PledgedStatusDomain_1176" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetPledgedAsCollateralMember" xlink:label="loc_us-gaap_AssetPledgedAsCollateralMember_1177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PledgedStatusDomain_1176" xlink:to="loc_us-gaap_AssetPledgedAsCollateralMember_1177" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1161" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1178" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1179" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_1179" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1180" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage" xlink:label="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage_1181" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage" xlink:label="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage_1182" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold" xlink:label="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold_1183" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDividendFeaturePercentage" xlink:label="loc_abl_DebtInstrumentDividendFeaturePercentage_1184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_abl_DebtInstrumentDividendFeaturePercentage_1184" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_LongTermDebtFairValue_1185" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_1186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1178" xlink:to="loc_us-gaap_Assets_1186" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1188" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1189" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1188" xlink:to="loc_us-gaap_DebtInstrumentTable_1189" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_DebtInstrumentAxis_1190" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1190" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1191" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesLPMember" xlink:label="loc_abl_LMATTIncomeSeriesLPMember_1192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1191" xlink:to="loc_abl_LMATTIncomeSeriesLPMember_1192" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1193" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1193" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1194" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1194" xlink:to="loc_us-gaap_SecuredDebtMember_1195" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1196" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1196" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1196" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnerMember" xlink:label="loc_us-gaap_GeneralPartnerMember_1198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" xlink:to="loc_us-gaap_GeneralPartnerMember_1198" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnerMember" xlink:label="loc_us-gaap_LimitedPartnerMember_1199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1197" xlink:to="loc_us-gaap_LimitedPartnerMember_1199" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1200" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1200" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1203" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1201" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1203" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1204" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1189" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1204" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1205" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_us-gaap_DebtInstrumentTerm_1205" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionOptions" xlink:label="loc_abl_DebtInstrumentExtensionOptions_1206" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentExtensionOptions_1206" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionTerm" xlink:label="loc_abl_DebtInstrumentExtensionTerm_1207" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentExtensionTerm_1207" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDividendFeaturePercentage" xlink:label="loc_abl_DebtInstrumentDividendFeaturePercentage_1208" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentDividendFeaturePercentage_1208" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold" xlink:label="loc_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold_1209" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold_1209" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentMinimumInternalRateOfReturn" xlink:label="loc_abl_DebtInstrumentMinimumInternalRateOfReturn_1210" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentMinimumInternalRateOfReturn_1210" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentInternalRateOfReturnCap" xlink:label="loc_abl_DebtInstrumentInternalRateOfReturnCap_1211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentInternalRateOfReturnCap_1211" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNetInternalRateOfReturnAtCap" xlink:label="loc_abl_DebtInstrumentNetInternalRateOfReturnAtCap_1212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentNetInternalRateOfReturnAtCap_1212" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold" xlink:label="loc_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold_1213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold_1213" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1204" xlink:to="loc_us-gaap_LongTermDebtFairValue_1214" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1216" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1216" xlink:to="loc_us-gaap_DebtInstrumentTable_1217" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_DebtInstrumentAxis_1218" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1218" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1219" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LMATTIncomeSeriesIILPMember" xlink:label="loc_abl_LMATTIncomeSeriesIILPMember_1220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1219" xlink:to="loc_abl_LMATTIncomeSeriesIILPMember_1220" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1221" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1222" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1221" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1222" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1222" xlink:to="loc_us-gaap_SecuredDebtMember_1223" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis" xlink:label="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_1224" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_1224" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain" xlink:label="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_1224" xlink:to="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdOneMember" xlink:label="loc_abl_CapitalCommitmentThresholdOneMember_1226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" xlink:to="loc_abl_CapitalCommitmentThresholdOneMember_1226" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdTwoMember" xlink:label="loc_abl_CapitalCommitmentThresholdTwoMember_1227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" xlink:to="loc_abl_CapitalCommitmentThresholdTwoMember_1227" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_CapitalCommitmentThresholdThreeMember" xlink:label="loc_abl_CapitalCommitmentThresholdThreeMember_1228" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain_1225" xlink:to="loc_abl_CapitalCommitmentThresholdThreeMember_1228" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_srt_RangeAxis_1229" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1229" xlink:to="loc_srt_RangeMember_1230" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_1231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1230" xlink:to="loc_srt_MaximumMember_1231" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1230" xlink:to="loc_srt_MinimumMember_1232" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountAxis" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1233" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1233" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain" xlink:label="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis_1233" xlink:to="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnerMember" xlink:label="loc_us-gaap_LimitedPartnerMember_1235" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" xlink:to="loc_us-gaap_LimitedPartnerMember_1235" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralPartnerMember" xlink:label="loc_us-gaap_GeneralPartnerMember_1236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain_1234" xlink:to="loc_us-gaap_GeneralPartnerMember_1236" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1237" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1237" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1238" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1240" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1217" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1241" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_us-gaap_DebtInstrumentTerm_1242" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionOptions" xlink:label="loc_abl_DebtInstrumentExtensionOptions_1243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentExtensionOptions_1243" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionTerm" xlink:label="loc_abl_DebtInstrumentExtensionTerm_1244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentExtensionTerm_1244" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends" xlink:label="loc_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends_1245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends_1245" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDividendFeaturePercentage" xlink:label="loc_abl_DebtInstrumentDividendFeaturePercentage_1246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_abl_DebtInstrumentDividendFeaturePercentage_1246" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaap_LongTermDebtFairValue_1247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1241" xlink:to="loc_us-gaap_LongTermDebtFairValue_1247" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1249" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_1250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1249" xlink:to="loc_us-gaap_DebtInstrumentTable_1250" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1251" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_DebtInstrumentAxis_1251" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1252" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1251" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1252" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PolicyAPAMember" xlink:label="loc_abl_PolicyAPAMember_1253" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1252" xlink:to="loc_abl_PolicyAPAMember_1253" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SPVInvestmentFacilityMember" xlink:label="loc_abl_SPVInvestmentFacilityMember_1254" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1252" xlink:to="loc_abl_SPVInvestmentFacilityMember_1254" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1255" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1255" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1256" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1255" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1256" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1257" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1256" xlink:to="loc_us-gaap_SubsequentEventMember_1257" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1258" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1258" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1259" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1258" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1259" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1260" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1259" xlink:to="loc_us-gaap_LineOfCreditMember_1260" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_CreditFacilityAxis_1261" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1262" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1261" xlink:to="loc_us-gaap_CreditFacilityDomain_1262" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1263" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1262" xlink:to="loc_us-gaap_LineOfCreditMember_1263" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1264" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1262" xlink:to="loc_us-gaap_SecuredDebtMember_1264" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1265" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1250" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1265" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue" xlink:label="loc_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue_1266" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue_1266" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1267" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1267" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_us-gaap_DebtInstrumentTerm_1268" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentNumberOfExtensions" xlink:label="loc_abl_DebtInstrumentNumberOfExtensions_1269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_DebtInstrumentNumberOfExtensions_1269" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentExtensionTerm" xlink:label="loc_abl_DebtInstrumentExtensionTerm_1270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_DebtInstrumentExtensionTerm_1270" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1271" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDefaultRate" xlink:label="loc_abl_DebtInstrumentDefaultRate_1272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1265" xlink:to="loc_abl_DebtInstrumentDefaultRate_1272" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/ShareholdersEquityDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1274" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1274" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1275" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1276" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1276" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LongevityMarketAssetsLLCMember" xlink:label="loc_abl_LongevityMarketAssetsLLCMember_1278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1277" xlink:to="loc_abl_LongevityMarketAssetsLLCMember_1278" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1279" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1279" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1280" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PublicWarrantsMember" xlink:label="loc_abl_PublicWarrantsMember_1281" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1280" xlink:to="loc_abl_PublicWarrantsMember_1281" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1282" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1282" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1283" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1283" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1284" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaap_MeasurementInputExercisePriceMember_1285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1283" xlink:to="loc_us-gaap_MeasurementInputExercisePriceMember_1285" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1286" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1283" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1286" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_1287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_ValuationTechniqueAxis_1287" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_1288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_1287" xlink:to="loc_us-gaap_ValuationTechniqueDomain_1288" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BinomialLatticeModelMember" xlink:label="loc_abl_BinomialLatticeModelMember_1289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_1288" xlink:to="loc_abl_BinomialLatticeModelMember_1289" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1275" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1291" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1291" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1292" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1292" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1293" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1293" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1294" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1294" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1295" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1295" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1296" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NumberOfVotesPerCommonShare" xlink:label="loc_abl_NumberOfVotesPerCommonShare_1297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_NumberOfVotesPerCommonShare_1297" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockSharesIssued_1298" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_BusinessAcquisitionExchangeRatio" xlink:label="loc_abl_BusinessAcquisitionExchangeRatio_1299" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_BusinessAcquisitionExchangeRatio_1299" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1300" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1301" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1302" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1303" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination" xlink:label="loc_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination_1304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination_1304" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering" xlink:label="loc_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering_1305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering_1305" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1306" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionPricePerWarrant" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant_1307" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant_1307" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionNoticePeriod" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionNoticePeriod_1308" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionNoticePeriod_1308" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold_1309" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold_1309" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays_1310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays_1310" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod_1311" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod_1311" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold" xlink:label="loc_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold_1312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold_1312" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare" xlink:label="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare_1313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare_1313" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod" xlink:label="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod_1314" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod_1314" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage_1315" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage_1315" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent_1316" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent_1316" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent" xlink:label="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent_1317" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent_1317" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1318" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1318" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_WarrantsAndRightsOutstandingFairValuePerShare" xlink:label="loc_abl_WarrantsAndRightsOutstandingFairValuePerShare_1319" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_abl_WarrantsAndRightsOutstandingFairValuePerShare_1319" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1320" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1290" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1320" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/EmployeeBenefitPlanDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PostemploymentBenefitsAbstract" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_1322" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_1322" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_1323" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_1322" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1324" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_1322" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1325" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_1326" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_1322" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_1326" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/IncomeTaxesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1328" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1329" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1328" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1329" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1328" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1330" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/RelatedPartyTransactionsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1332" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1332" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1334" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1335" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1334" xlink:to="loc_us-gaap_RelatedPartyDomain_1335" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_1336" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1335" xlink:to="loc_srt_AffiliatedEntityMember_1336" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwnersMember" xlink:label="loc_abl_OwnersMember_1337" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1335" xlink:to="loc_abl_OwnersMember_1337" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaap_RelatedPartyMember_1338" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1335" xlink:to="loc_us-gaap_RelatedPartyMember_1338" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1339" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_DebtInstrumentAxis_1339" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1340" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1339" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1340" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_SPVInvestmentFacilityMember" xlink:label="loc_abl_SPVInvestmentFacilityMember_1341" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1340" xlink:to="loc_abl_SPVInvestmentFacilityMember_1341" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1342" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1342" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1342" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1343" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1344" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1343" xlink:to="loc_us-gaap_LineOfCreditMember_1344" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1345" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1345" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1346" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1345" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1346" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ServiceFeeAgreementMember" xlink:label="loc_abl_ServiceFeeAgreementMember_1347" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_1346" xlink:to="loc_abl_ServiceFeeAgreementMember_1347" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_ExpenseReimbursementsMember" xlink:label="loc_abl_ExpenseReimbursementsMember_1348" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_1346" xlink:to="loc_abl_ExpenseReimbursementsMember_1348" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_1349" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_srt_CounterpartyNameAxis_1349" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1349" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_NovaTradingUSLLCAndNovaHoldingUSLPMember" xlink:label="loc_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember_1351" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1350" xlink:to="loc_abl_NovaTradingUSLLCAndNovaHoldingUSLPMember_1351" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_srt_RestatementAxis_1595" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1596" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1595" xlink:to="loc_srt_RestatementDomain_1596" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_1596" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1597" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1352" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1333" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_1352" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_1353" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_1353" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_1354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_1354" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1355" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1355" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_1356" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_1356" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1357" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1357" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LifeSettlementContractsOriginationExpense" xlink:label="loc_abl_LifeSettlementContractsOriginationExpense_1358" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_abl_LifeSettlementContractsOriginationExpense_1358" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1359" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1352" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1359" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1361" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OperatingLeaseAssetAbstract" xlink:label="loc_abl_OperatingLeaseAssetAbstract_1362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1361" xlink:to="loc_abl_OperatingLeaseAssetAbstract_1362" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1363" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_OperatingLeaseAssetAbstract_1362" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1363" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_1364" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1361" xlink:to="loc_us-gaap_OperatingLeaseLiabilityAbstract_1364" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1365" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_1364" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1365" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1366" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_1364" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1366" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1367" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_1364" xlink:to="loc_us-gaap_OperatingLeaseLiability_1367" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesLeaseExpenseDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1369" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaap_OperatingLeaseCost_1370" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1369" xlink:to="loc_us-gaap_OperatingLeaseCost_1370" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaap_VariableLeaseCost_1371" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1369" xlink:to="loc_us-gaap_VariableLeaseCost_1371" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaap_LeaseCost_1372" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1369" xlink:to="loc_us-gaap_LeaseCost_1372" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1374" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaap_OperatingLeasePayments_1375" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1374" xlink:to="loc_us-gaap_OperatingLeasePayments_1375" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1374" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1376" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1378" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1379" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1378" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1379" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1380" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1378" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1380" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_1382" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1383" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1383" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1384" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1384" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1385" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1385" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1386" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1386" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1387" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1387" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:label="loc_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_1388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_1388" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1389" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1389" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1390" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1390" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaap_OperatingLeaseLiability_1391" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1382" xlink:to="loc_us-gaap_OperatingLeaseLiability_1391" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/EarningsPerShareNarrativeDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1393" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1393" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1395" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1395" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1395" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_1400" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1396" xlink:to="loc_abl_PrivatePlacementWarrantMember_1400" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1587" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1587" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1588" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_PrivatePlacementWarrantMember" xlink:label="loc_abl_PrivatePlacementWarrantMember_1589" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1588" xlink:to="loc_abl_PrivatePlacementWarrantMember_1589" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1394" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1402" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1402" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1403" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1401" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1403" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1405" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1406" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1405" xlink:to="loc_us-gaap_NetIncomeLoss_1406" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1407" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1405" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1407" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1408" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1405" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1408" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_1409" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1405" xlink:to="loc_us-gaap_EarningsPerShareBasic_1409" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1410" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1405" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1410" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.emslp.com/role/SubsequentEventsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1412" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_1413" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1412" xlink:to="loc_us-gaap_SubsequentEventTable_1413" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1414" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1414" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1415" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1414" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1415" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_1416" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1415" xlink:to="loc_us-gaap_SubsequentEventMember_1416" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1417" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1417" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1418" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1417" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1418" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1419" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1418" xlink:to="loc_us-gaap_LineOfCreditMember_1419" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_1420" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_DebtInstrumentAxis_1420" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1421" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1420" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1421" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_OwlRockCreditFacilityMember" xlink:label="loc_abl_OwlRockCreditFacilityMember_1422" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1421" xlink:to="loc_abl_OwlRockCreditFacilityMember_1422" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1423" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_CreditFacilityAxis_1423" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1424" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1423" xlink:to="loc_us-gaap_CreditFacilityDomain_1424" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_1425" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1424" xlink:to="loc_us-gaap_SecuredDebtMember_1425" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_1426" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_VariableRateAxis_1426" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_1427" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1426" xlink:to="loc_us-gaap_VariableRateDomain_1427" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1428" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1427" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_1428" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_1429" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1427" xlink:to="loc_us-gaap_BaseRateMember_1429" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentAxis" xlink:label="loc_abl_VariableRateComponentAxis_1430" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_abl_VariableRateComponentAxis_1430" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentDomain" xlink:label="loc_abl_VariableRateComponentDomain_1431" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_VariableRateComponentAxis_1430" xlink:to="loc_abl_VariableRateComponentDomain_1431" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentOneMember" xlink:label="loc_abl_VariableRateComponentOneMember_1432" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_VariableRateComponentDomain_1431" xlink:to="loc_abl_VariableRateComponentOneMember_1432" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentTwoMember" xlink:label="loc_abl_VariableRateComponentTwoMember_1433" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_VariableRateComponentDomain_1431" xlink:to="loc_abl_VariableRateComponentTwoMember_1433" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_VariableRateComponentThreeMember" xlink:label="loc_abl_VariableRateComponentThreeMember_1434" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abl_VariableRateComponentDomain_1431" xlink:to="loc_abl_VariableRateComponentThreeMember_1434" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_1435" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_1413" xlink:to="loc_us-gaap_SubsequentEventLineItems_1435" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1436" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1436" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1437" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1437" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm" xlink:label="loc_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm_1438" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm_1438" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum" xlink:label="loc_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum_1439" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum_1439" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_1440" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_1440" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_1441" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentTerm_1441" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1442" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1442" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentBasisSpreadOnVariableRateTerm" xlink:label="loc_abl_DebtInstrumentBasisSpreadOnVariableRateTerm_1443" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentBasisSpreadOnVariableRateTerm_1443" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1444" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1444" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentDefaultRate" xlink:label="loc_abl_DebtInstrumentDefaultRate_1445" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentDefaultRate_1445" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentAmortizationPaymentPercentage" xlink:label="loc_abl_DebtInstrumentAmortizationPaymentPercentage_1446" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentAmortizationPaymentPercentage_1446" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter" xlink:label="loc_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter_1447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter_1447" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage" xlink:label="loc_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage_1448" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage_1448" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary_1449" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary_1449" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary_1450" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary_1450" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary" xlink:label="loc_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary_1451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary_1451" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantLeverageRatioMaximum" xlink:label="loc_abl_DebtInstrumentCovenantLeverageRatioMaximum_1452" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantLeverageRatioMaximum_1452" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="abl-20230630.xsd#abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum" xlink:label="loc_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum_1453" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_1435" xlink:to="loc_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum_1453" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g423260g01y03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g01y03.jpg
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MG]$?(LMDX6X>Y>I;CNJR>MICU!;T1GY45=T\ 5'*W="ERE,AWQ.MX8[AL0G
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IB'B(>(AXB'B(>(AXB'B(>(AXB'B(>(AXB'B(>(AXB'B(>(AXB'B)_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g423260g10a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g10a01.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1C^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &.*^8W X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0&1@           *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M         #^    X0DE-! T       0   !:.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!$0      !     "   "0    D      .$))300>
M   $     #A"24T$&@     #00    8              )X   $;    !@!G
M #$ , !A #  ,0    $                          0             !
M&P   )X                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   )X     4F=H=&QO;F<   $;    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   !&P    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
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MOUG-G]%N]'[3Z/I?IM_I>FM^/A]R4?ZPDHBWS[ZK9O[:QK,3$QC9^@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\ H7&"-S@L$D-$-DDJ*R\1DG-T=55UAEI-'3_\0 &P$!  (# 0$
M      $"! 4& P?_Q !#$0 " 0,# @0$ P8!" L    ! @, !!$%$B$3,08B
M05$487&!(S*1%:&QP='P0A8D-E1BD]+A,T5257)U@X2BU?'_V@ , P$  A$#
M$0 _ .^L!*(Z *>HZ\=-![./'AR#MX=^N@#T4JK<#WB?[G_WXC^?12J1W X"
M8G#\(?+B'#L#\@[AZ*4-2>\0/'<#^.W]H^'12EJ0/M%#^X'Y?LT^7@/12JM
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M^0'W_<*X[Q3I6HW6A:C!;7EU>RR=&1;:1+5,QPSK+)'$;:W@=B4'"NTA<HJ
M;FS4&7DP\N[2F8;3AO9G<;,F68RZXVE:?#SF4W$(]K-0H59HK^-ZFS7)S.LF
M+B&G86.C4$D(IH+J1GI9%%-B@BJY4*BQ_'W/'?M_3ZC)&!7'>&M1U&[:STLZ
M9=":W,43W6QHH;>* JHEF,J@I)&JCR EI7   )('6)+[-F?)&6DW[#R@^TY
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MX^1(Z8MW=3@=P<#Z_3-;VY!N](N%MX70W%C.L$+H(W_$A<1J4SA"V00IP5R
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MS/IN(FNI++J_AB0 NUIM4AED5B8TBE296; &$;=75GY-K(&8<L["^S7D3/L
M%=RS:<>IO[3'IPK6N X23EI9G7)T\"T;-&D0M::JU@[,Y8-6C1LV<2RB:#5N
MF4C<EU[#[]ACC/!Q\QS7TG0KB[NM'T^XODZ=U-;(\R[.GR2=K%  $+IM<J
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M+M!6G$Z-TPQ.PM6OF'KW682=G)S_ *@XP]?B)=\QFVDP= Z<C(+1,24DIY[
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M!![$>QIE)+9CV<IBUL+Q+8!PW)7.+.V&-M3W&=+<V!B9F8"M#-I9:).]1.U
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MZ=P\ U'0=1TU"UI_IKK?'_4&B<_^[U;C[?SJ)_\ 1_3_ /S/4./_ $++^/\
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M52F":)2I(HHI)D'=(1-)(A"EWA'0I"I@4H<1Y!S$1YCTA550%50JCLJ@ #Z
M8 J22Q)8DD]R223]2>:\*<9&(RCJ:2CV2<N]9-6#N2(V0*\<LF0N%F;59<$^
ML4;ME73E1%(QA*F9=42@&^;7Q6VMUN)+I88UN98XX99PH$LD43.T4;/W*1M)
M(54\ NQ'<U<RRF)83(QB1WD2,D[%=PH=E7L&8(H8CDA1GM5QZSUM-TOM<]PF
MOM?J=W#7OX]/>O.EU@\MTOLZZ[B?N?J<M?V<.712EUGK:;I?:TUW2:^U^I_
M\>BE %.S=*' >.XGQT*/9N=_'X:AV]%*(*:C[)0Y?9)[P<_4_@>/12D"FH#Z
MI0_N)^Z;\'?^SAV]%*0*:C[)0Y<B$]XOX/C^P>SHI0%01 ="D#B'V$Q][\'P
'^'SZ*5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g423260g10a02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g10a02.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1@&4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %^J^82(X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M         #^    X0DE-! T       0   !:.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!$0      !     "   "0    D      .$))300>
M   $     #A"24T$&@     #00    8              ,    &_    !@!G
M #$ , !A #  ,@    $                          0             !
MOP   ,                       0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   ,      4F=H=&QO;F<   &_    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   !OP    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
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MO^#6KA96
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #  ;\# 1$  A$! Q$!_\0
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MX.:AQ-S>F.^ ?(.4>DGZ9\Q[T^$\H 4_&9+R(G#J3'XOXN4  *'!@ZV^*7"
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M:+$XMV8CG#;6,IV[]M=9XF("G^$<G@(\YCO0]Q'DD#C-8G!NX !R8EZ3< (
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M2T3&5LJ[*#Z0R<R)N%I^'XC&\,YJF1<F;CL35:ZQTX]L"+B9P)6HNQ-)E1[
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MP0.T02 9"L$;Y5@$>EU8>!,8P#\0;\N!^H1-XA5480J0IJ\^(F0A0*DF8J7
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M/B<@L1;A$ %9K94/;1&)V%.%Q)6F:=NCIF'GA98;LS1!["V!PLZGX55-*JI
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MX%Z4U/I/\W=A]?YXJ#@Z&V'I1M^A$$B]Y8"VY,Z3[5+J%.JUUF+Q*7&Z7:8
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M;-=JHV?O/]:=I*KAXFDU!H]S3H#)GA;P,:[V5AA*+>BVA2:TR"!1 $3,]2"
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MG]G2/L!$@=OB5JR@&-#6-<U@G*QC7-#9))RM; @DR>B03)5YEOU6$ Z7%A(
M<EZ38]R&<0$HB4PB887D1$P"/Y>-3+Q\\_;XWX_GM6@IVW_G_"R?'RK?[U/_
M ,W60O\ !=,S_IG[?^5.3M/\_N3X^5;_ 'F?_FZR%_@NF9_TS]O_ "F3M/\
M/[D^/E6_WF?_ )NLA?X+IF?],_;_ ,ID[3_/[D^/E6_WF?\ YNLA?X+IF?\
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ME#U5O]J7Z"?W=$R#B?5[D]6;^XO;R[$[?^71.;;V^KW(#9N'D!0_ ! __CI
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M"4>R?<IA$1 ?9\A$1$0\A$1$>XZ)D'$^KW)ZJW^U+\P>1/( X /D_,   >X
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M/[NB9!Q/J]R>JM_<7Z"?W=$R#B?5[D]5;^XOT$_NZ)D'$^KW+CG12(<1*4!
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MJCM-!'UH4R)F6*FD"PD3\04TQ4 GB"0@KK&(03<%%542@ J'$ULVO3-]LUO
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M><)$ZS^C)OVZCL4CE*@?GM\Q^+@IA].KZ+<X&*.YJ)$IA 3%-0<J"41#C@1
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MS1!S"E2S?2YMLZ1K$Z6[K*AITSK38>]K3[0IA$1'D1$1'S$1Y$?RCJY <27
M.)U) ).UR;Z65V]!H:SH-$PUO1:)))@" )))-M22H:C(SZ+?LCW*V=_TG?:/
MO4IA'I'N/;R^]W#4.)RN9)RB(;\T29,-T$FY@7-UF]SK=)V^Y[.U?9%]2J")
MZ9O0(<1,0UGPSU$-[13<PF2 'J*/(#R   \@/(!QK\A^&S6MJ84M:&D.JP0
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M]%($.NJ]&-1BFR9Q(FV&G+V#S<OXJG19(J^C%K0V6@'"407D-9T6-<'%[FS
MEQERM0?-!I)( !XW)<3%R<Q$&+7T @JX]KN/[IZ1+/D-O]W!03Z'P)CIS)AL
M5P;96AD5W$:+M1DUW.7Z$>F!N,W;DFSE]3(5VS.\K3!RQ>M3H&(W\3BQE*G@
MF<RR"\VJ.UBS3$PTM=#FPUV:67,N+7.V:\D [;:@;[S?O WB;&/=)@4I6B($
M3\(! YA)SU&*<ZAS*=9^3"HH*@F,JJ8QC*J"90YC&,(CXF<5.F-#II:+18D6
MB+6MMHMVB /?.M]=US-%9-$31$T1-$5 WF/X1_/K-ORE3^#[I1=!/_M5)_P=
M;^S1UUX/]8'UZ?XK#$=0]Q_!?D;6[[+;5^,L]^EG>OZ-Y/\ U2C_ *G]5Z^*
MJ_*.\/NA6]KL6:W;PILMG<R[8MQ&X"*L9FEEPU&1=MK&/O@=_(N[ICZ(G(>$
MR[<62K94C<J-"^,=:2(W=)+)+'DY9^!1&%,*?@X[E/T;%C#G-#S&</RM:_F6
MU6L(S P]K:C@\0 YA:[KB=F8=U1I>"[: "1-X)$-.A@1>9)5GRFR/<=%U!:^
MO:5#C4C8>KF>22K7)6/W*S/$=FM!JK'WQTW^-,.(UU*9(C&/U31K>0;O/66X
M&< 47"^/QLTNR!YG.607@'-DYP- YT](M)?&X!^:%/HCXS2\M%R>E$3 @AIN
M28V!, 7UN]_Z.O=\PM;:H/\ &T"TL+[)V.,2K(HY$QXLT97K,%52ON.8HY1O
M0^ UNU?=(+PJIP*HV]838APHW,0+MY9HM9F=4&5HJ%SBX2!2<65)'.9B6&,P
M )-@))"GT2K(:,VPTUS3E()9!D$&28Z.H$KHG.Q'=&V^+BI\?1C).W1F5YN*
M76OF-'$4DUPE/MZYD=O+RCB^%CH!W2YV12BUF<I)1*UA\9%4J#M-LBJ.HY68
M7.:#TFP"+;@&Q-2"(.K9 (()EKHCT:IK.NFNQ@S#1!MJ0#H1 (*R!D79>&']
MI>3LIY/87BFYTQ#NOKVW>Y4.0LM/<U@L/9L52N1X]\Q7;,%'2T@"<6R0:/V]
MLD22Q'9G:+HK=^"!.9_+$UJ=-I);5I/J!P<;<V:0L!4T<*@.HL# ))(V9A"&
M$N/2#A,S>22;Y; 1$3!VBX5ZY&V1XXI^[G:[MY@['D^\P&>:9A&_6>0CFV/Z
M[96;+,L0G+,*C25IJUQM);39"R*+1JYM5AC5EP7C'2!%3G1'6;>67.HU*LAI
MINQ #><<YKA1J/IAQ<)< \,S%HIO+2>@*D2^WHH#FB7$'+<!HU X@S$[D38]
M&X;<=F]'&XAL*52Q0C6^W#-63Y;<%/0%,BK9B)M6\68^V[WQ*FVY]E=XG/S!
MQ,T9-[<O+SE;E7E=8V6.BH4B1S@W,-#RLYU=[<]1K6E@'2< 2YH,#I@$DD !
MKC<Y8#EF^D&#+E!.62;$Z@D\1 @B1I?0DCSLRSB7(F#,@3>+<JUY:JWROC'A
M-PJCF.?IHA*1+":C'T>_B7\E'OX>9AI*/FX219NQ3D(B18O3)-3KF:(>[A*_
M/@$/+A+FF3-VN>T@W)!:YI#MPX9=1"Y'C(2#.UH@W$ZS>UY$6NL< (BGWYYY
M$._GV,(=_HUV/$%X/[GK .ZR?,-GMT\/S[%]DGU*E]AV\[\9\,?H7)&OR+X<
M=?#?6J_T\,OH^1.J?#VUE]=R?R _";^L.OSRGU!WN^\5]&=?!OL"GU=0FB)H
MB:(FB)HB:(FB)HB:(FB)HB:(J B/6<.1X#IX#D> [:(NL>JK$%4Y%E$RI)D$
M!(<B13*BLCT(*'<@JB + '0*J:93)IJG#D% 3-J:-\LWZTR";0;^&OA>RJXD
M [=LQN+>/^-UYGT7>AN4R#3Z]=JYM\Q":"L\:A+Q*DON.GV<BLQ=]1T'#AK#
MX/M,<W!P3A=!%O.O_#;J)%6%LN"K-OW.H,:XMG2-0)@@$3#8T.N_$ZKG-0@D
M2?6?_P"E<Q]T.[ #" ;?,(<=O+<M;^/(/?MOYU3FF?D#W*,Y/_$([(/O/M61
M,%[D<G9%RC8<7Y*QG5:!)Q%#C<AL)"G90DL@MY.'=3TE7E&ZK>3QI3#LU2OV
M1P$0X.<I!\,#^R=2SZ3&TV.%R[,"" ;S$B "( _>$G:4#W$QF)B\B03V1?NV
M[UNDR$_AIE.8YA*4"\J&$QQZ0$H"<3*K")Q  $QC*&,8W(F$!$0#B.OY'JDQ
MW;=FBZ6]4;]\_C=<POR0_+^<=0K*;1$T1-$7G5O\](+0MC59@CO:[:LK9AR+
M($@L18,H+5S)7.\2YDN#/DVL6SEW<=6V:P@E(RSR,\!)4BQ4Q-QU%]'D_D_T
MRH)JAK?G G2,TM:,LR0)S2YK9!@F6CDK5Q3<6DP; #343,AUQM! -C!@KR7P
MW]4;51ME$<3[UMN%_P!JLPL_!NE._"3ZUQ\6?H)TIVVMOZU 7*,2.F=!RF\K
ML)-,#M%4W:C@A5S"'T&)^"Q-(NPV(:8%VDYGGI@@M>RFT"1(.>;6EK>D,AB[
MWFQ.I@$ #8R3<WC2W&%OCE;TL>)I&[X$PMLSL%,W4YASKD"'C%8JJ6%](5B@
M8R3*+N[WVXV.+$Z4$I"LR%:,HE51)XG)&60?(-W21T@\"ER16P^<XD5FL9<E
M[P]UQ((=#F$ N$MBX@#@>BEB6N(ZI,Z1;>T.,DZ6OQ*]%<X9DK6!,.9,S7>7
M+@M3QK29V\3947:J*YF,&R.]%@S5(!.73M8RK-N()"<YSLRF*(%3YY,+A7XW
M$MH4B<Q) B0",A=+@W,=&.,1/"=[XBNVFPORB(L <LD%K=0;%Q,V, DS%ROS
M?]^/I1]U&^NXSCRZ7>4KN(4'<@O4L05>8>1-+1BD&XK1)9]")<-7]AF))NQ.
M[5>2A7+EDY>*LVRA6[9(A?VODSD7"<EX!M&OR?A:N(:YQJ5JV&;6J$U*KLO3
MJ4V. 92<QH #&@ D-<XN<_X^IRA4J8ZHPU'EK0P@$@#Y(.) #@+GL)WM9?5O
MM4]#UZ+_ ')[0L&9,2P&\1D,K8LJEFEK7'Y2R@RL36=?PR/QC58>L3JD>D+&
MQDDFR+0C/P2H-TP,4P!X _FN,^$>*P/*#VL+&MDY*0IEE(-YL%@<!7:2_*X2
M9(YR7-;<3]'2PPJT@0'"1<@D$W@F TS<: Z&-X7R=^DRV0SOH]]UDUAR*M,A
M8JL\A8O(F+;H\22CI<]6E%P0%BX!B*9"RT%)MGT*F_3$KMV$<#Y<XN'"AC?I
M?(F)P/+.'9BJN$PSGU<S:C'TJ3RUS#49E)=F),,:63JTL< ) ;XN.I8N@XAE
M?$-8",N6I5:T3DV:!$$DDDD23,NNO2[T-'IA<Z8XSKC#;=GB^3F2L$Y3L453
M*PZM<C(O+#CRRV!VT"&<,K*_=.Y%W7%Y.92;.X514K<B@*MT"$*0O/C?"SX/
MX?F35PF$HT:C0<IH4VTLPS4&PYC&-:3!(:7 EI=(+1(3DG&5FU"VM6?4'_,<
MYYTJ&1F=W$@<"(,"?MPR9C6K9?Q[;L79 B0L5-OE3?U.X,3F]21FX>P-#13\
M4%TS=3"23 /6F:B72) %$ 4 Y %/\LPM1V!>VO1J.I5VN@U&NR5,P:6])S<I
MR.;4=3G-(!<&VB?JJD/F (.C0 1VQ))F!>YF([O(."]'#NJQ#MMM6S'&^\BD
M16U"1:V>'96NY8G>.\ZXPQ?87TB]M5/@+82ULZ-(M"-'\H4EDN$.X>E;JCR?
MH)X@^JWE+#8NN,2^D:F(:TLS YRYQZ#027N<YP#>;:0WJ&""&LR<3Z;LI:0T
M-))DM()BQ)D 1:;N@P"#<SYS();?Y7%;&G$DI.C>AMV'2:"$W-O5R/+!ONW+
MQLXH_5@T5T&S)K.UN.MSIX9Z@E+2$9.V!TF!P9)PX#%>OR<,76Y4Y4I/C$8]
MXPC*+JSGU:>'I'#NYZLYU0%SF4@:&8, YVKS30P DMY1F)LYS:+3$#HESR 8
MTB3<90>B 22"7./K(GZ4BL8RKN*;CF_:AG';YMWRU(5R QKEVQ(X[?52*^%D
M$F]17MU5JEN>67&T)*,4VSB&-*1:2*46HT%)-- 2$+\WA<%B\;7Q@;4<]X%)
MP%1SW!Q<'NJ02UT$O!+C!'.$%V4R5V,>+![2V#K$@G8B1&EX$D#20 5["PSQ
MI(Q3"1CW2#YA(MDY!@]:JI+-7;)\'K31RV61(1-9NLW53415*4043,4XG4$P
MJ&X,G-]"(RR"+6.IT &IX>>JZVF6@\>&FJ[+1631$T1-$31%0-YC^$?SZS;\
MI4_@^Z4703_[52?\'6_LT==>#_6!]>G^*PQ'4/<?P7Y&UN^RVU?C+/?I9WK^
MC>3_ -4H_P"I_5>OBJORCO#[H5N_[<%6Z952'6 K45$D%GY0Y$%_&4(U.D\C
MS !@1%5NJ54Y *8!X-QKI<3,3&D7CO\ &UB;"3.RQ)OKV:Q%@9U@B.(U@+=+
M&._/+^&YZJR=%J>-HV/K>*KOA(E,>P=V=TZT4F[*R+S()K-$&R+$LY";F/AU
MTX;R\E"@LDNN5N155-(BRGAXSDPXJN^JX$M+Z3X)<!FI"F6&S2##J;3UC,7D
M2%V4<1S;&MOT9O&SBYM^E?K$3$R.,SVKKT@N7WM5?4DM&PRUJJ^W5OM1&*95
M&XE)'88@[HG?JO7DA+>')598EO!RJ[=E64%%(I4P%,$2%)S?$?2!R'.'BH3+
MR<_-FE(.34TW%NVIMF-]#C+01(B-&Q$AUX=$$]FV\D"Y+#Z3_<I8+#9K$$9B
M.)MMIRY@#-*TK%5V<6>-\E[:(I*"Q0[!%>R.$FD>UA&:B$RC,D=K2K\ZLP@H
MFG(DUE4Y$!<<S'.AM5G3+_DZ[F/JL@L((>YC9%P ,H$ IZ9;A<&P%RT'*0 X
MP8,B0+7*@OZ3'<([8MV[:MX@:E)%YTA(5T%(DTYJ&9;GKL6^9(<PTJ>S$>0D
MS+6...XC74>=H:%5+)*,Q;DDS I8<E.%^D28F[A)$Q_PS;6;B00(AH @XMO#
M2VD6U,=*=!,'O.Y5H9UW_9RW$TS(%2R) 8P4894RI5,ZVB6B82PQ<Q,Y J5+
MC,>5URP,TMJ:D2R1K46FHNV2.F!5)&4$0Y?._%NSD:S(!&5I8TP9##E!%Z1F
M<H! @D 7$@"CL=<C62,P.YN1,/M8]E^$6NDGI)<RCDJAY=)CO 890Q[5,;4*
MJ6IQ3;K(/X:NXHE*J\IZD(P+DMC')OTYJM1,>[?H-6;@L*>01\0Z*RYE9^)!
MD>S*<CP_,PDD.%4N>Z1S9%R23>QL#>%'IUY),B(/E$P\.%A!)N1I.]<WI-=R
M*3NKN86&Q- KUMGN$AQC8JIV,26*N;FK(6Z9<I-C0?79ZBUK4Q:5%[2QE6;I
M6Z1<LWCB03QJPB8A!GHWX/E_Z0AX:YS7"'OZ)IQ!M3LV6@%LAK@2' M<X.MS
MAJ-#Q%Q&C;@D@F9,DZDR8B9$0-%[A;WEQG'E@<LVC55P9%NT0:J/G";:-CFZ
M47%$*\EGLC+O5O@UFT%U(3$@[F)%T*SZ775D7#DX^O1I&A8W=Q.AF3:S>-_#
MQY7MBY !,VVV&DQ)T%[3 @2%;/<4^1  $>X@  'F;GY@ ._F/;N/?OYZZ"[.
M'NM?+II:WX+%X@-'?[1Q7V1_4J7V';SOQGPQ^A<D:_(_AQU\-]:K_3PR^CY$
MZI\/;67UW)_(#\)OZPZ_/*?4'>[[Q7T9U\&^P*?5U":(FB)HB:(FB)HB:(FB
M)HB:(FB)HBXYO]H?_P /]71%USPX$'Q5>@I$ .8P&$Y1,W+X!Q63.F43"J18
M13(D(@"@&,4.!,(C-$3E U)(%IXVVUX^HW57::]_=:3V@;C2_8OGOQS.KP5&
MJ\+CS*&\5Y28F);QM:<M]J&*YAHM%LNIN@9E*.7[1=^Q 4S%8NE6Z9UFA43F
M$XCXA_9<QSB26-OQ>08VD<T8,1(DQL3JN8F#&>-+99V\?:KT^.-Y^Z-O)_\
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M45NBJT!%93]C/PTY-KT'OJ=9P;84V%]G6A@KOJ$Y1N#<7B+?*#DVJ<;4>YI
MZ/2N#'-0>FYD:@"SA(OO"^ZW9_@%IM4VR84V]MI89T^*J-$0+R43 _ARLZX.
MX=3KULFX(0S>.7G7LDXCTC$(9)F9#K+U@<!_'<?7HXW'U*H:T$F6,.2S12:T
M.(&A<ULP 8)R@NU7V-$"E3 U$W!-Y+CI)$7[A.TKXF/JD#--(R;ORAZC3Y=O
M*O<18?@:E9'[(4'#0EJ?V5[8SL"/&QCI&=1T=+%!4@'\1J[!PF8"K%/S^I_
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M]%AI@$%Y>2T9G36>1F<: .A O<   VE?)XJO5?B:CI):<@$.<!\FT&(D 3J
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M90OH1-*J430<BLZ/F6[Y)R'@(]><75NG4<;7Y2Y#7Z58*TSCWC>PU=Y6%_\
MU939E/DSD;E%E2H&XBI3I.<7!K'UFD32IM#S%/*7A],@RPRTL,@-+73SU @
M4Z9,6LT@D%Q,B=(.HT.P!D=:[])%AH;'N$@JI &I-8R?MXSGAK'4OCW$"-2N
M31_D;(]+M..8'+[>0RR^<6E#&;6'NM6BBUJ+:1-:@G1HJ)1(P55,Y[V\D8Q[
MZ1=5J/R5#4ASZCB(IU6!S#D$/&?K3](7D*.?HM#CD9):!+6"-08F3P&D[7L0
MO#@HD%-,.1/PDB7Q134245 B92@JLFNJLLDX4  .Y1454.DN91,3FZ>=?1X:
MFZA092?4&9F>9>9DO<Z#(!M,7"P<]SG$LEK3$!LANFP%KF2>V53$O'(\_P 8
M>P_A_P#A]_6O,DCHF>%Y';H%DYKG:YO6@_('R_)Y>?S:L&EC7-.HB?$SO'%9
M/&7*+VG778K[(OJ5+[#MYWXSX8_0N2-?DOPXZ^&^M5_IX9?1\B=4^'MK+Z[D
M_D!^$W]8=?GE/J#O=]XKZ,Z^#?8%/JZA-$31$T163=ALQ:W9@I7P;\;U(>1"
MJI2XG^#UK(G'G-' ]$?V--FH<4V[CJ$I#%'@P^UP+\/?"?BO%$^V&7RG8)R:
M@L;V##6XN%/CM2SW"EOQK./*[=74Q+3UZL<DJN;X/?M75/9U<Z;&N-$S+/CH
MB]!:1(HH:..A[^';Z^_?=/='Y[]=KKV%R%DN Q)4OC+:I!XO[+-A%QS-(74K
M;+&Y-ZNSBX)@AUN5Y"><B"2*)"@R9$4*]5%#@5 DR/9'GK^,^'!!^?\ '^%X
M>9^G\U96WNX,QG=;-(019)]3Y>7Q_7':XQV.*VZF#3#N.F'B"Y"3EC"K-R.Y
M=\H54473ATT14]322* W&D;"T3)-X%_9$;*! U]NFEIXZ<;S$KU$>M+W5,PY
MQMJ=#EI]_8Z=0Z9AY!D5D,(XCH>*7/(E?S:@"SKB2-JG),LG'S*:AGS2,:JD
M(=JFU1(WM.DGAMXV\O%)X[F%T6-L"V6HV3:Q3I%F>5JN#,>7:9DY<J"*<8;(
MLH[BXEHQ:H.1$02C"2]H5A52%3 C5@DZCRMVZB:9'Y]JG\Z_G\["+Y*VH0=F
MBZ;9W-XK,Q 7:S9(NMKLQI%-+P'*TI/R2\0=HJ4YE#@W@!BF F[F3*@F@4P(
MID(#\[S^??NH'M[MK=\]_#9;5-1$6Z74*8CT]O"^1T@(@0 _ 3I P?,8!#12
MJ^B)HB:(FB)HB:(FB)HB:(FB)HB:(FB*B8 ZQ$0 ?+S#GYM9&SR3)' W&FP-
MM=46J>\?:Q1]YF!KSMTR%.V6N4V^FK@S,E4E8YK,)?%^S0=I9F;N).&D6A14
M>P+9L?GKZDU3IB7G@I?1P6/=@:S:U(C.T.:#G<T@.!$-<UX DD3T3(D;JIIT
MW"',:X:P6M-]M9!VVT'9?Q _]& V8$,4$LV[E.E(A$4S$G<9>RFD0$BD*(X^
M$P%(4H$ HCV .G@..-?54_AURA38UA<XY9N[&U)N21,NFT[KRZW)U*I4<YK&
M-:2"&BDV 0UH)L-3$DZJD'U+WLN#RS/N2#N(]IG%P=Q'D1_[O/,1$1'WB/.K
MGX>8\B"21P.,>1]Y9_%;/HM_^,>Y/_1?-E_W:-R7\M8O_P O-1_X\Q_YQC_[
ME(Y-   @ : ,  G6(%I4P_4ONR[I-T9>W&G,! **@SM !0X+ Z;N2"#>AII
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M>(UL0KU:>C4W:.$74C8:) 5&&C[9=:+9377(&.X9W 6"@R-7;W6/4AY6XL;
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M%5%,AA*82$$Q!$Q!$H")#&^4)1$.2B/SB' C\^B*<         X  [  !Y
M?, :(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB*D<0Y^^'G]_RUFX@RV"3M;N/?
MHBXJA2B8>HH"(=(^T "("40.0>X?N3@!R^XP 8.! !U0TG&2#?O,>SQ[T54G
MR0_*/Y1$1$?RCW'5FAK6AKBS,)F2-R3O!T**;5II\6>;432:?%GFU%*)""/4
M)"B8 , ")0$>#  &#GCG@P%*!@^<"@ ^0:33XL\VHJZ8 !     []@#@/,?F
M#5A$=&(VB(]5M44^I1-$31$T1-$31$T1-$31%0-YC^$?SZS;\I4_@^Z4703_
M .U4G_!UO[-'77@_U@?7I_BL,1U#W'\%^1M;OLMM7XRSWZ5=Z_HSD\#T6D8$
M].\7^4?NOBJORCO#[H5ND649N$'3=V+%<%2%;O&PF"19/"G(JDY:I$$ 7Z@3
M335!40*<A?#,/04H!T5&4ZDBHQM3<AX#A8 WS"!M?7P"YW3)\P?5$1.TVF(!
M$02MU)O?AG>Z/+BSO,U',%\S(4R*S[=:G4HAME;*-0QTX@B-&=A6>S*4>=:3
MB8F).^(@O"FL"T%'S<LJ\EC*R)_G\3R52=4/-T6"FTYJ8RVIES"'Y)8\, +W
MAH; 8UQ8W*P93WT<15;3:!4> )$->YK3+S>Q )<;DD$N=TCTG2O01;TL=.-O
MD0S&TA;C#[5&6>2[BYNB5_&-8B;W:LD&Q2ZP]'N[HZ=9EFX9TC MC%<1ZS*T
M0[E)BJDH1D@Y47;%X?B2<-S?-LYP4#1-7*TD/R07EQPXDEP:XG)!(;T( 5_2
M"7EQ<7#-F G:18#/ $"-8 T=$K1N4](7G=DV5I,6K57F$82N0N/XG$DOCQ-&
M@,JW7KV\R)5'S^-0>2;F,L;'(S^0MKRP.74DK/N'7P29ZI74F!"=]+D;#@9O
M1Z6=[R][LDR[+DL"S3(T#* 0",Q&8YC45G6&:Q!:V"!JXZ<;DS?L)U5BY5WQ
MY[S-66-8R1)5FSR3/.4[GTEN) M4+<^R=,A!H6.7%O'34=&/&(-J]7X^&JCA
MN2,0AXYLS436,TZQT;R-AV7;AJ8Z#:=V ]&GF#;%I <,QEP;F=;,70W*-9QU
M<8DD;ZD$F9%B&\8M  62XCTGFY^#O5DR"U=XW&Q67-];W!2I7=,2)&$S?38:
M0K[2UL!)8>64B_92LHWGHA "1SLBQ4UC*HF #8OY'H$<US#>;%)U$-@VIU T
M/:.B#)RM&<DN!DYAF)<Y]PDASLTAQ+2(S G*1!M<FP$&\C0KJ&'I#<[M*]&5
M9A"XJ"#KF*\ZX>91R-3?@HE0-R4V,MEMD*;:SD;-1D9)$%$GK)(KJ';*.*ZT
MX8,$TP.Y)H'-FP[2'.:^[+2V""T9):"6@EHAA,EP.=TP*Q^DZ0"(@"[@=OG&
MY F#I!T56Q;^,E9;;2V/\V-ZT3#V0HK ]2R-%8UI;)C84Z?MN9RS7'M@QJM,
MV!9,MM@8*;FH:$))?^J"I(]D^>LAE7#I0_.WD:DRMF90:W+GR]$PT5G"I4@%
MEFN< Z!H8  :(7-5KO<]T5'P2#EG7*T!IUV[")FXE8(W);@;?N2RB2]6Z<D)
MKX*J-7QY O9HK,U@?5>G5R(K,;(VM2.7<QI[-(DAR35E,P6.P4M#V6>M2E*L
M&O;P?)S6"&L:)+G1!@%SJCR02WZ3S B!8-@668?4,$O>+: F3E !!&F@B!;M
M!UP![ )\$ X%+[(=8B)C= ]/6(CY@<0$Y1^U,&N\L%/.P  -RV @7O:PUF=%
M5\VF3J).MH'YXK[(_J5+[#MYWXSX8_0N2-?D?PXZ^&^M5_IX9?1<B=4^'MK+
MZ[D_D!^$W]8=?GE/J#O=]XKZ,Z^#?8%/JZA6C:+"QJ\7.6*7=+-H6O1;R6EU
MT$7;Q1G'Q[([MTY!G&H/7RH)M@<+B5)H=4PMB])!#I,:I#B9$D&U@;6.XGC-
MQMKHJEP$]FOM!U$CC?U+$!-S&+>/_;+^J "8 .GAO-"Z9P P@!B*H8Z%)0HA
MQP9,1#C]T8>1'9K2; 3&Y@SKIT+JF;M/K_%WG;WJ!MS>+@$0\;(X^7<N%LV<
M>7S<XW$?P]Q[Z@T7N,Z3MG8V/"1'EVJ[2(%_,WU[U+_I.8N_?LD?S+9K_P M
MM1S#^/\ W6?W*9'$>84G^DUBL!$?%R. B/4(_67S6 B;I G4/_9OY]  7GSZ
M>WEJPH/XM\:S ?OA6!X0? 'UPJ2NX_$SQ%5DHKD &[ELNU525P]F-L55%P!@
M7*17XE-5$3G*8Q>L4DS<]RF$.DXR,,\B<P\*K;=]S([CQ&M@D3<CC<1ZXB-)
M@Q>\7(P=B!;:9@AS:Y/&D#D2">720!_857.-LVRZ[QTBJX51,CZU5EA3224<
MN#MP*8/ %=0$O#!0Y1J<,^234[8-5N\;&#Y]I4!S1NV-AMW7!_#O6?B[E\5)
M%(F57(*)2$(4J1<,9E$I" 0 (4O@X]73 O3QP4JI^D."FZ3 )0KS+A;.+?\
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M=S(B5PB5)VZM\2O>T5&$9*E,O9F8X&&EK<SII@_.%LH#9@EM@8&,=F+2)RN
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M$6C&,>J1;-)-@((FKZ74YSG*E5[Z@^<ZHXG0"Y+I-@ "7&S1:P5A2I 1S-(
M7@,;$WOIVS$0"3$R5D^+V6[</B#::)/8FJ-AC<D15389'&7;3+]2T?6_CV[>
MF)/)&>DY:=AH^I>& U"+;2/JE;3Z0A46*?"1;'E#$AP<W$UFY00V*I$ F2"
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MU,UTW1%H24,FY=D<2$6=JY='?/3.%14>.A4N,9BQ'_F:Y@0)JU"0+&02^9(
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M, E,4IBF^4!@ 0'CCCD!#@>. \_<'NT1!(0>H!(40,/)@$H#U#P!>3<AW'I
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ML9(B9-H>PC3;]/%A_BY=G%:"4/*M6T4F9Q*QC59&&>/F3IZ<RB[91 Y?4DU
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M\Q$.1^D2ZF3Q/FIRNX^L^Y0]4#[1+^*']W23Q/F4RO\ I>LKB*,%>LQB 0Q
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+B)HB:(FB)HB__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g423260g10a03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g10a03.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1'.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $;*^13 X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN
M=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !       /
M<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R
M;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R
M:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,
M8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O
M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@E+P         *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M         #^    X0DE-! T       0   !:.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!$0      !     "   "0    D      .$))300>
M   $     #A"24T$&@     #00    8              +0   )A    !@!G
M #$ , !A #  ,P    $                          0             "
M80   +0                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   +0     4F=H=&QO;F<   )A    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   "80    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
M   $     CA"24T$#      ',P    $   "?    +P   >   %@@   '%P 8
M  '_V/_M  Q!9&]B95]#30 "_^X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MJ=IAQ7 BS]B"ZVL^5(;W(W$?$,GF(+Y3M!RF9. ",G!!!'/5'LZ%G,,>3F(
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M,K5@0S7*'T,L2\EVZ8")-CB9ZOB&1E-L,UY^ZOVFOXG;$?V@[D?HV>.J?9A
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M&;5V%=<4>%*X^X^XDJ.ZX>26U/)V@X6 5$!Q>2$#)/3&H?9EF(3$8;4.)/$
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ML#%+295RJ>WBINZ7_P"6O_KY1K'/-)J2I]UJ&SBNPNU!GEV^*CW;G[QSU_\
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MK11)C+PMLH?94'#\%OA<2H+)Y<D=3\0ZZG."*SB:AA(,)9R\,QG.BT3%#$
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M4&]9GL4U4V;TG4BOW5=+2(;EWT6H-PVHT*JTFDLR-Q6]C%$'=P)"$%ID!S%
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M_P TZ/!D.[_!3'LX6V4A!OC=\H224H-_U I!/,D),+ )/,D#GZ=/>]H"2+&
M$U/,Q.=9OIT>#(=W^"C[W*W.'@]O6\'!PJ1P^Z!4.'@5S4CA\BQPJ/-2<8/I
M&GO>TKS,#F9/,13(H?G3HT'5'=_@I/>W6Q@)]NV[O"E(0![?9^ @*"@D#R+
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M_&BQY#'$@E/>L2&'V\\;3K2PE:<P<IM(0/BAB,IQ/$<,#$)ZQV+/,V<OA$M
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M(Y:=-M'>3S#M-B7(^;$S.9FG0X,SWM#992U*([-UOI7WB;ZWB2YP!OO!N!5
MO@'!A'$(7%P#NV\)S@=VC \Q.'3;2DF=V;&<_FK,STG-7H<.<67S&F5$'9MM
MY*4(%\[Q!#:@IM(O^J!*%)X\*0D0<)4.\<P4@$<:\'SCF].M'=YT=IM*3WM
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M[W:?!&1[I%C\C]I7;_6G)8$D@4#TU9(PR]"BZ5P!T ]0U%&&0V*4--C&&T#
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M3KUHPR&P*.!X#U#1&&0V!,#P'J&B,,AL"8'@/4-$89#8$P/ >H:(PR&P)@>
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M5)(P"/C'71%A];NZW;<0E5;J\:FCR=^4MV<M;*"TPDJ<45I 2A*4I)41GEG
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M@ D+U!(5AP"Z<5\!/W/Q'7TH*'7Y!?27._99^H)MO_J-2_.*?K5K_4B_./\
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MKAORX$4QJKOJ\D I"MQ;JH\Q^8'JDY3JQ383S2XT=AI'*^!C.%V&LXEYM*3
MNS*10PO1XG!A!F,9DO/_ $9,ZWQ.D7'7TA-5EBE4H!(%O41U+!4$!*$BJ5CE
M+D<*$@)2RA('" .@QDVE2]9$9N,!JDYG*J&A/RR>4G,PQ:<CXS"DA0:?36$1
M:9%9BQ&U*4F$RVII+ZU_#<>D.\3CRU9\Y2U*4H]3G7A!.R;%SI)E28?6SR<K
MSF.(W7)9Z%_$UD?.2JL 9P!S.3\9\3XG67.=:Z5S];**.3XGUG15SF=I3)\3
MZSHCG,[2H:*)HB:(FB)HB:(FB**>H^4?CT5AJ-8\5[*Z'Y#^+1=UE-D_3+$_
ME-?[U&MV?S#7#_G"NUC\\'YO.!=.*^ G[GXCKZ4%#K\@OI+G;LM@'8/;@'F#
M J8('7!N&>#C6K7^I%^<?Y1(L8LZGUFIWUVNX%!J$2E5N1?EG1H53F11,AQG
M7MCK 0PX_#)"9+;3BPMU@_LR06\C.==' $)+_BHU7T^G4(?$CUZQ#K-]E+,N
M2QZ-5*+=53J%:J;M?>DFI/OL&',;<2C"J32VD-,4R%'!(+;7$M*$\\J&D3&8
MRGH.GU@E)>O6>DK=TBG0Y)"I+#$@H!X5/LM.E )2H\)6E12"IM"CC'G(0>J1
MC"J\VX$!IP/-,L(>2D(2XAIM+G /@MA:4A7 /0G/"/#1%;:%^V%R_P YQOR5
M!T19+HB\W24MK( )"20#C'^WEHBP;<3;ZS=U+*KUB7_;U+NBU+GIC]+K= K$
M5$RG5*%(!2Y'DL*'G)(Y@IPM*@"E0(SK=G:165I#:0DPQ0&\(@6((Q!P(68A
M>A(S#>O39K3W9\[*FP/9=M:=9NP^V%O;<V]69SM5JT*B0TMJJ$UP^<Y*6XI<
MAQL8PA)60V.2< ZW;\LM+8O':11D4<D^+CMW.L068A'R@=@;UEJ(DT]X&V+=
M65!5&IN%X*SY$V"HIY@E7#DE/HSG!Z<CKRWB8@P=_P .G0P\7&YO7?: AX:3
MH?0\*M@IVK;MN,X%L4> TYA8"TQ4)Y+!"P5!&<*!PK]]RSGKKISL8^&)P,I$
M:<.*YB,D2BEHDSR:DI+Q1:5KAM37L'1W>-?>.I,-I1)'0@E!YISR42<>C&J[
MZ 6D)#9XK##(*OIMOT2E2 Y3*93XCAX@MQEA+;H!R2$K"1\)749P<=.0.HJL
MBT1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T12+Z#Y?T'
M6(Z#7Y%%K+>[ZC>ZOVN[R_-^H:MEA^8>2D5#J/@K[MS](%E?T6H7Y-C:W%4Z
MSXJK6$;_ $E[Z^T+MA^?.]6HBZ"T1:\OF^*;8K5+EU-I^0W5:U HZ!''$8[D
MEUYQ+JAG! 2$DCTXP0=$6&L[];?/-./,SIRPPHMO!J,I:DK1YJPK!YGB!R0?
M''74[#NXHJM_>BRH;O=JG27>\CQ9*5-1U+<;1--/#:%_O5I]D6^))&0K*>>,
MFJ/N[/'!9?9][4:\HLF91'Y#[<)T,.E])3E9R"<>C)'/T@D:*J>Y/V16?WH_
M1JBD6KS"AK#K\BL/U%4T1-$31$T1-$31$T1-$31%3S9D&GQC+JDZ'2X>?V>?
M+3 @>'PUX^/F3\?IT(D7D-@<OI<L#F*@K+AV=V?7IF^X##!:ZD;CPW7%-V]3
M*C<C@'_?&P:51DGE\*KN#N&>0SFDTMTD@9SU/BOG16F$VVE_/.7SQR]Q*-P#
M0B59"8FS9"6:QN8JMU[Z8JTZN,G(-!HA-)I?-(20Y(60NM I2@8J:F_-0$@8
MP!.<)'ANG3*LA-\&6>D7S5Z-LU3<.^$U[1HD2GQVHD&-%C1&5K<;;CQQWKKK
MG"7''' "I:UJ0@J6HE1*$Y4<#7#G"^#X2>0UZ"."A(8AF(UTW8,^)JTI>_",
M_#&<_%U]>ISNF'UVK"\\GQUE>=-$31$T1-$31$T1-$31$T1-$44]1\H_'HK#
M4:QXKV5T/R'\6B[K*;)^F6)_*:_WJ-;L_F&N'_.%=K'YX/S><"Z<5\!/W/Q'
M7TH*'7Y!?27._99^H)MO_J-2_.*?K5K_ %(OSC_*)%X[/<]W>U #S'ND6/UY
M_P#@O8'S#U#PUTBI!JX*"L6OR"Z1X4Y!P,IS@X&1GD<>&1UQUUA51T12D#!Y
M#H?0-$6.4+]L+E_G.-^2H.B+)=$31%*K 221T'ATU(@2"!5%3JP4*4,G 'P>
MO,@>'0<\C7,0/66C1K!DB^?OT2+MGGL*=F.[=^X=HN7K4Z74*;0Z'1N\DM4U
M=7KBULQ9E8?B)5*:I\=396\I@%9 "49)SK['L?V:.7^T.2\E!,)MK40DC 1.
M3\Q ?2:4#+R<IMHK.RCB =@<P7V$Z]6#D+DCZ&']%'N_M][';A7U5]M:7:=\
M;975;]MUV/2Y%2?MBOQ[@2EUB;1WIZ$/-/L-KX7(3A*B05Y \W7M]O>Q?=ML
M8!$;I#@$ D,6'XB2#F<93DO-R;E)M/BR(>1:<CJ(R?-A)?39_?&'32ZU4+1N
MP+8*>\D1*>M<5U:7C%4B.H<U!*AQX(/($Z_/0 F$D_AECJR];5]8!X3%HRX&
M1S<:57>[=35)5W5K7.MPN+:9:>A*;7)+;+DA<D*X?-0EMM0SX^'3565M:VZN
MFN4^FU%#$F.U-C>6(:D<EH)/#PJ'7ED\C\OQ:(LIT1-$31$T1-$31$T1-$31
M$T1-$31$T1-$31$T1-$31$T1-$31%(OH/E_0=8CH-?D46LM[OJ-[J_:[O+\W
MZAJV6'YAY*14.H^"ONW/T@65_1:A?DV-K<53K/BJM81O])>^OM"[8?GSO5J(
MN@M$5IJ%+A5!/#/CL2FPOC2B0$\*5#DDC(P%)!(! R/'1%;(UMV]&2OR>DT]
M)*CD)B(P>?,? PH>*L\^O,]2,#4.HM6[0H_>!NCPF^]5W[JVXB5+*E'C.,I)
M&2 >') (&!D  C>O6[)76#!@Q4+,**B(%9)*6TMA7$,\12G /(Y((Y>GGHBQ
MFX\\9R<G@3D^)Y<_1^+5%(M7F%#6'7Y%8AJ*IHB:(FB)HBC@^!]6LWH<_%9O
M0C'<>"8/@?4=+\.>X\$OPY[CP7JMQE$=];CC#;4<9,J00E*>G,G(_P#OZ=;O
M0S8@NTSAI(9P:CR7FOU(9@#K-1OEABRUW-W'M6&LQ*9*D7+/Y_K>VHZI.%="
ME=;;!H[1Z@I6X%#HKGD:A($@0<\Z3$Z-/)\<EH1@UPP)>CD')F[*L9K&I=TW
MO5N45F#:$$)PKB/L[< )Y9[V5W=$'/T.TZJX//&1R\-X@U)#T)-,%YC$2"Q8
M7LW) .. &N5*"MF%"@JD>R%3D3+@J(!":G7GQ4>$G_R8C(#-&Y9RJFH</HX1
MS2(Y+[2-3!V]=BQ>B#.\V+DNXF[N9G16DW97-("$A" $('1"0$I'R)& /5KS
M+R*/Q>CPT11R?$^O15R:D[5#11-$31$T1-$31$T1-$31$T1-$31%%/4?*/QZ
M*PU&L>*]E=#\A_%HNZRFR?IEB?RFO]ZC6[/YAKA_SA7:Q^>#\WG NG%? 3]S
M\1U]*"AU^07TESOV6?J";;_ZC4OSBGZU:_U(OSC_ "B14NSGU7^T]]LBQ_\
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M2A74IR0GGRZ CT8P0<^@Z]J]JY][+'U ]M_YNJ'YPS=$5)LY]5_M/?;(L?\
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M7!UP!S^[UT<YG:5.: R[OW6E[PW'@VY<2+;8MVN5:8Y!$YR73X15!80]+1'
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M^@X'3SL_&.73KS%82D/]X93>BET8@:B!)\/5*:%C-UU&70:)*J=*HT>J3F5
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M=):-+@'QU*$/Z;P51[2K9_@FF_U5_P#/I+JP]V'@C#3M/%/:5;/\$TW^JO\
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MIC"N\*,FILX3A84)ST+3[9F3SJQ;'&3*N!BS-@YG=F' >3BH< '2J^M7I:%
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M@PABS%],Y/4$4=VF)ABOSSQ:3UDS#5AFV"KZLKLG5J767ZCVA(R'*I>-V77
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0/CST11  &  !X#D-$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g423260g10a04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g10a04.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[1>@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %X2^8" X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@E+P         *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M         #^    X0DE-! T       0   !:.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!$0      !     "   "0    D      .$))300>
M   $     #A"24T$&@     #00    8              /D   )A    !@!G
M #$ , !A #  -     $                          0             "
M80   /D                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   /D     4F=H=&QO;F<   )A    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   "80    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
M   $     CA"24T$#      -!0    $   "?    00   >   'G@   ,Z0 8
M  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(
M# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,
M# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ 00"? P$B
M  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*
M"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4#
M##,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q
M8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75
MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
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M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M P$1  (1 0,1 ?_$ !X  0  !@,!               ! @0&!P@#!0D*_\0
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M0X)/'H?ASZ_?Z_?J1!',**@X(U!'>%UI9;;:4$MD\LA*DH*0XH-E2D!*G5!
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MQ>5>BAUI2A1)2CGI25'I_6.>% ? *Y">Q'' UD>2;$W( ![U1R0 \"R@$I2
M$I">/YH"2?N44\%0^/"N0#W]1J&E]9^EK#L4,HZ(I$MI2H+3U(4.>%(6M)X(
M((]U0]U0)"D_94"0002-00*H,YSJ"X/?*:\;^].%E,E*4$% ".DA20@=*4+'
M!2XVA/"6W4* 6AU 2XA8"T*2L!0C=ILP;,9'4$9@O(+@YJ  &;*VO>K$S+"F
M,@<@9!53W,7SK'&Y"L5S2!%:?E4RW@HO1[*(L>7<8W**E_7-3(0ZI;"WY=:8
MERW$GL1B44UX=5%=._14QJHWC3O$$$2*J2"X#=8 D $@6D5589%5%6Y53:H
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M>$H^\!7/'8D@:JH-=0)'2F''R4^;'O<\USC="!QV\>&WG'W8]M\1^T9" ?Q
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M)20L)("Q,7'O7AQ=\EK;4#N&\M9]<];!\VAM;-#0CL,LCL&V&V3]X1P0._\
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MR9$]Q3BY$H/",ZM);*(B%DEA2DJ+8:CALN=70H'G@\;Z+JKL56<".A_JG16
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M-3SK;33^T&^\%A+RT(7*L%Y;L%.9C0TK*0ZZ($"VDN(Z^2W%<4GCH/$M&3Y
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MO<EDR .[<-C"<:M77'>Q3,D16@I*G$ZM2'.<79O9ELCY+([FDB X %K&_='
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M\\ ?KT4BX?563E698[A-#9Y)E=S74%#30I$^WNK64S"KJ^-&;4\ZX_*?6AI
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M;MF9DFTDJY9CPYC<R0VB0U21YLER9D./35DQI56ZT6Z7S?.BJ2VTE(N1#@V
M8$R'TM&3SIHW@OB^!5\,JIQMC(P6+[H/6$U.V]O$A@T-Q?/U.^CW^F9P?QQ;
MH85LGCF!9+!S%S;67F.X-Y.2S&QZFM*P08[\"G*@'K%F1,?<\MT !*?7D \#
MUS 8M-Y@D<AE))FY78^#?%SM5-%&(2:R *B8&\U+M!;D[$LS.O<I3JTI)*U
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M$C,<8 2  /KZN[ #@#O*Y]/GINT?B\1Z*>D&H_E_)/S@8/\ \<L9_P">ZO\
M[5JC#\0\?16^T4:CO_)/S@8/_P <L9_Y[J_^U:,-1X^B?:*-1W_DL+;:7%?D
M.[F[F14KK4^AD-XG4LVD?]+739T"N4U($24.&9)9<[.^5R$J3QR3V$M>T 2)
M'$P,N YE[XQ4]1.1/Z .8=X@\!=MHD_93^ _JU5;5-INY?O*CHI31%@+?C9?
M'][<#M,8GJ?BS@8D^BN(A6B?3W5;,1/KK&&^E276I,66WYK:^H\(6\RH*8DR
M&G8(!@K'70"+:19_3GHM(]L=T[JMR1W97>4-4>ZE*T^U2SUA,>KW-JH'VKND
M#H0AFY6A32)./J6'TEP.13(*V$NZ]>$!4XM-^5AGH[ESE*TZ\,$NT<3V]X A
M\XF"MBCZGMQW/8C@C[B/A^&M!:!N>94-%":(FB)HBFZ!QRM704(5YR>WEL-
M<^TR)!*4-C@'E1(2.YX[=I9^]GR]R%<,<A!8B8!N22>[22M5,DR6Z\1N5JV/
MV@L'1B$9]N#NQN97K68L6L8(]MP^@LU#RK"WDJ'3)N8G2U"22AWJ*NV]1A@D
M$C,N7&3MZB+OQ6YL] Q7EQPYU<G%3. (+EK3Z;8!@F.[=XG1X7C5=$K:6BK4
M0XC,1L,IZBM)6?=/+BEE/6XI:E*<5PI1)'(V0( %LO-;NYT8BX+'@"]K\)GN
M++(>BR)HB:(FB)HB@K[*OP/]6B+SB^D#^CTV=\>NVCN+YY %;F-&Q(."YW!'
M39X_+=;6H,R&RHM3ZM3_ $+E193+Z.@*4P$.E*A>EBP+OW @97RX=LRN1\6^
M'T;9AD$$56!DM\SNW,%VU:(7A3]#?X$-X_!;X\M]J#>&E?8AXUMBA6(98AIY
M>.Y'06-X[USJFR?48S*VFHC;TR*E2/90L]:0A/:U/5,B.MREIDV'CWKSOP[X
M=B;'M)J-(%-(-0<@P#!!>S2_:5Z-;\^/3>/Q$;CW'AN\ K+,LT\Y=#N;XBGV
M6I.-8M)'Z.;48.7V)$.[R!H%U@RBV_%AR2EU2%!&JD@.T0SYGB>!>&DL)&7?
MJVDXKT8=1D$$C-[,0T?G9@3GWPK_ $:.V6STIW<#/%3-T=W<D=389/GV:/JO
M<BMI3RDN2XSEA8+?>@PFU]037UIAP0@="8_1[NHAB]\AI=Q ('+L<2JX7PXU
M8E.-B$M3536!!#TD$OFP=QF6.2]0*^JK:N*Q!KX4:)$C]+;,9EI*66T)  2E
M'!3PG@!([]/PXU27X-X^=NQ=H;K0/#M%^<+L@@!20$I">I/NA( '<<]N. .?
M@/XZE6506T$A72.1P00...#R/3CXZ(IB ?4 Z(H*2E7'4 >#R.1Z'_7]OQT1
M2K0"">_(2>.%$#L"1V! _;HCM.DJDZ$J'0L)4@]N%I2X.#QSSU=7K\>?720S
M:]W%5>FJ(+PS-X,-%K-OMX3-F=^<8M:'.<-I9K%@U(3)0]7M/1'W7&UI3)5%
M]UE$MOJZF9["6YS*P%L2&E@*U+VL,K>)OWK6Q]E&-170(WJ:A.I!M.O+M-O'
MF93^*WZ+2W3.PAW)-^_",S*6Y;[<6DIZ\S+;ZL>?\^;8X)>RQ(G3:Z''+KK=
M#)F2".CR&$M]N)WB(%F#B9<.[Y&<OHN,,/'V(D.^'I!C-C+2(8M&:V+\=6XF
M">,KZ+/Q!9=LI:-9[59!MU82JJO@13+MV;F"^W-<IK.J2#*9MH<MI+1KULI=
M;=;2HA2#QJQ(:&O((#\8S\^-VR;=_P#D?#=KIHG?V?$IH>X-5+R2;@FQ+3<+
MS@^B&^@^A8*O&O$IXMZ-$W-U&'>8/MA,6XIG&4CRGX-SE+:74&59N<AR-5/%
MQ,%*4^>E?/ @P'#AS ER!J7@>/.ZY/P3X&</=Q<</(JW#!=@02U4!\KGA8_5
MA'889+2&F4-AOI2CI''2E*0@(3_-0$I2 @$( '9(Y.J$DER7BS+VE%(H#4V-
M_#T"[+1631$T1-$0CGMHBII2&RRZIP<I".5=SST)/4>/D0 2"/>![I((!$55
M;H-0RE0:15U38D ]Z\T=\]OLGV)S:=OYME4KR#%<E7!B[KX3 4L.38C2%F-E
MM)'/F=5W4M'^RFXP0NUAH7'=1(DIBJ;[7P['&*10:FJ +$B&>J&B\-8@1$OJ
MXN#N@D909T[VNT7!U8'*^%9QBVXN/5^68=;1[BBLARP^UREYAY(_LB)9-$]<
M"TC. MO5;J/-;2%+=6VI(;/6&\[%@0[B> !#W#N'@9 &ZY=;"HB9.D6>9A7A
MJ5":(FB)HB@H*/ 0E2E%2>$I')4.H<@_)/'/4K^2GE7PU!+ G1%C;<S=+$MI
M\>=R;+K-+;9=+-740652;7(; *2F-2X]5I*I-K8R7U-M*">EE*%J<64MH4=4
M+U/2!)#3D\@U$,W  $DN&=6W06!D$][26!OVL'@KI/#1M/E&7Y>KQ [R0$PL
MGL:ERMP+"5OAV'M_B\AU<EB G@(1/N94917;6*P77A(7$8)JT=4GC[=CFAZ:
M2V51$C[KM!EPU[9K=V7#I>181>S%C+$M&6<+T'8;Z'!SW)*B225$%74I7O$D
M\$D?$#@)3QPE('*?>G+] ,@S-9=$, P_2_>\2J[4HN)Y*5MJ"DA0'"AR/10/
M90/J% ]PH<$'N"#HBL_+(BI.*9&Q&:6N2[26C$=#2>MU;KT*0RA+:>1U..%0
M03W4OGWNKT,B_OL6/$=HNQRM;NTT6)MH\^PM_;W$XSV44,9=91UE780IEI&C
M2(-A6PVH,F')CRW6'HSZ)##Q6A:%@\<)('&K"!'S.QM'?;(3F"RUZ30_7/5
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M;J7PVM*NI*BDI5R%)6 E*PM!3V4A:"% ^G'?XZH006([??HN_17370X9Y&?
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MVUFW6_FU?AOR.YE1-Q-W*ZYL,8:\DKK^*@)<,29-40TS+E-!U<=E2PM;;9<
M(4#JP =I?P, \+SF&A:.-MV'AXM&":A35B5"D2S.6#DDMH+N?&V/$SXUL$\+
MN3[38OF=!F-O-WJR08=ACE!!9DL+R13J$(A27%/H#86)4=23Z!/!)[$Z-9P0
M\Q+O8#3M+K'M?Q/"V&JFG&WB:CNTAKU.0SN+EA?-7-X9?%KMWXI*/+;; !>Q
M9FW^6V6#9E07T!R%9T>3U)"9E<ZHJ+,M/20\W(86MOI6D ]B  !9GT+Y$V,<
M?0K)LNWX>VTFO"=J9J&>K&3RTOHIMI_%SM/O3NSO9LQ@]W)D9IL1:U-7F;$E
MCR65_6D1YQB=5=7!FP!.C2Z]Z2SUM^?!= 4/-1U  3GV:"YU$6BZRC:\.JK=
M!#BX[P_(%G;O74Y-XP<2K-W<HV0P['LHW*SW!,:A95GE;B,6-.1B==<LR'JB
M-/<>>:\ZVG(9+D6J;6B0\DI3[O5RF&OPT#Y9Z- /Y(-JI-8H'6,.V3D"[Y/-
M]%86Z'CWVWVMVOV(W:M\0W$F8QX@,AQ+$,.8ATJ5VU?F&9(+F.8YDT!R6TY5
MV4]\2(KH<6M#+L;W_LGJ-D1FT',&1'OFF+M/1M526%75 :^39ZSF8)U6;X>^
MPF;R*V4.$YDQ;LX!#W".5RH<5O#V*Z=/DU8K)TY#_F"S:DQ7$>SH94LKY2EP
M*X.I:0!#D,3S+$G)K%LQJK4XM)%1JEJ:BQ!#$ &XR!MP+6E8%PGZ07;'<&TK
MEX?C>>WN%VF]/YBH^=U]3%>H6,W7D4;&F6;..Q)78UM,JUD>2S>R& Q*""E?
M2D@Z@@&9,P[&7^@(XN5@P=MPL4C<9B=U\@0W%\P_Y%;TY+:JQ_';2Z8K)=L[
M65DVS375R4N6$U<&,Y+1$A(6I*%RI"F_*CH<4E!=4D*(')T%\]"U^(6]5B-A
MUU@EJ:*B1F=T.P%B>%EK;X5/%AB?B^VH8W@V\I\BI,3F6]O30G,FC-1)TR9C
MMG(J;A4=EIY2/)C3(CK:BH@+(41VYU)IS%N,'C?3/BZU\':Z,0"H &D!CFY(
M&C3-KB_!6[@?C1Q+/O$?N-X9H6'YO69UM?20LBRR;90V&:*-3VO*:5Z+)#Y\
MY=JLI3'(^R5<+X*=!2[@N#RM''/1V'DJ5;;AC$% #D7$NP)O(9X;6-9QE2?2
M+X?D.4;R8O5[8[L3YFP^4UF([C)A4T)PU=O<,IEP6X3:97M%HE<-:'^B*A2R
MA0' .A ;B+^(B9D7'J%KX7Q'#KVBK#.\U-0IJ&0)JW2!+\HOG"O/=#QP8SMK
MOOA7AYF8/G]WGF?X[9Y3C"*:LBFJLJJCK_K"Z6N;*D(]G7 C_P!M84"HNA24
M\G@:!@^\'CW[N%;;?B&'@XN#AT&I\2JFD4AG:IW)):Q&3P- ZV0V>W*1NS@U
M1G,>COL;CVSU@W]29+!]CM8BH$Z16K*TCD*8=D1'7X[@/2Y&=:<3RE2>8/)N
M3SQ#RM_ J-=!))),@D\!5P@C/MY>:WTS4L(\,&+T:%K5,R???9^JA-I[K6ZC
M,($E:$ =R5-([CUX'(^^Q^6DSF+\YUOEP;BN9MSBO" SQJ1&0ZV6D/\ HO6?
M'6O*IZQ@**2Q @I(4>#U".A+B>/F>."#Q]W'H:EH;0/S[/?FNA@-N#D/KQ/F
MKD5ZH_'_ *QJ%D/ST\O53Z*Z:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:
M(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(N$I2%+/''"2?4_('G1#:[7[.*\8?
M'B\K;3QO?1^;V*3Y56_G61[/7LQ'NM1X.;Q4N5R'WN"D(?L4(0A"B"IQ0"3W
M U8F08,"#.6AGCVWE<#;#N;3LQ8MTE B&>L-YZOPT]D9;Q:KGY,:.N6XB,\X
MTRVI*77G$M*4AI"E>XE;B@$)*O=!(ZNW.JNTKN_/20,W\.X^B\!O%'X4/$GO
M95M;^T^-WM3XB<+W^H\YVYPJ99TJ*>-B./.MU,6O5?M*+L1BUQZ&@6D5(+;D
MIQTJ3^D43;YC+DODS-H'SNO/;7\/Q*]HPL8ES1CX=6Z0-W<HK%1+M<99ENU9
M%^D-\/&^_B?7X)[R@VLER%[8;FUVY6ZU(C)8$2761/9X<:THJJ>VIKS;5'DN
M/M.MEM"XZ @*0KWM6RI#, =XR)L'!=Y6'XY\,QOB9P3ATDC#QC74!5NDC>/5
M!((I+9RT1"O+PB[-^)SPS[2^)1:,-K9#F5YED^1>'O:AJTA3+S'6+I2O9(65
MY@^PTW;21)7]8.>8W*<C1@N.)*_A6<LCP+7ST'&+EUL?"-AQ=@V?$P<1Z34*
MA13O/N[U(I -3#>,0[ZD:X=Q3PG>(78CQC[!>(7;/&K_ #:ARS9]O;[Q*P+>
MUHZ9^(Q/L6+*CF16F&2;N\QJU1-D6<UXAZ16,^SM*"WE$@=V8,"QG77OC+C.
M7#V'$HQ-^E[-4#&\7+V$@$ @F\O8MF'$=CM\O#)XTO$IO=AVV\C>';;Q1Q\-
MO'A5Y!#I\CP+,<3@.5<BHLFK1MQEZB?8=\QB7$4I457)#2SP%'9[%PTY.QUG
M3\UDP]CKHQ:L2F=\SJ.L[""[ -8/<:J]/''X>MY=^/#WL\SAU!BK6ZFSN^VT
M^_:\(CRFX./VJ=O[&SL+##JV<MKH%D[6V)K6;!<9J*9S+3Z^AKGA?=8B8;26
M$3DV64NZR;5@55T@"6J!#EM039X_286P^UL+<O,-S<FW:R[ YVUT=_;2DP"B
MQF[L8%U:SYZ;:_RNSMYCD$ICPH4)Z0U"AL<]4M/"5K;/3J7(J!L20UB"UQ)U
M%G@066085=>%4:>J>CJ#'K$$T@@F!&]D+R O*7;_ ,"6]5+OEL)NOMK@U]X<
M\]_.7C^;>**LI,Y%YL?E^,$S9>4L8QC9;#/Y27MTW6N/.I8BKK)$AQ]DO*:!
MU5CX/]>V,IY+G[+\/KP:J*F8O+,V0!LX<B6X!X*^@+*G9S&*WZH<"1=36J&:
M8M=#<2T[82FX#Q3":=7[C;DQX)92M1"4EP$]AH\OQ?C?LGZKMUTO@8E# DX6
M( )&\:J" #F)(?.]X7D)]'OMOXI?#%X;=H=A;_9A3601]T\C?SG(7<CK95'3
MX-D.=S[J;:1FD(#CUN:2?T>QI 2J0WPI8)&K"HTP;OW"/?YEQS-CV+$PL(4.
M\[U1OE2XD0'$DW> RO\ V9V3WBH?I&_$YOK?[?R:K;#<[;C!L*Q:_5:Q)BY,
MW#)*IDA^3 ^U':E%2T-DE7 ">YXXU--4EA<2YL S$NQN)M?/*IV.NG:-]HK&
MZ1>Q<$1+[O"YR6)_#3X-MP$>+SQ1[T;HXKD6&T&<;TX-NUMA,A9()4>QC8E5
M,4,RIR"JCJ0RI%JXPF:VAU#G0TKI'<<ZB"7((#'B[EVR9YMP/%:.S_#<0;?7
MB%Z:3B=)0<GZ0]4P\BUFL757XP_#1NSNWXZ-A=UX&W=]D.TNW&WVX.)Y-9X]
ME$:BN7K7+:Q4:*NG!4V^AE@*XDD+Y7SQSP.-'-4@0TL18F2!J6.KA9OB6P8I
MVO9,1B117AU$0& -1?K6\W9FNO2WPX.;@*VSK8>X6(' YE+.?H:#'E6S=S-:
MQ.FB0:V@FW5BR F1<6<>.[,FIZ3TOK)4I2N3JIOY6XC*/;KN;,2,-K0Q#6@'
MLT+.P7G-])O)_+W>[P'[ LI+CV6>(&'GES$:]]3>-8-",YR8^T.26T3BP"L]
M@L)/W:DB*0Y,/R<COSS[ER]N)./@B!^]//-B6+R(%GL\+V.KPD,M(5[W0A"4
M+/VUJ::2%.*'S4>Y)^_@:BKA9ADV7LYW"ZF"7'8V67C[G)^W5ZH_'_K&H5S\
M]/+U4^BNFB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(
MFB)HB:(FB)HB:(H'T/X'1%0E:N""20001ZD@CN/F?PT45!P?TC/P7F!]*UMI
M<YEX4,FRG%F"]F&R]UC^\F+]"5*D&QP*R9NT(0I/*PM3$9\$(')1U#WN2#>H
MVL8%@QM'AS X%FY6U80J%-1#FBH5 D.TO!U< ]\9K9;;#Q#U6X'AAP[?VACS
M+VLO=NZC+7*VO'M$EQ^1#9:G1E>6EUQIR)-+ZYC:6U/-MMK(;ZD])DL:8&3O
MX7#2+V\UFHQB:15346 !+&V6=I!S9S%YL[&O%)D677N/TE3LSF#RK/$,FRF1
M8O2BQ45SM%93*J%7N29E5%6I-VY!=?C<,%Q+3K"A'6#YFJ@R&#>K%KEKL=7U
M-["JJH R7%S+.T<M1(S;2IR/Q46&*X;%R2SVKR,2Y,2AFR:J"ZY*1'>O:>PM
M!$,M-8I:IC"8"H2D>S-#VB3'0I;97SH&'S D\\^-FXN^O.V_B ,' CY1#>/#
MZY-U=_XN)=+/S>(=G\Z4Q@V,UV0LV[\-U%?=L6#E,1#IBW$4X_,KFK22J8TD
M%;OLCJ!P5<:.)827SMQM:3' %#55!J))NYN"[@<#'-B862<ZWNML3M:^%5[;
M9+DM9*VQRW<J?>UI\F)7*H4LS*_'9#;\<NKM+X292F&D'S4.(XZ.4GA$@#4M
M$"""\F<Y%XE2:JXZTNS@WX,6>_%IS5H8KXH9^47FUU2C;++(<;<*XS2LD7:T
MK-=CDC&G;!/^ZZE5C/$6P:KW'F7U&(GK\A2''RKNC,-,GF;<&^FCJ!77$F_?
MSB0!>/HJO<CQ)7& 3<WBIVMR:R;P^;C$1FWY<9JKM&90W[5A<1YJLGN=%=&:
M?9M'$H=$.Q5'@]*Q)T=K!NV1S[0XLW(RJ-9ER;L6<,1$-S!TLX=6W/\ %V]&
M-_!KMI\[L;N#B#&:U="Y"F1YLZNEX[MW/AQ)!56O1HC[MMF4VM2@/ONJ=QJ]
M+L=GJ*4PX&7'/AH;.;Z&4WZQ%)/80;AM)9I.>5PLP'?*&S6[)V4S'KNM1O)[
M.B$P_'=<<QZ;*QB9E,:OMDHC.%A^4F$[6+><9CI3-6T2M"N-26&0SAR^;:1:
M[$J=^N&WO&0&\\](;CB2T\6&15<+(;3\T.7)K**/LHCSW%+*)MCO']4R[!#;
M"8A66,)K;)HVS@!\B0B4RX$D "##0X_(&SOGKGHAKK.9M$N[S;. 0 SZK)>[
M6_$G:]Q03@&5YDA$:CF3',9BN33#8N+:-6O*0PW%492H<1Y=BZVCE:VV>"D$
MG4D 7#YWB?RMF^H*GI,2EV@,!>W:1X6Y2L<S/%^U6Q,CFV.W.6-1L<3MM+EM
M,1)STJ5$W$HI,Z)Y+8K4A$NFM&FX-I&'=HN)"E(/.HC3STD=A(\+J#B5P2;#
MD[B#':8:'&2ISXN)\)C/WI6S>>B5B&.X7<PH[$.4ZK*9^4T^/V!IZCF)T)>J
MW+GV22%<^2[#E!?2I*@))< -8ZDCEZ3]4%53FK[QER[O ?1I<JIG^*U46YSJ
MK_-3GCD3$,=B9%7Y _">8J<A@RE8_P!9AE,"0XP]7_E!S9-AEYU2*Y]0;44G
M4@BFPU OFQ'=:#/BHJ->(1O;U4B]W8=UXX,LHX%O"[EN?6V&+Q>37MU>(XYE
M3=\'YCU?9?E*]-#T&N6]#C(=16"(TN2M3O6VX\![.GUTN;-#@$WSTE[39^#"
M*:ZJ"V\V9DP,^Z[C.Q7FEM[*/B:^EFW#SEA)L,#\(^ 1=LZF<K]-">SK+2BR
MO50E]T!V+$##$E:25)<"DGC@\P9)9F Y1^I:+E:VZ,7:L,U#?%-08WU>;$ZZ
M6R=>WZ&FT]*DH2"$\ @#L"!R/U\=]575%(%@V7<N7@'C[O31&#OFFBE-$31$
MT1-$31$T10/H>_'W_+4$$@M!4$L'.2DX_P#>?O\ _'5-VO\ %XE5WQH?#U40
M.X]_G[N?7]^I%-0(<N.94BL$M/OM4^KJR:(FB)HB:(FB)HB:(FB)HB:(FB)H
MB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(N!2B$@I6
MA+?']L61Z_\ S<?AW[_CHBX%/H2.''VT@?R?,"7>.!_.7\OG\_GHCBSSHAD%
MP<MNMJ /=#2@ISC_ .59'X\=M%#@V(*KM%*:(FB)HB:(FB)HB>NB*GZ0D]TI
M[=^X[?C\-$5KY=CE9E.-7>.6<5B5!NJV; F,OH"VW8\R*]&=0M*N4J26GEIZ
M2""">=2'+#NT]SST6/%H%6'B0STF;2Q;R[KY+Q8^CARJ?X>-Z=Y_H_<_E)99
MQG(++<W8>3/ZD,Y!MME$MZ585,53Q2AR726+JV_8VTK2W%4.E/'<V!:+;H.<
M/]2[>+9-P]AQ2:CA5.X, C0R)G-VOQ9>W[<2*TVEMN.TVE+8; 0A*>$ DA((
M (2">0/0$G@#G5"77=HI I9@QGO]E%PX;@(<B1G 0@%*V4*2>CLCE*@4DH'9
M)(Y2.P(T3< U\/13*BQ7 &W(L=:.XZ%M)6GA1'(Z5 @I[#W2.!P.!VU+GS\;
MIN#CX>GDJP0H@2$>SM%"4] 24@IZ"E22D@\@I*5*!2>0>?34)N#C$Y>BE:KX
M++;;+41AMIH%+;:&DI0@*^T$I X'5Q[Q]5=^>>3R<ZIN"+QR]%.["B/H6V]'
M9=;<(*T.(2M"RD<)*DJ!22G^22/=(!'! .B;@(8DF&EK=RE,.(E2GDQF0]T!
M/FAM(<*4'K2@K ZBA*@%!'/2#W YT3<#-/AZ*D5&BK#*5Q8ZA'*3'"F4*\@I
M2I"5,\@^4I*%*2%(Z5!)(!X.B;@X^'HI#"A%I3*H<93*U*6MM325(4I:BHJ4
ME0()"CRGD'H[!'2  )<FY)[4Z.D6<=WHN5;+*RDJ9;)1QTDI[IZ04CC@_ '@
M?+X>@U";@U/AZ+B5"A+#J5PXJTO]/G!3*%!WH(+?F<@]?ED M]7/1_)XT3HZ
M>/AZ*<QHI !C,$!16.6Q]I1))Y]>>5'C^;VZ>.!P3HZ>/AZ*"XT9:5I5'8X6
ME:%?HT\%"T)0I)![="DH2"CCI(2.W(!U+F9O!4C#!(N2#'L!:@^,_P 1&/>%
MCP_Y[NS/91];5U.JHQ"FCI;39W6567F5V-TT)MLAQ]Q^R=:?*6DK\MCEQ2>D
M$ZM20 3][V WOLA<[;\7H*:JW#BW,NS9QFTD<RL*?1=>'F]V5V#AY%GO$K=;
M>2VF[H[D37%J7+5D.5/+LG8<AY:4K=;K8S[49H'LV0I X XU77C8OQS&=NSN
M38 :J!B&29G-\Y%Y?DTA>H'IJ%TTT1-$31$T1-$31$T12.$I22"!P0>_IQU#
MG]HY&B*D=>\M7*BOH< Z0I24@\ DE/JL]AR0D$\>H !.JUU;M)JT]64BG?.Z
MSN\=CZCS5.;&)W <0>#[WZ4!0Y/ ^UT #GCGE0]>/4C6#[13,@MQ&O,RWO7)
M]FJ'W>TTOY.? JJ9>2XM(3T\$'CU)/NGXA13\#Z^H]/AJ]&-360 Q)>W!_1K
MW5:L+=#L.YN$. 3>8\)59K,J)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)
MHB:(N%;G 5QW )Y/5T\$ >O(].3_ %ZI2*MXW9R )UR".+.'T>>Y<7FDCW2X
M?CVZ"/U'GDCY<]OCQJ*Q40=TU \"-#PU[5+@7 YN1/>RCYI'8ESM_>M_QUEI
MI.[2Y<L')%3DMFP98367+-?WFGG?>Y_@M?\ U:G=/L5?VIOG0>/JI#(5R>SI
M_P#E;_CK&:*W,U#L/JK])3^'S_N">T*^3O\ @M_QTZ.O6KN/JG24_A\_[E'V
M@_+]Z-2,.MA?^?\ )-^G7P*>T'Y?O1IT=?'^?\DWZ=? ^B>T'Y?O1IT=?'^?
M\DWZ=? ^BAYZ_P"__P %L_UJ&IZ,_BJ_J_M*C?&A\/5<R%$D#J)/KZ_#UXX'
M^O.C'CI[A*:G)NS?H/<GD%Q%Q8)'4?71756.X'X#1%'1$T14;\MF.VZX^XAE
MA@<R)#K@:;:'J25JX X[=^0/7TT18@F;FS;1TQL'KA;)'9S(K):H.-(X/)$5
MU2?-M5)^RIN D-D#M8))T]^_R=%T+M3?6SWFY!FMVM/?_<RC<700AZ\\,,J^
ML%<'D<\D<'GG4@!Y,"8SR[7>-+E5).EVN68\>';)AI77O;?8=R3*H&9SY[^U
M6"G)#H!^'47#_P!?X=]"&<,Q.9T;A?0S;1!ULXS UYF>39YHC;_$HX*X<!ZF
M4?\ ^+K9S];)^7'+3G4.3W!^/KWU! (SX&II$'Y<YAXSM='D=Q $.UWX#(3E
M*[5#6;T \ZES.5/9[<5V7(-G#/)[!-PLFW)//')5\._8C1B&>'_6-5((+ME=
M7)2[D!Z<Q29/%<QBX?6!$,A[SJB>2KLF%9_9>E *]^$Z0D)'4"HCC4/]? MX
M*5E?K4LC@E!X_1J"@MMP#N?3@$_CJ453HB:(FB)HB:(H$ ^H!_'1%QN--J0M
M)2"%(4D_#L4D<<_A\=%!#@C(@CZ?5>//TEGAWS*2W@GBUV&:<B[X>'ZP&05K
M,1*FEY/C(=0YD&*35,@+?3:0F7H[*'"I =>"N.XU)+E_?OW"Y6/LAPJ^DPP*
M3!+"+YF7@"]X+LMW?";XG,,\5NSF+[IXG(##UA'3 R;'GU);M<6RJ 0S<T5K
M%4?-8>CRTN);4XE'FM)"D I()$.'':!]8@9Q&5G"WL#'IW0*F-1#-5E#"YB2
M.W1;4I;1\0DG[N/_ -=0L[C4=ZF\M _DC12I]$31$T1".00?0]CHBD\M'\T:
M(GEH_FC1$\M'\T:(GEH_FC1%*M"$I40D<@=M"BZJPDM1(4N6ZXEEJ-&>?==6
MM+2&DM(4M;BG%%*4(0 5*4H@!())TI=P\SX#7ZY*F)5NT55.Q +92T-VKP.?
ML)/TFGC/@&K<D3O"AX3LBZ(]BX@N4&Y^\L#E,^T@E7+,RHQMHHC1NH.M+DH=
M4VL]CJQ8G0.9EAGWG0,N%CT5[7C4@G>II9R9<YFQ!?(::.P]\:N%'A1XS$1"
M6F8S+,9M"4A"?+0D ]( '8]()([']FE1<Q8"/KXKM8-%-% %-(#1 9V [Y7=
M:JLR:(FB)HB:(I5\E)"3P?@>>.._SU!#AA" M)L-53/%2622YQ\2OJ*>E((Z
MCU#GN$\\>O)'WZJ":7-1AQ<Q?P[.4*I>LMAP= 23;(M.9.BQKG.Z.,8#':<N
MYTEV?,*6ZBCK679UY;+*A[L:NC K(X)4MYWRFFV4....H2VM2=?%VW!P@22!
M4\4P"9REP&.;9+>V?8<;&BD$AYKG=!#P*B).3!@[E87L,UWAS(J5%?A[64BR
M%,(3&:O,PDQSQTKDF:335@<(^S'2\ZWR0)REA*%<G:?B&)72V%B&@D.]) -@
MT/SS?GGV=E^%4TU/BTC$8LQ(9QO."&!) L&,BUR+9D;;P;)!7E%]F&7..GEU
M>0Y':SHZCR%?V/!8=361$ ]PCIZ4@$( 6$ZX9VCX@<3K[5CU88?>I.(=V &)
M  !ZQ< F[-8+LU;'L5% -&S8--8+@C#H%1EFWCU@>  !>;KKQLUM<I05^1U0
MDI(*UE,I+SA/;JZT/!?4#WZAZ\'X$\91CXA '25 VDDE]7?/M[EAZ#!<GHZ
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MR*MQY.,V%'.R2>]96\*/?5QD/UDFQ?4IRP6RX@E@NJ*FT*"5*)'?C;5A"B6
M.]52=VG\.? :D7;)=C"D S8'O&??YK:CL>#Q\!]H 'T^(^!Y]?OUSZBPXF/S
M695 ]!^ U9%'1%U$VSC5\5^9.DHB1(H*I+[J@D-)'?U/P]/7OZ_?HBP+*ES]
MQ7O:;$RHF#%#JJVC"E,R\D*5=[6\2GA1A-<=*:%W@/IX60>VH+RWOZ')LGN5
M!;/+/O'OFKG;0VRV&64(;9  2TA"4-I2!P EL (0./@D :E2ITDI'"3Q]_J?
M\(\J_?I[[[J&!G3W^FBE  ''P^7KZ_CHI4?CS\?F>_''RY]-$402GT/[>_\
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M?VBILX:U>TP;2$0I$J');;6TXDIZ?34L*F9@2 89N69>>UET,'&IQ ""X/\
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MMX*6IQ2RHD\@Z&!SS>XXY9W!X:K:V7"  )N0#9])!+\?SSVA2E!"?=2.C[/
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MMU^3_P )WA@)/<\JOB?G\<XU!^.?#L\2D?[J!_\ VL@^!?%!_P FMAJ*V_\
MHI#^=?D_\)OA=]3ZJO\ G]?^_C5A\<^&L/W@MKA_^Q3^POB9_P"5B]E-3=G5
M4W&ZW])/A@_Y6]'[CF_(_7I^W/AO\0?^+_V*/V)\3_@8A_VXO]BR3MYLHB-,
MR#<#)\AH[?<3)HC,*NRW%ZQF'7XM518QB5D>@1:2K=QSH*BXZ_-?L$2GR$NM
M!LI1K1VKX@,4-0:0"=X,7!=IN1D &T=;%&P=%\P.\  7O%P'I#<<]%F>JN;K
M'D,U>6//3HM=5LR)>=35U=;%FRBZ651YL"&AE$&4EM(=Z6&41W2KJ2AL<)&E
M@X6)BN6))<AK\0Q&5_86QTM-#@D!A \=1=LWS9EDYJ2V^RF1&7YS2D)4@I/*
M5)4.0M)![@I(5^!Y';61B(-Q!YHNMM;:/2ULZXG.EJ)7Q)<^2I9]UMEA'4/7
MMQP#^'?MSQHBP=A$28W1(LK,!-WD[\G)+E*?5E^X)FL1DJ'/>)';1#;23RAE
M7EI[<  9N3FPR$R+Z3=^ 53V6N>8N(?@<NV;FT5DT1-$31$T11\AWYG]H_\
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M6TVIM"7A)PJ; :'[N\&RNQO)9B6C2_[=V A][#%76# T&DBJU7^:X$ B0:9
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MIJGE5ZFD%_RO-\A#BDI4HA*U#WC!V<N::6 !+ 4L!38 $ @!K 1PNJCXG@5
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M+0N;R&0./*1QSSQTCCGCCG\>.VH5ZB:OF.]_U3YJ8-M@$!">#\.D?AHH  L
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MM-GU0D\D*]!]H<<'\1P._P!PT65R+$B&[#<<BH]">PZ1V/([>A!Y!_;HH42
MH$$ @C@@]P0?4$:(0#!#C0KA4TPVGJZ$(#:5<*">GH!]2.D<COW)&B@  ,!&
MF5F\EK;X@/"MX?\ Q,8M(QK>_:W#L[@.LO-,2K6OC.6-=YZ2/:(%J$-6%=)2
M"/+DQ93+K:@.EP=^9<EG),YG\QYCFM+:?AVQ;2=_%V39\3$I'4KKPJ*JZ?\
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MMW>0*TL\3N,'-\UI<,]K-:C,-A?$#AZ;%+*)*6I&2V^R]4Z%QW.RS&JG["8
M.X#:U  <G7#^)B3E!(.IW3PXN'U:Z[7PW!JQ6 S=ASKI .K.2!_N8W6N]UX6
M9V1W,S(+W<B[EV<C\DA7UXKPQ35M9B-M&E.18M2VH1%N7U9%;@6 * 9K$AQI
MY*DKZ3QL&D[[9DFT%G!CS#RNGC_",3%IWA($."6#DB^X;.02\%S9U;U9X+6X
MUC4OS=T<PLY<2'!JILJ2TY!G7HKXBFF7[N8VX')T6&Y8SIU7$>4M$1^%6%E
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MDY&J6NO:5N16O.74LH8CJJ+8*<46D"VDW+B1($G4L8XO$0',E:=>-ND@TM5
MN&8M!).G6<%PPLQ6,[SQM[#YA%R+=3#]JK6?N3MQX>\XW>V\R7*,4QV6^=OU
MM9E%SFSJ["-?(#V.T^0;7C&\Q@45_'E.S30V<=ESZPBK5!RY>#GP@]Q67[7L
M#"*?EJJ$8<TC>-1'6FD-6"79W,,5'+/I'<0Q_+\+F"KZ-IJ.MWB8WHN',9C+
MN7<LP79+;W=HM8% :R-;JJ5QK,:V$1;B0U=-*4EOS(U9]=@Y#S!?(7;\P[-P
MLH.V_#_Q8?"<.S!PV^[$,'+3#&2,QS_'K@=5D;U!+VBWA:MXV!7NX=RAK&*.
M',KL:QK+!B<R>Y4V>45-C*$^8*NQ@+2ZL+K\@J'4<ID2U)/9YR:V@OE8=TQ>
MM6W4819R#!N"0[9.'#5$SP (6SNRF\^([\[>U>Y>#^>K'K>PNJAA-HPY!GPI
ME/.^JGH\B,\$JAVGGH6I=#;)<LDD]1>Y2288QPX03F)\ _?GV=BVNG%I!<ES
M<F' J<&2TZ<K@++(]1\.X[_+175N9S(:B89E4E]SI:CTMT2LD@*+\9MM 41W
M[E8'8\\^FAIW27-S9WTSXOVV#,JTD5 "P@'EFTK"V\W@=\-OBWVHQ#%]^-L*
M/+9-9BM/!J\@5&=AY%C[IJVDN+IK\I%E$5U'C]&\$*5P'.H$#5@; AY'.+ /
M'ZE:7Q'X7L>T@T544D"*3U' $N.J1R$YL 2O'G;G_8[NU^TWBHP7<ZFR6KW-
M\/D5ZW=RS:+=6IC7,LJ54S8E:J!/1'+=FU$FNQGD(GM+2VIE"N2H=C@$9ZY
MWR]CA=>;H_PAL72TXAIWJ14*B*J: [%P'&&2) FDCLAO=K!?"%X8ML5MO8'L
M/M/B4H )#U1AN.PGN.P[+CU[:N?3@\@GCXZ@D3 GGZPO18?PW8L.>APWUW:#
M.0<C]'-UL-#JJVN;#,&M@1&4\!+4>*RPA(^24-(0E('/P' 'PTWJM3V1IIR6
MW3A8-,"FCNI[!Q78@)[ -H[#@ )^'W<?AJ%DW:=![^G"RBEE(XX2D#GJ(XX/
M/Q/IV.BLN?1$T1-$31$]?71%#@<$>@X/W:)9<7E-=75VZCZGW>3^[14WQH?#
MU4>AL!7''<'D=O>[>AX'?GT/W'1!6"0)GEZJ3A/''0C@?=^OYZ*ZB.GCHZ$]
M)[$<=N#V/;[QZZ(N4)2D )2 !Z  =M$4VB)HB:(H$ @@CD'L0=$7&M">E7"1
MR1QSQ^'&B& 3HJ0H"2H]([D%1X^T>WJ?C\M%7JU:.>3Y_KXJ1332PI*F6E!?
M=04D*"C_ 'P5R#^L'U.IWJM3WE0,+#):H.#=V['C58XS+9W:S<& _69GMYAN
M30I"%MO1[K&JBT:<0X.' IN9$=2KK3R"".#R='U //W[,YE8<;8-DQ8JPL.I
M\S306<ZFDQ9QIV+Q_P#'_P#0S[*>)#;['\6V#V[V>V+S![,8,^_SVHPVMB7,
M?&$,K1/:APZ>+%<F2'UAI!CNO>0>0XYU)0H&7$=5C))!([KLT'\EPMN_P[LN
M-15T5%&'B56-+"0TCJ5-J](\65Q^#KZ#SP<^%V13Y39XX-YMPZ];+YR_<%42
MRBP;)CA0>I,;;C)IJLMNCJ9<:8]K:(!4\5 ZOB54[C%WN0S:1>>1/('.?AWP
M"C8\2FL[V)5<[P  9[ 4$D->6<$L+K=%H)A[Y[P5Q2&_,CX7;1D) 2E,1['8
M=(PVE/  ;0JE=2@)[#C@<<<:\9MX_>UD:R__ $Q;1H?/O7U'X90:-G!@!BPO
M8D\&NS9,RO[CN#Z%*DJ21ZI4DA22#\"" 1^&N:MYCB.[:$&WU4>X;4$]+?2A
M2FW2/=8=2%J:DE)0XE8C.D/ELMJ#O06R/?Y&;#J)Q:2!F6'8>3S)S6GMFR5U
M;-B=$#TC4[A#WWZ7;=I.3RQXPO.[8[PD7&Q&]4W<"SW=H+J-FMA?6F34&0,*
MJ9M]G%_)?3!RVN?%ZEAC(K2+*]CR.G=J'X/GN/*AK8GRS(;W:F?P$-<."Y@3
MPLZX(V'XB7W3B%R3)Q2+Q]VS%N=C=45%X VX>'9@N1FD6-N;D>^.3;D8_N!7
M4T]AJ'BF:;T0][LCVOD5ZL@L)<FDRN=$9I\OAPG:MG(*U+\5YM\'R5RT0"[A
MB #<P,GDB1 $2)45;!\1J!I)JF7-6+ @DEZ#HY)$-?2RG/ #G-?<0K7\^T&3
M;OIV4:JI%Y06#EE!E[7^(G*/$4QCE,Y,R-DJJ_JC)9FW=/CGGB=58TP6#_N;
M$=8U4 V(OSAQ-C=F<-(NP5/V5\18D;Y#;U\2*9!+]'(@SXZ=Q)\ &9*K<18J
M]\[.IR&B1O5!R'<."FZ?SK(&=RL W)PBDNU.R\GL!7Y53OYC$RYVR1&4Y9SL
M;IV'GF%>5(9D%B3SF)))FX:UHC.SUQ/A7Q*BAQOEL_WKLXIEL,:G/6]QWNWO
MA,G4^YFUV18_O\J8_L[*;=S+"JRYD9%!??O/K>QR(R\<D7MS&Q5F;D#U-8UD
MM+4!U28=C5Q4JAR7P<6)3#@0'!(G2>0,#@7U?=V+9_B&'52*S6YLYQ')W:HI
M>F\$L'@%K%>CQZD\$M^2I;DH%+@Z"XEQU"VEM-HY2V PA*>D#@-)Z4CC6G42
MYRL&,Y#F!867IA5M&'@U=+- (WB=XSO, 26%\G@B ]H]P"$D^A"PD]BGU/I_
M)X^US\#J 3/'.]O6Q=;6!M-)H!OF(#N#5H6?3P5CT$E(\0T);+,B8NDVBOC)
M:BNJ0A7U_F&/*CK>4@GGRTX[)4E!'*@GH23R==+X5&V80F:<0PX^[4SC/GHV
M0GA_&,:G$V;$  !WJ'ME73+@GSGL=;3&HK9[2FFI\SI3/9GK$>WD-.>:V \(
MSZ6G IF.VI 4XPH=#J.4*2H$@^M7E%13<&J+./;MR)=R1>):1(,;(K2/Y8;(
M5U5BH\E"X)! ZS'\HJ'97()T5:FW2_N58V;8!0#'<LN!89 F3^1%M1(2,DNF
MX+4:-6R 'Q%7*5'^L0GGS)I:#[A[EPJU/T'GEXL0.Y82V4^[VBSCL#NKFV;8
M;C[6[=QVBM4=G"\<8:\Q1>6M+=/#_2//+Y6M:_BI1[GUY)T/Z=Y]RLE'8/.1
M9P6RM.>BR).KJZP;:$V#$F".ZEYE,J.V^&W1Z.(#B5=*AVX4.X^>H5S2#?O5
MGY#24%723["/CL!Y4-N1-3$B5\0/RGDMJ4IED>6E)?E*2EML%2>MXM E2NE)
MO20X]0!G>-"=7*T\6CJD 2X/%S^O+M9>7.Y.Z\_)654TS"MNK"%!Q9C*ZJ0[
M6V*H(O4K9<5CEHU%O*.XQ^1*:?>@M"3'M(5E(6X@3(A*X2ZDN9:^7C/Z\(6A
M514&<"]F((;(L!S.O,J^,>\5"V(LB5,PC&&J[&]PJBK>K:RIEP[3%=O)-77H
M>OIZ%6,U=;:Q+RSB,O'V7V5JI$I4J/#*/.U),$$"[,(;D9N;CNA7%6X-ZH.'
M+0VEA+%Q)<OD;+(C/B"8L**YRC'\*J'XU7MYE%Y5,V#$5'U98XG:RZZ.S-F1
M(ZVU5UPM:9$ 04J:;(D(:DR$\A$W>':GA!%SRSB_@+=,[G=@4DN088C.T^[1
M7[>^(>IR#(L8PE_;JQ=NK-I4"7:O5U;75D=,:3(;EMN%Z%Y,:2W+:$U%6T.I
M5=.KIS:BN8X$U>+39QF#E&AEK7)"S;/6,3$8M\I/_P!;/8R'&3CB5NK%QO'2
ME+2:.G\M+9:4!"C.!26RR4A*T,I;*$>6V.GCW2V@) "0-0Y]^_<:+>Z.F[,=
M8?R_/5UW[42+#:2U$C,1FD]DML-(90!W/ 0VE*1W)/8>I)]2=%6JD 1KPX\'
M6OOBI_\ ,3F?_P#.X3__ +_BVBHM@H'_ )%%_P#N&_\ \HT6:FW=_P#6E85W
MEQC!KR%!L,MM;''+2H<F(QG(J&9,B9%$59)B"TAU:*Z//G34SD08@EP15SHT
MA,6.'FW A*1K8^S4XP)-(J:;/+,3\I%GY]S;6!M5> >I751 !-)8_,2 ""&8
MDN7#.ZP$,9PGI[[V[]DK6EYP+QJ[847P4J\Q;(VR8#;H6E)Z?*:+:DA(;1T!
M*>?5\/H!)!JH!'W0T_R,\> B%T\/XKM( ?$%99AO5U$BEFRQ0T%B)$G53'&,
M$( .]F_?(6ET?[WKO@.I\LI6.=N/M)+;?2KU'EHXXZ1Q'[!%8%1Q*^L-Z2'&
M],_NG!GFM8_'ZJ:Z@102*R"]&(7(JF>D8AQ>QO(9#CF#@J5^>K?OJ6 E:ABV
M4*4L#C@*4G;@I4!P.X]WL.GMQJ?^'<]^J0W^9A^/5OQNMJC_ !&P .SX!87-
M-3$ZCKB\F^97$<9P/W =ZM_N&@4M@8Y>@-@J*B$)5MMU(!42K@^]R>3[W.I_
MX=H_'B.S?YE,9L/W4!\@L1_Q'5O5$8>%2Y)( KC(#_-E@P' )^36"=_^&K?_
M -[GJ_WNWG?D 'G_ (-N_( !Y]0 /AI_P[0[[^(X_P#VT_\ J4?\25_AP^ZO
M*W_-3\FL$)2H[U[_ /*5%:3^3MYRE9 !4#^;;D*( !([D =^PT_X>I_B8G_<
MI_\ 4A_Q'67!HPB]W%?_ +$&-8($E(WKW_"2GI*1CMWP4COT\?FVXZ?N]-/^
M':/QXG_<I_\ 4G_$F(?NX?=7_P"V%%..8$D$)WMW]'/KQC]\.?B?3;;Y]^/3
MG4_\/#(XO\]'_J63]OXA8G!V<N+G#K<\_P!Y=1&.X&"2-[=_@2H*)_)^_P"2
MH=PK_P V_J"20?4<GCUT_P"'>.+_ #T?^I3^W\3^#L__ &Z]&_B:1R6>=J:+
M \;I[:WQN]>NA8O*F9#DE_.ER+Q^0RWT,,6GU@AN0PB'&0I+#3R&6XZ.4-,M
M)'2.CA[/@X( HPL.DT@ U"BD$[L.2 .;PN5B[1C8Y?$Q:ZPY-(JJ)%(,L 20
M&R:P89*Y49!.RA]V)BZ5QZ>96H=@9[#D5TN$Z\'5!R-7U\E+@6^DI(6IY/EJ
M/![C698&&0;6&].]7Q7T<* IZ2EJ.[:2FFT39Y88;ERU-I "I#C8!4>>5=/5
MT)YX0 GC37B7/-2K'W=Q][)MM\UI(P*)<V@EM0 W[JA*C*3*B.M\<$.Q9+;;
M["TD*:>0AQ!2L).B*P\ R&+E&$XW?QDKZ;&G2_(;>Y4]$F-MH,R _P!7O"2Q
M*+T=H*[I2TE(X U+,'@@N)>"X\<]&C@JN[ .]X:VN8(_4*Z?W?CZ_KU"LK>N
M<1Q;(I]):7V.4ES98U-%ECL^SK(<Z91V 9<CB=4R)#+CM?+##KK/M$5;3OEN
M+1U=*U G]L%CZ'")?HZ7N[#-0?VYV_DN9&](PO#WW<PD5DO*W':"L<7DDJF#
M8J)-VI3!59OU@9:$!V87G(@:;\E2.A/&9G_#EE$6SXK7.#A%_P!W0Q+GJTRP
M8/&D?JJ65@FW\Z#]5S,)Q:56_4C^->P/T=:[$_)V2['?D47LZXA:^J7WHD5U
MZOZ?97'([*UM%3:2*;U/X!X>B?8-E_@8$@#_ ":+ N!:P,CC*ZL;4[3B0Q*&
MVN#B3&93&CO_ ),T_FL1T42<70RTLPNIMI.-H10A"2$BH0FOX]E2&@WA^$>'
MHJ_L_9/_ (^SO'_)HR##+(0-!9=LG:[;5#YDHP/"4R%8RG"U/IQRI#QQ!!4I
M&,%P1NLT*5+6I-43[$"HD,\G5]UOP]W_ /U^B'9MGJFK PB69SATDM:[/9=Q
M44]3006:RCK(%/71S)+$&LB,0HC)FR#+EEN/'0VT@R91,E\I2"Z^2ZOE9ZM8
M5M486%AAL/#HH&E%(I'<&79<<]N>.>W/RY^.BR+%V[[Q<Q-C%F%J%GG%[CV*
MP&03U+;<FL*N'T $'E%%%EV+I'!/05J*B.TV&9?@,I/'2V953?*)>S6$NX)9
M\LLEM%!C-QHT9DMHYC1FQ]@?R$A"/PZ$#I2/@GW1VU"D@&\\Y7:^6CM[B>P(
M'NCL">2/3T)[_CHI$6B_BG2D^J4G]0_AJ7(L2%##0=P4>!\A^P:A&&@[@G '
MH /U:*5'1$T1-$31$T1-$31%#@?(?L&BAAH.X)P/D/V#1&&@[@G ^0_8-%*<
M#Y#]@T11T1-$31$T1-$31%#I3_-'[!HH8:#N4.A'\U/^"/X:*4*$'U0GX'[(
M^!Y'P^>B*0M-A!2&T >O 2..2>2>./UDZK6^[4T%D4BF^W9([\'L.#R"">>!
M\3WTI+@/X\/?>I!8OG/BM'MSNG$_$?BU@\\MNNW.PJ9C064$LF_Q&4Y:U#:W
M>./.EP+6VX4H]2FX*4@@(X'E/BN'6-IW@^Y#L6I;= D-N$.-207O=>H^&XPJ
MPZ:2SF"-)),6%O4-;(A2V.>5$J^'3R4\_?\ #^/';UUSS2 +SV#PN><\6 75
M GY2,OUF>?'@Z(ZR2E"2MQ2'$,HZPVDOK;4ECK47&@EL/*07"%I5T!73RKA)
MG!(&)23Q_P#J6S&?%354129MW7F)\EY_^)/PZ;J;F[P8?N+M;=P\=ET$#;ZH
M*K>U@VV'9'B%+N*<FR"ERO;BYQ6S>@RH0,B1AV6XY:P[6OOT54Q;RH3,AMS>
M)EV$]K=DCOTM,<O:?M%0;"Q<7#.6Y74#)!8L#<. -58M)L9XVY VI&=^('(0
MB5D-@=\+G%,FK\>6BJA;<3J*:[M]%MJ-Y+U?)S9=%EM11S$(C0*]5I'@MM27
M.H3OC,&8SD"[NTL[:N."XU&S_%:<2BL[7M>[23552,;& ZPJEMTWJ)JENL#5
MD5)?^';QA,0<+=@;L5N4Y1MWNYN?88EEN372[9F-ML[A^[55MYD%]7VN/38C
M^<5MGGV+5.2JKF$!ZAQ"T*'VTK2XVWQ#/!@&^AN6S8:7<"#M-\2D?:]J8ZXV
M*S& ,LV=XF#D._I=E?&TU:8,)V_%G7U,+":MZ]C2+*OR">SNBW+I7[2#9MVF
M%LQ[_;7(ZZ-85E?[>I"ZMQEY;4=I^8]5U&/$KZA(+$,!5P!9N$0TO8ZJM6%\
M2Q*=P;7M1).\W38K&H5;SD&G.22USS5X>$K97>;;C.=WLWWFF0+^[W4P+P[L
MVM]&R2QR27=YGMMB.38WFMU+$BNCQJFNLK.X$ZCJVW&VHU9:QH<=!;@I0-8U
MXA!)JJ-+V)Y :@L+>;,^WL>S[7@U UXV,3U@#57B$A]ZJIC52/F+$ZD/DM[>
MHD<'T 'Z^!TI^/?I!X ^ [>FJX;&L;TAL[0&#Y<.:[->)55@58=9-1($$DF*
M@9!.H!MDZ))3U=/ 4I"D]7/'3U)*>2?D >3SV[=^VL=8ZX <<K6$D#2<KJ*1
M2*) ;/+,Z?J]BK.\.C*\IW1WDSYI:ETT.QH]O,?<)*D/1<7AFRN7FR>0"NZN
M78K_ $\=4B&\7/T@/'H?A>$1B"LTB*:NLTR*@SLQXL?!>?\ BF)1N;@9W%FO
M!ECH["^HB-I+&A<ZC-I)"*2>[/;D6+\6/&#EDRDA"F9GF(*7"XT2TAYQ*EL%
M7F-%*T)UWCPO[]AX7"745F:MR'V(&0P48M9SK"=!J*NWL89>O406RM4BM3'(
M2^VX$]:DO +0G[()/&I]^_;*'%BVOB6R;+ST==MF41R5B621H_2W)E45M'CH
M*0\6WWH#Z$MD#LI()2 CYD< D#4AS[R]Y!4K8"P'&!I?7Z%E9FR=K#N-M<&D
MPY)=0SC%77/J*NEU$ZKC-U\^+)9)Y9>8E17DA"@%!"4DCA0T>.1^FN3Z/.@:
M<>$3O#7=(+D'/,9GL<9DY7=GEQ/QW&+.XJ6XDR?"9\YF+.GKA1)!3SRRN0U$
MF/)*@/=2RR'5*X"'&^YU CLU<OESS5L:LTTN+R6=N\B0+B,UJ36[N[UW$2+N
M,JDQYO:V!C.5Y%-@1K1J5-G_ %16N/,0)5BI+DIE;,B))/\ 8U.AY!4CVIWG
M@:M-V#9,UA=\VR+]IE<^G$QM_>K+X9I)9[69R2"X8G-IX%61 \7\!JO;14[(
M7K;$N!,LXZV8]BQ5R$^VP6X;4.7"Q>490L7);CPE*8(0EI;IY'.@J:P R+O-
M[M>^G+16.-0!:_)Q9K&VI<OQ=7O@.^N;9#>6U+D>T570R4L9=/;LXMG83(1K
M\;M[2)[),>FXC$)FMQVJR;''446*YSKC*#Y*AJ09S>7\3>Y(@A\\]+C%I)(
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M.Q#:3Q6P9BECRDK4*V'YZM^@&1Y,A9_R:,FF7B3EJMC8'(B,H((+:0T>?FV
MD_M()T66FUOST(X-9Y6%\[2EW='"FW$AQMO",\G);6 I")</)=L8L64E*N0'
MX\>SL&670/,;1-E(00E]P*H,84U&DM!D9@.SB>;QIE*RC -=!J%W(^NF3->
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MP0[@QE9F>+19K%M%L7#@PJZ)'@0(D>'"B,HC18D9E#$>.PV E#++"$A#3:
M$MI 2 ..-$7;I0@ $)2#P.X2 ?3Y\:(BVFW/MH0OLH>\D'LL<*'<>BAV5\QZ
MZ(M*<56O;;<[*MJ[)18ILGFS<WP69)44PE)D/@Y30Q^5!M,V).?$NG8;X+,>
M> RE(C$:B6R?S@6MG$Y/8EQ#3?WVO].T6SC^'/']]Z_KY[\_/GXZE2FB*' ^
M0_8-$3@?(?L&B)P/D/V#1$X'R'[!HBCHB'C@\D <=RKT ^)/W#X_=HBPKB+B
MMU-['+AA2W\*VG;D5-8X.5Q;;/)\!<*ZMH3_ "6G(U72RFZR*\V2IIQRQ80M
M*7'$F/?9'=E'#NCS]+>?85N@4I//*1W'2>WJ/E^&I4J;1$T1-$31$T1-$31$
MT1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$4JSPA1^[4$."-47 XLI;Y
M)/8]_CVY3Z_,>O[_ ):D-R' ?HL=1(J!EFUSD<1X+6;Q/X!=9EMX+7$D!O-<
M%GL9;A[B'"TVY9UBDK]B6MLA;3-K",NHD+1QQ%GR$J]Q2DJYOQ' H^RXM1$T
MT@@L"9KILP.KN_&876^%XI^T44;S"LF^?5J>;7X$Z%6%MQG-7N3A]/F%.DH1
M/C>795CZO)FTUO')9N:^=&X!8?JK!I<(M$(\UQUXH!:CMD>4+ &9.0&7$@C2
MQ$N7 *]2*CO 9,SVD%@&(+O.88 /)B]P>._ /'ISZ<_#5:2 026;/2%>NG>I
M-+L^?:IDD!'EG^U]/3T#[/'2I'''IQT+6GCTZ5$<<'6;I09WG[V[F;\UCI%-
M#@TO9BPGM+<'4?,5U/%145O<^:H@DN=?'7UD_:ZP!SSZ\#0XU[#DX)O=Q&>>
MJR#$PB-P4T EMUA2+28!TX%N"B'% MD=BTI"VR.>6U-N%YM2._NE#I+B2."%
MDJ]3JG3M8_UH:**@0::2"&((!<>R5(DAL("$I0&T*;0$@CH;7[/U(3QZ)5[+
M&Y2.WZ!K^8GATIJ&[)?(5/SABI!HPCTAII#7+#0TC3\6J@>DE:N/4LE2E#@D
ML-N,L$GL"6FWG6VR>>A#JTIX"U<TFQ?*.5NX6458V'67%-+L0" '8D$A]XW(
MEM."BE)4I*1_*6E/X!2@DG]0)/ZOAZZFDL1QA8V-1=K]RQ;O-N =OL,L)58W
M[;E^1+.*[?T;: N3:Y7;N(K*EPLI'6N%"FRV)MDL I1 CR5KX0E7&7"I%>("
MSW !DP'XG*S39,8FC#+$ !G-H!#LYSF<GUE;#; ;=C;';G'L7><5*LTLR+.]
MGJY"[&_N'EVMY.?5P2^])M)DB0'75*<+;Z6R3Y X]ALN#3AX0(#1H'DF-=>>
M=PWC-JQC7BD/!)\!D7L'81;3/./0GDJZ4\GL3P.>QY]?Q[ZV5@5LY+C]';PV
M3:08+IAR$/Q)<B-%=>KG^H],N$Y)C21'E-J(6RZ@-K2X$E+J" =$6)HMIE6W
M::VJNG;+.<41'N9][G]M90&;S&&F67)L)&04\2FB+L8BF&UQ6YK"UV!4&PN!
M( +V@X]X]/J\Z!8ZW:W#07S+'N G5F6L:+"MR>1.R[8O&/$"UBF0R7)IOMM+
MW":##\IFJ),VRIL9S7*(C[$A<A)^L)ZZ&F=FK3U<O\=[278%G.K=MRXO)-^;
MZKL14'$-D)X,&\,[.Q'%9T&XEO&?J;>@\7=K$EM)#\.?E'AY,5]!4%!"X<G)
MW$.E*@%)*VCPI((*3W!H9F+O):#SN/;A2YJNYBQ(\FL7#0TERRIW<3SIZH<Q
MU_%?%O\ 4SD5ROD4SE[X=W(<B(\VMIV((B,C0RZTXVI:%,N=,=;:EI6.#W=A
MG_5=N0EN#\++'7A/2Q%64..QNJP':<GR*E@8WG-37U];6X[XM8%;#93#@PHE
MOX<F8<:-''0S$CL(RI*6?(20D-Q$^6D>O';0E\FM+BS$#0<SE(@0L?05,SUP
MX WA'+J-:P&6158C&MQ&9;L]C&_%PU.?90P[,&0; B:\PT26V5NKR4I6RV5J
M*4$\)*CT]B>0)!>9 :W#46_+FG05.9K!9OF:W.CC*Y32[I)Y<31^, J2A1Z4
MY#X>TJ< 2KAOS4Y,A3()/5YG4 C@_/4[SW?6XT,6%^+Z,GV>H?>K_G'TH_)4
MK<'<KH\QNJ\72T/N!+3PRGP^NM/,K4XME<1]>6*1(7TM@N!*RHK /*BDD07>
M]Y^8>!@97#AVL85*\&MF!Q;CY:Z0"9:]+GZZ,JINFW0*RHT/B_6AL% 6NZV#
M;=62>H)2D9/TE))*BOT)X/QU!>"Y[])\NYWAPIP\"O/I'MUJ[6MU9:6SDL\%
M<R(&Z1<(CUGB_=<'Z(K1E&Q!$4GWO(<:3E)0%* [I?262!PM)44\"YU.>K:O
MGIP%[%UMT89H+G>LTDG3@-#FZKJR9'PZXA9GNM@>_<N-1N..1,XW/M<'R?&L
M$3)8<A.WQI\/R&;75#<=B1(:EW$>L1*BUTF<T9*(\B0T\!:6Y7;F_,2SP<H6
M0BTY'B\$2X[M VBW[KW&WHC+[+@>8?0'F'4J6H.,N@+:6"OWO>00>#W'R'IH
M;^\UFIM=_I;B>?:L/9FII&Z6$+<6&FG<0SZ"MUUMKR53WKS;67!@A^1^C:5*
MAP["46@H!Q<-MW@K:[5W*"7--+ZD#*2^>7;K<&^_6 PJJ F*2<X@0'UT%[JL
M$9\I25LK2K@=22IMPI/'=)6B<$+X/(ZD@)5ZI ! U>G=IL-WD"/*H*AWJKE^
M9!\Z2NIR3%HF54=WC%W"DO560U<JJGLI4B&Z[!LX:ZU;4:8Q-2ZVET*D@CGW
MO:'0L<K5U6Z2MFWZ@(/S'YH9NL6=LB;L7A4.%06?#HJN[TBQO]WB=+1<A8@O
M_#+M=DLFKG7%#?+<HL5K<2C.0L@R"/YM+5T=Y15S=AY%JE-A-;J[RY0\\X%E
MU^4IPDEY14Z7%!(.)6"29IJ-V=R>QCD[7LJ5;-L];/@819FWL.DQR:!F+.0K
M?3X1-G8]HS=1\=O(]A%LDW$4JR?)U(-N[.^M)EMY(N"E%C.LRJRE2AP^].6N
M2XM3Q*].DQ;])66 O54>'(=K<%J5;)2*RU  WCNBD,!+ACN@#_:& NNZR3PS
M[;9CD#F0Y'5W\FQ"Z545]K*LJK5P(=,MA]N+#D1;E*VFGI==7/.I;6GS7$%Y
MQ)<'5IOU_P 2H//SEL^-R6[Y;*#LE)DT6+$,2& :":78#R89+IT>$39T5LNH
M<QRWDUUBRAN=%>R?)W$D)D5<PK47;=7G/ARCA.NNJ!<=3$=2LGSU NDQ)?$K
M_F.=H>W88[$^QTM8'-VR&8AG?D!#NR@SX0=F(E8Y7-XE8I9ENV"[![ZVO')]
MFBY@HJ)C5C+-F7YWMC#77,]I6[[6HJ6\'%'NZ7$9NDKX=>IO.)OKPS?8P 6#
M0<C\I#$,P?B[-9F@;$5-'&I*VOJZ]A]NOKH46OA-$DEN'#8;CQ6R530HE#+;
M8*E#J)'*NYU.]6;UU5&;U%__ /3];K>%%--(!II %(!ZL6%WH/FJ[V=__P!6
MO_\ #_V_4;Y_%5WU?WJ>BI_!1W4_V*@PIQ+F9YLY'<0\6(M)'*$#SV&I"8_,
MAL3"%!Q26SU*:"SY9Y!';6,DZOQ^DK(($!N$?HLUA".!PE)[#OTCO^[12I]$
M31%@+>_:U6X^/LO4TE5/EF.3%7F'Y$VLID1+CH6WP7&^'VX3C;BVWFT*2VMM
M:TK!2M0)#8K%^TFZRLT198KE$9K'MSL8(CY+C/2A9;8'*1=4[DH)%S3.='F.
MRV_,F-J7T)/<:1#EG.5^ 8_1CRR@OE>+V\)69?W_ *N/W?#\-%*:(FB)HB:(
MGZN?N].?N[\>NB+7+<W<*VR+('-EMJ'TS<\M&6TY1?0UE<;;3'97'M4UY;:O
M8IUVP.IM+:7%2&N>1P!R0XC+6/2,SXJ/=N^WT6UFVVWM'MKAM/B=3%+$2MC.
M(4I2^M^5)DO*D2I#RAW=?DON./2''"I;KKBW'"5J4=!&<^[:>\U*R3HB:(FB
M)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB$ ]B.1\C
MHB@4I/8I!'R(&B@@&X!YJDEL1E1G4.L(4RI!2XD)2.6U$!?P].DDJ3W"ARD@
M@D:@T#$!H(%0J#&FH @\"""#R(*G>.&U=)W32001#$&X(9N8M=>:.ZN/VGAC
MW!L-SZ6IL+C9W/)R'=RZ6D8+CF&Y X4M0LWK8#0\I%6I@AC(&XS2'0PZ[,/4
M]'2=>=^([%N/510 ,]VE@#8#JTQ.A$NPT])\/V[I 177O56>NK>U<$FMY#%[
MB&-WS]27=1D53!O,>LX%W3VT=$VML8#X>A2X2TC^R83W=Y;:'"&G&Y7$A#A)
MXX2=<2O$HPL*K>HI)I%S27/69Y-,2TR(<,NS115BXE)!-(-Z=Z?ECY=ZES>"
M18W7:\<GL"1^_P#=K!1M-%3 4TB+,,KL-[M[]%DQ,,X=))(JYEV\ S^BB>LD
MGA( XY['J[_Z]^_IK9--)!JBV3-P%O9*U:,2BJL4BBD'([H!D$P7?@5+K$PT
M'<%LJ(]?3G[N.=7H-%%6\0&8Y#/FRBIF.\ 1F" 09T,74Z3[PY;2KO\ 842A
M)4?L=9'P"N#P>ROLGL3K)5C8=4"FFQG=I?MG+RS6'H]Y]P"EX# 4Y2Q (&;G
M*ZMK,LPQO;W&[++LNN&:3&JEAQ^9;R GS"X?<5&K8K']FS)BE+2U!982M2I2
MFNW'.KX-(Q,2FC<@O.Z&+"6N2QO$:YD,.O!._76:J:0":#43214X&] #$YEB
M2"0"RQ9L'A63;T9\SO\ ;D5<JDHJ=+T?:#!9A#CN.07V7F'<CNVUCI1F-]">
M6Y9H0VD4K*X\"&\I,F9U=[9=FP][>.'12!\KT#B+L+$@DM!)8 $!<W;]J-%!
MHIKWJB_RL+D&U+AF+4B[ O42"3Z)-M(0X%!+21TA*.$I"SQU?$ '@!2_PY5\
MSKLB P@:"!W+RY+U ER3F9,:F_!56BE2.@%M0(Y''H=$5K9&A QG(QT)X--;
M*(Z1QU&%(Y5QQQR>!R?4Z*E=FR8QVTJPMF&4)VIP4--M(7^3E<EO]'[@*D=9
M2H-@'H4OE2@?=*CU*[]]2"<LX?,:<=!]#"UZ0#2(!_4^VU6 ]XMF=P,PW;;S
M[$KN1CZL>P]F/C3D&Y9B19F8,W3<Q2;V%%@R9<^H?K/.BRH\OS8K[0;9>;4V
MD)U8TF"Q(86SCB\<QP6+$!-18M&1!F<K#MEY+PL7W. ^+;(J2Q?O=W&1'94Y
M'C0<>R"CI:WV!W'ID&6JXL(6,1K!]R/=F&[Y3TE;3)2ZHIZN.(W26+1S CWK
MVK4Q/M&[&)6P+Q6 0)#D.+6/BNBF;+>)V>QB#U5;8%*:Q2.Z*7V25#4EN1*3
M5"2\A].+>3(A3XT:9[0E*QYDMWSUA2CU$QR#B(@N0,Y;Q8:J:*=H-\2HR&+D
MPTD'/BT1VK,4C&?&*C!)+$?,\=1F*<@1*KWHCT*-$13-8Q-0_ 4A>'S&2TO+
M$U[[38C@(KENLAQ+:>DF-F<&8(?G#\M.U;(&+N@FHN"7=[<@P.1YOD"NHDXW
MXTYR%H=S'%37.S9;+\64_7/N3\;>M.'(R4IP6%'9N%5J_)8D2ENQVT)=\UAQ
M:D*28P\:6!OV3F'TA0.D::BQ=G)$<Y<\Q 8"76%6M@?%DSAF(8W-R3#+=."S
M*S\DJP6$.*(L.)B.05[\MVRE8N]]?SS?V\":XA:8]>@Q8ZTH*X\=2)8G*P/:
M2(+N 9O<V<E4K%9#/4X(D5 . ]K"Y N0]C"R!+LO&%B>281$LY$^\HK/+X,B
MZ>QD4$HU^/N6%:P*EX+PYQ3(1'+JIOLBX2&JY-M.;F(D1V Y <D6.8#Y1%SX
MMWW@58HW9JNY )EY(R##26T@OF+8G"-Z\/W*W G9];PIV%Y/(M[FABQ;%V9)
MCV$BZ(;1-C3X4R3 B(K A^F8K\@:AM>VVL%ZI#,"L<CP00)%_?9RX<%L;/TO
M25"NJJJDT$@55.TTL6MJ!P>Y=9<\1+*4^'_>E02D<;5;A! "0.D+Q6V2OC@=
MNL$A0 ]X'@D\D:#Z'R*W*MW@[TZ/<++]'_\ L>K/ Y57PUJ/'=2U1VRI2OFI
M1)*B>Y/<ZA2&R9N"ZZ]QNBR=CV*\J8EM&:>+[:)K##YC22TIGSXWG)4&G"TI
M3?F-E+@0I2>K@D$I5G?F=VW^.)P%'XJ5[?U*/Q*NAT(ZCZGI 3S]D <:AAQ[
MSZHHC9W;=(X3B< #J2O@&R ZD+4ZA7 >^TAQ2G$GU2M2E#@DG1N?>?5%Q*V9
MVU5R%8?5J'4%<*38GNG[)/Z7U' X/PXU*)^:#;0*"_R3J^L<^]TS^H$\\^\5
M$]R3R223\2=%#G0Q_P!/U/FH':#;0@@XG5\*YZATSN#SU \CJX/(4KU^9T4[
MQ_#X4^O'VP45[0[:N<=>)UB^%%8ZDSE<+))*ARH^\222?7DG1-X_A\*?5!M#
MMJ%^8,4K L%)"P)X4"G[)"@KGW>3QW[:)O'\/&U/KX67+^9W;<@#\DZ\@#L.
M;+@#X<#SN ./EJ&''O/JBA^9S;;_ (I5_P#_ )'_ #VC#CWGU17C0XU0XY$7
M!Q^K@5K#CA?<1$B,QT%TIZ?,4&VTEQWI]WS%]2R.>I1)/,HKD X 'R '[!HB
MCHB:(N/RFN0?+1R$%L'I3V0>Y0.WV3\4^A^6B+67>O8*MW&<A95C]I(Q#<2A
M2J30995%<.2T$]C!=DQE-251U< J9\SI/424^NGLH?>2U\A>(#+]KI2<=\1^
M(V%0&%EB+NAB]<JPQ*RC<G^R;N$PA3M4OC@%Z*@*YY(4/74=IR?WD^H;P3W'
MG/OFMEL5S+#\W@-VF(9%0Y)"D=T2*FZ9GH2._K%:<BS1_?#IY3R!W/K82;,X
MULSOV<7[V#P8#W;Q_/P/#*Y V@<]29 'S;7[1Z_AR 1\M3NC2KL(J'DSJI)U
MI[01YE<X0 /=;0DCU>#H6SW/8<2R$D_#E)YY]#\-& I):]Z@=X9LSQW6UR1W
M,'/Y9%AJ)["/HL<9UNQMSMM',G-\QI*%1/":]]QJPL"1SV%)1EZ['?T)DGX<
M^NH)?,#AN\HM DR[P+A2UA.<N_G<VAF#K7MS<7=SQ!/N8WLSCMMM]A+SA9M=
MSLCAJ;R&?$' +N(U:^ENE+@ZOTEV'7@GCH)6.3"GWW7]C6%MYL_LCB>T5"U5
MTT=R?-E/NS+6XGE+]A93'N?.ESY;@5(DR'5=W'GG'%N'[2E$<Z*5FWH0""$)
M!'H>D<C\#QV_5HBFT1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1
M-$31$T1-$31$T1-$31%*OIZ25?9'<^GP(X]>WKJ#5N@U3&ET;>C5=+<U%1<U
M4FMM(4:;7RFW&WH\E*"TM#HZ'4GD$)\Q"E(/ ]X**3V41JIHIV@,0:@8L"]G
MUB)/!*<2O9Z@06 XG*98@7/<O-;,-@MVO#_;6&8>'?RL@P*?+79W>T5^]+<J
MF2I1]H<QKR0[]0S"'2\'X,7AU37E2FGV''&U>>VWX0:Q732&%0 M(,%W&&6D
M'(DB#FO1['\3!JH%51W@['>;(W>N7$-K-Q214X-XK-J\DE(ILJFR=J\O\U33
MF,;C%./QG9C:5>:BERLLO8U;-GA:T1OK!=D4IZ',=A%1G1N4?A=6 SBP+0(,
M9]&-9+9B'==<;1T["F02#5(8TAR1=WB&+0^0I.S"76)+#4F.ZVXW)0'$2DNQ
MUQ)+:AU(57N1)#S,H$=RL(:_1=2P.!QK&2Q%!@-<AP3FQ!8O=P SV#*XV4TD
MXHG<(<#+>##>!H!IS8N2<B5*@ *Y4H. !1Z"0US[IX]]7(!!X(!!ZR @#E6I
M:D9TG@[/WU$>"L2> Y%_H.]XNI),F/7Q5V$^2U"B!'6N5-]DK8L=M'=2UV$Q
MY<1I! *"\_%\OW@2]'[R&\>)0:Z2*8)+ @MF#>2(?(M8G2K;T.;N6<D !S N
MQ$ /#7>=7<L\6> Q)KF+[60;7>O.''!":J<(ASWJ6NL75!MI%MFJ0]02FTJ)
M4I.-2+J:@IX;B(7P1EP-D-1 +F\R&(-0-Z98@SR:5CQ,<8 )(-(I+ DB?EM(
M_$Q! G@77?;9^&_/]S<HJMSO$S-:E3*][VC$]L:-#[&*8=(CA3K<@0U..^?=
MI(3YUK:.63SC@"FIT%\-P1Z#8]@W,6G$J 8;Q8 9TFD.] UN_6,W=^/M7QDU
MX5>%1)JW2Y)<M4*H/2$@"6B &#"1Z-0H,6"S'C1F6XS++266F&TH2&VFTJZ$
M\( 2D ?O)^).NP,.D6'EW6[UP<3%KK<U$ER]R9/,]BK_ '2M)Z4DIYZ5<=QR
M#STGX ^A^>KK *GJAV.4:1REW7)HLBXGOL'\1HBZ"]9<DT-U&805O2:N?'9;
M24I4X\_$>;;0CK(25J6H !1X)['D=M2+^_0^2QXCPW'Z<1YK5W;?=+#(VUU/
M0?G(Q#'<GJ:!^C?AY3D5'43ZS(XHDQ6TV-=,B!+3,1YL/I+#9:>0E*%!25=6
MK.") &3\SI>!+F\C-UK M#MD1H>X@#ESBPP18VF[+J4+A>*C9Y*',?G1Y:I.
MX- $*N7V$ANQC)15*3$C1YJ$O,H:/,>,LQFN$$#4!]78OF1 T($@ YZ,86*O
M>,[P ,,:@Y&C&=+-JTJU(V-V+^WFX&$7V^>R<BJR6[AW,>'!W=A1:Z,MZT18
MY&R\MJJ2X8UFRE];E7Y3D21YBVWT%!*M3+$;PU+DEY?CGHQ\%@%%1WJ=ZD@G
M> WA<&8+]PYD$PN#%Z+<W&:.FI:7Q9[-XO58^A#-52P,NQ>P@"L2[-+->Y[5
M3H*6@W)@M*!; ZFE*Z>0#J&,C>$ YPQ:W.QRUR6>B@@ .&R S=GY 7UOQ60L
M\M=PY;N.#!?%%M=$%7A\.KOE6NYE"CV_+&&,D>E60817J9++S\Z@'6HI66([
MJ0CI"4Z@ O#NS[S@=[&"?#-9L2BKHQUA2Q$DL_(D ,0_'Z]!)O-Y3/DR(WB=
MV9+;MR;2)%3N13#I8#M2'(0CIJ?(DM-0Z^T4B&[U1PN:ISI"ASJTZB[Y7>#V
ML<F:SF%KDU,1O 9EC<2WBS2(@W<8\M,M\0T;)*RBA[^[>67UA%N9+>1TFXV+
MFGCO3'+156B<U8U*V[!4)A0AO!]MQ<)?U/[&4M,)(@N,P9''MYY.9[+Q754+
M5#*Y&C,;,0\$B,P]KWDVN[L67(>I_%CM+)#S<5%6[=[E8K^D>9K\-CF1*JFJ
M)R$ZB7)CYY+=B$+9<<LZP+ZO9.6S'4<>M!SF<Y\750*A/2 @L)K$G,;IEB">
MYFR-+/&[,YJ'6#Q=[;)COMU"+&P1NI3UMI+4S=RK2[35FEB5:ZXOL,5-7"D(
ME\MPO;XBFO)DJ&A>)>S!W''NR#,=6E9,(UTUGK.-PAM\"7ID6.6@9XT&T&^>
MZ6W]OLEN;C=5G6-9!D%[M_D&+45!CN30<@N;/)LAQZ;55-;%@UDMZ?:/.VCK
M"E)2 5,K>+JTH"DZ$,_#1[N00;Y.UG#1)6P:Q<ER6B^EM6B7C6P6UM&EQNJ@
MM.JZG68S++A 0D!;32$+ ;;]UH!0(\KU;^P>XU!@GW.=N*V,,O2#'9Z9'OYK
MLRA"N"I*5$>A*0>/PY&H5U-Z>FB)HBEZ4GU2G]@_AHBAY;?\Q'^"G^&B)Y;?
M_JT?X*?X:(GEM_\ JT?X*?X:(GEM_P#JT?X*?X:(I_3TT1-$4.E)'!2./EP.
M/V:(H^GIHB:(FB)HBEZ4_P U/KU>@^U\_3U^_P!=$74V=#5745Z';0(D]E]"
MFUB5&8?'ED %OI>0L!![CH *>/D>-/<SV\^*+43,? SL[D,]V[H(MEA.0>K%
MKC,Q51+84?4LR:\L/M'G^8M/J!SVY#W[LHUSYV5CN^#;=2$O_>[XH=V8+ ]&
MY^79-8.<#GCWW;18Y/X\<< ^FG+5_P ^:-Q;N/9(M[X*9/@MSRV/EY?XD-V;
M>-_<S&89''8X[]O*%GT<*' /NGY>FBE95V\\&FRFW;[=G#QAFWND=E3[5WVU
M]?<GJ+\IMQX_@5>OQXYT]Z>^,H.[DMIXE?$@LIC1F&&(Z$>6W'98;98;;_F(
M:;2EM* !P$I2$@<]M$57T(( *4D#T'2.!^ XX&B*;1$T1-$31$T1-$31$T1-
M$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31% @$<$ @^H(Y!_4
M=" 8(<:%$Z4\<=*>/EP./V:"+0UFCR0S>><KC<:0I*P$-DK3TGJ3V4/3A13P
MHCCD<<_=Z:((M#6:&[EA[<783;'=6(N-FF*U5@MQH,*DB,RIXM)<2X&E*=:4
MI3?(^P5=//';5*L+#K^;#HJ_ZJ:3IJ#HLU.T;11\N/C4_P#3BUTZZ5#4K4.3
M]')A5,_)?VPS_<':L2%+68V#9A?XU#4M9[J>@TLR!%?/25)_2H/3R%#E:4G6
MKB[#LU=%0HV?9Z:RV[4,'#IJ <$M5NO(!%FYN5GH^(;:*AO;9M55&=%6T8U5
M!NST&MB 2#S#WOT2? /N>EQ75XK=[78ZE#AD[BYHVOH*AU)5)1<><D]//!;/
M?[*B4DZYI^$XF\]/1 <P&AK"AN)?L:RZ-'Q:D4M7TI([7:<ZPSL&EPYR#+O*
MSZ-O;.=.;LMS,ES#=26PM+C"\YR>YR@,K2>08_U](L#'Z5\+3Y0!Y X((!UO
MX&P8.&!TF%A5LY+T45/\PG>H+W&KM*U,;XCBU@C!Q<;"+ 4U4UU454V!8TXD
M.'=KN<B0MU<"V?V]VVA-0<2QBJK4(:\E;K,..AYQ/EJ:(6M#*2X%(6I"DK/3
MT$CCCMK;IP,"GY<'"IXTX= .8R$06(# YK2KVC:,3_,Q\:L:5XM=0R-C4<P#
MP*R6&FQQPV@< )'"$CA*?LI' [!/P [#X:R@ 6#91$:+"PT4W2D$D)')[$\#
MDCY$^I_7HB<#Y#]FBAAH.Y1T4J! /8@$?(CG1% H0004)(/J"D<'\1QWT4$
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JG^4>BN)"$-H2VVA+;:$A*$(2$H0D#@)2E( 2D#L   !Z:*0 + #E"__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g423260g10a05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g10a05.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[17&4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %:J^548X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN
M=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !       /
M<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R
M;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R
M:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,
M8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O
M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M         #^    X0DE-! T       0   !:.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!$0      !     "   "0    D      .$))300>
M   $     #A"24T$&@     #00    8              *(   )>    !@!G
M #$ , !A #  -0    $                          0             "
M7@   *(                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   *(     4F=H=&QO;F<   )>    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   "7@    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
M A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R
M@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$!_\  $0@ H@)> P$1  (1 0,1 ?_$ !X  0 !!0$! 0$
M           (! 4&!PD# @$*_\0 8!   0,# @,#!0H)" 4(!@L  0(%!@,$
M!P 1"!(A%18Q$Q0B05$)%Q@F87&1H='2(R0E,E)46(&6)S5"EZ*QX? S-#9$
MP4935F*"E++Q0T559)+3&3=(8V9VDYC"U^+_Q  : 0$  P$! 0
M     0($ P4&_\0 01$!  $# P$&! 0$! 4$ @,! 1$  B$Q05$2 P1A<9&A
M(H'1\!,4,K$%0E+!%=/A\5-BDJ+2(W*"XC.S5,+#8__:  P# 0 "$0,1 #\
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MF)4U+M8<OEKSD+6E,3J\.U[4,'FKJ#G1-(Q*3H,?R^3WKOIV*VF;L=2Z6F,
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MKS.92'/G&48DQWQ?-K; 8MF/,>+[R/P7LOM>58IC<P;9SE@,80&-$W,@'=F
M@[%4W[K<YZJ0"A'HIA@DTQ'FDG[P[::+EM^2@ N+0BZY"Z;TG/\ ^3X8EAM\
M%ZF&IBZK72FE*:T4JW.3;9/%KY"^H _W#Y/9MO\ 3X>O3QW\<^O-7=C#O%NG
M^\>&Q,[0ID;3/N&C(E_G;"S-=O%%[6A>:L/6(26[-$83U,S8PI)2,S15"E)[
MT@!4S23!YTJFON6M'I#.3C,;GOB(UPQF9AY=V[Q?.@G3D=$1DDMTDRF!D>'J
MSBG)L'S+ (UDS';Y0D4/ES6AQ9W6T6DBI34"#Z.Q*7I*U*00KE//360"D)4M
M=LXWQPX8<SU1$K#7N]D]0I.8XG<GCQK;VJUUII2FE*:4II2FE*:4II2FE*:4
MII2FE*Y7\3?$',<ARN^X:<!/MVQ.%BCFSIF!G6%7^-F92@48V@W*>4YGF*$I
MJTP0#!X547.=D5:L3*^7:W],VP88649((\ID86?*(\7M/X@7W/96:VR7,.LQ
M=:#:#"(Q,ZDDS=L38ABN,(NSQR.,;:RL[59>9-#3:#^;_#P)'R$=>@WZ;C;6
M"^]8\6%$G228TG$3EQY-3NGXV8X;M- A_F)T-IQKO7*/CSCD<<O=5O<JS>QU
MEN>TWC*)>#=L[,?/NPV,]A >O?KT\>G3;U:Z3H)(N_EK,3J''G->%_$+A[_V
M!&+GXA"+DM[,CABV#4W9<-;Y]U'@#UQ$8XA_#IA[*< 8\_VN28%EN.8IF]X>
MR\LM4&[_ +X(6^#Y>PWR4#O5OU@0)'B=3F-N)Q.SO^X;X=*V_P 16[NI:.?B
M2T_F3M+'5 DF?C2(C."M*\#N<7V;\<>081Q$\+5OPU<7[7P^J5(E0B^97/&6
M2\7F:L2A,0M ZR$$A)WEZU)"2/2(WT3DXYVWSXPYAR1%8_X5V]W:=IT]IV?X
M=W3:=-I$_#?-[:@RELJ-LK,$]-V#^Z&,=>K[JC[F5?Q>$PN6RYS9<R[MDK_)
MT:? &)^*C-GP1B8'< ;I21S%6X'-T3J0T>-??5S&QD!^2T_BG:MG:=D6%EUR
MD6W1%SU61U]6(9^(4(PQEJ-O#KF9]X2.'?W4IPQNZ4(EQ.8,R_[Y^2,./,:5
M(.'Z(]O2]3(&7"%-BD06(^1T5)BE)3V#&B8-S)(,.KX$81(P:B$2KB=C)IE.
M\76_C+=%_9@P1=;=\=MJ%]I=;'4EQ<=74D6]6I*'*?'9QR\/O#-\*#(S'@.:
MP[+$#X8++!28\S3)M+%D_*[(7R<O.5614C([MQ3QW2H$\L9&_1:0,0Q,XQ,O
MA\YB..)EL][[6VWKNZ;K;P+4ABYRI;;:#=:'Q=0@PIGLTW-D+BBRW%N([-O!
M!DR]C>1FV3\$,XS/&\EMD<3'')A=!$GN/OD.?&5)5&.[Y'ITME<WI!*PDA03
M($F3,YR01,0CC0NU/&-=/\2[P]E=?;K/9=HE]MIU6_\ H_I.HCI5Z;Q'0NMU
M)B9[DAQ15WC'7!OPAQ6?6^.')APG*,G3"UFN."XC+;4K)T])9L(/ID@!"3VY
MWXE)*SR]003MJL0>GMG:<Z0$')HG/^$]X>T^%NQTLEULMJ?BL603DMG^4RS(
M3=M?#''YQI\2UK[\6$,+6LLQ^P\6<GQ)+\:7;3#VQN8<$,)W7-#-G_) E'OR
M /@4 (@84K=25)2 "J8Q,[Y_MX9A^O#\Q>BDH77%UK;;=:6X;<W##FXFXFUA
MZF7IR>*<2_NA66^)?B^P7B%SX;W"APU9@Q8S6MU-H&]1XO>,)SV^I^'X.2'>
M1".C\X'8]"-]P-3!*#(.&'3E/#Y9<^%CMKSM+K>S;4&X+NFSL^JU;K!Z;B,B
M3;^HF6.EBT8^]T;S'><4K=A#/&^ 7>8\09C.*FF0X?4YXARW@@/7Y"[C9O3(
MSS9&E@]7+W,W\ =]QALO7$&?*#G.K.H\2J9JO=_XD]O<&#JNADL"!>KXKK;
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M.G:!5NE6MY8EQ+CG!L$:,9XEBK;"H.Q%R\SCMH=P>W"2^/8!ZR!1/4DC<[[
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M#,&>F>JT9'$:X>3X3,+-?4:F\<DM@SWUNZVK;7?K/SVRCKL\,PDOAL/"1[
MD<WCXC<>V=-?YCS8QZL&\!MG3MA95RZL.^L2*P.(\M*O-&5Q6MVSY"5QRZ+#
MN9)M)&8]@G<_SV2?B_X;;DCUGVZCC&,2^KQ.GG^U6Z9C&/((%GB35=6-#9JR
M";1:N^VT<L75M<;GL9T>KV[M7=F<6UA:V'L+F[<(D0W/Y<21N/#KN?$RQZ>F
MV-7AT>,QIGZP860\GCIU8Y-7,XVJJ>)8U-K-8/="OVVWNEZU,C1=QZ\9]K_M
M]Z##T)DGAU&Y'.D $;@@@1&)TQH_<?*1SHXDWXPP:#!*9RVZCA,ELSO:]3;I
M+E#&469[B12.?1-M8+:\B[->.W:[,&P.DY>^P6'F)W WD1  'M) (!('G'CO
MB9CWE8,:F:?B:O4)^F5-'@"W%J+,8(,;Y#6?XW1JW%"XD<:M_-0UV5YYV[LY
M[/'BR=3UZ==NO3PZ[:0XX^O[?/4S4=;"2&=VUF?TY#3Y,YT*_;*21QRJ^1:I
M%&W*XZ_BEF\,SETW/LW/CZSTZ?O+60S!S\M'T-YTC0[F'$:9R+OF6#:(DQ/F
M6:ADF 5Y2SP:RG,<N9@_1MUDT;CUJ\=I=O1=B>0QOCV#OMUZ#=/,"=QZCO+$
M$0QGSY-#C$PQ\HD#;74"Z?ZADB#:1Z6-#:LRTL_4?/\ 9KG6I<P8PCF5('((
M;*6JV<F=^9W1F>;/UN#5UV!'3VC]WAN"=MG9O3.=6"$,R,RSKIM)K71B#,0^
M"0BNQAR&,Q!&:O7 AER23'',AQ+DEUKO.7N'B3G&LR=75(2Y3",%"GO%>2R$
M)/27P!5 UZI',9@Q2E)(Y 5;1DE\364WG?0GIXAU6*[=U[?\6V%%MPQF#*,Q
MF N+2-;9P(5T*2HBFGVG?K\RO9J+@%#[Q7J6J@OWFO;5:M32E-*4TI32E-*4
MTI32E6*]N;>SI5[NM7\VH6P/G-U<D;<@V]+<C;E&XV/0'<  >.K!O,!O$ZXT
M^]9KEVEP&NF7Y?:>>-<5QFPM=5N)?+,_XKGO\98)5VGCW ]J!MV%@EA>0&1\
M._KRS(T^^>2=MD)Q>.J4ZB?WTC&/]_GF?'PNW[5ONN<PR9A(BV)(R#=@T;HD
M*G-KQJM32E-*[?C7?<?2FE/QKON/I7UNG]'^T=*=%O'N_6FZ?T?[1TIT6\>[
M]:^=*?C7?<?2FE/QKON/I32GXUWW'TII3\:[[CZ4TI^-=]Q]*:4_&N^X^E-*
MXTTI7ZDC8D'KTY?[C_DZGLYDG7/]^*MW7_U6'#SK_5MCBHA<4F/)3<-+1E+%
MNU#+^''<Y Q9='KO)60$/T)(\.[N68WVYB[QW!?_ !VUN[)8DU/EMSK@\2,.
MA-3WI>P1,9D9F&;>9C*:8\8FND>$\L1G.N+H%EF'FN&'(,<;9'96][3HI<K-
M-RBG4JM#LG\(M#W'JA-&N".95:BK9*P!55JE^]IUC;->X']O])G./&MTZBIJ
MTN7Y@_S_ .D.IV?,_:ZN/;?I^^2N.V.KTYYXGLZYUNB+F,PR2'ARQ=X ",XJ
M>MYV\[C;F$JS2'Q'-XD8^B_[L7:LW*:?.=#E@76!@FO&+_Q.UN<II9!/PVR"
M8_F8NV,F-ZF?K'4535:5]6M+B@U5[>W<;NSWL[NZL^TFSM/U[[[GQ'CZODWU
M.)Y#EG?WUT-<[5TWQ!(A/Q$Q!#C0G?62(UYVPWC-R1*K"#L9BV/VZ<3+&TH9
M?/39O/=JQXGX+-&&"/F%>PA)!)@4QPF3;]\-R -]SK3Y['@8!995S'B$D8@K
M-^=&(#1P=3\0Q&DRA,Z2P!FM\7?%YB1LHGR]>1N(\+*\:8>2V2W^4V/XE?'J
M$'8DQV*9&?&2,*W)_GY.P().H9?.<_,S+GSCF=,U+WNW;J<LP(<+;\$1U &(
M9V@JVX:XC+C(.4\GXY=VIZ[1:Y@U&(68B/=R21&!ON,8%/3[Z;&9$"PD2.<O
ML7!V'-MX#?IP27&F8E3&,98G;?5VI;WOJN0E,PQ#L$@0",+,6YA2V7(+/BJQ
MJY.M_&VIIGKE+VIWE#-W)$>/><N;%-6"!ONP[PC=/>)\8U?_ )-/?<[I 41!
MON2Q)Y1Y[[AAG%/S=DN;I<=+:+,:.J+=CRBXA6TT17XQGR21=N=8=%[D5FSX
M'$FO);>0[>-3R,<2.3A WQF8X09&9-'Y$ ">O-U/B>B=.1(3,2_/3G]CYUF.
M_1D)1MC$$3%TA:,K!\.$T#^;<^6L_P!PS\,TPS[BRP;KAQ8;57F;3D%G>=BY
ML4S[BOC.^,;#(@000]C;J"2"1L>4)\M#]X<8E1=<@ZR59[V%O5:EQ 2R/4?"
MVQG;JNSF")%FO'B5SS*<&ICY\RCC;'W6-RB]>,KRR'3*28U8)0QE@["9IRG'
MY!Q_'I8"^*.4)43"X5V!U!*M-7F''CF =D],8QB.UW>NEACS)1CB+'5ZB6!B
M1 :S>8\1F/X%+:\-E5"26]PUL\$>7>0VD<[1@S$UY6F9@D%>.W#R]>\3$8P
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MMPV.9<</(,CN7&"2^3QB\M+N1Y,;G,.N=&8SV<PU4WYD%^CN5H\>]*D@B&]
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M^U2]FM9%[TUUPZBUM+/*.[9$8W!H2^0/*D.9F3<=O]Z9"D2<R97Y_,D!0,1
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MU?8VRO=O_JKJTV-Y0)/]&JA2R#L?8I&W3;H?FUO52W_VGSB3[CFO;[L'X8^
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MX[9/OZFI_-']5GJ_Y=/AJ<(/[2N%/X[9/OZ4_-']5GJ_Y=?OPU.#[]I'"?\
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M,9('5>D&9@"3>9UF-JM;::4II2FE*T!0X@,37&33AZTFK)<9& (,;M[M*JH
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MQIQ!Y8?_ '2++/!?D!FQY#W+*4^PWF? 62B;YNRS.\?1"-L.5<E0N;TZB*V
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MR6Y(77I"9Z\['+=N*M5O_P!%+[GM6N[B^K<+6-KB_N;TWMU=E+P5=H^/-UD
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MOGX8Z'?[I"!>M[.6ZZ)L_4O_ *<A:0W-V6U\+JU=>>Z%S&MB9^GC!C>+7;[
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M/CRI-)%-"8]*LAK88V:9_">173J+YPM*E3EB".IP<QC]V#06>&+6]_>TN[,
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M%X><:,NLK[&D2NJ,[DK7)Y@DLR-I%)V3R'8K^\[>F7ZW#.TA,A*16JJIIWJ
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M/[8F=.0F2K1I)\I_:',!DB'4!(=VS#%>.,@733=S:%QN5.#"I19KE_:*;D;
MJ*5*4@+"NI6U()W!',1T/,0KF/)MG/SCG#GS^=:K^S+AYG6/_;#ASJ!F8JRU
ML'XEKO-:0U,>Q)+U<SNQR6IT+)05>JG]-D$<1-%JWW3(3'2&#O"%^7\GN%+W
M21J_PLJ1\Y=2?736=,1+62_NMMRS;+.OQ$3E_GXQ."5QF'X;\!X=:K-C;&S&
MD(;VZ+R14PC=G:1QH0AADRC647IB2$D,]QRO+QN$)24]M5E(---15-9;6?\
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M"H'U;%(V5JZ&H^&Z3&>F//3 ^6#(]F.F(VS'!Y?7.M0E]XO(^"+BM=<.4X5
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MB.8[ $>MC.9\O];99X\&(6NGY>76%@T&?']:;&GUK?S3"6-GZT*'G%<?[S=
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F*5;]*5]?[Q_VO_YZ4KYTI5PTI32E-*4TI32E-*4TI32E-*5__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g423260g10a06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g10a06.jpg
M_]C_X  02D9)1@ ! 0$ E "4  #_[12N4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %)*^4F8X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      !  E,S,  $  0"4S,P  0 !.$))300F       .
M         #^    X0DE-! T       0   !:.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!$0      !     "   "0    D      .$))300>
M   $     #A"24T$&@     #00    8              *\   )8    !@!G
M #$ , !A #  -@    $                          0             "
M6    *\                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   *\     4F=H=&QO;F<   )8    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   "6     -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
M   $     CA"24T$#      *$P    $   "@    +P   >   %@@   )]P 8
M  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(
M# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,
M# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ +P"@ P$B
M  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*
M"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4#
M##,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q
M8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75
MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0>SS<1KFO@4@P1U$R9DG*,NH+K82X23/9&ACN-8XUTOFH5TT1?GO?1,C:?\
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M=Y*Z8]'$MFW6FW(J)Q;4AEQWA+DM7AI)]FMARYLK1NRVD--'&P&H'9!!,UN
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M;M&T18D9U%2=ZE6C(G28IQ@LQ)@R*&"0#0 D9D VDS-*K]:OHQ 3TC],Z0
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M(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB*1S]C7Y@>HKS/(
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M-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T14GR
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M;BE<=7*>SM4![?;Y_>/^('RY\QY:D.<3 /@%4A@O[S/<A"?<!Q\_'M^[^_\
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MNR=W?9)M3M_=Y);PK>_ML&H;>QL*]CT>/)FS:F#)>?+!)#"G'7E*+23PT2M
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M>OW:2.H52(8;GF208KK+RE+3#XW#UC2;',^X5\5ABS28M<VSH)%:& 168XK
M$<_5NWP^[W>,'E-<^7'BIC)7(4WS]>(Z%/%/(:2I?:#PGUCUGWK@Q'!H+C9H
M<XWL"XFP)[@3H"N(LJZZ]I\<F95$AP;JVCX)N]@>U663'E16Y+%7F6*W>9S=
MSZFJIOCN^N<0Q>BQK)9ECZ/CK4FUK\6R.TJ&_1X00$<>)O3PZA-1,ZT\_P!/
MPJQ4 M$DD4()+B PF!G -I@2 =DN=8'35S8*C[K5$EF$5N+?A4N834@)M;."
MAJ&B)C4H7*FS07$2>BA=N55LRIRJ-;NT[N-37&*NL<Y!]QF>[NA2[;\&H:ZM
M8H^E2 2-RSH$1-"9W8DRR>L7ID9IS?O;PT;50@.!R<NKR!AA#(S*SPI*RT[4
MKE,VORNI+3$TL3D0H*7:^XDR/",9N0SC'92D]_5U9U%YD2S:!B4F:B"010W-
M *F8;(W2,R8*Z096W+8:E(6@L28L-YI45:U,.,26D2693#JCXWBS(RDGL*^U
MM2N6TH(3JV'_ !,/_.R_6/C0+J8T%S3%B#G'V3J3(KE!SA9-TPN4"L<W"<HL
M!N,!+N]^Y[EW%M3)2_E.0N9$U\:YI%;?>=2Q67C[QDL1(28U7'2A:(41AD!L
M>N*--"+_   '9-A3O7I858L9=EE;RZHBF:ZK3[!]X?U:JNE8I7@?'64_\*0?
MQXS")U SX'X!+^[Y[U:,@VEVSRR^C93DN#8U>Y)"K)]+!O;2KC3+:#56K"XU
ME7P9SR%2(46>PM3<QJ*XTF2D(\7O+:"F29,FY6+MGP7DE^&UQ(@DS,1%Y^;W
M6-*Z=-AUM!A>T> *83745.&%8U6E@5&,6!M<>J?!+'AFLIK(^FU]>4^B1I 2
MMMD%".TLO0=D%>89K]KAQX>_4JZR=C]GYE@W:RMML.D6+5V]DB)CU'"<?3D,
MB(N!(N^]31YM7X;CD=Z>09+K;KH6XHNN%3YO32W5\T">@[),\PR;YWUB8\\U
MXU]/^R#D9,->U.!JC(;J&DLG&JSL2U03I5E0M "."&Z.?-DRJ= /;6.NDP0P
M$H"60&0^>WM5QLNS@ #"; $"]JTF9S-UDTC;/ )613,MD8C1NY184/R8FWZH
M3?QM)Q\.2'?BAV<.)"H7B2GU^$5^:E)43RTUV)\E8X&"3)PVR01.<&^?]LE8
M:38O9S&EU+F/[:8;3+H8LJ#3*KJ.%%-9#FRF9TF+#\)M/@1W)K")B64<-M2E
M/2&DH>DR%NI^8'SY9*!LV (C";0R+Y]9]_'4K3<_I9PM[?6JW7@-TM91QL$S
M7 KK;^/BM:]09,,YNJR]N[&Y)2VV5O3:6K+J51GDJ<AI/(\1XN3)F>O0&>[C
MUC+@]&P 21A-DS-#G?.G T@V6TXO3UL8B/&"-I\"(;G5MVDG&ZQ95<UM:W50
M+=:E1^7;*+6(1!9GN R1$2&?$\,=HB?GY]ZJ=CV8F3@LO)O4\1,%7%G8K9N/
M'IXC&V>&-QL?N6,AI&$T4'PJN[BQW(D:SA-EHI8EQHKKD9AU !986IIL);/;
MHI&R;.((PF@BQ$SU7MPMWJ9C8S9V-,AV#&VN'-3:^->0X4A-'"\2-%R52%W\
M=HELA+-NMM"IS?!2^I*2H<@:?/SW#WW4>A[-_)9G>3<0;G111L=L^W'J(K>V
MV'-L4%F_=4J6Z.$VJKN)5>:F3:07$-)=CSY%2HU3TMM8?=K":]:S$^HZ9S)G
MK]_SF=2AV/9C ."VDZYP3G4TN:WU*N\3:[;J!B:<#A85CD;"41WHB<39JXR,
M>3%D.%YV.FH"/04M*?/CI0&0EM_A]L(= 6)D@1-/D*XP,$#=&&T-M%8R&O =
M4 BJ\4O9S:J?2PL=G;>XE,HZZ4[-@U<JEA2(<66]%5!?DLM.M+"'WX:U1GW!
MZSS)*'2I/EJ)^36W$U[$]'P2(YML3.=^N9R'<%63M'M@FVLKWY XJJXN8B(%
MM8+I83DFRA(@FK$::MQI7I+*ZDBH>0Z%!^H0W5/>)7M-1D!2WS6?G]2JC9-G
M:XO&$T.-R)$R0328K FEANVHLJIL<HL=JH5'15<2IIZZ.U#@5T%H1XL.(PD(
M9C1VD$!J.RA*6VF4<-MMI2A"0A( +9K6L&ZT0!EV1[@KU[/9HK)HBQ2N\\FR
M?[U)_P":IT16;/L"Q;<C&YF+Y;7?&E-->KI*HP>=B26;"FL8UK63XDII:'F'
MX-E$C3([K;B"'6D^UOO2HJEC30@?,CX_,!60;/X <FQC-;''(%GF5!7FNBY3
M-@Q'[UYH1X\5#TNP0RA3LI;4:.%.^2D%':UX3?"0K(,F09_NLCLNSEV\<)N]
MK6:1!O<0*\ M>6/2?L/)5D<^EVTQ3!\JR!J0MW-\*IX.,Y@Q)LGDRK-YG(:Q
MJ+9,R)THEVP<;DH5,4ISTDN!QP*?-:]^9[U7T/9OY3:4N[AQX!7'$>FK;ZA&
M;/Y"PK<2XW"N*:]RN[S1BOL9=G,QVN:J,?:3&9CL0V&*6L:1!KVHT5AM#84X
M0MYUQU<R:\?GL[%;T; /_+;XY2+SH8ZJ+*?I,8 W?X]D,;&JR(O$L3R+$J2B
MA0HD6EA5N2NU8L&W(+3*&'4SXE7!;?CR4NL!,=(2A*U.>(FV4: #2+#A?Y+T
M; D'FVR! H>,S6#,UD5K,RK_ %NS^U=52V6.UNW^)1*&[#7QS4,TL+XNMTL!
MH146<931:L&H:&66X+<M+K<)EIIF(EEI"4!)@C(WH*J?1\$3^[;6IOPX\.^3
M<F8N[/;6OX\WBC^ XL_C;4I4YNF?J(K\!$Y<A4IR>&74+'ISTA:G'YA)DODE
M+SJT^KI)IPMX9WR%4]'P*?NVTM>GCV=5+ !6A&T6$1<IH,J8I&6W\(KIM;A5
M:R$1,=QEFSCL5MHNJK8R68S,J7"9$5QQ:%J:;4\W'\-N0_XD9SV6^>W7-0W9
ML!I#AA@$6,DD99GY-;U6T2A+;80@$)2HA/)Y/"89XY/)Y/D/,'ST)FZV #8B
MD*U8CY8W4?\ U8_^5<T4W61Z(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(
MFB)HB:(FB)HB:(FB)HB:(FB)HB$\ GYASI9%3\3[GX__ &:KOMU\#Y(H*<(2
MK@>?!X\_?QY>[3>!L:Y4-\LD5!#CA4GN5R"0".U/ER1Y<@?O:@;\U,#LKPHI
M,6 [9->S*5[-74)HB@?('[QT1>:0ZMJ.XZ" I*5J!/9QPE"E#GO6V@#D>96X
MVG]LM(Y4+- ),Y"?<J/):V1?LT.L#Q'6OG)OS'WFF[]X9E\1C(6-HMMZF%E5
M^Y%FVJX<R/63D6;UI J\:3$RES-(TV(FL7M]8T>6T^84;O;!E4MD^J5&@YTH
M/C2=1)%1:1%0 3YF-C;4,6,-Y:V!,L81!<6@DN:"+6)FY!W3)UICZ.JJ_K<K
MB89E6=7U'.?S:MQS.7[?&F:VQSMZMP"UP_(FX.95]/;0=K\;LY^:5%UC+\*P
ML;]=,_7MR9#CL+F8G4BH$G@;TRH8I.0TR#^4*GGI!) (P\!HF!#B2RU00" 7
M6%5'<; NMS.\7GU3S$&VFS;ASY2TMM;8<W@^10:;<ZDO<#;P%N+,;N<=$;"Z
M6;67+EW(\.T5ELB58(FRZ^"]$B#!M\Q;6XGJF8(6C';>7X>]B2TO:'#<P0"W
M>$@$08+9!<W@6Q0GH7>E6.*VQV-7NVO< 7$G=G:B52Q:QK'$VL+<=V67*)K)
MF:=<:K8PV%+*ZVS55L!1KW$NNMR93B9"ZOC=B*@D10Q%Z94$C@;R(7>^HKI0
M1P-KTTM;C6YS:^-;0+2KF,&5$LHDFOE1@_(BF1&F,JCOL"3#4F7'+S3BFP_%
M4F0R5>(PH.I2=<#KNZRO/Q6AS7-(D.:]I$D2"7 B142*2*Z+YN[[WG3_ +>;
MP# '^E:-NG*^E[M_GF97.,1IUO)Q/"&+K)-MJ6T<QQZ #!@8E@(W.NY466MF
M18XRNYQJ,^BFR*?$DY%SCF#23(!M2LBQI .L4S\?$V+9VVP;BK@_%= W2*;S
MZ11T$3$0=V0?#)W8^#JQZJLMQJ?!:MF;7U*=P(:JO:W.<4M5OHJ]S]WL456B
M=C=8SC]ID='4;EY=C\UQ=/4Y+&L,BR>1:UC-U=,6(EW2!/787[-.K+. >5V'
ML[22W#@@$B7O$'?<X S-1   HZCB6 .8[R;&VW3YO!EE?B-OTS8M1YCGT3=>
M^R&1B+V8W%3CM1M_F])8S(>?W=MB.)*L+R^S+=B4\W&I6;NDCS%VLB9>^ Y*
M?,5@"(@&]8($F+5N+6C,+HV7I.@M:TBLM+@;AT$2Z;AN0$ DDRX_4/M"%1FF
M4I:0WX:&6VFVT(;"(Z8326VDI#:0W'"6VD!':@@+2 X.[4X?\1G^=O\ J$Q?
MYO1>]@M:6F14-:1<6'"AL+Z+8'3VG(T8_EQR/.*3.''=TL^>H_B)459Q/&',
MADLT^%VBV&T./6./L1_"ERYQ>M)*U^)-ER7?JA]@>K.=:"* WD13KO6)77A1
M0T%9B<Z#7MCWV71R?8/O#^K5%TK7;$>W?R#+!%L$1FA:0.WQ(16 /DY$!)6'
M1W<#C@\#D 'CUCJ-8UK(X#JX'KRA%=O0\F]UVR1[B*Q1!'S@^-Y@^[4HGH63
M_9IK^2U?G]$3T+)_LTU_):OS^B)Z%D_V::_DM7Y_1$]"R?[--?R6K\_HB>A9
M/]FFOY+5^?T145U60.%2EVS"E*"05&K7SPD\C@^/R./N$'Y]$5;T+)_LTU_)
M:OS^B)Z%D_V::_DM7Y_1$]"R?[--?R6K\_HB>A9/]FFOY+5^?T1/0LG^S37\
MEJ_/Z(GH63_9IK^2U?G]$3T+)_LTU_):OS^B)Z%D_P!FFOY+5^?T1/0LG^S3
M7\EJ_/Z(GH63_9IK^2U?G]$5@K(=Z,AR4JN6E+*:4*3\5K!21#3Y\^D GO/F
M/FY'EY'09T[YBPM6>NMYLH[3X>2OJJ_(U^VX84GCU>:I1X3[N"7R1Y?=Y^[H
MI4!79(  +AG@  <U:SP$C@#DOD^0 'MT1%5V1JX[KAE7:21W5:U $^T\%\^W
M1$%=D:25)MV$J(XY%4H'CY@0]Y?O:(H"MR(<CXW9\R@GFK622@!*.27^3P !
MY\^7MY\]$4X@Y,  +ID    5:N !Y #ZM[ -$4?0LG^S37\EJ_/Z(J9K<C*N
MXW#)/!'G5K(X)[CZI?[>2KS)XY)\^=$55,*_0CA5PP>"YY&L5Y<15)2/],#V
M#S''G[O(\<J\+Z&V8O\ !.WW=]OTX+T8:E:,7I$.N)><3"2''4H+:7%]Z^Y8
M0HE2 H\GL))3]:22"=+<;?/FBR;1$T1-$31$T1-$31$T1-$31$T1-$31$T1-
M$31$T1-$31$T1-$31$T1-$31$T1-$5-U02TXH^Q+:U'W>023[?WM2!) -9($
M=:AQ@$Z GP7*&:=3U!AN]&.;)JQW(+F_N:>5D<V7#91XD6AB5EA+=G4-4VT]
M*S&5"76.R,@H*MR+D%36O)G1JZR268[O0-CWF[VZ(_S4O%RXW,1 K2"9"YSB
MN!B]!4@")%X@6K,P)D6$KR+ZML";]"913YM)M9&8.83*I'<=31SZ^R9IJ3(9
M%I,3DLJE2S21:W)\?,@LJFV:G;%,2+"DSZZS81<; Z1T8$BLUN)D;Q #9@B\
MB)E1SIF'& 14Q2-9('<>N=<%S#K7PRN7@R,7DH6O+,LVZ1#5D=;)AMY5MAGA
MRF5'W"PAN/(,F6U/A81DPQ:)/2AVZ+$0HC.KE-\V=LNX#O;L@$D!X):YH)+#
M!@DB#2Q!$5!->< UD$12^<@<(,=DS(7:];:ILHD"P9$AAB<F.\VU-B.,2$M/
M%(;[XQ =8+H//+RCV<@D=OMXW0#2E<SU@0)D D7-[!;->3%34C(:QI->S59#
MJJV31%*I/<./^OOTLEU;_B^,T4J2"E2/62KN<*U$)*>YQPN%;JU _5''2M;B
M@E;BE*2DBV\(]6L7GQ\]<UF,, R#%9B/UKVJ0,M)67$H"7%(::4M)*5J:8+J
MF6E*!!4VVI]XH;)* 7%GCDG55I"E4RTEMWA*4]Z5%U2@I?B_4_#YD<DF0E+8
M" EWQ.$ (2 D  HH!PBO5'C1:0WX5G2:/$V<(1CREN;D8C\K/E&]!X.$*G2G
M<D^)$V+4D"\37L=]0B&IB>)2$IA.-K"U"K_4/^85SL8]U8K700<<7(91;J!(
MB>O(T (B%KCR!>! 4.[@I4 I*D\CE*DJ!"@1Y$$$$>1!&N%_VO\ J^*X'7[_
M /4Y89*VZP*;.RZUF8=C<RQW QZ'B&;S)5+!DR<KQ6#%FPH^-WSKS"UVM((5
ME8Q'JN5XL.7'GS&93+Z)3R5X3']AQ\_F L'LD&W2, 0*2"*=E,IFJP#<?IUV
MCW6$%[*<::C3(#-75/R,9:8HYMOC54R(,7%[NQJC!MG<:35>D4QKD3 U%JYU
ME$AAEJ;*0\^>P?.>@7&<(/Q '3)+1K1O1%B'"ECDT" L[JML]NJ/('LKI,(Q
M.GR:1\9)=O:K'JRNM2BYG,65NRB;#C,OM,6DZ-'DV$=I:&)CC#/I#;B6T)"3
MW]GS?YA=8P6@DB!)FU)X"8'9$9+.5-I7P%'CW%14I/ /M)*"%)X]O<D]P]H/
M.K8?\3#_ ,[?]0\ENR00!P'917OI>..#'-PW<;P>\PAM[?#<YV^1>&2AS*,F
M>R-'QME]<A]]T-5-Z^ZJ1$B1$L54?PULP8<=KZFGU[ WC.EY@"W S$D9ZKNP
MA6:$DY< +TR&65EU>GV#[P_JU5=*Q*N0E-UE?"1ZUK!4KGSY/R9A'GSY]_S>
M6H!-1H:=H"?/SWKF3=KJMIMJ,S;PNRP7<"R,W*,(P6KOZ:E;=HK#+\^;>ET-
M) F2'V6Y4WT5KPY+:.0V^0V2E?EJY@$B.%*Y\=!3.JYW8CA8Y7I0]45X5K!L
MMOXIN=4Y1B]+D$ENRQ29;5#M@]C64>CU>2UBV77E6$:PJW5ER,] [2@OI+K"
M4-G@N APQ RK%^R.,U' 5@"ZKZ5A@'>< 1(,DS(O'1 T@B032X4V'[LX-GN+
MXWG&*9G17&+9?&],QZVBSXOHUHTZEE3*X(==07$,I4XR[&)$ER0ID]B"L-F8
MM47CB>-3V12:6S#:L(B=X5D"368F(B;2=3E0A89MOONWN/&WK<BXU<U=ELMN
M-E&VUI32?!4_>6M!CV/Y=!FTSH5VNQ+JER>M7&:6 \E2@TXE*P= )TH*Y3GG
M:1)%X KJH&T3OD&-W(B.(O!H*.'=5:WV<ZV=L=Z)F*0JR/D.*OYWM2G>7#$Y
M7";K6\CP1RVBTLB9'E+<+$2=7V,^LC.QI*D+5\:15("^U[L$1PTG.Y[X$1VB
ME5#=J:;D-D$B?/7K[<EU4G*:-:XC*+NK>>G%Q,7P9\=8D.1'5IE-QTH<4I[M
M6E<;AH+4'FEM+"'4* ;I.8O2#>*TX9>!A;^DX-)B2,C20 #G,S-*?%4FLPQU
MYH/M9'3.-%I4E3K=G!<;$=*TL&0I27RVW&\50;<<<6AM+_:EM:^X#403'&U;
MW^:YV4^D8%.DTR39TV/Z$3I-)@BPPMP:^;D60XZM3E><>E4U:W8SI$-B)>3[
MRJ3;QX587'PYZ5$B.LID^(V%KDH>9CLN *6E!)@5ZO&MJ4^;P-JP"8I3.L3>
M,P8%Q/1@@U,*\C,\;:90^]DM*6E,+FJ?59P6&U5T!Y2+*>VDR% QXSJD,..!
M:D$=H)2?,H)_N///W5"':L U!;$$BL4$-F<Z@D#.:4,JNG)JOPI;OQU5J:A&
M,U*?,V,VU'EK4 &9*EO=L9,L.1 PEQ14IQUY*.0DE,0<Z>_M%#U:^^YQ<."1
M!I2ITD:YYUF+76F]W>H:FVHN-J:%='D.5S]Y[R^Q?#G,8CQ[&$FYH\,O<U6Y
M+DJDLL^B2*3&+65'6ESM>4E("@A14+ 14P:&*P)F+R,J\5S8FT;I@5F8(BF5
MS21$D2,^I7W:'?G!MZ, P[<;$[()J<VB2)%/76A%;>*<J)TFIO(3M9**753*
M^\A2ZQQ,8OH<4PHH64E*A $_#PZNX2:+1NTX1:#F0*5WIBL"DUG0$ZQ"Q_,^
MH*MQ+:7.]V45,^RA81'S2;\2*FT];.R:NP==JJVETDJPG,0$.2(D&5:US*WU
MN2*^/%;* _(XU,=AF@(()%!<T)GJ6#]MPVM)D"#23 =$R 8F16@WG0*3()WE
M@.2PLYPC$<UA-NMPLNQFAR>$V^ AYN)?5,.UC-O);4I"74,RT)<"5*2%@A*B
M.#JJ[&.#V,>*A[6N!%H< 1[UEOA-_M?QJ_+HK)X3?[7\:ORZ(GA-_M?QJ_+H
MBQ:O &29. !P$TON'[D3[?G]@]O/SZ(L'W7W.J]J\3E9-:HE2E+LJ7'Z.LA(
M[YUSD^26Z*7'Z6,PGN6/3;!Z.AQ\@I3%+TCU4(44R ,]#G%:QU6XY3=<[\1S
M1-1ZL4N>P6I)ZX"Q.TZC-LJ+.J7;.^R1NJS"Y3!C.5[C+TABHN;)NK?@8[:V
MD=M<&!D5BW:LNU55(<;=GQ.)#1[2"8M>D"OC[HKF)LK>E8+8#B-X1O"3>Q!@
M4@@R!6U0*+84?<3#)4R; CY;3/SJAJ9)MHS<^'XL2-""46$MYKQ^YB-5=R5S
MBHD,.$H=4A0($QQ'S6:2:1X]P;5LY) (-Z D4%S)B8^%M;/5;T[67M3,OJ?/
M\8LJ6OD-5LRSK[F#+BQK*0TMZ-'=6T\6RXY&4J0IKO2M(C$J"0AW0";97X9]
MM*TXZ(-HPB29&Z#Q[K4H#4\-0LTAY#63H+5Q%M($FG6P]+19L2HSD"3&#(?\
M=N4T\Y'3'BH46WI"G0E3C9/"1RE+YZB+SV^53,;-Q,-P)@$$ @R0 .C)\:B)
M%LUC\'<C#K.ILKNMRW'Y=-4@?&5FU:P7(E:%M)(,Z07THC^&@IE)4\6T3$N!
MN(7"!S%>&>?S\.$JO/X-:MZ)BA,4<9F9)GU09RUHI5[EX4W3_*-W+Z)- N0B
M(Q8HL8AB/S%*[3"1)+Q'I2%I<6Y'*/';C]I=0D<JTBGS_;,=684>D;/$RV/:
MDP:Q$#QK(F9BBQ>?O/CE?G>"X=)D'T+<R)+5@^6Q7695%?V]976=S:4;"V5*
M[)3-#52;.,OO\-_L= 5RWP9B@-Y$R#2#;+(S-YL%0;3A%Q B#1IF08,&LBLP
M,JZ3"W:DE;""L<*]BT\@\*]"(4"H<!7!)'(\C[1[M"()&BU!WHC/WJV8B G&
MZE(' $8CC_[5S4*;+(]$31$T1-$31$T1-$31$T10/D#]XZ@T!ZBBI=ZOG_$/
MR:RWW:^ \D3O5\_XA^33?=KX#R1.]7S_ (A^33?=KX#R1.]7S_B'Y--]VO@/
M)$[U?/\ B'Y--]VO@/)$[U?/^(?DTWW:^ \D3O5\_P"(?DTWW:^ \D3O5\_X
MA^33?=KX#R1.]7S_ (A^33?=KX#R1.]7S_B'Y--]VO@/)$[U?/\ B'Y--]VO
M@/)$[U?/^(?DTWW:^ \D3O5\_P"(?DTWW:^ \D3O5\_XA^33?=KX#R1.]7S_
M (A^33?=KX#R1.]7S_B'Y--]VO@/)$[U?/\ B'Y--]VO@/)%(X2IMQ)\P4*!
M "22"DCCA0[3S[/6]7Y_+G5FO=O-K]H::]2AUCU'W+GW(NF_:3*\FR#+,AQ]
M^RLK^K-7.7\>7D01UN5@I7[F J%:1359%\5!$3Y3URHN1-L([6[(=J=>DW:]
MH:(;B0T&D!E*U$%L -% V( @" N<L:;BIZZ_J3V=]->_J6-OFXV.8:F^RJ'@
M4:ZH+X;?W&0/Y8U.RO&[\9X[-^5.92+W.W4SY3%<U9M1<A:0JNHUPB$P[:X1
M-.VO: "\8G2#34-8TP 2 1NUB\&F8$T4-8W>#=VD@&)@FEH)H121%HFRS9WI
M2V"=B1(CF 5SZ*Q,)-.X[9W[L^D;J:SXIHH]!9+N56-#&QR$7$XK%IY4*/BL
MJ3+L,=:K+"9*E/<C]MVC$];$G_HP@ :UAN&-3,5.9H(Z.9P_Y0ZY>.\[WB;"
M<EOR/";B-1FT^+]21%CI6X_(??+44\,)>D/.N/OK]I<=?=<=?*EF0MPJ63SE
M[W&9]PM4V XGP4AC-+ &9=<$1GE-14&LS*NO>KY_Q#\FHWW:^ \E*=RC[_Q#
M\FF^[7P'DB=RA[_Q#\FF^[7P'DBA[3Y^?)\_W_;J0YQ(KF,AY)=3^$W^U_&K
M\NM57<;IXGS4CC82VX4)]<(44>T^L$DI\B>#Y\>1]OLT0-:"#%N)7*'5$S@Y
MI=JU9V,I2R=]-N/DH[B(\9Q>:MVTQ6-MY&MU*GVL8^- RF\#;@;$)3J2 V%I
M%7^KE?J/JN&5^/D25GB@1,&>E72A.?'(9<!"LB%%0Y)Y*RX5>SS*2./9[./N
M<<^_7GXA(+NOW[T^Y>5BN<'@ TDY#^HZ:J8$CV$@_."01]T$<$'YB""#Y@ZQ
M5-]VO@/)2%*2KO[4]_'!7VCO(_W2N.Y7_&)T58Z0=F#O \9F8M>MJJ;17.(\
MW=X#R4P)44I[DI'( 4L)*4^?'<H$$%(]I"N01SSY:OA_Q&?YV_Z@C7$N;)^T
MW359_P!/C61IQ_+G<ES>ES9;NZ.?/4"J54<LXKC#F1/LTV%SE1VFO&LZ%ACP
MI$N:7[:2ZZ%SIDEPE1]<1!&EC4\#,ZQ(\"++U,+*L5L#,#3J)GLU71R?8/O#
M^K55TK%*_P#[<Y3_ ,*0?_1B%J!=W7\ BY1ZLMN]PMQ!LFC <:@W?R"W^V\W
M5R!V;;P:U#5/@\V5-D,L1Y+@,B5*$HMI<2 ZCPTEM:">1<B2>L^!\!6Y@7T"
MY7@T@2 )ZZ'(7CM)/<M'9ITL;G95O;D&0!^MDTF2;^;:[K1LYDV9-WB^!XCB
M%537VS<*M4A2'*S)'J*4W,4$+B2X>7V<J053&(SK$$3:!)S,YD $7@7)X7%C
MYF)L&)B8F(\'>YS$+P<FBIW9DR8(%!]D1T3"YWG]$&_3NQ^V.U5%0X53RMMM
MGY>(0K.EM8D14K/&,^QN^A9-&0T\S%A5MO5XO7RIU@N,B[1*/HOI3<5^4R[)
M ZB*9WF:F@&FAC19GDW%<T< 1((.\=XD.C>$4,5!INV7>&QFW.Y&!3NI^YR/
M'ZYJ1N5O5;[EX3#8N8,I#U9,VZP?&(T:<^VZ6XSRY>%..2#ZJFC*=#?#: D!
M6214U%J7)$YV-AE%%V-V=S><, EQ%)!%;D$TBMZ>7'^,=#F2T'0,WM(C;ZJ_
M5"N;38SMS/N',FCSW5MXWE;%PX*G()$UY%+!GK,J:N'5F&J0ZN.B8EY45A;*
M_$FD3D3/:9&>1FRH-E<&$1TC:HAH!F@!K-.H21NGHK.G^C"_^GZ<XB-286W$
MN-MG?U&*8[D[%8QMOEV%99?9[FD5;,R',E6%1GN37LMVP51S8X=:/@/%4(-Q
MT"-*B 8H(@5 R(I>N53GS/V'$YS>95OLAP;!H7"IB"28X.F:!:AA]&.]4+#Z
MW'$8+BD66ULOU<[?6HC9;&<8E93NGGB<SV8<=\4]TEC%8ZU*KUR$GXH*A&9#
M4=MN.@ 1]F36X--/&M1!C-5]!Q1$@#UFP7-DEP<1PEL@W@P)DR#FC72QOF]?
M7&02\>HI4Y-KT79=4M2<GB.O761[!LOL;H.O/+\0,2+N-)->N: V[9,-(0ZM
MTN'E!F8O6H%2+Z7T'#*J>A8TR&B982"YL$L$.F#FZ-Z*@YR*XO"Z-]Z/0,1K
M[' \;E?$V/\ 7)CL@IRJ#X:8F^N<3\PVO9;:"FTJ^3#,IF$RTL+9IT-J9@ML
M,M-M)0= :$1G(I2#<7B#.MU#=AQXJ!5KA=HJ1(-,VDT,B2(, 5G:Z2-_W:R[
MI9=0U!AWVTO2/CUP[09A5QY;6XVT3.??+G+A%FJEP+:/:7$_&';%5HT[(OJJ
MKDN+*I#J5ZB,X!IW&N5:P#[Z2 .S#PL7=#2;,8#6\#<U)J6S,Y325O?<7ILW
M/RVAZ'**TQW';F'LEG4C*]U(U#:NXTWZ+])K<+;N/$QN/'DMR&X[=AF34AV'
M'D>$VU #+),=(3J;Z"F9C7J@S84C,9KI&S%S6API-2(J7$$:VB9OVB%8-VND
MK<)[='')NT&/8E0X!@,_IKLL'CP[B572XT';C=:5:[FT*FW5/-P6;C$;%IUV
M3"#,K()CSRK9Z:^IQ1@FL@$10$0#2QG6:K#%V'$+R6C=$C=U$0 09!UDFH@W
M!IJ*3T9[VS:C<&KGXQC#U9E43K)QO&,,M,BAR*#%Y/4%DJ\EVTW$$3U8ZI./
MP7','L*A"$S(GG)KO1HY*-2*$-BE0*TK,&]IB@FT6!7!B<G8I)@"N\ UT#=W
M@0UU'"U-T$7 $1;ZP;(TM[B.SVV6,Y)#3!NL9P+#,:L(34A,MMF?2X[6UDM
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M+A[?5!4A'8D<)4!V!/EX?'AD^L4E7GI!X?>'FDCC]T^2B,@H >1-BCU"WP.
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M$*4-L<!( /:!C-&H$@>21VUO/)^8J_?U7>Q39Q[Q3L^"N"RD@=4?HB-EMG5
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MHB=B/VJ?X(_)HB\;C322LAML$NN$GL3SYQ5$^9'/F?,Z(K7B1YQRI/EYQC[
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MOA(\/&PVX9( NTF>UPS)BR]5@@3F*\<N'42+>Y=*L*4I2N3SQSQY#W%/S#7
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M;B<MQ3./5,>)*DLJ3+0"W:P"#>H-,NTYQ%YX$+J^L<)IW2&NAA>2"XSNBH!
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MD64G&<LOH-0PN/C4./ E0KNBJ\7N$6DEE+HLUOQ'HS@;DHDX.RP20X $S#C
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M':7K]_.D/3%+DU-O9PX:VWP^F-+*0YZC*D1GE?K]_P"JZ&X#&AK6B&M  :-
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M@L2&X;A2ASP M#:DP(@<;TM<#KO)ZM5 V40 X;QF9M<>K0VH+TD30DE9';;
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M:"))AQW&H$Z-1O?5Z9B;&D-53Q+M>B.LE6DUG.E<Z6K\>O4J#L6S$@G":2
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M4%)Y2E1'(<2.0"?-3D="!]]:TH'M4I(Y(##?(D^ \U!Q<.##3,&/6OE< =Y
MXJGZ6XMU*4/#R=4WX:&VG"X/""BKD.\H#1/*E$#YBDCS$$.#H^R*9>-2:9QI
M$*6D.;.>NM+#KG.G&*GBYK%J2]EY,_8TB;>:YN!F4+Q+)U3LEEBJO9L2MB--
M.V#G8A3+33*%I9\59X6LNNE1/N;'LVRO8,1[27-:'278@;O -<32!2X$]8BI
M\O;,?';+&N #@00 TF"7B)-C2-2!%UJ[?.BBXAM9D^48=BL-&14Z*VSJX[>)
MV]X[=^BWL=N7B\6N0EUQF7?1@Y3L6LA/HT%V6B7WLEKQ4]HPL"8+9J00'F1
M!!,&@,=QWK"GDE^-3I1G.ZV#6" 8(&M:"*FTZ'D;D6^+?'E1-V"=RV=4Y1+H
MHV3/0\JK*:YD" ;QDU\''<#NDPL>GQ9<*%@T^QM%O9I 8FWTFSHA'7$=DX.S
MNLW=!!H'.)$=%QDR"6NB8! L0I#L:1)I+9EH@34"@%P"9D:BA"O>:;DJPG#L
M?OKC8>KAV^:9I(Q7"*AEG-LD<O*UOXV:@7L]-/B\;Y.*M9M?515.W#[%97MW
MYE2BVS%"D1S.S3$F 3(!.\W,-<*P(,MIO& 2Z"9UG$B8H;3 H'03$UB#PJ1
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M:^PR3$\PJ:RT*4U\NTHK.K<L%OD*@QXJWVBP9-@A2)%?'4L2Y4-Q#B8P6KM
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MHZFL %Y.6IZUTOJR]%-$7EDKX840X&R$J)<(!#?J*Y6>[U2$_7'GRX'GY:D
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M+29#KCJY#S'K&9!$1E,@T/2J"WQB95SREL)806 N+F.:[I$#=YS>%08#I;:
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M$-A? "^P$)YX];MY/'(U7<:"1%>SC4BM^O*Y7BX6SN:2&8A&D;N1$5F33=\
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M38<2T:VIQT[5']1GU:>_ITW:Y]_.'6_/[_,/GG[^IYSAX_HJ_4O*PL3^$_\
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MZW[5ZG)M,1@R+F'K(+!G&5>KB"OT]HO[$W_](G_%K^?Q_$?UN_U+[7#]5O\
MD_\ 8KEJZE-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-
M$31%3=<2RTZ\K@):;6XHD@ )0DJ/)/D!P#R3Y#VZ(L?E6[4)R(Q*L&VW9TSX
MNB-.",P],F-M)=EMQ$R%M+E^ PS)>0F.PIQQ0\-"75);0X,6.<"XSUT[3[P@
MK[K1XGWV[E< \I/:'W$M -K+KO':TD) 0M0<6%(2MM\H2TE9[5M%:U)<(!1
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ML3[/$<PN)^W%3 R>GV]QO+\?ELR7'7_$L-OXM[D\B;<RK.SEXC$QFO;+X;O
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MOB=$G(+%N.%Q8JSF_&P.;>T,G>:0P %NY+6@-LT'-TS4 @%H#9G?Q# )H1!
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M;5S<P<:8PFCV0:BIBW=W8*@-1GL1RYY\L4CC2T6,EYQA?A(Y4@1%KQ?L'?\
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M?L@_WLO_ /'J6W'6/>K&Q_Z/])74.#?ZD<?_ .#F?ZU:]3#]1O4O2POX3/\
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M3"1<;,X+:M5V$)VW@MSZE$IN-@C;QD,8RVV\M2/BV*\0Y#0I)=A$)$5QD(2
MWL3V9XG>D^']LD^K=@I_]+ATXXGY^/DJ5[TI=.>36,ZWO]F\+M;:RKL>JY]G
M*A.KL)47$W&G<:6],3(3(5/I5,M"!:^(+1AM 9$SPB4%O8GLC\7DK#D[809&
MS8<]>)I!CIT)%S=;,Q_;?!<4NLKR+'<9KZ>[SE^-*RZPA)D(>OI<2,Q#8EV
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H(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g423260g21g64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g21g64.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2,R4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (Q:^B8(X0DE-! 0      #(< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  64&%N;F5E<G-E;'9A;2!4:&EL86MA<CA"24T$)0      $,(6#G) O"V#
MC@@']_L0UFPX0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T
M    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#;')M
M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585
M  $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3
M &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB
M=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O
M;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
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M9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO
M;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O
M<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-!"8
M      X             /X   #A"24T#\@      "@  ________   X0DE-
M! T       0   !X.$))3009       $    'CA"24T#\P      "0
M     0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ !
M &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M   ! #4    ! "T    &       !.$))30/X      !P  #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      ,U    !@             !$0   8
M     0                         !              &    !$0
M               !                         !     !        ;G5L
M;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !$0    !2
M9VAT;&]N9P   8     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L
M:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M    !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T
M960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P   1$     4F=H=&QO;F<   &
M W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M   !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O
M;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M
M#T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
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M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !R * # 2(  A$! Q$!_]T
M!  *_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$!
M 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2
M,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D23
M5&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&
MUN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A
M<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C
M%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W
M1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#*ZCU;J[>I9K6Y^6UK<FX-:,BT  6/
M#6M:+/S56/6.K@2>HY8\_M%W_I16LCI>7F9O4<FIU%=->;=4ZS(NKH&]S[+&
ML;Z[F[O8-R'^P\O_ +D]/_\ 8['_ /2B#7/%XMIU'UO9=90[)S-]7TB,JQS"
M016ZIMK+7,=<UY_F?YS^<_<019]9]VU^5FU'8ZR+<FUDMK/Z<MW6_P" ^G>W
M_ ULM?9_-IATOJ;22W/Q 7$N<1U&D$N=J][OTWTW_GN3.Z1U!^W?F8+MH(;.
M?CS#OYSW>IN=ZG^$W?3^@DJCX_:D_P"RW:TB[J+B\D"MMUY?HUEH<:P_=LLK
ML:^IW^$4?4^M&@^U9V^'N-?VB[>&5N?3=?96VPN913;59798E^S.JS/[0Q9B
M)_:57![?SWDF;TKJ3?HYV&W4GV]1I&I^EQ;^='N251\?M2%GUN%ME)NSP^K?
MNF^Z)KU<UI]3Z3_9Z/\ I?4J_P!(F>/K=7NWV]1;L;OLFZ[VMC<3;^E_1[?S
M]_T%$=,ZJ"2.H8H+OI$=2JD]O<?6]R9W2NI.!:[.PW-=HX'J-)!'\H&[W)*H
M^/VM<=7ZQ_Y8Y?\ [$7?^E%K?5+J?4[?K-TZJ[-R;:WV.#JWWV/:1Z=A]S'O
M<URSOV'E_P#<GI__ +'8_P#Z46A]6^GY.#]:NC^N:G-R'/LJ?3:VYCFM;=4\
MBVDN9[;&[$E#BL;[L_KCU+J=/UHZA53FY-53'U[:Z[[&-$U5'VL8]K6K'_:_
M6/\ RQS/_8B[_P!*+8^M&!D9WUMZN*#4T4>E9:^ZQM+&M-=%32;;BUG\X]K5
MF?L/+_[D]/\ _8['_P#2B23Q$G?<M@,^M9-8;EY9%M8M:\9=A:&N9Z]?JO;:
M?0?97MV-M_?K4)^M?JMJ.1GL>]QKKWY%S0YX&_TF;K?YVQO\S7].[]'Z:B.E
M=2:26YV&"8DCJ-()VCTV3%OYC/8S^0D>E=1< '9N$=KMX)SZ-P=P'^IZGJ;F
M_F>[]'_@TD4>Q9-=]:7UBQF3G/:XM#-F1<[>'[VLMH_2?I:=]3F>HS\]+=]:
M@X,.1GBUSC6R@WW"USPUESV5T>IO>YE5U5COZZBWI?4VAK6Y^(UK/H@=1I &
MD>T"[VI#I74FDEN=AM+C+B.HT@D@;=Q/J_2VI*H^*1K/K:ZYE0R,X^IL+;/M
M%WIQ8WU*WFS?[:]GY_\ P=O^C3;?K@=@W]2W6#<UOK7;H\7,]7<S]_W_ )GO
M41TSJ@=N'4,0.B-PZE5,#MN]9,>F=4)D]0Q#V_Y2J_\ 2R2J/BU_VOUCC]HY
M>G_=F[_TJK/2NJ]6=U; 8_/RW,=E8[7-=D6D$&VMKFN:ZSW-<U"'0\H"!D]/
M '_=['_]*(V)TS*P^I=+OM=193;GT5,LQ[J[QO9938]CG4.=L<UCVN24.*^K
M_]"IE5MLP<^MPEK_ *Q-8Z.8<W)8Z/[+EUG_ (W'U<W[ Z_=K#3?!@$MW;?1
M_DKE;_Z+F?\ TR,_)D+U&UE=A<'U>H 2)E\1N+OS6),< #=BWFA_BS^KYX-Y
M_P"O_P#J%+_QLN@_\/\ ]O\ _J!=)3750\OJQ]KB-I/O.GAK6C?:+/\ 1'_I
M_P#I))?P1[!Y7_QLN@_\/_V__P"H$O\ QLN@_P##_P#;_P#Z@75?:+/]$?\
MI_\ I)+[19_HC_T__2:2N&/8/*_^-ET'_A_^W_\ U E_XV70?^'_ .W_ /U
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M>&/UV>B8@[CMV_:-O^%L_P"W+/\ 2((]L]OQ>-/2>I@D'IEFX:%NU\@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                          #_X3]4:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60]
M(E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS
M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U
M+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @
M("(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^"B @(" @(" @(#QX;7 Z0W)E
M871E1&%T93XR,#(S+3 W+3(R5# W.C U.C0P*S U.C,P/"]X;7 Z0W)E871E
M1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!0:&]T;W-H
M;W @0U,V("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \
M>&UP.DUO9&EF>41A=&4^,C R,RTP-RTR,E0P-SHT-#HS-RLP-3HS,#PO>&UP
M.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C,M
M,#<M,C)4,#<Z-#0Z,S<K,#4Z,S \+WAM<#I-971A9&%T841A=&4^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA
M9&]B92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/DUI
M8W)O<V]F=,*N(%=O<F0@,C Q-CPO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/E!A;FYE
M97)S96QV86T@5&AI;&%K87(\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QD8SIF;W)M
M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \+W)D9CI$97-C<FEP
M=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @
M(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O<U1Y<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @/'AM<$U-.DEN<W1A
M;F-E240^>&UP+FEI9#I&,SA!-44T,S,U,CA%13$Q0C%$-4(T0D0P-SE&.45#
M-3PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT
M240^>&UP+F1I9#HU13$S1C$R-S,S,CA%13$Q0C%$-4(T0D0P-SE&.45#-3PO
M>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C
M=6UE;G1)1#YX;7 N9&ED.C5%,3-&,3(W,S,R.$5%,3%",40U0C1"1# W.48Y
M14,U/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-
M33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HU
M13$S1C$R-S,S,CA%13$Q0C%$-4(T0D0P-SE&.45#-3PO<W1%=G0Z:6YS=&%N
M8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTP-RTR
M,E0P-SHT,CHT-BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D8R.$$U130S,S4R.$5%,3%"
M,40U0C1"1# W.48Y14,U/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z=VAE;CXR,#(S+3 W+3(R5# W.C0T.C,W*S U.C,P
M/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A
M<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R
M86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @
M=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T
M:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO
M=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A
M;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I&
M,SA!-44T,S,U,CA%13$Q0C%$-4(T0D0P-SE&.45#-3PO<W1%=G0Z:6YS=&%N
M8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTP-RTR
M,E0P-SHT-#HS-RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&
M<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T
M4F5F.FEN<W1A;F-E240^>&UP+FEI9#I&,CA!-44T,S,U,CA%13$Q0C%$-4(T
M0D0P-SE&.45#-3PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T
M4F5F.F1O8W5M96YT240^>&UP+F1I9#HU13$S1C$R-S,S,CA%13$Q0C%$-4(T
M0D0P-SE&.45#-3PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T
M4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.C5%,3-&,3(W,S,R.$5%
M,3%",40U0C1"1# W.48Y14,U/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^
M"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B
M92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @(" \<&AO=&]S:&]P.D-O
M;&]R36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_
M/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_  !$( 1$!@ ,!$0 "$0$#$0'_Q  >  $   8# 0
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MTOX2TDP!YQ=Y;?$/7L40';MV^?B(I1$?2(YY=,%Q>$L=AV0M,X2$44,1>.H
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M*>:W-&+OS+<(=$Q4F&V6'44:E,5!E'"#B3T2L2ZLB^GR]$8  "@WQJ( "RA
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M37 L2)J8NJ,-P8$ $.3,0M%$8NMB1B)+5#M-@H:HN;C+[4G.&G9RUEB5AEW
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M/4$[-=45T,)Q!*4Y103*3;AK)D+=H;U'#=\!<0 %_/N'%<1DAYRN<!Z3TW$
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M"4R)-//DX+M@)8J(<C75'U5]'9Z+ YI5W/)TP1I/S_I-80V$?/$UM;SKV$+
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M:U),WS94PS*HYWLQ$9NL<5,7<1D\#>_<*CV"H3K$VHR3#?RP<0 %L2&U.Y;
M8"AXKG !)DKYZE$0PG.!> 1@%KHXX2)QO+-SBTF-20K.P=&OF/;B#5Q=K*T'
M)3'@RI"^G_)2DIO.>BDO*C'!!%<1EO>]4< 0-JV(BZ0L&L7;LVXC%AL=@31S
MB:] ^'8R)V)H7N!EB#&Y%Q! #D$NP!M7%R*YN9,$;FVB3DE@7I-3G?WVKLZZ
M$*$BH+[7 >]G'=@CO<6T1S?-7O.#9TKB ,7%*EPXTX8$/4L[":T=C39.6O<X
M<EH0P%?:RH6-31^4=?%6Z;50;"BRWZV*<N24<2"JFUE&1#<5OB4P#M'5$! 0
MML$+"([0NH3G3(%U31P 9W2<8#%F:; Q0D&$@$$1 PD$2#N[$3E,N31@%NUT
M&_F%:2?L,)7N-K!C,=[%]GG7=X.>";?S[7UHUA;H+NB@Y3_NFI_ZO]7,86-1
MK/,JG!KPP?M<T2H73$]$BS?=D$GN-;F)M:GC]0JOPF\.6?G>R%;#N2#/H]DD
M[!3G_*8F(O&H\\*N\)/!>3:K/G@6^/0V=#;R$?QXJ7_;5>,6KAK/-"O<\$_!
MH^KCYH%L7J_3I=>;KCJ+:;\C+N!%9,4S0>2F*,*>#FY;JQF:ME*)G,=ON5%.
M6',B4;$,(Z^H/E31<^WI@1A/5)=BS<6S@2:3AP)3)(:8!F;A.8!"MH]&17F(
MH+L!L2;AD),&E$;:')MFH8)<B4X(B$"*MPRG<!!;XPUU*7(0' NL:%$VQ!"(
M83-]_P#G9AR(W31@.-C?NY*S$K]#FIZ7:L9X24O,N-QGDYM6J"+A &44&&"$
MDE*=R&$HW%Z##+\]#'6UCCK;(FV'*=#SG?IG5"#6FC7.5\V$W(H]RRHI>CKR
M$S$E.<D\L*2Q+BHC$G5V:*HJAAW5\IKF+M, $&'JW,(ZHD /*VQ/3V<R!P)L
M/:XJ["KS&G9=;!$P1,$3!$P1,$3!$P1,$3!$P1,$3!%(%_Z$J7L8J_D!@B\-
M7)%_FQY,?]5F0]UT#$QW:_\ N5\WX6=_9_5P\]HNK.#T!?(3V16Q^:KMBCE-
M3JAYUCE/S,?5GUXUFYR+?]+N;KV9IA^WN+&3?(#7'ZT*O\"_E+;S#ZQ5:\E!
M^8]E=[(SY]QA\;(Z#S(N=1PYIDGG1^K M=60CH)^DU]EW/\ HQ8N*4??'BY@
MJG4OYD?/@]:):(DP/X+'18>)]L2WJ?*5^7#U>F%\;@ 8CHAB.NC;UY> YCQ
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M'6@W\PK23]AA)]QM8,:1WL7V>=<'@YX)MM$5H.(&(#D"PMT%W10<I_W34_\
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M[4$][!%*%&E;%34^=GD1O)S<5I:4--RBH@$!/4Y,=76N4P6U=4 &]P-K<0@
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M!3G_ "F)B+QJ//"KO"3P7DVJSYX%OVT-"+.*&BZRCJ*9RH55N3+W<:7*1Q
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M8\NHU)IVK2:!/J4!V[H,"IY95O@J2$XP3ANZ K1QN9$(+C@I18<4Q2B<JU$
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MYH-9=J&@H2E3M[TQGY- <:0W"3;<?8MX5M5'<%NPQ*Y3[S$$D-S:H1!,BPQ
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MC4>>%7>$G@O)M5GSP+?5H;4]2F]%SDV6DR#&GIAHJCY<9$R5, 'GT\7E5Q#
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M.C#<*6DL5GO1T4A?K*0%6FI7&DKU.%3776RQ7C5M<*C!KN4T(1%NU2!MP]<
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M,3AJO?1@M;CK@$WOD6H35F$FO$UJLTU:U*J.C+S1RD(L^$?>TV@$(Z6L2
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MTA6ION:3N1*NE\5[;@JQZGP@$"(P9NV$-IQ(D]2ZVR#5VEG+3QM]:=RZ7 !
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M#&M3:3HMLHTJG!*[JN":>[?2.:"F%/DC#4BHBP.L!0$3 6&CFU>,=8PV -4
MQ9#B'"9#/*@P;%M.I>VX+,>I\!+M#"<3+-.=0%H2'+2XRML.]^HEQ *B2=]G
M$R4RX^L&^ 0V=.PF]8.DFPFX#M(<K;AQKM0?*Q$C.##N>+$.=-#Q*)WM5"ZI
M$/N*2/AX*4WM5"ZI$/N*2/AX(F]JH75(A]Q21\/!$WM5"ZI$/N*2/AX(F]JH
M75(A]Q21\/!$WM5"ZI$/N*2/AX(F]JH75(A]Q21\/!$WM5"ZI$/N*2/AX(F]
MJH75(A]Q21\/!$WO5'ZH$KW"I']_8(F]JH75(A]Q21\/!$WM5"ZI$/N*2/AX
M(F]JH75(A]Q21\/!$WM5"ZI$/N*2/AX(F]JH75(A]Q21\/!$WM5"ZI$/N*2/
MAX(I;/R-1DN#'49=X2*N64(,SN7,M6$GDF]42B!!5BQC"4UA  'E8[+W$  +
M*!S-M0Y.@4R:(5HQI)S)GGIKC)UXR^26E6"M9BLL"Q)B P%S+[,K4ILZ41[C
M$( <5[%B 7I;0'I"&,HKJ$$<;@ 7&6G2!@5\UX6SM8(L888KW?.BQ>7<U(TS
M#JFLX/0%\A/9%;'YJNV*&4U.J'G493\S'U9]>-9N<BW_ $NYNO9FF'[>XL9-
M\@-<?K0J_P "_E+;S#ZQ59<E#>8]E?[(KW]QI\;36'S8O64\,.^R3_<YH5KL
MR#=!2TFOLPY_T8L+%"TK%J]BI9)\Q.J'^[$K[\C!2T&9JMFG@SD&!,0!93"+
M^^0O<!67%L$;  %MM$?.$!  ';CH#3AJN+?IQ*UP6G:$$/(D/<T4+,"')$KR
MPNF"O9 "*W]ORM2/ORL/;YUK!?\ GOB%[\DL);0&XI*(W 1OL0G>TQ^!@L5T
M;CH&ORC<U(YHM;E',A./SKVMQ?\ 5M?U-N";-3A]E6TT71%3FQ*\S!,):1+#
M, $K*\TR22 7]0 MK7V7 !$;[#!<;8)LQP;V+HFI1I)X7GH+?E@VC^^Y-( >
M+;>]C!^(1#ICQD;IR_XQ4UW 1OL0G>TQ^!@B;@(WV(3O:8_ P1-P$;[$)WM,
M?@8(FX"-]B$[VF/P,$5,M=$1XR68NY:>(%57%LYC  N*S$ PV* &&^P1$!L/
M2#C'"<WD7//TE=1 S!M'3$W3VJIMPF_]CTKVO"^%@B;@(WV(3O:8_ P1-P$;
M[$)WM,?@8(FX*/\ 8Q(]JP\$3<!&^Q"=[3'X&")N C?8A.]IC\#!$W 1OL0G
M>TQ^!@BX;A(^L0-R4_;K7 90NVWGV((]+I#;^G&0[V+BYUC%.TA)8EC/B-XE
MLX[EJ?TVJ>FRFC%S33$G)R,M,"VVT(S,M)D&QN$IB7N!-@F'6*-O4$ #8-\1
M,7<3X<8K78\B5QN%&<>I]H8A$3UO^=G D] +G8D.TY.%YT-!OYA6DG[#"5[C
M:P8TCO8OL\Z\?P<\$V_GVOK1K"W07=%!RG_=-3_U?ZN8PL:C6>95.#7A@_:Y
MHE0NF)Z)%F^[()/<:W,3:U/'ZA5?A-X<L_.]D*V'<D&?1[))V"G/^4Q,1>-1
MYX5=X2>"\FU6?/ M\>ALZ&WD(_CQ4O\ MJO&+5PUGFA7N>"?@T?5Q\T"S%K6
MY9MM9AP3EZI;P9++>&6E[2+<E9)8*@IBA4R&\F^)-PCZI1&H$-O1## &P" #
MK"!3&$I1]ATL<*TD+Z7EEU[+Y8WAL&J\[M;5)!8 D!8_5,S45&ITGU%I\JN-
MAS">V)53II)S*^KN].J09SERT1:L@MKBP@.$0VN1(WNW:?EM9;(<!#4N..JM
M#-Q(@&;SOV)TG*>%.F"N=.9GZU-]I/Y;@-5NK<"GDLUUN3"4E%R&*]3.J(L(
M6.\P6U]QEN5KBM/<7N 6"(1BFN#0*8=:7T"['1*M]>.23:1Y <6:^5]TIXJG
MPS:5DB1)DDQP"R)&Y1@U5UJ1G7/$B;I:ST?+, J0X4)Q';Z'  8;-<984:.,
M#E<:)*"].4&ANPJ=_3IA<FK]-G'O-%3#ASJ+JM!82$ID1$Y)J*WE-(J+-34B
MK4Z<B 9;-4)#15U#7>$37 Q]Z"0)P:D1WDN<YBO0IXK3&(K35?IQOQ:5U00
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M1(=0 IE*H(2SBW_)=.#)QV.%+D$$166U=OB+E/F"B5C*N@]8)"F90L\PQ81
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MERX4*8_9*#VA5?!_$,,1R[ECU[3^)=?"52S[(P>YY3\'\2T/C?A*RZ_%X_\
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MPE"9^9IM_P#1*Q\]PE,78 AJF-:XCL#RH )@ /+".(##:3SUF;]+RJ67-X3
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M7 !#;>]\;K3JJ;1P!?<ST$@39O<!(S+@LM,#$B0)<F$,"0\I:A4&98&<U)1
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MD^#@\'C<WO)V3R3RGX+7X:^!I>-&P8+&SCT4+Z[G$;\8;/*&O;UO4"^W$"*
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M:_7DT+[I2?!P>#QN;WD[)Y)Y3\%K\-?":7;1K@7_ )9-%"\>S?.(?SW((?\
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M_%YAF1^+%Z)W)VOV_P#3Y1]V??3R V>7K+<V/X/-7_%YAF1^+%Z)W)VOV_\
M3Y1]V??7'R!&>3K+<V/X/57?%[AFQ^3BVGW%H[6[?^FM_N8]Z>0(SR=9;FQ_
M!ZJ[XO<,V/R<6T^XG:W;_P!-;_<Q[UR\@1GF#:.2W-@ >>.7FKP#^CO9YW'L
M#9LXL6<P@=X;A?*6 G/3JUW3U"M[.P(%E;.(>\%E&:L&E$7+:"O4OR.-0ZM%
M%FYFAE:RT@JG2.;7U:FL1MRE4*>O!@&6@@ ^]W8J+!>R+ CQH,*)&@%BDAB8
M?W:&4P$*<#E"$PDO#%"&+@ABY+$-$+R"SX+T_ O)H\FCMH;6SM+(RS1'!'#)
MHF(!S26S;LTRO8@5=R1A1:M5:J49>TRC5(*G5:4T&I#DG%E+I?3YVO.?1DI9
M020QF%2&WT:8&# .8!*4L0Q#B<HB8HB;6/O[HL #%)I!YX/-S)Q/2&:5CA/D
M\>46,,$$$4<H@T$$41>(/-@*@2FX+FXE>3 N0G/*</*Y+LV!Q,-_*9>:NFX@
MVV'@\V<5Q_F&XVQSHX(P:$:6B'$V9JN.,EXOJ?U"MC&8HK"WAJ.ZLXX:#3&"
MTWI,TI**\@-GEZRW-C^#S5_Q>8G,C\6+T3N4=K]O_3Y1]V??3R V>7K+<V/X
M/-7_ !>89D?BQ>B=R=K]O_3Y1]V??3R V>7K+<V/X/-7_%YAF1^+%Z)W)VOV
M_P#3Y1]V??3R V>7K+<V/X/-7_%YAF1^+%Z)W)VOV_\ 3Y1]V??3R V>7K+<
MV/X/-7_%YAF1^+%Z)W)VOV_]/E'W9]]/(#9Y>LMS8_@\U?\ %YAF1^+%Z)W)
MVOV_]/E'W9]]/(#9Y>LMS8_@\U?\7F&9'XL7HG<G:_;_ -/E'W9]]/(#9Y>L
MMS8_@\U?\7F&9'XL7HG<G:_;_P!/E'W9]]/(#9Y>LMS8_@\U?\7F&9'XL7HG
M<G:_;_T^4?=GWT\@-GEZRW-C^#S5_P 7F&9'XL7HG<G:_;_T^4?=GWT\@-GE
MZRW-C^#S5_Q>89D?BQ>B=R=K]O\ T^4?=GWT\@-GEZRW-C^#S5_Q>89D?BQ>
MB=R=K]O_ $^4?=GWT\@-GEZRW-C^#S5_Q>89D?BQ>B=R=K]O_3Y1]V??3R V
M>7K+<V/X/-7_ !>89D?BQ>B=R=K]O_3Y1]V??3R V>7K+<V/X/-7_%YAF1^+
M%Z)W)VOV_P#3Y1]V??3R V>7K+<V/X/-7_%YAF1^+%Z)W)VOV_\ 3Y1]V??3
MR V>7K+<V/X/-7_%YAF1^+%Z)W)VOV_]/E'W9]]/(#9Y>LMS8_@\U?\ %YAF
M1^+%Z)W)VOV_]/E'W9]]<?($9Y.LMS8_@]5=\7N&;'Y.+:?<6CM;M_Z:W^YC
MWIY C/)UEN;'\'JKOB]PS8_)Q;3[B=K=O_36_P!S'O7T,A&>2P#Y"[-C;;<?
M(\U>U>,0V_P>B \7G[!\[%C,(<9A:3R(K@&%9"8*6?!W*8+",G)[8&9 ZW:/
M4R SR0]^.E;,M#CE+S7TUTD&6Y[5&RQYAJ?,M#CU1%PO%X4<J*S6ZC N4;?#
M>0RK*TO()&R(FBQH4$OER_NL6$77+KAK0!%"9B*$!@7!#N)&C4P!DN[P2ZFV
MN3943:65I9L"<Z.".!R88C+/-[ @-0'6O?-,_P"6'_\ $_\ X"XL"O%%S%?1
MH^^/%S!=F(6*8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@
MBXP_\H;_ /+_ "XV"S@KQCFB7?&^>'_WP_-X+*.@U^PJ')Q#Z_\ P#$Q5.L\
MZP@[X<?,5SQ"Q3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1
5<(7']\?S,;$FO%#S!9P5XQS1+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g423260g22g59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g22g59.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1@D4&AO=&]S:&]P(#,N,  X0DE-! 0
M    & B^85(X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M         #^    X0DE-! T       0   !X.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!!X       0     .$))300:      ,U    !@
M        O@   ;X          0                         !
M      &^    O@                     !
M !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG    O@    !29VAT;&]N9P   ;X    &<VQI8V5S5FQ,<P    %/
M8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '
M9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90
M  !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P
M(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   +X
M4F=H=&QO;F<   &^     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M    #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M    .$))300H       ,     C_P        .$))3001       ! 0 X0DE-
M!!0       0    $.$))300,      VS     0   *    !$   !X   ?X
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MT2[W1M;_ &T*12#^T_\ SW_^22C^4_\ SW_^20\3JG2<AE#GL919EVOIQZ;
MT6/=7N-C?2'O8ZMK?TS'_P RH.ZYT#0U.KR!&XFIK717LNO^T_F^IC>GBW?I
M:?5]3_!HT55XIP/Y3_\ /?\ ^2699U'J=%KFVX%UE9>YE+JGV'<)_1.=K8YF
MZOZ?Z'^<_P +Z/Z1;6+]BRJ1=54W87.;[F!IECG5/]KA^^Q&^S8_^B9_FA"E
M5XO/NS^L^J"WIMWI"=S38[>=&[=EGJMJ;^DW^_;_ #?^#1#G=1W[&]-R![PW
M>;B6[=P#[/;[OYO>]BW/LV/_ *)G^:$OLV/_ *)G^:$J57BX;\KJK'VM&&^\
M"US:GML<QIK;LBU^^VQ[_4WV;/3_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 /_A/TQH='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_
M(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@
M>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#
M;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @
M(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S
M+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,C,M,#<M,C)4,#<Z,#4Z-# K,#4Z,S \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/DUI8W)O<V]F
M=,*N(%=O<F0@,C Q-CPO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP
M.DUO9&EF>41A=&4^,C R,RTP-RTR,E0P-SHR.#HR,"LP-3HS,#PO>&UP.DUO
M9&EF>41A=&4^"B @(" @(" @(#QX;7 Z365T861A=&%$871E/C(P,C,M,#<M
M,C)4,#<Z,C@Z,C K,#4Z,S \+WAM<#I-971A9&%T841A=&4^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B
M92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/DUI8W)O
M<V]F=,*N(%=O<F0@,C Q-CPO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E
M;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @
M(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/E!A;FYE97)S
M96QV86T@5&AI;&%K87(\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q
M/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QD8SIF;W)M870^
M:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @
M(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E
M240^>&UP+FEI9#HU.3$S1C$R-S,S,CA%13$Q0C%$-4(T0D0P-SE&.45#-3PO
M>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^
M>&UP+F1I9#HU-C$S1C$R-S,S,CA%13$Q0C%$-4(T0D0P-SE&.45#-3PO>&UP
M34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE
M;G1)1#YX;7 N9&ED.C4V,3-&,3(W,S,R.$5%,3%",40U0C1"1# W.48Y14,U
M/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I(
M:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HU-C$S
M1C$R-S,S,CA%13$Q0C%$-4(T0D0P-SE&.45#-3PO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTP-RTR,E0P
M-SHR-SHT-RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C4X,3-&,3(W,S,R.$5%,3%",40U
M0C1"1# W.48Y14,U/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(S+3 W+3(R5# W.C(X.C(P*S U.C,P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F
M='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^
M+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE
M=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@
M:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD
M+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T
M97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HU.3$S
M1C$R-S,S,CA%13$Q0C%$-4(T0D0P-SE&.45#-3PO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,RTP-RTR,E0P
M-SHR.#HR,"LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F
M.FEN<W1A;F-E240^>&UP+FEI9#HU.#$S1C$R-S,S,CA%13$Q0C%$-4(T0D0P
M-SE&.45#-3PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F
M.F1O8W5M96YT240^>&UP+F1I9#HU-C$S1C$R-S,S,CA%13$Q0C%$-4(T0D0P
M-SE&.45#-3PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.C4V,3-&,3(W,S,R.$5%,3%"
M,40U0C1"1# W.48Y14,U/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @
M(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(#PO<F1F.D1E<V-R
M:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@
M(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B92YC
M;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R
M36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_;
M $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M ?_  !$( +X!O@,!$0 "$0$#$0'_Q  ?  $   4% 0               0(#
M!P@$!08)"@O_Q !D$   !@$" P,$"@L+!PD%"0 ! @,$!08' !$($B$)$S$4
M(D%1%1874E=QD9*6T0HC,C-35F&7L=;7&"<Y0G*!H;*UT]4D-SAW>+;2&24F
M-DAU=K.T*4=GA\)$1EABAI.EP?#_Q  < 0$  @,! 0$              0(#
M! 8%!PC_Q !1$0 ! P(# P@%" <$"00" P !  (1 R$2,5$$09$%$Q0B87&!
MT3)2H;'2!A4C0F*2P? S-5-RHK/A-%1TPA9#=9.4LM/B\0<D8X(E@U5SH__:
M  P# 0 "$0,1 #\ ]MN2<@6B/L[:F4QW$QLT$8C89B8G(B3GHV'BG,J$0Q-Y
M"VGZOY8L\,+Y0$B/3 B9L/-S=V0Q8J'"V>XR,Q;MSU( .NY:=2H\.+038[IZ
MMC$$P#V2"+P8LK<^W+.'*4#WG'I#[  E-B.V&Y!V^Y$Y,MJ$,8H]!,"ARB("
M(', @8=)]9X^L<XL1;Q@@_CFL8K59](Q , ,G=J)(S$^U5 O&<0  ]OV.^@
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M+410T>#KV"B6ML@7E&;0V=*RVBZW>X"/2HT=<:'7)H'[.:R.:6);"(VI1=&
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MBK32[&"S6O/43.U61%P$PNBN-B#G?,$SI:]HC0SF %+=L)):2 14#0YKY:0
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M8SG+(#;&. ."J)>Q\@@WQF[6C\7RF#BMY7)CJ?@7F'I(PB]QBI7G]O6C;!3
M4^WEJLJW5KL$X %(Q@F*9#:GZ2_7=;>"?9K&^V? U^;&YFCGBGZ,[P9,!LS)
M!DNS,QO6UJ<.W ^N#D5!I)U76)T,$R!D\]VHSAWB0JPO8VG/WOMX!:1K448X
MIMH5THI&-U3*'2;$,H81 5+==QW^D[?OSB!>U]R?-K;@4!Z)'HD3UI#CU#)W
M1A@D9"+<S=8[X1U:AC>BN'^-E8/$LG%2>+/+\IE1GJ$_A8="OPZU2O'MJ/8X
M9>-@&K:#:-&3YJ5M%-THH@D9HE0+!YS(N=<>L[?%MVL7@^)5AR>2,/-. SC
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M)<1A-B3 ,B(FV6\>2]"BTB9$"T6OX6RW'M"RF,W0,!P,BD8%# =0#)D$%#E
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MG$AC',<Q3)@0O,!E5$@'F\G*=9-10R0 />G02*"O*)BE#P#4?3?S#B)D-!)
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M+*21*U3!FHYE:W<O*FT2=(O-O[.TMV(<F-Z6RFW:#3>7"DW9V.#FN)IEHIN
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M:  1$XG7AT%PW"%0T(+(%@9RGK.()/HR1:3<1![([H&X@+= 0$# **0@8 ,
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MQ[EC#6AQ<&@.<22X !Q),DDYDDW)-R4 Q@Z 80#U (A^C4<Q0_8TO]VSX4<
M\0\!PT< X<#*AZ2F_C$Y@(;TD _W8%'Q+S[CS;;<WIWU4;+LK2XMV:@TN,N(
MHTP7&9EQ#;F;R9,J0  &@0T" T6  L !D!%H4 *4O0H 4.4";  !YA0 "EZ?
MQ0   "^     :ENS;,QV-FST&NF<3:5-KISF0T&9[50TZ9S8P][6GWA1 1
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M_/P[% VBF2 ").Z\F.R9)U (("RK0.)F_,!S&#E3$IN<3^:(]! ^X\VX;><
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M^_Y3*^1HK.G2R" G!)%1TN<A""L<3/\ Q^-]?%/;WW_\?U.IG"S(EYX:LO\
M$-7>'.YC+2]]HR4U/1=<6%ZE3I&6F*ZD#MA()@86LHYC(A8[U!!VBHU;JN%E
M$^;O3AI/YMK_ .>" 7_/CK'@-TPNL?B<KD?C#M!L0UWAE8EJ%ED0HI['7:>W
M(S@T)EU;79WC>080I6S)A%/*4*+J:CS)@R<+G*9PFJ&QQ=T=FD]OXI%\_P (
M/?:/S>%Z(B-T%&Q4E6[<Q#HB15(4DQ2,"H%%8@D$HD%-0P )BB E-L', [!H
MBK]V3<3<A.8P@)C<H;F$.781';<1#D)L(]0Y2[?<AL13  % "E  *
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MSM.H?M"L-R+:UMVE/XA<9LX]CE*KH&21;R;=XU24C+_7VQ1[LL5+D %G;%(
M3B'3@6BAP ")D^9<M\B5.1G]8#FR3U@#:),.)ITH!&4"Q!#C,$]!R?M/26P3
M+A;ON ,B;CN%HMFNW=0X@"B@& IQ$Q3('5$H&4*0%4>4XCRI "  JX*F.P@/
MG .XB;G&4N<?-^LZ;WS)B+'L! L<KRM]YP Y$@F#<2>_2TY;BO'UVQ';DWFN
M7FX\+7!E935_VK/SPF4,[0(%E)I:415<Q\O2,<LQ%,B*T0]179S5B;JE52%
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M"3/;:?;[U(BQN;&)\9\=US&5\EDH7B$P<!2@3,^,>38.3EOE:$O+MYO*(.5
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MVCN)U^2J;'/IRP6#1=H@B1,6L(!C+.)(@KZ192$,',*9 $Y1*8!*7<"&\2>
M^:(@&Y=Q*/CZM? 7%O..QM!L1+@#;("\:>^R[4& (MU1&&US?=I)'99>"[[)
M7HT?6./VFVEHF5LID+!U1F91=-,I.>0@I^RUD7JIR 43NU8F/9Q)G)Q,L,:V
M;QXJ>2MTDB_:_D'68[D3;@6M<^@VL*;H!=3^C#P&'%+8<[%;#UB2!)D\KRPQ
MH?4>&MDDDG""9( DDQ))U-MU[+##L3,XRV"^T0P "#I=" RO/IX=N;-%RL@W
M=,;XV<0\.8R"1BI+HMK3/5YZHFJ0Z973%V[$H+%%0=CES8:>V_)[E*I58VK4
M8:CJ=5[0^LW QKL+*CFN<V2T@B8B6@PM/DFM496M4J!N(",;H%C%I!L)B0((
MS*]XO:+9I?\ #EP1<2F8XM=PSGJ=BRT+5]T@82'3L<RQ-6:^Y;*HF251=$E[
M P[A8ARK =LD " D#?Y)R'2%3;:=.JT/:VJ 03U88X/%H,L+@ 6FQ!(-['I]
MN<6T"X$@D7BV8@WW&'9W,#L*^74\<O'CQU(R+LS^5=OG3U_)',)EWLBX654=
MOCJF$RAE7*QU%3J&.8YA.(F,.^^OOW)S&4J+328VF<!NQH8>R[0%R;B7O=C)
M=;ZQ+LXG.5[YOL;6F,J_V>;NT)M4R.KSF^_3BZYDDP660A4J[4@$RO+SJ)I^
MUYTDES"()IB*9>4@FU\?^756H_E&HQ[WN :YPQ%T$OJO#HDWLQN(Y&",Q"ZC
MDQK646EH ):)( !! $&Q%Q-C -YOFO0<"*94SE,4AQ(COS&*41$Y W!3J'W?
M.(G WB!C";?<1'7&,:UC):T-)9)+0&DDMN21$DR9G4ZKU'.+K.)(W DD#<
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M!O)-C.=H@Q9=17"GCR]=H+GB![0?B)KDC X5HKMX' C@BRM5DW4/'*"5!]Q
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M>SXX@V'"_P 9W#_G:2W2JU2O[+VU=US)F)2+ W+4;:9L4HD$BZ,+*N'[0H&
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MD_9*3,-(TMDV>D<):UWT=*FR#=I)L 9@DB3)LN'>RK6VBN7E[V.KU'-!+BP
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M+X!\0?HUJ+74=$31$T1-$31$T1-$31$T1;ICC_/SCW_P/E;_ -7CC4'-O?\
M@5G;D.X>Y=@FI4IHB:(FB)HB:(FB)HB:(M"81*<X\Q@\XW\8=@ZCX>K58 ).
MN\Q;NXJ<X$"V@N>_55P$AB!SD VY2\W,4!W$ #QWWWV'UZC&-#[/-0J9DB&
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MSGVQ*M1F+!^)^(.CS.-,QX^J61*//)&2EJ[;HIG*-C*IE,5I(,TGC9PFA(-
M'O&3U'N73,_(=%<@@)1W-EVVM0=BIU',+;0TD!PG(C$+9W%YR(-QJU*#'Y@&
M<YM'=;PO8BUP(7GPRI]C48)?7IOD+AKXBLM\/5BCI<\U"MSMF&0&L)*HF'N5
MX.30E:E98-1FGLU:ND9PTDBW2*11ZJ<IU#=(/E56K4J>SUJ5-XIM%,N:]Y=#
M>J#S;WNOD'=<"0#U<EH#DYM-SG-.;G'(99$&&BW?N,&\K07KL$^)/.L;&U3B
M3[4K-N6*)'N4'):K*UFP2$>1JP5%9F4I['DF>C1>- +S)O9)&3> X 7"SURX
M,=PHH\MT=F+ZE&@T.)F0UE/$; %Q:\$^B 3A-K*[Z#ZEBXFQWN<<M2T#VCM6
M>G!OV*G!#P?3$;=8:H/LM908JI.8Z_Y;696AU#K%$ARR%9K$<V1K$$=90HK(
MRA6:DL3F*95\HL4RJFEMWRGVK:&FGSO,,N"*51Q>X&;%SGV @ 8&M,6F+++2
MV)@.. \F#=HB^^ #)-_2)@W 7;^5)(NQ@(3FYP5[P0+SBIW0(@H)P !%04=D
M>?[H4OM>_)TUX)>*K;&6[B-,[7(_\E;C6X<[G*]XM&@NMS3V A-MMN0NVWAM
ML&VWY-0!  &X1P5E-J431$T1-$31$T1-$7R[^U;_ (1[C;'T^[UDK^T(W7WK
MY.D_-W)8DQ\W;%;_ /2![EPVU$]+VJYMM%>+G]M4\AP6 QNJAM^NX#OO_*UT
M5<DLN2;C-:[2>M<^D1GNM94S"H(B '4  Z 4#&  #Q#H'0 ][^0->=7V5SVS
M$M<,0@$YQ,]4B=%D:QER0PDWF 77N9M/;WRNY;A?S9PKP'#/PI8NSO>J&\:5
M7CHF\OYJQU<L?7>T11,(VNBLJ0LF\1-1Y6&G7,C[!NG9FH"^9(%DFW<'42!)
M0_-[3L&V"I7?1+VN-!K:9:Y[6\ZPUCA(:T6&)L26R202 %Z-&I1 8US0 '$N
MLVS2 !V[C $Y;\AN@Y#[-M2&KS^0;XB7R4CC#C1IL>^9XEO!,=1.1)>[*V/A
M&L&1JLQQNBWNB4/3D'C-F^9MQ?0JJT.296.JES:POH\J.ZAVK;"QL0'5MH+<
M-Q#1!@!Q%C:)L!<":))<6LNXB &QON)(FUH %\YDS?K(/%CV?>3LE2=JR#+X
MJM0%+V=AHZS6/!]CDR)5'%<"E3N*#';8A\9*$+#A%LVCR'C6B:<0<Y2K(-"$
M(F)=:CL/*-,=6M68"_:7$,?7Q%U6N^HUTP",37$O;%WN):1!!@NH$B6-G"P2
M0R8;3 PZ6B [,C,$JVS;-79IX]BFM@J#:EA>*+Q!DR!3+34,7NY92XT65XK6
M-G>UJ:2R#C&M-J6YJ&#625>KIJ9D:1K[Z)/(Q]AH*DX[<-C^@W9N4#AFO7PD
M#$UU2OB'5F9@R"X"0X-< 7.QPT-. NI];JM$$@ AND 0"3&9!!@@#-:',G$O
MPRSS3.MDQC0N&CB*XA\D\;>4I_'4%8N'J^E6G,%978'84UP"A,64]XM9(BXR
M\?,/4)^5<KM'QI)PZ='>G=N%(I[-MS64VFKM( IM!;SKSA($%IPR#:TMD"+.
M,B+$TRYP :+N.X3O!SWB1?.,@1)PY[0*UX8=6^&@L38IB<2.;+$UF]YAJ!<;
M0%.D<.90"EQM/ON(X4\<U"8BZ[39BJR=G]@SNSD>3-^;JN@<R44JX'T=D;M(
M#>=JO?&1%1[FN;B/-S),DMPX]Q=)  @+1>&XG6 $DY &QD]@$VC<,R<UU]]Z
MKYAC@5,P[F,DB<QD2"/44TA$0$4B"/*01V$2@&O?V=HP=8!Q!'I">,^U06@M
M, 3(O&6>^%*H.XB/I'8=_CYA\=1M36M=2+6M:2&GJ@#>=%?:/[/3_= /W,EZ
M//L9#_3KR?\ EX<;%O\ 3*C:XKY?WY+IS>X%[V)$B^J]'D+])X?BX>ZW<O>:
MG][3_D%_JAKXZVS6@90/<NN.9[S[U/J5"TZ^P\G@.QT]_P GV]'Q_ITG0]ZD
M9^#O<5U,4J[U1NECS'+N=;M[O,8W4N<7!\IRO9*L0#JMP,M),MR@W%W%RUBA
MF LSB!WC-Z\E3@8(X5";(V2O6 (>XB?1Q/W _9(';VSK(U'EP)AQ Q'>1%R-
M<NX7N<H5U3'243#[:0O?D*8RZ;F/720*_2(S8)M18O>5T85TA,FN0 !4YC+D
MZGW-C/)U<$B:UG$>D_<3/^KL+VU@9%6;4I@-!(F!,Q<@"<S;7/C*JG( B;F[
MU,.^1;N"&:"F",HX*"K%F949(ODOE#<0440'DZFZD#E -1\WUK=:KOCK/RM<
M=2^8SM>), *W.4]6]OHY?>M;\3"VR-F&L@>7!)K)I&AI)Q!KE=0\BR;JND&*
M<L91K)O&[N,?-3(+E*W=M5%%ET.10AS%,7;$:5=I+>;>0TX9P/),6F0!F1?6
M<A=8N>;?T;$W@9$F(ZT3:V?B%N0F3'G P   /(X[M9 6Z(HCYI7+M5=!:,YA
M#E(91)LJ]V 54BG,8@5P;1(^C=V2Q]]9N!V^6:CI#1-F]7L%],W<9F=U[*S6
M3,]XYQ-)(1=T>3K!=W3['D KIG2[5-0R-0ISB&0N$D[FXB//'QQ8I>7A4SF$
M7*;8)$Y2K'*H)S[(V"NYH?+AB&+#+Q&(3$8#$:>\)S[=^$=MLI'VM<LX$ Z&
M[;!^PDF#"3CG2#IC)-&TDQ5.4Y$G48\03<LWC<556TB8'#95-8AW+=!$P* )
MTT@\T+?-]>/2=EJ[A/-YW_\ !E3TAA&3-=P/C!MX=HR"X@_R/ LL@5S&IF\F
M>?M5,N5RK3PB+!>)?MZ1,5EA,,57+45"F<-5K/$-EN8YC 9P)3;]X;FMT5PL
M9G)V<B(!/H@W)W7_  RBI3,6W#+#G8G>(W6)UW2N.VG--)J-PD:"^8W5_:8F
MJ(WQ>)B:=9Y=4]=>S"T1"/23,>P"$3CEWB<DW6,MY4NH QG?G6433-IT4ZFX
MW@B,YN!,V(RONC>YRGI_R\!NO[^ N&_G(*(]CRRTZR8%E9-C!LE7(HE,ZEY-
MNA*Q#-)(%D'":SR-8+G,BJV06'OEB*HIG.J76(\GUB20ZK!)-B^+G+]'VQ#<
MO"5B-=@)$-B^8 ([^M?PB)&LJK*3T)!$C7,[+Q<(A*3\5 MUGBA#M1F)A11C
M$Q:HE>"9NXDBH X2;J<J@+*[F+W@B.H^;ZX$8JIRO+\\_4C77+> @VAD?4M$
MY&),7()XKD6.@ N>: 0.]2.2G9)*Y;G)Y7Y,BH7'9T %=!T=P@978IE!<[*'
M/U<!WF^MJO1;3HTFX>NUC0XX>L2&P7., DDYDZWT1KW%XN<)=D#8 W M>(R
M\,BNP%$3=R43#N;D#<=SCUY Z@)Q$_C[\1-[X=]]>>WZW[Q6V,A^?>JH> ?$
M&K(HZ(FB)HB:(FB)HB:(I1(0?$I1W\=R@._]&B+;UCJ$$Q$BBL/.MR( ;NS*
M\K<RQ2@X'[T'?@"(#N!"%'E,&P;:B!H. 4Z?G>5YE<[]H1VR>2,A9+P[PI<
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MR*4921(:(1&3629O9EJ[(H"6A2V$U*;GAS0,?-BSK$N:P0X-<UTN=#<!()(
M=DMKG/1N[T<0FUHWB9-M1G,WN;98B[5#$F6)+#;9KC3-E8B\VXER]F6H2UEB
M*6<X5S!\FM"75&6AZUD6RV*-2)(-U$(:;>P3&OV(P(+LGYD715#7=R;4 =#F
MES7M80"0)>689FF()%1I@8C<!N)Q ,\\=#>\WW;I+CF0<X$2;1*XC%=KUAF;
MQ7+9MBL;9;D,=1EJQ)5G<Y&/L52JR+S,<J-9@FYXMID1RJPM,%,ILVEHH[Y
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MXUTQ5\IAGR#>3<M!,\(S.H!@&]/DU]1E-[7M+7R!9TX@3+1U1) :XNBXPF)
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M* ".XB8=Q -QW,(FZ^D1'Q$=,!U'M\E"U!  "E     H   &P       '0
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MY)T_ F^8?^_TZ?L']X;_ +ZE_P!1.8K:NXCR3I^!-\P_]_IT_8/[PW_?4O\
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M][K_ /$5_C3HM#]FW@/)/<$PA\$&,?H%5/\ "=/G'E'^]U_^(K_&G1:'[-O
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M*( 0H%.)C& "@ &$_4PF  V$3;CS".^_IWT11  * %*  4         #8
3Z  !T  Z &B*.B)HB:(FB+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g423260g22g63.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g22g63.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1K:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &KZ^:$8X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M         #^    X0DE-! T       0   !X.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!!X       0     .$))300:      ,U    !@
M        O0   BX          0                         !
M      (N    O0                     !
M !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG    O0    !29VAT;&]N9P   BX    &<VQI8V5S5FQ,<P    %/
M8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '
M9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90
M  !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P
M(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   +T
M4F=H=&QO;F<   (N     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M    #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M    .$))300H       ,     C_P        .$))3001       ! 0 X0DE-
M!!0       0    $.$))300,     !!J     0   *     V   !X   94
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MY4L4H[KMZCD
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "] BX# 1$  A$! Q$!_\0 '@
M  8# 0$               4&!P@) @,$ 0K_Q !>$   !@(  P0&! @("0@)
M P4! @,$!08'$0 2(0@3%#$5%B)!46$)(S)Q%QA"5H&1E=(D)3-24Z&QT28T
M0U158I+!TPHU1'*3E.'P&39C=H*BLL+Q-T5U<W2#M>+_Q  = 0 !!0$! 0$
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M[<V[(7]]JZ]RIEAJK:=6J2MFB748G/M&<!,.HQ)ZW\(]21K]K:OH^PIO&?\
M!72<J10CAL'<+ =+91-?=8/:G.SZ:"H> :]K4K^[LTN\5_)?1?8:;QEF9P=N
MLE75O2.2X>R,*A!5*-JC* RW0JY0L@PE#Q^U8MJQ57I2UIM,Q4I$1[10KM\J
MZ3/WRQSF#LVAIN]]1X\X'\:/W]^K,+P9RWT<U)D)^RR,'E:^0<19Y3+S]Q7F
M\+6+$@!LMX=J^#LAG/899NI(B?T/56%BBS"J(E=NA=I_6FY@-N8]WW5O33>
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M;ARCL--R !$0UI(@ 5/E  #@86:FT$>\$$>  %#10  [KN-   '<_P!#H/\
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M;0\L1:,<2#5J],W.X;H*$'-;ZO0N";]MC<5VU+L*L@)37*%*5I=03F^J7!"
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M.8AUVNTE"]ZQ7.W5%$6XM731J)@C'_AS"WV)4U01$4_Y/IQ>2K'J;(9R2!9
MFII8=5)4$F@#4L6AC2U,<N;_ $07.X)#D-L,I:IC(R_<-E5E01(U304=NE%7
M+=G&LRJD326\2X=F(D7O$DTR*F./MID*4XB4I0X,),Q.4O*F%(<L4+ !(#W(
M%0-+@,+4N*6AR0:E@X8D@$FX>HS*8:9B=28V%<*&*54O>'.=J@N@X(LU5(=)
MVF1",=LSM5! D>[0122TF/(=),B8[(0I>'8F;, ZT@U#A1EEZA@14N&:@H:"
M&A230* 3F-[7)4DBI)=S8N:@N2WCC0-E1#H)1#6NG37,(A\QT(=/AP85<TS
M#,6H.1ZRC747Y ^V&95IQTI*"4I*TNE)(2W,"G;W0SY+ ]T'U"/ERB/(7W?S
MM@ >[7N\P^>^EPQ=-0"2!=_!R[FOEJ>GIEE.$0I "3E%4C*H.6))2 =P*T:,
M!E78=1%H'7H/>J@._AL1']7"C"GZ@"2*DI)=M;(!:%/#%?6GK.G6FDO_ +N
MG-NQ43(3PYEFBC%4X&0<@[;*.%0765<M6C@312BRP=ZH<2D,=7ZPYA,("#^A
MQP RSYR0[,F9.3:OU;7NXJ=6AIX7AU YNC)+^L4J)V))1R+&CTK01X$V^ RI
M@;H@98B2:Q@3(!EB($[M$BH[VH1%/ZM(I]@F3V2 !>G%4K6KULI[4D^\0SHD
M"R4#_1WOKK&7IQ?SVUW\>=Q^]P#.GU<J>QQ[H7HD?91^R?Z4<"UA?@KH&Z0!
MTV )EUU]WF4 _2'3S'8= 4O[N7W&^^W.IM_,U5ZNO\KL9\KBO*MJ1H]9W_\
MFZ/_ &'_ (\-SG8?M"%^9G[*O]KX1O"Q21"F(4B94S@4IB% 2E."2AE2 8I
MT)2*F,J0!Z%.83E #"(\"<'/3^B5,1OT:EI&M>JB]?"(OHN53I%E6K$H(<L[
M$R_&T<GK"^ !*!6I0%4ZY@!14 ,LJ;G46-Y[54./,HH(\QS:,(B/4&KP,XD=
M.#,.\[,JY>@7+.W(\X!PN6?T<QM#E( .K=1!K6-H6=_[T4S#TZ^\=?,?/W[Z
M!KIL.H#Q)(4M3N2UV4YK;5C7VMR,3X;!4)"134CNN$N]-.^%/4YIZ[<ON\*4
MH VY@+K0<P[]HH;WO0[$W7>@$/E2Q:UI) *DD'0D -J&I5]&9CM'.<<PTQ)!
M22@/H5 $.&#!(%N9!?F!"Y,Z$WDF7IOW!\/=YCT^>@_1Q!C)\F:&"$/2H0D%
MJ;%[C06$8JD!*7#=@RTK<L/=\8Y5W11:'6= S%HBL1RNLZ<MFS1BX3*!$W"S
MIZ8I"*ID I"*\P'(4.4# 7A<(G&AC(Q&(E!6DN?,0U&%9;7UKH!H'JK(!8#2
MA:K/=AS/-KB.@7)CK[%<BSE43F;(F3)XE1D=45S=\+5T8ZC4RWUIY*.$X"KI
M03<P /"XS 8V2!FG8A3?:F3JER6]1+LY+BZB27!$-EL6=( O:CT%'%ZV-"^H
M$ '!M=$P'] #_O ?[?[.*<F7+2?SLM$PG6:A*W[,PN/OM1XNI2%#;8EG->8.
MG?W0TN<5=X?OH#U ]>,)MCO8ZUH=^8_WC[AXWO1H)^DI3 ?5:@#!^[VLWN\\
M^5</Z"8N<L S@F<.F+*FT6K_  GK   ,RC0 14:G_*A]YOZ@'7'TS-)'#)+%
MOS<NW:F/SLG2))X9,Q!E2NG40HSS+1TQ)GI"B9K9R5 E))4Y!(-#&L2B IF\
MC$*":8AT.1/8>P3WE3\ME+HNA#IPDM"/L(8L25)%7 U;O[7A48Y$XLC"2@6I
MEPX#,2-%FM"/"/! B9B(;,F9/H@F19@+DX#W6P8LG9BFDM]RB'L%.(]TD @(
MIE MV6A#52FM@1J_(,GM+C>+24XE8'1REB@<)0L'0%LKO;E1V)(C6(:YC) 4
M1, E,LDOWZ A_--H1*)1$1V'EK] A"4)U2FO\D;!F+;=^U!$6+2D_520XJ&N
M+T>A!<UWO6-:ZA"-7!U" =--D +$.4#$5#W=X40,!O(.A@'J(]>G"!"1]5-2
M;@.07]OBX'@N$2EJA-'%19S<$ [7I]\+7$5)H4YBS'D_4FDQ%UN;I$!-5MDX
M,0RC>*EH8OAT':8;)XU,- 41*!BCR\@@'-O#QG$YTMTIGSDD$@9%D5&E)@O5
MB]6-#'?83T02I\Z@L'*2%95 $BH=6&<,26->0/5,.2&-ZZ/4%G8CY!M90 U[
M_EU\M]?+W;#BI)XM.)(.(G#D5$O2OK32S4+:Q;G>AL@63+#Z911NS#N27T H
MW. &.:\!N<%70'T!><%E0-R@3NP#F\] G[ !O7)[/V>G%;\HE6R%MNA/]=$7
MY&C[0\/_ +:!^#BO?TCK_ME>#\HC]@_ZD_UT+^1W\KS_ .'C ^.Z_L/;>=>@
M[7/\M?DCL1V :_OXEG<26E8RXB:D[)6I('[,P :[> $4?H/#)4PP\IG9AATL
MP9PQE]Y&\33^CUN2\;F3-&%V\.DC"1.-<7Y+9V,R+I20>.K',7*L*0JBHI^$
M=LHYI5F;QNNJL9^5607,<@%<',/K'HCC^DPJA,6I1*$J<D*+I(%<R[]8DD@F
MM"Q+^M>AV!EX61,3)DRI*9B$%8E21+=:"SD(2D*!SFJ@5 NQ&90-V7';1Z1%
M&[#"W;1HSOMOV[&,9=&-INS"W/\ $D\]L./92S3=XG;G$3D,PAW;Z<#'\[CR
M*@UE8J.FKOCJKY+CX\[B/BY*T(G$I1MN?+F?.M^4)Y'N'G2%[;,G=I:PYDRA
M3L:6"\&N%BK7I"!J1[&PC?P21,&&(QMT;*4V=Q:XH\99)UI*7YIC*\DR[>X2
M1N\G'QC]J6'A2&0 /&I_=V5UM[0FOE@]N9K0=]=CUQ;.V\ABK(>/:S7\LN<H
M5FZ4>XX\F7T_V?)2Y/\ %LMD,Q9;%N1IB1LZ]13N2-6AI[O+%%AWI6DS3#>+
M,+B01.-5M>T>>W:!QS[Q[-"^P;[G8S'G9S[7V.;=E6YP$#.UVO7*^$-?FM:M
M^*0R9-U1YDS*LW(L\*71Q(-XI]%,:W+XS4D[)VA08Y8B(>&M=-K\R#**AF@%
MN[L/Q?Q8\X&[:CL\['XB+9< )98C\1T9KFV6]+Y/;18)6UZ!XWO7+@YCJ1Z<
MBK!LF===6-"-,Q1E259LVB74FD]5;F.FL!U%9K^.[=FG/<4UA=?>]&>HHSTV
MV-='?SA((JQ0[.$JCF'-+>Q8!KUKI=Z[3L)VD(>^F1QY)1(H16+:'4'E5<UV
M2>GN9[JM;J]<)=1T-9"".RG 5]=@\4H!UVN*@]W+GL7[H;6MB"[/OM33V^^'
M3[ 4!D/&^ ,;X6R'A"6Q$YQ=0JG72'>S6+Y2-M5A0":)/R,"6A7"QMP*D=I'
M*F5? BJKXX_VRE5-P@[NVM>ZM!?R(=;1]6I>O8:N0:ZQ/O@@@<$$#@@BL*;K
M_:E'MBTO/,3CU]^#9":LV +33#2E6":/AQY&ISD;F?O_ ,,I:\HR9Y7A4$6T
M&:B&OS>GRSMDD_*S<KI'"3I;:E6'<'M7QO",'YM\>VCZ? -9[P0L#@@@<$$5
M?]KBO=IZY9#Q_=,(TA=PT[.UGIN2J['O).M,#9IEII\I7<A4F!>KYHJD6W1:
MXB5D1A7.1:1(-D;=.Q;UGIQ")*)%_>].=1>U]M=(+FI_>>VE;>-:Q!>D7OZ0
M7-"MX6Q7E;)Y)6-RZ3T\VF8#&R[>JU,5;JWI<?$QLC<Z16HR9;RC"ONLK8@F
M+2[N#6%=01(F:N+>4E@$\]GGOA&KJPK>]N>FU17P?USB_MPSE@A3V%QVA5*S
M YEK-Z=IM<DX9B7SZ"99?RNT?UR%&,E4#NH)WBJ6Q<Y=1<@HFQ=2,5(BHF*P
MEY4V&V[WT.IH_,^Z#N\FX]G(6BYX3&%#8B(B)M#L1'8<F]=?GU^_A86*(K$)
M?6"5Y1-KTK*= URCK>A  Z" AO\ 1KCY2G$)4K,4L"J[:7NVMOY3ZQQ95@@2
M^5P3F?H;ERW<6%=6%XJEJ>,NTC1#9YDX6MY$4/8+;%.6@Q]TH\;<9>2?3BLA
M(][<)R=<51>HLV,DT:DODA0:K>R-4DD J94DR$+I</Q.'0&4$N4EV"206:I4
MH%R [AP"I-004I=FP7\EA5VDLPY:"K$$.3I>#]>W]H(+*^I<%9+!-Y+D*&:'
MBS2KB.BD:M9X/&T)-6&PV2HH5 F+#DD)-9_$Q5CALI6^OEO]CBXQ%D,;$H]S
M4Z>4[!*7+D4#-0BF8D5>Y%"$DU#,Z/#,""DUN%(8!W<AGV-="!9H<A.3[1K&
ML6BD,8>X^L$Y,R<_196Q2] <W>LXUKTO04K93YJ8+**U1]E&;37OZ6+W"R)T
M7Y&S$'RW(D7E7I9+5#%S?HP34L15@!1P22?JBI 42<,:!5GOT8%-R1R)W%@*
MI!3\%!]LI"<;#(RDVE$I6:/]159>=QH>+KM"5N,ZM:8'M$N4XT[R[9'3HR2*
M<$[Q6+!%M)))J-UR'*42I,GRM.;>HS.2*N"*,'<U<@BP3HL*79@"[@Y+$4)Z
M@:@H34DVM#R8%CL],W,L?+3J<69&K-9YBVB2I,NJ^OS0)7UXGJH./V<<,#C=
M7<3Z)9V;Q+@@M9#D2 1.(YZIR'- U2 R+L2Y8ZL7<69B74QT.$86![)1%'9Z
M'O(-6+':QG$Q2>K:_L@/\:FUT#741UK_ .40^[?PX\RX]U' H,YY.')&S_%X
M])]$YI&%(HW6 [ LL;V \'A@L^3F=*[=Y.;J"EJ9XG+V?<F!.3;-*C/JY3,B
M2H07X.K;'HHL390EPCP;6L73YA 6^ 1YF(ECB" <2\%PZ)TA96EYN:24$A59
M11B.D(9!2H9S*=2NLX ENGI3&U)F*^=*&B@J[5J EW+EJIL1K5DPT[?+N0GW
M9]="U<VFM((7#T4IGV6ORTI3)P\'=X KI>+R$MBY2RQM&O\ 6Y&34B+TAA5.
M%A$&G*BS(1/KJ"3PY ZR444021):A%0&2]*U!V(8F'C"J%@:Z,:*(W9MGVV+
M%TK3*[VI\Y0[-&TLLEQ&/,A1DJ62BK)<Z6U8K8<DL<^@6,2&JD.1HS-#;+Q@
MEF]O+7TZ\C!CI- KH/5'B88GAB!U@AREZHP@H#E3=0>ME,DOU6<0?-B#>V4?
M6T!+$-9B&8FX+D,8=OLO8;SCAJ_S%3MC6)FL8P]._P &+:15(ZT.OWL/.^KT
M6G F9$CHTKEYD*&%B.&J:U,@PK+4J0N6(TVFX/%EH"W('6)42[I2",X#C,K,
M0Z03F+NA82L$P2)2Q)(47=502UB7#T(:@%'T AXNT*(&0K','-MW*B.^O-H"
MZYM[WO73YAQK^C,U) L[D:48$O>E2*_?'O\ \DDY*5S+64UKY6 N*O1M\HB,
MO,?^;_4/'9Y\7]K_ &IGQCWCI<1O,\5_&!S'_F_U#P9\7]K_ &IGQ@Z7$;S/
M%?QBN2<G\[5&MSS^XSM^K;->Z $*6SV2FL/6E*#B;RJZAHRX8XC\K(UJ1R H
MXBE(BEMVZ#N"48LSH/$S-D!3Z&<K+ZXDW#9!N"&-6%2 =06<,T<7A<?C%*^L
M[EP1-<!V_6$-L=C0@DB+"()XL[KL)).V4G&*2$'&R#AG,'3\<TYP+SLW1DCB
MH$@?IWG-]8;\H=].,Z9B\,BJ@K=T]&W<ZZ[TUJPCI<-.Q2DW+AF($S<&SFQW
M)8W+U@X$OMAL-CH.8=;$=;$!#X]!UU^'RXHS5(^<I;*X-!2H-0/"\7IZ<2F<
M D+:]IE:/5FM#^]G,0&]OP$   J$EH Z"'=S,!R:#W<@"/)K[/76@WQA>EJD
M?-V H4*!<"B6'.]#R9H\N^4:=BOFR+T (?I&<HF))-= K2PO2)H!T$>8!'>N
MFMEV ^_?NT/ZP'CR_"3>'A;D2V%@!(<M5S5C4-V4CY[IJ1U=4W)/O;V14S3,
M;]M3&%/R.G#IS<];I3)%)L,K8V+O 2T]<I\F39V4RZHRFG1P?-<0'Q8W1A:>
MGD%W"7]AD$B4*T>)0_=@'687&\+0A)"<.ETD$)Z J$Q R$S I9(*RRRI)Z,E
M3("2A<I*!B642*!G< @V + 4(9JJ !)-05*VZ2': S7F_(>%[OCN_P!.Q;8\
M*6J1I4,N_P /H4U6TT;)D!ZM3LU;&+K+T\YFK65F_:OZ.YJRJ4C6'3B/<T9P
MQ56(:XA/"PC,DX8JZH$I*9?2ME45*=2!*ZJAD4,_29R!*0J6<PAZ0@D]8L?7
M4 SDT8 V -"0S E2LR22\W91QQF/%<Q>*?DQ%G)TRMQ5,AJ3=G3UL+^9BX+O
MFPM4&:5C._C*X2MLV;E)=Q5*>]"P/EG3$EM<JG4'$Q\_ATLD%,L4I20"$E(*
M2P4"$J21D(&:S!R'<9C@Y2]2>K5G)!90+.#<6#,X:LS76P;K?#PW,&_/?,'M
M??H= /GRC\^,3"^L#R![RSGMYQL% &-DEJE207'(U--:=_=#$CT*/F(Z 1#Y
M";6P#X[#]7'2X8/+%684[?A:T>H"7_$Y7\P/VDNUK/;D\ %#Z >8V]^0B/0
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MXY\   E!J Z$.@AH-!\/=H0\M\9^.+J58.X % X>O;UA7ERCF..3$AB]=BS
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M""!P002*+)@)2*'(@[55*@9911$BWB$F_I--LW3T47Y$BG5,5$#&[LG?'#F
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M#YP.7L_I0=*O[<SQ7&7@T1 P'.L8IDT4C (F$#)-T46Z"9@'0"F@W;-T$2"
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M3F$>&$K^HJ8E+@@))2'2"$EA1TNIMLRFN8:4RBIS+1K]1+E[N=?.U?.]V7E
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M#[QT7C/F89"2RC,#UZF6VC=44L>5JN\;$I06,P=Q>KA]S4\A4,33:-PB(G*
M&$ Z^8^73WZ^_I]_%6:#\Z0]'(!%OJ[;;1/)PRCB"2&!8N7>KNQRZ5/(P\^"
M@_PQ? (AKU<E0V _"8KVMB/3K_7QB>E_]S@@'U0S_P Z6*]K::/'G'RF85I"
M#5@E!K<E.=5.KW=M(E8]=*,HZ1=HL3RBK-F+EBU34%-9V[T.FPCL!,7[(\IM
MAYCR^_CS[!X=4U8#$[4(#@BIZIH:EJ6J6CP'I%%JE]@/Q86YC74@5A1O;UO3
MME*1LS0:I39N%DB%GK5=DLHU;'M/>N,:JY!0QC9WLS0(R3#+3E^B_JJ48U*,
M%/2JT8E5#1\H5&HCVF&X,A:4G*@YDE1=*63E*DURHFD*44YCF5J,@*"@K!,4
M]R0^O<:6- 69G:_6%%Q9\_9ZMB3RKQ%9B<2O+MBCU\I+UV[F9Z\P,O"C3)N>
MJ3]O#X_MK E@D*\^L[(R;&CVJ6H$F,<-JIKXY4PX?@L A=#+2U#8*#,ZOJ@Y
MC1@.L<Q#I4(%3*5N>0!(L+N.="7 =R&$+WLIYGR3?I:^X^RS'2+"^8MBZ[&S
M'\7Q*\*K+.%%6ZRDG+131F1>?5E4'[A5ESUF.4AUXTA@%$B8AB\6PXD*(8)R
MM5@/K .62"]68Y1IF?*DA60 0X<VJ'IV@ 49[;AB#$PI, -%3@B #J)E.7H
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MGD\1QH>>\KKY$H%)RG7J530MC*-;(.6D#DJ1)9;2>#FK&I5HBT S_!U&VI2
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M2X:AZH T!KIS,&E6K-;I5>AJG4XQI 5JMH WA8UH(MVC%L4HIE;L6C8B:#-
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MG>:DK@ZYJ7" *!189R4E*2/5E%*LHJ0EIB25YR,G5:Y9\S%Z.6!626T<9B0
MDE0)"63J>25[4%9/3K5.X]IV1KTZAH:KSBC9;&F2ZA JFMCFHK,6SN<EZNX(
MV=Q$-=H1[*PC1E:+J!$'ZBE=YN\ U_!\&4O.DC-E<=7KI*DG*64E!2$L6"QG
M"B'2Z23#_G5$V+DA_55E*'<@?6)#E*0A@;.EB=X'[1-0S_#NI*KIJ1[R,@JR
MO/1T@^A$92/E)%H$K*0JL>,P$DFJU3#T,,D_J-1.$ET%03"(!0XIP=4M5DIL
MY% #<O\ F@&*:!20"XJ7N'$@FI)<A@4I4P9G?,DL"7)*E!G:@ #XR  9H_ 0
M 2^#DBB76P$O4.77D(#OR\AWQ2 RXZ3S4EVU9(^$:_"P?GLABSJ0174BO>2.
M^(2F54!+F$Y^H@'0QNO4?GU\NOSX]2&((P,D FB "*O=J]:/>&G#A\DI*JH1
M0E672A U>HYB/#.#)IB(J* .]CL3;Z^_SZ[$=:W[OUQ2BN:6!)*OYSUOHKS?
M1Y5XA<H9BHLWVC4TTS"M+\XBI1NUUB>]0+FQH/W"#-Y->AZ?"L&,S-W>?B8R
M.7E8JWH4J/K;:65AW%=BK7+D4*N9((&(+/ (3J/,&C)X/-G]8NP2[,H5#D$I
MZ"C"QT#D.IE1FS?2$R"$YR*J)J2"%U6D/B 0ZF-@[9!^;)$26@;'%V>&B;'6
MI=M-PT]%LIB)?1RJZK=>,E^C9P!U_9,!0$1*?>R=.4=@&LC/,T4^S%=7H;EJ
M6 >IUH8T_G,S=0W<ER&)< %RXJ=A8:P:]XK_ $QO^T-_?P9U_:5^T?C#OG$S
M^7_M?TH[$C&%(1$3")M#L=C[^O*/G]_$(G334*.76JG!\6\F(^DG!^LHN2?6
M4;]\=/./P#^O^_@Z7$;^U?QA.EF[J\5?&&!O':%J=)RE4<4/09^G;!#-I^0D
MY%5VQB82/?KC 13--Z@!4W5DL5C_ ()#1\D;T><X""0"/&OP[#S9Q9U$L]2L
MM2E@:ER6<CL:,;B7')DALLQ2647J0"Q#@_G0S-IUM"7!;@[./:+C.T+$VF3C
MX$L"O6I-C'J,C3R4T<5YRLC/141*E9H-O!W8Y!_CQBQ *S%ZW#&YMB)Q'#S9
M=BL'*Y&976  +T"7!9RQ8$E@&H<.XW,FOFF*47N2"0,S,_3%TI>E"H@C,2:Q
M(TAS;,&QUK?OUT+T]_O$.OQ^_C-P.(FK<%2WL^93D[OF+G<QKB9.,]/774CU
M5*9C<7AR\8<PR<P/M?XD4!\]B03BH!?F'>!S\H].?VOM=>,/CR)BEGK*J 15
M5&8EZ4!)K')^G,N<K#()46ZHNIZ*%;;&'M$NQT&MAT_1[A_JT(^6]<<ABTKE
MK <@$.Z26>W*_P!W*/.Y,\A+@FE Q[':O,]T-!G3*Y,+8SG+\YB3SGHEW7&
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M#)MD]HRQU 5*OUD[;->5TG,;$T-:V+5I5VJC94S/W[1Q;K$LV75*HJW7%D=
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M8L 8TXHQ-;)7&E"EL:XZN"U!F*; OJ6=*.5<JFISF&*,.N\%TX-SO7(#L%3
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M!CS$]@QS%$=QG@DIR"B[L<B2Y8N!^:+T%"='UM#T?&S9<VP(=>,W9R,KESX
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M2AWB9^*4[@QE DI*2U1UJ',6;-)"@&H*W9R]"U #]I  ?>OW$&A9F+O68D<
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M('*  ;6^80Y3".@'BB%S+!1((%RKVUJQKLU@+Q3Q4O#@52G:TMRW<Y:[OWW
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MZ>0E)/T1(ZJ0^?AZ68 U8&K@%U"A+;0X+=PF\;MGJ)A%J_0!VF("/*4@^0%
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M23IZW+LI4Y1#5^M(.]'',&%/H%Q-(8(Q- S?GO[)'3^&'&H@/^%D> C[NZ=
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M(,D4$=% .(62TU2Y@-/SBU+H 0!^<4P'W-NT ]*N')8A&&8!@D(PX#FK]7$
MN-PR2">4. *Q1UK0>?N#KY>[8>7S^/% X10+(3E;[%'?F /96+2/2[!J!"C+
M6W.20'?[6*\UC>QG(^&.=>0=>%!P/L<Z950V'PV!M=!#KOS ?>/45@<0I-5+
MJU I9(<:C(P)J'&ALYC$XAZ88-"B4*0@"X0N4EZ:Y<4+LU*DW8FG4%^J0?\
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MJFHD)%"@'4?=T#77R"PC#K!H"&?U0K<BX2+\JZ]C$\?EH8F:%N=5"X+,0J<
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MM3* ]6H=>TQ3PZ^*3J&?/(O69B"311(^L 10-44JP8%8%UKD'H0 Z%Z<FM"
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M)O45B)D #?\ &G97SVP-V\Z"O;Y&L/D"28&*8$R 8A.[(8"% Q2!Y$*(!LI
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M@X)!7?0@U)+WI$ZN!XQ=%KFJS#-UU357'6O)8,'( -[.3#@AC^R]=,T1'Y.
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M!KIL#:VH'Y7Y6^*^%"DFBB!34@N_X-X"&3U3\'1"U!Z$I4L,6)HV5N<<'/\
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M4Y $;,G R2 1+3K=*+. S!!WJS[[,Y;%VG(L&L@R*JX82#<':0*"*2Y"=/9
M1'8!UURAT$=_#B)U&Q-R'J;$MKRN2+6K3'"Y!N$N]PE(=^=&\U-8W/"H>%71
M>\ID$6FCF(&RG]X ?0:-\0V [#8^_A"I0U- [UV-F-.UPW-X4*DL^5)>]$#F
M2&/?2NFE$_B4*>;%&.1QZ#LU(+4*ZYJ!GQA,_-6FL* L$WYC;,=R_P!?6\_\
ML/0V]#IN-5,%U$$ .Y(9KNYJ7HQ%WI8QK 2BY*4 O499;J#:::BQVVAQR%$
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M>C(EN2PEK2'T=@I+,[@*?15B&'G4_B885?H%'>AK<LP#UNQ!<R$-O0!OKOJ
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MQ:K4\]2 ""EQ<Q "T'<X7Q!2,X5,44K2J6I*LJ@I(+@*"ED*8@%+L$J 4CK
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M-8Y7THZW#9HW3,/<I)%[Q <S-MR@((GUT]D%1'6_N^'OZCUX]ZQ3?1\H<D5
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MQLT.L9NU5E'9TDDU'"IE/;O0HGYJH97)EA3DL&< @,#4EBS49@6CN_1DLB8
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M62+Q$'RB_P 92UQFJ_;CPZK%Y(*XCEY:JI/P/SD$PIBH(',42B"BIA" H=8
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M2S&%Z/-L'D/(,5E&4BW%NX(FN=(XD$0+]L@@(Z\_=OX^0A;P7R>>C^&(Z.2
MV4!I&%!#6_P#,&H&C,QDY>*24S22%!O646N_K$BKU# 7#5AMOQ/,+Z 0BI,
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M:2<0L+$,$V359PNJV9,V2#9)5994J8'4,([7#>%R<&E2)2RX 3F*$ D4+,D
A78EWJ'U,:V"X?*PJ2)9ZUBK*D.'H  *"@)J22Y?2/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g423260g22g64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g22g64.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[11P4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %%2^4@0X0DE-! 0      "H< 5H  QLE1QP"   "   < E  %E!A;FYE
M97)S96QV86T@5&AI;&%K87(X0DE-!"4      !#_:K_5@\&E&_Y=LNRGHR4+
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0%@            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M         #^    X0DE-! T       0   !X.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!!X       0     .$))300:      ,U    !@
M        @P   E,          0                         !
M      )3    @P                     !
M !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG    @P    !29VAT;&]N9P   E,    &<VQI8V5S5FQ,<P    %/
M8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '
M9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90
M  !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P
M(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   (,
M4F=H=&QO;F<   )3     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M    #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M    .$))300H       ,     C_P        .$))3001       ! 0 X0DE-
M!!0       0    $.$))300,      G_     0   *     C   !X   0:
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M]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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MUE*JS<%-5VVOM^EMI*FRG$H552EJD^A<8WH7K*4S.6DM%GSIB*O.9QH,R>T
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M2TYUDAJ/U#A,0*@+Z7AVF=5N>M:!@N,\LM3?CB^.I WD]0 =8B.^W$=D<X
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M. #92@Y!AQ32]=ZZ;MG*=O-"TNEUHU4L<5=S*N;>V[/S7S1V@PW$U+:($SM
M<O=X<!R),[(PEFAKW&@RC1[/]?!8Q,4P=UR\R2X+@B&=W<@&\@,^7+T;JKF.
M2=>'5!J;N>%401JTA)?4JRS.,'9P1+#(C+F!@>)A,ZCYQ@3!@PQ&1<OHS :6
M,]&?0T=#LX5"B2#+.H,^3!TC0L69N I1).@#1PBSQK?.\VX<2D(?KO<!$\T9
M2#O9%8?QG7,#(]H;><XSQ[4:1TSVVURZZ#94"P?1W]3D$'B)(EPS2&;]I;9-
M23T=KV\8R!('/]C(;10DLX!WPQ*E2B<>_@HAG/8.8.Y?.,AE;_BNXPTAK,'U
MX\3[YM2UZB1_L;1?_P!$O\F(IN#AV'[5-F\[*6E?]#.37U:ZW;UH:DN.ANUD
MM5PEP.!R8BW*GE/D/"7/AX9 ;;SP;$]DO=N)UX#7D<!+$,""/1#] .\#QOK,
MQ'&?H'LL@3:JMLJJ7$TU+=44^:NQCX66XD[)0V@$]LU[>NV"R4O$=J8S#9#@
M40P)8B[QHV@[=>G*J'9DAB"09=B7 U;>)+6A09X!SU(.+6=8@0FN!+2-75O:
M<FU5+#/H$JW-_J$I1EB<3LS);:/HPB<0"6V3LF8(E,8)9BD,$2Q;A+!R9 )C
M7B0"Y8"YJB5XB);>3+E(YS9 #=CJ"@_YT5(6S-_+57V2U-3MXX9-<HH5::C=
M[44$NH;ST:2P0N11GLSEHLIR(*X4!$O-UDHFV8!$ '  80\ @NU_5);0,'M<
M6K1A[0#YI4E@Y !27+=9?)B0Y8S-2#*),]R/;P[_ '\#W_<B""+^\M]5=00;
M>^?UU7$5-$*40I1"E$*40I1"E:\1 .(Q(!)85!+ G2FZN+=!AVK:U>]+B.I#
M9S32@$RPON&LZM3B / 1,<P<!$>'<" B XR(  Q)2&=XRX]A)Z7;3.N"]MP\
M$!2R  6#@J+M##<43EPM(BHI2M2-]KN"8--VGU4E-ZI$G1KN:D)ZK:ID59#!
MP545CEDS;H+DDXE$V9[3:';W,X"B$!&7$$QPAB[CKR:7J!BJQ&W0R2TF0>.0
M,Z-FXR&4&G+4A<$"U%V]8+S0Z6I(;I#3TW,MHVF;@3"A@ *[W(6ZUSP 0'O/
M&7V%   .R'.I(GAF8S>[R^?"HY KE:BEIYI,CI"@_?&9#BL@G)_Z8*R8>L>[
M'7+OJ! $_6EZ;BW&NV)P$0# 2GTY*A!V<<1$)/$0#&1R HTBTJD:, T:P0;9
MFH\519GS:2&#\4@]#\<J>QKZ9-.[')T=E6)M T@' 8;]N&@E&#/? 9*"0..<
M"..(#@<X#$[P]')KOT7!9N%6\6PP&"1>S _2) ZOK-.[(;J#)EB$E'2)0#P_
ML=)# ?O2E'(> 0P'?#O16M-S[_</56,I-!IK%,,A4:[<4I ]ST540$E2#MXX
M()#2^(>/.0XCQ !4J+#BT):3W16]=R[*-IENOB O:U4M5M.^:/  /<O2WTUJ
M.8,XX!S^.W:$ #C,/;O'K9NZLOBN&9:=9N^>\7T;FPT/:DO,L?JEM24:VQ]_
MPNFAR2F$]J=5%(=>F#G!!1T.]K#+)=;?QV;;M9MW3AP$ #&8.>YI.3^ILBX^
MH,!2?-4=T!@DSH&E1&M@(S>E Q]6385G2F6NO*TUFP%XU>J"4W69<HZ69N/:
M8!1EYM;<R28&P_@ X$VI$DU,\0#:/,9LH '%@QN"'+V#,V9-[.Y>T37)&-O,
ME0*5.X"K 2 Q+%SF6OD:FN6442 81[0SV#X?$,"HN6+2V7LK8$A@X>'S]M9$
M4J]$*40I1"E$*5R5N3R0G)^ZA;@O*\=U;%D=3_?#H<56Z5XST>22:N42JDU%
M$#$07'()+ )4D  A"DYL2F P%QB/:V#X2;;LVSA&SJPTX8+,K#"R-PJLX2
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MZ_5&YR4#).< QL;0",TQ2@ E@<Z! (B?K<:DQ,P*;+X03B&!)!/%P6$E#7(
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M3:)7GLZX;15@>%I;DI92D5+=OQ$)SB(LD,!999B#,,;=YYMH<R7BTIE53',
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M"J?-%!7+-6F^!F^L'YS:"7,DE*02X'9#CGQL904M1 2$DP$C= :W-(!!&9
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M<[/Q.0 ),O:DY\-,AD>@ZZ<*9(C3N[?62$^Z(K5GK2SI>9%K&VL8N8[: <&
M;H/-#$P-TLP3' ;;6RJ-LA0 ]2_9N9K4**1(!?7/OLQN"Y < M1CG 9X(>1%
MB2-'(9R"*D^V&JW62A)[7:2"D(""BTG0TE!1:66FIM G ( !"DEE++#&,X)@
M<CM#M#DP<TEP^>?OT-4D-JQU#2'''WO4(Z.L<+V;MPR-_41=6;(5+NOFF2G-
M2MVVR?6,.<R'TN-)>MNRI*Y;H:<Z,2J0A;X5;KE/*H"<89A)N3F$<FUK*6#R
M!+1<S+0X9WU(N'K"O%()#N 20TQ8W!W0; #FC0UI[NW.<MG$-1OTN7!N^XVE
M:AB&K':P$$MG3)RXF(B,OS5UY+@N!N-,Q7"(RR#LM1X%(  4 9 ]H3XT=2<L
MK<.:>GU,6K&-M%]XE@(2#G#N4 /)!(<F73!!9.3J(;=&W%^VKUU9W@MQ<:D<
M*:Y%<SII+-A<AJ)BZD2RH:()&_9=V6S% =(*Q',43RSO0"B)2G#!BB\9+?K9
MO+1F-T>L1I!H=MCSV<E1 "BH.\ON$,7=PH03S5 BKRAK8MNFWI2R>>-<-2T*
MVTBLLK0&,SSVU1%%&F,1&1""8UN1= OYTB^D5RRY36=^P4@[!60!-D(>.$!R
M88!XR9GYNI+M!ZZA&W!QSB6 <,2RK GFF2P)(@."SQ4@:2@N$HL)(1:'4K>&
MKJJI5*\:2Y5+26?%QUR65'$Q4<)?F+;J@@9$1$X,\#<,B?9#@Y8XH$L"UHGJ
M U;(-</-;$;8X!4Y>)AW+^CUL9=X<&EXTG)/'492(ZU<ZXE?5O:V#H74:UT]
M':!;<IR8Q5I@(:XL$7"-O><SA"8\:8X29CMFTYNMU_:IS#*E&E[!<,2(D>J7
M>&?B=6K:SWZO4;]G0\R6F?"IK35=73T5+.K*R;(IJ:E *JJJ:G@4  !$!Q@
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M6!9:QD! )8D[L>/S0%'9'(B2F)AN.;UAB2P<DB;\--:G*6ZF'0/5TE](;"<
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M8ORT%WH8@!F[+N"Z[?\ -.J8<1$F^"V!C&$ .8N^;/UQD)L-+M?IKW<4.@@
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M+0$EWW@P)AFA>8=\WEW-.\W$MU-!3J)#63+<-RW75"GU1;9 HQ3N@N4![IY
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MJC@D[P=FEJK4<M3+=2W786YB*J5"O2T,]LGK#U"35]"4L(Q@7 V9@[.SW4O
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MA24M( _,E\(9R( .0 ,@.<@(X ,*5BBA(\I5FKLM,IBJ]32]%,J$I<J @7.
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MV?G1V1ZF%B !CYIZ<S)L\5>]?K ^19/IB:NON)M=^>%^/SK_ *B_]QA="/\
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M55BI65C@K&XLJ3F3U0-PD#*(N>9R.6Z+=%\!M< WT0.(]H/'"NY?-[AE:C(
M,X)!>#U*G(C7(&"2[R3$P +$E]2SM\+660:%L& ]F"MJ/7[[K$OH34JW'O'T
M%+]?O7:UGS.&EZW?I6[DXXX"YW#N@"/5P\0[Q<S!L?49%N\.(:H( 9B[:$6;
M)W@7NPOQ$2 $!+LCPQV#Q'OC'II452F0;BS&US=VH00K>$O<0-*]-[DH_J<V
MCG]I)J_DA'\X_"/\H;1_?#Z&'7V6P_B^L?3%=%S?.S_N?RH\X^9U)^JM-,S?
M_P"DO<[[D57_ -47JJ_-/5ZQ7+VY<[4#)?CV7+:I554)Z8D-A&;B4XJM&46R
MO>HS[75U:1$0;B\'$+BW);/$>''P\-R78,6#1TN3DQX-WM)Y.&9S>>CFV>^8
MC@2(:D7.K-5<FI4*V0W0J:<'%TRD;U4*.(8-O[_=L+BB.,;DY:X"8 QVY[>Q
M*7!X#)B2X8N[3J=TD&;U:2_ BVA>()ZA+=#@TSJ/4>Y$)?"N2W&TW>YG';%L
M]+25<4Y.0FPAO-?7%QY"B-^X_?;WK8'=8>(]N<<41(+/J0P8Z&6XENN(U=VL
M2&<'BUQD^?2S6:Q-U23J%(1*VA4E$&S_ &'2.JE5T=.4U[ +[%ZX6_U1O5[>
MMNK2'<WM =\Q#&<&$.ZV8G,N08&=SJ(+9, ,Z@7X2!$G1BT'O#C2E*U;EWTF
MW%:#)=#61:?KRC2UER=$2!]8R9ZO=>^K?FC.SAA%1&SO1WA7AP''(8U,^<EW
MS@P#=^\/QHHDEBSB>,Q]7N&KJ98$<, ^?_ONY8_?>3A#\81FQASW_5![R*T-
MW!^]OOI]]@!X@/ >SA_7&0X0.<.[-]]16GJZNF3J:=65DZGIJ>G+FIJJD1 N
MR !D0P/8 8P B/@QP$8Z!(%AEQ,#_C+2H=@Y+M=M=/=M8%;2)J:R(4HA2B%*
M(4HA2B%*(4HA2B%*\RSE?@$G*5ZLRB/S-S991X=\K*;W'O\ >\>(S+'/46NJ
M9R4+=X+\>%?BGPIP"/"&(3FI9 XJ*6/G=,4O;!:OM.5KV ]=/#G2WHX["75T
MUN9@W&JDIC"#V&^BXM;\(SR1$4+T#;3+47SI&PY\@\C3$ HB)<9"01KP<!YO
MD^=[D#6 =N!C)PME"5!P<%27E4A04B[,Y0EY<(WF2JQ<%V<H7I^7K;D9*DVK
MDO).)I&L5I;IFFO-QF;LHSFM4\#K2Y?Q&RX7>8'#N\8K;938*TB'$Q"@)A()
MBC+@BP>T*S$]3Z-$Q8UT'A39)!0Y9D[RL1DG>#D,AF8-,,26"IITGAREFDM<
M>MN'3,M2_5BI8EQM2W5#A6&@T#/5#:M[VBWT1EO)"*+G*V0<EK%\QG(%LO6@
MSBFP9C;J 0I(.+&S%CFX8,"QL6#$ZLQ,7^,]C(;DTLZR&4M)YZ0E#-@A]Q2=
M[=/-=PR=YZ15E>4W8;9IV937D4+COM98^JRVM[RO=*MTT6V#Y8S(MB%IUMG]
M12W/+,@"Z!*ACDLUVF>(%$'P<!,)HA)2%.78,0R7>7+.""#&1!N01?ST>&-G
M!23AA0"T**25*WMQSNE2L%9YX)"@I*DF'"MU@RUW-96G=W:3%C3^W&@[*AS)
M@ #%=5(D>9R7:\TM??3X&Z*&@7'=C:?W#&Y)=T=\@P B]=L3"(%-MZ7/2SR[
M&&R XV %0?"^S$!/)@YN58C\X[T_@PFYNV8$, -7<C7N9+TVZ8;,Z=GB[&6Y
M[:6"?-D+NO6JMRSDYR+C8>]Q9+W6T5CO87"ZW,WVZ/-F;.R(M+ FSM[(@26"
MAS9=@;";D@DS9V<Z<)U*^$.RE* $.,-&XKSP.=B+4&?#45.%W9+R&9.\J0%Q
MN5!MLZ;S/Z=1);L4K-/&QBLVF*KU5NK;)URK$WU7+,L.TX7E9.7%ZX.#) 0
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M,,B6?I-S)8SF*W[Y9MYWZQ;?-ZU\E2!+JKGW*K7)64S@%MIAB>:2XA*1Y3$
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M6!G?R8<J-3W?9IY-8OI#N_C4K_03^4+!E5#>&U[3ZXWOZXZ)YJ3-XI?4O46
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MP'TOO_/-S/XY.&%=Q;K5ZS3]PJ:(4HA2B%*(4HA2B%*(4HA2B%*(4HA2HBK
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M1I9%=0SBU5!5!TNEJ:;B40QD0,  /AQD0P.>/#C"E8 N)&FKDUO ITQURFI
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M#YNIS+[N50WUI*5Y08[12[,VTN_<57J'VEK*O26J=[,9>6PA@("CO47\Y&D
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M2*5TK0*JBFH"76*ZK74U"DIM+6U:G5U9A+0TE 3,PYC#P( % A1, "(B &*
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MQF+I:&$I<F7)9@ULSD1-C!WSZSE]W#2LZKK:9-IC5M=5T]#0TP9J:JHJP*&
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MV\#J2PI@ #UD8TNH !.4!X&( D[VT.0VO3P?A+MFRI",(X.&E(9*>1*MU+
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M3L$^M+^]#]$*55"E$*40I1"E4[!/K2_O0_1"E&P3ZTO[T/T1##0=@I56 #L
M @P%@!2B)I1"E$*40I1"E$*40I1"E$*40I1"E$*40I1"E$*40I1"E$*40I6%
MS$G'3.;+TKHNQS_';V=C.,Y\/'.,^.%*S84HA2B%*(4HA2B%*(4HA2B%*(4H
MA2B%*(4HA2B%*(4HA2B%*2JNV&\ZZ66FN5&3EU/E3T):ET2I2RJRF*JI2C-5
M4^NYF<4Q!GTBA)EU4H3 )0F%P8IB"8HJDB2-#ZC2JA440I1"E$*40I1"E$*4
(0I1"E$*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g423260g37n37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g423260g37n37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1):4&AO=&]S:&]P(#,N,  X0DE-! 0
M    $CZ^1G X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!L
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))300-       $
M6CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]       $@ U     0 M    !@
M 3A"24T#]P      '   _____________________________P/H   X0DE-
M! @      !     !   "0    D      .$))300>       $     #A"24T$
M&@     #00    8              $L   &Z    !@!G #, -P!N #, -P
M  $                          0             !N@   $L
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   $L     4F=H
M=&QO;F<   &Z    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   !+     %)G:'1L;VYG   !N@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $     CA"24T$
M#      (H     $   "-    &    :@  "?    (A  8  '_V/_M  Q!9&]B
M95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ & "- P$B  (1 0,1 ?_=  0
M"?_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0'_P  +"  @ +T! 1$ _\0 '0   @,! 0 #
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'\?'Q\??_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420682352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Abacus Life, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-1210472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2101 Park Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Orlando<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">561-4148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001814287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPrimarySicNumber', window );">Entity Primary SIC Number</a></td>
<td class="text">6282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Jay J. Jackson<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2101 Park Center Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Orlando<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">561-4148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPrimarySicNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primary Standard Industrial Classification (SIC) Number for the Entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPrimarySicNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sicNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417442416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,611,122<span></span>
</td>
<td class="nump">$ 30,052,823<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">829,595<span></span>
</td>
<td class="nump">116,646<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">32,206,622<span></span>
</td>
<td class="nump">33,282,927<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">177,931<span></span>
</td>
<td class="nump">18,617<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">32,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">140,287,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets</a></td>
<td class="nump">240,816<span></span>
</td>
<td class="nump">77,011<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount', window );">Life settlement policies, at cost</a></td>
<td class="nump">9,889,610<span></span>
</td>
<td class="nump">8,716,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies, at fair value</a></td>
<td class="nump">56,685,617<span></span>
</td>
<td class="nump">13,809,352<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Available for sale securities, at fair value</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Other investments</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent', window );">Due from members and affiliates</a></td>
<td class="nump">75,582<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_StateSecurityDepositsNoncurrent', window );">State security deposit</a></td>
<td class="nump">206,873<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_CertificatesOfDepositNoncurrent', window );">Certificate of deposit</a></td>
<td class="nump">262,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, at fair value</a></td>
<td class="nump">1,801,886<span></span>
</td>
<td class="nump">890,829<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">277,334,437<span></span>
</td>
<td class="nump">59,094,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">524,400<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">401,500<span></span>
</td>
<td class="nump">40,014<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities&#8212;current portion</a></td>
<td class="nump">227,561<span></span>
</td>
<td class="nump">48,127<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_AccruedTransactionCostsCurrent', window );">Accrued transaction costs</a></td>
<td class="nump">182,571<span></span>
</td>
<td class="nump">908,256<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities&#8212;deposits on pending settlements</a></td>
<td class="nump">981,217<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">185,831<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">13,894,422<span></span>
</td>
<td class="nump">1,302,409<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredLongTermDebt', window );">SPV purchase and sale note</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Long-term debt, at fair value</a></td>
<td class="nump">66,165,396<span></span>
</td>
<td class="nump">28,249,653<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities&#8212;noncurrent portion</a></td>
<td class="nump">16,864<span></span>
</td>
<td class="nump">29,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">9,320,240<span></span>
</td>
<td class="nump">1,363,820<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantLiabilitiesNoncurrent', window );">Warrant liability</a></td>
<td class="nump">2,438,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">116,835,522<span></span>
</td>
<td class="nump">30,945,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES (11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>SHAREHOLDERS' EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">188,641,886<span></span>
</td>
<td class="nump">704,963<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings/(accumulated deficit)</a></td>
<td class="num">(29,382,362)<span></span>
</td>
<td class="nump">25,487,323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">877,306<span></span>
</td>
<td class="nump">1,052,836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">355,789<span></span>
</td>
<td class="nump">899,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' equity (deficit)</a></td>
<td class="nump">160,498,915<span></span>
</td>
<td class="nump">28,149,697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)</a></td>
<td class="nump">277,334,437<span></span>
</td>
<td class="nump">59,094,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>SHAREHOLDERS' EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A common stock, $0.0001 par value; 200,000,000 authorized shares; 62,961,688 and 50,369,350 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">192,595<span></span>
</td>
<td class="nump">10,448<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">21,252<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">258,759<span></span>
</td>
<td class="nump">42,227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">10,473,748<span></span>
</td>
<td class="nump">2,904,646<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">10,415,154<span></span>
</td>
<td class="nump">263,785<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">78,310<span></span>
</td>
<td class="nump">198,364<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abl_OwnersMember', window );">Owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 717,429<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of the successful Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_AccruedTransactionCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Transaction Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_AccruedTransactionCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_CertificatesOfDepositNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Certificates Of Deposit, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_CertificatesOfDepositNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_StateSecurityDepositsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>State Security Deposits, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_StateSecurityDepositsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_WarrantLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_WarrantLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of receivable classified as other and noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abl_OwnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abl_OwnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694423863792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATE BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694424573568">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total portfolio servicing revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 354,366<span></span>
</td>
<td class="nump">$ 419,422<span></span>
</td>
<td class="nump">$ 590,057<span></span>
</td>
<td class="nump">$ 990,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceInvestmentIncome', window );">Investment Income from life insurance policies held using investment method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,263,499<span></span>
</td>
<td class="nump">5,965,466<span></span>
</td>
<td class="nump">16,655,833<span></span>
</td>
<td class="nump">13,980,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodGainLoss', window );">Change in fair value of life insurance policies (policies held using fair value method)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,760,900<span></span>
</td>
<td class="nump">2,014,013<span></span>
</td>
<td class="nump">4,339,084<span></span>
</td>
<td class="nump">3,305,505<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Total active management revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,024,399<span></span>
</td>
<td class="nump">7,979,479<span></span>
</td>
<td class="nump">20,994,917<span></span>
</td>
<td class="nump">17,285,971<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,378,765<span></span>
</td>
<td class="nump">8,398,901<span></span>
</td>
<td class="nump">21,584,974<span></span>
</td>
<td class="nump">18,276,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>COST OF REVENUES (excluding depreciation stated below)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">973,400<span></span>
</td>
<td class="nump">666,119<span></span>
</td>
<td class="nump">1,462,950<span></span>
</td>
<td class="nump">2,086,075<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,405,365<span></span>
</td>
<td class="nump">7,732,782<span></span>
</td>
<td class="nump">20,122,024<span></span>
</td>
<td class="nump">16,190,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">683,841<span></span>
</td>
<td class="nump">1,019,498<span></span>
</td>
<td class="nump">1,412,845<span></span>
</td>
<td class="nump">1,649,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">577,539<span></span>
</td>
<td class="nump">5,499<span></span>
</td>
<td class="nump">1,274,431<span></span>
</td>
<td class="nump">646,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Loss on change in fair value of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,445,229<span></span>
</td>
<td class="nump">333,879<span></span>
</td>
<td class="nump">2,398,662<span></span>
</td>
<td class="nump">375,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss (gain) on investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(672,936)<span></span>
</td>
<td class="nump">1,039,022<span></span>
</td>
<td class="num">(798,156)<span></span>
</td>
<td class="nump">1,054,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,034,771<span></span>
</td>
<td class="nump">2,398,996<span></span>
</td>
<td class="nump">4,289,923<span></span>
</td>
<td class="nump">3,728,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,370,594<span></span>
</td>
<td class="nump">5,333,786<span></span>
</td>
<td class="nump">15,832,101<span></span>
</td>
<td class="nump">12,461,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(584,075)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(941,458)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,457<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">121,601<span></span>
</td>
<td class="num">(127,455)<span></span>
</td>
<td class="num">(21,651)<span></span>
</td>
<td class="num">(242,247)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(462,474)<span></span>
</td>
<td class="num">(127,455)<span></span>
</td>
<td class="num">(955,652)<span></span>
</td>
<td class="num">(242,247)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Net income before provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,908,120<span></span>
</td>
<td class="nump">5,206,331<span></span>
</td>
<td class="nump">14,876,449<span></span>
</td>
<td class="nump">12,219,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,184,571)<span></span>
</td>
<td class="num">(120,132)<span></span>
</td>
<td class="num">(528,104)<span></span>
</td>
<td class="num">(296,806)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,723,549<span></span>
</td>
<td class="nump">5,086,199<span></span>
</td>
<td class="nump">14,348,345<span></span>
</td>
<td class="nump">11,922,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(26,596)<span></span>
</td>
<td class="nump">406,641<span></span>
</td>
<td class="num">(487,303)<span></span>
</td>
<td class="nump">406,641<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME ATTRIBUTABLE TO SHAREHOLDERS</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,750,145<span></span>
</td>
<td class="nump">$ 4,679,558<span></span>
</td>
<td class="nump">$ 14,835,648<span></span>
</td>
<td class="nump">$ 11,515,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>EARNINGS PER SHARE:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">50,507,728<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="nump">50,438,921<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">50,507,728<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="nump">50,438,921<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,723,549<span></span>
</td>
<td class="nump">$ 5,086,199<span></span>
</td>
<td class="nump">$ 14,348,345<span></span>
</td>
<td class="nump">$ 11,922,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent', window );">Change in fair value of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(119,663)<span></span>
</td>
<td class="nump">2,017,559<span></span>
</td>
<td class="num">(231,976)<span></span>
</td>
<td class="nump">2,017,559<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,603,886<span></span>
</td>
<td class="nump">7,103,758<span></span>
</td>
<td class="nump">14,116,369<span></span>
</td>
<td class="nump">13,939,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income (loss) attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">56,111<span></span>
</td>
<td class="num">(1,011,909)<span></span>
</td>
<td class="nump">543,749<span></span>
</td>
<td class="num">(1,011,909)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Abacus Life Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,659,997<span></span>
</td>
<td class="nump">6,091,849<span></span>
</td>
<td class="nump">14,660,118<span></span>
</td>
<td class="nump">12,927,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total portfolio servicing revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">329,629<span></span>
</td>
<td class="nump">419,253<span></span>
</td>
<td class="nump">543,076<span></span>
</td>
<td class="nump">620,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total portfolio servicing revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 24,737<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
<td class="nump">$ 46,981<span></span>
</td>
<td class="nump">$ 370,169<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment income associated with the company's insurance services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the gains or losses recognized and realized during the period on investments in life settlement contracts sold during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) from increase (decrease) in instrument-specific credit risk of financial liability measured under fair value option, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417619472">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Class A Common Stock</div></th>
<th class="th" colspan="2">
<div>Common Stock </div>
<div>Class A Common Stock</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Non- Controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,369,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 766,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 704,963<span></span>
</td>
<td class="nump">$ 205,048<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (148,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Distributions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,017,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,412,291<span></span>
</td>
<td class="nump">605,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,922,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,515,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,641<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12,306,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">704,963<span></span>
</td>
<td class="nump">9,320,746<span></span>
</td>
<td class="nump">1,412,291<span></span>
</td>
<td class="nump">863,754<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,513,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">704,963<span></span>
</td>
<td class="nump">4,951,188<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(148,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Distributions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(310,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,017,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,412,291<span></span>
</td>
<td class="nump">605,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,086,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,679,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,641<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12,306,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">704,963<span></span>
</td>
<td class="nump">9,320,746<span></span>
</td>
<td class="nump">1,412,291<span></span>
</td>
<td class="nump">863,754<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">28,149,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">704,963<span></span>
</td>
<td class="nump">25,487,323<span></span>
</td>
<td class="nump">1,052,836<span></span>
</td>
<td class="nump">899,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Distributions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34,451,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,451,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_StockholdersEquityDeferredTransactionCosts', window );">Deferred transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,841,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,841,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Public warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">960,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,726,500<span></span>
</td>
<td class="num">(3,765,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_StockIssuedDuringPeriodSharesReverseRecapitalization', window );">Merger with East Resources Acquisition Company (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,592,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_StockIssuedDuringPeriodValueReverseRecapitalization', window );">Merger with East Resources Acquisition Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,796,225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,849,091<span></span>
</td>
<td class="num">(20,646,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition of Abacus Settlements, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">165,361,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">165,361,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(231,976)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,530)<span></span>
</td>
<td class="num">(56,446)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 14,348,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,835,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(487,303)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="nump">62,961,688<span></span>
</td>
<td class="nump">62,961,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 160,498,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,296<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">188,641,886<span></span>
</td>
<td class="num">(29,382,362)<span></span>
</td>
<td class="nump">877,306<span></span>
</td>
<td class="nump">355,789<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">35,662,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">704,963<span></span>
</td>
<td class="nump">33,572,826<span></span>
</td>
<td class="nump">967,454<span></span>
</td>
<td class="nump">411,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Distributions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34,451,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,451,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_StockholdersEquityDeferredTransactionCosts', window );">Deferred transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,841,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,841,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Public warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">960,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,726,500<span></span>
</td>
<td class="num">(3,765,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_StockIssuedDuringPeriodSharesReverseRecapitalization', window );">Merger with East Resources Acquisition Company (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,592,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_StockIssuedDuringPeriodValueReverseRecapitalization', window );">Merger with East Resources Acquisition Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,796,225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,849,091<span></span>
</td>
<td class="num">(20,646,575)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition of Abacus Settlements, LLC</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">165,361,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">165,361,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(119,663)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90,148)<span></span>
</td>
<td class="num">(29,515)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,723,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,596)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="nump">62,961,688<span></span>
</td>
<td class="nump">62,961,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 160,498,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,296<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 188,641,886<span></span>
</td>
<td class="num">$ (29,382,362)<span></span>
</td>
<td class="nump">$ 877,306<span></span>
</td>
<td class="nump">$ 355,789<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of the successful Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_StockIssuedDuringPeriodSharesReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_StockIssuedDuringPeriodSharesReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_StockIssuedDuringPeriodValueReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_StockIssuedDuringPeriodValueReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_StockholdersEquityDeferredTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders Equity, Deferred Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_StockholdersEquityDeferredTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694413461680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,723,549<span></span>
</td>
<td class="nump">$ 5,086,199<span></span>
</td>
<td class="nump">$ 14,348,345<span></span>
</td>
<td class="nump">$ 11,922,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized (gain) loss on investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(672,936)<span></span>
</td>
<td class="nump">1,039,022<span></span>
</td>
<td class="num">(798,156)<span></span>
</td>
<td class="nump">1,054,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss', window );">Unrealized gain on policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,319,588)<span></span>
</td>
<td class="num">(3,305,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Loss on change in fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,445,229<span></span>
</td>
<td class="nump">333,879<span></span>
</td>
<td class="nump">2,398,662<span></span>
</td>
<td class="nump">375,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">252,659<span></span>
</td>
<td class="nump">999,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(193,462)<span></span>
</td>
<td class="num">(1,379,579)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(105,655)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361,486<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(725,685)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">402,363<span></span>
</td>
<td class="nump">72,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractPurchasedFairValueMethod', window );">Life Settlement Policies purchased, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39,556,677)<span></span>
</td>
<td class="num">(7,211,509)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractPurchasedInvestmentMethod', window );">Life Settlement Policies purchased, at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,374,605)<span></span>
</td>
<td class="num">(7,204,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,364,171)<span></span>
</td>
<td class="num">(4,751,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of investments</a></td>
<td class="num">$ (250,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(250,000)<span></span>
</td>
<td class="num">$ (250,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ProceedsDueFromPaymentsDueToAffiliates', window );">Due from affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,760,627)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,060,627)<span></span>
</td>
<td class="num">(250,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Issuance of debt certificates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,206,351<span></span>
</td>
<td class="nump">9,463,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,841,551)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDistributionsToAffiliates', window );">Capital distribution to members</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,533,072)<span></span>
</td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from receipt of SPV purchase and sale note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Due to members and affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,151,369<span></span>
</td>
<td class="nump">680,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,983,097<span></span>
</td>
<td class="nump">7,744,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,441,701)<span></span>
</td>
<td class="nump">2,742,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD</a></td>
<td class="nump">$ 102,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,052,823<span></span>
</td>
<td class="nump">102,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,611,122<span></span>
</td>
<td class="nump">$ 2,845,405<span></span>
</td>
<td class="nump">20,611,122<span></span>
</td>
<td class="nump">2,845,405<span></span>
</td>
<td class="nump">$ 102,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(182,147)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,764<span></span>
</td>
<td class="num">$ (77,657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractPurchasedFairValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract Purchased, Fair Value Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractPurchasedFairValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractPurchasedInvestmentMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract Purchased, Investment Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractPurchasedInvestmentMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ProceedsDueFromPaymentsDueToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds Due From (Payments) Due To Affiliates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ProceedsDueFromPaymentsDueToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments in life settlement contracts held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDistributionsToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDistributionsToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for financing costs associated with business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421554832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">DESCRIPTION OF BUSINESS </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Organization and Merger </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Abacus Life, Inc. (&#8220;the Company&#8221;) was formerly known as East Resources Acquisition Company (&#8220;ERES&#8221;), a blank check company incorporated in Delaware on May&#160;22, 2020. Abacus Life, Inc. conducts its business through its wholly-owned, consolidated subsidiaries, primarily Abacus Settlements LLC (&#8220;Abacus&#8221;) and Longevity Market Assets,&#160;LLC (&#8220;LMA&#8221;), which are incorporated in the state of Delaware (collectively, the &#8220;Companies&#8221;). On June&#160;30, 2023, (the &#8220;Closing Date&#8221;), ERES, Longevity Market Assets, LLC and Abacus Settlements, LLC consummated the combining of the Companies as contemplated by the Merger Agreement dated as of August&#160;30, 2022 (as amended on October&#160;14, 2022 and April&#160;20, 2023) with LMA Merger Sub, LLC, a wholly owned subsidiary of ERES (&#8220;LMA Merger Sub&#8221;), Abacus Merger Sub, LLC, a wholly owned subsidiary of ERES (&#8220;Abacus Merger Sub&#8221;), LMA&#160;and Abacus Settlements, LLC (&#8220;Legacy Abacus&#8221; and, together with LMA, the &#8220;Legacy Companies&#8221;). Pursuant to the Merger Agreement, on June&#160;30, 2023, (i) LMA Merger Sub merged with and into LMA, with LMA surviving such merger (the &#8220;LMA Merger&#8221;) and (ii)&#160;Abacus Merger Sub merged with and into Legacy Abacus, with Legacy Abacus surviving such merger (the &#8220;Abacus Merger&#8221; and, together with the LMA Merger, the &#8220;Mergers&#8221; and, along with the other transactions contemplated by the Merger Agreement, the &#8220;Business Combination&#8221;) and the Legacy Companies became direct wholly owned subsidiaries of Abacus and ERES changed its name to Abacus Life, Inc. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The condensed consolidated assets, liabilities and statements of operations and comprehensive income prior to the Business Combination are those of legacy LMA. The stocks and corresponding capital amounts and income per stock, prior to the Business Combination, have been retroactively restated based on stocks reflecting the exchange ratio established in the Business Combination. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company&#8217;s common stock, $0.0001 par value per share, issued to legacy LMA&#8217;s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Business Activity </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company, through its LMA subsidiary, is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life settlement assets, as well as consulting, valuation, and actuarial services. The Company is also engaged in buying and selling of life settlement policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout or to sell to another purchaser of life settlement contracts for a gain on the sale. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company, through its Abacus subsidiary, also is an originator of outstanding life insurance policies as a licensed life settlement provider on behalf of investors (&#8220;Financing Entities&#8221;). Abacus locates and screens policies for eligibility as a commercially desirable life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known, collectively, as origination services. When the sale of a policy is completed, this is deemed &#8220;settled&#8221; and the policy is then referred to as either a &#8220;life settlement&#8221; in which the insured&#8217;s life expectancy is greater than two years or &#8220;viatical settlement,&#8221; in which the insured&#8217;s life expectancy is less than two years. The Company is not an insurance company, and therefore the Company does not underwrite insurable risks for its own account. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694426810736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation</div></div>&#8212;In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). Under U.S. GAAP, ERES has been treated as the &#8220;acquired&#8221; company for financial reporting purposes. This determination was primarily based on the LMA shareholders having a relative majority of the voting power of the Company, the LMA shareholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the &#8220;acquirer&#8221; for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Abacus Merger will be accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will be recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, will be recognized as goodwill. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In considering the foregoing principles of predecessor determination and in light of the Company&#8217;s specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unaudited Condensed Consolidated Financial Statements</div></div>&#8212;The condensed consolidated financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2023, and the condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023 and 2022, respectively, and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022, respectively. The condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for Abacus for the year ended December&#160;31, 2022, and the financial statements and notes for LMA for the year ended December&#160;31, 2022. All references to financial information as of and for the periods ended June&#160;30, 2023, and 2022 in the notes to condensed consolidated financial statements are unaudited. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Refer to this note in the LMA annual financial statements for the full list of the Company&#8217;s significant accounting policies. The details in those notes have not changed, except as discussed below and as a result of normal adjustments in the interim periods. </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Consolidation of Variable Interest Entities</div></div>&#8212;For entities in which the Company has variable interests, the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Company </div>first evaluates whether the entity meets the definition of a variable interest entity (&#8220;VIE&#8221;) or a </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">voting interest entity (&#8220;VOE&#8221;). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company&#8217;s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;810, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidations</div></div>, requires the Company to separately disclose on its condensed consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of June&#160;30, 2023, total assets and liabilities of consolidated VIEs were $57,577,034 and $52,474,820, respectively. As of December&#160;31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January&#160;1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the &#8220;Providers&#8221;), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the &#8220;Option Agreement&#8221;). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321. In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815 and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the share price has no readily determinable fair value. The Company&#8217;s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provided $0 and $127,455 of funding for the three months ended June&#160;30, 2023 and June&#160;30, 2022, respectively and provided $29,721 and $242,247 of funding for the six months ended June&#160;30, 2023 and June&#160;30, 2022, respectively which is included in other (expense) income on the condensed consolidated statements of operations and comprehensive income. See Note 11, Commitments and Contingencies. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the period ended June&#160;30, 2023, and for the year ended December&#160;31, 2022, the Providers were considered to be VIEs, but were not consolidated in the Company&#8217;s condensed consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of June&#160;30, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $318,178 and liabilities of $450 and held assets of $483,167 and liabilities of $184,621, respectively. As of December&#160;31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $126,040 and liabilities of $0 and held assets of $861,924 and liabilities of $358,586, respectively. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October&#160;4, 2021, the Company entered into an operating agreement with LMX Series,&#160;LLC (&#8220;LMX&#8221;) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series&#160;2024,&#160;Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its condensed consolidated financial statements for the period ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March&#160;3, 2022, the Company obtained an 80% ownership interest in Longevity Market Advisors,&#160;LLC (&#8220;Longevity Market Advisors&#8221;). The Longevity Market Advisors legal entity was established primarily for </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the purpose of acquiring the assets of a broker/dealer, Regional Investment Services,&#160;Inc. (&#8220;RIS&#8221;), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price payable in exchange for RIS was $60,000. The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of the RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being registered by the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;). As there are no tangible or intangible assets of value from the RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise 100% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of Longevity Market Advisors in its condensed consolidated financial statements for the period ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November&#160;30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January&#160;31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Noncontrolling Interest</div></div>&#8212;Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the condensed consolidated balance sheets at an amount equal to the noncontrolling interest&#8217;s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholder&#8217;s additional contributions, distributions, and the shareholder&#8217;s share of the net earnings or losses of each respective consolidated entity. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholder&#8217;s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the condensed consolidated statements of operations and comprehensive income. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div>&#8212;The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reports amounts of revenue and expenses during the reporting periods. Company&#8217;s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life Insurance Settlement Policies</div></div>&#8212;The Company accounts for its holdings of life insurance settlement policies in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;325-30,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments in Insurance Contracts</div></div>. The Company accounts for life settlement policies purchased that we intend to hold to maturity at fair value and life settlement policies that we intend to trade in the near term at cost plus premiums paid. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">The Company follows ASC&#160;820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements and Disclosures</div></div>, in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level&#160;1 relates to quoted prices in active markets for identical assets or liabilities. Level&#160;2 relates to observable inputs other than quoted prices included in Level&#160;1.&#160;Level&#160;3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company&#8217;s valuation of life settlements is considered to be Level&#160;3, as there is currently no active market where we are able to observe quoted prices for identical assets. The Company&#8217;s valuation model incorporates significant inputs that are not observable. See Note&#160;10, &#8220;Fair Value Measurements.&#8221; For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that include medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the condensed consolidated statements of cash flows. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost of Revenues</div></div>&#8212;Cost of revenue represents the direct costs associated with fulfilling the Company&#8217;s obligations to its customers, primarily policy servicing and consulting expense. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes</div></div>&#8212;The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, the provision for income taxes represents income taxes paid or payable (or received or receivable) for the current year plus the change in deferred taxes during the year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid, and result from differences between the financial and tax bases of the Company&#8217;s assets and liabilities and are adjusted for changes in tax rates and tax laws when enacted. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not (greater than 50%) that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company&#8217;s experience with similar operations. Existing favorable contracts are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow for the utilization of a deferred tax asset based on existing projections of income. Deferred tax assets for which no valuation allowance is recorded may not be realized upon changes in facts and circumstances, resulting in a future charge to establish a valuation allowance. Existing valuation allowances are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-examined</div> under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets and liabilities are also remeasured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the statute of limitations has expired or the appropriate taxing authority has completed their examination even though the statute of limitations remains open. Interest and penalties related to uncertain tax positions are recognized as part of the provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations</div></div>&#8212;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying condensed consolidated balance sheets. The Company extends different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company&#8217;s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer&#8217;s financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of accounts. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Two related party customers accounted for 12% and 13% of the total balance of accounts receivable and related party receivables as of June&#160;30, 2023, and two related party customers accounted for 75% and 16% of the total accounts receivable as of December&#160;31, 2022, respectively. The largest receivables balances are from related parties where exposed credit risk is low. As such, there is no allowance for doubtful accounts as of June&#160;30, 2023, and December&#160;31, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for 27% of active management revenue for the three months ended June&#160;30, 2023. Two related party customers each accounted for 20% and 20% of the portfolio servicing revenue for the three months ended June&#160;30, 2023. One customer accounted for 26% of the total revenues for the three months ended June&#160;30, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for 29% of active management revenue, while 16% of revenue related to 2 policies that matured that were accounted for under the investment method and 1 policy that matured that was accounted for under the fair-value method for the six months ended June&#160;30, 2023. Two related party customers each accounted for 25% and 27% of the portfolio servicing revenue for the six months ended June&#160;30, 2023. One customer accounted for 71% of the total revenues for the six months ended June&#160;30, 2022. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div>&#8212;The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 480 <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div> (&#8220;ASC&#160;480&#8221;) and ASC 815, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging</div></div> (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock and whether the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the condensed consolidated statements of operations and comprehensive income. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694423877904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">BUSINESS COMBINATION</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">BUSINESS COMBINATION </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Merger consideration conveyed of $531.8&#160;million was allocated <div style="letter-spacing: 0px; top: 0px;;display:inline;">between </div>the Companies based on relative values derived through both the discounted cash flow method within the income approach and the guideline public company method within the market approach. Within the discounted cash flow method, the present values of cash flows reasonably expected to be produced by the Companies from their operations were summed to produce an estimate of the Companies&#8217; business enterprise values on a controlling, marketable basis. The cash flows used in the discounted cash flow analysis were discounted at the weighted average cost of capital of 14.5% for LMA and 16.5% for Abacus. The discounted cash flow method resulted in a business enterprise value range of $380.0&#160;million to $460.0&#160;million for LMA and $180.0&#160;million to $195.0&#160;million for Abacus. Within the market approach, Company applied the guideline public company method, which employs market multiples derived from market prices of stocks of Companies that are engaged in the same or similar lines of business as the Companies and that are actively traded on a free and open market. The guideline public company method resulted in a business enterprise value range of $400.0&#160;million to $440.0&#160;million for LMA and $180.0&#160;million to $190.0&#160;million for Abacus. Management concluded on a business enterprise value of $165.4&#160;million for Abacus and $366.4&#160;million for LMA based upon the relative fair value of the Companies allocated to the consideration transferred. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The preliminary purchase price was allocated among the identified assets to be acquired. The primary area of the acquisition accounting that is not yet finalized is our estimate of the impact of acquisition accounting on deferred income taxes. An estimate of deferred income taxes has been recorded in the Company&#8217;s books based on information available as of June&#160;30, 2023. As the initial acquisition accounting is based on our preliminary assessments, actual values may differ when final information becomes available. We believe that the information gathered to date provides a reasonable basis for estimating the preliminary values of deferred taxes recorded. We will continue to evaluate this item until it is satisfactorily resolved and adjust our acquisition accounting accordingly, within the allowable measurement period, as defined by ASC 805, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combinations</div></div>. Transaction costs incurred as a result of the Business Combination were recognized within retained earnings/(accumulated deficit) on the condensed consolidated balance sheet ending June&#160;30, 2023. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All valuation procedures related to existing assets as no new assets were identified as a result of procedures performed. Goodwill was recognized as a result of the acquisition, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Assets Identified</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangibles</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">140,287,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current Assets</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,280,100</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Current</div> Assets</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">901,337</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Tax Liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,310,966</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued Expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(524,400</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,171,739</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Fair Value</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">165,361,332</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Value Conveyed</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Abacus Purchase Consideration</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">165,361,332</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMA Business Enterprise Value</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">366,388,668</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Consideration</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">531,750,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets were comprised of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 35%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Type</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Life</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Methodology</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships-Agents</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">5 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Multi-period&#160;excess&#160;earnings&#160;method</div></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships-Financing Entities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">8 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Multi-period excess earnings method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Internally Developed and Used <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Technology-APA</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from royalty method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology-Marketplace</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">3 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement cost method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trade Name</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from royalty method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Compete</div> Agreements</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">With and without method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State Insurance Licenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement cost method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Fair Value</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr></table> <div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Useful lives for customer relationships were developed using attrition data for agents and financing entities which resulted in a useful life of 5 years and 8 years, respectively. Estimates over the useful lives of internally developed and used technology contemplates the period in which the Company expects to utilize the technology and the length of time the technology is expected to maintain recognition and value in the market without significant <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">investment.Non-compete</div> agreements have a useful life commensurate with the executed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-compete</div> agreements in place as a result of the Business Combination. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined as of January&#160;1, 2022. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proforma revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,263,455</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,090,817</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,769,650</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">31,290,963</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proforma net income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,432,047</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,589,315</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,373,444</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,788,486</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420665824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIFE INSURANCE SETTLEMENT POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsDisclosureTextBlock', window );">LIFE INSURANCE SETTLEMENT POLICIES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">4.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LIFE INSURANCE SETTLEMENT POLICIES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, the Company holds 167 life settlement policies, of which 122 are accounted for under the fair value method and 45 are accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value is $195,205,585 as of June&#160;30, 2023, with a corresponding fair value of $56,685,617. Aggregate face value of policies accounted for using the investment method is $39,520,877 as of June&#160;30, 2023, with a corresponding carrying value of $9,889,610. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2022, the Company held 53 life settlement policies, of which 35 were accounted for under the fair value method and 18 were accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value was $40,092,154 as of December&#160;31, 2022, with a corresponding fair value of $13,809,352. Aggregate face value of policies accounted for using the investment method was $42,330,000 as of December&#160;31, 2022, with a corresponding carrying value of $8,716,111. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">At June&#160;30, 2023, the Company did not have any contractual restrictions on its ability to sell policies, including those held as collateral for the issuance of long-term debt. See Note 13, &#8220;Long-Term Debt.&#8221; </div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. The following tables summarize the Company&#8217;s life insurance policies grouped by remaining life expectancy as of June&#160;30, 2023: </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies Carried at Fair Value</div></div>&#8212; </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 56%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Life Expectancy (Years)</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0-1</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1-2</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,314,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,855,769</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2-3</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,886,778</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,530,949</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3-4</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,631,467</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,174,200</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4-5</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,755,193</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,564,469</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">78</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">113,618,147</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,560,230</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">122</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">195,205,585</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies accounted for using the investment method</div></div>&#8212; </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 57%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Life Expectancy (Years)</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/> Life</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Insurance</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying<br/> Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0-1</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1-2</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2-3</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,131,679</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3-4</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,281,524</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4-5</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,362,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">518,736</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,658,877</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,957,671</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,520,877</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,889,610</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of June&#160;30, 2023, are as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 81%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023 remaining</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,024,151</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,243,423</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,310,936</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,044,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,288,619</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,911,769</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is required to pay premiums to keep its portion of life insurance policies in force. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differ from the estimated life expectancies. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For policies accounted for under the investment method, the Company has not been made aware of information causing a material change to assumptions relating to the timing of realization of life insurance settlement proceeds. We have also not been made aware of information indicating impairment to the carrying value of policies. </div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for life settlement contracts including the accounting policy for life settlement contracts and the classification of cash receipts and cash disbursements in the statement of cash flows and, as applicable, for (1) life settlement contracts accounted for under the investment method based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts, (d) the life insurance premiums anticipated to be paid for each of the five succeeding fiscal years to keep the life settlement contracts in force as of the date of the most recent statement of financial position presented, (e) the nature of the information that causes the Entity to change its expectations on the timing of the realization of proceeds from the investments in life settlement contracts and the related effect on the timing of the realization of proceeds from the life settlement contracts and for (2) life settlement contracts accounted for under the fair value method, disclosure would include, based on remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, (c) the face value (death benefits) of the life insurance policies underlying the contracts, (d) the reasons for changes in the Entity's expectation of the timing of the realization of the investments in life settlement contracts, and (e) (i) the gains or losses recognized during the period on investments sold during the period and (ii) the unrealized gains or losses recognized during the period on investments that are still held at the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//325-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694423879840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT---NET<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT&#8212;NET</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">5.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PROPERTY AND EQUIPMENT&#8212;NET </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;net composed of the following: </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 69%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2023</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144,202</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,300</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,444</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,299</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,902</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;gross</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186,801</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,346</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,870</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,729</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;net</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">177,931</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation expense for the three months ended June&#160;30, 2023 and 2022, was $1,098 and $1,098, respectively and depreciation expense for the six months ended June&#160;30, 2023, and 2022, was $2,141 and $2,141, respectively. </div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694426568432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">6.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">GOODWILL AND OTHER INTANGIBLE ASSETS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill of $140,287,000 was recognized as a result of the Business Combination, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. The estimates of fair value are based upon preliminary valuation assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. Refer to footnote 3 for further details. </div></div>  <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The changes in goodwill by reportable segments were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Abacus<br/> Settlements,<br/> LLC</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at January&#160;1, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at June&#160;30, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at January&#160;1, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">140,287,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">140,287,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible Assets Acquired comprised of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 41%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 36%; font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Type</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Life</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Methodology</div></div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Agents</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Multi-period&#160;excess-earnings&#160;method</div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Financial Relationships</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">8 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Multi-period excess-earnings method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;APA</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;Market Place</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trade Name</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Compete</div> Agreements</div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">With or Without Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State Insurance Licenses</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694422971296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">7.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">AVAILABLE-FOR-SALE</div></div> SECURITIES, AT FAIR VALUE </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible Promissory Note</div></div>&#8212;The Company holds a convertible promissory note in a separate unrelated insurance technology company. In November 2021, the Company purchased a $250,000 note and then purchased an additional note in January 2022 for $250,000 as part of the Tranche 5 offering (&#8220;Tranche 5 Promissory Note&#8221;). The Tranche 5 Promissory Note pays 6% interest per annum. The Tranche 5 Promissory Note matures on November&#160;12, 2023 (&#8220;Maturity Date&#8221;) and will be paid in full as to outstanding principal and accrued interest on the Maturity Date unless the Tranche 5 Promissory Note converts prior to the 2023 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $1,000,000 (&#8220;Next Equity Financing&#8221;). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">In October 2022, the Company purchased an additional convertible promissory note in the same unrelated insurance technology company for $500,000 as part of the Tranche 6<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>offering<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>(&#8220;Tranche 6 Promissory Note&#8221; and collectively, the &#8220;Convertible Promissory Notes&#8221;). The Tranche 6 Promissory Note pays eight percent (8)% interest per annum and matures September&#160;30, 2024 (&#8220;2024 Maturity Date&#8221;) and will be paid in full as to outstanding principal and accrued interest on the 2024 Maturity Date unless the Tranche 6 Promissory Note converts prior to the 2024 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $5,000,000 (&#8220;Next Round Securities&#8221;). </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Company applies the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> method of accounting for its investment in the Convertible Promissory Note, which is a debt investment. The Convertible Promissory Note does not qualify for either the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">held-to-maturity</div></div> method due to the Convertible Promissory Note&#8217;s conversion rights or the trading securities method because the Company holds the Convertible Promissory Note as a long-term investment. The Convertible Promissory Notes are measured at fair value at each reporting <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">period-end.</div> Unrealized gains and losses are reported in other comprehensive income until realized. As of December&#160;31, 2022 and June&#160;30, 2023, the Company evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000 and there was no unrealized gain or loss recorded. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br> -Publisher SEC<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//940-320/tableOfContent<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694427677280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Investments: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible Preferred Stock Ownership</div></div>&#8212;The Company owns convertible preferred stock in two entities, further described below. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;22, 2020, the Company purchased 224,551&#160;units of an unrelated insurance technology company&#8217;s Series Seed Preferred units for $750,000 (&#8220;Seed Units&#8221;). During December 2022, the Company agreed to purchase 119,760 Series Seed Preferred Units for $400,000 in cash consideration by way of eight monthly payments of $50,000 starting December&#160;15, 2022, resulting in a total of $950,000 investment as of March&#160;31, 2023 and $1,100,000 investment as of June&#160;30, 2023. Upon conversion, the Seed Units held by the Company would represent 8.6% control in the technology company. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">On December&#160;21, 2020, the Company purchased 207,476&#160;shares of a separate unrelated insurance technology company&#8217;s Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-1</div> preferred stock for $500,000 (&#8220;Preferred Shares&#8221;). The Preferred Shares are convertible into voting common stock of insured consent at the option of the Company. Upon conversion, the Preferred Shares would represent less than 1% control in the technology company. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company applies the measurement alternative for its investments in the Seed Units and Preferred Shares because these investments are of an equity nature, and the Company does not have the ability to exercise significant influence over operating and financial policies of entities even in the event of conversion of the Seed Units or Preferred Shares. Under the measurement alternative, the Company records the investment based on original cost, less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the investee. The Company&#8217;s share of income or loss of such companies is not included in the Company&#8217;s condensed </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">consolidated statements of operations and comprehensive income. The Company tests its investments for impairment whenever circumstances indicate that the carrying value of the investment may not be recoverable. No impairment of investments occurred for the three and six months ended June&#160;30, 2023 and 2022. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Noncurrent Assets- at fair value: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">S&amp;P Options</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div>The Company is long S&amp;P 500 call options and short S&amp;P 500 put options which were purchased and sold through a broker as an economic hedge related to the market-indexed debt instruments included in the long-term debt note. The value is based on shares owned and quoted market prices in active markets. Changes in fair value are recorded in the Unrealized Loss on Investments line item on the condensed consolidated statements of operations and comprehensive income. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694515971248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATION OF VARIABLE INTEREST ENTITIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">CONSOLIDATION OF VARIABLE INTEREST ENTITIES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">9.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">CONSOLIDATION OF VARIABLE INTEREST ENTITIES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company consolidates VIEs for which it is the primary beneficiary or VOEs for which it controls through a majority voting interest or other arrangement. See Note&#160;2 for more information on how the Company evaluates an entity for consolidation. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated any entity in which it had a variable interest upon formation to determine whether the entity should be consolidated. The Company also evaluated the consolidation conclusion during each reconsideration event, such as changes in the governing documents or additional equity contributions to the entity. During the six months ended June&#160;30, 2023, the Company&#8217;s consolidated VIEs, LMA Income Series&#160;II LP, LMX Series LLC (LMATT Series 2024, Inc.), Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets of $57,577,034 and liabilities of $52,474,820. For the year ended December&#160;31, 2022, the Company&#8217;s consolidated VIEs, LMATT Series 2024, Inc., Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets and liabilities of $30,073,972 and $27,116,762, respectively. The Company did not deconsolidate any entities during the period ended June&#160;30, 2023, or during the year ended December&#160;31, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, the Company held total assets of $801,345 and liabilities of $185,071, in unconsolidated VIEs. As of December&#160;31, 2022, the Company held total assets of $987,964 and liabilities of $358,586 in unconsolidated VIEs. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421704048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SEGMENT REPORTING </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Segment Information</div></div>&#8212;The Company organizes its business into two reportable segments (1)&#160;Portfolio Servicing and (2)&#160;Active Management, which generate revenue in different manners. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">This segment structure reflects the financial information and reports used by the Company&#8217;s management, specifically its chief operating decision maker (CODM), to make decisions regarding the Company&#8217;s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC&#160;280, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Segment Reporting</div></div>. The Company&#8217;s CODM is the President and Chief Executive Officer. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Portfolio Servicing segment generates revenues by providing policy services to customers on a contract basis. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Active Management segment generates revenues by buying, selling, and trading policies and maintaining policies until receipt of death benefits. The Company&#8217;s reportable segments are not aggregated. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review asset information related to investments nor expenditures incurred for long-lived assets given the Company&#8217;s investments are recognized using the measurement alternative, and the Company&#8217;s long-lived assets are immaterial to the condensed consolidated financial statements. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">Revenue related to the Company&#8217;s reporting segments for the three-month and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> periods ended June&#160;30, 2023, and June&#160;30, 2022, is as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 46%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio servicing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">354,366</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">419,422</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">590,057</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">990,328</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Active management</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,024,399</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,979,479</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,994,917</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,285,971</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,378,765</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,398,901</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,584,974</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,276,299</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Information related to the Company&#8217;s reporting segments for the three-month and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> periods ended June&#160;30, 2023 and June&#160;30, 2022 is as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 42%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio servicing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(76,705</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">280,303</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(166,128</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">668,752</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Active management</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,482,070</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,452,479</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,288,152</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,521,472</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gross profit</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,405,365</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,732,782</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,122,024</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,190,224</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(683,841</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,019,498</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,412,845</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,649,498</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General, administrative and other</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(577,539</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,499</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,274,431</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(646,705</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,098</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,098</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,141</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,141</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other (expense) income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121,601</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(127,455</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21,651</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(242,247</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest expense</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(584,075</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(934,001</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss on change in fair value of debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,445,229</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(333,879</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,398,662</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(375,513</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain (loss) on investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">672,936</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,039,022</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">798,156</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,054,975</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Provision for income taxes</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,184,571</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(120,132</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(528,104</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(296,806</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Less: Net loss attributable to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,596</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(406,641</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">487,303</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(406,641</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Abacus Life, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,750,145</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,679,558</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,835,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,515,698</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694515971248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">11.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">COMMITMENTS AND CONTINGENCIES </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Legal Proceedings</div></div>&#8212;Occasionally, the Company may be subject to various proceedings such as lawsuits, disputes, or claims. The Company assesses these proceedings as they arise and accrues a liability when losses are probable and reasonably estimable. Although legal proceedings are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company&#8217;s business, financial position, results of operations, or cash flows. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Commitment</div></div>&#8212;The Company has entered into a Strategic Services and Expenses Support Agreement (&#8220;Expense Support Agreement&#8221;) with two commonly owned full-service origination, servicing, and investment Providers in exchange for an option to purchase the outstanding equity ownership of the Providers. Pursuant to the Expense Support Agreement, Abacus Life, Inc. provides financial support and advice for the expenses of the Providers incurred in connection with their life settlement transactions businesses and the Providers are required to hire a life settlement transactions operations employee of an affiliate of Abacus Life, Inc. No later than December&#160;1 of each calendar year, Abacus Life, Inc. provides a budget for the Providers, in which Abacus Life, Inc. commits to extend financial support for all operating expenses up to the budgeted amount. &#8220;Operating Expenses&#8221; for purposes of the Expense Support Agreement means all annual operating expenses of the Providers incurred in the ordinary course of business, excluding the premiums paid for the Providers insurance coverages that are allocable to the insurance coverage </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provided to Institutional Life Holdings,&#160;LLC, which owns all the outstanding membership interests of the Providers if unrelated to the Providers settlement business. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June&#160;30, 2023, Abacus Life, Inc. did <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">no</div>t</div> incur expenses related to the Expense Support Agreement. For the six months ended June&#160;30, 2023, Abacus Life, Inc. incurred $29,721 of expenses, related to the Expense Support Agreement, which is included in the Other (expense) line of the condensed consolidated statements of operations and comprehensive income and have not been reimbursed by the Providers. </div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421785920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">12.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FAIR VALUE MEASUREMENTS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company determines fair value based on assumptions that market participants would use in pricing an asset or a liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;2 inputs: Other than quoted prices in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level&#160;3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recurring Fair Value Measurements</div></div>&#8212;The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 46%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Hierarchy</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> securities, at fair value</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">S&amp;P 500 options</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,794,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,794,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,246</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,246</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets held at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">1,801,886</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">59,285,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">61,087,503</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrants</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,438,600</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,438,600</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities held at fair value:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">68,603,996</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">68,603,996</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 51%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Hierarchy</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,809,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,809,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> securities, at fair value</div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other investments</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,300,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,300,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">S&amp;P 500 options</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">890,829</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">890,829</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets held at fair value</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">890,829</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,109,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,000,181</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities held at fair value:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life Settlement Policies</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></div></div>The Company separately accounts for each owned life settlement policy using either the fair value method, or investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For policies carried at fair value, the Company utilizes valuation services of a third-party actuarial firm, who values the contracts using Level&#160;3 unobservable inputs, including actuarial assumptions, such as life expectancies and cash flow discount rates. The valuation model is based on a discounted cash flow analysis and is sensitive to changes in the discount rate used. The Company utilized a discount rate of 16% at June&#160;30, 2023 and 12% at December&#160;31, 2022, respectively, for policy valuation, which is based on economic and company-specific factors. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Subsequent to the reporting date, the Company sold 3 policies carried at fair value. As of June&#160;30, 2023, the Company valued these 3 policies using the price at the time of sale. Valuing these 3 policies using the takeout price resulted in a decrease in valuation of $231,775 compared to the third-party valuation. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For life settlement policies carried using the investment method, the Company measures these at the cost of the policy plus premiums paid. The policies accounted for using the investment method totaled $9,889,610 at June&#160;30, 2023 and $8,716,111 at December&#160;31, 2022, respectively. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Discount Rate Sensitivity</div></div>&#8212;Changes in the 16% discount rate on the death benefit and premiums used to estimate the policies issued under LMATT Series&#160;2024 Inc.,&#160;LMATT Growth Series 2.2024 Inc., LMATT Growth and Income Series 1.2026, Inc., LMA Income Series, LP and LMA Income Series II, LP (&#8220;LMATT Policies&#8221;) fair value has been analyzed. If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of June&#160;30, 2023, would be as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Rate Adjustment</div></div></div> </td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">+2%</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,987,508</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,698,109</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No change</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">-2%</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,857,879</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,172,262</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Credit Exposure to Insurance Companies</div></div>&#8212;The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company&#8217;s life insurance policies as of June&#160;30, 2023: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrier</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrier</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rating</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">American General Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ReliaStar Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lincoln National Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a roll forward of the fair value of life insurance policies for the six months-ended June&#160;30, 2023: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at December&#160;31, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,809,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Policies purchased</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,543,580</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Realized gain (loss) on matured/sold policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,898,958</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Premiums paid</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(879,462</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain(loss) on held policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,319,588</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in estimated fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,339,084</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Matured/sold policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(20,885,861</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Premiums paid</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">879,462</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Long-Term Debt</div></div>&#8212;See Note&#160;13<div style="letter-spacing: 0px; top: 0px;;display:inline;">,</div>&#160;&#8220;Long-Term Debt&#8221; for background information on the market-indexed debt. The Company has elected the fair value option in accounting for the instruments. Fair value is determined using Level&#160;3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i)&#160;the S&amp;P 500 Index price, (ii)&#160;S&amp;P 500 Index volatility, (iii)&#160;a risk-free rate based on data published by the US Treasury, and (iv)&#160;a term assumption based on the contractual term of the LMATT Notes. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total change in fair value of the debt resulted in a gain of $1,602,042. This gain is comprised of $90,148, net of tax, which is included within accumulated other comprehensive income and $29,515 net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $1,445,229 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the three months ended June&#160;30, 2023. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The total change in fair value of the debt resulted in a gain of $2,705,918. This gain is comprised of $175,530, net of tax, which is included within accumulated other comprehensive income and $56,446 net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $2,398,662 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the six months ended June&#160;30, 2023. </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a roll forward of the fair value of the issued notes for the six months ended June&#160;30, 2023: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at December&#160;31, 2022</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Debt issued to third parties</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,209,825</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized loss on change in fair value (risk-free)</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,398,662</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain on change in fair value (credit-adjusted)</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">307,256</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in estimated fair value</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,705,918</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private Placement Warrants</div></div>&#8212;Simultaneously with the closing of the Initial Public Offering, ERES consummated the sale of 8,900,000 warrants (the &#8220;Private Placement Warrants&#8221;) to East Sponsor, LLC (the </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Sponsor&#8221;), which included the sale of an additional 900,000 Private Placement Warrants in connection with the full exercise by the underwriters of their over-allotment option on August&#160;25, 2020, at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $8,900,000. Each Private Placement Warrant is exercisable for one share of Class&#160;A common stock at a price of $11.50 per share, subject to adjustment. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y)&#160;the Private Placement Warrants will be exercisable on a cashless basis and be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> so long as they are held by the initial purchasers or their permitted transferees and (z)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Private Placement Warrants were accounted for as liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented separately in the condensed consolidated statements of operations. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants were considered a Level&#160;3 fair value measurement using a binomial lattice model in a risk-neutral framework. The binomial lattice model&#8217;s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The implied volatility as of the reporting date was derived from observable public warrant traded price provided by Bloomberg LP. </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the key assumptions in the analysis: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 79%;"></td>
<td style="width: 16%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/> Placement<br/> Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected implied volatility</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">de&#160;minimis</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.09</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term to expiration</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.0 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Price</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.03</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend Yield</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 10%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other Noncurrent Assets: S&amp;P 500 Options</div></div>&#8212;In February 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, purchased and sold S&amp;P 500 call and put options through a broker. The Company purchased and sold additional S&amp;P 500 call options through a broker in June 2022 through their 100% owned and fully consolidated subsidiaries LMATT Growth Series 2.2024, Inc. and LMATT Growth and Income Series 1.2026, Inc. The options are exchange traded, and fair value is determined using Level&#160;1 inputs of quoted market prices as of the condensed consolidated balance sheets dates. Changes in fair value are classified as unrealized (gain)/loss on investments within the condensed consolidated statements of operations and comprehensive income. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial Instruments Measured at Fair Value on a Nonrecurring Basis</div></div>&#8212;The following financial assets, composed of equity securities without readily determinable fair values, are adjusted to fair value when observable price changes are identified, or an impairment charge is recognized. Such fair value measurements are based predominantly on Level&#160;3 inputs. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-Sale</div></div> Investment</div></div>&#8212;The Convertible Promissory Note is classified as an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> security. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> investments are subsequently measured at fair value. Unrealized holding gains </div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> investments using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. The Company initially purchased a $250,000 convertible promissory note from the issuer in 2021 and then on January&#160;7, 2022, the Company purchased an additional $250,000 convertible promissory note from the same issuer and then an additional $500,000 in October 2022. As of June&#160;30, 2023 and December&#160;31, 2022, the Company evaluated the fair value of its Promissory Note and determined that the fair value approximates the carrying value of $1,000,000 and $1,000,000, respectively. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other Investments</div></div>&#8212;The Company determines fair value using Level&#160;3 inputs under the measurement alternative. These investments are recorded at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively. As of June&#160;30, 2023, and December&#160;31, 2022, the Company did not identify any impairment indicators and determined that the carrying value of $1,600,000 and $1,300,000 is the fair value for these equity investments in privately held companies, given that there have been no observable price changes. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financial Instruments Where Carrying Value Approximates Fair Value</div></div>&#8212;The carrying value of cash, cash equivalents, accounts receivables, and due to affiliates approximates fair value due to the short-term nature of their maturities. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421700528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG-TERM DEBT</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">13.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LONG-TERM DEBT </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt comprises of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market-indexed notes:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2024, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,866,900</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,621,141</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,866,900</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,067,291</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2.2024, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,333,391</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,446,527</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,333,391</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,354,013</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Growth&#160;&amp; Income Series 1.2026, Inc</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">459,553</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Secured borrowing:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Income Series, LP</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,889,444</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,124,676</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,428,349</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,428,349</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Income Series II, LP</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,041,851</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,041,851</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unsecured borrowing:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sponsor PIK Note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,471,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,471,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total long-term debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">65,003,234</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,028,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV purchase and sale note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sponsor PIK Note </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On the June&#160;30, 2023, in connection with the consummation of the Business Combination and as contemplated by the Merger Agreement, East Sponsor, LLC, a Delaware limited liability company (&#8220;Sponsor&#8221;), made an unsecured loan to the Company in the aggregate amount of $10,471,648 (the &#8220;Sponsor PIK Note&#8221;). The Sponsor PIK Note matures on June&#160;30, 2028 (the &#8220;Maturity Date&#8221;) and may be prepaid at any time in accordance with its terms without any premium or penalty. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2024, Inc. Market-Indexed Notes: </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March&#160;31, 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, issued $10,166,900&#160;in market-indexed private placement notes. The note, titled the Longevity Market Assets </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">Target-Term Series (LMATTS) 2024, is a market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The note has a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the note on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-to-one</div></div> basis. As of June&#160;30, 2023, $9,866,900 of the principal amount remained outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2024, Inc. notes were $9,621,141. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are secured by the assets of the issuing entities, which includes cash, S&amp;P 500 options, and life settlement policies totaling $11,195,701 as of June&#160;30, 2023. The notes&#8217; agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2.2024, Inc. Market-Indexed Notes: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">On September&#160;16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $2,333,391 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (&#8220;LMATTSTM Series 2.2024, Inc.&#8221;) is a market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 120% of the performance of the S&amp;P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investment will experience all subsequent losses on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-to-one</div></div> basis. . As of June&#160;30, 2023, the entire principal amount remained outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2.2024, Inc. notes were $3,446,527. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $3,331,872 as of June&#160;30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes: </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Additionally, on September&#160;16, 2022, LMATTS Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $400,000 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (&#8220;LMATTSTM Growth and Income Series 1.2026, Inc.&#8221;) is a market-indexed instrument designed to provide upside performance exposure of the S&amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2026, the principal, plus the return based upon the S&amp;P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 140% of the performance of the S&amp;P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investment will experience all subsequent losses on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-to-one</div></div> basis. This note also includes 4% dividend feature that will be paid annually. As of June&#160;30, 2023, the entire principal amount remained outstanding. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes were $459,553. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The notes are secured by the assets of the issuing entity, LMATTS Growth and Income Series 1.2026, Inc., which includes cash, S&amp;P 500 options, and life settlement policies totaling $517,218 as of June&#160;30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">See additional fair value considerations within Note 12. &#8220;Fair Value Measurements.&#8221; </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-year</div> periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at 9% which would require a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the six months ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10.</div> As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10-50-6A(d)).</div></div></div> In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-30-25-2,</div></div></div> as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">810-10-30.</div></div> As of June&#160;30, 2023, the fair value of the secured borrowing was $22,124,676. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA Income Series II, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-year</div> periods at the discretion of the general partner, LMA Income Series II, GP, LLC. The limited partners will receive annual dividends equal to the Preferred Return Amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the three and six months ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10.</div> As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-10-50-6A(d)).</div></div></div> In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">860-30-25-2,</div></div></div> as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">810-10-30.</div></div> As of June&#160;30, 2023, the fair value of the secured borrowing was $20,041,851. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Purchase and Sale </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;5, 2023, the Company entered into an Asset Purchase Agreement (the &#8220;Policy APA&#8221;) to acquire certain insurance policies with an aggregate fair market value of $10.0&#160;million from Abacus Investment SPV, LLC, a Delaware limited liability company (&#8220;SPV&#8221;), in exchange for a payable obligation owing by the Company to the SPV (such acquisition transaction under the Policy APA, the &#8220;SPV Purchase and Sale&#8221;). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The payable obligation owing by the Company to the SPV in connection with the SPV Purchase and Sale is evidenced by a note issued by the Company under the SPV Investment Facility (the &#8220;SPV Purchase and Sale Note&#8221;) in an original principal amount equal to the aggregate fair market value of the acquired insurance policies. The SPV Purchase and Sale Note has the same material terms and conditions as the other credit extensions under the SPV Investment Facility (as defined below). </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Investment Facility </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;5, 2023, the Company entered into that certain SPV Investment Facility (the &#8220;SPV Investment Facility&#8221;), between the Company, as borrower, and the SPV, as lender. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The SPV Investment Facility, among other things: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">requires certain subsidiaries of the Company to guarantee the credit extensions provided under the SPV Investment Facility pursuant to separate documentation </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">is unsecured without collateral security provided in favor of the SPV and subordinated in right of payment to the Company&#8217;s obligations under the Owl Rock Credit Facility, subject to limited specified exceptions and circumstances for permitting early payment; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for certain credit extensions in an aggregate principal amount of $25.0&#160;million, including: (i)&#160;an initial credit extension in an original principal amount of $15.0&#160;million that was funded upon the closing of the SPV Investment Facility, and (ii)&#160;the SPV Purchase and Sale Note in favor of the SPV in an original principal amount of $10.0&#160;million to finance the purchase of the insurance policies under the Policy APA; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides proceeds from the SPV Investment Facility for payment of certain transaction expenses, general corporate purposes and any other purposes not prohibited by the agreement or applicable law; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">matures on July&#160;5, 2026, three years after the closing of the SPV Investment Facility, subject to two automatic extensions of one year each without any amendment of the relevant documentation, but also subject to applicable subordination restrictions in relation to the Owl Rock Credit Facility; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">provides for interest to accrue on the SPV Investment Facility at a rate of 12.00% per annum, payable quarterly, all of which is to be paid <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-kind</div> by the Company by increasing the principal amount of the SPV Investment Facility owing to the SPV on each interest payment date; </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">provides a default rate that will accrue at 2.00% per annum (subject to applicable subordination restrictions) over the rate otherwise applicable. If cash payment is not permitted due to applicable subordination restrictions or otherwise, such default interest shall be paid <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-kind;</div> </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides that no amortization payments shall be required prior to maturity; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains financial and other covenants substantially similar and not materially worse than those contained in the Owl Rock Credit Facility from the perspective of the Company; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for certain specified events of default (including certain events of default subject to grace or cure periods), with the occurrence and during the continuance of such events of default enabling the lender under the SPV Investment Facility to accelerate the obligations under the SPV Investment Facility, among other rights or remedies, subject to applicable subordination restrictions. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The SPV&#8217;s investment resulting from credit extensions under the SPV Investment Facility is treated by the Company as debt for U.S. GAAP accounting purposes. While the timing of the Policy APA and SPV Investment Facility occurred on July&#160;5, 2023, such amounts are included within the condensed consolidated balance sheet as cash was received prior to June&#160;30, 2023. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694515971248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">14.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SHAREHOLDERS&#8217; EQUITY </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is authorized to issue up to 200,000,000&#160;shares of common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. No shares of preferred stock are issued or outstanding. Holders of the Company&#8217;s common stock are entitled to one vote for each share. As of June&#160;30, 2023, there were 62,961,688&#160;shares of common stock issued and outstanding. Holders of shares were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets available for distribution to the shareholders after payment of all liabilities. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company&#8217;s common stock, $0.0001 par value per share, issued to legacy LMA&#8217;s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. As of December&#160;31, 2022, this resulted in 50,369,350 shares of common stock issued and outstanding. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, the Company has 17,250,000 Public Warrants outstanding. Each redeemable whole Public Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment as described. The Public Warrants represent a freestanding financial instrument as it is traded on the </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">NASDAQ </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> under the symbol &#8220;ABLLW&#8221; and legally detachable and separately exercisable from the related underlying shares of the Company&#8217;s common stock. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed Offering. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will not be obligated to deliver any shares of Class&#160;A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class&#160;A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class&#160;A common stock upon exercise of a warrant unless the share of Class&#160;A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of Warrants for Cash&#8212;Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per Public Warrant; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than 30 days&#8217; prior written notice of redemption to each warrant holder; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">If and when the Public warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class&#160;A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class&#160;A common stock is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption of Warrants for Shares of Class&#160;A Common Stock&#8212;Once the Public warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class&#160;A common stock: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price equal to a number of shares of Class&#160;A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the &#8220;fair market value&#8221; of the Class&#160;A common stock; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon not less than 30 days&#8217; prior written notice of redemption to each warrant holder; and </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, if (x)&#160;the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company&#8217;s initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (y) the volume weighted average trading price of the Company&#8217;s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Price&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of Market Price and the newly issued price. Further, the $10.00 and $18.00 per share redemption trigger prices will be adjusted to be equal to 100% and 180%, respectively, of the higher of the market value and the newly issued price. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company elects to redeem all of the Public Warrants or the common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange, management has the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. However, in no instance can the warrant holder unilaterally decide to exercise its Public Warrant on a cashless basis. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the Business Combination, the Company accounted for the Public Warrants issued with the IPO as equity instruments. The Company accounted for the warrant as an expense of the IPO resulting in a charge directly to stockholders&#8217; equity. The Company estimates that the fair value of the warrants upon the Business Combination is approximately $4.73&#160;million, or $0.274 per Public Warrant, using the binomial lattice model. The fair value of the warrants is estimated as of the date of grant using the following assumptions: (1)&#160;risk-free interest rate of 4.09%, (2) term to expiration of 5.0 years, (3)&#160;exercise price of $11.50 and (4)&#160;stock price of $10.03. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694422974160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLAN<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanTextBlock', window );">EMPLOYEE BENEFIT PLAN</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">15.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">EMPLOYEE BENEFIT PLAN </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has a defined contribution plan in the U.S. intended to qualify under Section&#160;401(k)&#160;of the Internal Revenue Code (the &#8220;401(k)&#160;Plan&#8221;). The 401(k)&#160;Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer up to 100% of their annual compensation on a pretax basis. For the year ended December&#160;31, 2022, the Company elected to match 50% of employee contributions up to a maximum of 4% of eligible employee compensation. For the three months ended June&#160;30, 2023 and 2022, the Company recognized expenses related to the 401(k)&#160;Plan amounting to $13,075 and $2,577, respectively and for the six months ended June&#160;30, 2023 and 2022, the Company recognized expenses related to the 401(k)&#160;Plan amounting to $25,315 and $8,048, respectively. </div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715-70/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694428377648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">INCOME TAXES </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Before June&#160;30, 2023, the Company elected to file as an S corporation for Federal and state income tax purposes, the Company incurred no Federal or state income taxes, except for income taxes recorded related to some of their consolidated variable interest entities and subsidiaries which are taxable C corporations. These VIE&#8217;s and subsidiaries include LMATT Series&#160;2024,&#160;Inc., the wholly owned subsidiary of LMX, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATTS Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, the provision for income taxes was attributable to amounts for LMATT Series&#160;2024,&#160;Inc, LMATT Growth Series, Inc. and LMATT Growth and Income Series, Inc. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three months ended June&#160;30, 2023 and 2022, the Company recorded provision for income taxes of $1,184,571 and $120,132, respectively. The effective tax rate is 15.0% for the three months ended June&#160;30, 2023. The effective rate for the three months ended June&#160;30, 2022 was 12.0% due to the impact of state income taxes and the release of the Company&#8217;s valuation allowance, as there was sufficient evidence of the Company&#8217;s ability to generate future taxable income at June&#160;30, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">For the six months ended June&#160;30, 2023 and 2022, the Company recorded provision for income taxes of $528,104 and $296,806, respectively. The effective tax rate is 3.6% for the six months ended June&#160;30, 2023. The existence of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-taxable</div> flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to be significantly lower than </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the statutory rate. The effective rate for the six months ended June&#160;30, 2022 was 18% due to the impact of state income taxes and the release of the Company&#8217;s valuation allowance, as there was sufficient evidence of the Company&#8217;s ability to generate future taxable income at June&#160;30, 2022. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not have any unrecognized tax benefits relating to uncertain tax positions as of June&#160;30, 2023, and December&#160;31, 2022, and did not recognize any interest or penalties related to uncertain tax positions as of June&#160;30, 2023, and December&#160;31, 2022. </div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421700528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED-PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED-PARTY TRANSACTIONS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">17.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">RELATED-PARTY TRANSACTIONS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023 and December&#160;31, 2022, $10,415,154 and $263,785, respectively, were due to members and affiliates primarily for reimbursable transaction costs as well as distributions to owners of $717,429 as a part of the Business Combination as of June&#160;30, 2023. As of June&#160;30, 2023 and December&#160;31, 2022, $10,473,748 and $2,904,646 was due from affiliates, respectively. The amount to be received as of June&#160;30, 2023 is due from the Sponsor as part of the Sponsor PIK Note. Additionally, the SPV purchase and sale note for $25,000,000 as of June&#160;30, 2023 was also recorded as a related party transaction given the transfer of cash and policies between the Company and the SPV. Refer to footnote 13 for more information. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has a related-party relationship with Nova Trading (US),&#160;LLC (&#8220;Nova Trading&#8221;), a Delaware limited liability company and Nova Holding (US)&#160;LP, a Delaware limited partnership (&#8220;Nova Holding&#8221; and collectively with Nova Trading, the &#8220;Nova Funds&#8221;). The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided by 12.&#160;The Company earned $197,629 and $205,224, respectively, in service revenue related to Nova Funds for the three months ended June&#160;30, 2023 and 2022 and earned $411,076 and $406,129, respectively, in service revenue related to Nova Funds for the six months ended June&#160;30, 2023 and 2022. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the Merger, LMA used Abacus to originate life settlement policies that it accounts for under the investment method. For the three and six months ended June&#160;30, 2023, the Company incurred $837,975 and $1,627,975, respectively in origination costs for life settlement policies that were originated by Abacus. These costs are capitalized on the condensed consolidated balance sheets as life settlement policies, at cost. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023, and December&#160;31, 2022, there were $72,600 and $196,289, respectively owed from the Nova Funds, which are included as related-party receivables in the accompanying condensed consolidated balance sheets. </div></div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421557360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">18.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LEASES </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities for its operating lease consisted of the following amounts as of June&#160;30, 2023 and December&#160;31, 2022: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">240,816</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">77,011</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liability, current</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">227,561</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48,127</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease liability, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,864</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,268</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease liability</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">244,425</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">77,395</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes lease expense for its operating leases within general, administrative, and other expenses on the Company&#8217;s condensed consolidated statements of operations and comprehensive income.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>The Company&#8217;s lease expense for the periods presented consisted of the following:</div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 60%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,471</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,921</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,942</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,842</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Variable lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,704</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">612</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,925</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,223</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,175</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,533</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,867</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,065</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows supplemental cash flow information related to lease activities for the periods presented: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 74%;"></td>
<td style="width: 5%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 5%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash paid for amounts included in the measurement of the lease liability</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,557</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,842</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ROU assets obtained in exchange for new lease liabilities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"></td>
<td style="width: 19%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 18%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average remaining lease term (in years)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.58</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average discount rate</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.54</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.36</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr> </table>  <div style="clear: both; max-height: 0px;"></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future minimum noncancellable lease payments under the Company&#8217;s operating leases on an undiscounted basis reconciled to the respective lease liability at June&#160;30, 2023 are as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 88%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Operating<br/> leases</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining of 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,176</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">118,057</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease payments (undiscounted)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">248,233</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Imputed interest</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,808</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liability as of June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">244,425</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421597152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">19.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">EARNINGS PER SHARE </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic earnings per share represents income available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding during the reported period. Net income per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the Public and Private Placement Warrants to purchase an aggregate of 26,150,000 shares in the calculation of diluted income per ordinary share, since the </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">average market price of the Company&#8217;s Class&#160;A common shares for the three and six months ended June&#160;30, 2023 was below the warrants&#8217; $11.50 exercise price. As a result, diluted income per share is the same as basic net income per share for the period presented. </div></div>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding and earnings per share were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 11pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 40%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Longevity Market Assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">6,750,145</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">4,679,558</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">14,835,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">11,515,698</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares used in computing net income per share, basic and diluted</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,507,728</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,369,350</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,438,921</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,369,350</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted earnings per share:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.13</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.09</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.29</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.23</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421704048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">20.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SUBSEQUENT EVENTS </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated&#160;subsequent events&#160;and transactions from the condensed consolidated balance sheet date through the date at which the condensed consolidated financial statements were issued. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Owl Rock Credit Facility </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On July&#160;5, 2023 (the &#8220;Owl Rock Closing Date&#8221;), the Company entered into that certain Credit Agreement (the &#8220;Owl Rock Credit Facility&#8221;), among the Company, as borrower, the several banks and other persons from time to time party thereto (the &#8220;Owl Rock Lenders&#8221;), and Owl Rock Capital Corporation, as administrative and collateral agent for the Owl Rock Lenders thereunder. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Owl Rock Credit Facility, among other things: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">requires the Company and certain subsidiaries of the Company to guarantee the loans provided under the Owl Rock Credit Facility pursuant to separate loan documentation; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides credit extensions for (i)&#160;an initial term loan in an aggregate principal amount of $25.0&#160;million upon the closing of the Owl Rock Credit Facility and (ii)&#160;optional delayed draw term loans (which can be drawn on multiple drawing dates) in an aggregate principal amount of up to $25.0&#160;million available for one hundred eighty (180)&#160;days after the Owl Rock Closing Date (the &#8220;Delayed Draw Term Loan Availability Period&#8221;), subject to the requirement that on each delayed draw date, the liquid asset coverage ratio shall not be less than 1.80 to 1.00, together with other specified conditions to drawings, the proceeds of which may be used for working capital and the business requirements of the enterprise, and to fund acquisitions, investments and other transactions permitted by the loan documentation; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides a delayed draw commitment fee rate of 0.50% per annum applicable to undrawn commitments during the Delayed Draw Term Loan Availability Period </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">matures on July&#160;5, 2028, the date that is five years after the closing of the Owl Rock Credit Facility; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">is secured by a first-priority security interest in substantially all of the assets of the Company and the subsidiary guarantors. No pledge of any equity interests in the Company is required by any holder of such equity interests; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for interest to accrue on the loans drawn under the Owl Rock Credit Facility at the election of the Company, by reference to either (i)&#160;an alternative base rate (such loans, &#8220;ABR Loans&#8221;) or (ii)&#160;an adjusted term SOFR rate (such loans, &#8220;SOFR Loans&#8221;) plus an applicable margin. The adjusted term SOFR rate is determined by the applicable term SOFR for a relevant interest period plus a credit spread adjustment of 0.10%, 0.15% and 0.25% per annum for interest periods of <span style="-sec-ix-hidden:hidden91072234">one</span>, <span style="-sec-ix-hidden:hidden91072235">three</span> and six months, </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="vertical-align: top; width: 9%;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">&#160;</div> </td>
<td style="vertical-align: top;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">respectively. The applicable margin for each type of loan is (i) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6.25% per annum for any ABR Loans and (ii) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7.25% per annum for any SOFR Loans, with interest periods for SOFR Loans of </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden91071985">one</span>, </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><span style="-sec-ix-hidden:hidden91071984">three</span> or </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">six months</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> (or other periods if agreed by all lenders); </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides a default rate that will accrue at </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.00</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% per annum over the rate otherwise applicable; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for amortization payments based on the initial principal amount of the loans outstanding of </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1.0% per year (</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0.25</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% due per quarter), with adjustments made to the overall amortization amount upon the incurrence of any delayed draw loans; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains provisions requiring mandatory prepayment of the initial term loans and delayed draw term loans with </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">100</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the proceeds of (a)&#160;indebtedness not permitted by the Owl Rock Credit Facility and (b)&#160;certain specified asset dispositions and payments (including in respect of settlements) in respect of property, casualty insurance claims or condemnation proceedings, with the proceeds received under this clause (b)&#160;subject to certain specified reinvestment rights and procedures set forth in the Owl Rock Credit Facility. The Owl Rock Credit Facility permits voluntary prepayments of outstanding loans at any time; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for a prepayment premium equal to (a) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4.00% of the principal amount of such loans prepaid on or prior to the first anniversary of the closing of the Owl Rock Credit Facility, (b) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3.00% of the principal amount of such loans prepaid after the first anniversary of the closing of the Owl Rock Credit Facility but on or prior to the second anniversary of the closing of the Owl Rock Credit Facility and (c) </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.00</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">% of the principal amount of such loans prepaid after the second anniversary of the closing of the Owl Rock Credit Facility but on or prior to the third anniversary of the closing of the Owl Rock Credit Facility. No prepayment premium will be applicable for any such prepayment made after the third anniversary of the closing of the Owl Rock Credit Facility. The prepayment premium is applicable to voluntary prepayments and certain specified mandatory prepayment during such applicable periods; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for financial covenants such that (i)&#160;a consolidated net leverage ratio cannot exceed </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.50 to 1.00 as of the last day of any fiscal quarter and (ii)&#160;a liquid asset coverage ratio cannot be less than </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1.80</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;to 1.00; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains affirmative covenants related to, among other things, delivery of certain financial reports and compliance certificates, maintenance of existence, compliance with laws, material contracts, payment of taxes, property and insurance matters, inspection of property, books and records, notices, collateral matters and future subsidiaries, in each case, subject to specified limitations and exceptions; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains an affirmative representation and corresponding covenant that the Company and certain subsidiaries of the Company do not, and will not during the term of the Owl Rock Facility (or if the term of the Owl Rock Credit Facility continues for longer than a year, during the Company&#8217;s and certain subsidiaries of the Company&#8217;s most recent fiscal year), derive more than fifteen percent (</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15</div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%) of their aggregate gross revenues from securities related activities; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">contains negative covenants related to, among other things, incurrence of debt, creation of liens, mergers, acquisitions and certain other fundamental changes, conditions concerning the creation of new subsidiaries, conditions concerning opening of new accounts, disposition of assets, dividends and other restricted payments, prepayment of certain indebtedness, transactions with affiliates, investments and limitations on lines of business, in each case, subject to specified limitations and exceptions; and </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td id="fin527481_35a" style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provides for certain specified events of default upon the occurrence and during the continuation of certain events or conditions (subject to specified exceptions, grace periods or cure rights, as applicable) each as set forth in the Owl Rock Credit Facility, which includes among other things, defaults with respect to nonpayment, breaches of representations and warranties, failure to comply with covenants, cross-default to other material indebtedness, bankruptcy and insolvency matters, ERISA matters, material judgments, collateral and perfection matters, the occurrence of a change of control and subordination matters with respect to certain specified indebtedness. The occurrence and continuance of an event of default that is not cured or waived will enable the agent and/or the lenders, as applicable, to accelerate the loans or take other remedial steps as provided in the Owl Rock Credit Facility and the other loan documents. </div></div> </td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694423903104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems', window );"><strong>Subsidiary of Limited Liability Company or Limited Partnership [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Unaudited Condensed Consolidated Financial Statements</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation</div></div>&#8212;In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). Under U.S. GAAP, ERES has been treated as the &#8220;acquired&#8221; company for financial reporting purposes. This determination was primarily based on the LMA shareholders having a relative majority of the voting power of the Company, the LMA shareholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the &#8220;acquirer&#8221; for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Abacus Merger will be accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will be recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, will be recognized as goodwill. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In considering the foregoing principles of predecessor determination and in light of the Company&#8217;s specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. </div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Unaudited Condensed Consolidated Financial Statements</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unaudited Condensed Consolidated Financial Statements</div></div>&#8212;The condensed consolidated financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial position as of June&#160;30, 2023, and the condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023 and 2022, respectively, and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022, respectively. The condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for Abacus for the year ended December&#160;31, 2022, and the financial statements and notes for LMA for the year ended December&#160;31, 2022. All references to financial information as of and for the periods ended June&#160;30, 2023, and 2022 in the notes to condensed consolidated financial statements are unaudited. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Refer to this note in the LMA annual financial statements for the full list of the Company&#8217;s significant accounting policies. The details in those notes have not changed, except as discussed below and as a result of normal adjustments in the interim periods. </div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Consolidation of Variable Interest Entities</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Consolidation of Variable Interest Entities</div></div>&#8212;For entities in which the Company has variable interests, the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Company </div>first evaluates whether the entity meets the definition of a variable interest entity (&#8220;VIE&#8221;) or a </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">voting interest entity (&#8220;VOE&#8221;). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company&#8217;s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;810, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidations</div></div>, requires the Company to separately disclose on its condensed consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of June&#160;30, 2023, total assets and liabilities of consolidated VIEs were $57,577,034 and $52,474,820, respectively. As of December&#160;31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January&#160;1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the &#8220;Providers&#8221;), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the &#8220;Option Agreement&#8221;). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321. In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815 and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the share price has no readily determinable fair value. The Company&#8217;s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company provided $0 and $127,455 of funding for the three months ended June&#160;30, 2023 and June&#160;30, 2022, respectively and provided $29,721 and $242,247 of funding for the six months ended June&#160;30, 2023 and June&#160;30, 2022, respectively which is included in other (expense) income on the condensed consolidated statements of operations and comprehensive income. See Note 11, Commitments and Contingencies. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the period ended June&#160;30, 2023, and for the year ended December&#160;31, 2022, the Providers were considered to be VIEs, but were not consolidated in the Company&#8217;s condensed consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of June&#160;30, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $318,178 and liabilities of $450 and held assets of $483,167 and liabilities of $184,621, respectively. As of December&#160;31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $126,040 and liabilities of $0 and held assets of $861,924 and liabilities of $358,586, respectively. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October&#160;4, 2021, the Company entered into an operating agreement with LMX Series,&#160;LLC (&#8220;LMX&#8221;) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series&#160;2024,&#160;Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its condensed consolidated financial statements for the period ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March&#160;3, 2022, the Company obtained an 80% ownership interest in Longevity Market Advisors,&#160;LLC (&#8220;Longevity Market Advisors&#8221;). The Longevity Market Advisors legal entity was established primarily for </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the purpose of acquiring the assets of a broker/dealer, Regional Investment Services,&#160;Inc. (&#8220;RIS&#8221;), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price payable in exchange for RIS was $60,000. The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of the RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being registered by the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;). As there are no tangible or intangible assets of value from the RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise 100% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of Longevity Market Advisors in its condensed consolidated financial statements for the period ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November&#160;30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January&#160;31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. </div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Noncontrolling Interest</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Noncontrolling Interest</div></div>&#8212;Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the condensed consolidated balance sheets at an amount equal to the noncontrolling interest&#8217;s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholder&#8217;s additional contributions, distributions, and the shareholder&#8217;s share of the net earnings or losses of each respective consolidated entity. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholder&#8217;s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the condensed consolidated statements of operations and comprehensive income. </div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div>&#8212;The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reports amounts of revenue and expenses during the reporting periods. Company&#8217;s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsPolicy', window );">Life Insurance Settlement Policies</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Life Insurance Settlement Policies</div></div>&#8212;The Company accounts for its holdings of life insurance settlement policies in accordance with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC&#160;325-30,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investments in Insurance Contracts</div></div>. The Company accounts for life settlement policies purchased that we intend to hold to maturity at fair value and life settlement policies that we intend to trade in the near term at cost plus premiums paid. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">The Company follows ASC&#160;820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements and Disclosures</div></div>, in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level&#160;1 relates to quoted prices in active markets for identical assets or liabilities. Level&#160;2 relates to observable inputs other than quoted prices included in Level&#160;1.&#160;Level&#160;3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company&#8217;s valuation of life settlements is considered to be Level&#160;3, as there is currently no active market where we are able to observe quoted prices for identical assets. The Company&#8217;s valuation model incorporates significant inputs that are not observable. See Note&#160;10, &#8220;Fair Value Measurements.&#8221; For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that include medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the condensed consolidated statements of cash flows. </div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Cost of Revenues</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost of Revenues</div></div>&#8212;Cost of revenue represents the direct costs associated with fulfilling the Company&#8217;s obligations to its customers, primarily policy servicing and consulting expense. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Income Taxes</div></div>&#8212;The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, the provision for income taxes represents income taxes paid or payable (or received or receivable) for the current year plus the change in deferred taxes during the year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid, and result from differences between the financial and tax bases of the Company&#8217;s assets and liabilities and are adjusted for changes in tax rates and tax laws when enacted. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not (greater than 50%) that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company&#8217;s experience with similar operations. Existing favorable contracts are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow for the utilization of a deferred tax asset based on existing projections of income. Deferred tax assets for which no valuation allowance is recorded may not be realized upon changes in facts and circumstances, resulting in a future charge to establish a valuation allowance. Existing valuation allowances are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-examined</div> under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred tax assets and liabilities are also remeasured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the statute of limitations has expired or the appropriate taxing authority has completed their examination even though the statute of limitations remains open. Interest and penalties related to uncertain tax positions are recognized as part of the provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized. </div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Concentrations</div></div>&#8212;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">available-for-sale</div></div> securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying condensed consolidated balance sheets. The Company extends different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company&#8217;s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer&#8217;s financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of accounts. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Two related party customers accounted for 12% and 13% of the total balance of accounts receivable and related party receivables as of June&#160;30, 2023, and two related party customers accounted for 75% and 16% of the total accounts receivable as of December&#160;31, 2022, respectively. The largest receivables balances are from related parties where exposed credit risk is low. As such, there is no allowance for doubtful accounts as of June&#160;30, 2023, and December&#160;31, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for 27% of active management revenue for the three months ended June&#160;30, 2023. Two related party customers each accounted for 20% and 20% of the portfolio servicing revenue for the three months ended June&#160;30, 2023. One customer accounted for 26% of the total revenues for the three months ended June&#160;30, 2022. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One customer accounted for 29% of active management revenue, while 16% of revenue related to 2 policies that matured that were accounted for under the investment method and 1 policy that matured that was accounted for under the fair-value method for the six months ended June&#160;30, 2023. Two related party customers each accounted for 25% and 27% of the portfolio servicing revenue for the six months ended June&#160;30, 2023. One customer accounted for 71% of the total revenues for the six months ended June&#160;30, 2022. </div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div>&#8212;The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 480 <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div> (&#8220;ASC&#160;480&#8221;) and ASC 815, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging</div></div> (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock and whether the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gain or loss on the condensed consolidated statements of operations and comprehensive income. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-2AA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for life settlement contracts including the classification of cash receipts and cash disbursements in the statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694415423584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase price allocation</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Assets Identified</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangibles</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">140,287,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Current Assets</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,280,100</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Current</div> Assets</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">901,337</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Tax Liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,310,966</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Accrued Expenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(524,400</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Liabilities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,171,739</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Fair Value</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">165,361,332</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Value conveyed</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Value Conveyed</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Abacus Purchase Consideration</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">165,361,332</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMA Business Enterprise Value</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">366,388,668</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Consideration</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">531,750,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Intangible assets acquired</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets were comprised of the following: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 35%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 3%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Type</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Life</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Valuation Methodology</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships-Agents</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">5 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Multi-period&#160;excess&#160;earnings&#160;method</div></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships-Financing Entities</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">8 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Multi-period excess earnings method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Internally Developed and Used <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Technology-APA</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from royalty method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology-Marketplace</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">3 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement cost method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trade Name</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from royalty method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Compete</div> Agreements</div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">With and without method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State Insurance Licenses</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement cost method</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Fair Value</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro forma financial information</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined as of January&#160;1, 2022. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proforma revenue</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,263,455</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,090,817</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,769,650</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">31,290,963</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proforma net income</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,432,047</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,589,315</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,373,444</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,788,486</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421500192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LIFE INSURANCE SETTLEMENT POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock', window );">Schedule of Life Settlement Contracts, Fair Value Method</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies Carried at Fair Value</div></div>&#8212; </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 56%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Life Expectancy (Years)</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0-1</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1-2</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,314,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,855,769</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2-3</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,886,778</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,530,949</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3-4</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,631,467</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,174,200</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4-5</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,755,193</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,564,469</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">78</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">113,618,147</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,560,230</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">122</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">195,205,585</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock', window );">Schedule of Life Settlement Contracts, Investment Method</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies accounted for using the investment method</div></div>&#8212; </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 57%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining Life Expectancy (Years)</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of<br/> Life</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Insurance</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Policies</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying<br/> Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0-1</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1-2</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2-3</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,131,679</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3-4</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,281,524</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4-5</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,362,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">518,736</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,658,877</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,957,671</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">45</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">39,520,877</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,889,610</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of June&#160;30, 2023, are as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 81%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023 remaining</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,024,151</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,243,423</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,310,936</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,044,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,288,619</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,911,769</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of life settlement contracts based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate including: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of life settlement contracts based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate including: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts, and (d) the life insurance premiums anticipated to be paid for each of the five succeeding fiscal years to keep the life settlement contracts in force as of the date of the most recent statement of financial position presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421547168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT---NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Summary of Property and Equipment, Net</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;net composed of the following: </div><br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 69%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2023</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,<br/>2022</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144,202</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,300</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19,444</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,299</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,902</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;gross</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186,801</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,346</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: accumulated depreciation</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8,870</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,729</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 69%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment&#8212;net</div></div> </td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">177,931</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 1%;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 69%;">&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 7%;">&#160;&#160;</td>
<td style="vertical-align: bottom; width: 1%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420606240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The changes in goodwill by reportable segments were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 77%;"></td>
<td style="width: 7%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Abacus<br/> Settlements,<br/> LLC</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at January&#160;1, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at June&#160;30, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at January&#160;1, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additions</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">140,287,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">140,287,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible Assets Acquired comprised of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 41%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 36%; font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Type</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Life</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Methodology</div></div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Agents</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Multi-period&#160;excess-earnings&#160;method</div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Financial Relationships</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">8 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Multi-period excess-earnings method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;APA</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;Market Place</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trade Name</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Compete</div> Agreements</div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">With or Without Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State Insurance Licenses</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Intangible Assets Acquired comprised of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 41%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 36%; font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Asset Type</div></div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Life</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Methodology</div></div></div> </td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Agents</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Multi-period&#160;excess-earnings&#160;method</div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Customer Relationships&#8212;Financial Relationships</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">8 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Multi-period excess-earnings method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;APA</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internally Developed and Used Technology&#8212;Market Place</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trade Name</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Relief from Royalty Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Compete</div> Agreements</div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">With or Without Method</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">State Insurance Licenses</div></div> </td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,700,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Indefinite</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">Replacement Cost Method</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,900,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694415417696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Summary of Revenue by Segment</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">Revenue related to the Company&#8217;s reporting segments for the three-month and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> periods ended June&#160;30, 2023, and June&#160;30, 2022, is as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 46%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio servicing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">354,366</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">419,422</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">590,057</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">990,328</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Active management</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,024,399</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,979,479</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,994,917</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,285,971</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total revenue</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,378,765</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,398,901</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,584,974</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,276,299</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Information</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">Information related to the Company&#8217;s reporting segments for the three-month and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">six-month</div> periods ended June&#160;30, 2023 and June&#160;30, 2022 is as follows: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 42%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio servicing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(76,705</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">280,303</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(166,128</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">668,752</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Active management</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,482,070</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,452,479</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,288,152</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,521,472</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gross profit</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,405,365</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,732,782</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,122,024</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,190,224</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales and marketing</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(683,841</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,019,498</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,412,845</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,649,498</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General, administrative and other</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(577,539</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(5,499</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,274,431</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(646,705</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Depreciation</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,098</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,098</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,141</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,141</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other (expense) income</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121,601</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(127,455</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(21,651</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(242,247</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest expense</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(584,075</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(934,001</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Loss on change in fair value of debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,445,229</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(333,879</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,398,662</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(375,513</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain (loss) on investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">672,936</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,039,022</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">798,156</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,054,975</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Provision for income taxes</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,184,571</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(120,132</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(528,104</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(296,806</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">Less: Net loss attributable to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-controlling</div> interests</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">26,596</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(406,641</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">487,303</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(406,641</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Abacus Life, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,750,145</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,679,558</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14,835,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,515,698</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417734832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value Measurements, Recurring and Nonrecurring</a></td>
<td class="text">The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 46%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Hierarchy</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> securities, at fair value</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other investments</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,600,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">S&amp;P 500 options</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,794,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,794,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,246</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,246</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets held at fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">1,801,886</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">59,285,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">61,087,503</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Private placement warrants</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,438,600</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,438,600</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities held at fair value:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">68,603,996</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">68,603,996</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 51%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value Hierarchy</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December&#160;31, 2022</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;1</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;2</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;3</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Life settlement policies</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,809,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,809,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Available-for-sale</div></div> securities, at fair value</div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other investments</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,300,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,300,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">S&amp;P 500 options</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">890,829</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">890,829</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets held at fair value</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">890,829</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,109,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,000,181</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 51%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities held at fair value:</div></div> </td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 51%;">&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom; width: 4%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text">If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of June&#160;30, 2023, would be as follows:
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June&#160;30, 2023</div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Rate Adjustment</div></div></div> </td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">+2%</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,987,508</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,698,109</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">No change</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 65%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">-2%</div></div> </td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59,857,879</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; width: 5%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,172,262</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the key assumptions in the analysis: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 79%;"></td>
<td style="width: 16%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private<br/> Placement<br/> Warrants</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected implied volatility</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">de&#160;minimis</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free interest rate</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.09</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term to expiration</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.0 years</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.50</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Stock Price</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.03</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend Yield</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 10%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedules of Concentration of Risk, by Risk Factor</a></td>
<td class="text">The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company&#8217;s life insurance policies as of June&#160;30, 2023: <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 61%;"></td>
<td style="width: 11%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 10%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrier</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage&#160;of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrier</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Rating</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">American General Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ReliaStar Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lincoln National Life Insurance Company</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">14.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">A</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a roll forward of the fair value of life insurance policies for the six months-ended June&#160;30, 2023: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 78%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at December&#160;31, 2022</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,809,352</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Policies purchased</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">58,543,580</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Realized gain (loss) on matured/sold policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,898,958</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Premiums paid</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(879,462</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain(loss) on held policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,319,588</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in estimated fair value</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,339,084</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Matured/sold policies</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(20,885,861</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Premiums paid</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">879,462</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56,685,617</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a roll forward of the fair value of the issued notes for the six months ended June&#160;30, 2023: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at December&#160;31, 2022</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Debt issued to third parties</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">35,209,825</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized loss on change in fair value (risk-free)</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,398,662</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gain on change in fair value (credit-adjusted)</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">307,256</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in estimated fair value</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,705,918</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; width: 79%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value at June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; width: 79%;">&#160;</td>
<td style="vertical-align: bottom; width: 6%;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421574304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long-term debt comprises of the following: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market-indexed notes:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2024, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,866,900</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,621,141</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,866,900</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,067,291</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Series 2.2024, Inc.</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,333,391</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,446,527</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,333,391</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,354,013</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Growth&#160;&amp; Income Series 1.2026, Inc</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">459,553</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Secured borrowing:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Income Series, LP</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,889,444</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">22,124,676</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,428,349</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,428,349</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LMATT Income Series II, LP</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,041,851</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,041,851</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unsecured borrowing:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sponsor PIK Note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,471,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10,471,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total long-term debt</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">65,003,234</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">66,165,396</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,028,640</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">28,249,653</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV purchase and sale note</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,000,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421843760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_AssetsAndLiabilitiesLesseeTableTextBlock', window );">ROU Assets and Lease Liabilities</a></td>
<td class="text"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;">The Company&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets and lease liabilities for its operating lease consisted of the following amounts as of June&#160;30, 2023 and December&#160;31, 2022: </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 14%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">240,816</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">77,011</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease liability, current</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">227,561</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">48,127</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Operating lease liability, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">16,864</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">29,268</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease liability</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">244,425</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">77,395</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 55%;"></td>
<td style="width: 19%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 18%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December&#160;31,&#160;2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average remaining lease term (in years)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.00</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.58</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average discount rate</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.54</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.36</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Expense</a></td>
<td class="text">The Company&#8217;s lease expense for the periods presented consisted of the following:<div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 60%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,471</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,921</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,942</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,842</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Variable lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,704</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">612</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,925</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,223</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total lease cost</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,175</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,533</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,867</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,065</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table> <div style="clear: both; max-height: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows supplemental cash flow information related to lease activities for the periods presented: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 74%;"></td>
<td style="width: 5%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 5%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;Ended<br/> June&#160;30,</div></div></td>
<td style="vertical-align: bottom;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash paid for amounts included in the measurement of the lease liability</div></div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating cash flows from operating leases</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,557</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,842</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ROU assets obtained in exchange for new lease liabilities</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Future Minimum Noncancellable Lease Payments</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Future minimum noncancellable lease payments under the Company&#8217;s operating leases on an undiscounted basis reconciled to the respective lease liability at June&#160;30, 2023 are as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 88%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Operating<br/> leases</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Remaining of 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,176</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">118,057</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thereafter</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;">&#8212;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total operating lease payments (undiscounted)</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">248,233</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Imputed interest</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,808</td>
<td style="vertical-align: bottom; white-space: nowrap;">)&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Lease liability as of June&#160;30, 2023</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">$</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">244,425</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> </td>
<td>&#160;</td> </tr> </table>  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694421557360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding and earnings per share were as follows: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 11pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 40%;"></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 4%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2023</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2022</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income attributable to Longevity Market Assets</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">6,750,145</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">4,679,558</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">14,835,648</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">11,515,698</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted-average shares used in computing net income per share, basic and diluted</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,507,728</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,369,350</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,438,921</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom;;text-align:right;">50,369,350</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr>
<tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: bottom;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted earnings per share:</div></div> </td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.13</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.09</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.29</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom;">$</td>
<td style="vertical-align: bottom;;text-align:right;">0.23</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694423778880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessAcquisitionExchangeRatio', window );">Exchange ratio</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_BusinessAcquisitionExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_BusinessAcquisitionExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694416652608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation of Variable Interest Entities (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 04, 2021 </div>
<div>USD ($) </div>
<div>investor</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>provider</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>provider</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>provider</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,334,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,334,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,094,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,835,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,835,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,945,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_NumberOfProvidersInvolvedInOptionAgreement', window );">Option agreement, number of providers | provider</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 584,075<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 941,458<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership', window );">Number of unaffiliated investors | investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_RegionalInvestmentServicesIncMember', window );">RIS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration paid to acquire business</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=abl_LongevityMarketAdvisorsLLCMember', window );">Longevity Market Advisors | RIS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,577,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,577,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,073,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,474,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,474,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,116,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount', window );">Contribution amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | LMX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Longevity Market Advisors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">801,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">801,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">987,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">358,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Provider One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Provider Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">861,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Expense Support Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 127,455<span></span>
</td>
<td class="nump">$ 29,721<span></span>
</td>
<td class="nump">$ 242,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_NumberOfProvidersInvolvedInOptionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Providers Involved In Option Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_NumberOfProvidersInvolvedInOptionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Unaffiliated Investors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial or other support the reporting entity has provided (explicitly or implicitly) to the Variable Interest Entity (VIE) that it was not previously contractually required to provide or that the reporting entity intends to provide, including, for example, situations in which the reporting entity assisted the VIE in obtaining another type of support.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_RegionalInvestmentServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_RegionalInvestmentServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abl_LongevityMarketAdvisorsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abl_LongevityMarketAdvisorsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=abl_RegionalInvestmentServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=abl_RegionalInvestmentServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=abl_LMXSeriesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=abl_LMXSeriesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=abl_LongevityMarketAdvisorsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=abl_LongevityMarketAdvisorsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abl_ProviderOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abl_ProviderOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abl_ProviderTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abl_ProviderTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=abl_ExpenseSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=abl_ExpenseSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694416337584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | Customer 1 | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | Customer 2 | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Customer 1 | Related Party | Portfolio servicing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Customer 1 | Nonrelated Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Customer 1 | Nonrelated Party | Active management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Customer 2 | Related Party | Portfolio servicing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Investment Method Revenue Benchmark | Customer 1 | Nonrelated Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=abl_Customer1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=abl_Customer1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=abl_Customer2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=abl_Customer2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=abl_InvestmentMethodRevenueBenchmarkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=abl_InvestmentMethodRevenueBenchmarkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694424522176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">$ 531,750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Customer Relationships - Agents</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Customer Relationships - Financial Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">$ 366,388,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">366,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA | Minimum | Discounted cash flow method</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">380,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA | Minimum | Market approach</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA | Maximum | Discounted cash flow method</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">460,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA | Maximum | Market approach</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">$ 440,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember', window );">Abacus</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">$ 165,361,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">165,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember', window );">Abacus | Minimum | Discounted cash flow method</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">180,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember', window );">Abacus | Minimum | Market approach</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">180,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember', window );">Abacus | Maximum | Discounted cash flow method</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">195,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember', window );">Abacus | Maximum | Market approach</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationEnterpriseValue', window );">Enterprise value</a></td>
<td class="nump">$ 190,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember', window );">Abacus | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_BusinessCombinationEnterpriseValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Enterprise Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_BusinessCombinationEnterpriseValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_BusinessCombinationMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_BusinessCombinationMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417425952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Purchase Price Allocation (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">$ 32,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">140,287,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">32,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">140,287,000<span></span>
</td>
<td class="nump">$ 140,287,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current Assets</a></td>
<td class="nump">1,280,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Non-Current Assets</a></td>
<td class="nump">901,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred Tax Liabilities</a></td>
<td class="num">(8,310,966)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses', window );">Accrued Expenses</a></td>
<td class="num">(524,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther', window );">Other Liabilities</a></td>
<td class="num">(1,171,739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Fair Value</a></td>
<td class="nump">$ 165,361,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417298256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Value Conveyed (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember', window );">Abacus</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">$ 165,361,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">366,388,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration</a></td>
<td class="nump">$ 531,750,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_AbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417829776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Intangible Assets Acquired (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">$ 32,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Name</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">State Insurance Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember', window );">Customer Relationships - Agents</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">12,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember', window );">Customer Relationships - Financial Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">11,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_APATechnologyMember', window );">Internally Developed and Used Technology&#8212;APA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_MarketPlaceTechnologyMember', window );">Internally Developed and Used Technology&#8212;Market Place</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-Compete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">32,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Trade Name</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | State Insurance Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Customer Relationships - Agents</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">$ 12,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Customer Relationships - Financial Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">$ 11,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Internally Developed and Used Technology&#8212;APA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Internally Developed and Used Technology&#8212;Market Place</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus | Non-Compete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_APATechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_APATechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_MarketPlaceTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_MarketPlaceTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694413452800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATION - Pro Forma Financial Information (Details) - LMA and Abacus - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Proforma revenue</a></td>
<td class="nump">$ 18,263,455<span></span>
</td>
<td class="nump">$ 14,090,817<span></span>
</td>
<td class="nump">$ 34,769,650<span></span>
</td>
<td class="nump">$ 31,290,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Proforma net income</a></td>
<td class="nump">$ 6,432,047<span></span>
</td>
<td class="nump">$ 4,589,315<span></span>
</td>
<td class="nump">$ 13,373,444<span></span>
</td>
<td class="nump">$ 11,788,486<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417427664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LIFE INSURANCE SETTLEMENT POLICIES - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>insurance_contract</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>insurance_contract</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractsNumberOfContracts', window );">Number of life settlement policies | insurance_contract</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts', window );">Number of life settlement policies accounted for under fair value method | insurance_contract</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts', window );">Number of life settlement policies accounted for under investment method | insurance_contract</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValue', window );">Face value of policies held at fair value</a></td>
<td class="nump">$ 195,205,585<span></span>
</td>
<td class="nump">$ 40,092,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies, at fair value</a></td>
<td class="nump">56,685,617<span></span>
</td>
<td class="nump">13,809,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue', window );">Face value of policies accounted for using investment method</a></td>
<td class="nump">39,520,877<span></span>
</td>
<td class="nump">42,330,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount', window );">Life settlement policies, at cost</a></td>
<td class="nump">$ 9,889,610<span></span>
</td>
<td class="nump">$ 8,716,111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractsNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contracts, Number Of Contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractsNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417458896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LIFE INSURANCE SETTLEMENT POLICIES - Fair Value (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>insurance_contract</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>insurance_contract</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear', window );">0-1 | insurance_contract</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths', window );">1-2 | insurance_contract</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo', window );">2-3 | insurance_contract</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree', window );">3-4 | insurance_contract</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour', window );">4-5 | insurance_contract</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour', window );">Thereafter | insurance_contract</a></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts', window );">Policies | insurance_contract</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract', window );"><strong>Face Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear', window );">0-1</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths', window );">1-2</a></td>
<td class="nump">12,314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo', window );">2-3</a></td>
<td class="nump">16,886,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree', window );">3-4</a></td>
<td class="nump">33,631,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour', window );">4-5</a></td>
<td class="nump">18,755,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">113,618,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValue', window );">Face Value</a></td>
<td class="nump">195,205,585<span></span>
</td>
<td class="nump">$ 40,092,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear', window );">0-1</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths', window );">1-2</a></td>
<td class="nump">6,855,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo', window );">2-3</a></td>
<td class="nump">10,530,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree', window );">3-4</a></td>
<td class="nump">9,174,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour', window );">4-5</a></td>
<td class="nump">7,564,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractFairValueMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">22,560,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Fair Value</a></td>
<td class="nump">$ 56,685,617<span></span>
</td>
<td class="nump">$ 13,809,352<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractFairValueMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract, Fair Value, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractFairValueMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract, Fair Value Method, Face Value, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of life settlement contract accounted for under fair value method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of life settlement contract accounted for under fair value method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMaturingInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of life settlement contract accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMaturingInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMaturingInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of life settlement contract accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMaturingInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of life settlement contract accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under fair value method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under fair value method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694424534304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LIFE INSURANCE SETTLEMENT POLICIES - Investment Method (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>insurance_contract</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>insurance_contract</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract', window );"><strong>Number of Life Insurance Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear', window );">0-1 | insurance_contract</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths', window );">1-2 | insurance_contract</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo', window );">2-3 | insurance_contract</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree', window );">3-4 | insurance_contract</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour', window );">4-5 | insurance_contract</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour', window );">Thereafter | insurance_contract</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts', window );">Number of Life Insurance Policies | insurance_contract</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract', window );"><strong>Face Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear', window );">0-1</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths', window );">1-2</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo', window );">2-3</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree', window );">3-4</a></td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour', window );">4-5</a></td>
<td class="nump">1,362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">29,658,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue', window );">Face Value</a></td>
<td class="nump">39,520,877<span></span>
</td>
<td class="nump">$ 42,330,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract', window );"><strong>Carrying Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear', window );">0-1</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths', window );">1-2</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo', window );">2-3</a></td>
<td class="nump">2,131,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree', window );">3-4</a></td>
<td class="nump">1,281,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour', window );">4-5</a></td>
<td class="nump">518,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">5,957,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount', window );">Carrying Value</a></td>
<td class="nump">$ 9,889,610<span></span>
</td>
<td class="nump">$ 8,716,111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract, Investment Method, Amount, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract, Investment Method, Face Value, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract, Investment Method, Number Of Contracts, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life settlement contract accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life settlement contract accounted for under investment method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life settlement contract accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life settlement contract accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life settlement contract accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under investment method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of life settlement contracts accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694422937088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LIFE INSURANCE SETTLEMENT POLICIES - Estimated Premiums (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear', window );">2023 remaining</a></td>
<td class="nump">$ 1,024,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths', window );">2024</a></td>
<td class="nump">1,243,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo', window );">2025</a></td>
<td class="nump">1,310,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree', window );">2026</a></td>
<td class="nump">1,044,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree', window );">Thereafter</a></td>
<td class="nump">3,288,619<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid', window );">Total</a></td>
<td class="nump">$ 7,911,769<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contract, Investment Method, Premium To Be Paid, After Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life insurance premiums anticipated to be paid to keep the life settlement contracts accounted for under the investment method in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life insurance premium accounted for under investment method to be paid in next fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life insurance premium accounted for under investment method to be paid in remainder of current fiscal year to keep life settlement contract in force.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life insurance premium accounted for under investment method to be paid in third fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of life insurance premium accounted for under investment method to be paid in second fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694413681360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT---NET (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment&#8212;gross</a></td>
<td class="nump">$ 186,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(8,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,729)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment&#8212;net</a></td>
<td class="nump">177,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation expense</a></td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">$ 1,098<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
<td class="nump">$ 2,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment&#8212;gross</a></td>
<td class="nump">144,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment&#8212;gross</a></td>
<td class="nump">34,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment&#8212;gross</a></td>
<td class="nump">$ 8,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,902<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417378272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill by Reportable Segments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill at beginning of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill at end of period</a></td>
<td class="nump">140,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=abl_AbacusSettlementsLLCMember', window );">Abacus Settlements, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">140,287,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill at end of period</a></td>
<td class="nump">140,287,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember', window );">LMA and Abacus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill at beginning of period</a></td>
<td class="nump">140,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill at end of period</a></td>
<td class="nump">$ 140,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=abl_AbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=abl_AbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417449856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Acquired (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">$ 32,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Name</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">State Insurance Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember', window );">Customer Relationships - Agents</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">$ 12,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember', window );">Customer Relationships - Financial Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">$ 11,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_APATechnologyMember', window );">Internally Developed and Used Technology&#8212;APA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_MarketPlaceTechnologyMember', window );">Internally Developed and Used Technology&#8212;Market Place</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-Compete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Fair Value</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipAgentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_CustomerRelationshipsFinancialRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_APATechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_APATechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_MarketPlaceTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=abl_MarketPlaceTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417701216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 07, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of convertible promissory note</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield', window );">Interest rate per annum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert', window );">Equity financing threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Equity Financing Threshold In Which Shares Convert</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average yield of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (a)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417937600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 21, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 22, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>payment </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>entity</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld', window );">Number of entities, convertible preferred stock ownership | entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=abl_SeriesSeedPreferredUnitsMember', window );">Series Seed Preferred Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased', window );">Units purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,551<span></span>
</td>
<td class="nump">119,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 950,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue', window );">Number of monthly payments | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue', window );">Monthly payment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee', window );">Equity ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=abl_SeriesB1PreferredStockMember', window );">Series B-1 Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockLineItems', window );"><strong>Conversion of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased', window );">Units purchased (in shares) | shares</a></td>
<td class="nump">207,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee', window );">Equity ownership percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Number Of Securities Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly Payments To Acquire, Equity Securities Without Readily Determinable Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Entities In Which Equity Securities Without Readily Determinable Fair Value Are Held</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Monthly Payments To Acquire Equity Securities Without Readily Determinable Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of ownership of equity interest excluding interest in entity that is consolidated and equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=abl_SeriesSeedPreferredUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=abl_SeriesSeedPreferredUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=abl_SeriesB1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=abl_SeriesB1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694415410112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 277,334,437<span></span>
</td>
<td class="nump">$ 59,094,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">116,835,522<span></span>
</td>
<td class="nump">30,945,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">57,577,034<span></span>
</td>
<td class="nump">30,073,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">52,474,820<span></span>
</td>
<td class="nump">27,116,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">801,345<span></span>
</td>
<td class="nump">987,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">$ 185,071<span></span>
</td>
<td class="nump">$ 358,586<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417324960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694416390832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING - Revenue by Segment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Portfolio servicing</a></td>
<td class="nump">$ 354,366<span></span>
</td>
<td class="nump">$ 419,422<span></span>
</td>
<td class="nump">$ 590,057<span></span>
</td>
<td class="nump">$ 990,328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">11,378,765<span></span>
</td>
<td class="nump">8,398,901<span></span>
</td>
<td class="nump">21,584,974<span></span>
</td>
<td class="nump">18,276,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember', window );">Portfolio servicing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Portfolio servicing</a></td>
<td class="nump">354,366<span></span>
</td>
<td class="nump">419,422<span></span>
</td>
<td class="nump">590,057<span></span>
</td>
<td class="nump">990,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember', window );">Active management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Active management</a></td>
<td class="nump">$ 11,024,399<span></span>
</td>
<td class="nump">$ 7,979,479<span></span>
</td>
<td class="nump">$ 20,994,917<span></span>
</td>
<td class="nump">$ 17,285,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 220<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417685792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING - Reconciliation of Net Income (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross profit</a></td>
<td class="nump">$ 10,405,365<span></span>
</td>
<td class="nump">$ 7,732,782<span></span>
</td>
<td class="nump">$ 20,122,024<span></span>
</td>
<td class="nump">$ 16,190,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="num">(683,841)<span></span>
</td>
<td class="num">(1,019,498)<span></span>
</td>
<td class="num">(1,412,845)<span></span>
</td>
<td class="num">(1,649,498)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General, administrative and other</a></td>
<td class="num">(577,539)<span></span>
</td>
<td class="num">(5,499)<span></span>
</td>
<td class="num">(1,274,431)<span></span>
</td>
<td class="num">(646,705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="num">(1,098)<span></span>
</td>
<td class="num">(1,098)<span></span>
</td>
<td class="num">(2,141)<span></span>
</td>
<td class="num">(2,141)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income</a></td>
<td class="nump">121,601<span></span>
</td>
<td class="num">(127,455)<span></span>
</td>
<td class="num">(21,651)<span></span>
</td>
<td class="num">(242,247)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRevenueExpenseNet', window );">Interest expense</a></td>
<td class="num">(584,075)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(934,001)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Loss on change in fair value of debt</a></td>
<td class="num">(1,445,229)<span></span>
</td>
<td class="num">(333,879)<span></span>
</td>
<td class="num">(2,398,662)<span></span>
</td>
<td class="num">(375,513)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized gain (loss) on investments</a></td>
<td class="nump">672,936<span></span>
</td>
<td class="num">(1,039,022)<span></span>
</td>
<td class="nump">798,156<span></span>
</td>
<td class="num">(1,054,975)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(1,184,571)<span></span>
</td>
<td class="num">(120,132)<span></span>
</td>
<td class="num">(528,104)<span></span>
</td>
<td class="num">(296,806)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net loss attributable to non-controlling interests</a></td>
<td class="nump">26,596<span></span>
</td>
<td class="num">(406,641)<span></span>
</td>
<td class="nump">487,303<span></span>
</td>
<td class="num">(406,641)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME ATTRIBUTABLE TO SHAREHOLDERS</a></td>
<td class="nump">6,750,145<span></span>
</td>
<td class="nump">4,679,558<span></span>
</td>
<td class="nump">14,835,648<span></span>
</td>
<td class="nump">11,515,698<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember', window );">Portfolio servicing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross profit</a></td>
<td class="num">(76,705)<span></span>
</td>
<td class="nump">280,303<span></span>
</td>
<td class="num">(166,128)<span></span>
</td>
<td class="nump">668,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember', window );">Active management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross profit</a></td>
<td class="nump">$ 10,482,070<span></span>
</td>
<td class="nump">$ 7,452,479<span></span>
</td>
<td class="nump">$ 20,288,152<span></span>
</td>
<td class="nump">$ 15,521,472<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRevenueExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest revenue (income derived from investments in debt securities and on cash and cash equivalents) net of interest expense (cost of borrowed funds accounted for as interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRevenueExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=abl_PortfolioServicingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=abl_ActiveManagementSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417306640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>provider</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>provider</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>provider</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_NumberOfProvidersInvolvedInOptionAgreement', window );">Option agreement, number of providers | provider</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">$ 121,601<span></span>
</td>
<td class="num">$ (127,455)<span></span>
</td>
<td class="num">$ (21,651)<span></span>
</td>
<td class="num">$ (242,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=abl_ExpenseSupportAgreementMember', window );">Expense Support Agreement | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_NumberOfProvidersInvolvedInOptionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Providers Involved In Option Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_NumberOfProvidersInvolvedInOptionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=abl_ExpenseSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=abl_ExpenseSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694416567888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Recurring Fair Value Measurements (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies</a></td>
<td class="nump">$ 56,685,617<span></span>
</td>
<td class="nump">$ 13,809,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, at fair value</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Other investments</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantLiabilitiesNoncurrent', window );">Private placement warrants</a></td>
<td class="nump">2,438,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies</a></td>
<td class="nump">56,685,617<span></span>
</td>
<td class="nump">13,809,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, at fair value</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Other investments</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">S&amp;P 500 options</a></td>
<td class="nump">1,794,640<span></span>
</td>
<td class="nump">890,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">7,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets held at fair value</a></td>
<td class="nump">61,087,503<span></span>
</td>
<td class="nump">17,000,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">66,165,396<span></span>
</td>
<td class="nump">28,249,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantLiabilitiesNoncurrent', window );">Private placement warrants</a></td>
<td class="nump">2,438,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities held at fair value:</a></td>
<td class="nump">68,603,996<span></span>
</td>
<td class="nump">28,249,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">S&amp;P 500 options</a></td>
<td class="nump">1,794,640<span></span>
</td>
<td class="nump">890,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">7,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets held at fair value</a></td>
<td class="nump">1,801,886<span></span>
</td>
<td class="nump">890,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantLiabilitiesNoncurrent', window );">Private placement warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities held at fair value:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">S&amp;P 500 options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets held at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantLiabilitiesNoncurrent', window );">Private placement warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities held at fair value:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies</a></td>
<td class="nump">56,685,617<span></span>
</td>
<td class="nump">13,809,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, at fair value</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Other investments</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">S&amp;P 500 options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets held at fair value</a></td>
<td class="nump">59,285,617<span></span>
</td>
<td class="nump">16,109,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">66,165,396<span></span>
</td>
<td class="nump">28,249,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantLiabilitiesNoncurrent', window );">Private placement warrants</a></td>
<td class="nump">2,438,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities held at fair value:</a></td>
<td class="nump">$ 68,603,996<span></span>
</td>
<td class="nump">$ 28,249,653<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_WarrantLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_WarrantLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694415549232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 14, 2023 </div>
<div>USD ($) </div>
<div>insurance_contract</div>
</th>
<th class="th">
<div>Oct. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 25, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodGainLoss', window );">Decrease in valuation compared to third-party valuation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,760,900)<span></span>
</td>
<td class="num">$ (2,014,013)<span></span>
</td>
<td class="num">$ (4,339,084)<span></span>
</td>
<td class="num">$ (3,305,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount', window );">Life settlement policies, at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,889,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,889,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,716,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets', window );">Total change in fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,602,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,705,918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome', window );">Gain on change in fair value of debt, included within other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest', window );">Gain on change in fair value of debt, included within equity of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Loss on change in fair value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,445,229<span></span>
</td>
<td class="nump">$ 333,879<span></span>
</td>
<td class="nump">2,398,662<span></span>
</td>
<td class="nump">375,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of convertible promissory note</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember', window );">Private Placement Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightPricePerWarrant', window );">Price per warrant (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of securities called by each warrant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractsNumberOfContractsSold', window );">Life settlement policies sold | insurance_contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodGainLoss', window );">Decrease in valuation compared to third-party valuation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractsMeasurementInput', window );">Life settlement policies, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Price Per Warrant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included In Equity, Attributable To Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Option, Change In Fair Value Gain (Loss) And Credit Risk, Gains (Losses) On Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractsMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contracts, Measurement Input</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractsMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractsNumberOfContractsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contracts, Number Of Contracts Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractsNumberOfContractsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the gains or losses recognized and realized during the period on investments in life settlement contracts sold during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of life settlement contracts accounted for under the investment method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417970464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Discount Rate Sensitivity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate', window );">Life settlement policies, fair value, impact of +2% discount rate adjustment</a></td>
<td class="nump">$ 53,987,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate', window );">Life settlement policies, change in fair value, impact of +2% discount rate adjustment</a></td>
<td class="num">(2,698,109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount', window );">Life settlement policies, at fair value</a></td>
<td class="nump">56,685,617<span></span>
</td>
<td class="nump">$ 13,809,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate', window );">Life settlement policies, fair value, impact of -2% discount rate adjustment</a></td>
<td class="nump">59,857,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate', window );">Life settlement policies, change in fair value, impact of -2% discount rate adjustment</a></td>
<td class="nump">$ 3,172,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of life settlement contracts accounted for under the fair value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481493/325-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481463/325-30-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694422726752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Credit Exposure to Insurance Companies (Details) - Life Insurance Carrier Concentration Risk<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember', window );">Life Insurance Contract, Face Value | American General Life Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember', window );">Life Insurance Contract, Face Value | ReliaStar Life Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember', window );">Life Insurance Contract, Face Value | Lincoln National Life Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember', window );">Life Insurance Contract, Fair Value | American General Life Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember', window );">Life Insurance Contract, Fair Value | ReliaStar Life Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember', window );">Life Insurance Contract, Fair Value | Lincoln National Life Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=abl_LifeInsuranceCarrierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=abl_LifeSettlementContractsFaceValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=abl_LifeSettlementContractsFaceValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeInsuranceCarrierAxis=abl_AmericanGeneralLifeInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeInsuranceCarrierAxis=abl_AmericanGeneralLifeInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeInsuranceCarrierAxis=abl_ReliaStarLifeInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeInsuranceCarrierAxis=abl_ReliaStarLifeInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeInsuranceCarrierAxis=abl_LincolnNationalLifeInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeInsuranceCarrierAxis=abl_LincolnNationalLifeInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=abl_LifeSettlementContractsFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=abl_LifeSettlementContractsFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694423854928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Life Insurance Policies (Details) - Life Insurance Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value at beginning of period</a></td>
<td class="nump">$ 13,809,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Policies purchased</a></td>
<td class="nump">58,543,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings', window );">Realized gain (loss) on matured/sold policies</a></td>
<td class="nump">1,898,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid', window );">Premiums paid</a></td>
<td class="nump">879,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings', window );">Unrealized gain(loss) on held policies</a></td>
<td class="nump">3,319,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Change in estimated fair value</a></td>
<td class="nump">4,339,084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Matured/sold policies</a></td>
<td class="num">(20,885,861)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair value at end of period</a></td>
<td class="nump">$ 56,685,617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Premiums Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Realized Gain (Loss) Included In Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=abl_LifeSettlementContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=abl_LifeSettlementContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417378128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Issued Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,249,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Debt issued to third parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,209,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Unrealized loss on change in fair value (risk-free)</a></td>
<td class="nump">$ 1,445,229<span></span>
</td>
<td class="nump">$ 333,879<span></span>
</td>
<td class="nump">2,398,662<span></span>
</td>
<td class="nump">$ 375,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets', window );">Unrealized gain on change in fair value (credit-adjusted)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets', window );">Change in estimated fair value</a></td>
<td class="nump">1,602,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,705,918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at end of period</a></td>
<td class="nump">$ 66,165,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,165,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Option, Change In Fair Value Gain (Loss) And Credit Risk, Gains (Losses) On Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the estimated amount of gains or losses included in earnings during the period attributable to changes in instrument-specific credit risk arising from loans and other receivables held as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417784672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Assumptions (Details) - Private Placement Warrant<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0.0409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember', window );">Term to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember', window );">Common Stock Price</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">10.03<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember', window );">Dividend Yield</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420804720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - Long-Term Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 65,003,234<span></span>
</td>
<td class="nump">$ 30,028,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost | Market-indexed notes | LMATT Series 2024, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">9,866,900<span></span>
</td>
<td class="nump">9,866,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost | Market-indexed notes | LMATT Series 2.2024, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">2,333,391<span></span>
</td>
<td class="nump">2,333,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost | Market-indexed notes | LMATT Growth &amp; Income Series 1.2026, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost | Secured borrowing | LMATT Income Series, LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">21,889,444<span></span>
</td>
<td class="nump">17,428,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost | Secured borrowing | LMATT Income Series II, LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">20,041,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost | Unsecured borrowing | Sponsor PIK Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">10,471,648<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Cost | Line of Credit | SPV Investment Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">66,165,396<span></span>
</td>
<td class="nump">28,249,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Market-indexed notes | LMATT Series 2024, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">9,621,141<span></span>
</td>
<td class="nump">8,067,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Market-indexed notes | LMATT Series 2.2024, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">3,446,527<span></span>
</td>
<td class="nump">2,354,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Market-indexed notes | LMATT Growth &amp; Income Series 1.2026, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">459,553<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Secured borrowing | LMATT Income Series, LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">22,124,676<span></span>
</td>
<td class="nump">17,428,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Secured borrowing | LMATT Income Series II, LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">20,041,851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Unsecured borrowing | Sponsor PIK Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">10,471,648<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value | Line of Credit | SPV Investment Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries2024IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTSeries2024IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries22024IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTSeries22024IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTGrowthIncomeSeries12026IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTGrowthIncomeSeries12026IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_SponsorPIKNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_SponsorPIKNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694424545872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - Sponsor PIK Note (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured borrowing | Sponsor PIK Note</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 10,471,648<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_SponsorPIKNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_SponsorPIKNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694422750288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - LMATT Series 2024, Inc. Market-Indexed Notes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,334,437<span></span>
</td>
<td class="nump">$ 59,094,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries2024IncMember', window );">LMATT Series 2024, Inc. | Market-indexed notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 10,166,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage', window );">Market downturn protection percentage</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold', window );">Note reduction ratio for losses below threshold</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries2024IncMember', window );">LMATT Series 2024, Inc. | Market-indexed notes | Asset Pledged as Collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,195,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Market Downturn Protection Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Note Reduction Ratio For Losses Below Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries2024IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTSeries2024IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417124672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - LMATT Series 2.2024, Inc. Market-Indexed Notes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,334,437<span></span>
</td>
<td class="nump">$ 59,094,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,165,396<span></span>
</td>
<td class="nump">28,249,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries22024IncMember', window );">LMATT Series 2.2024, Inc. | Market-indexed notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,333,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage', window );">Upside performance participation cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage', window );">Market downturn protection percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold', window );">Note reduction ratio for losses below threshold</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries22024IncMember', window );">LMATT Series 2.2024, Inc. | Market-indexed notes | Asset Pledged as Collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,331,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries22024IncMember', window );">LMATT Series 2.2024, Inc. | Market-indexed notes | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,446,527<span></span>
</td>
<td class="nump">$ 2,354,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=abl_LMATTSeries22024IncMember', window );">LMATT Series 2.2024, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Market Downturn Protection Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Upside Performance Participation Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Note Reduction Ratio For Losses Below Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTSeries22024IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTSeries22024IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=abl_LMATTSeries22024IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=abl_LMATTSeries22024IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694416506304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 16, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,334,437<span></span>
</td>
<td class="nump">$ 59,094,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,165,396<span></span>
</td>
<td class="nump">28,249,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTGrowthIncomeSeries12026IncMember', window );">LMATT Growth &amp; Income Series 1.2026, Inc | Market-indexed notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage', window );">Upside performance participation cap</a></td>
<td class="nump">140.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage', window );">Market downturn protection percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold', window );">Note reduction ratio for losses below threshold</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDividendFeaturePercentage', window );">Dividend percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTGrowthIncomeSeries12026IncMember', window );">LMATT Growth &amp; Income Series 1.2026, Inc | Market-indexed notes | Asset Pledged as Collateral</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTGrowthIncomeSeries12026IncMember', window );">LMATT Growth &amp; Income Series 1.2026, Inc | Market-indexed notes | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 459,553<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=abl_LMATTGrowthIncomeSeries12026IncMember', window );">LMATT Growth &amp; Income Series 1.2026, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentDividendFeaturePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Dividend Feature Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentDividendFeaturePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Market Downturn Protection Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Upside Performance Participation Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Note Reduction Ratio For Losses Below Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTGrowthIncomeSeries12026IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTGrowthIncomeSeries12026IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PledgedStatusAxis=us-gaap_AssetPledgedAsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=abl_LMATTGrowthIncomeSeries12026IncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=abl_LMATTGrowthIncomeSeries12026IncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417897872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT - LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>option</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 66,165,396<span></span>
</td>
<td class="nump">$ 28,249,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember', window );">LMATT Income Series, LP | Secured borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentExtensionOptions', window );">Debt Instrument extension options | option</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentExtensionTerm', window );">Debt instrument extension term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDividendFeaturePercentage', window );">Dividend percentage</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold', window );">Return rate in excess of minimum internal rate of return</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentMinimumInternalRateOfReturn', window );">Minimum internal rate of return threshold</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentInternalRateOfReturnCap', window );">Internal rate of return cap</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentNetInternalRateOfReturnAtCap', window );">Net internal rate of return at cap</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember', window );">LMATT Income Series, LP | Secured borrowing | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 22,124,676<span></span>
</td>
<td class="nump">$ 17,428,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember', window );">LMATT Income Series, LP | Secured borrowing | General Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold', window );">Return rate in excess of minimum internal rate of return</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentMinimumInternalRateOfReturn', window );">Minimum internal rate of return threshold</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember', window );">LMATT Income Series, LP | Secured borrowing | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentInternalRateOfReturnCap', window );">Internal rate of return cap</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold', window );">Return Rate in excess of capped internal rate of return threshold</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentDividendFeaturePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Dividend Feature Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentDividendFeaturePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentExtensionOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentExtensionOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentInternalRateOfReturnCap">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Internal Rate Of Return Threshold Cap</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentInternalRateOfReturnCap</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentMinimumInternalRateOfReturn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Minimum Internal Rate Of Return Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentMinimumInternalRateOfReturn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentNetInternalRateOfReturnAtCap">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Net Internal Rate Of Return At Cap</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentNetInternalRateOfReturnAtCap</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Return Rate In Excess Of Capped Internal Rate Of Return Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Return Rate In Excess Of Minimum Internal Rate Of Return Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_GeneralPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_GeneralPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_LimitedPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_LimitedPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694424663152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT - LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>option</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 66,165,396<span></span>
</td>
<td class="nump">$ 28,249,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentExtensionOptions', window );">Debt Instrument extension options | option</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentExtensionTerm', window );">Debt instrument extension term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">$ 20,041,851<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | General Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDividendFeaturePercentage', window );">Dividend percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Capital Commitment Threshold One | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDividendFeaturePercentage', window );">Dividend percentage</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Capital Commitment Threshold One | Maximum | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends', window );">Capital commitment threshold to determine dividend rate</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Capital Commitment Threshold Two | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDividendFeaturePercentage', window );">Dividend percentage</a></td>
<td class="nump">7.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Capital Commitment Threshold Two | Maximum | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends', window );">Capital commitment threshold to determine dividend rate</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Capital Commitment Threshold Two | Minimum | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends', window );">Capital commitment threshold to determine dividend rate</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Capital Commitment Threshold Three | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDividendFeaturePercentage', window );">Dividend percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember', window );">LMATT Income Series II, LP | Secured borrowing | Capital Commitment Threshold Three | Minimum | Limited Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends', window );">Capital commitment threshold to determine dividend rate</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Capital Commitment Thresholds To Determine Dividends</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentDividendFeaturePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Dividend Feature Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentDividendFeaturePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentExtensionOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentExtensionOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_LMATTIncomeSeriesIILPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_GeneralPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_GeneralPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis=abl_CapitalCommitmentThresholdOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis=abl_CapitalCommitmentThresholdOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_LimitedPartnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnerTypeOfPartnersCapitalAccountAxis=us-gaap_LimitedPartnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis=abl_CapitalCommitmentThresholdTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis=abl_CapitalCommitmentThresholdTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis=abl_CapitalCommitmentThresholdThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis=abl_CapitalCommitmentThresholdThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694424708096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LONG-TERM DEBT - SPV Purchase and Sale and SPV Investment Facility (Details) - Subsequent Event<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 05, 2023 </div>
<div>USD ($) </div>
<div>extension</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_PolicyAPAMember', window );">Policy APA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue', window );">Insurance policies fair value</a></td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember', window );">SPV Investment Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 25.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentNumberOfExtensions', window );">Number of extensions | extension</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentExtensionTerm', window );">Debt instrument extension term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDefaultRate', window );">Default rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember', window );">SPV Investment Facility | Line of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember', window );">SPV Investment Facility | Line of Credit | Secured borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentDefaultRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Default Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentDefaultRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentNumberOfExtensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Extensions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentNumberOfExtensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contracts, Special Purchase Vehicle, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_PolicyAPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_PolicyAPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694413563424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares) | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_NumberOfVotesPerCommonShare', window );">Number of votes per share | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares) | shares</a></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares) | shares</a></td>
<td class="nump">62,961,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares) | shares</a></td>
<td class="nump">17,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of securities called by each warrant (in shares) | shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination', window );">Warrants, business combination exercisable term</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering', window );">Warrants, proposed offering exercisable term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant', window );">Redemption price per warrant (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightRedemptionNoticePeriod', window );">Warrant redemption notice period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold', window );">Common stock price threshold (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays', window );">Trading days</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod', window );">Trading day period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold', window );">Common stock price threshold for redemption for common stock (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare', window );">Warrants, common stock issuance threshold price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod', window );">Warrants, common stock issuance trading day period</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage', window );">Warrant price adjustment percentage</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent', window );">Redemption trigger price adjustment percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent', window );">Redemption for common stock trigger price adjustment percentage</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_WarrantsAndRightsOutstandingFairValuePerShare', window );">Warrant outstanding fair value per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PublicWarrantsMember', window );">Public Warrants | Binomial Lattice Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PublicWarrantsMember', window );">Public Warrants | Risk-free interest rate | Binomial Lattice Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">0.0409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PublicWarrantsMember', window );">Public Warrants | Exercise price | Binomial Lattice Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PublicWarrantsMember', window );">Public Warrants | Common Stock Price | Binomial Lattice Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants and rights outstanding, measurement input</a></td>
<td class="nump">10.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember', window );">LMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_BusinessAcquisitionExchangeRatio', window );">Exchange ratio</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_BusinessAcquisitionExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_BusinessAcquisitionExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Common Stock Issuance Threshold Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Common Stock Issuance Trading Day Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issuance Of Common Stock, Redemption For Common Stock, Trigger Price Adjustment Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issuance Of Common Stock, Redemption, Trigger Price Adjustment Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issuance Of Common Stock, Warrant Price Adjustment Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption For Common Stock, Price Per Share Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightRedemptionNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption Notice Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightRedemptionNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption, Number Of Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption, Price Per Share Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightRedemptionPricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption Price Per Warrant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightRedemptionPricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption, Trading Day Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_NumberOfVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_NumberOfVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding, Exercisable Term, Business Combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding, Exercisable Term, Proposed Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_WarrantsAndRightsOutstandingFairValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding, Fair Value Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_WarrantsAndRightsOutstandingFairValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=abl_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=abl_BinomialLatticeModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=abl_BinomialLatticeModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=abl_LongevityMarketAssetsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420601056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLAN (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum annual contributions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer match (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Percent of employees gross pay (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Benefit plan expense</a></td>
<td class="nump">$ 13,075<span></span>
</td>
<td class="nump">$ 2,577<span></span>
</td>
<td class="nump">$ 25,315<span></span>
</td>
<td class="nump">$ 8,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694413442928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 1,184,571<span></span>
</td>
<td class="nump">$ 120,132<span></span>
</td>
<td class="nump">$ 528,104<span></span>
</td>
<td class="nump">$ 296,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417489920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED-PARTY TRANSACTIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total portfolio servicing revenue</a></td>
<td class="nump">$ 354,366<span></span>
</td>
<td class="nump">$ 419,422<span></span>
</td>
<td class="nump">$ 590,057<span></span>
</td>
<td class="nump">$ 990,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">10,415,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,415,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 263,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">10,473,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,473,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,904,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LifeSettlementContractsOriginationExpense', window );">Origination expenses for life settlement policies</a></td>
<td class="nump">837,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,627,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Nova Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total portfolio servicing revenue</a></td>
<td class="nump">197,629<span></span>
</td>
<td class="nump">205,224<span></span>
</td>
<td class="nump">411,076<span></span>
</td>
<td class="nump">406,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Expense Reimbursements | Nova Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">72,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abl_OwnersMember', window );">Owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">717,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">717,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total portfolio servicing revenue</a></td>
<td class="nump">329,629<span></span>
</td>
<td class="nump">$ 419,253<span></span>
</td>
<td class="nump">543,076<span></span>
</td>
<td class="nump">$ 620,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 78,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 198,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Service Fee Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party transaction rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Service Fee Agreement | Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party transaction rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | SPV Investment Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LifeSettlementContractsOriginationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Life Settlement Contracts, Origination Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LifeSettlementContractsOriginationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=abl_NovaTradingUSLLCAndNovaHoldingUSLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=abl_NovaTradingUSLLCAndNovaHoldingUSLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=abl_ExpenseReimbursementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=abl_ExpenseReimbursementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abl_OwnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abl_OwnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=abl_ServiceFeeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=abl_ServiceFeeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_SPVInvestmentFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417699264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - ROU Assets and Lease Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_OperatingLeaseAssetAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 240,816<span></span>
</td>
<td class="nump">$ 77,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">227,561<span></span>
</td>
<td class="nump">48,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, non-current</a></td>
<td class="nump">16,864<span></span>
</td>
<td class="nump">29,268<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 244,425<span></span>
</td>
<td class="nump">$ 77,395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_OperatingLeaseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_OperatingLeaseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694413675312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Lease Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 12,471<span></span>
</td>
<td class="nump">$ 11,921<span></span>
</td>
<td class="nump">$ 24,942<span></span>
</td>
<td class="nump">$ 23,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">7,704<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="nump">8,925<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 20,175<span></span>
</td>
<td class="nump">$ 12,533<span></span>
</td>
<td class="nump">$ 33,867<span></span>
</td>
<td class="nump">$ 25,065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420586400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 24,557<span></span>
</td>
<td class="nump">$ 23,842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets obtained in exchange for new lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420586400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year 6 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">3.54%<span></span>
</td>
<td class="nump">3.36%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694424614688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Future Minimum Noncancellable Lease Payments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remaining of 2023</a></td>
<td class="nump">$ 130,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">118,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total operating lease payments (undiscounted)</a></td>
<td class="nump">248,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(3,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability as of June 30, 2023</a></td>
<td class="nump">$ 244,425<span></span>
</td>
<td class="nump">$ 77,395<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694417970464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">26,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember', window );">Private Placement Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=abl_PrivatePlacementWarrantMember', window );">Private Placement Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=abl_PrivatePlacementWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=abl_PrivatePlacementWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=abl_PrivatePlacementWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420679408">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Basic and Diluted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Longevity Market Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,750,145<span></span>
</td>
<td class="nump">$ 4,679,558<span></span>
</td>
<td class="nump">$ 14,835,648<span></span>
</td>
<td class="nump">$ 11,515,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net income per share, basic (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">50,507,728<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="nump">50,438,921<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net income per share, diluted (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">50,507,728<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
<td class="nump">50,438,921<span></span>
</td>
<td class="nump">50,369,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of Business Combination.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140694420691712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details) - Subsequent Event - Line of Credit - Owl Rock Credit Facility<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 05, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm', window );">Additional borrowing capacity availability period</a></td>
<td class="text">180 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum', window );">Liquid asset minimum coverage ratio</a></td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentDefaultRate', window );">Default rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentAmortizationPaymentPercentage', window );">Amortization payment percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter', window );">Amortization payment per quarter</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage', window );">Mandatory prepayment percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary', window );">Prepayment premium prior to first anniversary</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary', window );">Prepayment premium prior to second anniversary</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary', window );">Prepayment premium after second anniversary</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCovenantLeverageRatioMaximum', window );">Maximum leverage ratio</a></td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum', window );">Maximum securities related activities percentage of aggregate gross revenues</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">7.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Variable Rate Component One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentBasisSpreadOnVariableRateTerm', window );">Basis spread on variable rate, term</a></td>
<td class="text">1 month<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Variable Rate Component Two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentBasisSpreadOnVariableRateTerm', window );">Basis spread on variable rate, term</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Variable Rate Component Three</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_abl_DebtInstrumentBasisSpreadOnVariableRateTerm', window );">Basis spread on variable rate, term</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="nump">6.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Secured borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 25.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="nump">$ 25.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentAmortizationPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Amortization Payment, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentAmortizationPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Amortization Payment, Percentage Per Quarter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentBasisSpreadOnVariableRateTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Basis Spread on Variable Rate, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentBasisSpreadOnVariableRateTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquid Asset Coverage Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Mandatory Prepayment Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Prepayment Premium After Second Anniversary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Prepayment Premium Prior To First Anniversary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Prepayment Premium Prior To Second Anniversary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Securities Percentage Of Gross Revenue, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_DebtInstrumentDefaultRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Default Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_DebtInstrumentDefaultRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Remaining Borrowing Capacity, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>abl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=abl_OwlRockCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=abl_OwlRockCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_VariableRateComponentAxis=abl_VariableRateComponentOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_VariableRateComponentAxis=abl_VariableRateComponentOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_VariableRateComponentAxis=abl_VariableRateComponentTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_VariableRateComponentAxis=abl_VariableRateComponentTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_abl_VariableRateComponentAxis=abl_VariableRateComponentThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">abl_VariableRateComponentAxis=abl_VariableRateComponentThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>d423260ds1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:abl="http://www.emslp.com/20230630"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="abl-20230630.xsd" xlink:type="simple"/>
    <context id="P01_01_2023To06_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P10_01_2022To10_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To01_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="P11_01_2021To11_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn10_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="PAsOn11_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="PAsOn01_01_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="PAsOn10_04_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2021-10-04</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_07_2022To01_07_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <startDate>2022-01-07</startDate>
            <endDate>2022-01-07</endDate>
        </period>
    </context>
    <context id="PAsOn03_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abl:OwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ExpenseReimbursementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:ProviderTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:MarketPlaceTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:APATechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipsFinancialRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipAgentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipsFinancialRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:MarketPlaceTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipAgentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:APATechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SponsorPIKNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">abl:OwnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MarketApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ExpenseReimbursementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LongevityMarketAdvisorsLLCMemberdeiLegalEntityAxis_RegionalInvestmentServicesIncMembersrtOwnershipAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:RegionalInvestmentServicesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:LongevityMarketAdvisorsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">abl:BinomialLatticeModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_InvestmentMethodRevenueBenchmarkMemberusgaapConcentrationRiskByBenchmarkAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:InvestmentMethodRevenueBenchmarkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFaceValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:AmericanGeneralLifeInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:AmericanGeneralLifeInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFaceValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:ReliaStarLifeInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:ReliaStarLifeInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFaceValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:LincolnNationalLifeInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">abl:LifeSettlementContractsFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">abl:LifeInsuranceCarrierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:LifeInsuranceCarrierAxis">abl:LincolnNationalLifeInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_PrivatePlacementWarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">abl:LifeSettlementContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTIncomeSeriesIILPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:LimitedPartnerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis">abl:CapitalCommitmentThresholdTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:PortfolioServicingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">abl:ActiveManagementSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">abl:ExpenseSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ScenarioPreviouslyReportedMembersrtRestatementAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ServiceFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">abl:ServiceFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">abl:NovaTradingUSLLCAndNovaHoldingUSLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P10_04_2021To10_04_2021_LMXSeriesLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LMXSeriesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-04</startDate>
            <endDate>2021-10-04</endDate>
        </period>
    </context>
    <context id="P10_04_2021To10_04_2021_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-04</startDate>
            <endDate>2021-10-04</endDate>
        </period>
    </context>
    <context id="P03_03_2022To03_03_2022_LongevityMarketAdvisorsLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LongevityMarketAdvisorsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-03</endDate>
        </period>
    </context>
    <context id="P03_03_2022To03_03_2022_RegionalInvestmentServicesIncMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:RegionalInvestmentServicesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-03</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">abl:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipAgentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:MarketPlaceTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:APATechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P06_30_2023To06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">abl:CustomerRelationshipsFinancialRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="PAsOn07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-22</instant>
        </period>
    </context>
    <context id="P12_01_2022To12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn03_31_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesSeedPreferredUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="P12_21_2020To12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-21</startDate>
            <endDate>2020-12-21</endDate>
        </period>
    </context>
    <context id="PAsOn12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">abl:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-21</instant>
        </period>
    </context>
    <context id="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="PAsOn08_25_2020_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PrivatePlacementWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-25</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn09_16_2022_LMATTSeries22024IncMembersrtOwnershipAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-16</instant>
        </period>
    </context>
    <context id="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMembersrtOwnershipAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-16</instant>
        </period>
    </context>
    <context id="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-16</instant>
        </period>
    </context>
    <context id="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-16</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_PolicyAPAMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:PolicyAPAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_LineOfCreditMemberusgaapCreditFacilityAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn07_05_2023_BaseRateMemberusgaapVariableRateAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-05</instant>
        </period>
    </context>
    <context id="PAsOn08_30_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">abl:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:SPVInvestmentFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-05</startDate>
            <endDate>2023-07-05</endDate>
        </period>
    </context>
    <context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-05</startDate>
            <endDate>2023-07-05</endDate>
        </period>
    </context>
    <context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:VariableRateComponentAxis">abl:VariableRateComponentOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-05</startDate>
            <endDate>2023-07-05</endDate>
        </period>
    </context>
    <context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:VariableRateComponentAxis">abl:VariableRateComponentTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-05</startDate>
            <endDate>2023-07-05</endDate>
        </period>
    </context>
    <context id="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:OwlRockCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="abl:VariableRateComponentAxis">abl:VariableRateComponentThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-05</startDate>
            <endDate>2023-07-05</endDate>
        </period>
    </context>
    <context id="P09_16_2022To09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTGrowthIncomeSeries12026IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-16</startDate>
            <endDate>2022-09-16</endDate>
        </period>
    </context>
    <context id="P03_31_2022To03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries2024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="P03_31_2022To03_31_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">abl:LMATTSeries22024IncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-31</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2022_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">abl:LifeSettlementContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">abl:LifeSettlementContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AbacusSettlementsLLCMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">abl:LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">abl:AbacusSettlementsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001814287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Year">
        <measure>utr:Year</measure>
    </unit>
    <unit id="Unit_Day">
        <measure>utr:Day</measure>
    </unit>
    <unit id="Unit_Month">
        <measure>utr:Month</measure>
    </unit>
    <unit id="Unit_USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_insurance_contract">
        <measure>abl:insurance_contract</measure>
    </unit>
    <unit id="Unit_entity">
        <measure>abl:entity</measure>
    </unit>
    <unit id="Unit_segment">
        <measure>abl:segment</measure>
    </unit>
    <unit id="Unit_provider">
        <measure>abl:provider</measure>
    </unit>
    <unit id="Unit_option">
        <measure>abl:option</measure>
    </unit>
    <unit id="Unit_extension">
        <measure>abl:extension</measure>
    </unit>
    <unit id="Unit_payment">
        <measure>abl:payment</measure>
    </unit>
    <unit id="Unit_investor">
        <measure>abl:investor</measure>
    </unit>
    <unit id="Unit_vote">
        <measure>abl:vote</measure>
    </unit>
    <dei:DocumentType contextRef="P01_01_2023To06_30_2023" id="hidden91072615">S-1/A</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="P01_01_2023To06_30_2023">0001814287</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P01_01_2023To06_30_2023">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="P01_01_2023To06_30_2023">Abacus Life, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="P01_01_2023To06_30_2023">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityPrimarySicNumber contextRef="P01_01_2023To06_30_2023">6282</dei:EntityPrimarySicNumber>
    <dei:EntityTaxIdentificationNumber contextRef="P01_01_2023To06_30_2023">85-1210472</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="P01_01_2023To06_30_2023">2101 Park Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="P01_01_2023To06_30_2023">Suite 170</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="P01_01_2023To06_30_2023">Orlando</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_01_2023To06_30_2023">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_01_2023To06_30_2023">32835</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_01_2023To06_30_2023">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_01_2023To06_30_2023">561-4148</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Jay J. Jackson</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">2101 Park Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Suite 170</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Orlando</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">32835</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_01_2023To06_30_2023_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">561-4148</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="P01_01_2023To06_30_2023">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="P01_01_2023To06_30_2023">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="P01_01_2023To06_30_2023">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="P01_01_2023To06_30_2023">true</dei:EntityExTransitionPeriod>
    <abl:DebtInstrumentBasisSpreadOnVariableRateTerm
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis"
      id="hidden91072234">P1M</abl:DebtInstrumentBasisSpreadOnVariableRateTerm>
    <abl:DebtInstrumentBasisSpreadOnVariableRateTerm
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis"
      id="hidden91072235">P3M</abl:DebtInstrumentBasisSpreadOnVariableRateTerm>
    <abl:DebtInstrumentBasisSpreadOnVariableRateTerm
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis"
      id="hidden91071984">P3M</abl:DebtInstrumentBasisSpreadOnVariableRateTerm>
    <abl:DebtInstrumentBasisSpreadOnVariableRateTerm
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis"
      id="hidden91071985">P1M</abl:DebtInstrumentBasisSpreadOnVariableRateTerm>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">20611122</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">30052823</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">192595</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">10448</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">78310</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn12_31_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">198364</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">10473748</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">2904646</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">21252</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">829595</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">116646</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">32206622</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">33282927</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">177931</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">18617</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">32900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">140287000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:Goodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">240816</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">77011</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">9889610</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">8716111</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">56685617</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">13809352</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1600000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1300000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">75582</us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent>
    <us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:OtherReceivableAfterAllowanceForCreditLossNoncurrent>
    <abl:StateSecurityDepositsNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">206873</abl:StateSecurityDepositsNoncurrent>
    <abl:StateSecurityDepositsNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</abl:StateSecurityDepositsNoncurrent>
    <abl:CertificatesOfDepositNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">262500</abl:CertificatesOfDepositNoncurrent>
    <abl:CertificatesOfDepositNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</abl:CertificatesOfDepositNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1801886</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">890829</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">277334437</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">59094847</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">524400</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">401500</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">40014</us-gaap:AccountsPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">227561</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">48127</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">10415154</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">263785</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn06_30_2023_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">717429</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn12_31_2022_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">981217</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <abl:AccruedTransactionCostsCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">182571</abl:AccruedTransactionCostsCurrent>
    <abl:AccruedTransactionCostsCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">908256</abl:AccruedTransactionCostsCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">258759</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn12_31_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">42227</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">185831</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">13894422</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1302409</us-gaap:LiabilitiesCurrent>
    <us-gaap:SecuredLongTermDebt
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">25000000</us-gaap:SecuredLongTermDebt>
    <us-gaap:SecuredLongTermDebt
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:SecuredLongTermDebt>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">66165396</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">28249653</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">16864</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">29268</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">9320240</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1363820</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <abl:WarrantLiabilitiesNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2438600</abl:WarrantLiabilitiesNoncurrent>
    <abl:WarrantLiabilitiesNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</abl:WarrantLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">116835522</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">30945150</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn06_30_2023"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2022"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">62961688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">62961688</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">6296</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">5037</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">188641886</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">704963</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-29382362</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">25487323</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">877306</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1052836</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MinorityInterest
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">355789</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">899538</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">160498915</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">28149697</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">277334437</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">59094847</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">329629</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">419253</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">543076</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">620159</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">24737</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">169</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">46981</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">370169</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">354366</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">419422</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">590057</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">990328</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InsuranceInvestmentIncome
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">8263499</us-gaap:InsuranceInvestmentIncome>
    <us-gaap:InsuranceInvestmentIncome
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5965466</us-gaap:InsuranceInvestmentIncome>
    <us-gaap:InsuranceInvestmentIncome
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">16655833</us-gaap:InsuranceInvestmentIncome>
    <us-gaap:InsuranceInvestmentIncome
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">13980466</us-gaap:InsuranceInvestmentIncome>
    <us-gaap:LifeSettlementContractsFairValueMethodGainLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2760900</us-gaap:LifeSettlementContractsFairValueMethodGainLoss>
    <us-gaap:LifeSettlementContractsFairValueMethodGainLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2014013</us-gaap:LifeSettlementContractsFairValueMethodGainLoss>
    <us-gaap:LifeSettlementContractsFairValueMethodGainLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">4339084</us-gaap:LifeSettlementContractsFairValueMethodGainLoss>
    <us-gaap:LifeSettlementContractsFairValueMethodGainLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">3305505</us-gaap:LifeSettlementContractsFairValueMethodGainLoss>
    <us-gaap:InsuranceServicesRevenue
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">11024399</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">7979479</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">20994917</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">17285971</us-gaap:InsuranceServicesRevenue>
    <us-gaap:Revenues
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">11378765</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">8398901</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">21584974</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">18276299</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">973400</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">666119</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1462950</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2086075</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">973400</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">666119</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1462950</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2086075</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">10405365</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">7732782</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">20122024</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">16190224</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">683841</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1019498</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1412845</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1649498</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">577539</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5499</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1274431</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">646705</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-1445229</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-333879</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2398662</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-375513</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">672936</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-1039022</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">798156</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-1054975</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:DepreciationAndAmortization
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1098</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1098</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2034771</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2398996</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">4289923</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">3728832</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">8370594</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5333786</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">15832101</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">12461392</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">584075</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">941458</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">7457</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">121601</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-127455</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-21651</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-242247</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-462474</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-127455</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-955652</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-242247</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">7908120</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5206331</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14876449</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">12219145</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1184571</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">120132</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">528104</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">296806</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6723549</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5086199</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14348345</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11922339</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-26596</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">406641</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-487303</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">406641</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6750145</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">4679558</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14835648</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11515698</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      id="Fact_91071780"
      unitRef="Unit_shares">50507728</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      id="Fact_91072953"
      unitRef="Unit_shares">50507728</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      id="Fact_91072958"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      id="Fact_91072952"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      id="Fact_91072957"
      unitRef="Unit_shares">50438921</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      id="Fact_91072951"
      unitRef="Unit_shares">50438921</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      id="Fact_91072956"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      id="Fact_91072950"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="P04_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P04_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P04_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P04_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6723549</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5086199</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14348345</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11922339</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-119663</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2017559</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-231976</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2017559</us-gaap:OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6603886</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">7103758</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14116369</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">13939898</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-56111</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1011909</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-543749</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1011909</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6659997</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">6091849</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14660118</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">12927989</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_91072998"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072982"
      unitRef="Unit_USD">5037</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072983"
      unitRef="Unit_USD">704963</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072984"
      unitRef="Unit_USD">4951188</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072917"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072985"
      unitRef="Unit_USD">-148155</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2022"
      decimals="0"
      id="Fact_91072986"
      unitRef="Unit_USD">5513033</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:Dividends
      contextRef="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">310000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">310000</us-gaap:Dividends>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P04_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">1412291</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P04_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">605268</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2017559</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">4679558</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">406641</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5086199</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">5037</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">704963</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">9320746</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">1412291</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">863754</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022"
      decimals="0"
      unitRef="Unit_USD">12306791</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_91072996"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072975"
      unitRef="Unit_USD">5037</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072974"
      unitRef="Unit_USD">704963</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072995"
      unitRef="Unit_USD">33572826</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072994"
      unitRef="Unit_USD">967454</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072993"
      unitRef="Unit_USD">411900</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn03_31_2023"
      decimals="0"
      id="Fact_91072992"
      unitRef="Unit_USD">35662180</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:Dividends
      contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">34451607</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">34451607</us-gaap:Dividends>
    <abl:StockholdersEquityDeferredTransactionCosts
      contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">10841551</abl:StockholdersEquityDeferredTransactionCosts>
    <abl:StockholdersEquityDeferredTransactionCosts
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">10841551</abl:StockholdersEquityDeferredTransactionCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">4726500</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-3765600</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">960900</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <abl:StockIssuedDuringPeriodSharesReverseRecapitalization
      contextRef="P04_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">12592338</abl:StockIssuedDuringPeriodSharesReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P04_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">1259</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">17849091</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-20646575</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2796225</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="P04_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">165361332</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">165361332</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P04_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-90148</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P04_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-29515</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-119663</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">6750145</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-26596</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6723549</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">62961688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">6296</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">188641886</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-29382362</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">877306</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">355789</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">160498915</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_91072999"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072991"
      unitRef="Unit_USD">5037</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072990"
      unitRef="Unit_USD">704963</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072989"
      unitRef="Unit_USD">205048</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2021_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072918"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2021_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072988"
      unitRef="Unit_USD">-148155</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2021"
      decimals="0"
      id="Fact_91072987"
      unitRef="Unit_USD">766893</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:Dividends
      contextRef="P01_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">2400000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2400000</us-gaap:Dividends>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P01_01_2022To06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">1412291</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P01_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">605268</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2017559</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">11515698</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">406641</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11922339</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_91071827"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91071834"
      unitRef="Unit_USD">5037</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91071835"
      unitRef="Unit_USD">704963</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91071836"
      unitRef="Unit_USD">9320746</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91071837"
      unitRef="Unit_USD">1412291</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91071838"
      unitRef="Unit_USD">863754</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2022"
      decimals="0"
      id="Fact_91071839"
      unitRef="Unit_USD">12306791</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      id="Fact_91072997"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2022_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072981"
      unitRef="Unit_USD">5037</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2022_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072980"
      unitRef="Unit_USD">704963</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2022_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072979"
      unitRef="Unit_USD">25487323</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2022_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072978"
      unitRef="Unit_USD">1052836</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2022_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      id="Fact_91072977"
      unitRef="Unit_USD">899538</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn12_31_2022"
      decimals="0"
      id="Fact_91072976"
      unitRef="Unit_USD">28149697</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:Dividends
      contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">34451607</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">34451607</us-gaap:Dividends>
    <abl:StockholdersEquityDeferredTransactionCosts
      contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">10841551</abl:StockholdersEquityDeferredTransactionCosts>
    <abl:StockholdersEquityDeferredTransactionCosts
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">10841551</abl:StockholdersEquityDeferredTransactionCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">4726500</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-3765600</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">960900</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <abl:StockIssuedDuringPeriodSharesReverseRecapitalization
      contextRef="P01_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">12592338</abl:StockIssuedDuringPeriodSharesReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P01_01_2023To06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">1259</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">17849091</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-20646575</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <abl:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2796225</abl:StockIssuedDuringPeriodValueReverseRecapitalization>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="P01_01_2023To06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">165361332</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">165361332</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P01_01_2023To06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-175530</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P01_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-56446</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-231976</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">14835648</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-487303</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14348345</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">62961688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">6296</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">188641886</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-29382362</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_AccumulatedOtherComprehensiveIncomeMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">877306</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023_NoncontrollingInterestMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">355789</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">160498915</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14348345</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11922339</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:DepreciationAndAmortization>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">798156</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-1054975</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:LifeSettlementContractsFairValueMethodUnrealizedGainLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">3319588</us-gaap:LifeSettlementContractsFairValueMethodUnrealizedGainLoss>
    <us-gaap:LifeSettlementContractsFairValueMethodUnrealizedGainLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">3305505</us-gaap:LifeSettlementContractsFairValueMethodUnrealizedGainLoss>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2398662</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-375513</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">252659</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">999927</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">384</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P01_01_2023To06_30_2023_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">182147</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P01_01_2022To06_30_2022_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P01_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">-125764</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="P01_01_2022To06_30_2022_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">77657</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">193462</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1379579</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">105655</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">361486</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-725685</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">402363</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">72938</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <abl:LifeSettlementContractPurchasedFairValueMethod
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">39556677</abl:LifeSettlementContractPurchasedFairValueMethod>
    <abl:LifeSettlementContractPurchasedFairValueMethod
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">7211509</abl:LifeSettlementContractPurchasedFairValueMethod>
    <abl:LifeSettlementContractPurchasedInvestmentMethod
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">11374605</abl:LifeSettlementContractPurchasedInvestmentMethod>
    <abl:LifeSettlementContractPurchasedInvestmentMethod
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">7204753</abl:LifeSettlementContractPurchasedInvestmentMethod>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-38364171</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-4751170</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">300000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">250000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <abl:ProceedsDueFromPaymentsDueToAffiliates
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-6760627</abl:ProceedsDueFromPaymentsDueToAffiliates>
    <abl:ProceedsDueFromPaymentsDueToAffiliates
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</abl:ProceedsDueFromPaymentsDueToAffiliates>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-7060627</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-250000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">35206351</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">9463779</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">10841551</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">23533072</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2400000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">25000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">10151369</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">680375</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">35983097</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">7744154</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-9441701</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2742984</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">30052823</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">102421</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">20611122</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2845405</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;DESCRIPTION OF BUSINESS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Organization and Merger &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Abacus Life, Inc. (&#x201c;the Company&#x201d;) was formerly known as East Resources Acquisition Company (&#x201c;ERES&#x201d;), a blank check company incorporated in Delaware on May&#160;22, 2020. Abacus Life, Inc. conducts its business through its wholly-owned, consolidated subsidiaries, primarily Abacus Settlements LLC (&#x201c;Abacus&#x201d;) and Longevity Market Assets,&#160;LLC (&#x201c;LMA&#x201d;), which are incorporated in the state of Delaware (collectively, the &#x201c;Companies&#x201d;). On June&#160;30, 2023, (the &#x201c;Closing Date&#x201d;), ERES, Longevity Market Assets, LLC and Abacus Settlements, LLC consummated the combining of the Companies as contemplated by the Merger Agreement dated as of August&#160;30, 2022 (as amended on October&#160;14, 2022 and April&#160;20, 2023) with LMA Merger Sub, LLC, a wholly owned subsidiary of ERES (&#x201c;LMA Merger Sub&#x201d;), Abacus Merger Sub, LLC, a wholly owned subsidiary of ERES (&#x201c;Abacus Merger Sub&#x201d;), LMA&#160;and Abacus Settlements, LLC (&#x201c;Legacy Abacus&#x201d; and, together with LMA, the &#x201c;Legacy Companies&#x201d;). Pursuant to the Merger Agreement, on June&#160;30, 2023, (i) LMA Merger Sub merged with and into LMA, with LMA surviving such merger (the &#x201c;LMA Merger&#x201d;) and (ii)&#160;Abacus Merger Sub merged with and into Legacy Abacus, with Legacy Abacus surviving such merger (the &#x201c;Abacus Merger&#x201d; and, together with the LMA Merger, the &#x201c;Mergers&#x201d; and, along with the other transactions contemplated by the Merger Agreement, the &#x201c;Business Combination&#x201d;) and the Legacy Companies became direct wholly owned subsidiaries of Abacus and ERES changed its name to Abacus Life, Inc. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The condensed consolidated assets, liabilities and statements of operations and comprehensive income prior to the Business Combination are those of legacy LMA. The stocks and corresponding capital amounts and income per stock, prior to the Business Combination, have been retroactively restated based on stocks reflecting the exchange ratio established in the Business Combination. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company&#x2019;s common stock, $0.0001 par value per share, issued to legacy LMA&#x2019;s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Business Activity &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company, through its LMA subsidiary, is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life settlement assets, as well as consulting, valuation, and actuarial services. The Company is also engaged in buying and selling of life settlement policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout or to sell to another purchaser of life settlement contracts for a gain on the sale. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company, through its Abacus subsidiary, also is an originator of outstanding life insurance policies as a licensed life settlement provider on behalf of investors (&#x201c;Financing Entities&#x201d;). Abacus locates and screens policies for eligibility as a commercially desirable life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known, collectively, as origination services. When the sale of a policy is completed, this is deemed &#x201c;settled&#x201d; and the policy is then referred to as either a &#x201c;life settlement&#x201d; in which the insured&#x2019;s life expectancy is greater than two years or &#x201c;viatical settlement,&#x201d; in which the insured&#x2019;s life expectancy is less than two years. The Company is not an insurance company, and therefore the Company does not underwrite insurable risks for its own account. &lt;/div&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <abl:BusinessAcquisitionExchangeRatio
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="INF"
      unitRef="Unit_pure">0.8</abl:BusinessAcquisitionExchangeRatio>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Basis of Presentation&lt;/div&gt;&lt;/div&gt;&#x2014;In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). Under U.S. GAAP, ERES has been treated as the &#x201c;acquired&#x201d; company for financial reporting purposes. This determination was primarily based on the LMA shareholders having a relative majority of the voting power of the Company, the LMA shareholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the &#x201c;acquirer&#x201d; for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Abacus Merger will be accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will be recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, will be recognized as goodwill. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In considering the foregoing principles of predecessor determination and in light of the Company&#x2019;s specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unaudited Condensed Consolidated Financial Statements&lt;/div&gt;&lt;/div&gt;&#x2014;The condensed consolidated financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial position as of June&#160;30, 2023, and the condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023 and 2022, respectively, and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022, respectively. The condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for Abacus for the year ended December&#160;31, 2022, and the financial statements and notes for LMA for the year ended December&#160;31, 2022. All references to financial information as of and for the periods ended June&#160;30, 2023, and 2022 in the notes to condensed consolidated financial statements are unaudited. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Refer to this note in the LMA annual financial statements for the full list of the Company&#x2019;s significant accounting policies. The details in those notes have not changed, except as discussed below and as a result of normal adjustments in the interim periods. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Consolidation of Variable Interest Entities&lt;/div&gt;&lt;/div&gt;&#x2014;For entities in which the Company has variable interests, the &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Company &lt;/div&gt;first evaluates whether the entity meets the definition of a variable interest entity (&#x201c;VIE&#x201d;) or a &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;voting interest entity (&#x201c;VOE&#x201d;). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company&#x2019;s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;810, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Consolidations&lt;/div&gt;&lt;/div&gt;, requires the Company to separately disclose on its condensed consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of June&#160;30, 2023, total assets and liabilities of consolidated VIEs were $57,577,034 and $52,474,820, respectively. As of December&#160;31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On January&#160;1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the &#x201c;Providers&#x201d;), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the &#x201c;Option Agreement&#x201d;). &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321. In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815 and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the share price has no readily determinable fair value. The Company&#x2019;s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company provided $0 and $127,455 of funding for the three months ended June&#160;30, 2023 and June&#160;30, 2022, respectively and provided $29,721 and $242,247 of funding for the six months ended June&#160;30, 2023 and June&#160;30, 2022, respectively which is included in other (expense) income on the condensed consolidated statements of operations and comprehensive income. See Note 11, Commitments and Contingencies. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the period ended June&#160;30, 2023, and for the year ended December&#160;31, 2022, the Providers were considered to be VIEs, but were not consolidated in the Company&#x2019;s condensed consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of June&#160;30, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $318,178 and liabilities of $450 and held assets of $483,167 and liabilities of $184,621, respectively. As of December&#160;31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $126,040 and liabilities of $0 and held assets of $861,924 and liabilities of $358,586, respectively. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On October&#160;4, 2021, the Company entered into an operating agreement with LMX Series,&#160;LLC (&#x201c;LMX&#x201d;) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series&#160;2024,&#160;Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its condensed consolidated financial statements for the period ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On March&#160;3, 2022, the Company obtained an 80% ownership interest in Longevity Market Advisors,&#160;LLC (&#x201c;Longevity Market Advisors&#x201d;). The Longevity Market Advisors legal entity was established primarily for &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the purpose of acquiring the assets of a broker/dealer, Regional Investment Services,&#160;Inc. (&#x201c;RIS&#x201d;), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price payable in exchange for RIS was $60,000. The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of the RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being registered by the Financial Industry Regulatory Authority (&#x201c;FINRA&#x201d;). As there are no tangible or intangible assets of value from the RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise 100% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of Longevity Market Advisors in its condensed consolidated financial statements for the period ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On November&#160;30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On January&#160;31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Noncontrolling Interest&lt;/div&gt;&lt;/div&gt;&#x2014;Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the condensed consolidated balance sheets at an amount equal to the noncontrolling interest&#x2019;s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholder&#x2019;s additional contributions, distributions, and the shareholder&#x2019;s share of the net earnings or losses of each respective consolidated entity. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholder&#x2019;s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the condensed consolidated statements of operations and comprehensive income. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt;&#x2014;The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reports amounts of revenue and expenses during the reporting periods. Company&#x2019;s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Life Insurance Settlement Policies&lt;/div&gt;&lt;/div&gt;&#x2014;The Company accounts for its holdings of life insurance settlement policies in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;325-30,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Investments in Insurance Contracts&lt;/div&gt;&lt;/div&gt;. The Company accounts for life settlement policies purchased that we intend to hold to maturity at fair value and life settlement policies that we intend to trade in the near term at cost plus premiums paid. &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The Company follows ASC&#160;820, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Fair Value Measurements and Disclosures&lt;/div&gt;&lt;/div&gt;, in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level&#160;1 relates to quoted prices in active markets for identical assets or liabilities. Level&#160;2 relates to observable inputs other than quoted prices included in Level&#160;1.&#160;Level&#160;3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company&#x2019;s valuation of life settlements is considered to be Level&#160;3, as there is currently no active market where we are able to observe quoted prices for identical assets. The Company&#x2019;s valuation model incorporates significant inputs that are not observable. See Note&#160;10, &#x201c;Fair Value Measurements.&#x201d; For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that include medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the condensed consolidated statements of cash flows. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost of Revenues&lt;/div&gt;&lt;/div&gt;&#x2014;Cost of revenue represents the direct costs associated with fulfilling the Company&#x2019;s obligations to its customers, primarily policy servicing and consulting expense. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;&#x2014;The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, the provision for income taxes represents income taxes paid or payable (or received or receivable) for the current year plus the change in deferred taxes during the year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid, and result from differences between the financial and tax bases of the Company&#x2019;s assets and liabilities and are adjusted for changes in tax rates and tax laws when enacted. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not (greater than 50%) that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company&#x2019;s experience with similar operations. Existing favorable contracts are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow for the utilization of a deferred tax asset based on existing projections of income. Deferred tax assets for which no valuation allowance is recorded may not be realized upon changes in facts and circumstances, resulting in a future charge to establish a valuation allowance. Existing valuation allowances are &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-examined&lt;/div&gt; under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred tax assets and liabilities are also remeasured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the statute of limitations has expired or the appropriate taxing authority has completed their examination even though the statute of limitations remains open. Interest and penalties related to uncertain tax positions are recognized as part of the provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Concentrations&lt;/div&gt;&lt;/div&gt;&#x2014;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying condensed consolidated balance sheets. The Company extends different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company&#x2019;s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer&#x2019;s financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of accounts. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Two related party customers accounted for 12% and 13% of the total balance of accounts receivable and related party receivables as of June&#160;30, 2023, and two related party customers accounted for 75% and 16% of the total accounts receivable as of December&#160;31, 2022, respectively. The largest receivables balances are from related parties where exposed credit risk is low. As such, there is no allowance for doubtful accounts as of June&#160;30, 2023, and December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;One customer accounted for 27% of active management revenue for the three months ended June&#160;30, 2023. Two related party customers each accounted for 20% and 20% of the portfolio servicing revenue for the three months ended June&#160;30, 2023. One customer accounted for 26% of the total revenues for the three months ended June&#160;30, 2022. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;One customer accounted for 29% of active management revenue, while 16% of revenue related to 2 policies that matured that were accounted for under the investment method and 1 policy that matured that was accounted for under the fair-value method for the six months ended June&#160;30, 2023. Two related party customers each accounted for 25% and 27% of the portfolio servicing revenue for the six months ended June&#160;30, 2023. One customer accounted for 71% of the total revenues for the six months ended June&#160;30, 2022. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&#x2014;The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 480 &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Distinguishing Liabilities from Equity&lt;/div&gt;&lt;/div&gt; (&#x201c;ASC&#160;480&#x201d;) and ASC 815, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Derivatives and Hedging&lt;/div&gt;&lt;/div&gt; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common stock and whether the warrant holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cash&lt;/div&gt; gain or loss on the condensed consolidated statements of operations and comprehensive income. &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Basis of Presentation&lt;/div&gt;&lt;/div&gt;&#x2014;In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). Under U.S. GAAP, ERES has been treated as the &#x201c;acquired&#x201d; company for financial reporting purposes. This determination was primarily based on the LMA shareholders having a relative majority of the voting power of the Company, the LMA shareholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the &#x201c;acquirer&#x201d; for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Abacus Merger will be accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will be recorded at estimated fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if applicable, will be recognized as goodwill. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In considering the foregoing principles of predecessor determination and in light of the Company&#x2019;s specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. &lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Unaudited Condensed Consolidated Financial Statements&lt;/div&gt;&lt;/div&gt;&#x2014;The condensed consolidated financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial position as of June&#160;30, 2023, and the condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023 and 2022, respectively, and the condensed consolidated statements of cash flows for the six months ended June&#160;30, 2023 and 2022, respectively. The condensed consolidated statements of operations and comprehensive income for the three months and six months ended June&#160;30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for Abacus for the year ended December&#160;31, 2022, and the financial statements and notes for LMA for the year ended December&#160;31, 2022. All references to financial information as of and for the periods ended June&#160;30, 2023, and 2022 in the notes to condensed consolidated financial statements are unaudited. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Refer to this note in the LMA annual financial statements for the full list of the Company&#x2019;s significant accounting policies. The details in those notes have not changed, except as discussed below and as a result of normal adjustments in the interim periods. &lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Consolidation of Variable Interest Entities&lt;/div&gt;&lt;/div&gt;&#x2014;For entities in which the Company has variable interests, the &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;Company &lt;/div&gt;first evaluates whether the entity meets the definition of a variable interest entity (&#x201c;VIE&#x201d;) or a &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;voting interest entity (&#x201c;VOE&#x201d;). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company&#x2019;s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;810, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Consolidations&lt;/div&gt;&lt;/div&gt;, requires the Company to separately disclose on its condensed consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of June&#160;30, 2023, total assets and liabilities of consolidated VIEs were $57,577,034 and $52,474,820, respectively. As of December&#160;31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On January&#160;1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the &#x201c;Providers&#x201d;), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the &#x201c;Option Agreement&#x201d;). &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321. In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815 and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the share price has no readily determinable fair value. The Company&#x2019;s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company provided $0 and $127,455 of funding for the three months ended June&#160;30, 2023 and June&#160;30, 2022, respectively and provided $29,721 and $242,247 of funding for the six months ended June&#160;30, 2023 and June&#160;30, 2022, respectively which is included in other (expense) income on the condensed consolidated statements of operations and comprehensive income. See Note 11, Commitments and Contingencies. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the period ended June&#160;30, 2023, and for the year ended December&#160;31, 2022, the Providers were considered to be VIEs, but were not consolidated in the Company&#x2019;s condensed consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of June&#160;30, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $318,178 and liabilities of $450 and held assets of $483,167 and liabilities of $184,621, respectively. As of December&#160;31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $126,040 and liabilities of $0 and held assets of $861,924 and liabilities of $358,586, respectively. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On October&#160;4, 2021, the Company entered into an operating agreement with LMX Series,&#160;LLC (&#x201c;LMX&#x201d;) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed. LMX has a wholly owned subsidiary, LMATT Series&#160;2024,&#160;Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its condensed consolidated financial statements for the period ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On March&#160;3, 2022, the Company obtained an 80% ownership interest in Longevity Market Advisors,&#160;LLC (&#x201c;Longevity Market Advisors&#x201d;). The Longevity Market Advisors legal entity was established primarily for &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the purpose of acquiring the assets of a broker/dealer, Regional Investment Services,&#160;Inc. (&#x201c;RIS&#x201d;), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price payable in exchange for RIS was $60,000. The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of the RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being registered by the Financial Industry Regulatory Authority (&#x201c;FINRA&#x201d;). As there are no tangible or intangible assets of value from the RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise 100% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of Longevity Market Advisors in its condensed consolidated financial statements for the period ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On November&#160;30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On January&#160;31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the six months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">57577034</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">52474820</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">30073972</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">27116762</us-gaap:Liabilities>
    <abl:NumberOfProvidersInvolvedInOptionAgreement
      contextRef="PAsOn01_01_2021"
      decimals="INF"
      unitRef="Unit_provider">2</abl:NumberOfProvidersInvolvedInOptionAgreement>
    <us-gaap:InterestExpense
      contextRef="P04_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="P04_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">127455</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="P01_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">29721</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="P01_01_2022To06_30_2022_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">242247</us-gaap:InterestExpense>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">318178</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn06_30_2023_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">450</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">483167</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn06_30_2023_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">184621</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">126040</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022_ProviderOneMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">861924</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022_ProviderTwoMemberdeiLegalEntityAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">358586</us-gaap:Liabilities>
    <abl:NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership
      contextRef="PAsOn10_04_2021"
      decimals="INF"
      unitRef="Unit_investor">3</abl:NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="P10_04_2021To10_04_2021_LMXSeriesLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="2"
      unitRef="Unit_pure">0.70</us-gaap:VariableInterestEntityOwnershipPercentage>
    <abl:NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership
      contextRef="PAsOn10_04_2021"
      decimals="INF"
      unitRef="Unit_investor">3</abl:NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership>
    <us-gaap:VariableInterestEntityFinancialOrOtherSupportAmount
      contextRef="P10_04_2021To10_04_2021_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">100</us-gaap:VariableInterestEntityFinancialOrOtherSupportAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="P10_04_2021To10_04_2021_LMXSeriesLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="2"
      unitRef="Unit_pure">0.70</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="P03_03_2022To03_03_2022_LongevityMarketAdvisorsLLCMembersrtOwnershipAxis_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="2"
      unitRef="Unit_pure">0.80</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="P03_03_2022To03_03_2022_RegionalInvestmentServicesIncMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">60000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="PAsOn06_30_2023_LongevityMarketAdvisorsLLCMemberdeiLegalEntityAxis_RegionalInvestmentServicesIncMembersrtOwnershipAxis"
      decimals="INF"
      unitRef="Unit_pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Noncontrolling Interest&lt;/div&gt;&lt;/div&gt;&#x2014;Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the condensed consolidated balance sheets at an amount equal to the noncontrolling interest&#x2019;s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholder&#x2019;s additional contributions, distributions, and the shareholder&#x2019;s share of the net earnings or losses of each respective consolidated entity. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholder&#x2019;s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the condensed consolidated statements of operations and comprehensive income. &lt;/div&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:UseOfEstimates contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Use of Estimates&lt;/div&gt;&lt;/div&gt;&#x2014;The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reports amounts of revenue and expenses during the reporting periods. Company&#x2019;s estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves. &lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:LifeSettlementContractsPolicy contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Life Insurance Settlement Policies&lt;/div&gt;&lt;/div&gt;&#x2014;The Company accounts for its holdings of life insurance settlement policies in accordance with &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ASC&#160;325-30,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Investments in Insurance Contracts&lt;/div&gt;&lt;/div&gt;. The Company accounts for life settlement policies purchased that we intend to hold to maturity at fair value and life settlement policies that we intend to trade in the near term at cost plus premiums paid. &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The Company follows ASC&#160;820, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Fair Value Measurements and Disclosures&lt;/div&gt;&lt;/div&gt;, in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level&#160;1 relates to quoted prices in active markets for identical assets or liabilities. Level&#160;2 relates to observable inputs other than quoted prices included in Level&#160;1.&#160;Level&#160;3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company&#x2019;s valuation of life settlements is considered to be Level&#160;3, as there is currently no active market where we are able to observe quoted prices for identical assets. The Company&#x2019;s valuation model incorporates significant inputs that are not observable. See Note&#160;10, &#x201c;Fair Value Measurements.&#x201d; For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that include medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the condensed consolidated statements of cash flows. &lt;/div&gt;&lt;/div&gt;</us-gaap:LifeSettlementContractsPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost of Revenues&lt;/div&gt;&lt;/div&gt;&#x2014;Cost of revenue represents the direct costs associated with fulfilling the Company&#x2019;s obligations to its customers, primarily policy servicing and consulting expense. &lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income Taxes&lt;/div&gt;&lt;/div&gt;&#x2014;The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, the provision for income taxes represents income taxes paid or payable (or received or receivable) for the current year plus the change in deferred taxes during the year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid, and result from differences between the financial and tax bases of the Company&#x2019;s assets and liabilities and are adjusted for changes in tax rates and tax laws when enacted. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not (greater than 50%) that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company&#x2019;s experience with similar operations. Existing favorable contracts are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow for the utilization of a deferred tax asset based on existing projections of income. Deferred tax assets for which no valuation allowance is recorded may not be realized upon changes in facts and circumstances, resulting in a future charge to establish a valuation allowance. Existing valuation allowances are &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-examined&lt;/div&gt; under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred tax assets and liabilities are also remeasured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the statute of limitations has expired or the appropriate taxing authority has completed their examination even though the statute of limitations remains open. Interest and penalties related to uncertain tax positions are recognized as part of the provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized. &lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Concentrations&lt;/div&gt;&lt;/div&gt;&#x2014;Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying condensed consolidated balance sheets. The Company extends different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company&#x2019;s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer&#x2019;s financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of accounts. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Two related party customers accounted for 12% and 13% of the total balance of accounts receivable and related party receivables as of June&#160;30, 2023, and two related party customers accounted for 75% and 16% of the total accounts receivable as of December&#160;31, 2022, respectively. The largest receivables balances are from related parties where exposed credit risk is low. As such, there is no allowance for doubtful accounts as of June&#160;30, 2023, and December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;One customer accounted for 27% of active management revenue for the three months ended June&#160;30, 2023. Two related party customers each accounted for 20% and 20% of the portfolio servicing revenue for the three months ended June&#160;30, 2023. One customer accounted for 26% of the total revenues for the three months ended June&#160;30, 2022. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;One customer accounted for 29% of active management revenue, while 16% of revenue related to 2 policies that matured that were accounted for under the investment method and 1 policy that matured that was accounted for under the fair-value method for the six months ended June&#160;30, 2023. Two related party customers each accounted for 25% and 27% of the portfolio servicing revenue for the six months ended June&#160;30, 2023. One customer accounted for 71% of the total revenues for the six months ended June&#160;30, 2022. &lt;/div&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="INF"
      unitRef="Unit_pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="INF"
      unitRef="Unit_pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="INF"
      unitRef="Unit_pure">0.75</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To12_31_2022_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="INF"
      unitRef="Unit_pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P04_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P04_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P04_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="INF"
      unitRef="Unit_pure">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_InvestmentMethodRevenueBenchmarkMemberusgaapConcentrationRiskByBenchmarkAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_Customer2MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2022To06_30_2022_Customer1MembersrtMajorCustomersAxis_CustomerConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_NonrelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SalesRevenueNetMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="2"
      unitRef="Unit_pure">0.71</us-gaap:ConcentrationRiskPercentage1>
    <abl:WarrantsPolicyTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Warrants&lt;/div&gt;&lt;/div&gt;&#x2014;The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 480 &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Distinguishing Liabilities from Equity&lt;/div&gt;&lt;/div&gt; (&#x201c;ASC&#160;480&#x201d;) and ASC 815, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Derivatives and Hedging&lt;/div&gt;&lt;/div&gt; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common stock and whether the warrant holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-cash&lt;/div&gt; gain or loss on the condensed consolidated statements of operations and comprehensive income. &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;/div&gt;</abl:WarrantsPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;BUSINESS COMBINATION &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Merger consideration conveyed of $531.8&#160;million was allocated &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;between &lt;/div&gt;the Companies based on relative values derived through both the discounted cash flow method within the income approach and the guideline public company method within the market approach. Within the discounted cash flow method, the present values of cash flows reasonably expected to be produced by the Companies from their operations were summed to produce an estimate of the Companies&#x2019; business enterprise values on a controlling, marketable basis. The cash flows used in the discounted cash flow analysis were discounted at the weighted average cost of capital of 14.5% for LMA and 16.5% for Abacus. The discounted cash flow method resulted in a business enterprise value range of $380.0&#160;million to $460.0&#160;million for LMA and $180.0&#160;million to $195.0&#160;million for Abacus. Within the market approach, Company applied the guideline public company method, which employs market multiples derived from market prices of stocks of Companies that are engaged in the same or similar lines of business as the Companies and that are actively traded on a free and open market. The guideline public company method resulted in a business enterprise value range of $400.0&#160;million to $440.0&#160;million for LMA and $180.0&#160;million to $190.0&#160;million for Abacus. Management concluded on a business enterprise value of $165.4&#160;million for Abacus and $366.4&#160;million for LMA based upon the relative fair value of the Companies allocated to the consideration transferred. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The preliminary purchase price was allocated among the identified assets to be acquired. The primary area of the acquisition accounting that is not yet finalized is our estimate of the impact of acquisition accounting on deferred income taxes. An estimate of deferred income taxes has been recorded in the Company&#x2019;s books based on information available as of June&#160;30, 2023. As the initial acquisition accounting is based on our preliminary assessments, actual values may differ when final information becomes available. We believe that the information gathered to date provides a reasonable basis for estimating the preliminary values of deferred taxes recorded. We will continue to evaluate this item until it is satisfactorily resolved and adjust our acquisition accounting accordingly, within the allowable measurement period, as defined by ASC 805, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Business Combinations&lt;/div&gt;&lt;/div&gt;. Transaction costs incurred as a result of the Business Combination were recognized within retained earnings/(accumulated deficit) on the condensed consolidated balance sheet ending June&#160;30, 2023. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;All valuation procedures related to existing assets as no new assets were identified as a result of procedures performed. Goodwill was recognized as a result of the acquisition, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 77%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net Assets Identified&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Intangibles&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;32,900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;140,287,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Current Assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,280,100&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Current&lt;/div&gt; Assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;901,337&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred Tax Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(8,310,966&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued Expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(524,400&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,171,739&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;165,361,332&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 77%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Value Conveyed&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Abacus Purchase Consideration&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;165,361,332&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMA Business Enterprise Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;366,388,668&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total Consideration&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;531,750,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Intangible assets were comprised of the following: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 35%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Asset Type&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Useful Life&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation Methodology&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships-Agents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;5 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Multi-period&#160;excess&#160;earnings&#160;method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships-Financing Entities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;8 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Multi-period excess earnings method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Internally Developed and Used &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Technology-APA&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from royalty method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology-Marketplace&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;100,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;3 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement cost method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Trade Name&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from royalty method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Compete&lt;/div&gt; Agreements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;With and without method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State Insurance Licenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,700,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement cost method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;32,900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Useful lives for customer relationships were developed using attrition data for agents and financing entities which resulted in a useful life of 5 years and 8 years, respectively. Estimates over the useful lives of internally developed and used technology contemplates the period in which the Company expects to utilize the technology and the length of time the technology is expected to maintain recognition and value in the market without significant &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;investment.Non-compete&lt;/div&gt; agreements have a useful life commensurate with the executed &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-compete&lt;/div&gt; agreements in place as a result of the Business Combination. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined as of January&#160;1, 2022. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 44%;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Proforma revenue&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,263,455&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14,090,817&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;34,769,650&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;31,290,963&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Proforma net income&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6,432,047&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,589,315&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,373,444&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,788,486&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="-5"
      unitRef="Unit_USD">531800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <abl:BusinessCombinationMeasurementInput
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"
      decimals="3"
      unitRef="Unit_pure">0.145</abl:BusinessCombinationMeasurementInput>
    <abl:BusinessCombinationMeasurementInput
      contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"
      decimals="3"
      unitRef="Unit_pure">0.165</abl:BusinessCombinationMeasurementInput>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"
      decimals="-5"
      unitRef="Unit_USD">380000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"
      decimals="-5"
      unitRef="Unit_USD">460000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MinimumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"
      decimals="-5"
      unitRef="Unit_USD">180000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MaximumMembersrtRangeAxis_ValuationTechniqueDiscountedCashFlowMemberusgaapValuationTechniqueAxis"
      decimals="-5"
      unitRef="Unit_USD">195000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis"
      decimals="-5"
      unitRef="Unit_USD">400000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis"
      decimals="-5"
      unitRef="Unit_USD">440000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MinimumMembersrtRangeAxis"
      decimals="-5"
      unitRef="Unit_USD">180000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_MaximumMembersrtRangeAxis"
      decimals="-5"
      unitRef="Unit_USD">190000000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="-5"
      unitRef="Unit_USD">165400000</abl:BusinessCombinationEnterpriseValue>
    <abl:BusinessCombinationEnterpriseValue
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="-5"
      unitRef="Unit_USD">366400000</abl:BusinessCombinationEnterpriseValue>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 77%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net Assets Identified&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Intangibles&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;32,900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;140,287,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Current Assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,280,100&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Current&lt;/div&gt; Assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;901,337&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Deferred Tax Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(8,310,966&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Accrued Expenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(524,400&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,171,739&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;165,361,332&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">32900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">140287000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">1280100</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">901337</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">8310966</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <abl:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">524400</abl:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses>
    <abl:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">1171739</abl:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">165361332</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 77%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Value Conveyed&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Abacus Purchase Consideration&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;165,361,332&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMA Business Enterprise Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;366,388,668&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total Consideration&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;531,750,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="P06_30_2023To06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">165361332</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">366388668</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">531750000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Intangible assets were comprised of the following: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 35%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Asset Type&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Useful Life&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation Methodology&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships-Agents&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;5 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Multi-period&#160;excess&#160;earnings&#160;method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships-Financing Entities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;8 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Multi-period excess earnings method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Internally Developed and Used &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Technology-APA&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from royalty method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology-Marketplace&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;100,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;3 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement cost method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Trade Name&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from royalty method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Compete&lt;/div&gt; Agreements&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;With and without method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State Insurance Licenses&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,700,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement cost method&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;32,900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">12600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P06_30_2023To06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">11000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P06_30_2023To06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">1600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P06_30_2023To06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">4000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">2700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">32900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P06_30_2023To06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="P06_30_2023To06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined as of January&#160;1, 2022. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 44%;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Proforma revenue&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,263,455&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14,090,817&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;34,769,650&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;31,290,963&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt;&lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Proforma net income&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6,432,047&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,589,315&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,373,444&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,788,486&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">18263455</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="P04_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">14090817</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="P01_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">34769650</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="P01_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">31290963</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">6432047</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="P04_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">4589315</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="P01_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">13373444</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="P01_01_2022To06_30_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">11788486</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:LifeSettlementContractsDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LIFE INSURANCE SETTLEMENT POLICIES &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June&#160;30, 2023, the Company holds 167 life settlement policies, of which 122 are accounted for under the fair value method and 45 are accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value is $195,205,585 as of June&#160;30, 2023, with a corresponding fair value of $56,685,617. Aggregate face value of policies accounted for using the investment method is $39,520,877 as of June&#160;30, 2023, with a corresponding carrying value of $9,889,610. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of December&#160;31, 2022, the Company held 53 life settlement policies, of which 35 were accounted for under the fair value method and 18 were accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value was $40,092,154 as of December&#160;31, 2022, with a corresponding fair value of $13,809,352. Aggregate face value of policies accounted for using the investment method was $42,330,000 as of December&#160;31, 2022, with a corresponding carrying value of $8,716,111. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;At June&#160;30, 2023, the Company did not have any contractual restrictions on its ability to sell policies, including those held as collateral for the issuance of long-term debt. See Note 13, &#x201c;Long-Term Debt.&#x201d; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. The following tables summarize the Company&#x2019;s life insurance policies grouped by remaining life expectancy as of June&#160;30, 2023: &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies Carried at Fair Value&lt;/div&gt;&lt;/div&gt;&#x2014; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 56%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Remaining Life Expectancy (Years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Face Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0-1&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1-2&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,314,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6,855,769&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2-3&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,886,778&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,530,949&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3-4&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;33,631,467&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,174,200&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4-5&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,755,193&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,564,469&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;78&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;113,618,147&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;22,560,230&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;122&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;195,205,585&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies accounted for using the investment method&lt;/div&gt;&lt;/div&gt;&#x2014; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 57%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Remaining Life Expectancy (Years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&lt;br/&gt; Life&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Insurance&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Face Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0-1&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1-2&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2-3&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,131,679&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3-4&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,100,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,281,524&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4-5&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,362,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;518,736&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;35&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;29,658,877&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;5,957,671&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;45&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;39,520,877&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,889,610&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of June&#160;30, 2023, are as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 81%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2023 remaining&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,024,151&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,243,423&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,310,936&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,044,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,288,619&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,911,769&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company is required to pay premiums to keep its portion of life insurance policies in force. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differ from the estimated life expectancies. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For policies accounted for under the investment method, the Company has not been made aware of information causing a material change to assumptions relating to the timing of realization of life insurance settlement proceeds. We have also not been made aware of information indicating impairment to the carrying value of policies. &lt;/div&gt;&lt;/div&gt; </us-gaap:LifeSettlementContractsDisclosureTextBlock>
    <abl:LifeSettlementContractsNumberOfContracts
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">167</abl:LifeSettlementContractsNumberOfContracts>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">122</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">45</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValue
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">195205585</us-gaap:LifeSettlementContractsFairValueMethodFaceValue>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">56685617</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValue
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">39520877</us-gaap:LifeSettlementContractsInvestmentMethodFaceValue>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">9889610</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount>
    <abl:LifeSettlementContractsNumberOfContracts
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_insurance_contract">53</abl:LifeSettlementContractsNumberOfContracts>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_insurance_contract">35</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts
      contextRef="PAsOn12_31_2022"
      decimals="INF"
      unitRef="Unit_insurance_contract">18</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValue
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">40092154</us-gaap:LifeSettlementContractsFairValueMethodFaceValue>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">13809352</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValue
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">42330000</us-gaap:LifeSettlementContractsInvestmentMethodFaceValue>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">8716111</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount>
    <us-gaap:ScheduleOfLifeSettlementContractsFairValueMethodTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies Carried at Fair Value&lt;/div&gt;&lt;/div&gt;&#x2014; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 56%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Remaining Life Expectancy (Years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Face Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0-1&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1-2&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,314,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6,855,769&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2-3&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,886,778&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,530,949&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3-4&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;33,631,467&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,174,200&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4-5&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,755,193&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,564,469&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;78&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;113,618,147&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;22,560,230&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;122&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;195,205,585&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfLifeSettlementContractsFairValueMethodTextBlock>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">0</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear>
    <us-gaap:LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">10</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">12314000</us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths>
    <us-gaap:LifeSettlementContractsFairValueMaturingInNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6855769</us-gaap:LifeSettlementContractsFairValueMaturingInNextTwelveMonths>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">11</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">16886778</us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo>
    <us-gaap:LifeSettlementContractsFairValueMaturingInYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">10530949</us-gaap:LifeSettlementContractsFairValueMaturingInYearTwo>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">10</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">33631467</us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree>
    <us-gaap:LifeSettlementContractsFairValueMaturingInYearThree
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">9174200</us-gaap:LifeSettlementContractsFairValueMaturingInYearThree>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">13</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">18755193</us-gaap:LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour>
    <us-gaap:LifeSettlementContractsFairValueMaturingInYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">7564469</us-gaap:LifeSettlementContractsFairValueMaturingInYearFour>
    <abl:LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">78</abl:LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour>
    <abl:LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">113618147</abl:LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour>
    <abl:LifeSettlementContractFairValueMaturityAfterYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">22560230</abl:LifeSettlementContractFairValueMaturityAfterYearFour>
    <us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">122</us-gaap:LifeSettlementContractsFairValueMethodNumberOfContracts>
    <us-gaap:LifeSettlementContractsFairValueMethodFaceValue
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">195205585</us-gaap:LifeSettlementContractsFairValueMethodFaceValue>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">56685617</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies accounted for using the investment method&lt;/div&gt;&lt;/div&gt;&#x2014; &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 57%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Remaining Life Expectancy (Years)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&lt;br/&gt; Life&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Insurance&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Policies&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Face Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying&lt;br/&gt; Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0-1&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1-2&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2-3&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,131,679&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3-4&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,100,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,281,524&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4-5&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,362,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;518,736&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;35&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;29,658,877&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;5,957,671&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;45&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;39,520,877&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,889,610&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of June&#160;30, 2023, are as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 81%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 6%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2023 remaining&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,024,151&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,243,423&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,310,936&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,044,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,288,619&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,911,769&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">0</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">0</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">2</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">4400000</us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2131679</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">4</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">4100000</us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1281524</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">4</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1362000</us-gaap:LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">518736</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour>
    <abl:LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">35</abl:LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour>
    <abl:LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">29658877</abl:LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour>
    <abl:LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">5957671</abl:LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour>
    <us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_insurance_contract">45</us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContracts>
    <us-gaap:LifeSettlementContractsInvestmentMethodFaceValue
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">39520877</us-gaap:LifeSettlementContractsInvestmentMethodFaceValue>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">9889610</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1024151</us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear>
    <us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1243423</us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths>
    <us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1310936</us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo>
    <us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1044640</us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree>
    <abl:LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">3288619</abl:LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree>
    <us-gaap:LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">7911769</us-gaap:LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;PROPERTY AND EQUIPMENT&#x2014;NET &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment&#x2014;net composed of the following: &lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 69%;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Computer equipment&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;144,202&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;34,300&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;19,444&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Leasehold improvements&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,299&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;5,902&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment&#x2014;gross&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;186,801&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,346&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: accumulated depreciation&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(8,870&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(6,729&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment&#x2014;net&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;177,931&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Depreciation expense for the three months ended June&#160;30, 2023 and 2022, was $1,098 and $1,098, respectively and depreciation expense for the six months ended June&#160;30, 2023, and 2022, was $2,141 and $2,141, respectively. &lt;/div&gt;&lt;/div&gt; </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment&#x2014;net composed of the following: &lt;/div&gt;&lt;br/&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 69%;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Computer equipment&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;144,202&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Furniture and fixtures&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;34,300&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;19,444&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Leasehold improvements&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,299&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;5,902&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment&#x2014;gross&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;186,801&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,346&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: accumulated depreciation&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(8,870&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(6,729&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 69%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Property and equipment&#x2014;net&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;177,931&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 69%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 7%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 1%;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn06_30_2023_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="0"
      unitRef="Unit_USD">144202</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_ComputerEquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn06_30_2023_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="0"
      unitRef="Unit_USD">34300</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="0"
      unitRef="Unit_USD">19444</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn06_30_2023_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="0"
      unitRef="Unit_USD">8299</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis"
      decimals="0"
      unitRef="Unit_USD">5902</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">186801</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">25346</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">8870</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">6729</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">177931</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">18617</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1098</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1098</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;GOODWILL AND OTHER INTANGIBLE ASSETS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill of $140,287,000 was recognized as a result of the Business Combination, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. The estimates of fair value are based upon preliminary valuation assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. Refer to footnote 3 for further details. &lt;/div&gt;&lt;/div&gt;  &lt;div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The changes in goodwill by reportable segments were as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 77%;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Abacus&lt;br/&gt; Settlements,&lt;br/&gt; LLC&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at January&#160;1, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at June&#160;30, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at January&#160;1, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;140,287,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;140,287,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Intangible Assets Acquired comprised of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 41%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 36%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Asset Type&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Useful Life&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation Methodology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships&#x2014;Agents&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;5 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Multi-period&#160;excess-earnings&#160;method&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships&#x2014;Financial Relationships&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;8 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Multi-period excess-earnings method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology&#x2014;APA&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from Royalty Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology&#x2014;Market Place&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;100,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;3 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement Cost Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Trade Name&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from Royalty Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Compete&lt;/div&gt; Agreements&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;With or Without Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State Insurance Licenses&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,700,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement Cost Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;32,900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2022_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="0"
      unitRef="Unit_USD">140287000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The changes in goodwill by reportable segments were as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 77%;"&gt;&lt;/td&gt;
&lt;td style="width: 7%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Abacus&lt;br/&gt; Settlements,&lt;br/&gt; LLC&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at January&#160;1, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at June&#160;30, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at January&#160;1, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 13%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Additions&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;140,287,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Goodwill at June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;140,287,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2021_AbacusSettlementsLLCMemberdeiLegalEntityAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="P01_01_2022To06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="PAsOn06_30_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="PAsOn12_31_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="P01_01_2023To06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis"
      decimals="0"
      unitRef="Unit_USD">140287000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="PAsOn06_30_2023_AbacusSettlementsLLCMemberdeiLegalEntityAxis"
      decimals="0"
      unitRef="Unit_USD">140287000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Intangible Assets Acquired comprised of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 41%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 36%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Asset Type&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Useful Life&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation Methodology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships&#x2014;Agents&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;5 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Multi-period&#160;excess-earnings&#160;method&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships&#x2014;Financial Relationships&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;8 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Multi-period excess-earnings method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology&#x2014;APA&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from Royalty Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology&#x2014;Market Place&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;100,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;3 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement Cost Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Trade Name&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from Royalty Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Compete&lt;/div&gt; Agreements&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;With or Without Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State Insurance Licenses&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,700,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement Cost Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;32,900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Intangible Assets Acquired comprised of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 41%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 36%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Asset Type&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Useful Life&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt; &lt;div style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Valuation Methodology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships&#x2014;Agents&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;5 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Multi-period&#160;excess-earnings&#160;method&lt;/div&gt;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Customer Relationships&#x2014;Financial Relationships&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;8 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Multi-period excess-earnings method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology&#x2014;APA&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from Royalty Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Internally Developed and Used Technology&#x2014;Market Place&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;100,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;3 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement Cost Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Trade Name&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Relief from Royalty Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Non-Compete&lt;/div&gt; Agreements&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;2 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;With or Without Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;State Insurance Licenses&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,700,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"&gt;Indefinite&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;Replacement Cost Method&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;32,900,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">12600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">11000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="PAsOn06_30_2023_CustomerRelationshipsFinancialRelationshipsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">1600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="PAsOn06_30_2023_APATechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="PAsOn06_30_2023_MarketPlaceTechnologyMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">4000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="PAsOn06_30_2023_NoncompeteAgreementsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023_LicensingAgreementsMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis"
      decimals="0"
      unitRef="Unit_USD">2700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">32900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;AVAILABLE-FOR-SALE&lt;/div&gt;&lt;/div&gt; SECURITIES, AT FAIR VALUE &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible Promissory Note&lt;/div&gt;&lt;/div&gt;&#x2014;The Company holds a convertible promissory note in a separate unrelated insurance technology company. In November 2021, the Company purchased a $250,000 note and then purchased an additional note in January 2022 for $250,000 as part of the Tranche 5 offering (&#x201c;Tranche 5 Promissory Note&#x201d;). The Tranche 5 Promissory Note pays 6% interest per annum. The Tranche 5 Promissory Note matures on November&#160;12, 2023 (&#x201c;Maturity Date&#x201d;) and will be paid in full as to outstanding principal and accrued interest on the Maturity Date unless the Tranche 5 Promissory Note converts prior to the 2023 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $1,000,000 (&#x201c;Next Equity Financing&#x201d;). &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;In October 2022, the Company purchased an additional convertible promissory note in the same unrelated insurance technology company for $500,000 as part of the Tranche 6&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;offering&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;(&#x201c;Tranche 6 Promissory Note&#x201d; and collectively, the &#x201c;Convertible Promissory Notes&#x201d;). The Tranche 6 Promissory Note pays eight percent (8)% interest per annum and matures September&#160;30, 2024 (&#x201c;2024 Maturity Date&#x201d;) and will be paid in full as to outstanding principal and accrued interest on the 2024 Maturity Date unless the Tranche 6 Promissory Note converts prior to the 2024 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $5,000,000 (&#x201c;Next Round Securities&#x201d;). &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The Company applies the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; method of accounting for its investment in the Convertible Promissory Note, which is a debt investment. The Convertible Promissory Note does not qualify for either the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;held-to-maturity&lt;/div&gt;&lt;/div&gt; method due to the Convertible Promissory Note&#x2019;s conversion rights or the trading securities method because the Company holds the Convertible Promissory Note as a long-term investment. The Convertible Promissory Notes are measured at fair value at each reporting &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;period-end.&lt;/div&gt; Unrealized gains and losses are reported in other comprehensive income until realized. As of December&#160;31, 2022 and June&#160;30, 2023, the Company evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000 and there was no unrealized gain or loss recorded. &lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P11_01_2021To11_30_2021"
      decimals="0"
      unitRef="Unit_USD">250000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P01_01_2022To01_31_2022"
      decimals="0"
      unitRef="Unit_USD">250000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleWeightedAverageYield
      contextRef="PAsOn11_30_2021"
      decimals="INF"
      unitRef="Unit_pure">0.06</us-gaap:DebtSecuritiesAvailableForSaleWeightedAverageYield>
    <abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert
      contextRef="PAsOn11_30_2021"
      decimals="0"
      unitRef="Unit_USD">1000000</abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P10_01_2022To10_31_2022"
      decimals="0"
      unitRef="Unit_USD">500000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleWeightedAverageYield
      contextRef="PAsOn10_31_2022"
      decimals="INF"
      unitRef="Unit_pure">0.08</us-gaap:DebtSecuritiesAvailableForSaleWeightedAverageYield>
    <abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert
      contextRef="PAsOn10_31_2022"
      decimals="0"
      unitRef="Unit_USD">5000000</abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert>
    <abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1000000</abl:DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other Investments: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Convertible Preferred Stock Ownership&lt;/div&gt;&lt;/div&gt;&#x2014;The Company owns convertible preferred stock in two entities, further described below. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July&#160;22, 2020, the Company purchased 224,551&#160;units of an unrelated insurance technology company&#x2019;s Series Seed Preferred units for $750,000 (&#x201c;Seed Units&#x201d;). During December 2022, the Company agreed to purchase 119,760 Series Seed Preferred Units for $400,000 in cash consideration by way of eight monthly payments of $50,000 starting December&#160;15, 2022, resulting in a total of $950,000 investment as of March&#160;31, 2023 and $1,100,000 investment as of June&#160;30, 2023. Upon conversion, the Seed Units held by the Company would represent 8.6% control in the technology company. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;On December&#160;21, 2020, the Company purchased 207,476&#160;shares of a separate unrelated insurance technology company&#x2019;s Series &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;B-1&lt;/div&gt; preferred stock for $500,000 (&#x201c;Preferred Shares&#x201d;). The Preferred Shares are convertible into voting common stock of insured consent at the option of the Company. Upon conversion, the Preferred Shares would represent less than 1% control in the technology company. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company applies the measurement alternative for its investments in the Seed Units and Preferred Shares because these investments are of an equity nature, and the Company does not have the ability to exercise significant influence over operating and financial policies of entities even in the event of conversion of the Seed Units or Preferred Shares. Under the measurement alternative, the Company records the investment based on original cost, less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the investee. The Company&#x2019;s share of income or loss of such companies is not included in the Company&#x2019;s condensed &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;consolidated statements of operations and comprehensive income. The Company tests its investments for impairment whenever circumstances indicate that the carrying value of the investment may not be recoverable. No impairment of investments occurred for the three and six months ended June&#160;30, 2023 and 2022. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other Noncurrent Assets- at fair value: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;S&amp;amp;P Options&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;The Company is long S&amp;amp;P 500 call options and short S&amp;amp;P 500 put options which were purchased and sold through a broker as an economic hedge related to the market-indexed debt instruments included in the long-term debt note. The value is based on shares owned and quoted market prices in active markets. Changes in fair value are recorded in the Unrealized Loss on Investments line item on the condensed consolidated statements of operations and comprehensive income. &lt;/div&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <abl:NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_entity">2</abl:NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld>
    <abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased
      contextRef="P07_22_2020To07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="INF"
      unitRef="Unit_shares">224551</abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn07_22_2020_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="INF"
      unitRef="Unit_USD">750000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased
      contextRef="P12_01_2022To12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="INF"
      unitRef="Unit_shares">119760</abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">400000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <abl:NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
      contextRef="PAsOn12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="0"
      unitRef="Unit_payment">8</abl:NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue>
    <abl:MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
      contextRef="P12_01_2022To12_31_2022_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">50000</abl:MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn03_31_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">950000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn06_30_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">1100000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="PAsOn06_30_2023_SeriesSeedPreferredUnitsMemberusgaapFinancialInstrumentAxis"
      decimals="3"
      unitRef="Unit_pure">0.086</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased
      contextRef="P12_21_2020To12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis"
      decimals="INF"
      unitRef="Unit_shares">207476</abl:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="PAsOn12_21_2020_SeriesB1PreferredStockMemberusgaapFinancialInstrumentAxis"
      decimals="2"
      unitRef="Unit_pure">0.01</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="P01_01_2023To06_30_2023"
      decimals="INF"
      unitRef="Unit_USD">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;CONSOLIDATION OF VARIABLE INTEREST ENTITIES &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company consolidates VIEs for which it is the primary beneficiary or VOEs for which it controls through a majority voting interest or other arrangement. See Note&#160;2 for more information on how the Company evaluates an entity for consolidation. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company evaluated any entity in which it had a variable interest upon formation to determine whether the entity should be consolidated. The Company also evaluated the consolidation conclusion during each reconsideration event, such as changes in the governing documents or additional equity contributions to the entity. During the six months ended June&#160;30, 2023, the Company&#x2019;s consolidated VIEs, LMA Income Series&#160;II LP, LMX Series LLC (LMATT Series 2024, Inc.), Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets of $57,577,034 and liabilities of $52,474,820. For the year ended December&#160;31, 2022, the Company&#x2019;s consolidated VIEs, LMATT Series 2024, Inc., Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets and liabilities of $30,073,972 and $27,116,762, respectively. The Company did not deconsolidate any entities during the period ended June&#160;30, 2023, or during the year ended December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June&#160;30, 2023, the Company held total assets of $801,345 and liabilities of $185,071, in unconsolidated VIEs. As of December&#160;31, 2022, the Company held total assets of $987,964 and liabilities of $358,586 in unconsolidated VIEs. &lt;/div&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">57577034</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn06_30_2023_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">52474820</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">30073972</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022_VariableInterestEntityPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">27116762</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">801345</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn06_30_2023_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">185071</us-gaap:Liabilities>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2022_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">987964</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2022_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">358586</us-gaap:Liabilities>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SEGMENT REPORTING &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Segment Information&lt;/div&gt;&lt;/div&gt;&#x2014;The Company organizes its business into two reportable segments (1)&#160;Portfolio Servicing and (2)&#160;Active Management, which generate revenue in different manners. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;This segment structure reflects the financial information and reports used by the Company&#x2019;s management, specifically its chief operating decision maker (CODM), to make decisions regarding the Company&#x2019;s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC&#160;280, &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Segment Reporting&lt;/div&gt;&lt;/div&gt;. The Company&#x2019;s CODM is the President and Chief Executive Officer. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Portfolio Servicing segment generates revenues by providing policy services to customers on a contract basis. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Active Management segment generates revenues by buying, selling, and trading policies and maintaining policies until receipt of death benefits. The Company&#x2019;s reportable segments are not aggregated. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company&#x2019;s method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review asset information related to investments nor expenditures incurred for long-lived assets given the Company&#x2019;s investments are recognized using the measurement alternative, and the Company&#x2019;s long-lived assets are immaterial to the condensed consolidated financial statements. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Revenue related to the Company&#x2019;s reporting segments for the three-month and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;six-month&lt;/div&gt; periods ended June&#160;30, 2023, and June&#160;30, 2022, is as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 46%;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Portfolio servicing&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;354,366&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;419,422&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;590,057&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;990,328&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Active management&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,024,399&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,979,479&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,994,917&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,285,971&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total revenue&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,378,765&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,398,901&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;21,584,974&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,276,299&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Information related to the Company&#x2019;s reporting segments for the three-month and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;six-month&lt;/div&gt; periods ended June&#160;30, 2023 and June&#160;30, 2022 is as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 42%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Portfolio servicing&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(76,705&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;280,303&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(166,128&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;668,752&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Active management&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,482,070&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,452,479&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,288,152&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;15,521,472&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total gross profit&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,405,365&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,732,782&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,122,024&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,190,224&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Sales and marketing&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(683,841&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,019,498&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,412,845&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,649,498&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General, administrative and other&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(577,539&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(5,499&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,274,431&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(646,705&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Depreciation&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,098&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,098&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,141&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,141&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other (expense) income&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;121,601&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(127,455&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(21,651&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(242,247&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Interest expense&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(584,075&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(934,001&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Loss on change in fair value of debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,445,229&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(333,879&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,398,662&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(375,513&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized gain (loss) on investments&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;672,936&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,039,022&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;798,156&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,054,975&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Provision for income taxes&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,184,571&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(120,132&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(528,104&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(296,806&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Less: Net loss attributable to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;26,596&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(406,641&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;487,303&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(406,641&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net income attributable to Abacus Life, Inc.&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6,750,145&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,679,558&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14,835,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,515,698&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="P01_01_2022To06_30_2022"
      decimals="INF"
      unitRef="Unit_segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock contextRef="P01_01_2023To06_30_2023">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Revenue related to the Company&#x2019;s reporting segments for the three-month and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;six-month&lt;/div&gt; periods ended June&#160;30, 2023, and June&#160;30, 2022, is as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 46%;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Portfolio servicing&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;354,366&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;419,422&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;590,057&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;990,328&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Active management&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,024,399&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,979,479&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,994,917&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,285,971&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total revenue&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,378,765&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,398,901&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;21,584,974&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;18,276,299&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">354366</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">419422</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">590057</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">990328</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">11024399</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="P04_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">7979479</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">20994917</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="P01_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">17285971</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">11378765</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">8398901</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">21584974</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">18276299</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Information related to the Company&#x2019;s reporting segments for the three-month and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;six-month&lt;/div&gt; periods ended June&#160;30, 2023 and June&#160;30, 2022 is as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 42%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Portfolio servicing&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(76,705&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;280,303&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(166,128&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;668,752&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Active management&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,482,070&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,452,479&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,288,152&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;15,521,472&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total gross profit&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,405,365&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,732,782&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,122,024&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,190,224&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Sales and marketing&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(683,841&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,019,498&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,412,845&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,649,498&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;General, administrative and other&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(577,539&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(5,499&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,274,431&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(646,705&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Depreciation&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,098&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,098&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,141&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,141&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other (expense) income&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;121,601&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(127,455&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(21,651&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(242,247&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Interest expense&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(584,075&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(934,001&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 8%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Loss on change in fair value of debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,445,229&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(333,879&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,398,662&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(375,513&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized gain (loss) on investments&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;672,936&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,039,022&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;798,156&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,054,975&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Provision for income taxes&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(1,184,571&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(120,132&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(528,104&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(296,806&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;Less: Net loss attributable to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;26,596&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(406,641&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;487,303&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(406,641&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net income attributable to Abacus Life, Inc.&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6,750,145&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,679,558&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14,835,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,515,698&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:GrossProfit
      contextRef="P04_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">-76705</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P04_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">280303</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">-166128</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2022To06_30_2022_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">668752</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P04_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">10482070</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P04_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">7452479</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2023To06_30_2023_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">20288152</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2022To06_30_2022_ActiveManagementSegmentMemberusgaapStatementBusinessSegmentsAxis"
      decimals="0"
      unitRef="Unit_USD">15521472</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">10405365</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">7732782</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">20122024</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">16190224</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">683841</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1019498</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1412845</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1649498</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">577539</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">5499</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1274431</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">646705</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:Depreciation
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1098</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1098</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2141</us-gaap:Depreciation>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">121601</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-127455</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-21651</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-242247</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-584075</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-934001</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:InterestRevenueExpenseNet
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InterestRevenueExpenseNet>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-1445229</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-333879</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2398662</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-375513</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">672936</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-1039022</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">798156</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">-1054975</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1184571</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">120132</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">528104</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">296806</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-26596</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">406641</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-487303</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">406641</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6750145</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">4679558</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14835648</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11515698</us-gaap:NetIncomeLoss>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COMMITMENTS AND CONTINGENCIES &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Legal Proceedings&lt;/div&gt;&lt;/div&gt;&#x2014;Occasionally, the Company may be subject to various proceedings such as lawsuits, disputes, or claims. The Company assesses these proceedings as they arise and accrues a liability when losses are probable and reasonably estimable. Although legal proceedings are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company&#x2019;s business, financial position, results of operations, or cash flows. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Commitment&lt;/div&gt;&lt;/div&gt;&#x2014;The Company has entered into a Strategic Services and Expenses Support Agreement (&#x201c;Expense Support Agreement&#x201d;) with two commonly owned full-service origination, servicing, and investment Providers in exchange for an option to purchase the outstanding equity ownership of the Providers. Pursuant to the Expense Support Agreement, Abacus Life, Inc. provides financial support and advice for the expenses of the Providers incurred in connection with their life settlement transactions businesses and the Providers are required to hire a life settlement transactions operations employee of an affiliate of Abacus Life, Inc. No later than December&#160;1 of each calendar year, Abacus Life, Inc. provides a budget for the Providers, in which Abacus Life, Inc. commits to extend financial support for all operating expenses up to the budgeted amount. &#x201c;Operating Expenses&#x201d; for purposes of the Expense Support Agreement means all annual operating expenses of the Providers incurred in the ordinary course of business, excluding the premiums paid for the Providers insurance coverages that are allocable to the insurance coverage &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provided to Institutional Life Holdings,&#160;LLC, which owns all the outstanding membership interests of the Providers if unrelated to the Providers settlement business. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the three months ended June&#160;30, 2023, Abacus Life, Inc. did &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;no&lt;/div&gt;t&lt;/div&gt; incur expenses related to the Expense Support Agreement. For the six months ended June&#160;30, 2023, Abacus Life, Inc. incurred $29,721 of expenses, related to the Expense Support Agreement, which is included in the Other (expense) line of the condensed consolidated statements of operations and comprehensive income and have not been reimbursed by the Providers. &lt;/div&gt;&lt;/div&gt; </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <abl:NumberOfProvidersInvolvedInOptionAgreement
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_provider">2</abl:NumberOfProvidersInvolvedInOptionAgreement>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P04_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="P01_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis"
      decimals="0"
      unitRef="Unit_USD">29721</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;FAIR VALUE MEASUREMENTS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company determines fair value based on assumptions that market participants would use in pricing an asset or a liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&#160;1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&#160;2 inputs: Other than quoted prices in Level&#160;1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Level&#160;3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Recurring Fair Value Measurements&lt;/div&gt;&lt;/div&gt;&#x2014;The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 46%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Hierarchy&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Life settlement policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Available-for-sale&lt;/div&gt;&lt;/div&gt; securities, at fair value&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other investments&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S&amp;amp;P 500 options&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,794,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,794,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,246&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,246&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total assets held at fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;1,801,886&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;59,285,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;61,087,503&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Private placement warrants&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,438,600&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,438,600&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total liabilities held at fair value:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;68,603,996&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;68,603,996&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 51%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Hierarchy&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Life settlement policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,809,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,809,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Available-for-sale&lt;/div&gt;&lt;/div&gt; securities, at fair value&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other investments&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,300,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,300,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S&amp;amp;P 500 options&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;890,829&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;890,829&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total assets held at fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;890,829&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,109,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,000,181&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total liabilities held at fair value:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Life Settlement Policies&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;The Company separately accounts for each owned life settlement policy using either the fair value method, or investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For policies carried at fair value, the Company utilizes valuation services of a third-party actuarial firm, who values the contracts using Level&#160;3 unobservable inputs, including actuarial assumptions, such as life expectancies and cash flow discount rates. The valuation model is based on a discounted cash flow analysis and is sensitive to changes in the discount rate used. The Company utilized a discount rate of 16% at June&#160;30, 2023 and 12% at December&#160;31, 2022, respectively, for policy valuation, which is based on economic and company-specific factors. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Subsequent to the reporting date, the Company sold 3 policies carried at fair value. As of June&#160;30, 2023, the Company valued these 3 policies using the price at the time of sale. Valuing these 3 policies using the takeout price resulted in a decrease in valuation of $231,775 compared to the third-party valuation. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For life settlement policies carried using the investment method, the Company measures these at the cost of the policy plus premiums paid. The policies accounted for using the investment method totaled $9,889,610 at June&#160;30, 2023 and $8,716,111 at December&#160;31, 2022, respectively. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Discount Rate Sensitivity&lt;/div&gt;&lt;/div&gt;&#x2014;Changes in the 16% discount rate on the death benefit and premiums used to estimate the policies issued under LMATT Series&#160;2024 Inc.,&#160;LMATT Growth Series 2.2024 Inc., LMATT Growth and Income Series 1.2026, Inc., LMA Income Series, LP and LMA Income Series II, LP (&#x201c;LMATT Policies&#x201d;) fair value has been analyzed. If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of June&#160;30, 2023, would be as follows: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Rate Adjustment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Change in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 65%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;+2%&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;53,987,508&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,698,109&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 65%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No change&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 65%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;-2%&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;59,857,879&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,172,262&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Credit Exposure to Insurance Companies&lt;/div&gt;&lt;/div&gt;&#x2014;The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company&#x2019;s life insurance policies as of June&#160;30, 2023: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"&gt;&lt;/td&gt;
&lt;td style="width: 11%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 10%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 10%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrier&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Percentage&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Face Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Percentage&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrier&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rating&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;American General Life Insurance Company&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;A&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ReliaStar Life Insurance Company&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;A&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lincoln National Life Insurance Company&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;A&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table provides a roll forward of the fair value of life insurance policies for the six months-ended June&#160;30, 2023: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 8%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,809,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Policies purchased&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;58,543,580&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Realized gain (loss) on matured/sold policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,898,958&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Premiums paid&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(879,462&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized gain(loss) on held policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,319,588&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in estimated fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,339,084&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Matured/sold policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(20,885,861&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Premiums paid&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;879,462&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Long-Term Debt&lt;/div&gt;&lt;/div&gt;&#x2014;See Note&#160;13&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;,&lt;/div&gt;&#160;&#x201c;Long-Term Debt&#x201d; for background information on the market-indexed debt. The Company has elected the fair value option in accounting for the instruments. Fair value is determined using Level&#160;3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i)&#160;the S&amp;amp;P 500 Index price, (ii)&#160;S&amp;amp;P 500 Index volatility, (iii)&#160;a risk-free rate based on data published by the US Treasury, and (iv)&#160;a term assumption based on the contractual term of the LMATT Notes. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The total change in fair value of the debt resulted in a gain of $1,602,042. This gain is comprised of $90,148, net of tax, which is included within accumulated other comprehensive income and $29,515 net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $1,445,229 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the three months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The total change in fair value of the debt resulted in a gain of $2,705,918. This gain is comprised of $175,530, net of tax, which is included within accumulated other comprehensive income and $56,446 net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $2,398,662 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the six months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table provides a roll forward of the fair value of the issued notes for the six months ended June&#160;30, 2023: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Debt issued to third parties&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;35,209,825&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized loss on change in fair value (risk-free)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,398,662&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized gain on change in fair value (credit-adjusted)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;307,256&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in estimated fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,705,918&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Private Placement Warrants&lt;/div&gt;&lt;/div&gt;&#x2014;Simultaneously with the closing of the Initial Public Offering, ERES consummated the sale of 8,900,000 warrants (the &#x201c;Private Placement Warrants&#x201d;) to East Sponsor, LLC (the &lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#x201c;Sponsor&#x201d;), which included the sale of an additional 900,000 Private Placement Warrants in connection with the full exercise by the underwriters of their over-allotment option on August&#160;25, 2020, at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $8,900,000. Each Private Placement Warrant is exercisable for one share of Class&#160;A common stock at a price of $11.50 per share, subject to adjustment. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y)&#160;the Private Placement Warrants will be exercisable on a cashless basis and be &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-redeemable&lt;/div&gt; so long as they are held by the initial purchasers or their permitted transferees and (z)&#160;the Private Placement Warrants and the shares of Class&#160;A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Private Placement Warrants were accounted for as liabilities in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-40.&lt;/div&gt; The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented separately in the condensed consolidated statements of operations. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Private Placement Warrants were considered a Level&#160;3 fair value measurement using a binomial lattice model in a risk-neutral framework. The binomial lattice model&#x2019;s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The implied volatility as of the reporting date was derived from observable public warrant traded price provided by Bloomberg LP. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents the key assumptions in the analysis: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 79%;"&gt;&lt;/td&gt;
&lt;td style="width: 16%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Private&lt;br/&gt; Placement&lt;br/&gt; Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected implied volatility&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;de&#160;minimis&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free interest rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4.09&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Term to expiration&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;5.0 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercise price&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11.50&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Common Stock Price&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10.03&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend Yield&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 10%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other Noncurrent Assets: S&amp;amp;P 500 Options&lt;/div&gt;&lt;/div&gt;&#x2014;In February 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, purchased and sold S&amp;amp;P 500 call and put options through a broker. The Company purchased and sold additional S&amp;amp;P 500 call options through a broker in June 2022 through their 100% owned and fully consolidated subsidiaries LMATT Growth Series 2.2024, Inc. and LMATT Growth and Income Series 1.2026, Inc. The options are exchange traded, and fair value is determined using Level&#160;1 inputs of quoted market prices as of the condensed consolidated balance sheets dates. Changes in fair value are classified as unrealized (gain)/loss on investments within the condensed consolidated statements of operations and comprehensive income. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial Instruments Measured at Fair Value on a Nonrecurring Basis&lt;/div&gt;&lt;/div&gt;&#x2014;The following financial assets, composed of equity securities without readily determinable fair values, are adjusted to fair value when observable price changes are identified, or an impairment charge is recognized. Such fair value measurements are based predominantly on Level&#160;3 inputs. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Available-for-Sale&lt;/div&gt;&lt;/div&gt; Investment&lt;/div&gt;&lt;/div&gt;&#x2014;The Convertible Promissory Note is classified as an &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; security. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Available-for-sale&lt;/div&gt;&lt;/div&gt; investments are subsequently measured at fair value. Unrealized holding gains &lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;available-for-sale&lt;/div&gt;&lt;/div&gt; investments using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. The Company initially purchased a $250,000 convertible promissory note from the issuer in 2021 and then on January&#160;7, 2022, the Company purchased an additional $250,000 convertible promissory note from the same issuer and then an additional $500,000 in October 2022. As of June&#160;30, 2023 and December&#160;31, 2022, the Company evaluated the fair value of its Promissory Note and determined that the fair value approximates the carrying value of $1,000,000 and $1,000,000, respectively. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other Investments&lt;/div&gt;&lt;/div&gt;&#x2014;The Company determines fair value using Level&#160;3 inputs under the measurement alternative. These investments are recorded at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively. As of June&#160;30, 2023, and December&#160;31, 2022, the Company did not identify any impairment indicators and determined that the carrying value of $1,600,000 and $1,300,000 is the fair value for these equity investments in privately held companies, given that there have been no observable price changes. &lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Financial Instruments Where Carrying Value Approximates Fair Value&lt;/div&gt;&lt;/div&gt;&#x2014;The carrying value of cash, cash equivalents, accounts receivables, and due to affiliates approximates fair value due to the short-term nature of their maturities. &lt;/div&gt; </us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="P01_01_2023To06_30_2023">The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below. &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 46%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Hierarchy&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Life settlement policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Available-for-sale&lt;/div&gt;&lt;/div&gt; securities, at fair value&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other investments&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,600,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S&amp;amp;P 500 options&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,794,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,794,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other assets&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,246&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,246&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total assets held at fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;1,801,886&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;59,285,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;61,087,503&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Private placement warrants&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,438,600&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,438,600&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total liabilities held at fair value:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;68,603,996&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;68,603,996&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 51%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="14" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value Hierarchy&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As of December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;2&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&lt;div style="display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Life settlement policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,809,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,809,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Available-for-sale&lt;/div&gt;&lt;/div&gt; securities, at fair value&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Other investments&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,300,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,300,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;S&amp;amp;P 500 options&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;890,829&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;890,829&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total assets held at fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;890,829&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,109,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,000,181&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 51%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total liabilities held at fair value:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 51%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 4%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">56685617</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">56685617</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1600000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1600000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1794640</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1794640</us-gaap:DerivativeAssets>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">7246</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">7246</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1801886</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">59285617</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">61087503</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">66165396</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">66165396</us-gaap:LongTermDebtFairValue>
    <abl:WarrantLiabilitiesNoncurrent
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</abl:WarrantLiabilitiesNoncurrent>
    <abl:WarrantLiabilitiesNoncurrent
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</abl:WarrantLiabilitiesNoncurrent>
    <abl:WarrantLiabilitiesNoncurrent
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">2438600</abl:WarrantLiabilitiesNoncurrent>
    <abl:WarrantLiabilitiesNoncurrent
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">2438600</abl:WarrantLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">68603996</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">68603996</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">13809352</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">13809352</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1300000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1300000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">890829</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">890829</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">890829</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">16109352</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">17000181</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">28249653</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">28249653</us-gaap:LongTermDebtFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">28249653</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">28249653</us-gaap:LiabilitiesFairValueDisclosure>
    <abl:LifeSettlementContractsMeasurementInput
      contextRef="PAsOn06_30_2023_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.16</abl:LifeSettlementContractsMeasurementInput>
    <abl:LifeSettlementContractsMeasurementInput
      contextRef="PAsOn12_31_2022_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.12</abl:LifeSettlementContractsMeasurementInput>
    <abl:LifeSettlementContractsNumberOfContractsSold
      contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_insurance_contract">3</abl:LifeSettlementContractsNumberOfContractsSold>
    <abl:LifeSettlementContractsNumberOfContractsSold
      contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_insurance_contract">3</abl:LifeSettlementContractsNumberOfContractsSold>
    <abl:LifeSettlementContractsNumberOfContractsSold
      contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_insurance_contract">3</abl:LifeSettlementContractsNumberOfContractsSold>
    <us-gaap:LifeSettlementContractsFairValueMethodGainLoss
      contextRef="P07_01_2023To08_14_2023_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="0"
      unitRef="Unit_USD">-231775</us-gaap:LifeSettlementContractsFairValueMethodGainLoss>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">9889610</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount>
    <us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">8716111</us-gaap:LifeSettlementContractsInvestmentMethodCarryingAmount>
    <abl:LifeSettlementContractsMeasurementInput
      contextRef="PAsOn06_30_2023_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.16</abl:LifeSettlementContractsMeasurementInput>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="P01_01_2023To06_30_2023">If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of June&#160;30, 2023, would be as follows:
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td rowspan="2" style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Rate Adjustment&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Change in&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 65%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;+2%&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;53,987,508&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(2,698,109&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 65%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No change&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 65%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;-2%&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;59,857,879&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 5%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,172,262&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table presents the key assumptions in the analysis: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 79%;"&gt;&lt;/td&gt;
&lt;td style="width: 16%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Private&lt;br/&gt; Placement&lt;br/&gt; Warrants&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Expected implied volatility&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;de&#160;minimis&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Risk-free interest rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4.09&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Term to expiration&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;5.0 years&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Exercise price&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11.50&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Common Stock Price&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10.03&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Dividend Yield&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 10%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">53987508</abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate>
    <abl:SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2698109</abl:SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate>
    <us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">56685617</us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount>
    <abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">59857879</abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate>
    <abl:SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">3172262</abl:SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="P01_01_2023To06_30_2023">The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company&#x2019;s life insurance policies as of June&#160;30, 2023: &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 61%;"&gt;&lt;/td&gt;
&lt;td style="width: 11%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 10%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 10%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrier&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Percentage&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Face Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Percentage&#160;of&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair Value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrier&lt;/div&gt;&lt;/div&gt;&lt;br/&gt; &lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rating&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;American General Life Insurance Company&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;A&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ReliaStar Life Insurance Company&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;6.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;A&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lincoln National Life Insurance Company&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;14.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12.0&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;A&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis"
      decimals="3"
      unitRef="Unit_pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"
      decimals="3"
      unitRef="Unit_pure">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_ReliaStarLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"
      decimals="3"
      unitRef="Unit_pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="P01_01_2023To06_30_2023_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFairValueMemberusgaapConcentrationRiskByBenchmarkAxis_LincolnNationalLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table provides a roll forward of the fair value of life insurance policies for the six months-ended June&#160;30, 2023: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 78%; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="width: 8%; vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt;
&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;13,809,352&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Policies purchased&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;58,543,580&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Realized gain (loss) on matured/sold policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,898,958&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Premiums paid&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(879,462&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized gain(loss) on held policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,319,588&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in estimated fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;4,339,084&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Matured/sold policies&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(20,885,861&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Premiums paid&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;879,462&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;56,685,617&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="PAsOn12_31_2022_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">13809352</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">58543580</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings
      contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">1898958</abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings>
    <abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid
      contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">879462</abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid>
    <abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings
      contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">3319588</abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">4339084</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">20885861</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid
      contextRef="P01_01_2023To06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">879462</abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="PAsOn06_30_2023_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis"
      decimals="0"
      unitRef="Unit_USD">56685617</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1602042</abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">90148</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">29515</abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-1445229</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2705918</abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">175530</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome>
    <abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">56446</abl:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2398662</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table provides a roll forward of the fair value of the issued notes for the six months ended June&#160;30, 2023: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at December&#160;31, 2022&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Debt issued to third parties&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;35,209,825&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized loss on change in fair value (risk-free)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,398,662&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unrealized gain on change in fair value (credit-adjusted)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;307,256&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Change in estimated fair value&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,705,918&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 79%;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair value at June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px; width: 79%;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 6%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">28249653</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">35209825</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2398662</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionCreditRiskGainsLossesOnAssets
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-307256</us-gaap:FairValueOptionCreditRiskGainsLossesOnAssets>
    <abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">-2705918</abl:FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">66165396</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">8900000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn08_25_2020_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">900000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <abl:ClassOfWarrantOrRightPricePerWarrant
      contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">1</abl:ClassOfWarrantOrRightPricePerWarrant>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">8900000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis">P30D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="4"
      unitRef="Unit_pure">0.0409</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">10.03</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="INF"
      unitRef="Unit_USD">250000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P01_07_2022To01_07_2022"
      decimals="INF"
      unitRef="Unit_USD">250000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="P10_01_2022To10_31_2022"
      decimals="INF"
      unitRef="Unit_USD">500000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1600000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">1300000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:LongTermDebtTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LONG-TERM DEBT &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt comprises of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 44%;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;br/&gt; June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt; December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Market-indexed notes:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Series 2024, Inc.&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,866,900&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,621,141&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,866,900&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,067,291&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Series 2.2024, Inc.&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,333,391&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,446,527&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,333,391&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,354,013&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Growth&#160;&amp;amp; Income Series 1.2026, Inc&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;459,553&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Secured borrowing:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Income Series, LP&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;21,889,444&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;22,124,676&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,428,349&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,428,349&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Income Series II, LP&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,041,851&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,041,851&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unsecured borrowing:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Sponsor PIK Note&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,471,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,471,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total long-term debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;65,003,234&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;30,028,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SPV purchase and sale note&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Sponsor PIK Note &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On the June&#160;30, 2023, in connection with the consummation of the Business Combination and as contemplated by the Merger Agreement, East Sponsor, LLC, a Delaware limited liability company (&#x201c;Sponsor&#x201d;), made an unsecured loan to the Company in the aggregate amount of $10,471,648 (the &#x201c;Sponsor PIK Note&#x201d;). The Sponsor PIK Note matures on June&#160;30, 2028 (the &#x201c;Maturity Date&#x201d;) and may be prepaid at any time in accordance with its terms without any premium or penalty. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Series 2024, Inc. Market-Indexed Notes: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On March&#160;31, 2022, LMATT Series&#160;2024,&#160;Inc., which the Company consolidates for financial reporting, issued $10,166,900&#160;in market-indexed private placement notes. The note, titled the Longevity Market Assets &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Target-Term Series (LMATTS) 2024, is a market-indexed instrument designed to provide upside performance exposure of the S&amp;amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&amp;amp;P 500 Index must be paid. The note has a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the note on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-to-one&lt;/div&gt;&lt;/div&gt; basis. As of June&#160;30, 2023, $9,866,900 of the principal amount remained outstanding. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2024, Inc. notes were $9,621,141. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The notes are secured by the assets of the issuing entities, which includes cash, S&amp;amp;P 500 options, and life settlement policies totaling $11,195,701 as of June&#160;30, 2023. The notes&#x2019; agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Series 2.2024, Inc. Market-Indexed Notes: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;On September&#160;16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $2,333,391 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (&#x201c;LMATTSTM Series 2.2024, Inc.&#x201d;) is a market-indexed instrument designed to provide upside performance exposure of the S&amp;amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&amp;amp;P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 120% of the performance of the S&amp;amp;P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investment will experience all subsequent losses on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-to-one&lt;/div&gt;&lt;/div&gt; basis. . As of June&#160;30, 2023, the entire principal amount remained outstanding. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Series 2.2024, Inc. notes were $3,446,527. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&amp;amp;P 500 options, and life settlement policies totaling $3,331,872 as of June&#160;30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;Additionally, on September&#160;16, 2022, LMATTS Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $400,000 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (&#x201c;LMATTSTM Growth and Income Series 1.2026, Inc.&#x201d;) is a market-indexed instrument designed to provide upside performance exposure of the S&amp;amp;P 500 Index, while limiting downward exposure. Upon maturity of the note in 2026, the principal, plus the return based upon the S&amp;amp;P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 140% of the performance of the S&amp;amp;P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investment will experience all subsequent losses on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-to-one&lt;/div&gt;&lt;/div&gt; basis. This note also includes 4% dividend feature that will be paid annually. As of June&#160;30, 2023, the entire principal amount remained outstanding. &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of June&#160;30, 2023, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes were $459,553. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The notes are secured by the assets of the issuing entity, LMATTS Growth and Income Series 1.2026, Inc., which includes cash, S&amp;amp;P 500 options, and life settlement policies totaling $517,218 as of June&#160;30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;;text-indent: 0px;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;See additional fair value considerations within Note 12. &#x201c;Fair Value Measurements.&#x201d; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-year&lt;/div&gt; periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at 9% which would require a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the six months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;860-10.&lt;/div&gt; As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;860-10-50-6A(d)).&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; In accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;860-30-25-2,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;810-10-30.&lt;/div&gt;&lt;/div&gt; As of June&#160;30, 2023, the fair value of the secured borrowing was $22,124,676. &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;LMA Income Series II, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-year&lt;/div&gt; periods at the discretion of the general partner, LMA Income Series II, GP, LLC. The limited partners will receive annual dividends equal to the Preferred Return Amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner. &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the three and six months ended June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The private placement offerings proceeds will be used to acquire an actively managed large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;860-10.&lt;/div&gt; As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;860-10-50-6A(d)).&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; In accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;860-30-25-2,&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;810-10-30.&lt;/div&gt;&lt;/div&gt; As of June&#160;30, 2023, the fair value of the secured borrowing was $20,041,851. &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SPV Purchase and Sale &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July&#160;5, 2023, the Company entered into an Asset Purchase Agreement (the &#x201c;Policy APA&#x201d;) to acquire certain insurance policies with an aggregate fair market value of $10.0&#160;million from Abacus Investment SPV, LLC, a Delaware limited liability company (&#x201c;SPV&#x201d;), in exchange for a payable obligation owing by the Company to the SPV (such acquisition transaction under the Policy APA, the &#x201c;SPV Purchase and Sale&#x201d;). &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The payable obligation owing by the Company to the SPV in connection with the SPV Purchase and Sale is evidenced by a note issued by the Company under the SPV Investment Facility (the &#x201c;SPV Purchase and Sale Note&#x201d;) in an original principal amount equal to the aggregate fair market value of the acquired insurance policies. The SPV Purchase and Sale Note has the same material terms and conditions as the other credit extensions under the SPV Investment Facility (as defined below). &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SPV Investment Facility &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July&#160;5, 2023, the Company entered into that certain SPV Investment Facility (the &#x201c;SPV Investment Facility&#x201d;), between the Company, as borrower, and the SPV, as lender. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The SPV Investment Facility, among other things: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;requires certain subsidiaries of the Company to guarantee the credit extensions provided under the SPV Investment Facility pursuant to separate documentation &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;is unsecured without collateral security provided in favor of the SPV and subordinated in right of payment to the Company&#x2019;s obligations under the Owl Rock Credit Facility, subject to limited specified exceptions and circumstances for permitting early payment; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides for certain credit extensions in an aggregate principal amount of $25.0&#160;million, including: (i)&#160;an initial credit extension in an original principal amount of $15.0&#160;million that was funded upon the closing of the SPV Investment Facility, and (ii)&#160;the SPV Purchase and Sale Note in favor of the SPV in an original principal amount of $10.0&#160;million to finance the purchase of the insurance policies under the Policy APA; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides proceeds from the SPV Investment Facility for payment of certain transaction expenses, general corporate purposes and any other purposes not prohibited by the agreement or applicable law; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;matures on July&#160;5, 2026, three years after the closing of the SPV Investment Facility, subject to two automatic extensions of one year each without any amendment of the relevant documentation, but also subject to applicable subordination restrictions in relation to the Owl Rock Credit Facility; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;provides for interest to accrue on the SPV Investment Facility at a rate of 12.00% per annum, payable quarterly, all of which is to be paid &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in-kind&lt;/div&gt; by the Company by increasing the principal amount of the SPV Investment Facility owing to the SPV on each interest payment date; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;provides a default rate that will accrue at 2.00% per annum (subject to applicable subordination restrictions) over the rate otherwise applicable. If cash payment is not permitted due to applicable subordination restrictions or otherwise, such default interest shall be paid &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in-kind;&lt;/div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides that no amortization payments shall be required prior to maturity; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;contains financial and other covenants substantially similar and not materially worse than those contained in the Owl Rock Credit Facility from the perspective of the Company; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides for certain specified events of default (including certain events of default subject to grace or cure periods), with the occurrence and during the continuance of such events of default enabling the lender under the SPV Investment Facility to accelerate the obligations under the SPV Investment Facility, among other rights or remedies, subject to applicable subordination restrictions. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The SPV&#x2019;s investment resulting from credit extensions under the SPV Investment Facility is treated by the Company as debt for U.S. GAAP accounting purposes. While the timing of the Policy APA and SPV Investment Facility occurred on July&#160;5, 2023, such amounts are included within the condensed consolidated balance sheet as cash was received prior to June&#160;30, 2023. &lt;/div&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Long-term debt comprises of the following: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 44%;"&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;br/&gt; June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt; December&#160;31, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Market-indexed notes:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Series 2024, Inc.&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,866,900&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,621,141&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;9,866,900&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,067,291&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Series 2.2024, Inc.&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,333,391&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3,446,527&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,333,391&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;2,354,013&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Growth&#160;&amp;amp; Income Series 1.2026, Inc&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;459,553&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;400,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Secured borrowing:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Income Series, LP&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;21,889,444&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;22,124,676&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,428,349&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;17,428,349&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LMATT Income Series II, LP&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,041,851&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,041,851&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Unsecured borrowing:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Sponsor PIK Note&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,471,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;10,471,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total long-term debt&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;65,003,234&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;66,165,396&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;30,028,640&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;28,249,653&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SPV purchase and sale note&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,000,000&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 9%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">9866900</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">9621141</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">9866900</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">8067291</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">2333391</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">3446527</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">2333391</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">2354013</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">400000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">459553</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">400000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">400000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">21889444</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">22124676</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">17428349</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">17428349</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">20041851</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">20041851</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">10471648</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">10471648</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"
      decimals="0"
      unitRef="Unit_USD">65003234</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"
      decimals="0"
      unitRef="Unit_USD">66165396</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"
      decimals="0"
      unitRef="Unit_USD">30028640</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis"
      decimals="0"
      unitRef="Unit_USD">28249653</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">25000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">25000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn12_31_2022_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn06_30_2023_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_USD">10471648</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_USD">10166900</us-gaap:DebtInstrumentFaceAmount>
    <abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage
      contextRef="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.40</abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage>
    <abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage
      contextRef="PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.40</abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage>
    <abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold
      contextRef="P03_31_2022To03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.01</abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">9866900</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">9621141</us-gaap:LongTermDebtFairValue>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">11195701</us-gaap:Assets>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="PAsOn09_16_2022_LMATTSeries22024IncMembersrtOwnershipAxis"
      decimals="INF"
      unitRef="Unit_pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_USD">2333391</us-gaap:DebtInstrumentFaceAmount>
    <abl:DebtInstrumentMaximumUpsidePerformanceParticipationPercentage
      contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">1.20</abl:DebtInstrumentMaximumUpsidePerformanceParticipationPercentage>
    <abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage
      contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.20</abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage>
    <abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage
      contextRef="PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.20</abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage>
    <abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold
      contextRef="P03_31_2022To03_31_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.01</abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">3446527</us-gaap:LongTermDebtFairValue>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">3331872</us-gaap:Assets>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMembersrtOwnershipAxis"
      decimals="INF"
      unitRef="Unit_pure">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_USD">400000</us-gaap:DebtInstrumentFaceAmount>
    <abl:DebtInstrumentMaximumUpsidePerformanceParticipationPercentage
      contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">1.40</abl:DebtInstrumentMaximumUpsidePerformanceParticipationPercentage>
    <abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage
      contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.10</abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage>
    <abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage
      contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.10</abl:DebtInstrumentMaximumMarketDownturnProtectionPercentage>
    <abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold
      contextRef="P09_16_2022To09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.01</abl:DebtInstrumentNoteReductionRatioForLossesBelowThreshold>
    <abl:DebtInstrumentDividendFeaturePercentage
      contextRef="PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.04</abl:DebtInstrumentDividendFeaturePercentage>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">459553</us-gaap:LongTermDebtFairValue>
    <us-gaap:Assets
      contextRef="PAsOn06_30_2023_AssetPledgedAsCollateralMemberusgaapPledgedStatusAxis_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">517218</us-gaap:Assets>
    <us-gaap:DebtInstrumentTerm contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">P3Y</us-gaap:DebtInstrumentTerm>
    <abl:DebtInstrumentExtensionOptions
      contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_option">2</abl:DebtInstrumentExtensionOptions>
    <abl:DebtInstrumentExtensionTerm contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">P1Y</abl:DebtInstrumentExtensionTerm>
    <abl:DebtInstrumentDividendFeaturePercentage
      contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.065</abl:DebtInstrumentDividendFeaturePercentage>
    <abl:DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold
      contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.25</abl:DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold>
    <abl:DebtInstrumentMinimumInternalRateOfReturn
      contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.065</abl:DebtInstrumentMinimumInternalRateOfReturn>
    <abl:DebtInstrumentInternalRateOfReturnCap
      contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.09</abl:DebtInstrumentInternalRateOfReturnCap>
    <abl:DebtInstrumentNetInternalRateOfReturnAtCap
      contextRef="PAsOn06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.15</abl:DebtInstrumentNetInternalRateOfReturnAtCap>
    <abl:DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold
      contextRef="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.75</abl:DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold>
    <abl:DebtInstrumentMinimumInternalRateOfReturn
      contextRef="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.065</abl:DebtInstrumentMinimumInternalRateOfReturn>
    <abl:DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold
      contextRef="PAsOn06_30_2023_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">1</abl:DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold>
    <abl:DebtInstrumentInternalRateOfReturnCap
      contextRef="PAsOn06_30_2023_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.15</abl:DebtInstrumentInternalRateOfReturnCap>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">22124676</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentTerm contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">P3Y</us-gaap:DebtInstrumentTerm>
    <abl:DebtInstrumentExtensionOptions
      contextRef="PAsOn06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_option">2</abl:DebtInstrumentExtensionOptions>
    <abl:DebtInstrumentExtensionTerm contextRef="P01_01_2023To06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis">P1Y</abl:DebtInstrumentExtensionTerm>
    <abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends
      contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">500000</abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends>
    <abl:DebtInstrumentDividendFeaturePercentage
      contextRef="PAsOn06_30_2023_CapitalCommitmentThresholdOneMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.075</abl:DebtInstrumentDividendFeaturePercentage>
    <abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends
      contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">500000</abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends>
    <abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends
      contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MaximumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">1000000</abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends>
    <abl:DebtInstrumentDividendFeaturePercentage
      contextRef="PAsOn06_30_2023_CapitalCommitmentThresholdTwoMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.0775</abl:DebtInstrumentDividendFeaturePercentage>
    <abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends
      contextRef="P01_01_2023To06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_MinimumMembersrtRangeAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">1000000</abl:DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends>
    <abl:DebtInstrumentDividendFeaturePercentage
      contextRef="PAsOn06_30_2023_CapitalCommitmentThresholdThreeMemberABLDebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis_LimitedPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.08</abl:DebtInstrumentDividendFeaturePercentage>
    <abl:DebtInstrumentDividendFeaturePercentage
      contextRef="PAsOn06_30_2023_GeneralPartnerMemberusgaapPartnerTypeOfPartnersCapitalAccountAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">1</abl:DebtInstrumentDividendFeaturePercentage>
    <us-gaap:LongTermDebtFairValue
      contextRef="PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">20041851</us-gaap:LongTermDebtFairValue>
    <abl:LifeSettlementContractsSpecialPurchaseVehicleFairValue
      contextRef="PAsOn07_05_2023_PolicyAPAMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</abl:LifeSettlementContractsSpecialPurchaseVehicleFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapCreditFacilityAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">P3Y</us-gaap:DebtInstrumentTerm>
    <abl:DebtInstrumentNumberOfExtensions
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_extension">2</abl:DebtInstrumentNumberOfExtensions>
    <abl:DebtInstrumentExtensionTerm contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">P1Y</abl:DebtInstrumentExtensionTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <abl:DebtInstrumentDefaultRate
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.02</abl:DebtInstrumentDefaultRate>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;14.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SHAREHOLDERS&#x2019; EQUITY &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company is authorized to issue up to 200,000,000&#160;shares of common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. No shares of preferred stock are issued or outstanding. Holders of the Company&#x2019;s common stock are entitled to one vote for each share. As of June&#160;30, 2023, there were 62,961,688&#160;shares of common stock issued and outstanding. Holders of shares were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets available for distribution to the shareholders after payment of all liabilities. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company&#x2019;s common stock, $0.0001 par value per share, issued to legacy LMA&#x2019;s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. As of December&#160;31, 2022, this resulted in 50,369,350 shares of common stock issued and outstanding. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Public Warrants &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June&#160;30, 2023, the Company has 17,250,000 Public Warrants outstanding. Each redeemable whole Public Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment as described. The Public Warrants represent a freestanding financial instrument as it is traded on the &lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;NASDAQ &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; under the symbol &#x201c;ABLLW&#x201d; and legally detachable and separately exercisable from the related underlying shares of the Company&#x2019;s common stock. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed Offering. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company will not be obligated to deliver any shares of Class&#160;A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class&#160;A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class&#160;A common stock upon exercise of a warrant unless the share of Class&#160;A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Redemption of Warrants for Cash&#x2014;Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in whole and not in part; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;at a price of $0.01 per Public Warrant; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;upon not less than 30 days&#x2019; prior written notice of redemption to each warrant holder; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;30-trading&lt;/div&gt; day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;If and when the Public warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class&#160;A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class&#160;A common stock is available throughout the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;30-day&lt;/div&gt; redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. &lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Redemption of Warrants for Shares of Class&#160;A Common Stock&#x2014;Once the Public warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class&#160;A common stock: &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;in whole and not in part; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;at a price equal to a number of shares of Class&#160;A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the &#x201c;fair market value&#x201d; of the Class&#160;A common stock; &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;upon not less than 30 days&#x2019; prior written notice of redemption to each warrant holder; and &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;if, and only if, the last sale price of the Class&#160;A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;In addition, if (x)&#160;the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company&#x2019;s initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (y) the volume weighted average trading price of the Company&#x2019;s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#x201c;Market Price&#x201d;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of Market Price and the newly issued price. Further, the $10.00 and $18.00 per share redemption trigger prices will be adjusted to be equal to 100% and 180%, respectively, of the higher of the market value and the newly issued price. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;If the Company elects to redeem all of the Public Warrants or the common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange, management has the option to require all holders that wish to exercise the Public Warrants to do so on a &#x201c;cashless basis,&#x201d; as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing (x)&#160;the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the &#x201c;fair market value&#x201d; (defined below) by (y)&#160;the fair market value. The &#x201c;fair market value&#x201d; shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. However, in no instance can the warrant holder unilaterally decide to exercise its Public Warrant on a cashless basis. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Upon the Business Combination, the Company accounted for the Public Warrants issued with the IPO as equity instruments. The Company accounted for the warrant as an expense of the IPO resulting in a charge directly to stockholders&#x2019; equity. The Company estimates that the fair value of the warrants upon the Business Combination is approximately $4.73&#160;million, or $0.274 per Public Warrant, using the binomial lattice model. The fair value of the warrants is estimated as of the date of grant using the following assumptions: (1)&#160;risk-free interest rate of 4.09%, (2) term to expiration of 5.0 years, (3)&#160;exercise price of $11.50 and (4)&#160;stock price of $10.03. &lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <abl:NumberOfVotesPerCommonShare
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_vote">1</abl:NumberOfVotesPerCommonShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">62961688</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">62961688</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn06_30_2023"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <abl:BusinessAcquisitionExchangeRatio
      contextRef="PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis"
      decimals="INF"
      unitRef="Unit_pure">0.8</abl:BusinessAcquisitionExchangeRatio>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">17250000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <abl:WarrantsAndRightsOutstandingExercisableTermBusinessCombination contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P30D</abl:WarrantsAndRightsOutstandingExercisableTermBusinessCombination>
    <abl:WarrantsAndRightsOutstandingExercisableTermProposedOffering contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P12M</abl:WarrantsAndRightsOutstandingExercisableTermProposedOffering>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <abl:ClassOfWarrantOrRightRedemptionPricePerWarrant
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</abl:ClassOfWarrantOrRightRedemptionPricePerWarrant>
    <abl:ClassOfWarrantOrRightRedemptionNoticePeriod contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P30D</abl:ClassOfWarrantOrRightRedemptionNoticePeriod>
    <abl:ClassOfWarrantOrRightRedemptionPricePerShareThreshold
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">18</abl:ClassOfWarrantOrRightRedemptionPricePerShareThreshold>
    <abl:ClassOfWarrantOrRightRedemptionNumberOfTradingDays contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P20D</abl:ClassOfWarrantOrRightRedemptionNumberOfTradingDays>
    <abl:ClassOfWarrantOrRightRedemptionTradingDayPeriod contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P30D</abl:ClassOfWarrantOrRightRedemptionTradingDayPeriod>
    <abl:ClassOfWarrantOrRightRedemptionTradingDayPeriod contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P30D</abl:ClassOfWarrantOrRightRedemptionTradingDayPeriod>
    <abl:ClassOfWarrantOrRightRedemptionNoticePeriod contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P30D</abl:ClassOfWarrantOrRightRedemptionNoticePeriod>
    <abl:ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10</abl:ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold>
    <abl:ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">9.2</abl:ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare>
    <abl:ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod contextRef="P01_01_2023To06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P20D</abl:ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod>
    <abl:ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">9.2</abl:ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare>
    <abl:ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">1.15</abl:ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage>
    <abl:ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10</abl:ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold>
    <abl:ClassOfWarrantOrRightRedemptionPricePerShareThreshold
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">18</abl:ClassOfWarrantOrRightRedemptionPricePerShareThreshold>
    <abl:ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">1</abl:ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent>
    <abl:ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent
      contextRef="PAsOn06_30_2023_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">1.80</abl:ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="PAsOn08_30_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-4"
      unitRef="Unit_USD">4730000</us-gaap:WarrantsAndRightsOutstanding>
    <abl:WarrantsAndRightsOutstandingFairValuePerShare
      contextRef="PAsOn08_30_2022_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="3"
      unitRef="Unit_USD_per_Share">0.274</abl:WarrantsAndRightsOutstandingFairValuePerShare>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="4"
      unitRef="Unit_pure">0.0409</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputExercisePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">11.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="PAsOn06_30_2023_BinomialLatticeModelMemberusgaapValuationTechniqueAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_pure">10.03</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:DefinedContributionPlanTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;EMPLOYEE BENEFIT PLAN &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company has a defined contribution plan in the U.S. intended to qualify under Section&#160;401(k)&#160;of the Internal Revenue Code (the &#x201c;401(k)&#160;Plan&#x201d;). The 401(k)&#160;Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer up to 100% of their annual compensation on a pretax basis. For the year ended December&#160;31, 2022, the Company elected to match 50% of employee contributions up to a maximum of 4% of eligible employee compensation. For the three months ended June&#160;30, 2023 and 2022, the Company recognized expenses related to the 401(k)&#160;Plan amounting to $13,075 and $2,577, respectively and for the six months ended June&#160;30, 2023 and 2022, the Company recognized expenses related to the 401(k)&#160;Plan amounting to $25,315 and $8,048, respectively. &lt;/div&gt;&lt;/div&gt;</us-gaap:DefinedContributionPlanTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="P01_01_2023To06_30_2023"
      decimals="INF"
      unitRef="Unit_pure">1</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_pure">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="P01_01_2022To12_31_2022"
      decimals="INF"
      unitRef="Unit_pure">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">13075</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">2577</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">25315</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">8048</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt;&lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;INCOME TAXES &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Before June&#160;30, 2023, the Company elected to file as an S corporation for Federal and state income tax purposes, the Company incurred no Federal or state income taxes, except for income taxes recorded related to some of their consolidated variable interest entities and subsidiaries which are taxable C corporations. These VIE&#x2019;s and subsidiaries include LMATT Series&#160;2024,&#160;Inc., the wholly owned subsidiary of LMX, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATTS Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, the provision for income taxes was attributable to amounts for LMATT Series&#160;2024,&#160;Inc, LMATT Growth Series, Inc. and LMATT Growth and Income Series, Inc. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;For the three months ended June&#160;30, 2023 and 2022, the Company recorded provision for income taxes of $1,184,571 and $120,132, respectively. The effective tax rate is 15.0% for the three months ended June&#160;30, 2023. The effective rate for the three months ended June&#160;30, 2022 was 12.0% due to the impact of state income taxes and the release of the Company&#x2019;s valuation allowance, as there was sufficient evidence of the Company&#x2019;s ability to generate future taxable income at June&#160;30, 2022. &lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;For the six months ended June&#160;30, 2023 and 2022, the Company recorded provision for income taxes of $528,104 and $296,806, respectively. The effective tax rate is 3.6% for the six months ended June&#160;30, 2023. The existence of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-taxable&lt;/div&gt; flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to be significantly lower than &lt;/div&gt;&lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;the statutory rate. The effective rate for the six months ended June&#160;30, 2022 was 18% due to the impact of state income taxes and the release of the Company&#x2019;s valuation allowance, as there was sufficient evidence of the Company&#x2019;s ability to generate future taxable income at June&#160;30, 2022. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company did not have any unrecognized tax benefits relating to uncertain tax positions as of June&#160;30, 2023, and December&#160;31, 2022, and did not recognize any interest or penalties related to uncertain tax positions as of June&#160;30, 2023, and December&#160;31, 2022. &lt;/div&gt;&lt;/div&gt; </us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">1184571</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">120132</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P04_01_2023To06_30_2023"
      decimals="3"
      unitRef="Unit_pure">0.15</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P04_01_2022To06_30_2022"
      decimals="3"
      unitRef="Unit_pure">0.12</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">528104</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">296806</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P01_01_2023To06_30_2023"
      decimals="3"
      unitRef="Unit_pure">0.036</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="P01_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_pure">0.18</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;17.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;RELATED-PARTY TRANSACTIONS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June&#160;30, 2023 and December&#160;31, 2022, $10,415,154 and $263,785, respectively, were due to members and affiliates primarily for reimbursable transaction costs as well as distributions to owners of $717,429 as a part of the Business Combination as of June&#160;30, 2023. As of June&#160;30, 2023 and December&#160;31, 2022, $10,473,748 and $2,904,646 was due from affiliates, respectively. The amount to be received as of June&#160;30, 2023 is due from the Sponsor as part of the Sponsor PIK Note. Additionally, the SPV purchase and sale note for $25,000,000 as of June&#160;30, 2023 was also recorded as a related party transaction given the transfer of cash and policies between the Company and the SPV. Refer to footnote 13 for more information. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company has a related-party relationship with Nova Trading (US),&#160;LLC (&#x201c;Nova Trading&#x201d;), a Delaware limited liability company and Nova Holding (US)&#160;LP, a Delaware limited partnership (&#x201c;Nova Holding&#x201d; and collectively with Nova Trading, the &#x201c;Nova Funds&#x201d;). The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided by 12.&#160;The Company earned $197,629 and $205,224, respectively, in service revenue related to Nova Funds for the three months ended June&#160;30, 2023 and 2022 and earned $411,076 and $406,129, respectively, in service revenue related to Nova Funds for the six months ended June&#160;30, 2023 and 2022. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Prior to the Merger, LMA used Abacus to originate life settlement policies that it accounts for under the investment method. For the three and six months ended June&#160;30, 2023, the Company incurred $837,975 and $1,627,975, respectively in origination costs for life settlement policies that were originated by Abacus. These costs are capitalized on the condensed consolidated balance sheets as life settlement policies, at cost. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;As of June&#160;30, 2023, and December&#160;31, 2022, there were $72,600 and $196,289, respectively owed from the Nova Funds, which are included as related-party receivables in the accompanying condensed consolidated balance sheets. &lt;/div&gt;&lt;/div&gt; </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">10415154</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">263785</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="PAsOn06_30_2023_OwnersMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">717429</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">10473748</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">2904646</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn06_30_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_SPVInvestmentFacilityMemberusgaapDebtInstrumentAxis"
      decimals="0"
      unitRef="Unit_USD">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis"
      decimals="INF"
      unitRef="Unit_pure">0.50</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="P04_01_2023To06_30_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ScenarioPreviouslyReportedMembersrtRestatementAxis_ServiceFeeAgreementMemberusgaapRelatedPartyTransactionAxis"
      decimals="4"
      unitRef="Unit_pure">0.005</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"
      decimals="0"
      unitRef="Unit_USD">197629</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P04_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"
      decimals="0"
      unitRef="Unit_USD">205224</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"
      decimals="0"
      unitRef="Unit_USD">411076</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="P01_01_2022To06_30_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"
      decimals="0"
      unitRef="Unit_USD">406129</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <abl:LifeSettlementContractsOriginationExpense
      contextRef="P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">837975</abl:LifeSettlementContractsOriginationExpense>
    <abl:LifeSettlementContractsOriginationExpense
      contextRef="P01_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">1627975</abl:LifeSettlementContractsOriginationExpense>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"
      decimals="0"
      unitRef="Unit_USD">72600</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="PAsOn12_31_2022_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ExpenseReimbursementsMemberusgaapRelatedPartyTransactionAxis_NovaTradingUSLLCAndNovaHoldingUSLPMembersrtCounterpartyNameAxis"
      decimals="0"
      unitRef="Unit_USD">196289</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;LEASES &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The Company&#x2019;s &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets and lease liabilities for its operating lease consisted of the following amounts as of June&#160;30, 2023 and December&#160;31, 2022: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"&gt;&lt;/td&gt;
&lt;td style="width: 14%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 14%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt; December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Operating lease &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;240,816&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;77,011&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liability, current&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;227,561&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;48,127&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Operating lease liability, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,864&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;29,268&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total lease liability&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;244,425&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;77,395&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company recognizes lease expense for its operating leases within general, administrative, and other expenses on the Company&#x2019;s condensed consolidated statements of operations and comprehensive income.&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;The Company&#x2019;s lease expense for the periods presented consisted of the following:&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 60%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease cost&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,471&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,921&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;24,942&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;23,842&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Variable lease cost&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,704&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;612&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,925&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,223&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total lease cost&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,175&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,533&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;33,867&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,065&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table shows supplemental cash flow information related to lease activities for the periods presented: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 74%;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash paid for amounts included in the measurement of the lease liability&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating cash flows from operating leases&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;24,557&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;23,842&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ROU assets obtained in exchange for new lease liabilities&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"&gt;&lt;/td&gt;
&lt;td style="width: 19%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 18%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt; December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-average remaining lease term (in years)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1.00&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1.58&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-average discount rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3.54&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3.36&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Future minimum noncancellable lease payments under the Company&#x2019;s operating leases on an undiscounted basis reconciled to the respective lease liability at June&#160;30, 2023 are as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 88%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Operating&lt;br/&gt; leases&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Remaining of 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;130,176&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;118,057&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2027&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total operating lease payments (undiscounted)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;248,233&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: Imputed interest&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(3,808&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lease liability as of June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;244,425&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:LesseeOperatingLeasesTextBlock>
    <abl:AssetsAndLiabilitiesLesseeTableTextBlock contextRef="P01_01_2023To06_30_2023">&lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;The Company&#x2019;s &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets and lease liabilities for its operating lease consisted of the following amounts as of June&#160;30, 2023 and December&#160;31, 2022: &lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"&gt;&lt;/td&gt;
&lt;td style="width: 14%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 14%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt; December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Assets:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Operating lease &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;240,816&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;77,011&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease liability, current&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;227,561&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;48,127&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;Operating lease liability, &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;16,864&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;29,268&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total lease liability&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;244,425&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;77,395&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 55%;"&gt;&lt;/td&gt;
&lt;td style="width: 19%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 18%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Year Ended&lt;br/&gt; December&#160;31,&#160;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-average remaining lease term (in years)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1.00&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1.58&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-average discount rate&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3.54&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;3.36&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </abl:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">240816</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">77011</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">227561</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">48127</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">16864</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">29268</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">244425</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn12_31_2022"
      decimals="0"
      unitRef="Unit_USD">77395</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="P01_01_2023To06_30_2023">The Company&#x2019;s lease expense for the periods presented consisted of the following:&lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 60%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating lease cost&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,471&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;11,921&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;24,942&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;23,842&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Variable lease cost&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;7,704&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;612&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;8,925&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;1,223&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total lease cost&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;20,175&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;12,533&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;33,867&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;25,065&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The following table shows supplemental cash flow information related to lease activities for the periods presented: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 74%;"&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 5%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six&#160;Months&#160;Ended&lt;br/&gt; June&#160;30,&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Cash paid for amounts included in the measurement of the lease liability&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Operating cash flows from operating leases&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;24,557&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;23,842&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;ROU assets obtained in exchange for new lease liabilities&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">12471</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11921</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">24942</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">23842</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">7704</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">612</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">8925</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">1223</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">20175</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">12533</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">33867</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">25065</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">24557</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">23842</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="PAsOn06_30_2023">P1Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="PAsOn12_31_2022">P1Y6M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="PAsOn06_30_2023"
      decimals="4"
      unitRef="Unit_pure">0.0354</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="PAsOn12_31_2022"
      decimals="4"
      unitRef="Unit_pure">0.0336</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Future minimum noncancellable lease payments under the Company&#x2019;s operating leases on an undiscounted basis reconciled to the respective lease liability at June&#160;30, 2023 are as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 88%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Operating&lt;br/&gt; leases&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Remaining of 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;130,176&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2024&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;118,057&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2027&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Thereafter&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; width: 6%; padding: 0pt 5pt 0pt 0pt;;text-align:right;"&gt;&#x2014;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Total operating lease payments (undiscounted)&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;248,233&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Less: Imputed interest&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;(3,808&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Lease liability as of June&#160;30, 2023&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"&gt;244,425&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size: 1px;"&gt;
&lt;td style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 0px;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  </us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">130176</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">118057</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <abl:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">0</abl:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">248233</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">3808</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="PAsOn06_30_2023"
      decimals="0"
      unitRef="Unit_USD">244425</us-gaap:OperatingLeaseLiability>
    <us-gaap:EarningsPerShareTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;EARNINGS PER SHARE &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic earnings per share represents income available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding during the reported period. Net income per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the Public and Private Placement Warrants to purchase an aggregate of 26,150,000 shares in the calculation of diluted income per ordinary share, since the &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;average market price of the Company&#x2019;s Class&#160;A common shares for the three and six months ended June&#160;30, 2023 was below the warrants&#x2019; $11.50 exercise price. As a result, diluted income per share is the same as basic net income per share for the period presented. &lt;/div&gt;&lt;/div&gt;  &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic and diluted weighted average shares outstanding and earnings per share were as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 11pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 40%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net income attributable to Longevity Market Assets&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;6,750,145&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;4,679,558&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;14,835,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;11,515,698&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-average shares used in computing net income per share, basic and diluted&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,507,728&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,369,350&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,438,921&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,369,350&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic and diluted earnings per share:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.13&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.09&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.29&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.23&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2023To06_30_2023_PrivatePlacementWarrantMemberusgaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"
      decimals="0"
      unitRef="Unit_shares">26150000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_shares">26150000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn06_30_2023_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="P01_01_2023To06_30_2023"> &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic and diluted weighted average shares outstanding and earnings per share were as follows: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 11pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width: 40%;"&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="width: 4%; vertical-align: bottom;"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Three Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Six Months Ended&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2023&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2022&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net income attributable to Longevity Market Assets&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;6,750,145&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;4,679,558&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;14,835,648&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;11,515,698&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Weighted-average shares used in computing net income per share, basic and diluted&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,507,728&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,369,350&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,438,921&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;50,369,350&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-family: Times New Roman; font-size: 11pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"&gt;
&lt;td style="vertical-align: bottom;"&gt; &lt;div style="text-indent: -1em; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Basic and diluted earnings per share:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.13&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.09&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.29&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom;"&gt;$&lt;/td&gt;
&lt;td style="vertical-align: bottom;;text-align:right;"&gt;0.23&lt;/td&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">6750145</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P04_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">4679558</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2023To06_30_2023"
      decimals="0"
      unitRef="Unit_USD">14835648</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2022To06_30_2022"
      decimals="0"
      unitRef="Unit_USD">11515698</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P04_01_2023To06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">50507728</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P04_01_2023To06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">50507728</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P04_01_2022To06_30_2022"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P04_01_2022To06_30_2022"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2023To06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">50438921</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2023To06_30_2023"
      decimals="INF"
      unitRef="Unit_shares">50438921</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="P01_01_2022To06_30_2022"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2022To06_30_2022"
      decimals="INF"
      unitRef="Unit_shares">50369350</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P04_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P04_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P04_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P04_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2023To06_30_2023"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="P01_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2022To06_30_2022"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:SubsequentEventsTextBlock contextRef="P01_01_2023To06_30_2023">
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 4%; vertical-align: top;;text-align:left;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20.&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;SUBSEQUENT EVENTS &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Company evaluated&#160;subsequent events&#160;and transactions from the condensed consolidated balance sheet date through the date at which the condensed consolidated financial statements were issued. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Owl Rock Credit Facility &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;On July&#160;5, 2023 (the &#x201c;Owl Rock Closing Date&#x201d;), the Company entered into that certain Credit Agreement (the &#x201c;Owl Rock Credit Facility&#x201d;), among the Company, as borrower, the several banks and other persons from time to time party thereto (the &#x201c;Owl Rock Lenders&#x201d;), and Owl Rock Capital Corporation, as administrative and collateral agent for the Owl Rock Lenders thereunder. &lt;/div&gt;&lt;/div&gt; &lt;div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;The Owl Rock Credit Facility, among other things: &lt;/div&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;requires the Company and certain subsidiaries of the Company to guarantee the loans provided under the Owl Rock Credit Facility pursuant to separate loan documentation; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides credit extensions for (i)&#160;an initial term loan in an aggregate principal amount of $25.0&#160;million upon the closing of the Owl Rock Credit Facility and (ii)&#160;optional delayed draw term loans (which can be drawn on multiple drawing dates) in an aggregate principal amount of up to $25.0&#160;million available for one hundred eighty (180)&#160;days after the Owl Rock Closing Date (the &#x201c;Delayed Draw Term Loan Availability Period&#x201d;), subject to the requirement that on each delayed draw date, the liquid asset coverage ratio shall not be less than 1.80 to 1.00, together with other specified conditions to drawings, the proceeds of which may be used for working capital and the business requirements of the enterprise, and to fund acquisitions, investments and other transactions permitted by the loan documentation; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides a delayed draw commitment fee rate of 0.50% per annum applicable to undrawn commitments during the Delayed Draw Term Loan Availability Period &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;matures on July&#160;5, 2028, the date that is five years after the closing of the Owl Rock Credit Facility; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;is secured by a first-priority security interest in substantially all of the assets of the Company and the subsidiary guarantors. No pledge of any equity interests in the Company is required by any holder of such equity interests; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides for interest to accrue on the loans drawn under the Owl Rock Credit Facility at the election of the Company, by reference to either (i)&#160;an alternative base rate (such loans, &#x201c;ABR Loans&#x201d;) or (ii)&#160;an adjusted term SOFR rate (such loans, &#x201c;SOFR Loans&#x201d;) plus an applicable margin. The adjusted term SOFR rate is determined by the applicable term SOFR for a relevant interest period plus a credit spread adjustment of 0.10%, 0.15% and 0.25% per annum for interest periods of &lt;span style="-sec-ix-hidden:hidden91072234"&gt;one&lt;/span&gt;, &lt;span style="-sec-ix-hidden:hidden91072235"&gt;three&lt;/span&gt; and six months, &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="vertical-align: top; width: 9%;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: top;"&gt; &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;respectively. The applicable margin for each type of loan is (i) &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;6.25% per annum for any ABR Loans and (ii) &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;7.25% per annum for any SOFR Loans, with interest periods for SOFR Loans of &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;span style="-sec-ix-hidden:hidden91071985"&gt;one&lt;/span&gt;, &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;span style="-sec-ix-hidden:hidden91071984"&gt;three&lt;/span&gt; or &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;six months&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt; (or other periods if agreed by all lenders); &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides a default rate that will accrue at &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.00&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;% per annum over the rate otherwise applicable; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides for amortization payments based on the initial principal amount of the loans outstanding of &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.0% per year (&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;0.25&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;% due per quarter), with adjustments made to the overall amortization amount upon the incurrence of any delayed draw loans; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;contains provisions requiring mandatory prepayment of the initial term loans and delayed draw term loans with &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;100&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;% of the proceeds of (a)&#160;indebtedness not permitted by the Owl Rock Credit Facility and (b)&#160;certain specified asset dispositions and payments (including in respect of settlements) in respect of property, casualty insurance claims or condemnation proceedings, with the proceeds received under this clause (b)&#160;subject to certain specified reinvestment rights and procedures set forth in the Owl Rock Credit Facility. The Owl Rock Credit Facility permits voluntary prepayments of outstanding loans at any time; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides for a prepayment premium equal to (a) &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;4.00% of the principal amount of such loans prepaid on or prior to the first anniversary of the closing of the Owl Rock Credit Facility, (b) &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;3.00% of the principal amount of such loans prepaid after the first anniversary of the closing of the Owl Rock Credit Facility but on or prior to the second anniversary of the closing of the Owl Rock Credit Facility and (c) &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.00&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;% of the principal amount of such loans prepaid after the second anniversary of the closing of the Owl Rock Credit Facility but on or prior to the third anniversary of the closing of the Owl Rock Credit Facility. No prepayment premium will be applicable for any such prepayment made after the third anniversary of the closing of the Owl Rock Credit Facility. The prepayment premium is applicable to voluntary prepayments and certain specified mandatory prepayment during such applicable periods; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides for financial covenants such that (i)&#160;a consolidated net leverage ratio cannot exceed &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2.50 to 1.00 as of the last day of any fiscal quarter and (ii)&#160;a liquid asset coverage ratio cannot be less than &lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;1.80&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;to 1.00; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;contains affirmative covenants related to, among other things, delivery of certain financial reports and compliance certificates, maintenance of existence, compliance with laws, material contracts, payment of taxes, property and insurance matters, inspection of property, books and records, notices, collateral matters and future subsidiaries, in each case, subject to specified limitations and exceptions; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;contains an affirmative representation and corresponding covenant that the Company and certain subsidiaries of the Company do not, and will not during the term of the Owl Rock Facility (or if the term of the Owl Rock Credit Facility continues for longer than a year, during the Company&#x2019;s and certain subsidiaries of the Company&#x2019;s most recent fiscal year), derive more than fifteen percent (&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;15&lt;/div&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;%) of their aggregate gross revenues from securities related activities; &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;contains negative covenants related to, among other things, incurrence of debt, creation of liens, mergers, acquisitions and certain other fundamental changes, conditions concerning the creation of new subsidiaries, conditions concerning opening of new accounts, disposition of assets, dividends and other restricted payments, prepayment of certain indebtedness, transactions with affiliates, investments and limitations on lines of business, in each case, subject to specified limitations and exceptions; and &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="clear: both; max-height: 0px; text-indent: 0px;"&gt;&lt;/div&gt; &lt;div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"&gt;&lt;div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"&gt;
&lt;tr style="page-break-inside: avoid;"&gt;
&lt;td style="width: 5%;"&gt;&#160;&lt;/td&gt;
&lt;td id="fin527481_35a" style="width: 3%; vertical-align: top;;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width: 1%; vertical-align: top;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: top;;text-align:left;"&gt; &lt;div style="text-align: left; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"&gt;&lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"&gt;provides for certain specified events of default upon the occurrence and during the continuation of certain events or conditions (subject to specified exceptions, grace periods or cure rights, as applicable) each as set forth in the Owl Rock Credit Facility, which includes among other things, defaults with respect to nonpayment, breaches of representations and warranties, failure to comply with covenants, cross-default to other material indebtedness, bankruptcy and insolvency matters, ERISA matters, material judgments, collateral and perfection matters, the occurrence of a change of control and subordination matters with respect to certain specified indebtedness. The occurrence and continuance of an event of default that is not cured or waived will enable the agent and/or the lenders, as applicable, to accelerate the loans or take other remedial steps as provided in the Owl Rock Credit Facility and the other loan documents. &lt;/div&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapCreditFacilityAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">25000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <abl:LineOfCreditFacilityRemainingBorrowingCapacityTerm contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">P180D</abl:LineOfCreditFacilityRemainingBorrowingCapacityTerm>
    <abl:DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">1.8</abl:DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.005</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentTerm contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentOneMemberABLVariableRateComponentAxis"
      decimals="INF"
      unitRef="Unit_pure">0.001</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentTwoMemberABLVariableRateComponentAxis"
      decimals="INF"
      unitRef="Unit_pure">0.0015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis"
      decimals="INF"
      unitRef="Unit_pure">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <abl:DebtInstrumentBasisSpreadOnVariableRateTerm contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis">P6M</abl:DebtInstrumentBasisSpreadOnVariableRateTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn07_05_2023_BaseRateMemberusgaapVariableRateAxis_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.0725</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <abl:DebtInstrumentBasisSpreadOnVariableRateTerm contextRef="P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberusgaapVariableRateAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis_VariableRateComponentThreeMemberABLVariableRateComponentAxis">P6M</abl:DebtInstrumentBasisSpreadOnVariableRateTerm>
    <abl:DebtInstrumentDefaultRate
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.02</abl:DebtInstrumentDefaultRate>
    <abl:DebtInstrumentAmortizationPaymentPercentage
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.01</abl:DebtInstrumentAmortizationPaymentPercentage>
    <abl:DebtInstrumentAmortizationPaymentPercentagePerQuarter
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.0025</abl:DebtInstrumentAmortizationPaymentPercentagePerQuarter>
    <abl:DebtInstrumentCovenantMandatoryPrepaymentPercentage
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">1</abl:DebtInstrumentCovenantMandatoryPrepaymentPercentage>
    <abl:DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.04</abl:DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary>
    <abl:DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.03</abl:DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary>
    <abl:DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.02</abl:DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary>
    <abl:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">2.5</abl:DebtInstrumentCovenantLeverageRatioMaximum>
    <abl:DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">1.8</abl:DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum>
    <abl:DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum
      contextRef="PAsOn07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis"
      decimals="INF"
      unitRef="Unit_pure">0.15</abl:DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_91071780"
          xlink:label="Fact_91071780"
          xlink:type="locator"/>
        <link:footnote id="FN_315464" xlink:label="FN_315464" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of Business Combination.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071780"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91071827"
          xlink:label="Fact_91071827"
          xlink:type="locator"/>
        <link:footnote id="FN_315465" xlink:label="FN_315465" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of the successful Business Combination.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071827"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91071834"
          xlink:label="Fact_91071834"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071834"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91071835"
          xlink:label="Fact_91071835"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071835"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91071836"
          xlink:label="Fact_91071836"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071836"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91071837"
          xlink:label="Fact_91071837"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071837"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91071838"
          xlink:label="Fact_91071838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071838"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91071839"
          xlink:label="Fact_91071839"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91071839"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072917"
          xlink:label="Fact_91072917"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072917"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072918"
          xlink:label="Fact_91072918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072918"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072950"
          xlink:label="Fact_91072950"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072950"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072951"
          xlink:label="Fact_91072951"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072951"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072952"
          xlink:label="Fact_91072952"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072952"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072953"
          xlink:label="Fact_91072953"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072953"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072956"
          xlink:label="Fact_91072956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072956"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072957"
          xlink:label="Fact_91072957"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072957"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072958"
          xlink:label="Fact_91072958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072958"
          xlink:to="FN_315464"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072974"
          xlink:label="Fact_91072974"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072974"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072975"
          xlink:label="Fact_91072975"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072975"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072976"
          xlink:label="Fact_91072976"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072976"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072977"
          xlink:label="Fact_91072977"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072977"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072978"
          xlink:label="Fact_91072978"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072978"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072979"
          xlink:label="Fact_91072979"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072979"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072980"
          xlink:label="Fact_91072980"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072980"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072981"
          xlink:label="Fact_91072981"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072981"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072982"
          xlink:label="Fact_91072982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072982"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072983"
          xlink:label="Fact_91072983"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072983"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072984"
          xlink:label="Fact_91072984"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072984"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072985"
          xlink:label="Fact_91072985"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072985"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072986"
          xlink:label="Fact_91072986"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072986"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072987"
          xlink:label="Fact_91072987"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072987"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072988"
          xlink:label="Fact_91072988"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072988"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072989"
          xlink:label="Fact_91072989"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072989"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072990"
          xlink:label="Fact_91072990"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072990"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072991"
          xlink:label="Fact_91072991"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072991"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072992"
          xlink:label="Fact_91072992"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072992"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072993"
          xlink:label="Fact_91072993"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072993"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072994"
          xlink:label="Fact_91072994"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072994"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072995"
          xlink:label="Fact_91072995"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072995"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072996"
          xlink:label="Fact_91072996"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072996"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072997"
          xlink:label="Fact_91072997"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072997"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072998"
          xlink:label="Fact_91072998"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072998"
          xlink:to="FN_315465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_91072999"
          xlink:label="Fact_91072999"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_91072999"
          xlink:to="FN_315465"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>108
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MM9AM;ZLV%,>_BL6DO6H+F#S=+HF4INF6KK>-FNY.VK07+C@)*MB9;9KFV^\
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M.5].:"/*R#&K2:#_V\%I&P9NC/$:8^S%^$M9CEZS/'>ABNU)(0&*(QN6;=D
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M,%8]*>8Z0-U?,":?)KKKJ;K<X"]02P,$%     @ G(I>5V-*G%!X"P  1#H
M !@   !X;"]W;W)K<VAE971S+W-H965T-"YX;6RM6VUOHSH:_2M6=[7J2+<3
M_(*!;J=2VY"9KCIIE:1W5[JZ'VCB-&@(9(&T<_?7KTUH"/:#FYGA2QO@^,!S
M_'8>8RY>L_Q;L1*B1-_725I\.EF5Y>9\,"CF*[&.BH_91J3RRC++UU$I#_/G
M0;')1;2H"JV3 7$</EA'<7IR>5&=>\@O+[)MF<2I>,A1L5VOH_RO:Y%DKY].
M\,G;B4G\O"K5B<'EQ29Z%E-1/FX><GDTV+,LXK5(BSA+42Z6GTZN\/F(^:I
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M >OJZ!U]>!0J!% $ZZ/+Z#U4.]#&*>-CK'*V$:KW2ZMH[?V R74H\SQC) 2
MRC4'>J() !F1.*(GF@"0RE3!IZ1#@,8V8ZO1N[S?A[[+S,'  R +D,-/P/3
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M+-!5 9"$X "S#HM%&L-)[(;SX<=$ #PAQC)E,LP'B)3)/M5M)@1TB8\=?4D
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M775&#S^9=73,\ ,$!XX_@)UP34J=[GP(,.QJ-(")5J2AC=)+V2^4:2BF$KE
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M8*&UR=>HS4RO-D\C'T@X:*FM[5J,F=U!"E62KM',#IFZ1.I'1VU'N$974?'
M>AB6L$S;[ X_J$(R%EJ; 8W<S/2"\&$WIW?DXC9<[W)R(XLBEENISDN_D[=O
MYV#/ PM=+9-;E'/6[7I401@5;36^&AZJ8Q\5+<!":].H48297K^=EL=D??GR
ME''JVE:7.*BJ+BK:"A7-0T7SH08N\\2\NT@',C0M<:!,MPG1",E,KZ+J\YAU
MX=;H+;APN.B=-5!7!:.BK5#1/-87L*EJ$=4;W4PFJM\ \'M:BH<&'^! H^2R
M2>M^-:E,#I*DKT%:S+6HU5V-MAAMN1QMN=+7;7+G8J+YJ&@!%EK[[ME&$>;Z
MI;[Z9"+(C!JQ-7Q8AG =EW;'#[WSR3?#]AV7].G>#=M?"4P=QQ+EO^X=L7W3
M4^9RAW&K,_OP 5/'5H=I5[H'[+AIVHX+'\Z\44;YU-6TFD7?4+]='G$P=-<S
MIF"X0$5;<F#5+[PX =6OAXKFHZ(%6&AMFC:2+)_Z((A1U/R1QRO,>5^[5"=L
MBU&G*]'I\2?3CHW)'P+1P;?E [7@ILT<UEV@ %BZEBT.UAW4%.C;"4H/A<MV
MYQX\:X'_PO0AQQ02%ZAH2U2T%2J:AXKFHZ(%6&AM@C9R+M?+N4?3A[RO@@ZE
M#_6N)A,*=14O*IHWOE%\5,<!%EJ;+8W^RH\\V&%2^I #&N5 ^E#O=S)U4-?_
MHJ)YXQO%1W4<8*&UJ=,(MUPOW(Y('_*^M FF#_6>)I,%59X%Z@"G#P'#@?0A
M:H !%EJ;!HWPRO7"*V[Z4.]L\H0(5;WET%I@,'V(ZM=#1?-1T0(LM#;Y&I&7
MZT7>GT\?<D!\A-.'^E FDPD0H/OI0R"Z@?0A6 \X?8A:D0 +K<V 1N+E>HGW
MQ].''%B*.I ^U,<PN>LQT5;CJ^&A.O91T0(LM/9C]QH-6.@UX&GI0P&(II2Z
M5E?86.B]3B4.*MH*%<U#1?.A!G8-VDU$!9 =<TTZ]!C&1FH6>B58GST4_6<>
M6#;CINC>!:GW,KG_4=??HJ)YHJ]#6[:INJQ[]D%U&P!N3]7DW!U('XM&Q!5Z
MO?4G4X>BKS\.I Y'6RY'6Z[T=9O<M:C/64!%"[#0VBQIU&"A7T+[ ZE#T7]T
M[%#J4.]\\NC1=PRD#J'P!E*'@.E0ZA P!5.'@)TN=2A*5;2]IU&^A%[Y^DS_
MN$S598,Z\9-DM[U5IW\U?WP^QDFZ*_(B?.Y<]5$:11EY##/R-8QWDCR$:GYP
M*V7Y,H8B2_-'6;U0(?ZFOJ_+ZY"[-"-A')/'+%);CU)];')2=5-2/M6\2,O7
M.)2O8Z@":)!5#.6.PP#RZO'O]0_U!/=M=%=-4%Z2,">APLIW<?'=)M^MU150
M?K>+R>4N5_7.\W)J<QLE83E/?@E1?W;PL/YM>555OAPB)^MTEQ1E(Q[LW;^
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MH#07E,9 :1XHS8>BM2M18\I1O2FW7P%;3>%?WEL$JZ><75= ;3E0&J,J6VY
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M/0  &    'AL+W=O<FMS:&5E=',O<VAE970X+GAM;-5;:V\;.;+]*X0W660
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M%X_80GK74N<:1$^,*8E:G&K82FAWEY/.6T&XAFR,- S3:PK62-KNRF2-DU!
M;YS?0 GEC(]96.^C 1*7]YWS>?=J5_U\>GI)@4DWN24VSA)W9UWNWB3NKEKN
M/IHI!89*!%96-4F5*13S+,DBM^J"]=T@'A36;W<2BS !)]&PSJXIA_PFZH%S
M:%MX.1P6SJ1XD3;^5"(>1".*<DN*4BJW'H9 ;$X(R8F\^L&G))A4*)W_!MPB
M9 ?N+(*_LXM@?B"B%17)'FN_:&<IXL%G\"K")D!#+1J+MG!=,2<VOF#HA5OU
MA%@?#Y]]^7#.?XV>_8"8),()KUBB\\O%>3\*3BLP1'&I5(A=>'/*UKJ:([M
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MG#".FD0:T4E^$$^>9:8$3@#EGDG'M/%LA[ OH(Z2?P,?BZ:T3#@/,"]J'%G
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MXU$LP\^50&^P] +V%\;X^H$$--_>+O\'4$L#!!0    ( )R*7E<\$NV%*@<
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M565G# 2EK-I?_K7C8<]@ZC]C$'8&H</=+N10?N"6GY]JM6::9L,;7;BM.FN
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M-!P2#XX!8QI>90YKH:KE,1Z7Z-=S.V+W0K!;!5;!-?OQAVD8^N]N:,X#S?E
M<]QH\([=4-:*KS4.$?"VH7,('2B,6Z/6:L[GA6!5XTC$4AO!M<$L.@\13EFY
MF2[Y\1B\%MPXZFNA#6TZ%X0,@IPS8[F5QLJ,%\7&8WRQP%(8GV]P:$)]( FL
M@GM.6:A%#I*0Q:N-(0NB%2,@T@,>D-I>4H6H+&MJ3O<C=FU)#2@>O&(@7Y:4
M7B -MQ(.,C>/ !+N+DHM 4""R8VFV.2=U?<F\$@;QUUOE7$#\#C_&;;0BJ+
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MJG27*X%M:IJ YPN%XTMW0POT'W'._P-02P,$%     @ G(I>5^ PH+DO P
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M4&\X&3D@6SEN%UK45@(W0I.@6C.C/QA*XT#?MT+HT\(0=/_$Y;]02P,$%
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MZ9 $A(>"X,P1-:#S8JXD-5X&\Q6,YX*:=0]FA72!@2Y&9J"JK*FL%![# ,F
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M:+T#WR\-5W%K^ "[>3_\"U!+ P04    " "<BEY790.B$G@%  !_#   &0
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MX0$+%+CD5 IZ)K/GZ3_M"<XH.ASDI62Y2H'1L?E3*F[>8"T-%RO@PB Q-Q9
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MTUD$MIXH]89,&;IX8XAG0ECF/(31>@.^WQI#SQOOH!GKHW]02P,$%     @
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MASI>V]3J")- +";#<3 93T4_",=1$(TB<8Y]UJ6XN%OQJ9JV_&V.7\@U]=[
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MO\SG_'XE@)FQ6OG.]=.[9T[Z'FUR#R,RJ=CI"@I0]ERU\NFU@8C/%'O6N-6
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M-N[!'U+*D>EZ*V,B,W81_Z,ZZ4\BN3RQ*E$(@%;P;C2^=OV*Z+3UXZX%_>2
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M%MSU'0<HXHYM?-O@M@O41H+O6V0&FFA]Q!SE@F![:7CJ62=H[#(0FE<35&I
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MT!%"@8EU"(S^5GB)0C@@HO&UQ0PZDTZQ_[Q%?^]])U\6S."E$K_SU.9GP2R
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M)T#[F5)V^^(,=)]1\[\!4$L#!!0    ( )R*7E?RB"J3CP4  '$-   9
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;*57;6_;-A#^*X2;%2V@VI+\FC8Q
MX*0MVB[IC"3M, S[0$MGBRA%JB05-_OUNR-E6VX=H\4^)!:I>WF>N^,==;;6
MYHLM !S[5DIESSN%<]7+7L]F!93<=G4%"M\LM2FYPZ59]6QE@.=>J92]-(Y'
MO9(+U9F>^;VYF9[IVDFA8&Z8K<N2FX<+D'I]WDDZFXT;L2H<;?2F9Q5?P2VX
M3]7<X*JWM9*+$I056C$#R_/.+'EY,2!Y+_!9P-JVGADQ66C]A1;O\_-.3(!
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M0C&1$;G-:H( F^NL%3@1]R*+E-1]B.7,LZGV]#[$![)T((3#DD4D!U7P*Q=
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M+$5E8[/"MAB8P*E,(=B[3AQA#$IH7%BO7D_V4$6GNMY#..H7DXY$/.<J338
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MY[L7;F8Z4E27=0HW Z0QRDAM;A3'?=9)1#+2T<LS_U25VO6%19!1GT$G!S'
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M-@1;\.52H2-WM #OY]:&YH88M/_;<?E_4$L#!!0    ( )R*7E=<!&]\L10
M (U#   9    >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;-4\:6_;2)9_I>!)
M!@F@R))\IG, CN/TJ.'8AIVD=['8#R6R)%6'9*FK2,ON7[_OJ"J2,D4[W=/
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M?<_< !O0&Q0"/ :LG).-6"_!IX-LZ1*XZ&VE6;.PI> 9D]+[8C!C#"!9]=P
M2 V1 9.DX1Z_&BZ/<@7^LS Y. _@(65$J-4H!!TWFQGX(2827"]G8"%G LPO
MP<UR;,E1P:\ FM)DI HUURCIUN3A]DB2@'WTJQH3*;\I";%K@UP<%PR:4<S
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M/RM)VP[TM8UV_V8E[RD*!0ZI4"M&V@#@1+UGAZ/!:#1JRV;=5:D3'RZ+<Y.
ME&06FC-)W9Q!3PU4(-JVNDV<SU'T/SIHVIH(KG?]"%>\QS6N&6"E 2&>5Y9
MVFR+P$\!J7!H'0L%6H*Q<)RCL4FUP&K'#L:7?>IJ\;1(P8##IFLNPQOX>%*5
M2RY@! GX-+VX/JF%]X1XAXZ5 B8!6?5"(P,P[RWBMUKZN$<72VV( J&S-A7X
MUERID*91.J__8#K[T$?R6JH64P(O,P.:36>VE1C-C8]FTS;A03(@Q 2?DW%*
MD0)-@2:^S9* S0;)^KK"2WW?QK,*EA1.)ES=V"[FE'Q1]*OA-O 3S\,!M2&)
MMAM_ A*P:29VAL;K-E_W U9UNR;^;6;UPMSZJ"TF']A?:,0I@^VH;306!CX
M(#L3@X2Z,,(Q.V5$!D0LYXO)P'%L0JX2]@=VK^K9 09KREE.@.[G*X(0LA0
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MF"N5SK#"[(<<TD@8 ,OYL1C.96(ER#WL?S69:546_(%L7%Z+(G74HY#H=CA
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MZ'*N'P&1(!LI"E\.!U(N-O41\:LAY9;OK?*S2PNN^2BT?@#!$"(#_WMX5,\
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M\S!U\X;Z1^??N^F8$RJ?#-C1@0?L< .P3FBVC:NTYSXP$<G05+NR!:['E:6
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M$& N69\02V>])VMG%TV2S@1DH@!I63 J*^0+>AGF&<F! N0B8WQPIZ"#1L]
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M$ U(PN:T3/6=>/Z=U?H$R"\6J3+_R7-]UAF0N%1:9#4Q2)#QO/JE+[4=?H3
MJPD\(W=UD9'RDFIZ=B+%,Y%X&KCAP*AJJ$$XGJ-3[K6$70YT^NS3]/J.?)U^
M?KPB-U?3^\>[JYNK+P_W9/^!SE*F#DZ&&F[!L\.XYGA><?2V< S)C<CU4I&K
M/&'))OT0I&M%]!H1S[V=#/\H\R/B.S;Q',_?P<]O5?8-/W^;RI1+\I6F)2.7
M7,6I4*5DBOQ[.E-: DK^TZ=SQ7+4SQ(CYU@5-&:G P@-Q>2*#<X^O'-#Y^,.
M@4>MP*-=W+L"WS"*TD)4:&63.Q:74O)\06B>D"\BE\U"GPJ[+WE8,D*58EH9
M9BFG,YYRS<$R675I0J@F3&D.L0"3.4JU,E)A=)'V;HP27G'12P:'8B'!*(7(
M$]PM4K 3*D!XC@>ZC):<22KCY2NADA%CRASOJD]J@TDRPU1R9'7,\GM#9TT5
M$7,"D&$M9,AGMF(I<>M?K_[UR8/0- 4*5/K8^LSGC,!0IY5TA4AYC.J_)Q_>
M19[K?=P8!:$=1H$=NN.-B35=49ZBG(>0,0\535E+U/RZMN,X^+<>67^"?A+T
M7(&!C7=[J,*6JAY9]Q]H5GR\)0&LB@+3G(+=\61DAR.GAT.]4]]6NWML>Z/P
MF\-FU3(F:@XN66HPT''8>V :.? 7A9O6F=A>:YT0U(S&=N#X8.065F!QD2\.
M-9,9I-&9WF+G,+3=,+#]2;@QL6XE7P$..W!ZIE+2/LMY]LB/T&;K4:U8%^7?
M:G>\321DX=N32J1VL@N0EPR$G('-?=> TOLUH'1]\,;$]@-O8_(K0>FW5/X.
M4$83QXZ\R3?T]?H/X*SAL*$NP&&M[MC([4;N3Z#,BP#N$SL,_(W)_P63+3QW
M%(2@+0C!3Q0$<IT799V^<9.:MN>!Q<N<_U4RU5<3=M]S/3=I-X$J*4JX0&+
M\3R&[D]!5A823-I,9J\ XH+)&"2!;@Z0RG/=5@$BFHQ39C4D2J32HJTH77>#
M0M!/LHI4T8S99A0O:;Y "?K+$/TV]]O0%);@L)G9G8L4*@=@HJ]*W*$,T^2_
M985UTC'R17OO>M'ZS=O#1 >A;W);!)-]SPXG$6*2'%A?1"-OISH< A'DQB@8
MV]%X0GS;'7NV%WH$RV\E'M9(4^B:^J>,[D_L=<-\=4FD.4U?H=P>-PG1NGHI
MH./%HID5*8??E4@!"@#?5W 7]I \X\JZX^KI<"X9J@71 0:MW#LZ NGWK <,
M&/3.2\%EA:3@R"&OC$H%5X"?N4()>6R*@'L4.-:%R#(X=Z]%_$1NFRWG"/+^
M)5_QA $6_L4Q?IH@V=L1#&$;#.%.D-[#.R4IL2\ EUZ(' %82PP+J*:-X,0!
MN"_60O8%PLX[^ON[?I<)5!3=4SV8S,MC!J\AXZT4TSG/(6(IR$DX^)-A?]01
M&KV-?=9+S,!WKK.'6FB3AN8@0--QR;=;ZV:L"EIP1D'S5V/I\4?U]NJVD/0$
MS;%U :44*ABY7<<S'/J$]U<1\79C'2HU)4036,6:9@QP0'/R#Y9#14R)*6C7
MK1BUE,0%V)$]Q!'^3*T[!CGW7E.YC2"LSGOU^<^0E42:DR_&AM^_IZ8C._ W
M;O$W_L%D;).J;#=).<'&>-VCGV-;;)/'7,P0008O)F7C&8  A*B1O@^>.T7H
MA^>6E%+C$_IUV()]"6U3TH!F$T;;( -$56+F+R0S;[U#AF^]MRCZU$G-NJ<%
MVFA1;AON10E]DRDI060'(]\.(@?P0%/^/UA;0%T@^_!F4P=H78@P-/10"<@J
MK8#0CT(:G@01)$66\3(#KI0G9!]RKCV";'M@/<);J<-RS='4]Y:3;_ON!"2(
MK(O=M6=D^_X$VMR1==,KTKX'[0L4@2ATX?9-L6JIWMAKLSIUWQ@[0!NUH(U^
M&+2=;ND7('>G'+\*N;ABDFM"<J%[(4M^$K*=YO 2^\GZ&BB5>LE!GH)*8TD_
ML#V =N0%7:PAS-"VZTZF(_B^;&KR ;Q4?(!P"*AX@]3MU-"))5P?4M/"L.0
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MJ.9):!0CR_H:GDN#EWHMKO 5Y<HZX/^%Q'(VBDVP>Y='_P%02P,$%     @
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M5ZTT@BNX2<J#EOBU0#D]N;F^>+A^@(-'.BV9.CP;:51J/HWR5L&E4T#>49#
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M$-_/DB1_?5,([)XF=_$_4$L#!!0    ( )R*7E<H+!T D 4  .TP   9
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M[,[[LE-]N,WF,MRL"E?&LI5/SU;*:YW@*3..3+WXF?SY69Y#QH(%\5]5T^T
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M+Q>!RT7@7"]Y:Q%KJ8_(PDD9YGC_=:6/H;'BL?R[SM6M2EJO,KL9SN2*3?G
MT=DNN7CFSO#C![_C?0$<)J7#!-(^-.&5=:YMA8-<.+NMGH<$GWK97]]]KC%+
M2[,4-'LOV(RC&Q;S.JN@;,N !*5GP?$1#"PXW"D=[AR"X%:X4T$0PJ];&NV"
M1B>**1V01*X%2Z8<785371_K/0 UM0Q.K_2S=WPT>Q8</BT=/CT$S=,]-'$7
M@-/W3/'U0+L7>8'G MWQB&51DLMP)77]'2UXHFI]@36VC)-?H0O_^- 6.H_L
MLV$''ZSE3>@6TE5X?=R!\#5EWH?K_)OX?@T3?0>'+-H]4^L>:*)M\ QE^-0"
MX#:XQ#=DXH.EOQ'P8!]PWX, -ZS@-]("%PF+HA=TR9_U,^]*/S&Q9(8>I-ZX
MY]-EDD;IXN7CAQ[V\9?1[:C60=!(V_ 9EO&[%B"W03B^81P?Y(=&R'O[D(.W
MN&$.OY$ZWH/X-1-/NM>ZC70H:AT%K;4,(S:$A#T+3](V* D;2L(@?31!7TCO
M0 \@CRM-!TPK-VGR^2*-5UP_DXT6@O/X+<Z&%;4-D&$A3"R :H-VL*$=#+<J
M3:#2/5 I5,&QX0X,<\?5]2B_?4>/3+??M;9M]!W84 SN6$#3!J-@PR@8;ER:
MT.SNH0DWO-CP H9Y81=.] ^">V!86]LX&3+!IQ:PM4$9Q% &@7N8IEF&]ZY6
MF)BR3^"ROX?L>[IC6'?;F!GJ(!8&5L3*Q*HRLCIL9D7>UR030P4$IH(]H%MT
MS;")MK$SI$(LC+>(#9XAAF?(01.N0KHZI(2[9F+8@L!LH9^<Y^M(W[_SVAK=
M(!V@%\Z$A&)@V(.\DSV.T=##-MOB:CB&6. 88H-CJ.$8>A#'%-([N0@V]-2P
M#(59IB$7&Z1[C;E(#6=0N-W8R\7CS!I@JVV1-:Q"+?0FU$9O0BMO40[J30KI
MG6R$"B,U-$+AWJ0I&6%IW)R,AAPH3 Z')F/3& 0VWQ9APT#4P@2,VIB 4<-5
M]* )6"&]DY504AH^H?  K"DI86G2F)2!88D 9HF]I/S_$QI8<]N7GX9E @MO
M50(;/4Q@^"@XZ*U*(5W--W!"$QC*".!&I"'A&J2!*NA6/J/(/DG116H1)A)%
M?*Y5>2==O1BQ_<ICNZ/25?YEQ6.J]%-AOKGD;,9%=H$^/T]3];J3?:Q1?FLS
M_!=02P,$%     @ G(I>5_IDFA;X @  ZP@  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#0N>&ULK59;;]HP&/TK5C9-K;0U-R=<!I&X56,J+2KK]C#MP4T,
M6$UL:CO0_?O93LBXI AM?4GL+^><[^++E\Z&\2>QQ%B"ERREHFLMI5RU;5O$
M2YPA<<56F*HO<\8S)-64+VRQXA@EAI2EMN<XH9TA0JVH8VQ3'G58+E-"\90#
MD6<9XK_[.&6;KN5:6\,]62RE-MA19X46>(;EPVK*U<RN5!*282H(HX#C>=?J
MN>U1H/$&\)W@C=@9 YW)(V-/>C).NI:C \(ICJ560.JUQ@.<IEI(A?%<:EJ5
M2TW<'6_5KTWN*I=')/" I3]((I==JVF!!,]1GLI[MOF"RWQ,@#%+A7F"38EU
M+!#G0K*L)*L(,D*+-WHIZ[!#4#KU!*\D>(<$^ K!+PG^N1Y@28#G>@A*@DG=
M+G(WA1LBB:(.9QO -5JIZ8&IOF&K>A&J]\E,<O65*)Z,^@^S\>UH-@.#NTE_
M?-O[-KZ[!9_ E#-@%@)<$XIH3% *QK38EGI]+X98(I**2X6]F?0 H@GH/2(5
ML#(\S(;@XOUEQY8J0.W&CLM@^D4PWBO!^&#"J%P*,*()3FKXP]/\\ 3?5H6I
MJN-MJ]/W3@I^S>D5\)V/P',\OR:>P?ETKRZ=__,^^F?O>\7PJZWB&SW_M:V2
M"V41 O3BYYP(8C;"SQME V.),_&K;L$+25@OJ2_!MEBA&'<M=<L)S-?8BCZ\
M<T/G<UVUWU)L^)9BHS<2VUL76*T+/*4>J;-J#J:ZMM>8YKAN&0J%P"CHUK&.
MW*87^C (.O9ZM\0U0.BTG*;;V <.CX$^;(2M,'#V@:,:H.NUG%;H5\"]M(,J
M[>"\M*GJIH3&+*O-/#AR'T+?<^!!/H-C' R:+=\]*-#P&.?Z?L.'$![D70-T
M&\TF;(8'>=L[MW>&^<*T30%BEE-9G,[*6G7FGFE(!_:^VQZX-?:AZN1%X_TK
M7_P&3!!?$"I BN?*E7/54.'RHK46$\E6IG<\,JDZD1DNU=\(YAJ@OL\9D]N)
M=E#]WT1_ %!+ P04    " "<BEY7H44JQ$0#   S"@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970T-2YX;6RUEFUOVS80Q[_*01N&%DBC9UG*; &)XV >4C>(
MD^W%, RT=+:(4J)+4G8'[,.7E!7!M90LZS:_L$CI[G_WNR,ECO=<?)0%HH+/
M):ODQ"J4VE[8MLP*+(D\YUNL]),U%R51>BHVMMP*)'GC5#+;<YS(+@FMK'3<
MW+L3Z9C7BM$*[P3(NBR)^/,*&=]/+-=ZNG%/-X4R-^QTO"4;7*)ZW-X)/;,[
ME9R66$G**Q"XGEB7[L4T,?:-P2\4]_)H#(9DQ?E',YGG$\LQ"2'#3!D%HB\[
MG")C1DBG\:G5M+J0QO%X_*1^T[!KEA61..7L5YJK8F+%%N2X)C53]WS_$[8\
MH='+.)/-/^Q;6\>"K):*EZVSSJ"DU>%*/K=U.'((W&<<O-;!>ZV#WSKX#>@A
MLP;KFBB2C@7?@S#66LT,FMHTWIJ&5J:+2R7T4ZK]5'H[OYG!?+%\O+]<3&>P
MG#T\W,[>SQ8/</?A=CZ=SY;P#A9$"&+*#6^N41'*Y-NQK71THV%G;:2K0R3O
MF4@_U]4Y^,X9>([GP^/R&MY\_Q9H)6M!J@S_R'BEA.[J@/+T9>5KS+2RVRA[
MKU:V=:6Z<GE=N;PFE/],J'FU0ZGT*E;R#"X9@P^J0 %'M^&WRY5LPOT^5*.#
M?# L;[;LA=R2#">6WI,2Q0ZM](?OW,CY<:@L_Y'85Y7PNTKX+ZFGB[I<:7*^
M!D;7"!*58F@J %O.:$91PE^OZ^[5(5#4!#)OG5WJ1J.QO3M&[=N$?F?R%4#0
M 03_%H!D&:\KA3GHUR745:[MUX0*V!%6(Y2H"IZ_&C/H8WK>"6;?Q@^',<,.
M,_P_,&FWHO\I9MA#",(3RKZ)&P]31AUE]"+EC5[F;5<T:4=6(,N!J*.F#65\
MD Z/TTE"SPG#^#3QOF7@.(GGAL%P^J,N_=&+Z=\^TYJSOT]^U-\8412'D7NZ
M@_J&KA\[B1]ZP[G'7>[QMY3^9%%)6FWZBVH(*.YO =.->'0*U#<,/-]W]&\8
M*.F DF]O1L;EX*I/>BLCB>,D<IV3I/MV\<B-7-<]R=D^^J2;X]1[(C9Z_P'#
MM?9TSD=:0AR.*(>)XMOF*[_B2I\9FF&A3W4HC(%^ON9</4W,P:$[)Z9? %!+
M P04    " "<BEY7+4J^\2\$   ,%@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970T-BYX;6RUF.UOFS@<@/\5BYVF3;H4;&->NB32FJ:ZG+I>U+2[CR=*G 8-
M<&:<9B?='W_F)9!BXD:H^9( \>_EP<$/,-PQ_B-;4RK KR1.LY&Q%F)S:9I9
MN*9)D%VP#4WE+RO&DT#(7?YL9AM.@V41E,0FLBS'3((H-<;#XMB<CX=L*^(H
MI7,.LFV2!/S?*QJSW<B QO[ ??2\%OD!<SS<!,]T0<7C9L[EGEEG648)3;.(
MI8#3U<CX"B\GB.0!Q8CO$=UE!]L@1WEB[$>^,UN.#"OOB,8T%'F*0'Z]T F-
MXSR3[.-GE=2H:^:!A]O[[#<%O(1Y"C(Z8?'?T5*L1X9G@"5=!=M8W+/='[0"
M*AH,69P5GV!7CB5R<+C-!$NJ8-E!$J7E=_"K.A$' 38\$H"J '1J *X"< %:
M=E9@70<B& \YVP&>CY;9\HWBW!31DB9*\VE<""Y_C62<&-_.;J9@=K=XO/]Z
M-YF"Q?3AX7;Z;7KW .9_W<XFL^D"#,!-$''P/8BW%'RZIB*(XNSST!2R?)[$
M#*M25V4I=*34G]OT F#K=X LA,'CXAI\^NTSB-)LRX,TI/^$+!5<3FM'YHD^
M\S4-96989$8G9S;EJ:K/%ZK/%RI*X2.EYBR.PHAF7?AEI-T=F5^/E]DF".G(
MD!=<1OD+-<8?/T#'^M)%_$[)7D'B&A+KLH^M 03_G38S5V4FI\B4KQDO8VMH
MOAR2:&OU)+%K$EM+ @?H9!);(8%M%&VQGBBD1B%:%#3 )Z,0%06V4+3%>J(X
M-8JC1<$#^V04Y^U9T1;KB>+6**X6Q1Z0DU%<%06W4+3%>J)X-8JG17E84WDC
ML!*4GTSD*42NUR+2UNQ)Y-=$OI9HOUB?S..K,X10"T@=@TD]Y%6;T&HD;&FM
M<B//0"G83JU:[RF6]\KV&O7@?@.^Y99.QC**:#RB3]RW\4;\4*O<7"6=C:..
M_PR&MF4I_9]#Z;!Q.M1+7?JCLW]5X-#Q/,=5KF1]_K[]-R:'>I5+:73VKVH;
M8T=.@..V^S^'O6&C;ZCWMS1%9_\=KO9<0J#?=H,^?]_^&V=#O;0;/71B='@:
M8@=ZT%;FX1R^AHVPH=[8;ZRU'9+V";((\4B;PU66+'G5^P@2^X@/&A-#[PT?
M[!^X.GM\)Z=6&.<P-&P4#?6./N8#5;/*>JI-W+-QU#@;:45YS =5U&'CCD>(
MZ_BM]O7I^[;?>!CI/7Q$!U74Z_MM@BW?5OH_AX[1P7.X7L='=(!4'?O0M9%B
M8WWZONTW-D9Z&Q^Q 5)M[!+'MM5_SSEDC!H9([V,]3) JI,1(HZ%L#(+YW R
M:IR,]$[6K[-5\.$"3QQY,3NPK;2.D1![EH\):JG /'A5E[\G_1;P9_EL F*Z
MDJ'6A2MS\/+58[DCV*9X>_?$A&!)L;FFP9+R?(#\?<68V._D+P3K%\#C_P%0
M2P,$%     @ G(I>5Y1[*>$R!   ,18  !D   !X;"]W;W)K<VAE971S+W-H
M965T-#<N>&ULM9AM;]I(%(7_RLB[JEJIQ)[Q*RD@-82H5$D6A:3[<34Q UBU
M/>QX@%;:'[]CX]A@FPNR0CX$O\P]]YPQGL>XM^7B9[)D3*)?41@G?6TIY>I:
MUQ-_R2*:7/$5B]69.1<1E6I7+/1D)1B=9451J!/#</2(!K$VZ&7')F+0XVL9
M!C&;")2LHXB*WS<LY-N^AK6W T_!8BG3 _J@MZ(+-F7R9341:D\O5&9!Q.(D
MX#$2;-[7ON+K(;'3@FS$CX!MD[UME$9YY?QGNC.>]34C=<1"YLM4@JJ/#1NR
M,$R5E(]_<U&MZ)D6[F^_J=]EX5685YJP(0__#F9RV=<\#<W8G*Y#^<2WWU@>
M*#/H\S#)_J/M;JQC:\A?)Y)'>;%R$ 7Q[I/^RB=BK\#"1PI(7D#.+3#S C,+
MNG.6Q;JED@YZ@F^12$<KM70CFYNL6J4)XO0R3J509P-5)P?WX[L1&C].7YZ^
M/@Y':#IZ?KX?/8P>G]'DK_OQ<#R:H@X:QQN62'7Q)'I@<LEGZ.,MDS0(DT\]
M72H7J9;NYQUO=AW)D8[?U_$5,HW/B!C$1"_36_3QST\HB).UH+'/_O%Y+(6Z
MN@W*0UCYEOE*&6?*Y&QE7<U8,6VDF#:2M3*/M'I<1Z],(#Y']\&<J0G*>Z )
M#P,_8$G3O.PDK6;)]'Z]3E;49WU-W9 )$QNF#3[\@1WC2]-4O)/807JS2&]"
MZ@.C@]%_YUVRFYV2DRFE:\IF8/3TS7X2L%?+)%:1Q *3X XY.XEU,@G8JV42
MNTAB@TE(QSP[B5U+0BI)P%XMDSA%$@=,8G:LLY,XM216)0G8JV42MTCB@DFL
MCGUV$O=D$K!7RR1>D<0#DSPOF7I(F$NUYIT;R*L%,NU*(K!GRT3=(E$73'1R
M!3\[:+=^Y:I!ZT.P5PPYL(^-$MP&B* [-3/H!PW7K)'!QGO"YKW4#J/N/:/@
M4[QIS+BKLH$5&19N:[Q\2L @AE.\-!HG)U$""[<U7@(>PX17-&DT7J>Y91GI
M7]7^):".2ZIC&.L*(8WVZPBW<*/]2Y <ERC',,L5-QKMU[F-38<TV+\$OG')
M;PP#O(1%8XHZLTG7L3W/=:LQ+L%N7,(;P_0^L<#6@6UV;6(TQ'!KRY1%3//@
M:W=HL:0R]D &#*D0OX-X =A\)\;F42Y!;%PB&\/,/L:!.EYK=P0HW-(X*5E-
M0$ >XT!>!1F'A=L:+\E+8/(>X4!>=7 /8Q,[;K=J_Q+\)7N_TF'^'N$ J?,7
M$P_;I/K(#<NWM5]2F, 4/L(!4J>PC3W7=*KN+P%A4D*8P!"&,4#J++:[MNNX
MN)KB$BPF)8L)S.+32VPNL+^^=SVOZ^#:O5P?Z+G8P1A7.*#OO<]+7Z8^4+%0
MOT50R.:JTKARE838O9_<[4B^RE[QO7(I>91M+AF=,9$.4.?GG,NWG?2M8?&6
M>/ _4$L#!!0    ( )R*7E=!F%Q#CP(  &X&   9    >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;(65:V_:,!2&_XJ535,G=4WB7$B[$(G25&/J!16Z?9CV
MP<"!6'7BU#;0_?O9#HU02>F7Q+?W?<YQ[)-TR\63+  4>BE9)?M.H51]X;IR
M7D!)Y!FOH=(S2RY*HG17K%Q9"R +*RJ9BSTO=DM"*R=+[=A89"E?*T8K& LD
MUV5)Q+]+8'S;=WSG=>"!K@IE!MPLK<D*)J >Z['0/;=U6= 2*DEYA00L^\[
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M.^MI"]%4MZ:C>&TKRHPK79]LL] _!!!F@9Y?<JY>.Z9(M;^8[#]02P,$%
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MS>&1JH%2U5"B:LB?.'!CP@M;70]SFL4\I[BT?1J_%,=RIUM!I_ZEE-)\I;1
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M XVO14R#9. 3Q:_BN<\)%8^R0"J]#"**MD&\(1<H2+)-RMN4U;H\55E(F%O
M>C4Q<,>2GZ8D7DLYIZ6<#U2YAG1.)9VCE>XVR84:ZA$C9F8DIB/C\JSM43/5
MHDZ5!!+F0L(\Y]UD.U0,R%U#L7ZE6%^KV)Q0.</F1*R4]]6:^91&[9II8:=J
M!@ES(6$>),P'@C7D'53R#L!#H0&DQI P%Q+F0<)\(%A#XV&E\5 [A=5D1?F&
MAFNQ05Z@LR@M _QS$>P<#?6G6NJI.@_?AQ1VM]?#S:7.?5\,XV'?.7S605;-
M!X(UM,'6?G=L_?_1C-[GJ=J5M'IHT>^]CRS<EG+=MDBEI1S&;:%*2\%ATW&S
MTVLI"?S!W4$BM_RBD\N=+Q,SHCQL[5<M]N1^A:2Y):T^=P:''0_IT(>B-36T
M]QK:6@WOFLKI9H,6=+)JD#2WI-6'>,O4\D"=^E"TIG+[] O6[OS?EKS]ECLG
M-!02!BO2*A]H[@64YH+2O)*&[?IFX-(:](:-S^$J^2/R+'B?:,'Z3$NY0YC^
MBFL;!!5)MHH)FD(!I;F@- ^4YD/1FB+O4RZX![Y/P* Y%5":"TKS0&D^%*TI
M]3Y%@_4YFO^Z7<#O$QFVU>_VG>9R=:-W?[*0H+D84)H/16L*N<_<8'WJYL?L
M+/KM\8IUJ#)H\@:4YH'2?"A:4^5] @=K<P<G!U,%3>ZLZB$&/I0/-"\#2O-
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MT@:8_5P(?9S8 X9?4_P74$L#!!0    ( )R*7E<9W4G!HP,  !01   9
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MAQ.!:U\1.)7 N1 XSA6!6PG<UWKH5(+.:SUXE<"[%+A7!-U*T"UB7P:KB'2
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M)4EQYI@BM8[1F7_WC1][WP\$/VJ#'PVI-\&?;/! -.SQ2#FWL8H#E"BIR/J
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M[$R?#22+TW/T,Y/J5)Y>+M5W$'"]0:W/&9.O WTT+[ZLW#]02P,$%     @
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MMO^-E@GUE=Z2Q2+_C_9E6\="RZV0+"F#801)E!:?Y+D$<1" _5<"W#+ _=D
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M-&]8<+>1N]O0NSMZG$S*EX.?>;Y/=_E>1D&+7W7F@, *0]',AZ()&K)-2.)
M8 7BK9QX2QL#"7%/$8^CMXRP'L5!/RCA41DYK>&%Y.YS<O>GR>W-*GT3F41)
M*T,DX_QHC>BEV(W]M#M(3&WO%W*S+57;K4I3I]@=F\03@'8RBV63J#>\E.F>
MBK$!%RKY3%]H];U5S5XHM.+88#4V&'3ERN"@R .A%<DK/67K!56U@IN!%0JI
M9=7L5MT^2.R2EE9YK;65*+*UTJ-Z$#_1D'+BHS'A0EZ5,@*53E!HQ0%2XLFN
MPT:R5HQ5)@^$5B2OI)BMUV(#;^.Y5'X)6U$^D^SEE^Q2SBE*O![GD?DN>*\A
MI&REI&RM7JD>YWVR\H2,\SX+ D\D4S]92L^6S'?1%QD"/]'0DV^DF2X50"49
M%%IQ#)4HLUNPJ0"DLC+RU]!LMA)M]@G5=F8JI"@VWE^D[ZQF_3 =KJ'2L%)I
M6"^JKI$.(_+F!>O@O,30^U<U-J#0BJ.IE""V01,#@TH]*+0B>27UL%9-=7>1
M,5.1(?+($$QJH%@*Q0/B[E*($U&:/%E/^P*G;L5_!\FC]^A2QDK?X1/Z#C1Y
M)EMV9LJ ;L5!H17'4.E.#+L;AT$U)11:D;S2E%B_(W=F+<E0WM62=\5$W]VE
M=)1*Q) [=N?E0[5B KKC!X56'$VE5#'LIA\&E9A0:$7R2F)B_98=9#%IO2LF
MME5:3:XA++$2EE@O+*^2/5Y8(7N I&@VFM<0MHX2MHX%FCT.J Z%0BN25SK4
MT>]( F9/UM-)*:;WZ%+&2GPZ>O$)G#SRZLPO]GJ_*L?--02ML_<#L .;-+ _
M"E]#B3I*B3KZ'= SQ5B&4MCCDF*L=9@/UU"6CE*6SHG?>J^2#Y7*B=[#RL%Q
M#6GK*&GK-& S U2)0J$5R2LEZNCW3"'+2?-,,:9WJ2IE<^^04D#Y(CF[%4E"
MZU"DYY7RI_GYL,?D5)2IFJ>'RT:$+[PP0CZ=2U/KKBFY\/2\5GHCV"HY\C1E
M0K @N5Q2XE(>-Y#OYXR)W4W<07YJKOL_4$L#!!0    ( )R*7E=LFBZS?P,
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MW:?G0IO;N6NNS?\02CO!C"^%T'<=>T6O_K#&_P)02P,$%     @ G(I>5[G
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MA=X[.38+79_8(5VG%-(I X(U,H6->M-F'+>"0-_0AW0;(+9)YMK$] ./?<J
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M2*4!X/N%$'H_, ZJMK/W#U!+ P04    " "<BEY7]VV:MU %  #/&0  &0
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( )R*7E>,5BU$K@8   TX   /
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M<W[N%O'V_&NV\R_Q/OT+4$L#!!0    ( )R*7E<@%;X0A (  "8R   :
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M#?4V KT-]38"O0WU-@*]#?4V KT-]38"O6WRL9) ;T.]C4!O0[V-0&]#O8U
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MOSS3WK3#<WZV_&?AYA=02P$"% ,4    " "<BEY7!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )R*
M7E=A'(11[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( )R*7E>97)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ G(I>5]&?_[J@
M!   YQ0  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( )R*7E>(=<H_G0H  -0R   8              "
M@>,,  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "<BEY7
M48=?K> "  #Q"@  &               @(&V%P  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ G(I>5V-*G%!X"P  1#H  !@
M     ("!S!H  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M )R*7E?VCROA[0L  .YC   8              " @7HF  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " "<BEY7"EP06D<*  !_4   &
M            @(&=,@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ G(I>5TC\VTH("   *14  !@              ("!&CT  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( )R*7E<T&.VTW1,  '\]
M   8              " @5A%  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " "<BEY713+@D& (  "'$P  &               @(%K60
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ G(I>5SP2[84J
M!P  T!$  !D              ("! 6(  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " "<BEY7X#"@N2\#   ?!P  &0
M@(%B:0  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )R*
M7E??@@'L\P0  "0+   9              " @<AL  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ G(I>5ZL*7U+, @  ^P4  !D
M         ("!\G$  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " "<BEY790.B$G@%  !_#   &0              @('U=   >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( )R*7E<N13(R?@0   \+
M   9              " @:1Z  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ G(I>5^Z!YOB7!@  IPX  !D              ("!67\
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "<BEY76N5!
MF+0"  #B!0  &0              @($GA@  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( )R*7E>W=R^&YPP  !0E   9
M  " @1*)  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
MG(I>5VEFG-T=#P  1S@  !D              ("!,)8  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " "<BEY7Z$@9%3,,   $)   &0
M            @(&$I0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( )R*7E?DA:O6@@,  /H'   9              " @>ZQ  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ G(I>5XO[^F^R!
M4@T  !D              ("!I[4  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " "<BEY7\H@JDX\%  !Q#0  &0              @(&0
MN@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( )R*7E>O
M%&YQW@0  $4+   9              " @5;   !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ G(I>5PPI.*4F!   M@D  !D
M     ("!:\4  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )R*7E<$%'V7Z@(  "X&   9              "
M@>;T  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ G(I>
M5^(!>*T !   Q0P  !D              ("!!_@  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " "<BEY7JA_S%? $  #J"@  &0
M        @($^_   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( )R*7E=M,<H\5P<  .X4   9              " @64! 0!X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ G(I>5YJCM)N1 P  HP<
M !D              ("!\P@! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " "<BEY7Y,VC,N,$  !&#   &0              @(&[# $
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( )R*7E<8U_TI
M_P(  *P&   9              " @=41 0!X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ G(I>5Z7L8C17 @  ZP4  !D
M ("!"Q4! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "<
MBEY7E>RE%L()  !9;@  &0              @(&9%P$ >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( )R*7E<H+!T D 4  .TP   9
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M970T,RYX;6Q02P$"% ,4    " "<BEY7^F2:%O@"  #K"   &0
M    @(%?. $ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M )R*7E>A12K$1 ,  #,*   9              " @8X[ 0!X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ G(I>5RU*OO$O!   #!8  !D
M             ("!"3\! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " "<BEY7E'LIX3($   Q%@  &0              @(%O0P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( )R*7E=!F%Q#CP(
M &X&   9              " @=A' 0!X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ G(I>5W?MT/:&!   ]!P  !D              ("!
MGDH! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "<BEY7
M@WQT#U<#   \#@  &0              @(%;3P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( )R*7E>_/RL[!@0  %44   9
M      " @>E2 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ G(I>5XZ7[N>K P  N1   !D              ("!)E<! 'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " "<BEY7ZH5_[# %  !7(@
M&0              @($(6P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+
M 0(4 Q0    ( )R*7E<!.P%X0 ,  $(,   9              " @6]@ 0!X
M;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ G(I>5^J$N* P
M @  I@0  !D              ("!YF,! 'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6Q02P$"% ,4    " "<BEY7&=U)P:,#   4$0  &0
M@(%-9@$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( )R*
M7E?:E:\Y^P4  %L:   9              " @2=J 0!X;"]W;W)K<VAE971S
M+W-H965T-3<N>&UL4$L! A0#%     @ G(I>5X0 R/". P  [P\  !D
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M=#8R+GAM;%!+ 0(4 Q0    ( )R*7E?'[,7L7P,  .<(   9
M  " @1>, 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @
MG(I>5^<C%>7O P  0P\  !D              ("!K8\! 'AL+W=O<FMS:&5E
M=',O<VAE970V-"YX;6Q02P$"% ,4    " "<BEY70#O#]34#  !E#0  &0
M            @('3DP$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4
M Q0    ( )R*7E?QS6RL*@8  $$O   9              " @3^7 0!X;"]W
M;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ G(I>5Q'?S3 L @
MR00  !D              ("!H)T! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX
M;6Q02P$"% ,4    " "<BEY7WB6D!GP#  #X#P  &0              @($#
MH $ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( )R*7E<2
M7O4<\P0  (XB   9              " @;:C 0!X;"]W;W)K<VAE971S+W-H
M965T-CDN>&UL4$L! A0#%     @ G(I>5R!*=XS-!   @QT  !D
M     ("!X*@! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )R*7E=%?]%&50,  $L.   9              "
M@:#$ 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ G(I>
M5].,;&/. @  LP@  !D              ("!+,@! 'AL+W=O<FMS:&5E=',O
M<VAE970W-BYX;6Q02P$"% ,4    " "<BEY7*&)'.LX&   ^.   &0
M        @($QRP$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0
M   ( )R*7E=S-Z/<I (  /8'   9              " @3;2 0!X;"]W;W)K
M<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ G(I>5SG3,1[E @  ?@D
M !D              ("!$=4! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q0
M2P$"% ,4    " "<BEY7F3Y&_YT"  !W!@  &0              @($MV $
M>&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( )R*7E>*S[+?
M70(  /$%   9              " @0'; 0!X;"]W;W)K<VAE971S+W-H965T
M.#$N>&UL4$L! A0#%     @ G(I>5\*7JFD? P  ,0L  !D
M ("!E=T! 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4    " "<
MBEY7?U* 42 #  !.#   &0              @('KX $ >&PO=V]R:W-H965T
M<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    ( )R*7E=?V\<*0P0  ((.   9
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M 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "<BEY7(!6^$(0"   F,@
M&@              @ &;^0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " "<BEY7B6[,?BL"  "[,   $P              @ %7_ $
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     70!= ((9  "S_@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>300</ContextCount>
  <ElementCount>368</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>105</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>16</UnitCount>
  <MyReports>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - COVER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/Cover</Role>
      <ShortName>COVER</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - CONDENSED CONSOLIDATE BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATE BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/DescriptionOfBusiness</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - BUSINESS COMBINATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/BusinessCombination</Role>
      <ShortName>BUSINESS COMBINATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LifeInsuranceSettlementPolicies</Role>
      <ShortName>LIFE INSURANCE SETTLEMENT POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - PROPERTY AND EQUIPMENT---NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT---NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure -  AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue</Role>
      <ShortName>AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure -  OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets</Role>
      <ShortName>OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - CONSOLIDATION OF VARIABLE INTEREST ENTITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/ConsolidationOfVariableInterestEntities</Role>
      <ShortName>CONSOLIDATION OF VARIABLE INTEREST ENTITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - SEGMENT REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SegmentReporting</Role>
      <ShortName>SEGMENT REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure -  FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - LONG-TERM DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebt</Role>
      <ShortName>LONG-TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/ShareholdersEquity</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - EMPLOYEE BENEFIT PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/EmployeeBenefitPlan</Role>
      <ShortName>EMPLOYEE BENEFIT PLAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - RELATED-PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED-PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/EarningsPerShare</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - BUSINESS COMBINATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/BusinessCombinationTables</Role>
      <ShortName>BUSINESS COMBINATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/BusinessCombination</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables</Role>
      <ShortName>LIFE INSURANCE SETTLEMENT POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/LifeInsuranceSettlementPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - PROPERTY AND EQUIPMENT---NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT---NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - SEGMENT REPORTING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SegmentReportingTables</Role>
      <ShortName>SEGMENT REPORTING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/SegmentReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure -  FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/FairValueMeasurements</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - LONG-TERM DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtTables</Role>
      <ShortName>LONG-TERM DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/LongTermDebt</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/Leases</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>1036 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/EarningsPerShareTables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.emslp.com/role/EarningsPerShare</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>1037 - Disclosure - DESCRIPTION OF BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/DescriptionOfBusinessDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/DescriptionOfBusiness</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>1038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation of Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation of Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>1039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>1040 - Disclosure - BUSINESS COMBINATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>BUSINESS COMBINATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>1041 - Disclosure - BUSINESS COMBINATION - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails</Role>
      <ShortName>BUSINESS COMBINATION - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>1042 - Disclosure - BUSINESS COMBINATION - Value Conveyed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/BusinessCombinationValueConveyedDetails</Role>
      <ShortName>BUSINESS COMBINATION - Value Conveyed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>1043 - Disclosure - BUSINESS COMBINATION - Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails</Role>
      <ShortName>BUSINESS COMBINATION - Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>1044 - Disclosure - BUSINESS COMBINATION - Pro Forma Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails</Role>
      <ShortName>BUSINESS COMBINATION - Pro Forma Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>1045 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails</Role>
      <ShortName>LIFE INSURANCE SETTLEMENT POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>1046 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails</Role>
      <ShortName>LIFE INSURANCE SETTLEMENT POLICIES - Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>1047 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Investment Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails</Role>
      <ShortName>LIFE INSURANCE SETTLEMENT POLICIES - Investment Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>1048 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Estimated Premiums (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails</Role>
      <ShortName>LIFE INSURANCE SETTLEMENT POLICIES - Estimated Premiums (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>1049 - Disclosure - PROPERTY AND EQUIPMENT---NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT---NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>1050 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill by Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill by Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>1051 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>1052 - Disclosure -  AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails</Role>
      <ShortName>AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>1053 - Disclosure -  OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails</Role>
      <ShortName>OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>1054 - Disclosure - CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails</Role>
      <ShortName>CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/ConsolidationOfVariableInterestEntities</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>1055 - Disclosure - SEGMENT REPORTING - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>SEGMENT REPORTING - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>1056 - Disclosure - SEGMENT REPORTING - Revenue by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails</Role>
      <ShortName>SEGMENT REPORTING - Revenue by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>1057 - Disclosure - SEGMENT REPORTING - Reconciliation of Net Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails</Role>
      <ShortName>SEGMENT REPORTING - Reconciliation of Net Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>1058 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>1059 - Disclosure -  FAIR VALUE MEASUREMENTS - Recurring Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Recurring Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>1060 - Disclosure -  FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>1061 - Disclosure -  FAIR VALUE MEASUREMENTS - Discount Rate Sensitivity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Discount Rate Sensitivity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>1062 - Disclosure -  FAIR VALUE MEASUREMENTS - Credit Exposure to Insurance Companies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Credit Exposure to Insurance Companies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>1063 - Disclosure -  FAIR VALUE MEASUREMENTS - Life Insurance Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Life Insurance Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>1064 - Disclosure -  FAIR VALUE MEASUREMENTS - Issued Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Issued Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>1065 - Disclosure -  FAIR VALUE MEASUREMENTS - Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>1066 - Disclosure - LONG-TERM DEBT - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtLongTermDebtDetails</Role>
      <ShortName>LONG-TERM DEBT - Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>1067 - Disclosure - LONG-TERM DEBT - Sponsor PIK Note (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails</Role>
      <ShortName>LONG-TERM DEBT - Sponsor PIK Note (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>1068 - Disclosure - LONG-TERM DEBT - LMATT Series 2024, Inc. Market-Indexed Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails</Role>
      <ShortName>LONG-TERM DEBT - LMATT Series 2024, Inc. Market-Indexed Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>1069 - Disclosure - LONG-TERM DEBT - LMATT Series 2.2024, Inc. Market-Indexed Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails</Role>
      <ShortName>LONG-TERM DEBT - LMATT Series 2.2024, Inc. Market-Indexed Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>1070 - Disclosure - LONG-TERM DEBT - LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails</Role>
      <ShortName>LONG-TERM DEBT - LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>1071 - Disclosure - LONG-TERM DEBT - LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails</Role>
      <ShortName>LONG-TERM DEBT - LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>1072 - Disclosure - LONG-TERM DEBT - LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails</Role>
      <ShortName>LONG-TERM DEBT - LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>1073 - Disclosure - LONG-TERM DEBT - SPV Purchase and Sale and SPV Investment Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails</Role>
      <ShortName>LONG-TERM DEBT - SPV Purchase and Sale and SPV Investment Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>1074 - Disclosure - SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/ShareholdersEquityDetails</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/ShareholdersEquity</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>1075 - Disclosure - EMPLOYEE BENEFIT PLAN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/EmployeeBenefitPlanDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLAN (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>1076 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/IncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/IncomeTaxes</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>1077 - Disclosure - RELATED-PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>RELATED-PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/RelatedPartyTransactions</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>1078 - Disclosure - LEASES - ROU Assets and Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails</Role>
      <ShortName>LEASES - ROU Assets and Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>1079 - Disclosure - LEASES - Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LeasesLeaseExpenseDetails</Role>
      <ShortName>LEASES - Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>1080 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>1081 - Disclosure - LEASES - Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails</Role>
      <ShortName>LEASES - Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>1082 - Disclosure - LEASES - Future Minimum Noncancellable Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails</Role>
      <ShortName>LEASES - Future Minimum Noncancellable Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>1083 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/EarningsPerShareNarrativeDetails</Role>
      <ShortName>EARNINGS PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>1084 - Disclosure - EARNINGS PER SHARE - Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails</Role>
      <ShortName>EARNINGS PER SHARE - Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="d423260ds1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>1085 - Disclosure - SUBSEQUENT EVENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.emslp.com/role/SubsequentEventsDetails</Role>
      <ShortName>SUBSEQUENT EVENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.emslp.com/role/SubsequentEvents</ParentRole>
      <Position>85</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abl-20230630.xsd</File>
    <File>abl-20230630_cal.xml</File>
    <File>abl-20230630_def.xml</File>
    <File>abl-20230630_lab.xml</File>
    <File>abl-20230630_pre.xml</File>
    <File doctype="S-1/A" isDefinitelyFs="true" isUsgaap="true" original="d423260ds1a.htm">d423260ds1a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g423260g01y03.jpg</File>
    <File>g423260g10a01.jpg</File>
    <File>g423260g10a02.jpg</File>
    <File>g423260g10a03.jpg</File>
    <File>g423260g10a04.jpg</File>
    <File>g423260g10a05.jpg</File>
    <File>g423260g10a06.jpg</File>
    <File>g423260g21g64.jpg</File>
    <File>g423260g22g59.jpg</File>
    <File>g423260g22g63.jpg</File>
    <File>g423260g22g64.jpg</File>
    <File>g423260g37n37.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="948">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>114
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d423260ds1a.htm": {
   "nsprefix": "abl",
   "nsuri": "http://www.emslp.com/20230630",
   "dts": {
    "schema": {
     "local": [
      "abl-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "abl-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "abl-20230630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "abl-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abl-20230630_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d423260ds1a.htm"
     ]
    }
   },
   "keyStandard": 281,
   "keyCustom": 87,
   "axisStandard": 36,
   "axisCustom": 3,
   "memberStandard": 48,
   "memberCustom": 49,
   "hidden": {
    "total": 7,
    "http://www.emslp.com/20230630": 4,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 300,
   "entityCount": 1,
   "segmentCount": 105,
   "elementCount": 638,
   "unitCount": 16,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 948,
    "http://xbrl.sec.gov/dei/2023": 26
   },
   "report": {
    "R1": {
     "role": "http://www.emslp.com/role/Cover",
     "longName": "1001 - Document - COVER",
     "shortName": "COVER",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
     "longName": "1003 - Statement - CONDENSED CONSOLIDATE BALANCE SHEETS (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATE BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_CommonClassAMemberusgaapStatementClassOfStockAxis",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome",
     "longName": "1004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:InsuranceInvestmentIncome",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity",
     "longName": "1005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2021",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
     "longName": "1006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:LifeSettlementContractsFairValueMethodUnrealizedGainLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.emslp.com/role/DescriptionOfBusiness",
     "longName": "1007 - Disclosure - DESCRIPTION OF BUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.emslp.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "1008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.emslp.com/role/BusinessCombination",
     "longName": "1009 - Disclosure - BUSINESS COMBINATION",
     "shortName": "BUSINESS COMBINATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.emslp.com/role/LifeInsuranceSettlementPolicies",
     "longName": "1010 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES",
     "shortName": "LIFE INSURANCE SETTLEMENT POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:LifeSettlementContractsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:LifeSettlementContractsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.emslp.com/role/PropertyAndEquipmentNet",
     "longName": "1011 - Disclosure - PROPERTY AND EQUIPMENT---NET",
     "shortName": "PROPERTY AND EQUIPMENT---NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets",
     "longName": "1012 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue",
     "longName": "1013 - Disclosure -  AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE",
     "shortName": "AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets",
     "longName": "1014 - Disclosure -  OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS",
     "shortName": "OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.emslp.com/role/ConsolidationOfVariableInterestEntities",
     "longName": "1015 - Disclosure - CONSOLIDATION OF VARIABLE INTEREST ENTITIES",
     "shortName": "CONSOLIDATION OF VARIABLE INTEREST ENTITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.emslp.com/role/SegmentReporting",
     "longName": "1016 - Disclosure - SEGMENT REPORTING",
     "shortName": "SEGMENT REPORTING",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.emslp.com/role/CommitmentsAndContingencies",
     "longName": "1017 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.emslp.com/role/FairValueMeasurements",
     "longName": "1018 - Disclosure -  FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.emslp.com/role/LongTermDebt",
     "longName": "1019 - Disclosure - LONG-TERM DEBT",
     "shortName": "LONG-TERM DEBT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.emslp.com/role/ShareholdersEquity",
     "longName": "1020 - Disclosure - SHAREHOLDERS' EQUITY",
     "shortName": "SHAREHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.emslp.com/role/EmployeeBenefitPlan",
     "longName": "1021 - Disclosure - EMPLOYEE BENEFIT PLAN",
     "shortName": "EMPLOYEE BENEFIT PLAN",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.emslp.com/role/IncomeTaxes",
     "longName": "1022 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.emslp.com/role/RelatedPartyTransactions",
     "longName": "1023 - Disclosure - RELATED-PARTY TRANSACTIONS",
     "shortName": "RELATED-PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.emslp.com/role/Leases",
     "longName": "1024 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.emslp.com/role/EarningsPerShare",
     "longName": "1025 - Disclosure - EARNINGS PER SHARE",
     "shortName": "EARNINGS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.emslp.com/role/SubsequentEvents",
     "longName": "1026 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "1027 - Disclosure -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "27",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.emslp.com/role/BusinessCombinationTables",
     "longName": "1028 - Disclosure - BUSINESS COMBINATION (Tables)",
     "shortName": "BUSINESS COMBINATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables",
     "longName": "1029 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES (Tables)",
     "shortName": "LIFE INSURANCE SETTLEMENT POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfLifeSettlementContractsFairValueMethodTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfLifeSettlementContractsFairValueMethodTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.emslp.com/role/PropertyAndEquipmentNetTables",
     "longName": "1030 - Disclosure - PROPERTY AND EQUIPMENT---NET (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT---NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables",
     "longName": "1031 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.emslp.com/role/SegmentReportingTables",
     "longName": "1032 - Disclosure - SEGMENT REPORTING (Tables)",
     "shortName": "SEGMENT REPORTING (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsTables",
     "longName": "1033 - Disclosure -  FAIR VALUE MEASUREMENTS (Tables)",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.emslp.com/role/LongTermDebtTables",
     "longName": "1034 - Disclosure - LONG-TERM DEBT (Tables)",
     "shortName": "LONG-TERM DEBT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.emslp.com/role/LeasesTables",
     "longName": "1035 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "abl:AssetsAndLiabilitiesLesseeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "abl:AssetsAndLiabilitiesLesseeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.emslp.com/role/EarningsPerShareTables",
     "longName": "1036 - Disclosure - EARNINGS PER SHARE (Tables)",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.emslp.com/role/DescriptionOfBusinessDetails",
     "longName": "1037 - Disclosure - DESCRIPTION OF BUSINESS (Details)",
     "shortName": "DESCRIPTION OF BUSINESS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails",
     "longName": "1038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation of Variable Interest Entities (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation of Variable Interest Entities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:Assets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn10_04_2021",
      "name": "abl:NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership",
      "unitRef": "Unit_investor",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails",
     "longName": "1039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
       "div",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
     "longName": "1040 - Disclosure - BUSINESS COMBINATION - Narrative (Details)",
     "shortName": "BUSINESS COMBINATION - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "P06_30_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_LongevityMarketAssetsLLCMemberusgaapBusinessAcquisitionAxis",
      "name": "abl:BusinessCombinationEnterpriseValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "div",
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
     "longName": "1041 - Disclosure - BUSINESS COMBINATION - Purchase Price Allocation (Details)",
     "shortName": "BUSINESS COMBINATION - Purchase Price Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
     "longName": "1042 - Disclosure - BUSINESS COMBINATION - Value Conveyed (Details)",
     "shortName": "BUSINESS COMBINATION - Value Conveyed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "P06_30_2023To06_30_2023_AbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R43": {
     "role": "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
     "longName": "1043 - Disclosure - BUSINESS COMBINATION - Intangible Assets Acquired (Details)",
     "shortName": "BUSINESS COMBINATION - Intangible Assets Acquired (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis_TradeNamesMemberusgaapIndefiniteLivedIntangibleAssetsByMajorClassAxis",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails",
     "longName": "1044 - Disclosure - BUSINESS COMBINATION - Pro Forma Financial Information (Details)",
     "shortName": "BUSINESS COMBINATION - Pro Forma Financial Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMemberusgaapBusinessAcquisitionAxis",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails",
     "longName": "1045 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Narrative (Details)",
     "shortName": "LIFE INSURANCE SETTLEMENT POLICIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "abl:LifeSettlementContractsNumberOfContracts",
      "unitRef": "Unit_insurance_contract",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:LifeSettlementContractsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "abl:LifeSettlementContractsNumberOfContracts",
      "unitRef": "Unit_insurance_contract",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:LifeSettlementContractsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails",
     "longName": "1046 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Fair Value (Details)",
     "shortName": "LIFE INSURANCE SETTLEMENT POLICIES - Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear",
      "unitRef": "Unit_insurance_contract",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLifeSettlementContractsFairValueMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear",
      "unitRef": "Unit_insurance_contract",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLifeSettlementContractsFairValueMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails",
     "longName": "1047 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Investment Method (Details)",
     "shortName": "LIFE INSURANCE SETTLEMENT POLICIES - Investment Method (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear",
      "unitRef": "Unit_insurance_contract",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear",
      "unitRef": "Unit_insurance_contract",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails",
     "longName": "1048 - Disclosure - LIFE INSURANCE SETTLEMENT POLICIES - Estimated Premiums (Details)",
     "shortName": "LIFE INSURANCE SETTLEMENT POLICIES - Estimated Premiums (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.emslp.com/role/PropertyAndEquipmentNetDetails",
     "longName": "1049 - Disclosure - PROPERTY AND EQUIPMENT---NET (Details)",
     "shortName": "PROPERTY AND EQUIPMENT---NET (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails",
     "longName": "1050 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill by Reportable Segments (Details)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill by Reportable Segments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:Goodwill",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022_AbacusSettlementsLLCMemberdeiLegalEntityAxis",
      "name": "us-gaap:Goodwill",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails",
     "longName": "1051 - Disclosure -  GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Acquired (Details)",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Intangible Assets Acquired (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_CustomerRelationshipAgentsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails",
     "longName": "1052 - Disclosure -  AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE (Details)",
     "shortName": "AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "P01_07_2022To01_07_2022",
      "name": "us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn10_31_2022",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleWeightedAverageYield",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails",
     "longName": "1053 - Disclosure -  OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)",
     "shortName": "OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "abl:NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld",
      "unitRef": "Unit_entity",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "abl:NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld",
      "unitRef": "Unit_entity",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "us-gaap:OtherAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
     "longName": "1054 - Disclosure - CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Details)",
     "shortName": "CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:Assets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R55": {
     "role": "http://www.emslp.com/role/SegmentReportingNarrativeDetails",
     "longName": "1055 - Disclosure - SEGMENT REPORTING - Narrative (Details)",
     "shortName": "SEGMENT REPORTING - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "P01_01_2022To06_30_2022",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "Unit_segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2022To06_30_2022",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "Unit_segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails",
     "longName": "1056 - Disclosure - SEGMENT REPORTING - Revenue by Segment (Details)",
     "shortName": "SEGMENT REPORTING - Revenue by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023_PortfolioServicingSegmentMemberusgaapStatementBusinessSegmentsAxis",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
     "longName": "1057 - Disclosure - SEGMENT REPORTING - Reconciliation of Net Income (Details)",
     "shortName": "SEGMENT REPORTING - Reconciliation of Net Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:GrossProfit",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:Depreciation",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
     "longName": "1058 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "abl:NumberOfProvidersInvolvedInOptionAgreement",
      "unitRef": "Unit_provider",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023_ExpenseSupportAgreementMemberusgaapOtherCommitmentsAxis_VariableInterestEntityNotPrimaryBeneficiaryMembersrtConsolidatedEntitiesAxis",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails",
     "longName": "1059 - Disclosure -  FAIR VALUE MEASUREMENTS - Recurring Fair Value Measurements (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Recurring Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis",
      "name": "us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "1060 - Disclosure -  FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:LifeSettlementContractsFairValueMethodGainLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails",
     "longName": "1061 - Disclosure -  FAIR VALUE MEASUREMENTS - Discount Rate Sensitivity (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Discount Rate Sensitivity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "abl:SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails",
     "longName": "1062 - Disclosure -  FAIR VALUE MEASUREMENTS - Credit Exposure to Insurance Companies (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Credit Exposure to Insurance Companies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023_AmericanGeneralLifeInsuranceCompanyMemberABLLifeInsuranceCarrierAxis_LifeInsuranceCarrierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis_LifeSettlementContractsFaceValueMemberusgaapConcentrationRiskByBenchmarkAxis",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails",
     "longName": "1063 - Disclosure -  FAIR VALUE MEASUREMENTS - Life Insurance Policies (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Life Insurance Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022_LifeSettlementContractMemberusgaapFairValueByAssetClassAxis",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails",
     "longName": "1064 - Disclosure -  FAIR VALUE MEASUREMENTS - Issued Notes (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Issued Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2022",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
     "longName": "1065 - Disclosure -  FAIR VALUE MEASUREMENTS - Assumptions (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS - Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis_PrivatePlacementWarrantMemberusgaapClassOfWarrantOrRightAxis",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
     "longName": "1066 - Disclosure - LONG-TERM DEBT - Long-Term Debt (Details)",
     "shortName": "LONG-TERM DEBT - Long-Term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_CarryingReportedAmountFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
     "longName": "1067 - Disclosure - LONG-TERM DEBT - Sponsor PIK Note (Details)",
     "shortName": "LONG-TERM DEBT - Sponsor PIK Note (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023_SponsorPIKNoteMemberusgaapDebtInstrumentAxis_UnsecuredDebtMemberusgaapLongtermDebtTypeAxis",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
     "longName": "1068 - Disclosure - LONG-TERM DEBT - LMATT Series 2024, Inc. Market-Indexed Notes (Details)",
     "shortName": "LONG-TERM DEBT - LMATT Series 2024, Inc. Market-Indexed Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:Assets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn03_31_2022_LMATTSeries2024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
     "longName": "1069 - Disclosure - LONG-TERM DEBT - LMATT Series 2.2024, Inc. Market-Indexed Notes (Details)",
     "shortName": "LONG-TERM DEBT - LMATT Series 2.2024, Inc. Market-Indexed Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:Assets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_16_2022_LMATTSeries22024IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
     "longName": "1070 - Disclosure - LONG-TERM DEBT - LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes (Details)",
     "shortName": "LONG-TERM DEBT - LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:Assets",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn09_16_2022_LMATTGrowthIncomeSeries12026IncMemberusgaapDebtInstrumentAxis_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
     "longName": "1071 - Disclosure - LONG-TERM DEBT - LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing (Details)",
     "shortName": "LONG-TERM DEBT - LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023_LMATTIncomeSeriesLPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
     "longName": "1072 - Disclosure - LONG-TERM DEBT - LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing (Details)",
     "shortName": "LONG-TERM DEBT - LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023_EstimateOfFairValueFairValueDisclosureMemberusgaapFairValueByMeasurementBasisAxis",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023_LMATTIncomeSeriesIILPMemberusgaapDebtInstrumentAxis_SecuredDebtMemberusgaapLongtermDebtTypeAxis",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
     "longName": "1073 - Disclosure - LONG-TERM DEBT - SPV Purchase and Sale and SPV Investment Facility (Details)",
     "shortName": "LONG-TERM DEBT - SPV Purchase and Sale and SPV Investment Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "PAsOn07_05_2023_PolicyAPAMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis",
      "name": "abl:LifeSettlementContractsSpecialPurchaseVehicleFairValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn07_05_2023_PolicyAPAMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis",
      "name": "abl:LifeSettlementContractsSpecialPurchaseVehicleFairValue",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.emslp.com/role/ShareholdersEquityDetails",
     "longName": "1074 - Disclosure - SHAREHOLDERS' EQUITY (Details)",
     "shortName": "SHAREHOLDERS' EQUITY (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.emslp.com/role/EmployeeBenefitPlanDetails",
     "longName": "1075 - Disclosure - EMPLOYEE BENEFIT PLAN (Details)",
     "shortName": "EMPLOYEE BENEFIT PLAN (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:DefinedContributionPlanTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "us-gaap:DefinedContributionPlanTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.emslp.com/role/IncomeTaxesDetails",
     "longName": "1076 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "div",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
     "longName": "1077 - Disclosure - RELATED-PARTY TRANSACTIONS (Details)",
     "shortName": "RELATED-PARTY TRANSACTIONS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023_AffiliatedEntityMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis",
      "name": "abl:LifeSettlementContractsOriginationExpense",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails",
     "longName": "1078 - Disclosure - LEASES - ROU Assets and Lease Liabilities (Details)",
     "shortName": "LEASES - ROU Assets and Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R79": {
     "role": "http://www.emslp.com/role/LeasesLeaseExpenseDetails",
     "longName": "1079 - Disclosure - LEASES - Lease Expense (Details)",
     "shortName": "LEASES - Lease Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails",
     "longName": "1080 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)",
     "shortName": "LEASES - Supplemental Cash Flow Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2023To06_30_2023",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails",
     "longName": "1081 - Disclosure - LEASES - Lease Terms and Discount Rates (Details)",
     "shortName": "LEASES - Lease Terms and Discount Rates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails",
     "longName": "1082 - Disclosure - LEASES - Future Minimum Noncancellable Lease Payments (Details)",
     "shortName": "LEASES - Future Minimum Noncancellable Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2023",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.emslp.com/role/EarningsPerShareNarrativeDetails",
     "longName": "1083 - Disclosure - EARNINGS PER SHARE - Narrative (Details)",
     "shortName": "EARNINGS PER SHARE - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "div",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails",
     "longName": "1084 - Disclosure - EARNINGS PER SHARE - Basic and Diluted (Details)",
     "shortName": "EARNINGS PER SHARE - Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "P04_01_2023To06_30_2023",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R85": {
     "role": "http://www.emslp.com/role/SubsequentEventsDetails",
     "longName": "1085 - Disclosure - SUBSEQUENT EVENTS (Details)",
     "shortName": "SUBSEQUENT EVENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis",
      "name": "abl:LineOfCreditFacilityRemainingBorrowingCapacityTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_05_2023To07_05_2023_LineOfCreditMemberusgaapLongtermDebtTypeAxis_OwlRockCreditFacilityMemberusgaapDebtInstrumentAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis",
      "name": "abl:LineOfCreditFacilityRemainingBorrowingCapacityTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d423260ds1a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodNumberOfContractsFiscalYearMaturityAbstract",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value Method, Number of Contracts, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Policies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r389",
      "r390",
      "r788",
      "r904"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueFiscalYearMaturityAbstract",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodFaceValueFiscalYearMaturityAbstract",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value Method, Face Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Face Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodNumberOfContractsFiscalYearMaturityAbstract",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Investment Method, Number of Contracts, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Number of Life Insurance Policies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_Dividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Dividends",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends",
        "negatedLabel": "Distributions",
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r144"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Abacus Life Inc.",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r207",
      "r209",
      "r219",
      "r620",
      "r643"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodCarryingAmountFiscalYearMaturityAbstract",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Investment Method, Carrying Amount, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 35.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFaceValueFiscalYearMaturityAbstract",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Investment Method, Face Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Face Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r298",
      "r787",
      "r841"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r94",
      "r412",
      "r805",
      "r806"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "OTHER INCOME (EXPENSE)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r46",
      "r47",
      "r99",
      "r153",
      "r787"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 31.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r60"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PartnerTypeOfPartnersCapitalAccountAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partner Type [Axis]",
        "terseLabel": "Partner Type [Axis]",
        "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r686"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r407",
      "r424",
      "r560",
      "r794",
      "r796"
     ]
    },
    "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Partner Type of Partners' Capital Account, Name [Domain]",
        "terseLabel": "Partner Type of Partners' Capital Account, Name [Domain]",
        "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r686"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r453",
      "r458",
      "r517",
      "r569",
      "r811",
      "r812",
      "r813"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "periodStartLabel": "Goodwill at beginning of period",
        "periodEndLabel": "Goodwill at end of period",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r368",
      "r615",
      "r803",
      "r821",
      "r893",
      "r900"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Benefit plan expense",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation",
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r96"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r96"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Fair value at end of period",
        "periodStartLabel": "Fair value at beginning of period",
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncompeteAgreementsMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-Compete Agreements",
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r820"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r420",
      "r434",
      "r509",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r638",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r878",
      "r879",
      "r880",
      "r881"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r96"
     ]
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Gain on change in fair value of debt, included within other comprehensive income",
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r716"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentNoteReductionRatioForLossesBelowThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentNoteReductionRatioForLossesBelowThreshold",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Note Reduction Ratio For Losses Below Threshold",
        "terseLabel": "Note reduction ratio for losses below threshold",
        "documentation": "Debt Instrument, Note Reduction Ratio For Losses Below Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r61"
     ]
    },
    "abl_DebtInstrumentMaximumUpsidePerformanceParticipationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentMaximumUpsidePerformanceParticipationPercentage",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maximum Upside Performance Participation Percentage",
        "terseLabel": "Upside performance participation cap",
        "documentation": "Debt Instrument, Maximum Upside Performance Participation Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentDividendFeaturePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentDividendFeaturePercentage",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Dividend Feature Percentage",
        "terseLabel": "Dividend percentage",
        "documentation": "Debt Instrument, Dividend Feature Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r422"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r61",
      "r601"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentExtensionTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentExtensionTerm",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Extension Term",
        "terseLabel": "Debt instrument extension term",
        "documentation": "Debt Instrument, Extension Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r382",
      "r383",
      "r385",
      "r601",
      "r602"
     ]
    },
    "abl_ClassOfWarrantOrRightRedemptionNumberOfTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightRedemptionNumberOfTradingDays",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Redemption, Number Of Trading Days",
        "terseLabel": "Trading days",
        "documentation": "Class Of Warrant Or Right, Redemption, Number Of Trading Days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "terseLabel": "Class A Common Stock",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities (in shares)",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "abl_PublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "PublicWarrantsMember",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Warrants [Member]",
        "terseLabel": "Public Warrants",
        "documentation": "Public Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightCommonStockIssuanceTradingDayPeriod",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Common Stock Issuance Trading Day Period",
        "terseLabel": "Warrants, common stock issuance trading day period",
        "documentation": "Class Of Warrant Or Right, Common Stock Issuance Trading Day Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "EARNINGS PER SHARE:"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightRedemptionNoticePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightRedemptionNoticePeriod",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Redemption Notice Period",
        "terseLabel": "Warrant redemption notice period",
        "documentation": "Class Of Warrant Or Right, Redemption Notice Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r716"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r146",
      "r178",
      "r487",
      "r488",
      "r867"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r716",
      "r734",
      "r942",
      "r943"
     ]
    },
    "abl_ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightCommonStockIssuanceThresholdPricePerShare",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Common Stock Issuance Threshold Price Per Share",
        "terseLabel": "Warrants, common stock issuance threshold price (in dollars per share)",
        "documentation": "Class Of Warrant Or Right, Common Stock Issuance Threshold Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightIssuanceOfCommonStockWarrantPriceAdjustmentPercentage",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Issuance Of Common Stock, Warrant Price Adjustment Percentage",
        "terseLabel": "Warrant price adjustment percentage",
        "documentation": "Class Of Warrant Or Right, Issuance Of Common Stock, Warrant Price Adjustment Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense)",
        "verboseLabel": "Other (expense) income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "abl_ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightRedemptionForCommonStockPricePerShareThreshold",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Redemption For Common Stock, Price Per Share Threshold",
        "terseLabel": "Common stock price threshold for redemption for common stock (in dollars per share)",
        "documentation": "Class Of Warrant Or Right, Redemption For Common Stock, Price Per Share Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentReturnRateInExcessOfMinimumInternalRateOfReturnThreshold",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Return Rate In Excess Of Minimum Internal Rate Of Return Threshold",
        "terseLabel": "Return rate in excess of minimum internal rate of return",
        "documentation": "Debt Instrument, Return Rate In Excess Of Minimum Internal Rate Of Return Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentInternalRateOfReturnCap": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentInternalRateOfReturnCap",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Internal Rate Of Return Cap",
        "terseLabel": "Internal rate of return cap",
        "documentation": "Debt Instrument, Internal Rate Of Return Threshold Cap"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentMinimumInternalRateOfReturn": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentMinimumInternalRateOfReturn",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Minimum Internal Rate Of Return",
        "terseLabel": "Minimum internal rate of return threshold",
        "documentation": "Debt Instrument, Minimum Internal Rate Of Return Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 34.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "abl_DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentReturnRateInExcessOfCappedInternalRateOfReturnThreshold",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Return Rate In Excess Of Capped Internal Rate Of Return Threshold",
        "terseLabel": "Return Rate in excess of capped internal rate of return threshold",
        "documentation": "Debt Instrument, Return Rate In Excess Of Capped Internal Rate Of Return Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentExtensionOptions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentExtensionOptions",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Extension Options",
        "terseLabel": "Debt Instrument extension options",
        "documentation": "Debt Instrument, Extension Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromContributionsFromAffiliates",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Due to members and affiliates",
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r422"
     ]
    },
    "us-gaap_ConversionOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockTable",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock [Table]",
        "terseLabel": "Conversion of Stock [Table]",
        "documentation": "This table may be used to disclose all the information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction. It may include a description sufficient information to understand the nature and purpose of the conversion, as well as the financial instruments converted from and to (for example, preferred, common, treasury, etc.) the amounts converted, the new shares issued, and the value of the new shares issued, if applicable. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ]
    },
    "abl_LifeSettlementContractsSpecialPurchaseVehicleFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractsSpecialPurchaseVehicleFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Special Purchase Vehicle, Fair Value",
        "terseLabel": "Insurance policies fair value",
        "documentation": "Life Settlement Contracts, Special Purchase Vehicle, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Axis]",
        "terseLabel": "Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Axis]",
        "documentation": "Debt Instrument, Private Placement Offering, Capital Commitment Thresholds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "abl_DebtInstrumentNetInternalRateOfReturnAtCap": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentNetInternalRateOfReturnAtCap",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Net Internal Rate Of Return At Cap",
        "terseLabel": "Net internal rate of return at cap",
        "documentation": "Debt Instrument, Net Internal Rate Of Return At Cap"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred Tax Liabilities",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132"
     ]
    },
    "us-gaap_ConversionOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockLineItems",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock [Line Items]",
        "terseLabel": "Conversion of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentPrivatePlacementOfferingCapitalCommitmentThresholdsDomain",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Domain]",
        "terseLabel": "Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Domain]",
        "documentation": "Debt Instrument, Private Placement Offering, Capital Commitment Thresholds [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abl_CapitalCommitmentThresholdOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "CapitalCommitmentThresholdOneMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Commitment Threshold One [Member]",
        "terseLabel": "Capital Commitment Threshold One",
        "documentation": "Capital Commitment Threshold One"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "abl_CapitalCommitmentThresholdTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "CapitalCommitmentThresholdTwoMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Commitment Threshold Two [Member]",
        "terseLabel": "Capital Commitment Threshold Two",
        "documentation": "Capital Commitment Threshold Two"
       }
      }
     },
     "auth_ref": []
    },
    "abl_CapitalCommitmentThresholdThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "CapitalCommitmentThresholdThreeMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Commitment Threshold Three [Member]",
        "terseLabel": "Capital Commitment Threshold Three",
        "documentation": "Capital Commitment Threshold Three"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCapitalCommitmentThresholdsToDetermineDividends",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Capital Commitment Thresholds To Determine Dividends",
        "terseLabel": "Capital commitment threshold to determine dividend rate",
        "documentation": "Debt Instrument, Capital Commitment Thresholds To Determine Dividends"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentDefaultRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentDefaultRate",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Default Rate",
        "terseLabel": "Default rate",
        "documentation": "Debt Instrument, Default Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "terseLabel": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r557",
      "r558",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r733",
      "r735",
      "r768",
      "r926"
     ]
    },
    "abl_WarrantsAndRightsOutstandingExercisableTermProposedOffering": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "WarrantsAndRightsOutstandingExercisableTermProposedOffering",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Exercisable Term, Proposed Offering",
        "terseLabel": "Warrants, proposed offering exercisable term",
        "documentation": "Warrants and Rights Outstanding, Exercisable Term, Proposed Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Acquisition of Abacus Settlements, LLC",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r28",
      "r144"
     ]
    },
    "abl_PolicyAPAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "PolicyAPAMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Policy APA [Member]",
        "terseLabel": "Policy APA",
        "documentation": "Policy APA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Additions",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r803"
     ]
    },
    "abl_DebtInstrumentNumberOfExtensions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentNumberOfExtensions",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Number Of Extensions",
        "terseLabel": "Number of extensions",
        "documentation": "Debt Instrument, Number Of Extensions"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightRedemptionPricePerShareThreshold": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightRedemptionPricePerShareThreshold",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Redemption, Price Per Share Threshold",
        "terseLabel": "Common stock price threshold (in dollars per share)",
        "documentation": "Class Of Warrant Or Right, Redemption, Price Per Share Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightRedemptionTradingDayPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightRedemptionTradingDayPeriod",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Redemption, Trading Day Period",
        "terseLabel": "Trading day period",
        "documentation": "Class Of Warrant Or Right, Redemption, Trading Day Period"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightRedemptionPricePerWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightRedemptionPricePerWarrant",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Redemption Price Per Warrant",
        "terseLabel": "Redemption price per warrant (in dollars per share)",
        "documentation": "Class Of Warrant Or Right, Redemption Price Per Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "abl_WarrantsAndRightsOutstandingExercisableTermBusinessCombination": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "WarrantsAndRightsOutstandingExercisableTermBusinessCombination",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Exercisable Term, Business Combination",
        "terseLabel": "Warrants, business combination exercisable term",
        "documentation": "Warrants and Rights Outstanding, Exercisable Term, Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "abl_NumberOfVotesPerCommonShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "NumberOfVotesPerCommonShare",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Votes Per Common Share",
        "terseLabel": "Number of votes per share",
        "documentation": "Number Of Votes Per Common Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r61"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionTriggerPriceAdjustmentPercent",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Issuance Of Common Stock, Redemption, Trigger Price Adjustment Percent",
        "terseLabel": "Redemption trigger price adjustment percentage",
        "documentation": "Class Of Warrant Or Right, Issuance Of Common Stock, Redemption, Trigger Price Adjustment Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r136"
     ]
    },
    "abl_WarrantsAndRightsOutstandingFairValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "WarrantsAndRightsOutstandingFairValuePerShare",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Fair Value Per Share",
        "terseLabel": "Warrant outstanding fair value per share (in dollars per share)",
        "documentation": "Warrants and Rights Outstanding, Fair Value Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightIssuanceOfCommonStockRedemptionForCommonStockTriggerPriceAdjustmentPercent",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Issuance Of Common Stock, Redemption For Common Stock, Trigger Price Adjustment Percent",
        "terseLabel": "Redemption for common stock trigger price adjustment percentage",
        "documentation": "Class Of Warrant Or Right, Issuance Of Common Stock, Redemption For Common Stock, Trigger Price Adjustment Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 22.0
      },
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "totalLabel": "Total revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r227",
      "r271",
      "r272",
      "r283",
      "r288",
      "r289",
      "r295",
      "r297",
      "r298",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r528",
      "r622",
      "r906"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Domain]",
        "terseLabel": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r557",
      "r558",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r733",
      "r735",
      "r768"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating Income",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r284",
      "r290",
      "r293",
      "r800"
     ]
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Operating lease liabilities\u2014current portion",
        "terseLabel": "Operating lease liability, current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liabilities\u2014noncurrent portion",
        "terseLabel": "Operating lease liability, non-current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Tax and Reclassification Adjustment, Attributable to Parent",
        "terseLabel": "Change in fair value of debt",
        "documentation": "Amount, after tax and reclassification adjustment, of gain (loss) from increase (decrease) in instrument-specific credit risk of financial liability measured under fair value option, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r500"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings/(accumulated deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r144",
      "r629",
      "r662",
      "r667",
      "r676",
      "r717",
      "r821"
     ]
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://www.emslp.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Percent of employees gross pay (as a percent)",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Expense",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 15.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r62"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r189",
      "r227",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r497",
      "r501",
      "r502",
      "r528",
      "r821",
      "r906",
      "r927",
      "r928"
     ]
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionRate",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction, Rate",
        "terseLabel": "Related party transaction rate",
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r835",
      "r836"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails",
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "totalLabel": "NET INCOME ATTRIBUTABLE TO SHAREHOLDERS",
        "verboseLabel": "Net income attributable to Longevity Market Assets",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r132",
      "r162",
      "r187",
      "r205",
      "r208",
      "r213",
      "r227",
      "r237",
      "r239",
      "r240",
      "r242",
      "r243",
      "r247",
      "r248",
      "r255",
      "r270",
      "r284",
      "r290",
      "r293",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r514",
      "r528",
      "r636",
      "r736",
      "r759",
      "r760",
      "r800",
      "r831",
      "r906"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r263",
      "r600",
      "r670",
      "r695",
      "r706",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r716",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r735",
      "r738",
      "r739",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r761",
      "r826"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r130"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r840"
     ]
    },
    "us-gaap_NetInvestmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetInvestmentIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Investment Income",
        "verboseLabel": "Active management",
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r639",
      "r640",
      "r746",
      "r831"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r130",
      "r224"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED-PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r558",
      "r561",
      "r678",
      "r679",
      "r680",
      "r742",
      "r743",
      "r744",
      "r765",
      "r767"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r740",
      "r741",
      "r744"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r740",
      "r741",
      "r744"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r471",
      "r472",
      "r478",
      "r479",
      "r480",
      "r482",
      "r671"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets Disclosure [Text Block]",
        "terseLabel": "OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombination"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "BUSINESS COMBINATION",
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r147"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r107",
      "r404",
      "r538",
      "r805",
      "r806"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r161",
      "r631",
      "r821",
      "r866",
      "r882",
      "r919"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfMergerRelatedCostsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Merger Related Costs, Financing Activities",
        "negatedTerseLabel": "Transaction costs",
        "documentation": "The cash outflow for financing costs associated with business combinations."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r523"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "terseLabel": "Exercise price",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r150",
      "r207",
      "r209",
      "r217",
      "r618",
      "r641"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Dividend Yield",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Term to expiration",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r136"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r384"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income (loss) attributable to non-controlling interests",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r78",
      "r92",
      "r207",
      "r209",
      "r218",
      "r619",
      "r642"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r405"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r301",
      "r358"
     ]
    },
    "abl_LifeInsuranceCarrierAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeInsuranceCarrierAxis",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Insurance Carrier [Axis]",
        "terseLabel": "Life Insurance Carrier [Axis]",
        "documentation": "Life Insurance Carrier"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r263",
      "r600",
      "r670",
      "r695",
      "r706",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r716",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r735",
      "r738",
      "r739",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r761",
      "r826"
     ]
    },
    "abl_LifeSettlementContractsFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractsFairValueMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value [Member]",
        "terseLabel": "Life Insurance Contract, Fair Value",
        "documentation": "Life Settlement Contracts, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "abl_AccruedTransactionCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "AccruedTransactionCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Transaction Costs, Current",
        "terseLabel": "Accrued transaction costs",
        "documentation": "Accrued Transaction Costs, Current"
       }
      }
     },
     "auth_ref": []
    },
    "abl_WarrantLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "WarrantLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liabilities, Noncurrent",
        "terseLabel": "Warrant liability",
        "verboseLabel": "Private placement warrants",
        "documentation": "Warrant Liabilities, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r121",
      "r200",
      "r628",
      "r663",
      "r667"
     ]
    },
    "abl_ProviderTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ProviderTwoMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provider Two [Member]",
        "terseLabel": "Provider Two",
        "documentation": "Provider Two"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LongevityMarketAdvisorsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LongevityMarketAdvisorsLLCMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Longevity Market Advisors, LLC [Member]",
        "terseLabel": "Longevity Market Advisors",
        "documentation": "Longevity Market Advisors, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 36.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r193",
      "r632"
     ]
    },
    "abl_ProviderOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ProviderOneMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provider One [Member]",
        "terseLabel": "Provider One",
        "documentation": "Provider One"
       }
      }
     },
     "auth_ref": []
    },
    "abl_CertificatesOfDepositNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "CertificatesOfDepositNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certificates Of Deposit, Noncurrent",
        "terseLabel": "Certificate of deposit",
        "documentation": "Certificates Of Deposit, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "abl_StateSecurityDepositsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "StateSecurityDepositsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State Security Deposits, Noncurrent",
        "terseLabel": "State security deposit",
        "documentation": "State Security Deposits, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Cost",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r98"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Asset",
        "terseLabel": "S&amp;P 500 options",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r527",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r722",
      "r723",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r796",
      "r825",
      "r939"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair value",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r527",
      "r805",
      "r806"
     ]
    },
    "abl_OwnersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "OwnersMember",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Owners [Member]",
        "terseLabel": "Owners",
        "documentation": "Owners"
       }
      }
     },
     "auth_ref": []
    },
    "abl_StockholdersEquityDeferredTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "StockholdersEquityDeferredTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity, Deferred Transaction Costs",
        "negatedTerseLabel": "Deferred transaction costs",
        "documentation": "Stockholders Equity, Deferred Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "abl_StockIssuedDuringPeriodValueReverseRecapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "StockIssuedDuringPeriodValueReverseRecapitalization",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Reverse Recapitalization",
        "terseLabel": "Merger with East Resources Acquisition Company",
        "documentation": "Stock Issued During Period, Value, Reverse Recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "abl_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "ROU Assets and Lease Liabilities",
        "documentation": "Assets And Liabilities, Lessee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "LONG-TERM DEBT",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r821"
     ]
    },
    "abl_StockIssuedDuringPeriodSharesReverseRecapitalization": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Reverse Recapitalization",
        "terseLabel": "Merger with East Resources Acquisition Company (in shares)",
        "documentation": "Stock Issued During Period, Shares, Reverse Recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractPurchasedFairValueMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractPurchasedFairValueMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract Purchased, Fair Value Method",
        "negatedTerseLabel": "Life Settlement Policies purchased, at fair value",
        "documentation": "Life Settlement Contract Purchased, Fair Value Method"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractPurchasedInvestmentMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractPurchasedInvestmentMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract Purchased, Investment Method",
        "negatedTerseLabel": "Life Settlement Policies purchased, at cost",
        "documentation": "Life Settlement Contract Purchased, Investment Method"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ProceedsDueFromPaymentsDueToAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ProceedsDueFromPaymentsDueToAffiliates",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds Due From (Payments) Due To Affiliates",
        "terseLabel": "Due from affiliates",
        "documentation": "Proceeds Due From (Payments) Due To Affiliates"
       }
      }
     },
     "auth_ref": []
    },
    "abl_WarrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "WarrantsPolicyTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Policy Text Block]",
        "terseLabel": "Warrants",
        "documentation": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LongevityMarketAssetsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LongevityMarketAssetsLLCMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/DescriptionOfBusinessDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Longevity Market Assets, LLC [Member]",
        "terseLabel": "LMA",
        "documentation": "Longevity Market Assets, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "abl_BusinessAcquisitionExchangeRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "BusinessAcquisitionExchangeRatio",
     "presentation": [
      "http://www.emslp.com/role/DescriptionOfBusinessDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Exchange Ratio",
        "terseLabel": "Exchange ratio",
        "documentation": "Business Acquisition, Exchange Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "abl_NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "NumberOfUnaffiliatedInvestorsInvolvedInVariableInterestEntityOwnership",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Unaffiliated Investors Involved In Variable Interest Entity Ownership",
        "terseLabel": "Number of unaffiliated investors",
        "documentation": "Number of Unaffiliated Investors"
       }
      }
     },
     "auth_ref": []
    },
    "abl_NumberOfProvidersInvolvedInOptionAgreement": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "NumberOfProvidersInvolvedInOptionAgreement",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Providers Involved In Option Agreement",
        "terseLabel": "Option agreement, number of providers",
        "documentation": "Number Of Providers Involved In Option Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ExpenseSupportAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ExpenseSupportAgreementMember",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Support Agreement [Member]",
        "terseLabel": "Expense Support Agreement",
        "documentation": "Expense Support Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LMATTIncomeSeriesIILPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LMATTIncomeSeriesIILPMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMATT Income Series II, LP [Member]",
        "terseLabel": "LMATT Income Series II, LP",
        "documentation": "LMATT Income Series II, LP"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LMATTGrowthIncomeSeries12026IncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LMATTGrowthIncomeSeries12026IncMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMATT Growth &amp; Income Series 1.2026, Inc [Member]",
        "terseLabel": "LMATT Growth &amp; Income Series 1.2026, Inc",
        "documentation": "LMATT Growth &amp; Income Series 1.2026, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LMATTSeries2024IncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LMATTSeries2024IncMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMATT Series 2024, Inc. [Member]",
        "terseLabel": "LMATT Series 2024, Inc.",
        "documentation": "LMATT Series 2024, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPremiumsPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Premiums Paid",
        "terseLabel": "Premiums paid",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Premiums Paid"
       }
      }
     },
     "auth_ref": []
    },
    "abl_SPVInvestmentFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SPVInvestmentFacilityMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SPV Investment Facility [Member]",
        "terseLabel": "SPV Investment Facility",
        "documentation": "SPV Investment Facility"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract [Member]",
        "terseLabel": "Life Insurance Policies",
        "documentation": "Life Settlement Contract"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r810",
      "r911",
      "r936",
      "r937"
     ]
    },
    "abl_DebtInstrumentMaximumMarketDownturnProtectionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentMaximumMarketDownturnProtectionPercentage",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maximum Market Downturn Protection Percentage",
        "terseLabel": "Market downturn protection percentage",
        "documentation": "Debt Instrument, Maximum Market Downturn Protection Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "abl_MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "MonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly Payments To Acquire, Equity Securities Without Readily Determinable Fair Value",
        "terseLabel": "Monthly payment amount",
        "documentation": "Monthly Payments To Acquire, Equity Securities Without Readily Determinable Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://www.emslp.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer match (as a percent)",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825",
      "r827",
      "r828",
      "r829",
      "r830",
      "r870",
      "r871",
      "r915",
      "r938",
      "r942"
     ]
    },
    "abl_NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "NumberOfMonthlyPaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Monthly Payments To Acquire Equity Securities Without Readily Determinable Fair Value",
        "terseLabel": "Number of monthly payments",
        "documentation": "Number Of Monthly Payments To Acquire Equity Securities Without Readily Determinable Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "abl_NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "NumberOfEntitiesInWhichEquitySecuritiesWithoutReadilyDeterminableFairValueAreHeld",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Entities In Which Equity Securities Without Readily Determinable Fair Value Are Held",
        "terseLabel": "Number of entities, convertible preferred stock ownership",
        "documentation": "Number Of Entities In Which Equity Securities Without Readily Determinable Fair Value Are Held"
       }
      }
     },
     "auth_ref": []
    },
    "abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate",
        "terseLabel": "Life settlement policies, change in fair value, impact of +2% discount rate adjustment",
        "documentation": "Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "abl_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecuritiesPurchased",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities Without Readily Determinable Fair Value, Number Of Securities Purchased",
        "terseLabel": "Units purchased (in shares)",
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Number Of Securities Purchased"
       }
      }
     },
     "auth_ref": []
    },
    "abl_FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "FairValueOptionChangeInFairValueGainLossAndCreditRiskGainsLossesOnAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Option, Change In Fair Value Gain (Loss) And Credit Risk, Gains (Losses) On Assets",
        "terseLabel": "Total change in fair value of debt",
        "verboseLabel": "Change in estimated fair value",
        "documentation": "Fair Value, Option, Change In Fair Value Gain (Loss) And Credit Risk, Gains (Losses) On Assets"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractsMeasurementInput": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractsMeasurementInput",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Measurement Input",
        "terseLabel": "Life settlement policies, measurement input",
        "documentation": "Life Settlement Contracts, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r497",
      "r501",
      "r502",
      "r580",
      "r581",
      "r582"
     ]
    },
    "abl_LifeSettlementContractsNumberOfContractsSold": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractsNumberOfContractsSold",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Number Of Contracts Sold",
        "terseLabel": "Life settlement policies sold",
        "documentation": "Life Settlement Contracts, Number Of Contracts Sold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "negatedTerseLabel": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r62"
     ]
    },
    "abl_ClassOfWarrantOrRightPricePerWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ClassOfWarrantOrRightPricePerWarrant",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class Of Warrant Or Right, Price Per Warrant",
        "terseLabel": "Price per warrant (in dollars per share)",
        "documentation": "Class Of Warrant Or Right, Price Per Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Unaudited Condensed Consolidated Financial Statements",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r797"
     ]
    },
    "abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEquityAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included In Equity, Attributable To Noncontrolling Interest",
        "terseLabel": "Gain on change in fair value of debt, included within equity of noncontrolling interests",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included In Equity, Attributable To Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r84",
      "r88",
      "r89",
      "r496",
      "r497",
      "r501",
      "r502",
      "r580",
      "r581",
      "r582"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current Assets",
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 37.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r190",
      "r793"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r496",
      "r497",
      "r501",
      "r502"
     ]
    },
    "abl_PrivatePlacementWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "PrivatePlacementWarrantMember",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrant [Member]",
        "terseLabel": "Private Placement Warrant",
        "documentation": "Private Placement Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "abl_SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SensitivityAnalysisOfFairValueChangeInLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate",
        "terseLabel": "Life settlement policies, change in fair value, impact of -2% discount rate adjustment",
        "documentation": "Sensitivity Analysis Of Fair Value, Change In Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Non-Current Assets",
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentAdverseChangeInDiscountRate",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate",
        "terseLabel": "Life settlement policies, fair value, impact of -2% discount rate adjustment",
        "documentation": "Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Adverse Change In Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT\u2014NET",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r173",
      "r176",
      "r177"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangibles",
        "verboseLabel": "Fair Value",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Ownership percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "abl_SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SensitivityAnalysisOfFairValueLifeSettlementContractsFairValueImpactOf2PercentPositiveChangeInDiscountRate",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate",
        "terseLabel": "Life settlement policies, fair value, impact of +2% discount rate adjustment",
        "documentation": "Sensitivity Analysis Of Fair Value, Life Settlement Contracts Fair Value, Impact Of 2 Percent Positive Change In Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeInsuranceCarrierConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeInsuranceCarrierConcentrationRiskMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Insurance Carrier Concentration Risk [Member]",
        "terseLabel": "Life Insurance Carrier Concentration Risk",
        "documentation": "Life Insurance Carrier Concentration Risk"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractsFaceValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractsFaceValueMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Face Value [Member]",
        "terseLabel": "Life Insurance Contract, Face Value",
        "documentation": "Life Settlement Contracts, Face Value"
       }
      }
     },
     "auth_ref": []
    },
    "abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Earnings",
        "terseLabel": "Unrealized gain(loss) on held policies",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Unrealized Gain (Loss) Included In Earnings"
       }
      }
     },
     "auth_ref": []
    },
    "abl_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetRealizedGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Realized Gain (Loss) Included in Earnings",
        "terseLabel": "Realized gain (loss) on matured/sold policies",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Asset, Realized Gain (Loss) Included In Earnings"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LMATTSeries22024IncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LMATTSeries22024IncMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMATT Series 2.2024, Inc. [Member]",
        "terseLabel": "LMATT Series 2.2024, Inc.",
        "documentation": "LMATT Series 2.2024, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r569",
      "r570",
      "r571",
      "r805",
      "r806",
      "r811",
      "r812",
      "r813"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "abl_SponsorPIKNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SponsorPIKNoteMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sponsor PIK Note [Member]",
        "terseLabel": "Sponsor PIK Note",
        "documentation": "Sponsor PIK Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "abl_LMATTIncomeSeriesLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LMATTIncomeSeriesLPMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMATT Income Series, LP [Member]",
        "terseLabel": "LMATT Income Series, LP",
        "documentation": "LMATT Income Series, LP"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.emslp.com/role/DescriptionOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r180"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrants outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/ShareholdersEquityDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r117",
      "r716",
      "r734",
      "r942",
      "r943"
     ]
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Intangible assets acquired",
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Class A common stock, $0.0001 par value; 200,000,000 authorized shares; 62,961,688 and 50,369,350 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r627",
      "r821"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "NET INCOME",
        "totalLabel": "NET INCOME",
        "terseLabel": "Net Income",
        "definitionGuidance": "Net income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r205",
      "r208",
      "r222",
      "r227",
      "r237",
      "r247",
      "r248",
      "r270",
      "r284",
      "r290",
      "r293",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r495",
      "r498",
      "r499",
      "r514",
      "r528",
      "r622",
      "r634",
      "r682",
      "r736",
      "r759",
      "r760",
      "r800",
      "r818",
      "r819",
      "r832",
      "r861",
      "r906"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r259",
      "r260",
      "r261"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r158"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST",
        "negatedTerseLabel": "Less: Net loss attributable to non-controlling interests",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r151",
      "r205",
      "r208",
      "r247",
      "r248",
      "r635",
      "r861"
     ]
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableOtherPayablesMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Market-indexed notes",
        "documentation": "A written promise to pay a note to a third party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured borrowing",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r564"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 33.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r202",
      "r227",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r496",
      "r501",
      "r528",
      "r821",
      "r906",
      "r907",
      "r927"
     ]
    },
    "us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityFinancialOrOtherSupportAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Financial or Other Support, Amount",
        "terseLabel": "Contribution amount",
        "documentation": "The amount of financial or other support the reporting entity has provided (explicitly or implicitly) to the Variable Interest Entity (VIE) that it was not previously contractually required to provide or that the reporting entity intends to provide, including, for example, situations in which the reporting entity assisted the VIE in obtaining another type of support."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDistributionsToAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDistributionsToAffiliates",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Distributions to Affiliates",
        "negatedLabel": "Capital distribution to members",
        "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income per share (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r239",
      "r240",
      "r242",
      "r243",
      "r245",
      "r253",
      "r256",
      "r257",
      "r258",
      "r262",
      "r513",
      "r514",
      "r621",
      "r644",
      "r798"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT REPORTING",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r282",
      "r287",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInNextTwelveMonths",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year One",
        "terseLabel": "1-2",
        "documentation": "Number of life settlement contracts accounted for under fair value method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Four",
        "terseLabel": "4-5",
        "documentation": "Number of life settlement contracts accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Revenue by Segment",
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Name",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Three",
        "terseLabel": "3-4",
        "documentation": "Number of life settlement contracts accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Two",
        "terseLabel": "2-3",
        "documentation": "Number of life settlement contracts accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchase of investments",
        "terseLabel": "Purchase of convertible promissory note",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r221",
      "r303"
     ]
    },
    "us-gaap_LifeSettlementContractsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsPolicy",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Policy [Policy Text Block]",
        "terseLabel": "Life Insurance Settlement Policies",
        "documentation": "Disclosure of accounting policy for life settlement contracts including the classification of cash receipts and cash disbursements in the statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r343"
     ]
    },
    "us-gaap_ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfLifeSettlementContractsInvestmentMethodTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Life Settlement Contracts, Investment Method [Table Text Block]",
        "terseLabel": "Schedule of Life Settlement Contracts, Investment Method",
        "documentation": "Tabular disclosure of life settlement contracts based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate including: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts, and (d) the life insurance premiums anticipated to be paid for each of the five succeeding fiscal years to keep the life settlement contracts in force as of the date of the most recent statement of financial position presented."
       }
      }
     },
     "auth_ref": [
      "r883",
      "r884",
      "r885",
      "r886"
     ]
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment\u2014gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r192",
      "r633"
     ]
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Fair Value Disclosure",
        "terseLabel": "Other assets",
        "documentation": "Fair value portion of other assets."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 32.0
      },
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment\u2014net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r623",
      "r633",
      "r821"
     ]
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "CONSOLIDATION OF VARIABLE INTEREST ENTITIES",
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49",
      "r50",
      "r170",
      "r171",
      "r174",
      "r175"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LeasesLeaseExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r544",
      "r820"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodStartLabel": "Fair value at beginning of period",
        "periodEndLabel": "Fair value at end of period",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LeasesLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r820"
     ]
    },
    "us-gaap_InsuranceServicesRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InsuranceServicesRevenue",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance Services Revenue",
        "totalLabel": "Total active management revenue",
        "documentation": "Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Commitment fee",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants (in dollars per share)",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LeasesLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r820"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.emslp.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r298"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income, Interest",
        "verboseLabel": "Interest income",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r273"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Investment Method, Premiums to be Paid",
        "totalLabel": "Total",
        "documentation": "Amount of life insurance premiums anticipated to be paid to keep the life settlement contracts accounted for under the investment method in force."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r53",
      "r56"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fair Value",
        "verboseLabel": "Long-term debt",
        "terseLabel": "Long-term debt, fair value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r93"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Consideration paid to acquire business",
        "terseLabel": "Consideration",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r9"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityAbstract",
     "presentation": [
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other current liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r53",
      "r56"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r474",
      "r625"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other noncurrent assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r160",
      "r227",
      "r338",
      "r395",
      "r397",
      "r398",
      "r399",
      "r402",
      "r403",
      "r528",
      "r630",
      "r718"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r452",
      "r462",
      "r463",
      "r464",
      "r465",
      "r572",
      "r599",
      "r657",
      "r704",
      "r705",
      "r769",
      "r770",
      "r771",
      "r772",
      "r779",
      "r790",
      "r791",
      "r801",
      "r809",
      "r816",
      "r822",
      "r825",
      "r903",
      "r910",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Proforma revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r493"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest (expense)",
        "terseLabel": "Interest (expense)",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r163",
      "r214",
      "r274",
      "r537",
      "r745",
      "r831",
      "r941"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Proforma net income",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r492",
      "r493"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r462",
      "r599",
      "r657",
      "r704",
      "r705",
      "r769",
      "r770",
      "r771",
      "r772",
      "r779",
      "r790",
      "r791",
      "r801",
      "r809",
      "r816",
      "r822",
      "r910",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 16.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrealized Gain (Loss) on Investments",
        "negatedLabel": "Unrealized loss (gain) on investments",
        "negatedTerseLabel": "Unrealized (gain) loss on investments",
        "terseLabel": "Unrealized gain (loss) on investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES (11)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r110",
      "r626",
      "r715"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r452",
      "r462",
      "r463",
      "r464",
      "r465",
      "r572",
      "r599",
      "r657",
      "r704",
      "r705",
      "r769",
      "r770",
      "r771",
      "r772",
      "r779",
      "r790",
      "r791",
      "r801",
      "r809",
      "r816",
      "r822",
      "r825",
      "r903",
      "r910",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 9.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing",
        "negatedTerseLabel": "Sales and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating right-of-use assets",
        "terseLabel": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r462",
      "r599",
      "r657",
      "r704",
      "r705",
      "r769",
      "r770",
      "r771",
      "r772",
      "r779",
      "r790",
      "r791",
      "r801",
      "r809",
      "r816",
      "r822",
      "r910",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Ownership Percentage, Parent",
        "terseLabel": "Ownership percentage",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r926"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r810",
      "r911",
      "r936",
      "r937"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r407",
      "r424",
      "r560",
      "r795",
      "r796"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued transaction costs",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive Income",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r18",
      "r206",
      "r209",
      "r216",
      "r529",
      "r530",
      "r535",
      "r617",
      "r637",
      "r859",
      "r860"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Contract liabilities\u2014deposits on pending settlements",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r451"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r470",
      "r477",
      "r478",
      "r481",
      "r485",
      "r489",
      "r490",
      "r491",
      "r677"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total portfolio servicing revenue",
        "verboseLabel": "Portfolio servicing",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r272",
      "r283",
      "r288",
      "r289",
      "r295",
      "r297",
      "r298",
      "r449",
      "r450",
      "r600"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails",
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "totalLabel": "Total lease liability",
        "terseLabel": "Lease liability as of June 30, 2023",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES",
        "terseLabel": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r227",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r497",
      "r501",
      "r502",
      "r528",
      "r714",
      "r799",
      "r833",
      "r906",
      "r927",
      "r928"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 10.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Profit",
        "totalLabel": "Gross Profit",
        "terseLabel": "Total gross profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r227",
      "r270",
      "r284",
      "r290",
      "r293",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r528",
      "r800",
      "r906"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInRemainderOfFiscalYear",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Remainder of Fiscal Year",
        "terseLabel": "0-1",
        "documentation": "Number of life settlement contracts accounted for under fair value method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_MarketApproachValuationTechniqueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketApproachValuationTechniqueMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation, Market Approach [Member]",
        "terseLabel": "Market approach",
        "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsFairValueMaturingInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMaturingInNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value, Maturity, Year One",
        "terseLabel": "1-2",
        "documentation": "Fair value of life settlement contract accounted for under fair value method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/Cover",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r197",
      "r198",
      "r199",
      "r227",
      "r253",
      "r254",
      "r256",
      "r258",
      "r264",
      "r265",
      "r338",
      "r395",
      "r397",
      "r398",
      "r399",
      "r402",
      "r403",
      "r422",
      "r423",
      "r426",
      "r429",
      "r436",
      "r528",
      "r672",
      "r673",
      "r674",
      "r675",
      "r683",
      "r684",
      "r685",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r716",
      "r737",
      "r761",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r838",
      "r864",
      "r874"
     ]
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments",
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsFairValueMaturingInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMaturingInYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value, Maturity, Year Two",
        "terseLabel": "2-3",
        "documentation": "Fair value of life settlement contract accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMaturingInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMaturingInYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value, Maturity, Year Three",
        "terseLabel": "3-4",
        "documentation": "Fair value of life settlement contract accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r563",
      "r565"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMaturingInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMaturingInYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value, Maturity, Year Four",
        "terseLabel": "4-5",
        "documentation": "Fair value of life settlement contract accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r787"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMaturingInRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value, Maturity, Remainder of Fiscal Year",
        "terseLabel": "0-1",
        "documentation": "Fair value of life settlement contract accounted for under fair value method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r172"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodFaceValueMaturingInNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodFaceValue",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year One",
        "terseLabel": "1-2",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of securities called by each warrant (in shares)",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodFaceValue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Two",
        "terseLabel": "2-3",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r225"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodFaceValue",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Three",
        "terseLabel": "3-4",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodFaceValue",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Four",
        "terseLabel": "4-5",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodFaceValueMaturingInRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodFaceValue",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Face Value, Maturity, Remainder of Fiscal Year",
        "terseLabel": "0-1",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income per share (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r239",
      "r240",
      "r242",
      "r243",
      "r245",
      "r251",
      "r253",
      "r256",
      "r257",
      "r258",
      "r262",
      "r513",
      "r514",
      "r621",
      "r644",
      "r798"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation expense",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r275"
     ]
    },
    "abl_AmericanGeneralLifeInsuranceCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "AmericanGeneralLifeInsuranceCompanyMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "American General Life Insurance Company [Member]",
        "terseLabel": "American General Life Insurance Company",
        "documentation": "American General Life Insurance Company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year One",
        "terseLabel": "1-2",
        "documentation": "Number of life settlement contracts accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r366",
      "r367",
      "r420",
      "r434",
      "r509",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r638",
      "r802",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r878",
      "r879",
      "r880",
      "r881"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOptionCreditRiskGainsLossesOnAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOptionCreditRiskGainsLossesOnAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Option, Credit Risk, Gains (Losses) on Assets",
        "negatedLabel": "Unrealized gain on change in fair value (credit-adjusted)",
        "documentation": "This item represents the estimated amount of gains or losses included in earnings during the period attributable to changes in instrument-specific credit risk arising from loans and other receivables held as assets."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Two",
        "terseLabel": "2-3",
        "documentation": "Number of life settlement contracts accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "abl_LincolnNationalLifeInsuranceCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LincolnNationalLifeInsuranceCompanyMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lincoln National Life Insurance Company [Member]",
        "terseLabel": "Lincoln National Life Insurance Company",
        "documentation": "Lincoln National Life Insurance Company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Three",
        "terseLabel": "3-4",
        "documentation": "Number of life settlement contracts accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Four",
        "terseLabel": "4-5",
        "documentation": "Number of life settlement contracts accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "abl_ReliaStarLifeInsuranceCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ReliaStarLifeInsuranceCompanyMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ReliaStar Life Insurance Company [Member]",
        "terseLabel": "ReliaStar Life Insurance Company",
        "documentation": "ReliaStar Life Insurance Company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInRemainderOfFiscalYear",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Remainder of Fiscal Year",
        "terseLabel": "0-1",
        "documentation": "Number of life settlement contracts accounted for under investment method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Amount, Maturity, Year Two",
        "terseLabel": "2-3",
        "documentation": "Amount of life settlement contract accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Amount, Maturity, Year One",
        "terseLabel": "1-2",
        "documentation": "Amount of life settlement contract accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "abl_LifeInsuranceCarrierDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeInsuranceCarrierDomain",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Insurance Carrier [Domain]",
        "terseLabel": "Life Insurance Carrier [Domain]",
        "documentation": "Life Insurance Carrier [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remaining of 2023",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Future Minimum Noncancellable Lease Payments",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r298",
      "r787"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Summary of Property and Equipment, Net",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue",
        "terseLabel": "Total cost of revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r227",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r528",
      "r906"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Consolidation of Variable Interest Entities",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r83",
      "r85"
     ]
    },
    "us-gaap_CostOfRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenueAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "COST OF REVENUES (excluding depreciation stated below)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interest",
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.emslp.com/role/LeasesLeaseTermsAndDiscountRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r820"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Unaudited Condensed Consolidated Financial Statements",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r267",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r298",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r386",
      "r387",
      "r388",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r803",
      "r845",
      "r936"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total operating lease payments (undiscounted)",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring",
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r94",
      "r96",
      "r152"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS",
        "terseLabel": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r196",
      "r227",
      "r270",
      "r285",
      "r291",
      "r338",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r496",
      "r501",
      "r528",
      "r624",
      "r728",
      "r821",
      "r833",
      "r906",
      "r907",
      "r927"
     ]
    },
    "srt_AffiliatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AffiliatedEntityMember",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r789",
      "r826",
      "r912",
      "r924",
      "r925",
      "r926"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r496",
      "r497",
      "r501",
      "r502",
      "r562",
      "r789",
      "r905",
      "r908",
      "r909"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r354",
      "r357",
      "r466",
      "r467",
      "r468",
      "r483",
      "r484",
      "r503",
      "r505",
      "r506",
      "r508",
      "r512",
      "r658",
      "r660",
      "r683",
      "r942"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherReceivableAfterAllowanceForCreditLossNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivableAfterAllowanceForCreditLossNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Due from members and affiliates",
        "documentation": "Amount, after allowance for credit loss, of receivable classified as other and noncurrent."
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_OtherLongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Long-Term Debt, Noncurrent",
        "verboseLabel": "Long-term debt, at fair value",
        "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r713"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r28",
      "r184",
      "r211",
      "r212",
      "r213",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r263",
      "r354",
      "r357",
      "r438",
      "r466",
      "r467",
      "r468",
      "r483",
      "r484",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r512",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r553",
      "r658",
      "r659",
      "r660",
      "r683",
      "r761"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r233",
      "r496",
      "r497",
      "r501",
      "r502",
      "r562",
      "r789",
      "r905",
      "r908",
      "r909"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r467",
      "r468",
      "r683",
      "r870",
      "r871",
      "r872",
      "r915",
      "r942"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PostemploymentBenefitsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets, at fair value",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r233",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r538",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r865"
     ]
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r184",
      "r211",
      "r212",
      "r213",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r263",
      "r354",
      "r357",
      "r438",
      "r466",
      "r467",
      "r468",
      "r483",
      "r484",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r512",
      "r529",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r553",
      "r658",
      "r659",
      "r660",
      "r683",
      "r761"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r10",
      "r31",
      "r504",
      "r507",
      "r553",
      "r658",
      "r659",
      "r859",
      "r860",
      "r861",
      "r870",
      "r871",
      "r872"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by (used in) operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/IncomeTaxesDetails",
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provision for income taxes",
        "negatedLabel": "Provision for income taxes",
        "terseLabel": "Provision for income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r179",
      "r247",
      "r248",
      "r278",
      "r475",
      "r486",
      "r645"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Purchase price allocation",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r262",
      "r355",
      "r356",
      "r484",
      "r511",
      "r512",
      "r513",
      "r514",
      "r539",
      "r552",
      "r553",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r669"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r262",
      "r355",
      "r356",
      "r484",
      "r511",
      "r512",
      "r513",
      "r514",
      "r539",
      "r552",
      "r553",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r669"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r538",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r865"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r114",
      "r115",
      "r157",
      "r159",
      "r233",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r538",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r865"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Non-cash lease expense",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r66",
      "r67",
      "r104",
      "r105",
      "r107",
      "r111",
      "r142",
      "r143",
      "r233",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r538",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r865"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Amount, Maturity, Year Three",
        "terseLabel": "3-4",
        "documentation": "Amount of life settlement contract accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "abl_LifeSettlementContractsOriginationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractsOriginationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Origination Expense",
        "terseLabel": "Origination expenses for life settlement policies",
        "documentation": "Life Settlement Contracts, Origination Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from receipt of SPV purchase and sale note",
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "SHAREHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "auth_ref": []
    },
    "abl_VariableRateComponentThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "VariableRateComponentThreeMember",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate Component Three [Member]",
        "terseLabel": "Variable Rate Component Three",
        "documentation": "Variable Rate Component Three"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Term",
        "verboseLabel": "Warrants term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Cost of Revenues",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r792"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Amount, Maturity, Year Four",
        "terseLabel": "4-5",
        "documentation": "Amount of life settlement contract accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r453",
      "r458",
      "r517",
      "r570",
      "r805",
      "r806",
      "r811",
      "r812",
      "r813"
     ]
    },
    "abl_VariableRateComponentTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "VariableRateComponentTwoMember",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate Component Two [Member]",
        "terseLabel": "Variable Rate Component Two",
        "documentation": "Variable Rate Component Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r517",
      "r571",
      "r805",
      "r806",
      "r811",
      "r812",
      "r813"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- Controlling Interests",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r438",
      "r870",
      "r871",
      "r872",
      "r942"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Debt issued to third parties",
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodCarryingAmountMaturingInRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Amount, Maturity, Remainder of Fiscal Year",
        "terseLabel": "0-1",
        "documentation": "Amount of life settlement contract accounted for under investment method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax:"
       }
      }
     },
     "auth_ref": []
    },
    "abl_VariableRateComponentOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "VariableRateComponentOneMember",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate Component One [Member]",
        "terseLabel": "Variable Rate Component One",
        "documentation": "Variable Rate Component One"
       }
      }
     },
     "auth_ref": []
    },
    "abl_VariableRateComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "VariableRateComponentDomain",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate Component [Domain]",
        "terseLabel": "Variable Rate Component [Domain]",
        "documentation": "Variable Rate Component [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentAmortizationPaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentAmortizationPaymentPercentage",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Amortization Payment, Percentage",
        "terseLabel": "Amortization payment percentage",
        "documentation": "Debt Instrument, Amortization Payment, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "abl_BinomialLatticeModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "BinomialLatticeModelMember",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Binomial Lattice Model [Member]",
        "terseLabel": "Binomial Lattice Model",
        "documentation": "Binomial Lattice Model"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total shareholders' equity (deficit)",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r90",
      "r184",
      "r185",
      "r212",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r354",
      "r357",
      "r438",
      "r466",
      "r467",
      "r468",
      "r483",
      "r484",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r512",
      "r529",
      "r531",
      "r535",
      "r553",
      "r659",
      "r660",
      "r681",
      "r718",
      "r734",
      "r762",
      "r763",
      "r785",
      "r832",
      "r866",
      "r882",
      "r919",
      "r942"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFaceValue",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Face Value, Maturity, Year One",
        "terseLabel": "1-2",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFaceValue",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Face Value, Maturity, Year Two",
        "terseLabel": "2-3",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFaceValue",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Face Value, Maturity, Year Three",
        "terseLabel": "3-4",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFaceValue",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Face Value, Maturity, Year Four",
        "terseLabel": "4-5",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "abl_ExpenseReimbursementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ExpenseReimbursementsMember",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Reimbursements [Member]",
        "terseLabel": "Expense Reimbursements",
        "documentation": "Expense Reimbursements"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ServiceFeeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ServiceFeeAgreementMember",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Fee Agreement [Member]",
        "terseLabel": "Service Fee Agreement",
        "documentation": "Service Fee Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFaceValueMaturingInRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFaceValue",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Face Value, Maturity, Remainder of Fiscal Year",
        "terseLabel": "0-1",
        "documentation": "Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "abl_NovaTradingUSLLCAndNovaHoldingUSLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "NovaTradingUSLLCAndNovaHoldingUSLPMember",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nova Trading (US), LLC And Nova Holding (US) LP [Member]",
        "terseLabel": "Nova Funds",
        "documentation": "Nova Trading (US), LLC And Nova Holding (US) LP"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetPledgedAsCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetPledgedAsCollateralMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Pledged as Collateral [Member]",
        "terseLabel": "Asset Pledged as Collateral",
        "documentation": "Asset pledged as collateral."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r707",
      "r817",
      "r935"
     ]
    },
    "abl_OperatingLeaseAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "OperatingLeaseAssetAbstract",
     "presentation": [
      "http://www.emslp.com/role/LeasesRouAssetsAndLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Asset [Abstract]",
        "terseLabel": "Assets:",
        "documentation": "Operating Lease, Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Policies purchased",
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.emslp.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate percentage",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedTerseLabel": "Matured/sold policies",
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Premium to be Paid, Year One",
        "terseLabel": "2024",
        "documentation": "Amount of life insurance premium accounted for under investment method to be paid in next fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "abl_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LeasesFutureMinimumNoncancellableLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Premium to be Paid, Year Two",
        "terseLabel": "2025",
        "documentation": "Amount of life insurance premium accounted for under investment method to be paid in second fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Premium to be Paid, Year Three",
        "terseLabel": "2026",
        "documentation": "Amount of life insurance premium accounted for under investment method to be paid in third fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "verboseLabel": "Diluted weighted average shares outstanding (in shares)",
        "terseLabel": "Weighted-average shares used in computing net income per share, diluted (in shares)",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r258"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodPremiumsToBePaidInRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Premium to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 remaining",
        "documentation": "Amount of life insurance premium accounted for under investment method to be paid in remainder of current fiscal year to keep life settlement contract in force."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "terseLabel": "Impairment of investments",
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Additional borrowing capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "abl_OwlRockCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "OwlRockCreditFacilityMember",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Owl Rock Credit Facility [Member]",
        "terseLabel": "Owl Rock Credit Facility",
        "documentation": "Owl Rock Credit Facility"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.emslp.com/role/EarningsPerShareBasicAndDilutedDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted average shares outstanding (in shares)",
        "verboseLabel": "Weighted-average shares used in computing net income per share, basic (in shares)",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r258"
     ]
    },
    "abl_DebtInstrumentCovenantMandatoryPrepaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCovenantMandatoryPrepaymentPercentage",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant, Mandatory Prepayment Percentage",
        "terseLabel": "Mandatory prepayment percentage",
        "documentation": "Debt Instrument, Covenant, Mandatory Prepayment Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r298"
     ]
    },
    "abl_DebtInstrumentAmortizationPaymentPercentagePerQuarter": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentAmortizationPaymentPercentagePerQuarter",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Amortization Payment, Percentage Per Quarter",
        "terseLabel": "Amortization payment per quarter",
        "documentation": "Debt Instrument, Amortization Payment, Percentage Per Quarter"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentBasisSpreadOnVariableRateTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentBasisSpreadOnVariableRateTerm",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Basis Spread on Variable Rate, Term",
        "terseLabel": "Basis spread on variable rate, term",
        "documentation": "Debt Instrument, Basis Spread on Variable Rate, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Available for sale securities, at fair value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r304",
      "r364"
     ]
    },
    "abl_DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCovenantPrepaymentPremiumPriorToFirstAnniversary",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant, Prepayment Premium Prior To First Anniversary",
        "terseLabel": "Prepayment premium prior to first anniversary",
        "documentation": "Debt Instrument, Covenant, Prepayment Premium Prior To First Anniversary"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCovenantPrepaymentPremiumPriorToSecondAnniversary",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant, Prepayment Premium Prior To Second Anniversary",
        "terseLabel": "Prepayment premium prior to second anniversary",
        "documentation": "Debt Instrument, Covenant, Prepayment Premium Prior To Second Anniversary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Available-for-sale securities, at fair value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r308",
      "r364",
      "r616",
      "r877"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "abl_DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCovenantPrepaymentPremiumAfterSecondAnniversary",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant, Prepayment Premium After Second Anniversary",
        "terseLabel": "Prepayment premium after second anniversary",
        "documentation": "Debt Instrument, Covenant, Prepayment Premium After Second Anniversary"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://www.emslp.com/role/EmployeeBenefitPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Maximum annual contributions (as a percent)",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.emslp.com/role/ConsolidationOfVariableInterestEntitiesDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentCovenantLeverageRatioMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Maximum leverage ratio",
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCovenantSecuritiesPercentageOfGrossRevenueMaximum",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant, Securities Percentage Of Gross Revenue, Maximum",
        "terseLabel": "Maximum securities related activities percentage of aggregate gross revenues",
        "documentation": "Debt Instrument, Covenant, Securities Percentage Of Gross Revenue, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LineOfCreditFacilityRemainingBorrowingCapacityTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacityTerm",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Remaining Borrowing Capacity, Term",
        "terseLabel": "Additional borrowing capacity availability period",
        "documentation": "Line of Credit Facility, Remaining Borrowing Capacity, Term"
       }
      }
     },
     "auth_ref": []
    },
    "abl_DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtInstrumentCovenantLiquidAssetCoverageRatioMinimum",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant, Liquid Asset Coverage Ratio, Minimum",
        "terseLabel": "Liquid asset minimum coverage ratio",
        "documentation": "Debt Instrument, Covenant, Liquid Asset Coverage Ratio, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r821",
      "r940"
     ]
    },
    "abl_VariableRateComponentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "VariableRateComponentAxis",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate Component [Axis]",
        "terseLabel": "Variable Rate Component [Axis]",
        "documentation": "Variable Rate Component"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0,
       "order": 17.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsIssuedNotesDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "negatedTerseLabel": "Loss on change in fair value of debt",
        "verboseLabel": "Loss on change in fair value of debt",
        "negatedLabel": "Unrealized loss on change in fair value (risk-free)",
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "abl_RegionalInvestmentServicesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "RegionalInvestmentServicesIncMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Regional Investment Services,\u00a0Inc [Member]",
        "terseLabel": "RIS",
        "documentation": "Regional Investment Services,\u00a0Inc"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LMXSeriesLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LMXSeriesLLCMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMX Series, LLC [Member]",
        "terseLabel": "LMX",
        "documentation": "LMX Series, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedules of Concentration of Risk, by Risk Factor",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r46",
      "r47",
      "r99",
      "r153"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      },
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative expenses",
        "negatedTerseLabel": "General, administrative and other",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r739"
     ]
    },
    "abl_BusinessCombinationMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "BusinessCombinationMeasurementInput",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Measurement Input",
        "terseLabel": "Measurement input",
        "documentation": "Business Combination, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r564"
     ]
    },
    "abl_LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractInvestmentMethodNumberOfContractsMaturityAfterYearFour",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Number Of Contracts, Maturity, After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Life Settlement Contract, Investment Method, Number Of Contracts, Maturity, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractInvestmentMethodPremiumToBePaidAfterYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesEstimatedPremiumsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Premium To Be Paid, After Year Three",
        "terseLabel": "Thereafter",
        "documentation": "Life Settlement Contract, Investment Method, Premium To Be Paid, After Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/DescriptionOfBusinessDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "abl_SeriesSeedPreferredUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SeriesSeedPreferredUnitsMember",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series Seed Preferred Units [Member]",
        "terseLabel": "Series Seed Preferred Units",
        "documentation": "Series Seed Preferred Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r564"
     ]
    },
    "abl_SeriesB1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "SeriesB1PreferredStockMember",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B-1 Preferred Stock [Member]",
        "terseLabel": "Series B-1 Preferred Stock",
        "documentation": "Series B-1 Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r564"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured borrowing",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Value conveyed",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71"
     ]
    },
    "abl_DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "DebtSecuritiesAvailableForSaleEquityFinancingThresholdInWhichSharesConvert",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-For-Sale, Equity Financing Threshold In Which Shares Convert",
        "terseLabel": "Equity financing threshold",
        "documentation": "Debt Securities, Available-For-Sale, Equity Financing Threshold In Which Shares Convert"
       }
      }
     },
     "auth_ref": []
    },
    "abl_Customer1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "Customer1Member",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer 1 [Member]",
        "terseLabel": "Customer 1",
        "documentation": "Customer 1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r536",
      "r564"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleWeightedAverageYield": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleWeightedAverageYield",
     "presentation": [
      "http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Weighted Average Yield",
        "terseLabel": "Interest rate per annum",
        "documentation": "Weighted average yield of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "us-gaap_DefinedContributionPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanTextBlock",
     "presentation": [
      "http://www.emslp.com/role/EmployeeBenefitPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLAN",
        "documentation": "The entire disclosure for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461"
     ]
    },
    "abl_Customer2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "Customer2Member",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer 2 [Member]",
        "terseLabel": "Customer 2",
        "documentation": "Customer 2"
       }
      }
     },
     "auth_ref": []
    },
    "abl_PortfolioServicingSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "PortfolioServicingSegmentMember",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Portfolio Servicing Segment [Member]",
        "terseLabel": "Portfolio servicing",
        "documentation": "Portfolio Servicing Segment"
       }
      }
     },
     "auth_ref": []
    },
    "abl_ActiveManagementSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "ActiveManagementSegmentMember",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Active Management Segment [Member]",
        "terseLabel": "Active management",
        "documentation": "Active Management Segment"
       }
      }
     },
     "auth_ref": []
    },
    "abl_InvestmentMethodRevenueBenchmarkMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "InvestmentMethodRevenueBenchmarkMember",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Method Revenue Benchmark [Member]",
        "terseLabel": "Investment Method Revenue Benchmark",
        "documentation": "Investment Method Revenue Benchmark"
       }
      }
     },
     "auth_ref": []
    },
    "abl_CustomerRelationshipAgentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "CustomerRelationshipAgentsMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationship, Agents [Member]",
        "terseLabel": "Customer Relationships - Agents",
        "documentation": "Customer Relationship, Agents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Secured Long-Term Debt, Noncurrent",
        "terseLabel": "SPV purchase and sale note",
        "documentation": "Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "abl_MarketPlaceTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "MarketPlaceTechnologyMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market Place Technology [Member]",
        "terseLabel": "Internally Developed and Used Technology\u2014Market Place",
        "documentation": "Market Place Technology"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r234",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r248",
      "r262",
      "r484",
      "r511",
      "r512",
      "r513",
      "r539",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r669",
      "r844",
      "r846",
      "r847",
      "r848",
      "r873",
      "r890",
      "r891",
      "r916",
      "r922",
      "r923"
     ]
    },
    "abl_LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LongevityMarketAssetsLLCAndAbacusSettlementsLLCMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails",
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Longevity Market Assets,\u00a0LLC And Abacus Settlements LLC [Member]",
        "terseLabel": "LMA and Abacus",
        "documentation": "Longevity Market Assets,\u00a0LLC And Abacus Settlements LLC"
       }
      }
     },
     "auth_ref": []
    },
    "abl_CustomerRelationshipsFinancialRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "CustomerRelationshipsFinancialRelationshipsMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships, Financial Relationships [Member]",
        "terseLabel": "Customer Relationships - Financial Relationships",
        "documentation": "Customer Relationships, Financial Relationships"
       }
      }
     },
     "auth_ref": []
    },
    "abl_AbacusSettlementsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "AbacusSettlementsLLCMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Abacus Settlements LLC [Member]",
        "terseLabel": "Abacus",
        "verboseLabel": "Abacus Settlements, LLC",
        "documentation": "Abacus Settlements LLC"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee",
     "presentation": [
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage",
        "terseLabel": "Equity ownership percentage",
        "documentation": "Percentage of ownership of equity interest excluding interest in entity that is consolidated and equity method investee."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses",
        "negatedTerseLabel": "Accrued Expenses",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfLifeSettlementContractsFairValueMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfLifeSettlementContractsFairValueMethodTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Life Settlement Contracts, Fair Value Method [Table Text Block]",
        "terseLabel": "Schedule of Life Settlement Contracts, Fair Value Method",
        "documentation": "Tabular disclosure of life settlement contracts based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate including: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r888",
      "r889"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_LimitedPartnerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedPartnerMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Limited Partner [Member]",
        "terseLabel": "Limited Partner",
        "documentation": "Party to a partnership business who has limited liability."
       }
      }
     },
     "auth_ref": []
    },
    "abl_BusinessCombinationEnterpriseValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "BusinessCombinationEnterpriseValue",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Enterprise Value",
        "terseLabel": "Enterprise value",
        "documentation": "Business Combination, Enterprise Value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary of Limited Liability Company or Limited Partnership [Line Items]",
        "terseLabel": "Subsidiary of Limited Liability Company or Limited Partnership [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractsNumberOfContracts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractsNumberOfContracts",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Number Of Contracts",
        "terseLabel": "Number of life settlement policies",
        "documentation": "Life Settlement Contracts, Number Of Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "abl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Other",
        "negatedTerseLabel": "Other Liabilities",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r803",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902"
     ]
    },
    "abl_APATechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "APATechnologyMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APA Technology [Member]",
        "terseLabel": "Internally Developed and Used Technology\u2014APA",
        "documentation": "APA Technology"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipTable",
     "presentation": [
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Subsidiary of Limited Liability Company or Limited Partnership [Table]",
        "terseLabel": "Schedule of Subsidiary of Limited Liability Company or Limited Partnership [Table]",
        "documentation": "This table describes the key aspects of a subsidiary (partnership, corporation, or other entity) of the Limited Liability Company (LLC) or Limited Partnership (LP)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_GeneralPartnerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralPartnerMember",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Partner [Member]",
        "terseLabel": "General Partner",
        "documentation": "Party to a partnership business who has unlimited liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PledgedStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PledgedStatusAxis",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pledged Status [Axis]",
        "terseLabel": "Pledged Status [Axis]",
        "documentation": "Information by pledged or not pledged status of asset owned by entity."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r707",
      "r817"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.emslp.com/role/PropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r803"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "SHAREHOLDERS' EQUITY",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r226",
      "r421",
      "r423",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r435",
      "r438",
      "r510",
      "r764",
      "r766",
      "r786"
     ]
    },
    "abl_LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractInvestmentMethodAmountMaturityAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Amount, Maturity, After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Life Settlement Contract, Investment Method, Amount, Maturity, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "terseLabel": "Related Party",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r557",
      "r558",
      "r559",
      "r560",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r733",
      "r735",
      "r768"
     ]
    },
    "abl_LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractInvestmentMethodFaceValueMaturityAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsInvestmentMethodFaceValue",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Investment Method, Face Value, Maturity, After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Life Settlement Contract, Investment Method, Face Value, Maturity, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PledgedStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PledgedStatusDomain",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pledged Status [Domain]",
        "terseLabel": "Pledged Status [Domain]",
        "documentation": "Pledged or not pledged status of asset owned by entity."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r707",
      "r817"
     ]
    },
    "abl_LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractFairValueMethodNumberOfContractsMaturityAfterYearFour",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "abl_LifeSettlementContractFairValueMaturityAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractFairValueMaturityAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value, Maturity, After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Life Settlement Contract, Fair Value, Maturity, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "terseLabel": "Nonrelated Party",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r868",
      "r869"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]",
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r803"
     ]
    },
    "abl_LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.emslp.com/20230630",
     "localname": "LifeSettlementContractFairValueMethodFaceValueMaturityAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": "us-gaap_LifeSettlementContractsFairValueMethodFaceValue",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contract, Fair Value Method, Face Value, Maturity, After Year Four",
        "terseLabel": "Thereafter",
        "documentation": "Life Settlement Contract, Fair Value Method, Face Value, Maturity, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities held at fair value:",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r821"
     ]
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets held at fair value",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidateBalanceSheetsParenthetical",
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/Cover",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r197",
      "r198",
      "r199",
      "r227",
      "r253",
      "r254",
      "r256",
      "r258",
      "r264",
      "r265",
      "r338",
      "r395",
      "r397",
      "r398",
      "r399",
      "r402",
      "r403",
      "r422",
      "r423",
      "r426",
      "r429",
      "r436",
      "r528",
      "r672",
      "r673",
      "r674",
      "r675",
      "r683",
      "r684",
      "r685",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r716",
      "r737",
      "r761",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r838",
      "r864",
      "r874"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails",
      "http://www.emslp.com/role/SegmentReportingRevenueBySegmentDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r298",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r387",
      "r388",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r803",
      "r845",
      "r936"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Other Long-Term Debt",
        "terseLabel": "Issuance of debt certificates",
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r298",
      "r787"
     ]
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "totalLabel": "Net income before provision for income taxes",
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r861"
     ]
    },
    "us-gaap_FairValueConcentrationOfRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueConcentrationOfRiskTable",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Concentration of Risk [Table]",
        "terseLabel": "Fair Value, Concentration of Risk [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. Such disclosure may also include quantitative information about the market risks of financial instruments that is consistent with the way the Company manages or adjusts those risks."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r101",
      "r153",
      "r154"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConcentrationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46",
      "r99",
      "r100",
      "r298",
      "r668",
      "r787"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Public warrants",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r65",
      "r144"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRevenueExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRevenueExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/SegmentReportingReconciliationOfNetIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Revenue (Expense), Net",
        "terseLabel": "Interest expense",
        "documentation": "Amount of interest revenue (income derived from investments in debt securities and on cash and cash equivalents) net of interest expense (cost of borrowed funds accounted for as interest)."
       }
      }
     },
     "auth_ref": [
      "r270"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails",
      "http://www.emslp.com/role/OtherInvestmentsAndOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "verboseLabel": "Other investments",
        "terseLabel": "Equity securities without readily determinable fair value, amount",
        "documentation": "Amount of investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "us-gaap_FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueConcentrationOfRiskFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsCreditExposureToInsuranceCompaniesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/AvailableForSaleSecuritiesAtFairValue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r164",
      "r165",
      "r183",
      "r302",
      "r305",
      "r524",
      "r525"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 27.0
      },
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/FairValueMeasurementsDiscountRateSensitivityDetails",
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value",
        "terseLabel": "Life settlement policies, at fair value",
        "totalLabel": "Fair Value",
        "verboseLabel": "Life settlement policies",
        "documentation": "Fair value amount of life settlement contracts accounted for under the fair value method."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r351"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodFaceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodFaceValue",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value Method, Face Value",
        "terseLabel": "Face value of policies held at fair value",
        "totalLabel": "Face Value",
        "documentation": "Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the fair value method."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in estimated fair value",
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodNumberOfContracts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodNumberOfContracts",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesFairValueDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value Method, Number of Contracts",
        "terseLabel": "Number of life settlement policies accounted for under fair value method",
        "totalLabel": "Policies",
        "documentation": "Number of life settlement contracts accounted for under the fair value method."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.emslp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Common Stock Price",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk-free interest rate",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InsuranceInvestmentIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InsuranceInvestmentIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_InsuranceServicesRevenue",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance Investment Income",
        "terseLabel": "Investment Income from life insurance policies held using investment method",
        "documentation": "Investment income associated with the company's insurance services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LifeSettlementContractsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsDisclosureTextBlock",
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Disclosure [Text Block]",
        "terseLabel": "LIFE INSURANCE SETTLEMENT POLICIES",
        "documentation": "The entire disclosure for life settlement contracts including the accounting policy for life settlement contracts and the classification of cash receipts and cash disbursements in the statement of cash flows and, as applicable, for (1) life settlement contracts accounted for under the investment method based on the remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, and (c) the face value (death benefits) of the life insurance policies underlying the contracts, (d) the life insurance premiums anticipated to be paid for each of the five succeeding fiscal years to keep the life settlement contracts in force as of the date of the most recent statement of financial position presented, (e) the nature of the information that causes the Entity to change its expectations on the timing of the realization of proceeds from the investments in life settlement contracts and the related effect on the timing of the realization of proceeds from the life settlement contracts and for (2) life settlement contracts accounted for under the fair value method, disclosure would include, based on remaining life expectancy for each of the first five succeeding years from the date of the statement of financial position and thereafter, as well as in the aggregate: (a) the number of life settlement contracts, (b) the carrying value of the life settlement contracts, (c) the face value (death benefits) of the life insurance policies underlying the contracts, (d) the reasons for changes in the Entity's expectation of the timing of the realization of the investments in life settlement contracts, and (e) (i) the gains or losses recognized during the period on investments sold during the period and (ii) the unrealized gains or losses recognized during the period on investments that are still held at the date of the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r348",
      "r349",
      "r353"
     ]
    },
    "us-gaap_LicensingAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LicensingAgreementsMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsIntangibleAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Licensing Agreements [Member]",
        "terseLabel": "State Insurance Licenses",
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r469",
      "r913"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Discounted cash flow method",
        "documentation": "Valuation technique calculating present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails",
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/DescriptionOfBusinessDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71",
      "r494",
      "r814",
      "r815"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome": {
       "parentTag": "us-gaap_InsuranceServicesRevenue",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value Method, Gain (Loss)",
        "terseLabel": "Change in fair value of life insurance policies (policies held using fair value method)",
        "negatedLabel": "Decrease in valuation compared to third-party valuation",
        "documentation": "This item represents the gains or losses recognized and realized during the period on investments in life settlement contracts sold during the period."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails",
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/DescriptionOfBusinessDetails",
      "http://www.emslp.com/role/GoodwillAndOtherIntangibleAssetsChangesInGoodwillByReportableSegmentsDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r814",
      "r815"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesIiLpAndLmaIncomeSeriesIiGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmaIncomeSeriesLpAndLmaIncomeSeriesGpLlcSecuredBorrowingDetails",
      "http://www.emslp.com/role/LongTermDebtLmattGrowthAndIncomeSeries12026IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries2024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLmattSeries22024IncMarketIndexedNotesDetails",
      "http://www.emslp.com/role/LongTermDebtLongTermDebtDetails",
      "http://www.emslp.com/role/LongTermDebtSponsorPikNoteDetails",
      "http://www.emslp.com/role/LongTermDebtSpvPurchaseAndSaleAndSpvInvestmentFacilityDetails",
      "http://www.emslp.com/role/RelatedPartyTransactionsDetails",
      "http://www.emslp.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r64"
     ]
    },
    "us-gaap_LifeSettlementContractsFairValueMethodUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsFairValueMethodUnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.emslp.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Fair Value Method, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Unrealized gain on policies",
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of investments in life settlement contracts held at each balance sheet date, that was included in earnings for the period."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails",
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/DescriptionOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71",
      "r494"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodFaceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodFaceValue",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Investment Method, Face Value",
        "terseLabel": "Face value of policies accounted for using investment method",
        "totalLabel": "Face Value",
        "documentation": "Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the investment method."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationIntangibleAssetsAcquiredDetails",
      "http://www.emslp.com/role/BusinessCombinationNarrativeDetails",
      "http://www.emslp.com/role/BusinessCombinationProFormaFinancialInformationDetails",
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails",
      "http://www.emslp.com/role/BusinessCombinationValueConveyedDetails",
      "http://www.emslp.com/role/DescriptionOfBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Pro forma financial information",
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r843"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 28.0
      },
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.emslp.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Investment Method, Carrying Amount",
        "terseLabel": "Life settlement policies, at cost",
        "totalLabel": "Carrying Value",
        "documentation": "Carrying amount of life settlement contracts accounted for under the investment method."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r345"
     ]
    },
    "us-gaap_LifeSettlementContractsInvestmentMethodNumberOfContracts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LifeSettlementContractsInvestmentMethodNumberOfContracts",
     "calculation": {
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesInvestmentMethodDetails",
      "http://www.emslp.com/role/LifeInsuranceSettlementPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Life Settlement Contracts, Investment Method, Number of Contracts",
        "terseLabel": "Number of life settlement policies accounted for under investment method",
        "totalLabel": "Number of Life Insurance Policies",
        "documentation": "Number of life settlement contracts accounted for under the investment method."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.emslp.com/role/BusinessCombinationPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total Fair Value",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r547"
     ]
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails",
      "http://www.emslp.com/role/SummaryOfSignificantAccountingPoliciesConsolidationOfVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.emslp.com/role/CommitmentsAndContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsAssumptionsDetails",
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrants and rights outstanding, measurement input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsLifeInsurancePoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r96"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r412",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r517",
      "r569",
      "r570",
      "r571",
      "r805",
      "r806",
      "r811",
      "r812",
      "r813"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.emslp.com/role/FairValueMeasurementsRecurringFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r517",
      "r519",
      "r520",
      "r523"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.emslp.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "ROU assets obtained in exchange for new lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r820"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.emslp.com/role/ShareholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2C",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b),(d)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2AA",
   "Subparagraph": "a",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4M"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-22"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-30"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-30"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205-20/tableOfContent"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.18)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-23"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//940-320/tableOfContent"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//942-320/tableOfContent"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "220",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-5"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//325-30/tableOfContent"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481493/325-30-45-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-10"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-10"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-4"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-4"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-4"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-5"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-6"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-7"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-8"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-8"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-8"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-9"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715-70/tableOfContent"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-4"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-4"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-4"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-5"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-8"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-8"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481463/325-30-50-8"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>115
<FILENAME>0001193125-23-266296-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-266296-xbrl.zip
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MF0;0O";;;R5F>_;6[WQK<LLI<$E%-_9NQ6\E")G)JV,TE#EH.?-M IP#ZBM
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MPZ&,EE=1F&*&V4TN]S?:;G+8YK!07J:H,PT=VJ0<&62K\SY]=H_!>XSLX=\
MZXEYT'^/_!5(<U%>LC&=0UF\"26R^B:4/S$3#[0VFQ2N$",5D+O[)=S)US!6
M&73+<W\=P#RYI/R\2=931*OS?7$,OB^J\[WK^T0G<U+'7"QAT#4I3E%>*MCO
M)J:]W1&'S*D<:/.FOXPY+%3XNL '=@:NC2MG#>;,CR!5+A/51Y+8E@*UT!K2
MY^BJ'F-HJ;FH1S)O<VE6XNFQ1<UAJSZ?$CQ8_9&8@;>-SQS;R"C(6H59Z,B"
MUBM-QFUSL6.K>LXJV'$Z+6JR)9@[K^)5[^6B%N$,=-16G'E4!$Z;6(HJPD5M
MH<H,8GA0\]QA_P1_U8*";"8\UN2='\D0E#A6#![*)>#0&ZPCOEE%5_6Q_R:5
M''LB+HCXHVDYS7]M:M9'^I2:"\>UW?FZT2DVBW#YZ4=^B48V,>EQY-C+0%T+
M9%X4*ML\:" \5YR5NL3<KK417R05Z#.8PW^EA'?=H)%16XVONA:"\J@+7R^E
M_P+*:K!_5.2V_BXDR'=A6+[M'E6(S=?M8+O1A+>JM+)\-JNU-SXNJ[);U\#<
MI:\O,>__C?>PO4PVV[W"6U.G[A4=$69M>)DN.&W$Q:J%S;IT)H[;VE[-MW-I
MGTSF"@,SSAQI>YCGU7-^7C!S(;.:0((GRAM)E*R3V_J2\<02Q(2*>W]EVMN]
MPYJ-'>;Q4"'Q4K1X=;YI3V2V-2^3BH,*'@Z,M(6]CK*0IF[H*LINL^U6/S,8
M?X$_IL1B-IYD1OD2^A3VL\C8:"1[JE9^:^OMT>?."&\9# =7!:9T3K]1VVK@
M0_X*/%?/)GFU;OBJJFNR,V;EF90G$W&^K;3)OFP@#[ANALNK;-.NS(22EUCW
MG,WC6YBP^ZXGKG43PWW,O-_PH8=/J3=T9$"MD;FN/F9?.:O84RTX;+^%(+F)
M;YN((=6Q\% T/#5QZYBLJZ9.J_BIL"9J$\\;SL)<W2$?L_G"'W%FTA'EX=-,
M5(4!6?,NIT*\'##X8QT$IZ![QWWT*'^2:8#08;SDS9B;._WPJ!@O"I>OH^'7
M<TP[L#"74,YONN]S]ACX(O_7Q1U+"(YKV]!"E&78[/SQ%N2M,96?/1&?BIBX
MD$AVB&8S^_:R4,6OV-QGISO$7H/:A[,-?-'$KY@#-N5ZRQ7\'LXN1G*R';FB
MT4W]^+EPS6R!.H)8-7JP^Y@OR[1NB5U.KP1%_F;*YH2I;2_;JW2>U\7A6$.B
M1D :&Q&O/#LU/"3JG)3V!W.W5W+"5X=1#KPA [+CH0?0:,Y6&89JL\*W2S,-
MBUJ$EQJEW)AO;T#*'5ZJ2;G;5?07MN-*@P1H-KYZ)Y64%5)8_A>++7%^<(5Z
M"\MS(Q YWM"+Z%?(B5P"<9,XM]2AG-C)QL55O,WF[Q1GI\K.$W!T)O!%.;:4
MA1BI,M+ !;.=@:!^?"Q+L%/7W'G\&;.Z1/5X[2+R%RZ7>KA6^@>*.&3P7I<!
M52.#8XIG55 K(RP2GEK\1U-Y$8EJ<R9JY/O>X?]R6!23J;ZX/EX'N7/+:*-[
M%I7DJVR\A,;DS9:9EVDV+5<^*Q5E3%P7.6I<KFSR-<C2ZQU9FC@#%8*YX?78
MO;_B3:F-)H=D4JX@P>@A?:M@HX+L8Z!B#TO>B7VDR>W0N0USO<!X!@(B*8Z\
MX#4?<I/ C?OL^ %W1ARP%X>+A:$I,J<-K<=6YNY016!W'U,K$ V+4URZ+I>+
MX%?4=I\W66_U*"(?\\KLU=0E[E<>LW"Y5-RD!%]_O%6.F6Q%WD['*,[CH4JY
M87@0AV-U*>;:TB.+OX>;0P45RZW@8V/4>3@;4QQQUV1U%#&5O!S<Q>7E1EGM
M'Z<[[^/G4&%E.]AF#X^IHI@8 5I<H1^0IE?S/%=2$95Y/51)QHLO@[4R4:J)
M[6MY#-0F$E[ MK-_._SZO.HG:X?^:W3C/>/F[?7C8LP>;,?0S&E3]X\UB>]G
MZ%!Q=_-HAK,9Q3#(M3P)]MI=+IEP 38J]II9,:J)S4.6EPYFH<FUJ-J8K9"X
MJ&RTX:/J"C%2IWP-'V=7B)%:Y<--76]$PC@KA\YZ>X;!U(V2X&GD)303N3Z0
MP]KBT#N>$IV1P$YD!#7KJ<7IUY;7,5E1/- IVL?P0!?,K'<;5=7$^5S.ZMQ@
M&3,RHIU(D<W9O &?Q4*5H^#PA&M]I#=[]-L.T9J2_\?4HDOASDPYL>#S?4/6
M\MS^1MR1TCR5%SLZF%QW+-&Z-PQ\[#78L/$"TPOS1$X[3'<C[JY<O PT-&4:
M4<%!_+VJ.C*.'WIK&LEDL?H&Q0?7IW@-,7X374=L>FEPHV$F]=K'>=>-".">
MXFC#C:"VWR%O:@]0659KTA#>7()?--QFM:&IXF7*V1SZ@6!)M_X1R#6L,,C;
MD!7SZE+4.[EL#(P(PJ8Z64FF7K,[A46R%=[<2D6=##<S^OZHXZWV$9;)1(QT
MQ,]F?DS,FD>=UTMP6?M'[RWM<=W#5>UR#UQ?DG@C!GV2GU>#^4U:,Z]LOV0-
MKS?CTA5BKO[>'QK66U+>FQ@$66Q5B$,$CS8S(^NFT6!$)N4*YSXSQUTR8O>)
MC]/"G6M1NTDY]M&O+1 X!!,@.DY:'G%\Q%OX,KFI*]XW<)](V*?O)_)(=WST
M#68Y^:C1?,_BW%0Z(0ROCNE2>I1[G_:0KWR/U9BRY6/ /?&JT=ED+P/EY1D"
M=:#HS/N4>/)D;#WD\O67E/<2KS"EB#L&DXUN3NJ(SD>\"6CS1U]68ZRV%:3A
MLST&6T(>B'2,W.6]#!RZ=J@O7>Z'-^2&QXX=.9LQAZ-7%1C^^EM N)\%[;%%
MC_-V\(JQ^T0=/&"&.!;Q7;X><;IZ$^@7Y.Q0!8A]49,5I\0:;FYLQ&79(V7'
MY?!3%]XQ9<K=D. HNGSJ=AGW?-UQ&)[Z 3/X4:$OSN1KJV6"F^JLMZZ7#"Y?
M33'B(_O&U:+BL2ZE]/%^>1)>[AMN/7CM.X;+<%*7G+$3,C<S[W &+7I>>('?
MCO!'@;\$EY4./L!P>\+R&E,T\7!OK<NY^RS3$.$=&*--?3NJL%5;[V>_!\P2
M[@8^VG8_F<]\I(&0QU1YZ>,?83Q4 GP;,- :21;>0_J0!.#,9IM,ZMW+0$T(
M-9[CF<]%39(UG'V<QT-=>#6;<YS'0Q&I3CUS 9/M3_\/4$L#!!0    ( )R*
M7E<[U31D=Q0  /]M 0 4    86)L+3(P,C,P-C,P7V-A;"YX;6SM7>MO([F1
M_W[ _0^*[[/']OAN-SO())!E>V# '@FR9S?!X1"TNRF+M_U02+9L);C__<AN
MO<5G=ZM)2@*265OFHZI^Q4<5JTI_^LM'$G>F &&8I5_/KCY=GG5 &F813-^^
MGN5D=/['L[_\^=__[4]_.#__!E*  @*BSNNL<WO_\+WSUYOA8^<AQ21(0]"Y
MS<(\ 2GIG'?&A$R^7%R\O[]_BD8PQ5F<$SH!_A1FR07]^Z_EA)WA]:=+^BO]
MZ?KRO!^2[!6@\\^7GZ\[_WWY\Y?KJR^??_Z?SK^Z3_]W?LZ(B&'Z^VN 08<2
MG>*O9VO3?+RB^%.&WBX^7UY>7RP:GI4MOWQ@N-'Z_7K1]NKBKT^/S^$8),$Y
MG'.R[,6&X?6[^N677RZ*O]*F&'[!1?_'+ Q((48E71UA"_;;^:+9.?OH_.KS
M^?75IP\<G3$9H"P&0S#J%--_(;,)^'J&83*)&=G%9V,$1E_/@M>XD.3E3]>7
MK/-_]+(T BD&$?V! @(C!N5-$#..G\< $'S688/_&#YL<  2'$\*X-A?+W2&
MN:A%Z(\TR"-(BAEVIWHF]%^F9K@_ZD^80C+%ZJ:T43)!8$P[P"EXH#J< "V&
MFIRN+<9[ 1[?Q]F['F25QJW'RDV.80HPIE)ZA6DAM$&.PC%5Z@&"(>C&\7RU
MW (2P%B/D0JCUF/C$8XHMCA'A78#0N)"4@,JNQ "?!] ]&L0Y\"$">,Q]\K"
M0SH%F+!/G@ 99U&#G B'WBM#=YC A.GU ($$Y@END"/QV/58&J",;BUD1K>5
MNW_D<,+F_ Z(">6J(>H1^ S>V(!#,,D0H5>#(9B"- <WL_D?3"C5'JMIDL,L
M#6$,B_VA/Z+"*7?M>K2K!JW'Q'(S> (!U<IRFZ:3Y@C1V;E_-6&GSO U%S$=
M$N!AEG<QIE<&JK7%)X\P>*72)'2M&2U;_=&:(+OX]^YCPHY2<S*YO9L@ZSXG
M%*4GF,(D3[Y3O62;6!S3UJ!H, AFQAI2<>2"G3"(PSPN5L8C)7Z#+?!! +V+
M1 O&V&3-GOR%O9"%&[,6;3*T*4TV*::S%O?P48!?B\MXCL_?@F!RP>1\ 6*"
M%Y\4DB^D/O_@[QS:V+[PEL)_@NB!7K@('$$FJ[EVAG1_1B#ZEF71.XQCIJTK
M1:5MJ!$5T8UD0245,X@+VO^^]QDOG)<:E_8^&0/$]))N7+1CV:-Y^9G,O;T"
MNFA3J $*%P32'W?4?],HG+>XH!,FQ6CG]#:?+/J/4):TI!]S#K+6Q9EC*I]L
MPH8.XK-.AB* OIY=G77> 7P;D^)'?>7=V4#I!XURL?9)P1!'%[LWCWN>\AA4
M</]2Y&O>YY7FG;NE>MTP1#F(YA<,WB[8M,QV9CPI7@-"Y.O==56]<^J\O@4C
M0+?WZ"7X6/MC2P>V:/)CT-HVY<E7X/\\" 7N6;AH]DX7S#V(D:^E_U7Q8EE;
M21<2DNC4JLDQJ<"*:SYB/]E"K$G=?$A)D+[!9>/B"OHR#E(-M6B9CF/2O99%
MRU?PGW<5_&++P]:TTZW!E]'VUB-G=@IM?T2O)Y+5(^W5XFXBH:-+"(*O.6&*
M]I(Q%TF6$HH3G?Z-:A5  ,M\AK5'MKKB-5#=7K6U&5;ZG%J^P$H8HK_%.8O9
M&;!W*8K-WG2EVDP'I#O5!*#T(K6K2L6IPV'R,</XGAYQ:0B#>'%XS98/@?V"
M@>Z(<L5641K18S .,*;'7_GXTHW^-R^?_#?%,@C8G5NB<;8(<E4QZRSH;66V
M)5NE!ZM=G1^@; 0)8UJBA^N-CD$WUOE5.FQ.]TZ)>BU#/Q0:MM6NQ06P,7/-
M&T*%L:PN)RXZVXNA E-*]U'+=T2_-CDM5-1;E#7?3TD\W9+GSS8W( 645HGH
MA3VLXK"K-=L@".E6.BM:7@ K?6K8)JH[L!< 5V>/KP=_M+4R*9E9>3=@1#+6
MYHHK.]/$?:R"UXQ*[QQV8F[Y6/YBU5BM JBJH]VS3\40UXPS1NWJTM[AN C_
M+PG5VF-%7?R"2LR' *2J@6P-@%12IEY,.RU]@V2+? $2E0.[ZF]SF_PH[O#<
MU@=X3''Y%&!GS;6T)%(2=2=I:Q4VB=H)L5!%J5W9B_*Y!1,$PC(?IYM&W82I
MX#^+7R6@2'NY <^V:FV#(V5! ).U,)<?*0)!S)[/OP4P93K73U>'IFSY*'OZ
M@9:2#0%B/UE;6%OO KUQD+ZQ',_EYPM&KB3HF0SB!Y F' DPM><L*2LZL'B8
M;I3 %&+"F)YJF%;*GGZ@IV1# )DUO\8S*&Y-E."G /T.UGB4@"7KY =.,@X$
M$%ES5WQ#=+67#C?9 EIOY08(Z@O@!M&"D 9K_H9>ADE_-,\FEP:W;+2S*GN.
MKNR&HFR0*Y"ZO:BD.66R.]NJB>O"7E$JD+.UB!U6F6)5D*+'#.@@)'@M1Y^5
MV%A<-B1@F YD%;)MY=K&RY09 :K6' ?+6B/;'D.I(T[8QVFL)'0+8.&$GK2Z
MI]U3'A<Z]1LDXUZ.":47W7W,_5LLA)O^+Y+'%E<:S6DH*W$D )GC@SC%%\FV
MBF> IC $6'W3$7<Y'5Q[=X;+T=K3068Q$N9P#C)3[,P/-J=S>58U %NTW>B<
M[/^L=-DTB,LR5)@@&#**Z1^*\./U#]9:#@""641%CE@MHEM0_G?Y"$5/H\(I
M-Z0LWHU&()1F/K1,2+OAGXQ>:@!-(56<F]D/S-+1YA'@]+ ."9RJ$O%-!K$;
M/VU%HS@1I=KB:K;$31.1I"$ $5Y>\M@++KL)L0^ZHU%1]$ZJ*]HCV(Y!-5P6
MG !5/3X=2P):I_L!XYP=8?W1,RO_QZHZO,KV28V^!X2J@$/7$ESF5?CZHUOV
MD+'0PI=,;[7J]/8=4QT>7:M;LB+Z": W@(8@#HI['";8[/ V'NE@X-;DU\%L
M#LX>5 2"/F;IVPM 2:5]FC."[U#K\NE8!HF \]*2K'DIYPYRNI0;B4N[%H>6
MNG"+_RU4][9TJ"YKZ>9 <7*S$G2ZG5U<WA(E7Z^RI\NB8QDH"SHID64]F.XT
M@$7)Y/L,/5.5+JZ2\^+4\CW<="1/P:[,KS)?I>5C6R""9:!%G4V=.\AI4S<2
M5\.9,MQ=G>_07]0LC[:_&T.PO1N/XN+2E^C]^CYOS*LZEZ:!TKP*JK8>:*K!
MN#/(X:*XPZIS:3B[>U%9/Z4L&ZE7KM9@#$^AKL"I:TD[NZ3/:S!7Q9C7_>#@
MY3&I3@)R -DL9]>-8,;ND::P;O8]1$PW.70M74BPRQA\XX?V" <'KMD7:MC+
M+]JE?(# )(#+^N+S@']J310L58!<;\"#TP ]MIU+3A+O4T,0 FI 5MW(U[L?
M'-@\)M5)3+92W8MO#QLR&OHCRGRAB^N9JQHU/HR'\AQR<X9=2Y!:;$3FU;.4
M/3W'5LF?:SE7QY447!_@^MG"%C.]]&*4=S/;:\=T\X;T7!&J,ZY.3&M9+0ZU
MED-]D"L6>5A/1SM53[%^)!N75;&7M^9=]=>:X*A+P]I(+]/]@G.7<[1;>R@W
MR!?BMG8Z3Y)+L6-Q_J=<U_9R75W8B\(L#8N8*3I\?[2LP-W^IG0JF.]RQ>AV
M"^;;,VH/I82[%EZF?J6336D#I8IFH[5 BJ-S JHAK._GLQ@\46[5\WO/?*=8
M^W9,26UH3A_WL9(0[]B7 Q]H(7P=D*H5O[>6UK/N-=)TG/F PB:]KGWURZ%6
M,]6"IF(E4WLQ (=5R50+(_,JIO9R6'RK8JJW2-3U2WE9(/MVTE"*Z+%&9E0Q
M6&K,A%WS*3_MNV06A SB("5;U,A?%"3=6E3:;ACF25XD>:\?5?3G&' ><(1T
M2WAM;@K;7PBF1'I[]33'NFM.("&IQ8911?/G';W#6,60,XYM%D"Q5JAM$4DQ
MR&(80F9J;V:+M;^7"B(\M@GK!0C-V*4@86&;YJ$RJO'VDOZV/6DYV5- 6%KN
MK/C*Z+^! -UG.>)P)$X3,QK7ZMJJA:XZ7\Y($(X]*%823<D:,^LEBM/X#/ZK
M4.,B<:Q&60-\O5!29#9E<U.<U&E7)HZ]533!V'NV9VUB$YQT:5LBCKV3U&3K
M.[WPOKR#> J>:-=QA2#IZC.==$LH&L=>?&KR-P1) *E5A?JC>X@IXFPQ[4_3
M!-.=U$TN'^VWJY--K2?_^R $Q2M[?55?&ZH52WHY7_/&M&IH'Y;I#K+FIK1*
M#,U6_&M=Y?=A2$L']UIMFA2$8_4'Z['4D-$L'_VD.G(KV5J&=DV>FC"096.?
M]$9F$5>N8VA1;9JWAK4F.7)%TC5_KUQ_2^#PMB?35W^F(]<M(UOWBO.^<#)V
M]63_/4]>F927#>HK.6?(5HS?G7F;-X)UI_!A]0J1-S>*=<7B6@W/JI+:AY6L
M-<E!Z-4^!.-:#=%F>&O(C-:;Y:1;(LFX5L^T(>::L+-UYC@I%E\NZAJJOJE5
M\W:XT60G15,(2%VDU3>-VY.=;C[C2?=TI*0N)>N(_;[,M';&<-^J[5<W\%LQ
MW%X,]M6<M0USU5 N+D<M!-7&MXIU/^*YM[BH9TM+!_->%>HP[T<\MH"%BN:O
M?+0C50>OXJE%/%2Q6&5C':LN^!,/S>&@OI&I->@1ZH:O\<P<5AJR"_5'/D)U
M\3P>V7D3KT8<LGBD/1MV34<A&X[LP2JL$(-L* 0_0I#E3#5E#_H9@*RK,@V*
MP8_P8SV.:MN-G@8?MZHV7H4>:[)4S[[T,O"X79WQ*.Q8S5&3AJC?0<>M*9&W
M(<=JUAJW6 \@X+@UO?(]W-AY6[:!,&/UB&W8MGL(,JXX@P<+MD:(<46A>!)A
MK,==HT:PM_'%ICJU![%X$EULQEHS5K*_L<56]<JOR&)#WAHPHWV-*[:K5!Y%
M%>MSUKB9[7U,L34E\S:B6)_%_9CAAQ%/;$WO?(\FOL,$)JSP^0"!!.8)=L9,
MWTG%AE/ A'M+Q1QGE"&P(/DENP&# $;F:Z'*'*TD#,^G7<RZ-"5%-V/]A%C%
MR"XN[NJ:8)XOK!"/'Q', J:6XFDTA5,Z^&&J4Y,2\B,,6I.E)O(V)4.?M$DN
M'S]"J-4,-9^LJ3/'2;LT!>5'?+::LSUE:&I/=%(X$VEI!WSOW:(" 09XF.5=
MC '!W30J/GF$P2N,(:%&5?LV5'_Q[:$;I,PDRBSLT>;7OO)I8-^PGB,$I,FC
M&GVMKB\%(CM? ZMFQS';0T!QKRIRO0."K2?'S$:41K%I%?_.OYG3@J.'S=[+
ML#0G?-6F15W^-4 4NACH4,AI:_<@WZ9Y6T<Y!#N]E2CDSVOL-@ \BAW;&.YS
M0J]V3S"%29ZP0X=YB^-XJ3:#8,:N;#:\PX#>LH!@GUV2)<]$TAZBKF]7-M'B
M@DLGT@K(JC:6Y95@AM6&>[8:OX[M9+H2T(F=,A[*2^RKL^N:Y]2  :7KW7RL
MHP'?T7(1)AS(W>2F(QT/\BX6A]"DW\2E77G(H] $]TM!Z#!B['NN,>CAJX7K
M]1[6XHD"YD.?$\U<>Y0G[E]MQ.$L'=BKI)VEVU_Z+B+O6-.J^BU *$C)VBQ2
M!S$S)N1=++^[Z$AYW3*2,^.: 92E;R\ );?@=94H(],=?GN/(%)PXHRCQXL]
MJ'Q2,]M^)'W:]&&2,4!5R%=UM+H4E SM^#H5W#AFMMT"!*=4$%-0TBS!:;>I
M7\CLTN^8*77WCYQ>Z9[9CE3LO;]!,LYR,@1!!.,9W8OHY@I3YI)><JTL,5QC
M3+_0K<&H8^93=TK/G(+0##T',5CQQ$[6U6^R$T%["+] UN=+V_)Q*?>EC<+A
MWF!=C4?M FO[OFU2@B,691#1'W 6PXCEF-P$<9&%,@;L_+%BV7;3Z)EDX>_C
M+*:BP>6VJ6?;"KJVN(QVIW](PSB/J (,,E3H-"$(ON:$;1(O&;,3F>)D<5PD
M*]%# $C?UIN:P!7S38KV]HIKBGG'+/(GF&:H8$8)_VY3JT VJ^[;<.\RZ]B#
M8C<,\X3)'42%5=7+D@D"8[JKTCL\E426@,<,X^^ ]$<OP8?L/F0ZT@'#;BP+
MQRS6(?/)I""Z"U!*V<5K_-R"$0RA;('K=#Y@['78=\PH[D81+&DI@^-[P002
M1IAXL8MZ'#"P0IX=LVWI9I-D:2$+E6-\M^D!X[?+K',&[/).J6<L>'H'WN"@
MV6K=Q_6VU]1#GK4RU_1 !)2RJ+P2T9O0.ME =LE0]G05(VT&'*LL?<AI5!IP
M54^=LE;8N; \UA^,];"2]7(>)1GQKI5*+ESI(%HG5^8UX[5V'0\NT?I5A5N_
M=JGS"GF-74>!1[-KA6*IE8SRM=-0!PM)'U<@V6*"XR<2<>!:S=7%XQ![\^WE
MF%""D4$^KEYW3V#38Z;AXJ9<TV:N0"_TRH\I070JEODG63O,1%!U<AP%'19<
MJP):7DQ,#AIA#\?14=+O6LG,PRPQ8 !4I>H"O"J3K=T46!@"'@0SY@74NB9P
M.WB"CXA\ 2[6' 3S+=EHDY/T\0<=$0>"EUZ./^"HXF24,; ;D:\M'L_EO/I.
MDMWV#@1_28_C78H%.EK5)\*]H_8 (G $:7. ^Z-;,,DPE/NBV U/V<M!86O1
M+1!Y5?<'5^3/A$X_#]6<S6E0/WHH>SDJ<B7= I%;<W84BW$(0@"G[$@OJDUT
MXSA[9QOR?89Z"$20%!$BVKN1\7 .@EF/(0'*IU0#9R*317@WGE?PV?G$ JV%
M764PAV&NPHX WU.2@:,8-YE1\-FUKU'9+BM;%V;5>/[AK.)( +0U9]*F\VO(
M2.B/?N R>U';][?3SV'@%)0+ ++F5?J69=$[C&6QJ*LF#HM]1:0@U-M:F,A#
M2H+T#;)[=ND> .3N8QYUJ2%]O>X.(Z/'@  U:\$C Y31A4QF@SA(23>-V!5Z
MPO9=>=B<O)O#*,D)%Z!C+ZNFX$7#_[W9SF'Y;U$J$+@UC\H @4D HWG5::H?
M:_Y.-0Q:O1T 1_$6H<6& #EK7I(M7P_;?C4?QP6=W,=)1KT 'GO^C/GKXXI<
M+8#DW=R'2$Z_ "1K3HE>@,=TN;/_L'-Q&L2LL%*7+*PO91J07G_W8=-D1("?
M9@6#"S;U*S6>_OS_4$L#!!0    ( )R*7E=X*P/,*F,  .B=!@ 4    86)L
M+3(P,C,P-C,P7V1E9BYX;6SMO>ERX\B6)OB_S?H=<K)_1X9([=?Z=ANU9<E:
M$>1(BLRR'ANC(4"GA H08 *@0KQM\^YS'. "$K[#'7ZH++-;E2$)[CC?^1R^
M'#_+?_^?[[/XES>2Y5&:_//7WF]'O_Y"DC"=1,G+/W]=%--/%[_^S__Q7__+
M?_^_/GWZG20D"PHR^>7[\I>;N_NOO_S[U>/#+_=)7@1)2'ZY2</%C"3%+Y]^
M>2V*^3\^?_[Y\^=ODVF4Y&F\*. %^6]A.OL,?_^C>N$OC\>_'<&/\*_CHT_#
ML$B_D^Q3_ZA__,O_<W3^C^/>/_KG_^\O_V?PY?_[](D*$4?)C^]!3GX!H9/\
MG[_67O/^/8M_2[.7S_VCH^//ZP=_K9[\QWL>[3S]\WC];._SOW]Y> I?R2SX
M%*V0;%K1;ECM>I>7EY_+O\*C>?2/O&S_D(9!4:I1*M<OW"?H3Y_6CWVBO_K4
MZW\Z[OWVGD\V<L$SDV+SFGH'IY^K/_Y*U96E,7DDTU]*2?]1+.?DG[_FT6P>
M4X3E[UXS,OWGK\'WN%3ZT=GQ$7W/?[M.843\^@MM_^WQ?@</F>7QO*21_O7S
MZLG/+5^73$B2DPG\ X9*-*&#["J(*1=/KX04N:(L\F[L"[KS@E&0P0?P2HHH
M#&)CH45=M@/P+0D6DZ@HW];4U5,!_Y]^P?EP.IS3;YU^LX,$'IK-,_(*#:(W
M<@_3PXPH@;/YNJZ 7[\&R0O)[Y.G5]#\:QI/8*ZZ_6L1%4O+F(5OZ@QND+_>
MQ>E/M4_,J-]V4)X6LUF0+8?3I^@EB:;P%23%( S315+ &C6"=X<1R=?_54*A
MVV4[ #<D#[-H3@?W<'JUR*.$Y/D-*8(H5A-7W$$7VMV27,KP1Y!%T!-\F@7)
M2%[<PL,%/*8#RLV+.U)&"&-\-5TYP<SJOQVT];"!J?5[E)1=?PTR^HXWH@-!
MJ1_KHHX66?@*^Z%1%H5D$,>KC59+P66]6H?Q1Q O"-#[1I9DTE)X=E_6188O
M#1:I"+ZY09[#;F00POJ4M99>VJW](92E=VDV"^[@YR2,@O@^F=*?;8PCE:[;
M 8)7P :I6,+FB&X0YG21_4H*'<%E7;03\/<TG?R,XAAZ'\)F-=LG>+/763]X
MM7PD\S0KZ'3^1%[*78,.'+LO= O>QD?4^AWM(*[>^0:+;JFYM1A?8;%:9/2$
M4KU6!Y)VGZT/;[8W,1UO3ZI16PUCV# \DC>2+,C5<O4'K:V(:E^V10Z!W"B.
M5AJ#":@ZW[637=9IVX$SFT6;(0J<TY>2)-0>+/)NV@EZ%T19N2_X0H)\D55'
M,= .?$SP*N9?=0"TZ=X!,*/]JV)/#L2]ALDX*F[?YRG]U7-ZG\!_J9F'6CN"
M1',PM7V% X /T91LWK@^S+3&).[5 0Q8<Q:SN?;93KFO=B(_I,G+,\EF-^1[
M4?^WCJC2/NR)^#2G*V0VBGY\30NM#U6A%XN:A,UZ\40R&%KPS FL'E^"[ ==
M1B;DG4SH6[4&@W'?;B YQ=0YJ-^S]&?Q"DMHM<A78O2@S9E]C*;OL@JY_NZ'
M.0BS][O?YP]Q^$3783*Y2C,0&9;C%K#;O<\9]/N()<Q]Y!*^V3MMSI]O:RL5
MB/$4Q.5_YF_;4]-=0'>^Q=)\;M5^0\LC0>.R0VOOSV_=3JQ'$M,KC%&0%<MG
MV&SD0:B]!Y#VT4[$VR!+8)CE(Y*5:C#: ,L[:6M#_YZ3OQ8P;F[?= \8W+8.
M+F#,;UZZN66P>*'@P)IJ:BIM/3?63P-/I"CB<J.MI31I'TY,M6ULM*[MDU8,
MD&V%'+S!MTZM9W=I1I>A<G4MS6>#8G.X4I)4L:=N#*)6+:$=F4!MVCYM6Q"-
M+(0.+8!M37].;!CF%@N;FU?MO:C]K:7AGK+U3@V>29>$7)&$3*-B% =J*R:S
M73M1JG/+<_"N.%1WGG>SI6ZUEVX]0&&PJVX45H_:W;4;[=)M[\J-MN,.]I'/
M=,DPOGA?MW:ZI]004;$G)_M+#3$E/;C=:VK(J=J5@P540TIA>WN+J<XP9#2S
M,6GJB+#3P.GW:60%T>[3[B960Y.\IG87)0V!>$V=DKSYR"R2W.S3*83M\>X+
M*5Y3+><?TZZ= KK-BVA6[M%@THL6,[V;%M.^.S RZ.#0Z]#N+&(T\\D[<;"<
MWD1Y:91\!$J?:%@'O%#3\&_4KP,H]WF^,+A95.[+^L%3ZW) T-S:,51'(%8S
M&UN9QW2Q<I-,)N5O'J+@.[WETG19T>C-AMCE_[]]G]/(&WTQF:UMB/6TF,^K
M^3N(UW$_AN[5>AU:TRG=+E/VZA.*P4!0Z,N&R'>+ J:0+U$2S18S:B.FBVA<
M+D/E Z-@J>W<9]BSW6WH59!'8:FZ>%'H^4>K=E4*'&3A6N;5/^N];^)IHZ3X
M/(EFGU?/? [B^%<I2$YD[SHPEX;TGI;@R][:B /_IFM>FGR:D&FPB N+PC'Z
MMB1J.@NBQ(VDJZY;"5KV\6E&9M]I7+,]*7?[;2/B*TB3A8OOY-,&ND5!F;VW
M$3=)BX'5[V;=82D4C$Z8K.BB\ !=[;R$O!<DF9#)^C54&GDH>YEF( UW>BHC
MP]*L*6^^!IZ3\+>7].WSA$2?Z0Q'_U%.=17Y)!JODR/4EC&0F-P7(,6Z8YAG
M25R^;BQK,NX=G:]4X$+:\O9N>?M>6MY+]<*\&J43CJ2\Q\>]XZ,&48-L5UX8
M*.MN5V/&\#.=9NE,1WLK(5)5'(L<)$M+;Q :B9]F$Y+]\]>><QH&DTE&\GR4
MYK =^M_1_#J=$"$1K ;C7N_R\*C@(V&3T7=(!@-%:?M2_WK+QP%PWPD1M=U)
M>_6+I:^FY'^$:5+ +'M;;=5A6J]L"]N_QVE.)O_\M<BHOP6;L>.N/A^2K_[Q
M#/T/WB/>K"MN-.Z=7IPXH4^PK$OIK%,C_I)X@-CDG#@DIR;'S<Z><(^/QG-4
MXE,W4QEGE[JK?R5]-FG@X6!K_A2MYL>[!P)G#.P>:1Q2L 7$IN+,(17;2^VD
M",+BR\XBND<'\UF*X,S7NLX;TDW-BV1G:]U\=SL-\N\EHD7^Z24(YI7J25SD
MZ]]L.5C]8KS)7',=!WD^G#X5:?B#LTA(V\!$?'PX2X0B'#9+%YVR5)>,.W/Q
M'P8@;I9N^;JAJ&0V,SPD;$HN#XT2WPN* VYD2TKOJ(-S"IV6)6<3^@C(>W%(
M!\.F[!P=NS^8/Y*7*"^R("F^!C/QD7SW43C"NEDAG![&61@XNG=Y#K^F6[^,
M! (S2/V1<:]_4#:HINP<';L\.=-4IO'H-4W(UX5@2[K_&,C;.R1=L^7GZ-OE
M8;CZP)Z#]_L)0"@CN<K4:B+E"]O U^GHC.QRAA&"X=#B\J1<2747Q22[ALW!
M2YHMA63L/ F#Z?SP*&! X"C>Y;FXDN5I%L3Q-NQ2H/B=)T'J@]K1<"%P%-_!
MQ<^,9"]1\E*E/ZBRQXA'/K,%H#C .P<!% XAYJ=@!6,=@)B48?AQ\,(SU-6?
M&?>.#VK:80C/4;/YR59UW%\3FG<U+E-Z_"\B'O%[SX+D![BE9X+@7*VY/+/N
M&'17_Z$0>BJ7-/7G8:O@S1S:^IJS"81#A?NC[2B+:&:!IRA4V(/N/TP-NP=U
M#A#"X'#@\HC+&Q5]S<^A3R&XN6WN^'M8(^&0X?(LO+JS&)$L3Y.$Q );#^M1
M*OA!K0P"$!SMNS\9KT9"::(=9J,L?8NJ.BW2KV&O"4RK!W@V$&'A<.+^6$Q]
M\[-Y6N6I+T6[IN[.V5+JGR1L":@<W=*X9$@!$H<H]\?HU>BAAL5A]IS^Y-WW
M<YX&Z0_J0"&$P2%A#?#SKC^I=0]3:8$B#U?>&X6JW'77M']J?B PD;<64T,S
MU-$+MYV<'8/O]&XB+ 0H5+L8]\Z];%]EVMX=ZV:H;#NQNJ"R!87CWJ47N[<9
M&6:$5AAM.\ :S2%5!LS='#[\2:3Y]+CGYZ!HDRXN+-L.KRT_M>M5)C&M>7*O
M$>C!RW'2T>?%1&?;%=:$MD$89@L84PU1!:QQVP L+P=0586S:9+ L>TV:\+2
MJFAA\K(3]+N44R5N" "QK&$:?*E@LNU@:_AIT9-9/@J6U"52Z;MB- ! 7HZI
MK3\J+A8,?KAEGB>M68_3 B!YN0=H^0V)P%CPP&T$8,,OUA-M+<G>=9H7 M7+
M&X' 7DP&9MI7Q8/"WS9-2AQ_1L7K]2(OTMEVP"@L/"K- :P7$VF[3T<=F767
MW!8;O%I^$^4-7K,-X/+B9V%E@\>#8]VKU\[Q2>O8!.= +[ZG[8CAX;#NZVN^
M0ZB=M;<YLJ6[!&8KP';P1UHI/.LNQ!:/2VH$RMH"3BR'7',:U4!:]T\VNS[8
M1P@3>;R8E'4GLE+Y19%%WQ=EP=7GE(*@2W0:@Q0OZRSQ"L8HNR\"#6+9W)@;
M'!UHQ+ISM=&F:#*)*@E&000;@^M@'A5!+-H2L5N,>Y=>UUT7#'$V42(%6'?<
M-B'UD6;>2LADG: +MGV+V:),[GX#W(21Z..7-P:DGN_JNJ):51?6O<;]+0_.
MEP70F%<K7G>CQZ:^K+O!FXRP+U&29B4,Z5C9?Q10>-TK=L<Z&[EU_WHS2]9L
M1EVE0!6K@DP"J]7NHX#8J[VC._[8R*T[Z!M:L-;+3WG\I($R&7FET?9OI#+J
M/*1Y_I44P^ES\"ZV:^GT!&/8ZX&]P\V=B6*LAPR8# [8D! XL6Z->[5S3UG0
MCCL8)"U!75BNW8S/;TH0;40=,*][_J0)WZEKV?:=(@.,K E(B^6R6IL0-6S6
M0PY:&J+5+- @.Y8+4!N>.A4<Z_$'IAL7;C$_X1Z&TPJP8;DM-:9*"L]ZF(+1
MGJ7*TB\W.NX^..Z='I _,$MVZ[$'1MKGUDHI"Y%O?E*Z$-#O;-P[\[IU8/'"
M8= 0FR2XH1N6JSEC*R2]D$\7Q2,))E%,2[.0;!8E);IU393!C#HE"<@V[A/T
MXG5WHLYY2X@<ZKLUR92'E$<2DNB-"CJ8@M"#.$Y_T@ 7&,O7L.F-BO+(HGQI
MJ]D=:,/KMD>=<'-T'*Z[-=^LBTC2&D%%HUXYEU-1,QID>AC<R5%P?/^[#IF:
MUFJKK3VD\EHM*EHM[AI.0$O8K4EG89/N8,1Z-;6J<VJ.CL-UMQ:7=8%XR986
M]O!>;T8U-D$U>3D:[M;SJ!)(/8J&^3P@]FJ\U-4_4WP.'=U:1$89F0?19%7/
M;%TC>$=JX3HD;0U8$6PEF 3P5B5%3!S^.C:C!/DK-17 ?^CR^0;G'&H\*-8S
MK/122*4]X$6P_&APJ(&*PV+'%I550,EV(PM;(/68&E8S0(?@G*[!F1P,AZIN
MS2][!XY<B2A^(T"&X&BM09,,"H>D;JTGJNO7_JSNU8"L_\4TI>=HOUL#!N<,
ML%]?N^V)2=P?'"H.9(O8 AZ';BT;!O-Z\QK.Y57Z8)(/IS=DGN:1.$9 H17(
MC-PRH0R"$]W>K6&BMC%5MP3N/P]XO'H!:9KZV.)SZ.C6=G"?%$'R$E$K9"4D
M*6[?5RXMOZ?IY&<4BYRP59J#>@Z$+'4T'.ZZM4HH\+.5^NQ ;#^[$G/T[#-X
MZ3%Z>2V&TV]Y-4A$4Y>H'>#S>K&L,87)87!HTK(J,)?T\OI[=3.V7"UK<J<E
M22N0&<&>6;:D*X'@*+Y;0\#&1X%7$Y7]X+AWXF9.8E9#-7.H8$E,WVNI NI)
MMV8 RZ7N3MQ\14JE[H0$B:ED ^$0U*T)H'5)M1-'9Q4;5>Y.&BD[94@XG!Q8
MY<&3BP,H<Z=+CJS,W8F/B))2U &WDBK_84#D]8C"^P XC'#DY^1%Z_9\_TC*
MH(51D!7+6DJ=_&I9_XMDT5'O!)"[V48[6H5TD7$X[=9(4!=-.@4V'P8DCJR:
MRLN2KMKEY-6A<4CJUAI@@20LZY1+MF0+UVFWM@4XT&4U.:5K%_-YP.7UJIOW
M7;!Y$4#@4&+!.R'/BAH=\-.6"OAA/)A.HSBB,E4IY+D\\!\&!%[OKM5(D,G/
M84#+H,"TY Q_)B3+N7K=?P2D\>J!HZ9-MM0<'7:=>T-C5FD^#$B\7O'K32D\
M^3E,^"OYL%/Q <2%+>,K*:(0I#N<\@_0H:]T :"R85:*-"G=H48D>WH%-4I/
M>\+6@,AS4@BVCD7'/P5 &.H]U(0M)<OO\WRQ_8;$?-5; "2O$Y(Q1TT0&,HW
M- 0<+HJ\"!)ZU:E#3JT9@/.Z9+=DJ($$0PT'XZN52S>&8-VK%0$!+(EM7JT<
M\LW*I1MK9"N;UJ4@OY00"(9R#6V-^/TC1^X3-BY6J)*5;?<E$@S%&"Q0@L5>
M99$;F7FJX_O(EM<J_2.O/BZ\X:]\K5+*;Z'X@OWMVF!1O*99]"^]K?2V%4#S
MG/VPU69M'XBX/H/;<_ZW)%A,HJ(\YS=K/&Z PD!<>5+!7\M$*8V,7H=D ^@X
MYS0MR3&</I(WDBR(0@0F\_EQOX\MF4NI1]Z@YT+ <;*OB:?*!(CO-<!!H%,%
M$BKI,1S?-SZ9JXA/E<1&W#8 "]U:P/\L)# PG-HWB0.&I1S7KT'R0O+[9//[
MWT$M-+U'3T"7>B< W*L_JX01-HVZ\#"<\K\E&0EBNNM8"S=,MA%/HA54TA(@
M>@TR,F)0"1.&P_\-@8U6&)4[+]AX#68T5>N_RA\%E E: 32O[F)&=$GQ8# *
M-)#IK&?C_K'7(!<C6C@H,)S^GTB9MA@&RY<@^T%J0HK."MQ&H 6O-SA&],C@
M8# ._$X20!;3CWHR [U25 4<*N5D25H"1*\W.D:,*6'"4<^Q80!8I_-N62"C
M9<_C/KJ<I\)CL@6P* I#"I"8D0W8O)ZVK1%9 4%1%G*4I=,J-Z. D^U#L)I[
MKE>A0\&^W'C*/DKJ'XQ(%J4TJWY&8U1O2/5?%:-(Z\['?5=!5TZL)Y;PXJ@J
M*0!S%R5! L>=>%-+<<_B4&9=I8M$,GDD(;WUJ1)HT#]-_F-1G6)W5Y#*8<]P
M-+D3"!CQ>QRU-*;T1ZQKG:(HM[G9!6]QJYR*MT_#7'Y ^SDN !1U*K="62YJ
MUZYCT)!7$[ >Q3:PHBAPN2GCLSI<7L'9<RJL:LEI 9@.:!,A!(&B!B4L.]M!
MUO++U.X+U@[/)6AUR#2$AZ(0Y([LJA2"_ >T'#)$1U'#<5V*=AURH'#6XC4!
M5 =DIA"C0%&?<5_$JR"/0@UBRN<!CU=SO5C/:MS4@*"HC?@GH=FSR&3P!GO<
M%_)U054PG#8"$&2$:?4#^+U&-YD0:0#01M5$5P3?1/&"^@)J1-IH]@0Z\.K#
M8Y%D,404)1GWT:Y$UIAB5RT D]<;-AN3[ X4%&4:?\]@KU39LD67G]NGQOT^
MN@!0_@ZD(3B* HN"ZQO+IA++;QKW3P_HN.8$/(H:D::QCOTC-]9O[5A'/FDL
MB2W&.G9<YK'K%%_]GIOOLTTX9$4ADVQ=9"CJ-[;-'M7O.;*IN$CQ5:I=3EX=
M&HK"BQ9(PA(RZ9(M60QEQZ48[:3XZO>PI?@JOPN.T9(/ 47%Q+;)D?H]KP9+
M/3)X\J.HK+B*K%*)7]I_%%"@RPC#WP*RI4=13G$MFH+NX;SI]:S$UJ)8XY7,
M* H?WB?Y(BL3@)'L+0I)+@^?Y#4!Y%Z=?G28$&- 4<QP)=$=X%P7LZ)EV*\7
M>0$G[&Q3!H;6;H#_3<0^N0:]@2X\)SS4_K+TX:$HAJA6[7D=TR9@6:\CT(!7
M%P\=@DV0H:BAN)EIMH&(J]0*"C/L?AO Y=6IRFB*98- 46(13@7IKG/?NEZQ
M?/,G;3ON'WO=DVMZ=:C!L5$JT8Z7-5=@D2NJL"$@]+I]5Z2 S9\*-!3E%DUX
M$^'RND=I19D$%99JC.6MC)RCO2<!@U?S4"MFF%A05%C<7TR5_+C930"55P>-
ME@R)0$F*-&+)OK5),5)Z+;RF,8B9W_ZUB(KE(27>.CN06UE')>*U;V6IOM1N
M9:G$%F]ENUTZ-F"J$4W=!-*$#GS5++2L=J 3-PM^JZO74^XI2 $,ANQ=>]))
MK_*8SP,<1Z=3_9RT?'6S>1( PI"_RQH_6&Y;[1,EK?_7*6&#,%S,%N4U%R]<
M5'K-I]P'+"E>XT<$'P^;1$UD&%)VL9W55*[.N<T G%<#D39M<C 8,G;54O,J
M9HBN/0OPO=K$M3GA(,"0K6LPF425 *,@FMPGU\$\*H)8/N^)V@$\K[>,^G.=
M' V&E%V/I  @9++VI5=P0F$U@&G ZW6\-CTB&!AR<MFMX]$_<V.4<WUZ8@/!
MD2.K;=6(,T=6. N%/$HM<]8=#A(4*;$L<(+NH-2>'-D)J>,L6JU+>9QYO:WC
M?0"B;5I3?A19J_:3(-U7^\D=@_0C;/KOTNQGD(F""C5[ AV@2Q+#M\X:@;.1
ML(E9OK9\=U7$[V:1T1BK,J%5Z0U#_32R'/X35IM-?FYIPY[&_7.O=T=&5.RR
MV@HYBLQ/3<B6PQKMO "4[_7$9F&LN% (BG11-]%;-"')1'2:V#P#0]_KV<XB
MD7N8;&2(XD_2.P+>D"G),C*IA1C1BBXL O0Z "1>C< VIV0-P"BR/HG6D4$(
M*/*2#?&97:T+0.UUVVM[-E6&C"+'E$IB49G_H:0YH/7JTF:18'6X*))4:2?2
M/O=Z>+%(U#XH%*FIG!0$/_-ZNV.1,CE,%.FGMCF-\^>4<Q7R9Y#!TEY4*X'P
M7DBS+QC,7B]8+=)MB-U&;BH=ZT,U%*V8'X1= 3JOWL5N[0\*T"59K=!XN ;Y
MZUV<_LP/R9_UHN.2UJ C^G]TU+P%,57<(\F++ JIAN$/9:KX^B]J3[*SV&^L
M$K?O8>EC_ @H;Z=3(JY0VZD@XV._T8<\YCG+K0?=8'#BA6TZ!0,;1&HPF5PM
MO\'7?I^LRAPD+P,XC[\!=4KY$O0[ T6@RXS,'R2F^#!X (/0(2&3G(90TQ6)
M1FX.I^4)[B%-7IY)-KLAWT7L*O8 D+UNRDQ)XIZ<U$%C\"16AV_E0P;@7@_)
M=MG6Q8W!$[D^0LNX>7H]0<UJ]!>#Z32*(YCC)"8/E1X LM]83&<?MA0T!@=E
M]DST1,)%!J<+DZF[UA9@^@V-[F#2;L#%X,P\"I:KH]0-K1NZ'H3/J=J7*V\-
M4/U&@=IE5A4P!O_HK;!?2/9"LE5:M/)R2V\]UNP)5. W-ML1YQK@,;A<MSI3
MNCK'@WK0E0=U="ROH*)R\M8-:;YP<Y32#FGF,\22V&9(<[=7A)TGFKY Z*]_
MP<W*H(L,A;-XZQS&%[X=^'75+B>O#@V%L[@%DK!X]+MD2^KBWW4>UY99C2\\
M9Z!D?Q%R1NKRHRC9:RGE]X57*X >'P((*-RW.:>@3;5A&U<K@LY $P=T_V:*
M#X67]8[SQB.!?6\8Q62GCN9S:F\LN'C=N'_IU??;E'_V:'*G(12UAM<>T_K%
MH"4M :/7!< =;^QQHJ0.%![HFT3(PU*036:YS>_7J9%[ O;5.P'D7JW&70\$
M7<V@<%97RYG]#79)U+F,V$LPWNP2M.+5XMSU>&FG)Q3>\$WAALDVZZ9HD$A:
M D:O#B!=CP4E=:#PN+\A\XR$4>EF.D@F@QF-:>3Z[BJT FQ>W;>ZWR](5('"
M)W\#[H&Z(3[2DL?#*>"FQ3&*NLP*"=4UNP(M>+7H=#T@S/2#HJ)TTUUU V85
M;Z!P%%7O!)![=13K>F3H:@9%&>NFT(,P3!?EK6M(HC?)[:5*<T"++$1+S(LJ
MNSRD*"IE-\4=960>1)/U 7B=F3VI\G66TY=H"VC6(6@$6:8(.]RK8T=1]IH_
M>$?!TO@37[4='Q\A2U-@]_O>@8FB.#93UFQ!)@]1\#V*9;YE*LT!+;) 2VND
M,I&B*)#- %W&VR]@CJ&W*F;D<OH W,@"+NTP+(2+HL0V1V::6J@2VV Q9O8
MF)&E][%(,1NLC6K<S/!HMOUOM,C"5Y!ILF<'9'"GWPD@0I:238<^4[PVBG>;
M,+@UX+6A<+\7P(0LN8]E#MF 4=3]UL[^<N'UK&+W0GP?%XHJX.H0K3C&P%C$
M&+]FR*@N;A35R#E"5[.&)9<H06>@"73I:+5=HJ3X;%0W9RZ9Z["ZFZH0]SHN
M!WZ4A*NI-P8$&&==J<Z;"Z4.7A1%RM6A6_DFQ\<]C YGFDR;XD91NGP])F%
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M+F5IC%>Q?"*@LO)6]L^H>$T7Q2,))E&\!-V1; :;$Q@!=T&4_1'$S$1SEM\
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M1["!!H&#%W+['L:+"7Q:H*\\C:,)S02X2GA398DKEE\(*&%27<<0T9'.XEM
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MTQNHPJL[OR5*]2%C2%ZV/=H+U+!9C-1MW<J]P1+LP8.S+>?&0"T:PCNN!57
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MA+ -S/A>KW]%X[UIBU" <O!)(T[=F.'<+"=R*!\B1<2I(S-=RQ01IXURP"I
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M"A/R-7NB*YK7I5;_2V4/ #/<'/*[]3ZXS8MH%A1D.&WUV>MT0^%[-1S9HMT
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MR_6O"86C\[7YAI$*[C-]Q_<@)__C_P=02P,$%     @ G(I>5V;9OP&/C0
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M_"A'W*!D<QE.3Q08MZ9M47]VF#$]VNVB4'CFJ31-@ZHPY)C>IFMS1Y87(ME
M.45*TV"G<:YJKKD8'E$'="DD&@.Z% ^P;O5&D;5!51C#O=XH\AQ47-<-5GJ&
M$11&<;@-3$B=;@,0(."]\;U'/V!S$II,PXT@_7,4;-BGF?W]P/<S]#-2\RH
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MD6JHR-B3E%.#6\IF#YM++XY?_?!)NZCH5AWH>4@G>YN;_EM*CO60LJ))9=F
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MG_C48F7"GE[V\M\3-I59"RENXO%N;G:E_A'M<LD9&7;ZV48U[%,84R\0R_1
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M5&A2"44L Q6S9TRY2^/[=G7-R%$UN 547_\'^BDN+6(%77&4X_L'&^<ZOG.
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M8!G,^F+F3BX7MQ_F=U,^H\?D:C\HUSG;#\= ]R+*/<9I$(A@\NJO3%*MF%4
M>BO"T*;FI8BR%.-C$.37(2J_=F1(L?MJS4L$-I\,,\7>D1XFPX9-)?AI]-IM
MLTB<=ZS @1&AGY'SZQF9WSU\NI_>7<[(PVRUNIG=SMB*PX5EACTV#5/A*8 )
M]5+;GL;IZS+@:Z!PPY/A[[F&!F[?0!;VI3:M)2WQ&4)F0H24F'*5<H[X>>,O
MU/*<F=GGP06:G7^WJ\8%^)FY/S42G7+S?2V]Y\\7K/XJWBGA3Y0LN9?_P^__
M^/[=^S_?S59.<LW"T7=!* @#/T;1YK,?!$RG>9BR3\)/X;.[HD?5#-R^93V
M'+2UL [-0EZP[UA#?@'ZA(5.# V=OF@=KYT^ISN -1DT;"MR#;(J=VJ!6?21
MH[^QB\75+_.;&S%V+%8_S>[9DF$UO?LX_W S(],'MFI 729T0VPG1J)O%?$(
MIGQX2U^/@4UVVT7:2G"VC/2V*;>-1(AB,8-+7RO1BHX,'/:?4;%_9/@-H?$Y
M#W/%;KWX-YKR*+R&BN'FDDW5/#]<Q=Z&AP-W&%S&:Q('^T/WFX(I/.:\Y,JQ
MN1;:O.$E\C9)WF@^Q'WCUA@'V)/3GZ?SFRD;^2ZN%_<7#],;OFUV^>E>W).;
M\"<?KZ?S>_+S].;3S!%O,PHI%;YI%$:"OL0DWN_-DX'S)S+RW*BGR5"MUF^]
M:T9XR:E[+T@?1\I?MZY4.BER#$\:R87=6_L-A _9FTL]P0$3TMZFB<F0K1.$
M#$+7V=">S\S%U9V]*?D"CE_ROLU>*2Z7=7>+.S:2W?/S'_QEG1G0&O'M1B@#
M8<K/7NSSL8\M)RG[_NDL3-D8:$<:BSH ^6-C61U_A2PIA$DF[1:M^EAXN;A[
M6-S,KZ9%E/S/T_LYGS'R;9/9/>,=80P3\T5,?EG#LTXU:VS"1$K3)SX)O:=[
M_IP2FUCJYV9R$<AH:+G>C2#AK"@IRSHR.])U?2,06-/O*'BQ\\]&TH@H,O-8
M34 YY8P[&C7[*")9[F?+Q3T/G7>)&A9NU@)B((2YC'8[/X]88ZOX2(3OTY '
M[UNMB"WK 221K86-"<!17JQI3VIP;U';Z8/64=KI:[J#5Q-?;UN1:XA5SEF-
M(8L^&O2W=7%[.Z^L?=E\G0\/LSOL>,=N2.W$1)RAH\R37(F^-Q@IU&* --/H
M7P=:):'SR2T2)[R^R;>H0\OD0Z !R<2%:^20H:1R6C(LH;MC:T/*TS%R.YL^
M?+H7\>:H?M<(329<P#JT>DRM9MXR = C)HG.S9.CQ]2]*;.ZRYO'.ZK^AKGF
M$X5/*QKON"I&-WK:RT->WI%HW+C"PLI=\()94 .^0S16?''W\6(UN[\E5[,/
MJ '82G TKM2HD &"Y2R6P,#/U0L"HK>A8_WKY]$V;KBS]AZM?_GV[H39I$T9
MR)ZC8,,(F*EQ%Z74;OEN40?DAJV%93(,H;N\/D8\_#2]G_VTN+F:W3_\B[B:
MLOHKZDZM+=0:^[6V.(.Y"18E*=WM@T@D2_Q 0[KUC:Z9ZP0A;WOI;&C<>CH1
M((6$(U[7[),T;CH9?0^H:#D_I&*+*?8?#SRO K]_9>*,]:*P\6XZ.UH"VK@(
MJ<J(2X0.>.,.YLQNES>+O\YFY,/L;G8]7Y'ES10U'8@IM%HBZ8QP!?7T:;2C
M*^^+U>I<*07[Q*E"^Y9G35EIPHJ[MUHW^ XMSWWJ/@(6A,RN1ZC$<$&DOJ;0
MBB)TEVIKQMWEXG9&5M._X!XHF:#' /DXWO.>!CS]^]*+T]=5[(4)?QZ!)W+2
MNU"]*" %#.RHXR<7(4*&5(4<\:BFWZ8.+M,/@PHP.U=K58L#L#/S8 H$.N68
M>UHYNYFN9E<7RRE/C;&ZG]X]\#?/%G>H7KL#+DUYANW3;_C3Z28>O%X0\N"A
MKF-CXUX4<,03M_=H8].^M3N!/GF24%H^AYEI8G0$I1$$A83&AB9$N,"D\HQK
M 1ITCVEORVSZ@)P'S@A"3<R;X ?FQ,J+0Z9"LJ3QP[-G-J]0R$">8RDT;VPB
MY64)*TQ$:0?@;F7 ]/YN?O?Q@2QG]T2<2Z >RNE TSB?TR$&YJCN\)C0OQ]H
MF,Y>##/9RD4@#^+D>C>.K,JB)"OKR%Q U_6-DRI-OZ/@Q>@H5RZ#B!CE*6<3
M,NBNT4K_3Q\>9O_QB=^GF?V,':^GA8P.Z$B><?U,-X> +K9<'W_C>_'K8GOC
M[WRV5+OQO4<_\-/7RVBW]\+719S_@:_A0O8YG_W]BM^V5-%BH 8@.314GS0
MFU?,G]DZ5LW_E==!RMI)7CV)XO*/E1884WD;6"0]WPX"=0F#<JOA/P8E5G=G
MD\1IQ=&P?QV=#/O'WX[O^=&-N(S-$^U\\=O>RU,7!W  &GV;]Y..14E1EDV[
M6&E@8HZH. 1A3'!2P-\$)*!@OHIVGM]X+UYA52& ".A29T-D9.4= ?5 RF,"
M^Q0S.FB? @9L =1A2+GQ0SI/Z4[U&FK_JH&74SW[H6W5U6=>P^LFHG+$)=KY
M] GT&G (UK0M%8>@#-#5]LH#SN(%Q5>SB^PJ,=!KZTK]Y8..>.0[$R"_YO]%
MWT^QM.93Z!TV@E],<$/#)/OI.*RV/5&.>SU=C[;F970]U."ITIZY*E//E#?J
M.K!(I+%,PRA9;C;'N=;':#X(2LQFTT%GZ&:"6"7W3. *3\1RM&5]O8CK#^*U
M3=#M2-J]?BP"]^@1#;FK-?/97>.)Q0EI7=4Y3OX!.^R.$9-?'(B"@(=L%%1Q
MQ@GT98O20?2E"N9KE5JGH)'#?Y-2BDG%,Y2NT;*3:?,P.<1LFGMB9/$8O(./
M3ZH9980SH.#F%QH>Z#6SJU#C%S]]OCPD:;2CL?EBT;8BT!!G2QN;4<ZB L*_
M?LDL\IG508I*W*%7;VMY=GD^W<TK0F57-W@VPYR[8!.$?Y\2NMC.DM3?L2%3
MM4=;+PC(GX:.C2V*1!P/ET7<&W.L3< $?3LFZJ!N!P3L;4/SX4$N@G'+4.\$
MCS<,W0-S)S-P(:U#C/1V(?)>X)KRX8*O>^[]Y+?+F&[\E/^DWEB02\%N%RBT
M;]D$.)8FO!!;Y@N!_!^ND:"'>=C;=3I0M:R_=8@RX8/W& B,O_WA^[<"Y^P7
M?_O%B]FRJEAZJ#RYLC0 KM7:UC]X41(?L-WTQH"H 1X*:$*!81.M#WR)+* _
M2N>"C"0?O,1/%MOI>AT=1)[E3%?SZ9-I!8#CB[%-]:\@!/ED^RCJWO#2W[HE
MTZU KLB5?G8'N7:HK8]:=I %CJS_<$C\D";)=/WW@Y_X8E;PX;7R+Z/K)9VJ
M0XF:M[)7%0)>5$2J-4W(XVOU%WFD-SZ+!^J +)\V8\T+?:4;-^+7[1$LCU:W
MAR],]G8_9.[RQG^A&_':^H8G[2I^4W]\76C+YL73A(=;'6VZC':/S*\**S@H
MC=*_C]PP9/[XL?NPD;==5'\AZA?#WK'-_)?'5HN7,HMVB9>((,(31U-IW!F_
M MZKE3[SLC[S\EI1$^*#$+2141^$G< 3DGNZCIY"_ICOG$T-4W_K<YU/+ C+
M"%-^MR))V,)H8^S2!F\)91HS5"^I9CC'-LBQD::G"H_!T#Q0)F_)&0\U?I\M
MF=[/7D+)/O;7S"T%@B*,3V[,CP8EE'SJ-"B;8/8BFI.]91Q=1_'.FX=;_A_3
M]8]U39"[$]96-A;R+2L=_@A]1$0MI%*-,ZSO;S6W3Q0DVW(WPC^*HFY'= -N
M8U^B&VJ!YP.2"*%CJ-TM39^CC=W0;U\IRBC?P7;5@*X(C3M62;(ZG6&R$[WA
MQDC>E0KR0;LK#]SP >6+8@.Z 'F=+GD A>4=(5]Y+N_<' ! 9SC-?QT-K.FO
MXP#,^RMQM*=Q^LI?(TC9TH&_#+/G:IK0W$08\AT6$UM:)J!":"*>R4C%0KL4
M=(:=G4Q[..QV^7WJ0O[4O FYHZC72,S1UWANQAAZP(/HQRC:?/:#P&Z8;)%"
M&0C;M%=Y]Z*\,T3I;XH;@Y 41O)A1HHA8 9<RW?'.VP?6]2&PA@;:U7PNU8?
M6;G'+QC#W6"C-:3E++7&,S![->=;'1AL62,*BVVM5@':X #:/3;#=H ;K.X$
M=3FS.^$<Z-(E[QL_\,56,S]$*N^G/= G$?>WBJJA@687,+M7"GH9LX?MS8N9
MU<HJEQ:SJYI%A22-3B,M7>'[H)U165X6O?#X6O0![B7.OG!O7NCLBW7H3,Z9
M5O=T'\4\%K9RTO3A-?^CW2AN62-.KF9+JY6YA[/BI*RL>@ [J2#=&7(/V ]'
M9A=&SMTXD^V)<$4"Y2[PAHE*+;:)*U$=M]3CCV5M%B'S3(<X9@J+\/=/8?28
MT/@ERZBT/Z2GCLLH%G64YB C4,?IKT;<:7EX,3D)S"J:(OQ:8]$8$:U-2+4]
M(AHDM2F%*\[DK'L1-49U1+HV(E-'Y"KHA"59;$\NG;(9EI_\]N&5__]K;\T:
MMIFL6-6&,%&QLU8V21&7ODZO4?.9N+@\S68G_ >2U>:,4\'J !=F+!T@+INM
M=, W[$PE#T@]"41M\4NLP%T4QB=NROS.S B-8<Q2ANPK^>A:#*AY0L7CD,K/
M@ZL5.^,K7.T@)^86@Q-,.K,8G%UGXXFX?#XU6C^'_M\/%-8Y&;1_9O[*I$?-
M&)K-^A-!SK)6<JSVJ_)B<-UV[K[-F+)CN#MCOF)X0(@-HZ%:PO-J(V]PY(>_
M7]L.T?GTG4/^;?0MH6'9"'Q\=>G%\2O355C"W7&1=W)3VL<6P5?T,9V'21H?
MLA,X^]"40=I!.>H:IH=4!V!%"QD#LTE#V4@E=E]LP_"&2*4E9[S4V?28"WM4
M@Q)/?M8V(.M@LOLS)TIYEFIC#R.5@,SH+]6ZD?">E^2O;"3N'&9;:D]F7_8\
MPQEJ9GXU3!HY^=48 4(VFR70Q9[RC>3P2:A4/BMWZZ6'F/W7 O4=:@-E1!=K
MFWCCM4Q(60_)^5-6->'Q7X^4+#U_,R%%Q0Y1:XANN#ZP@I3<^J&_.^SX%NF:
M/Y<1!,+(C)1+[Q5];.L!\29C.^.[<[[<M@V)3 \M+>W$@3+J6MA31UR1$N<T
M$P[CG1!'IU=/Z^X7GXI%KLCU(PA4J08K0:\M *L9>U'09Y+"=S04@F?Z/<ZJ
M9UX<,J^4+&G\\.S%E*_SUTS-*S\XI)TR=UG6B+(.MK5:M7XKZB*L,B)JFXBM
MI;5@9%XCNI]QH _<6*MV KQ\5=H)[<ZE$>9:&I';M"I'TP?G=@Z5.AB=P_@6
MNYI6N(KH/BF%JW#&2GPW_>*KWMR22N FLLNU-DE81W[EA=W)1M=?=>2,<U7$
M&&26J\(%#>19(DIZ%>T\OS$#UYA;DT4&?MT2LYR-A1CY-1-TB XC&81-DE;$
MF="E%6Z=-VMNHO")OHC-H/@WFF9+Q9N;RUNZ>Z1Q"Q-,A( V9K2Z-_9!"P&2
M2>2[%VPE?'-)?LW$$+9@[.VXG6+MK9CAI;JC @@6DWV404$#_TI2TR'<L%_,
M4[JSG*55Q'!'K*K^9I,>+D&$B#O#U*!6((]-#409#$L-.'4>D5HJGWU9/[,.
MI?><V)(Q22\&-"H9Z&\VA2FDB!"#'Y8Z&%*J'+>I##5&F2*H.DJ!PL=DG *
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M0@0MU909A$X23P'BQR@-U9 XP@_?NC%[I%LJA+F)=:-^Q[FQ3K]QX#'KT2Q
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M,'F5$.#FB%+WEM5W7I@<2R/'PML:<''9L !S"T&/G?K:7P\<$-#/PPW=#O+
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MJT#MR<@J2AWDY#4#S6"4S"ISEI&YK8,0DM=U#GR4V/RO%_]V/G2L8K0?&ZL
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M5!9YR>K$'17K'52G15%,C&N 4L>W!B4@V+X^Q*&?'F+*QIAK_PO_2>_654*
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MR9#T'8,+=<Z/083.6UE, 3:O?*"49T9B2L5T\RGT%7?7382 MIRTNC?.Y80
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MXJ45,C@\:'4;K$#YD4U5N\WP#&0!66)B22,D0LBX.J7K;A$J)XPA5:>%,9Z
MPCYB_\7C(3.97LK0CWI1T/"/AI[-T(JB2/9H)];[5UI%'_[@[?9_7I)_>_N6
M1'OT5]EE$&B&@[1_?Q@/7GLFZWA5^O0Y+94C-ZX"TI^;V]7A:3@DC][=IE,3
M$D]<VSA:>#(E0O7^EG!L# *66(0[MY<.3[K#>X4@] F^RH;V8W#E% GQ+-_>
M$D](H!_?:V'4>H:OQ1#N:J'+*L&-U8'MJ@!GY6RC?K9HSM#>LEYV<FE@O23
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M.2\O^@EL!BX:'&Y0^3'KL9 ^\<GK"GBV+>N]6U<VG\=FUH@3YQ-:G9O[$=7
MN)^\J?-T/T4_ ;F?]C2JO3ML3V,_VLS"#:#K4?:<6+X3+R4TW/"\C)F"(]G-
M$T.DSEG^2)_\D$]CY/:?J0,^\2TC.N 3QP+K@&]\[Y%IEK)1$SR =[RV,5ST
MB#VI\MF59K_>>-Y_JKY%<99C^P&I]QS;"9S1?+;HBM=YDAP UM2-]LYN9MOL
ML?&GMV6;$\);Y5<WS_HP2]^'5_0Q)3[_ZX:D$4F?_9BMM=E4]*M8:DM8-\YT
M3T(YIYU4(C%AK)6WIKTS<%*Z'@-T4J.NPT==CW;J1)M%J?N;$?VZ0+DC<0Y^
MVLCQ#.6GC;P.K)]>B"<K+MF,V$_YJQ;\%"GAAT@T6839M3@3]VM4#897-;-/
MY2RS&MCB2M21/XHBJLE.VVAVF)S5-=91B#'[N]E;.R+G]JS+8*)C"!%YLQ85
M7V3/8]/--TY0W@+#4B9; !B$H+]X<>R%:3(--_?^TW.:+)@W2;UPPYQ'Q>L(
M+Z,@J%TU@ 2UM*\.V$*<, F254 J-9Q.<40E.,NG(<V,,S.CJIF[BIE^FYF0
MA.R"V3HANP 6A)#UQF=?:+SV$[J,_;7\K48K:4#ZF5G3. BODVI""D$B))'R
M8O6SJC1ASXMA$L@"8W7>6  ,A2X/SU[<D2M-442BM-AAP!(AY21%#.RYC'8[
M-B%\2*/U;YD-+G%$!BP=062H0AI,]G3-YM-7_HN_86OJ>S;G[S"FR"M!'5H4
MMAF-,)D\*2H@O ;':&1E9&G(7WT:H.Z:V.-0/^[H0(A",/%@9TSI/&2?ER9I
M)X*I*D$DF-(V X)Q><(K($4-+C+,RDI>^&++3?(+DV)6WB6JZ1&IHYH>CJAC
MV8K&N\YC6%78@;'KQ!:;,8L+.D8D(YN$WFE$Z)>]GSUZ[!)WY! S'9Z:^ +A
M"C_EGH=)&HL[*[IW:EI+ [*A7=LZ5![6SW1S""@_![J)PJ<+@1UQGG\43G ?
M@X&P!)(0"AS5&:  $0+D;PR22$LET*!_HTA/7(.' RF9Q]$=#]X-S*@AW@ ,
M",RYOV!?9\=U6;%V-&\#M1<'!+A$WT8.^Q,W."&\*.K30,/K#0EL%4KJJ%9!
M! 72VB=]9 *(L)8_;-X*$-1W=<;1'1/>ZL=MU' !@?A=E-)DZ;WR6=$B?:9Q
M_G.B7;AJ)0%!K[>BCB A0?)B$R*$BG\FR.M5>VMNO?@WFE[XX89^86OND%>
M20-#5-7Y8 @I$&(\\$ UNN'4U%*AI2P@^-LT;2SLLC+94@X7W3;J/D9Q''WV
MPR=,,$N14(>O% 8@@/T4)A:0;2T-"-IV;9M1>8D[P+55V0GP*E!1AZ\"$C"S
M;;9L76RS $0M?ML*0\ZRVW1M>6-<[*3E<;.XZ.V@,>I$6@J&QB1:B@2$W3W-
MID=;8;0]/<G&06-+#'&O8T"%\7;O5%L<<D @@/?.V^FW..0B:$ ^T5N#C@GA
MI9'W.493'P_D3>RHH=X$3O>7>&^GJ]4#C7V:O&=__-=YN%8_PRLO#_4&KT+C
MQI#,RY*L,'G_+2\^X=GMOL5\@7<(_=$>X-7!Y>3U71"L&#V].W2?]^/;1[:T
M29]9G=&.9@V]8P5_,.*>7A:2AP:6M/=O)DC^X.WV?R:9?-'G[WB?_R#Z')NF
M(YN'RF)3$#88#8I 8W8#?JI^Y*^J>+/4$[Z]/"3))1JW=^=)#T[(S1*;P_VT
M1Z6H"BH-6HZ.$V,J#M?CPS%M/K?E6E4"BVTG6AOT'YG/7:-<1Q.<X5T3.$KF
MC82:3MP;H.L[$_!A'X5)%"_G_Y.?2RJ9UUX4B'(2/1MG:EDQPLH17A"181TU
MQB*4"@A5)HV. A,*#="WW1FS_'D>OM DY4I>>VN1VD5-')4$%'^46C<Z;ODS
M.18G17E,-@VA/QJW]) YH1@07HR8-G2_#[(#:KD!BK[_:;65Y=KF9S?E7=CY
MM-GX=&;?LW]WPZ86^_!:N7V5)2)7GP]K)3$2B$FM4%T#%.50SX['TQ\EQ9<:
M2]*L7FH@@=!A&<6<W].T5*K\X<I/UD'$U=,&_%C5 D@3.^N:#_0*:9Y(\IAQ
M[R1UEVR@@P1AAR]8!V2'SP<"SDLOCE_]\.F>[IF&=#/=18<P[0)0ZYH 06IO
M92.?0"YI@5 8-]_?M,LH00UUZPC!.L,ZX@^$9;/\-=[%MM<88%<-(+\L[6OD
M7\O%>>BEY3  0[*>]ATS)F/RK L(ZR3K@D"$2+YK;TTS_BO8)!=!B^0[T5L;
M"L=+DZRX"W%\2N6%KEZKKGA!>TV8J(/VFACIO&5U6O&M]\7?'7;9-;:KZ'.8
M'N)P&4<I7?-9XY*RKQ>FWE-;KI!>M0%M>'6W5DN"O#*2U4:*ZLBQ/G*L$'ZW
M;#C+<P,WA8'[HX%[J8%06VL]X5S=>7,!RR8;<RYB>B!WQ _$[NGF()JZYYUP
M'<59*O0/-(@^KUA-R7,4M+V_UZLV%'=D8ZT^/)V?+)>U$5$=?X.-9!4242,I
MJ\1V2'UL%Z;&I:DB21C9,E.#S-1'86HJ,Q7'-5E#6^Z:<'!M[YI<P3?,9FM
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MD0Y=";R*^5<= &VJ[P!8HSZJ6%,'S;T.TEQU>(0)V!.-(X,7!ME'Z\;+ZNT
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MF:6E8/XB+ ,V0)Q\-B=6"(=#*89<HR+YY1.S,;PKCB(2"H9;UJ-T*N?8>"N
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M5IX%S(Y)G (8'.JT=95>J!L"\$E^5B;T9KR(EN(S@-&QF0JC^1R*;)9/QDE
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M+LYZ_A@TO%#MPI:4]U)K\H;<.AZW+U0S?#?%!;KZ5"=(0B4;A-NWH[6]FP(
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M(:X<K]DY_1-)5H%/THV]5+I[I0C8 UG@:M3;F2@XK+J2*F=K"(4IVLOA(;)
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MFDJMMGR#\E4;F33Z^A3*@HV0E=<^OCLUP!RG<"4"MH@R5YJW[D]_H39BJ-4
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M#O)@-W>EHC;@)%'/NRR"5FC-4+7J >KZ#>=1:IU*A].K"' BAP$UH(7=(9L
M=[=O%C)U>138^BH>A-LU"EO,"IU05 PHZ3?ZA]48E2XF+ <HD&-]Y#9F=R %
M6.[VE]()^#X%E]=,4T=A%7@Y/NDW6J=H+J7=?M;ST&KD6!N1-3D;^7P@[CK_
MTQM8ZRT.H<'I6H_ML0NL7ZC@^N4'P>;]1KT\9<!TR4@/<48T5SNJ=0 ZY)@7
MEK4Y*QT]4.YVDYOY(HP_R/;^(1I?T&=82YQF)&\!G<MMVJ RIQ(7!%+Z#6BY
MIG?ODDGQQ#*UI$KWD14%+-B!*PJV9O<B-6SN=I[=)5X]AV!NWJHUR1*4>CD^
M[3?@A-$6M4UI?C' @'^I@=C O)UD&2AW^\<F/]#82[*/Y\2+4K!%?FJK/U?C
M-4&AQ\B* CO]QH'P&J37BS1J 83(T1IJ'+![EC90=SM:?O=?G]UJ_4*%3E1^
M$.S<;\C#/4E30LIW)"KI7>*"@ ,YY(%E5\[J7@&)NYY_XR41H**I,_(5?Y^+
M_,JK59;[G"+ 0K\!!=6&J'0);IF7XS/D@ &Q7=G]0@+'W2[QM'Q-R=]+J.]F
MU?,.2?75*GO^G"+ 0L][_I6&*&E?O#+0>NS]?:%=.:J7&([+74(EB< G2"9P
MTG-@VI/_1B;+D*9P!-\))D%NY?M@'F3[:]<^KN+YPHL^1LGF#W1*'H$7O 6+
M9\EMAF9>\'*"'=(FXXS3(0VB[ZKWMG"T-,D*3@8_[1T,?GC9A_Z1R384=?@>
ML)*^B!X'^-BIW W26'84.6[.-0".T7X=S[T@TB!^70!,@+0;*R=&C<@B#DY.
M+4?2G39T_?MMPC+)-*Q-U6!>9)VKNQ'"K(W8+NA*6N9++PW2T;3R+?Y8_Z_*
M?%^M C 5\D:W&;+9CJ1C [:[N)*@N73T0-U)1,7 +,BQIUVZAAPYVR%<N?.N
MA(]]AF2-6M4[1'6 P;#O0>S+5>1F8/N-?H9C"_QF9U68W8V2ZH%9UAQ0SZ>:
MU@^&QLZTW9>_M3,1VQ==N87O:PJ3S)LT"^:2&RC*#P)T['S8'7H'"RN;9OWK
M\W!HYB3GD@XEPG(O)R?82DJ'3J  G:.AN7);WB-9D6A]T>@6WE]!]G:U3+-X
M3A+U*:Y>16 [Y)CX+MVFB2TX?N3*A7J[F#5UC^$5 7M8L%'6E6^(47.\ %6;
MU9O5^H0Z/ 7P&*3?KJ#!04;_)9ZK\DJ!5;!EN&YGH&+@''?H2=]E7N;]EY<D
M7K3]!HKZN>!I0/<)Y3 I8 Z=[;52E.S@N;[<Y\XX5H[PDY.>T_'OE/]'XL>S
MB.8MNIL E<$T(.MFKK-=@[] N[=^2[>2TG0Y)Y.<&:5@%;-O DLAKPB;,"O;
M9S=H&@LWW!OYY=;,Q9SKEQ^%G_2<3[VZEY-3Y*B-+CQ,%[^%&_@:;G0;1/!5
MO0]6><>Y@Z_0=/^;:J[471=+Z5=X;ZKJ=T@I84&G+P9JD)40<Z[9AZ7<#EU@
M=-EQ$M_&R=R[BZ;T/ZK#H&9-8#RW;NX0N%DCZ%W%&Z!?V='[?+JOBSM.3GM.
M8;#[L'+TVT+6H.PMGNA-5C3K!/1N7.N1LR2;J30"_UEFO1SP>V,:="=NI6!2
MY'"1'OQ)@KZK^2_:M3&]#_W=7AYS<MJO8,)M4:LK8XI.ARQK*)J<W=M4 ;I[
MED=V/4SOW0OGDIB3LWZSH^V'\6T[]3Y]M5*  'EMT\#@LD\<!^5GF13=\H6!
M!C*T<FU@1.1-X@Y<11.]VS+@'K9$7VK@1EHU@C&1]Y@[<*4&%NA*D.L_I7WO
MWWN3B>U/SOK-AT*WMR(_"(/-_0F%X*5-&]/GN!@ JQ8-UK12P(\=XRYDAA?Q
MU0[O9YD-5&U7D'$O/S9_U!O*M6H$8V('K#=PGE9@W=5"F+G;>Q^ZN\C@?G+>
M;_+$76,V&W*E<(2-=2>CZ)'>/I=0IXPF#W&4;'_,C^^I[Z(:?QG8"WGG5,XF
M9Y^T(UNX_3DP815:?K/[Y[]%P=]+TJ^'2M\/1"%K%9A.JVB>S[%"34?34J0N
M3.^"]-OE!_W?6S!VG.A,:31J R,BBQQ-?:PQ6+>C0BI=B]&9\M[S-8I?4Y*L
MU@=<%\NLO'QH,,:U?1,8'UD#,32:F3&$VSDM=B81C^O&7='@ZX &Y*B)UOYH
MW!I=9<[H]]:AWA=XINX>.CGO]P*)O2IPY27)!_A,[E9TOK8]ECS9.1M\9VFS
M[R)H['*_D-:36@R\!ZR$+,"(V)/)+\8,X.Y6^B87=-^=M&GR\),++:6%>:*-
MM0Q:9\B6]B&=XM!69)6#9;MRE]#'X[92D5N$7A&O/%IR2H QD-4 .;E*$-Q>
ML;,2V^^.=7[QLF4"_]7@6KLV,"+RBEW'#QK"<W>CN);@O>_OG,D+ DXN^KV;
M>3]/JC:)+F9\^&)<!^$R:W3\5*M&0(X< BWF1#;-; #6W0GE-4G])%BLQ;_M
M@9]KDGE!V&?'&R4S+PK^E6,J)?X"NX\+>/,@+ _6X%[X!+\AJD=AC-3_<CK
M.BDC/X*JG)5=K2K BJSP&*1,UN-U3.+VC)J!E).?75("C(&=%K41?6Q7$()T
M>\[-@K8^$4RX*=J5RX*!D*/!A,RID\U A;K5Q51"J$Y+5OGL/_E&LK42<']_
M]87,7TG"X%%>"* B"X**;-2%$!5@;F\4,4QSKY!;7U0,S(*=%+3;8;N"U/5T
MYO-Y'.4WFX^]9)3D\YM)+G3O;L_C^X%"Z9?30TORM? I9%.O# XU?SES&&=
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M\1P6;K?%!L6AML5XPZWJY>P,/?2JIR]5!;/;ZH0BYK9#CK@^,"2RAM6;\["
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M#<1QG.0L9#NPC#U]Z<I#HQ9J-5M"GX2\LGU"'ZFA;<>P_[UEF I\P&?_D2P
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MLE8EL7V9, 4LN!?.2LG29:L&$5DH:D47"TQGE\&VY.N/)/Z>O4%KXSE9-W\
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MK<@ZDNW6\^%3+AAI)24H2N1C6!("ZI],.1RW;SVC5^+"J^?4, HW%[(>IW9
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MZD-6E-H'6<?JGGT=KZN9!E4D9:H<XR18T=W9T//S8+R_Z+Q%D@)96.9E<'R
MO Q1)*.N8Z@ <UO&O J]-!U--\!&21X\)?DT<<N\#$ZPA<D>/RPR,QA2, UE
M#6SK$]*/@: 4-0BR<"DC2X/B$B9#:J4VR7V-W2?8$J.< NUA^\2DP&C3I$UY
M<+M72!-IZA7T,XDL1[FSVJA:#?6..6POE<KB1NJGED8^]6/8:3KQS)*QW+Y%
MC_E)N7DGB1^D!+X=/MG],=W\-16%>S>JCUH2.;RP%[=K8YS.[N[K7_Z_]-+
MST]C@+W)Q/%-@..#DUY[[ /)[B*P+;F/4]&<I?0<;2:R^B2Q(+O'L$ 84M!7
M)'F-,8;<RCF AR6=B8^FN5'2T3)+,R^B>1KS;B(@6*L>:CMD.:*1 S0!:4B#
MMLU!-L-E#;J^B_!JHO9#UB9,.HD$IMM!N<R/JL8';-=AD#6-1H2+P+BM05>1
M;7Q8@]A-";#& 'FKP0BU93A=1<)V/PE^6KZFY.\EU'>SPCG\5FV!PJR75X2R
MT>^!N$I+I $LC,=IHY%7F1)[<L)0^%C<#B:I OM8\"ZTE)2@UD .,!*0I,9J
M&8K;810,;-(M,VX9:A'L"!TA5\K\EO"X/?NLH./NJ@F?IY9 %B5D+"EQ6T+C
M]O3S/HYF\.HYO5Q&83QF/4[M@!WXH#L8"W"XG86T"DPZ#+,+4%M@G[;B4Z3&
M:0F)XP>K@HB,IE?0RD ^]-8?IC; /BPE(H?#)P^'V]$+Y6N\).-M_6&PP2'R
M,E][M.6B<'N'OPQ+*6B85X3: SE.A$N2"J<U)*B;Y.RK5+Z'C['_;3V>W'I^
M?M)*&!TF*$%1(L=-2 @HLZ8&I[,MYYY"&TK(9'&\M8>I$>R2B^0C*Q<%ATI7
ME*(R+GGX+>-Q:@ADC8C+C@J9)10<.IW1AVB #0W\>%50#JK/4A,@ZT$"9CB"
M 0<$AT=75*!MGG2:PE ROE8?I0:P3/N1CJX<#!P279%\BJBD(VO]86H$9+F'
MPXN<Q!("#HVN*#V;(6:T(DE$HR%N@\B+_"":4:!/\339_>4NFI#WI^_>@OY%
M=?QM5B\U+;)NQ.5;.%*W@LOQ)%?4I4MZ[YZ*:Y0?I."1525-KIGMYY#7DYS$
M7*H68=$HY#CB*T7"YP'BD2MBD0H0#E>8]U8SF\S]K$I*4)A(,I"*^14)*V'A
M4(:I!#$;/8KXXY^\$ 6+I >IT:!(7140)RRA)T5(G;WG[[$^>[M"%"SBS;G&
MV*L"XK#7DPBDP1Y-C-J OWTQ"AA)[#'+8 T2AT-GE)_RY_]>X>PMKP@UB&5Q
M0;I!7U4L'')=D8/*6Q"WGB\_M<HK0@UBESQ4Y4IE&ZR&AT.P*U)1<0M^JW[N
M+KFYC),D_@[_N/(6\#=AMD:]BJCQ[(HH4G.&1B@Y+H*:[%D+![WGB//9UJ^(
M&@590-*BOA5*#O4]Z49,ZLOCV54,%O"H#?Y>!I/\1CGZJ_RN*TK+YLH?#ON-
MZJ*F05:5M!V@#5".#[@2S<3R_:\1@)IL_1WFMO,@R[^.9'OO%9A"\V.A5">8
M]-@NN:OY=T,',,>'W(RCXGQ.^ ]3(V#GV&D_=2P@X=#I2H:1,BYZ4C-]@H9[
MDU%47/.*DHJH5D$-AAR&98!Z*3[.T1%,%4X1@6!NJ%$#-8-=D5FZ<P(5>!R6
M70G9*@.^BZ 9),TONWS*Z,T"2I]^]4JHT>PZ MBDZRL@Y+A%3P*@0N>_)E-O
M&>80E+IZX7D*T2Y)3[=CU\%P^,),:UP)[9['21;\*S?TYNX98=_4K(&:P24E
MKQD\#LL]"7MM689__5]++\FX^RV-ZJ*F<4FV:PN4XP.8RAU;B?CB11-:P<<X
M(8M&/5ZI)FH6U[2[YC Y[-LGWA4P)&0>+.?C)(B3Y_@V2-)L&$7!"EK@)2SY
MOGVEU%B?0\[31,QQ#\RP,CU<3\2/HXEI_ZC5"N8Z<4FS,P>9XR&8P6R*P/*;
M*PW[![M.:BJ7M#U3@#F^@1DUQ]GD(,6=#>]=?SN(40$U@DNR7B-TG+PA]HAZ
M6PS[[,C[.=!H^D<2I^DCP(N6I GORK52<[DM_C6%S/&0]H(@,_G=[Q3%JY>2
M__[_ U!+ P04    " "<BEY7JY2FKR\"   >!0  $0   &0T,C,R-C!D97@R
M,S$N:'1MO53?CYI $'XW\7^8T.2>5/S1RUT42117)>& (-?K/2ZPRB:P2W:7
M\^Q?WP4U31/;)]L7P@PSW_?-,#/6-G[Q;&N+%BN[V[%B-_:0C;[WQY/!R#+/
MIO:;EP"PEL'J'98;)_"":&Z\;=T8&;"+WSTT-PK*2#\G])"KJ<]%B0NCR8%N
M1T,XA"DB;&OE?KO&'VFF\NGSX)$R W!!#TQCD+UJLZSP&E9B<:"LKW@U'59J
M!A<[X4KQ\NS:<Z;ZDOX@T]$O>X]+6IRF,2V)!)\<(>(EUDP+S]WX<T,T.@W;
M6MKH,Z<)5= 4#9:YM"TS;*J^I6 TOJ.$M.U)J\$)_!WR8PC6X/HK%"+]T&:$
M-NXN1A%:0?BZ]%P'%HX3O/JQZV]@[48O_T6O_48@QQ\$J)0UR8#7 @2IN%"0
M8:4=:Y*(&HO3 TMD-1L]]6 \'$]Z<*0JUY&R(JD"Q4'E!/:489927(!4.KG4
M/9# ][!(<%I+V!&EBK.W!Y[G0*J%83U9&5#6 D3D0*426%'.NIW=%00PRR 4
MO"6KY0"T:)TKFT\7ZEJ2AJEYQ7LNVC0-HJ$OU=Q@@#\1]%K[=^2F,0R7&EZ"
M'BA<500+"37+B&CC4ERUH ]?1E^?9NBS(D+)06,]S^"?_T93FK")%GJNXFT0
M^7'@ZPZ'+>_M?;L/;9C3 F>DJ'**>Q 2QN2I^,",XK^5?(]=MX-4\82(\UQ.
MAN>YO+*:^A;IW;E<)GUS&E]SX+2SO8L_ 5!+ P04    " "<BEY7P,"U\3<"
M   R!0  $0   &0T,C,R-C!D97@R,S(N:'1MO511;YM #'ZOU/]@,:E/26C3
M3JL2@I20:X)$ 1&ZK(^7< FGP1VZ<])VOWYWD&B:5$U[Z/:"\(?]?;:Q[2WS
MQ\CWEF0Z]R\OO#S,(^*3;_WA[6#HN9UI</?D -XLF3_#;!$D49)-G/4RS(D#
MJ_PY(A.GXH+U2\;W)8YBJ6I:.38&+B\,1< $,N5[\_#KV?^%%UB.[@>?N7"
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M6$RSO.-M>P/7H22OP7R[$"G_]<&G8J/1J#>\>G]Y.7I7(Y%2) ^:YTI;B-&
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M/. EVMP%'7_W@F5,^FPX8]=B2[8LEMDX>/NNP4+=R5 _*A\T/DLKQ:BQ;]0
MI@MA=.S956!4 ; P %88'+7&#_@'&JV#*HM_3\3R6,_,=STESDHMSN;,V4KQ
M6]^O@5YM+(3?L6=7@=\'^L2=A]?.,\R$"*O@'FX?C--MCCQ;8.#;B8,HR1IP
M8-1_-,3O'[):G/] 3<J>D3O?$I.\IMCM[<P-+B1*=F&FV/@&[=MCQ:=A<S6=
M*#!<O!@QL7!V?GW?J.\WC J(B=7FLNVNF-ALMJ@2$[LG)F*GGLIPJ%"&0]JM
MMSYG\-NPLHN@V+W9WS5QH'@^G>K++08T*] _\T3'RGM=,8<%](8]4^O:"8CS
MQ$"G"U[Y.A*F4'2LJ-(X*],X"W?J#=.5M5JGH6"7.*)X_(I=UL&0!DFHZGO9
M2_'"*GDALRF<.V&*$Y;B!-$2/R/DD9I]Q[7=IY%BA1*R G9TQFSM$A^T[]M+
M@U69117$?\[$[Q+N\ZQ"'XA('),1.W-5<<7N<,6;8;&=/'/THUY'/JD!S\2_
M?XCHK ZEUKU'>]3SJ/4=Z#O.(()6XP?$E1>Y4[LL,_%FC'FELU_;KQWMU^L+
MS?[8LTO-?MN_<]2LKW'6&?2 P..3\QC=>5^@83UW<U7-YUJYF.^#;6#/C'-Q
M0\YZ0\WZ.KD8PZA2\[@L%]<-J8N3WW(^OQKQR";RKK9S-O-'O&(]#%Q97XR#
MQYY=FH/5C*]IQC,Z.#.'2W$OV%%):M+Q#Z,II7'8]>F?(73I\IF.U5;+WBKS
MV4)Q-M*T+D]Y8#TKIZ,W)" =[QO%Q.]SK7O\H]X2/#M^;K0\<"<38K:-IPO-
M&O9JK>?C_7JK$,[-V$]U<1"\$$CP=W,L;#WG%/A;-Z#^/1EAA!C/R92_,Q;7
M5IW\GD.= EPXLX]]GT/E%6*M7J"-Q[%V\L,XG,1:AISC:3YEA,K4Y+XI8UKM
M%)WL&X<KFZ+?/?<EZ(OT:C$T VX>;LUTS1O?%D_=;HGU%<G88M3*%J,P3QXJ
MY)4&>5575[#V;$7UW:&OH_9]>P[&U+ITI:@:FX;5>B!A_5O@2BC!T@USZ%WO
MW*,6"^:)GA]W+_:#:_X43U\1D]ECY<7R0$C-$)['.YF%<J:-+83KY !32!VG
MR0I1.F/."OCJQIARMJJ91/5V<6<.][R)D3OW_TARV!=EY*UBS])IDQE34BIV
M*40 ;CM_YC/=XIIPY]ESW=IS _RQ&4%0CMV=,G+GSO.<4HF[KJ'>M;[;*A[8
M@!XH'=N]:\6XVSP@+)*[9^HYN'<NXV"<IP<2T([;\^([UXY%7SLO9(AWTJU&
M]>WP^A;RU?CP)JRY]]&N;%Q0?J;?#:WWE?AT+H<IU5A(M,B6,LITB94%E^+)
M.=%S(D>O_N,^[$)G9?!89IMS*X/F<D:[VMW&XU2^V-)1KJTHRE6MIJNVFJZZ
M*^M]O) 3+QQ+L7GQPNEGE\VT7)ISE*&Q8X;&IK7_;G-.*5;N/])MQ,>_W#GR
M.^VO-[D/E)V1MX"E2BZTRN=6P3'/ .O4VS'8E7C;$?'V^.(J\:;$VVZ(MQCL
M2KSMBGCK>U39;TK [8J 2^"^G2(N3O8!$:?2S][-O#N6?C9^X$8Z)6C>\5WI
M9Y<]QJT1E8Y22?!5@NN;DO"+06@Z#7[^ 7-%'0DS'Z$*HJ6&Z/9C5!9PBK')
M>C2I<WJ.!W,3,[-<N"+,^P>Q0_IUQ(N45J(<^(Q.\RF?,>J5;F]G2NDM'Y:0
M*AVOYG%]\SA6UG;I>8SYT?@!*Y&!ZXAA9A;M 7 \'Z0(V.!5Q[BN$&],U%V+
M7[C\,X11Q2N<TD_YU)&FCIN;(%(1.Z>S"9;]]GJ*OAD%RXL4SJ97N+8HNZ%/
MQ+[DO2PK6J"7IQ/=7.\I4^N9*'XR"L@UU[:9\Q2=&[Y=G#Z;XV91H)IS^D #
MPAQJ71+/@2'YNS2;^6.OYCRV+8N?*4#L>\*L:^><#%E [%V:SIDDJ.BLFF8X
M"/EYOGPABD/W:!\)]$R%SVVG9GA1<E1HMN.%4UT90D4'<!>Z,DI-E%H9%;]"
MV=2BK,PX4TI]8TI]A;.J3.XUFMRKY$YEG)7-.%OA;"OGQX:<'X7/:;(;JNPX
M9<>MKF!]@C-EQVW2CEO5K"H[;KUVW*KF46GVS6GVE4E<99N7T#8O=+93D4/*
MCE.1"BN+;$KA3#GH*S)1ZFCY)"ZMV*/ERSSKRI#;F"&W.I&K#+GR&7(KFVVU
MI%[KDGIU7*L<7IMS>*TLL%^9OV6.W$]-E%H/JWV-=>!,&=P;,KA7.*?*X"Z=
MP;W*V5:&VJ8,M17.JEI&K7$95?@\1KM8RHY3^QI9G*UFMU1I@<UJ@57-JK+.
M-V>=KXQ3E75>0NM\5;.M[+CUVG'+S&/H,#&)W^''C^^=BV0.!I3XH4?/F.\V
MZ\;1*=R,&HENQ:UB,_E-^GT"TFNR53EN?O<=S0[AN6F-XKUW-/EO2KS))L/
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MH?0;[_8;R7?\5O+E=?C[$ 'PU\.:7JOQ_RW9J681G?I5NV*O@,('-$<[U&'
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M3T3DL2$)0,>V=,0V<7^L*'OBSSS0KGN3PZ*OU#,9WSAD4<0-^I1[H6V+*(0
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M_7T?UE(/_]:N.YWO[=OSRRW"Y['"9Y7Q:>!J__'R ?VFWP\Z!]K5)1BI?$L
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MT%;#XUM1H_U'UJ#F1U6B5C.IAW"+CW1,D?Y ^YTZO%[Y2,^ G9OP<M4!?!R
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M<ZY]R%1I2-_/9+#<N,X3?<9=W&\B!*OM^W2\C9MO[?%\WGD=XR/QL X"T6R
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M^\(1UQB^?GYA5M"'8=1^W?N$;[3.OA"M[]'>;WM_"5P3Y#32'0_R/8=!P@#
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M3^-SMFPF#55\32/<O)C9/#<>X)=FP1=L=ZA+GC'=T+8$;V@CE-9"?(]0S/L
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M,I3GF,0?3&FMZ-N9$@MCASC05VK"LD@JV;CL"!8]#.B32),5QF%2FT$>W+-
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M@)X)6(>!(!)DY^*:6BN<LK\>UG2P"O!_NS$!=\^\^+(K,W2XZEHA?5%5\V-
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MCJM*6$3LASJ9<A)Q0[P!8II>R,T($F441DF$%JSN1]2*/KAKN$;J\=UL#+7
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MN;AAKM,A%X$B>*E*W7-J'$#H[7X-B<@.H_5XV=%A?GTU][/35A6FH4(^)M0
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MD%*X[B!0HCTPN89@VF;7>;"$.-P,CZXUP^N/9&2*[7E>7^>Y'./NRYH!0M-
MDD9U)-GI?P([,4SU^B/Z@!7N#:D?J[*AN6I$<T>%6OYZ&;029H8XR#Q:8DQ[
M%;]7\3=EN?KJ'3D2IHK'X_N-:H(<+*YB.D5L>VI9<0^>,]\6B]0&]X?J"Z)*
MPK;;??PSD0+5IB0ZKK/J5B6U,5Z#KTC2D@YS_/NVN+9J=,XYSR^+BC&(]>]8
MQC!U_JM;_IHZ%PO2.72.^!:5$GD >DAS)D6_W8]_](5BSF(7E :NU&90K7^N
M,@&'>/!"OFI\"=T^CD$'K3+/T$:+W#F0M\(\=%?-*HR['<)UO,D^MKBC7@*Z
M:]2>^WYG;E9R9K/6P,B?T]-&'?8>GK7T!&U:HKU2W"O%F[1[+7RN-G#C/L8!
M"LE'2UTV SE!@<Z*,X:SJ10U+/N$YN2C@Z>':!=T1ERO5%1 7-F%GE9#CR$H
M'6F$*]U#OO,/V\O_7OYOK#AK[OR@!:?3@_2/E2-R;TNBE][:WDNV-Y0H*,0*
M)MB3G ,Z-&F";T,[+X"PZ'5R#Q L?P90;O,3Q'>*]-)]WT;5TD_T!(T>*9"&
MQ(W<9%I<1.ZC9:@S"+&FTZJ2-B@"&:MG32*7#;%UAV8D>0Z^*%@0MN<"""S(
M;4^!,V@N3D-E0EU[:0B-D698[HFZ]F?X1L^P\JI<X0#'61-&WP!%DYP6L-,)
M/2>=)5L5'7FW@B/O#,Q4&$4$8BVQ-KG[SZF@",%:-V\B;HCX7 W_SIW>4FQ*
M^DDZ!4@_Z:(0?T9<&25WB:&2"G7;RCYE,)^2C?R/U(?OA-[=^@O;C=NO"[<'
MO2(JU)*[LK0$_=K: E'[O<;8:XP;LWK[[EW/%PM95@/TP;<Z"!K\(=9GZ1-J
M>X@?# I[$.YD<E:GTRR4F[E?TVW+"1AN&_:!L8=\BM)F]QR,=_'9IV^&-6*7
MN6IKBHP28Z)%$DV,=;Q=QDEB7$E1;;%I8_#<IG75-(]TX0D$"L/SN!$Q\)H!
M61+KIRHN@,OKS9]7[U^?'(=_^@<INF9L[2#-E=5S,9C\S[16N8OT,O4X$5/&
MB> (ZHB<>"ZJ@ KG9VI0#@7NJ5:X0P0E,H&* BR=1(/^75K$I>"N(R.)%*!F
M12:%.+YF0:$/Y#H@M$1@&61+0(#X9M@M(A66I54\-]_L,TY'>#^K_[[95__=
M??BI02226\"^V("X,@Z"07^0]G4#BN*FE$S>O'DQ>: 5V._^UY=>;T5=.49@
MQ7_-P&O(TP(LBSZ4-5BW28-6EA#KP(K#!0 QJHNDCAANTN(^<\Q2RC'TL?)S
M>NI(/][P5E)\&@;M5!M3"!6(^<MFW9>$5OX1H!EI2?8T:+W4HL_ZLMK5SF4
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M6M*N"66'+;] &A+-^3(*/)&/>%H'NZX[#)D0%,=<;PAYQ,'D34\,X8TW;;Y
MNY_2<*IK9,923RC$FA:]@>'.T-O4^]C]Q0V_2#JJH\A9<= 5-74K@"VX= I?
M?=[55#S/B[3.R? :_"9A9LE>#?X=9:U-8W>X.\RP$FZUSYWV*-8:G' ZE?OA
MPC( 8\:O4/@MO%$QD(IU,)&VW*[N@A'!]Z:*)6\:FW) 5_?2!*B/A5,CZ*-P
M8K#0E-Q96OMN['.GLYWA$TL9>Z?I\+6<>)L#5[?\)AP!?B!U$ ,X NJ/?#-M
MO;!CH1I-'?G!Y&4^G[-!.;ZUH%B=F2\Z"U-L1FC=NJ9[#[J![V(Z<^'K?MO"
M1JDGCT8"\ON<KT]',"+>D#_ZD=/&.1&<IBO$9&2I.#9Z+W.-S_:YQCN&)>&>
MW3UZD3/,(-=I[0SBG]TZ4SH?[;EZ)*B]("W(?\'I&1)]A8I!)8![>T(V;.][
MC(EMR"O'M= (<(+!*&.,FF%[7Z[S<%P15]DZ)'\^*2-"+@@5(Z%G$Y/BRR#R
M#?SE-&!FP$V[8/Q@NJI1Z,=*8&:O1_7%AM95.Z8WJ#$H4 TL8@:K)3HP8')X
M/?/UNZS?(K1%3F15QV#"!#E/*ETKW G![C0C-")$R!O8N*+^IRF96?K7V7D@
MCD0(F8W. BC/SD=RRT#^U:JM(2-NQ<[3T[RU?Z3MPA(D[,G*QSXHEY47>5V5
M'I0ZQ<U-,58BZ7 7'ON$%VQ-P*TA [T@)D9NE@R!!HB'-<!\AR"%)T)L>42$
MHAL^X$7)DHH3I?<O7]=L'(T:(GX=/%T+)"LG0D3GRM/ P[HFD^5YZL1GFJV0
M/[(P>RJ0](GL5)/5%["]Z?0)HI.?*YR6"UF-6VKYWV(1B](8O.XEP0IU,6-T
MP?YQ1963,;WC>-^&2 )9>.*:X45NA_X!BQG)!01DN&G1N6HQP()((&\UQQ@X
MQIP:ORUOHWR.ZA1]A,Q[52K?P2++VNZ/*K5:60C.*B<.!Y.?B/OS4TJV(6E\
MQAH?U,A.TMC-[+Z9WZ%Q#W?&6C2Z+/.:E2RO75";I)3#D_KN%<4.IN=@ZO/A
MVU:KM,\0=B5ULB;6#"X<<P]E%X)2+'%OV=0,5.":)6?'+M,RY4MC3EE&7*6L
MW-S8Z9!49<%_1^E;@\ 5'7F^='W%ZHIXD8HUP^7*2%OVO^6KI[I.K$G!K 1O
ME!)<]2R S='+/,[^>$!,P@MD5>%Q(TOI_N\%MEQI3WAW8KGN8?1%./\CAO_V
MY<;:#:UWZOGAXE[?@*/=W1$;WV Y*WU<+>- E @8H>/1A6F8YD16;T=C#5[[
M00D/& #6)U)_I(_QPV&GIG]5J#;RX22(O7/T5H5-UR(U.\]F:"JM:A8,IQ3<
MFI:".^C%T3>MZ8KBRWCW3\YLSV<I9O3!Z1'/U* !U.X])K.L)9QZ1GC2M7]5
M7AO"8LGOA80 -E5F GOHPS:'.0^!53;F6 5,"2C6:7]W+.LJG2$^K>L#[>(.
M5%,E_!3/:Q/>+ J='C86[8VE,I5,<2?71MS9#65V\P:T,G6UK!&3[V_IB#4=
ML O<%J;L"-D WMV-J7I9U@!_A%T,R5GD1F E;IU>I'EAEG/L0N:8(%V#@T$Q
MIY$T>S]UAY+VCL$U=3VIWVR1!71-BOU2%@K-:"A%<5?=B@0TI\NU7%$*F09$
MD&STV+&!;4X2Q&)S)_."P]8!LUB1JR0;14&?L[JZ+#M*7JZ8)07-&Q S%-Q4
ME5  -%//U:VSLY2@(V&@NHLTE[R95/A@+V;N!T6UC)*]JA=(B' 'I5Z6PC:-
M&G(L7T4O7X*TOEL/W*3J2FX+UT790&*E$ONLJ9R<C?N=M/V,KX>*&?U5=)D=
M-ZS!C(5'4"ON;B"CPR,VFG3/R-L2D9)&S<CFGZLL^Y<D9T+BTG/X&.S]M2I3
MCD*GS#// V/L M+C=.U;/66+NS+XYCY/5?DTA?\%U>YM7>R>^&UTZ6DG_#['
M"SNQ6"=$ E;5418-^W([I@1%!8J-2F],>&5CG4&X8F#*88RTP%L:/$Q]$CO7
MW=R4^-51J1DG1>!'FR0^O\FI RFT&9N"EL_DT5-]&J5Y;H"!NHZP>+'6&F7&
MEH05@/K9)?&^V"H#\LM/F1X#1\CX!51@(**?!Y\Y!"Y.2?456DJ8CYZRYQ8J
M" M:MO6Z=TYI9<A8J;/E2LX]<>8]HOJ#-5DK'VG]+L\K.D4+JELK;9!_[GRZ
M,0UM[<I8YFEL%W9H:I-HNRDGAZ=TG(7?*:]EV4FQR-BY1B)?IJ6GAV*7%[:+
M\S#AF8 ID(9]ZFLJ^8]LU'#1G'N??<MS^M4#':+S>E9-6GB%1''^3!-;4F,W
ML@9X6=D(V@-RUH2V,J=XQK&&0$7B=[4T-B3&N_>WF7/VR5D1E(VAKH26]N^,
M\T?>=0_^^L%]3B9\NT\FW+%DPC5K(1 ;_$2%V CC:K1T%EWB4..VOJ1S>CA.
M .NC\Q?1<8D@YG>,FWX@X-[9T&]&5H+G<^J<3/*SG4J2EF.Z"L04XAN&;.I=
MFB%1_:;-D#O<M[XL"[I2ZV5/UV$T4J"=E><I, @'@V+:;"4EW(1F>R'U#%&O
M-950#3^@CQ'2DQYW>3K[S-=M!C1J3L5"$K.)K]OU_K(M$196@&[YBP8H.%?4
MJUURV[YJZ.HF!V=*_609DMH89G:64L*HR&?&VQ\3?1V\L-HD4@RUD/A*/^9!
M&0,(R2R;%ESS(8Y&DUDQP7ZQ$[TJB_1ROBKHX!2*S+WM\8A$7/"<%H/5]F-3
M@H'>9-G'+RZX"$"N?0FAU3T=@QXQ5K(E4/)QG=C(M8Y]M](CC*^)>(9,W7I?
MH0Y*K%J%@PI3(X@6Y'*\XNOUL#*O1JI><TD5;:I##$D)30S2V8_]\*'GLCG7
M.EEOW"GFB9!9Y.-Y")DB/AB^FD4^\QT,@/TEIPP ^1#%6@M^2)&<$E)G&CC"
MEBMG@$\IFMT)O7;7RZLC+(+8HL$"98TJ7"S,9MF/0PZT#(6\]>@+*3[/T3ND
M%B?5TI<10UA'=<1OX [_F>O45&TF!*VX2/TIY',:@NDTL55[7M4Y$PRY#;_,
M",-!NA*&5BFF2_2K7M5G[N__4IY>TO'GSD7-^8A95 6E92-W"(#RH1=BB5)L
ME2A-IC[BP!JS]Z"VF1V[X9LP#,E?6^124W6O]0-Y@[G^-2L37YQE@WBGSD$G
M#[\&IJN> 8X5ID97.*.::\G3F1P00^ D^91*,E>H;L? 2><YT2PS9MRC/:L9
M6-;=9S-SGYFY16QSM,9L<=1KCF7QV?1U_^ZV7%12SZ'-OK3&FBV@VLZ5VVA^
M#7<NN7=K\\0D4]O"C7M>IZN9F=!E[;9G5KF''\ IH373V=LC)Y?>V"9%,B?)
M;?+$G?5"QDMX"^9C-U"4>GC09QQ<%F:?CHZ+2?2[GZVJ;N4N_SEU]^GDZ/#Q
M(=_FQXN,U'KI!KIR$H#H!"S]UP@RL4-C#[I&+6K"/';'K7)BP\:!CV&0<0.2
M2!1UT)T!&:-]"^6<IVDY4&.O^/2B*0XF?X/]!V%W6^0.&^HM*8/5K' O.R,Q
M";FN7F:PH%1=H2,DT$RG(6:1-,!(E.V?<VR?CJL/O56FY[58>VQ:3S?II9LH
M8*/ZK*TEZP%5UO_6B<5QX8-$%# XJTS!SS7"-<;&&H[<#!5=W$%;Q#KUL!+S
M>A8(E/H%V2A2'^V$R+BJ+DN492CQU1!@[YQ^3#B67A2B(,9,OZ%T_U7;:6IJ
MG5K=8A/#A_[Z8:BZQBB]2-D\I\71L@ NP4)XO=W4F_&!<MO*E8@E\-$6-'C9
M)VTRL[5FTG\9=I\?T1F*R"3 BT[LK%81"9>4U(T%WSD0Q=BHD=3?,$B]N;C<
MAN9S'D>-5E5TPA>Y";X*T7L(A6/U,,UUTV:4DOF),[3^QI(_3#*G**OU0*/Z
MIN''4TW,EW7VW6:;A;/LG078,(B]9DU\J6E$SAOQ:B>Q ,@!L9UK8RU92FNH
M]IN['CY&'8$J)]VQ1OFN"YKF6F^6T1<Z_TH.-O8'L1GROWQP;^1'E!UI.HT.
ML[PA6DQ85_GP 0YZG!OF9?"H&-9</ 3)'BG><K8OTQ7''6RQ!27LD5\>8!8-
MIEM1-1Q>,.-4VS8P!0?QA.FED@EI\9X!$CQ.NK*2'U)+8D<J6V?IPITP=U&5
MZ_Y%-5=Y=K^R"_89]M>]3B!\MT\@_"82"-R!G4+%!T]'CK^]O.0D>*:4X50>
ML$E16T)P&V2+I46VN6@QBI'L8@!J,OOZ]LBM1RRL/<*1&[UNM<HM+#BR]!N:
M,U@YA@9TT\,7OLHLP.+B^GTFWR:"YAEO*PO7+5L/6'CG]@C:),0'7W0WKY2U
M(@/N_!RN-)5Z2L/-'!+@(^5TD1C67>EBX>J'O[4BEWTL]'B.I5N,&61R!\ )
M8\?? TMG"!/@/[?&S-O+ZA'54&G,'+$-2N(+DCI DS3<J%4^>:M0%9?XG/T^
M/91#JV,W;U/?CA0=>Z^N-Q24V9,[/%H_')Q2"M7H2C6CK_7,IL- "F=UA6BX
MJITX D]C+@AYC6YX[LZU/EQ>;MSUGU8U+>S"5F*G9\JDK878Y&U[0>V_7HO^
MN6%[EJ5NR3VD#$JBM05WL&=4]M1*N,&L$9QP@R.P:0NW]OG$#:324B8/[W:
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M/Z8!;"UB><\HKI[5X.31_ZL%+>"KV VCA0:!6=)*"]++;4#F[+B\'D@&]UA
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M]]+N$)VW Y-$Y_7MSOV:"K4#K?&-_<X$^=5+_+'FA1-MX@=9RB>:=!G!#QX
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MVN[S:!S+.:'2SG2WW_+'U)G1B##3QLLWI[U_^-#FM'?38*9E-P#C)PWL#9J
M@69K$\V&[H0':,1&>K/+^5KO:?F 24MGUYX?/M.B4!O/O/"::WZH33T_UFZ\
M(!,-.R?\BI*:.L.61U2*U"_W2R,VG(Y^]VF_T_I(;:>HWXZ7/T-89P#73N1@
MBU+[\,,;7O2+)&6C&\S78+K=!-=+L[E:MSAE4_:<&$#WR;_3*D>=!XD\(!O5
MD4_IC,>5;%<*_A O)E[<&0[:N,TG5'3_''1:)SD(&?7;)7(QCP"R?\OB&Z6
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M^UY0HCS)-Q-H8^&%=_ ^M8V:V"MX2B:7HJ[;]@S$FP *+_+&?V5^XHO[KKC
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M2#:*>9K%.!;QHLC#P"+86R%T;N <83F92+7%KB2XUV-5?U)6Z IT)X6>IO*
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MWD06%8KFC N9,P%+4)=5X!0<GVO7 G4;\AXVGMWYLEJ !%L\4,@)V($2<%:
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MUQ(] B7H/H=?$^'CSM>EE(:B;TGB@V:8>B&7G4*D:X,G*K$DS(OS>=$;N-"
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MPF.38#B\"=V6P-E7T5JON_:RY=C,<MOE:ZS=8#1&S#;[;2DX(YWI3K\=)R/
M@64.>XT#@]D#G8UZ;C<;3!^,V&A8%U\DR_G4,)!F2'AL$@R$1\)CDV @/+;%
M<FY]+NK6IIF4B4K0$70MA:Z5;L+:$FK>5YO8BCZ,HI_"MC%1HB&B;&B[UJ.P
MY0[%(3-=B]FC?B<?.&SD.LSNN6/5<)GK.&QHM2N5MW8T6&PTU'M/#=: #<TA
M_.DW:S!,G>FUY?=VR\:H31Z_V=0L.6_>MT$@GRV)9HE?*9_7NMX^:[F -MG
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M^I-T!NO0GX(R!'<XKU]YVBSFT[__]+<T&H.ECIC&O-XWL$I9+.,!R'"A@!=
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MDVRQB.)4QIX%8A!:#*PKP/.8>,+3-)!K*F/YV"YD&=T59(C+[BI/Q588B%,
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M9*[R"E8?($:(&0R4"-'09R4-)SG7+L"V3T5R$'KK?K9LN-BU'X?U$@$\Y@I
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M(<ACIQZ,)QUI'98)1(]'5BX>,!ED<+*TL9?,V!*5JK1%F0H9^%-\0PK'7+"
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MK@[_S9U^&;KS"M_A&>ZTB@%>IAA(NO;'N,\WOHCL *D4'JA+!=1%?K<* V+
M(7_$Y;O+/#AXO@%PH=<)0E%$AC>4[KX2;GQQXL^!1+V01UF"K63'?V6^\"^&
MRJ\J0EIJ$+*XOQ))T3A<C?[,VQ">-_,7N?.R> <K(WW>>.;S&XD1Y24N08'[
MQER,+Z[$=E,1:$W.M=\JASU9.<#++47%FC9^9;"55PIW=L6C"NN\XMI_OW\'
M0%]EJ?P>/;Z5Z+,X?5&&A 8X]N?XW00W;K)\5;D&0%6JDA8\?&>>NB"2317!
M1(%P3)<WB:?S),T[^!9 MWKTCSC%-/NG_F=TR'W3\W'#6AS=YG;Z8TSYRN5M
M<FIL6&8',;2/XV,;ACITU!O@F*2ARP=S79.W;D=3I>W..@,T;%<W>NZ@,LP!
MLQVGC0ZJ.D?CV".F.VX+::%N+]T9L-%S>R]R6'//U<]36\,ZW^>&\6G99NU4
MX@QMI@]:R3::Z]?N"$*(.(X2]"!-]1YV*Y753O!:XB^$$$)(4[CN"4/-:['"
MY4BSLF'*2#/V".&[SW9\S&UKTQWSV+."$>/2L7_#0X1,-"<1D;EHJO'O8YXD
M>6U='J"&+WXV0&L8C!PL;/KP\6*YPH)I'S[OMBY1KX3)^Q/-NXIN.-ORT D(
M20QO\>\^B(U*L=H.:) U6Z("T9].00!AU1F@8'7,95$]IK"$JP9-R;4VKEG[
M_;,(#BXA%B[\PJ]E.</[LIRN",WNB*-CU^2NFT,KC:"4ZG@J(B[BF#EA+A$R
M/KC80]@\]]QY"INO M R'"MJ *.LB!BO;RM<YZ>)K%KELKHN%!N,NQG%R2I-
M54>HKE+4&KR2D(I:)<6@L?1H!0H1>.]W;';7NA&WAIAH\Y_1H8#-\6.SE_YW
MBLSN'IG5*"A+0=G6QB I*$M!60K*UN0[QJ"LLU=0M@/AR#/3-IEI#WJ.!M/4
MF3.BJ"P0Q,@XW^]04%"V^T'9D6TPVQFVD6LTUP/<$800<50ROW2=(K$4B=V9
M;C!3;B^=K"/GAY@K$<91&&L9;&UGIT";.@4>HU/@$6+KTA(MPY*)_WWWH.3#
M-QTBK@ZLFCFF>PX_C=C -$3K;1&F5&"5%::5\/?."_Q9^2SDHW=Z4@UA]"$S
MS,VI WN%T1^!A08&T96J?PIJO2> 7K8>0!@'AL4,>R2V1APO2X=?QN,XDX7@
M\BD+[TZ6(HLN!(*BH@U;_.&S]N'#&_&L]2_?OX?O&;:77'#171+;@7M!! \3
M)>8X[$5VWUX#ONQQ\$ X716R/Q[?Y@G))N<E2S0C5)B34LPF%E=\&2']1& "
M351KZK)-*C9#$(U*9;&[Z$;LQTFZG ,"3&+C:>U;SL.0>F52SD/W>F6V**!/
M=>B4\D 1_HXAI+Z.H93R\("I7E@]OYS0M5QGL-^R!S@#JXV1&>J=2231FF #
MI4!T/P7"-ME@1$'N+O!3HHT6T ;E0O0T%\)@]F"O-C%TE+J)$"*,+M>@KQK?
M*U$D9;<<J-OYIL!X)09:#1QYX=*UHJ'TEI@W3\:Q?Y77B8MHLEI& T.[4H<Y
M"GX?&\KUM)]-ESG#P=;P[</1VVHXUC"881@R,.PPX_[0;![S+:<S/AR=O0]G
M30O+"FYZL.VNS@YX( XK+Q13DW%>0''YZ;OZBZ.<8!H,8DE!GWK?MTY'/'1G
M_XMD:18X#_A8#5"8XKAJ'+\,' FV*UY$<@"E'!'.<1YE("CZ-U!S_8FGB6;L
ME35A8_M%E(BYWY57P 5RU$(8%8^!)VY["MZ.^4*@!:^A+.9C=)I/JG,?UL8\
MJ .U-"8\;_"/8]+?PKVW.-OSS=(J<66WLR@([M9GJ /;_?#Q?\O.'!_>5![_
MO^7#Y6R)]1D"U8GKY]K%&%<!' =S/1!O.=O H=(S'_LLH*!%!L:!PE<SC*IW
M;)QSH5[ZC^B6@]"6F_%KEOP_]MZUN6TC61C^GE^!RMI;<M58P?T2Y[C*ZR3[
M^#EQXC?VGE//1X@$1<0@P,5%LO;7O]T]@QL)2J0(D@ Y6YN$(H&9GIZ>GKYW
M&&,,%NS*31CS)<,1*2)1AG]"_JRL*E$!D^#.%*UF M3&%*<1761A@SGU4)/R
MC93.>87A&LSVUIG8F((<>N@'NF.,P_#KY<N:^R>.<1A4S?UM_*$'F&\,X)T1
MD0_ J2T+&\BPASX*M8Q_X;(EZ,&-Y)O5N-$'>&@,:QM:SL67M=!TE6F&?O%H
M8*IM,M.0;4$!&ZZ[5X&/81C''[%!K=KSQ-8S--# VE\>J=+E'T6JP'7 ,V":
M%B7L[K@;#&3':3VY/B&C+#/->DD/:_K+=@(.-S\*\Q5Y2IPW60.^"C"?C"/K
MXY<I8E.>#2(ZD^9%GJ0/_$U,^-!>*M."+#K<!,9WA(./^681&3]%"\@[/RJX
MT8;;/4:9<6K)C--C9)SNQ!R^\Z,HN??C2<#)?@X3!^ECUKS=CF.8*9@X&3VT
M;+8)2*IWV.OTHY]^#7+E798%>4:&59B$,-_(GW28ZFI,MW1AL>2%9Y%?Z:K!
M-$_%IQZ#N#R%W,A)B5BU?;-JJ=IE([UP:Z6E2VNEM%;V7856X69*Y9=UIG%Z
MY5T:)\=.TR>SQ36LDJ>GXY.A0+]4%$@#I#1 2@/D[@W9=)=IZGY='<_ [J9[
M-G/5O<Q-9X$& [0ZF0A!A=OVPL+(;(]BW\GRZ+BUX?%PM5ZV,SIN-3\:[;:8
MD]L=C6M;&![=4QL>\0$>Q(4_K$?B$9BUZ;$R%976R2E#4##4.:"E9<5LAH5O
MXEP)J S6I#)@KJ[*OPDC-  !%+=!''"<%U@H9]4"Y.<;2_507ZQREI:0LGY.
MOG\;)T#I?&PAI"@S6-#K? Z2P>V\$=T6YG-1K*<,8H3%W0=11/&1W6:DKC"Y
M1TU+RL0O,A$\U[''O&-3!D<Z!)SZ<1X]* !M@&3IQQU[NZO];@O*1NO=EF:[
MJ]\^OGO59;S3#.8Z-M-5^WG6.^ (LQE,@UQB4ZAC##^74T=)EO'2<DS37&:8
MYLJ\E@$7K6?B,XU#?P-$. OSM9!M<3ELC-ONG-J A1FZNS(Q8,%UW"WGW6(6
MSS*9ZEDKL^BFQES-ZI[FPLV9LL"4-&?VK/L.HL"4M&M*NZ:,,1QW::5Q(F2?
M>G'C7[TT?![<\/FAEF%%TM/H#9ZNZS'/'&7])%E22Y+$@:V>YU::8)V!K93O
M%WM_B#3J[4R<CTZ(=HG')B&[GZY?ZSHW:JK7:J=5LUDU/]YD\]H"(NUIB%:,
M5CQ!EXR.'>8I@ZFNRQQC-;;,MAQF.\:*&47L('O$5-,QAV7K3+>-5?N7J3-+
M73745#/L4#N@:UF6RVQKU0+EJ<Q3]>X9#YTK_V9=?/J3@"-CUA_+@.=A9^+\
M?PYNJ3I#^<RQT^37<KB3]-:/X>U,"0&<F]*@&\9X$N\3P/0R2;E!+..P9\I5
M*+@R_C0#@3.!W["+ VX(;O!56#[A\Z, DX/<AV^7V>25=3P-[H*XH.-3'B:L
M+1_#S]FU\C/O:8$' -X,&E4P9LF$[,S"%/VI N5S!4JYFFOE7<[/)O:DX!Z&
M>D@0(H/T'F=MFL 3X#$5-K", $Z'DZVM2*R=UVE ^R!9P>&5#NP<O]3%ESGP
M#;%S,&E:3,@9D08S+)&0B=+]L1]/0C^"%0"O6M25 _CN9THAN/H:_50\J+G#
MR"3)NH_)_DA6DWD8S)2$'P;L-0*_DU5\X7_%>C+O__CYXRN&.,,OJI^1X=WZ
M5%/@D9G+76)X^J."G@;^ !L(3!E].Q-^ FE!  *M$!FVGV7P&B?IAB.$(FJQ
MM ,@K :9[S_N,)4YH &H=LJ[S^\5W5694A]MQ!EM]F:@<<7(T<D90]CYY5LP
M*8BT_D!O$Z %*'7]O!Z??H(N0JY(JCS'67F0J2X"^3UH)ZAGQ$-]1F"/844
M&]8!0BK#*A)YBKZZ&S\+,WZM=AVRQ^:[*1Y@,J \V,.2"<&@-02A\/IAT'8N
M.MXTVEEP3QGVN0E\V-/*K;!Y [OX(E;?B!/@([>W2+AP4U^/.:_!EGD-@^^D
MA8<%CF:4W%.I)T1")DX?$&:Q7$9T?%98.Q5)X=<N,<4T 6HO7==PG&JV)VC[
MQ^-+44^6(.JX\+MK#UV6,U#F-DAG8,_V8%F)91S@G1&1#\ ')BNQ2"^I3(20
M_L"C^ ._)"BC"Z%\[*Y PS*98>\5\S]^YY>I><S4]ZJ[<B:NKRO;8JHURA20
MWE&A[8<&V4ZG9IG_3#%BF-LNSJ*]PY5C,T>UY#GY_BT:U UUK\"!,\'$E6$Y
M3%5EYABO9>;TRSY/$CK1DO6JX(#'G"SMR I^G5)*F;9K+:OGEK):K5S?!6WE
MR<T:;MK5,M]^:QB$8*L$IS1 EQS,4J8X8>UQ$0( 5\!?Y,N$ 3]MANM::=X8
M/)4,O;S;(UX<14*\[KQDNZ'^V67$5G%_2\O@5-E&MLA_:W4.R(G:)DE&R7#E
M'O%@"@\K Q(AZ9;[LE&D:UI,N*.@?F.=\BX\ZT8:VJ6AO6=#R^?PFS2S#QZ\
M,R+QX]L2\28\/>4>?]'ZQ2U:FLNEN5R:R[=0:RU/!;%Z+\UV_.9R#Y!@[*?>
MCQ\)5Z:J,MU1I;&'<"%-Y=)4OM&/8C--EU91P(5MN\RQI*,1\PT-D[FN9)_<
M5KZ?)^D\;.7B0D6+I:D>H_Q:;X;R\9K)Q2GD9F+=:MC)CX?VOFSD)JS%UL1:
M#&L+&[F@."9([@09.SL?F95^XIA.Z3JT ,-^^6@C9+$-_32_?H0H'S\J+[ B
MFJG9O*5RN98R618@RA\ZAJ1FU[JC,\M1#WHF7FBJQ5R+%X'4#XW1G4[!2LOV
M1\X!EG$U34)F2'E]=?FZUE%J.9@X)9T@!?>IY)%W/+_L8YU?]E3JB'T!#BUM
M-X>6V8,C:?ACG)&U_T29([(OQO# .R.JECXLZ<.2/BSIPY(^K!-Z+C2-8=UJ
MP]NKO^KX/3@.\QR/F<X8T="W"=)@JFDR3]_+'GLNN'"O][+02V_6&7NS-)69
MKL[4_1R_9W)2'&9:NN2@)0?5/69Y>S6Q/Q-<F.KU7M$A0_9G;2YWM6*:+V]4
M;IQWC]7(O-OZO0W4+RH2Y@X1[5@@KSH7UH%M^@%NFPO$TI^;G0WYRL M@W>Y
M/S1HTQ*_:E,G)#HOFU_!V%;SBPM/KS ]:8V6UFC9HUG:HD=$T](6+6W1TA8M
M;='2%GU"&RRH1YX'8KAVX=D$FL-TUV*>(\T':$IQ5)=YYABK4O6-"UV[WBLV
M6!JCS]@8#=Q3=UVFR8P"9*$6LW2-F9*%H@66.;;-;%?B JZ3PUFCQ]DLP)'-
M H;?+&!/YX.0H'@<NWZ,;)H]' \5M^*^$NU8R3]-W\"[XS@=Q+YLYW30U%6O
M@]'V.JPF$72D _A+@/H; )L' .P+C:F.P53;I%4TFI3E:T-5V4@W25QD99.N
M[-)]'3LV<!^^GT+Z.D[LZ_AR'T1W[=#[GV[2'][*%NY# >^,R%MZ (ZU:.WB
M%BU;L4O?A_1];&VC,9B.#7A'::3IT_>AJPQ.W64C 8A!T\=*#+U;[*QKSS O
M/8*T)HE^BQ"TWNBH[;#9$O*XX>.WC^^P)S#U= 448^?7VW"B9/-PEI.]X\FR
M*&GP6O2X;I1%P57TW]T9H&^VF?X<+'->H8'CY.A5$/X[>%#^4:[R8P"8G63;
M(>WW)'[]SW?O/I7X^K7J$/T1=K1(@Z-W+D>"0O,1RE1D7JJ;5F<Y?,$[\':V
M3)[[L*,W01 #G06<D#OZ.%-1ER(2?8+3X+:(1-]H&!1__(RU=6#[Q1._?!/-
MPM\GBT68967+;&P"_-@\_[K^?*T@;J^5_Z4XYC"'@_@U>*@)<K'+5L4K6U7C
M95%N53X'PO0!Q"Q7>!/KX,Z/"M[AM=GHG(EWRN\;W;*9$N+&A;,':C2; HV7
M'97I=-9GL^K>30LDY ,^,A28>>F<NE_MSHLKE\1PH# %],&2IF$:3')@'IQ/
M$>O E\JG&<'9A>$!MK5]-_VKR!!3O_SCPY>?WXV_+@DAJ?;(/,L^:EB[V4?U
MRJ;8'L<V\(>#Z4+;V5Z>T/AVYLV"(S]/.=Q1N'L"]O<K![ #M)/$BY3@KQRN
MP^+J]R#'^R=9!">6&%=92I@I<4""(< &,HWX%>7!:0"L&BX/$G*$<X:53^;^
M-^*D"?#>=#O>/?&S>4FG6]]F:T7LX+&%N,7@[L*+Z:]B6HIG@/)P!NB/\08(
M@?XF7 B#NRM,IJ\3V)W7_#->@<#\Z36XTQN7&U]6U?0<+I@BRL6,TT2)D\8E
MP]U;* %6MTES)+SC4=Y=E4+^_C=7UYPW&0HQ>9I$)"*#;%S$159@>W9:X\*G
M<EI1,<5+,YD$ =RRY+;#)7WZ]$F)$C]FRM)_X +/PH<G48+VT[Q3^JGF%;M)
M3>%!=,7+<A'F. J#03.2?G$2(=7 &F8^W+ H*)#/;QK<P).?_^XOEF\^*9:J
M*LN"B^! ^A%@CPM+A+/[($4I. ^X#(2%QE!84 )8?+( &6$>P/ZM>PIO<N5J
M&F034 $"W"[ZNHB!-T1 Z],*SC"^"S*"/7O%=J7);O*Z;A8#6T9^3'H!K& !
M\A3N-RI9MVG 'RAUI\U(+0D!GXKA]"HY=\AP'_*U\BZ#ER9SUE0UYK#B*<Z
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M,GHYVZ3R2A ?14<$,KTD3:D<RFK$8 &XY(].L,YJCD0)Z)PV? 4H(@-#N2V
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M=FK)26@NQ%LZ &;-((2R1!K%Z_ 2>2@>81V(5C0'AXWJ@W(YK?.60"[&G<J
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MNW ""X.WLS##\6;*+( OXN V@4$0 G3G!_YD7L(1T-(RG[>) RPDL+</:)>
MO2\7PQ207N$=/\H2-&-$Q13? _S= MPTPDV:? 7<39+%(LPP<("V(PCO8$[\
M'=>5!N'BID@S6BU.EZ=^G.$> /23!""^5E8HIT$&>MT7<&.;P.9YPJ-TU'YS
M;M5NSM.?UVW.TG?K-F?UT%UM^&,<P*AXV&Y1:R^=NM4;!XBW].*?J:\7_WC\
M1F>;\:-_?XCYQ@#>&1'Y&;?.&MBBC]-1:DB+?J&\G_OQ;7!Q"W_)@=E[]3_)
MSEH;BQ0V9&FA/SS#%3<H<[3&;-=CZ@G\$8-"@V,:S+AT)'BFQ9S>XON.B83>
MXQSUO7(E7NYJGM$/8?,HS0"@C@/GSD#-OGE07HA-9F@Y@&6^9*3PH_*=4\_G
M!6_K&Z#XK[0D?P6%*-3?EWX*O^7)UF_IU\J7>9A5D"CW?J8LTQ!6#)"OQ3O,
M81."%!] C;RR>0@+A+ CD!D"C30P!ME*R-IQ!W\E1:;,_ F96+("C1)9:;28
M!GX^5VZ".)B%><:4B9_-X9DT1<!3>#LJ OB:S"Y866>2^S&\AN8)/L(<KEIX
M$*Y#90E[[X<Q3BU048$$U_D4EQS 4DM(TB K(F'A(<.)0 4:.>#=VBR"!AEE
MZ8?3.O3CTHT>VFY&#[L'8\/PQS@C??#T#=T5:>,8 GAG1-/2QB%M' >S<?2D
MZH]S]=+0(0T=NZMT!M,MG3G&A>OX!M-<BZGVA:/!=O:M-WHFEHZ]BH,,V<[!
M=YC,''K#R)&!X+^KB>/I=\C 44. .GX97Q(^9NEH&@+0+E %2TRB$#].PS28
MY&3ZR)1ID:*Q 4$LPRU@\&D:PD2X9&$VF<&^"4M&:3JI#!-E,(@(N1!O-&T/
M47*?,066GX=^!! GLUD6Y!0)HTR#&E1AA2'(^.()>"9^8!M7@?$N,#*.$85Q
MH-R'^5R)DW3A1PP#0HJ45GE39/!K)DT?,MY#FCYZ%9__7^"GI=7CYV 2+&[@
M'!N:-'I(H\<(E<&+U/]AT=K%+5H&=DA[A[1W;!_1P%1JN7;\/O"#0@,F&]O,
M<,P1HJ%W79]IIL%LX_BU,(>'"W,O@ABRX:/:9;)]F&;#^/$ HK\P830E?[)@
MK%D]'GE8Z]O<(:P)7$GO1F&G=J^L";T-;7_C,/LF0M&F<8(0,L!;VQ7  R%,
MP[NW_-]PU^(WG12!=]0*'/A5XT+FM:E_]*-[_R'#FQ(F^.ZG>75WBZO6H_^]
MF7.1P5A^$^JSIJID._AI;KW]R5?F:3#[K^__EB>3[]]^H0U)9LI[6"7F%?WT
M@P\@PX,$+X!>SM&QU.;/?";WV@I;6,';^4WSIB9+1_D-G< ?2^/'P;8)QEZU
MF^FXYA>FZS';=8CP7F#\H\8TQ]K?I+:-V:S+(H8PV0;3/>>HAK2>TP.?S@;\
M,XC(\O@)L/0PC'S .>7UI0*P)0%&?V%ZVCQ<<J3B?O^>W/G*KR#A9AA.AM\D
M]W&0TNZ)P?Y*PCC'O;^/%4U[649VU6]>*Y]$2!LRY&9B'N7@X8;>)G#CQ)R3
M-Q^8P&)2?Y*+I,&Y?Q<H-P$0:2-Q#UX!_,PY%08\(Q''I&0_4$TX:[\!JDD7
M&9S+^!8>)NKBV8!(8;3>-<@F<T!_>3.$:8DI6#3L!B#A6OD5:P#G67>VH;A0
M:D2P$F5PQ<39^GS!OPL_*E\#6L]XSN55^$K1*[S&<+Y:\7S5-2>"_>"OJQ!>
M>:%3Z^%+MR0;TI(L+<G]9P[*,+KA@7=&5"W#Z*0978;12;/R*,W*G1K/V W+
M%M,\B]GJ\9L5#PH-)O-,EUGZ\9M"# H-NNDPU9$693@7XS<H_[I3)B":#M8C
MX2K='FTKC7@SPZ47/+TRG:&5*L,<N_ NB!YJ*W7#U$+F"%_)J?$]&>"H!M%R
MF2;?P@6,&STH+RR;V:X+_ZC"I*?JS% =YEEF:P:1A-@TQY$=IV%]@,&KV6L3
M'V4K=ICV2ELV)C9NM'S\]O$=-X\<"K&V1R^XC^(5H-@.F9H&C,WSF&/S_7IA
M4,\/-*"P%6P^8D\\D+NC;:;C]L-R.X7S@[,C<GU8Q\MM#5I4M6I/W,(STGR=
M*+!%3MS>BS6R&N6P,$UTK5X6>G\<FSFZ69JW-<]FFNUT&Z=KSQ$22&/.K*9A
M'-5@I@&7G>%)(YHTHDDCFLQ$E2:T\="T-*%)$YHTH4D3FC2A#<5HXC$/U"KO
MTG-1/>;J'K,\^[+10/8*<XSFU+Y-:'MU!1J6"6V;/-/=[#R.3B]HKM&[!<VS
MF>V83"TM:+JK,U<UF0M*_]!,:/TC5E.-7BUHGLYLUV*6,TH+FN!&5![N6'G3
M>QK/_/[,9R9S'-@JJXH.U5T3SH:WG_G,9H9N,M/4+MQ\9GK2?";-9S*;61K.
M1D'-TH8DLYEE-K.TF4F;V1"L)"[3+(.9UJ5;BQS2+IU15B_K,_X."WRY8R2&
MOJUF>P7?#<MJ]D#2_*8,953)UU*1*ZO.YV:;O$;<F<&M.X;6O]W,=2C76E6M
M,O+,IL1KQ]-733W=II=VYK8@:0I>,AY/VQ96E+YRMW<VN=2 UTG<(CM5Y*K6
MN:T&LW6'><8&(TK#_#3Z+'!/9H&/)0O<8$ B3-<-.@\I[TFQ4J"@:46L$[YG
MBF:_Q)^Y4;D[958,@U-JQLO3)U^_3S*R< IID"EM(7'M9SS0_TR3+%,^$F0G
MRM,NX>ID2LCUTA Y!Z4$A^GTM4A,KGN,5FG]O"=IUGJNM@SSUJFX6^U&'/ ^
MD,5]$$64]KW:C;1NX5J9DJ>*<'64><H=O65Y1Y$I=H6=A.(73-9>), >_\._
MP/8C<19<*W7K6NR52C2Z0FW*,BHRZK;: )ZG>E,?$>J,0HG1HJ-K2E<+YFL3
MH%B*(X6EW5(O$TRY;K>=;:X[NU;^*,3:8.DX.Z V6035/;P$/M7J\EKF<8<3
M7-"T[H;KX^58HBD#'&.Y@W"F)#%M=!K\NX K97H-U%DM2Z"%_SY!)17PEHL&
M,0NXFX""FM12=?SE%4]Y$QJDA"D=W)!O9(/$KN'&;.Q+.5^S8VYKX^!OD FP
M&0S?501Z25CS,T!A18 \$W^Q+(!]U@_!]G9L>CU;3>PH?30?A;\G_I*.-RZ.
MDR.L#9O93"O180J+BI)EZ=^@1L,Q2#0%3)(EL_P>P.("P<H P3? 4D;"2PE-
MU2RXG@4)RT>PQ;#X9!'1.9J%Z:)DNJN09#DVT!$;#]C["^4&L3UBD7BH1=\?
MH#Z\*UY3E8L;X*FP"7?8A <FSG(2QJ:XH%D1<<JE@3%RF\3)4?M<B$7N&;.L
M[N9T<0;?^::/M9R1F?I"$_^EVT6Z7<86KSR8Y1['RS2,Y<H89>EO.:B_945)
M';VGA5FJQ8P3E D=" (\S"C6]\KG'O/R+=-ECCK&V/2^/2M6OUV ^^>=HV&1
M;??'9  ,LW<O'#,P\-<\?KWM(6$!,*!96'WAHK'@. XSS#$ZZ'L_%7LAX0@<
M=/S2)_?2?$J369B?!2?5F.?:S-&.?WZ&A 6=:9H'F#A^XX(A8>%*,PRF[]>]
MX=69\-*KO8*=7DEQ=)5G<L_V6?#,_<K0O1P]GS!ZT]3Z-PK^<-R'GJ#1P\-X
MNC#"M6B15GB=L&M0:3#GF+7!FB%%D\<"6J9%*[B.DF(I1N4U1=DUPRK*4 $>
M8H>)NI:SH<A7.SVRCG1I13?Y#TF15]T 2A]^$#S>-^((6:IK"&OMJ="T*&)2
M/=6>IH\#O$-''$PCY0&5FW9:9[H)"K9F;K'5*]%'-$ 5QI8E$:V[3M;&X35F
M.BZS[?5,U8-O.[^3EZ3'K.8D<R$0=]D^UB9S</@B&^# (+KW<@\0#&>WMSM2
MI&^;F,(C>]N$M8NCY//FP5FG+649I"MD+)IH<(Z08C!S$F-X"PR:=\)3HJH0
M.=FW\#O&.BTQGH<'+(EP'P1;/ WTFTQHUM4H,7X, %$\*OC2HWA,5T;QR"B>
M<ZL\*&-X9 R/C.&1,3PRAD?&\,@8GC[;,C#'P X5Q^].,1 $@,)HHYY\L4%,
M5Q8(<88M/2?D19*N$QG)LRVUV,RR7&98E^UYM9BEZ\! CU^7=$A8T)AJV$R5
MU5D1%[WY&&4LSZ7$\AC,]31FG*!!V)"P8#)==X"3C$L:[UT*,PR+V?9^HMB9
M\-*KO<+KI4!ZSK$\_<7,CI-/&'L)6S*6YSQC>=H1 <*X0:6R-/L4=<JW">0I
MG]\ND*==AV8].F?8D3B5IL3WQ#O6GCPS$&>\1<8<5189&UZ1L4T%\K:+ZC*9
M;8"2H-F'B>HR@%>Z\,^PHKJ$.D#\PMV-7;#G\8O-,5V&^O+Y\QOZ+B^//Z"K
M4=Q,1G,=I1%&'U%40VF$L7DM9Q3_,IQ&&,IAHR64-+DOPR(>CQAI/#BFZ)''
M%[CKJT/%T#X1)ILP=$;'6<9W'7ZY^_0 D8%-EQ+89#'+<)EY@NX' T& SFS'
M9>I^"9^CMQ'KS+55[*@G_?)OM?VJK4A?TB4%-VD:PZKUEC&N\F8'0(.E.Q<?
MWG1EJ=CQ="_^<2XN^==[Q?O)\*9+#&]RF6WJS+2.7RQQ6%@P7)NYZF4'>>F6
MQ>Q1=J?K/8!CX(QT9/SRG$*;>KMCQ\DC9)FBX=/HZ[TN\V'T4WR\$%)E/.&A
M.JKS>*]!I:<V@SN7/GH\9@(T.$=EGNH^\BXZNT57P68\55IV.;OGO<$R99J&
M\!5BIT;5QL9=*T5[$!,SH(RZ3>1:. 8U'>.Q'5A1J=%P+LK6B@!1#R-<ZB3W
MXPDV9,02*KSU$@6+P+)=UU@#/IG->(^GQ]!0+:31#V]H@64KH7Y<125:-7NE
M5+5)J<WXAST*.K5"_AXG8,OVF*Y[V"_.QVZA193S[F)MTN(M2)\D,-&]=(;=
M2ZN>8QOF;R_AAE,[4<^) X16^!27J+?IA_I<'O5(1)#Y<O<)F\6==F..:R%
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MA$^N)%Y924VU"[$2)G+&_BKB"96@1::EX#N=#R.)\@S"VQ1IWT^)SHG$D7*
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M,;@1'1!4>6E?7HW.TD5)<K]W]D*?EI]C:[;I^'"?']3L>"PSACAGS_$\KP"
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M6PFSH;A&"N8#1.;P-V&<I%P"SGRYR NJGA4NQX>IC3"9X0>]X8SH=%CM%==
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MFK;Y"/N)FZ;XN>:*(^KIT+6$N]D706K,*)+O=IAV"<CUZ8)>?5O7E1T\#QX
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M?,-H6_1Q6@,<E#+Z.3@9WIGL^WAE*VGQQVSMXR\^Z?OBDZB41=H/R#%P#_J
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MM20MZ3A,!:#GWS $<T2G1(.M(3V?37D,9],TN8XOD]@.P?J0_KRHN,I_BLJ
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M\@57>')\_'CM)8YZ+[%ZW_":7[*)^&.VOY-D^NL_KG3D:!%4W%T-T,U[TC;
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MT_T3"X*-T^(#70((F-.1V*I?3\^?G?[?I%F@LTZ])O'YZYZG'4H+08UF)DA
M WPPSU?P 8ATY:^'8S ]PQB1")/$TP6R7!+[W.W4@SH?=(E+F*&EK]LP3T=2
M]Y1"*V/+'/!%L6E]2$[#HW$OQJ+! _(;M:U7@'MW.Z04^97>QD'R7)[&2 [Z
M7@CW1/@'#OH<:05-.HH]8>ZKE5N48*SA1C*Z+YKQ.^79?HP-O[QMKVO]ZV'
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MA V'=\7N!NK(RLKCR2=)*AJ;BQC"TD.G2D$FU$X6-N6$2]V3EO<Z_CZQ+Z1
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MDZ3]N,WJ5[K&MA_]-6:DH4Q*(C9?2]:#E^'S+2P,7*3.UA+SS1?AUDMJU+5
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M3.R7$^P4::EBJUD>+!@>DQW*NJUIM](]?OWZS[=R)&?$'&S7FYL;G] <&PV
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MCVJXA9!+_]AQZ1_'%XEY,DQW?PKKB(?4_#E%*?U,W21.C0XLHR$MS<,U>AQ
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M*'D^A"R<H0TGRBK+':4NX/*=MQ2!U$?$ (TF75S%TI"0A,ZUL8<383Q/Z?X
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MN:2@0.8!1.1W](5 2M]'L_L+($KXNYUR).>,RY (FU$: X%4:C/EV,PN4/[
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M8L[DIRG/ZEAUMF5*[($E=R#(S01@)A8[QA3 9,DQ4:Y%W5DU,Z=)*9/B[*=
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MQ!Z0K9R<+_5'^=7Z/?CVB##'IN,=F]$,F"X(EN);;CU::N:/!35>O=YB"<&
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MUA,,74FSZB]+OC5D6 )>=\7(#[MZ3Y_1D>5;N53852U[^CR3T+ !;04/#CH
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M0W0(2;%<I$>Y:J9%%7?1Z*]:^$V(V B)@KF6T'8?,3.&VCY;9E=G3-U673Z
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MUY- ZTF@+S0)M%V8!'IY!?_Y?/KEZM([_^B=7YQ^/<8W>/4S00\ZCYL)>K"
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M>_"A:B+@,TSL6$6%M]5$EV[_953>JA9&USJOUGDK(:EKG;=0G?<+_"_*\(H
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M99B*ZR?=/(//,OAA +0@2@?>&+@***9?'1Z(JPQC(/2#?AI^_ 46=>L=PP[
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M>#E"YQI,KD^?3ARVDB_,_D[?QLY<F[CW\IMX'GO'^0W(-SF5^_:IU''O,,W
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M%^)51K'QQ^;RCM8T77%8IRM^+EU1YRMF+W(#DQ/64UOF:%>>=/MD/Y)CGAQ
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M>YU>"+P;L)=CM$#'M[X+C^&];;<:_F'KP.!1L*LS"Y5"(8A5P1"TN,DHEG?
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MH,5,,[GBNUF&LHT?@4\$I8422.>K\>^4T@("=RES^S ^S_@<%MO;K2R6!8Z
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MD[E8F)TI'O9V@%53G)%C9*^!R7)*/Q C!_&L>#RX-A!DZ@*R?QF<D]S,4B;
M_OV0YH)/)M%XNK!!'7(@Q)TT5I882+8S#$Z"F2X-O.<8Q%:D5L,91H.@JQ'/
MM9X&/@MN;G!J#4&+"VCE@=_<IPIT_EM>01]*L>DXT=:+!D1M!"4T&^&+:\<9
M1R",2D%2NEN_A!90B#VW0[>*[J:GIYY[?K(UD;<<O-#,!9L8X#7!CGU*P3(W
M3/!!%;P:8I/%!$L,BPWTF.29F>#Q?;)#B6J5"C9)JN+"=HNGQUZDCPD:'*%$
M!Y5VERW[D\?!4"E&*1Q%.C,X3CBE1.M8' YKF1@KDG/OT\E%Q6/&3_5QE/4M
M334G*6\2;G[Q<'N3A_LQ+V&?>$S\6.>=*4A,']F=T&A+@_%/UAR\)>9U J*G
M2;(YQ66$X&P^^-TJ!*A^ASD$U,1RUSJEL%^G%.J40IU26,&4PI/4[@D/TD2C
MI%">-E/9/?V"O4YCI]G8N3PZVFD?^]I@MO]#\?&0'8HL2[H1B7AKK)A&]IP'
M614Q.W](TIX<.J7D+(,AR I.O"HTPM%Z/V2,#1476GBC5]56686*]WI)Z!J;
MTTQ-<7R-1:<'YA2O%-!,-7^H F&T@'NIHX=4Q24++Z&-_8IB@V5VP++4Q#:N
M<S]*,ZR/>#"5<#SP5JHJK*(0ZR6ZI,O):I7'8(P<_IL,EC+I\&H2+4Z!SV5E
MYOF$*6>[0EL#[3TZW+$%M.C!0P(,0'%@T^91SG=MO]L,D+K#@Y\#J3MH/PZD
M[K 2I&X1]WB&%H[.K Z.62U'CZO'!X,+A>[?WK1T[X$H/74_*6\7%J)6E[';
MZE+5=S 947$"+ER$$RKA?YW^9=8O_H7!OE,<WO>('TV$P!_Q6^XA$>7T*$+7
M^_+,^])\PK[4^)25F@[]:VT%L*9:]R:JK8.]MK]_L+>H5N\U)4-SW^^TC_SV
MP7[=2[:Q/:4U->L.W6=2!L5.!KMDIE81FZ$B_*/] __HJ%G#6;QPZ_M7$]2J
M''VT5DB+Z[#&5R_>\R&F5^'\>*>NR2^I-9'T1>;TGHTOER/\]PZ;_GZS_=J%
M?\L_ $+L';5JZ?^\Y^Y#&"=4J8\G[T^5<#Z6A#.7$IV;K+(_<0"?63LL#_:H
MU?8/VH=^H_,D2VQ)9_$9L&GWUW^4QL\Z;\]S]'XO3<Q,IKTJS]RS&V&S0I]O
M'QGW+##5C+MO-78;U1'O^;ENQF.TNOR9$.XZT;.QB]!-STW.26IN;FQNG7&>
M:GH^ VY6;6$^MKB]K"[G2Q+O&)6G*G&F%TW6P8DZ.+'TX,0Z<?9RPAO-PY;?
MV']23'<#PAMMOWEPZ'<.GQ3FJ77/4Z,;FWE<%^WZ=_R#UOX"/?^:%G449&84
MI-A+]AQ'M0Z?U.&3.GQ2N_MU^&0%Z+G"L.,G28SESJGNJ#A)PUXT]KY&V?<E
MM=E_+ <61SR348+=5!'B_9A^&*O'G/ .K!?B)E)^HQ3?J,LM60)12O@+,MJ$
M6I-=#.9HG#/^!#7.^ 03A(ME-!9L')$>]H^"(_4A)"2Q)'U Y/8\)7"+DT0L
M<GCFVQ8WGI=WQB-J6QIA&Q'WFV/'%38819E>)>%S!C'<CGK=K\-!%-Y)GY"%
M6R9W(X0FK""+##H:DB'333]RWQ5$@;" HQ%#8<4@\2VX:FFWFH#@*,7&%5ZR
MP>W+<;\UMK("M&\9U(@*3&V%'.$TTW'/5 '=. VEM=] ;",CT O@=0X>NH\8
M"T!#H(77XP%3#'N<W2;I> >Q3P3R9LV[L _J+NRZ"[ONPE[!+NP7TS26.%VB
M=F$ZE6'U:\0LD-HR8H'Q6)UY+!6P[&1!$7K2'&-*%"J];A5GK#6>.C(Q):(P
M%4)A!LTU$P6GA>BUZ\>]^"L,X&JTK^(<K<O=I30^SS0J9NZQ[I4V1J+^L9JA
M0,:O6 )$T$EX0 (X2\-N&-VQB5"&JY<% [U060[B8P91Y2_ *H^S/H.\X-_V
MRM'^1BP^,'L8N#3. OZY I81.$"$EHRZT8@[\L<"XF8@ZWE$P-GD"O@BA='C
M$ILAE,LM-IL\61A^)PC[80 6%NPM?9LS5D!RG87IG8QE&.5PKRU9<P]A<I)K
M@8MFW.&8D1%QR5F2I]TPVU;8C<,HGKAY'I?<GGK\8V:'7,,B7B/VY6UR7THQ
MWF PZ;I5(X&V%8R=:L.W2'4;@2^3=F_)R\C%O9#Q00]53*DQ?P@K8>(M\/*R
MMZ/;1\(3^!P9<'I;M?!WU1KJX&<[]N5.B^G(UWWXEGDW@0%0P B8*X)>B)/Q
M[8]^+8;I,'FEXH)HU+UY_PF\QP%*B$;SM^8[*X1B7[7(5-A/FNF\VO_-$Y3=
MQ+PR (RFKC"?9ZP*\43A*BV99/$(PKNZ/Z-?!;',P;&N)AX/U%4&/\.(IDS/
MU2CY,8&"L.3)\CYXWQ$>]7[*$VL8G?(N&>3#T(:WQ7?#,Q?%<.NA1&58-,8,
M*DEH6^QJF>!226RI9O[',']KY9G_?$) *DAR8 YY%=S!IGR]ZYW^"!#[DX)@
MU@4M]7N%]/>?.8Z50NLK/53$R^Y=YCB*^"3U"&W8T0B KH%)K%E\82S>7GD6
M_U9B!6CC 6PDXJ,LLU%Y;<.'F*C:YD%#"EA.2=ARL3T'USVW!W@6"RXI8AAU
MH[2;#[%#I:ML4=L\0F.1;5_;2ANB]XNXHPC:>).D-.5#@)W5###T>( W] S$
M,B./S&@>WX2Q26L-]L,LVYM@,<TC(\+_]U *I"'JTXE!EL:>=(Q$,#QQN@BM
MD-]7IH)E3BQ;H$/+%[.",>VOH9JTV67-OIP0PXE@^L-)0(>-\<&41TBN'^%:
MIZ$U%Y0S*VB3T#]E&JB-$+N:],95'AMTYDML]0K2WK*B.V=JL@E&U!I\EDQN
MHW2AOR<XQG-+Q?Z/+W_7\Q($N:[T9]]&-)M3_>[X\IO^V<S@":YMIW&@@(*\
M#^$UAQ%:O^$_V:@],;-74?V?DS%R+J)XZS*_'L\'=;AWV-AI-;;M*,V4B;VP
M!(QXXT13,B!.X;W')D!R?@\?,93^(Y;0:>[O[)DE6#2;FU:*N.H>E'5#B'!T
MB]T9FFJD1FGB!_R31SQ5/2T<1%0)J!(^<CR'20\E/(E.@;7W,IS-8?#S:.P3
M+:+K[B<E1ZW/]'!FBE[P%^.(%;4U(#GNJ?>.9#'6H-JLFXQ",TK$A#-'3!)2
MRXF:A5"0E00';.T\$"AT-S^!S>??<@2#1Z;P@0"#)\,A3N,TP1&0F3T*U\"U
M9P)I;5ZNA_R.;P6.6ZCAAR<2TP3.#C+AAXSI1#+P ,W92_V9#0_@V;UL%J2D
MHJ\]9H/Q-XD7%%RZ&JTP<Q%1?T=H8Z*J@L)-3O1@4,48/_>6""E*F)W(/"63
MB5HRD8=@X:_5= ,BM8X65PY0O@SAF/"%EZ<G<!H'"-)I8.[U;>!PW412!(]S
M4X;PGCP.1L+=G#F5 6CT&,8$QZ?BK8D;;C46/$)]AS(1I9\#S7 Z6=)C/0MV
M4IKH<;+DZ\NP9-C? <B27L)GQTP0N@Y!.,8RR*F$2LW):@.ZBQ0OZ!-2_FL>
MW$8_(N,[5 -:Q_ ASM? 45 !#X=5B601=FX0>\VSPX=U=KC.#M?9X17,#C_)
M(/]LBJDT:+1458EF!Y&IYG]U>4PEF]T^34W"ZQ^PLUWI*=^6@$JVXJ"KOC7H
M4N2O;Z?; C.BTHS;+DD",IW*QI@OP0-#QO7:N][%M]\_G9UXYQ\_GGX]^_+'
ME(4\BUMUD:<X-TM'!"HFQA1R>? &PL,: (+__@8_UZ5:#A8WZ6N-#RXZGFJU
M[L&6P)F&K/2BE$94[& 'G0S"DYD;$MQ17N"^+YZ@JL-2$\/XLO*%(5N:(3><
MR\/JPF9C5UV)1B!>O>N=8FX>_ZF*'WG@2VP-)JD&=9\K@P_WVKD-!GUEMLGM
M+?QX05#7GI7LRY_\L?*=9*WWMPG\Q+V$K;&![ *#X=F3?GCQ\%0)G<WQ9D1#
M0[KF[KY%.C7EQV"N![U_PX;15FYE8>A]P7EWG>UEG;D].'-?S_X):L&[^'1\
M0LKAI4_=933,!R#APB3/0*CI-#\Z4Y;]-_4P7HZ *7FLIAK&63:SJ>,?V>?@
M0J8^7>BI3W]JC/["OCHGHO)WOLX"ZD>7G"^]"N'4RMOQ, 22$CS3)TF7R*%7
M/)((RY4S,S# +M^80D^<'8W.,CNV--\P')?<KFI(UVUH!GE=I2CSCE7-\9GC
M']A#&Z9/O[-&%-H?7TC5T?@IKUNY7'@JB/[K4,?=^WG<*TZS4/=G&ESR1(6M
MPJ1-R_O."K.?!L&]%(',V)2(U- ( SKWX(7>@F1<FOK?WP7[^A-9K!?'7Z_^
MY5U]/?YR>7R"-O8T>[5*)CUSM5_"I=6R.4L;</V/7(F"IF\%@R?DH9)_TIMI
M28_,&:;KOI>.]584DCE=O;;4\3%S)LF4MVA.-)H%F>,\M?(^:@%E@E6+-'XE
M%E"%?2$.1P\2:R"ZU/ AH24>W5TM-C&M,LMBF7E!H,7U#JQ_!_Y;&)W#,\]*
M!D<7*1V)7*R<XXDDM22$B@[K6CF@QA@H1G'U4E*)@=KS\A'''DOT9]-OEO!/
M^4@9/1!89@?+2Y;;L_>Z=X5M8A*>*JJ%.:8@'9?:R5EB;EW<>W**=)."5"TT
M?JTD,:=!:+"L-2-.C12G^<Q35!1E.?^1 X?Q,51'4.U J@YAT[) ^K)D>0C0
M[.H6>#7S_MR%]:77X1ALBG^DNSZ9PF@1YZE3\]<#V8TSD#UJX@^I,BFC*;$9
M&%7J56V2R?MZX4"J&DD)X<G0#LETST-23T)/Y7F4,DAA1[@RPQLD\0V^<_FP
MSU68:EFR;EO[EITI%+7:>9PI& 8@8G;RD1(#5+:5R=Q,V#TP6Y#; CA_K+*U
M4:RL' JBT#'!</*#9/29,4F "=(W5T\G6#B&QX5[R)EE2 Q@4OX)JU7U9G0&
M>?Z3B8>K0AQ%+XXFIFA#T3\QNC%@(1&D@XA=,:YW2_KOO*WFMA:?-#>:_S('
M40P\RV*:)B5]?/162^X)VYE1"9VVIZ9*V,BU,95IB2=M$/T'\R/\B&&8WF#\
MGW5(^ .'0M^8@>9F6JE5F"QY-3ROO/TH]?AYDI.P-Q2C/#H!0P4:F.I2#^*3
MZQJ.E(L*LEO?WAN](APR"KKB81<-?60S+?@H4*&&4+MFQ:V:P*86H(\$%FHD
M]S$L]#8:*0NX>)PX'(;JSE>URO2!W"2$CRNTAUJ 'I9-L]^]FP1S1P&LWK=8
MT2P*E$O8A3T-4FKN#&,J=5$)"%C"7\BZ>% UW*!NT*PFORB+>E&0"LT".$B#
MB#*DG*N3"<Z4?M2'] PL#'&A%,<<\\2XYM$>&"H?\Q1I[ZO1XM/('O6]:EY=
MZU1(ITZ%U*F0.A6R@JF01]E/OY0J3(Y02)?4 'NB*'*BG3;1W\;?"K&7F60L
M=\2+5_:VV7)";^([4O(9XU0AUPS(H&J0Q"2UZ2^:I8WU#3ZL)$EO@CCZ+[?S
MXP?=8$2^O'RDPR6#Z'NX+=[F@_(9^+^@3WBL/0@7%3V:[0*JN[0;.W(#94?A
ME$TIFT-2A#$5E*HF,C&H5; .'VH;0.P(3#-W+#NBS"N^Q@W")ZE6HKEJ-\04
MW%7O<!P_6#4$1H.;AQ3"5EDP#%W#F0Q4LD6TO9L5#3K' B(]"[<8J8@EK,%]
MPY?W(H[)?T7W\3K![!T71<H[%R/9%^<^[=]<+F)A[]!$KO !R7J$?R8W5H$*
MA@8RLE+ ZN&S*=TF8"C*C%DLEJ9R>UFO+K6X*G3;3:X%+L]">P69'5?E2BW\
MX?'E[Q8,P6&SHV$(3JRE[1 DG&=_I. (3#7="?[<)'N^:8@#NBMQR@Z7 3MO
M79Q-S'53.U9Q:G!/)8_P"JKGL]#?J2?UWE!TGEL$2ULN)[=1/'SZ)4=^J[?Q
M/E#2[P <ZL.VN$&I^G"WV2I(Q%V'9@0!$F=TP(.Q";D7(SZ9XI;_4B$1)E]N
M0WY#N#-U#J%=VTUB+G+SMJ)=>!3+]F$(=K'M?/VT&XD5J/C7M;*Q@NXM9L[)
M@.854T[3!+BMW/@ @QJ"&W%9M??WJFK*>E_Q**B\]4G+=XN=F2R8E$<5DH;F
MQ;CNR[Z":_HD5TL*4"='<ARU67;D2/"X/&BSGZ4C\QC#^9;W /NK"L2V/?K.
M2A6+I(5K=,.NZDHK]ML69>TQB>N)^:!4-.;FRA5$#94ZV!$,2MQ(91T6,1A%
M4-(#C!=7QT$S<O[\A>PIEW$X^ZJ#K?A=Y=[NDF)D;!SS+HCW<UT:IM5'+.-.
M6-(7OMP@X^AWR'U8/B.SP':KN$\Q>F5/>G/"@>YF:!^:2_'@R^ [5Z7BADBZ
M2GG>Z.SBC48)2$MI3>3"EO*MX-X1I-$M+#>,)3X8)R(-JTZJDERFT-$<6?ZI
MB1J5/ICB1\M(8LW*&!WWL!\[(T@I8*W+?(36L7>L8WS+@R$J#2I2 D#6YML&
M:L)A;K&-]SC^"QN2)OG-K1/.JPBT8P%)/AQJY5'!0GC0,!CC!-BP6".09X_O
M$V41ZZB,/%)95F]M%8SP$CY)2' [,%2$IXI#HQZ)!3[;[CYELD_*1MKU9-XR
MA22Q3!AS)J7"CVM>)Z5@%%,)%XL2 CIXV]J3@H"58]NO8D)<!"D<^4\)J(+E
M-;WH'GZN6PN=.&HWR2KT186#9#$*1FYQ_[(JGJ5$#87GPF#HF6@AV]$6 X*,
MYY(^I2.2:_#UQ0KSO0$0T&$&S/]3Q;<H!TGKFU:=/Y.4Q/().ZR\!<HJAH7(
M95BF88QBIT&HZ09O\2B+NY98 7RSI-($(!PEMX@,"#T@;L!3="^+%*\:DR$(
M&R>91BHAL>HB S1\4=1DW!1!AB@<:VG8Y,0?&=OSB8J?K@%APM#R0&G"0WE]
MM)I(5#TFD*6I+;G']"C9/I&IY(#WOP%)$4\UA%K2D51I(V$)!D8U-&I:"<F5
M+0ST0M*#P3L1&9Y$SRG6X\M3VRY3D*@GCB .S3.+"TR+RZP%27FA<I/FVSW?
M+L:3XT=;LH7KLJ(+Z*C=Q&&X+9M%)AKEE$=\'U5)2Y_QL5-*0V7] TXIHR&3
MVLY+'M..@]L>8[OOP-X&O2#2BV3U&/N\>#QU<8UCSYO[ZLI,B_7T\L*>1*VH
M\>,MEFKQ";(ZJ"0/:PRDZZB?IUUCF[+E)O8[L935.T5M^5V0HR9C00A0S?U=
M[^_ WW>8EN#,BR2#G9 =;?B T/WN=151@&YM&(P5B@!>J$HU;72D*:>#4R':
M^R2RX'U[:7"/.6?A+-M8L4 KQ97#T-T@NL5<D&L&&.PB]5+RO=#2X@_]=/A,
MOV&$_3@"IS/-HD93-<7-^V^8)A:&1\$-G]C,->]I.:H3.74BIT[DK& BY\F>
M(48(M$U<J>J4)6206D32.3^WQ"D56KG1"_4399!0'<Q(:E='NG:5A7V2?.?/
ML*"BM'B\:+]7%FUI^S1R"MFZ8#L#&5)PBN]40J(7]@,M\RG.D(9B(G"/AUMH
M.(;#?B.QR[G,"V5N2JE(/L1"!#:*)>5Q@PV60BCZR35HG"$%;882>A)X778M
MZ<=SV*5/LT)7SF=5/+1,;_4\]CZ&UZG5![OO+] 9^TE7+ OE2G5DY\+55,Z:
MKEH%#X[BDWE,)45B>9JT(C%[_C@W8)H3)[^O=N-L+PU?T!A;)NA2AB4Y00_E
MS F\0%4=DAW0%@_^+H@&*A8,WB&6D.)>2D51H6=A_A/IU*(6I :Y:G ,WX*7
MX-2"JZC<5!_/?H\B?S'7O6W;7$96,ABN*D:;%>W:JMX-NS(293I(K"Q#=/N8
MO+RQJ0-W@QA:-*-(>@JCVM)0M4-:,4J[GE4VH>$E536&4S5)V6:9#!:]#)[>
MHT._V3K@)^++J7C#N#1=7$%6-PY[R.L&UIH(AII-+CI&X-O?!30H8!HSO&T=
M[/N'!^VGL0$32!XH#4%/WE14=4"'7@@RMS>Y!?II$V]!CU\DV5^ZX.#<6<:^
M<J,K('-URDBE\*(4Q-$I2C7R0X\1"(0,K(LT 741# HA:S;9\"/S(XF)5 8X
M1(@T_2.01^W] \T_3N#5E@X"C3F?S"K>7KH:"F\F9A*&ZN-DWK!C04!L!5(U
MK!/&NH+)U6QEEF=U+?)UQ5VMA(=33N"490PQYXW!!?N7I2\O@>6@VPT'F"H/
M+=7L6K% X-,[0<7[P,8NE5HI,!(R$*-XF[.;]D$SVV^DW;3%C,S14Z7 !7^
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M-'([(HFA9'"/&CDB2>-B<GO"@KY-#"G8 S2HNV I)CCWX[DW''C9+X).6B@
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M$:.RHAOZY56&<XZ0;V6RTPF2+S8H7LQW3LT?(.LEV;Q+L"'#;U.L7\<9X[B
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M4JLZ;/ JO8FU$0!UZN*Y4Q?U&5^),[ZTBJPLO\["_^2H'Z5P2-?NC,L*MFB
M+<^+'0?=6U*L%=>2TB;@NSC".\;>93@:6Z>TN<>^*U=G=0=!ED7]""N7,ENY
M-[U>K@>EYAG9F$'L);#P](XRWD-JZ??^DR=CLD<#K.4B0<'?\#Q:-8;8>F6Y
MZ6/?14;5#I(,JP6B;EC^,_F.QL%?T]+IU0KH9RR_0EB EX:#\ Y_V /+A<O!
MIE3'8;&7@N%C.#2"WG/,(NLYUO;J,C7ZIL=CDH,AK:7P"G SK/!*\IM;O(Q+
MS'"V_3@-<*BO3(16=)ZQ9-YHL^; ->HJ5@MDQ,*+Q/O?/$B!_P8/LI<R6+C
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M@<SASX;$TPMPZ(8]!,%G(X#K'G%C(-8XH4;AXC5%O0Y)L55,$Y%/((="#ZA
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M9123I-@=JI*XLEO/_0[O0C48=%@!WW"PA(,UNPT]GR=1TL S'=\4SJ\DL/I
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M,0IT[L,:MY6=+;EX<R2OGA.4]Y7 LV=A9@)TNBN<V0MM#CG75; RO/#24HY
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MJ;:51_N@$8Q=H&BI@&B)YA#D>+-DPY) 89=L3EVXH:D1'D<LAR*80</4LT7
MGIRPG')]7)VV1G0<S%&"7'DCSC'&C8;*$4F3*,\I3%0F/ACP"(4%M$*2X$@I
MD&< C%)%A-;6B=G",$AY2"P@!-)1VT0WBVU0@P8"LO2UW:JBR';*2C@^EOXN
M/]3 <_V4ZV#?+F^S35HF.J3*CWU4BPX:.M'K&EM'@^+PI4_?G3!+6PFM)XKI
MM9$J*H R!IB4;$J8I&V@*5%:&<5&B#X8%Q.VOZEH6[GC.&7EF]]4!$['<4IT
MC>0JIR8JIZE6BEYH.>@:R0ZYWT]Q+XRP[S1(0\<!<,7CKZ!AGSIIJ'OIX8VN
M".R(\_K:H\L_E/G"G]Q![1>4 @2,LAE PB-V2/#!7G1ZX;FW8^K?PZSZDHJ[
MS%(&T]>,WQ?DC=@,RP?CASA"M1X9?;J1)*/SCS#\G-'L38@3>C+1KA0/*'M.
M3[-)M*9)C X.ZBD1D04H^WJ;Z(T.:9K%#E]%;1^%0('-'MSXUF"_AS5M DJ?
MY-8D[286]):.RB)D1(?HS78]Y0-R_CIS_G,ZHXS0IY!T$K/]Y^/E[1$\XF2$
ME(]X0,LJ="*&KC*M$=T])>.R&%]_TR!MO5A<HO:/,N#-:__+\GTK%=,]0O8/
MI2\2#&DF4;)&KY,&NU)-=/,7Z.9_ Z8/QM>/.8<5S;\ZCE-BSB%2 ^8<HF:Z
M1<XA']^<FLIT?)II3JY:2>YE\"\;)C$QR[!(S!7@<C!4TFE M\^]^!Q0R:RH
MP#V.4Z*2B=10MI*)3M+#5T7/AC]^],<_>H.Q&+A\-AR,^X/?>X,S&,'\0=-^
M+5<W+4]JOF>IU]K,W=_;(>^OV'6GT'2.H8*ZDS?IN$^!_<FU'79K_ 4%6GFS
MZE.^0E+%O54%[:\HR)5#.[HR4'[D%=1\[U[UO@\OSGM7(QX":'U6>O][W1__
MG_+AO/>M?]8?HP2IU5)5WEL-ET+MO.:=D\X<*P@$1KM,C-_?,\$?A-[D3Z+\
M;9^<]W5EQ'-'L,]+RQ_ZHQ!ZC_T!U2^7U!_=63Y]N<69>  _?#?=WXP_")0<
M_M9PQI=8T\[LYYSZ/^5:B<>O/_BVL<^OB$.F^OE5XY#JJ:JJ>1V9EEY0YN]Q
M*%B"6&4)U&>E%K3+X1IT%^&=Y[/EI@73;,"7*YQ8-SC5+HGT?:?218GNFC+=
M91*UXD,I8ME:$=IP$0:AQ:<D5!HG6QZK'P2+BE-94R>=ID::[;QR@14B<Z>'
M0U6UY5]KJ:HZ)S)58C0[Q,@-&:Z\L#^"DKQ2L3E(.7U["=% \?(_%RX52JBA
M,M6>W5C^J7,ZX5"5;VG\+9TH[&%SRL[U0)TC3'O-(5FN%!:O#+ZQ*)KH6 ]=
M.*IW;-R\#=4F48V:MFH^)%="=SJU ?*6D]EP;J+VMLQ\;ME3=FK)<"?6W XM
MYQC9;P+D2P:2OGLF0%%6G^,V:38TTFXC9RT)BP7D?+74!K,+L,5$3=CJ\<6_
MKFAHL=^F"K5\EWTC^.V#-9DL[A=\U@.C^9D]L<.20V#ELH\/+_./"$(]":!N
M IYS 9V="82 ;>L?)Q]?[TI@M'5F&.X^ ?C7HY(,;\)L$6TF3-)HMXBAUU1.
MH 2HLP1(4;WBB3E;WOW<IW>4(?F!*C8OTS]D ?#J&(P(/KQIV5D:.J*'P847
M0.>"X6QL/95C';1;C%^H:!GL&;.%-*9039VTC9K.63QNFV$G_I>!YWX$2O,]
MA[UR*WFNS4C/IT%XC"SXA\V@;8?/?0F#<GBL89JDU<;QA$6CK@ FVNYTB&GL
MI7,;UME5M.;H.$Z)=79(#=C, 0=(;3M BB=PW'D.H^ @JH.@_UTPR:U\. 8G
M\"O#)R".+J'3XU!AYJ&S@.262]%VN1N&OGVS"&$V[-B#OE6)!E^NVLK@0QJ=
M-NEH)JJNE41Z,=WL->AFW]E+;@;JO!65_\=Q2M1YD1JPMP36!A?>YHQWF*A>
MQ7"^W/[;'AMJ==WIJO944K->B(P9#=(H.$VU1/6W#I@L0*<U.T3M-$B[@3IM
M)71:@\GWJ;=@MLY!JS%5.6;EM=JJ .I(CIG#M-C_P?60/>#$H9;/3W\'AWN*
MMRA[ ,GGKM.H7E*)-759J]3T-2#<@;XH5MM::;NCBC6!%";+?8;B,QB.'"B6
M#_.2>13]UK<<IMC[H>+-E/".!E0$U^U[$&M,\P[H%'[CM@Q/BYK9KN5.;'"3
M1@4VP:F2Q=/R:<49VINJX3GP2CUA%X2T;&3(6S*A</8E\;4=$6QQIG)HX-O'
M]]Q"*+9, !??P\R/-0R%FT_+D(#74G;D#65:#]B1SJ/U'*1NY%VL@,C1"IJJ
M_O)9B:ZO =M.F9J::1 E^A\S-7];2X2:<:JWX=N9K9XV6SF[E2]_YE]_E$O?
M,.4/-FHI=S[H=?_#-,*3:"%WX3B?,V:K8#1C8$UPQ:"3&-R8O_]F;4B,2RQ;
M@J-]:MJ,%-.?!Z,U/H(O-FLM0F_)JN4OG;S ]+8CQTUH/P\B[R'*]'<_!G3R
MT7[ZZ-,IO/L)6JRM?"6#08[ %Y]9XNU<O5UIJK"G;#.VV] -O:G^;)]L);=7
M]K;QL7*@\2+LNE^[9]<CY:+_K4>4_N L3QQDCV+H)SNFO;7"MTCBJRQ970^Z
MU^?]<8_W #WO#4;BM]'PHG_>A9='8_9#= H=?E.&E[VK[KC//B#[AOZXO.I]
M9U_K_]$#A Y_])27*;7^C*2RN/PVO%+&WWOLWU6OI_P8#L;?I?.M_^_HSQY#
M\KGRS^M!3XE;"L!'P >Q&>8R"KRQ"4+TE'$@7DL[?Q/3(/N12)S#H;/O\(U\
M$E[S0C']?@7RL"@_\=Z#Z58A<:FL[$PH/%,Z\6 DKN=&&]Y("SCYL@43D[O4
MJX"@E0T51\'O644^D]GG7-N=4,>1P]"X?Q/^EL\2GL^T+L.?*=55P1;$*W+B
M&6<L\9@U80N\/?8A^0Y[J&/- _9J]%O\5N;,)VL]HLF[TR7]W&S_PJV0G+=T
MMO=U[AGYC=P?!_>8=\0CV^_)P8N<U)(XDVM\:G)#?=M Q<O/67D:(S9&7NX_
M3IHGKSWY[=)U133G2%>Q6&QFEJ=(C9GE3)4?['-W@=)C+'/Z]QN?$42F+U*6
M6^T&%P4\![$YLI_VA\MCYR'ZL5(=F#AU8Q''C"P=D54?9.'-JA&R"KQ9F#&(
M&8-O[Z;4^Z,WN.Z-/N'(D#HM5>6]'>925=[;82Y5Y;W5<"DLID4%(&=M* R<
M,2794P+J/]CP)<6G#]1=E-Q!JWXWJEI+57EOA[E4E?=VF$M5>6\U7 H]!]B%
M\QU]F$4'3LA+?]ZW\E"1,K0K<?9OOG</.<3PH7_9X=W9(F"+4+_W)+LQ=(.
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M/+ WK]UW'V@0<GVA[TZ8%JW,F';-P#.#)OS!PK?<"57FGF-/;+;^'76FRB(
M_Y&=?/.>AG?>]'@]2?T(4 DT!3#+]1>UB=XT2*.#*3OE8K,86](DG:9)&NC_
M*PF;Q?I_M"9IFB9I&P=3-5(3=!9S.36#=-IJX;<3?3VHM.6L?79GN;>@GRDS
MR_:5!\M9\,$NZ[2V#WGZ6^JK0G^KQ)#,_7"5"P:X$4."PSUGD6\Y^,9 ] =
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M7@BORL*KB)&^1JJY?07LO"]&@RGA&FFJNW<HX;3PX[DJ"*^*L9;:,0B,NQZ
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ML!C_$#N[F"FV-);L=>-B6PLA.MC;K(.#.&7AHN5 X'0<IT1J0&I :D!J0&I
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M03X*)Y^$8)YA)P"G-%Y37T^ *:'TCB>O/"%Y."<F.,M+^(AW2&^M243<\AD
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M\JO*+U?<4&)T%IL"8V]N3X2FW=94DB-[1<\WF9^X-3];\SR>KS%YQ9++&&M
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MLIY]H^MDYZZ3@?>0SHR(<R2AZYJ,:RF,<LEZS*X,>1"1 2Z;X^A!4HR3S$2
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M\6'!"=.Z%P"1(9 9D%,)QS3<7SESMK@UR4&*$X2$5 ]L=FD8+TOV>:KTGNQ
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MN]@V%;#D.AJ'M<8YH%B;MCD+9E&ZQS><+_LF@GE^HN.I;?XGH)\C>EP!.;X
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M67:7$MZ61C.,4B^F^BM/'."X$0N,4= ?(,\F#.V9+[8Y,<<Z2P:9@)I";>S
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M!Q(.L@0+!6V US8ZC[*#<L+L"'/9MSXG,F=4ZQHB/P>8O ?*!O8N^PNKEQ"
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M;_-H:C2=?0B/N*;'^T[IXS&H5O@&A%M_-BW37\!AG]HL"10_=]D(STRCX@]
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MZ];",[U0E$#>4+9>*9 <Y$^W7^#-ILU6FWHEK)@:_+5+E#42[^*/ EGSXPE
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M*"\ 'KAS;#?\YR?=,[T_0K/[1,=3VP3WP'O"8,L3"-LGRQG_M>QVJ FW(Z&
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MYPA%,US#FV5S'X@72T>:DQCW:%B4,.@-&3 :I2IY)='D:3KO#@?<P_/2'&
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M)MYNF<8C&3?PU-'8L-^44S1"]/)G<2O]I7W^J *%^^B#!C,G@&ZQ'/C3=V@
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M3#[8'C5D^D'NF'#["0AQ8;5:#D(B <%3V-_XM^C.?.<R8?AQ1ZK"(4W(_S$
MF>>\>)\4X0W%7%UX$PD;,E&ID'R.NC*[E.(IY^%#0D>Y]^!<!+ZX(.EA>F_-
M6>SY#[VUA4;3_GJ=',@=%YUW@>2\%6)QP0"YTI.]#WD%U@P*\ .,G7O#?F)[
M4ZEJ<[!@U&UGM1S^0N\MD)D63/NL/#+_A;'\[N^'%^<@EET$?'.^OTE3E:QP
M3*)>0T;(F[ _E*7>G[!/RUOYK#C/S,WO_D;+[B"6/5_"/I\[_& 6>U][?+88
M]8.HX300,VSK:[N%3+0<4WL.,NE X"90?A,8VP'ND+"[IY(X)7+002,'57>,
M'-1<!_ZD53SDH-8Z\]/*N8<.@B&N,R%MG^!!P8OLB66EU9"_'UM(62)=\@(N
M!/1?9[7T(X(7.H3,2AY'PM?)'$N98RES+&6.I<RQS$WFE<RQW#NU9(ZES+&4
M.99[R+'<KA/L_5F69;5<U=1F;;83M\RR7 -F[.Y/Y0XT5]!)N<K9Q>,Z#_F2
M>R+(K0W;W'KCV[P6W^5!;R=R"W!]RD%#AA H(R*V WA%Y13O$G!L=XA]^::T
M[]IA_Y^8KM]CKF^@R6C#AN2];@*L3#KWT5QZ@N<^H<%%TD9T2PF%SH(@VK4Y
M@*T<@#B>!QB.W3'#PS$8]Y\,3!N++90[C1_E&I<[?#HPFV62(>Q!T7G&,O/8
MU5-?K2@@SFJAA*@O=9&79GWD?%V!D2PD$AW7[4>C!P;^563+P:80";:&<L$L
MXP5UZL#*C]3Y ,8RZ ,%MP6+JXHRXR%&VNAP1>WBC3NI'BWSB3M]^-$@@%H#
M_A*^>MR9I]X$S$WB$H_K*:3DB"6.SN*(NSBK1@.:W=S!$/?M0]@C5NX[5@*6
M$_:#S9UM46)ONO@$XY=1#*O'D[<-T4N+IUQ/O21:17Q8C LO84;$9Z?+EI3
M'Z.^8@C_I#BN"03'G,[I'A*)3,PE8H4NX4*JGR*=N)$Y?TRAJ\,#:818L6BL
M\NQP+TARY\F^H5O&03Q=,&P9?,Z3I3WZ>@4RD0MP0/Z_1^S_LBJ+2W4@H0ZD
MT58J!*LJ!.0<"\[S57=TRC7121*D1,9>20C+W+; R'K@'*)S"[ZQT&_L'K&
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M;79\=5UMU36UWIQMG+?6^1<P,SF=YW"SN),6+\ZTPF14 \\R.6LX%KYE_HT
M[CP!%C0/L$ G'"G5!<.$7J%@5PS70"U-%!R*YAK/AFF1"83<!??ZKODXB>?
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MU@4/# /7R9>G[QCQ(.J!&Z> V N$GXL//#4^SJ\X#I[6MOM<%L4.T4[T4*Q
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M70.)#C0>3]S>D#I4V(KQ].2R)[P6GK)8(V_#$=,WK0G6]G19#TNX3.9U7CD
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M%,\)P3A#?!T.BH3#<02T#=T16A6G< 1;$[(0X#Z144"E<#!!BP/G?)SZ"J8
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M(/+B<2$G2<=/M$*P_(54>D:D?%FNN659!+0,UPEN[5S.ACS1G:@0RO'4%9>
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MA(3)BQ_K4":,5>=:"#B/?6_WQ4G&@>F">N'[=?@SOJ_J@JWF3.-Q/(]G3O1
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M)\3,]CEY,:TOXB*(G> 6<+/>M>"K 6B#<6C)0HK!M3L6YG+@%9R0&#:RCB_
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MX!LS+EAR2>/\0#-S#1=H6:WX_<J*O_%6?),H:7O3NV:K:]?J3;J5,3.R>PM
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M:+9[=KO7>9BSY[Z[O%.7\$"7&.?I$N@@H@NQ'A(-N]'M/P 2K6[+;O1ZN6_
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M^3X-'W2R)%*C@G1'!D<HK?5)C:F4[.A365O?"_ 0R:7&CC8*\S"0C3V>RAU
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M.3]I9L+3[;6I?GH@Y:B)+VTM:%@@[G6_^HBZS@5UZ^*65N1'DXVX A&Y,IA
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MT8GA!0>A:>Z&H1_<6L=^A(Y(VIV4FE+!<O NAD4F[RZ2=SU\%R,M'2L4"R<
MI=V*/0K<$Q,C)"\2XZD'TN75+<44P;A[UJ$'4U\3^A.RIX,)%W$PGCH8>N0
MVG/A2YI.Y9E[YB.P $ E)#?.C)^"-?VWX\4.+))("E(?/0Y0%5ALI**:SG&1
M\+,-'UP*RGO?04@T:A^3KS(0H^_K']]S9.'*QS"P-+1"]X<%,BKZYJV=SB_O
M8761 "(6X:>P>B^>WS7.W"&'L0:9]#<VB&(V]7KICZ_XK L2\6<G62C![<:=
MS72U  R0C>%OAT)K_3@*(W@&=[\ &(S=!< 27W+&XR"FXY2+!J*.8%N>"\Y^
M)L(P ]3L5N1="G$:Y G^BM'V++ZQ(<=A8CAP(.!\,#8XG#H(#7\\CH&9N'R.
MR[<,V,P5T$Z^HJE+@HH"S'/I>AAQBY4.KG4<[ZTK\,Z3X=@:.^%4QY'B..+'
M&/<(=^==7=61U_ _!HID#7GL+VKLY*X\<U0OH-C)./(EAC568E@*,FM0';>/
M0X3._+YXSH@G"V2O0KS.'93+DN1)H><]'\\B<6<%$M,M!^5WIF0*P)-HNOX6
M,RSE!.LH:SZA6%H*$PK:14(J>KFD@I:KZ,%(+")3A*H106B9!*'UC 2A)6O(
ME+4&3K>J@;/Q-7#>W,ESEK%K)<]IE8WGM/-YSAE:\( :C'$OKDEVGIGGF+*C
MLUC,_G][7]_<-I+C_?]^"M;<Y,K>HQU1[TKVF2K'<68]Z\2^V)F]K:>>VFI1
M+8L3BM3PQ8[NTS\ NIMOHF39IBQ1[JO;26*3S6XT@ ;0P ]84(*$>KYISNZ8
MXR++'X% '87,Y0737$(7 95D!0O26($@98I7Y"FV2FL;, %[0C!%(SZ,,F\G
MM20K7AZ)TI(_8Y"CL3@"N8/82!518@*\ CMX-)6L6TZ'4<P5HS]T0%F]]U)$
MB/%)M$-#.NQ1P/ 0. H3YE)?&'(LYN'Y*B#R%QZD+Y;@&*X/PX(VFF;HNP9Y
M<5>FG%%9E0&R,V9.($MPX%\$615PJA"#X>'8=&"JW!L=&]\\43D$K]TRL%KH
M-'-!XN2@XBTZV0R?]HLJ(#AX&R&"7\$AZ)/E$SFNH88Z-DY60EUEB<-QEJ(*
M#:LITGECU5&>27%J(X[$<3QZGD7%ET"\ O\'U9"%2^J1,B9J@L]%417/)P,N
M0PW<;J0%+,S&B,5(1U8JCZQT:QM9N;SY^]E7X_S+[V?7-UB]=$W%3.*G7RZ_
MG'[[^A5^:IQ<7Y_![[8<"BGI!W])XGR>JO&%"J:=BLXHF^,:#+WOQN6]!YIY
MXLP4]RP,17]_YV#=J?V3"N/(I[,GLG_O%8,YB7E#G\*S\=X'=1F1IC?!(PB(
M=",>VH$SY*CU7?_^Q<EWZ1F_Q>Y<UBF(N$=CF4?;;+;-3L<2#\<>JE:T"KPU
MG59Y)*)W%3CD9,$+Z::( <FQ[77RMA@]^0U_GQI@WV98]9J<KF+.Z8,&GN9%
MZ,9[*D,.,(X>XFG0/[;>X!A1X+O*?BD+JGT4L(WJ+'K([:<Z9Q0'L$ZMMCGH
M-9!.#ZZZDYXH$X81.E%3C>=-7YXVV9-LQ?'XXN8IL%%^)DWK 59J],QVKRL>
M5B[ ^/$!SR)//6CD?4AZ9"\(:2ZFHE@OHS1HEOG 0_&W9.]D%0$Y.W<^V<PP
MY:GOR8_Y2QT=:9'X,U6(G:'@$K9?F$:1T:4O!Z19C^%WQ+N1YJC@=Q>L-H]A
M**G$^PC5:C(:  5I@3(9XSKDN0%DF3K02'J4'@6#3&7B)3,<^5R4Y$_8G;#2
MV=!Q\0W8:_Z#![:3QS7 TG>P')&#?=@W S,K1/&[J%HBQQ4D/8$*@&FHHX*\
M6;4XX=G";S->A620S+J!.,5EHY&N\ :6$#4OJ<):#8L !4,27OPJ.#..B&N&
MDKW20GXXWQPDY-PT9FY,$P)S&_XB$ G0%@YC5_B1"-O@#T,>W#%Q<#I )?4<
MF<\P;P2&  T0,EM@&*A+3P<37-"BPT^ [G" O5B0G;"DCO@)YSG$@D1WD/X1
M$ 7DB2B3'7X2QN#V"+$@] NQ\?"<&X^$1Q.5# A6!^4AD?JZCN /P6(PX*78
M>U^Z2:<Y3^A<?/_@ KY^F$=7 &<$F;S ]"0(*8#"/0S$D<-L)[#C*08:;2(C
MH2WPU-U9=&F*2!1L+G$<B!5@3-R>8W 5L]\CDJ6SH1A.( $N'GDIO4KG;.(Z
M?:DQ^\7W:!6PO!-P8:/P*.\,[YJ%>_V?;#I[?P6,15Q5C2VK!H73$ YMX3:#
MF+GR5 H%)]VCVYN>Z=$D\./;"0CB,/"_"[!JU*:@K/RI8X-%-KKEACK590P%
M2/.=BURU'Y2:3&&A, IBI=;SHI8&-^A1O#\1@B(X&00TT5'*K+CWR"P;&7_&
M/GY9?%*H&A%/I L*^7/0E:>I^LG&!0*>./%J-IG0QP5I#"_K#!FNX\&40/I5
M+%\JF%"I!!T,J#P8T*MM,.#T\LOUY<7YQY.;\\LOQN4GX_>3K^>8-&&<?[DY
M^WIV?6.<?;FA)(EMAP+R)IN='G>A\?OYF3B71*S7B5 FD?=!WJ:8.#"$,PKL
M(@?_#H_]?EE\7MJG84:A3-D?/MTF2%,ZO2,+9$@1#C046B%48 S)FTCR14QU
MHW@=3VD*Z(UES+.3-*Y])4TP=8>)$YOZ <^A%\'_3_S[TA"DT'AHNXD =4H:
M>/&XYM=X?7V-M_/7>#<E3(FGWUQQ)9Q<B:2),,,="QPFG54A53$ZF2F_PU&=
MQ,S1QDSN7.20X83<S2'/:H)1WGXE9+!\H#XG&_@O..G)I<EVR< 3ETZ-0.8]
MWA&.$MGE+,QZ"CCD+5JJ'KX\\FUI0:!KL'!;2#K&&<;2FO$SRTG"/<J"76G
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MS#(;[8[9;6IGHF9"5AM9DH"+$?NQ7TYXOS\P!VTM-S63F_H?3E]X)!HFL$B
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MA-J,)\I9)"]0R@-G@0>/BJ?$H2@R-U;D@& *(YZ@XFOYHR_1ZV'ARMZ!M;S
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MQ(Z<R)65QECDQ^\0\T"05N+=&3<((!6):FFY#0>TONM#N1\(<%'X=J8O('@
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MJ7$X91$H[XZ8KJ)*;G-#N28&S_X@"L&3;?$\,##U9<Z\F*ZQ@HDF)CAE/,#
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MAETQR 9PU/:DC^?ROJF[W2"VPH4^NT&L;B!9ICY/T5;%5$RE-#6 ?-5S?.W
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M+(@D07 /)LY,6+]?_#MFW 0,5:!Q\.WZT#0N+DZ- ]SB9N-]]M?T(^L]/,&
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M<+.*S2^2<-E!-ORU'Y<DO8'9ZFZN!.UUG0<7/ S?&>?361R)GBW4>G(O^.3
M,@>]9_FPA_I0T(="'0^%B^(=QHIV/G4/8%8*X[6_4MX2$C;R8[Q7VI*8/V(2
M:]4G9C9']\)3.NAQO?!ZM>V%=_WMP_79?W\[^W)CG/T._]V!MGBY1JMWS(VQ
M/E7P7!@/0_YGC&5YV#XS"L6/,;,XTX<[3-M*YMI &@@FEW2R^\P">R(3T-JD
MQ5NB!Q\]Q:),H_&QX\$H#G:E38'HJ 6F$X8Q'ZUJ9;?TLO]Y>?.&,P).=+QV
ML]7L-OYM]=A/O_Q5>O /_EGO)M+-ABX7>':Y@.MX_$BNHWG<6$/OO\]?MC=+
M+MN7<$7V6ZV'O]5<^):URJHM9[_V$O;+FH6/UDS_\F.L>XC=$9;-SPW?H__(
M+L5I3;T-@R157M&$6OSZE!L3A\?&/[EHCHE=,F%C)GX GQ]E>F7.>!#BJ#Z^
M=@>GES&'#U-K^9$S'G/$PL]^[]@X'^/KOL?5&V'9*PC:Z2E0R_P0)CTOUX83
MD^LSG(@FC%DZ^.,I^TX=+CUL/XHI1+X1PD&,% BQ5;(=!P(Z@-J6SM52'(_^
M]0?\-APYI*1!O:("1=*)H6!V(7.I+2E^"=Z<.E&$RC5#=@;Z=LI%!^4BU=EL
MQEF TUND.H[*;)@=ZG;:-F'-)_J>_E[8J,LX,(9Q"!L9AF;F$  2CAQ!-?#S
M8U>@DOIY5%(U4 @TFXL-%]5^8'XX>"31&O#;L'VEO /_\&$&]WP(;T0I862;
MZ87I/N$,>I8TI!5!,!M;:C><I>O;3':S%GN$%EB"H1K D_#X'6YY-:MXYI%"
MIV+G_1OCD_,#9OT5V>&:>PXPY!<?JY1&,4?SH+]B;LUE^B:=FWCDJ=::FNS)
MAY/3;]?&Q?FG,],X_W*ZJK-U9QVUGG,<5I]&2U1Z]TDJO2Q72QQQ3>O-XLK7
M/.*R3A!:!4_GI&85NW7U]?+ZZNSTYMMUA7F->I<J\H *"J#T#^$8/%,K5<-+
M#APPQC6<+2[\*2:T RS^?__Z_^1DBEOY'$U4/LPS1GDQ&S2'O%#%;->PSA=G
M^Y!UKEVGC59:5ZRAR-D'DDAGO]D&;7#R]<8X/]^TN;2.!CC_\NGRZ^>3F_/+
M+\:7RQOCZ]E_?SO_>O81S!-C^0&XZ9G"O"(^Q=2&AO7>:H$U3[[56=)V8&R<
M@S-!T2&TUS]BEP)G& N':OEDEX6\*C*E97$]0H6 6$4B_H3XK\*K2+HFS-A<
M/#\WT+LAO\'CTK-RY'M.=H&CS *5,9YQV(8</:> WZ)S&*#;=0)^G0+(0O^/
MAY$S1</>1.02#NI%5>E?GYW*-X4'9(PY%^^7S!R'RLU^E0G[&FH^^LW'U7P\
M4(VOJPS*) Q9]&N613_Q[93O57EI9W8;K>-^0V=Q5,(BG\Z_?#TQ/CDN*D)@
MC]H#K2WQ:YX[P[_JY(%UD@=NF4M<1*>?,CLT2VV+I6K#.2<V)1HJ):399R?8
MI_X:Z;,3HA',/.Z#QZ YZAD<M2_I3#II\64/B>HZJE/"NI;=5RR[^YZ*^.3(
M3XU3$9MKI"+^=<=2#!<R"F\H%63,9:@/IF+'HL7$D(5I5D F]$CY'Y0!,Z)?
M>3$F6&.,4@4PA17,P#(.D.KN'(;U,!EBR(T1'U.Z!&6$.*$1P02/'Y7%N)GT
MB']RX]YQ79@B$R"G% LU,X%06!*1:4GT-A=170C8FK)I ?H)] H\S@+"XK']
MZ<QU*/!+OZ&DQ1S! P,#X\W&^Z$;PV^^$_Y/TWION.P^7![Y#57@=WG0=T64
MO[_Q*'\;4VE&?.HY8Q !1;>/3@"D]0-!\<LQ_(X'*S---A+COQ;[*S26U>ZH
M+?WXZ^E%F@>&D+K@_P4195#=PXZ:N%WXPV#F"THG8$U#'W<<QADE2X2W;@/F
M1<@>1(EHCC_SY:K-S*-I+V8U-C= 68E^&!*S-XSQ10=^"#(W#'Q&#"9RL^"7
M]D1])B&X@):";V$6DV$[@1U/@0$3(0[CX1\P >)3^9#KP&@B=>KELY@PR<N>
ML #62_,;SE$&3,P/ ]K,E0P37COH*9AY/),JC.2,I^+I2%4&(FDFJ7N4YG4O
M=8$BUIPRNPI;D6P1_@N3QO)/<_B8/U<1 ;%1IH+>&L>N"U(*\DF9?4GR'-ZP
M?.0N,A)'X<YJC87M<3R9\US<4UP8,LJ]$PH$O(!6S8*YW.[L)UY^"\\] T]C
MD9%W+[,KZ7)25.-ACN*,$7\75\9N Z[RN5%5+FX+_P%ZDS#-U 9)(@7\SQB>
M#(T8MVSJ T6%-&$']%NQ->D.PF^F\#5@=]BEE/$3I'\Y*&X["Y#,0VR_SL)$
M]3L!Z7%PW8$STRGZ03(O2M0D-F-NZ!L(]$E?40]GN2Q3U@0SB@-D@*UD$(:+
M>T*2$U(B)9(#9&^E%BJ^CJF8<4H5>?>IZ$6@Y!FR'Z3R$'!G.HR#,&G[DYS4
M\$P< #,=TM[@LRF WG5ZK)[8T9:9'R<D] 2M(</=2@TMRH;DXRP:8)YUJ0XC
MD8+[B8_Z8,I MS%*1IU38C%^ A@6U(\ !(1MRSTC$X)%A88)6^I00C)LMLTY
MT7_(;18#/V!&<( 5&Z1W N.>X:&8<''*\>H$E;,VR\Z6)%<W1-M '%DVV*%F
M;KTD-4ICJUMM-KI#L2ARPW&-JR?.SX\L73RQZQE >:.V<VQ\Y;@FXYJY(G'E
MFY?F:604T(N;M)>>\5OL<5D*VU!%5#(W_]3U25=**?T@,^E1Z(:.)W4]Z%OP
M\")EQYPHC45J^\JE0@/C,P]N0=P/\ GIN,@?)<]+!^:0#+<1!Q/%&:;]W(HH
MI^0S.J3/0.I_S-.Z+G1/K^T)'\7 >%;[Q!@3PFGBE&74O;B8D2U\X M3\%;I
M ,I2I9,0)=N-$7-H?H.S[3=F?P]1'5YS6.EG^PMG+NBQSRR";]T;OS+/OP/O
M3)B$_^!W#DX.=L_XAQ.0@6!S6,.(OHX3!Z'Y7M"*^&&J^1AQY:=)_6:+EV(@
M!''5Q><3^L[)D-E@9ESS*!*S76V5;]ZMZQX#G2?.T)&I1)^22HSK9-O4GKV\
M$!RP0V.Q/I3^_@[<&M<!/78!PHHD5LO 25*]Z#47!Z_\!;FO/R3/L3!?ZY%+
M7TE6OB)[JEM)TNVC W$B*WF+B5AXH*R9B?68O*O>FV(H6/Q\0,?7!FXDUH3;
M?;\8&E]HS/#4PZM?18*H9.Y'63M6)M*\JA@!W=&9R^;O'(^2IH<NJ,#*5_"%
M(I*;[OGYR(U\3+!^^R3\2&?R#)57/C9;R%?,Y<\_KW-A<XMM1<OV4EQX#=Y;
MQ]9?_[H91J)P?V)$3Z)H]N[MV_O[^^.0V\>W_MW;D\">@,D0ON6C6Q:\';&(
MO;7Z5KO9[[T%9K"L0<MJ=IJM9KO7:77?CD3*.1Q*EG4\B6 ZG_Q@*FQ0X*M[
M-(7 Q$O,,#R-V"]K7+WMZ=8V86MW=&<[W79GT #;N=5H=7IO$:(J/N(_FM:_
M>V)G5]G>)E6JCF35[$E\&X=1SNQOFABQHL@DA<+.&%@\7WGHQX%-H9$_8R<D
M1SQUU]'@E';\=3R$?U^<FLKZ7/CY!8P*!G T1^"&[SPR3JBA)OUVB=DJW\2:
M9QG?'HFP&M5#VSR%B2CZ!\3D.:.N;,_[1_^09IRTV,KHHB6BN:,"(55=L]EM
M#@:=MR-0=,UN9X0B(56=$P 3GP OC4@LP$==7T8N[<A/8**LMA82)22EA-%2
MTMIM*6E9C7ZKVP:#H#?H=GL9*;G&/C"CIXK)R2QP7(G"DP20=E-(Z*Y@B9#
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M*Y\,]'N2!GO!HRB+IK3,]%1996:9. @8H5+4/87LN]74G%>?'P8LNJN984O
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M5DD4I-GN'QI[H^/ [2Q)\:_9T?G01=5)/'*6G582B 7O>Q'&%6^#YIP%H2$
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M$@>L W4Q"1X,*7,T;LGIK=Y<Q"OTE?2H;-(]4YZ)QJ(X@Q5GH@29*,]4E!3
MR]G_YY.!DN)"%B9242+*WRAVZHS%$HK&B^$R7JD7A*!B!"F#^#""0-V*N2#$
M!4#V'U(*\<MAI)PK**Z^2BJ;L*_=:9^_W"R55Q?'OJLHJ6Y7.ITN2_/**#H
M0$*A, _#Y9:R.4H369+!,J5DHF,5R#D<*9[PTJ$8$Z+(XOQ[S$,EF8J2DB;%
M%UQ5!?F\Y\N))6FB4(K/"^ $'L5))L'V(02<!\_C^[SE?HJ.8DPE%HL1(2^6
M+P6(40FFJLSNP&\Y+A9C0@R!5UY4AT)M101S<>JY&T0H7\ER B,#%2694A_N
MQY($4U(9 *$LR.L.5.6I@0A<"EFHTD6E5^6ZH)O^K]W',N!\_]7*O\L(*531
MP.\+!H!0-'!QU[-RY3J6>SZ,P:08@U=R02ZO%.27<D$K*"@'P7((Y(!P.0_L
M#ER2MR8.Y0OYLW\(Y;><-3 D-,ZF_A&,"W+6AD'15HHB*JOFD8H@D@F&SJ<6
M2RQ(\<..$.FCTHDN%T!5"]3 L@:340^)A8C$5;(L_R>&T0G<FHWA%25F/$$E
M:2]><HE =4GYT2M/AWQ,L)(+(X5Z79#T>T)!/!0(,I5\\#>AZJ3?DZJ>3FJC
M3/&;W"5S[%*Y4!0+X)6 , SP12*3)>)6FP,BL2@@$UE$8I5() 4$)E'"I@BF
M? IA#E,(TRJI+JD3B?BF"*$7<4!1X1*+V/SY2R;JU#$C>D1DR@NSETDD!CA\
MD30BCWBX:D*DL%8)^ &/2,7>#)AD8I%-)@[8Y.) 1"$VN=22=$ A#@2T4A&E
MD:0I30%0*A;II*)T_M<D%?&-,A%JD(IU5KG89)5ETAY%)N%59E#_^=^T3"E.
M>_52$>AB2W I@C:SW$P5[A4 +\I\E;\ RC;4%!!IV.:*TC)S59-%*K/(I#.S
M39.)L$+KE:)\ZTPRT6^722Y*JQ1LMR@EH@C;//9>0"6MF:^Z#T42MK5LOWA5
M$A.E96]+V *DHH!)PJ:Q/<("D3IVL'1FMO_E*K,J8[++%#*N+.1UR6RZF"(H
MSC@RII!17 "T,<J@+N,.H1)S-I"2$::<V1J):[(NGE&BMYG("&+(Z8,^FUMI
ME8))E4I-Z=228, =5+-=%[> =D9OUXCI+!\PR@J D,$*NIT..8$YH(S/20@=
M;FXPAD69A,<!IUP\,^0C?7S<&1/XE1#'SS/(@BY,&5)%-2%^5A^F.)((;+$3
M,=P5=1< XQY2S<5)6!..:1S1&!**Q>/)!(TA*<K,]B_;?)54;&+I8G+))"PA
M//D^"\JD8HG,HK/)Y#:S/J@*N#,!MRQ; *0\RK1<IS3S+7J)W*X.>5.RG%IJ
ME@:"F,66=81< JU$S#-:]+A:%LCX;)%TH-!D==@M5X1\$9_<QD/CAEPZ&X@5
M $&.,1=46R*,SFJ#C6;"YW+88QZG',*=D)EP1WT4YHC1'@64]'"OU/P"($=*
MJ!T. @ZYH[&DEW0C_DC<$(EA&!G71.-Q),O0<4X*P%BB2?.,D.4I)D5%0AL_
MGA$X_49'"-/"!*C-"GP%P)"=,:%IHX:(JB"I)A!T1AP1O<DDL9IL8D J=X9Y
ML "!:"<IM7MRV3#L)C1<@#" !)1S:AD)3PAXS 3?XY.D!*X"H$#*<0%IB35$
M<YU9)1SPY*2L6^1T\("4AY,+$J2(*R(T(DL 3WN5<ILP8^=JDOF7F!N.HEG,
M#&.@00"E['#*5 !,:-4&+PW&K;:@W6[FN:,JD3(<BJM!TB;PV'V:A-#*L-V)
M<0+AI,MHLU& Q"Y"4,+ URL05SR4L/M"=,+N@N X4 #4D5D];!<KDDC.PXVD
ME5J$S@HM?%7,B2F,A#J%LIEIS(_"4MPL$)C\(.WB<BAKSL(+@)P,R&H4!/)9
M(R(P:#,4 +,ZRAZPX XN9+8%Y';$(X-QO5*C5SALL@QCC<14M E4R\T"I?Q<
M8]D7#:!71K76E-9/( #$LSE4":$Q6 #$,)/6&H'TA!D#E6JNRN[W\N,)E,)=
M4CB$)C WG8+LM XC/#$O[3'PU!&'R>[D!\0.BB>.A>(>?EP@=[H*+U4SY?S;
M.*-+6+):A=-F,=KB056<->C2?+52I!+-",(Y 1P$C'H_J[.8B#:.H F'*Q%-
MJ47&N) VXIFLMP (1WTA&4Q%N&D>SRE0QT($$H-U@%9J!31D)&73J^S<E- *
M.31NH1N29QP6A"3,@0Q'DTJ'(R;*F#/ !HU,#J1%_ (@Z@3E/(Y-$< C::T#
MR:6M&HG$[M.&K"X0L=N"J8C7CH>KVQ4!HN%<$':CM$.40D4Y<5SG(+DQM5T1
M46L-Z0*@W)+P8D'2"PHTTA -0X!>BT)\?TX+Y<PI#4DH+0+:(=0P L*3!1B0
M]J1P#I%",()P93+Q($8G4S:A/FBW<")5)D +9>+V',7$]'%'E*:$2-:?\ND<
M=C44H"QRD\4<M'OX)D,@8XI*=?&XPQ70B&T1@4CDBJ,$"<!9!<BST5FK%5!5
M\9  ;"F]G1_4<&BI$I'')88@9@_D-$9?1*%)Z%$!%N/@7 9W^<0HS4M2#AZ1
M=>;D*J%>"[*1!#_ J((.!\XGE8%450W=:I&"8OLIAMM260N@366A-!D$,UK
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MK+>:U!FB&9X;1$1:Q,>H-:@[9+90 (\K\,83/(^73[G#,1X, @3D1QA:$2T
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M!:,)FG2X,V[$BCFK/%A"[:(E/$XN@>= 9PS20*R=%MHS%ZPO_/&7*IM2^UT
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ME/+AE1*=2U,M7'A_93$FWSM&LT$BLUBJ)9G+=%@-26\6(RO!,K!P58L6TOY
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M!.F4!NE04$#E;?#H\9SCN>]WW[WO_WGO\V'@BCGJ.^:8<\RU6(O/\GSR? &
MIRRO) ] 0$  Q,!_ .<[)-\TK!UACL[6CA!J/DYN@/!M)35D9 "<2)::+2!_
M-@&LY A& "0R!@5R1   _H\<40-P7<,,# :!H,X@>U<S!VH=:QM[,SLSZ*45
MPZ45WKEMRYCOJRRR;R;EVSD9#-<N9:*7LM4+.7Q#N&Q=@T!MP+ [+C"("PS>
M1+G@:3C#M,T='>TO-93 ,! ([.+PX_SB*&,/O6CC7MIJV[A?:-RV@5W8_.D3
M!%4W<P#IR!GH_ 3[;J !=72TU ;!7"!WS&TMX&PL@ 8 "G"$_U@"J ': !
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M8 G:O8866FH;H 2MOH :MQI$!F1MH^@)!6E[JNM8>-I9B !I;TEBBKN+NCM
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M''#9]Y49Z&@!=_]G6/R\9N9"/#R\'.;<0" '+P\_'X<(4!C$P<<-X@$)F_/
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M"2GHZAN ,M^.P%V2(5Q\O/!7R.\?.D1"@PMEX+$A("%=?$H0%>$''@ 9'X6
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M7(HN'UL%U@JM%P!2:@LFB;(4=:_@8N%[UD8E!@\%/O+8/KL#KCF,NS[,L>*
M ))VH;L-Q V:MK/6(>#6B4S&F)KHGEJ]/;6VO8ZN=W@\R%5M?HWNT]L3RH<C
MT7J*1A^C7YEL+%CW='1)*@]MT"4/CYV0ZMHJ]>=NP'+>^/06KG[U6AT\?J 7
MJ+9?$OQQ2BU,W]/9)ED!E**>T4<.GDG,PADS8T%.2;PEJVBP1[V:B6I\RX/7
MJ5CU2<7MI8=C42WQ=;:KI&N/NVSO3/&,B=['J XM8"SX;&EXFU&O?SCU/>J
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M]44<=H)^_ 0QQK/D+>X97=<Y(**M93W'BIAYU^FTW.W!+;R)+S/J1N@17I0
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M"FH^R4.7(A/>+^#X_L'LZ*4!4$0'0I XA]A,?>_!\/A\^BE?_]E02P,$%
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M*4F.VO>OWS<0*3$Q*1DI!1D9!0T9&1G-X8&,YIL(Y;^CX* %H"3 &)^+#>(
ML"A!V)2@@RF,HT0';2!EC)6XH*/V/8S8  @+!Q</GX"0B!CT5R8(P,+^P:0
M0#@@;"P<+%Q\/ )<;!)Q#),2&X>=2A17U1A"S>$:+(9'DYA7>9J3ZX1)*U1<
MPBWDI1K^R233C;E-F+LD;7Y5*+=ZLAE<XW$!6HJNW_P5XGUUV),!C_DM39Z4
MPJLUJ6V#"]NW:MN'7N]8V'J&7R^ZWS&\N"NM96GG%7'C=EWGR-(>)8"%A;$6
MY\@F?#Q<R2,3V$6I<# 6N')0XXH%)](<6M!J\G)#G LZYQ:2I&9Z N8NL7D2
M[]  ?&[)Q_T8(PKHX!KF4FC$JY\F_+,%/'^8<# .D& ?85("RL"V-,72P_KN
MZ<W2>#L9L@.@\2;#_ &@?0 LI.Z9&I_L@YTSY JJ+/[4^7(F,5$_AN9^-(,^
MREU5JFEQV*+G<MJ(=6#QKM]%P[RWOC$'0%C)^.B=_"1;98Y&+\CPQ/KT"T?W
MKMW ,/:)B.8]Z?WXO0.@GU]OY;S^7"^+6"M,PCTV8>JEV' SZD[O],S+R9W<
MZ;H=_WF6GL8;=<+]$K+E0@X[DY\JO13+)BSO.5N86Y96;]>.V>#F6#4RW:J/
MNRW4H9;9$9A'5O4PYN;Y.N<=V-<<3J^"YNU4WXOZ_/SW:)NLL\Y)?/HJTS01
MYE0C/OY&6>-==6#!N^D#X.6GYMG1PLE');OU,2 =O(H7G[T:R8O?-CM>O'
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M$7HN<;/K&PPG>:1#\AFY)=Q:9=2LH.X1:;?OUST>GL-@,&/@L7]]!S7P X0
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MOM7\J^G<&O'S\O>!A4S%F43AD],6@O>)UFZ.) A]]DQI:F[?:AB.!F&EG%J
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MT%2R?CE3TNK6439Y,T=3'EL,+P&0Z]0J,6@,%KNS>G:B[TQ0!(*+6JZY1)S
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MUN@QT:D],7#&0%3WA;-A1B0D).3IO<YHO%-&TH)<-  "9D$(AA^YEQ8&FGW
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ML#DV%J[Z<:O/>)% "K\*_@+*O"B]A1IAD1#V.*+(>SK8W(XF1'Z[G6F?9KW
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MAKN+_DN'0Y'\%U]B8@;NY\BAU9W*W 5ZW(Z<#U7";3.\Q&F9MJ!A$@-P:],
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M=[97)^X'^VZFQ^88_^CSZ$FTT+>T=5YY541^"M5<PDYM1U0(&4QQW^<T[6=
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MC%?QGOT\M9TO.K[8L*M8E\GY<)=IN3LU.3*DXZ*NE4%JG?-X0AFZU1AM/XC
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MHKUBHQ;1EQ1'SQ\FMG8?C1S?;/+_L'XW6^PI>"VC_"56_>M.)U#C&Z4WB_<
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M8X(M6CB0J6!LM)?*;QP:'ZT1#0XQ*2G=2F:#@3  PD)!,?@?;^RPM=\4[D4
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M!':=G(/SV#BT63&Z\OJ2\C%0Y9E3"7/R0=\A6,+?GXTXCS=?UHX$<"[>.P"
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MJ&UJNN3F\K@3?[E9BG9O5+ Q9 VAHV%^BJN 9"FCIY^RE;'D]BMI(Z3W\P
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MS30PN((OU+,-Z;AJ[?YG4TO%D[?;FE,9'HW_8J*+@ 7I-JF-^^R3$2^Z^BO
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MVRR].='>1IL.[4G@W)4R=]F^2YY7C<*J> M\>V?9K2TI%ZSTVJZ7^O!)NE8
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MEI-+6#-IR[!A$.H4PL7%Q6^?*9;HHU4/B:FWOMG.@(67&R,:!33(U)/2$@X
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M6NF%\!6RVXK;(UO,!'PKF1K6DCD-BZ4\&]FQ5+.]2G.;[TX]2\R.X9OD-ZN
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MMQNIU,OI;>6*9\RE;PC?)J_0+3>%+'P4LG8<?8Y?R^T$:IS6KT>VJB10-^7
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M#,68%(U?CMPKK").?KP?'R0CVA_&J?$:J2]&K<;@TYXUD#BMB3-B*BGXZGV
MF)=]E(&$E,KES?,P]Y&YV;+;,HWD!JAP"N^"BZEGR88VJXQRN5N):RD\WG*7
M$)6R3[Y-Y[O(#;>0,&"7C LW=0*4B/8TT(]BO\\,B0.J/?#79NJ!OJ0"T0@"
MSMA3U5XKQ8V8"K5P6-7<O)ACT ^#G75Q&9F3G@?/5]>W?AI<_5"?<I'V('VI
ME7>@9-"M &*3JCV^-KJJ=MF@M+"9NNU3M$7D@.JJ>O:Y,/<G;6CX1J8DI\+P
ME,-E[M$LJI)BEA ?O 3',UBK#J3N\08U['7D%M^:!!=FA.<M$N)?^PA%P6%T
M7SYEW\4CGF^4+__$&:"V.R$7MGP3M;Y#JV.9HE$QP1+<7,A605[$IHU/8L,!
M7'Y"PQMUE<91%4ODFO&TM<Z*0F8BS/AU[8%HWU9N^V8KZ^$<R2WXEBXM2#Z6
M/)XM3NBI9;QQZ50C26#I%X9KGJ:WW/1=WV_%.WV8I,/FO^502,4FMJRMK1,U
M,_C2^TRW!=>K'B?92RB)ONFQFPW9E @B17PI@.OMW:=!X"K[0AR3\E)%/Y3T
MW6SE#*LT(7-^/.$4I=8-^8;^T,K+_$X/C*#]']:UR\6DS6#KMPM$-();4A]9
MHTC\;M4* JYO#R4Q::\N FREWF7-T9@&Q.MDD.7'47%7*" M;VH^?C<WU<[>
MMX<>ZH18TV^^TYJ[[33_K&I/.*X#!;:$VVY:\E'9>%;"IP9\^8OZ*X2A"G=:
M2I0:TV!/[A.YD/?UW\/15GW(@SNNK01("\B,P>N^U$M OB.,14 %5NG1,[TP
M:SI[&\$'MVZ"CS6;V3B0^)7YSENT:G7P=*=<O*V;H7:G0[B6TIR?PF2<AL48
M.N'8C>)_(-(/$VHH)JM*2597SK$6Y<0)E8[2[RXU8)G4N%9T:?1QP0!7[_1
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M(M!6X(VNCVQ.^1;LN6>_M*-^]9#%+ML]PMB#V2(@GFW?\$&WXN;NZP^O_8X
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M? :0F7Q/2:XL'VH"9'X-#&#%>G(^(R]OK^$($$4Q&O_6\ :!F=_5L!L=SQ9
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M(A^Q>*.CW-D< BPNSO?$4^8L+A<LQI@#ML".X<!3YMT&K <M/'V1&;J]RAZ
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ME]T.S#P9!QP&"B.EI4NU(_GQF:RO8("H%6V=\NZQ6'0W&K!(OIQPQ^%,7]>
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MYY#J1Y?K7FO:$KYN5KH@[VBF(R@6A 1MR"EW;=CY69:Q^IVKS66>3L:H2&O
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M5V@VQ2;<BT=*,[C1[G2%M]%3S=]E_7"ZG;* '3=/O9S%2<JH9K2:[VS[O=@
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MD@L=%R#$A(X>UEIXWJNQ,:[T0QF:(<?B#6$%8 [1:848+]Z/C]F7H<^,,%M
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M1?RQ^_L6@P4>X]"S.^+.>415?1Y>/2Q/3%%# D EKUI=6>J9S.49VAB>ARV
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MF-M-F#,U'R<W0%A610,9&7!62.X^MZ3^JPI@I4 P!2"1,RA1( ( 9_\4B-H
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MX;K\U#HOE&RVD\R#78FBDZ\E6I9EG63(NOC1NN:(O)*\1MFXUZ/E:U=:W]^
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M$2OHC)V.3M)27.S"4ER(L-8\6UDQ@+7H[MS<>5@%0ZID=544\KP6&;,6>4?
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M9'.OKC;@+EW04P\0E6=\X^XDXDQ"WQQ3?-#/*K;.EMW#O0Z5E!B5>5K[3&N
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M5"ZJMC'4-MPO*H:_@99X1)H6>+4%@%"\D6"]3C/KPKFU#++9RC$LB,E')D5
MUNIG<H%3[?D<(ZG>&!B0FY$OQ%DJ!\;=&:X[J"K3@,P#QNLH6"3N,UDJ4SS/
MQ"Q2N7)$_#3]6>1L][H Z^];?Q+R,-68;"6ZAW*!6E2ALWV/IS\>KLKC]3 7
M"M-I*WE9V$%JQ[35K'<Z5>,"8^:"(*K2JAG:TL9&HZ9#!,.O3!N5J&\'=;*"
M!@#^O2L2S[J/4C\;W4XI:]Z:?S;XE&>=DS2QW28'6R%D?L, HX1VXJK0T!-.
M JV KIJ<;KL2QP@"L'RRMZV)1"=^EGDA-JHQC>[,/7_88U[S>W<:F4JW7GK?
MCSQ1<AIU41JM$!5U[FRE!\T.::X;Q)%5&$_Z(##4-8UZ"U5-JS(%8^?T3$ZF
M9"EN:-2/O^)\]3%"8VH*>[5N4GVI^4 N-L.B*RO>\B#&GKYR31!+:-4!5*<]
M@&G0HPC2K'PBEENE3&=X&[GBV><6[@71W10Q#Q3&4<W)B$IX$[BAO;4\?THX
M@VXP5(,?I'?<'669BIY?1 0 4%6=TI.#ZK\"U$CZ,RJOTW@4P!9U-VS$&!4_
MR(Q?Z?+8&9UPA;C7&*H8H._)ER5"G"7+'R<B$G";Q(IT?O!_K\8E.CXR63A@
MCXB0O@%M>XW/,"? ]F(;(6@[*C#U(!V85,JC\PJQ\<-5]W"'_$AI[C8@2W%Q
M6'YY$9-/#F>Y5$Y+1UUH1OQG$;N#KP#?0R;*,8WNK:'VQ7G2VE';7461=(["
M446]9,.<9&"=O'K(L!Z=10T0@\W*1/+C=MPXB[>#717 7\92@Y$BB5WE&A<!
MKZ(ET8L**R<SJ6:65P+8$^P$RBWV%+.1@"N,SVLLR>P(GQE<K7<UO.>'] 6S
MSD%\VR_!:ZUOJZ2'#5JTM('<@R="8>*\SIL>(9GLH%^T!5:S(LC/1Q&Q7G@H
MT$ZX,TR76*9+G'BO*8[:KD1A"5,Z8*[^QNQ70+!>4*U1#=Q:GZ>X]-W3X^'A
ML% 3>K)[1P%E=?+ LE&_0"Y[C_[NB=2,"1Q"CQ+^-%MPRCL1%81.;_/CE"]M
M#ESTT;6$P_.[V2YF-*_YN]E*Y-PSL@4GX"_I39JD)2V/Z6V,&MI?M72DVZ,P
M=)CL(I/C.2N+!LH$&DA..QZ\<Y)G,1AW")@WEA?9)<^R?"-BW&8[PD<:?<]E
MNL+<.=FVG%UQ+ )+W:PKE#3).#(I%5)-CPX<G6YX%CU>ZB7&V>=/CHFE3;FI
M$VM7G -F#[7O(@M^\LM3QK-3?18][W/"W$SAC\HJN@C4) !CYD.$CX=QN?Z9
M^G$B**Q M"'J>3:3PPAW7HSD6:=\9!J5"?$XVMSNJ@H0Y\#LU8=^> R00^Z3
MNJY$!C7<[7 [2=L1PV*7#UC/3"PX<)P<TX2+L^V?Q+6%T70"9X!\N8'@&]>N
M#@ 72"QW\]7576HM@Z.Y)P0+<*/H%3S:IPX^] LQ=[N22-2QOK91I.J9K)41
M\5-1T_ .#O>Q0>)FG6460J&PZ5#>2S'FU]'\!" SUCV+C.5.@XJGA)& OF6*
MI1S0PE=3PO91\;-5C5<Y_C/*G"C9)J5MB]?#*>U4"55413ZHZ'PX!6<2HKYD
MB\EL=7DYHA3GJ-$)H-I7H@=LL6?C)_CCQV1*I2*J'"?HO=+^M%4N+7&J^#!O
M/RNO5(R0-_I>KIJ=:N#@4##02Y>X.A.-^KZ[W*0V/8L41#I&!CE*!K&0+WT5
M,VB:Y3'Y\6!P0I>JMHPTV@<:%31*%MF.*YR"=[>2)F7]32FEU>X98\K&/2&D
M\TCC=FQ7TE:T?!HXLY0-(*VL?;;:VO,DGQ>5VII(;Z)MM]2E :/-31G/]+8!
M[Q0&EU+EO8K%";!K>/)^K_I=T;PG=8LC*<D<K9FM5CH:7NXZ%F)[^NW%0E%B
MK;CRX474]=@C@!@$:E,% U"L 1'40*,80'R[-!"-)BP04\S_HY#CR(?192F3
M^5%K1I[3MI96C\HU[\0PO RH*H7]8Z;<M,4C-Y>),"P)5J0RE$G0TJ*AJIK6
M<&,3CD#-S)Z!X-5 -8GW%81=GH *EY+D@-'1;2 C^3L! $*5L+,Z7^ ;[/)F
M&=)M\4QTJ9* 3SX?C<50GSN(INF&&\2APK*V^PUSI.E]$QT7!W.-YDEVY[GR
M]<DB2&/U$5744]Y.>0<#<HO$\UKIHW,3=L2B!>CNO\#;V*I(+>[VDJZS?3I2
M;4F.5V-B0Q-M/1HM<02Y$Z]O9#$VM>"1;.1VHZ+BWD01"\2CEA?O!FFBQ, ]
M@94(A+L%>SPQ8BARUP^]_-].?K;.874)&\FGE4;6,@[$FL 4C*BL&)7"W">.
M+5KCG@ *I+\-EBF+.R[M20DE)I=-L53=-51[\>@*BRY&'\7N2U1Q_AH1#^:5
M U]HC]_J+D?I*8G/<DC&W2M^Y.#(X(* M[1:MQCHHRF8Y4.&9L6W\(.C)U^)
M4R+%@TX>YK^=?O!: 14'@/:P=],L#=LB<"5E% ?+C9&UD9/4ORMK'3_GJO/"
M45P\+;F=?BV2IK$[.M[GMW5FNEI5.T@O P5$1?*M ,ZG#]ST'5'#Z>^4/R81
MV0XVT7MRG?PQ[O'0>Q32FSTFNB76Y>3Y:BZE)=:<''>%INZ++.28&[VM7:C6
M^2R$FTN5",S@KTI/D2:+7\]-M+_YLNASY+N/^M:+J#O]'N%;PT\D6%?&*8P)
M"7.+''NUQ4L!,ZHWM$P)14--]?$)40\GY-)3QY#V-@U7:GU3W48J)I8;G)E:
M[H?6+4B1"4Z"-B6(6G/T-%B6J>XO(1/2'.BQJ-EU*.F ']^-\7+>R<V@>%JW
M$S!UMB>G;AE]@5GS>7@Z\@7/8B)A5-#6+% >;< 9BZ:!> ?+OG"#M/29J"H-
MIUT8'EN,7]$^[^L=?#*D$')69AH&^05SG$6DE4>/1F<$/KWKLR#U6/.R?T^[
MBNO100KDR"G/8G2P4+U9\(:#?\%_+B;PHXJ+FI&RCJRLS.K 5T VV8?-!LT-
M(H(0LB+@OA@NU=:;D:I)L-_BF,:+L5+BZW-.-03&FJ#(22O8B&F_1F5D05I6
MPN"09ED:GI[1#? -0:*[=R50FMD+\X:4$DCQK=J]4TY.HC/W@YU6HVW(J95C
M^;S7S6*QU<QMDE[45@>73*UN/"&\/3N1!7=&S09X]$-RZU&\7@R&<@F9'B?0
MW2=(,_12C3OH@;T0S_1V29]NL52C9K&@455Q>A.#L!.9N"5K4/3:GV]VN:-B
MT6%(RF>KU=:SX3532+U7SYJ</'$:"X,*1W8PVSHS/!I]32QVXH#R"Y)VE0ZX
MYY2$,?Q##@?1]&G"I/DT=74OM_I+Z1?%'3OL,*IL*YE2M2>\9.3&;G=+-)$J
M"LI?K::AZ:5XYS\P &,CAP8F.78\]:, "JY%SKJY,+<6-Q;G!HRPHT2KQY?4
MU\:58EP#DD\*1H49CG?%O;5 I1&=-*U4>\W:?;,_+F6CPTZC-TI0O6"0-$RS
M#L1JZ30N@AV,S#N@39CD2;F[&?S)NI![F^.97:;M/4 @Q)_"WR34V@.3;VPM
MFC(Q::&GD^UJ<*R@';UR8TQ/"6:3'0DOT]/U]*[[5SKT@WD':39IG@<LUKTD
M*UU>;82CY/M;AROY [)\RMIE V."@=*ZNMDXA<B((LOSN_TF&F=WN1HYRN[M
M]U,,0EQX'B,$I)294J'OVPK]EDT2&?(MA1.+R3--P5UVU8#YJ$=%0SL^G13V
M([0SW#LX)4%9(BBOM6\-*[_.(IW%[;?M=7+U_J E^13HM;<<9>"D!QU<TH?K
MIM+V4[ZM]72KXRG%!O)_0:]UI35>6!=>'8HX67+4-YE/P*GUC^6EQ%8=K4MH
M*7$)PU_+;DL/'8_@202U%3U,MXT15Q%:L,YP7;):1QYN1+_'1=T#X8BQ,M^O
MLM@9$/U\GT%%19J5/F$_H6@XUX?FG;FJA=\"<N-NEUQY&92&E>SJW1?@@^ZA
MLZT7IYLD+%LHTPT^3*3W8P=M[FJE\ "HKN*2DD@,AO&Q\H<,K'ESJ%"9YT_9
M@91-&:KQA[)U_?)R!0>_6)$YL8QE5Y"I'4H-,H!,4(/&3JO<RFNK6!_CF(@_
M=7US"('F=_KUZ(H[!L&6>CA%FS(:&^YTV9=I*7.*L"KBN=;Q+#X_?FS<Z;^/
M7%1)WQ7+\.YPQ;[PYE3<U1NAH;FB$\WMR*D6G4U885"3:HN)EY &T^"!WQ_Q
M:QL]/,'9OYD=BFQ/JHTW0BQVJ-K$%*U%]Y;@_;58B89Y!>0-?R[L E@RU:)#
M7SO/:&56,F=2N?D[P_Y$FL]+$+5;;BTJMW7?7G?A8/(?E(&P,Z#)L2C+@42N
M%;>BUH?66VZFB0 M>1#LC:IFY_6%/N04D8\//>M$4<%%L*E:(A.^0[<MLQ@;
MK<MR\P:F<5DT,48"HK0[.]-K7165F;NE5*C:1D]=4E\;>^@IIY!8'C:DM32^
MUFJI5=4Z,K;D"VI0CQ4D0GQ'/LAIBK%)6EP6\E+=V%'>Z:YPO@XEE:G)JEYT
M(4UMMPJLK*VP,AH_)P> O#HTI(:IS-YCW>GA,>N@D)"1AABNG!]N%7?=:F&Y
MM-W^3=78:=W3],FRD6F0D4>77:*0@V?$P.AH%H.J'MW84LMM>SD'TZ%$X9V$
M0-DP<?I[/'HHSI8W^"PW-U/[- A/,_SI>;#DJ?*ZN)),WC<^L^JX3Y0_%MZ,
MGW)21\$ 4(S&C4D0'"!H-E-%19,U5=(U.R53UD(?&DZFV=]$^-3<%J1!YQ5D
M*4?RPL"_3H).P'PHL( PB^^).[,R?$\XM_!Q8/Y);D(PL_!K/W,23(K<^"$-
MPQNW3T<]R&A_?Q <V "(D::;>RPM2?\%*>OSGD*4IYCDX_%2<KH>IUMM/%J$
MWGBZTJY^3T-'@U6T\)B54A;2(D3P:'EC2+HSD;>BRWEGWKKPW,P6,JX>:YNN
M '64@F;>F1P_ZO$75QV^A42597"#\R.#Z8T^-U+-J24/-=.1Y1%=?&1[8>A.
M'.N*U=/&,7X&%BR9R"?WO55UFSY=)>QO]+R^3FP;MY >*BGB4M(A0"!TE"9F
MNIV[<'WU5&56GFI2536Q8R?I;@)]IH0R:J#6F.1.@\1^?3$@2#24_FC7?(SE
M^VC5G,F39MXK9+_KL_=H2N?X)2#QEA>J06D-_0[E DZQX)[Z!_=(OL+:ZC@6
M(3D\5I';X[3J^]S-5&8BAA0?HYKBK7;,E&CEN]PY)!U\8@JBJGT*,$-'KW*L
M@M>&YK15:C2XJ /?T MP4RB??5-C_60FD_-0+<3*>D*LAS0)JX-)R.QQN+5V
M9;?IK:1\*QO]*8-7-8_=T=$P(R!X#]8X6EEH['0@!^$$PT,)];ISJO'#CR4L
M&,.C&&=JGYN';^AZ%J%:P+)LI:ZXEBE0NW0PJ"@OOW7'%3DUW^WH,-!M;!@T
MBR =!3Y;>-*GXR$?7#W(\3#;\&.)[F<?[;M76%0IS1GH]TITN:9C1&[Z?6!-
M/"FH/'KS?,]T-WG9HV%*P)L<H*;G?&Q.QQ57UAL!T=YW9-FF[8P@9A PC2RJ
MPSGZX-SX.:?N>K=VC2_XHW(D9*':'JV_DJOGC3DQ,Q150Q.&:XG"B;5EM#'0
MP;$>,M'AH9K+DBY$!7PZ;V>G*\N:0_T<WS\DQER'U9U959G^;L  2B!#IJ4G
M>0!/DOSHU6&D.J:1)2;UIA&:21@.WR&.FX,0/E!]F*+8$;\#6!S>XZF:5I,(
M'4YP8+HN.ZXM#Q<T-8W)%4= J,F.5D[F0GKQ(;W8($"'/J0*\.I5M\KZB[!(
M"$'STGHYLNJQ%&X#_ $W^P<*];$C8EP+GW(DJ"\$N78Z?4?\P0"FH?IHDM\S
MC)OM^/)*Q,TY)@&[W?"Z$6,+\&.42HIX]1!Q\Z 4ZHK ]G[V\K6T%LJ[70VM
M:U*BB5$F-E)&',FC(;76.N8U%FM&!RY,AB_(7CZ+J;_GEI]7Q"&O5W%215%9
MPZ"'L%MEQT?/?^IJ($P?)X/0\XKX*<STD<BJA3%=,W1#,8*10?&SJ:ZO>T99
MV=VQ)(X<$=;FJ3?N&8^^="\LEQ@PFM*GA/LY)^2?/)E7 !(Q=X1**9Y>[U+L
MTV8H86C+7!J-V3H E9?8V=5.K3XL97F8:B')PXS5\H1ORD-UAW80HNQS(V&'
M5$?&#V2AP6)/PVJ:D L$6L%[%LRE@$@*Z98&L31!:NIN;_I+Q[@9I$(BIZEZ
M8*X^&1VJ-*/0=*PO$OH/C#3*#-;[IX;5.S(3)EJ[XHGAXS=UXZG<*D$=^HPC
MXTXLM?6*BEY T2\FA_J6AKMVR>D]>#THW2<&#1E>L(G)5V_*>8EWPJXJP.VV
MRXLR/&D[8501L4($8L7)WIK=G-JL4D]V?%X;SK3K$3D5UQ0J8H!=1QXT]9[P
M'I+5/,HNW6%T;W"[_<X;U.7HT;F>:5NG";F6Z-WZM*NIH6))CN]:55(A5VV7
ME2F=B)VD6ZF2"T>'-B2/(:^4Y9;[/A'O\]NOCV^M$:TT%_M[%MSG<U@D]2:9
MV=86K15BIV#>M0NDWW,V1*S#)%)M%$&=^D /1!4GZ/"3K9.DX)O?S$BZ5:1M
MCK;@[O(V=M-MN%,9N23.;S/K)26QCTG.Y N#P,/G\>0<@\M)HSN"Y<LH\1R-
MCMNCU3VO0C'6<=_YF<%03NM*V#^6SK^3EIW)TUX;.E%DD$W#H@$6*R4LBAXO
M5<PA[!K7+%139$3Y^W]N?K?=F!@&8.H(F<!%+1CV=?6ZYD*B($'M\@KY?JQD
M(]XU/C53L;%LPPQWJP@GQ.24_$S>&_OFC^"6N#C'MP1WZU%KI>JZ*;\"GI,"
M,+X"Y@!(JX"](:_C-9.B#VBH>87U^$,]U[NE,M"N'7LY+1])U'T%'(8J<(2=
MF#85[>G;3["Z)Q)]6AD/%7^36_KXVOCB?IY\7")2;&8NHFH@(1K&!D ;V9SO
M5HONWN?IN.&5[;HN,0.%56I@!!!!T-G<?TMYS[QH0E47[4;T>H.N?G9E,C,W
M":JNM+(.9A<./4 *7_0^ZV8A?4-6;QKC.A1_@:/8N<2NQ%<J*59T^8YZK%F:
M+KKR]F*=.-++KP WP75ZY,P))"]5R2VB/LHP:OMB;'=$)5501Y=6&M6A^#OA
M230*C^W9NG2_]P?3>,>*L@@GTH"3D/ [WA?!:+VYBW/Z5'#W)'/\*^"X)4>0
M:=M^HZ!?XZB_Y"M@O /Z8FFR3NLKX.Y8G!2B"M7=##6<=JF8S\7/F;9OV7T9
M3JX=1VGEL.?<4:S*W; X,)_OS*COSRS7")2J:$69!5>NC%D)D NXR)I&$".:
MNJM*#EJN#;O.Y=[$/EJDMN:R$6UJ8ML(=169F PNRW1JLS9.,D$A#F$KAXBY
MA WI\AJEF?3<6_^X2^K;J>\@VOCY4]&M(PPGFV8ZM)M[B<_%^W@4T>(7>5JJ
MFL*KA@! LR<NW7(K0#!#'-UK]?I>*=+AQM=AJF]79463$H&Z^G$)>X%HU'NY
MVQVKP7&!:D^/11&6',MZ!MGNA\PU2!I9+BO<YE)Q\!6QKI6J*&&;>*)WDYXJ
MI[K:5)EJ)R$[=B+*&,T522O!3%=II6+NG0%Y*S% HFU>6\Y:9@F-346P/=_=
M@])$<&]_P83G08KU#C%^\AN99&6/46472Z; UVKJ@D$6V*T@67;K*@J4#M92
M=24Z[XE8>Y47@,V^7E?I7 *=O,AXQH6X0WPOD]4KE9U(L8?7DA^O;G[\O!\9
MKQ]WI%H28X5VF#6,$3^0AWB?AB)F/LRK\?9M<*>EDB/2-G;0YQK*AC&GV"HW
M'++$M-S17BGV)JGK&^I*?H^,,5, VA8K;J,M#[/$%>%5K^*HX0_,0TY+QO31
M**F,7D9G:%EN+Y:XG#S4/,"\%?0YR&-:Q]?%(]Q,6Y:279STSK&*F36)R.:U
MSIA$M/EQJ9CK,LLOE)&BR"/<9CT$)=;M] Y, R1<%<K4PNK!&1&!?"&I,+["
M,A8G3N%WMOAC]=+'7>+;'?-;1P=#J+ZNHEO#QP1KB<OWD%'MY:QWMA_PO$J8
M8']8ITK!4=3<D9+RYLF[5%PY&G1O55>C&F[DO:N+%(]BLOH/>$<KD+HG-]]S
ME+#+:S-$O;1:H_"GJ*9:64H-CG++%!;_;-_<6%1A,R/YT(9_ $IY5.J=H@J[
MVBFX[(K'T(Y"DF(P,LW.8J'K\G04([LB<DN;NB4D[::W;/\ (B-XZYXNDHQH
MKZ(D,S5&CT(1G3 0>Z&IYQ4;AS!<ST" S!K/,5-@#J6<PCQQ!<^EC5XX&!@T
MWB^>]>+M]N>PXT_O9-PI)S!WJL8^IL3A'+P1WJ<$[.8\MM@D>[)CGLJ6_VV+
MR,P<DXBWBJ]\(MU/HN;M0A8=-[!QJQ8D4U2>82OJZ*^&1_,R?*&!]P8ZY74U
MK.KY<OCQ)+H1Y:<AG*(M!L.Z27:3]!?46FDFW@$1GWHF'#-?!;=T"U9Z7+&[
M'=XEEJ$XYVA7<:W8Q8[X 07Z_DZ9 ]5MZV-/AT>S<P[[@U!J'E^!U<+2ETX=
M'*1/(U9@XTG)YHW;!^'VA.'O]:W*QE2P-JXPSKX$Q)>$T!B"J7C<CB-+B#K6
M.6L'XI:NX+M*##0[6MQ&D0L#EX%XH6MK!95K!4G[$V8M!H1@ [1T*_T^\R9,
M>DTUHL>9:PBVS[TC3U*L]2ENN<I,Q<R@Y(IA+E!,:$PF.S7XEF5LX 2N0=<6
M\;@GIR?75 2OFJ^)MJT^LDCYHFF\Y+[U\5G1.\JX7?6A*L,]!T&_#%<FP60D
M!SU[]6JTX?%1&^?9T-SAJ$CN8MH74P+R^D/$O-*6,S%D\]R[CASWO#+ZAAOC
MW=8"QPZ($%<.,!W8*FYE^NZG)$U.+Q.:E'MZID&1O>X=A&RN/_F4$J2AK^DS
MS+Y@-%S?#!D:9W1\1AF5]Z! ;+G\.J#TJO&X"9>%972VTYB07-7P<!S8?\/(
M8#K<Z7!B/:%OG2>2[RIZ\I/ZWM<.P9ZQ<MT..Y,SP4UPXR4!T^+5!^IB"</=
MH36&? 9DYHH?--8'%B6;K7CGZ3JE[]%BUO3NABY?<4HM*0$64._;5ZOD/7C$
M>PC%9EUM/3& TIL6DS5&ZE)T1\(<*LI:.W>PDKI[^>:L/ P?1(FOVL4M2N_:
M0FVN$6#$/?T*H%!*9=O%#*?PX+]O6Z'^::8O22/&XXW["](9E\&HZG"4JX\+
MD:!/GF WR]T0MGI=V^W)!V?TLGOOK7N(@Q?6)#()Y4DV:W_ :8.IDJX0IOS&
MY,%,/VR^I38V=+*WZ-90<X6YUX9B)9H'JXD+,OUM'1$"+\2,98JVTE&LH4CS
M6Z**ZX[VJ%X!TBAQ%(.T^5+LK^A;1=_UR+66KS@IM$W-:';LG-RGZ'+QP@UA
M2[\QSN3,EF\YS@5Z9L1B]6+U0T(<A_7">)!1D+(-G[.951U9EN4CCKVR>*3X
MELFR3;G4^]5.")DY,LBF =28N)03'Z@]'268(J+F7I=/=SC?NH/46<"79.,U
MKW>MNI/M(Y-\FT=2A%"\SU!M1==KJ[S2@=-(6M[3)+7=Z>CC*,$"W&Q&7H0J
M3M_J:DVPD&K%03Z]D8RE6?$U8]QU2Z@RR/O]?>RFO@R8 L9.3P1Y0,3 >S[S
M?0KD40'!SV+EY?W$[M[(AF1FSJ7%!F2$=FOB(,F)1>,.'K,#W((>-(84(,,2
M"N2E>$9#<)IM1WOKT2K6;4/"SLB7X/8)?C/Y4 I6+:88+=0G7RA6HRFK;-<L
MKN@5?7\&H-#Z_ D.QHS+03WJ_>$3?FV+B!L,ZG/=8Z;$WJHQU:4'6F@L-/*X
M8K@BXB=2Q2&/GH\ A:?3MQJ?\;O+,.S-6:0<B6TO%YK-\Y@H+JTG33/8F[-R
ME7J*T47/R,XWAB>244@4C+,P>XZM4=1DCA&CV2O(X3"PN+ 8KSE>Y8]QT>"T
M VEH6B9[>? 0!U8+-KZBQ*OQS!6_QSDG)R_NP=D7=UW\<+X0Z"7NSDSP4C*=
MRD=YPU\_ 9XG3_4>J\&"$M F@O4&M!\FB)F2)XXOVT%]W.N?QY2UN%=X-^'1
M^N,L>09YS_FSB'"%$VWS'P@B[>G(00MS"_%& J?K\T(BNJZH8!,IZ<J5\Q-N
MR=W/HZ>^&^BE4KZ-J^7/@<,NIV[C]L!6+5C"I-O!R;1M0N/(95[WTS&S6T%V
MY=W"VXFNWDB% 2_1M2149YQQ"97R\SH;>O#AN7&\!$Z<H22H<J<F37+BN%?>
M^!3ATA.QL#HMLHK)/S4!V4?F/62P%MQ)_&Q$B*_W=IH^_J46O?/TP^<.HY-'
MM[+)#UV:\EYQ#W[Y8"G0#44R,]1+D,PCRE,5OPM( DG15.[$F!M#12GPDRGS
M$3_GNL.%N 7/M@^Y9,/WKM#K^KR<*JD*\V=Y@ 4(HK3LKID'I6K.(%:V4E4K
MT_,\123-(:?-4[N;F"=Q2ZA#-QU=[6Z<+TL,X@.DV)<WZ#^[K:@&*@/-8V.P
M,ST%E]/L(H"-Q>QJAS?A%(0^P^-3=($XT*FL4(J@%9DU)>I =+(&0(C@8<X;
M3-7T(@D6LV=IL@EULA)OS*CSICIG\,U8YV.\Q)E]7U(JZ,@@E/98\PARQ0II
ML^3JL]+*^&8>3VL0285$H,.+)C1*XXZ+/6&517RL@9W. E'+@(6WY" '#!=G
MAXV%A40\W +BE%A6DS"*&M*D%"5,:',V= [#>-A5Q<MY2SFFATQNZ2K\P%RU
M5PDKLXPOR?))5>OKW?G*0Y+88F07EBW*#)X49Q.CT@><3"%ID6:RW3(W,%PZ
M&F/&$)-R\#/<DG8JS#H>5X;5"(Z"X^Q3B^-M%ZV&B746]$:58O3O5;H2I03J
MQX4T1FC/O[;'##=27Z*O5K/.#GTQQ':@8*!=XD'@0FK#.X=Q: K*"UB#U/"L
MM;%O93>3F<;X9[DG9.H,#@C'+.RN>72+L!N$V^'.';AQ"OAIK51[&+0+!:K%
M1^A_:F^O(#,=+I>X+15#A_KL@78+E!D-(^FD\?!IRD<=IY"%^H9"='2_PW ?
M=W9V>R0)+W,@\,V,]1.JF"&%JR%!A;D&"!,\E,%]/G,G\T/NB5F4XQXYY=X8
M#U_JQW<'-JP8*FOC:",S,\6NH%%6V]\A"=!KJ+FSP_KN)%U*@=>3\2&#JE;T
M9".&$81MYPZL.T%X/I@@-DX7U3+."_U0&JDV2CF9R=]E:?[5H.?-:X+].A3.
MA=C==%6IV-W%JH&AT:=/%YP)>H&(NIE2*?&Q"8\65*7I/<2CQ^Z]/?RB:D;^
M:?F(>4_'<'&XB$7E?+]/OP-X^%)O.J9<15,9?0.U2(I+5C'VX295.#GYI_T[
M#%3WA#A+@:CWL9\JSP )Y/P+WL9O=7;<7HY?O2V^):P8^F)'[WAS/NL8#GF?
M)Q9O*(/4X3'%O)=P^/!EV >CQVYQ;I^HO*FR@XH 5^OP;ZP0.7PX!-OQ=\8&
MAVA9H\\G%"DN&-+#[U.*.:,^&]]Q@]5+2%]QE6(^#@104$W2%0S6%KAFM8N-
M=Y9J57\%['ST\\%BVM317!C)#13W<!I3IG#'H'R.,9^IS.9&:R)QO?B+[CT5
MIKL'@8",&2\E*GJOV[I GO"#U.)<8PIV45NC?/=-BS:"]YD?)D:L&E##N['?
ME1]\JKL68_S16(,]8K1ZD];)WN9U<57:S74X.<J\<0,^:J44K;IRF(=,.+U\
M(L[[TT!7V*VD-D3%?=GLYMFF&P;/\*2QZ**CXT1DG%B5623O!N-GYXAE:DE)
MGJP2OP283IN/--C6O'5ZJN"X@"D<J16$"O5\Q!:!869WF\V$P>*@5V=D\NK&
M%?ZU3T0F1#W",-'@E,[,U=$5=ZSZB<#71#<DZ#B6H*"^Q(U:2NUL0<"!\@P
M'S4A4Q@I8"5^9_YYM$:71/$\,(9>]\X8$4_P=17)5UB'$CT>*E+>#,]5COO\
M*%9]NXN:\WI#CV5#*XR^ ISEO@*(P2=3T>X2BZ(T+4=*Q1553YL(QI_>5M2*
MXUG0ETLFI@^E&6BZ^2D61"LNK)[/84X:AV$1RQ%S1VD)F*V%%/](;/GQ\J:D
MIH".=+>PC7!=,C?G>Z<^@F,.*M/L9]9JI74,77HH-*YLCUBO1+@;QE+%[JM
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M$GKGO#Q?>GI<%%W*A.&F&!3GJ;'PMK9'@&/Z!&="7MZZ\CWO C;E/4T8.7;
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MNXSV>U;CO6O\@?N+\U3(51>?&RK:#SWP+LM%VW;*#F#E:_U[%]?V5P (&GL
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MUG3G*+2,8K ARR( ::IF<>HH:@/[57\#DYS@4F 9_L*Z4,SJ_7L)]V"6IR>
MA=1 F>PJA=L;S?+KIZZ)1>+<IM:*VE<MG;69]1Z?LK4</_HZ>X<S2^EDU-\$
M.)NV2DH1!_RN5%5"87QS!4('&KE4TIUZ&G!>_F*4+W_P2 %SZ"Y([38Q>0/7
M<8)(X8S=F,.,M2WUVW;*,8P619SG, XT) >;"PK91^FL67N[<OO\5N%5].@/
MB'+)L>K[#6N607) >.GHL<>YHS4(22?%.)$5C6*KD\*^T']HJY(]O_B_GVHG
M4'W)=+UG*\BFLG<KK DY+C?KGYO+!A#,[3[S%%X3^#J#56G4%.&O"5L_6T/W
MIL99L8P2,^LZF*@JFIUYIW\D$;1%OY!9K^]SDH*H7CN;$FG)4HNTP/ 9@?0-
MG1'K0>3U:KMG&FA>NQ<'01\*I]1LV#$(/NR^")PX/"'5B:1LDB)[[!FK2]<Z
MAB.#)-TS:@N;+OS"^PT.>/9\_(O')=;!\Z$16XKG;9*6T(6U/IT<FZ[#MHH!
MZWKZ0O'**?WXKP*W>TK$G^TU1?KPBI)2#E!O!VA7*_VOX0TEQ\GM(PM)P1_R
M#]J=B4[V'$]C[E/OJ)DAXX;P%-#?OA/>S40836C9+GN&+% M ?"."?T)&AK9
M5 4K2\4U1$GLOBM'-A2_H#<.:TZK5<]X[?MF/ (82'A;$Y?(-GR3MGFW>;>L
M:Q!70(-1<Y:OBOQKR(FIOWBU3\U'"<S*FQML:GR\[DI@T#!G5Q)TX74]D2A:
M=OQEL7N6-^;'GW^ ;-(![.4A<ZSR#K>MJT!JA=&9'.%=R5.?&M$[Y;V@:[Z=
MXU;G_=UI42AY=V#U]E3^MO&>4%]H9!M%)0SG+YJXNI;HO>R>7PXXZ%?NX: X
M78Z8^H1"J]#KW?3VBIUVX"5]C \87F7VN8#2YX?3!Y/%%;BS%W-54J#;M*BH
MAGPR'=='FI$D;*\'@[XNG0"'HB^+4BDOOV[44!F Q:(3N-ZJQ4C\SI1^/3L4
M40(_YPM-9O_\/K[^3Z91%14#(1<4,6+8I"\91T9-TZ0>+-D-O[K)_FS[OAC=
MY2/*XV/1>8IHX^:UQH]U9[$(S+[2+2QL*FCPI U^U(@&\N98C9"]Y:3&M8!H
M<@]@<$]V -<)5=K7)"&U[]CMFH$+0J40BC(F9&%!Q;T,1F&P2F!:D.I([MC-
M\^O[%\JXLHO-5RW5D$Y.Z\Q(VQS<LM.-=3N2#0\GS^:W26FBS\X9Y0T;$XGT
M(QPH1(C;G"#).^KI$>8S"SG-Q,ITMPKJ5K)HUD*6U#$/SAZ7#S(UF)OKM"P/
MC(-Y71Z\(F 93\-M5&DE+'%$!GFA<&<?53(Y1F!IH\L8_F]8DAB"I/?3%>]/
M*ZM?AP>J#A5PD$*:@:ZYUCFT^?JLRSVM_ 6UG0D>7#X#@584/2O[;PR4.)%D
MJD("QVIZMX$X$9F>P:971U@Z^N<P8"H,D I.#5X!" *01[#Z905R;HM=?PHM
M2AC(RXFR8P_OB9))E&Z[+GDUIOJE_J<D18>E_AQW+A8VYG X?W9COB/H3K2*
M9T)KK2G4#EO.'P^VHD6*4SCPY<)WM=8#RAO=LZ60OLB;#<I]7%H&'P2!QH4+
MMEY(]\95*IL_9)85E0DL+*K158E37A.ES]UAM5/M_0/89HW ED23!O#B+5Q=
M$2T+YS:HH]@D<2V$B>P?6\X>#5$TLMSE#$@3J:)10,W)>7 KZ2/-.8&9H<VF
M_'88JML6?<-9+I'A2;;O,A=D%X/N( ^]_B:>E-72H.EZ!3&(!;6 93.*KR3+
M#P6,4E:&NCJU*HW\E7C93H(_W&BE^.@X*/\ SH@N$RS!BK8GJI2?YOA%N8;=
MUIL#VYO'I:W8P+D/Q\^_:W\^L=RK@D3/IF]F1;VOW.W</Q"I\@XL'1[.93?X
MN,L(1PV$]+'0UFO,I&G!Y(UBCH#-6(9304FDF?UGL@ >&-B[\=*JJX//X]!+
MSS;F-&IJN<5S[[4^'=*$8I87%A1V,Q-VS;]?*#PG[ MS6_&Q*S?/PEJ_8\J5
MMJ]"( I'@E^3,[%RFW895B7O>"47M#/9[GC>U'5-<=GSUTW748?4=E%>U9S\
M879\?%KI3C;3-&:4LOLY;$['\WR0IHJ:P)F.$2N@UOAALS74>596W#&_U!B3
M'\7SRH;6=9IFC2#<2RO23AQ+SI/_6$C_0CA6 (*S*^]0O#OG>RT+"!UV"K@9
M07ZP5VE3IIU]F'NZS,ZPU95'ZL$4NJVYGB''P.#6UN90%^F@&,#>+6CZ8[[X
M<2-_]*W;]"\QPPG3NS2_J.<Y1;_4_PXEI>E(<'HKGGT8@NF"KP\\=OS^ 3#Q
M/<M*1D,DVWU8*25PC+P/J"BG7*2_W?;#A8[@DNK^GB5K"/$914S49NJJEB\Y
M3HTB?Q?;_UD;[B2-.(=PR([T5$G-AQ_=(209Z/U4#-J"5=K ]1)F-6<9O<9^
M[VO);JQYM(+*[C8D$RN-?/L52E=2R9ZOUS0WD\7SLE$0(MG07GL!5[>D<S2"
M)'T&9E8>/;.=[(]P/U&%)OS]?75V5@GI;%?)^68@_E?N#RQ0?2%$C)*05WGM
MQYW8&G)!H+?HDCO:2-%,EP\86Z3C;CLWUU^N)!9?4YEV/\(OM=0*E@#O=35R
M^6OX'P";;I/"><=_+0QOCIFD\T<K*T?"X8)'RZ6ZHGZ2NI%D,M9<T=8G G8Z
MZ:2Q5>^,CU942]D2ZP8S&FJ^]#<%NG)E,;\YF0K*[(AC@A$]0KI$1, F2*XB
M<1>#Y3?3.XDN3$V+34ZK&6!'8#G4HC]]8Q2S0%(K^6C4U5HR45F?HU"[;=8I
M;?*NH)2E(34V&0LSR%0I<FXV92J3-^2Y"\D$HRS;,2Z.@*T-6T]997U]( (3
M<_#N0?#WTZNU<R"I87ZX0PY_L&6-VV>>)6.+%MX4\(2#3^9<C7C".YIK'GFM
MM=3PQNTF +%X.0D;89F=L&'+-'G$"IC1^C4QU,_H0FM6AHJV#E"23C*IV$!P
M<*[()?#$H%+) *P4<_:%(=&38Q?X@GT]2#W?'M10G=B/QN>(>QK>#B_'93O4
M_2D%$78-!+5;JU29J#>83%,MUK5#^HD(=C<[&H+&:/9KTX[%;9\6ULF73<\^
MMBUXNP/H83U&+[UN?K=91)$&BQ<_-.ZOX/1=Y'"EI<2HTC]37UOW>O?2>72E
M!!+='DCVFO9=1S;.R6.V#1!P3AYDJ;)[.W1SG#@PD0_".HGZ"@<QE2#X<P(@
MI"9(^ 2 ]$!Y;T[)U[5!V=":*U3G=SJ>IO62\9$8HA#3%>8K&;M#Q&!%U@"Y
M2>9W&:5";EK_B/W#96])IRY()'K<OG5OIL"#.[8[RY A9F[#V!P:>H;O>F,W
MI][1&/VS,;[[?'1L!"-UOCHW<7!I^KC62PH;C^%LR!^*OR37$42)RL%J_9)P
M#<T/_F3*Z@RJ")%&U;%DW]V&7?>@JG1@=[B7;= ,R8<1HAK;J^K$UY:C,[;B
MOL<I]A4'\S@\[+JPEII/UV3T6,ZHY\@(RU*"'T:^!RNYE+]!RI.\.%:4X@MY
M;2/$_+%"5ITLZ=UF8"T""EK1E7(.H=/.L-37<'BLZ$>RY*S\PB+RZLNG%!:>
M3;;\N_X/1F0=90-EM=GAX.9?6Q:CR5%K4BXUQ82IBU#&!]N$=T]X<B>-S!\U
M>[A/"F,2<H+1-D*92Q=N?1NU>PY\\'$*-<XGO_#4]?LKOG]2H?DDK22/[%'$
M+!XP6(5V/7L?Y27Q#_##C__JS]*A66-59,3J=PF*:89#=BUR*8.-^B(>>;UE
MBCS%.@>*1%)ZEI4S!0%W$<['>9.2>Z-7]K\T$>+5A MPM<6H90"4TZAK?N:;
MNEQ%K"\=T%P[/V/3M!S")QF[%%R6+@G8^)I#SO?T]-]\6S[KULA9#(?PZ3IR
M4>\!U6SW@\(R4QCLI)+;D/$#3L,?COCS;2YF,"B '9M]]T7$S>P,XOXNZ,7A
MR'@L75.=081;H!C5T$VN9).E6#$:2]5(4%C3M("_M'J)0K,0_'5^.JW=I:$J
M@EP$W^PPKWT#!_6;=<=T48W7_(WHYSZZR/?Q ">.=:&R-'2/N(UY[6[\C(1E
M0X.^*@@U0Q(N^%RKJQDWO)0!B%>2(/X)H,PZ9+GRN+FWP=KP>%%0F8O\F1CL
MZ?R;&V<'<_9.5"N=*.'P%M+]E].MNRAMH(MD-_ ;US&/:K\$8;15RM@XL+^@
M:71)*W6EF16A;M_?EI,>U((7#8;2E80SH"-BZK52LB,PRIO]RD :/>PC\R;N
M L7>D-HYEPYL]#$+#*!0&R7+ SO@1JM4%[I#<Q&V*-Y)3-U;9&9V&V\.(RQ(
MWJ?<Y"&IEE!Z6UJM=B9>O.:9\7%A)7'+(FK</'AY.?686+%V#A:/(W+W#VO5
MFM=_(A$ \[$R^#0$$32??2IOM.#%:<E&S9!%2.I*DM-Z#.GU$.F1$F#A"".Z
M"M%D8J],";)Y0G:QM7.ZSXF"Y#>,@: J\=^(B2K>0@& '.33?6G%--Y%Y<-?
M+2=D;V1X.)@+.5/30O?8N67="<4^E:H^58>@@J64TX(F<-&X*1;$&46XES0A
MS_MX 5[T9H&(U>MYB[D"4#3[PN)X(]RH\21H7VDZQ]*28871LBI#9%I0S4DK
M+P_*>)!S%'O(;T?>+RI355V+YK]WN?KIX+ ",=N;$6<^P/EBT;.Z>5ES0;D8
MK/?9='N"A68^I/=-MF6VF1<U.)DATLP20R%+.TU3>"XZ_:\ZDGR\NS9W#6Y7
M@Y*52L.NG.T1J;6D&.@ [H1=F7N., B!>X+_)_<EU>XRJ:96*S"-MC_6*;K=
M^W==$C (VUD>.7?QYN'Y]'!0*\E \29DZX^6)(X86Y5B2O PJ<>+G=+V_*@T
MI89Q^LV=&HK</8),X$(B**6P,LNKM@-U6IH<>22@M\1LN..U9+O<!.YW-G;2
MGTQ>D;O3O 6E3SLX0"PO\JXVB 9<BY$*#%2,AZVJ@%=5=5P,^S1*@<-W\&?C
MIJ0D"97\4*--#)8$-'B]T]/U=SM9\6#=)&>%'CGQ[$W:8*Z?'N!VLU$V?Y-V
MO;A/*"PF'=H1IJ%N2JT=,6\\FJL=42FQAT_SY0"NQ V&M5 _0D'6/; D;M_.
MJIN/@1[K_@GK)22&S>E%V @3[E\6XVD=,H10"3X=%+J>5VSO8)76.P %:4V0
MB\O$]"1T&E..FN(,:CE0/8LDI0 #^EERGN9G]>$1]!_S)F[\KKB*H38:. WW
M+%3R%RL)LM]5ET20%^SAQ]K&Z3_")-W#V<-!%GE UQRTSKD]'P7M8Q 0NB&.
MG6_$4%AH2O;1ODHUX<#7.VY59T^%URQ8:MA-WQ-_J9YN]4 M%_)!J81E23F-
M5N)@ %<K[PQWX>Z\X9C>! !(V]V_FIK-898UW?A.O?,7.FN<I<[T%XWGT1[8
M%%GC9WO@71'6EG1HJ<U0V'S4D%"[W4HEEO-K]*$%ENSIC').H6C,^D-/VO^3
MEF0$#0]8Z/+B%^F04,6-<'@K$N\R"D0\1CG%GB 45)/R\?<R+;AW[$V>?!C5
M:2*< '?-?Y73ZLL\1MV,B[V$%I[=9 !+A1VY\*;:Q;/GETQQCQ!$\48ZT5_A
M6LO1?[IKBS?0C1S/2"&$'W@Z<EP+9+S37?-*TXQL6QZY]*.-[PNA!)+*BAHD
M2'5W)>C(XEE"BO%<4VR\1Z./[XS-F9%XD;RFM-.J?@17.DN?]Y$=.!GUEIYT
M; =!PFA]KK\=85+)Y@=VS8;FFC,3R#^=9+ONI.D3+%TAGFHB=:@9PG^+TV)*
MUFM0_&<(<0-L#N"*E'I,#<7JC)FZ?;W3]"9+J]HMSN@Y*AW((K2JN?$?$M.G
MY,%A"2UAS*X6_U4JFA)K#9ERVHS=+R!^4%G0&DDJ?HY0= L#CA3@/:62Z=ZZ
M'.78V5ONHMB.+CU9/>'*X](F>\;O$LHC+H'=A/_6\Z4F+RD$3Z&%$DLKW1KK
MJ>;UP'U4?-U96G"]"M7L#A=TOD&XW;I,(D+C<>'ZU4KG;MTE*WW!E=@U8C9<
M)F"R[;@\UYVM";S!N]X<5/*(1,M\P#1A)MFF85;^;1^RDC*&<J/!LX$#]^5K
M[O'.URA$!$@P-,+.R@NV^ICC\:6C>C77=I2EDUS;,4R> T,65'?<Q'X&MS+F
M=OI2S4X&D+-%<:^">6I"*P^6/ ,+_-NM.6>X[/K3ZGFM#9 V9Y[#U_P2J6)C
MM:QN?K;_Y&][3DY=_\U)*W1Q2A(WEB.AL9=:87#!@ #Y(7O<39EAQI4\\FT_
MY2G<CB>;6<.V(*<&V^[\7"F(51:3ZZMJC$1:$Q.K01(!XCNQK%3$3!>$MR4]
M*\XW'(3NP+>L+QELJXY00H_+K9V^<D".T%T'1Z$?7NL^HD#%,3_=%73:J@&Y
M:A%(E5479CC(P<G!25YED+LH7#)@V3P@:+K4K@S@Z&Z73=Y6>&V+4<%L)_1Q
M+&R),.5*VC9R5-X4M@ 3!$U(354/N"+/M:I@BVA]F^#,/[HG(JW^V:Z\PW$#
MB2B;Y-X"720Q?U 9++Q=M*9MQD8Q=*PXXFMEDL!378;\' .CWJ?*#N]X+3Y]
M>S>FTO6SMN'CO=3\Z\P>^'P8]P\P[1[X6*D6="2;.,,4YP. &Y"^/U>=^H#]
M#T!:F_MR6?UW\1>F;&*!?T&\;.!!31O/63\UJ]4!7#:+YR>GC1&8BB]+TEO$
MYLELQ39X_?L6WX3'P50D@5*Z^KH=8GC-2@!7E)Q*$#G9_L"G'1VN1X-H;B>P
M8LJ2)VB<M%CFH&W8P[Y/\A)T;,NSZE0(&5:,N*EJ&'+A(-&2*C\SS?_(W!-.
MUM*9;O>%;S;3$8-]W99C][U_456VGK24%7FK;-6Z2F\E,5(.ROU848[!PZUS
M;J([YLOHJIA<N2^I[,LU ]P4"+DUIV+!:6!HO#GB"Q=0F!S\4N-3S(_:*1:D
MA_Z!G5-?SPD+)PF7B]04,0CP^MI>@Q D.'8\?UQT01$[X,-P\N'72R#P?<?T
M'^!FG.@?(.?T'^#"X!?V@) _?M>LS*_NV_\W5$UK1KH'@JWM&?A,E:KY25MT
M&I.PP+EEY9_PK<IR'T%81&!]M_HN72I&5=*4%47C&<1H4B6,%BRKJSBMAT_)
MHGE89EN4UY\="U1757=$R[4-M=:<#M_^YUN&'GH CPG%U@;6/&%.\=[4!^ K
M4U3XMUQ5=T..3V<59ET0T!)L$+J=N?::B&(X4<(0S4GL@?(!;?@K(-:6(%#%
MAX5FG6R^K7*4;/7K(:;Z92&3:J.BL!G'Z1-/&?):.PPKC"H+DJ],K2)2&#EG
MA"7-B;:BV/:P"Z<9J_RB9_.KU2VU4N"ZEW5VX/$IB.HN.J2)_C5GPU,X:B>Q
M)3%RMQ(IS\D;@HGW/^Z?,4[!PTRZXA+XQW3-T'XQMPM.(&XJ#Q\R!!=7,$?0
M QKPZ-<YHHOABJ,7'>0D3]<NSZ3-J00]&W#2J4Q<0T>6H2)ZW+D<.M*MM&8V
M&$)YW! )F90<JVD&Y\_3'M$IJH$5R$X9+SIE"(&X7*Q&EA>GU%>#3@[W&+II
MI/R+HX-*.RBL!O,G37 A%NV>T;.[7HL_%-8,&!<DHR9D^AE.F>3UGU19&:R$
MG1CL-+)UT=2!KCQB0?_U<</VGX2Q(<-!;/;7&9?,=>2Q_]?&M&NL&^&/ ?5=
M[ G"JS"/YW#5FF#L<1*2DX7,0&C(L;.L<HXHR])2WD3$6*SFZ<(_@,2A=.KX
M[]]HFG!8J27&4&;T;F=**[\6CXDJV<$N"IG5"'%$;5/+YHG+C5Z/Q8+/X:*2
M@<&8^]>&^^/^);P1D$>J?4/S<',B<V)OKTM9<0NO*Z/3++H%"\ZFS*CU>>I"
MN4>U^J6DL,=&84UJ@8W"(N7(1)^[;JQG#]KAALQX2DTY;F3*_T7;6P=5$FQK
MOAMKK'%W:'2CC;L[-+IQ=W>7QMT=&F_<H;&-T[B[N[N[0T^?<^;./3/S(MZ;
M]]ZM?S*B*B(KHVK5M[X5F96_KJ_"WFR_+?5B["?CY':OT9H?B0G:(>O&ZA6X
M77@S=X /6DDQ1C.21P=S!OL/%*)M0_@P"Y_S5Z\-AX&N4HH2Y5+(TY^?<Z@#
M/"SI*4PW*RRY:B2()(2AHS?&1"4/S: /-Q'^ "1BEVWN2MRA^%3&I]?7$N:6
M3)X?+%YJG.@L%8",LM'[(8&;7I^I%N<P]+4,N^&(X..F+T[(HC;)BM:$2)W.
M'&F;]9'9C4 QX;(@5?8 :'X*].=?[GBIW$R*="<55CNUGSHQ+1+([\!C9EHR
MFK;P .@B0LRK'(#4Y>S5KDK:UH: VYEN7NL4'Z_X<\]9($!92$;$*^DBV!_6
M<=*."RK7_X,GQ5116YA,ESRA&QJ9:^N&G^OI*-((XAYP%(D@HSJH"!LTM.=%
M<O_^FPA-I@$2_G)(>C<$E1=2TD#HO96\X9@V*8^6"!%>&<4..[F9B\]Y4EV]
M9C!7EX+5>KU?];B<M)V5,P@)N]Z^*7@\?3/+:"&,N]?2K-9@+GA8=/Z<'^U1
MQ];R6XKXHZ88^*4U/:='.VND2QL=7P-AKJ.2I2GBM]?"X+($.]84N5=&\(EP
MP^EHP^I@>O('G6^4K,M$#]$PYV4/*TOJ?N>:EHS7+<OJR6#N[<'25EI=7\2L
M==X@8^OZY_1$N*,;7%F?YNP=4LV@B#3DRX2LSJCHK]</7T0[B>.-.5AFR*(D
MK(W>7.VHX'?ICNJO8=)LB@HTS]6$F]30RRNVQ%G.EUL"7YUUBNO+I5C2P6$,
MA0W6"R.ZM@LS^9A! Y52%M9#I(*XDY,QJU3K?P![WSFMBR,VEZ^!>1=(*NV)
M=O"U#)R($RCY!$<"(8$U^-? G8T8#&=77/<? DO?M"/-\:1N<H.<D\%IBJ::
M+4-.[*#^OFX9T&'1]RO2+H?M,7BG3T5;'K>M>V\86^8H[CB$?)%-GW$,A!E4
M8$<.0^+F@]UP31I"TT4-.Y,+"AUGD@M)R03'A624(2'@ &Y2>R?!B3II42P/
MR<HT2'(Q;_R09PUJ_]R>%S76VR(R0YF OK4$%@BWKSO)#\\O&9< 0(=[#+A(
MA(,65[4+4AQ1P1?7!1D)\9^.$]VNGN4:.5NN/H-5Z8:8=5(<C"XZ,2!DD>7"
M9["-31L2)M/GW96G/T;LOHJ<&^8YKHM% ".+7_61!W$+%:VL_.FE0KWR\J\6
M2,5D3W:V+@(E%,WE']K$N^<#1I[4'*/L&/GU4PT7IB]H*L/H!1:!GF&)@G5?
M--D4=!"E)B!7Y^T*QFW)9%UMR\CJ%P@F^@.0=SP HFN\80'QGT[3M!'"TWG$
M<\RPMLL4__NF>317J"E <>EM(&$*<MZ0(,7UI/+OQ!S5JSGTKFPT8]NQ=7I9
MR^M#)YO6<0:P+OW\G+"ILJT3 :"PF)V17RVQC /,H@^RI:$N2LZS<C1ER)-4
M80+-0,?/)@VQHXYW :09\>:;A U,,#9F- @>?GG0%5Y--SQ+Z*=5]"'?"'VC
MSQDH&EE#A-?>7O+VBQIR==+PSX%$$SA0,<5:U:C$T4/'00NTFIZGCFLRSB#.
MD#550A<X;<!S6 1;NYOV%NUIB)_U1]<RX)DC3KD1'#DXKR7F2U.*8;D"]:XI
MKJ3_EE#P"H24I$ZY7D[O@"%6]C2QKY\%91_;9:KG\G<\@=I6"%**A#1._)@H
MIE GF"@.>=VPS:1'D9.C7VCE@0FU>$75L@VIT9*BTJ>N=AT(HC2REGNN7-N*
MPOQSG3X7-:)?/EZQ^20MV@BK[,[9-#(M;L\8WCOZ=OF3%0=T38E,=8.!J0D%
M4D&&VDBE+(;#<0P+Q-$O%%^OM;!#@@;A21TKX-!N>0DD?>HP?M W'K,)ZMP+
MC;41!IB1"_1@T:_A],HER<;Q<,#0LJ:B5_&GC(7D86%00U(SA&]JA5__R)PK
M8"1 :D2622[BZYF39C>2%\LA?5>YL#$9*E$_A7>?,Q]@T4EYT@]]R1@=\6HP
M5&U,9S ZOC3L&1$SJZS(TDH%4WCS]^#,Y3=2#-G*#=_$)1UZ"I$KBXM<?=9Q
M9!6P<G<30L0W8<ZHLBFG;CNJFAR'#9[[BLO.A9.,EX0;8G+)TX3[HWB1,BVU
MK9^;K&ENU,J1J:PK/SB1'9J8:.L9BR"3[//<+V.JRI_2W,[7ZL2L84]V?3:;
M38.?T/1-J?B>JJ7?\K[E?%D>9CD<,&U9J-.,(_X6@J/6Y[9BG8.>3 F$1RUQ
M-D'6BF7YYN2ZO)>\BI*JK@Y:E^[>7UC0X#1&1E1WG<:UTY9%SC,MO<6WW M;
MM;P9/7)-:9VU!ED!\5/Y> >G7@/R$=Q \Y"I?P .L[V_DU-BIQMR2(CK=!O!
M:O/9W2TXUR4?#B8@7DVS/CC7!%,J!J1Q&_BX>H3/4D=>$_0]#9+O3%K9KO)B
M$7<Q)/+NG@CN'"#';\PD;"NZ%U_,?WAF"$P\63D.SS*=';-8TTDG48WF.F=<
M768R\*-\PBUK#("D)19).2CF,QL=H1SDR:)5DIZ1WN+G:Z'A\J9QFMN3]LH5
MLGMO'>^Y/.%8[86A/->3U29!C'&79HA":(-*D_$92C+V\<)-3"W4:^^-!;-8
M7V#>RCO9Z-'NY>72:C9<PIXH?@;HPR$=I&X\>QMFIZ"$GQ5@=ZQD?C8F::MH
M:Q]F^4R<GY^3/T#_B@B[,@:L7.AEJ#L=$=$*T6>1C6,0T"(P%9:!D9ZYKB&[
M3&Q*1O'*H6ZH*@Z8^]*0@ND4' R(W28C!22]W_A@W?+?<0I*:Y8V"1IWIU .
M"(K'B^L0G'BMEC)6(7,C+&!Z7JTYYB/:,=(7KQO:<<Y 8A>/)')+D5$$P5D4
MIK$%5M:,@2>_N]7813PEA>P&)]U2+*)+/R5*4[=,2TI*;B/HCQ5/D+QCGD\^
M8\7Z%30R>KBCB.N%P;UW[Y[DILME?42Z';Y%#@I.K_P3J?>SYPUJ<%[TEK+>
M;UIBS2]!X_"%$]2AU@DU+;E\Y1>F$%?N:P*V?Z%9C;NA(_SK*$[*'KZ3;,_N
MGI2\C=I<_0%,JZW] 21H;+YPBOO&QO5@W#+4;_[G.;&CHS<RV>?DY<FC$CN_
MH4KG=Z*R?Y#M:.^X]/T]7DH.0.:"^=DM?P!?:B?OW&+_#E7LZ.MOP/6]>I4>
MKZ@T4OF)E=?*C\^0>$':2.',^(>+HS%X2"Q!F[4R$"20;,[5G9P^WJJA1) P
MY$R(OA7-  #@#@!Q?29PNZE8#27T#_RWCJ5I WIA(472\%;.GL_:]6N#>+7W
MX_;@I\UR2J&VT"^ZBZUC&=\#X9TH.VR:WW[<&"X-.*9'2QG<8Y/8[C5/*[\U
M4E<F04.5V/\JM2A<$^2^U8*G([M&VI[0.N$4Q,]L7_7#XU>Z/3,L;$R?JW\+
M\/X6.HM^'P\@_@Z%/Q?G?=*?-#S%)>>E3?<\F;&K*BZ4H,@)_0.IHM?$.:BO
M;H1+,GP]90TKU**^W -\>G; [/4\6"?!]2J^$M77[<L%VP32FU,87?3O]6O+
MG #;C?4'Q@QB&QVPLD)]Y9UDJ1>UD_0D<]P?3)U\5#'?%>B^NX!VUU,'W+[Q
MLT/ZV\#\IM^:C'0Q5TN'UGK;.WIVUD$OZ0KN<M.-AHM!%JS;'PD.19FL*R+3
M[?2[=Y]U+'%M"5SO? ,5D'-N:6;X?5Z2"G7U=_H#P-*FCI315>%+YP9+Q0YB
M=6FXTPRA%AP1!B$):.N^8C!^LP/<G4EDXT)S,=S5]_G6,&+;103]PIN(&V!)
MQPNQ4MW^(/NNR-7L[IKX(&NN=HU>KI&J/U:W4KM>7,6@"??MD^J1(:A<MC>'
M,!XT-%_6FPD@=D)UV1Z^^R'C8%76]9DT47] YP20M5QS;+9@2XS5X%')IXY:
M&J6O#\<CDT"$5"V22ZF,O0V54G4?6Z*6KW+2K#P2YV./(%1WHA0F@6L%Q(R!
M>L49-F4"UL]>Q+F?/?+_]BW2&3_,JOX?= MA?5/]@(\J--=R61^^FD)*"#&@
MCD.\)'2B0@EQ>^YO94;\2\)Y1SCC#J9*R!6PL(?PSJI?$^P XXWV$]55D<6]
M&[-,@[I'S,:*:V@*2.>T*CW3,D+S:RX[1ST^(D?UH ]E,?8.:D-%HDF:K8:@
M ]ZUN_EB&CGNHAXEKH?)!7Y7)2O_I^+R^)L^=$+49R:E-Y8G]55]) +/.(,G
M]L\:MFJ]QA-9J1FR-V;$6+2@"U2ULV%&5^ SHG*N1VE*<Y4*.JOOT 73SPM=
M0OXD\QZFL! Y:D6KEY2&[>(9+C@ \A:R!TF87]S@8?X2R(6ZR5YTZ/X>GP8S
MP/"@8(;[,/;M]L3'1?E?3/< 0""*@S"TS^"B6&L\VXH"&2G)XILK19*G*N8,
MBY(RNJ<2T8O4O4#6]Y;=1RNLE,9$H[ME2OJ1*(O/LF$,)00@.ADOT$((=16\
M^M%4[9R4.N"1[Y%:F<+?]O2,'O<.%"&KPIE]F9/CN\0$X3YJQLET=+0NZX?Q
M00(T,UTE2IDP]27E$, P=75+B6E6-TTW:BB_W5E<7^BYS79L+C,_I4;K'7;/
M86>5;GX0Y+L<=CPMKD3(\DL^]$HDC;X@_&I $0:Y[VU8FSG<]/H,UD@]/8^9
MLPE"&3W%K:O(1+/4M*YTD0UBSL\_\T9X!NIHCO/W1H#$H*_8*G2B8U&H)UO2
MM$WZ>ZO#"KXN1U@Z. /0!!3K:7FK"-VV8GWYW@;7RZ,W7+; <(RXO4./_.E7
MJJW_P9E05!8)D DCC85[CDMX[?3C%P:$LB! SI2:J?>DXRW-%'R]1087I\Z.
MA^'3:-"0Y^D$C*@(D4)RGTE4B:L:QEM0)2(&PCLR'98'PJCG6$\0S5UEIV^E
M$[Z/7TWZ1ENM6$=F)QBDVK1_D"4V!UU^D;,VG:32'M9*G(^&KN=&?C:UX^ER
M3'._<CO/K]012,,N/X9NMO)#TE)FU+RI_0)E97SV)(K06OH388D966&,A2+&
M*8Q/C;/TVA4D3&&\^AB^;C,@,Y(X^Z"&Q&L?)+"E* S"@_&V"]_PW.(D'D:C
MR%LD$%G=2JINQ-TZ0$Y%GAQRI")>9K3;%[GL[YH-?EYYU&82SS;TU%$[W.7V
MY?31NT$O+E+54Q]%H"7T;QAT7=2@3AC1M:![YH.:J'=I8!XIL83^G!UAX&&Z
MU2W,E[Z^^9OY:W5B=6JWUFY\)U\CVTL6[.Y(*@$I@#=I=I#XI^7,% K=B_#O
M2#O5>._P[3'-CKW*L5PGA\^,O+,L:YLX@SL#DMH7$TV!@9.T2$T'K.>0RJTY
MVA;'=CPIE^X I\)QKF1LS@ATH@T)/9[1GL@RMBB3-Z<XNL^[H8U+3Z5U$Z;1
MWKTY$'[-"S-ZJ&CI*[TI<>=KTHA*Q#-]R^.UC,>IV@B.<NIDEM[!>78-P]JE
M_3%QH4"RKN&@2Y34>ZDY_T]:E4^8".$;A6B9#_7F24>NLQPV-<&9ZG6I[MI]
M,(^'L(Z)7J>[(]'DNTME-PO07OAL0(?\01L:\-H\#M404,JSGU(&8<_H?"E)
M'LLL?F 1):_3Z[2+L438?W)ZMB/!.6%FYHO3+/\?@%4GOJ[AWJ M8[_,BJV/
M0(0R#[S4*^G=33(-<B%'$3@P=4U+=;(T8],C(Q<TXIF*[#RN 9+Z!>%&1)[C
M<5GN#PUC2B1#!HA%<7 1[RO&UY+!C%6N41H)R]LC%H8F]KZ!FQ8&K&NX$<@V
MNLUD9UN"F[&B%Q=*2-)Y47^F  \QI4&Q0[X=]ER-Z#+)C2ET2<,\::1M(WD]
MO60Q@*#$O+=AF\4[I2:2/7G.CYBY2PRG]Z!I];,GP=Z2?Y@*\GK16<N'-;_W
MI)@_@ )7@L$PASN%^JT_ .1<$E62L=3Q/P!Q L</<>/<HW7Y=ZTG%+%7 92K
MX^M[A?_Y&N?)8M<_:;C_DQ^A)CA_C'ODK'V]8\=PWOHG';BWI 5YV&9Y+[MT
M-5"%2XE+GG.8Y(MOU5Y<\\/<7[O#??Q2\L]>G) 2EG]R$2B CTDHMG%7) =_
M0S8@>^?\ ?C&BF<VFR_EFG=_$/&/D)MR.%(G-/(ZH)3\ 1C5_KZS"\VW^YY2
MUMW[LX--&9$5K-=S;L71:UO[/+X\;?N!(VLRI&C64X)35)TQI4XDW*)$QO("
MV4P87 DI1#UEA?5H.>5.MPR>FD%?M803D80@WWZ9=/(U292^D.8A!0B!CHK^
MG;?T[PTFCR2T ^_+]6KN A?/EY])ZI^,:>,86=%Q]8GD^):TN FO1%2D9,*H
M0ZA#W._GOG)[;Y<8Y?W$^8Q[)> ]JL5)T'W1:V?)M*?!+EH?!H..AM?(MTR8
MJ'E"/7PA): @_'1[6IX!RV0^Y^Y63H@ /R;=E/P;L>V7UBOKT<SR(,DMG;US
MJXG[.R']((/_(G')G4/UDM ? +3/1BL"(#-'] 3!A>TT"0?P,'GLUGH8=&=]
M%JAWTI&>NL^0],!4EQ7YW)FS]Q%[L&+%[TWB/KN8+;$5@69Q."@55%WZ%5A+
M<8#\73_L8 QL#+@:KVLSF]'J<]#2NO&')+2C0PIV/-T')X=.<5]>4)"LN*SM
MV)9T<G _[OVUE:0/Z6GIC\FMD^%!$,6]<I*6Q8DYP> 560NARW5X22F1MEP?
M4J:6QT;>DFL/7_==7V";?.#X91Q!^48\U_GQ)'')XM_C_N1DA.=_,)$B5>/1
M\Q4 %(F^0E";8GIJ/I2^-#<=%;VUNJ'+TE9^?8+AEA-&N,9*VK+5NRKRI>+#
M]?#P- X2JC9 1%7OB9]@$^IX>/E"U$$08:AO5KW.>QOAME"0"H#J<A?'C:-9
MLZ!K,WA,LF=C6FE7L8"3D^Z7Y")WJ#0E@IOKA)S188.6QEC621JM3ID3=B-P
M,$M11'6_ 77I:*;+$;95U-<O<].D9^.GFK#;Q@[*>"X\GW?H?3 E*2"ABR_@
MM/LYUG/WW@K[)/-_"9Y_92<@::" P4L,)NK'X!R6M:E&OX"<N*FT/7SZ5(F8
M3YBQ0$X# R-;(>I/!>B[TCCO)C_YE[1?H_&3N36)W3$!\E18+O'2;&@;O+M
MZD8/\<;9,X$8)CR:%3K.K*AM]7X)82HWS!*5/(4FWA(&4R0U"3H8K%\L8M"M
MK\)SX@\%HS8_2X/,[:HE><V\-G16KIJ?H,]<+^:\@GO]<9>(B/Q],>@V:>R*
MKE9FJ@M+"XMT0B@-*.D0A15,R2S(A%X<-W?+486->'U>&-^Q9G61\?;,NYIC
MCXDJ&J=E_N.MA0L)%.0.BND@U\W$5Q?"!&R&..6=#M]3-ZT?E[+;0:GE:NR6
M!W(&657JU-@[C&V0QSMI(;Q*Z$@+ZZ2*Y,A@#8(LG7-^SO@?,Z!K;3T(\1%I
MQ12W:D8CPI$+:*6[JW!AYK;:[;#^8Q6)\+! ;!R*NO)ZIKHH.6;RR=QEPRY+
MT317&M:PUOR7G&]X,+(BR2'HA[2(RJHC,@%+);95H;>HXC_1]0Z((MI?:+/P
MG6*8H'B3+GLF!25RYG!XLL>:R(:.SS3>M@[)H#%Z?'H3GJT \3(JB7"P3=0*
M3:HW 3PM%LU07:1=A6+K8YR"/A<U9PI'+U>GT<-QM&JT$]+L*<\Q\ITBU53@
M7RF /([^859T[YQC'UJ^*VG"(%CK\I)"U+T!-V>W:U=8\\(8XOWJC>S+C#5"
MX\_]S%SG?8- NA,M$2@9M'RVWM@\&B"\8U_)F"/P'L)*D6AP5$/.5?5618'=
M,4R.PW&5V6RT6]<P-1%2V3\Y4$K&4T98<*,PX*5YZSM[N+(.NFZSPT&=PXNW
M7?]PUYF 7JZ[G6"%NCC1_RYD_P\:S [@LY]>>-Y4G%["Y*28T HZ%U3 4^[+
M1'B.%F"+ N"K$W<RG3N.R5?\SN/G^='I.2V;V>*C*S>3FW9_E"?WGWBSGPI&
MWE[.CWXO%MF=>E&%375&^74] R[)@R'ZGW2>;XFT%/LT$@J:7R>Y&E'C5QG(
MK)6H_2$$D:"XO/G>5:U+01*48N!S+%0/_V_N3,A\L$K#UV$[29[?O<R^5>O1
MX1](S)W1<UMJ[8KT7,,K+,AVA*\\V98XX8USDRW3$,G[!Z;<T4!1[5=9-/WF
MUI&+WK%-F=>;XA&B]1(7@<F 0H=.7PRJ<2,P+'1(G4(/&(0G]$='L8,5A,BC
M6'<'%BKBQ_<*E=\C@/Y5GN@^G7F_M7D=A?;7)!;>8J+F8\HDIM!@.< :KN:\
M>;W<=CU?_TS\5(''KMP7/\G7)CFOB8?L$VT$B3=\TRH#+9V S<9I1Y_7_3+<
M7X4F:LM.N;!0))7URCQ3+/*L-87.S8=G_ EJ>0AEQ-L3AL2BIYBVE/LDS)'Z
M*\1H S'M@9'6!HB1G:*#Z!X<?E&8)U?.#><@I4&4A2YTL^0#^],S@H+8Q6@R
M+?,CA[:G51:"RERITM3STG3MYJ<0=2WY_IKS'X!>GJ[3OY#&:S(\V"J\#M(7
MDO=H^0S(+T+MS.I/Z5>WZ4;2MO2F7\EJ2'NK5T2"6Z,CTVFSY5CHJC";1Z</
M&@)#./(F^>@9"$O41A@1#Q E LW,QEI6S6#8&T7BMQ08G[;[738EFL*'/[Y\
M9S-*Y3:*(B@"SQ[:FAVI-O.8#HS4PO@H[PTS$&,&V"*5+LA5YI'UG$9*'9_G
MQ1](&68>+NEG#K*GF96R8GQAO-! F3\[G3I7M?LW3E[ /_R3*S0D;A@LA?*S
MQ8?%O!>/()SR(6A#102='Y;0RMUR=ES$I>2WX>;B7Q>Q6'S.XY&K(A),@YD<
MB]+E]G1[M?5R! 0T$U.B4I+'PA)ZN0L.JHFC N[PO\2&9_PO4+[_UTTDPIW@
MWT(6$Q<V047<ZHAH$H8OX4J@E7;*R(EA&7&\IDC0C8%CL.?3EM# /B\)X[KD
MB5L0&A+W+-FH;4]JM*=]'QR1KXV'TQZ]U]U[-2Q4E,^BS6INYR&VSF3X;A:9
M'-53XVPH! <6-H]I5=;)J?%W2ILBM2Z;3TNV/M_<M.29(F:[?H"G")0/J@E8
MS+A^<B$S.*4>._:',,A2I#B7"@H3YGL<KC1QZ" XE *$H3KV@CB17;)U;6;4
MJH5@?Y/_ME<(GS/WG2Q?8=[>T53[5[BL?\P=.@E*=.[6$A]?H, VWQ/%;1=-
MK\@%IS58-=;W<=QM>XN"W3G3W79$5Y/<R;(XB8:RP_!7;&Q&R8VT<=\01B0)
MX< -*H5E2MM\Q2NI>^QL._&)C8A(QJ$F;"U0-$Q[C1R57L#\8MY\T>OU<GR%
M(%-'07YB:@<_#._9#F_5CE>R?8^V+J!;Q2U[<W/,[C7'QRG&>-9(%2OT/GKM
M8K8*3_H"U_X$*T3+]%S3JEW;>"183]B1^9;983](VS^&8> :<?@<]\?2CSDC
MPZ0(.79E.+3FI3 7NX2L;]S."733EXC>MYIAIMY^C9J;$6*Z>QHAJKYS9EP4
M?%[\J>3:;3*1.+S8O(DZ+/J_"M-HL8P==:SSABU$K5P\_:WZ..SPSZ30Z+6_
M= ]4)9Z<96K/T=2@#1D(H4A5,'<N(,,SFF0C>MVC6[.$:RLKWMI6,>0"+33H
M-(D G^8Z)6'/2TN:?'F)5$)GS*A9VNY4VU$@5TP8-H\_M]F*M/Y]]D U;I$P
MNZV7%PL#C'S&QCTR6Z[5 'X$6[E2^L1 3#@RT40XOH2;RY<[_+;V5?H?)&:N
MJM7QPM\#WGJN)0W).[:3CK]MV.88EV-#[12@Q;4MC;&7%OUX[J1:J;BAF1;>
M)F,25L^>R5';5J>E)2720!T,YU[K)CY/K>DO(-P^?_*@^%59CPJ%1^I6"S7O
M'9@O2?A=!?9D7MU1\O\TF?R?9Q^L([]_3"7O()44U$F2$G,_$;]YO?\!\&."
M#(<\F7!\XQ_FFWT9/N*RPZ5 C3-->INN-W#^*0WW;FBHWO ^.6_@\<@9\)PD
MA/EO<G!5RBL][/3M;M9F3-,,,_,5C$JD_T!QF><IX'&(EP"R(\,T&+SFUBH$
ME/3-64.&)9^=]>?WX?]4WO8-)HCVUPJL0T(^\.[OF*KI\A#U#6="Z)(FH0HQ
M-F,5B-JNX)_=I[$;[ 4C&0J7O%YOF]-%K"N/'/C2!'TCF,UY[0W%HQ?'P+]T
M'<WH:K%?\KI]F)=<']9=>T*[$-1)&;GP%BF_R81P>:00@,15B442Y5L<]#FT
M2Q=6GAY7K)Z7OF]O;WX9K>,2 '*L.JV/_?7_&L_$1,@]!D7CM8<F&OA-NE$^
MGLRT1>'-KFZ-B(P<W+:?QO;<TJC>EJ,D6L'60^>XC;OS;2%*O0X[)?12&P!4
M@/FG=&:\E&8!O*^"GYLGX(ZO17=8<=>)YNN&\TV3JK[FCHZ1$U=]W:%J+2?4
M2(D6\YHVC!=[I$<_4M<\0BJB.09 8U-G0A0>?!!2VMK\1L8R3(J6IW25-G*7
M5#%CU.D(QD;6O?-\#^UY@'7GO/6X1L&>TU0/T7!?-H^,SK0RWFV![ECT'23,
MR5HXB$Q\F,#T8)YU2C5>9+6AQ%-2QR;/0@\I J%9+!#JB#JVF4BS$E;5F XL
M,S==U987?%8YR-!05_V2+P=@-A):WZB?D48=G*V!W& ".V6WH(SW%YRGTC4_
M976LA23TCK$0[I36:Y4W:,RMEULOH-,>_NK?E6_$1S3"+QI@X. FHJH=8?*\
MX]@F5'?>UC;U\%>*4C5)DD)1NP^!^K:QLD^WO*9/6S5:5NZDX]6=J44W5+N_
M*&])A[8GX6J HRT3'S93!"DB.OX3DG^+BR?DB/_U2MWWK_*GF 33Q.FQD6UC
MX9P<YDCN3H2WF[Q(:KZM/F5?P?Z>'JS/(+J+:FKY?# I$LJ?T>6%L.2ZL?:K
M14 K.<1Y[A<[9Z<0!)Z'27.;+J9/"2*.^V/RCO*\;%1C >N&20OL<BBQ=IE,
M>X]WD0XJ;V&A0\'J+XK;IQ,K .YC[^E*:[,J?E#BE: >D_L(Y!FF%'!WQ_OC
M<K>\ MV]:[C#![9.9>4_:&+_?Z2X_ZLFL -ERZ]"3,?D:IIZ-FAR@YOOX_Q?
M7RL>)ZC\]3C^ZESO)'*I]SN7'4P!C;X+CDU5 :4I5.P(48MZ&=2B\@XWJF?:
MC:/KR H$KQX.0L"7YP;D3P8FI$SF+Y**ZL17A%"/)*%YKLDN_Q()+3Q?E/"#
M!LX&;GE^D*>FCZAMG-9@;>CHQZ*</<P3-ON%0"$>? PM15BZ*T-STE2CRY6+
M2E^);^3QFXJJPBVD0(4H'^T[[@?N]R_[S]B68*[SW52<:JU&2&(E']J/7*S*
M=B_R!56-HF\YI?-?*7\X9KC2"#O:@(L7ZL+T95.IT@VNQ)[CQDQ8M0@X>W]=
MQ=ZB6\8_8OM\^91WKWW[3!U) ;0<*$57':9]R6\OD]G=426)3X2%X;N^(KUQ
M1?>H]E__*8;HP1FOYF9;GVG9S&6F$&B*:PN3P_1C%_P$%E6S-JJ;C\':D\Q;
M7FS?10(?F:FXIZ[TJ/'2@3/'/RT8:01A\Z=J+37C>@N59Y06!B+=)G&T'S1"
M]:A/EVW7=\\OB#J"71876.L@&#%DQIGV]Z:/2DLFX@3$D6!<>O9H7_:EH_#T
M5V3WF5=MVK6EI=,*^;C)LAHD[>S/%PA1PJ:#-*KCNU"%O8D.#?,LSJ9JQ,A[
M(]# Z5%XX6._-I-[F5=$&=@V[1W!J_ B&*O30"A572S0WQ H=#ZCNYK&^N([
M]>XWYR*^NSC+"J-_;MWC1#6([LCPOOQJ<1%W'E/&G>*-7-:8-$1G.@^6/EQ7
M(D32?/G)869KSRTH3Y<"CFW$<WW^W/=JM]7A5!!/J;8@"[B7\A]6W]*P]:M/
MFMPM$E^-W^/V;MWH,I9B>+0D"GC'^5ZCXBMX'Z-J(LC/UZ'R\E\=Z!:1<2G$
M#3<^F( GYTG[TP^>H#2,.UHM6!;>=(_1Y@O\FF)M0Y-V!/SA=O8+3+AJ5"_L
M>Y\L\5**G'XQY^/;74V@[18!_;VY#D-^:^AR, 6D9J_N=F=39HV9;-365?7[
M$\7UD_.FOX"?6YGSW>+I3IL(K$:G3W;>VT>4FO,D]JIFD_9SHR_!#6^Z$B>&
M.UVU#7-H>V+K!RVD#C.5G!(2*R-(>'[05!91VS8-0"9TT@5KZ0<%N&H_P,>.
MY5@/"XN2@"\%J5&*)-!/:'!3@ ,OOMO&80BP_U) ;!&8-7K._F1LS^E5)QQF
M&*LH;":+.(QY@OJWM 0=(85$*,TE'6%T4]?RL&>AWJ)?&K"=,]:>^V'T+%D5
M9]GN6/$VA';(B_)&I>*,ZVS@?=<ZWXR4X0.O G!JS6P_M$V#S%1PI@A#S"63
MYN+34R9*2^L9^"GXUD*QP2]J\2A& (!FKL@SAC&A#\)PW?F3MRU5.[6565Y.
MI<G-S L0G-L_,7LI?W9I-F;PZ&1BEHEF#5)/KZ6,HTQYMT0[Q,U6G>_.!,C'
M,'8<T]\W'7:[P*"P$PE!<#]8,+JB6;2.<+3SE*]#<S5?H@QANUWJRLOMPJ)7
MKJ\5F'P]\Z99JWR$'L@SU=RW(\=FVS-R7:0?\LIG>R3VK.%9<<)C%"^WM8B_
MD0%=W#O]L+Z:$M \FD+9"[(J7* A,D9>YH:\3!J_4\,^\GA<]:E:>0]?K_@N
MZDAE3$S*0BB+VOLC3"9E5?T +Q'QQP%WDI"3MKSJLL)WJ<@C1VM1QH''C^$3
M#C&S*>=/8MX'/]H4).:5-53G(6J2S"L/#++5[,,Z>\QNZ$R1,=*9[28@4!QB
MU6D)U:X>Z$H4DM3HJ.5%/PSJK;ZIHYT=F<K2[0,=Z(+*+ &B\7VW]-+#E=K,
MY8U<#0E*Y5H94:BBJ!#-0P0.#)8:./ OPFZ##K9T:6&[GN<7.)8=@C]*G]=]
MOJF7:HPO)D@,I)M-\**K&VM_J] DEN6LP_TL P?4EY'B"81(9T4>T#^"V]DW
MZ%YUJ)5:,Z-VO8'FQ!D3W%.[VP.7#UZORA;34:[R:FIRC+//#\NF8JA_8DV<
M1D?'+LQS*@3^IN4A5%;4518))\R&N9UJ? KI4",W7-2@+,O/ES!WX84P\M"T
MM@]1P,;-C3HO-?;@N,G]4MAWH+TZ*^),%3TG/4ME#':BM<,B2LU1YOLQ^X5G
M)3(<D4S,[5#9<DP[FIAS5H"Q\<JME1E0"K"$B+63PF<;KV;JUFXFB2&4%;@F
M:=[ RS-\[C!S;;R+KZ.OLTWFP,N/4; >L=2+HA#XOK]26<0\]$JIPQ28#<.X
MU<Q71>@\O>1)JPK>CA860A;O:X.T)\LAT%AP3*&>80K;XY:X,;KW-F[#.+ 1
M &F&7[ 8@D0<YE?76-(=M(-73+W%\]61+/SR:3'K0B"Z>% )PG^'1Z3C$.=9
M;W^71.[(KV1MGYL#EIK 5[@$,(TP9=%-NO Y&/-:=SZIAZ7_$/!SSS%_.L\!
M17_)J .6UY47U+ST'%MGTHKP9SN0_P'8&@J5MF(FWWC@?T)I)^9_;59;]24+
M"XH*"A,NNZ8M3I RM\H>IJR44( 2.C7A\'9*:.-BEW FCGTEB+.Y#_)3-OGE
M$[OPY:=\@E9=0ZS(#S<Q2?W8+7Y&"=<2C!&5'(,;.P4^T9'-KM)%88K$;X$*
M$.IPY (;>M8^K,H]?%^-[BRTYEFI-WURRX-7O*OL"KX&4%H($0V#I"[X/0CC
M.@?W"R>,W@ZU][N;J\W6=MI)60<*)42K4N/_ /+O<XFL1THJ#6@*:R$1I)2V
M[N&.9"-V#SRV@@;7!_/*+&RA;L\>#UIQD9JY46HP#JK%O0JN_P JK;!%;V='
MYQ7R6_\K9?V?I:Z,,F;]("%%+N@&-AMUY=QW@FZ A)B)SI;/WH<D<ZGP6=7^
M4)-X4F],LG7.@[M=I44G;&.KD.P5DPQ.))S648CB$4J-2C@(\O-^7@Y_4TK7
M*O+!;#TVPXSB%[Q3I,.*J]EE/'OLBMPD?)[]YO!)KEF&,J#K(?I,<FA\D7>$
M=B0$/.VC,'E%$T]%0_7EI#04Y]6%0%27/:8O)I_TI:FV]JM"S,;<4T3/XTL<
M]VH6K6DV+7#7B.NV:JZ_1O55AK'/:)$X-, 2BQ2\5T)$JW",*==IS"B[-[8"
M.W$Z:>N'TE=CT3- .8[[Y&H7S^E.4ZDBVSB@F7JNB7.,='7=^4&]N)5S$V1-
M.:2W9&?KMF_7^(5% XUR0>S!P[&*IKP$7-R^JN+)*#!;E3K5? 2'(-)QKDTK
M^A768R@3%F9#C23V.RO!CCGT]HQ4[P#['(QV8<SN/'0@D"&K08QNM(=Q_"GK
M:K*ADQ([F@,LFJYGFK2G1_R05R$%8F)>8$RN,0E).4#Y->LV(Y;R;G#X8ZV$
M7 (QEJ)F6W.4O*OQ=LHQ*DV;!&[)T0TI%P,6[9@=(03S4N#B_DL\TC?.:-'.
M0NLP1P7X#3(W\@&!;H^053ZK/P".O%$.GX[.:SK(C878]*=HA5JCD5@3M1\F
MF6UC5O,8)IKC'F&%:JQGYS0,^^BP;@9=M=FNE]'-$SK\8>C1<B]ZXXK,[7]K
M&G\ATLS1);!AGQOO]W86CYEK8,>2V^K0!A'X6I($J=U#=0_U^(8/D;EOBUO]
M2_YPA<2:Z0GUDON8D8XX4$EU&(G^"M/-&P>)FY?(7&'<I'?IM "[4L;\^T1!
MY1EI&V !Q;&\@\_QR6M#]^GJL7YL>PZW0KNLONV\X?6A_0M?\=;N0]GJ*P$O
MXF<>L-/*$;;\PE+&@@T.7FFQ,X- 9VC+ML_"%\.&5#1N#DW9UN%& U5=4GBK
M &1M1;D<0>F07Z_:B$ZW2./#3=:,78>V+NX/,TF _ &[,P-=K<F<3.NWZHD-
MXW@9XYX0^&,DD=!!?N79'C7PI'S14"D!NJA&X"*Z*[8'JJ8)KNIBB%))N1=/
M$'$M] P<%;2]"1,I$]#M#Z K]5[Y,K7'KG-E:W&#\'9S0D\PTR._LG!"_&!P
M_ZF;U72?WAAWV8;U6=K;9=TZCB?U2W6=6!B)27MQP+S&D^ BF"5'-K?N3: =
MO[3L1WL]AQ !EQ-E,VQ@IW]=B3ESY&8Y(3P.2"LOPVA1U)&!UQ#8C(+98SG_
M&M/"O)6JW(B:G ;!'QK'U/^T6>=;T:3+%! A"BF/30HI<5T>".".(+OMV/:$
MO_,^_QVI_UF/P"W,T/[!4,X$[5&!W(][2'?HU%1I=FL9V5W@Q+;0+-Y_=^$@
MT4^RMA"Z7/0[T""A B'FJ]U[#_^'Z2"K\5+MUU\AR+<=2ITJS0D0?4GN_B-_
M ,O921NT)(7V?0<OF^=O&56_ULZ;NW]5:KVKU5(Q?EMCD2F6\OV&TDA4)BXK
M:I+B .F=PS4WJY**@W[0Q8I^9D>U.$F;'=OJ%O,0.7",4^L@)GMQU3)LY(<D
M@-0$0<S$IW0I<;33@DT@G&4OC]2F;<B"+44I61L3H<HLRE)"6AY;R%*HU=QC
M!@Y3/!25.28:Y FG'")EWKG0K3//=.!3BYV\6A-N6@S7RY"GEA8>?A&=_WK#
M8%;KJKZ+TBMQ=K$9&Q.R[D'@[A-_SKAF^["UX\F>PY\LD=_BM<A0J6)140(C
MUQFJ@; CC;C__7H2*H9PGE14%LW()*#,N"(D<T?[$W#EX9L$A9(>D9B0 9+X
MR\*MFUGK75-O4*9_57U56+-&0->!\H1O:!"Q:KT[JU;?<;YPU<],5Z,A^ 1'
M<V+>>JJ2PKO..I4BNJ3RS&?M\!'^U@N;OFB.!F8D"]AZD8ENS_&[S.&WCHU+
MB%?($=DXTQQ2P\,T9OS'N0WV(!'6K!^OHHG:8CM==/R!/0KK95^ R-\$J<E_
M\[VF,=E1[&Z%DW3PW1IIM(=C>_,Q&5?TB#*0Z3V*H";3OS>6%2=B[H2-2[90
M7VY9T6Z;X7'H3;@CE@7JN'%H>KQFY3:IEPN2O SDZ;S=W=R#CJK_BZL)V*D/
M6#$52JNM0&EH5,DRTMC= S\D3!5"DAG6*ST#'SIM2^=T#\7ANBS-P ?#ND>-
MCQNC=WCE0@)"A.',!C($!3I$$%HN-*F3TAS_A11GZ<H 3!"!9-A7+FP[M?E@
M6LPYT0Q:+$C1AG8B':A-O*K45134>^V [3#DS17<6R9K)K>+ @8G<+NW6!I)
M E)JB81Z:IJ.Y5"2[.F/%6W0.'AER+Z,GTH6W\#D<MMAALF>/2/:R!(+I&0
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MW@&DLSEP_P"?L_@>W6);=U,6DQ>GAU<1A,=@^1&99\T1TA#():2D$H2.E''
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M>5),/S062>0PP19AJ&.N;\,RW> 9I^.X(J'25#HYWMX@@N(O7D1XODLB;?\
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MUL&RK#EY^\+S$PY5!!\:^^V)6^;VESAECEN(8I5^*N=]4S*"Q9N\@R_:_?\
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M[L(;INKE%"4 $2%!,2K(U*^YQ_(F7P- R,4>GY N^'==1HEOLKS?+BWLV3\
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MY$7[2%Z4I^:N69$ :S\8CZ#W=[_T \ AD/<!F-G[\@'HW=]@8@W^_@%(E/X
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MYY%Z+\5_"J4]SM[S+%W&+JI!>+P0QF[E77+RJ$>TM"=";, '@#X&>E>O;^R
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M-J!;TK*J'@N()$+%-5MQJV(0+ZMLK0\WZI;"GUBF;N88D[]LPUDIZH*>RVM
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M+@I&5G:VL3+[39=_U_:X)Y]9\XM%]M:>  V-;I+)RT7X]"R"8_7&&/\#H"Z
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MG$L2&7;]U0 M84F,S8F3,$2%KT0G1#A32UC!)0B)<H&1!8DZ4%_V54$<VIO
M\'']R6GV#]^GBJW?.%QZ*9S=OVV&'D?B,.JC31=HP@2WOJ,I"1UO%X4^K[2
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M0Q)_$"U,5P*;:<P]V2]_[9H2;!XWN#(UZ+=Y<>SU;Z^IVO]@/9?2.73H:JF
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M&@)R+O?>'+HY%:9.4-^OILH-WECE.XZ;2F+M&$-)&G/5*9B^JE1B!Y=!&U)
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MXD(0VA+;:$MMH2$H0A(2A"0. E*4@!*0.P   'IHI  L .4+_]E02P,$%
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M:P 0P ^PP'R^Q^"?] OO1.?5?ZCPD_Z<0 !P)RCTNZL /$N$$QR,_-OX!:&
M/UP^3OI?$@[PM\P$R/^9P2=N:/],T._-04)M0!"D'E3]>(AA_07GS(D,<T&.
M^9P]*:@J_F+[K+4CPLG^+RP\A*.-M<W/V?.ZSK&2U@D/4R:R<$(AE"%PB*,%
M"@(^\=[-_L?D?_Y[Y6/.L4059LW\?Z'].$Z.T+\L(2?!_RM' VG]UV4&SP**
MTK6P_@N/& 3!Z$%<4:I(%5T-]1\3V;D?[+]4QK^+<'27@]I8_X@4R??&J_Q@
M'T<7#+&R<#J9R?"=(8ZHWU37^\'^:W4"2VL%!!3A^$MPR;XKR"O_%!R[H8F
M'W_CHQ#VF.4*"?DU<.>AF$#^@TMH>3(E_H-/X'@\\?V-?3*:+GW7PWRP99<!
M?_+)3BZQOL]0N!=.2L<=BGU2)CPQ>N6/@+W ?##76%\P:P#FFH $0 / .NH_
M6@ 0RH$1EA!S!0T ]M$B@/BD!  _.-8[0@.>  C/G3N'?XX0'Y^0C. \ 1DE
M"2$A"24-!04E!04-&>$)_?'U>\(B(B @(B8B)28FO4!,3'SA^$1\X;L*V7_%
MP%$5@.P<QOD7.%BL &PR+!PRK*-A3$//']5AR6*\/(-U0G^$$0> A8U[!N_L
M.?SS!%A_%V(!L'%^"$D!6+A8.-BXV&?.XIT[@T,HB!&2X>"RD //R-VRH&!U
M>"B =R'D98X\&SNE=K6EH)#CHPZ%LQRA.LMC*R"D,-6KW,><BF&ZX.LUKU$B
MU)VWQR&K>4]JNYPFUI2XPM]XYT?4=4^N)Q?4]WS=T+-R?AJ94MC0.[4IJJQO
M[>(3E5K4V#>]10; QL9XBWOBTUF\,\(G+K  R7$Q'CBP4IP1>!ARX=B#:NV.
M94%VRS''1Z$*.I0@I- *!]ZQ V<YA6LZ,4Z\I@9?ORV"@HS_=.'?/>#ZTX6C
M00 AS@DF&4 6<$JG=$JG=$JG=$JG=$JG]/\\'8U=<[^+0ME+\/'!D;P6QS<W
MO" $C,_5PIX/R,O/!Y"2=;6W -E!4,R6$,PMMC3K4MD'5F8;L#2KOK &OX:]
M N2NC8J[(T3'75,7Y&X'$@>SRLJ<EW*5<(79PR H"V97&!2.E'"59CTQ+H&Y
M/F;SL3*?5$'92;.>W%(Q&VC<9%9 .$*8Q7F!/"!^?B"SJ#BOA1A82%18\"JS
M +^ (!^_()^ ( ^_F(2PB(2@*/,?Q"IS'G.6<@1;26@K*OV!ARE)L_[1,!<7
M%UX705Z$HS4?4%Q<G(]?@$] @ =3@P?I!D=9N/+ D6S?C?RPHPA!@AQM3AZL
M,A^7+2P13BAI5M;SS+_0'PV#V?\$^FT$?Z=D_XMW?U'""#!*@K]5 H-^ZM@[
M.4)/V@,&\4&@$!@$CD)B]("_!_OQF/Y?('^(_]5;3!,U-/YS(V&PWVHB4=>=
M4?]9$WG\I(!/&X)$.#F"(->=,4UA^[TI;<B_!.WWIC#5?VL(96/U+W:.)?\:
M!(BKS;^H'4N^J\G\J2>%"9J$@B/$ @51Q'QDCO.7AU^41T! EU]4@E]80HC_
M"N8LR"_%][>:O[.!<-1%(* R&C8@1P02886JR6+61SB",:,"*/*+@3^J_<V"
M!@)L8^7V&R\$!3&CZ%<O?JGY=QN8(0NV0%G\EZS\6O<7.YC<EKCIB  [@2".
M_]:4O]3Y11<,D@!];Z',7_KF9+3J0!S^ROTA@-K(_/YG)BF^/\1_-<;W3VM2
M?+^%/G;("N$(LT#)V, LK"%\$'NDU4G=/[B_MOO' ),X>3*&"3)$1DB*[W?L
MOT9=0T-"%8Y$6<"/'XK*8!B\-C9@"5$P4! "$13D$101Q70#4 C"8RDH:L$C
M* X&"8%$Q$&BPN(G'?%7]7^85D2 G(XG#HSL^\P,1H PYO]T"R(N#!&'B(IA
M)ER( &9&%K+DL100%N2QQ$S*XF 1B*4P6.P'T"_&_@'T_=FL!?27.L=M 6/
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MN&GC"H$:*-I@0HD\]D.$7^0/I;]+?JMI^*<<*"+PJZ;A/S2_#Y5?'@U\?^[
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M:05'@%5"=&^QA%DJ;1@U=(P"D->;)+%EN-(@%_8"%MU@(1*LQ:DMWAS(;\G
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M<+!LOW]5V]I2>T W-GUQU+'3ZWG;H7#!FRV>XG$U+ZYWH,_3BT<E@@M&YIV
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MH6')WX;:LJLH>,PNFR<*H7X?F(AU?(&CBX\[\[%LA==EF)1X&FFXU$213%<
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M1V1L<JL4RUQ8K0,Y8_:ENF;K=JZ"L+W:SH'V+MPJ]J5^>$\XTJ>(:UA A&Z
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M+:0;(M=\YSIC2TX.(;$'!4[#)EU%&(MO5G1MH'C,<N1N@\<=%'G:?(J[NJ/
MN1PF6@\Z='8W2[%>NY5+$,5W85W8W*_O&H5Q;ZW*3F?T>9SZQ[A#)+7'IG$9
M.$,>Q];ZLA/<&CB)6<;IAY=$:9C?+8UJM'O_9QZ\$?/ASUI($V4+)/D4QDIO
M;#.DM,#*D[*8;_5K'V>--U/!^2T-PTB&#F.!4_X@[3G#P-^5F<+D6<D+QO>@
M]JS!SC-Y2SS1Y!=?^RM> J/WNO=]FBWLG'5197 ^ZB?L?351#SKO1TL08)%=
M@F(F2RY@_WVD=Q<6.*B^]75MCB;:1%FX83LPZ$N!95&L"MB=E63_AT-+1D9V
MY_\G\?LO+E>I&!X5=[(1+XH%P_P&85]$CR_VA?W0EG.RU-S;T_;8G@!D+99C
ML$D"#2O23!UR7S[%.UO%NZ^HL</"=D0+L5G3-?L],H('0Q5E1_7J_[1N_>5_
M$.#_>UJ_^[0X%U ">P)8[,^,=CYW3BYZG2AKS;?S1V8+ 5#EYVG =F0-_'-U
M.WULN[%V*UOVSS28U_K_XP#M+%C9+DRC0&-JM1Z;BU0G4EETX5O5FM]M=,,)
MT*'Z_9&-JX5)N$O;M==9G^/! 6Z"Q'1O-/'5><8F3W-N5Q'F-;=5'X5:KV?]
M3ZKW 1OX8!.4(A^!1J8+K=_KG)S2/=JOOI38@G>=0T);?B8H[OX*CC$+9"A[
MV938K4^&5.B:C5E?*=)R:58^^N/3A)F\' K8&KMW[X&3UCU4K=+XG[?SU\\<
MDA(,Q@VID3CWKP'#1O(.XX> ?DMKZ<T'Q2?O+(6XU&7#F!1DS:Q@4PR?@6XR
M.A:C\*.MSYLN5V<5YC[)OFQ_[,G!8]96O40'#71;;KW^%E%#AVTWJQ_A[HNO
MAE0DB9 4I(HN2.IQ"0>&C/(4T)8QAY.;/V[%4YW.IP=BULW."W=('<.PDA"!
M6EH>;4AB=N%ZT ,&?7.6RPB*Z'J U*#253ZV_0]M JV3 .^+BCJ)H.F!X8Z[
M?P2\GOV_J5MMB6:F 2N6D ZGQ@END>-)375?Q+0#:H%GRMTG\ONYM<IZ&0$_
M(>]=T^74=)O,11TH:IS%G"S*G03D65A4+4/Z0.YM1=<K.")>4Q>.#1POJ]\O
M9:)ZW)-P.(,\QE<] 6)^JGYB*E)HHTC>^W^=C?\5;-O8^(5 P!/@LXCYST)(
MCLEM0>?#6!&L^'G 7\\#5!K\OU:X_Y( :-=7 [SC0$>O7E,;AGY2LSB8H!1_
MTMH'0]I77&14S.KY\C&O!)<'U5&W=;A4E?$T1ZI?RY8@6?;FI8TY_>"W;,DR
M!QL$>-7,S00AN5-[%TZH2J>P9GEV@3I?"/+"*0B:' >:8&_%#[Z4>X OBR5^
MCF5DDQUEFQ_)0R\H5U?(R6?L2U?UU(H4TV63E)6#,ZQ$/ZFT'/2[C%3X2\(4
MW4L]F!3'>HP:M<RD!JG)7I Q<5G#']MK*=[5#?H$9W&E'9OKME5@J]6).F<1
M'SHU(9]K"(@_ 0Q?\BRX+D/_'$-<W<^F"X6\K!\VIF.WYXR!XUE/ )/N(O(?
MU%,ICT#,@>'7 [!?VDCA5^5"D!^^64Y([]QGU!'_VJ*K8%:6-1_FE'5'W[YD
MV,0)_QL588XP7<CV *'\/1.2RQ@L1)>\>">9\5O[?LR0$4]6FN<C)QSQ5<5T
MS-73Q+;1_0%80J&3@'_KF@IU2M"97F@-3[G_<6.'6171_%-OECJ54\ERB4_9
M.?:3;6[@3_%3@YN7!@MF*EQT(CAO$:JG%XE +31YV6V(%K4*2'^"SRSM;2]O
MFM,[.9]Q77Q".7 "JCH"Q1R0Z 4QYR[5M?H7Y(_*&TCX>J;3H>5T9:G$1"\Q
M[%</&$L %FR^O?E)%-8"I9.?M5]O"4"F'&8405N1KD[CNQZ_!371LR2NCQ!@
MMI+KN:/9EC%*A_)/>ES#=?]J!-1;>YQ1-@_V3J9*W0K6%G^Q1."D:Y((JLE-
M-V;VT&A1OG%%!OP=''H_HI1=W3 T7&:%.+LX=W,""<8&;VA*K+JG+8S9Y\1X
M<9XJ$KA@)T;-W,XRZ?_G$V\?TVN0-6.9*:ZT_%D2JPI-^_6]7^[V7@%RP.3A
MH#*G&'N/FQ<+B1V%+J<QOKP;Z&<5(L%N\EO'[DAI:U'CWQ7M/FE4D&A$6,F>
MG/Z]9/I+:9]4:<?P&36L@HZ8U[/6I&R/T#D RZZV6/VZVM7._HRH[D5)5*!!
MB_E&&K8SI_6>O(2Q6K&7C-EP2H;'VU+=DIHR<H;6!H7[[ ^&:7M:K>,^?[%*
MY>/(#:=T'&QP2'<E9/OLT.AD:@:[13T'9]T4^6>.0U+"U>?9+(8KK=3NZ_7#
MZ7]6,O<IYJIB,J#<J9=E##6>!L9L*/M2T]*"HIJ@XWBRBJ#6JXX:,1DJ**$Y
M+?,@^+75-'#Y76N][.*_[6/4@B>V^K!\[\G+"W)Q\;$KREHUT%^)1-D#?E7B
MF)%9$7!Q&*OHS  PHDTEEYT8V/4W=V7<G!'+[)N-LJ26IZ2FII0*MHTSVR8P
MDL:H0>[03R-B>ARMF8QEQ:*_>AR?G(6[SIZ>Q8#L]3-E0E:JL\%D@P[E]H:,
M.3>=!Y2U&O<BE X7I?Z@T,Y;=8WF^?_DTF=H,(@UP1QA(R%7V^KJZD1FZ4]!
MP!/@/CL?3XI[!:M79X[\R]H6I,:WI+V9FT<@@C-!=2N!QI#E?Y'VED%Q=MO6
M*"$)@6#!W=W=W:'QQET:=VG<$MP:MP::!&G<W1.L<4AP)WAP)Q D]SU[[U/U
MG>_>[]:MNO7\7O/'FF-:/7.-44D<]+E[RE1PT$ZOPFMQC,M[K55)$Z,NS29]
M,CGFYC.P2%SPEQ\2!>;2,)48.#/X_F'!O'^&5F2:C[T K_=6_-9X^7_=\]05
MB*U2W,7&R@O>L=34;E_#ON[-*&?K]Y+WYO"$)CO[K]C[=D-MW0)""!,;$G[Z
MH%$V33)9Y0:*P;Y1-K1#A_^<:<;\KC8;&^'\CE5*IW $,FL.;<1K01>[E0@Q
MDPQY-HY?U0O\I_K5,-XBN>!*^0GNU#V#6JN1S^Z5_B)9=TB48-$-6SB4FXCN
M&)#)K7GI196$,>X:&TJN&P1 #TB'=/\9H!!E#8XC3C\"!2A<SSY3'BJQS82:
M!K+9LG?#%1P%RF<[Z6Q(_(=K4>P8O?$PMG8HUF\8T5/BI,/-K>C5WL1S;U>4
MK#F"]-%T<1IZ:.4P<WAV6,IZ!:J. <8$1).-[_:9^78XR"!93PA.8C93U;-?
ME3#A2 FP^QS;##/@,UIC*J>MWS=)H"W_)Y:'@7*1!#@%Q:4=@H<%L];:IE8J
ME]./K#$#GO0B97D SLO"%W7)9B)>F>_B&U(L^D@B-N16U+Q:Y117"M1',U8&
MGV.X3H%!47^1@O6[Q$*K;&+!RYWS,LH"(YQ_<$K7YIU;_BMZK>O.3U)+JPY&
MT6$1?')F907FG9WF*/O'KQ9M6517K=I*-'8+/@8"5@'Z;^.\&<4FJPV\$IUI
M7-/XC,T>8.NWA6\)W9SL;$/06+38WO)O'+*6E5<XH>T#L/F?_R+UFCX?HK^Y
MI JU"/4BBQDO7JK[$M(9GWOWWS0Z;T.^.W?^17K+GD[0\(K32/3H772N3H?8
MX^GN/27]+1+:?AZ;5ZAZBYCD\G.ORX.Z_?F[@0][T]%R?KB@Y8HHRK8RMT4K
M5P>IU[+S+)H?Z;U=)()PZ@_;JMPMI(%(*]X3[7=5OH1#T5 ,S;SG8^.#"?_E
MS 9&^6&L9V/[5#1YHV_(@89?^5D*2A\A?S(CCI>HW(IAX(F0:P**G_>2O[%
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M[P.HW8](G,)CY/15$A.&=8P;Q<H;0C$?:]/2RU= //5PE+&8QH9)LG@<#66
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M+#-9X(C 0KK'5H3ICK7XSERY5.S!FTB.L6._0=M&3$T,#4]<[&@-6GC <F5
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M).,,RQIWYRB;YDI]R- 969>G32TM.)^VT'T4EAO0H:AD'OF\UU+!HY4SQL;
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M8ESC^_^4YBI9YQST2G()YH0HR2B_I+>OG;:9YYVW_8"S?8:V?9BTYO-]>HS
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MT[/*$\;_@0OH,$BV&W36+,\-7,XCDMQI\Z=;C<E@>BK*B2-K@)8QK*E0)-Y
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MI9\5=![_-*T MK?Y(Q'?'03HJRHHH@]8I^<0)B8(TM5*#CD)^%%4G1'_D"G
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M0IF_],WI;#6 .OU5^D,!A\G\_N<4*=X_U'\UQOM/:U*\OZ4^<<@:Z>P 0LG
M'$ V4%ZHHXOU:=L_I+_&_6."29R^ 4(G&2HC),7[._%?LZZM+:&.<$&!$"<O
M_V30 AX8#")A+<0/M;(2Y.<6@@B(<HNBJ]QB8F HMY"0H!4() [FMX8*G7;$
M7^'_,*V$!+N>+!QHW?>5&8($H\W_Z19(1$A(' 3BY[:&@ 6Y(2)"UMP@(6$A
M;K"8* 0L)(PF _TD^L78/XB^OX,$P7]I<Q(+!$W&#Q&R@EA#T;% ^<6XK:#H
M6$ B(M;<8E K47XQ,7$H2-SJ!\5OS/R#2@WF@NXGS_^[,7*ZPCN"T&/D9/V0
M9OFQ@+#\ W"".5W2)$#@DVN#C O(#0J1XOV+[-]!L']VYG\O ?^ _SN'NRT4
M\9L)*O!C@O[2ZM^-G,Q+=Y S5-X&G6>9[Y?G/W_4%!#B$6&Z; Q#0)#N+IP_
M3/X5\^^VP;8@A T4(L/[ _A#\(_>^>T<_?]&MXE;"T"@5A P-T@<),PM#D5/
M#7%1?A W%&PE#A$2 (N 08+_&]TF?M9MOW01&(DX>1O_?]%U:!X0^FX3O?[+
M6#LC'9A CHYP&!AT@N)U0T#^N(C_7/*84$BF7Y?S?QCY?Q@L!.H,^[\9I;]X
M^3-/3/]_"_H_GIC_O8OCV<3\F_3O]SS_=C7]<>OP?6RJG(RN_UYG2YW>OO\G
M2^G?X+^S#OF?WF#\ _X[Z\C_]#;F7\W\,_._)/A7[<D#RLE]$!IV.IUE^*5X
M_R'[>WN3DRZ!NY[JQ$7XT(67_V3_!_17]=^A-_YKZ(W_ OJGZCH"AI(1^ /R
M-_$OJ).GJ.]WP@:.(#!41D186%!8BO?OXK\C=&$>4+B)$@R=2I<3/T1.O/NM
MYK?(&W_J^46%?T7>^ ?R^U3YY=7 ]_<.O'^\>) A1/?>C[<>OYNP__OEC.2,
MY(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SD
MC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.2,Y(SDC.1_
MF83PS^\(0!$0:19W%EF9XU& (@#C/RPG1OY3&QC?/Q56B&F"A4'QXU-AC0#&
MDR^@X?WR&3    ,3Z^0S8-@$1(3H!NY_? L,$QN;A 2'G)B( ./T.V$ / I\
M2BIF:A9^>0*:<WJ$YUD%KAN#G&*>]O3U7[@HJ&_H'QN7D/B@: BH$%_72\O&
M(22BJ&IBY>P:D)[9L,XN+&K@?O=U<6G]U(R2BA'4!17X[%79 *>8LAK$+:AD
M TU,CW8)"^/OGIU^H0RMU:$ H)W"PL+'Q</%QL;!PCGY?AD%,S^6O!XV)0CG
MY!-E:%>H!?2+ZM9Q:11BTWNGSK$*&EAMX#F_FCZO&! '=GE6WP=D$Q)6,LQH
M.!X!$&.=?N., B +V%]9+_TF8G8,>(]GF/N!I&:TD^AR\\W1$:D\TUG$C?2F
MBAWD&$ZS EAXZEP[F.^N9Y[C1ZE=&JJ=FRHRX6\2%8N<+&>"%Z2F_$Q:,?:T
MQX&TW# 7?R"2;IB7PV'TL9_EA5M^REE,8FOJY]DO<TA8RX"BTF.6UE\$OC)3
M2Y,AI&'YDLN1QJ<&]\S^L+#&X+4O>@P(Z4+(BM9$5/$;3WWT+CT8O+]6YYDW
MEV<L011TYXD=KC9'<8_2(764L7G:%YH11F3-P=&=.\&M:+20^Y[76[6/S4]9
M]Y),-PI]#*L2^?V99/RB95W%/U<^W5_D*:CMK5+\YG,,F"]A7-]^T]E\#*@(
M>/;Y/A)Y#%#SO$R6'K<TFRH3FZ+BL2EK7(N5]F8J]4[AJAW>GH?\@S?4(C.[
M2<*TE.[%CT),&8Q;,#5;R,8#K_%QMBCS[W,R%!R.<A3[?O2^]U[L8 XKK:[[
M380).IAA:_^]U\> E+O>7/CB8/K#HF. K:HGAN)V[Z%I%&O1@9;:)E"C:C)F
MA77)MSO%?'4?&X/U]L6[43<J&$@BE[A\/*84]2]?F\H]+P1WUY.UX!_('I&%
M'0/J"XX!K?V^=5'V=&NBFQQ#V3IOU]K3"AXL#:TP%A\#6CXR-M--'F[,Y1Z&
MO*7F:8E1/&@>N[EL5TS_2@U764[F:7>1ZG9OC=EA1FFTS^[:U\-C@('.<$3:
M2,LQH/QC:_YV%G/.;3EAQJI#ZC<%<4N?TKAC1^3;-H\^U1RN\>+''!P#:EV3
M]L_[5ZNNY:A1A8\,)F-Q*+];-6F!28N\Y5C&8()Q5X;N<UKF]W6[M3G0SG0<
M"GN3R7I>3:N::Y$Z(D&]_L3S[A->+[ NBY5)2_^)09/<W",K C)J2AMB=S4'
M'>>HSQF5%3)@J$@HUCQ>AN4!V>N1Z#OX> M8'_)#]E"7=)<=^W3%.SD#]6(Z
M3%^0&K<P7=JX^4WD*\?G#*_RG4L)(_R[2O<:C@$J^3K?)!M@BY(7/]0\G@V<
M#4G82(\L_$H[*[VD^$7_T Q3M5<5IL-@OJ]]#$AC,#]J6AOBJ@U<7G%)J8GJ
M<6)L1*A(!ZY)V_E6L]PM529A2?^"R9ON6PE^@2P.[CT&W/UX9'_],/3#8=Z=
M@XAO8=MKYW9]PY%#6JZPG:B1.^LONC?*NJ>V^GWKA?HE+Y*HJI>*'%S\V5-)
M2WVG/35E?&<6=H KG8>L_MB:9OE8%NO-E9_1W\>:QXCQ4,,;)GNQPG#H^OJ;
MQ(2]N444*> 80(5OCI6TSN<:Q&@.OACB1R(WWX3Q,B=U/_L?*3 [NC15_.5Q
M!'SBW:;\IF+[7H^J\;?[FPQ?#E%1QHPPBPS9O:9/QX!TQJ'L;U+U[L^7[0_@
MT@_D.RY\K5H7W-894MMVW4D8X5V_U[V)DIUJ;=L[!NSR5?E%>>KD;YP,9X=:
M#;Q/&965]'>>I/:D'4U\\?3^%K]QL-^)'OUYI4=\+"&[Y>SI7W5W<O9G&$>/
M ;T,I^VK=N&I/5'?[-#42W9OUK_<$3R_-N69N_^1<91Q9W3VV8_I>D1QYXB]
M_!O#39'L(X:RKTD?=_D,?9PB5HX!BV3 0]0#XYLPBZ=',L> +=,[#8/' $&Z
MHWG"'PW8*+[H2ULPW'EO8!LU1LE[A^PA7F(Q.BNDPUMTPR/=D@&<\@]NWL21
M-9NY#3X:9MB8IP[?OWQ42"U)\>I Y?S$Q1MDX_L!FCUFL,: CWE96.US4N0%
MT@COR-<CL@T[DWZF3B11FA21C]_OZX9+NE5V$=E2,Y@TE^[1TMHK;T63P#34
M\@*5#U^B#M)&$*5-*[CSXRUAE#..;C-DG7G3;S>(+[]VEKALU,NJQ.,W_>SE
M<J90;R)F_%T<<H*9FRD.H[+I#BG7.FX>I=%1$98EBI5%/BQ,_S#AY,A7=,E]
MJF2!UT0[2- LT/P>I(=*29M"2.E_>%#&FB6;D&#)G"A,VR!K2[]"F9&TD:'&
MI:!(++5A$*Y!IP8KN9K;E 9DPMXL801FQ_H\?$U7/5]*,.$(QP"V80(Z/PGJ
MVI+IW63;V9T2%\PMP^QVW'D#S'@0LG!;-*REY45O)H0@L";E[KO!J5*$VJLP
M+/(.V$B;N9UV 2QT]AAP_D;C2Q"-V)C*Y!L!U5+/\^3D[, 8Z0LQY-@SUTIQ
MF=J2B!X\]NB\L"24DR]<$</'$FR$M%]_LGQ(79W%7<I8N2P8-HJ8<[@_?[EH
MZ.'EX97/;W?HI!_V?%7"G!%.0(CPVEAB:F1>UWC S'7Y?KH@?<R]\I8.-<>)
M7#]5T3=JOANXQ%],%>UP=Y75FQU)V6]APD>4#[A-!Q$U5+Y4%MG9<0E-90UE
M^A+K'1&#.96NU.4S,:/NT-T79,-C7W?Z[VUSM[Y';#UR/J*,)LP<:$M:(HRC
M*C*9ALL1P.5SMJ.4RCR,$,3WKK]<HL43<2!C)UBG8?)S?D+;+R],<?V+G5#+
M['.N4%1N&#.7VKHW#5MZ8D9I)K>&)VF"P,N^FL<9N4H9I?++6TX7YVMQF.HN
M*;4E<USNR.$II9P"=D-LP>6#8D.:\T\MA)2_KOE0L:(O"D*6KV,.V-LF'T^9
MQT>_D(K!\_/VOZQAT.ZQ.=/)*.W;=<0(GA&$VE^0H+B'39?JCN=UUTZK+D^K
M,&HN6&K&*D:OYL'KRB45(SYE)6V"F]T85[CT9CVWVC87RM,$=+ &OW;/#$W(
M,L*^M#$U?YGS126_7'V^SI<2>K-2.-0_AQZLD<"@,_8-<"0C=714\,TGV_,]
M,9*^.7N?9FPH1,Q0GH7]O5=?W*XLX-O#0MD2V]LMLWID,Q_W"R(7%;/I+//=
M/P,6#QC:/[WT?N TVYW3O/K*I&]N0+.5U;BMQ+J8/3.95X0^/W@K(Y^ >5/?
MY_&S[CE+H\8/(LZ[:L366_ER@U:4/B8<SQX9J!>"1;Q5@S&TYR. K8&BT1[S
MMH(6*\5W<*0L/B)!CW(^/@SM1!;J557T*1%HSYR_8O6 ;^0B'3SQG9G_7E>E
MU6CS<Z>'TUNV-R)G[)SP'>,*D^KW#2*'P&M"1S/X,Q16<CQ/HH%?2)A(.VQ%
M1!^W\E=/O[]U,90]T5\D!ZO">[1R^/% 7F6*&1V@@]M*-2:^+="&C+:"Y"9X
MN+%LTM+24/A3.*]Q']O=[C@F3A@T6V%\<W-H<&ISYQW?^M?6!5':6M+= M,/
ML8 #E4DC%667QR'T#RAJL$/9N03-&NUX-32V;J705HX&N0;US)@(+P^YC"Z[
MT#=G5)A\\1")?>4=B6,!R;)I)2EMI$6/].L7;X=R2PQO8-YNU:V8&T\1/"^"
MLKSUMO4"_[G67#I<F9#:,0CM_<ZX@=C6+422^P%24*H%L]6MD$?\',X#K7H!
M=KOG-ZNS[\7+F0>?U^)]H3_K7FVHY&6@CV5+>9' ISCXD=H%4N,/3EA.%]Q3
M0D5'E.I@(3HO]$C/ >L(.J<%TTVAL7VP"5@ F=J\($"-A8O#XM++,:$!?KAC
M7D3XUT+CMT$N/*E>G-?9]Y4J'^IHIW[Q6%%RAAY"1N897=4B/X=)US3XP<6-
M<4N>7"R'V3D)=;Z]WX^P:L( O*5)9<GH50V"-$E\9OU$Y>HV1[>M7&5[!V,L
M_W'Z:.X7$\HK^0*BN[B(V3'#ED+KY].)Q#GD7<IF<Z/L66(C=[/'% SQY>@;
M$D6<)^=56"TW11^JV]JR7RN(%559'J/#$T>(F&N6RPO?TPY[+(D'Y]&];2?*
M?K7MY=7UJ\]K(5SX*)=G;Z+,BJYPY[\/DBC%6K^.WU98[$45]X" -Z"_M>C<
M$B7F[>W1H/84<7+B5G9\-[=<"GZP=#!$[FVC[9.,6:58+?E[#_T$HSTH8,4-
MSE?=1BI3^+)*&MG4G4O:KDX8:?BSDVA7YSKU>.2\$\DU>'&K"F=PW%R%VC!2
MS5C&JX#WJE6Q).J+''. .GF/VJ= R2+:B;L]JL_>O#'IC.:0#)SGD4E<S:XS
M*+\-BT(F=%J,CL)K&T B.CA+>)Q9P8.*RHNCR/)MA&6O5F%135X(KG8OZ%GB
M(K@Z%Q^>.$;DB&-?U[2O?<_1@K2IJ8Z*G3%@V4B*P9^N:O@:H/,B%G9HT0=^
M#!;XQ:VE?IET8)B?O!],CQKHO5(XXO"NW"Y6^=I':Q$M*%D-%H/;.5$0L\@6
M6X/B]GP1@2TM01PQ070-^",;@OF*)^>R3.WY*U.21"3=TAR@HN[DJH=$S^FH
MF9NMB/4;"]SA%^ZV8J]1*IL"J9@&^I,!G4JCP@LJ@PC)+;K@^ZQ S5<\D.G/
M#D*EB',"EPFN!]4PX=_U)O+P^!J!,O4X-\VW!]N:(!@,3!#Q9+=E5Y)HE@NK
M]8:Q&)+J-#&_NJ)DX$9,T<MONG-3\LJR _NGVJN&(FM7%>-C%Y\+X-UL@=^X
M)^\>6PGN:2QU&$QQOL)QKC_8W/UN!;?E1?4=>U!'"I?*<FETGRH=1LZE:'E!
M,[\"<=D+&,P]0&W6*Y;%#T<5."F0MF4*\B\)1N$#N&5LA4WYY$Z?E2[F!7L4
MDF]\Z.!K!X]);J00>!&&FLXR:[],%Y.(ZQB]+ Z]M5J'4]&;9:W\_,GRA6_>
MK'6]7G?E<?N(WKT;0D"2C9<51Y>;=HO4[6TN^]TW_>!B^]&.7_#*@A+%-]M$
M+57D#(@&9E!D8AI_ .5DLCZZT<0] 9.,?"$*B>@E %VB-!UFR1AA"LKY4$2G
MP.H<"<0"X?D+X0(/GW?MO\YX%[194+#./=$N\MG1L34YN!OLEFS^N*A6N=WY
M:C,-S37EF"QV878:EY+N-Q(O+J8R.GPED2HDL5,P9?*?6KFISO\R2JT*E?CR
MTEKQINE[:'K0K! Y0HX%&$;'PYI%0$[07F0 "(#=Z,>B>;XU+TULO7=>U<Q^
MD$'Q(9CPZ7CG)@]>\,JVMV0*\8<#6$GDR$"9R-7+.O6%=D,,A;Y'%R?BLS/*
M9 A[V\DW*9[?.@0V^W*]?.OHHF@.B9Z("ZV=JX/%1(\+B#Z7Y&$U)1!]\LQ:
MZV+@V[>9LQ99XBK6(PCAZR7*;%EXB8VO6V>?"W.CPKF"X2MY='/\7,]GV"N:
M<A&O'ERU8>:,W@>=>^Q)?CM<M<2_PV3-%A4-$Q1'Q#G1?C8CK(]2;;P?8?76
M%2.)7U_[5ALM3\$25;KY,\AZ9*+ OKT9?!5ID'(GUH9F[YY8Y_YR'.UMBK*]
M*I9G*33XL99N%]5\*JI%ZA\R>',J6M+5QJS@V8TX3HO7/*-XD!R")03*5V/!
M^!1+S.G6ODYGT MCQWDN]Q00^5*M4SNAZORGH_F#3)F,RJA7;VZ?:ZU$=.YT
MT+;NM!\#&-((X9\.4C_EYCP<[<6Z]NK#H]$HOLP,S]AS4E6N'P,[RENHB/#7
MKK$RK"R2X]+689L8;J4#<".<RJE8H;Z?0X5PRJ!E@6%4 MSJE,3$DT[^FT!/
M!@+ZR &LE@?,<HZ%M5)1Q9[V(]9]Q37YW@PIII\/Y!C!X=,NEO13IF+W/H&O
MDZ(O\UB;=F-' T_7&&.,&%O>;.L(DU5UO_9?_OIUEZQB;K?$F]XG0^R+6J[@
MB# LFYQ#+C._$=CT),YTA\2C,_><47!TUEN-$<&/"N6SF8//*I?.+[3J*>:+
M3,O/R3S!D:)Z)XGH*58.H^TW?+QT_1D+*BG[PM7&)('+MZ)) $!K.9$X08W"
MP<)GY%2]LEJ+ ,#C^R-?_*3\L$AS !BK %+ +LD="><ICD1QK93'9;8<>=.T
M&S>?+C-%1$%Q9VSJ\ I3[!9]/#5S_\<WS-\/:HO,9?AZZO@W" G6.)DY@K =
M;X?*@*08IL4FM](O8J),WSAOO? FHWC5!G,R@^\W4\[L\["I(\/UQLTJ9 P<
M5 /-P ^&]69@27H325TW1H=>3O?[\]1+2F_1Q9)9Y,<'V(]OTA"U=$D4YK9O
M6!*91AP#WG@MX.;0B:?BTSJ8";RBC[ZYHF OL@KN9LXP@@@'.M&WYZ6NFO:Q
M(\1584:)IAO3PS17L0?>C<%0USZYI">04.7M^H_0:-9%8Y2L^-:3=3V08GM<
MC"096QKT8HBVMQ=\?L]."\=)PA=JEF]O/NMDD0*.D$TM"=05CBAO]7T)+=T^
M3^'IU$INXKG0OK+=W*=*N6CO61H7>F64'!K\$OTD$/W!]:(1+E/O?#2= 3R'
M50W5#]'8E8R$>W\V%XA554KJ#U^>K]WNK#WLM,]NN%[6?5,GIZ(RKX/K>B+O
ME4JOG=7$@O95'QSN+DB;J][5KGN]NCURSLWOS3^X <6[TB8P 3G2E+WX(;3D
M0&4">RO2U65$@!R3'PX/9V_<Q <J79K'2S6IOBG.*Q#4>5+EB$M=CRY>/&\K
M@;(Z<&.%E#JM;&H%![RU7IY!O<\<5;8::<NK/"K8?&<H)G"=0']*E<36[7#2
M"Q$*4&-74H90$NN.:,4"8VWKQQY:0TBTN5@"N+&I;/DPI''.>Z^P6#K,2Q)!
M!6T'/M ;2L:8"_H4%RVZ#=0GK0CB[I3*3*<O>9FLZ-]T#@CO)61]E<W2M:JK
MX236Z4D.2:+!3NGC# ]_#X&Z%K]7.R^4$1;E^;"W2+?T6B^BWMWR^?QXWDW.
MACZ]Q]!R4WOG3R5%'*;9E(^8"O8S*;+*+3.*-?IX@)$,3MI!?L'U^MD<"P<[
MKM#1PN[N-K,HI9MI9#T"<4>V-3JVLY?BWE8<&;5A5K=.DO%X']WAY?9]<\3H
M<"')0_(-M'H*DWTOB3231!UH<UNW,'X.KMMI;I2T_:RFH/_B7N&"7P).W-S:
M0G?GUZ^;THW?&@)WA??%1CA@&)T/UY0DOLWEX(@-Y7J8B-6(87(\8]=2IWF2
M9P_EE+$98/A8]=7UV09?QR-W*W,MS5P#3:XJ\A Q2P*JRJ7!P]S6KR$SWRH+
MQ4.R[U7'NV3KU,\-UV"MS9/T[EX_D.\_-]74FFUUH.=D$RUY,THY8/MN&Z*O
MNU##Y)P@<_&Y^CRL5B="PLLKA#=48S8J;&PDC3HB0KI"7))TP 1)='L>=1E-
MM_#4DZ/)<$:#RD"@+6@]D2($XLZ4_)3E5B,YQ) WDXYF_<&7@==Z^]YW=V2K
M!(>*QB&N1 /T=Z\4TBL^>+]K0%S6^'RCF9JGO]->0\\Z3AB!DVX>;&&H'\\-
M]/:<S5.==F K!^6-B+A-7L!>_;)1EJKNW6]5NK%D&,9EM)F(/T:A4EXIH: E
M1*%R^'AX)C&H^ UA:?L4S:'T]5F/G443_B+RRO'Z2]I@P[76#B>>W-&'$PRY
M*^UE',U-_5O:TB3(_(<+'\PHL!Q$XC\_.Q_MEF>U+&<N/C0Y7<="US5#;+OM
MA^O_.O43NS)IYQP]>W#G!5BV1M4T]ON4MD#U3EUB4YUZ_V)=D2C(2Y676J]9
MVW8$AK*4)VG[TM]@U>0WEQI?MA'J7%HS?_[&JXPWO]58G8=;U <L&-\5@%U1
M<'7S,1ZS W-CB%CL%;;,C-CWO1*J*#^ GQPVI3PPCB/^AGP5.2=3"(89)9=!
M)I.2C2;_GLZ&K8>-J:*ML_1<XRY5SD0.UW[D2&= N[!BT4O"O2R(?:>,*?#:
MRXBQ6=I[>9'' +\<'FIV1>X,M\N:XI+GB2?Q^!A5Z\3(^.G>N0M@M:@W AP?
M:9HY3,ED,!BOC(J+A:!01?13;%L*BP^-!RFU3.Y/J<=[LTM*1J.JRD?//3)P
M[4,F?1EZ:4(IT#%TA3M;=S6K9Y6Y,]M<@R*[*72 K>B!XT,"OB?LMUT'2;SM
MOI71$6I5Q6V8+[/(T25UNY39,K2 IDOR8J>9(]WHPK*VUINP2]*?.;P%Q-89
MO3=.5S)Z3Q N_T3< B+Y8#UCY9K#[2%+J+[H;<::I18K-WO"QA=?\X5'S=)6
MWC116;;I(00PZ0M>IYB..LVU6%W]$$,Y&MN>^/EM%-,*[SP#Z6>ST&\FG\+L
MUXLNUBF\QU_ NH^/\PK ]OP88 (BF:;#Z"*A 9)&"\)88@0@#VWA#M^NEC>,
M:Z/6^J]G]8V.C1B!4(&Y^W<_-+B1+B,F^$MOL/?W+5RH\4Q@3Z4/OQ)V%2*\
M[89YD;XM-7:TW5.;+V-)G,S>WKQYNB;O(\\MNB<EF74'=]^MP\N+$:OEH ;;
M^35:J:=!BE7L3&/WWSZA *KFL\OS7:[U=;7HO[,4W>:V)'1P4!W(,*KE4\T0
ML.,KBAN[SW,Q93?O^:10$4AJ6#M$F6V8R"+A]8L->B<-3TT"DR^CKV7)B 4=
MD><B'457K' 3*_J3>,9A_ J0>?7LP0N08G7) "XU!XFVBB$Y$LS]P-J/A ]T
M4K8C5B,[Y\NS/O%"18G I0\8GU3EYS4_M4EB7UQ.,*-VA#/&$(YGSEW(LNQS
M[@.K0IGW7/6RI<@["D0>X(6N:C5AGRL6[VH>8;"6<Q&Y#]=R:.619C\O%)+L
MY,*$**-8,7:_/!D#5%5.]^\?PWB]-!8]176.7<WTCJ\O3976JWOT":]864=R
M:89+ZU52@@?T9CY2UW5[^29@F!RI1D$W5N<*G@N'LW0:%!<M/9,$X9K<N[WX
M6:/*:]T3B\HIHU^\T!$[1)%_C)^^OG?1$18,F(^]^![#E@?WHZG0,#D3H,?6
M]BF5?,Q#[5"@,9"1L&"8X[EV][CM;1UWG5*SIA*Z",W8]P3$;2D1:Y:;H.T8
M40X/)XT71!>B>^]:ML1HJIZ[FF4ME^40G'Y%<@X1)Q,Y4X9'AC\M/C;ZLL."
M2:H,CR(*[$2ZP<.69\]/KW8AT*>19+-)UI2 _991\-L8[% DZ7TLZFKCBS?K
M->6C5SBN[P7/6"*T:^UKOXR+S%Q8U;NAJ!BIG!WRTA,BE9G;F][\1C-A9[<X
M3UCW^DR5L!U.Q6MV&7J?SIM?;E^HEF=UIZ+88&KS:(PF/61[!R1@SD8I*=F*
M*Z>4A#%GW6HBTGI+>9FE/AG+YVF%+&%M._1#FK'@\XWQ=UF-[KON$B8?Z1W>
M=U$975@YJF_+"7S8EVA:NAQ9W3$M%LO@)>;P <0@V.&*J"QI\(U<X9YOXW@:
MO"P@P71I)M@]=(+#P^66:*;V@F4<N%W,QB-0P+WVO0![ I*N28Z<U)BX8\IC
M=+= -+P;[C16B-4N@,@72,TH(FZV9(NTU'X54G%!,2E8M?3&=:U[+S\XEV0M
M#ZG*:!IP8;.QVP;-W)60X/.4I,,C(L.8&XYH^. H(LK_+GAU>;+LD;TIM#QJ
M@OD=J5/P*_PQP?8C_7H>WVR*=Q35VC#2I$0_%I8$YA+^IAI2U["R<<Z;'"Z7
M:(N[&ER\W8X!(H4M=D^N5X2;.W2*"'K?%FU:R8.8M#AA#ET:DS3LLI-2'5[-
M!_=X:$2GM\P>^42!&L8G[%-JAQ U&:6*'P2P'BY>!9X+"8Z#8L7SU>&EW^J0
MGPC$;;P0K:PV(Y'0]]J7:B79\L.*$/5*HBHH?L7=XGR-N8'#=J:%%9^HH[O]
MHX:-E?2 FZEE"OQ2TN&V P:&HZR5C[-[1Z1L1EWN+7&_>-3L2S<Q: 5Z3>:!
MP!/B'XZT?RC/),&/$1.B*I+.(HKXZ%_94T&N6=M_/3U &>S6)QXHVNFX%E1F
M77H,X&^:;1FM_NP$T]&[I+GF,PA-_&9X-&GE*!':D,<OT7G'X;%6LF[#!6R8
MT_*YV38^VC1^7EE<>IXOKP8;8L55S%5Z0M_O3 H5TXO1-S,W8KG!IU?&Y*79
M 2V:MAD.>X# 2GRZ[9QM/^Q+Q 3P.M(4A>);QP!"E2;0<)F.1T0P9T7RLRJS
MWM6C+T7QT#+'YXRM[Q]/MXVVV;L+$A'6>JY%<G;:#I3"V36@C>&7PIO\)BOS
MZ-K$JG=$V)F<&AM'7FY,[#2HN]$YFNQ<X*\*7>:H:)27F@+$ *8]5;$O<+]T
MD0NPU;SOCYFNI#L2K94O^=B;)2EK&C4^4#J*8.[<M.C\Z'E)DE\[H;[)MJA=
MT.(EY9$$Z8VF>V @CE;X/DMU+D]'DIRN+SR[*D-\<0K.@Q A&NX:!)5=RKQ;
M_D 2YDO5QL/# Y".# X#2$@P 4+B'7?-\1]<&O9C0G3E)O&)!7H51HVY>=T5
MTI#6-Y4JUO .@V?:J<,WEJASU3DG U3Q;EZ_NT,LQ6>FVXQE;"Z$%;OU3BA6
M[BDP7.Q]<J6S#&CO&,!3^ ZT.+W&1K_8MUXA+E.?9ARI6M6][NQ=L_"8SRW)
MI<Q,;EIF4,F&89NDF>91& 4_HBV5ZHHJ_GI-2!1N1Y#W,6 LUA.O8[QN:]>_
MN:)T///]DJU5\8M%X!UC-R5.-VF_T'QAR2R2PHV:!Y]O]*0= RIUM&7W2$;)
M#LERA[8*>6CG(@TD5JKDUQJ=IE9O>A;=V4L1I2<6O,:-@RJMSNQ_R&(;ELX>
M^C\]9+CL"'_U7^+JW 1LZR0S!>!UU^%%@18T@=K"Z;.U.<&8X9>RC.S/<YN#
M:@]L[VM9P9EW9<SNW7"804!Z'BM$\Y^#C]Q'?#2##MKWSHQ_,O7L%V\D]% )
M=L[GX2EJM"6)403>E+MF39)CGS-PPPSXE$"/2T/W,XC'1T_FHO$$N?Z"LV%T
MN@<A7NO&=JWIE*\(JSI&?U(.K';GR:?S*6%1X4-^ES"O:1\5T)-G AWE])B"
M\BU?%P0NDU5[NLDA#R%295CT9'BO_9O-=SA*)C^RI4F&K7B(MBGMMSD1LMFB
MLALU0QHUZF5*@+SE;F0@U4&*I?B8N:=-MQ^:6C"_#6 NP58R=;A&<^]IDR<V
MTC*108- 35XCKMM+GH&332?OCA>#CU+U'K*C;B-QP4_NZ@XY?BO@BD2!(;'J
M/4: STQ N'XZY<CYJ<UIHU2=_MX]U@8?6ZFGUX0*SCTXE\")[0X,7,AW#%MP
M;-DN-KAW]UOJ1>X;Q3-((>28_])K7>G4O<IN"4]W)DOQI"J?M*&%]MNN6R&<
M$P7QC"J<D671LH1Q^+&E]?3F8UY<F$(/YL[GL>=.'(A3/M)_9/S"4<OF]OMN
M*N^(O?8O?!,SG^D;\3&Y-3#4XC;:4$E;6&LD"I]N-B![L%%Q_:7?MF>;C5^/
M<J7:['4A^J90+KQ%[;1QTZ_M&=K?V?=TY 4Q*U\=;58EF!E0,P9LZBS=E/>\
M';>CQ6!#'SP-HC>J='\2$Q:@2A (G=Q,K5_6W_5G&XA[H/S>WB KSG6]2Q;W
M&&"A0:"[:.]^VY"RZ!@ VGGB7(!_M.LG)E/O7;*-GC^:GH)D]MNC; /28@7,
M_9:/S8WO!;85BJ4T)Q/IY.&+'UWGWQ.5^ Q,ZR^KFH <\!WPR'[#LPA<5&4K
M1R+YNJRUK2NYJN*:MS*,/;H$'PZKNE++=HY^+CQ\<;OF6_>K;Q-IQ=\>O)#L
MCHUZ,9KMOVG &&A?$,2L+LV%^$I(ZNX4W+U]+R\SA*8[:):ZES+6DY#>64P/
M. K;O]$FU6%JWB[\I&>0V/%I*$<.;8TQ_VRUP@Q&XWG**RS &+6D0B,E&K$]
MT?TU@R/QQ=ON'4V-%6-Y$HVQTYX$IKT9U&+%NXP%\L#45<\AGJXO#V(>01(-
M;6JU1ZF8*S<B2'4].:A]8@PP+]L_):5HT*8!?J/S\2@;B4<U57L+T2GZ[)6\
M:J?LS.R$DY%?#DCFX>Y;:(]/3T@ 8M_?D$F <_NRFLROXI6+$$2\5V,@+Z./
MB@",!*J75E]]$A6(+,2-U>W6/*AN-PSXL.[$Q7Y]*M?^!K(B@UG^E=%+77P=
MNW"QY6U7G9'\2!:S2S:<6VOY_8<Z$845>'5E0R9;AYI5;VGJ>],?J72QR=LD
M!%$_H<E(DZ%I99@4SMDW:,/&G![_7)7A S]JZXQS,<V+ EJU989U+WQIPZLK
M&=(UL#_4O%UM#K,SI1=S#7/DU-[C>$ $M=.YBXE)G<G,^EF?+#6MA#[BA>_6
MBZ&>0KNHY_S2,:E>H;M,>R(2B_B*X,R(*7R'DN+X9^1%"H:CD><-Z0G@>#XN
M8P%K7BF;^)P C#LCCZ.6JQ&-0L@H8V9L&(Q2[/)^-N5[;YV&@]RQ/5&O%4\R
MYG>)NS$*BAK0F4V-5FZ'RZ4:WG)^TQ[<S.J<^H9!.)PX5TS;,PXY/Y"(-J>^
M]MG]>A&;/B'T:I^F;B_W@RX5.RYTGZXX01&HBJHE8Z]'@*E2G,NF80L-JB%3
M)2U H%!\)M;=I\Q,&%B+2#8JG*X)TA#*FY^Q>@_X[)^RJA-LJ_!$\P*[).GQ
MI9WHJ4U//)+#N,2+O*!V*9.#^K6^V@[I+"<.U\KFRBI>F?^(*E9D#'IPC.&8
M:&FG:ML;,'T,J:7V,0Z+QC9Y&+:\P%6@\;"6Y%V5QOMGO:OK"4*;#/)&''9J
MKAD>VOER3X(X+V_[(":]VV:_?H[YJ.G&7M%E'_S97-'+T.^6;G&*_BNK()V!
M"\VV3-NC:Q33KOG];^8=7 ?E\#(?C^DKW%8X'S*<#_ (ZE6@[I'3<TS(!3';
MZ;%I )?>E(QR%,OLTNX@Q<=E<IJG9N:S&7%W+1J. 7/V[O'B\.AY#LBTX0T]
M,SM3<XW8$F8-($W&BTA*;S_,AD7+=OOJD?OC^3Z1$Y7Y(6S3@/=6 5<((C]L
M&+!.CGTNP<&1OKJ&OZSGQ#J;F:QF^I X;D1>?3\)@(FOCJ&.<8O+X.#ZJP/%
MM<>L'WIT!I 9_M=J:X3UN28G/\<_;>3('!]W';QXM3*$7U*400%8_)FMFU;-
M;-'U:IM/Z81&0[[(JT1S.8(9O2_/8I]ES:\E=MRO=7]=K&USESCG'.]LWK68
MBSO:;\/ZQ#I[9[7>!+H4-&$&?:FJ)J(OK#IJA)>;)E[0O,=:3Y_;0QM;0C'V
M*M9((W%*]_#*K)-B^:UY?B[J?')G%7:_D9?VYTHYZ',,P_=$*E>-/='3I5QR
M?*/B@D^ X?DVIDQU."? 6=5*0Z_E 9+!=,Z]MR;$<S2SJJJ9J5P?UCPR8"?.
M>,'?O'BJ,<WSL](W.@OWI]T4EWA61ZY/=(24D:;&)ZBZ(@4,AVV9Y4FY58.
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M5%GZLG4C ^_>;M\HJD'T3$]+-RF:/#^YG?37,"(T(E#PUZA7)^0TCO5C"B#
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MS/)>_.*'DAK9&2<I\O1N*WN\05P'K[DG*<WIB?INTWV]3(G5 23$ 9!&-4S
MN'!.D>EGJ:6'"SZEDW6MS(.ZFBVB!I,'8]X:2ZF#@Z64GW93?*?Z*JCZ!L'I
M/97A(X\"@+GP\CF'?._^+B@^K)DZB4H]J;!2BY1I8MP319)3XY>TB!M'A<6'
M'\9'$!<?WJ0*<GV3LA!UB_*E=-ICKX@>Q'/K1>5[D7R=R4M!9>F5S:^"]\FC
MPZX7BP^JE"<-W&]DDW_8DF=N6UK:D-_VU%^42G-1T7P:$.B!8??M-N:M5O'
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M$;M7)'N-,X9[V4K>EX0M2^ACIK%XU,C+D%G\]67,P;'BDHQ.+!"]<VN*=GJ
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M%HO'@99&HM(9ZNMTL[:;#W92M4T1>?'NZPPZO=R!SV&X%W BZM5\8SLTB^&
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MO5SE1U]O(I&-(H+7GZ2SRGGE[]?]R:3L%$&%E5X5<><GQD!\D#9Y^(K)%?C
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M)9Z@$6"9(P1PQ56^HNS&O7S]$[XY-U?*1NGU+-)H?RMLP%]##P)?5+N]B4P
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MBUH#>GU,C)*YC=9$YR[[#XU\30?.([>D^O (U&I=8"DJ["G@4\A75_%<U'\
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M1*W_+G<1WAOF/:@*C[_+4]F*A@71=KA<&H4&\U=_EUO,#VX#_W^V([-><Z\
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M; 41N)9KV0^ZN"W4?(^X.8?V$8>X^V6PT*PH3$J(()E5;:[@\A\4:E;H-@A
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M4NP(1C8>A( EC2(O"0$LY)(MH,&0]C?P(B9"L4)0AV8A9,;@9\MGZA(D[Z<
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MIF(5'0$SIJE; >R?EAHD30M3@9IDE#6F6O ;+,AQ@[N<I-$2NV 0G1Z0DLJ
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M<Z90AS@4NA,A=\\'.E]:DU<_?!XF3.@+9ZUC9.J?8V%:VN"U'1D:@MB SZO
MGB!OW2VQS9[L^/#!F?VWI U,='8(+$@+'B+*/[W?,_7FEP67(LHB'W";=.ML
M!L TY)HS.1GG2]SIA_6#@915%#-P&$,7<JK$RL D/'&C&S374HGQ/O&V'AB$
M0'/IPGT;:W$Y=</(Z;RSZ<9_5Q82?JL/:5/V DJC.?>\MTS9=<E3,^Y\EC"(
MP94H1?J@4,E"6S7T%;#S]QO9!!<!C@T@=I)\"'DKX,&1[I]GB7P&IC::R/1
M3*+@AOIB!7M&[(2_.?*,J8(0.2_5LL[8/1^5,T498X19PQ0P5?#%4;\\KB@J
MJ:BT-"/(1M6-./JM/] -DIP2+W.'1<VW>+ZQU15^\DZPZ)9F&,:E;@1D;J;]
M*>BR;_(%H+5GH"=?-Y1.5U-/9RKA@.I=<YE?C,2^^C'5U%=0M.8DZB]"(]K\
M0Y/QI$09<3B)(=T#[\AB)-H)GG+YP%RM-Y6!)W)>2J[;(WMG^A3.TJI]=D$A
M#2\3>#((=JC@"2]&['7V.Z*NG0]3 47H%-7)J6PVF<PB;] 0L*44E>4@PN_/
M2=O5U=KFBLX"H?DY\5 >SG>=I=@R 9=#5KI0/5T[W\DEJ\R8H7T()Q:9.N+F
MMZ7=Y9HPB4K55LGESD 0JM.TBFW$62.,_G^9/K Z& Z9%'A/%_(.82>OO2MO
M*C(YZ]Q#''NT[#J&K$:'H(?<?TGYY33RB* #A@T\+;ITR^T3FV/_ ^N/-GOQ
MGVT$H.;8W2%'CHV%WZ22]L*V^3KUV"/6VO5U(=2#>Q(Q%9?C;: T'??"4E09
M(+SR$E'BP0FP7A\866X99% '1[W7V^P)(-"#76@0Y6K8H]R*NW0-Z!)PHO \
M;VS?N>P#V[ENB!6S;&X@X[ 8,ZU;-( ;:X,7+B@&6C+Y!13),,#RU'^^5T3@
M>/ZP6TF ,I$3(3)#Z1IO(+)9W4AL#D]'^\N+DKGI1N@1*^.J'H&FT,\!8-:@
MDL[7'19N YG+:&V*(M$Q)1\E(1R@B5*H$/D=^&HEQS?8U4:22M+/R_]5VS=8
M9JE],Q$ZIK]]R]<O^1]3>OUNV%F=Q2Y4"4T6N4U!!S#)8/WM?=!8STNU-^S<
M>=S5\O]SK+S [G/\\D-MY:/QG?X+P")#Z#.7]?]SG>53F"&I>X^SIWK-,T.P
M[R [_3V*G[WO(ME!XA4*;3YI'@TI.S;)UA>@E+'$3H 1((+-X6WA_U>#/)%/
M<RYLU\M^[^"!UQU3TC39W M!UTW[T$GU>,JYKT^_YB3H (8#LK,"S2"5[7C^
M-W)"*4W0N:2U,=[U=*ZDQ!;(G#BH*0N ?/[M -2;*EH12;VD&^'8I;E=VSA+
MQXH$^CW.?,N85:>Q0CM*12RE2T!;4J-5#%8JU3#!Z+2J3YXT$W[@GH<3+#]3
M5%S; I)"T'@2+ !GS:122M9C1!M-?H9>]F]"_NXN.\$N)54*,[:5O- \:4R8
M'C+;\<JQJZI#PDEK96>;2@/96%M0TL7P:2 9,^A9(ZKJ1/$][;'NJ&H.F@7G
M&?SZ8,EE4F-;ZU](0#OW+%"\@2.71,C6"GO6):UU9&5\7+C\BU\WY+R6"4-*
M0JS&I6)R&(M'3RNG>3/LV@TQPIN/@#()JI?15@$5;F!67T(  DE%STOG'#!<
MM(EB\(&4P]G$U'FG_8A#QKH.:D(:DJFNKV?>$V+0K]4X)1+-89Q=VNK6"27<
M&X&O!K+KLN+6JFF\M,>)A2 [B$6/'X%EOC[PJ<1AOZR0.I(D$%&$T0==?F\:
M_?QD,X3]2S'4U!7)012+CW6FTXW8-?&HEI2ZL"R5M,\,9[$^H$/3^CU\(W$#
MB91*E/JM95>$93!K]?&0P:EQ;UZN#!"M/GH>11UZP- +73H*E[O/:GO.+J_$
M6EG30J?@VRW+P-_.B/."&$),OVW58+9*)I-H2"2'<2CNA$+-JM,M$F)WLN$W
M[R#>+Z\0-Q%C)",HDEDC$5D))X1&*9&^2NT3(Q)FG63"Q_6# '*\)MU6RUP7
M?WU=SI]3)W)V)GI2!_1L@ZF-@15AZ- *W,%(1#>QE]!I(;=F)P5R:.=,]G&/
M!9YS<UWK=_&4Y9(2$CE+7.F86, Z_4I0FS.M-K1)@PJ3I#*N6I:QJX!QO]MG
M!Q>OYQT$#<"%X"D<Z(B0/Y7(D!I&8.=--9S/<$;S:G[S"X:!SV3UODKZ,/)F
M [C&+[(J)1#@MO:C"KL3* M^>F^6Z6P5;F=]#"4!'*C.D1VJ-M-ABBMK  :*
M.GFM"Z]-]VH2!C\9=L/0=NQ"*]+AH7E.&5+SKM1#/YR.IX*.#RL!R5!O3I,:
M>AX2GXG>1RTH#DOV@Q>;?\::+R[6?7&^ '_4?BP>"<1$F7(C#[K96&<B6:S,
M1*"M;^P"?T)0$N\TQ*%T-;P(D* 12AGM]?"4\&@#MP"\1)L[<C;T4%G ((:$
M"WD49'<*$6IDR2CR&]]_YH[,9Z//@NWQOM?ZCQ/>S:N<!]]_Z%BEH(,W]>,3
MF6LWW-77-(+KR1+Y-<XT# 1_[=O&5;D\?\HL=:([TV=KLW2CZZ]Z$A;UB[O;
MF9CHOI5#[NUSG$[)<)6YDRYK[]E)S/$.2L(!'S;G4:#X<,_GN0G<%M/8 @\[
M\L#OI-G("0+Y4MUA#@&=/LG-RSP9M5/?OTV3X/7UWV[FFSJ4:0('#/RK9L/S
MGF<=V32KNLYX5:BG4)]VVU-$J<#$J_,+0SW3@#VS"11K*RY(XI^_NRD[I\DU
M"#]"KY ?\5"(F\-D8HVTXWA@;9J=VO0!T];L[(J=[NOZM6DBHX=F,6%]W6P_
M@5Y]"]RJ_B,SF^ZV.<V)E.MS8\@CYXSV$L=.WU>VD%-D-6LHRL2U38F51Z")
MD@D=<.UY=WIRQY!OF+Z;(?+5NN*ZAD06:^IFX]Y]1Z8IN5$!/I1L_N4F)9C<
M_&#8=N59,*#A@1CH^@MF3$;AJ*RI9GL?\VM+FS9=--G7R-AH5#%A#FN(21HN
MKVNSJ'3)J:OA.HV7PVCZ<89#[56WZB5ZB=F\+_X+]H[:6R0KH=^D:%X> RJ(
M_MG2?(B<>.&(Z&A"J*U([X25LR$:F#<\]EIUDL_963W*QESX*$TWP4+5"IE-
M,L:C!M'>W91+5DP53K8R,$X]E?:Z3A05C\,QQ[?YP*U9E,<:0+VW2W0N3R@%
MNW3%MC=;>:(<C6G%E&P^[Q[.']2?9+)'&>*%#OVTJF%;G6.2M.CB(636]8=9
M(JIC4@2CE#T>18A)>4$/(<H!NJ(TE19EM;Y6.F27OR'!CRD>N=:J$- !CYEA
MA<&0@<W*Q/4[/VZLHW>/B519Q"K)1F),?<5552#$5,9ZY%W1]+&MU5O$0(ZS
M<3W)UQ@AZJ*7L74LH*AIWW[\XCI;1[.A\.3R6TE.:! -,%JAG&J4YZ@%+R\J
M;/"9^N#HANYF D]H]0!OJ.W9M;HS>5>LIS0,GXO;F,$!OR7VWQ]M_Y71E5VF
M0Z\4VGF3L1''XZICC149M?HRS0C4;QFP/#(H4>PRL!PU:"8I'$5R)WGN:!(C
M\+^)<$ :G>TXO+"@#O9'HJYU7VG(Y@EM5_.?70<;AXSDRB5#1<H3)?$6[9='
M',2XI9DJJ]:J24UO"###B]E&3-9>Z1A0\@Z24=%2Y\%6GG!0""SL1H#5+ R.
M0)<31XH@2-G3Z!KF- V0[TO&=K&L,Y//K3&>%P2\LQ[..5:2_*"75<TH10)B
MDA+T784[ ;P+S<H6)H7^:K TOOK;4IRC* ^:'7O(Z"/N7)!6EJ]-6SD/F&JH
M/A-&S84 <0W4+D"6-!P]YECS^6=U03N5Z5]IJT)9G9<]74%)$9OM,/I6RN(6
M\6;P"AXT>JZ5DHRNYR%>H@IYH7<VQ5-@KR59L0V%=LBV=^R5:7,VR%S(["2C
M1\ML32Z5VV:XFSL[F=PU@E+.;?Q\UIY/[8JWM7-(A'@O#])/WV47A&HJ8UH$
M 2W""8!RSVAH F/"Q#MN8=*H 6G$=5-W"5!;Z> &AU?CBOIC]B6:>Z)(62G+
MC$#L)NL<9!#LJH2R2?^4]UMH*5)._5AP=1T=#I4D!UL\N^\\'ZRPSE9G:E75
MA62;UCU3,,(9Z_;;%JCYD%\4&L XH"(.AUY(ACKN05V08ENY@,^F9\=]C]YL
M:OBG7L+YJK?3M*;E^G2E[AIRC;E]QRP%>MB/_3I^[5S[<<.X"%V_4JIJ:)H_
M>: GU7,10>S^PJT).FF[5[4Y\#O%[>*Q!G'<MND-R72I %&K#32A+.\E/?U%
M4Y>HBNY$0E%1-JFZ7(5LE I-BZ?OLV^Y>.L/J,7Q15</[Y9GLQ!+:U)[O;&:
M /9QMH_60;9L"?"",AOB5'_J-WEVRRDWMO*)VE2FDE>[3@19_405G2<Z&55L
M;&(\$=T@3P'"/55?0&'FN(%FL>5W,S3RXCB7RC]V]G  $B'>=XJ?M>JN_Y]^
M8JHU@6')1Y#J,F^!1.A6@A]-$1HA6KIK/\A%@S)W'E6WR6R_C<7X($^P/')'
M$#IR3^(4A8.=)&A"N4L34*6F:;!02-":1JOA)YOY7(%+EDA9_OD"4NHO+P;;
M'LZ!1W77 $^*N?=_Q$-S%'E*^7!3AN*A'CK',D$+/-R IRT)59AO]02X)1_S
M-GN /&8V:(\9!UCVPOO']8!/[=%/^=XOP'VO4FF[(=2+NC?# XE@E?%O F5X
M8<;B.%3AQZ:W+\!"_ -);\5]F>/;[PNI\SH46 MX-AJ*E0A_[D2#C5FV+\"[
MV]-SU8][ C68^*#W:G^K-Z$?%/I8*K\)I%)+#1GW4;!0R?/)$J2AB27<J_'=
M[N[8P;6\5RMDPW2B8GZT D7?TEU%(I.LH-/ZSSB5'7<PT0&9F9$UVU0+1,)@
MT=ZQIICH3"D-N_.CS7\+O7C_(IW(B9 (X9V3+-@U%]1749DD2?3J=<-045,H
MA9"?Y&-6#'.I^2/,T_VG8)+9O0O6NC!^0#S?(PJ;"5\)/X3W'&D_O$.>&N9?
M_:%W%$*7^9$'L<8([2/\LDAU</<T(;Q_NUQ8MH._Y*'6(O;>?G)CZ@'$#L<4
MLR%HS45%8LG^H'?#BW+MEE/(VVM3 &Z-/<78UU.-M8Y>E6CL=WN$ZTHV(U:W
M5J=B!WR7[XM^WPCFC# (_A!(5#8-S]%11S;"0\\M00>#0-RD,@P#!_X:]E--
MD'JB$ 422?.LUU'DH?((D\'VN)X6^JZN<=G,[47GF[,'1BD?>@XT2MV+L>LT
M:'J6[I=OH*;CIIJ]QE$5.GKG:K(^_^G%86/DMBEG70M36Q!5KW:+<C\V+$=I
MQ[ 3;IFD-^JA0@S:'F]C<>[PL<P)8NZIO$SQK*.1#"7\>@;-8.$"$_?C8?9@
M#Q1W<>DT?V5,Q^(U;*..1V7-XTEL16:[.Q[2C0GG4B=?G337^%.Z>C*5H,1^
MG4Q*U96"3(#R=_ "+7SKC"UZB7+B*!9/2AM9Y%\<&6N4S61M1[;3KE#XBB =
M"(;8)N;.!G@"[%:P93.WIJZY4XC&E291EH;8((.YFH.@^ZXE&HN371%12B'5
M^G0N6Q6Z%KG8MKV"GAGL?IUP[:;C/BXT0)(BDO@*,=;Z(6T4YGN_+9>'S)6"
M-3Z2-@(F0U4[R2[CB:E3;?O*C"E[7407^&*!^=5TJ8G5:F7:%/F"BI,?-%SL
MSD]\X0^Z6'8QMQ^[7C366;=@HA:OX^]$93O#2Y"04B.=OZ]"\C4QU[M-&]06
M-6)F-LVZ3(3RR-G"AH4J;0OTL-6.HS@+J:I-/HT16MU(QZC,#U\7Z>MNW^JN
M: 2E!D^T3W)0VZ6#PDQQF#N=8#ALR. <3*53_R-U+?52U=^DK(GF#2S"64KD
MLQ$#&9FMJ!72I%.X$5 MD'2 5".E\X1ZP$TK2'Q:0# =>8KN=E5 Z$3OYAF:
MA8!&MIFGDOQ+W<EYVOXELMIW%S<\ W'+5K?G'V:#,RFEK:#$EF$=/M;JZK]D
M'2K^K<_F0$-TZEP*X-2OX6U2G[!2USB=?E1F:R84UQ5Y38FD-5>16N$I#ES&
M_5V. 9?-^3-(Y(WN,>YFKT;0>,RBA<THZD\"[I.C*6?G1#^3_YA\OGR. ]7S
M?7TOPEX%NK9T8%E"D0;H)&NA@8[5N1'?O],X:I(P[UU/3]$\<(_O"N7D"D[P
M\"!W<UY^OA\ )$64G'+Z1 >%S;IW5]M1H+3,N \>>[-])C=.T]\BP_QR2C3+
M1M/\W+E45!Y17;5O&W,J[D1>20GEKG0V*7T96:N;\CN]PM>J<XM&4Z@6@5%L
M]I-F..]WA=T)#Z1,G+?"D+H0C\Q"QR;5T#QMWL59G3D<ZMH::OL\<ZQ@Z(JN
M.<EZ@DGKBM@1K_F]^AJIW><"=-!'/\+&/)0)V6<VM;:>"#F=]<IST\;. E(F
MF\(LLPFF+XF$$8BOQ8?N_0W_9N^ 0:<]Y%D!K3%R29EV)%>FUX=>WDNQ0DE+
MTR@2F(3#>T!B=0DW?C-^O%:%TY9&@K[%,%I]^%B;.$L%/EA)QL+8QYUTB6,M
MI;SUHLCS??_[R0RWLT!0\2Z,+G@:NY;;M97Q( 5:;-_*^?CSK%7"H_+LF]J+
MM[5Z9>/R)+UKD+ IO7NK).71)K#^?Q8D_\F]B'LL%W;UQSY!7O(GH;RW]#'M
MK9S;) GS%G<CB9@0_%\!5K5$<N!LW\=R>I[B';X =#8! =L'2K^WW*AJR]%Y
M"+WK,0#ZQ-$7*YB1\)N1_U;1W&HMZ?MUM8HOMJM7%0O<K]PNZYI^^7?CYKH?
M=)_S(_O5IGBY9^1N2KB',G ;1/%G:C3AHE('GC'H_%3;XP?[M Z0Q<)*6',(
MFE!WQM)P(:_))!EP3NY(3C^BP2_[!<V]EM9O?>Q/W?GG,7&/X6S.E*]V_P*!
M'^V<F5I*MVC7I$Y,E:;*UM?''Y&SY%[II2FYG$SQS74([?U"JO4.VB+0'??1
MD(L8N=#YX6MBN0Q%PX]<M$578[?M"2"0 5"GXYO%DH$0M<B0B:0PEJ?)5<QY
MU[Z_:Q5"*S889R>E/E3O'YQS[RLZDO/U09?FP?1E3XZ/[E(RP3.I?=_GC5=N
MQHRFI6V"M;U.D-U+)IQ*".MK&>I,DF"^+4Q>NB.9UPX7?A,8#46;)\2'X-S:
M(I>ZA\VTRQQJS]\E6^T]"JC9L"_'GW3W=4.@*-<P$1B+U^#^-'EU5UFW:$+(
MU--)E6@R/C_@?HC^H_P%<%%,Q_34+"2M*H$$4HKP\)#F,NA^:RK(^-GML'HX
M[8Y)B<;3I;HWT*4 '7S:.6HC:=-RI4+PL3BG_/;1K6\_6IL>^[NMLUWI\J)N
M ?SG;R>4S\D-$FW4!D*F[_J)'77?[2.5[Q0/11&;G5S*J1;3/4VOVR9ND'_C
MAAM^W+.&@/_P?N],B]2_0G]EI&IR&6L:<OE1<9=+ED'A1@>4HHN*1OEX%[,'
MJ&6#P:ME9O1<M:85@4;MS^7U/\#&X>H_>^$D+]+HW!FA 9&".*3!0ZJ(B/'1
M9D$Z"-1FJ@U6M$Q\$#H/-I<:J[-?@,LLGAM84MR-P!-;*U+(5PC1+K R*K//
M=9*=R>B'KHH)'O?%U+9!O;M2)6(-@5"5/1/.I&FWCY,<MP&=;$0N>K;_*$;-
M#9R:ZO<09D86("AIOX^_Y/]J[ZVBXPB"+<$6D\5D6<PL6\Q,W6*UF&598*'%
M:*'%S,QJD<7,S,S,S,P\?F_FS9G=G3UG?O9OO_(G;T5&9&1 1E5%'23.",A[
M:)1;I4+\@U&\2>.'P,%Y,CP-F:N5>WO5VK^(SK==@HO6J1:J#$;;27Q!?=(F
M<-+)W'\;@764^;G@6 -__=6:-Y_<)#++3MOUN/KS.M_Q+E^AS5FYL6"(AF2Q
MG'N]W:-<:R/(H<D"8YJ(/%?WTX(8?$H*1'4QS>%LM*NOTV/Y,^^KU(_:3L+L
M&IQS#F/$7O-O7Z@CT@!"HI@C(OE0D.O+3P$NU-GFNQB+!H"OE1B9KG<M;@+V
MG'K]?A(:-1' LN?K)GT6O/']6()@J9B6&$RM./D-0(>F0K@T,>7MQ ? IZWB
M S!Y' 'PQ>MH[7[KB?']177MH&L<$0? ELGHT@8WZ'TMUD_]&39\C%5;AI")
MJ'2G"BF"1KP& \&*"$,@<I$G/T0$5<M55@!\6J>FMK6)!D T ^G2('-ABKK>
M]S)JV$Z$+L_D$N!S\;5V@TWU"/S9L2R^HJVVI(TY")W(Q18H7.F)O&1K]R3L
M=KKN=?_-?-W#8E7*9JK\)^M W>\.AEA6%*^19>VM(O[.N\^08$J*=NBO#5U$
MQ8S6Y=<81U"^PR!-;6(4LV[*D^D=RY]4F;LXU^@K[BPD!'%!:'DA:$[VJ?P!
M23ZGGS!AG)$X@X2RIW,-%_4URN6T_&2A'0D*/+;YM"QTW2*UE_AN7:_(FWM!
MT7]+3S516X=W!'J;1CG,*D^=D5<B>AM/RQ*;8J?)(DY%$"D0^>MQ!L,W4\"C
M1 18P[\0 >V(T6PAOJ 4*A])8QHIKT2-' 5SM1F<!O N;]]R0\HM:(9AW5K9
M!([G B)KI&)=6UF.<;W#@;4\FV&Z2AS1>^.J9.KY6P,*,'C$MVF3NL Y?2KP
MS1H_A 6;G:!?-07>/31;#XV>O*X99PB%!/NLN$)C# XD9,S%*ZLO*M^P&M@"
MSLVPX.**-FG#MI7U92ZC=>]5\G$<L^=)Y'>#^,U0C$-7?XWO!??P5>1MP)*A
MOM*L??$'1$<LE4<"KO<*#L^P%@W>KH"82_1.XP=@"%S  R[=Z\)TV1_C[MW1
MW^K?;;8=-(,\O#%F-W<:IR8H-@FEU'/O>?D)L3$[VV;0#7&@@VQWX8WO3 P[
M9"T%2U964ST6N!?+3/(A"P18!2#T))++'^R8N6(DXN9TD3WRD!PD <J6S#MZ
MZ2LI:\U3-TL[\E(69L)P5K08YY3RZO:F4LNT:>S6GC8PC98.)C;TR*@SZ4\@
MV6;\*F;73;)@AZ/,KM=]LU#5BG"J\)GA!^"J] T?YLD[Y .0(JF#6QM&5H'P
M5]NO)V/8WCU>/3FB"TY&M3O?ER 1<SE798V$O==U:M&N89[?>$)0SZWUZ[MP
MFI;@_\"G=>C.'&'7PEZW0OMN**,6"8Q,!.F(M4RN'+G=%8B;:Z0J/=I13OAV
M\7E^K_?F>1OE<W*D7^H1R0SS?:U2/';9K[#P68S(420RC%^7H',X"AJEH_,P
M(243 7CP>RKP"^HISO,;UG-E75]6-[RV5BL?IO%BCDU3<&?]:FV;T^&LNTU,
M6'!R-9&0U4XYKBE+]Q_4F2PLA\LP@E1MMV\K=8@V51NB3?N'4/="^&;0. .Y
M9J*B=#4NO*?[C[UZ=,Y([@I(X/$PPKG@(Z@RX(T/^1.'F;,S@3>DCN]Z#IT5
M!)DK98CP3P1GRO^]ICYKPZV(O9_/CWWCQ?[DN&J323N&727,_5\%]BE^+,__
M68:7I8./1B07,KP6F*CU>D\K(W#-XK0^('I%B$WW\6S?F;@X'B[^W_^CD/R>
MU"6I87\*5^CBP?O:41*.<4ZC8B+F^NPE-0;,U_U'Q#WT(#-GH1]=HHYWR]_L
MQ1TED]R8RS=>/8"Q3P9/^PQ$VXM:FNW>Q; )4T 8!F3^)FOYT"$J&1;B(+<
M60TT/L3G&:B.WLZ058$(G>B'D6CK))%OKB[)-QAV)QW&ZH/#[KJHF?\R2="S
M3[I9ZV--+=M511(N+[B/.EC,FU)D^Z;#P#O$J26Q!\KJ-4W#\O#PWMJ21=7!
MRT53T.?CP,7GNRH4=,WF*BMFU[Y%@VGHYPU2MJ3=N>T+F!-S-?O<!D/H_.XX
MF_?)9ZLC>62=PX.Y(P-)?W\N=-8NXXZJE:RI.%D:D 1N2%L/G?+^#AS3B4E.
M+G9A_=X$+Y'])71L)G8M>)1:,^!9%XZK$P[5KV#M5U,=-U=R]);#_;?]A!A
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M!#/>WH>]8'N_47CW51Q<O4K?M;S)GMF^J7\ XCX 1DT6QRK_^_++_V.0E%_
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M[\=KC,1)4;J"\2;#(VS+NMY([:7=UT&P*U)K0WDM+"6\#560P7T).TO3G-!
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MOTG'W-P(Z6(ZP-N 1K^Z"<0O]Y*,\\ 0_XCJ.'OY  BUCAH]&/%@R<H&0Z=
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MRBV^.XE7^X$V.#<%9G%K@Y6V-$1\3_>;A/.]/P <_\F$XZT2<["TV?$?<RP
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M#S^S^=TG&*INX036E3/0_0GVW4 3"H'8Z(#A;BX:EK>M$&QL0!.  A#$'QN
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MWZ*\WQZ_<?\4552\PE4:->-\:;CS%"#E>%UH;&;H=J>Y=*3R188C3IU5Y9)
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M&\S+&6[AR>8,H__NY(<?63#,"FI__NX*S5G;PA+B!A>CH[M$\PO]UB\GEY]
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M<#C$=_$#/J\T!+0*M.NV?APM\=&!OFM?0ETRBZ5[/21H'DP:/L1B'DRUY4I
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M1((BNH;6P'M/],U<<7#=3;#3I:0J[>FH.$,MZB3Y_@_.)!_8=C ;[8!6$7X
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M%KK''*'KT<%T*ES!7$*X6\B8YC3;?MQB6RZX&$5\L2GC;QSS"AOR'C^ZH?-
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MCERGN.:V'NN&4X)MJ1G[@C@^Y0:6OU;X^Q&2'>PI2E>N3PL4?'[UA=D)!'T
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M;=EREP6)UTI\)3ZR4$<0'+613/C>1"YP20J5'S@A[?>9-18?0Z7?G.'?N?;
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M;?DX+0RUJ!L[K;-0=C2_11H:9;,03]ZUDYK I'-;D[.08!(;I'F2UN%8[,Q
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MEI.6QHI#G+S"/3%CK,'_()VVR/W9I389HM:,-(6)D#D5N^&2?]9Z?*QZ\%/
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MB@K\=W8,OXC \D?TPU2JZ8E4@L>2B11L].P?V3^R,D/A-)X90&MM\RR"0$
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M_@?CJ47+?S&!Z6JL7UXTJWJU(HP/#F8(:,D:^[+/XH*=@=-/"  Z-DO/@$
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MF9*:)ZP' %!ER]F>A6K0F98VI(@OAMN1#;1W>WYT7;2VU+7JK5P7="-[?[A
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M:(-/R]W%:31Z)$E_W_L[X:"<USPB5Q*[DA2?Y'CH]6+>MKT,ZMJ ?TPR+\,
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M/.5S]!+ZDYGV5;+GG<FTM_F$^6OCWJ@4 4G!)$9[O])/(56_:Q8;V#WAAC<
M>(3A>[W/W[0LM=/FEBG%ZCRQ2@A)U#BJ%.DZA[>%LC=0691/F+@:<(R\9JY@
M$%/HU@DNB7D$'^"T0O7B/.LE#(L4GBH:=4NWG30)>G$2>^'42H71[0P3C(IB
M.@T(5R*75_QL8( 7PWYW6)K#GUE<F%I!Q9Y;F,6+H>[V49\O1.T%!GK2P,MO
M9W@$=W2OTR#U@:(Z?3L+LFLFSII[A%VBP=OCK/D3^K'\-"#LF9?Z<KM;((DX
MU^3@N(+5($&&5G6]$;M<%,K>FGW#N9$;7NZWCV,;H8W!AK8_(S4ROC!6-,T/
MA_W.8^I=3>?5JHVF>4_!(:<C#+[EP-_?/VR&5G6$=*)&DR;+Y!QR.F]R$\(.
MR8^Z[JTW>J&VY:51Q0W_]'D),P!\(Q:V] 7A950-M3=0G'9_4 X05*-.I:"J
MDY9,J!#HY,A)LYBDUY$0V] B#$Z4D5KWTD>;R&I*&X)R9IX&<G4?<-M5G>N/
ME[$.!3$1=9>HG62[>HAZ\FX7*;2:T"LXP6SVR2ZA3J/FD:&& LCL$6X %SUS
M"1-C!$"]R-TS*_>:D]RLE>++178A)M8RGVR-&R^02%&K9>0O\8!.^,76-X"@
M>QV\X6<7&Z^9#!7.*ZU;A4IQQ )WTHOP+NVVB!:%R(751:N7]"*Z_JR,+1?J
M2:ITJV5V,S8I(BYU>X?;(Q#;A[IP6<=<TZ>M^Z"J0T(&AV(R4G+0^#@DF57"
MZA::XTF]_T-)9)9)\X39ITBRW!N\(^D9*$PTFTK*J [<++,ORHGM#8#_C;KO
MIQD_Y6KW>23)'N%*;N]^SW);BTOB(,C^#5"+;$J4I+V )ML)RR_,%!W#+72E
M('=^'=O/Q_,26!>S5@[Y3MY.7N0G;$/,7M.>739%<V8H]-##_>GG24QI-,C.
M_,%&%M3Q!0,KE%P=8?.%B]]T.? @A-G)/KNPW3]OM,6+/S9CWTN+57<8'V4:
M146?%;\PDAQC1B$O,P/MS"J9L\-F"2-$/C>;U@3<L\Q=U_O*BAQP!GD#B.$%
MY\0QOY\K^8C_6/>S+%F$QC&"M)G1$YG-BR+>_:CS>/ELO"A@_N/V+@DZ8<ZF
MTOA^OOJUWB_.?]BR?>VSL7GKI4QY6Q"ZO-,04K8GU1\Z,B.$Q5)_!.[%<[B-
M[.YV5F%I!9$'SS/A^LOHC6JYP>>U_O*:?DWAK:Z4KO^HB,6%3:F:E_6IT)[N
MRSJ:ZQ@<92;$@2\.AG:05>>]AX1@)<)FOY.PAE\&FLX,2C\@E(C7CE#&,&Q1
M=5UQG:1A7R7+$H5X%VYFL9W=5V<BN(T7.UI=\TZ\5J>( ,<GBVZ6&S(I*RP2
M#B9,&(@!QD$!/RT3KO V)!:\NQ^E@&]O9@USQ8F8JE[U()T/Q:F!ICHN>@.H
M;8-RSWP4- ,_VR-@!>[O2[59!_]@0ZZ(4D0W#&!B/N]] PA#7E?V\UGO*7[]
M7'V9&.^J?/D#2Z0]+B=%9PU%)=^S><+: L_=G.D#$/Y,B(JG+-,#TY<:X_$*
MM&R2CI\$0JLE/@)1EZ/4MQ6SB7?C+U.-MXVO2PW["W]%0"4YG^LB'GPR_^BK
M?BS]O/]ZJ..K$WBZ?&L[6!Y5WQ.9Z&6SB;;STC3>5?4G_FW@':-@K;"G_3/7
M/4-Y5&%;@I]>D.^!?9!VU-*#*\Z[DTA%&/'.+(IG<[C"J=];\MD9E:\'*\H_
M^G)Z(_!V\\7LAZHC-ZWN>5O+"^D5C@C2^109H:B"]SUO]P<V #!2^* B Q'Q
M"A"_OD_3UO@?Z(U+@7,S+[+QV^><=QO+NP3F=M(_%IRJ0(@F_7E10MAT]"1F
M#)I>4\!JNQ*J_<C,99PMQY.I&2$T9+GTA"Q0L*%Z2H8N3D0B!!$(5L"]$PC"
MNN.O2O/U1NN9P]4MK4^U"<C3:-46IG]JGI\P.+L*XK_B:?2;<@\%GQP)B7WN
MM3N2GAJG\7[VW'IID]\6W.C]-O1R_WYO_[ _VW,B>^W:OGW3WGV0:'&K3/>#
M*9#@'S:Y^ @Z.?L*T*3X*O?;7R\/V'K-U<.^ =(5L5A(IN\@04)C9'\F=H _
M&F62HNA(_H"?70I:U;Z$W&++]^'*_9@I>:VT_:\IP*DZN*E-TTK[$I8'W2*-
M)'U.6UOBD<JY?&R)<6Q,H9:8%'.[))@YZ$DB (R<,X-K(R1NS([5I6\68#=-
MUQ4"6/(QPK3$IU:W06'+A( &_'-T=(MSX,*#B>PI@REE&SC^0_FI\'^DR&S9
M+_PU^JES%?_NDO7'*C%\%BY_ M$"Y5W)@XG>Z9BTJ+!LPZ?+/[4G+E;)52(N
MJR9_QAW%4?^91&4\#/[2I)("/;69@>[_U]YU!T7U)>M+&I X@#* A"$)XA &
ME"PY2490D!PD9U&4)'DD@V2)DJ,$@0&4G(><09)D1$ 9<IY%=^OM;VNW7NU[
M?^RKW7I_G:I[^NL^W5_WN??4J>H;51!DTBU.6\*:L#6<$L4.YN"$E@CY.8MK
M"+3CAX,6( !P<QO)X\_MO!CY*2%WP9^XM\[2G([F(A$:R9$5U1B42VP1#B?(
M8V &@ B0K&*9*FCT<];/W*3C94<XH<X3['-]^?V5R4M%T'Q\;:*V;<J>(.?A
MXS3];A.L[=OL8+VO43NHE0[A,ST>CV5+T8D),HC0KTLV7;>73.C!S"O*?"0\
MY<D,O(P.J@,Z!IC4K3S25C' <O6QS>#\<, D(Z3!P03MZN_VLG#>^%+4&)%Z
ML4U]WP7M^5L3^W])V^).N^V;  3NS$OZXWGW8B<9.!TJ<SL9"DAO=0ZR]^ 0
MR3]K68ST" Z^]^-RW(C[^E,-VLZEK5&DFR?5O?$Y=CWZ[RNS]][U=:JQ",FO
MBOHU/=CDE4T! \@M,I _.>!]K9.^S)DW*K[KS2(CUD?'(CDZ5W*Y5'7OY >X
M&$#'4B:6C_I>>X+A?+Y/ 9*& 'PP58ECV6J?%=>&+PQ[10/G+R0F%>H<4 N5
M)#MQX@#V,8#O-,HQO?_#^X/M\ZD=F0OFBA1*]DO=+KI/11:]1<43EX<ERCX4
M\3_4$IE.4T=7EC/48WGDG(RV,, K6M3"/-_%R-2K80]R#+ U>E1GOOQ,#@-\
M4+]E%#K?\.5RYUYL2[W$<R3#7:- G[.[%S]TCV??^FQJH1*S:LK<?.I)GNXX
MD<UQO8F 9#)>]DMX)H@+LAJ?CCN_^_)M:&4FP[=@N5^ILGMDAC66O9#DJ;HR
M%GG- %5JG,I-A74U_?D+IAJ=0HF-2-7HZ>#E 68*96D6R/@9DW6KU%G,*424
M!P-HV>^&\0-50,9[<V);W:=N%OO^<@845 ZHC<%A&Y8[V*H2O"M^H*L=0\\H
M=L)!@\A^##IJ#LYT?*L0[G+@F+]"(Z#P%)89+,E$C(48)4R UUU_]RF'AS+>
MN9BU.KSC1HZ+K.(S*#^_):B;0.XI8--3Y/K'3(G8=/I?II!==D9UUE&I@/EO
M\9!?5Y#9E75DD=Y$QHC:1+7YL&9LWS5IN*RCX$+11VJNFH%\?9[*<(6Q&G!6
M2NKV>;E?'W+JA1U4X@1'<X^K&O7>^P5#'VC$*K<76H?H'C"SGF,JA=/'X_WH
MCY:S9@H@S*O)*BBF<<"SI9%ZY)Y-"+X^=*#"3N#/"AYG(F4PD$44XFO0LGDO
MK17R0QD4'GM41$_K3C\)[I.' C1O?6G"!YYR05LR391IA/7&_WB.C_C][5,F
M\4^=X\GR6+)44^:[37_ &T)Z+Y6W/<-T",[AH*;3YAK\O S.=^%]SSLU;WQ3
MI7LU?G>MG_IQ]#,U 3;?7&EM0W[B9MI."M\D)4UZ#?(:116\CCN N@?#8<Z4
M1O58<=^;9SIVQ4-RC ]W7]F_CQQAAJ$0!,16&  LW J!8DNZ6:6&CDA^:QX!
M8YGVJ!ISG#(IR0$U-QJ3VD5>S3*'K#"[YC':#-7_--G=A% &-_";'"=1P@MF
M&T'A)- 9GUVEXBR6CN<Y&C49E5ZFGHMI-*3#_'/)PJ&1':OH/FP21CX<!#RF
MT;7\;L"+O$?SXTS'"N'IHSC'@OEFSWZR'\,NF?\X%3!MX@/:WU(S7,$ >!GM
M!F_D+J/#""(UO^_H<C/?YL@\;R55R\APZHAXHF+9')P9B I.$IQXJS$W4%GU
M'61 F[<&?K+)6EU+K1Q1L4E/K2=EC[7RH/CHD(MV051^<4^A"E? 89H>BIRU
MB#F03?9?2<S9H0C$"AO$EM(V_\ZC#;TZU<B\LQQWXCB;G']Q&!U95=0R7:5^
M#5Y9JK_8"UH=VA+77*+/N& 7.5-4T'MDLJW''ICTHM=+V&0V[4V/F$PE!LC=
M2_/)H?S 67J8R]@J)N^FN<PH/^A1-E52UBX>+D$N/'DJ)3)2]--6\YRE390#
M'95MU2!Z(_[XS?";)781#*#(KO?(<%M)(O"5E04#?-_^*-_L8Q/XE/=<=MUX
M W=3J;BA4&$GBG@KNU,\(GU_Z['.$J,\8W"=:]E^P$'.H\OQK&/E\+XGDJ1=
MEQ*F=UZ:\<6>YP\%NW8VDEYQU=(5E]Q4F5MGW13F5>OG$"?#BW_NXC-6\IDL
M[E7^$ :XT!%W T4[5GDT35=)$*"1/@H[,%'*^!.A!B*>X-0M$NB<]8%/M?5K
M\D6)[&/*"F'CV+"AC\=A4:(XBH)Z%H;;#QD#7PT=)C&V-)A/I7Y&71))_!EE
M$_^R6O$U^<+O*5'*1'>)%BLT^+G)!FA3N3ASDXTY:IMZ!HQ&$%L]:/7.-1.)
M'0<LK]V2.78S)VIW0BI_LVX:(7<Z87V$)D+[2W/,BNU4QEI[S%_"!\(I.=)?
M(KQSGG$%!-0Y:O$I8GU.[08HG& ,::S(+QFAKP]S12AV5=4Y]9]()5U8C5-]
M8HDH:!34DM'"I=W^N.@95&)R$^_ OQDJ-'B;GZ\@L)%81DN=OSY_IJ>%AH4<
MS$R=\_1K^_TAZL^M4DF\ WX6$O^@D4VI\U\:V>CM:KPV_V*X%7YR1.UE'QG0
M%Y:F0&H3XSY\6@Z[/IS4\5)[CNQ4)@DFL!16L85^*4*N[Z!=\3%F-Q\$D\2U
M\_5SO'\_"[+$@>A[&%JC_?6]6&F2B%J'<J$Q/Y3BHL645Q).H0*3M[O[L%[:
M0JN(X<5E=&3ZPZ(3GZ,8C;93P2XOR5!^*?+E-],ZU >,7(&\03_MN]5AC\,2
M?^649$3;[1M>,@.<2FQ-J08^Y\^/T2".U-J0@XA-8Q./3/O%[F9JF"^@WO.&
M?R)UBQ[:8'/#IYIC'KR8!AF9OK]:7'Y? QV5:8[62@O(@7Q@+CO,O=E*QY]U
MJJ]0G^;W_4VX-Q%CZ-_C5K;(M,7,O^F>:Z^;;.!M*A9?%,KOO"'^UI@P_)/]
MRNPRHW374EG0<% .79O9ZJTRVCGF7.9@%T1O0.+/K0,1+[TWFGPEX3',+NQA
M @,&AAZ< [*$%'>G49\R[)Q8B&4,^..WTTBL(L-F%JN,;4!8]/8YCW:_AN/=
MIIU]279A07[P25]AC,X)GR.P@LW7]LG]Z>,U1]W5^S)(8A,$\\H$C;U  W>A
ML?MDLK3(B!W$5E.,K1,#3'/!;YK,(MV(;J/5,_';U5ZL7>T!R1W3<>K7G"^R
M1LF1)*@I6'Z'>"#C527_%=EV&*8B/R7(;O(QX_HIV$MVW<B&8/-!B6&A[$XB
MV9]UIOGW>&E]DT)#2*^H\S3NCM5IEN1R49+;\$A9(<( 79.-<+B^K"YH():@
MI"S>-7=+ES3' OPN(,KS$Q=1]+>V$?*)1)VVRU[9RY0Z 7.<L=FB,2L5X;*=
M%*T4#9*Q%DN1-%L<@6;<:@G:U8&6$:*)MSIG#R,62>^MR^TCH]RU_ADN\D7Q
M%7GTY(RWE00#A:Q^XT1QQLFH3ZDD;@A/B4AYC'!B %O->J8V$9[<*D_4%$/!
MJZZABN/B]5])INBRREQ.=A$=+!'2A7ANK&P]7W.(7P2F(I==)H!U)YV.0'[M
MJ&^K/[[5Q<8 9TR0R9D]>1:$UR_)CW0TO1_6R448;L*#=UL*.VM>9+V$T03U
MIET;H;#=?$!_MZJ,$"8ZRY^NF\>YMEAINU"*U\.,#24*FH(@!YC U0A;5/+1
MW<;$B,";DU8!$X\3O%60B!&"K26:U6S?%O*@I10JM")>TI*D:]$VW@7E>?[%
MN':3SFE#(&/OH7=H/J@>;G-8UY-5U?S\0:6M[L3-,6JIS;FX^<:Y>BD?T2B3
MH/+P*GG9Q##:D#36N8!87X/+Z_H'Z07MZA&4B[")VNY8?F01IY:*P-O]C>O[
M=<1=!;V*;#VN=*D%<)NR&Q],&4C=MFH4Y9=-RQ?.!U9H)R1#:)9^[#W>JI6V
M?Z:(V^X[K!LATA+7':LYIB"N_H#=( X#.,?Y="#O"@^7.ZI]848/YD*:U;S2
M8]3J;E\N<F" ,'NZ;U?99O_VU?I(V +[WX!(G]O?C$4JUKMNR.U09K#GQ)8J
M^=0J22S-X(L(D*!F6(V$][..KPW&CCR89).896-$.P2DW02M;,?PT)UJ>N&N
MHS98-V,R?E!$'2-;!B("GKFA()'>'(W8KBO[,2]0ZD?7%,[U3=;E6^I$GX9U
MB<<98PGO>CP06<D_"\R^Y"IWS;[*](]RRQE*/+ZI)URL:<]"[[<,?Z6:2CVN
M6+F9$#DU&!=F;XPGO*OW0&3UNF= =B-7^6 8@U2=J+GX0ZX*K^OK*!O6S3C-
M'Z21Q\@V<9C[U<K"3Q21'3M:&6Q7OF@JU(J(+LT0_](6B^1?99Z!M/QM9&2N
MO%EM^K<-P TS?IR,U!G+M QH:]D]-U'T^Z0E?%B,2J]+\@S]'C9')G97WYD]
MMW3H1N![.X @21)7UJ660AZJF  SZ'LKR 5.JBNXH7B:2]^H#F;MN 97B?U*
M'?"NE;KC'=%;/CRY^>@Z")1<LK^NK+U2!=?-)22SR5?F!/EUO$:91EHT&C"=
M \2G4C;$>L=VJ*T4XMIEP[G*8_ I2H0YH./9[XR)T&-6#0TF%F?+$2LQ(Y>/
M2_'JK"KT%GW[RRN9%\GI)#-L]T@22P[7FCBWX]<,\8HJIASR[P0;%*%B/N39
M15O1Y<ESTB2\2"6IJ% MD.(E\"4)-:V-PZ?[MA0LY$ZI5->!L*/=,,][#2EL
MT(H<X,AT358,]B.GZ20'X_I=PVU+H[+[+(RM"6F:/;E_%5BMBU9-#$ UE7C%
M:V_EOY;8/]K_=Z_2_W-?_EKQ[>L=4=#9*K=.KQQ]L^/;@S%7&([L67IZM /"
M2W?W2AO-[EN'L(4"O ON9%EZ13N2CKYV#H[LNICKPX]6I4)4N<22:L-J[0+6
M7"K#9<4OAVH1@MA[Q$:.G;%X"#ME 8>0>UH0 H\?JG0\UQ>#*?:X];O]#1Z@
MAG:M[1I "UBYD#M@DZTJCSP6S\CFW@M]AHRT(@9GO:,#C3'PXI>\[2YO^1Y5
MJQ9E<X=$G'87MBQS7FJA91M>'7ZE!(T]VXL1HG?KGA#.+Q'N=R&<6.SZI<@&
MB@+'6R/?+?? B@[M^I+2PJK6@6)PL'!8B19 -UU#U\<:(QGZ-(18)IHF3X9J
M5(!PD/#3.[LX"R<K<QNZ6^9\ T(!:ZV6IGQ<E!66 %52D E/-+O8K'G,UI2N
MI,1I_?@BCW)NRUR#*=FW=DO9N0WL];J<20&ZR=+G7HP]+*@%4.NT)-U\-1VK
M\#"UR,_.W71)^]V#A+6N'??B2QZX,9\$%8_LCR=N34X7XII'5E_5H0+N'KVN
MYL=BXQ@ DF2IL-3Q+0TU?=&T?Z(PE^$MYOME=9.K/VIA3^?<R/0=8Q@DZR6[
MW2$&&%UE=//>W\6Q2BRI$9 (Z#=&NR.>OH89A<RFE<U@ /4X[R]'H]TDZ48?
M9Z<NR>[Y=*S1O#VN\&!_]B^Q/,D(E7<7^:7\_J.OD%K+KI6E:>^.[.K//AL?
M+M?N;ZP0#+(_<;3WP2_ZO'1$/'6>JJ]>F_;A"JWJ= 3_J?X/P.W;CE]/[7SJ
MHCS<L?E1$_HIC"W?2X\;V@0DV*E&?[#;N5TM3/^BSW.2YQ^YU>OSGQXS@WH_
MFC62[)C9*<!].3&Y'N=4],NZRQ9)BE"%%:_?_,V@W01LU]%BP]&Q.YZBV'CQ
ME<&>+18TQ: XN5[K.V--+!$RQ7)4CI:(QQ]'"/,5UR;'"TOD9W,U\LM 6 G^
M@/B1&R<,\A%&@'[?&D*+919#G>3CAM#"(G06EJ:\QD.L@> F,%NI( '7^P_Z
M[Y\3H;)1V4C$Q,!(=^]=!5QG5)895C];I6,_7T/PC9>LIG+%CVQS:3Q5LK7]
M\Q_EWJ6-7DE]HIR[?S*]ER&O]$2*%9ZDC?@JGT3-2VI"$5=!+!/2PVP6G*)[
M=I;5C',]66H]H+\O55W1,CZ2<@6]2L7;@DNNP!$@A:L)"1:;(O2[7<OMR.;.
MRRWMVN.\6\?=[]?>YG,[,?F3(W3&=&'/ZD;7"6+9WC7;G]=:/B'81<"R.)+/
MB*?P0AH)3\HJKT%D?ZJ,I"6!^X]ZJ(S$A/X-9R%]41UAPZ)Q_^'5^_^6_X>6
M779QK6)_ZQXW1'LB[%^K<>7/ZHGJUUPF?_UA/I\N&;[[XM<KP*.XD<>Y/PK5
M4746,CW7M#^! 5P9#O;YR-.5@1.B2G.'&D:6?J/Q9?#,.4,P&22CW&M+MX^I
MT]1&++@4*^CI+<(G.R]O^[?R/?,TL93<=(O2@O*CR%Z+/.ZK$EKEN;<_^0"D
MGSY^$^:.R+]Z<B!KP ,)HBLHF?C.RZU9T^9.7'Q'N9O5/C@99JVAO-I[5J(K
M-\E=:R=)+FW)' C":R%=DH]0P8KYL:-<B*P3T%;-C<]-P;ZJ$R&Z)#.^0<%R
MZ#VLB88]%0R0P(@!*#'  C>,$"W7IS/\^^[%,"DH]"]]=O_;(2Q<8A>! 78Q
M +< D="=3N$L0W3C*Y^CMKU7L.SWDUN<=*DRFQB@&?ZK>^ F@>AB5Y^.F'3'
MW_U ]^\'YZ"NHZX]>,6M>HT]O-0;RW3#/)@O?P)02P,$%     @ G(I>5\<1
M_8'OQP  \QX! !$   !G-#(S,C8P9S(R9S4Y+FIP9^R\!5Q47;<_?H;NEI!P
M&%*4;I!N!"1M$9@9<IB!86A00*6EI4M219"25FF0DFZD!*5%!"24_X"//C[Q
MWOO>^[Z_^[^_SX^E<\[9J[YKK[WVWN<,< Z&#Z8 *FUU+74 !,(!N8/< >!@
MA9%3WQJ%03E9HQS H@)"@)2REBX>'H E1J*7YH:_-P$^%M!5 )>92X,%!P"P
M_UEP] %Z?7,D$@Y'.\$1+N;V8&-K&X2YG3GZR(KKR(KJP/;5P)VZ;.9O-XJ7
M<S.Y2(]D,D>RN4,Y]@,Z:I$ZH&V0F O.& =G#+:)?\C3=\(86:!0B",-+20&
M#D<ZV_^X/CRK(-"';<HC6R,;MT,-91O,H<WO/N%H/7-[N+':9>.?8-\-]-$H
ME*41'./L<,'"%HIEDP'Z !I 8?]9 F# "( #&, 9<#@R(7'XJ?W#C3("@_PM
M(C(+9QL$Q@9YY!+;)C[25M&]<OY[2F4/]7'X_]!CFE]Z?,$!8X-".F&Y#$?]
M<L @?W0"VTD+],^&H963[N\2-%+E]P82\WM#QP+A]+.A9X5Q^=E0LT>H_FQ@
M\_B[:V6HG=5OB?@>(&"HH:R"/>$>7</ 8!C*V4(1-07\( TT\B\\9<1?]931
M,&,3)$:=PQ"! 7XA900,_'=\0R<$YHBO[X90O/R33>("AV)0:%5SC/G/JM"W
MTG?Z416'U[^=58Z2 +?$_)U[8VRQ_QW?"(KXSM='0Q6O_&130=$HATO6<.S@
M8L?+!FGU(V,4AP)#;$S** P&98] (:U^,R'[(3D,X1<^^0^^H8V5]:\"TA\"
M;&P_V8>5@[OR/0;<5]_$L=,.].-\5%7<1S**WWN@X//="H_\J'DX<]V.VDP_
MVVQ'7C>.VL0_[$!'5CQ4W]/\8_B_H^!N'EUK H*6EE@) GLD^,WH.^=A0N)/
MCLC1\2KV^(,C?G3D_YUSY//+T35V)AW\+>%^.!3_^V5'N2#ZGM&CN  <Q>^?
MWV1L/_/TO7WR\ I7_&?TW^DEUO3ES]3]E7[A'>F]_ \4?M+O"P. =$8<%AC.
M(:P%RAD)<_K3O(1BA'^$>5C,OQ02\*>* Y1_K\RC, Q_%MY1: 1."!LHW.DB
M0N=PZH#^@(-_),->T& _A$<-+=5??!-:H5'.#G]@$:#0-E8V/U=%-:-#HPM'
M/&R;W-P9@]* (^%H<PP<=A2]N\./19WDN_(AYU"B96\%_A_H/ZXS&O&'K>$H
M^7_DZ#I9_7'[(#!'8(S-K?[ HX#"L79P-XR6DZ:QKLZ/!8KH!_L/RL36*+2'
M$L+&ZD>F*+]W7O,'^S"[,+BEN?/1"D7L D=C_D;]X@_V']5)+:Q44 @4^I?D
M4G\W4-;X*3@,0P^%/#P38U .V&W("?YKXD@0V$3^A4MF<;34_85/BCY<T/[$
M/II!O-_ML!\<A8_ [WSJHTO0]Y4'C^ZH=3B@>$?M0WV O.2WA*5C/ZK8RRD
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MJ^-"X-4[8Y)MZ$M4: ')<9=6.M4[MX+VW'*8JRF5I*,+'XBB"9,J20PIQF*
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MLN1;SS-'[$^ T4!P7O"C!,Y6OHT<0V(B79\]5HM*8PI.W@#AX'@Z%UJ0-@[
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M.9+5/1^$[ '0=4OVR^*D$#J]:$3B,;T$TY//;1X?[3+KM.5R)U)EP_9A#@?
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MOWEY[ZV;?R^;3W77@MS:C^N%][L:.U*@GARV;Q8SP)&?3+:H86\'I$5" $E
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MN28[JFYE.A:$QX@!IY&G0:5*=*&FH8O4;V5+:\L9#9KK0&VR46D_M^C*\WY
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MN:-95(B&)&?UWY$CQ:21=-.$-I;7S511"KEMPG_+F;.RZEAPGJ^J5C)Y\'^
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MY%M%Y7[YV17^=W)HCB8_O$KKL%85:I#-DNA&ZW8VQQJ;H@X.+BW+YSTE.=B
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M+%B X [!'8*[:] $$B ) 6Z^WY%WSAOOOG?'>-;_=8^NJK6ZQZA:LVJM.5\
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M [)FGTHHF@)HJ:U[1 =S@(4?#1],Z[SU?IDM4H@R@IAV2#T50*P0MKOA3.<
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M]43;5M3FF_MCS/:;W:&Q4&B-P5 !:= &]MY[Q=2WW_XYBU "4 &X8APA1&T
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M#E]SD>[;7I]<SQR&?J=-B!AR[)V  P>\"19+5-[TS'AAA1Z*<SW=&ARC<*0
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MX-:W-I_PHY*.V+ X>RGAL*"E_CEW[8)^"9H7X,[)V&DVQ^O-L?;__21\UC
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MY.ODBB"7+OR@4-Q$1V#;<1'<1'8.HB/41'J(]=1S9[/;Y(I113V/L0GG>:H
ME+Y_HV'IYP></0WK'UCH60)$3!)G*? (I.X1/SB=),P"02'W(41,0PB<2#N4
M>8HG$3"4>@F$1$-QWU5K"X=:(G=_4:HM0!""4 Y"B&_. "4!\[QYO#;FZCN;
MQW$>NLXL -$DZ]GAHH\A $! A0$HF$H\H;@)Q$3B [=!.(B)A#J81$1WWT12
M#W8=.0.@&)]R7H4PAS%#_P#*82AN'@.P;AT#1%)W;?EY>X3Y=CEY>[)R\JAN
M=0NVVVQS@!SAML8WG&W'KI)U_(RX)_7VY\=ZK 0G*( 0H%.)C& "@ &$_4PF
M  V$3;CS".^_IWT11  * %*  4         #8   Z  !T  Z &B*.B)HB:(F
MB+__V5!+ P04    " "<BEY7SW]",'NI 0 F^0$ $0   &<T,C,R-C!G,C)G
M-C,N:G!G[+P%6%7;UC>^Z>Z0;J0[) 2E0[J[-IMF;]B;1D )%:1;NE&Z.P0)
M*1&0+FGID! !_0"/GG/N.?=][_O>^_^>__<\#%EKKSGJ-^:88\ZU%AOG]XGO
M'P&XBK(*L@ X.'@X3SA/ .#[-MF4F@W$!0*S@3C1\'%R X0D%901$0&71-;2
M8B/[>Q/ 2@%G $ @9Y2C@ < +G\HX-4 Q&KF8# (!(6!'-S,'6FT;&P=S.W-
MH==6C-=6N-_M6D<#VG+)OQE7;.5G,V)<RT2N92M7\LL#[KJ%X02U!;NHNKHX
MN;I<-I&N>&HP%TT+",3A6D,![ ("@5T=?UY??4HY0*_:.->VFK8>5QJ2MBY7
M-K_[!$%5S!U!6C)Z6K_ ?ABH02$0*TV0BZN3JH4=\)*-"5 #0 &0RW]6 !J
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M4*X;"M)_\(UB#86X.OV)A0R!VEK;_EH5932OC%2O>9=M+'-7%X@<" R"FKN
M+*^C]W3ZN:BC_U"^XEQ)%!RM:?XO]!_!%>KPIUO#=?+_S%&&6?_Y]H%L[N"B
M96[])QXV$'1I!_)P48#):RDK_5R@4'^R_Z2,9@.!>DDXV%K_S!3.C\[+_V1?
M9=<29&7N>KU"H;F!H"Y_HZ[SD_UG=0P+:RF( P3ZA^3B_3"0E/LEN I#!0*^
M^D1S@3A=WH9@H#\F#MWA,I%_X6):7"]U?^%C0*\6M']@7\\@YA]VEP?\O3W
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M'['?[WDW(P86!T+ 5]_(_@]&[1+'_/+I\/*.)6X%A3C2F#LY.=@"S:^LN-S
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M ;D!N0&Y ;D!N0&Y ;D!N0&Y ;D!N0'Y#X.@__X_XT%@2S$Z=[I[XM^G 5(
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MBTZ%5SJ-EU-6_)V"?#Y>PWLAE*+IC.5O?C:=W-@!9O3MIW-)CBM3[]U.+_9
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M=//?0M)S@30^=+H/A_"$0S8G%AO#6#_TZ*!U#PXHO550FEAU**;T""9ZAD4
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M7X.#^3=O"0:.BL_3>B7QI[\0[(2&,A]\SK,(N3=\N_49=40Z]^G3P87QA^R
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MSJWFNM^U?.16=HN[CEV<S&*$71#TDI9F^94^0)1A<@8S)QFQF4Y]WC>\+]7
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MK=BO>3XY7Q;DJTNHJ+8=)UB:S62+PQ-E)GJ?,]F;L9# :ZP],,5,N$<A_DQ
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MI*DLR?F!=_:-:\[7#A]5R$JSNK" EB9?'T=ZZ[R 37Y]EU.<)4HB+7EYC^?
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M.+;)74,?O;'65[BQ JE%3ME-8TN<M]>CR*B!WL=9TKH;U:L)$Q>AX*6%>H5
M%%>==/)_? W,^?9[(F*]%))LX4<)D438,BD(5,A1*D0I 3*4A=:(!2 !"E+H
M (!2% "@  FIY >)?MV&[0=FM3O;GW1\*V2I2H3.1;]*X]B#P='FK?9YRGP#
ML"=Y'5YY,B,='*J  $059_\ 14B@0$!_D0+K?$ H^EBS7J/;5P=+Z/'CV+%2
MS"KFO8]"2;AP7+EZU82CP;VX;SA2I8_JZ=$IEY:8DN]TO&,'MM/-N$:Y8+U1
MD*/?:\]8P2Z!+C2I51LTG6T/+$6C'$@U:O3-SN&Z"A!S6^KT+@F_;8W%=M2[
M"K("4URA2E:74$YOJEP0@"K@5 8YB7*K?TEF2ZY?\>7XF-*5.R&+,*U+#5=B
MI]_?9&%3D*O>RWIID1HS>22S9&Z/O^95&B*9$566F9U!0^K%02-; U(/;U:4
M.AW+M<-)\^M4,#HQ%;$ K*0U&!%?"%TS^EBRM%E1>QV(,<-[ V?TIQ$RKI6[
MKHHM:#F:UYUJT*>L"_&+)*2\[8Y^"L\R")5Y%$D8@]56[I$I6L]6J*^%6NUP
M#5Q2\ QS*'JG*06RCM'5S%*JO0@O8T+"#':$S]9^T3<F%UM#1G%GB8)M!13$
MCM95"-8-!'PS"/2$PE9,V^]-VS8J:"(;!(A!WPX4T/(\ZL=FHQ?5VBGBR"H4
M#"M2/K$/IL:,Y+DUCZ3?^3)7=\4.U?CQ=@FC7FI\;6PDL;Q)'9)E<EBB?1"B
MJ0%;=T6-31=D03.(D,83E( &.(N0IG%@:UW%!RL?+1V'HVM*9:TK+(4A)?K
MYDD,'&A"U%K4% U?J2REAR$RHM$K3,A(QX0W?%2[A)-3G*N*8K!O?V5NY1!8
M!'2G=);V!"@$L=QY\^=89U/LBT0Y#(DGYI44W((+)AX=RLS5$-@HJ81,8#"
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MXQ($]OI8Y54^=N<$&"K=ZT_SE!VU.8IA^)RCL="._/A,5\M7'Y-3PM:0 /\
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MRIVNTRBW.JJ=(2&.;F>KY;>. '_HG5O[@Q6SA_\ I70EZ\J6(A/H=+58(!Y
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M4M 7S1-)VK(Y,755=@,)(%AX@KT"@U1!,.']&P"/S5^J2G  D9KT#:TN&<5
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M K49(I0K-YZ <M>1>1E3\*G\F);!I LP;AIK>Q =1/8X#/K"OC!?-:CB:E]
MQ>C7:PJ6LSI=EVH]H7'%_G,=Y)AWDKCZNU=8].MR,T["$CPE)6!G6=8CX4[@
MS6:>HC)V.#1DGJ!E$V%/\&0WAW_='S.)<26M,P'ATM+90EL$IB.L]!-*7  %
M2DJ=A0$PN(5C5+9UN6!4.F<,!4.3H"+FU0\3B< 8>X Q 'KUYBB.PT76]^?O
M$?\ 6U\^.2.)Q"EDHX?+8E@V$6U[T5>K/M';^CLC&*0"<[EJGI6!8&I;4"FY
MCFV'\PG^R'&C])8G_LV5_P"#F?UD==EQ'VO:N  @ [ I 'N^ZV!=#W7]'O\
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M9#FL\=&R(=-A,5.6'/#Y20$J.96"F7"20!E*R"L@(#C+F5UE(2ZXRYN(G(4
ML3JL#E4H,2;AR*@.I0#J:]:1-VA+69:B4UU<S&4MCJOU\+(X6@7E::O+$K%
MHX,V8O%ERQS11;VU2E(4IU $Q@$1  Y;%8G$DE^&I S4!PLTD!RSDE((-'(
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MT>JX1=JL6:CILLHX;N5&J!W""ZJ)6RJZ*QB"HDLHW(1!10ABG.B4J1C"0H%
M@@L1<,EC+I-7#5THR<$-)H-^Y>O$'XJ=\5)T@T6.#105" X ABETH03@/-LQ
MB%OW4[!1K=KFG/>#WD()1*)2B41$1+RARB(FYA$0UH1$PB81\Q-U\^O!"0.0
M@"80*4!-L3#RALPB!2B)AUL=E(0H[]Q2AY%#1!"64FXQ-14JDDP;K&>LV2Z:
MKMF@NF\%@$B5N](HZ!1FH+;0E34(,B"8$.!%$RI&%?NWY^7'CO _M/;47I:P
M8OI301VLGD?),TG#15-ZD9MWR*C1=H^(HB)#$ K5=N*C-V0"'4(4!.?153
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MABE5+WASG:H+H."+-52'2=ID0C';,[500)'NT$4DM)CR'23(F.R$*7AV)FS
M.M(-0X499>H8$5+AFH*&@AH4DT"@$YC>UR5)(J27<V+FH+DMXXT#940Z"40U
MKITUS"(?,="'3X<&%7-,P S%J#D>LHUU%^0/MAF5:<=*2@E*2M+I22$MS IV
M]T,^2P/=!]0CY<HCR%]W\[8 'NU[O,/GOI<,734 D@7?P<NYKY:GIZ993A$*
M0 DY15(RJ#EB24@'<"M&C 95V'41:!UZ#WJH#OX;$1_5PHPI^H DBI*27;6R
M 6A3PQ7UIZSIUII+_P"[@)S;L5$R$\.99HHQ5.!D'(.VRCA4%UE7+5HX$T4H
MLL'>J'$I#'5^L.83" @_H<< ,L^<D.S)F3DVK]6U[N*G5H:>%X=0.;HR2_K%
M*B=B24<BQH]*T$>!-O@,J8&Z(&6(DFL8$R 98B!.[1(J.]J$13^K2*?8)D]D
M@ 7IQ5*UJ];*>U)/O$,Z) LE _T=[ZZQEZ<7\]M=_'G<?O< SI]7*GL<>Z%Z
M)'V4?LG^E' M87X*Z!ND =-@"9==?=YE /TAT\QV'0%+^[E]QOOMSJ;?S-5>
MKK_*[&?*XKRK:D:/6=__ )NC_P!A_P"/#<YV'[0A?F9^RK_:^$;PL4D0IB%(
MF5,X%*8A0$I3@DH94@&*0-"4BIC*D >A3F$Y0 PB/ G!ST_HE3$;]&I:1K7J
MHO7PB+Z+E4Z195JQ*"'+.Q,OQM')ZPO@ 2@5J4!5.N8 45 #+*FYU%C>>U5#
MCS**"/,<VC"(CU!J\#.)'3@S#O.S*N7H%RSMR/. <+EG]',;0Y2 #JW40:UC
M:%G?^]%,P].OO'7S'S]^^@:Z;#J \22%+4[DM=E.:VU8U]K<C$^&P5"0D4U(
M[KA+O33OA3U.:>NW+[O"E* -N8"ZT',._:*&][T.Q-UWH!#Y4L6M:20"I)!T
M) #:AJ5?1F8[1SG',-,204DH#Z%0!#A@P2!;F07Y@0N3.A-Y)EZ;]P?#W>8]
M/GH/T<08R?)FA@A#TJ$)!:FQ>XT%A&*I 2EPW8,M*W+#W?&.5=T46AUG0,Q:
M(K$<KK.G+9LT8N$R@1-PLZ>F*0BJ9 *0BO,!R%#E P%X7")QH8R,1B)05I+G
MS$-1A66U]:Z :!ZJR 6 TH6JSW8<SS:XCH%R8Z^Q7(LY5$YFR)DR>)49'5%<
MW?"U=&.HU,M]:>2CA. JZ4$W, #PN,P&-D@9IV(4WVIDZI<EO42[.2XNHDEP
M1#9;%G2 +VH]!1Q>MC0OJ! !P;71,!_0 _[P'^W^SBG)ERTG\[+1,)UFH2M^
MS,+C[[4>+J4A0VV)9S7F#IW]T-+G%7>'[Z ]0/7C";8[V.M:'?F/]X^X>-[T
M:"?I*4P'U6H P?N]K-[O//E7#^@F+G+ ,X)G#IBRIM%J_P )ZP  #,HT $5&
MI_RH?>;^H!UQ],S21PR2Q;\W+MVIC\[)TB2>&3,094KIU$*,\RT=,29Z0HF:
MV<E0)225.02#0QK$H@*9O(Q"@FF(=#D3V'L$]Y4_+92Z+H0Z<)+0C["&+$E2
M15P-6[^UX5&.1.+(PDH%J9<. S$C19K0CPCP0(F8B&S)F3Z()D68"Y. ]UL&
M+)V8II+?<HA[!3B/=) ("*90+=EH0U4IK8$:OR#)[2XWBTE.)6!T<I8H'"4+
M!T!;*[VY4=B2(UB&N8R0%$3 )3+)+]^@(?S3:$2B41$=AY:_0(0E"=4IK_)&
MP9BVW?M01%BTI/U4D.*AKB]'H07-=[UC6NH0C5P=0@'339 "Q#E Q%0]W>%$
M# ;R#H8!ZB/7IP@0D?534FX#D%_;XN!X+A$I:H31Q46<W! .UZ??"UQ%2:%.
M8LQY/U)I,1=;FZ1 35;9.#$,HWBI:&+X=!VF&R>-3#0%$2@8H\O((!S;P\9Q
M.=+=*9\Y)!(&19%1I28+U8O5C0QWV$]$$J?.H+!RDA650!(J'5AG#$EC7D#U
M3#DAC>NCU!9V(^0;64 ->_Y=?+?7R]VPXJ2>+3B2#B)PY%1+TKZTTLU"VL6Y
MWH;(%DRP^F44;LP[DE] *-S@!CFO ;G!5T!] 7G!94#<H$[L YO/0)^P ;UR
M>S]GIQ6_*)5LA;;H3_71%^1H^T/#_P"V@?@XKW](Z_[97@_*(_8/^I/]="_D
M=_*\_P#AXP/CNO[#VWG7H.US_+7Y([$=@&O[^)9W$EI6,N(FI.R5J2!^S, &
MNW@!%'Z#PR5,,/*9V88=+,&<,9?>1O$T_H];DO&YDS1A=O#I(PD3C7%^2V=C
M,BZ4D'CJQS%RK"D*HJ*?A';*.:59F\;KJK&?E5D%S'(!7!S#ZQZ(X_I,*H3%
MJ42A*G)"BZ2!7,N_6))()K0L2_K7H=@9>%D3$R9,J2F8A!6)4D2W6@LY"$I"
M@<YJH%0+L1F4#=EQVT>D11NPPMVT:,[[;]NQC&71C:;LPMS_ !)//;#CV4LT
MW>)VYQ$Y#,(=V^G Q_.X\BH-96*CIJ[XZJ^2X^/.XCXN2M")Q*4;;GRYGSK?
ME">1[AYTA>VS)W:6L.9,H4[&E@O!KA8JUZ0@:D>QL(W\$D3!AB,;=&RE-G<6
MN*/&62=:2E^:8RO),NWN$D;O)Q\8_:EAX4AD #QJ?W=E=;>T)KY8/;F:T'?7
M8]<6SMO(8JR'CVLU_++G*%9NE'N./)E]/]GR4N3_ !;+9#,66Q;D:8D;.O44
M[DC5H:>[RQ18=Z5I,TPWBS"XD$3C5;7M'GMV@<<^\>S0OL&^YV,QYV<^U]CF
MW95N<! SM=KUROA#7YK6K?BD,F3=4>9,RK-R+/"ET<2#>*?13&MR^,U).R=H
M4&.6(B'AK73:_,@RBH9H!;N[#\7\6/.!NVH[/.Q^(BV7 "66(_$=&:YMEO2^
M3VT6"5M>@>-[URX.8ZD>G(JP;)G775C0C3,494E6;-HEU)I/56YCIK =16:_
MCNW9ISW%-877WO1GJ*,]-MC71W\X2"*L4.SA*HYAS2WL6 :]:Z7>NT["=I"'
MOID<>242*$5BVAU!Y57-=DGI[F>ZK6ZO7"74=#60@CLIP%?78/%* ==KBH/=
MRY[%^Z&UK8@NS[[4T]OOAT^P% 9#QO@#&^%LAX0EL1.<74*IUTAWLUB^4C;5
M84 FB3\C EH5PL;<"I':1RIE7P(JJ^./]LI53<(.[MK7NK07\B'6T?5J7KV&
MKD&NL3[X(('!! X((K"FZ_VI1[8M+SS$X]??@V0FK-@"TTPTI5@FCX<>1J<Y
M&YG[_P##*6O*,F>5X5!%M!FHAK\WI\L[9)/RLW*Z1PDZ6VI5AW![5\;PC!^;
M?'MH^GP#6>\$+ X(('!!%7_:XKW:>N60\?W3"-(7<-.SM9Z;DJNQ[R3K3 V:
M9::?*5W(5)@7J^:*I%MT6N(E9$85SD6D2#9&W3L6]9Z<0B2B1?WO3G47M?;7
M2"YJ?WGMI6WC6L07I%[^D%S0K>%L5Y6R>25C<ND]/-IF QLNWJM3%6ZMZ7'Q
M,;(W.D5J,F6\HPK[K*V()BTN[@UA74$2)FKBWE)8!//9Y[X1JZL*WO;GIM45
M\']<XO[<,Y8(4]A<=H52LP.9:S>G:;7).&8E\^@F67\KM']<A1C)5 [J"=XJ
MEL7.747(*)L74C%2(J)BL)>5-AMN]]#J:/S/N@[O)N/9R%HN>$QA0V(B(B;0
M[$1V')O77Y]?OX6%BB*Q"7U@E>43:]*RG0-<HZWH0 .@@(;_ $:X^4IQ"5*S
M%+ JNVE[MK;^4^L<658($OE<$YGZ&Y<MW%A75A>*I:GC+M(T0V>9.%K>1%#V
M"VQ3EH,?=*/&W&7DGTXK(2/>W"<G7%47J+-C)-&I+Y(4&JWLC5)) *F5),A"
MZ7#\3AT!E!+E)=@DD%FJ5*!<@.X< J34$%*79L%_)85=I+,.6@JQ!#DZ7@_7
MM_:""ROJ7!62P3>2Y"AFAXLTJXCHI&K6>#QM"35AL-DJ*%0)BPY)"36?Q,58
MX;*5OKY;_8XN,19#&Q*/<U.GE.P2ERY% S4(IF)%7N0 2T"TOU"$DU#,Z/#,
M""DUN%(8!W<AGV-="!9H<A.3[1K&L6BD,8>X^L$Y,R<_196Q2] <W>LXUKTO
M04K93YJ8+**U1]E&;37OZ6+W"R)T7Y&S$'RW(D7E7I9+5#%S?HP34L15@!1P
M22?JBI 42<,:!5GOT8%-R1R)W%@*I!3\%!]LI"<;#(RDVE$I6:/]159>=QH>
M+KM"5N,ZM:8'M$N4XT[R[9'3HR2*<$[Q6+!%M)))J-UR'*42I,GRM.;>HS.2
M*N"*,'<U<@BP3HL*79@"[@Y+$4)Z@:@H34DVM#R8%CL],W,L?+3J<69&K-9Y
MBVB2I,NJ^OS0)7UXGJH./V<<,#C=7<3Z)9V;Q+@@M9#D2 1.(YZIR'- U2 R
M+L2Y8ZL7<69B74QT.$86![)1%'9Z'O(-6+':QG$Q2>K:_L@/\:FUT#741UK_
M .40^[?PX\RX]U' H,YY.')&S_%X])]$YI&%(HW6 [ LL;V \'A@L^3F=*[=
MY.;J"EJ9XG+V?<F!.3;-*C/JY3,B2H07X.K;'HHL390EPCP;6L73YA 6^ 1Y
MF(ECB" <2\%PZ)TA96EYN:24$A5911B.D(9!2H9S*=2NLX ENGI3&U)F*^=*
M&B@J[5J EW+EJIL1K5DPT[?+N0GW9]="U<VFM((7#T4IGV6ORTI3)P\'=X K
MI>+R$MBY2RQM&O\ 6Y&34B+TAA5.%A$&G*BS(1/KJ"3PY ZR444021):A%0&
M2]*U!V(8F'C"J%@:Z,:*(W9MGVV+%TK3*[VI\Y0[-&TLLEQ&/,A1DJ62BK)<
MZ6U8K8<DL<^@6,2&JD.1HS-#;+Q@EF]O+7TZ\C!CI- KH/5'B88GAB!U@ARE
MZHP@H#E3=0>ME,DOU6<0?-B#>V4?6T!+$-9B&8FX+D,8=OLO8;SCAJ_S%3MC
M6)FL8P]._P &+:15(ZT.OWL/.^KT6G F9$CHTKEYD*&%B.&J:U,@PK+4J0N6
M(TVFX/%EH"W('6)42[I2",X#C,K,0Z03F+NA82L$P2)2Q)(47=502UB7#T(:
M@%'T AXNT*(&0K','-MW*B.^O-H"ZYM[WO73YAQK^C,U) L[D:48$O>E2*_?
M'O\ \DDY*5S+64UKY6 N*O1M\HB,O,?^;_4/'9Y\7]K_ &IGQCWCI<1O,\5_
M&!S'_F_U#P9\7]K_ &IGQ@Z7$;S/%?QBN2<G\[5&MSS^XSM^K;->Z $*6SV2
MFL/6E*#B;RJZAHRX8XC\K(UJ1R HXBE(BEMVZ#N"48LSH/$S-D!3Z&<K+ZXD
MW#9!N"&-6%2 =06<,T<7A<?C%*^L[EP1-<!V_6$-L=C0@DB+"()XL[KL)).V
M4G&*2$'&R#AG,'3\<TYP+SLW1DCBH$@?IWG-]8;\H=].,Z9B\,BJ@K=T]&W<
MZZ[TUJPCI<-.Q2DW+AF($S<&SFQW)8W+U@X$OMAL-CH.8=;$=;$!#X]!UU^'
MRXHS5(^<I;*X-!2H-0/"\7IZ<2F< D+:]IE:/5FM#^]G,0&]OP$   J$EH Z
M"'=S,!R:#W<@"/)K[/76@WQA>EJD?-V H4*!<"B6'.]#R9H\N^4:=BOFR+T
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M:!))  #%Z UH6OZK.1%JO,/Q$/N$??QR*E%2B0]26&OLB\@9@&VUY;M#4YR
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MTH .;FPUT8?>F?%BG6?F)N^M:..ZAK1X-S .P\]>6Q_7L1^'77Z!XJ8B4L+
MWT#N:N&#5;V4B&>B6E851(%7&4-9Q:E7([><2Q[!>4I%SFW+^&C0;-&.A,68
MVR.WM+0CI=X_6L-KR!7#P2JZZ)FKIC&(5Y&0:JJ*F?%<2STYB@#E<QO8O0Q"
MQA5 9F,M!<!1)(8:,-WN;,SG-W7HW.2):T7=(46_DD)&K&BJN"1HP)>Y3CTF
M.S@G;+MC*JH)'3,=NH0JH$69JKIN!*F4C=PDV*?PNB)IE#8$#E*0-@   C\_
M/EX!R8> M[S[6I!F5N@41$J")1$Q3")4R (F((B0PB!0$3%$QA*(]2B81#6Q
MX((S A Y=$*'*!0+HH!R@4! H%Z= *!C 4 \@$0#6QX(()BN&RRBR:*R"KEH
M?NUB)BF[<(N##WP)*(MG F3*4^U"E?" $4Y#B(]# 0NGGV^.A$&P(HE*8I44
MBE/WHF*"9 *85SF46$P &A[Y0YU%=[[PYC'/LQA$2$C;P00FC.FQC FHZ:$^
MN*W5*!2%634-'B].B[*N\YV9S--$%,Y4WID (( 5 H* >\<_NW\M!KRVY]M1
M[.^L="2J+A%0X'*=NJ!P,.CE34(L \PHK'6=,'G>]>8I#F*8>8##OV0//G6!
MW'9R'M(YTO\ =![P00.""!P004"=$3=R*A1_@W?]P*J(DY.44O%_ROC?"=11
MYM<G*(EUR]."%\-F\AOO>L&_!"0.""!P002*+)@)2*'(@[55*@9911$BWB$F
M_I--LW3T47Y$BG5,5$#&[LG?'#F JA@/(Y^:^$&M/?:GPO:E8-CMT%-"HBD<
M0$P@)TR&T)B*IF$.8HZ$R:ZY#"'42+*E'95#@)!'#IN0Q3B!!.9;PZ)C* F9
M4P"J.Q, ;.;F67Z^T(]\KH/K!YB#[XZ%P &X:#70H].G7E'KTX((H?L(<M@G
M-] +*RA2:_)  -]GX#R@&]>_Y:X^3,=(6<X2I3NIV)U5HPLY]ACSO&2V4HI2
MWYPDL&)=5 6&A"B0=@=#">(HF=5,2* HY06,W(B=P@"[*4.5$IDEC-AYHDYB
M(( ;E%(3E22 PZ3((9\C#8FXF30V@6L;FP20+,=6N]##<.@J];1SH2"U2"U]
M]#<6!C:)C")A$1$3"4QA$1$3&*F1(HF'S$2I)))E$>H)ID('LD* 'TBO_%C_
M *D_UD3LK97MC$  "@0  "@7D H!HH$YQ4Y *'3E[PQE.76N<PFUS"(\)](K
M%L-_N3_3@91N#X&,0'1N<H'*;D32V :'NTC*&23$0Z\B1EE3)EWRD,HH)0 3
MFVSI\0"YE3.>:7,]KF(LJ_M>TQZ(@.]E,.SE5'9=[4+XCE4'?F<OBW?*?[0>
M*<:'Z]7F7YTMF5AQR_-'[U7@RK-U>TQ(S$O2M'W_ *6.(A[^F];^[73?Z..#
MX^<P50'K4[>7>8];]$4I.%- >H+@&I57QU]L.,CS)J"<IA(;O16YBF$IA6,
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MG-E&;U@"[CML\>W?) RIDS, :3#44+ L0]RY!',.+"(U<=<YW/B8^@G.Y\3
MX'.Y\3 YW/B8]Y!$PG$YN<R(MS&,8>8S?NSI"@81#9D!2442%(1Y!3.<G+RF
M, S$SE"LQ9!H76L@G:MXIRN'89W!D)JSI,L'<VE\S'H) !S*@"?>**E644
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M=.110FN4Y@$RI^R/ 1%TDS[:_P!I7QCTI2D*4A  A" 0"D* %*4"?8 I0T
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MCY'EI&T'J#6XHTZ'L)SR<4D=T-6EZ/)BOZ=>220G(=VO[X#3VWIXPP] [/\
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M) (,6F) (W$XMR 4R/+RMQ44%$H;!+O#B0"\QA%OT3,)HD#^;+5_4GS>(SZ
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M7K'2X!M*-U69$B0DN9N8I41+P6YZTN/-^QF$(]>5N_X::,0T+*N?23Y&</\
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M8=!$W0 Z#Y"(?#>]:Z"(>8=!V'$DE2)BGZJ@-\I#BN]P'/DQ6Q4W&89*B2L
M)S..E!TU=/M;LUB#0]LU"??WYO08RO34?676/#(3BTHYF0B:G:H2Z2DG;;76
M:@UE)I@#.4K2<>JR:.1$B=IBDY *EZ'1!+7DRI:PZ4!J"PJS@DN#J')!U 2$
MAHY?%^D^)PRBDJ42"7JNCD,"^)31K,!N7+O*7&UR-?\ 'U#OQ(I_"$N=8KUA
M]#/^\*_B'*T2*BS>0(<0.":Y]*+%.'*JILYP$=;QPI IU2'JV4I-&=Q=V<:4
M<N8Z&3B\6HBJE6H>DH"Q8]8L0[ D]NKN"&^;XE$-@/7SZ= 'RUH?OWPKR@*I
M0.Y(%7J'T^^-20O&* <9G&HFFH>HK8^V"5XX7%77.</_ (C^_P!X>U]GIO\
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MI0*T,W6;0%@6%:>-J).YB(]CS!F"1:LKQ4CP[^ H$O8&=F9U8CM_5,@1"4'
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M]8;9!'O<H\Q#=RES)E,5,W=DYB%.=-0Y2#K92G4224,!1 #'23,("8A1 @C
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MB(N)R5HFCHB9:0!U99*4&B;A( =Z^,,KF:.D7[2L^CXU[)^%])F> U*<XIB
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M&V?KVYF@WU-WZ=P+?X.AU"'[*3;5Y5UCC]#3/YOR?_=4OWN$^>X7]5*\)/\
M2A?IO _:E?[O^LA&26'X.;GH>T2&/7#^=@C1AHJ0&,? V5-"O D(8734ZHE.
M>)??PZ,$Y1\"[$7+44EQYAG1QB4 \G\V6/Z()0"11^I-!8&C.+=PHKQG#UTQ
M",+,+$CI429K.S>NH@U#U&]B 2L AIPQA.,#+"/-S"8&J8B)^?O.;F 1Z\X@
M<1WOO  ^]\.7QB0H$8AYO^>*)@HS>O-(I3LI"R\=@I=,*,-);26),LMK^C6-
M=_OKL]$2_,&H"6#WAMLB ^7]HB&O,H^0  ]-LD8S!S$YE29*E@@YE(DJ-RS*
M*W%!I^,7IOI!A53@RY>S!2'MI^>-KM\8?GL\1LHA99]9Q'+M2>AQ .\(8 Y?
M31M$$#"(  ";6@Z:V(>6N.+](,>E2EI44D6"%$$#K"R2M@&>GVFWCS?Y1N-2
M%8>4RT.FJ>M+%5(4D.1.(LH%P-M"QER5-4HZ[@^OB/F(?'FZ!Y"(>7PZ=!'C
MCT8N0BN26%/]E!;N*@3RH&<UCQ7!SB"#,4%CFK,!4O0G47WWT@JE8%I.,CLY
M6."19JG;JJM5$">'46::!HHH@<#)&4;:_@YS%$4"C]6)?(7''*5^C6L4#A*U
M)#AV]68?-@\79F)E)-!+#4IE(;:B@Q^'*$B;#M /?C9+-1&!\@F*0/3IVCPS
M_ODXA6 )-"R%46PV8D$LK"%EA.,B6)44C0<@R.= ;LSC25Z-6S@:T-)OMI31
MS%7I,&Q*)4A-RZ42D@$]GC#A&27'H5$0*'EUT(?I]K^[7NZCQF3,<%%W+G5P
M7&Q 7X5^$.,X#U"!KH&ML:VO0PU^:TET<47H>Y4$0@!,76PT;VAV'\TPB >U
MY_I\^I]'ER_I&4R0+6 W;?=AI:EH\[^5R8C^#W%L 3DFUZM3G7KFL!0W:H+1
M5@7[0>?F/3] AU_7Q]$8HD<-ED$BB*@M]8;1^:F,ZW#)QT:73?\ C"+]E>^/
M-CLX[':A.Z4'8[.G_1G'S,3_ %#;+\N!1-<I8DT8MJ-N5VA#GE@$*6#<L2+;
M,W8.^/0Z]1'8@+@0YQWRF=&$[DQ/AX@PB980ZJG$PJ<PCOBJHSP>K,G@$. E
M:P!4[:O7L:)$<6Q$H =-B*"C3%LS_P"<%7C5W90*F02$$J)>1$A2@)4R\_><
MJ9=:(4#Z4T4  #[-K?7BR"^C;N&W'C0=T/Q6*#5(KS#5J7=5S[7YQK<BFFT<
M%=$*J7P70"E Q?+?V>I0ZZZ 'EORUO@%S<,2'-#1AR?4O3W1'AI\I0JE%P"2
ME-:D6)/;O?5HFQV?[EBPV#L.C49B)B:Q^#2L.*\VDI)RJ];P_H8HBS=\X[\0
M&]<I@ P"'0!#CQ_B/ ,?-45S3-F*<G,HS5,Y+_X A+LP2& H&%(^I^'^D> E
MY0K%2P  ^:=*47#M><*D(U<"UWAX0NE1 =>M]9T'O]-M/A__ $0$0'X:\PWQ
M0D^C^.4,I,XC0'IBFC:&0U-&;WQI3O2GARJ#%RTDZIQ$D.S6RXEV:Y>MCR0]
MVC,.9)9,HF\NJE86<:NO(1S<9HL6Y8&=1[V+=*,GK>P]XT.YC)*2CUS('3%5
MA(/6BHF;.ETU'(X%Q&5^CF8F6XM*F8B62^A*9('<2T,_*/AE7G8:@H\R1J!<
MB==J5[MPK&%CH$4T8L(NS4^-8QC1JPC63"58,VD>Q8D[IDR8MV[=-%HT9I_5
MM6Z!$T6Y/82(0O3A5\"XA,I,FXF8-EG$+_XI1AWY2<*_7X7]J1S_ .\<SXF-
MQ[K4MB'K771U[RS3, W]PI  _=KS >,W$^CO$$3DDSYX +UF8@/0;X>H;8M?
ML"3O3#@\P@ X(%J9AA\S:M_&:@UT%-X??L?9MBYS.^6</,(F >-*UBK&U]/>
M&KM%S*OG5AM>08 U9F?J$VJ"D8C )RB+5JL=%%:7?+$3*=VL<_T#\G<K$X?!
MJ1,7-"NB3UE+4]%)#=8 #-<B] 12+F!XEA,9F,I$@C*[I3+H 0&ZJU!B5..S
M=WM5X]>C5BO.N?2 XDE)[M$L+(VL="JO9J=N$+Y;)MHFY4CVT6[&'?K6*IMM
MVZD-GCXHR=8<6BNM(NVTXY)N,.T>=XBF?AL.W7MV)T#PC_?SU;V_':.&[_2!
M8]J5@SU6F$,:SJ8"B'*<FBC-I1KNVW)J>MR$[5*RR6:^%DD*:QLT'ZQ'1,M9
M?X89O#U!VD)Q6'VOV]G[_A!V_=YI[MX<*C=L+'-HP1C_ #C8'*\,RR%99ZHU
MR&I:<MF!_8K%4YBR-Y)K4 I-=E9ZQ1"D+2K-,+O J<?(%K;-25D&U9DR*D*$
MB]J<K^RY\.Z 6W[7M^ \3WPHI'M?X#CW3*.C;NK9Y=?'M;RM'Q5(K]JN4I(4
MB[6.N56L2D5%5.-F2O4K/*7&OH5N.4,X514D&J[Y%ND05DQ_+;!V+,Q(W:IK
M"^/[]:^/NA_X&P-K/!-9])O+1\<]8LI--G8X65JLND0Q.98DK7K3&1LE#&YR
MF!1-^HN<0!01#90YB <_W<_/LO"'S=EJ,PAC.QY-GF4Q+QM?;M"-8>'52],3
M<M+RD56ZY!QQ5#D0%6QRDHU(1^]6*2*44%140-ONCSI['OW:/H\!;7W^UQRW
MIK=HC!!]L"ZO\FTW$\C2,6+VV9RA9L>61"B]H>,R!ZE$CL4.LLQCR:1BZ4QD
MV+ITS@[! %C;=6*^Z_@+*7%0R$J'>GMJWW^3W7A/9YYTWWA98%[3=]ROD1[0
M[;B^#HG@</4?+9WT9DY>Y)N$\AW.ZTZ)ADCN,=4SD<(.Z)-G+S&T;OF1  @F
M3$IY\]O[J0H(T[@0"]0=MM1V'6)N<$$#@@AILK7&T47'5UMM4K\=;)^J5F?L
MS&M25F4JZ$\>$C!EE&7I48*U&8E.F4$P J"@>UT*0ARB0\^;06UY^;MYTBO*
MP?2,V: IAL@NL2U"MP#2[XTQC9RY2S@YQU(X_OMJM]DHET@\CD>8PE:S3&^/
MK+$IF923B>>%O%;?QLZU$6YDS\ K^+>?W0/R]^GQNU^0J(G_ (0R8_R[B;'^
M2)"J35#DKQ58*Q.:A87+966@23213I$468G5:.AT<%"& P )3$V/M !R#N]_
M=Y_"'GX((3TL[D&\>\5C447,DFS?.&S)XZ5;)*N4P 4T#.4@$O( B)1UU*&C
M ) T)3SY>%IKMH-AY>(+8O[?N,K33\52U_2E,<V[)^.8+)R<$VC+]=:M 52R
M%M;BM.'.2XZBHU)])RL;57Q#1R39-PI)@*:*)U"D*8!=CHYT%0[:,]CKV-#;
M _$EN\]STYEX7T-VX< 3ZL"A&6.XF<6AM%OX1 ^,<F H^8V!]?6,([5*>IF.
MR:/9/'=L8(IE3)("+9D0P)B9,!7ENW=[O@Q\!]1;W^#^YW]J11^D8[)0-XA:
M3RT^JJ,_75+;'%O-"O\ 0EAK)F-EFHN=<C<Z]!G8L;,RK4VG ++"F2R$8E]6
M2)')S%50(:W=V#?S=R;E=!>HK^#?&X,.5V:,\R^=ZK=['*P2]:]6,KW_ !Y&
M,UXNSUMY*0E5/&@PGW4#?8>'GHUXZ)*(=XS4*FGLQ#%,< %,L"[)[^S3V>^
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M8\[^5?$E7R?8MG R3F[YJRXZUPP[*14,4.OQ'F-]X@ #_P"1X^H%C/PS#O\
M803XC=[:<GC\\)Q!X1,41<R]-.G&_P 8(K!8(FL0SZR3CTD=$QB'BWL@9,JB
M29-#T%H(BF!1Y1'J4 #?Z11!"BYT'ON=2_>26):\32Y?3Y0'<A(N22X%/54.
M]RYJ'O##6?M)56MR, "$-.O*\\E'D/;K$XCK##*4*3B$8I1PA+1LS"N0< <D
MRA,'+))U,#Q)0$P=WH!N(D@@.*^P, &/5J:@N<K=E8TI7 %3@X27H10D=:K
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MR2O/7.[7MU;&AY;TV:&.K99=VI6&!_\ F,S..,1 S$/!F2.@($XTT<54EAF
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M.B4  6  SG1O!J0<>KDW_HMY_P!D3AWS^1M*\$?TX;]*2/Y'^Q_61THQ$PF
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M<&9UJN>(*=F:X1..;0Z\=&R<*\D6@2;5=1J]0.H\*9OSB<9QNHR.)QYC&C)
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M1E4ITA!C*4*Q(.BP-NGD0K\>TE)+U1G)4"GZ"1P*;- )#N$GJJ*Z* (/4E+
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MABE(EHG3%KF+Z.6GI)KF8HLD K40 5%G4H)%"2P)#NGD)23]$2.JD/GX>EF
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M#F,;J;O 'R9C/0W&%@M:U,&ZXQ2B26>^"+L&":Z ,PJ["_*IP(9NDQ6!))<
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M<V.MKGGMII[/=V*BJ?2'8\M3NEH-,;Y72?W%:KLXQN*^*7XHK7%WE-H@H_\
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M2I8=DAV<%1*@JPZ$YDLEE$ A)*0IBI+R8S%)60E3OL+J8@,25:$EM&%#4E/
M&?XE;$1<O)5F<?1;TQU4(.+L>,K/XI@$D>'&:D;'6KO9,>LJI&KK*'F[4I?
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M4W.E*M$T@#0Z#S^(^0?+8?/0Z^'7CS?#X,SRP!(T&I-&+9"Z=.V/GN;.*A[
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M4\E46Q'SN.29Q,4T28K.#M4V\8P1*D"3%L4E%>-Q,U8.(Q$^<!1YLV9,!#N
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M!M2%%+N1*6=C"@*/EW(@! #NM=.[^Q\N(ORLP?\ DOVI7]?%?^!WC7^,8O\
MUV,_Y9'OX&\A_P"A&W[=C?W.$_*O!;2?&5_7PO\  ]QO_&<9_K\;_P MA_J)
M3;' U6-8R<>1)=#G$Z95P5^V8%#_ )0[$Z@=X;8CLXE.;VN.4Q7$Y,U!"PB8
MPH9F1>VI60 7#L*,0Q,>B\&]#>)X%DRU8F2 LN$&?+<$ZI&%0*N=*L6=Z+,:
M_)]!!N7?Q%0N_+WZZ:^&QWUXY]>-ERU'HPE#4:6,K:D@I6#5^W30QT<S@.+8
M/TI40'5^<*NT*,ESL;T-X:6]]GNMY(MN.;?;HTLLZQJ_;SM2AE0@%&"-C9R"
M<NSE7)EF9[1XEG*(IR;>M _"'1D$DGJ2)'1"J!?P?&2D@HF*0P/JS"EJ$&TT
M%U-4/5R2Q  ;^3F,('Z5A_G'JY%>@=N9+!MWC/%6 *UB)&Z*TV+(:0R#:0LM
MYF%@@$7<U/%:"P*J\"MLV%7B&I6( R+X%D0I6HBW_D@Y>#&\;4NDR;,F!F 6
MLJRI)LG\\0 Y)84HHU<NGY.8L4_.$F_Z4U_U 4"WDD0ZP04D(#_!0#W#HVM_
M< CO[]AQ71C)0+IR;DD);07"P1W<XCD<!QI#*Z6CW,TGD*2C[+:P23M-L4R@
MU1CF"2PH#S'$ZX)")O<<P[#9@\A$0'RZ=>-*5Q24@!RFFRD@/<4,T'L\D9^.
M]'\6 ?TI))N9MZL_YBM#VLU6A*_@KN7^C$Q^YX(C_4.^!/'Y=^D0&/VTM_\
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ML"G4Q.(2 * 4"1HSLVUR844+BQ]7HM"#@(2-BXMJ4"M6;,$&31N4#]X!&[9
MB2*0=YH_*F0H=X '^T "%CZ0DEFRV9CEUJ2/SF[UO74L]4\'Q*B,RIJC<%2E
MFO,F5S[*GG'4[I$\9LX\0S1%OX(.IG("7?W&'6_/]8>[H!])2ALSD '+:H<L
MLN&8/>A U,*G@^)'JJFI>M#,!UVE-3]^C(S%U((^QK1G=$8G-2'-5K+ZH&D7
M(GD%:ZI"E _I ZAA44>J?E**")A  YS:^RW%X[#@ !*&;0(%@X)!7?0@U)+W
MI$ZN!XQ=%KFJS#-UU357'6O)8,'( -[.3#@AC^R]=,T1'Y. #7SZ>?N^7N'B
MO(XC+)H3W% '@%N;_?O")X#BI9!2J<@<ND&[NTH=U.[=/V3!X7>+- VZKQ=C
MB3.&SP[*2!J^9'=,G NV;DS-XFL@9RU=B+ILN9/O$%Q%9,Q5=FXG3Q?"APE$
MM*2[,)2;W8B9J#45\*0J.!8Q-9:IJ"1=!FHH0R@2)0>G5-W#AH._P>VC_-4/
M^\\(>-80W3*/;T1]\R&JX)BU>LJ8K^<J<??+,= 4*R$\V* B/F(+]1^(]1V'
M]X (![PI8K'8?,GHP)8?Z@0FM/LKT[SM41%C?1K'S)H*YF(4!HJ9.9J&@5AP
M]1W1/'Z.&VFC<KYKPX^K3**EX7'V,<@*6XT@V\9*-+%-WJ 1KRZ[1L4#(1!:
MZE)HM>],BW<33U<B9%'BYU/3O1+%(FX=25$$Y K,Z4D,0"E\R[Y@2&HPKH?9
M/0/"3L'AIDE="J4A06I:DMD(2I+F6'S%0+?5"!>IB\SCL(];B*U0[56!;U'V
MF<A<G0<1!4QY')34Y9N^IM?(C+BX-#V2.G+D$-$V2DVWT1(EJMMKZ(1,J$=)
MC&3C<3', XKR\^/;IW0.2WBW=2]ARN3?5W7=9.QZRF9V'<Y&I2$I7ZX6U3T(
MI9X4DK UI P&3L<A%)JG?1,"874?N:?'7BA*NR*5N4\H4ZYSWM!1V>K>?//F
M'.XBQPM@A$K3#343-5A^V!XQG(QVSDXQRU2%,4W:<DDJFD=*,.W?>/,Z6 R0
MI&*MHY#I@;,="]]S]U_#0N7/(-<TT[[N6O=H*(W(=&E9LM<87RM/YQ6$):6L
M&RL,0I)&K9T61BRI8U)0[@(8R;IO)DDP5\8#)^T/WQDET@%:?O['Y5[FU=H2
MO[F>^U:4.KBUX5L7+QTW'-9B(DX^6B9!L#J/DVCY)RP?D,!1\8P?-%5TS,1
MO0R1N3J(@(!U,D+YWA,Y!R!6<55&QWV]3J$-5JG&#*34BY%;G;MP551,=NW2
M$POG4DX7CXV)CDBF.:17221(HJ<J9U[M_/=XU@/;6[/S9NTUN6MWL-%]KBE/
M[14*V\HF::[8+U?)O'<%&V?&-DA5SR\-0&F4%E7@+M' ,8\*P"Z *"<I#2#"
M5()"*%,L8\\[>XW[O%'\Z:T[1;0/S-#7#?:GHF;+4YIM;@<EPDVRQ]$9+43N
MU*EZJFI5;%8K-4X,1!ZY5YWCJ0J\S]H.8X,A4$P&(8A$\V]WAI"ACN_N//2Q
MWY@M$J^""!P01X  'D !]P:_LX((9ZAYDQ[DF.MDW3[:TD8JC7&P4"T+KJBP
M+#V2M/&Z<@V=G>"D4$46R[>48/!TE-Q4BQ6(=8J@"9:>>^G?3LA*_<WA7NKV
M^$.P1<# !DPYT0 -J"(['YAS" C[OT#UUOHD+'5P000RS].+C7DF#=ZZ"-;^
M),UC4TEU%P HCRM4U@$##H!V!!)R@ B&]"/!!VW]L,3BWM,XER[6*%9Z]:XZ
M'5R77$+E6*G<5T:G>WE<?&GQBG3FI2JQWS0KL(!X83G,!% CGYA, D.D!Y\U
M[?9O""OM]A;X4O?:%<QS7AV7! \7EG&THF_1;N&QV-TKK\7Z3P9@8PQ&S*21
M%7QGHJ9Y>4!!48-^0W5JHHF#W\QY[_A _.V[EG[.=6%>51'L=F+%TOW2<!E/
M'LX+LDG(MO1EYKLP55DU*JN\?E=-I@@F:1[7GDY-("BC'QY5TX\01C.=-R4O
MH3NSDW?8L]0&H&K0PHKWML;[>'?;L3>%<[U//=<L]GI@/U8:K7ZVX_<R*KVM
MRC*0>T^32;.I&!E*W,V&MR$"X(*A2R!Y?QABE.54I5"I%/!B=F- 30%WH=0!
MXLVU3"@U<DW!HP \:4=W^YFA9F/+%)Q(W5LMZDEVK)]8&4+'M(F,G9J7F9.6
M#;=O!U^"AI]_9A)O8%CG34"=0#E\^/S[XQASBL:4T)5-F%)*@ <R]"I)!;3K
M"OC'L$K$R@$@.$Y0:A.9@ P(SI*5$G1)^L*6CFA\GXSL+N%A8*_TV5EIR$C[
M-$03*RQ*L^Y@I%H#MC8VU=</QD0A$(<?2""C]P613,'>D+L-A7XEP68G#(*2
M0"01ZS5*382V&A'6T85K&@G%(8431OLI#C11!#%1T2@@AQE(8'L5O] 3+:P]
M>Z8 T18OKCNQP(GI;TBK=,B%K9A-@$1RJ-Y:**$@$()91J8"Z4*80<GA1<N]
M&>]"2#7J$4J&ZKN#0FH<8AQ0!W>S*!S6(4&).51)S$!TAR7CH"Y4P9*$CB6R
MJJRUJ0!_5X]O98-Q)6UDX8H">6AREYFTO"RJ[:5C8P6)63X\JW$40%4#"FIX
M4ILSU+@)J2&"747DA)S.<H!S AR 6!9\\3F (H&)5E !&:9E0D)G%:5I9"ED
M@RREP Q.7)>ZTN/D9"+?VNM-)2-A@G9M@XLT,VEF<.'>?X42C+D(UCXK^,6H
M]\S ([9$P]&:(7E:>%*>B26>E000X=NB.I^J$IH' 8,Y.)0D-F) ]7-E(2&2
M"ERL$OE*LTPJ4<RCG (!YD[_ $,Y*^LA>:<IZX!X>G">SQ:/KDKWP)@:I^R
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M1;-)N#E6,Y$NS)_89,I6-208%?$U[/CV93E#J'4!X/HZ=6JC=FZ2^@I+!VN
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M9M#IV>Q!380DRNR6;$C26:WB,'6/2(R!6LF)CR@(P115XO87!3*@A794&O\
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M^*+*2!/6"02"%*( ))TFJ) +DD9DUN36%)&@)8APX!T:H+!PQ-CN]HDMA['
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M06 (* >OULE&.53J< JDA1ZHPH=-K5+;*(ECZO6H>OM$VC8D(AW3?HB@FC(
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M-/+/4;Y%LH)SUVA8Z/(-S&U[ B.^-V293)"TIR@H!HD^H4@DA2D$#49BG;.
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M!(40^N$3*]-?Y41$5/YXB(FV(\$$ J*)"E(1),A"D[LI2IE*4J?*0O=E*
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M.8I0;D3655$4#MV#5$@II/%7CO12'32^K34YP.FF'*4Q2].%.'GD.ZO%>A
M( <AV%B+"[0AFIU &I9J,6!)<:TK4EMHU" F3*<I#*)%$%DR)"H\2(ELNW9'
M+5V<)*/'D( %VHEHA0_)#3YN F((>C FCU!!:I0*:N*\JT7$S4S%  "M+ !Z
M:@DM5VJ3ONB[G+/(I!D+ B0B9URG[P-\Q>NP.(>9?+0#[OT<:. EA(<_6!%G
MJS &E#8TJ^HN.LX%P).-0A1 4.J2" 2SA_\  KU>O9=A"&];9;X(?]U+^[QJ
M_-SS]O\ 1CL_R-X=_B\G_5X?^S1Z%OF YM=R'.)S'TV .<Q_MB;I[0G_ "Q'
M8F]^^#YN>?M_HPOY'</_ %$G_5X?^S1@I<9E$"O5%FZ:23CQ9':_@&2+-UW3
MA '*LB[.02N!0=ND>^[P%03<N$Q$2K*@9,)@IRW()%"7)5V5!0;5HYH34 PG
MY,<-TE2P7_5X<=U,/5W&E'HPRML4M,V=1)8%47";PA%A*@FW<I.FI"%2(];N
MR@;F432133*J!MD33(F E*0H@W%<(F*J7Y!B=C5Y5 [C>@)!@_)CA9O*E,#K
M+D7%*#YN^Q<6%-C'GK7+<P@ MQZ^?<%'6] '76^FAV/N\PZ#Q)A\.HBH9NXT
M%0V4\F?D"'>+*O0GAI"E&5+H';HY%VHSX4_NA=8_EGTG,+(O56P"6* P%11(
M71A$0$W0.@B =1#K^@ XHXR2'(4 6227K:@'JL&-J<W!+1S7$O1OA^%"BF4F
MAJ F0 &!));#ILSY30"U8=H! =?ZOF(^7P_7\..8/YP]4&Y-M#V/7\8XD'K.
M!K9M.SE  2@0R8%^K,J"YB  =V9<#<P+"4/9%7FT;O!#GV #O8 /#5868H44
M0Y"F=0%=QE.E.Z%;8@-9RQ#L6/80[;QM$44TEQ4Y2F1%0RJI43-11%41.L9U
MZ3<D8&%4WM*F4':AMB<1$.EEEJH2H%V)JX)-CF(2'>P\(;6^_P!X^!]L:RG$
MQBG3,85"F,<ITQ07.!C'!0Q@,&S%,*A2J&-L#"< ,(\P /$?S52RX)>AHJHJ
M[GF[5.T.S:=5K5!.C&U#2FCB-;D1*@N;F$--.8NAUH0\Q^0^_8=?,1'AV#0%
M* ;47%02S$TT#]E(EQ<SYLC,X2-W:[U-4AV%*Q'WUEFP !%RT -;_D2=-CY"
M&@#8?K]WW]I@L(DH!"0: .0#H*50=1>I;E;E,3Z6*PRRGI"D 6*B.3%L2BM+
M?!HQ]99H1#;AOUWO:>AZ?I'_ ,@/%@\/27R@=N5)]R#L0S!MC&<CTNXFMATT
MP"MYF(?>CXGF_9'OK/-"*QP<H[T@"YA29B)P;B/A@ ?&<T3X8.B'I(4NY#VD
M^4.O$1X,M3E-':@S"VM);7+BPORBXGTGQY )F3*C54]Z]N(J^K7)#.YC$+;,
MI@F(K%(#@Q3$53:MED0,GT*8  ! .3H)#=#  !RB <1#A1=F/,@/78_F]R3?
M?6L5/RPXG3\[,-+9YX<,2S_.06-VL '.D9^LTQ_G+;_LR_W<.^B4_J_8?Z$'
MY8<1_6S?&?\ VB',KKDSN&9.WAN98^N8I1$!/[("/.(]1U[A'S]X\<UCDL =
M"*N;>L&.A#C6M[:=/P?CIGGKJ-2;JI?+0=*1>O8"-W/^[T " #KW=/:^>NO7
M7OZ[UOI\<_#U4 &U#&M[.W.S Z<XV<=Q42F8MJ2" 14,/TB=QXP 1 P&'1=*
M<PGV!?;$Z?='$W\[G2'NC";[28]V.R]!G1+7(?0D;$%B:FR;V/MO"8?B/3@&
MA8,$@ME9B'!66Y$:CO&)FR8D,0R:9DS%1(8@E()3%;CSMRF*("4Q$#^TB [!
M(W4G*;A5RUX@-4M6Q+L0QUM1CX6@Q'$>@K049B;O]EEIK:I(]QCT$Q'\D Z^
M_7E\>@Z_M'Y<5BX.A')W?P$4$<263ZRCWD[4]<_&.EJ!41]D.\$0 -B&Q 0W
MOJ/QZ;UT'0=>%!#OS-?@+.*^1%R7B%$5/B27&I]>XKLU;,(W\PAOS'IKWB/Z
M.OGQ%E2BH<<@U?<\6/G*& -]PW/7-&P!4$":.8 *F5,@<QO82*'L)%#\DA?R
M2![)?<'#ABBBG7I0=@T'6%-H/G$OG=_JWW]:\>B*PD$@ID,3G14[LP;**C<
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M9WRU&H *7(8$&J3S<$2ROX$[F.,(@8-\PAL!$3_SA^)PYA#?F @ >[C/P$K
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M?NZ^9=!YZ]_]O <+P_3%S0PI^?D@DN+LG:W-X>" 0,S$4ZA8 <]B]^4;C%*
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MXG5?'J,?#!Z*5?G. G4>.2@(=X?8FYM  B'%F?-Q"W*Y$Q1)J%2EN[!P0"P
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M&VF?R!'!6#/4VZ;P[6%EH"1DRLC+&;-E)SOB)$5=',;V?T+7T.%4E:"Y0FI
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M_1SS_OSG_B<:/Y \$^P?]1A/[/&G^7?'?UO^_P 9_:8 ]FO& @4!CG@@7?*
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MVI_B^$U<'_J]*'QBI.]+^+X@'-,(N/TV))V=S.-=?C2%.&):F'^2<_\ :A\
M#^;O^OWC\M9J/D8]$$5;%D\T<.^[A_E@S1CGC6*5<)_:7_2>,1Q14@/S"W<B
M<H'(4XJDYBE.H150I3=US%*HJDFH<H#HRB:9S;,0HA>E?)'Z*)8!.+&4&PP
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M*/\ M*/_ !$[_!G,)4.SCC .H1;KH(!KQJW7>_GQKRO03@2 /S+T_4X0,_\
M[.?",J>A,QLP>I-S][^_>.<.SIC(!V$8Y ?D\6#_ .[^SBHCT!X$@N)9/;)P
MIIM^@U@=.B #RI[@(VE[.&+N4P>B7/*JIWZA?&*@4ZP\OUQP ?:5]DOUAMG]
MD.O0-74>A'!D@$(=QK)PQ;722(<):2!0!ZT U[7/MC(>SEC$P !HQV8 (1,
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M/I)5.=786:6WR$^48MID'?JF(:IOQG_C2)4MK3BZ,;U_=O-M2=/ W-8[4Y>
MF(S2YL''V^_%U,Q< V-OE;4\G-\Y)@)049'>@I ^ >?EO)R7\W)>SLMY.2_G
MY;S\8_FV)J?MYN<'E^3C@_GR.IS>KO,Z^7CS!3G ^01X^?D :;D@N(.3)]0/
MX@A%;AIE& \Z'C!"W)UE&,U$=/AUX$I0-W?U$ 34*$37V"G$TTG"F5%.%D<Z
M2#+(&^X-]7. !'E[P7PE@V08SXQ+(NNG9#Y&R)F(GZ<,X]DF 6*NHP]1\D%
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M#WGH;ESEA"LUWO >D$<2454GWA3ASHJ6X1[U4H!)>^VV=6JZD^W2#9G5@FU
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M]Y:?P<N?W#MF>*IU%,XWR<,P+"'>2LCLGSY<Y<.VLJQCK3Q:YOZVQR75G[C
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M7='ZL*=L4O[V0>(LAYK$^O$WH(*T*.?UI6_ '([![A6Z<L,DI(1BNNMMANX
MG;RE&,PDUR@E(G@]G\R*B7X^C=J5>0/&(W?_2G^R<EYBG/J$B@<\MX4,&@^4
M!%,,<MXJ;_<K$(7B@#(^.>8Y=#0WY+@:T=AK&VF2'"JX,(.%F2.I8A/HU:A'
M.C%Y-7#(A22R AF[77*U )( U6^ A"?=G"GY9T;]!I]I'/4*EEE&E*W%EV/S
MJ<+],H--,VR M@ .7")WW*)4*JN8C3U33T<X-?\5E4+NC>!B?LAQO'T^4/>
MF]N$I#W_2;@X1UHY.90E' 3>MW@"IAS0A8C!C9PZ:1F+!9@4YYY'K-(I_7;K
MDUX#1EG]_KQ^-<$S8U>2.)C'<_Q3965J@"<9SZMK&>]4BFL1=S4WO4NX-)O5
M;T@D14?6C H7B[&/<SX9P>C,B:-M8.U0+L[2)2CHM0]\$-:N0$566T9D-: ;
M/+*#6@ LD86;\WO67A2R$:PT4=?)56%M4XR)"<E5GV:>F9W=*&./HW&Q$(JD
M[68!B$F5E1+A,#2:R>R=JJ/]KDY/'Y8.!DZ\B7U>^DGIRR<&M-#W%[HN; 0
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MV@CZP8,:4B7,]\-1E>C=0?>\PI[9&GG:18\FKQ;?4?#T27CF95B!%]4_K2]
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MV*WV3"@:F^C8;<1IE^>75 (<_*H%/C]T\HP ,D.3>_37'RM'0*G03$HTR<.
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MT,78G/^?+;6_;%-7%XN&>96F)?\^X63B,[L;@K.S5E)<]B$S,B. >CAN;8*
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MVU@IE]),XO7.-"HCE<M6PGKLZPJ_EAHUQZNL6!XQ'HCP/+'4IW;.AE$C4O$
M%Q^;5E!JZ9KU;.VATKW%W-"O$=ERY&3Q@,Q5E8_#MG+YP=S(MRZV80%B#PWG
MHV113>P97[H4WH(AD]K6ZA0-LEY>$<UD0]C]6=42G4K392K?%=$9N5(MOH*3
MEU-AB*J2+0V9O23-Y;E3(C&D86+)<J[SK[S'^X,.V*EAOXUAI?]4=*029MB1
M<<FM]_PG2Q<>V1!R^XD_DQ"<3(V7CXY,'9&-?A[*O[G-GQ=];X9^=Q?C?JPV
MU]]&)/6]Y06ML@4/HB_S8K-\[I"9C3MV?\N\*KJQL5&8V89?C^O][?Y($Y'(
M; Y;UVVJ92$77NO&)^/ Q+6!]W[0UN_+TB!3H>@J+[R=%^M\6 !D_7'=UY.K
MIB4?*L%$\D>_ A]'*X $BL/ X#1 0 A+)%/PS?;E3VS[YU^RR^\CC,/4%9%W
MY5$B:RN:MNEE:@\7]I2TC3AE%;SB;) <%5*1X2DJA/'E+I/5K>8QP.8,3Y(O
MZ6N\-!9%%$D.!1PJ=$@;$YT?V^4=F)DCN-P<5B<WW QV)''3EPW^1H-Y-.@]
M)UGEQ]^ YTP-?+2[[JU]S KAP9G]G=?4F!$<:0B<07:-X0;O0F#U\[M^83J$
M64RT-[^F>2HG490/\7_%/&'7M%76Y*XV3;IF5^L^IZNW^A''"/U,]%LL2-KS
M24+5,>=56"Q*L+RSVYDZ)'",]\+Z<SVK8'HH38R8J]\G[>&OGWAGGON)_1NI
M/U3STHY<LSXT.1;?2)K=S/QO4?8?ZZIE:4>>: C_3J/ZRT;O[-F3'UI \3=@
ME*R>=*O"[9!S)FB4]:ELK3-&,L=F1/I4?N17V]BK+6$I/\;2"[L=%3/;A<(U
MMB?<:GY6WVDE[=C/_:V1O"FB[!F%_RWRSGOMIZND/2UVW!%>]NU7'Z[W:KPZ
MO$%^D'R)T-137_J\-Q!8]Q+AP5'I^LK_/U@\UY;:-],N.*;X/]PHW[]$JGI_
MAL%7L[*.0O,^,.U)%+6>SCVG]=^$NET5WZ T2_&'?\O2P-\8#J5AY]\PS?ID
M]"C:>C];>8/U(-*=]'F=0&_F).KB)#I\/W]\.V6V71P\;/\^(]16R-T,#,"Q
M:$"EPK/(?;&75-DHS?<FT$\3=G,@?VC:ZTTA%^HHM"#[8U>L%Q8K7Q5K9P*J
MBJ57Q[AD@D9'[/DKN^HAT:\_HKJV?T38>W#A9_HUU1Y,E9+[,7_\]NY7[-,_
MM\.R_?S7 >J_G'!C#%[9M6]0/"3;PY?UU+]5\Y7<>,W=TA8E6$VZ_@9>9_]M
M.:/_!D')O[S6_%_:MD:CX"V><$:'Q_3X ^__C&C+%_CKFZ9_.8 OHW]G43!*
MQ1,N(Q_NK.['=XS?0/NMN5E_5,8!P)]M2X87#? .2*1=RK?46PO"73&IO&'"
MG-1I1/ZB'[BB]1+G2'=T?GCD)7;VQ.VA6!QKB^5S"*E0__1=34(KA2;3P;9
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MR(M+$D]!]GO7(!B#$BI4!CQ7[LT=+">]GP%,\L3DX1VG#@>@$C/#*?W:-7\
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MD*)UZ79&"\OZOK*B@O05RT0][/#$:.XS[;H&*JUCO?W/A+@HG[F1$1 C5\-
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MPYL95BF7"ST#(#4VG$I*4^G=-G.--L*([,A!Y"Q*?)-T7:1O56JP 1E83@[
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M3LR+[ 'EPX,%2X..R=#M20 PO@K)-T <;*!IH!M0LZ=Q0\%@1S+$OP$TQ!Q
M6ROR&V@&-@!JRLK*<&4U.%Q-2U5%54MWO)K:>-W)$R;H3I@P64M-3(.7L0FF
MKJJJKJ&NJ:&AJ:.AH:$C.FGH2%RT_DZ @:N EC*4;IH\# G(:<'DM6 #K5!#
MX0,5,%LH2P68F ;+* _ Y,8I*"HIPU5483\K88"<O%2I"<#&P>3EQLDI*"DJ
M*\BKX2&EEORX&=I8!4!&,I*1C&0D(QG)2$;#:>"IS98PH9!'1*,Y A.*Z(71
MA,IEHV,I/#36!(,&K&QC>11J!"A$A(+0ML4:^;;T"A+!I%DC \S(&#+/$0QC
M+HSG@S[Q'K[4^ BJ)0UI:Z-B%4N,9?/8H)""B&6S. )BK#52')P(W8O$:"1"
M;"*,L$:*7U,1@60OA".7#R(()A@4%8/!(<PM3; $4U,+B_D(' :'06/,T5@,
M"H<C8@A$,SQBD) V*M#9BD^C$[V=7 ;A(,X:.=BNF)@8DQB\"9?/0&,M+2W1
M&!P:AT-!%BA!'$=(B45Q!(:2(-(X3J" RF>*OP(A1#P%VG4)K9%(%<0PD@#Q
M:/38(:01%11IH!+BT6.Y02T?VTM:]U]@_1+JET@TZI /#]K<B<M HZ)!%L@&
M.4(!Y(?]589D\K_.D<T>TU,@=(X6_FM/@6C+A?8&!=PH/A5TCH8R,1P[E#?X
MBS:/'0HR'S,03_KY]!<%E*HEM;?Y$<%*U(U$>R]?-W]G;QLL5"T3C D.A\5;
M(KSX7-%!BZ**!@H*C[-"CS >%@0J)M&1#T+;?"?HL(%&,QZ%P:/P&%\<EFB&
M)9I:H##F1 S&"OV3Y5@QH TKM)NV$9TBF$+$L%%.@3*)!J$D1(T:%FO0XZ=@
M9"Z-28\;F1#6%XLGBG(RFX<Q(^('$QIF^7,,:"K3*$+*WXHRW'9DA8F2.H+\
MO]&J$>;#PM"H1#J7SZ8(;9AL"@-$@SP!W0K]0SHR<S*92.((A!2.Z"..#20P
M83)I1+PEWL+"U,(,%6II;H$R#S7%H"B6. P*0P--S2AF&$O0 A0W9J3[J-!.
M7&J4:'I!.LFJ1^-2H?!#PXQ(Q5B 6%.0@C+%@004'6-*@8#,0!0=3\>:8BWQ
M=%RHN11H6+!10))O2136,!M16V@06"AH888U#[5 8;%T,Y0EUI2*LL!C35%F
MYC@*B"?@J30*30HQ1IA14 N9 F@@Q=F,F%WBY=('C!PIE2I83/'RR:/P!>(/
M6=9(Z3Q%CG(0^8A7#B)%/)]L!)1H$$IPA.S73LS1G?GW"C#*_=<8,6$@9_0@
M-\5+!_DPJU\'$7#IPA@*'[1G0'6VD3SZ?OQR!X<SP2!F!S Y-&Z,8(XTY$B?
M7\>FAE$X#)!F@Y8Z2@6C>@<MZ9[_B]U&,*<1S*E0C^$M"'04]/R'I@:!2D&!
M((6.P>)QT.SX3W3;C[5)UFU0%U&Y'-%7U7^CZR <"O0F!_(%-G0^EXV@\'@L
M)I4B\D)'<VB#3]>A)0\AY"*&+\RC@OP7&TL#^<Q_9Y0.RW*H3HC_;XW^QQ/S
M[ST<91/S)^G(IZ/TB3OZ:2I]=9",31?1Z/I[G6TE?DO^)TOI3^YC1:?];U\P
M1KF/%9W[3U]C?AEF=.6'%7C$6^C0NYGX=T+0*R]H@[5"CR66;A71/^T5)1M1
M].!.%-H$HX=VP6,-LO\\R4!D(#(0&8@,1 8B Y&!R$!D(#(0&8@,1 8B Y&!
MR$!D(#(0&8@,1 8B Y&!R$!D(#(0&8@,1 8B Y&!R$!D(#(0&8@,1 8B Y&!
MR$!D(#(0&8@,1 ;R'P91^?'_RD$.S1H9@[2U&6@&' '8/Z2!JX"J,H  +L-@
M6L! !3 - .3D83#)W\V3$%Q)6451#C9. 5+/%OWI()$>.DML%.3'*2K!Y)3A
M@(Z6MN[$"9-FJ.AA!QX!RI 18 O\6563$]EYQ\*?;S( Z(;D&B;+?<R>Y74C
M/R[+I7P .',CN%73QZ?ZM-$%TD6_U&KZ%[J%G6=75TI(Q]&,X$F:2@H!AK^]
M][$U[I]41 N"UQ<- -%3?9:TG@_PG?9UH;\JUL?OR_>#E]L:CTZK(I8@]WXB
M9UXYJ77F"7Q_G?OI+J95B</QH"NUN6>.//W\N?],\.5(?\'EE%L-\R]>.FY/
MBTHKR"/[.F8Y[-<SS2D_LJ%MAV7GIS?)J?>#(E< ^J?@IY.M'YN@'1PR6-C^
MMT*WB9N>=WCW=ZJ,WX-PRM-(/M_5'SYNCG6?8.;O,X]0;S7ZD 7%>JJD9_U6
M!+\U]SZ9:N@5?CCC5WNRD%Y2&G'</_%,9%P<[?;"T)UWP%LY"53VU >3"E?0
M#U3,=6N_83F#HK.A3AB9@N^W6O]'T>LY<*-K3]E*E3XID^IP"MC93H@,VJ/S
M)_>%5F77%6XZ,G,&_=8Z3=\*J]*Z<5NNP[>%M#9_?HK3ZKL.LT%HU>>DQ;Z;
M@Y3+O,#*OO;G F;)O%-W5ZU*<$-:[Y=+>#SQ@99CJ,;X/$>O;?/XSXH>+0RD
M61F X:2;Z?F=?75W*FXHO. K\^0%O?"C X!Z4K)]8H#[ %!++KE0LF:ZB 0?
M;K#\E:98XC-)=M>RM;:GJR]LPZU_?M753LE@ZYO@7;BPW*0C21JT5NL'PMZN
MG<L.[SXP.V=_5[Z@#T;JT=6MCU1@::RZD.M6K+&.@5CN%G[C='S4=%;D@>BM
MK4E"?X)="N'Z,M/5U^N?/_ S9Q+BZQ+JRSVT_HQ#VJV:Z04_Y;0S%\!6-V48
MIV?.[9R(O+91\W:H@HIV_'/AW;"K*R=VE49W)O20%#MGYQR(.+ZO%A_\,F9?
M9'[NP<N]P<=>+UN]?%[.6X%UEM\'M60Z,JSC.;VBVN6+R:W?#8F'._(2+39_
M[(B_7X':]^%5)<5ELRT"X7WSHAN*9E#4O67/ELN=;?:$'7K^>M&>$S>W\Y*>
MGU;*F*I=8=C CLY3=K>U.#+)X<C<"39++0K?5=L&>^/6U92%E+JLV5;CJ*"B
MIHA9=\0I<+/&K!W9SFXZT:UKZQ+W9I7N.5-M$YU-7E) ?SAK*E'8YGN7LWYE
M3LY^X^/-U*VY>4MKWZYS11&C$S2+YC%7^CV^?F*;)7##?9%#7>X#QR +C5C\
M'NK"F4TIQJD!K84;,2F5^?JGOOH[D\V.M7YL+C3PGJ:V^5Z1H+FQN\"A"7=6
M?:8VRT_HY[.DP:%*NR"_;/VE19OF33L3<1+'L'M*GX+X%(2*)VMA*1[+*==V
M[^O\T-(7&=_UN,^3&SSI;JV 45VG4G_@"*6E-\"I9FU&P_G/E>=3.E/C[KBH
M%-"V!>SNT4F@.;TX&+B7U'EAZL8B:M",S8=?+UUF]"6PI>A!3E_:-1.%J5US
M]=,O^AF_F>),\HYR[(K(;4-<T2TKN6B&NM S '@_< XJ??BX?X[!.G<=G093
M+5+-@W#:>M6JFX_'9[\N*WQM<G\_ROI5Y#DP_X210/=:XP[S;ZH+<-[)2VHB
M/ORU9>J>L&>&DQ\'L'5G+7'ZE//\K!T"V6#377XN[.*7B<'NUAOO1IF4I: P
M'7#%K"^"&ROB%>JTU^F?\SU>__V/5ZXOG_0H5[\.RN>W+[':Y+]X2>V\)^PI
MI<AV:L3&:N&]U4F3G/,$QDO]$VQO]/X6*N=^+,'OH5EM8S26-E\3JYP:F9]^
M?F[1J:8/;0#.R2-Q17[W5X&)Z].,P+@OQ!,'SQY=S(A/>=F[(+"^3R'Q?D-L
MK+%SQ&3_U-B[B1^KV(2,9XX;%(W5-U95[=P_2>O(A]/>N"#E >#]V<O^-PN,
M'>I)03U7IAMYO.FT];K(0=T+&J^?%M<X8>?)ZG4/G\@5%[W,#F[FSV[A$UH_
M;G"')U=45.PEI2^,XD^Q&A?'.#7_:4>TY=RG-[^>*>A^A]__;7&.W8W^\X<-
M,QO/?[_&OB3T=+(NN+5\77R9F?[R95E>"VM@4ZY/*\\(@27Y&^MNGC8[XYIB
MS>[P%T?4FY\>*LG[_'7'H=K07:D&5)K';5Q:>8@6]2-IU8:,DL-64^DF<^H*
MCQW*._\7^>3[U(,+@E=!;3 M_H;-_+[W2W@<_MP?M/OGC6DM:'IVWYO<>L<Z
M,P4_M(57>O^: YE NH-E/W%SS-&%F#2]7?[;,;N=3H>LN<;.VK>U@QA2G1B
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M!U!+ 0(4 Q0    ( )R*7E>J]AQC?AH  .@D 0 0              "  0
M  !A8FPM,C R,S V,S N>'-D4$L! A0#%     @ G(I>5SO5-&1W%   _VT!
M !0              ( !K!H  &%B;"TR,#(S,#8S,%]C86PN>&UL4$L! A0#
M%     @ G(I>5W@K \PJ8P  Z)T& !0              ( !52\  &%B;"TR
M,#(S,#8S,%]D968N>&UL4$L! A0#%     @ G(I>5V;9OP&/C0  <P$) !0
M             ( !L9(  &%B;"TR,#(S,#8S,%]L86(N>&UL4$L! A0#%
M  @ G(I>5S'\P?\1>   Y8@( !0              ( !<B ! &%B;"TR,#(S
M,#8S,%]P<F4N>&UL4$L! A0#%     @ G(I>5ZN4IJ\O @  '@4  !$
M         ( !M9@! &0T,C,R-C!D97@R,S$N:'1M4$L! A0#%     @ G(I>
M5\# M?$W @  ,@4  !$              ( !$YL! &0T,C,R-C!D97@R,S(N
M:'1M4$L! A0#%     @ G(I>5YPODZ"% P  >0@  !$              ( !
M>9T! &0T,C,R-C!D97@R,S,N:'1M4$L! A0#%     @ G(I>5WME%89 J 4
M(@%'  \              ( !+:$! &0T,C,R-C!D<S%A+FAT;5!+ 0(4 Q0
M   ( )R*7E?DB@V182X  -_!   1              "  9I)!P!G-#(S,C8P
M9S Q>3 S+FIP9U!+ 0(4 Q0    ( )R*7E=S^;1;+$X  #Z;   1
M      "  2IX!P!G-#(S,C8P9S$P83 Q+FIP9U!+ 0(4 Q0    ( )R*7E=Z
MLQZ/8,@  -0F 0 1              "  87&!P!G-#(S,C8P9S$P83 R+FIP
M9U!+ 0(4 Q0    ( )R*7E>LIUS7BJ4  ,7^   1              "  12/
M" !G-#(S,C8P9S$P83 S+FIP9U!+ 0(4 Q0    ( )R*7E='I'7)A4<! (&8
M 0 1              "  <TT"0!G-#(S,C8P9S$P83 T+FIP9U!+ 0(4 Q0
M   ( )R*7E>I)%;"5-X  !,P 0 1              "  8%\"@!G-#(S,C8P
M9S$P83 U+FIP9U!+ 0(4 Q0    ( )R*7E=0Z*]$)/\  -51 0 1
M      "  01;"P!G-#(S,C8P9S$P83 V+FIP9U!+ 0(4 Q0    ( )R*7E=I
M8?O>L-D  #Y. 0 1              "  5=:# !G-#(S,C8P9S(Q9S8T+FIP
M9U!+ 0(4 Q0    ( )R*7E?'$?V![\<  /,> 0 1              "  38T
M#0!G-#(S,C8P9S(R9S4Y+FIP9U!+ 0(4 Q0    ( )R*7E?/?T(P>ZD! ";Y
M 0 1              "  53\#0!G-#(S,C8P9S(R9S8S+FIP9U!+ 0(4 Q0
M   ( )R*7E>6%4X_0[@  &@( 0 1              "  ?ZE#P!G-#(S,C8P
M9S(R9S8T+FIP9U!+ 0(4 Q0    ( )R*7E<I>CM'O1<  'I?   1
M      "  7!>$ !G-#(S,C8P9S,W;C,W+FIP9U!+!08     %0 5 #0%  !<
%=A     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
